Citrus Sinensis ID: 040294

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360
Protein Sequence
YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRATELPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP
Secondary Structure (PSIPRED)
ccccccccccccccccccccHHcccccccccccccccccccccccccccccccccccccHHHHccccccEEEccccccccccHHHHHccccccEEEcccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccEEHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEEccccEEEEEEEccccEEEEEEEHHHHHHHHcccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccEEEEccccccccccccccccEEEEEcccEEEccc
Secondary Structure Prediction (SSPRO)
ccccccEEEcccccccccccHHHcccccccEEEccccccccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHccccccccccccccccccccEEcHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccHHcccccccEEEEEEEcccccccc
Coil and Loop (DISEMBL)
YLAALFQLdlrgnklsgsiptcFSNLTALRNLHLDSNELRHLVLTRtdfsrnnllgdipttIQGLKSLQFLSLghnrlqgsipnsfdDLVSLesldlsnnnlseiIPLSLEKLLlegeiprggpftkfssksfigndllcgspnlqvppcksnkpiILALKFGLISRCQKRatelpnvanmqpqasRRRFSYLELLRAtngfsannligrgsfGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLhfgfstpiihcdlkphnvllddnIVAHLSDFGIaklltgedqsmtQTQTLATIGYMAP
Flexible Loop (DISEMBL)
YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRAtelpnvanmqpqaSRRRFSYLELLRATngfsannligrgSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLltgedqsmtqtqtlatigymap
Low Complexity Region (SEG)
YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNsfddlvslesldlsnnnlsEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRATELPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP
Disordered region (IsUnstruct)
***ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRATEL************RRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG*******************
Disordered Region (DISOPRED)
YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILALKFGLISR*******************RRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED***TQTQTLATIGYMAP
Disordered Region (DISEMBL)
YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRATELPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP
Disordered Region (DISPRO)
*LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRA************ASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRATELPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	360	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.997	0.355	0.350	2e-59
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.972	0.357	0.335	2e-51
C0LGT6	1031	LRR receptor-like serine/	no	no	0.966	0.337	0.334	1e-50
Q9SD62	1025	Putative receptor-like pr	no	no	0.986	0.346	0.361	1e-50
Q9FL28	1173	LRR receptor-like serine/	no	no	0.938	0.288	0.336	6e-49
Q9LJF3	1164	Receptor-like protein kin	no	no	0.902	0.279	0.330	2e-46
Q9ZVR7	1008	Phytosulfokine receptor 1	no	no	0.983	0.351	0.316	2e-44
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.908	0.280	0.312	3e-44
Q9LP24	1120	Probable leucine-rich rep	no	no	0.952	0.306	0.310	3e-44
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.947	0.273	0.323	6e-44

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  229 bits (584), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 161/459 (35%), Positives = 226/459 (49%), Gaps = 100/459 (21%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
           +  L  LDL  N   G +PT   N + L  L +  N+L   +         L R D S N
Sbjct: 432 MTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGN 491

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESL----------------- 95
           +L+G +P  I  L++L  LSLG N+L G +P +  + +++ESL                 
Sbjct: 492 SLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGL 551

Query: 96  ------DLSNNNLSEIIP---LSLEKLL--------LEGEIPRGGPFTKFSSKSFIGNDL 138
                 DLSNN+LS  IP    S  KL         LEG++P  G F   ++ S +GN+ 
Sbjct: 552 VGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNND 611

Query: 139 LCGS-PNLQVPPCKSNKP------------IILALKFGL--------------ISRCQKR 171
           LCG     Q+ PC S  P            +++ +  G+                R +K+
Sbjct: 612 LCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKK 671

Query: 172 ATELPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEF---- 227
             E  N      +    + SY +L  ATNGFS++N++G GSFG+VYKA L    +     
Sbjct: 672 NKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVK 731

Query: 228 --------AIKSFDVECEVMKSIHHRNLVKIISSCSNEDF-----RALVLEYMTNGSLEK 274
                   A+KSF  ECE +K I HRNLVK++++CS+ DF     RAL+ E+M NGSL+ 
Sbjct: 732 VLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDM 791

Query: 275 VLYSSNC--------ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
            L+             L +L+RLNI I+V S L+YLH     PI HCDLKP NVLLDD++
Sbjct: 792 WLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDL 851

Query: 327 VAHLSDFGIAKLLTGEDQS-----MTQTQTLATIGYMAP 360
            AH+SDFG+A+LL   D+      ++      TIGY AP
Sbjct: 852 TAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP 890

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  203 bits (516), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 143/426 (33%), Positives = 217/426 (50%), Gaps = 76/426 (17%)

Query: 8   LDLRGNKLSGSIPT-CFSNLTALR-NLHLDSNEL---------RHLVLTRTDFSRNNLLG 56
           LDL  N L+G+IP    SNL  L+  L+L SN L         +  ++   D S N L G
Sbjct: 422 LDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSG 481

Query: 57  DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL--- 113
            IP  +    +L+ L+L  N    ++P+S   L  L+ LD+S N L+  IP S ++    
Sbjct: 482 KIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTL 541

Query: 114 --------LLEGEIPRGGPFTKFSSKSFIGNDLLCGS-PNLQVPPCKSNK---------- 154
                   LL G +   G F+K + +SF+G+ LLCGS   +Q   CK             
Sbjct: 542 KHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQA--CKKKHKYPSVLLPVL 599

Query: 155 ------PIILALKFGLISRCQ---------KRATELPNVANMQPQASRRRFSYLELLRAT 199
                 P++    + L+ R +         K   E     N Q      R SY +L+ AT
Sbjct: 600 LSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQN-QNDPKYPRISYQQLIAAT 658

Query: 200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIK------------SFDVECEVMKSIHHRNL 247
            GF+A++LIG G FG VYK  L++  + A+K            SF  EC+++K   HRNL
Sbjct: 659 GGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNL 718

Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHF 304
           ++II++CS   F ALVL  M NGSLE+ LY    S+  LD++Q +NI  +V   + YLH 
Sbjct: 719 IRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH 778

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA----------T 354
                ++HCDLKP N+LLDD + A ++DFGI++L+ G +++++   +++          +
Sbjct: 779 YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGS 838

Query: 355 IGYMAP 360
           +GY+AP
Sbjct: 839 VGYIAP 844

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  201 bits (510), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 162/484 (33%), Positives = 216/484 (44%), Gaps = 136/484 (28%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNEL-----------RHLV------------- 43
           +DL  N +SG IP+ F N+T L+ LHL+SN             R+L+             
Sbjct: 422 VDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTI 481

Query: 44  ---------LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP----------- 83
                    L   D S N L G  P  +  L+ L  L   +N+L G +P           
Sbjct: 482 PQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEF 541

Query: 84  -----NSFDD-------LVSLESLDLSNNNLSEIIPLSLEKL-----------LLEGEIP 120
                NSFD        LVSL+++D SNNNLS  IP  L  L             EG +P
Sbjct: 542 LFMQGNSFDGAIPDISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVP 601

Query: 121 RGGPFTKFSSKSFIGNDLLCGS-PNLQVPPC------KSNKP------------------ 155
             G F   ++ S  GN  +CG    +Q+ PC      +  KP                  
Sbjct: 602 TTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASL 661

Query: 156 ---IILALKFGLISRCQKRATELPNVANMQPQAS------RRRFSYLELLRATNGFSANN 206
              II+A     + R +K      N ++  P  S        + SY EL  AT+ FS+ N
Sbjct: 662 LLIIIVASLCWFMKRKKKN-----NASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTN 716

Query: 207 LIGRGSFGSVYKARLQDGMEF------------AIKSFDVECEVMKSIHHRNLVKIISSC 254
           LIG G+FG+V+K  L    +             A KSF  ECE  K I HRNLVK+I+ C
Sbjct: 717 LIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVC 776

Query: 255 SN-----EDFRALVLEYMTNGSLEKVLYSSNC--------ILDILQRLNIMINVTSALEY 301
           S+      DFRALV E+M  GSL+  L   +          L   ++LNI I+V SALEY
Sbjct: 777 SSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEY 836

Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS-----MTQTQTLATIG 356
           LH     P+ HCD+KP N+LLDD++ AH+SDFG+A+LL   D+       +      TIG
Sbjct: 837 LHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIG 896

Query: 357 YMAP 360
           Y AP
Sbjct: 897 YAAP 900

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  200 bits (508), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 157/434 (36%), Positives = 203/434 (46%), Gaps = 79/434 (18%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN----ELRHLV-----LTRTDFSRNNLL 55
           L  L+L  NKL+GSIP     L +L  L++  N     LR  +     L   D S N L 
Sbjct: 475 LLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLS 534

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL-- 113
           G IP T+    SL+FL L  N   G IP+    L  L  LDLS NNLS  IP  +     
Sbjct: 535 GQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSK 593

Query: 114 ---------LLEGEIPRGGPFTKFSSKSFIGNDLLCGS-PNLQVPPCKSNKPIILALKFG 163
                      +G +P  G F   S+ S  GN  LCG  P+LQ+ PC    P   +    
Sbjct: 594 LQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRK 653

Query: 164 LISRC--------------------------QKRATELPNVANMQPQAS-RRRFSYLELL 196
           +I+ C                            RA    N  +  P  S   + SY EL 
Sbjct: 654 IITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELY 713

Query: 197 RATNGFSANNLIGRGSFGSVYKARLQDGMEF------------AIKSFDVECEVMKSIHH 244
           + T GFS++NLIG G+FG+V+K  L    +             A KSF  ECE +  I H
Sbjct: 714 KTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRH 773

Query: 245 RNLVKIISSCSNEDF-----RALVLEYMTNGSLEKVLYSSNC--------ILDILQRLNI 291
           RNLVK+++ CS+ DF     RALV E+M NG+L+  L+             L +  RLNI
Sbjct: 774 RNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNI 833

Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ- 350
            I+V SAL YLH     PI HCD+KP N+LLD ++ AH+SDFG+A+LL   D+     Q 
Sbjct: 834 AIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQF 893

Query: 351 ----TLATIGYMAP 360
                  TIGY AP
Sbjct: 894 SSAGVRGTIGYAAP 907

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  194 bits (494), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 138/410 (33%), Positives = 212/410 (51%), Gaps = 72/410 (17%)

Query: 7    QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTI-QGL 65
            ++DL  N  SGSIP    +L A +N+               DFS+NNL G IP  + QG+
Sbjct: 653  EIDLSNNLFSGSIP---RSLQACKNVF------------TLDFSQNNLSGHIPDEVFQGM 697

Query: 66   KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL----------- 114
              +  L+L  N   G IP SF ++  L SLDLS+NNL+  IP SL  L            
Sbjct: 698  DMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNN 757

Query: 115  LEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPC----------KSNKPIILAL---- 160
            L+G +P  G F   ++   +GN  LCGS    + PC          K  + I++ L    
Sbjct: 758  LKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAA 816

Query: 161  -------KFGLISRCQKRATELPN-----VANMQPQASRRRFSYLELLRATNGFSANNLI 208
                      +++ C+K+  ++ N     + ++      +RF   EL +AT+ F++ N+I
Sbjct: 817  ALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANII 876

Query: 209  GRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIIS-SC 254
            G  S  +VYK +L+DG   A+K              F  E + +  + HRNLVKI+  + 
Sbjct: 877  GSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAW 936

Query: 255  SNEDFRALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
             +   +ALVL +M NG+LE  ++ S   I  +L+++++ +++ S ++YLH G+  PI+HC
Sbjct: 937  ESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHC 996

Query: 314  DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAP 360
            DLKP N+LLD + VAH+SDFG A++L   +   T   T A   TIGY+AP
Sbjct: 997  DLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAP 1046

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  186 bits (473), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 141/426 (33%), Positives = 188/426 (44%), Gaps = 101/426 (23%)

Query: 3    AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTI 62
             ++  LDL  N +SGSIP  +  +  L+ L+L                 N L G IP + 
Sbjct: 639  GSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNL---------------GHNLLTGTIPDSF 683

Query: 63   QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRG 122
             GLK++  L L HN LQG +P S   L  L  LD+SNNNL+             G IP G
Sbjct: 684  GGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLT-------------GPIPFG 730

Query: 123  GPFTKFSSKSFIGNDLLCGSPNLQVPPCKSN------------KPIILALKFGLI----- 165
            G  T F    +  N  LCG P   +PPC S             + I   +  G++     
Sbjct: 731  GQLTTFPLTRYANNSGLCGVP---LPPCSSGSRPTRSHAHPKKQSIATGMSAGIVFSFMC 787

Query: 166  -----------SRCQKRATE-------LP------------------NVANMQPQASRRR 189
                        + QK+  +       LP                  NVA  +     R+
Sbjct: 788  IVMLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPLSINVATFEKPL--RK 845

Query: 190  FSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK-----------SFDVECEV 238
             ++  LL ATNGFSA+++IG G FG VYKA+L DG   AIK            F  E E 
Sbjct: 846  LTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMET 905

Query: 239  MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS----SNCILDILQRLNIMIN 294
            +  I HRNLV ++  C   + R LV EYM  GSLE VL+         LD   R  I I 
Sbjct: 906  IGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIG 965

Query: 295  VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
                L +LH      IIH D+K  NVLLD + VA +SDFG+A+L++  D  ++ +    T
Sbjct: 966  AARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGT 1025

Query: 355  IGYMAP 360
             GY+ P
Sbjct: 1026 PGYVPP 1031

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4

 Score =  180 bits (456), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 142/449 (31%), Positives = 200/449 (44%), Gaps = 95/449 (21%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH---LVLTRTDFSR------- 51
             ALF LDL  N  +G IP   + L +L + ++  NE        + R + +R       
Sbjct: 462 FKALFYLDLSNNSFTGEIPKSLTKLESLTSRNISVNEPSPDFPFFMKRNESARALQYNQI 521

Query: 52  -----------NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 100
                      NNL G I      LK L    L  N L GSIP+S   + SLE+LDLSNN
Sbjct: 522 FGFPPTIELGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNN 581

Query: 101 NLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPP 149
            LS  IP+SL++L            L G IP GG F  F + SF  N L CG       P
Sbjct: 582 RLSGSIPVSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNHL-CGEHRF---P 637

Query: 150 CKSNKP----------------IILALKFGLI----------SRCQKRATEL-PNVANMQ 182
           C                     + + + FG +           R ++R+ E+ P +   +
Sbjct: 638 CSEGTESALIKRSRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESE 697

Query: 183 P-----------------QASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGM 225
                             Q++ +  SY +LL +TN F   N+IG G FG VYKA L DG 
Sbjct: 698 SMNRKELGEIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGK 757

Query: 226 EFAIK-----------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEK 274
           + AIK            F+ E E +    H NLV +   C  ++ R L+  YM NGSL+ 
Sbjct: 758 KVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDY 817

Query: 275 VLYSSN---CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLS 331
            L+  N    +L    RL I       L YLH G    I+H D+K  N+LLD+N  +HL+
Sbjct: 818 WLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLA 877

Query: 332 DFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DFG+A+L++  +  ++ T  + T+GY+ P
Sbjct: 878 DFGLARLMSPYETHVS-TDLVGTLGYIPP 905

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  179 bits (454), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 133/426 (31%), Positives = 186/426 (43%), Gaps = 99/426 (23%)

Query: 3    AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTI 62
             ++   D+  N +SG IP  + N+  L+ L+L                 N + G IP + 
Sbjct: 639  GSMIYFDISYNAVSGFIPPGYGNMGYLQVLNL---------------GHNRITGTIPDSF 683

Query: 63   QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRG 122
             GLK++  L L HN LQG +P S   L  L  LD+SNNNL+             G IP G
Sbjct: 684  GGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLT-------------GPIPFG 730

Query: 123  GPFTKFSSKSFIGNDLLCGSPNLQVPPCKS--NKPI------------------------ 156
            G  T F    +  N  LCG P   + PC S   +PI                        
Sbjct: 731  GQLTTFPVSRYANNSGLCGVP---LRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFSFM 787

Query: 157  ---ILALKFGLISRCQKRATE-------LPNVANMQPQASR----------------RRF 190
               +L +    + + QK+  +       LP   +   + S                 R+ 
Sbjct: 788  CFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKL 847

Query: 191  SYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK-----------SFDVECEVM 239
            ++  LL ATNGFSA  ++G G FG VYKA+L+DG   AIK            F  E E +
Sbjct: 848  TFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETI 907

Query: 240  KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNC-----ILDILQRLNIMIN 294
              I HRNLV ++  C   + R LV EYM  GSLE VL+  +       L+   R  I I 
Sbjct: 908  GKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIG 967

Query: 295  VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
                L +LH      IIH D+K  NVLLD++  A +SDFG+A+L++  D  ++ +    T
Sbjct: 968  AARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGT 1027

Query: 355  IGYMAP 360
             GY+ P
Sbjct: 1028 PGYVPP 1033

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  179 bits (453), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 129/415 (31%), Positives = 195/415 (46%), Gaps = 72/415 (17%)

Query: 1    YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV--------LTRTDFSRN 52
            +L  L  LDL  N  S  IP  F +   L +++L  N+    +        LT+ D S N
Sbjct: 628  FLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPRLSKLTQLTQLDLSHN 687

Query: 53   NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 112
             L G+IP+ +  L+SL  L L HN L G IP +F+ +++L ++D+SNN            
Sbjct: 688  QLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNK----------- 736

Query: 113  LLLEGEIPRGGPFTKFSSKSFIGNDLLCGS-PNLQVPPCKS-NKP--------------- 155
              LEG +P    F K ++ +   N  LC + P  ++ PC+   KP               
Sbjct: 737  --LEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPIL 794

Query: 156  ---IILALKFGLISRCQKRATELPNVANMQPQASRR--------RFSYLELLRATNGFSA 204
               +IL++     + C  R  +L N  N  P+            +F Y +++ +TN F  
Sbjct: 795  GVLVILSICANTFTYCI-RKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDP 853

Query: 205  NNLIGRGSFGSVYKARLQDGMEFAIK-----------------SFDVECEVMKSIHHRNL 247
             +LIG G +  VY+A LQD +  A+K                  F  E + +  I HRN+
Sbjct: 854  THLIGTGGYSKVYRANLQDTI-IAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNV 912

Query: 248  VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI--LDILQRLNIMINVTSALEYLHFG 305
            VK+   CS+     L+ EYM  GSL K+L +      L   +R+N++  V  AL Y+H  
Sbjct: 913  VKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHD 972

Query: 306  FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              TPI+H D+   N+LLD++  A +SDFG AKLL  +  S   +    T GY+AP
Sbjct: 973  RITPIVHRDISSGNILLDNDYTAKISDFGTAKLL--KTDSSNWSAVAGTYGYVAP 1025

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  178 bits (451), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 140/433 (32%), Positives = 198/433 (45%), Gaps = 92/433 (21%)

Query: 2    LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRT----------DFSR 51
            L AL  L+L  N+ SGS+P     L+ L  L L  N L   +              D S 
Sbjct: 718  LGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSY 777

Query: 52   NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
            NN  GDIP+TI  L  L+ L L HN+L G +P S  D+ SL  L++S NNL         
Sbjct: 778  NNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLG-------- 829

Query: 112  KLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKP---------------- 155
                 G++ +   F+++ + SF+GN  LCGSP  +    +SN                  
Sbjct: 830  -----GKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAIS 882

Query: 156  ---------IILAL----------KFGLISRC------QKRATELPNVANMQPQASRRRF 190
                     +++AL          K G  S          +AT  P   N    AS+   
Sbjct: 883  ALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRN---GASKSDI 939

Query: 191  SYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK------------SFDVECEV 238
             + +++ AT+  S   +IG G  G VYKA L++G   A+K            SF  E + 
Sbjct: 940  RWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKT 999

Query: 239  MKSIHHRNLVKIISSCSN--EDFRALVLEYMTNGSL-------EKVLYSSNCILDILQRL 289
            +  I HR+LVK++  CS+  E    L+ EYM NGS+       + VL     +LD   RL
Sbjct: 1000 LGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARL 1059

Query: 290  NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 349
             I + +   +EYLH     PI+H D+K  NVLLD N+ AHL DFG+AK+LT    + T +
Sbjct: 1060 RIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDS 1119

Query: 350  QTL--ATIGYMAP 360
             T    + GY+AP
Sbjct: 1120 NTWFACSYGYIAP 1132

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	360
255585401	843	serine-threonine protein kinase, plant-t	0.997	0.425	0.496	1e-98
359483198	1087	PREDICTED: probable LRR receptor-like se	0.991	0.328	0.491	1e-97
224139658	1019	predicted protein [Populus trichocarpa]	0.986	0.348	0.498	1e-97
224116832	1061	predicted protein [Populus trichocarpa]	0.991	0.336	0.480	2e-95
255572272	1089	serine-threonine protein kinase, plant-t	0.991	0.327	0.473	2e-94
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.997	0.314	0.478	7e-93
359485453	1202	PREDICTED: probable LRR receptor-like se	0.994	0.297	0.485	7e-93
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.997	0.297	0.480	3e-92
358344055	996	Receptor-like kinase [Medicago truncatul	0.975	0.352	0.468	3e-92
358344065	815	Receptor-like protein kinase [Medicago t	0.983	0.434	0.463	6e-92

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  365 bits (938), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 215/433 (49%), Positives = 263/433 (60%), Gaps = 74/433 (17%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR-------------------- 40
           +L+ L +L L  N L G +P CF +L +LR LHL SN                       
Sbjct: 292 HLSNLGELFLSNNSLFGPLPACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLSS 351

Query: 41  -----HL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFD 87
                H+        VLT+ DFS N+L G IP  I  L++L  LSL HNR +G IP  F 
Sbjct: 352 NSLSGHIPLSIGNLKVLTQVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPFG 411

Query: 88  DLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGN 136
           +L+SLESLDLS+NNLS  IP SLE+L            L+GE+P  G F  FS+ SF+GN
Sbjct: 412 ELISLESLDLSSNNLSGKIPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGN 471

Query: 137 DLLCGSPNLQVPPCKSNK-----------------PIILALKFGLIS-RCQKRATELPNV 178
             LCGS  L + PCK+N                    IL + F L+  RCQK   EL NV
Sbjct: 472 LALCGSRLLPLMPCKNNTHGGSKTSTKLLLIYVLPASILTIAFILVFLRCQKVKLELENV 531

Query: 179 ANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF------ 232
            ++    + RR S+ EL +AT+GF A+NL+G G +GSVYK RL+DG   AIK F      
Sbjct: 532 MDIITVGTWRRISFQELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEG 591

Query: 233 -----DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQ 287
                D ECEVM SI HRNLVKIIS CSN+DF+A+VLEYM NGSLEK LYS N  L+I Q
Sbjct: 592 AFKIFDTECEVMSSIRHRNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNIQQ 651

Query: 288 RLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
           RL +MI+V SALEYLH GFS PI+HCDLKP NVLLD ++V H++DFG+AKLL GE   +T
Sbjct: 652 RLEVMIDVASALEYLHHGFSAPIVHCDLKPSNVLLDQDMVGHVADFGMAKLL-GEGDLIT 710

Query: 348 QTQTLATIGYMAP 360
           QT+TLATIGYMAP
Sbjct: 711 QTKTLATIGYMAP 723

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  362 bits (930), Expect = 1e-97,   Method: Compositional matrix adjust.
 Identities = 215/437 (49%), Positives = 264/437 (60%), Gaps = 80/437 (18%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR-----------HL-------- 42
           L  L +L L  N+LSGSIP C   LT LR+L+L SN+L            H+        
Sbjct: 540 LRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSN 599

Query: 43  --------------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD 88
                         VL + D SRN L G+IP+ I GL+ L  LSL HNR +G I +SF +
Sbjct: 600 FLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSN 659

Query: 89  LVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGND 137
           L SLE +DLS+N L   IP SLE L+           L GEIP  GPF  FS++SF+ N 
Sbjct: 660 LKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNK 719

Query: 138 LLCGSPNLQVPPCKSNK---------------PIIL------ALKFGLISRCQKRATELP 176
            LCGSP L++PPC++                 P IL      AL F + +RC+KR   LP
Sbjct: 720 ALCGSPRLKLPPCRTGTRWSTTISWLLLKYILPAILSTLLFLALIF-VWTRCRKRNAVLP 778

Query: 177 NVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGM----------- 225
             +     A+ RR SY E+ +ATNGFSA NL+GRGS GSVY+  L DG            
Sbjct: 779 TQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQE 838

Query: 226 EFAIKSFDVECEVMKSIHHRNLVKIISSCSNE--DFRALVLEYMTNGSLEKVLYSSNCIL 283
           E A KSFD ECEVM  I HRNL+KI+SSCSN   DF+ALVLEY+ NGSLE+ LYS N  L
Sbjct: 839 EAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCL 898

Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           DILQRLNIMI+V  A+EYLH G STP++HCDLKP N+LLD++   H+ DFGIAKLL  E+
Sbjct: 899 DILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLR-EE 957

Query: 344 QSMTQTQTLATIGYMAP 360
           +S+ +TQTLATIGYMAP
Sbjct: 958 ESIRETQTLATIGYMAP 974

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  362 bits (929), Expect = 1e-97,   Method: Compositional matrix adjust.
 Identities = 215/431 (49%), Positives = 266/431 (61%), Gaps = 76/431 (17%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN-----------ELRHLVL--TRTDF-- 49
           L  + L  N LSG IP+C  NLT+LRNL+L  N            L+ L++    ++F  
Sbjct: 470 LVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLY 529

Query: 50  ------------------SRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVS 91
                             S N L G+IP+TI  L++L   SL  N  QGSIP +F  LVS
Sbjct: 530 GSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVS 589

Query: 92  LESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGNDLLC 140
           LE LDLS NNLS  IP SLE L            L+GEIPRGGPF  F+++SFI N  LC
Sbjct: 590 LELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLC 649

Query: 141 GSPNLQVPPC-----KSNK--------------PIILALKF-GLISRCQKRATELPNVAN 180
           G   LQVPPC     K +K               I+L + F  L+  C++R  + P    
Sbjct: 650 GPSRLQVPPCSIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEA 709

Query: 181 MQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK---------- 230
           +   A +RR SYLELL ATN F  +NL+G GSFGSVY+ RL+DG+  A+K          
Sbjct: 710 LPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAF 769

Query: 231 -SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL 289
            SFD ECE+M++I HRNLVKII SCSN DF+ALVLEYM  GSLEK LYS N  LDI+QR+
Sbjct: 770 RSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRV 829

Query: 290 NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 349
           NIMI+V SALEYLH G+ +P++HCDLKP NVLLD+++VAH+ DFGIAKLL GE++S  QT
Sbjct: 830 NIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLL-GENESFAQT 888

Query: 350 QTLATIGYMAP 360
           +TLATIGYMAP
Sbjct: 889 RTLATIGYMAP 899

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  355 bits (912), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 210/437 (48%), Positives = 263/437 (60%), Gaps = 80/437 (18%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------------------ 42
           +L  L  L L  N  SGS+P C SN+T+LR L+L SN    +                  
Sbjct: 506 HLERLSYLYLLENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFN 565

Query: 43  --------------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD 88
                         V+T  DFS N L GDIPT+I  L++L   SL  NR+QG IP+SF D
Sbjct: 566 SLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGD 625

Query: 89  LVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGND 137
           LVSLE LDLS N+LS  IP SLEKL+           L+GEI  GGPF  FS +SF+ N+
Sbjct: 626 LVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNE 685

Query: 138 LLCGSPNLQVPPCKS-------NKP----------------IILALKFGLISRCQKRATE 174
            LCG   +QVPPCKS        +P                ++LAL   +  R  KR  +
Sbjct: 686 ALCGPIRMQVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKR--K 743

Query: 175 LPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK---- 230
           L    +  P A+ R+ SY EL RAT GF+  NL+G GS GSVYK  L DG+  A+K    
Sbjct: 744 LSTQEDPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHL 803

Query: 231 -------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCIL 283
                   FD ECEV++ + HRNLVKIISSC N DF+AL+LE++ +GSLEK LYS N  L
Sbjct: 804 QLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYL 863

Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           DILQRLNIMI+V SALEYLH G + P++HCDLKP NVL+++++VAH+SDFGI++LL GE 
Sbjct: 864 DILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL-GEG 922

Query: 344 QSMTQTQTLATIGYMAP 360
            ++TQT TLATIGYMAP
Sbjct: 923 DAVTQTLTLATIGYMAP 939

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  352 bits (902), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 207/437 (47%), Positives = 263/437 (60%), Gaps = 80/437 (18%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN------------------------ 37
           L  L+ L+L GNKLSGSIPTCFSNLT+LRNL L SN                        
Sbjct: 536 LRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASN 595

Query: 38  --------ELRHL-VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDD 88
                   E+ +L  +   + S+N L G+IP +I GL+ L  L L  N+LQG IP S  D
Sbjct: 596 YLTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGD 655

Query: 89  LVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGND 137
           + SLE LDLS+NNLS +IP SL+ LL           L+GEIP GG F+ FS++SFIGN+
Sbjct: 656 IKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNE 715

Query: 138 LLCGSPNLQVPPCKSNKP-----------------------IILALKFGLISRCQKRATE 174
            LCGS  LQV PCK +                          +LA    L   C+++A +
Sbjct: 716 ALCGSARLQVSPCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKA-K 774

Query: 175 LPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDG---------- 224
                +     + RR SY EL  ATNGF  +N +G GSFGSVYK  L DG          
Sbjct: 775 FSIEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNL 834

Query: 225 -MEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCIL 283
            +E A KSFD ECEV++++ HRNLVKII+SCS  +F+ALVLE+M N SLEK LYS +  L
Sbjct: 835 QLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFL 894

Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           + LQRLNIM++V S LEYLH G++ P+ HCD+KP NVLL++++VA L+DFGI+KLL GE+
Sbjct: 895 NNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLL-GEE 953

Query: 344 QSMTQTQTLATIGYMAP 360
            S+ QT TLATIGYMAP
Sbjct: 954 GSVMQTMTLATIGYMAP 970

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  347 bits (889), Expect = 7e-93,   Method: Compositional matrix adjust.
 Identities = 208/435 (47%), Positives = 262/435 (60%), Gaps = 76/435 (17%)

Query: 1    YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN-----------ELRHLV------ 43
            +L  L  L L  NKLSGSIP+CF +L AL+ L LDSN            LR L+      
Sbjct: 595  HLKDLGYLFLSSNKLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSS 654

Query: 44   ----------------LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFD 87
                            +T  D S+N + G IP+ +  L+SL  LSL  NRLQG IP  F 
Sbjct: 655  NFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFG 714

Query: 88   DLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGN 136
            DLVSLESLDLS NNLS  IP SLE L+           L+GEIP GGPF  F+++SF+ N
Sbjct: 715  DLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFN 774

Query: 137  DLLCGSPNLQVPPCKSNK-----------------PI--ILALKFGLISRCQKRAT-ELP 176
            + LCG+P+ QV  C  N                  P+  I+ L   ++   ++R   E+P
Sbjct: 775  EALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIP 834

Query: 177  NVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK------ 230
               +     +  + S+ +LL ATN F  +NLIG+GS G VYK  L +G+  AIK      
Sbjct: 835  TPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEF 894

Query: 231  -----SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI 285
                 SFD ECEVM+ I HRNLV+II+ CSN DF+ALVLEYM NGSLEK LYS N  LD+
Sbjct: 895  QGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDL 954

Query: 286  LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
            +QRLNIMI+V SALEYLH   S+ ++HCDLKP+NVLLDD++VAH++DFGI KLLT + +S
Sbjct: 955  IQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLT-KTES 1013

Query: 346  MTQTQTLATIGYMAP 360
            M QT+TL TIGYMAP
Sbjct: 1014 MQQTKTLGTIGYMAP 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  347 bits (889), Expect = 7e-93,   Method: Compositional matrix adjust.
 Identities = 211/435 (48%), Positives = 257/435 (59%), Gaps = 77/435 (17%)

Query: 1    YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN-----------ELRHLV------ 43
            +L  L  LDL  NKLSG+IP+C  NLT LRN++L SN            LR L+      
Sbjct: 654  HLTNLAFLDLSSNKLSGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSS 713

Query: 44   ----------------LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFD 87
                            L   D S+N   G+IP+TI  L++L  L L HN+LQG IP +F 
Sbjct: 714  NFLNSQLPLQVGNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFG 773

Query: 88   DLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGN 136
            DLVSLESLDLS NNLS  IP SLE L            L+GEIP GGPF  F+++SFI N
Sbjct: 774  DLVSLESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISN 833

Query: 137  DLLCGSPNLQVPPCKSNK--------------------PIILALKFGLISRCQKRATELP 176
              LCG+P  QV  C+ +                      IIL + F    R Q + +E P
Sbjct: 834  LALCGAPRFQVMACEKDSRKNTKSLLLKCIVPLSVSLSTIILVVLFVQWKRRQTK-SETP 892

Query: 177  NVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK------ 230
               ++      R   + ELL ATN F  +NLIG+GS G VYK  L DG+  A+K      
Sbjct: 893  IQVDLSLPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLEL 952

Query: 231  -----SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI 285
                 SF+VECEVM++I HRNL KIISSCSN DF+ALVLEYM NGSLEK LYS N  LD 
Sbjct: 953  QGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDF 1012

Query: 286  LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
            +QRL IMI+V S LEYLH  +S P++HCDLKP NVLLDD++VAH+SDFGIAKLL G  + 
Sbjct: 1013 VQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMG-SEF 1071

Query: 346  MTQTQTLATIGYMAP 360
            M +T+TL T+GYMAP
Sbjct: 1072 MKRTKTLGTVGYMAP 1086

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  344 bits (883), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 209/435 (48%), Positives = 261/435 (60%), Gaps = 76/435 (17%)

Query: 1    YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN-----------ELRHLV------ 43
            +L  L  L L  NKLSGS P+CF +L ALR L LDSN            LR L+      
Sbjct: 660  HLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSS 719

Query: 44   ----------------LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFD 87
                            +T  D S+N + G IP+ +  L+ L  LSL  NRLQG I   F 
Sbjct: 720  NFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFG 779

Query: 88   DLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGN 136
            DLVSLESLDLS+NNLS  IP SLE L+           L+GEIP GGPF KF+++SF+ N
Sbjct: 780  DLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFN 839

Query: 137  DLLCGSPNLQVPPCKSN-------------KPIILALK-------FGLISRCQKRATELP 176
            + LCG+P+ QV  C  N             K I+L +        F ++   ++   E+P
Sbjct: 840  EALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIP 899

Query: 177  NVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK------ 230
               +     +  + S+ +LL ATN F  +NLIG+GS G VYK  L +G+  AIK      
Sbjct: 900  TPIDSWLLGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEF 959

Query: 231  -----SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI 285
                 SFD ECEVM+ I HRNLV+II+ CSN DF+ALVLEYM NGSLEK LYS N  LD+
Sbjct: 960  QGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDL 1019

Query: 286  LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
            +QRLNIMI+V SALEYLH   S+ ++HCDLKP NVLLDD++VAH++DFGIAKLLT E +S
Sbjct: 1020 IQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLT-ETES 1078

Query: 346  MTQTQTLATIGYMAP 360
            M QT+TL TIGYMAP
Sbjct: 1079 MQQTKTLGTIGYMAP 1093

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358344055|ref|XP_003636109.1| Receptor-like kinase [Medicago truncatula] gi|355502044|gb|AES83247.1| Receptor-like kinase [Medicago truncatula]

 Score =  344 bits (883), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 202/431 (46%), Positives = 261/431 (60%), Gaps = 80/431 (18%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSN----------------------------- 37
           +L L  NKLSG +PTC  N+T+LR L++ SN                             
Sbjct: 452 ELYLENNKLSGVLPTCLGNMTSLRILNVGSNNLNSKIPSSLWGLTDILILDLSSNAFIGD 511

Query: 38  ------ELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVS 91
                  LR LV+   D SRN +  +IPTTI  L++LQ LSL HN+L GSIP S + +VS
Sbjct: 512 FPPDIGNLRELVI--LDLSRNQISSNIPTTISSLQNLQNLSLAHNKLNGSIPASLNGMVS 569

Query: 92  LESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGNDLLC 140
           L SLDLS N L+ +IP SLE LL           L+GEIP GG F  F+++SF+ N+ LC
Sbjct: 570 LISLDLSQNMLTGVIPKSLESLLYLQNINFSYNRLQGEIPNGGHFKNFTAQSFMHNEALC 629

Query: 141 GSPNLQVPPC---------------KSNKPI----ILALKFGLISRCQKRATELPNVA-N 180
           G P LQVP C               K   PI    IL +   ++ +  KR     ++   
Sbjct: 630 GDPRLQVPTCGKQVKKWSMEKKLILKCILPIVVSAILVVACIILLKHNKRKKNKTSLERG 689

Query: 181 MQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAI----------- 229
           +    + RR SY E+++ATNGF+ +N +GRG FGSVY+ +L DG   A+           
Sbjct: 690 LSTLGAPRRISYYEIVQATNGFNESNFLGRGGFGSVYQGKLLDGEMIAVKVIDLQSEAKS 749

Query: 230 KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL 289
           KSFD EC  M+++ HRN+VKIISSCSN DF++LV+E+M+NGS++  LYS N  L+ LQRL
Sbjct: 750 KSFDAECNAMRNLRHRNMVKIISSCSNLDFKSLVMEFMSNGSVDNWLYSVNHCLNFLQRL 809

Query: 290 NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 349
           NIMI+V SALEYLH G S P++HCDLKP NVLLD+N+VAH+SDFGIAKL+  E QS T T
Sbjct: 810 NIMIDVASALEYLHHGSSVPVVHCDLKPSNVLLDENMVAHVSDFGIAKLMD-EGQSKTHT 868

Query: 350 QTLATIGYMAP 360
           QTLATIGY+AP
Sbjct: 869 QTLATIGYLAP 879

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358344065|ref|XP_003636114.1| Receptor-like protein kinase [Medicago truncatula] gi|355502049|gb|AES83252.1| Receptor-like protein kinase [Medicago truncatula]

 Score =  343 bits (881), Expect = 6e-92,   Method: Compositional matrix adjust.
 Identities = 203/438 (46%), Positives = 262/438 (59%), Gaps = 84/438 (19%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNEL---------------------- 39
           + +L +L  + NKLSG +PTC  N+ +L  +H+ SN L                      
Sbjct: 266 MKSLGELYQQNNKLSGVLPTCLGNMISLIRIHVGSNSLNSRIPLSLWRLRDILEINFSSN 325

Query: 40  -------------RHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSF 86
                        R +VL   D SRN +  +IPTTI  L +LQ LSL  N+L GSIP S 
Sbjct: 326 SLIGILPPEIGNLRAIVLL--DLSRNQISSNIPTTINSLLTLQNLSLADNKLNGSIPKSL 383

Query: 87  DDLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIG 135
            ++VSL SLDLS N L+ +IP SLE LL           L+GEIP GG F  F+++SF+ 
Sbjct: 384 GEMVSLISLDLSENMLTGVIPKSLESLLYLQNINFSYNRLQGEIPDGGRFKNFTAQSFMH 443

Query: 136 NDLLCGSPNLQVPPC---------------KSNKPIILALKFGLISRC------QKRATE 174
           ND LCG P LQVP C               K   PI++++   LI  C       KR   
Sbjct: 444 NDALCGDPRLQVPTCGKQVKKWSMEKKLILKCILPIVVSVV--LIVACIILLKHNKRRKN 501

Query: 175 LPNVA-NMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK--- 230
             NV   +    + RR SY E+++ATNGF+ +N +GRG FGSVY+ +L DG   A+K   
Sbjct: 502 KNNVGRGLSTLGAPRRISYYEIVQATNGFNESNFLGRGGFGSVYQGKLLDGEMIAVKVID 561

Query: 231 --------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI 282
                   SFD EC  M+++ HRNLVKIISSCSN DF++LV+E+M+NGS++K LYS+N  
Sbjct: 562 LQSEAKSKSFDAECNAMRNLRHRNLVKIISSCSNLDFKSLVMEFMSNGSVDKWLYSNNYC 621

Query: 283 LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           L+ LQRLNIMI+V  ALEYLH G S P++HCDLKP NVLLD+N+VAH+SDFGIAKL+  E
Sbjct: 622 LNFLQRLNIMIDVAYALEYLHHGSSMPVVHCDLKPSNVLLDENMVAHVSDFGIAKLMD-E 680

Query: 343 DQSMTQTQTLATIGYMAP 360
            QS T TQTLAT+GY+AP
Sbjct: 681 GQSQTLTQTLATVGYIAP 698

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	360
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.583	0.214	0.367	4.5e-44
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.480	0.147	0.397	1.1e-40
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.369	0.131	0.483	1.5e-40
TAIR|locus:2205260	1047	AT1G56120 [Arabidopsis thalian	0.472	0.162	0.409	4.2e-38
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.369	0.131	0.476	4.7e-38
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.505	0.156	0.407	4.8e-38
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.369	0.131	0.456	4.5e-37
TAIR|locus:2157042	953	AT5G49760 [Arabidopsis thalian	0.494	0.186	0.361	1.6e-36
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.369	0.129	0.456	2.2e-36
TAIR|locus:2156992	946	AT5G49770 [Arabidopsis thalian	0.494	0.188	0.371	3.1e-36

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 368 (134.6 bits), Expect = 4.5e-44, Sum P(2) = 4.5e-44
 Identities = 87/237 (36%), Positives = 135/237 (56%)

Query:   150 CKSNKPIILALKFGL-ISRCQKRATELPNVANMQPQASRRRFSYLELLRATNGFSANNLI 208
             C    P++   +FG  ++   K   E     N Q      R SY +L+ AT GF+A++LI
Sbjct:   609 CVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQN-QNDPKYPRISYQQLIAATGGFNASSLI 667

Query:   209 GRGSFGSVYKARLQDGMEFAIK------------SFDVECEVMKSIHHRNLVKIISSCSN 256
             G G FG VYK  L++  + A+K            SF  EC+++K   HRNL++II++CS 
Sbjct:   668 GSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK 727

Query:   257 EDFRALVLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
               F ALVL  M NGSLE+ LY    S+  LD++Q +NI  +V   + YLH      ++HC
Sbjct:   728 PGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHC 787

Query:   314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA----------TIGYMAP 360
             DLKP N+LLDD + A ++DFGI++L+ G +++++   +++          ++GY+AP
Sbjct:   788 DLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAP 844

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 345 (126.5 bits), Expect = 1.1e-40, Sum P(2) = 1.1e-40
 Identities = 76/191 (39%), Positives = 118/191 (61%)

Query:   188 RRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGM----------EFAIKS---FDV 234
             +RF   EL +AT+ F++ N+IG  S  +VYK +L+DG           EF+ +S   F  
Sbjct:   856 KRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYT 915

Query:   235 ECEVMKSIHHRNLVKIIS-SCSNEDFRALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIM 292
             E + +  + HRNLVKI+  +  +   +ALVL +M NG+LE  ++ S   I  +L+++++ 
Sbjct:   916 EAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLC 975

Query:   293 INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
             +++ S ++YLH G+  PI+HCDLKP N+LLD + VAH+SDFG A++L   +   T   T 
Sbjct:   976 VHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTS 1035

Query:   353 A---TIGYMAP 360
             A   TIGY+AP
Sbjct:  1036 AFEGTIGYLAP 1046

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 323 (118.8 bits), Expect = 1.5e-40, Sum P(2) = 1.5e-40
 Identities = 73/151 (48%), Positives = 98/151 (64%)

Query:   228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDF-----RALVLEYMTNGSL------EKV- 275
             A+KSF  ECE +K I HRNLVK++++CS+ DF     RAL+ E+M NGSL      E+V 
Sbjct:   740 AMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVE 799

Query:   276 -LYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG 334
              ++  +  L +L+RLNI I+V S L+YLH     PI HCDLKP NVLLDD++ AH+SDFG
Sbjct:   800 EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFG 859

Query:   335 IAKLLTGEDQS-----MTQTQTLATIGYMAP 360
             +A+LL   D+      ++      TIGY AP
Sbjct:   860 LARLLLKFDEESFFNQLSSAGVRGTIGYAAP 890

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)]

 Score = 328 (120.5 bits), Expect = 4.2e-38, Sum P(2) = 4.2e-38
 Identities = 75/183 (40%), Positives = 100/183 (54%)

Query:   190 FSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDV-----------ECEV 238
             F+Y EL  AT  F  +N +G G FG+VYK  L DG E A+K   +           E   
Sbjct:   698 FTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIA 757

Query:   239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTS 297
             + S+ HRNLVK+   C   D R LV EY+ NGSL++ L+    + LD   R  I + V  
Sbjct:   758 ISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLHLDWSTRYEICLGVAR 817

Query:   298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
              L YLH   S  IIH D+K  N+LLD  +V  +SDFG+AKL   + ++   T+   TIGY
Sbjct:   818 GLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYD-DKKTHISTRVAGTIGY 876

Query:   358 MAP 360
             +AP
Sbjct:   877 LAP 879

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 327 (120.2 bits), Expect = 4.7e-38, Sum P(2) = 4.7e-38
 Identities = 72/151 (47%), Positives = 96/151 (63%)

Query:   228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDF-----RALVLEYMTNGSLEKVLYSSNC- 281
             A+KSF  ECE +K I HRNLVK++++C++ DF     RAL+ E+M NGSL+K L+     
Sbjct:   739 AMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVE 798

Query:   282 -------ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG 334
                     L +L+RLNI I+V S L+YLH     PI HCDLKP N+LLDD++ AH+SDFG
Sbjct:   799 EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFG 858

Query:   335 IAKLLTGEDQS-----MTQTQTLATIGYMAP 360
             +A+LL   DQ      ++      TIGY AP
Sbjct:   859 LARLLLKFDQESFFNQLSSAGVRGTIGYAAP 889

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 323 (118.8 bits), Expect = 4.8e-38, Sum P(2) = 4.8e-38
 Identities = 81/199 (40%), Positives = 106/199 (53%)

Query:   177 NVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----- 231
             NVA  +     R+ ++  LL ATNGFSA+++IG G FG VYKA+L DG   AIK      
Sbjct:   835 NVATFEKPL--RKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVT 892

Query:   232 ------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSN----C 281
                   F  E E +  I HRNLV ++  C   + R LV EYM  GSLE VL+        
Sbjct:   893 GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGI 952

Query:   282 ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG 341
              LD   R  I I     L +LH      IIH D+K  NVLLD + VA +SDFG+A+L++ 
Sbjct:   953 FLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSA 1012

Query:   342 EDQSMTQTQTLATIGYMAP 360
              D  ++ +    T GY+ P
Sbjct:  1013 LDTHLSVSTLAGTPGYVPP 1031

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 311 (114.5 bits), Expect = 4.5e-37, Sum P(2) = 4.5e-37
 Identities = 69/151 (45%), Positives = 96/151 (63%)

Query:   228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDF-----RALVLEYMTNGSLEKVLYSSNC- 281
             A+KSF  ECE +K   HRNLVK++++C++ DF     RAL+ EY+ NGS++  L+     
Sbjct:   741 AMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVE 800

Query:   282 -------ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG 334
                     L +L+RLNI+I+V S L+YLH     PI HCDLKP NVLL+D++ AH+SDFG
Sbjct:   801 EIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFG 860

Query:   335 IAKLLTGEDQS--MTQTQTLA---TIGYMAP 360
             +A+LL   D+   + Q  +     TIGY AP
Sbjct:   861 LARLLLKFDKESFLNQLSSAGVRGTIGYAAP 891

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)]

 Score = 310 (114.2 bits), Expect = 1.6e-36, Sum P(2) = 1.6e-36
 Identities = 69/191 (36%), Positives = 110/191 (57%)

Query:   183 PQA-SRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK----------- 230
             PQ    + F++ EL + T+ FS  N +G G +G VY+  L +G   AIK           
Sbjct:   611 PQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGL 670

Query:   231 SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRL 289
              F  E E++  +HH+N+V+++  C + + + LV EY++NGSL+  L   + I LD  +RL
Sbjct:   671 EFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGIRLDWTRRL 730

Query:   290 NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 349
              I +     L YLH     PIIH D+K +N+LLD+N+ A ++DFG++KL+   +++   T
Sbjct:   731 KIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVTT 790

Query:   350 QTLATIGYMAP 360
             Q   T+GY+ P
Sbjct:   791 QVKGTMGYLDP 801

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0044242 "cellular lipid catabolic process" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 294 (108.6 bits), Expect = 2.2e-36, Sum P(2) = 2.2e-36
 Identities = 69/151 (45%), Positives = 88/151 (58%)

Query:   228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDF-----RALVLEYMTNGSLEKVLYSSNC- 281
             A KSF  ECE +  I HRNLVK+++ CS+ DF     RALV E+M NG+L+  L+     
Sbjct:   757 AAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIE 816

Query:   282 -------ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG 334
                     L +  RLNI I+V SAL YLH     PI HCD+KP N+LLD ++ AH+SDFG
Sbjct:   817 ETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFG 876

Query:   335 IAKLLTGEDQSMTQTQ-----TLATIGYMAP 360
             +A+LL   D+     Q        TIGY AP
Sbjct:   877 LAQLLLKFDRDTFHIQFSSAGVRGTIGYAAP 907

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)]

 Score = 317 (116.6 bits), Expect = 3.1e-36, Sum P(2) = 3.1e-36
 Identities = 71/191 (37%), Positives = 108/191 (56%)

Query:   183 PQA-SRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK----------- 230
             PQ    + F++ EL + TN FS  N +G G +G VYK  L +G   AIK           
Sbjct:   614 PQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAF 673

Query:   231 SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRL 289
              F  E E++  +HH+N+VK++  C ++  + LV EY+ NGSL   L   N + LD  +RL
Sbjct:   674 EFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRRL 733

Query:   290 NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 349
              I +     L YLH     PIIH D+K +N+LLD+++ A ++DFG++KL+   +++   T
Sbjct:   734 KIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVTT 793

Query:   350 QTLATIGYMAP 360
             Q   T+GY+ P
Sbjct:   794 QVKGTMGYLDP 804

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	360
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-41
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-37
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-26
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-20
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-18
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-13
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-05
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-05
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-04
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-04
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.001
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.001
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	0.001
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	0.001
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	0.002
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.003
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  143 bits (362), Expect = 4e-41
 Identities = 63/167 (37%), Positives = 89/167 (53%), Gaps = 19/167 (11%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           +G G FG+VY AR  + G + AIK                E E++K ++H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            +E+   LV+EY   GSL+ +L  +   L   + L I++ +   LEYLH   S  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 315 LKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LKP N+LLD DN    L+DFG++KLLT +   +       T  YMAP
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  138 bits (351), Expect = 5e-39
 Identities = 61/167 (36%), Positives = 86/167 (51%), Gaps = 20/167 (11%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           +G GSFG+VYKA+ +  G   A+K                 E  +++ + H N+V++I +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
             ++D   LV+EY   G L   L S    L   +   I + +   LEYLH   S  IIH 
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHR 122

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DLKP N+LLD+N V  ++DFG+AK L     S+T T    T  YMAP
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAP 167

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  135 bits (342), Expect = 1e-37
 Identities = 58/168 (34%), Positives = 82/168 (48%), Gaps = 20/168 (11%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIK------------SFDVECEVMKSIHHRNLVKIIS 252
             +G GSFG VY AR  + G   AIK                E +++K + H N+V++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
              +ED   LV+EY   G L  +L      L   +    +  + SALEYLH   S  I+H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+LLD++    L+DFG+A+ L   ++  T   T     YMAP
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  123 bits (310), Expect = 9e-31
 Identities = 113/400 (28%), Positives = 173/400 (43%), Gaps = 73/400 (18%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQG 64
           L  LDL  N+ SG++P    +L+ L  L                 S N L G+IP  +  
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQL---------------KLSENKLSGEIPDELSS 521

Query: 65  LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL----------- 113
            K L  L L HN+L G IP SF ++  L  LDLS N LS  IP +L  +           
Sbjct: 522 CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN 581

Query: 114 LLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQ-VPPCKSNKP---------------II 157
            L G +P  G F   ++ +  GN  LCG      +PPCK  +                ++
Sbjct: 582 HLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLV 641

Query: 158 LAL-KFGLISRCQKRATELPNVAN------MQPQASR--RRFSYLELLRATNGFSANNLI 208
           LAL  FG +    +   EL  V N      +Q   S+  +  +  ++L +       N+I
Sbjct: 642 LALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLK---EENVI 698

Query: 209 GRGSFGSVYKAR-LQDGMEFAIKSFD-------VECEVMKSIHHRNLVKIISSCSNEDFR 260
            RG  G+ YK + +++GM+F +K  +        E   M  + H N+VK+I  C +E   
Sbjct: 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGA 758

Query: 261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV 320
            L+ EY+   +L +VL +    L   +R  I I +  AL +LH   S  ++  +L P  +
Sbjct: 759 YLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI 814

Query: 321 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           ++D     HL    +  LL       T T+   +  Y+AP
Sbjct: 815 IIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAP 847

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  116 bits (292), Expect = 2e-30
 Identities = 56/172 (32%), Positives = 84/172 (48%), Gaps = 22/172 (12%)

Query: 206 NLIGRGSFGSVYKARLQD-GMEFAIKSFDV-------------ECEVMKSIHHRNLVKII 251
            L+GRGSFGSVY A  +D G   A+KS ++             E  ++ S+ H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 252 SSCSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDIL-QRLNIMINVTSALEYLHFGFST 308
            S  +E+   L   LEY++ GSL  +L     + + + ++    I     L YLH   S 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--LEGLAYLH---SN 120

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            I+H D+K  N+L+D + V  L+DFG AK L   +          T  +MAP
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  114 bits (287), Expect = 1e-29
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 20/170 (11%)

Query: 208 IGRGSFGSVYKARLQDGMEF-----AIKSFDV------------ECEVMKSIHHRNLVKI 250
           +G G+FG VYK  L+   E      A+K+               E  +MK + H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
           +  C+  +   +V EYM  G L   L      L +   L + + +   +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +H DL   N L+ +N+V  +SDFG+++ +  +D    +      I +MAP
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  113 bits (286), Expect = 2e-29
 Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 21/173 (12%)

Query: 205 NNLIGRGSFGSVYKARL-----------------QDGMEFAIKSFDVECEVMKSIHHRNL 247
              +G G+FG VYK +L                 +D  E  I+ F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++  C+ E+   +V+EYM  G L   L  +   L +   L+  + +   +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IH DL   N L+ +N+V  +SDFG+++ L  +D    +      I +MAP
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAP 172

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  110 bits (277), Expect = 3e-28
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 22/174 (12%)

Query: 205 NNLIGRGSFGSVYKARL-----------------QDGMEFAIKSFDVECEVMKSIHHRNL 247
              +G G+FG VYK  L                 +D  E  I+ F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVL-YSSNCILDILQRLNIMINVTSALEYLHFGF 306
           VK++  C+ E+   +V+EYM  G L   L  +    L +   L+  + +   +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S   IH DL   N L+ +N+V  +SDFG+++ L  +D           I +MAP
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAP 173

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 6e-28
 Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 27/179 (15%)

Query: 206 NLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLVK 249
             +G G+FG VYK +L+       E A+K+            F  E  VMK + H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNC--------ILDILQRLNIMINVTSALEY 301
           ++  C+ E+   LVLEYM  G L   L  S           L +   L+  I +   +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L    S   +H DL   N L+ +++V  +SDFG+++ +  +D    +T     I +MAP
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  106 bits (266), Expect = 1e-26
 Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 22/172 (12%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII 251
             IG+GSFG VY  R   DG  + +K  D+             E +++K ++H N++K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL---QRLNIMINVTSALEYLHFGFST 308
            S   +    +V+EY   G L + +             Q L+  + +  AL+YLH   S 
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SR 122

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            I+H D+KP N+ L  N +  L DFGI+K+L+     + +T  + T  Y++P
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV-VGTPYYLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  103 bits (258), Expect = 2e-25
 Identities = 57/165 (34%), Positives = 82/165 (49%), Gaps = 18/165 (10%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG+G FG VYKAR  + G E AIK   +           E +++K   H N+VK   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            +D   +V+E+ + GSL+ +L S+N  L   Q   +   +   LEYLH   S  IIH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+LL  +    L DFG++  L+      T    + T  +MAP
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 6e-23
 Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 20/169 (11%)

Query: 206 NLIGRGSFGSVYKARLQDGMEF-AIKSFDV-------------ECEVMKSIHHRNLVKII 251
           +LIGRG+FG VYK    +  +F AIK   +             E +++K++ H N+VK I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            S    D   ++LEY  NGSL +++       + L     +  V   L YLH      +I
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-AVYVYQVLQGLAYLH---EQGVI 121

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H D+K  N+L   + V  L+DFG+A  L    +       + T  +MAP
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.9 bits (237), Expect = 1e-22
 Identities = 56/169 (33%), Positives = 77/169 (45%), Gaps = 23/169 (13%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFD--------------VECEVMKSIHHRNLVKIIS 252
           +G+GSFG V   R    G  +A+K                  E  ++  I+H  +VK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           +   E+   LVLEY   G L   L       +   R      +  ALEYLH   S  II+
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGIIY 116

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
            DLKP N+LLD +    L+DFG+AK L+ E     +T T   T  Y+AP
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 93.4 bits (233), Expect = 9e-22
 Identities = 54/164 (32%), Positives = 78/164 (47%), Gaps = 16/164 (9%)

Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDVECE----------VMKSIHHRNLVKIISSCSN 256
           IG G+ G VYKA     G E AIK   +  +          +MK   H N+V    S   
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86

Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
            D   +V+EYM  GSL  ++  +   ++  Q   +   V   LEYLH   S  +IH D+K
Sbjct: 87  GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIK 143

Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             N+LL  +    L+DFG A  LT +++S   +  + T  +MAP
Sbjct: 144 SDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSV-VGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.0 bits (224), Expect = 8e-21
 Identities = 55/182 (30%), Positives = 78/182 (42%), Gaps = 39/182 (21%)

Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFD-------------VECEVMKSIHHRNLVKIISS 253
           IG+GSFG+V K  R  DG     K  D              E  +++ + H N+V+    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 254 CSNEDFRAL--VLEYMTNGSLEKVLYSSNC-----------ILDILQRLNIMINVTSALE 300
             +   + L  V+EY   G L +++    C           I  IL +L        AL 
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIWRILTQL------LLALY 119

Query: 301 YLHFGF--STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
             H        ++H DLKP N+ LD N    L DFG+AK+L G D S  +T  + T  YM
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT-YVGTPYYM 177

Query: 359 AP 360
           +P
Sbjct: 178 SP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 90.1 bits (224), Expect = 9e-21
 Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 32/180 (17%)

Query: 201 GFSANNLIGRGSFGSVYKARLQDGME-FAIK--------------SFDVECEVMKSIHHR 245
            F    +IG+G+FG V   + +D  + FA+K              +   E  +++ ++H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 246 NLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSALE 300
            LV +  S  +E+   LV++ +  G L     +KV +S   +     +   +  +  ALE
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV-----KF-WICEIVLALE 114

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YLH   S  IIH D+KP N+LLD+    H++DF IA  +T +  +   T T  T GYMAP
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 60/173 (34%), Positives = 85/173 (49%), Gaps = 24/173 (13%)

Query: 206 NLIGRGSFGSVYKA--------------RLQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           N IG G+FG VY A              R+QD     IK    E +V++ + H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD--ILQRLNIMINVTSALEYLHFGFSTP 309
               + +   + +EY + G+LE++L     ILD  +++   + +     L YLH   S  
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQL--LEGLAYLH---SHG 119

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM-TQTQTLA-TIGYMAP 360
           I+H D+KP N+ LD N V  L DFG A  L     +M  + Q+LA T  YMAP
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 26/170 (15%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKS--FDVECEVMKSIHHRNLVKIISSCSNED------ 258
           +G+GS G VYK R +  G  +A+K    D + E  K +     +K + SC +        
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL--LRELKTLRSCESPYVVKCYG 66

Query: 259 --FR----ALVLEYMTNGSLEKVLYSSNCILD-ILQRLNIMINVTSALEYLHFGFSTPII 311
             ++    ++VLEYM  GSL  +L     I + +L    I   +   L+YLH      II
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY--IARQILKGLDYLHTKRH--II 122

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
           H D+KP N+L++      ++DFGI+K+L   + ++ Q  T + T+ YM+P
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 8e-20
 Identities = 46/142 (32%), Positives = 72/142 (50%), Gaps = 15/142 (10%)

Query: 207 LIGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSN 256
            IG+G FG V     + G + A+K          +F  E  VM ++ H NLV+++     
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 257 EDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            +   +V EYM  GSL   L S    ++ + Q+L   ++V   +EYL        +H DL
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDL 128

Query: 316 KPHNVLLDDNIVAHLSDFGIAK 337
              NVL+ +++VA +SDFG+AK
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 87.2 bits (217), Expect = 1e-19
 Identities = 56/166 (33%), Positives = 81/166 (48%), Gaps = 25/166 (15%)

Query: 207 LIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVM-KSIHHRNLVKI 250
           +IG GSF +V  A+ +    E+AIK  D              +E EV+ +   H  ++K+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSALEYLHFGFST 308
             +  +E+    VLEY  NG L + +  Y S   LD          +  ALEYLH   S 
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
            IIH DLKP N+LLD ++   ++DFG AK+L   + S    +  AT
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDAT 166

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 87.5 bits (215), Expect = 4e-19
 Identities = 65/176 (36%), Positives = 86/176 (48%), Gaps = 27/176 (15%)

Query: 207 LIGRGSFGSVYKARLQDGMEFAIKSFDV--------------ECEVMKSI-HHRNLVKII 251
            +G GSFG VY AR  D    A+K                  E +++ S+ H  N+VK+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
               +E    LV+EY+  GSLE +L        L   + L I+  + SALEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 310 IIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLA----TIGYMAP 360
           IIH D+KP N+LLD D  V  L DFG+AKLL     + +     +    T GYMAP
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Length = 384

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 56/182 (30%), Positives = 79/182 (43%), Gaps = 41/182 (22%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV---------ECEVMKSIHHRNLVKII 251
           F     +G GS+GSVYKA   + G   AIK   V         E  ++K      +VK  
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN----------IMINVTSALEY 301
            S        +V+EY   GS          + DI++  N          I+      LEY
Sbjct: 65  GSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGLEY 114

Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YM 358
           LH   S   IH D+K  N+LL++   A L+DFG++  LT    +M +  T+  IG   +M
Sbjct: 115 LH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTV--IGTPFWM 166

Query: 359 AP 360
           AP
Sbjct: 167 AP 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 2e-18
 Identities = 46/143 (32%), Positives = 72/143 (50%), Gaps = 15/143 (10%)

Query: 207 LIGRGSFGSVYKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSC 254
            IG+G+FG VYK  L+   E A+K+            F  E E++K   H N+VK+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
             +    +V+E +  GSL   L      L + + L + ++  + +EYL    S   IH D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 315 LKPHNVLLDDNIVAHLSDFGIAK 337
           L   N L+ +N V  +SDFG+++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 83.0 bits (205), Expect = 3e-18
 Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 19/151 (12%)

Query: 206 NLIGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIIS 252
           + +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++ 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPII 311
            C+ E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        I
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           H DL   N L+ +N +  ++DFG+++L+TG+
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 81.7 bits (202), Expect = 7e-18
 Identities = 54/182 (29%), Positives = 82/182 (45%), Gaps = 34/182 (18%)

Query: 201 GFSANNLIGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRN 246
            F     +G+GS+GSVYK  RL D   +A+K  D+             E  ++ S++H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 247 LVKIISSCSNEDF-----RALVLEYMTNGSLEKVLYSSNCILDILQR---LNIMINVTSA 298
           ++        E F       +V+EY   G L K +        ++       I I +   
Sbjct: 61  II-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           L+ LH      I+H DLK  N+LL  N +  + D GI+K+L    ++M +TQ   T  YM
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYM 168

Query: 359 AP 360
           AP
Sbjct: 169 AP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 82.2 bits (204), Expect = 8e-18
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 25/159 (15%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII-- 251
           IG G++G VYKAR  + G   A+K   +             E ++++ + H N+V++   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 252 --SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             S      +  +V EYM +  L  +L S        Q    M  +   L+YLH   S  
Sbjct: 67  VTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNG 120

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMT 347
           I+H D+K  N+L++++ V  L+DFG+A+  T       T
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 44/143 (30%), Positives = 73/143 (51%), Gaps = 14/143 (9%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+K          +F  E ++MK + H  LV++ + CS E
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
           +   +V EYM+ GSL   L S     L + Q +++   +   + YL    S   IH DL 
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLA 130

Query: 317 PHNVLLDDNIVAHLSDFGIAKLL 339
             N+L+ +N+V  ++DFG+A+L+
Sbjct: 131 ARNILVGENLVCKIADFGLARLI 153

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 23/172 (13%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV----------------ECEVMKSIHHRNLV 248
             +G G++  VYKAR  + G   AIK   +                E ++++ + H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
            ++    ++    LV E+M    LEKV+   + +L      + M+     LEYLH  +  
Sbjct: 66  GLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            I+H DLKP+N+L+  + V  L+DFG+A+     ++ MT  Q + T  Y AP
Sbjct: 123 -ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAP 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 52/176 (29%), Positives = 79/176 (44%), Gaps = 32/176 (18%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G+   VY A  L +  + AIK  D+            E + M   +H N+VK  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSS--------NCILDILQRLNIMINVTSALEYLHFGF 306
              D   LV+ Y++ GSL  ++ SS          I  +L+       V   LEYLH   
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK------EVLKGLEYLH--- 119

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL--TGEDQSMTQTQTLATIGYMAP 360
           S   IH D+K  N+LL ++    ++DFG++  L   G+     +   + T  +MAP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 79.4 bits (196), Expect = 7e-17
 Identities = 49/187 (26%), Positives = 76/187 (40%), Gaps = 40/187 (21%)

Query: 208 IGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG V+           D    A+K+            F+ E E++ +  H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL-------------QRLNIMINVT 296
               C+  D   +V EYM +G L K L S       L             Q L I + + 
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 297 SALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 353
           S + YL   HF      +H DL   N L+  ++V  + DFG+++ +   D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 354 TIGYMAP 360
            I +M P
Sbjct: 187 PIRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 29/181 (16%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKS----FDV---------ECEVMKSIHHRNL 247
           +     IG G++G V  A   + G + AIK     FD          E ++++ + H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 248 VK---IISSCSNEDFRAL--VLEYM-TNGSLEKVLYSSNCI-LDILQRLNIMINVTSALE 300
           +    I+   S EDF  +  V E M T+  L KV+ S   +  D +Q    +  +   L+
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQY--FLYQILRGLK 117

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMA 359
           YLH   S  +IH DLKP N+L++ N    + DFG+A+ +  ++      T+ + T  Y A
Sbjct: 118 YLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174

Query: 360 P 360
           P
Sbjct: 175 P 175

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 1e-16
 Identities = 53/167 (31%), Positives = 79/167 (47%), Gaps = 20/167 (11%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKS--FDVECE-----------VMKSIHHRNLVKIISS 253
           +G G++G VYKAR  + G   A+K    D E E           ++K + H N+VK++  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    LV EY     L+K L      L      +IM  +   L Y H   S  I+H 
Sbjct: 67  IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DLKP N+L++ + V  L+DFG+A+      ++   T  + T+ Y AP
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAP 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 54/174 (31%), Positives = 81/174 (46%), Gaps = 30/174 (17%)

Query: 207 LIGRGSFGSVYKA-RLQDGMEFAIKSFDV----------------ECEVMKSIHHRNLVK 249
           L+G GSFGSVY+   L DG  FA+K   +                E  ++  + H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
            + +   ED   + LE +  GSL K+L       + + RL     +   LEYLH      
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLEYLH---DRN 122

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
            +H D+K  N+L+D N V  L+DFG+AK      Q +  +   +  G   +MAP
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 25/174 (14%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVMKSIHHRNLVKIIS 252
           I +G++G V+ A+    G  +AIK                  E +++       +VK+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           S   +    LV+EY+  G L  +L +   + + + R   +  +  ALEYLH   S  IIH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLH---SNGIIH 116

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKL------LTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+L+D N    L+DFG++K+      +   D      + + T  Y+AP
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 22/157 (14%)

Query: 206 NLIGRGSFGSVYKARL-----QDGMEFAIKS------------FDVECEVMKSIHHRNLV 248
             +G G FG V   R        G + A+KS            F+ E E+++++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 249 KIISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           K    C     R+  L++EY+ +GSL   L      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           S   IH DL   N+L++   +  +SDFG+AK+L  + 
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 76.3 bits (188), Expect = 6e-16
 Identities = 39/150 (26%), Positives = 73/150 (48%), Gaps = 15/150 (10%)

Query: 202 FSANNLIGRGSFGSVYKARLQDGMEFAIK-----------SFDVECEVMKSIHHRNLVKI 250
           F+    +G G FG V++   ++ +  AIK            F  E + +K + H++L+ +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTP 309
            + CS  +   ++ E M  GSL   L S    +L +   +++   V   + YL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+ +++V  ++DFG+A+L+
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 7e-16
 Identities = 53/168 (31%), Positives = 80/168 (47%), Gaps = 19/168 (11%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF-------DV------ECEVMKSIHHRNLVKIIS 252
           ++G G++G V K R +  G   AIK F       DV      E +V++ + H N+V +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           +   +    LV EY+    LE +L +S   L      + +  +  A+ Y H   S  IIH
Sbjct: 68  AFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            D+KP N+L+ ++ V  L DFG A+ L     S   T  +AT  Y AP
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAP 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.1 bits (188), Expect = 8e-16
 Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 42/178 (23%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFD------------VECE--VMKSIHHRNLVKIIS 252
           +G G FG V   +++     FA+K               +  E  +++  +H  +VK+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMIN---------VTSALEYLH 303
           +  ++ +  +++EY   G L            IL+   +            V  A EYLH
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL----------WTILRDRGLFDEYTARFYIACVVLAFEYLH 110

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
              +  II+ DLKP N+LLD N    L DFG AK L    +S  +T T   T  Y+AP
Sbjct: 111 ---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 23/168 (13%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           +G G+ G V K   +  G   A+K+  +            E +++   +   +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 255 SNEDFRALVLEYMTNGSLEKVL-YSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIH 312
            N    ++ +EYM  GSL+K+L      I   IL +  I + V   L YLH      IIH
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--IIH 124

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            D+KP N+L++      L DFG++  L     S+ +T    T  YMAP
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 31/173 (17%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII-- 251
           IG G+ G V+KA+  + G   A+K   +             E + +++  H  +VK++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 252 ----SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
               S         LV+EYM    L +VL      L   Q  + M  +   + Y+H   +
Sbjct: 68  FPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---A 117

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             I+H DLKP N+L+  + V  ++DFG+A+L + E+     +  +AT  Y AP
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLYSHQVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 20/167 (11%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG G++G VYKAR    G   AIK   +             E +++K ++H N++K++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
             ++    LV E+M +  L K++      L      + +  +   L + H   S  I+H 
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DLKP N+L++   V  L+DFG+A+           T  + T  Y AP
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAP 167

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 7e-15
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V++    +    A+K+          F  E ++MK + H  L+++ + C+ E
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73

Query: 258 DFRALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
           +   +V E M  GSL + L       L + Q +++   V S + YL    +   IH DL 
Sbjct: 74  EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLA 130

Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             NVL+ +N +  ++DFG+A+++  ED    +      I + AP
Sbjct: 131 ARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 14/163 (8%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           IG G FG V+     +  + AIK+          F  E +VM  + H  LV++   C+  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               LV E+M +G L   L +          L + ++V   + YL    S+ +IH DL  
Sbjct: 72  SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAA 128

Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +P
Sbjct: 129 RNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSP 170

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 17/165 (10%)

Query: 208 IGRGSFGSVYKARLQDGMEFA------IKS------FDVECEVMKSIHHRNLVKIISSCS 255
           +G G+FG VYKA+ ++   FA      I+S      F VE +++    H N+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            E+   +++E+   G+L+ ++      L   Q   +   +  AL +LH   S  +IH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+LL  +    L+DFG++       Q   +   + T  +MAP
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 25/162 (15%)

Query: 207 LIGRGSFGSVYKA-RLQDGMEFAIKSFDV--------------------ECEVMKSIHHR 245
           LIG GSFGSVY       G   A+K  ++                    E  ++K + H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 246 NLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
           N+V+ + S  + D   + LEY+  GS+  +L +     + L R N +  +   L YLH  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
            +  IIH D+K  N+L+D+     +SDFGI+K L     S  
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK 164

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 36/186 (19%)

Query: 208 IGRGSFGSVYKARL--QDGME----FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VYK  L   +        AIK+            F  E E+M  + H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMIN 294
           ++  C+ E    ++ EY+ +G L + L  ++                 LD    L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
           + + +EYL    S   +H DL   N L+ + +   +SDFG+++ +   D    Q+++L  
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 355 IGYMAP 360
           + +M P
Sbjct: 190 VRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 55/175 (31%), Positives = 78/175 (44%), Gaps = 38/175 (21%)

Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFDV--------------ECEVMKSIHHRNLVKIIS 252
           +G GSFG V   R +   + +A+K                  E  +++SI H  LV +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMI------NVTSALEYLHFGF 306
           S  ++    LV+EY+  G L   L  S        R    +       V  ALEYLH   
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLALEYLH--- 118

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           S  I++ DLKP N+LLD +    ++DFG AK + G      +T TL  T  Y+AP
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 13/140 (9%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+  + +  ++ AIK           F  E +VM  + H NLV++   C+ +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               +V EYM NG L   L      L     L++  +V  A+EYL    S   IH DL  
Sbjct: 72  RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAA 128

Query: 318 HNVLLDDNIVAHLSDFGIAK 337
            N L+ ++ V  +SDFG+A+
Sbjct: 129 RNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 71.8 bits (176), Expect = 2e-14
 Identities = 42/140 (30%), Positives = 62/140 (44%), Gaps = 13/140 (9%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + AIK           F  E +VM  + H  LV++   C+ +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               +V EYM+NG L   L          Q L +  +V   + YL    S   IH DL  
Sbjct: 72  RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAA 128

Query: 318 HNVLLDDNIVAHLSDFGIAK 337
            N L+DD     +SDFG+++
Sbjct: 129 RNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 51/168 (30%), Positives = 78/168 (46%), Gaps = 20/168 (11%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF-------DV------ECEVMKSIHHRNLVKIIS 252
           L+G GS+G V K + ++ G   AIK F        V      E  ++K + H NLV +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
               +    LV E++ +  L+ +    N  LD  +    +  +   +E+ H   S  IIH
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH---SHNIIH 123

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            D+KP N+L+  + V  L DFG A+ L    +    T  +AT  Y AP
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 55/179 (30%), Positives = 84/179 (46%), Gaps = 27/179 (15%)

Query: 202 FSANN---LIGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRN 246
           +  N    ++G+G++G VY AR L   +  AIK               E  +   + HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMI----NVTSALEYL 302
           +V+ + S S   F  + +E +  GSL  +L S    L        +I     +   L+YL
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLK--DNEQTIIFYTKQILEGLKYL 124

Query: 303 HFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H      I+H D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ YMAP
Sbjct: 125 H---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 30/159 (18%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           L L    L G IP   S L  L++++L               S N++ G+IP ++  + S
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINL---------------SGNSIRGNIPPSLGSITS 467

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTK 127
           L+ L L +N   GSIP S   L SL  L+L+ N+LS  +P +L   LL            
Sbjct: 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR---------- 517

Query: 128 FSSKSFIGNDLLCGSPNLQVPPCKSNKPII--LALKFGL 164
            +S +F  N  LCG P L    C  +  +   + + FG+
Sbjct: 518 -ASFNFTDNAGLCGIPGL--RACGPHLSVGAKIGIAFGV 553

Length = 623

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 27/170 (15%)

Query: 208 IGRGSFGSVYKAR--------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKIISS 253
           IG G++G VYKAR              L+ G +F I     E  ++K   H N+V    S
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI--IQQEISMLKECRHPNIVAYFGS 68

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
               D   +V+EY   GSL+ +   +   L  LQ   +       L YLH    T  IH 
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHR 125

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
           D+K  N+LL ++    L+DFG++  LT    ++ + ++   IG   +MAP
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSF--IGTPYWMAP 170

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 57/181 (31%), Positives = 78/181 (43%), Gaps = 29/181 (16%)

Query: 200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSFDV------------ECEVMKSIHHRN 246
                 + +G G+ GSV K RL   GM FA+K+               E E+ KS     
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 247 LVKIISSCSNEDFR--ALVLEYMTNGSLE----KVLYSSNCILD-ILQRLNIMINVTSAL 299
           +VK   +  +E      + +EY   GSL+    KV      I + +L +  I  +V   L
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK--IAESVLKGL 118

Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            YLH   S  IIH D+KP N+LL       L DFG++  L     + T T    T  YMA
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFT---GTSFYMA 171

Query: 360 P 360
           P
Sbjct: 172 P 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 20/163 (12%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHRNLVKIISSCSNED 258
           IG G FG+V +     G + A+K         +F  E  VM  +HH+NLV+++    +  
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72

Query: 259 FRALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
              +V+E M+ G+L   L +    ++ ++Q L   ++V   +EYL    S  ++H DL  
Sbjct: 73  LY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAA 128

Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            N+L+ ++ VA +SDFG+A++      SM    +   + + AP
Sbjct: 129 RNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAP 166

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 17/154 (11%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73

Query: 258 DFRALVLEYMTNGSLEKVLY-SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 74  PIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 129

Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 130 AANILVGENLVCKVADFGLARLI--EDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 49/179 (27%), Positives = 77/179 (43%), Gaps = 30/179 (16%)

Query: 202 FSANNLIGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNL 247
           F   N IG+GSFG V+K  R  D   +A+K  D+             E  V+  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL------NIMINVTSALEY 301
           ++   S  ++    +V+EY  NG L K+L          + L         I +   L +
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAH 116

Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LH   S  I+H D+K  N+ LD      + D G+AKLL+  D +      + T  Y++P
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.5 bits (170), Expect = 1e-13
 Identities = 49/170 (28%), Positives = 87/170 (51%), Gaps = 22/170 (12%)

Query: 207 LIGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS 252
           ++GRG+FG V+   R  D     IK   V             EC+V+K + H N+++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPII 311
           +   +    +V+EY   G+L + +    N +LD    L+  + +  AL ++H   +  I+
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 312 HCDLKPHNVLLDDN-IVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H DLK  N+LLD + +V  + DFGI+K+L+ + ++ T    + T  Y++P
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 38/182 (20%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSI---HHRNLV 248
             IG G++G+VYKAR L  G   A+K   V             E  ++K +    H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 249 KIISSC-----SNEDFRALVLEYMTNGSLEKVL--YSSNCI---LDILQRLNIMINVTSA 298
           +++  C       E    LV E++     ++ L  Y S C    L      ++M  +   
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           +++LH   S  I+H DLKP N+L+  +    ++DFG+A++ + E   M  T  + T+ Y 
Sbjct: 120 VDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLWYR 173

Query: 359 AP 360
           AP
Sbjct: 174 AP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 45/106 (42%), Positives = 56/106 (52%), Gaps = 15/106 (14%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           LDL GN L G IP   +NLT+L  L L SN+L               +G IP  +  +KS
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL---------------VGQIPRELGQMKS 213

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           L+++ LG+N L G IP     L SL  LDL  NNL+  IP SL  L
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259

Length = 968

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 20/164 (12%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHRNLVKIISSCSNED 258
           IG+G FG V     + G + A+K         +F  E  VM  + H NLV+++     E 
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72

Query: 259 FRA-LVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM  GSL   L S    +L     L   ++V  A+EYL    +   +H DL 
Sbjct: 73  GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLA 129

Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 130 ARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 32/191 (16%)

Query: 184 QASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIK------------ 230
            A     S  EL R        N IG G+ G+VYK   +  G  +A+K            
Sbjct: 65  SAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR 117

Query: 231 SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN 290
               E E+++ ++H N+VK      +     ++LE+M  GSLE    +    L  + R  
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-- 175

Query: 291 IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-T 349
               + S + YLH      I+H D+KP N+L++      ++DFG++++L    Q+M    
Sbjct: 176 ---QILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA---QTMDPCN 226

Query: 350 QTLATIGYMAP 360
            ++ TI YM+P
Sbjct: 227 SSVGTIAYMSP 237

Length = 353

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 19/165 (11%)

Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG+G+ G+VY A  +  G E AIK  ++           E  VM+   H N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+EY+  GSL  V+  +   +D  Q   +      ALE+LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+LL  +    L+DFG    +T E     ++  + T  +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 18/161 (11%)

Query: 207 LIGRGSFGSVYKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSC 254
           L+G+G+FG V+K  L+D    A+K+            F  E  ++K   H N+VK+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
           +      +V+E +  G     L      L   Q +   ++  + + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
           L   N L+ +N V  +SDFG+++    ED  +  +  L  I
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQI 156

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 16/143 (11%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSC 254
           IGRG+FG V+  RL+ D    A+KS            F  E  ++K   H N+V++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
           + +    +V+E +  G     L +    L + + + ++ N  + +EYL    S   IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 315 LKPHNVLLDDNIVAHLSDFGIAK 337
           L   N L+ +  V  +SDFG+++
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 54/173 (31%), Positives = 76/173 (43%), Gaps = 32/173 (18%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDVECE--------------VMKSIHHRNLVKIIS 252
           IG GS+G V+K R ++ G   AIK F VE E              ++K + H NLV +I 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLI- 66

Query: 253 SCSNEDFRA-----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
               E FR      LV EY  +  L ++  +    +       I+     A+ + H    
Sbjct: 67  ----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCH---K 118

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IH D+KP N+L+       L DFG A++LTG       T  +AT  Y AP
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 38/159 (23%), Positives = 66/159 (41%), Gaps = 31/159 (19%)

Query: 205 NNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------------------ECEV 238
              +G G++G V KA     G   AIK   +                         E ++
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           M  I H N++ ++      DF  LV++ M    L+KV+      L   Q   I++ + + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV-DRKIRLTESQVKCILLQILNG 131

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
           L  LH  +    +H DL P N+ ++   +  ++DFG+A+
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 32/179 (17%)

Query: 207 LIGRGSFGSVYKA----------------------RLQDGMEFAIKSFDVECEVMKSIHH 244
           LIG+G++G VY A                      R     +  +K+   E E +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
            N+V+ +   + E++ ++ LEY+  GS+   L +     + L R      V   L YLH 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL---LTGEDQSMTQTQTLATIGYMAP 360
             S  I+H DLK  N+L+D + +  +SDFGI+K    +   DQ+M+      ++ +MAP
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFWMAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 69.5 bits (170), Expect = 8e-13
 Identities = 56/153 (36%), Positives = 68/153 (44%), Gaps = 42/153 (27%)

Query: 13  NKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLS 72
           N LSG IP     LT+L +L               D   NNL G IP+++  LK+LQ+L 
Sbjct: 222 NNLSGEIPYEIGGLTSLNHL---------------DLVYNNLTGPIPSSLGNLKNLQYLF 266

Query: 73  LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP------LSLEKLLL-----EGEIPR 121
           L  N+L G IP S   L  L SLDLS+N+LS  IP       +LE L L      G+IP 
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326

Query: 122 GGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNK 154
                            L   P LQV    SNK
Sbjct: 327 A----------------LTSLPRLQVLQLWSNK 343

Length = 968

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 49/187 (26%), Positives = 78/187 (41%), Gaps = 40/187 (21%)

Query: 208 IGRGSFGSVYKARL------QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKI 250
           +G G+FG V+ A        QD M  A+K+           F  E E++  + H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL--------------QRLNIMINVT 296
              C+      +V EYM +G L + L S      IL              Q L I   + 
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 297 SALEY---LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 353
           S + Y   LHF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 354 TIGYMAP 360
            I +M P
Sbjct: 187 PIRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 26/183 (14%)

Query: 196 LRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKS 241
            R+   F   N IG G++G VY+AR    G   A+K   ++ E             ++ +
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62

Query: 242 IHHRNLVK----IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTS 297
           + H N+V+    ++    +  F  LV+EY     L  +L +        Q   +M+ +  
Sbjct: 63  LRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLR 119

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
            L+YLH  F   IIH DLK  N+LL D     ++DFG+A+      + M  T  + T+ Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWY 174

Query: 358 MAP 360
            AP
Sbjct: 175 RAP 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 37/185 (20%)

Query: 206 NLIGRGSFGSVYKARLQ-DG--MEFAIK------------SFDVECEVM-KSIHHRNLVK 249
           ++IG G+FG V +A ++ DG  M  AIK             F  E EV+ K  HH N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI---------------LDILQRLNIMIN 294
           ++ +C N  +  + +EY   G+L   L  S  +               L   Q L    +
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
           V + ++YL        IH DL   NVL+ +N+ + ++DFG+++   GE+  + +T     
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 355 IGYMA 359
           + +MA
Sbjct: 182 VRWMA 186

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 67.6 bits (166), Expect = 9e-13
 Identities = 50/153 (32%), Positives = 74/153 (48%), Gaps = 35/153 (22%)

Query: 208 IGRGSFGSVYKARLQDGMEF-AIK-------SFDVEC----EVMKSI----HHRNLVKII 251
           +G G+FGSVY AR ++  E  AIK       S++ EC    EV KS+     H N+VK+ 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREV-KSLRKLNEHPNIVKLK 64

Query: 252 SSCSNEDFRA-----LVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLH-F 304
                E FR       V EYM  G+L +++              +I+  +   L ++H  
Sbjct: 65  -----EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
           GF     H DLKP N+L+    V  ++DFG+A+
Sbjct: 119 GF----FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 21/152 (13%)

Query: 205 NNLIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLV 248
             +IG G FG V + RL+      ++ AIK+            F  E  +M    H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL-HFGFS 307
           ++    +      ++ EYM NGSL+K L  ++    + Q + ++  + S ++YL    + 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
              +H DL   N+L++ N+V  +SDFG+++ L
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 22/172 (12%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSFD--------------VECEV--MKSIHHRNLVK 249
           L+G+G+FG VY     D G E A+K                 +ECE+  +K++ H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
                 +++  ++ +EYM  GS++  L +   + + + R      +   +EYLH   S  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           I+H D+K  N+L D      L DFG +K L     S T  +++  T  +M+P
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 48/185 (25%), Positives = 80/185 (43%), Gaps = 35/185 (18%)

Query: 208 IGRGSFGSVYKAR------LQDGMEFAIKS-----------FDVECEVMKSIHHRNLVKI 250
           +G G+FG V+ A        +D M  A+K+           F  E E++ ++ H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYS---------------SNCILDILQRLNIMINV 295
              C + D   +V EYM +G L K L +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
            S + YL    S   +H DL   N L+  N++  + DFG+++ +   D       T+  I
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 356 GYMAP 360
            +M P
Sbjct: 190 RWMPP 194

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 52/179 (29%), Positives = 79/179 (44%), Gaps = 34/179 (18%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVEC------EVMKSIHHRNLVKIISSC 254
           F+    IG+GSFG VYKA   +     AIK  D+E       ++ + I      + +S C
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEI------QFLSQC 56

Query: 255 SN-----------EDFR-ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL 302
            +           +  +  +++EY   GS   +L      LD      I+  V   LEYL
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYL 114

Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
           H       IH D+K  N+LL +     L+DFG++  LT    +M++  T   T  +MAP
Sbjct: 115 H---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT---STMSKRNTFVGTPFWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 48/173 (27%), Positives = 86/173 (49%), Gaps = 25/173 (14%)

Query: 208 IGRGSFGSVYKA-RLQDGMEFAIK----SFDV---------ECEVMKSIHHRNLVKI--I 251
           IG G++G V  A   + G + AIK    +FDV         E ++++   H N++ I  I
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 252 SSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
                 DF+   +V++ M +  L  +++S   + +   R   +  +   L+Y+H   S  
Sbjct: 73  LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYIH---SAN 127

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG--EDQSMTQTQTLATIGYMAP 360
           +IH DLKP N+L++++    + DFG+A+ L+    +     T+ +AT  Y AP
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 40/180 (22%), Positives = 72/180 (40%), Gaps = 30/180 (16%)

Query: 208 IGRGSFGSVYKARLQD------GMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY+   +           AIK+            F  E  VMK  +  ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCILDILQRLNIM---INVTSALE 300
           ++   S      +V+E M  G L+  L S      +N  L        +     +   + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL    +   +H DL   N ++ +++   + DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 23/180 (12%)

Query: 199 TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKS---FDV-----------ECEVMKSIH 243
              F     IG+G F  VYKA  L DG   A+K    F++           E +++K + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL---YSSNCILDILQRLNIMINVTSALE 300
           H N++K ++S    +   +VLE    G L +++        ++         + + SALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           ++H   S  I+H D+KP NV +    V  L D G+ +  +   ++      + T  YM+P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 22/169 (13%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVEC--------EVM-------KSIHHRNLVKII 251
           IG+GSFG V  A+   DG  +A+K    +          +M       K++ H  LV + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            S    D    VL+Y+  G L   L       +   R      + SAL YLH   S  II
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLNII 118

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           + DLKP N+LLD      L+DFG+ K   G + S T +    T  Y+AP
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 49/141 (34%), Positives = 64/141 (45%), Gaps = 20/141 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
           L +L  LDL  N L+G IP+   NL  L+ L L  N+L   +         L   D S N
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP----- 107
           +L G+IP  +  L++L+ L L  N   G IP +   L  L+ L L +N  S  IP     
Sbjct: 295 SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354

Query: 108 ------LSLEKLLLEGEIPRG 122
                 L L    L GEIP G
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEG 375

Length = 968

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 21/161 (13%)

Query: 207 LIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------ECEVMKSIHHRNLVKI 250
           +IG G FG V   RL+      +  AIK+               E  +M    H N++ +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-FGFSTP 309
               +      +V EYM NGSL+  L   +    ++Q + ++  + S ++YL   G+   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 22/169 (13%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFD--------------VECEVMKSIHHRNLVKIIS 252
           +G+G FG V   +++  G  +A K  D               E ++++ +  R +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPII 311
           +   +D   LV+  M  G L+  +Y+         + +     +   LE+LH      I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           + DLKP NVLLDD+    +SD G+A  L G            T GYMAP
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 20/161 (12%)

Query: 207 LIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLVKI 250
           +IG G FG V++  L+      +  AIK+            F  E  +M    H N++++
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
               +      ++ EYM NG+L+K L   +      Q + ++  + + ++YL        
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNY 128

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           +H DL   N+L++ N+   +SDFG++++L  +D   T T +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTS 168

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 37/191 (19%)

Query: 200 NGFSANNLIGRGSFGSVYKARL-QDG--MEFAIK------------SFDVECEVMKSI-H 243
           N     ++IG G+FG V KAR+ +DG  M+ AIK             F  E EV+  + H
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI---------------LDILQR 288
           H N++ ++ +C +  +  L +EY  +G+L   L  S  +               L   Q 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           L+   +V   ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180

Query: 349 TQTLATIGYMA 359
           T     + +MA
Sbjct: 181 TMGRLPVRWMA 191

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 22/173 (12%)

Query: 207 LIGRGSFGSVYKARL-QDGME---FAIKS------------FDVECEVMKSIHHRNLVKI 250
           +IG G FG V + RL   G      AIK+            F  E  +M    H N++ +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
               +      ++ E+M NG+L+  L  ++    ++Q + ++  + + ++YL        
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAP 360
           +H DL   N+L++ N+V  +SDFG+++ L  +    T T +L     I + AP
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 26/170 (15%)

Query: 207 LIGRGSFGSVYKARLQDGMEF-AIKSFDV--------------ECEVMKSIHHRNLVKII 251
            +G G+FG V+  R +    + A+K   +              E  V+K + H  ++++ 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            +  ++ F  +++EY+  G L   L +S    +          +  ALEYLH   S  I+
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SKEIV 123

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           + DLKP N+LLD      L+DFG AK L        +T TL  T  Y+AP
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 64.6 bits (157), Expect = 8e-12
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 17/154 (11%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+K          SF  E ++MK + H  LV++ +  S E
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73

Query: 258 DFRALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L       L +   +++   V + + Y+        IH DL+
Sbjct: 74  PIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLR 129

Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
             N+L+ D +V  ++DFG+A+L+  ED   T  Q
Sbjct: 130 SANILVGDGLVCKIADFGLARLI--EDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.5 bits (157), Expect = 8e-12
 Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 24/149 (16%)

Query: 208 IGRGSFGSV----YKARLQDGMEF-AIKSFDVEC------------EVMKSIHHRNLVKI 250
           +G G FG V    Y        E  A+K+   EC             ++K+++H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 251 ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              CS +  +   L++EY+  GSL   L      L++ Q L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
             IH DL   NVLLD++ +  + DFG+AK
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 36/186 (19%)

Query: 208 IGRGSFGSVYKARLQ-DGME----FAIKS------------FDVECEVMKSIHHRNLVKI 250
           +G  +FG +YK  L   GM+     AIK+            F  E  +M  +HH N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLY----------SSN------CILDILQRLNIMIN 294
           +   + E    ++ EY+  G L + L           SS+        LD    L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
           + + +EYL   F    +H DL   N+L+ + +   +SD G+++ +   D    Q ++L  
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 355 IGYMAP 360
           I +M P
Sbjct: 190 IRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 54/193 (27%), Positives = 81/193 (41%), Gaps = 38/193 (19%)

Query: 195 LLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVECEVMKSI----------- 242
           L   T  F    +IG G++G VYKAR  + G   AIK  D+  +  + I           
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60

Query: 243 HHRNLVKII------SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN------ 290
           +H N+          +   N+D   LV+E    GS+  ++     +    +RL       
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAY 117

Query: 291 IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
           I+      L YLH      +IH D+K  N+LL  N    L DFG++  L   D ++ +  
Sbjct: 118 ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRN 171

Query: 351 TLATIG---YMAP 360
           T   IG   +MAP
Sbjct: 172 T--FIGTPYWMAP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 42/169 (24%), Positives = 81/169 (47%), Gaps = 22/169 (13%)

Query: 208 IGRGSFGS--VYKARLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS 252
           +G+G+FG   +Y+ R +D      K  ++             E  ++  + H N++   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 253 SCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              +++   + +EY   G+L +K++     + +    L  +  + SA+ Y+H      I+
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H D+K  N+ L    +  L DFGI+K+L G + SM +T  + T  YM+P
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 53/143 (37%), Positives = 71/143 (49%), Gaps = 25/143 (17%)

Query: 3   AALFQL------DLRGNKLSGSIP-TCFSNLTALRNLHLDSNELRHLV-------LTRTD 48
           +A+F+L      +L  N+LSG IP   F+  ++LR L+L +N     +       L   D
Sbjct: 87  SAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLD 146

Query: 49  FSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 108
            S N L G+IP  I    SL+ L LG N L G IPNS  +L SLE L L++N L   IP 
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206

Query: 109 SLEKLL-----------LEGEIP 120
            L ++            L GEIP
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIP 229

Length = 968

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 32/182 (17%)

Query: 208 IGRGSFGSVYKAR-----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKI 250
           +G G+FG V+ A                  L+D  + A K F  E E++ ++ H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSN------------CILDILQRLNIMINVTSA 298
              C   D   +V EYM +G L K L +                L   Q L+I   + + 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           + YL    S   +H DL   N L+ +N++  + DFG+++ +   D       T+  I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 359 AP 360
            P
Sbjct: 190 PP 191

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 17/154 (11%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+        + AIK+          F  E ++MK + H  LV + +  S E
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73

Query: 258 DFRALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V E+M  GSL   L   +   L + Q +++   +   + Y+        IH DL+
Sbjct: 74  PIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLR 129

Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
             N+L+ DN+V  ++DFG+A+L+  ED   T  Q
Sbjct: 130 AANILVGDNLVCKIADFGLARLI--EDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 35/172 (20%)

Query: 202 FSANNLIGRGSFGSVYKARL-QDGMEF---AIKSFDV-------------ECEVMKSIHH 244
                ++G G FGSV + +L QD       A+K+  +             E   MK   H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 245 RNLVKIISSC----SNEDFRA--LVLEYMTNGSLEKVLYSS-------NCILDILQRLNI 291
            N++K+I  C    S +      ++L +M +G L   L  S          L  L  L  
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL--LKF 118

Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           M+++   +EYL    +   IH DL   N +L +++   ++DFG++K +   D
Sbjct: 119 MVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 25/149 (16%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVMKSIHHRNLVKII 251
           +IGRG+FG V+  R    G  +A+K                  E +++       +VK+ 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-FGFSTPI 310
            S  +E+   LV+EYM  G L  +L   +   +   R  I   +  AL+ +H  GF    
Sbjct: 68  YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF---- 122

Query: 311 IHCDLKPHNVLLDDNIVAH--LSDFGIAK 337
           IH D+KP N+L+D     H  L+DFG+ K
Sbjct: 123 IHRDIKPDNILID--ADGHIKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 21/151 (13%)

Query: 207 LIGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKI 250
            +G+G+FGSV   R                LQ      ++ F+ E E++KS+ H N+VK 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 251 ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              C +   R   LV+EY+  GSL   L      LD  + L     +   +EYL    S 
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SK 127

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
             +H DL   N+L++      + DFG+ K+L
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 23/173 (13%)

Query: 205 NNLIGRGSFGSVYKARLQD----GMEFAIKSFDVECE------------VMKSIHHRNLV 248
              IG G FG VY+          +  A+K+                  +M+   H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           K+I   + E+   +V+E    G L   L  +   LD+   +     +++AL YL    S 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM-TQTQTLATIGYMAP 360
             +H D+   NVL+       L DFG+++ L  ED+S    ++    I +MAP
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAP 177

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 55/183 (30%), Positives = 79/183 (43%), Gaps = 31/183 (16%)

Query: 202 FSANNL-----IGRGSFGSVYKARLQD-GMEFAIKSF--------------DVECEVMKS 241
           F+A +L     IGRG+FG+V K   +  G   A+K                D++  VM+S
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV-VMRS 59

Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVT----S 297
                +VK   +   E    + +E M   SL+K       +L  +    I+  +      
Sbjct: 60  SDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
           AL YL       IIH D+KP N+LLD N    L DFGI+  L     S+ +T+      Y
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPY 173

Query: 358 MAP 360
           MAP
Sbjct: 174 MAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 44/177 (24%), Positives = 82/177 (46%), Gaps = 28/177 (15%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG+G+FG V+KAR  +     A+K   +E E             +++ + H N+V +I  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 254 CSNE-----DFRA---LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
           C  +      ++    LV E+  +  L  +L + N    + +   +M  + + L Y+H  
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH-- 136

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK--LLTGEDQSMTQTQTLATIGYMAP 360
               I+H D+K  N+L+  + +  L+DFG+A+   L+   +    T  + T+ Y  P
Sbjct: 137 -RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 18/144 (12%)

Query: 208 IGRGSFGSVYKARLQDGMEF-AIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG G++G+V+KA+ ++  E  A+K   ++ +             ++K + H+N+V++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
             ++    LV EY  +  L+K   S N  +D     + M  +   L + H   S  ++H 
Sbjct: 68  LHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAK 337
           DLKP N+L++ N    L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 29/172 (16%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKS--FDVECE-----------VMKSIHHRNLVKIISS 253
           IG G++G VYKAR    G   A+K    D E E           ++K ++H N+VK++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA-----LEYLHFGFST 308
              E+   LV E++ +  L+K        +D      I + +  +     L+ L F  S 
Sbjct: 68  IHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 25/171 (14%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK-------SFDV-----ECEVMKSIHH---RNLVKI 250
           LIGRG++G+VY+ + +  G   A+K         DV     E  ++  +      N+ K 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             S        +++EY   GS+ + L  +  I +    + I+  V  AL+Y+H      +
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH---KVGV 122

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY-MAP 360
           IH D+K  N+L+ +     L DFG+A LL    Q+ ++  T     Y MAP
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 40/151 (26%), Positives = 74/151 (49%), Gaps = 16/151 (10%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+     +  + A+K+          F  E  +MK++ H  LV++ +  + E
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRL-NIMINVTSALEYLHFGFSTPIIHCDLK 316
           +   ++ EYM  GSL   L S      +L +L +    +   + Y+        IH DL+
Sbjct: 74  EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLR 130

Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
             NVL+ ++++  ++DFG+A+++  ED   T
Sbjct: 131 AANVLVSESLMCKIADFGLARVI--EDNEYT 159

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 61.5 bits (149), Expect = 8e-11
 Identities = 40/176 (22%), Positives = 84/176 (47%), Gaps = 25/176 (14%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIKSFDV-----------------ECEVMKSIHHRNLV 248
            ++G+G++G+VY      G   A+K  ++                 E +++KS+ H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           + + +C +++  ++ +E++  GS+  +L     + + +        +   + YLH   + 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVAYLH---NN 121

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG----YMAP 360
            ++H D+K +NV+L  N +  L DFG A+ L       T +  L ++     +MAP
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 21/166 (12%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  A     G + A+K  D+           E  +M+   H N+V++ SS  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+E++  G+L  ++  +   ++  Q   + + V  AL +LH   +  +IH D+
Sbjct: 87  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY-MAP 360
           K  ++LL  +    LSDFG    ++ E   + + ++L    Y MAP
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 22/169 (13%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFD--------------VECEVMKSIHHRNLVKIIS 252
           +G+G FG V   ++++ G  +A K  D              +E E+++ ++   +V +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPII 311
           +  ++    LV+  M  G L+  +Y+     L++ + ++    +T  + +LH   S  I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           + D+KP NVLLDD     LSD G+A  L       T TQ   T GYMAP
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 28/156 (17%)

Query: 208 IGRGSFGSVYKA--RLQDGMEF--AIKS------------FDVECEVMKSIHHRNLVKII 251
           +G G+FGSV K    ++ G E   A+K+            F  E  VM  + H  +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFST 308
             C  E    LV+E    G L K L      + +     +   V   + YL   HF    
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHF---- 116

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGED 343
             +H DL   NVLL +   A +SDFG+++ L  G D
Sbjct: 117 --VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 15/143 (10%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + AIKS          F  E  +MK + H  LV++ +  + E
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L +   I L I + +++   +   + ++        IH DL+
Sbjct: 74  PI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLR 129

Query: 317 PHNVLLDDNIVAHLSDFGIAKLL 339
             N+L+ + +   ++DFG+A+L+
Sbjct: 130 AANILVSETLCCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.9 bits (147), Expect = 1e-10
 Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 37/185 (20%)

Query: 206 NLIGRGSFGSVYKARLQ-DG--MEFAIK------------SFDVECEVM-KSIHHRNLVK 249
           ++IG G+FG V KAR++ DG  M+ AIK             F  E EV+ K  HH N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI---------------LDILQRLNIMIN 294
           ++ +C +  +  L +EY  +G+L   L  S  +               L   Q L+   +
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
           V   ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +T     
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 355 IGYMA 359
           + +MA
Sbjct: 175 VRWMA 179

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 56/170 (32%), Positives = 78/170 (45%), Gaps = 22/170 (12%)

Query: 207 LIGRGSFGSVYKA-RLQDGMEFAIKSF------------DVECE---VMKSIHHRNLVKI 250
           +IG+GSFG V  A R  DG  +A+K               +  E   ++K++ H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             S    +    VL+Y+  G L   L    C L+   R      V SA+ YLH   S  I
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNI 117

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           I+ DLKP N+LLD      L+DFG+ K   G +   T +    T  Y+AP
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 29/157 (18%)

Query: 208 IGRGSFGSVYKARLQ---DGMEFAIKSFDVECEVM--------------KSIHHRNLVKI 250
           IGRG++G VYKA+ +   DG E+AIK F  + E                + + H N+V +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 251 ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRL---NIMINVTSALEYLHFG 305
           +        ++  L+ +Y  +   + + +        +      +++  + + + YLH  
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-- 125

Query: 306 FSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKL 338
            S  ++H DLKP N+L+     +  V  + D G+A+L
Sbjct: 126 -SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 26/169 (15%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECE---VMKSIHHRNLVKII 251
           I +G+FGSVY A+ +  G  FAIK              +V+ E   +M       + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            S  ++D+  LV+EY+  G    ++ +   + +   +   +  V   +E LH      II
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGII 119

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H D+KP N+L+D      L+DFG+++        +   + + T  Y+AP
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAP 162

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 20/166 (12%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK--------SFDV---ECEVMKSIHHRNLVKIISSCS 255
           IG G++G VYKAR +  G   AIK         F V   E  +MK   H N+V    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   + +E+   GSL+ + Y     L   Q   +       L YLH   S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQDI-YHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
           K  N+LL DN    L+DFG++  +T    ++ + ++ + T  +MAP
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITA---TIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 39/193 (20%)

Query: 197 RATNGFSANNLIGRGSFGSVYKARLQDGMEF-AIKSFDVECE-------------VMKSI 242
           R  + F     IG G++G VYKAR +D  E  A+K   ++ E             +++ +
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 243 HHRNLVKIISSCSNE----DFRA------LVLEYMTN---GSLEK--VLYSSNCILDILQ 287
           +HRN+V +    +++    DF+       LV EYM +   G LE   V +S + I   ++
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123

Query: 288 RLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
           +L         L Y H       +H D+K  N+LL++     L+DFG+A+L   E+    
Sbjct: 124 QL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP- 173

Query: 348 QTQTLATIGYMAP 360
            T  + T+ Y  P
Sbjct: 174 YTNKVITLWYRPP 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 23/177 (12%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKS---FDV-----------ECEVMKSIHHRN 246
           F     IGRG F  VY+A  L DG+  A+K    FD+           E +++K ++H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI---MINVTSALEYLH 303
           ++K  +S   ++   +VLE    G L +++        ++    +    + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              S  ++H D+KP NV +    V  L D G+ +  +   ++      + T  YM+P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 55/165 (33%), Positives = 82/165 (49%), Gaps = 19/165 (11%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG+G+ G+V+ A  +  G E AIK  ++           E  VMK + + N+V  + S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+EY+  GSL  V+ +  C +D  Q   +      ALE+LH   +  +IH D+
Sbjct: 87  VGDELFVVMEYLAGGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  NVLL  +    L+DFG    +T E QS   T  + T  +MAP
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 23/147 (15%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG G++G VYKAR    G   A+K   +E E             ++K ++H N+V+++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI---MINVTSALEYLHFGFSTPI 310
             +E+   LV E++ +  L+K  Y  +  L  L    I   +  +   + Y H   S  +
Sbjct: 67  VHSENKLYLVFEFL-DLDLKK--YMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRV 120

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAK 337
           +H DLKP N+L+D      L+DFG+A+
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 20/149 (13%)

Query: 206 NLIGRGSFGSVYKARL--QDGMEF--AIKS------------FDVECEVMKSIHHRNLVK 249
            +IG+G FG VY   L   DG +   A+KS            F  E  +MK   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 250 IISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           ++  C  +E    +VL YM +G L   + S      +   +   + V   +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
             +H DL   N +LD++    ++DFG+A+
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 43/181 (23%)

Query: 206 NLIGRGSFGSVYKARLQD-GMEFAIKSFDV-------------ECEVMKSIHHRNLVKII 251
           + +G G++G V  A     G + AIK                 E  ++K + H N++ ++
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 252 S----SCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLN------IMINVTSAL 299
                + S EDF+   LV   M    L  ++          Q+L+      ++  +   L
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGL 131

Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           +Y+H   S  IIH DLKP N+ ++++    + DFG+A+     D  M  T  +AT  Y A
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEM--TGYVATRWYRA 183

Query: 360 P 360
           P
Sbjct: 184 P 184

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 35/166 (21%)

Query: 202 FSANNLIGRGSFGSVYKARLQ----DGMEFAIK--------SFDVE-----CEVMKSIHH 244
           F+   ++G+G FGSV +A+L+       + A+K        S D+E        MK   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 245 RNLVKII--SSCSNEDFR----ALVLEYMTNGSLEKVLYSS-------NCILDILQRLNI 291
            N++K+I  S  S    R     ++L +M +G L   L  S          L  L R   
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-- 118

Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
           MI++ S +EYL    S   IH DL   N +L++N+   ++DFG++K
Sbjct: 119 MIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.9 bits (146), Expect = 5e-10
 Identities = 56/175 (32%), Positives = 92/175 (52%), Gaps = 30/175 (17%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKS-FD----------VECEVM---KSIHHRNLVK--- 249
           +G+G++G V+KA   +     A+K  FD             E+M   +   H N+VK   
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74

Query: 250 IISSCSNEDFRALVLEYM-TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           +I + +++D   LV EYM T+  L  V+ ++  IL+ + +  IM  +  AL+Y+H   S 
Sbjct: 75  VIKAENDKDIY-LVFEYMETD--LHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SG 126

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT---GEDQSMTQTQTLATIGYMAP 360
            +IH DLKP N+LL+ +    L+DFG+A+ L+      ++   T  +AT  Y AP
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 59.4 bits (143), Expect = 5e-10
 Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 19/165 (11%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG+G+ G+VY A  +  G E AI+  ++           E  VM+   + N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+EY+  GSL  V+ +  C +D  Q   +      ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+LL  +    L+DFG    +T E     ++  + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 58.7 bits (142), Expect = 6e-10
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 17/142 (11%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+  + +  ++ AIK+          F  E +VM  + H  LV++   C+ +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCIL--DILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
               +V E+M NG L   L      L  D+L  L++  +V   +EYL        IH DL
Sbjct: 72  KPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLE---RNSFIHRDL 126

Query: 316 KPHNVLLDDNIVAHLSDFGIAK 337
              N L+    V  +SDFG+ +
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 46/195 (23%), Positives = 74/195 (37%), Gaps = 48/195 (24%)

Query: 208 IGRGSFGSVYKAR---LQDGMEFAI---------------KSFDVECEVMKSIHHRNLVK 249
           IG+G+FG V++AR   L     F +                 F  E  +M    H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSN---------------------CILDILQR 288
           ++  C+      L+ EYM  G L + L   +                       L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 289 LNIMINVTSALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
           L I   V + + YL    F      +H DL   N L+ +N+V  ++DFG+++ +   D  
Sbjct: 133 LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 346 MTQTQTLATIGYMAP 360
                    I +M P
Sbjct: 187 KASENDAIPIRWMPP 201

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 40/181 (22%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVEC-----------EV-----MKSIHHRNLVKI 250
           IG G++G+VYKAR    G   A+KS  V+            EV     +++  H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 251 ISSCSN-----EDFRALVLEYMTN---GSLEKVL---YSSNCILDILQRLNIMINVTSAL 299
           +  C+      E    LV E++       L+KV      +  I D++++          L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF------LRGL 121

Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           ++LH   +  I+H DLKP N+L+       L+DFG+A++ + +   M  T  + T+ Y A
Sbjct: 122 DFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRA 175

Query: 360 P 360
           P
Sbjct: 176 P 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 20/146 (13%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG G++G VYK R  + G   A+K   +E E             ++K + H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYS--SNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              E    L+ E+++   L+K L S      +D     + +  +   + + H   S  ++
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVL 123

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAK 337
           H DLKP N+L+D+  V  L+DFG+A+
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 55/170 (32%), Positives = 77/170 (45%), Gaps = 22/170 (12%)

Query: 207 LIGRGSFGSVYKA-RLQDGMEFAIKSFD------------VECE---VMKSIHHRNLVKI 250
           +IG+GSFG V  A R  DG  +A+K               +  E   ++K++ H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             S    +    VL+++  G L   L       +   R      + SAL YLH   S  I
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           ++ DLKP N+LLD      L+DFG+ K   G  QS T T    T  Y+AP
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 55/170 (32%), Positives = 76/170 (44%), Gaps = 22/170 (12%)

Query: 207 LIGRGSFGSVYKARLQDGMEF---------AIKSFDVECEVM-------KSIHHRNLVKI 250
           +IG+GSFG V  AR +   +F         AI     E  +M       K++ H  LV +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             S    D    VL+Y+  G L   L    C L+   R      + SAL YLH   S  I
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 117

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           ++ DLKP N+LLD      L+DFG+ K     + + T +    T  Y+AP
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 27/163 (16%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSFDVEC--------------EVMKSIHHRNLVKII 251
           L+G+G  G V+  RL+  G  FA+K  D +               E++ ++ H  L  + 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSALEYLH-FGFST 308
           +S   E +  LV++Y   G L ++L      C+ + + R      V  ALEYLH  G   
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLLG--- 123

Query: 309 PIIHCDLKPHNVLL--DDNIVAHLSDFGIAKLLTGEDQSMTQT 349
            I++ DLKP N+LL    +I+  LSDF ++K    E   +++ 
Sbjct: 124 -IVYRDLKPENILLHESGHIM--LSDFDLSKQSDVEPPPVSKA 163

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 42/170 (24%), Positives = 73/170 (42%), Gaps = 21/170 (12%)

Query: 208 IGRGSFGSVYKAR-LQDG----MEFAIK------------SFDVECEVMKSIHHRNLVKI 250
           +G G+FG+VYK   + +G    +  AIK                E  VM S+ H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
           +  C +     L+ + M  G L   + +    +     LN  + +   + YL       +
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +H DL   NVL+       ++DFG+AKLL  +++          I +MA 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 37/188 (19%)

Query: 207 LIGRGSFGSVYKARL------------------QDGMEFAIKSFDVECEVMKSI-HHRNL 247
            +G G+FG V KA                     D  E  +     E E+MK I  H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVL---------YSSNCILDILQRL------NIM 292
           + ++  C+ E    +V+EY  +G+L   L          S +      + L      +  
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 293 INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
             V   +E+L    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T   
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 353 ATIGYMAP 360
             + +MAP
Sbjct: 196 LPVKWMAP 203

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 39/195 (20%)

Query: 193 LELLRATNG-FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV----ECEVMKSI---- 242
           L  LR   G F    ++G G++G VYK R ++ G   AIK  DV    E E+   I    
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67

Query: 243 ---HHRNLVKII------SSCSNEDFRALVLEYMTNGSLEKVL-------YSSNCILDIL 286
              HHRN+          S   ++D   LV+E+   GS+  ++          + I  I 
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127

Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           +       +   L +LH   +  +IH D+K  NVLL +N    L DFG++  L   D+++
Sbjct: 128 RE------ILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTV 175

Query: 347 TQTQT-LATIGYMAP 360
            +  T + T  +MAP
Sbjct: 176 GRRNTFIGTPYWMAP 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 17/142 (11%)

Query: 208 IGRGSFGSVYKAR------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCS 255
           +G G+FG VYKA+            ++   E  ++ + VE E++ + +H  +VK++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDI-LQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            +    +++E+   G+++ ++      LD  L    I +     LE L +  S  IIH D
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 315 LKPHNVLLDDNIVAHLSDFGIA 336
           LK  NVLL  +    L+DFG++
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 39/188 (20%)

Query: 206 NLIGRGSFGSVYKARLQD-------GMEFAIKS------------FDVECEVMKSIHHRN 246
           N +G G+FG VY+    D        +  A+K+            F  E  +M + +H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSL------EKVLYSSNCILDILQRLNIMINVTSALE 300
           +VK++  C   + + +++E M  G L       +V      +L + + L+I ++V     
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 301 YL---HFGFSTPIIHCDLKPHNVLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
           YL   HF      IH DL   N L+     D + V  + DFG+A+ +   D    + + L
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 353 ATIGYMAP 360
             + +MAP
Sbjct: 175 LPVRWMAP 182

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 54/165 (32%), Positives = 81/165 (49%), Gaps = 19/165 (11%)

Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG+G+ G+VY A  +  G E AIK  ++           E  VM+   + N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+EY+  GSL  V+ +  C +D  Q   +      AL++LH   S  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+LL  +    L+DFG    +T E QS   T  + T  +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 24/168 (14%)

Query: 208 IGRGSFGSVYKAR--------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKIISS 253
           +G G++G VYKAR              L+ G +F++     E  ++K   H N+V    S
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNIVAYFGS 74

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
             + +   + +EY   GSL+ + Y     L  LQ   +       L YLH   S   +H 
Sbjct: 75  YLSREKLWICMEYCGGGSLQDI-YHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHR 130

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
           D+K  N+LL DN    L+DFG+A  +T    ++ + ++ + T  +MAP
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 22/159 (13%)

Query: 208 IGRGSFGSVYKARL-----QDGMEFAIKSFD------------VECEVMKSIHHRNLVKI 250
           +G G FG V   R        G + A+KS               E E++++++H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 251 ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              C+ +      L++E++ +GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
             +H DL   NVL++      + DFG+ K +  + +  T
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 15/170 (8%)

Query: 201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFR 260
           G  A    G+    +V   R  D  + A   F  E ++M  + + N+++++  C ++D  
Sbjct: 34  GEGAPEFDGQPVLVAVKMLR-ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL 92

Query: 261 ALVLEYMTNGSLEKVL-----YS----SNCI--LDILQRLNIMINVTSALEYLHFGFSTP 309
            ++ EYM NG L + L      S    +N I  + I   L + + + S ++YL    S  
Sbjct: 93  CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLN 149

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            +H DL   N L+ ++    ++DFG+++ L   D    Q + +  I +MA
Sbjct: 150 FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA 199

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 52/175 (29%), Positives = 80/175 (45%), Gaps = 26/175 (14%)

Query: 202 FSANNLIGRGSFGSVYKA---RLQDGMEFAIKSFDVECEVMKSIHH-RNLVKIISSCSNE 257
           F+    IG+GSFG V+K    R Q  +  AIK  D+E E    I   +  + ++S C + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVV--AIKIIDLE-EAEDEIEDIQQEITVLSQCDSP 62

Query: 258 DFRA------------LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
                           +++EY+  GS   +L +     D  Q   ++  +   L+YLH  
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH-- 118

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            S   IH D+K  NVLL +     L+DFG+A  LT  D  + +   + T  +MAP
Sbjct: 119 -SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 52/176 (29%), Positives = 79/176 (44%), Gaps = 35/176 (19%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDVECEVMKS-------------IHHRNLVKIISS 253
           IG GSFG +Y A+ + D     IK  D+    +K              + H N+V   +S
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 254 CSNEDFRALVLEYMTNGSLEK-------VLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
                   +V+EY   G L K       VL+S +      Q L+  + ++  L+++H   
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED------QILSWFVQISLGLKHIH--- 118

Query: 307 STPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
              I+H D+K  N+ L  N +VA L DFGIA+ L   + SM    T   T  Y++P
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 21/169 (12%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           +G+GS+G V   R   DG ++ IK  ++             E +++  + H N+V    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 254 CSNED-FRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              ED    +V+ +   G L  K+      +L   Q +   + +  AL+YLH      I+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H DLK  NV L    +  + D GIA++L  E+Q    +  + T  YM+P
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 26/157 (16%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII-- 251
           +G G+FG VYKAR ++ G   A+K   +             E +++K + H N+V +I  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 252 --SSCSNEDFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
                     +     +V  YM +  L  +L + +  L   Q    M+ +   + YLH  
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH-- 132

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
               I+H D+K  N+L+D+  +  ++DFG+A+   G 
Sbjct: 133 -ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 35/195 (17%)

Query: 182 QPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD------- 233
           +P  S  + S  E+            +G GSFG V  A+ +  G  +AIK          
Sbjct: 9   KPDTSSWKLSDFEM---------GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59

Query: 234 -------VECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL 286
                   E  ++  + H  +V ++ S  +E+    +LE++  G L   L  +    + +
Sbjct: 60  KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119

Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
            +      +  A EYLH   S  II+ DLKP N+LLD+     ++DFG AK +       
Sbjct: 120 AKF-YHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP------ 169

Query: 347 TQTQTL-ATIGYMAP 360
            +T TL  T  Y+AP
Sbjct: 170 DRTFTLCGTPEYLAP 184

Length = 329

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 21/152 (13%)

Query: 208 IGRGSFGSV----YKARLQDGMEFAIKSFDV------------ECEVMKSIHHRNLVKII 251
           +G G+FG V    YK R +  ++ AIK                E E+M  + +  +V++I
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ-IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E    LV+E  + G L K L      + +   + +M  V+  ++YL        +
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           H DL   NVLL +   A +SDFG++K L  +D
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 13/140 (9%)

Query: 230 KSFDVECEVMKSIHHRNLVKIISSCSNEDFRAL-VLEYMTNGSLEKVLYSSNCILDILQR 288
             F  E  +   ++H N+V ++ S          V EY+   +L +VL +++  L   + 
Sbjct: 23  ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL-AADGALPAGET 81

Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQS 345
             +M+ V  AL   H   +  I+H DLKP N+++        A + DFGI  LL G   +
Sbjct: 82  GRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138

Query: 346 MTQTQTLAT--IG---YMAP 360
              T T  T  +G   Y AP
Sbjct: 139 DVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 55/175 (31%), Positives = 84/175 (48%), Gaps = 26/175 (14%)

Query: 202 FSANNLIGRGSFGSVYKA---RLQDGMEFAIKSFDVECEVMKSIHH-RNLVKIISSCSN- 256
           F+    IG+GSFG V+K    R Q  +  AIK  D+E E    I   +  + ++S C + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVV--AIKIIDLE-EAEDEIEDIQQEITVLSQCDSP 62

Query: 257 ----------EDFRA-LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
                     +D +  +++EY+  GS   +L      LD  Q   I+  +   L+YLH  
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH-- 118

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            S   IH D+K  NVLL ++    L+DFG+A  LT  D  + +   + T  +MAP
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 27/173 (15%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHHRNLVKIIS 252
           +G+G FG V   +++  G  +A K  +              VE  ++  +H R +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +   +    LV+  M  G L   +Y+    N      +       + S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLA-TIGYMAP 360
           II+ DLKP NVLLD++    +SD G+A +L  G+    ++T+  A T G+MAP
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ----SKTKGYAGTPGFMAP 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 43/182 (23%)

Query: 207 LIGRGSFGSVYKARLQDGME----FAIKSFD---------------VECEVMKSIHHRNL 247
           ++G+G +G V++ R   G +    FA+K                   E  +++++ H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTS---------A 298
           V +I +        L+LEY++ G L             L+R  I +  T+         A
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGEL----------FMHLEREGIFMEDTACFYLSEISLA 112

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           LE+LH      II+ DLKP N+LLD      L+DFG+ K    E  ++T T    TI YM
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FCGTIEYM 167

Query: 359 AP 360
           AP
Sbjct: 168 AP 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (134), Expect = 6e-09
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 24/174 (13%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKS--FD------------VECEV--MKSIHHRNLVK 249
           L+GRG+FG VY     D G E A+K   FD            +ECE+  +K++ H  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 250 IISSCSNEDFRALVL--EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
                 + + + L +  EYM  GS++  L +   + + + R      +   + YLH   S
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY-MAP 360
             I+H D+K  N+L D      L DFG +K +     S T  +++    Y M+P
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 44/206 (21%)

Query: 183 PQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKA--RLQDG----MEFAIKS----- 231
           P+  R     + LLRA         +G G+FG VY+   R +DG    ++ A+K+     
Sbjct: 1   PEVPRDS---ITLLRA---------LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC 48

Query: 232 -------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSN---- 280
                  F +E  +M   +H+N+V++I        R ++LE M  G L+  L  +     
Sbjct: 49  SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE 108

Query: 281 --CILDILQRLNIMINVTSALEYLH-FGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFG 334
               L +   L    +V    +YL    F    IH D+   N LL       VA ++DFG
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHF----IHRDIAARNCLLTCKGPGRVAKIADFG 164

Query: 335 IAKLLTGEDQSMTQTQTLATIGYMAP 360
           +A+ +          + +  I +M P
Sbjct: 165 MARDIYRASYYRKGGRAMLPIKWMPP 190

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.1 bits (136), Expect = 6e-09
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 24/172 (13%)

Query: 206 NLIGRGSFGSVYKAR--------------LQDGME-FAIKSFDVECEVMKSIHHRNLVKI 250
           N I  G++G VY+AR              ++   E F I S   E  ++  + H N+V +
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTV 69

Query: 251 --ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
             +   SN D   +V+EY+ +  L+ ++ +        +   +M+ + S + +LH     
Sbjct: 70  KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DN 125

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            I+H DLK  N+LL++  +  + DFG+A+      +    TQ + T+ Y AP
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYRAP 175

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 41/182 (22%)

Query: 208 IGRGSFGSVYKAR-LQDGMEF-AIKSFDVECEV----------------MKSIHHRNLVK 249
           IG G++G V+KAR L++G  F A+K   V+                   +++  H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 250 IISSCS-----NEDFRALVLEYMTNG---SLEKVL---YSSNCILDILQRLNIMINVTSA 298
           +   C+      E    LV E++       L+KV      +  I D+      M  +   
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM------MFQLLRG 122

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           L++LH   S  ++H DLKP N+L+  +    L+DFG+A++ + +   M  T  + T+ Y 
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYR 176

Query: 359 AP 360
           AP
Sbjct: 177 AP 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.4 bits (133), Expect = 9e-09
 Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 22/175 (12%)

Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G+G FG V   +++  G  +A K  +               E ++++ ++ R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFG 305
           +V +  +   +D   LVL  M  G L+  +Y       +  + +     +   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
               I++ DLKP N+LLDD+    +SD G+A +   E Q++     + T+GYMAP
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 55.3 bits (133), Expect = 9e-09
 Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 54/186 (29%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSFDVECEVMK-----SIHHRNLVKIISS------- 253
           +IGRG FG VY  R  D G  +A+K  D +   MK     +++ R ++ ++S+       
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 254 CSNEDFR-----ALVLEYMTNGSL-------------EKVLYSSNCILDILQRLNIMINV 295
           C +  F      + +L+ M  G L             E   Y++  IL            
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL------------ 108

Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ-TLAT 354
              LE++H  F   +++ DLKP N+LLD++    +SD G+A      D S  +   ++ T
Sbjct: 109 --GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGT 158

Query: 355 IGYMAP 360
            GYMAP
Sbjct: 159 HGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 25/174 (14%)

Query: 206 NLIGRGSFGSVYKA-RLQDGMEFAIKS---FD---------VECEVMKSIHHRNLVKI-- 250
           + IG G++G V  A     G++ AIK    F+          E ++++   H N++ I  
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70

Query: 251 -ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            I   S E F    +V E M    L K++ + +   D +Q     I     L+Y+H   S
Sbjct: 71  IIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQI--LRGLKYIH---S 124

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+LL+ N    + DFG+A++     D +   T+ +AT  Y AP
Sbjct: 125 ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 55.4 bits (133), Expect = 9e-09
 Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 23/177 (12%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     IGRG F  VY+A  L D    A+K   +              E +++K ++H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEK-VLYSSNCILDILQRL--NIMINVTSALEYLH 303
           ++K + S   ++   +VLE    G L + + Y       I +R      + + SA+E++H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              S  ++H D+KP NV +    V  L D G+ +  + +  +      + T  YM+P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 17/165 (10%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFD-----------VECEVMKSIHHRNLVKIISSCS 255
           +G G+FG VYKA+ ++ G+  A K  D           VE +++ S  H N+VK++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            E+   +++E+   G+++ V+      L   Q   +      AL YLH      IIH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+L   +    L+DFG++   T   Q   +   + T  +MAP
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 28/172 (16%)

Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG G++G VYKAR +   E  A+K   +E E             ++K + H N+V++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI----MINVTSALEYLHFGFSTP 309
             +E    LV EY+ +  L+K + SS    D  +   +    +  +   + Y H   S  
Sbjct: 70  VHSEKRLYLVFEYL-DLDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH---SHR 122

Query: 310 IIHCDLKPHNVLLDDNIVA-HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           ++H DLKP N+L+D    A  L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAP 172

Length = 294

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 44/174 (25%), Positives = 69/174 (39%), Gaps = 26/174 (14%)

Query: 208 IGRGSFGSVYKARLQDGMEFA---IKSFDV------------ECEVMKSIHHRNLVKIIS 252
           IG G FG V    +  G   A   +K   V            E +  +S+ H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSN------CILDILQRLNIMINVTSALEYLHFGF 306
            C+      LV+E+   G L+  L S             LQR+     +   L +LH   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLH--- 117

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
               IH DL   N LL  ++   + D+G++     ED  +T  Q    + ++AP
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 30/163 (18%)

Query: 208 IGRGSFGSVYKARL-QDG---------MEFAI------KSFDVECEVMKSIHHRNLVKII 251
           +G G FGSV + +L QD          M+ AI      + F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 252 SSC----SNEDFRA--LVLEYMTNGSLEKVLYSSNC-----ILDILQRLNIMINVTSALE 300
             C     +E + +  ++L +M +G L   L  S        L     +  M ++ S +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           YL    S   IH DL   N +L++N+   ++DFG++K +   D
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 28/172 (16%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSF--------------DVECEVMKSIHHRNLVKII 251
            IG G+ G VYK R  + G   A+K                D++  V+KS     +VK  
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDCPYIVKCY 80

Query: 252 SSCSNEDFRALV-LEYMTNGSLEKVLYSSNCIL--DILQRLNIMINVTSALEYLHFGFST 308
                 D    + +E M+   L+K+L      +  DIL ++ + I    AL YL      
Sbjct: 81  G-YFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAI--VKALHYLKEKHG- 135

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +IH D+KP N+LLD +    L DFGI+  L     S  +T++     YMAP
Sbjct: 136 -VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 51/170 (30%), Positives = 74/170 (43%), Gaps = 22/170 (12%)

Query: 207 LIGRGSFGSVYKARLQDGME-FAIKSF---------DVECEVMK------SIHHRNLVKI 250
           ++G+GSFG V  A L+   E +AIK           DV+C + +      +  H  L  +
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
                 +D    V+EY+  G L   +  S    +   R      VT AL +LH      +
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RHGV 117

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           I+ DLK  N+LLD      L+DFG+ K   G    +T T    T  Y+AP
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 26/172 (15%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSFDVECEVMK-----SIHHRNLVKIISS------- 253
           +IGRG FG VY  R  D G  +A+K  D +   MK     +++ R ++ ++S+       
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 254 CSNEDFRA-----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           C    F        +L+ M  G L   L       +   R      +   LE++H  F  
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF-- 117

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +++ DLKP N+LLD++    +SD G+A   + +        ++ T GYMAP
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 47/150 (31%), Positives = 68/150 (45%), Gaps = 27/150 (18%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSF------------DVECEV--MKSIHHRNLVKIIS 252
           IG GSFG+VY AR ++     AIK              D+  EV  ++ + H N ++   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI----LQRLNIMINVTSALEYLHFGFST 308
               E    LV+EY         L S++ IL++    LQ + I      AL+ L +  S 
Sbjct: 83  CYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKL 338
             IH D+K  N+LL +     L+DFG A L
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 49.9 bits (120), Expect = 2e-08
 Identities = 28/65 (43%), Positives = 33/65 (50%), Gaps = 7/65 (10%)

Query: 39  LRHLVLTRTDFSRNNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDL 97
           L+ L L       NN L  IP    +GL +L+ L L  N L    P +F  L SL SLDL
Sbjct: 2   LKSLDL------SNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDL 55

Query: 98  SNNNL 102
           S NNL
Sbjct: 56  SGNNL 60

Length = 60

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 54/181 (29%), Positives = 84/181 (46%), Gaps = 30/181 (16%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV----ECEVMKSI-------HHRNLVK 249
           F    L+G G++G VYK R ++ G   AIK  DV    E E+ + I       HHRN+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 250 IISSC------SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR---LNIMINVTSALE 300
              +         +D   LV+E+   GS+  ++   N   + L+      I   +   L 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLS 125

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMA 359
           +LH      +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MA
Sbjct: 126 HLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMA 179

Query: 360 P 360
           P
Sbjct: 180 P 180

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 37/181 (20%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK-----------------SFDVECEVMKSIHHRNLV 248
            +G G+F S Y+AR ++ G   A+K                 +   E  +M  ++H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYS----SNCILDILQRLNIMINVTSALEYLHF 304
           +++ +   +    L +E+M  GS+  +L         ++     +N    +   L YLH 
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLH- 120

Query: 305 GFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKLL----TGEDQSMTQTQTLATIGYMA 359
                IIH D+K  N+L+D       ++DFG A  L    TG  +   Q Q L TI +MA
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMA 176

Query: 360 P 360
           P
Sbjct: 177 P 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 24/176 (13%)

Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G+G FG V   +++  G  +A K  +               E ++++ ++ + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFG 305
           +V +  +   +D   LVL  M  G L+  +Y+  N   +  + L     +   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAP 360
                ++ DLKP N+LLDD     +SD G+A K+  GE    +    + T+GYMAP
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 50/171 (29%), Positives = 73/171 (42%), Gaps = 24/171 (14%)

Query: 207 LIGRGSFGSVYKARLQDGME-FAIKSF---------DVEC-EVMKSI-----HHRNLVKI 250
           ++G+GSFG V  A L+   E +A+K           DVEC    K +      H  L ++
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
            S    +D    V+EY+  G L   +  S    D  +       +   L++LH      I
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGI 117

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           I+ DLK  NVLLD      ++DFG+ K       +   T T   T  Y+AP
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 32/77 (41%), Positives = 43/77 (55%), Gaps = 7/77 (9%)

Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           DIL +  I +++  ALEYLH   S  +IH D+KP NVL++ N    L DFGI+  L    
Sbjct: 103 DILGK--IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV--- 155

Query: 344 QSMTQTQTLATIGYMAP 360
            S+ +T       YMAP
Sbjct: 156 DSVAKTIDAGCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 24/176 (13%)

Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G+G FG V   +++  G  +A K  +               E ++++ ++ R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFG 305
           +V +  +   +D   LVL  M  G L+  +Y+  N   D  + +     +T  LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH-- 119

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAP 360
               I++ DLKP N+LLDD     +SD G+A ++  GE    T    + T+GYMAP
Sbjct: 120 -RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 19/165 (11%)

Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  A     G + A+K  D+           E  +M+  HH N+V + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+E++  G+L  ++  +   ++  Q   + ++V  AL YLH   +  +IH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAP
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAP 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 13/172 (7%)

Query: 200 NGFSANNLIGRGSFGSVYKARLQDGMEF-AIKSF--DVECEVMKSIHHRNLVKIISSCSN 256
           N F    ++G G++G V K R ++  E  AIK F    E E +K    R L K++ +   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLREL-KMLRTLKQ 59

Query: 257 EDFRALVLEYMTNGSLEKVL-YSSNCILDILQRL-------NIMINVTSALEYLHFGFST 308
           E+   L   +   G L  V  Y    +L++L+ +        +   +   ++ +H+    
Sbjct: 60  ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            I+H D+KP N+L+  N V  L DFG A+ L+ E  +   T+ +AT  Y +P
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSP 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 19/145 (13%)

Query: 208 IGRGSFGSVYKARLQDGMEF-AIKSFDVECE------------VMKSIHHRNLVKIISSC 254
           +G G++ +VYK R +   E  A+K   ++ E            +MK + H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 255 SNEDFRALVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
             E+   LV EYM +  L+K +  +     LD     +    +   + + H      ++H
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAK 337
            DLKP N+L++      L+DFG+A+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 39/172 (22%), Positives = 65/172 (37%), Gaps = 22/172 (12%)

Query: 207 LIGRGSFGSVYKA--------RLQ--------DGMEFAIKSFDVECEVMKSIHHRNLVKI 250
            +G GSFG V +          +         D +   +  F  E  +M S+ H NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL-NIMINVTSALEYLHFGFSTP 309
                      +V E    GSL   L        ++  L +  + + + + YL    S  
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAK-LLTGEDQSMTQTQTLATIGYMAP 360
            IH DL   N+LL  +    + DFG+ + L   ED  + +        + AP
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 24/174 (13%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKS--FD------------VECEV--MKSIHHRNLVK 249
           L+G+G+FG VY     D G E A K   FD            +ECE+  +K++ H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 250 IISSCSNEDFRALV--LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
                 +   + L   +EYM  GS++  L +   + + + R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY-MAP 360
             I+H D+K  N+L D      L DFG +K L     S T  +++    Y M+P
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 23/174 (13%)

Query: 194 ELLRATN-GFSANNLIGRGSFGSVYKARLQDGME-FAIKSF-------DVECEVMKSIHH 244
           ++ R+ N  +   N+IG GSFG VY+A   D  E  AIK         + E  +MK+++H
Sbjct: 59  DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNH 118

Query: 245 RNLVKIISSCSNEDFRA--------LVLEYMTNGSLEKVLYSS--NCILDILQRLNIMIN 294
            N++ +      E F+         +V+E++     + + + +  N  L +         
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ 178

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTGEDQSMT 347
           +  AL Y+H  F   I H DLKP N+L+D N     L DFG AK L    +S++
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229

Length = 440

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 52/173 (30%), Positives = 77/173 (44%), Gaps = 22/173 (12%)

Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSFDVECEVMKSIHH-RNLVKIISSCSNEDF 259
           F+    IG+GSFG VYK       E  AIK  D+E E    I   +  + ++S C +   
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYI 64

Query: 260 RA------------LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
                         +++EY+  GS   +L      L+      I+  +   L+YLH   S
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---S 119

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IH D+K  NVLL +     L+DFG+A  LT  D  + +   + T  +MAP
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 19/154 (12%)

Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 61  DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 120

Query: 277 ------YSSNCILDILQRLNIMIN----VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
                 Y+   + +       +++    V   +EYL    S   IH DL   NVL+ ++ 
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 177

Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 33/176 (18%)

Query: 207 LIGRGSFGSVYKARLQDGME----FAIKSFD-------------VECEVMKSIHHRNLVK 249
           ++G+GSFG V+  R   G +    +A+K                +E +++  ++H  +VK
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 250 IISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
           +  +   E    L+L+++  G L     ++V+++   +   L  L +      AL++LH 
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------ALDHLH- 115

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  II+ DLKP N+LLD+     L+DFG++K     D          T+ YMAP
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 24/171 (14%)

Query: 207 LIGRGSFGSVYKARLQDGMEF-AIKSF---------DVECEVMK------SIHHRNLVKI 250
           ++G+GSFG V  A L+   EF AIK+          DVEC +++      +  H  L  +
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             +   ++    V+EY+  G L   + SS    D  +       +   L++LH      I
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGI 117

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKL-LTGEDQSMTQTQTLATIGYMAP 360
           I+ DLK  NVLLD +    ++DFG+ K  + GE ++ T      T  Y+AP
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST---FCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 38/184 (20%)

Query: 207 LIGRGSFGSVYKARLQDGME--FAIKSFDV---------------------ECEVMK-SI 242
            +G G+FG VYK R ++  +   A+K  +V                     E  ++K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 243 HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL------NIMINVT 296
            H N+V+   +    D   +V++ +    L +     N + +  QR       NI + + 
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF---NSLKEKKQRFTEERIWNIFVQMV 123

Query: 297 SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
            AL YLH      I+H DL P+N++L ++    ++DFG+AK     +  +  T  + TI 
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL--TSVVGTIL 178

Query: 357 YMAP 360
           Y  P
Sbjct: 179 YSCP 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.8 bits (126), Expect = 9e-08
 Identities = 48/169 (28%), Positives = 73/169 (43%), Gaps = 21/169 (12%)

Query: 207 LIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHHRNLVKII 251
           L+G+G+FG V   R +  G  +A+K                  E  V+K+  H  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            S   +D    V+EY+  G L   L       +   R      + SAL+YLH G    I+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG---KIV 117

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           + DLK  N++LD +    ++DFG+ K   G   + T      T  Y+AP
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 18/104 (17%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGL-K 66
           +DL G  +SG I +    L  ++ ++L               S N L G IP  I     
Sbjct: 74  IDLSGKNISGKISSAIFRLPYIQTINL---------------SNNQLSGPIPDDIFTTSS 118

Query: 67  SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
           SL++L+L +N   GSIP     + +LE+LDLSNN LS  IP  +
Sbjct: 119 SLRYLNLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDI 160

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 42/141 (29%), Positives = 58/141 (41%), Gaps = 21/141 (14%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGDI 58
           LDL  N L+G IP    +   L  L L SN L   +         L R     N+  G++
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420

Query: 59  PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS-----LEKL 113
           P+    L  + FL + +N LQG I +   D+ SL+ L L+ N     +P S     LE L
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENL 480

Query: 114 -----LLEGEIPRGGPFTKFS 129
                   G +PR       S
Sbjct: 481 DLSRNQFSGAVPRK--LGSLS 499

Length = 968

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 39/189 (20%)

Query: 208 IGRGSFGSVY--------KARLQDGMEFAIKSFD------------VECEVMKSI-HHRN 246
           +G G FG V         K + ++ +  A+K                E E+MK I  H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL-----------YSSNCILDILQRLNIMINV 295
           ++ ++ +C+ +    +++EY + G+L + L           Y    + D       +++ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 296 T----SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           T      +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 200 RLPVKWMAP 208

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 17/151 (11%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+ A      + A+K+          F  E  VMK++ H  LVK+ +  + E
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRL-NIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ E+M  GSL   L S       L +L +    +   + ++        IH DL+
Sbjct: 74  PIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLR 129

Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
             N+L+  ++V  ++DFG+A+++  ED   T
Sbjct: 130 AANILVSASLVCKIADFGLARVI--EDNEYT 158

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 24/176 (13%)

Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G+G FG V   +++  G  +A K  +               E  +++ ++ R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFG 305
           +V +  +   +D   LVL  M  G L+  +Y+  N   D  + +     +   LE L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAP 360
               I++ DLKP N+LLDD     +SD G+A ++  GE    T    + T+GYMAP
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 21/170 (12%)

Query: 207 LIGRGSFGSVYKA-RLQDG----MEFAIK---------SFDVECE---VMKSIHHRNLVK 249
           L+G G FG+V+K   + +G    +  AIK         +F    +    M S+ H  +V+
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           ++  C     + LV +    GSL   +      LD  + LN  + +   + YL       
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           ++H +L   N+LL  + +  ++DFG+A LL  +D+    ++    I +MA
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 50/172 (29%), Positives = 77/172 (44%), Gaps = 31/172 (18%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKS--FD------------VECEV--MKSIHHRNLVK 249
           L+G+G+FG VY     D G E A+K   FD            +ECE+  +K++ H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 250 IISSCSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
                 +   R L   +E+M  GS++  L S   + + + R      +   + YLH   S
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLH---S 124

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
             I+H D+K  N+L D      L DFG +K L        QT  L+  G  +
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRL--------QTICLSGTGMKS 168

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 35/147 (23%), Positives = 63/147 (42%), Gaps = 13/147 (8%)

Query: 223 DGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY----- 277
           D  + A + F  E +++  +   N+ +++  C+ +    +++EYM NG L + L      
Sbjct: 57  DASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAE 116

Query: 278 --SSNCILDILQR---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD 332
                C    L     L +   + S + YL    S   +H DL   N L+  N    ++D
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIAD 173

Query: 333 FGIAKLLTGEDQSMTQTQTLATIGYMA 359
           FG+++ L   D    Q +    I +MA
Sbjct: 174 FGMSRNLYSSDYYRVQGRAPLPIRWMA 200

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 5/99 (5%)

Query: 262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVL 321
           L+L+Y+  G L   LY      +   R+ I   +  AL++LH      II+ D+K  N+L
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137

Query: 322 LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LD      L+DFG++K    E++    +    TI YMAP
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 52/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)

Query: 207 LIGRGSFGSVYKARL-QDGMEFAIKSF---------DVECEVMK------SIHHRNLVKI 250
           ++G+GSFG V  ARL + G  +A+K           DVEC + +      + +H  L ++
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
                  D    V+E++  G L   +  S    +   R      +TSAL +LH      I
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DKGI 117

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           I+ DLK  NVLLD      L+DFG+ K   G     T +    T  Y+AP
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 21/170 (12%)

Query: 207 LIGRGSFGSVYKA-RLQDG----MEFAIK------------SFDVECEVMKSIHHRNLVK 249
           ++G G+FG+VYK   + +G    +  AIK             F  E  +M S+ H +LV+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           ++  C +   + LV + M +G L   ++     +     LN  + +   + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           ++H DL   NVL+       ++DFG+A+LL G+++          I +MA
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 18/147 (12%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG GSFG     +  +DG ++ IK  ++             E  V+ ++ H N+V+   S
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCIL-DILQRLNIMINVTSALEYLHFGFSTPIIH 312
                   +V++Y   G L K + +   +L    Q L+  + +  AL+++H      I+H
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILH 124

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            D+K  N+ L  +    L DFGIA++L
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 31/176 (17%)

Query: 208 IGRGSFGSVYK-ARLQDGMEFAIKSFD--------VECE--VMKSI-HHRNLVKIISSCS 255
           IG+G++G VYK    +DG   A+K  D        +E E  +++S+ +H N+VK      
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 256 NEDFRA-----LVLEYMTNGSLEKVLYSSNCILDILQRLN------IMINVTSALEYLHF 304
             D        LVLE    GS+ +++     +L   QRL+      I+      L++LH 
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHLH- 145

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             +  IIH D+K +N+LL       L DFG++  LT     + +  ++ T  +MAP
Sbjct: 146 --NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAP 197

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 28/173 (16%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDVEC-----EVMKSIHHRNLVKIISSCSNEDFRA 261
           IG+G+FG VY+ R +D    +A+K    +      EV  +I  RN++ + +      F  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNIL-VRTLLDESPFIV 59

Query: 262 -------------LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
                        LV +YM+ G L   L       +   +  I   +  ALE+LH     
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH---KY 115

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKL-LTGEDQSMTQTQTLATIGYMAP 360
            I++ DLKP N+LLD      L DFG++K  LT    + T      T  Y+AP
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 29/171 (16%)

Query: 208 IGRGSFGSVYKARLQDG--MEFAIKSFDVECEVMKS---------------IHHRNLVKI 250
           +G GSFG V  A  ++      AIK F+ + +++K                I+H   V +
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFE-KSKIIKQKQVDHVFSERKILNYINHPFCVNL 96

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             S  +E +  LVLE++  G     L  +    + +        +    EYL    S  I
Sbjct: 97  YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-YAAQIVLIFEYLQ---SLNI 152

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           ++ DLKP N+LLD +    ++DFG AK++       T+T TL  T  Y+AP
Sbjct: 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYTLCGTPEYIAP 197

Length = 340

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 50.3 bits (121), Expect = 5e-07
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 24/169 (14%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSF-----DVEC-------EVMKSI-HHRNLVKIISS 253
           IG G+F  V KA+  + G  +AIK        +E        + ++ +  H N++++I  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 254 CSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             +      ALV E M + +L +++      L   +  + M  +  +L+++H      I 
Sbjct: 67  LFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIF 122

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H D+KP N+L+ D+I+  L+DFG  +   G       T+ ++T  Y AP
Sbjct: 123 HRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYRAP 167

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 19/165 (11%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  A ++  G   A+K  D+           E  +M+   H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+E++  G+L  ++  +   ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAP
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 19/154 (12%)

Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  +  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 55  DATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRP 114

Query: 277 ----YS------SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
               YS          L     ++    V   +EYL    S   IH DL   NVL+ ++ 
Sbjct: 115 PGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDN 171

Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.3 bits (120), Expect = 6e-07
 Identities = 37/182 (20%), Positives = 79/182 (43%), Gaps = 27/182 (14%)

Query: 203 SANNLIGRGSFGSVYKARLQDGM-EFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRA 261
           +A  L GR  + +V    L++      ++    E  ++K ++H +++K+  +CS +    
Sbjct: 20  TAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79

Query: 262 LVLEYMTNGSLEKVLYSSNCI-----------------------LDILQRLNIMINVTSA 298
           L++EY   GSL   L  S  +                       L +   ++    ++  
Sbjct: 80  LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRG 139

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           ++YL       ++H DL   NVL+ +     +SDFG+++ +  ED  + +++    + +M
Sbjct: 140 MQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWM 196

Query: 359 AP 360
           A 
Sbjct: 197 AI 198

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 26/162 (16%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV------------------ECEVMKSIHHRNLVK 249
           +G G+FG+V K   +  M+ + K+  V                  E  VM+ + +  +V+
Sbjct: 3   LGSGNFGTVKKGMYK--MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +I  C  E +  LV+E    G L K L  +  + +      ++  V+  ++YL     T 
Sbjct: 61  MIGICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETN 115

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
            +H DL   NVLL     A +SDFG++K L G D++  + +T
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKT 156

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 29/168 (17%)

Query: 208 IGRGSFGSVYKA-RLQDGMEFAIK--SFDVECEVMKSIHHRNLVKIISSCSN-------- 256
           +G G+ G+VYKA  L      A+K    D+  E+ K I     ++I+  C +        
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE--LEILYKCDSPYIIGFYG 66

Query: 257 ----EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
               E+  ++  E+M  GSL+  +Y       +L R  I + V   L YL   +S  I+H
Sbjct: 67  AFFVENRISICTEFMDGGSLD--VYRK-IPEHVLGR--IAVAVVKGLTYL---WSLKILH 118

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            D+KP N+L++      L DFG++  L     S+ +T  + T  YMAP
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 53/173 (30%), Positives = 81/173 (46%), Gaps = 31/173 (17%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDVECEVMK--------SIHHR----NLVKIISSC 254
           +G+G++GSVYK   +  G+  A+K   +E +  K         I H+     +V    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCIL----DILQRLNIMINVTSALEYLHFGFSTPI 310
             E    + +EYM  GSL+K+            D+L+R  I   V   L++L    +  I
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEEHN--I 124

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
           IH D+KP NVL++ N    L DFG++  L     S+ +T     IG   YMAP
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 28/170 (16%)

Query: 208 IGRGSFGSVYKARLQDGMEF-AIKSFD--------------VECEVMKSIHHRNLVKIIS 252
           +G+G +G V+ A+ +D  E  A+K                  E +++ +     LVK++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--MINVTSALEYLHFGFSTPI 310
           +  ++++  L +EY+  G    +L +   + +   R  +  M     AL  L        
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG------Y 122

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           IH DLKP N L+D +    L+DFG++K +     S+     + +  YMAP
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAP 167

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 45/169 (26%), Positives = 70/169 (41%), Gaps = 21/169 (12%)

Query: 207 LIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHHRNLVKII 251
           L+G+G+FG V   R +  G  +A+K                  E  V+++  H  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            +    D    V+EY   G L   L       +   R      + SALEYLH   S  ++
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           + D+K  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 25/169 (14%)

Query: 208 IGRGSFGSVYKAR--LQDGMEFAIKSFDVECE------------VMKSIHHRNLVKIISS 253
           +G G++ +VYK R  L D +  A+K   +E E            ++K + H N+V +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 254 CSNEDFRALVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              E    LV EY     L+K L  Y  +C  + +   N+ + +   L  L++     ++
Sbjct: 73  IHTEKSLTLVFEY-----LDKDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVL 126

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H DLKP N+L+++     L+DFG+A+       + T +  + T+ Y  P
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPP 173

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 42/139 (30%), Positives = 69/139 (49%), Gaps = 17/139 (12%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  AR +  G + A+K  D+           E  +M+   H+N+V++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             +   +++E++  G+L  ++  S   L+  Q   +  +V  AL YLH   S  +IH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 316 KPHNVLLDDNIVAHLSDFG 334
           K  ++LL  +    LSDFG
Sbjct: 144 KSDSILLTLDGRVKLSDFG 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 26/172 (15%)

Query: 207 LIGRGSFGSVYKARLQ-DGMEFAIKSF---------DVECEVMK------SIHHRNLVKI 250
           ++G+GSFG V+ A L+     FAIK+          DVEC +++      +  H  L  +
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTP 309
             +   ++    V+EY+  G L  + +  +C   D+ +       +   L++LH   S  
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKG 116

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKL-LTGEDQSMTQTQTLATIGYMAP 360
           I++ DLK  N+LLD +    ++DFG+ K  + G+ ++ T      T  Y+AP
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT---FCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 42/194 (21%)

Query: 193 LELLRATNGFSANNLIGRGSFGSVYKAR-LQDG----MEFAIKSFDV------------E 235
           L +L+ T  F    ++G G+FG+VYK   + +G    +  AIK                E
Sbjct: 1   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59

Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 60  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 108

Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  +++ 
Sbjct: 109 QYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165

Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 166 YHAEGGKVPIKWMA 179

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 28/178 (15%)

Query: 199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----FDV---------ECEVMKSIHH 244
           TN +     +G G+FG V  AR Q  G   AIK     F           E +++K + H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 245 RNLVKI--ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL 302
            N++ +  I     ED    V E +    L ++L S       +Q    +  +   L+Y+
Sbjct: 69  ENIISLSDIFISPLEDIY-FVTELLGT-DLHRLLTSRPLEKQFIQYF--LYQILRGLKYV 124

Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H   S  ++H DLKP N+L+++N    + DFG+A++   +D  M  T  ++T  Y AP
Sbjct: 125 H---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM--TGYVSTRYYRAP 174

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 17/143 (11%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDVECE------------VMKSIHHRNLVKIISSC 254
           +G G++ +V+K R +      A+K   +E E            ++K++ H N+V +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
             E    LV EY+ +  L++  Y  NC  +++   N+ I +   L  L +     I+H D
Sbjct: 73  HTERCLTLVFEYLDS-DLKQ--YLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128

Query: 315 LKPHNVLLDDNIVAHLSDFGIAK 337
           LKP N+L+++     L+DFG+A+
Sbjct: 129 LKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 24/166 (14%)

Query: 200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSFD--------------VECEVMKSIHH 244
           + F +  +IGRG+FG V   + +D G  +A+K                  E +++    +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH- 303
             +VK+  S  +E++  L++EY+  G +  +L   +   +   R  I   +  A++ +H 
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL-AIDSIHK 119

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 349
            G+    IH D+KP N+LLD      LSDFG   L TG  +S    
Sbjct: 120 LGY----IHRDIKPDNLLLDAKGHIKLSDFG---LCTGLKKSHRTE 158

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 31/172 (18%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           +G GS+ +VYK + + +G   A+K   +            E  ++K + H N+V +    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 255 SNEDFRALVLEYMTNGSLEKV------LYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
             ++   LV EY+     + +      L+  N  L + Q L         L Y+H  +  
Sbjct: 73  HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY-- 123

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            I+H DLKP N+L+ D     L+DFG+A+       S T +  + T+ Y  P
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPP 172

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 5/106 (4%)

Query: 230 KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL 289
           + F  E   +    H N+V++    +  +   +V EYM+NG+L+  L      L   Q +
Sbjct: 51  RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM 110

Query: 290 NIMINVTSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG 334
            ++  + S ++YL   G+    +H  L  H VL++ ++V  +S F 
Sbjct: 111 GMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 38/178 (21%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK----SFD---------VECEVMKSIHHRNLVK---I 250
           IGRG++G V  A+  +   + AIK    +FD          E ++++ + H N++    I
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 251 ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILD------ILQRLNIMINVTSALEYL 302
           +     E F    +V E M +  L +++ SS  + D      + Q L         L+Y+
Sbjct: 73  MPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------GLKYI 124

Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H   S  ++H DLKP N+LL+ N    + DFG+A+  + +   M  T+ + T  Y AP
Sbjct: 125 H---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYRAP 177

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 32/189 (16%)

Query: 200 NGFSANNLIGRGSFGSVYKARLQDGME-FAIKSFDVECEVMKSIHHRNLVK--------- 249
             F    LI  G++G+VY  R ++  + FA+K  + +  ++++   +  V+         
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 250 --IISS-CSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             ++S  CS E  R L  V+EY+  G    +L +   +   + R+     V  ALEYLH 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLH- 118

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK---------LLTGEDQSMTQ----TQT 351
             +  I+H DLKP N+L+       L+DFG++K         L  G  +  T+     Q 
Sbjct: 119 --NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 352 LATIGYMAP 360
             T  Y+AP
Sbjct: 177 CGTPEYIAP 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 24/171 (14%)

Query: 207 LIGRGSFGSVYKARLQDGME-FAIKSF---------DVECEVMK----SIHHRN--LVKI 250
           ++G+GSFG V  A L+   E FA+K+          DVEC +++    ++   N  L  +
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             +   ++    V+E++  G L   +       D+ +       +   L++LH   S  I
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGI 117

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKL-LTGEDQSMTQTQTLATIGYMAP 360
           I+ DLK  NV+LD +    ++DFG+ K  + G++++ T      T  Y+AP
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 21/155 (13%)

Query: 223 DGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS---- 278
           D  + A   F  E +++  +   N+++++  C +ED   ++ EYM NG L + L S    
Sbjct: 57  DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLD 116

Query: 279 ------------SNCILDILQR--LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD 324
                       ++C+  I     L++ + + S ++YL    S   +H DL   N L+ +
Sbjct: 117 DKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGE 173

Query: 325 NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           N+   ++DFG+++ L   D    Q + +  I +MA
Sbjct: 174 NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMA 208

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 25/169 (14%)

Query: 208 IGRGSFGSVYKAR--LQDGMEFAIKSFDVECE------------VMKSIHHRNLVKIISS 253
           +G G++ +V+K R  L + +  A+K   +E E            ++K + H N+V +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 254 CSNEDFRALVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              +    LV EY     L+K L  Y  +C  +I+   N+ I +   L  L +     ++
Sbjct: 73  VHTDKSLTLVFEY-----LDKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVL 126

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H DLKP N+L+++     L+DFG+A+       + T +  + T+ Y  P
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPP 173

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 24/150 (16%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSF---DV-----------ECEVMKSIHHRNLVKIIS 252
           IG G+FG V   R  D    +A+K+    DV           E +++    +  +VK+  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-FGFSTPII 311
           S  ++D    V++Y+  G +  +L       + L R  I   +T A+E +H  GF    I
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMGF----I 123

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG 341
           H D+KP N+L+D +    L+DFG   L TG
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFG---LCTG 150

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 22/167 (13%)

Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDVEC--EVMKSI-------HHRNLVKIIS---SC 254
           +G G+ GSV K   +  G   A K   +     V K I       H      I+S   + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
            NE+   + +E+M  GSL+++      I ++IL +  I + V   L YL+      I+H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--IMHR 128

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+L++      L DFG++  L     S+  T  + T  YM+P
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 26/62 (41%), Positives = 38/62 (61%), Gaps = 4/62 (6%)

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           L+YLH   S  I+H D+KP N+L++ N V  + DFG+A+ +   D+S   TQ + T  Y 
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYR 171

Query: 359 AP 360
           AP
Sbjct: 172 AP 173

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 21/177 (11%)

Query: 200 NGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKS--------------FDVECEVMKSIHH 244
             F   +L+GRG FG V   R    G  +A+K               F+ E +++   + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH- 303
             + ++  +  ++D   LV+EY   G L  +L       D       +  +  A+  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            G+    +H D+KP NVL+D      L+DFG A  LT  ++ +     + T  Y+AP
Sbjct: 121 MGY----VHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 46.8 bits (111), Expect = 6e-06
 Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 26/174 (14%)

Query: 208 IGRGSFGSVYKARLQDGMEFA---IK------------SFDVECEVMKSIHHRNLVKIIS 252
           IG G FG V       GM  A   +K             F  E +  + ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCIL------DILQRLNIMINVTSALEYLHFGF 306
            C       LVLE+   G L+  L S+  ++      D+LQR+     V S L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
               IH DL   N  L  ++   + D+G+A     ED  +T+      + ++AP
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 44/184 (23%), Positives = 76/184 (41%), Gaps = 28/184 (15%)

Query: 202 FSANNL-----IGRGSFGSVYKA------RLQDGMEFAIK------------SFDVECEV 238
           F  NNL     +G G+FG V +A      +    M+ A+K            +   E ++
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91

Query: 239 MKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVT 296
           M  + +H N+V ++ +C+      ++ EY   G L   L       L +   L+    V 
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 297 SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
             + +L    S   IH DL   NVLL    +  + DFG+A+ +  +   + +      + 
Sbjct: 152 KGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 357 YMAP 360
           +MAP
Sbjct: 209 WMAP 212

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 27/172 (15%)

Query: 207 LIGRGSFGSV-----------YKARLQDGMEFAIKS----FDVECEVMKSIHHRNLVKII 251
           +IGRG+FG V           Y  +L    E   +S    F  E ++M   +   +V++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN--IMINVTSALEYLHFGFSTP 309
            +  ++ +  +V+EYM  G L  ++  SN   D+ ++        V  AL+ +H   S  
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SN--YDVPEKWAKFYTAEVVLALDAIH---SMG 162

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
           +IH D+KP N+LLD +    L+DFG    +  ++  M +  T + T  Y++P
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 28/174 (16%)

Query: 208 IGRGSFGSVY-----KARLQDGM----EFAIKSFD--------VECEVMKSIHHRNLVKI 250
           +G+GSFG+VY     KA  ++ +    E  +   +         E +++  + H  +VK 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 251 ISSCSNEDFRALVLEYMTNGSLE---KVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            +S    D   ++ EY     L+   + L  +   L   Q     I +   + Y+H    
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---Q 124

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
             I+H DLK  N+ L +N++  + DFG+++LL G  D + T T    T  YM+P
Sbjct: 125 RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMSP 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.6 bits (113), Expect = 8e-06
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 19/154 (12%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDVECEVMKSIHH-----RN---------LVKIIS 252
           I RG+FG VY  R + +   +A+K       + K++ H     R+         +V +  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           S  + +   LV+EY+  G ++ +L+      + +    I   V  AL+YLH      IIH
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLH---RHGIIH 127

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
            DLKP N+L+ +     L+DFG++K+    + +M
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 36/142 (25%), Positives = 62/142 (43%), Gaps = 19/142 (13%)

Query: 235 ECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY---------------S 278
           E E+MK I  H+N++ ++  C+ E    +++EY   G+L + L                 
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 279 SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL 338
               L     ++    V   +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 339 LTGEDQSMTQTQTLATIGYMAP 360
           +   D     +     + +MAP
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 39/162 (24%)

Query: 207 LIGRGSFGSVYKAR------LQDGMEFAIKSFDVECEVMK-----SIHHRNLVKIISSCS 255
           LIG G FG VY+ +      + +     I++ + E  VM+     +I+  + + +  +  
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78

Query: 256 NEDFRALVLEYMTNGS------------LEKVLYSSNCILDILQRL---------NIMIN 294
           N D   +   Y   GS            LEK++ ++    +I +R+         NIM +
Sbjct: 79  NIDHLGIPK-YYGCGSFKRCRMYYRFILLEKLVENTK---EIFKRIKCKNKKLIKNIMKD 134

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
           + + LEY+H      I H D+KP N+++D N   ++ D+GIA
Sbjct: 135 MLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 35/120 (29%), Positives = 66/120 (55%), Gaps = 16/120 (13%)

Query: 235 ECEVMKSIHHRNLVKIIS----SCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQR 288
           E  +MK ++H+N++ +++      S E+F+   LV+E M   +L +V+      LD  +R
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI---QMDLD-HER 119

Query: 289 LNIMI-NVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
           ++ ++  +   +++LH   S  IIH DLKP N+++  +    + DFG+A+   G    MT
Sbjct: 120 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMT 175

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 9/98 (9%)

Query: 264 LEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL 322
           +E+M  GSL++VL  +  I  +IL +  I I V   L YL       I+H D+KP N+L+
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLREKHK--IMHRDVKPSNILV 133

Query: 323 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +      L DFG++  L     SM  +  + T  YM+P
Sbjct: 134 NSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 46/172 (26%), Positives = 71/172 (41%), Gaps = 27/172 (15%)

Query: 207 LIGRGSFGSVYKARLQDGME-FAIKSFD--------------VECEVMKSIHHRNLVKII 251
           L+G+G+FG V   R +   + +A+K                  E  V+++  H  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIM-INVTSALEYLHFGFSTPI 310
            S    D    V+EY   G L    + S   +    R       + SAL YLH   S  +
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDV 116

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL--ATIGYMAP 360
           ++ DLK  N++LD +    ++DFG+ K    E  S   T      T  Y+AP
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 38/191 (19%), Positives = 73/191 (38%), Gaps = 42/191 (21%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV-----------------------------ECEV 238
           +G G FG V+    +   +F  K F +                             E ++
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----------YSSNCILDILQR 288
           M  +   N++++++ C   D   ++ EYM NG L + L           +    +     
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           + +   + S ++YL    S   +H DL   N L+  N    ++DFG+++ L   D    Q
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 349 TQTLATIGYMA 359
            + +  I +M+
Sbjct: 190 GRAVLPIRWMS 200

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 43/144 (29%), Positives = 71/144 (49%), Gaps = 22/144 (15%)

Query: 207 LIGRGSFGSVYKARLQDGME-FAIK---SFDV-----------ECEVMKSIHHRNLVKII 251
           +IGRG+FG V   R +   + +A+K    F++           E ++M   +   +V++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-FGFSTPI 310
            +  ++ +  +V+EYM  G L   L S+  I +   R      V  AL+ +H  GF    
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVLALDAIHSMGF---- 163

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFG 334
           IH D+KP N+LLD +    L+DFG
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 50/169 (29%), Positives = 72/169 (42%), Gaps = 23/169 (13%)

Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD-----VECEVMKSIHHRN---------LVKIIS 252
           IG+GSFG V + R +D    +A+K+          EV  ++  R          +V +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           S  + +   LVL ++  G L   L           R      +  ALE LH      +I+
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH---KFNVIY 116

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
            DLKP N+LLD      L DFG+ KL   +D    +T T   T  Y+AP
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 38/186 (20%), Positives = 74/186 (39%), Gaps = 36/186 (19%)

Query: 208 IGRGSFGSVYKARL-----------------QDGMEFAIKS-FDVECEVMKSIHHRNLVK 249
           +G   FG VYK  L                 +D  E  ++  F  E  +   + H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY---------------SSNCILDILQRLNIMIN 294
           ++   + E   +++  Y ++  L + L                +    L+    ++I+  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
           + + +E+L    S  ++H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 133 IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 355 IGYMAP 360
           I +M+P
Sbjct: 190 IRWMSP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 25/171 (14%)

Query: 207 LIGRGSFGSV-----------YKARLQDGMEFAIKS----FDVECEVMKSIHHRNLVKII 251
           +IGRG+FG V           Y  +L    E   +S    F  E ++M   +   +V++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN--IMINVTSALEYLHFGFSTP 309
            +  ++ +  +V+EYM  G L  ++  SN   D+ ++        V  AL+ +H   S  
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLM--SN--YDVPEKWARFYTAEVVLALDAIH---SMG 162

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IH D+KP N+LLD +    L+DFG    +  E      T  + T  Y++P
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 27/152 (17%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRNLVKIIS 252
           IG GSFG+VY AR +++    AIK                  E   ++ + H N ++   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI----LQRLNIMINVTSALEYLHFGFST 308
               E    LV+EY         L S++ +L++    LQ + I      AL+ L +  S 
Sbjct: 83  CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT 340
            +IH D+K  N+LL +  +  L DFG A ++ 
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 5/99 (5%)

Query: 262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVL 321
           L+L+Y++ G +   LY  +   +   R      +  ALE+LH      I++ D+K  N+L
Sbjct: 82  LILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH---KLGIVYRDIKLENIL 137

Query: 322 LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LD      L+DFG++K    E++  T +    TI YMAP
Sbjct: 138 LDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 23/154 (14%)

Query: 200 NGFSANNLIGRGSFGSV-YKARLQDGMEFAIKSFDVECEVMK--SIHH----RNL----- 247
             F    +IG+G+FG V    +   G  +A+K+  ++ E+ K   + H    R++     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59

Query: 248 ----VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
               V +  S  +  +  L++E++  G L  +L   +   + + R   M     A+E +H
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVH 118

Query: 304 -FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
             GF    IH D+KP N+L+D      LSDFG++
Sbjct: 119 KLGF----IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 27/178 (15%)

Query: 202 FSANNLIGRGSFGSVYKARLQDGME-FAIK--------------SFDVECEVMKSIHHRN 246
           F    +IGRG+FG V   +L++  + FA+K               F  E +V+ +  ++ 
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNI--MINVTSALEYLH 303
           +  +  +  +E+   LV++Y   G L  +L    + + + + R  +  M+    ++  LH
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG-IAKLLTGEDQSMTQTQTLATIGYMAP 360
           +      +H D+KP N+L+D N    L+DFG   KL+  ED ++  +  + T  Y++P
Sbjct: 123 Y------VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 21/144 (14%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSF---DV-----------ECEVMKSIHHRNLVKIIS 252
           +G G+FG V  A   D    +A+K+    DV           E +++    +  +VK+  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-FGFSTPII 311
           S  ++D    V++Y+  G +  +L       ++L R  I   +T A+E +H  GF    I
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMGF----I 123

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGI 335
           H D+KP N+L+D +    L+DFG+
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 44/121 (36%), Positives = 65/121 (53%), Gaps = 10/121 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSR-------NNL 54
           L+ L  LDL GNK+S  +P     L+AL  L L +N +  L+ + ++          NN 
Sbjct: 185 LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK 243

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           L D+P +I  L +L+ L L +N++  S  +S   L +L  LDLS N+LS  +PL    LL
Sbjct: 244 LEDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLL 301

Query: 115 L 115
           L
Sbjct: 302 L 302

Length = 394

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 21/144 (14%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSF---DV-----------ECEVMKSIHHRNLVKIIS 252
           +G G+FG V  AR  D    +A+K+    DV           E +++    +  +V++  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-FGFSTPII 311
           S  ++D    V++Y+  G +  +L       + L R  I   +T A+E +H  GF    I
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKMGF----I 123

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGI 335
           H D+KP N+L+D +    L+DFG+
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 31/176 (17%)

Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFD--------VECE--VMKSIH-HRNLVKIISSCS 255
           IG+G++G V+K    ++G + A+K  D        +E E  ++K++  H N+VK      
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 256 NEDFRA-----LVLEYMTNGSLEKVLYSSNCILDILQRLN------IMINVTSALEYLHF 304
            +D +      LVLE    GS+  ++      L   +R+       I+      L++LH 
Sbjct: 86  KKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH- 141

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                 IH D+K +N+LL       L DFG++  LT     + +  ++ T  +MAP
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAP 193

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 33/174 (18%)

Query: 208 IGRGSFGSV---YKARLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII 251
           +G G++GSV   Y  RL+   + A+K                 E  ++K + H N++ ++
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 252 S----SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
                + S E+F  + L   +    L  ++       + +Q L  +  +   L+Y+H   
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL--IYQLLRGLKYIH--- 135

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  IIH DLKP NV ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 136 SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--TGYVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 30/180 (16%)

Query: 208 IGRGSFGSVY----KARLQDGME--FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY    K  ++D  E   AIK+            F  E  VMK  +  ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYS-----SNCILDILQRLNIMIN----VTSALE 300
           ++   S      +++E MT G L+  L S      N  +     L  MI     +   + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 4e-05
 Identities = 19/47 (40%), Positives = 27/47 (57%)

Query: 67  SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           +L+ L L +NRL      +F  L +L+ LDLS NNL+ I P +   L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGL 47

Length = 60

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 27/158 (17%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F+    IG GSFG+VY AR ++     AIK                  E + ++ I H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI----LQRLNIMINVTSALEYL 302
            ++       E    LV+EY         L S++ +L++    LQ + I      AL+ L
Sbjct: 87  SIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT 340
            +  S  +IH D+K  N+LL +     L+DFG A + +
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 34/160 (21%)

Query: 207 LIGRGSFGSV-YKARLQDGMEFAIKSFDVE----CEVMKSIHHRNLVKIISSCS------ 255
           ++G G+ G+V    R+ DG  FA+K  D+E     +  ++   +  V  + +C       
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA---QAEVCCLLNCDFFSIVK 95

Query: 256 -NEDFR-------------ALVLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSA 298
            +EDF              ALVL+Y   G L + + S   +N      +   + I V  A
Sbjct: 96  CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL 338
           + ++H   S  +IH D+K  N+LL  N +  L DFG +K+
Sbjct: 156 VHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192

Length = 496

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 21/150 (14%)

Query: 202 FSANNLIGRGSFGSVYKARLQD-----GMEFAIKSFDVECEVMKSIHHRN---------- 246
           F +  +IGRG+FG V   + +D      M+   K+  +E E +  I              
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-FG 305
           +VK+  S  ++    L++E++  G +  +L   + + +   +  I   V  A++ +H  G
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIHQLG 121

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGI 335
           F    IH D+KP N+LLD      LSDFG+
Sbjct: 122 F----IHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.2 bits (102), Expect = 4e-05
 Identities = 27/116 (23%), Positives = 54/116 (46%), Gaps = 18/116 (15%)

Query: 230 KSFDVECEV--MKSIHHRNLV--KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI 285
           K  D E EV  ++ +  + L   K+++S  ++ +  L++E++   +L++V          
Sbjct: 34  KGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SE 85

Query: 286 LQRLNIMINVTSALEYLHFGFSTPI---IHCDLKPHNVLLDDNIVAHLSDFGIAKL 338
            ++ +I   +   L  LH     P+    H DL P N+L+DD  +  + D+  A  
Sbjct: 86  EEKEDIAEQLAELLAKLH---QLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 50/197 (25%), Positives = 80/197 (40%), Gaps = 48/197 (24%)

Query: 207 LIGRGSFGSVY-------------KARLQDGMEFAI--KSFDVECEVMKSIHHRNLVKII 251
           LIG+G  G VY             K   +D  E  +  K F  E ++   + H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSS-NCILDILQR-----------LNIMINVTSAL 299
           S CS+ D     + Y+   +L+ +L S      + L +           L+I   + + +
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQK--ESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ--------------- 344
           EY+H   S  ++H DLKP N+LL       + D+G A     E++               
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 345 SMTQT-QTLATIGYMAP 360
           SMT   + + T  YMAP
Sbjct: 184 SMTIPGKIVGTPDYMAP 200

Length = 932

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 21/150 (14%)

Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIK--------------SFDVECEVMKSIHHRN 246
           F +  +IGRG+FG V   + +D G  +A+K                  E +++       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-FG 305
           +VK+  S  ++    L++E++  G +  +L   + + +   +  I   V  A++ +H  G
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL-AIDSIHQLG 121

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGI 335
           F    IH D+KP N+LLD      LSDFG+
Sbjct: 122 F----IHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.8 bits (106), Expect = 6e-05
 Identities = 39/108 (36%), Positives = 52/108 (48%), Gaps = 11/108 (10%)

Query: 48  DFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEII 106
           D S  N+ G I + I  L  +Q ++L +N+L G IP + F    SL  L+LSNNN +  I
Sbjct: 75  DLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSI 134

Query: 107 P---------LSLEKLLLEGEIPRG-GPFTKFSSKSFIGNDLLCGSPN 144
           P         L L   +L GEIP   G F+        GN L+   PN
Sbjct: 135 PRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182

Length = 968

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 44.3 bits (104), Expect = 6e-05
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)

Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 139

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 186

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 47/185 (25%), Positives = 75/185 (40%), Gaps = 37/185 (20%)

Query: 202 FSANNLIGRGSFGSVYKARLQDGME----FAIKSFDVECEVMKSI---HHRNLVKIISSC 254
           F    ++G G++G V+  R   G +    +A+K       V K+    H R   +++   
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 255 SNEDFRA-------------LVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMI-NV 295
               F               L+L+Y+  G L     ++  +           + I    +
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-------EVQIYSGEI 114

Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
             ALE+LH      II+ D+K  N+LLD N    L+DFG++K    ED+         TI
Sbjct: 115 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTI 170

Query: 356 GYMAP 360
            YMAP
Sbjct: 171 EYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 33/173 (19%)

Query: 208 IGRGSFGSVYK--ARLQDGMEFAIKSFDVECE------------VMKSIHHRNLVKIISS 253
           +G GS+ +VYK  +R+ +G   A+K   ++ E            ++K + H N+V +   
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 254 CSNEDFRALVLEYMTNGSLEKV------LYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
              ++    V EYM     + +      L+  N  L + Q L         L Y+H    
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIH---G 121

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             I+H DLKP N+L+       L+DFG+A+       S T +  + T+ Y  P
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPP 172

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 29/179 (16%)

Query: 202 FSANNLIGRGSFGSVYKARLQDGME-FAIKSFDVECEVMKSIH------HRNLVKIISSC 254
           F    +IGRG+FG V   +++     +A+K  + + E++K          RN V +   C
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERN-VLVNGDC 60

Query: 255 S----------NEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNI--MINVTSALEY 301
                      +E++  LV++Y   G L  +L    + + + + R  I  M+    ++  
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LH+      +H D+KP NVLLD N    L+DFG + L   +D ++  +  + T  Y++P
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 38/177 (21%)

Query: 207 LIGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII- 251
            +G G++GSV  A   + G + AIK                 E  ++K + H N++ ++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 252 ---SSCSNEDFRA--LVLEYMTNGSLEKVL---YSSNCILDILQRLNIMINVTSALEYLH 303
              S+ S ++F+   LV+ YM    L+K++    S     D +Q L  +  +   L+Y+H
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSE----DKVQYL--VYQMLCGLKYIH 134

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              S  IIH DLKP N+ ++++    + DFG+A+     D  M  T  + T  Y AP
Sbjct: 135 ---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGYVVTRWYRAP 183

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 34/181 (18%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-----------ECEVMKSIHHRNLVKII---- 251
           +G GS G V+ A   D     A+K   +           E ++++ + H N+VK+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 252 --SSCSNEDFRAL--------VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
              S   ED  +L        V EYM    L  VL     + +   RL  M  +   L+Y
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL-EQGPLSEEHARL-FMYQLLRGLKY 129

Query: 302 LHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMA 359
           +H   S  ++H DLKP NV ++ +++V  + DFG+A+++          ++ L T  Y +
Sbjct: 130 IH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186

Query: 360 P 360
           P
Sbjct: 187 P 187

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 37/124 (29%), Positives = 56/124 (45%), Gaps = 10/124 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV--------LTRTDFSRNN 53
           L  L  LDL  N ++   P      + L+ L L  N++  L         L   D S N+
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFND 174

Query: 54  LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           L  D+P  +  L +L  L L  N++   +P   + L +LE LDLSNN++ E++       
Sbjct: 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLK 232

Query: 114 LLEG 117
            L G
Sbjct: 233 NLSG 236

Length = 394

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 34/180 (18%), Positives = 74/180 (41%), Gaps = 30/180 (16%)

Query: 207 LIGRGSFGSVYKARLQDGME------FAIKS------------FDVECEVMKSIHHRNLV 248
            +GRG FG V+ A+ +   E        +K+            F  E ++ + + H+N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL--------QRLNIMINVTSALE 300
           +++  C   +   ++LEY   G L++ L ++    + L        Q++ +   +   ++
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L    +   +H DL   N L+       +S   ++K      +       L  + ++AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWLAP 187

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 35/132 (26%), Positives = 69/132 (52%), Gaps = 16/132 (12%)

Query: 235 ECEVMKSIHHRNLVKIIS----SCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQR 288
           E  ++K ++H+N++ +++      S E+F+   LV+E M + +L +V++     LD  + 
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERM 125

Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
             ++  +   +++LH   S  IIH DLKP N+++  +    + DFG+A+       +   
Sbjct: 126 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMM 179

Query: 349 TQTLATIGYMAP 360
           T  + T  Y AP
Sbjct: 180 TPYVVTRYYRAP 191

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 42/177 (23%), Positives = 81/177 (45%), Gaps = 25/177 (14%)

Query: 208 IGRGSFGSVYKARLQDG---MEFAIKSFD---------VECEVMKSIHHRNLV---KIIS 252
           +GRG++G VYKA+ +DG    E+A+K  +          E  +++ + H N++   K+  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 253 SCSNEDFRALVLEYMTNG--SLEKVLYSSNCILDILQRLNIMIN--VTSALEYLHFGFST 308
           S S+     L+ +Y  +    + K   +S      +Q    M+   +   L+ +H+  + 
Sbjct: 69  SHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 309 PIIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAP 360
            ++H DLKP N+L+     +     ++D G A+L     + +      + T  Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 42/180 (23%), Positives = 74/180 (41%), Gaps = 30/180 (16%)

Query: 208 IGRGSFGSVYKARLQDGME------FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY+   +D ++       A+K+            F  E  VMK     ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYS-----SNCILDILQRLNIMIN----VTSALE 300
           ++   S      +V+E M +G L+  L S      N        L  MI     +   + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 20/169 (11%)

Query: 207 LIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHHRNLVKII 251
           L+G+G+FG V   + +  G  +A+K                  E  V+++  H  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            S    D    V+EY   G L   L       +   R      + SAL+YLH      ++
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS--EKNVV 118

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           + DLK  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 25/177 (14%)

Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIK--------------SFDVECEVMKSIHHRN 246
           F    +IGRG+FG V   ++++ G  +A+K               F  E +V+ +   R 
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNI--MINVTSALEYLH 303
           +  +  +  +E+   LV++Y   G L  +L    + + + + R  +  M+    ++  L 
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +      +H D+KP NVLLD N    L+DFG + L    D ++     + T  Y++P
Sbjct: 123 Y------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 41/178 (23%), Positives = 76/178 (42%), Gaps = 31/178 (17%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRN-LVKIIS 252
           IG G++G VYKAR    G   A+K   +E +             +++ +     +V+++ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 253 SCSNEDFRA-----LVLEYMTNGSLEKVLYS----SNCILDILQRLNIMINVTSALEYLH 303
               E+        LV EY+ +  L+K + S        L      + M  +   + + H
Sbjct: 69  VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127

Query: 304 FGFSTPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                 ++H DLKP N+L+D    +  ++D G+ +  +   +S   T  + T+ Y AP
Sbjct: 128 ---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYRAP 180

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 32/163 (19%), Positives = 62/163 (38%), Gaps = 40/163 (24%)

Query: 201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECEV---------------------- 238
             + ++L+  G+FG ++   L D      +    E EV                      
Sbjct: 7   RVTLSDLLQEGTFGRIFYGILID------EKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 239 -MKSIHHRNLVKIISSCSNEDFRALVLE-YMTNGSLEKVLYSSNCI-------LDILQRL 289
            +  + H+N++ I+  C  +     VL  YM  G+L+  L             L   Q +
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 290 NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD 332
           ++ I +   + YLH      +IH D+   N ++D+ +   ++D
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 3e-04
 Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 52/176 (29%)

Query: 208 IGRGSFGSVYKARLQDGMEF----AIK----------SFDVECEVMKSIHHRNLVKIISS 253
           IG G FG V+  + +   EF    AI              +E  VM+ + H+N+V+ I  
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 254 CSNEDFRAL--VLEYMTNGSLEKVL---------YSSNCILDILQRLNIMINVTSALEYL 302
             N+  + L  ++E+   G L + +            + I+DI ++L        AL Y 
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL------LHALAYC 134

Query: 303 HFGFSTP----IIHCDLKPHNVLLDDNI-----------------VAHLSDFGIAK 337
           H     P    ++H DLKP N+ L   I                 +A + DFG++K
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Length = 1021

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 5/116 (4%)

Query: 230 KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL 289
           K+   E +++K+I HR ++ +I +   +    +V+          V  S    L+  Q +
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLE--QAI 188

Query: 290 NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
            I   +  AL YLH      IIH D+K  N+ LD+   A L DFG A  L     +
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Length = 392

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 36/132 (27%), Positives = 68/132 (51%), Gaps = 16/132 (12%)

Query: 235 ECEVMKSIHHRNLVKIISSCSN----EDFRA--LVLEYMTNGSLEKVLYSSNCILDILQR 288
           E  +MK ++H+N++ +++  +     E+F+   LV+E M + +L +V+      LD  + 
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 121

Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
             ++  +   +++LH   S  IIH DLKP N+++  +    + DFG+A+       S   
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 175

Query: 349 TQTLATIGYMAP 360
           T  + T  Y AP
Sbjct: 176 TPYVVTRYYRAP 187

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 4e-04
 Identities = 21/71 (29%), Positives = 26/71 (36%), Gaps = 15/71 (21%)

Query: 8  LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
          LDL  N+L+      F  L  L+ L L  N L  +                P    GL S
Sbjct: 5  LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSIS---------------PEAFSGLPS 49

Query: 68 LQFLSLGHNRL 78
          L+ L L  N L
Sbjct: 50 LRSLDLSGNNL 60

Length = 60

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 38/121 (31%), Positives = 59/121 (48%), Gaps = 12/121 (9%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN---ELRHLV------LTRTDFSRNNLL 55
           L  LDL  N+L  +I      LT L +L LD+N   ++  L+      L   D S N + 
Sbjct: 95  LPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE 153

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLL 115
             +P+ ++ L +L+ L L  N L   +P    +L +L +LDLS N +S++ P       L
Sbjct: 154 -SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSAL 211

Query: 116 E 116
           E
Sbjct: 212 E 212

Length = 394

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 36/132 (27%), Positives = 68/132 (51%), Gaps = 16/132 (12%)

Query: 235 ECEVMKSIHHRNLVKIIS----SCSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDILQR 288
           E  +MK ++H+N++ +++      S E+F+ +  V+E M + +L +V+      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 128

Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
             ++  +   +++LH   S  IIH DLKP N+++  +    + DFG+A+       S   
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182

Query: 349 TQTLATIGYMAP 360
           T  + T  Y AP
Sbjct: 183 TPYVVTRYYRAP 194

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 25/147 (17%)

Query: 208 IGRGSFGSVYKA--------------RLQ--DGMEF-AIKSFDVECEVMKSIHHRNLVKI 250
           +G GS+ +VYK               RL+  +G  F AI+    E  ++K + H N+V +
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVTL 68

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
                 +    LV EY+ +  L++ +      L +      +  +   L Y H      +
Sbjct: 69  HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRV 124

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAK 337
           +H DLKP N+L+ +     L+DFG+A+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 9/101 (8%)

Query: 261 ALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHN 319
           ++ +E+M  GSL++VL  +  I  +IL +++I   V   L YL       I+H D+KP N
Sbjct: 79  SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSN 134

Query: 320 VLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L++      L DFG++  L     SM  +  + T  YM+P
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 27/152 (17%)

Query: 208 IGRGSFGSVYKARLQDGMEF-AIKSFDV--------------ECEVMKSIHHRNLVKIIS 252
           IG GSFG+VY A      E  A+K                  E + ++ + H N ++   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI----LQRLNIMINVTSALEYLHFGFST 308
               E    LV+EY         L S++ +L++    LQ + I      AL+ L +  S 
Sbjct: 89  CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT 340
            +IH D+K  N+LL +     L+DFG A   +
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 25/174 (14%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKS----FD---------VECEVMKSIHHRNLVK--- 249
           +IG+GS+G V  A     G + AIK     F+          E ++++ + H ++V+   
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 250 IISSCSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           I+   S  +F+ +  V E M +  L +V+ +++ +     +   +  +  AL+Y+H   +
Sbjct: 67  IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQF-FLYQLLRALKYIH---T 121

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT-QTQTLATIGYMAP 360
             + H DLKP N+L + +    + DFG+A++   +  +    T  +AT  Y AP
Sbjct: 122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 51/184 (27%), Positives = 72/184 (39%), Gaps = 51/184 (27%)

Query: 208 IGRGSFGSVYKARLQDGME-FAIKSF---------DVE---CE-----VMKSIHHRNLVK 249
           +GRG FG V  A  +   E +AIK+          +VE   CE        S  H  LV 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 250 IISSCSNEDFRALVLEYMTNGSL------------EKVLYSSNCILDILQRLNIMINVTS 297
           + +    ED    V+EY   G L              V Y++  +L              
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL-------------- 112

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIG 356
            L+YLH      I++ DLK  N+LLD      ++DFG+ K   G      +T T   T  
Sbjct: 113 GLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPE 166

Query: 357 YMAP 360
           ++AP
Sbjct: 167 FLAP 170

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 40.2 bits (95), Expect = 8e-04
 Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 11/103 (10%)

Query: 238 VMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTS 297
           +MK   + N +K+  S +      L+++Y+ +G L  +L      L   +   I+  +  
Sbjct: 64  LMK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVE 120

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAK 337
           AL  LH      IIH D+K  NVL D   D I  +L D+G+ K
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRI--YLCDYGLCK 158

Length = 267

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 21/65 (32%), Positives = 37/65 (56%), Gaps = 5/65 (7%)

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG--EDQSMTQTQTLATI 355
            L+Y+H   S  ++H DLKP N+L++ +    + DFG+A+  +    + +   T+ +AT 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 356 GYMAP 360
            Y AP
Sbjct: 174 WYRAP 178

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.9 bits (84), Expect = 0.001
 Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 2/44 (4%)

Query: 66  KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
            +L+ L L +N++   +P    +L +LE+LDLS N ++++ PLS
Sbjct: 1   TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKITDLSPLS 42

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 9/101 (8%)

Query: 261 ALVLEYMTNGSLEKVLYSSNCILD-ILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHN 319
           ++ +E+M  GSL++VL  +  I + IL +++I   V   L YL       I+H D+KP N
Sbjct: 79  SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE--KHKIMHRDVKPSN 134

Query: 320 VLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L++      L DFG++  L     SM  +  + T  YM+P
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 37/149 (24%), Positives = 64/149 (42%), Gaps = 19/149 (12%)

Query: 207 LIGRGSFGS--VYKARLQDGMEFAIK-------SFDV-----ECEVMKSIHHRNLVKIIS 252
           ++G GSFG   + +    D   +A+K       S  V     E  ++  + H N+V    
Sbjct: 7   VVGEGSFGRALLVQHVNSDQK-YAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 253 SCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
           S   +    +V+EY   G L +K+      +      L   + +   ++++H      ++
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVL 122

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           H D+K  N+ L  N    L DFG A+LLT
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLT 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 25/104 (24%), Positives = 51/104 (49%), Gaps = 4/104 (3%)

Query: 234 VECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMI 293
           +E  ++++++H +++++  +  +     +VL +  +  L   L   +  L I Q L I  
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEK 164

Query: 294 NVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
            +   L YLH   +  IIH D+K  N+ ++D     + D G A+
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 40/176 (22%), Positives = 81/176 (46%), Gaps = 23/176 (13%)

Query: 208 IGRGSFGSVYKARLQDG---MEFAIKSFD---------VECEVMKSIHHRNLVKIISS-C 254
           +GRG++G VYKA+ +DG    ++A+K  +          E  +++ + H N++ +     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 255 SNEDFRA-LVLEYMTNG--SLEKVLYSSNCILDILQRLNIMIN--VTSALEYLHFGFSTP 309
           S+ D +  L+ +Y  +    + K   +S      +Q    M+   +   L+ +H+  +  
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 310 IIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAP 360
           ++H DLKP N+L+     +     ++D G A+L     + +      + T  Y AP
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 52/190 (27%)

Query: 202 FSANNLIGRGSFGSVYKARLQDGME--FAIKSF---------DVECEVMK----SIHHRN 246
           F+   ++G+GSFG V  A  + G +  +AIK           DVEC +++    ++  + 
Sbjct: 2   FNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 247 --LVKIISSCSNEDFRALVLEYMTNGSL-------------EKVLYSSNCILDILQRLNI 291
             L ++ S     D    V+EY+  G L               V Y++            
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE----------- 109

Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
              +   L +LH   S  II+ DLK  NV+LD      ++DFG+ K      ++   T+T
Sbjct: 110 ---IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRT 160

Query: 352 L-ATIGYMAP 360
              T  Y+AP
Sbjct: 161 FCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	360
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.98
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.96
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.96
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.96
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.96
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.96
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.96
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.96
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.96
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.95
KOG0589	426	consensus Serine/threonine protein kinase [General	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.95
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.95
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
PTZ00267	478	NIMA-related protein kinase; Provisional	99.95
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.95
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.95
PHA03212	391	serine/threonine kinase US3; Provisional	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.95
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.95
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.95
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.95
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.95
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.95
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.95
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.95
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.95
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.94
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.94
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.94
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.94
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.94
PHA03209	357	serine/threonine kinase US3; Provisional	99.94
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.94
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.94
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.94
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.94
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.94
KOG0586	596	consensus Serine/threonine protein kinase [General	99.94
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
PTZ00283	496	serine/threonine protein kinase; Provisional	99.94
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.94
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.94
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.94
PTZ00036	440	glycogen synthase kinase; Provisional	99.94
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.94
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.94
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.94
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.94
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.94
PHA02988	283	hypothetical protein; Provisional	99.94
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.94
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.94
PHA03207	392	serine/threonine kinase US3; Provisional	99.94
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.94
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.94
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.94
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.94
KOG0610	459	consensus Putative serine/threonine protein kinase	99.93
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.93
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.93
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.93
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.93
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.93
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.93
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.93
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.93
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.93
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.93
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.93
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.93
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.93
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.93
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.93
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.93
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.93
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.93
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.93
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.93
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.93
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.93
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.93
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.93
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.93
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.93
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.93
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.93
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.93
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.93
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.93
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.93
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.93
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.93
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.93
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.93
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.93
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.93
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.93
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.93
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.93
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.93
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.93
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.93
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.93
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.93
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.93
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.93
KOG0584	632	consensus Serine/threonine protein kinase [General	99.93
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.93
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.93
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.93
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.93
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.93
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.93
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.93
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.93
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.93
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.93
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.93
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.93
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.93
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.92
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.92
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.92
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.92
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.92
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.92
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.92
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.92
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.92
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.92
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.92
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.92
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.92
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.92
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.92
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.92
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.92
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.92
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.92
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.92
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.92
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.92
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.92
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.92
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.92
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.92
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.92
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.92
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.92
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.92
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.92
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.92
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.92
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.92
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.92
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.92
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.92
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.92
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.92
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.92
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.92
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.92
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.92
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.92
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.92
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.92
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.92
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.92
PHA03210	501	serine/threonine kinase US3; Provisional	99.92
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.92
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.92
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.91
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.91
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.91
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.91
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.91
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.91
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.91
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.91
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.91
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.91
PTZ00284	467	protein kinase; Provisional	99.91
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.91
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.91
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.91
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.91
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.91
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.91
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.91
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.91
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.91
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.91
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.91
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.91
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.91
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.91
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.91
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.91
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.91
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.91
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.91
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.91
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.91
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.91
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.91
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.91
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.91
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.91
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.91
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.91
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.91
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.91
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.91
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.91
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.91
PLN00009	294	cyclin-dependent kinase A; Provisional	99.9
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.9
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.9
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.9
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.9
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.9
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.9
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.9
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.9
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.9
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.9
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.9
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.9
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.9
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.9
KOG1152	772	consensus Signal transduction serine/threonine kin	99.9
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.9
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.9
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.9
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.9
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.9
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.9
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.9
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.9
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.9
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.89
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.89
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.89
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.89
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.89
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.89
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.89
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.89
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.89
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.89
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.89
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.89
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.89
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.89
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.89
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.89
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.89
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.88
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.88
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.88
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.88
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.88
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.88
PHA02882	294	putative serine/threonine kinase; Provisional	99.88
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.88
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.88
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.88
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.88
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.88
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.88
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.87
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.87
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.87
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.86
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.86
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.84
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.84
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.81
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.79
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
smart00090	237	RIO RIO-like kinase.	99.78
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.75
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.75
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.73
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.72
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.63
PLN00181	793	protein SPA1-RELATED; Provisional	99.61
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.61
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.59
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.52
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.52
PLN03150	623	hypothetical protein; Provisional	99.51
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.5
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.38
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.36
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.24
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.19
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.19
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.18
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.16
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.15
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.14
KOG3087	229	consensus Serine/threonine protein kinase [General	99.12
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.1
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.1
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.09
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.08
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.07
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.05
PLN03150	623	hypothetical protein; Provisional	99.02
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.01
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.01
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.99
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.95
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.92
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.9
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.87
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.83
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.81
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.78
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.76
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.68
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.67
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.63
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.63
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.62
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.6
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.52
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.52
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.48
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.43
KOG1243	690	consensus Protein kinase [General function predict	98.41
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.41
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.4
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.4
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.39
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.38
PRK09902	216	hypothetical protein; Provisional	98.37
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.36
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.32
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.23
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.19
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.18
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.15
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.15
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.13
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.12
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.1
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.07
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.07
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.04
PF01636	239	APH: Phosphotransferase enzyme family This family	98.02
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.0
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	97.99
PLN02876	822	acyl-CoA dehydrogenase	97.93
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.89
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.89

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.6e-46  Score=394.27  Aligned_cols=343  Identities=32%  Similarity=0.561  Sum_probs=252.7

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|++.|.+|..+ .+++|+.|++++|++++.         .|+.|++++|++++.+|..++++++|+.|+|
T Consensus       452 ~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  530 (968)
T PLN00113        452 PSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDL  530 (968)
T ss_pred             CCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEEC
Confidence            344444444454444444433 235556666666666542         4788899999999999999999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc-----------ccccccCCCCCCCCcccccccCCCCCCCC
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL-----------LLEGEIPRGGPFTKFSSKSFIGNDLLCGS  142 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l-----------~~~~~~p~~~~~~~~~~~~~~~n~~~cgs  142 (360)
                      ++|.++|.+|..|..+++|+.|||++|+++|.+|..+..+           .++|.+|..+.+..+...++.||+.+|+.
T Consensus       531 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~  610 (968)
T PLN00113        531 SHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG  610 (968)
T ss_pred             CCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCC
Confidence            9999999999999999999999999999999999766554           27789999888888889999999999986


Q ss_pred             CC-CCCCCCCCCc---c--eeee-----------eeehhhhhhccccCCCCCc----CCCCCC----ccCCccCHHHHHH
Q 040294          143 PN-LQVPPCKSNK---P--IILA-----------LKFGLISRCQKRATELPNV----ANMQPQ----ASRRRFSYLELLR  197 (360)
Q Consensus       143 p~-~~~~~c~~~~---~--~i~~-----------~~~~~~~~~~~~~~~~~~~----~~~~~~----~~~~~~~~~~~~~  197 (360)
                      +. ...++|....   .  ++++           +.+.++..++++.......    ...+..    .....+++.++. 
T Consensus       611 ~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  689 (968)
T PLN00113        611 DTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL-  689 (968)
T ss_pred             ccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHH-
Confidence            53 3456775321   1  1110           0111111111111111110    000000    011223444443 


Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                        ..|+..++||+|+||.||+|+. .++..||||.+       ..|++.+++++|||||+++++|.+++..++||||+++
T Consensus       690 --~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        690 --SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             --hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence              4577889999999999999996 57899999965       3578999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.++++.    ++|..+..++.|+|+|++|||+.++++|+|||+||+||+++.++.+++. ||.+......      .
T Consensus       768 g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~  836 (968)
T PLN00113        768 KNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------T  836 (968)
T ss_pred             CcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------C
Confidence            999999963    7899999999999999999998778899999999999999999988876 6765543221      1


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||++||||
T Consensus       837 ~~~~t~~y~aP  847 (968)
T PLN00113        837 KCFISSAYVAP  847 (968)
T ss_pred             CccccccccCc
Confidence            23688999998

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-41  Score=316.66  Aligned_cols=174  Identities=48%  Similarity=0.742  Sum_probs=157.1

Q ss_pred             cCCccCHHHHHHHhCCCCCCCeeccCCCccEEEEEccCCcEEEeh-----------hhHHHHHHhhcCCCCCeeEEEEEe
Q 040294          186 SRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK-----------SFDVECEVMKSIHHRNLVKIISSC  254 (360)
Q Consensus       186 ~~~~~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK-----------~~~~E~~~l~~l~hpniv~l~~~~  254 (360)
                      ..+.|++.++..+|++|+..+.||+|+||.||+|.+.+|+.||||           .|..|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            567799999999999999999999999999999999999999997           367899999999999999999999


Q ss_pred             cCCC-eEEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEee
Q 040294          255 SNED-FRALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD  332 (360)
Q Consensus       255 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~D  332 (360)
                      .+.+ ..+||||||++|+|+++|+.... .++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++.+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 59999999999999999998766 889999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|+...... ....+...||.+|+||
T Consensus       221 FGLa~~~~~~~-~~~~~~~~gt~gY~~P  247 (361)
T KOG1187|consen  221 FGLAKLGPEGD-TSVSTTVMGTFGYLAP  247 (361)
T ss_pred             ccCcccCCccc-cceeeecCCCCccCCh
Confidence            99997654311 1111111799999998

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-38  Score=284.71  Aligned_cols=156  Identities=35%  Similarity=0.578  Sum_probs=139.9

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ...+|...+.||+|+||+||+|+++ ++.+||||.+             ..|+++|+.++|||||+++++++.++.+|||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3467888888999999999999975 6889999865             3599999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC------CcEEEeeccccc
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN------IVAHLSDFGIAK  337 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~------~~~ki~DFGla~  337 (360)
                      ||||.||||.++++..+ .+++.....++.|+|.||++||   +++||||||||.|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999998764 6888899999999999999999   9999999999999999764      468999999999


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+.+..   ...+.+|++-||||
T Consensus       164 ~L~~~~---~a~tlcGSplYMAP  183 (429)
T KOG0595|consen  164 FLQPGS---MAETLCGSPLYMAP  183 (429)
T ss_pred             hCCchh---HHHHhhCCccccCH
Confidence            987543   34568999999998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=264.98  Aligned_cols=156  Identities=34%  Similarity=0.492  Sum_probs=138.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..++||+|+||+||.++.+ +++.+|+|.+              ..|..+|.+++||+||+++..|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            567999999999999999999854 7899999854              3488999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      +||+.||+|..+|+.. +.+++..+..++.+|+.||.|||   +.+||||||||+|||+|.+|+++++|||+++..-...
T Consensus       104 ld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            9999999999999765 45777778889999999999999   9999999999999999999999999999999644332


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                        ....+.+||+.||||
T Consensus       180 --~~t~tfcGT~eYmAP  194 (357)
T KOG0598|consen  180 --DATRTFCGTPEYMAP  194 (357)
T ss_pred             --CccccccCCccccCh
Confidence              233458999999999

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-35  Score=266.03  Aligned_cols=155  Identities=31%  Similarity=0.467  Sum_probs=136.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEE-ccCCcEEEehhh------------------HHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          199 TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF------------------DVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~------------------~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      .+.|...+.+|+|+||.|.+|. .++|+.||||.+                  .+|+++|++++|||||+++++|...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3456778999999999999998 458999999843                  469999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC---CcEEEeecccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN---IVAHLSDFGIA  336 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~---~~~ki~DFGla  336 (360)
                      .|+|||||+||+|.+.+-..+ .+.+.....++.|++.|+.|||   +.+|+||||||+|||+..+   ..+||+|||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            999999999999999997654 4666677889999999999999   9999999999999999755   78999999999


Q ss_pred             cccCCCCCceeeecccccCcccCC
Q 040294          337 KLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |.....   ....+.||||.|.||
T Consensus       327 K~~g~~---sfm~TlCGTpsYvAP  347 (475)
T KOG0615|consen  327 KVSGEG---SFMKTLCGTPSYVAP  347 (475)
T ss_pred             hccccc---eehhhhcCCccccCh
Confidence            987632   234578999999999

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=272.01  Aligned_cols=152  Identities=33%  Similarity=0.565  Sum_probs=135.4

Q ss_pred             CCCeeccCCCccEEEEEccCCcEEEeh-------------hhHHHHHHhhcCCCCCeeEEEEEecCCC-eEEEEEEccCC
Q 040294          204 ANNLIGRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIISSCSNED-FRALVLEYMTN  269 (360)
Q Consensus       204 ~~~~iG~G~~g~Vy~~~~~~~~~vavK-------------~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~~  269 (360)
                      ..+.+|+|+||+||+|.++....||||             .|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            345599999999999999765559997             5778999999999999999999999988 79999999999


Q ss_pred             CCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eEEccCCCCceeecCCC-cEEEeecccccccCCCCCce
Q 040294          270 GSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTP-IIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       270 g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~-iiHrdlk~~NiLl~~~~-~~ki~DFGla~~~~~~~~~~  346 (360)
                      |+|.++++. .+..+++..++.+|.|||+||+|||   +.+ ||||||||+|||++.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            999999988 4678999999999999999999999   777 99999999999999997 99999999999865432  2


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ..+...||+.||||
T Consensus       200 ~~~~~~GT~~wMAP  213 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAP  213 (362)
T ss_pred             cccCCCCCccccCh
Confidence            33447899999999

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=261.77  Aligned_cols=151  Identities=28%  Similarity=0.447  Sum_probs=135.4

Q ss_pred             CCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCC-eEEEEEEccC
Q 040294          203 SANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNED-FRALVLEYMT  268 (360)
Q Consensus       203 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~  268 (360)
                      +..+.||+|..|+|||++++ +++.+|+|.+            .+|++++++.+||+||++||.|..+. ...|+||||.
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            34578999999999999986 7888999854            57999999999999999999999998 5999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      +|||++.+... +.+++...-.|+.+|++||.|||+  .+.||||||||+|||++..|++||||||.++.+...    ..
T Consensus       162 gGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a  234 (364)
T KOG0581|consen  162 GGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA  234 (364)
T ss_pred             CCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence            99999999765 458888888999999999999994  389999999999999999999999999999988654    23


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      .+.+||..||||
T Consensus       235 ~tfvGT~~YMsP  246 (364)
T KOG0581|consen  235 NTFVGTSAYMSP  246 (364)
T ss_pred             ccccccccccCh
Confidence            568999999998

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-34  Score=270.10  Aligned_cols=155  Identities=30%  Similarity=0.458  Sum_probs=141.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ..|...++||+|+|+.||+++. .+|..||+|.              +.+|+++.+.++|||||+++++|++.+.+|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4588899999999999999996 7899999974              456999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |+|++++|..+++ +...+++..+..++.||+.||.|||   +.+|+|||||..|+++++++++||+|||+|..+..+. 
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            9999999999998 4457888899999999999999999   9999999999999999999999999999999987543 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       ....+.||||.|+||
T Consensus       173 -Erk~TlCGTPNYIAP  187 (592)
T KOG0575|consen  173 -ERKKTLCGTPNYIAP  187 (592)
T ss_pred             -cccceecCCCcccCh
Confidence             234568999999999

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-34  Score=265.75  Aligned_cols=158  Identities=32%  Similarity=0.514  Sum_probs=141.4

Q ss_pred             HhCCCCCCCeeccCCCccEEEEE-ccCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC--CeEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE--DFRA  261 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~--~~~~  261 (360)
                      ..+.|+..+.||+|.||.||+|+ ..+|+.||+|++             .+|+.+|++++||||++|.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            34567777889999999999998 568999999853             4699999999999999999998876  6899


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ||+|||+. ||..++......+++.+...++.|++.||+|+|   .++|+|||||.+|||||.+|.+||+|||+|+++..
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            99999987 999999887778999999999999999999999   99999999999999999999999999999998876


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .. ....+..+-|+||.||
T Consensus       271 ~~-~~~~T~rVvTLWYRpP  288 (560)
T KOG0600|consen  271 SG-SAPYTSRVVTLWYRPP  288 (560)
T ss_pred             CC-CcccccceEEeeccCh
Confidence            54 3345667889999998

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-33  Score=261.74  Aligned_cols=161  Identities=35%  Similarity=0.534  Sum_probs=142.4

Q ss_pred             HHHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhhH--------------HHHHHhhcC-CCCCeeEEEEEecCCCe
Q 040294          196 LRATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSFD--------------VECEVMKSI-HHRNLVKIISSCSNEDF  259 (360)
Q Consensus       196 ~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~E~~~l~~l-~hpniv~l~~~~~~~~~  259 (360)
                      .+..++|..++.||+|+|++|++|+. .++++||||...              .|-++|.++ .||.||+|+..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            45678899999999999999999984 579999998543              477888888 79999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      +|+|+||+++|+|.+++++. +.+++.....+|.+|+.||+|||   +.+||||||||+|||+|++|++||+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            99999999999999999876 46888888889999999999999   999999999999999999999999999999998


Q ss_pred             CCCCCc---------eee--ecccccCcccCC
Q 040294          340 TGEDQS---------MTQ--TQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~---------~~~--~~~~gt~~Y~aP  360 (360)
                      .+....         ...  .+++||..|.+|
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP  256 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSP  256 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCH
Confidence            654221         122  568999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-33  Score=242.95  Aligned_cols=153  Identities=35%  Similarity=0.481  Sum_probs=138.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||.|+||.|.+++.+ +|.-+|+|.+              .+|..+|+.+.||+++++++.|.+.+.+|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            356888899999999999999975 6778999843              2488899999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||++||.|..+++..+ .+++..+..+|.||+.||+|||   +..|++||+||+|||+|.+|.+||+|||+|+...+. 
T Consensus       123 meyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999998764 5788888999999999999999   999999999999999999999999999999987532 


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                          .-+.||||.|+||
T Consensus       198 ----T~TlCGTPeYLAP  210 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAP  210 (355)
T ss_pred             ----EEEecCCccccCh
Confidence                3457999999999

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.5e-34  Score=249.61  Aligned_cols=154  Identities=31%  Similarity=0.426  Sum_probs=134.7

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      .|+....+|+|+||.||||+.+ +|+.||||+|             .+|+++|++++|||+|.|+++|.....++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            4666788999999999999976 7999999876             3699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      |+. ++.+-|......++......++.|+++|+.|+|   +.++|||||||+|||+..++.+|+||||+|+.+....  .
T Consensus        83 ~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d  156 (396)
T KOG0593|consen   83 CDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--D  156 (396)
T ss_pred             cch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--c
Confidence            987 444445444456788888999999999999999   9999999999999999999999999999999987432  2


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ..+..+.|.||.||
T Consensus       157 ~YTDYVATRWYRaP  170 (396)
T KOG0593|consen  157 NYTDYVATRWYRAP  170 (396)
T ss_pred             hhhhhhhhhhccCh
Confidence            34567899999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.98  E-value=1.2e-32  Score=238.41  Aligned_cols=155  Identities=32%  Similarity=0.535  Sum_probs=140.0

Q ss_pred             CCCCCCCeeccCCCccEEEEE-ccCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      +.|...+.+|+|.||.||+|+ .++|+.||||++             .+|++.|+.++||||+.++++|...+.+-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            356677889999999999999 568999999865             369999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      ||+. +|+..++.....+...+...++.++++|++|||   ++.|+|||+||.|+|++.+|.+||+|||+|+...+.+..
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9976 999999998888999999999999999999999   999999999999999999999999999999998766533


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                        .+..+-|.+|.||
T Consensus       158 --~~~~V~TRWYRAP  170 (318)
T KOG0659|consen  158 --QTHQVVTRWYRAP  170 (318)
T ss_pred             --cccceeeeeccCh
Confidence              2333789999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8.1e-34  Score=247.47  Aligned_cols=157  Identities=29%  Similarity=0.481  Sum_probs=135.1

Q ss_pred             CCCCCCeeccCCCccEEEEE-ccCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEE-EecCCCe-EEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIIS-SCSNEDF-RALVL  264 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~-~~~~~~~-~~lv~  264 (360)
                      +|.+.++||+|+||.|||+. ..+|..+|.|.+             ..|+.+|++++|||||++++ .|.++.. ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            46667889999999999998 568999999854             35999999999999999998 5666555 89999


Q ss_pred             EccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          265 EYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTP--IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       265 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      |||.+|||.++++.   .+..+++..++++..|+++||..+|... +.  |+||||||.||+++.+|.+|++|||+++.+
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999863   4557899999999999999999999422 44  899999999999999999999999999998


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..+..  ...+.+|||+||+|
T Consensus       179 ~s~~t--fA~S~VGTPyYMSP  197 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSP  197 (375)
T ss_pred             cchhH--HHHhhcCCCcccCH
Confidence            75542  34568999999998

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=254.68  Aligned_cols=154  Identities=29%  Similarity=0.503  Sum_probs=139.9

Q ss_pred             CCCCCCCeeccCCCccEEEEE-ccCCcEEEehhhH------------HHHHHhhcCC-CCCeeEEEEEecCCC-eEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFD------------VECEVMKSIH-HRNLVKIISSCSNED-FRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~------------~E~~~l~~l~-hpniv~l~~~~~~~~-~~~lv~  264 (360)
                      ++|...+.||.|.||.||+|+ ..++..||||.++            +|++-|+++. |||||++.+++.+.+ .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            456677889999999999998 4578999999764            5899999999 999999999999988 999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |||+. +|+++++.++..+++.+...|+.||++||+|+|   ..|+.|||+||+|||+.....+||+|||+|+.+.... 
T Consensus        90 E~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp-  164 (538)
T KOG0661|consen   90 EFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP-  164 (538)
T ss_pred             Hhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCC-
Confidence            99965 999999999889999999999999999999999   9999999999999999999999999999999987654 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ..+..+.|.||.||
T Consensus       165 --PYTeYVSTRWYRAP  178 (538)
T KOG0661|consen  165 --PYTEYVSTRWYRAP  178 (538)
T ss_pred             --Ccchhhhcccccch
Confidence              34567889999998

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=4.1e-32  Score=241.83  Aligned_cols=158  Identities=26%  Similarity=0.390  Sum_probs=139.3

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC--CeE
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE--DFR  260 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~--~~~  260 (360)
                      +..++|+..+.|++|+||.||+|+. +++..||+|++             .+|+.+|.+++|||||.+.++....  +..
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            3455677889999999999999996 47889999975             3699999999999999999987654  479


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |+|||||+. ||..++......+...++..++.|+++|++|||   ...|+|||||++|+|+.+.|.+||+|||+|+.+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999999986 999999988778888999999999999999999   8899999999999999999999999999999987


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  ..+..+-|++|.||
T Consensus       229 sp~k--~~T~lVVTLWYRaP  246 (419)
T KOG0663|consen  229 SPLK--PYTPLVVTLWYRAP  246 (419)
T ss_pred             CCcc--cCcceEEEeeecCH
Confidence            6532  34556789999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=250.95  Aligned_cols=152  Identities=32%  Similarity=0.580  Sum_probs=135.3

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEeh----------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHHH
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEK  274 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK----------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~  274 (360)
                      .+.||+|.||+||.|++.....||+|          .|.+|+++|++++|++||+++++|..++.++||||||+.|+|.+
T Consensus       211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~  290 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLD  290 (468)
T ss_pred             HHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHH
Confidence            46799999999999999888788887          46789999999999999999999999999999999999999999


Q ss_pred             HHhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccc
Q 040294          275 VLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA  353 (360)
Q Consensus       275 ~l~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~g  353 (360)
                      +|+. .+..+...+-+.++.|||+|++||+   ++++|||||.+.|||++++..+||+|||+||.+. ++.+..+....-
T Consensus       291 yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~~~~kf  366 (468)
T KOG0197|consen  291 YLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTASEGGKF  366 (468)
T ss_pred             HhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccC-CCceeecCCCCC
Confidence            9987 4566888899999999999999999   9999999999999999999999999999999544 333444445556


Q ss_pred             cCcccCC
Q 040294          354 TIGYMAP  360 (360)
Q Consensus       354 t~~Y~aP  360 (360)
                      ...|.||
T Consensus       367 PIkWtAP  373 (468)
T KOG0197|consen  367 PIKWTAP  373 (468)
T ss_pred             CceecCH
Confidence            6788887

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=239.23  Aligned_cols=158  Identities=36%  Similarity=0.565  Sum_probs=136.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCC--eEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNED--FRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~e  265 (360)
                      .++...+.||+|+||.||++... +|...|||.           +.+|+.+|.+++|||||+++|......  ..++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45667789999999999999965 588899983           467999999999999999999855444  6899999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEEeecccccccCCCC-
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFGIAKLLTGED-  343 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki~DFGla~~~~~~~-  343 (360)
                      |+++|+|.+++...+..+++..+..++.||++||+|||   +++|+||||||+|||++. ++.+||+|||+++...... 
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999876657899999999999999999999   999999999999999999 7999999999999876411 


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .........||+.||||
T Consensus       174 ~~~~~~~~~Gtp~~maP  190 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAP  190 (313)
T ss_pred             cccccccccCCccccCc
Confidence            11223357899999999

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=246.15  Aligned_cols=157  Identities=29%  Similarity=0.459  Sum_probs=139.3

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh----------------HHHHHHhhcCC-CCCeeEEEEEecCCCe
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF----------------DVECEVMKSIH-HRNLVKIISSCSNEDF  259 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~----------------~~E~~~l~~l~-hpniv~l~~~~~~~~~  259 (360)
                      ....|...+.||+|+||+||.|+. .++..||||.+                .+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456788999999999999999985 47899999732                25888999999 9999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-CcEEEeecccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKL  338 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-~~~ki~DFGla~~  338 (360)
                      .++||||+.||+|.+++.. ...+.+..+..++.|++.|++|+|   +.+|+||||||+|||+|.+ +.+||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999988 556778888999999999999999   9999999999999999999 9999999999998


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  .....+.+||+.|+||
T Consensus       171 ~~~~--~~~l~t~cGsp~Y~aP  190 (370)
T KOG0583|consen  171 SPGE--DGLLKTFCGSPAYAAP  190 (370)
T ss_pred             cCCC--CCcccCCCCCcccCCH
Confidence            7411  1234567999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=1.9e-30  Score=243.96  Aligned_cols=137  Identities=28%  Similarity=0.466  Sum_probs=125.1

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ..++|+...+||+|+||.||+|+-+ +|..+|+|.+              ..|-.+|...++|+||+|+..|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            5678999999999999999999854 7999999854              347889999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ||||++|||+..+|...+ .+++..+..++.+++.|++-+|   ..++|||||||+|+|||..|++|++|||++.-
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccch
Confidence            999999999999997654 5777778889999999999999   99999999999999999999999999999853

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=2.3e-31  Score=250.88  Aligned_cols=154  Identities=34%  Similarity=0.506  Sum_probs=139.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|.+.++||+|+||.||||+.+ +.+.||+|.             +.+|++++++++|||||.++++|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777889999999999999965 678899863             4579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+.| +|..++... +.+++.++..++.+++.||.|||   +.+|+|||+||.|||++..+.+|++|||+|+.+...  +
T Consensus        82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--T  154 (808)
T ss_pred             hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC--c
Confidence            9987 999999754 46889999999999999999999   999999999999999999999999999999988643  4


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      ...++..|||.||||
T Consensus       155 ~vltsikGtPlYmAP  169 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAP  169 (808)
T ss_pred             eeeeeccCcccccCH
Confidence            456778999999998

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.1e-31  Score=224.37  Aligned_cols=156  Identities=27%  Similarity=0.432  Sum_probs=137.6

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      +.++|+.++.||+|.||.||.|+.+ ++-.||+|.              +.+|+++-..++||||.+++++|.++...||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            3568999999999999999999965 677899873              3468888889999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          263 VLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ++||..+|++...|+... ..+++.....++.|+|.|+.|+|   .++|||||+||+|+|++..+..||+|||.+-.-..
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            999999999999998543 34788888889999999999999   99999999999999999999999999999876431


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                          ....+.+||+.|.||
T Consensus       177 ----~kR~tlcgt~dyl~p  191 (281)
T KOG0580|consen  177 ----NKRKTLCGTLDYLPP  191 (281)
T ss_pred             ----CCceeeecccccCCH
Confidence                234568999999998

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-30  Score=238.16  Aligned_cols=160  Identities=33%  Similarity=0.491  Sum_probs=132.5

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------------------HHHHHHhhcCCCCCeeEE
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------------------DVECEVMKSIHHRNLVKI  250 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------------------~~E~~~l~~l~hpniv~l  250 (360)
                      +..+.|+..+.||+|.||.|.+|+. .+++.||||.+                         .+|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            4567899999999999999999995 47899999732                         469999999999999999


Q ss_pred             EEEecCC--CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcE
Q 040294          251 ISSCSNE--DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVA  328 (360)
Q Consensus       251 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~  328 (360)
                      +++..+.  +.+|||+|||..|.+...= .....+...++..|..+++.||+|||   ..+||||||||+|+|++++|.+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence            9998764  5799999999998875422 22223788899999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCC---CceeeecccccCcccCC
Q 040294          329 HLSDFGIAKLLTGED---QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       329 ki~DFGla~~~~~~~---~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|||.+.......   ........+|||.||||
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP  284 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP  284 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccch
Confidence            999999988652211   11122347899999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=2.4e-30  Score=235.55  Aligned_cols=153  Identities=29%  Similarity=0.482  Sum_probs=137.4

Q ss_pred             CCCCCCeeccCCCccEEEEE-ccCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .|+..+.||+|.||+|-+|+ +..|++||||.+              .+|+++|..++||||++++++|+..+...||||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            46666789999999999998 478999999843              569999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |..+|+|++++..++ .+++..+..+++||..|+.|+|   ..+++|||||.+|||+|+++.+||+|||++-.+....  
T Consensus       134 YaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k--  207 (668)
T KOG0611|consen  134 YASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK--  207 (668)
T ss_pred             ecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc--
Confidence            999999999998764 5888888899999999999999   9999999999999999999999999999998876443  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       -..++||++-|.+|
T Consensus       208 -fLqTFCGSPLYASP  221 (668)
T KOG0611|consen  208 -FLQTFCGSPLYASP  221 (668)
T ss_pred             -HHHHhcCCcccCCc
Confidence             24568999999887

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-30  Score=249.26  Aligned_cols=156  Identities=28%  Similarity=0.425  Sum_probs=133.6

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhhH--------------HHHHHhhcC-CCCCeeEEEEEecCCCeEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSI-HHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~~~l~~l-~hpniv~l~~~~~~~~~~~  261 (360)
                      ..++|...++||+|+||+|+++..+ +++.+|||..+              .|..++... +||.++.++..|++.+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4578999999999999999999976 67889998543              355665554 5999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+.||++..+.+.  ..+++..+..||..|+.||.|||   +.+||+||||.+|||+|.+|++||+|||++|.--.
T Consensus       446 fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999995544432  46888899999999999999999   99999999999999999999999999999997432


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .  .....+.+|||.||||
T Consensus       521 ~--g~~TsTfCGTpey~aP  537 (694)
T KOG0694|consen  521 Q--GDRTSTFCGTPEFLAP  537 (694)
T ss_pred             C--CCccccccCChhhcCh
Confidence            2  2245578999999998

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.96  E-value=1.2e-30  Score=235.58  Aligned_cols=153  Identities=36%  Similarity=0.579  Sum_probs=128.3

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------HHHHHHhhcCCCCCeeEEEEEecCCC-----eEEEEEEcc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------DVECEVMKSIHHRNLVKIISSCSNED-----FRALVLEYM  267 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~  267 (360)
                      .|...+++|+|+||.||+|... +++.||||+.       ..|+++|++++|||||+|..+|....     ...+|||||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            4566789999999999999964 6789999864       46999999999999999998886432     345899999


Q ss_pred             CCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-CcEEEeecccccccCCCC
Q 040294          268 TNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       268 ~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-~~~ki~DFGla~~~~~~~  343 (360)
                      +. +|.+.++.   .+..++.....-++.|+.+||+|||   ..+|+||||||+|+|+|.+ |.+||||||.|+.+....
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            86 99988873   2445666777889999999999999   8999999999999999965 999999999999987654


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .   ..+...|..|.||
T Consensus       181 p---niSYicSRyYRaP  194 (364)
T KOG0658|consen  181 P---NISYICSRYYRAP  194 (364)
T ss_pred             C---ceeEEEeccccCH
Confidence            3   2345678899998

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=244.20  Aligned_cols=153  Identities=33%  Similarity=0.488  Sum_probs=138.6

Q ss_pred             CCCCCCeeccCCCccEEEEE-ccCCcEEEehhh-----------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          201 GFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF-----------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~-----------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .|..-..||+|+.|.||.|+ ..+++.||||.+           .+|+.+|+..+|+|||.+++.|...+.+|.|||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            46677889999999999998 457899999865           469999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      ||+|.+.+...  .+++.+...|+.++++||+|||   ..+|+|||||++|||++.+|.+||+|||++..+.....  .+
T Consensus       354 ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR  426 (550)
T KOG0578|consen  354 GGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR  426 (550)
T ss_pred             CCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence            99999998653  4889999999999999999999   99999999999999999999999999999999876542  45


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      .+.+||++||||
T Consensus       427 ~TmVGTPYWMAP  438 (550)
T KOG0578|consen  427 STMVGTPYWMAP  438 (550)
T ss_pred             ccccCCCCccch
Confidence            578999999998

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=245.32  Aligned_cols=155  Identities=29%  Similarity=0.546  Sum_probs=136.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEeh-------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK-------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +.+.....||+|+||+||+|+|.+  .||||             .|++|+..+++-+|.||+=+.|||..... .||..+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw  468 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW  468 (678)
T ss_pred             HHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence            345667899999999999999853  68886             58899999999999999999999998887 999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      |+|.+|+.+++.....++..+.+.||.|||+|+.|||   .++|||||||+.||++.+++.|||+|||++..-.......
T Consensus       469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            9999999999988888999999999999999999999   9999999999999999999999999999986543332223


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......|..-||||
T Consensus       546 q~~qp~gsilwmAP  559 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAP  559 (678)
T ss_pred             ccCCCccchhhhcH
Confidence            33456789999998

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=5.3e-30  Score=237.48  Aligned_cols=157  Identities=31%  Similarity=0.442  Sum_probs=134.3

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehhh--------HHHHHHhh--cCCCCCeeEEEEEecCCC----eEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKSF--------DVECEVMK--SIHHRNLVKIISSCSNED----FRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~--------~~E~~~l~--~l~hpniv~l~~~~~~~~----~~~lv~e~  266 (360)
                      .....++||+|.||.||||.+. ++.||||+|        ..|-++.+  .++|+||++++++-....    ..+||+||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            3445578999999999999985 489999976        34555544  678999999999987766    78999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhc------CCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG------FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~------~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      .+.|+|.++|...  .++|....+|+.-+++||+|||.+      +.++|+|||||+.|||+..|+++.|+|||+|..+.
T Consensus       290 h~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  290 HPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             ccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            9999999999764  589999999999999999999964      46789999999999999999999999999999987


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +..........+||.+||||
T Consensus       368 p~~~~~d~~~qVGT~RYMAP  387 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAP  387 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCH
Confidence            65443344458999999998

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.96  E-value=5.2e-29  Score=238.08  Aligned_cols=157  Identities=26%  Similarity=0.416  Sum_probs=136.9

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ..++|+..+.||+|+||.||+++.. +++.||+|.              +..|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4567999999999999999999965 678899874              3358889999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|.+++...  .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999998654  4778888899999999999999   899999999999999999999999999999876433


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      . .......+||+.||||
T Consensus       196 ~-~~~~~~~~gt~~Y~aP  212 (370)
T cd05621         196 G-MVRCDTAVGTPDYISP  212 (370)
T ss_pred             C-ceecccCCCCcccCCH
Confidence            2 1122356799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=3.5e-29  Score=226.14  Aligned_cols=154  Identities=31%  Similarity=0.462  Sum_probs=132.7

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCC-eeEEEEEecCCC------e
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRN-LVKIISSCSNED------F  259 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpn-iv~l~~~~~~~~------~  259 (360)
                      .|...+.||+|+||+||+|+. .+|+.||+|++             .+|+.+++.++|+| ||.|++++.+.+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            344556799999999999995 47899999854             36899999999999 999999998877      8


Q ss_pred             EEEEEEccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSN---CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                      +++|+||++. +|.+++....   ..++......++.|+++||+|||   +.+|+||||||.|||++++|.+||+|||+|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchH
Confidence            8999999965 9999997655   35777788999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCceeeecccccCcccCC
Q 040294          337 KLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +...-+..  ..+..++|.+|.||
T Consensus       168 ra~~ip~~--~yt~evvTlWYRaP  189 (323)
T KOG0594|consen  168 RAFSIPMR--TYTPEVVTLWYRAP  189 (323)
T ss_pred             HHhcCCcc--cccccEEEeeccCH
Confidence            97653322  24567899999998

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=1e-28  Score=235.55  Aligned_cols=137  Identities=27%  Similarity=0.430  Sum_probs=124.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.+              ..|++++.+++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999854 6889999843              35888999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            999999999999764 35888899999999999999999   8999999999999999999999999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.96  E-value=1.3e-28  Score=231.86  Aligned_cols=157  Identities=25%  Similarity=0.387  Sum_probs=137.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|...+.||+|+||.||+++.. +++.||+|.+              ..|..++..++||+|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999965 6788999843              35778888999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875556888888999999999999999   99999999999999999999999999999987654331


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       .......||+.||||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (331)
T cd05624         158 -VQSSVAVGTPDYISP  172 (331)
T ss_pred             -eeeccccCCcccCCH
Confidence             222345799999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-29  Score=237.86  Aligned_cols=153  Identities=31%  Similarity=0.512  Sum_probs=130.2

Q ss_pred             CCCCeeccCCCccEEEEEccC--C--cE-EEeh--------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          203 SANNLIGRGSFGSVYKARLQD--G--ME-FAIK--------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       203 ~~~~~iG~G~~g~Vy~~~~~~--~--~~-vavK--------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ...+.||+|+||.||+|+++.  +  .. ||||              .|.+|+++|++++|||||+++|++..+..+++|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            344899999999999998653  2  23 7886              456799999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      ||+|.||+|.++|+.....++..+++.++.++|.||+|||   ++++|||||-++|+|++.++.+||+|||+++.-.  .
T Consensus       240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--~  314 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS--Q  314 (474)
T ss_pred             EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc--c
Confidence            9999999999999987777999999999999999999999   9999999999999999999999999999988643  1


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .......-.-...|+||
T Consensus       315 ~~~~~~~~klPirWLAP  331 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAP  331 (474)
T ss_pred             eeeccccccCcceecCh
Confidence            11111112345788888

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=8.7e-29  Score=233.52  Aligned_cols=159  Identities=25%  Similarity=0.459  Sum_probs=130.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc------cCCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCC-
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNED-  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~-  258 (360)
                      .++|...+.||+|+||.||+|++      .++..||||.            +..|++++.++ +|||||+++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            35688889999999999999974      2356789974            34688999999 8999999999987644 


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC----------------------------------------------------------
Q 040294          259 FRALVLEYMTNGSLEKVLYSSN----------------------------------------------------------  280 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  280 (360)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6899999999999999986431                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccccCcc
Q 040294          281 ---CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY  357 (360)
Q Consensus       281 ---~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y  357 (360)
                         ..+++.....++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               23667788899999999999999   899999999999999999999999999999876433322222334567889


Q ss_pred             cCC
Q 040294          358 MAP  360 (360)
Q Consensus       358 ~aP  360 (360)
                      |||
T Consensus       243 ~aP  245 (338)
T cd05102         243 MAP  245 (338)
T ss_pred             cCc
Confidence            998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.7e-28  Score=231.14  Aligned_cols=157  Identities=27%  Similarity=0.413  Sum_probs=136.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+              ..|..++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999964 6889999853              45788899999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999765556888889999999999999999   99999999999999999999999999999977543321


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       .......||+.||||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (331)
T cd05597         158 -VQSNVAVGTPDYISP  172 (331)
T ss_pred             -ccccceeccccccCH
Confidence             122234699999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.96  E-value=2.8e-28  Score=224.67  Aligned_cols=154  Identities=30%  Similarity=0.474  Sum_probs=134.2

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+              ..|++++++++||||+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999986 57899999742              358899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          266 YMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |+++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999999888643 335889999999999999999999   8999999999999999999999999999998764322 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......||+.||||
T Consensus       157 --~~~~~~g~~~y~aP  170 (285)
T cd05631         157 --TVRGRVGTVGYMAP  170 (285)
T ss_pred             --eecCCCCCCCccCH
Confidence              22345799999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.96  E-value=9.2e-30  Score=221.34  Aligned_cols=155  Identities=32%  Similarity=0.524  Sum_probs=137.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------------HHHHHHhhcCC-CCCeeEEEEEecCC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------------DVECEVMKSIH-HRNLVKIISSCSNE  257 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------------~~E~~~l~~l~-hpniv~l~~~~~~~  257 (360)
                      -+.|...+.+|.|..++|.++.++ +|+++|+|.+                   ..|+.+|+++. ||+|+++.++|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            446777889999999999988754 7889998743                   35889999875 99999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ...++|+|.|+.|.|.++|... ..+++....+|+.|+.+|++|||   ...|+||||||+|||+|++..+||+|||+|.
T Consensus        96 sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceee
Confidence            9999999999999999999764 45778888899999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+.+..   .....||||+|+||
T Consensus       172 ~l~~Ge---kLrelCGTPgYLAP  191 (411)
T KOG0599|consen  172 QLEPGE---KLRELCGTPGYLAP  191 (411)
T ss_pred             ccCCch---hHHHhcCCCcccCh
Confidence            987654   34568999999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-28  Score=226.19  Aligned_cols=159  Identities=29%  Similarity=0.390  Sum_probs=139.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+...+||.|..+.||+|+. +.+..||||.+            .+|++.|..++||||++++..|..++.+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            45788899999999999999994 57899999854            568999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          266 YMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||.+|++.+++... ...+++.....|.+++++||.|||   ..+-||||||+.||||+.+|.+||+|||.+..+.....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999999753 345888899999999999999999   99999999999999999999999999999877654321


Q ss_pred             c--eeeecccccCcccCC
Q 040294          345 S--MTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~--~~~~~~~gt~~Y~aP  360 (360)
                      .  ......+||+.||||
T Consensus       182 R~~~rf~tfvgtp~wmAP  199 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAP  199 (516)
T ss_pred             eeeEeeccccCcccccCh
Confidence            1  111457899999998

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-28  Score=234.59  Aligned_cols=137  Identities=28%  Similarity=0.487  Sum_probs=124.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+              ..|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47888999999999999999964 6889999843              35889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            9999999999987643 5888899999999999999999   8999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=2.2e-28  Score=227.33  Aligned_cols=158  Identities=26%  Similarity=0.481  Sum_probs=131.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC-----------------CcEEEehh------------hHHHHHHhhcCCCCCeeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD-----------------GMEFAIKS------------FDVECEVMKSIHHRNLVKI  250 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~------------~~~E~~~l~~l~hpniv~l  250 (360)
                      ++|...+.||+|+||.||+|.+++                 +..||+|.            |.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467788999999999999997532                 33688873            4579999999999999999


Q ss_pred             EEEecCCCeEEEEEEccCCCCHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEE
Q 040294          251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSN------------------CILDILQRLNIMINVTSALEYLHFGFSTPIIH  312 (360)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiH  312 (360)
                      ++++.+.+..++||||+++|+|.+++....                  ..+++.....++.|++.||+|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999885421                  23677888999999999999999   899999


Q ss_pred             ccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       313 rdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |||||+|||+++++.+||+|||+++.+.............++..||||
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW  209 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence            999999999999999999999999876543322222334567889998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.5e-28  Score=234.04  Aligned_cols=135  Identities=27%  Similarity=0.431  Sum_probs=122.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+++. .+++.||||.+              ..|++++++++|||||++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688889999999999999985 47889999843              45889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            999999999998754 35778888889999999999999   89999999999999999999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=3.4e-28  Score=229.12  Aligned_cols=157  Identities=26%  Similarity=0.401  Sum_probs=136.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+++.+ +++.+|+|.              +..|+.++..++||+|+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888899999999999999965 577889874              345778889999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence            999999999999875556888888999999999999999   8999999999999999999999999999998654332 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                      .......+||+.||||
T Consensus       157 ~~~~~~~~gt~~y~aP  172 (332)
T cd05623         157 TVQSSVAVGTPDYISP  172 (332)
T ss_pred             cceecccccCccccCH
Confidence            1222345799999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.96  E-value=2.9e-28  Score=233.87  Aligned_cols=134  Identities=25%  Similarity=0.411  Sum_probs=121.5

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .|+..+.||+|+||.||+|+. .+++.||||.+              ..|++++++++|||||++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999985 47889999843              358889999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            999999999987543 5778888889999999999999   89999999999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.96  E-value=3e-28  Score=229.15  Aligned_cols=157  Identities=28%  Similarity=0.428  Sum_probs=137.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+++.. +++.||+|.              +..|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888899999999999999864 788999974              345788999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++......+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999876567889899999999999999999   89999999999999999999999999999987654332


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       .......||+.|+||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (330)
T cd05601         158 -VNSKLPVGTPDYIAP  172 (330)
T ss_pred             -eeeecccCCccccCH
Confidence             223345799999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.96  E-value=1.9e-28  Score=230.53  Aligned_cols=152  Identities=31%  Similarity=0.440  Sum_probs=134.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.              +..|++++++++||||+++++++..++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888899999999999999975 688999984              346889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            999999999999764 35778888889999999999999   8999999999999999999999999999998764322 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                          ....||+.|+||
T Consensus       173 ----~~~~gt~~y~aP  184 (329)
T PTZ00263        173 ----FTLCGTPEYLAP  184 (329)
T ss_pred             ----ceecCChhhcCH
Confidence                235799999998

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.96  E-value=4.1e-28  Score=227.69  Aligned_cols=149  Identities=30%  Similarity=0.405  Sum_probs=129.4

Q ss_pred             CeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          206 NLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      ++||+|+||.||+++. .+|+.||+|.+              ..|++++++++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986 47889999843              34788999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeec
Q 040294          271 SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ  350 (360)
Q Consensus       271 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~  350 (360)
                      +|.+++... ..+++.+...++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            999998754 45788889999999999999999   8999999999999999999999999999998643221  12234


Q ss_pred             ccccCcccCC
Q 040294          351 TLATIGYMAP  360 (360)
Q Consensus       351 ~~gt~~Y~aP  360 (360)
                      .+||+.||||
T Consensus       155 ~~gt~~y~aP  164 (323)
T cd05571         155 FCGTPEYLAP  164 (323)
T ss_pred             eecCccccCh
Confidence            5799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.96  E-value=2.3e-28  Score=233.81  Aligned_cols=160  Identities=26%  Similarity=0.394  Sum_probs=138.2

Q ss_pred             HHHHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          195 LLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       195 ~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      +....++|+..+.||+|+||.||+++.. +++.||+|.+              ..|+.+++.++||||+++++++..++.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3445678999999999999999999965 6788999743              357889999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .++||||+++|+|.+++...  .++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            99999999999999998654  4677788889999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .... .......+||+.||||
T Consensus       193 ~~~~-~~~~~~~~gt~~y~aP  212 (371)
T cd05622         193 NKEG-MVRCDTAVGTPDYISP  212 (371)
T ss_pred             CcCC-cccccCcccCccccCH
Confidence            5332 1122356799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.96  E-value=2.1e-28  Score=231.40  Aligned_cols=153  Identities=30%  Similarity=0.413  Sum_probs=134.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccC--CcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQD--GMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      .++|+..+.||+|+||.||+|+...  +..||+|.+              ..|+++++.++|||||++++++.+++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3468888999999999999998543  367998743              358899999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999997643 5788888999999999999999   899999999999999999999999999999876432


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                           .....||+.||||
T Consensus       185 -----~~~~~gt~~y~aP  197 (340)
T PTZ00426        185 -----TYTLCGTPEYIAP  197 (340)
T ss_pred             -----cceecCChhhcCH
Confidence                 1245799999998

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.95  E-value=4e-28  Score=232.46  Aligned_cols=135  Identities=27%  Similarity=0.431  Sum_probs=122.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+. .+++.||||.+              ..|++++++++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3688899999999999999985 46889999843              35889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ||+++|+|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|..
T Consensus        81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            999999999999764 35777788889999999999999   89999999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=4.7e-29  Score=234.32  Aligned_cols=156  Identities=28%  Similarity=0.505  Sum_probs=140.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCe-EEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDF-RALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~-~~lv~  264 (360)
                      ++|...+++|+|+||.++..+++ +++.+++|.+             .+|+.++++++|||||.+.+.|..++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56788899999999999998875 6778999854             469999999999999999999999887 99999


Q ss_pred             EccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          265 EYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      +||+||++.+.+...+ ..+++.....++.|++.|+.|||   +..|+|||||++||++..+..+||.|||+||.+.++.
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998765 56899999999999999999999   9999999999999999999999999999999998765


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ...+.+||+.||+|
T Consensus       161 ~--~a~tvvGTp~YmcP  175 (426)
T KOG0589|consen  161 S--LASTVVGTPYYMCP  175 (426)
T ss_pred             h--hhheecCCCcccCH
Confidence            2  23457899999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-28  Score=226.25  Aligned_cols=152  Identities=31%  Similarity=0.462  Sum_probs=134.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.              +.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888899999999999999965 788999974              345889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++.... .+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  155 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-  155 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence            9999999999997643 5788888999999999999999   8999999999999999999999999999998764321 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                          ....||+.|+||
T Consensus       156 ----~~~~gt~~y~aP  167 (291)
T cd05612         156 ----WTLCGTPEYLAP  167 (291)
T ss_pred             ----ccccCChhhcCH
Confidence                235699999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=2.9e-28  Score=233.00  Aligned_cols=157  Identities=26%  Similarity=0.412  Sum_probs=135.9

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ..++|+..+.||+|+||.||+++.. +++.||+|.+              ..|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3457888999999999999999864 6889999843              358899999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|.+++...  .++......++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999998654  4677778889999999999999   899999999999999999999999999999876533


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .. ......+||+.||||
T Consensus       196 ~~-~~~~~~~gt~~y~aP  212 (370)
T cd05596         196 GM-VRCDTAVGTPDYISP  212 (370)
T ss_pred             Cc-ccCCCCCCCcCeECH
Confidence            21 122345799999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.95  E-value=4.5e-28  Score=232.64  Aligned_cols=134  Identities=26%  Similarity=0.420  Sum_probs=121.2

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .|+..+.||+|+||.||+|+. .+++.||+|.+              ..|++++++++|||||++++.|.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578889999999999999986 46888999843              358889999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ||++|+|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            99999999998764 35777888889999999999999   89999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=227.16  Aligned_cols=157  Identities=29%  Similarity=0.478  Sum_probs=140.7

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhhH--------------HHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ..+.|+.-++||+|+||.||-++.+ +|+.||.|...              +|.+++.+++.|.||.+-.+|++.+.+++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            4567999999999999999999854 79999987542              48889999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          263 VLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      |+..|.||||.-+|...+ ..+++..+..+|.+|+.||++||   +..|+.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999998654 46899999999999999999999   99999999999999999999999999999998875


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..   ..++.+||.|||||
T Consensus       340 g~---~~~~rvGT~GYMAP  355 (591)
T KOG0986|consen  340 GK---PIRGRVGTVGYMAP  355 (591)
T ss_pred             CC---ccccccCcccccCH
Confidence            54   23455899999999

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=7e-28  Score=222.37  Aligned_cols=155  Identities=26%  Similarity=0.465  Sum_probs=134.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.+            .+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888899999999999999865 7889999843            4699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++ +|.+++......+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence            975 999988766666788899999999999999999   89999999999999999999999999999986543221  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.|+||
T Consensus       159 ~~~~~~~~~~y~aP  172 (288)
T cd07871         159 TYSNEVVTLWYRPP  172 (288)
T ss_pred             cccCceecccccCh
Confidence            12335689999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.9e-28  Score=228.05  Aligned_cols=152  Identities=27%  Similarity=0.467  Sum_probs=134.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+              ..|++++..++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888899999999999999975 6889999843              35888999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....   
T Consensus        81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            999999999999754 35788888999999999999999   89999999999999999999999999999986543   


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......||+.|+||
T Consensus       154 --~~~~~~gt~~y~aP  167 (333)
T cd05600         154 --YANSVVGSPDYMAP  167 (333)
T ss_pred             --ccCCcccCccccCh
Confidence              12345799999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=9.6e-28  Score=225.24  Aligned_cols=149  Identities=29%  Similarity=0.414  Sum_probs=129.2

Q ss_pred             CeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          206 NLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      +.||+|+||.||+++. .+|+.||+|.+              ..|++++++++||||++++++|...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999985 47899999843              35788999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeec
Q 040294          271 SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ  350 (360)
Q Consensus       271 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~  350 (360)
                      +|..++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            999888654 35788899999999999999999   8999999999999999999999999999988643222  12234


Q ss_pred             ccccCcccCC
Q 040294          351 TLATIGYMAP  360 (360)
Q Consensus       351 ~~gt~~Y~aP  360 (360)
                      ..||+.||||
T Consensus       155 ~~gt~~y~aP  164 (323)
T cd05595         155 FCGTPEYLAP  164 (323)
T ss_pred             ccCCcCcCCc
Confidence            5799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=9.6e-28  Score=228.53  Aligned_cols=137  Identities=27%  Similarity=0.435  Sum_probs=123.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+              ..|++++..++||||+++++++.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999865 6889999843              35888999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ||+++|+|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            999999999998754 35788888999999999999999   9999999999999999999999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=1.2e-27  Score=225.08  Aligned_cols=149  Identities=31%  Similarity=0.423  Sum_probs=129.3

Q ss_pred             CeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          206 NLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      +.||+|+||.||+++. .+++.||+|.+              ..|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 47889999843              34788999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeec
Q 040294          271 SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ  350 (360)
Q Consensus       271 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~  350 (360)
                      +|..++... ..+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            999888654 35888899999999999999999   8999999999999999999999999999998643221  12234


Q ss_pred             ccccCcccCC
Q 040294          351 TLATIGYMAP  360 (360)
Q Consensus       351 ~~gt~~Y~aP  360 (360)
                      .+||+.||||
T Consensus       155 ~~gt~~y~aP  164 (328)
T cd05593         155 FCGTPEYLAP  164 (328)
T ss_pred             ccCCcCccCh
Confidence            5799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-29  Score=251.14  Aligned_cols=162  Identities=29%  Similarity=0.422  Sum_probs=145.2

Q ss_pred             HHHHHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCC
Q 040294          194 ELLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNED  258 (360)
Q Consensus       194 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~  258 (360)
                      ++.-..++|.+.++||+|+||.|..++++ +++.||+|.              |..|-++|..-+.+.||+++.+|++++
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            33345678999999999999999999975 788999984              455888999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ++|+|||||+||||..++.... .+++..+..++..|+.||.-+|   +.|.|||||||+|||+|..|++|++|||.+-.
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999998766 6888888899999999999999   99999999999999999999999999999988


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +..+. ...+...+|||.|++|
T Consensus       225 m~~dG-~V~s~~aVGTPDYISP  245 (1317)
T KOG0612|consen  225 MDADG-TVRSSVAVGTPDYISP  245 (1317)
T ss_pred             cCCCC-cEEeccccCCCCccCH
Confidence            87554 4556678999999998

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3e-28  Score=233.78  Aligned_cols=153  Identities=30%  Similarity=0.426  Sum_probs=136.8

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      -|+.++.||+|+-|.|..|++ .+|+.+|||.              +++|+-+|+-+.|||+++++++|+...++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            466788999999999999996 5899999984              4679999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++|.|++++-.++ .+++..+..++.||+.|+.|+|   ..+|+|||+||+|+|+|....+||+|||.|..-.++.  
T Consensus        93 yv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--  166 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--  166 (786)
T ss_pred             ecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence            999999999997765 5677788889999999999999   9999999999999999999999999999998755432  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ...+.||++.|.||
T Consensus       167 -lLeTSCGSPHYA~P  180 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAP  180 (786)
T ss_pred             -cccccCCCcccCCc
Confidence             23457999999998

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=227.31  Aligned_cols=154  Identities=30%  Similarity=0.473  Sum_probs=137.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIH-HRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l  262 (360)
                      ...|+..+.||+|.||.||+++.+ +|+.+|+|.              +.+|+++|+++. |||||+++++|++.+..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            346777899999999999999976 599999974              356999999999 9999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC----CCcEEEeecccccc
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD----NIVAHLSDFGIAKL  338 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~----~~~~ki~DFGla~~  338 (360)
                      |||++.||+|.+.+...  .+++..+..++.|++.++.|||   +.+|+|||+||+|+|+..    ++.+|++|||+|+.
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            99999999999999776  3889999999999999999999   899999999999999963    35799999999998


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....   ......+||++|+||
T Consensus       189 ~~~~---~~~~~~~Gtp~y~AP  207 (382)
T KOG0032|consen  189 IKPG---ERLHTIVGTPEYVAP  207 (382)
T ss_pred             ccCC---ceEeeecCCccccCc
Confidence            8652   244568999999998

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=1.4e-27  Score=221.88  Aligned_cols=156  Identities=26%  Similarity=0.431  Sum_probs=135.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+            .+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467899999999999999999965 7889999853            468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |++ ++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            996 6888888766566888889999999999999999   8999999999999999999999999999998643222  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      .......||+.|+||
T Consensus       158 ~~~~~~~~~~~y~aP  172 (303)
T cd07869         158 HTYSNEVVTLWYRPP  172 (303)
T ss_pred             ccCCCCcccCCCCCh
Confidence            122345689999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-27  Score=223.00  Aligned_cols=147  Identities=31%  Similarity=0.412  Sum_probs=128.3

Q ss_pred             eccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          208 IGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ||+|+||.||+|+.. +++.||+|.+              ..|++++++++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999965 6788999843              3588899999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeeccc
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL  352 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~  352 (360)
                      .+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ......+
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQRE-GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            9999764 35788889999999999999999   8999999999999999999999999999998643222  1223457


Q ss_pred             ccCcccCC
Q 040294          353 ATIGYMAP  360 (360)
Q Consensus       353 gt~~Y~aP  360 (360)
                      ||+.||||
T Consensus       155 gt~~y~aP  162 (312)
T cd05585         155 GTPEYLAP  162 (312)
T ss_pred             CCcccCCH
Confidence            99999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=2.1e-27  Score=223.00  Aligned_cols=149  Identities=29%  Similarity=0.400  Sum_probs=128.1

Q ss_pred             CeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          206 NLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      +.||+|+||.||+++. .+++.||+|.+              ..|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 47889999843              34778899999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          271 SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       271 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      +|..++... ..+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            999988654 35888899999999999999999   6 7999999999999999999999999999886432221  223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05594         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCCcccCCH
Confidence            45699999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.3e-27  Score=235.80  Aligned_cols=157  Identities=23%  Similarity=0.311  Sum_probs=134.5

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-C-CcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-D-GMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~-~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .|...+.||+|+||.||+|... + +..||+|.           +..|+++++.++|||||+++++|..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3778899999999999999754 4 56788763           456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          268 TNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       268 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ++|+|.+++...   ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999987542   335788888899999999999999   89999999999999999999999999999997654332


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                      .......+||++||||
T Consensus       225 ~~~~~~~~gt~~y~aP  240 (478)
T PTZ00267        225 LDVASSFCGTPYYLAP  240 (478)
T ss_pred             cccccccCCCccccCH
Confidence            2223456799999998

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.95  E-value=1.4e-27  Score=224.87  Aligned_cols=155  Identities=28%  Similarity=0.416  Sum_probs=132.6

Q ss_pred             CCCCCCeeccCCCccEEEEEc----cCCcEEEehhh---------------HHHHHHhhcCC-CCCeeEEEEEecCCCeE
Q 040294          201 GFSANNLIGRGSFGSVYKARL----QDGMEFAIKSF---------------DVECEVMKSIH-HRNLVKIISSCSNEDFR  260 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~---------------~~E~~~l~~l~-hpniv~l~~~~~~~~~~  260 (360)
                      +|+..+.||+|+||.||+++.    .+++.||+|.+               ..|+++++.++ ||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999875    35788999743               34788899994 99999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||+++|+|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            9999999999999998754 35788888999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..... ......||+.||||
T Consensus       157 ~~~~~-~~~~~~gt~~y~aP  175 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAP  175 (332)
T ss_pred             ccCCC-ccccccCCccccCH
Confidence            33211 22345799999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.4e-27  Score=233.37  Aligned_cols=158  Identities=23%  Similarity=0.302  Sum_probs=137.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ..+|.+.+.||+|+||.||+|+.. +++.||||.     +.+|++++++++|||||++++++..++..++||||+. ++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L  246 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL  246 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence            447889999999999999999965 578899984     4689999999999999999999999999999999995 689


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeeccc
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL  352 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~  352 (360)
                      ..++......+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...............
T Consensus       247 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  323 (461)
T PHA03211        247 YTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA  323 (461)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence            8888765557899999999999999999999   8999999999999999999999999999998765432222223467


Q ss_pred             ccCcccCC
Q 040294          353 ATIGYMAP  360 (360)
Q Consensus       353 gt~~Y~aP  360 (360)
                      ||+.||||
T Consensus       324 GT~~Y~AP  331 (461)
T PHA03211        324 GTVDTNAP  331 (461)
T ss_pred             CCcCCcCH
Confidence            99999998

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=1.1e-27  Score=229.29  Aligned_cols=158  Identities=27%  Similarity=0.464  Sum_probs=131.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEc------cCCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  260 (360)
                      ++|+..+.||+|+||.||+|++      .++..||||.            +.+|+++++.+ +|||||+++++|...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            3577889999999999999963      2456799974            34699999999 899999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC------------------------------------------------------------
Q 040294          261 ALVLEYMTNGSLEKVLYSSN------------------------------------------------------------  280 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------  280 (360)
                      ++||||+++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999986422                                                            


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          281 --------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       281 --------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                                    ..+++.....++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                          13678888999999999999999   8999999999999999999999999999998765432211


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......++..||||
T Consensus       272 ~~~~~~~~~~y~aP  285 (375)
T cd05104         272 VKGNARLPVKWMAP  285 (375)
T ss_pred             ccCCCCCCcceeCh
Confidence            12223456789998

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.8e-28  Score=227.58  Aligned_cols=138  Identities=30%  Similarity=0.503  Sum_probs=125.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|...+.||+|+||.||+|+.. +++.||||.+              ..|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888899999999999999965 7899999843              45888999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999999765 46888889999999999999999   89999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.6e-29  Score=235.65  Aligned_cols=149  Identities=33%  Similarity=0.442  Sum_probs=132.8

Q ss_pred             CCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          202 FSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      |+..+.||.|+||.||-|+. ++...||||+              +.+|+..|++++|||+|.+.|+|..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55667899999999999995 5778899984              45799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      |- |+-.+++.-.+..+.+.....|+.+.+.||+|||   +.+.||||||+-|||+.+.|.+|++|||.|..+.+.    
T Consensus       108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----  179 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----  179 (948)
T ss_pred             Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence            96 4777777666667888888889999999999999   999999999999999999999999999999987543    


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                        .+++|||+||||
T Consensus       180 --nsFvGTPywMAP  191 (948)
T KOG0577|consen  180 --NSFVGTPYWMAP  191 (948)
T ss_pred             --hcccCCccccch
Confidence              368999999999

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-29  Score=215.82  Aligned_cols=156  Identities=28%  Similarity=0.495  Sum_probs=133.5

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++.|+..++||+|.|+.||++.+ .+|+.+|+|.             +++|+.+-+.++|||||+|...+.+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            345677778999999999999875 4789998874             35799999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec---CCCcEEEeecccccccC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~---~~~~~ki~DFGla~~~~  340 (360)
                      +|+|+|++|..-+-.+ ..+++..+-.++.||+++|.|+|   ..+|+|||+||+|+|+-   ....+|++|||+|..+.
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999997665443 34667777889999999999999   99999999999999994   45678999999999987


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.   ......+|||+||||
T Consensus       165 ~g---~~~~G~~GtP~fmaP  181 (355)
T KOG0033|consen  165 DG---EAWHGFAGTPGYLSP  181 (355)
T ss_pred             Cc---cccccccCCCcccCH
Confidence            32   234568899999998

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.95  E-value=2.4e-27  Score=214.61  Aligned_cols=157  Identities=26%  Similarity=0.438  Sum_probs=135.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+++++++..+|+|.          +..|++++++++||||++++++|...+..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            45777889999999999999988888899973          45699999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.++++.....+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||.++...... .....
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~~  159 (256)
T cd05114          84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSS  159 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eeccC
Confidence            9999999765556889999999999999999999   8999999999999999999999999999998754322 11222


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...++..|+||
T Consensus       160 ~~~~~~~y~aP  170 (256)
T cd05114         160 GAKFPVKWSPP  170 (256)
T ss_pred             CCCCchhhCCh
Confidence            33456788887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.95  E-value=1.5e-27  Score=228.43  Aligned_cols=158  Identities=26%  Similarity=0.476  Sum_probs=130.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  260 (360)
                      ++|+..+.||+|+||.||+|+..      ++..||||.            +..|+++++.+ +|||||+++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            46888899999999999998742      345799984            34699999999 899999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC------------------------------------------------------------
Q 040294          261 ALVLEYMTNGSLEKVLYSSN------------------------------------------------------------  280 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------  280 (360)
                      ++||||+++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885321                                                            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecc
Q 040294          281 ---------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT  351 (360)
Q Consensus       281 ---------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~  351 (360)
                               ..+++.+...++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                     13677788999999999999999   899999999999999999999999999999876433221112223


Q ss_pred             cccCcccCC
Q 040294          352 LATIGYMAP  360 (360)
Q Consensus       352 ~gt~~Y~aP  360 (360)
                      .+++.||||
T Consensus       275 ~~~~~y~aP  283 (374)
T cd05106         275 RLPVKWMAP  283 (374)
T ss_pred             CCccceeCH
Confidence            456789998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=2.3e-27  Score=228.29  Aligned_cols=156  Identities=24%  Similarity=0.330  Sum_probs=134.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ..+|+..+.||+|+||.||+|+. .+++.||+|.     +.+|++++++++|||||+++++|..+...++||||+. ++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L  169 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL  169 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence            35799999999999999999985 5788999985     4569999999999999999999999999999999995 689


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeeccc
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL  352 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~  352 (360)
                      .+++... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... ........
T Consensus       170 ~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~  244 (391)
T PHA03212        170 YCYLAAK-RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWA  244 (391)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cccccccc
Confidence            8888654 35788899999999999999999   8899999999999999999999999999997643221 11223457


Q ss_pred             ccCcccCC
Q 040294          353 ATIGYMAP  360 (360)
Q Consensus       353 gt~~Y~aP  360 (360)
                      ||+.|+||
T Consensus       245 gt~~y~aP  252 (391)
T PHA03212        245 GTIATNAP  252 (391)
T ss_pred             CccCCCCh
Confidence            99999998

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=2.7e-27  Score=221.38  Aligned_cols=157  Identities=26%  Similarity=0.435  Sum_probs=132.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCc----EEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGM----EFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.            +..|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999864 333    378874            34588999999999999999999875 4679


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      |+||+++|+|.+++......+++.....++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999876667888899999999999999999   899999999999999999999999999999987544


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..........++..||||
T Consensus       163 ~~~~~~~~~~~~~~y~ap  180 (316)
T cd05108         163 EKEYHAEGGKVPIKWMAL  180 (316)
T ss_pred             CcceeccCCccceeecCh
Confidence            322222233456789987

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.95  E-value=2.4e-27  Score=216.12  Aligned_cols=157  Identities=24%  Similarity=0.406  Sum_probs=132.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc----CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..+.||+|+||.||+|.+.    .+..||+|.            |..|++++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            45788899999999999999753    356788873            45689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++......+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+|++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999876567899999999999999999999   8999999999999999999999999999876543221


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      . .......++..|+||
T Consensus       162 ~-~~~~~~~~~~~y~aP  177 (266)
T cd05064         162 I-YTTMSGKSPVLWAAP  177 (266)
T ss_pred             h-hcccCCCCceeecCH
Confidence            1 111123456789987

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=3.2e-27  Score=221.68  Aligned_cols=149  Identities=32%  Similarity=0.492  Sum_probs=128.0

Q ss_pred             CeeccCCCccEEEEEc----cCCcEEEehhh---------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          206 NLIGRGSFGSVYKARL----QDGMEFAIKSF---------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~---------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +.||+|+||.||+++.    .+++.||+|.+               ..|+++++.++||||++++++|..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999985    35788999743               3588999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++|+|.+++.... .+.+..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            99999999987543 4677788889999999999999   89999999999999999999999999999985432221  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.|+||
T Consensus       156 ~~~~~~gt~~y~aP  169 (323)
T cd05584         156 VTHTFCGTIEYMAP  169 (323)
T ss_pred             cccccCCCccccCh
Confidence            12345799999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.95  E-value=4.5e-28  Score=229.35  Aligned_cols=156  Identities=27%  Similarity=0.494  Sum_probs=138.8

Q ss_pred             CCCCCeeccCCCccEEEEEccCCcEEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          202 FSANNLIGRGSFGSVYKARLQDGMEFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~~~~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ....+.||+|.||.|..|....+..||||            .|..|+++|.+++|||||+|+++|..++.+++|+|||++
T Consensus       540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn  619 (807)
T KOG1094|consen  540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN  619 (807)
T ss_pred             eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence            34568899999999999999888999997            477899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      |+|.+++...... .+-....+|+.|||.|++||.   +.+++|||+.+.|+|+|.++++||+|||.++.+...+.+...
T Consensus       620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq  696 (807)
T KOG1094|consen  620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ  696 (807)
T ss_pred             CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence            9999999876433 345566789999999999999   999999999999999999999999999999988777766666


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ...+-.++||||
T Consensus       697 gr~vlpiRwmaw  708 (807)
T KOG1094|consen  697 GRAVLPIRWMAW  708 (807)
T ss_pred             cceeeeeeehhH
Confidence            566778899986

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.95  E-value=5.6e-28  Score=228.09  Aligned_cols=148  Identities=26%  Similarity=0.489  Sum_probs=132.2

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEehhhH----HHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCC
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIKSFD----VECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSN  280 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~----~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  280 (360)
                      .+-+|+|+.|.||+|+++ +++||||++.    .+++.|++++||||+.+.|+|....-.+||||||..|-|...|+..+
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~  207 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR  207 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC
Confidence            356999999999999986 6899999874    47899999999999999999999999999999999999999998765


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          281 CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       281 ~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                       .+.......+..+||.|+.|||   ...|||||||+-||||..+-.+||+|||.++.+...   .+..+++||..||||
T Consensus       208 -~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAP  280 (904)
T KOG4721|consen  208 -PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAP  280 (904)
T ss_pred             -ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCH
Confidence             4555666789999999999999   889999999999999999999999999999987643   245578999999998

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.95  E-value=4.7e-28  Score=239.16  Aligned_cols=157  Identities=31%  Similarity=0.555  Sum_probs=135.9

Q ss_pred             CCCCCCeeccCCCccEEEEEcc------CCcEEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ------DGMEFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      +....+.||+|+||+||+|+..      +.+.||||            .|++|+++++.++|||||+|+|.|..++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3444578999999999999842      34678997            57899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEE
Q 040294          263 VLEYMTNGSLEKVLYSSN-------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH  329 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~k  329 (360)
                      |+|||..|||.++|....             ..++..+.+.||.|||.|++||-   +..++||||-..|+|+.++..+|
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence            999999999999997432             12677889999999999999999   89999999999999999999999


Q ss_pred             EeecccccccCCCCCceeeecccccCcccCC
Q 040294          330 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       330 i~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+|||++|.+...+++.......=.++||||
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMpp  674 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP  674 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCH
Confidence            9999999998777765444344557899998

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.95  E-value=6.9e-28  Score=233.25  Aligned_cols=151  Identities=35%  Similarity=0.584  Sum_probs=130.5

Q ss_pred             CCCeeccCCCccEEEEEc-cCCcEEEehhhH------------HHHHHhhcCCCCCeeEEEEEecCCC------eEEEEE
Q 040294          204 ANNLIGRGSFGSVYKARL-QDGMEFAIKSFD------------VECEVMKSIHHRNLVKIISSCSNED------FRALVL  264 (360)
Q Consensus       204 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~------------~E~~~l~~l~hpniv~l~~~~~~~~------~~~lv~  264 (360)
                      ..+.||+|+||.||+++. .+|+.||||.|.            .|++++++++|||||+++++-++..      ...+||
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            346799999999999994 589999999764            4999999999999999999876543      568999


Q ss_pred             EccCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec--CCC--cEEEeecccccc
Q 040294          265 EYMTNGSLEKVLYSSN--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD--DNI--VAHLSDFGIAKL  338 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~--~~~--~~ki~DFGla~~  338 (360)
                      |||.+|||...+....  ..+++.+.+.+..+++.||.|||   ..+|+||||||.||++.  .+|  --||+|||.||.
T Consensus        97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            9999999999998643  46899999999999999999999   89999999999999984  223  459999999998


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +....   ..++.+||..|.||
T Consensus       174 l~d~s---~~~S~vGT~~YLhP  192 (732)
T KOG4250|consen  174 LDDNS---LFTSLVGTEEYLHP  192 (732)
T ss_pred             CCCCC---eeeeecCchhhcCh
Confidence            86543   45678999999998

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.95  E-value=4.8e-27  Score=226.47  Aligned_cols=159  Identities=26%  Similarity=0.474  Sum_probs=132.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCC-CCCeeEEEEEecCCCe
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIH-HRNLVKIISSCSNEDF  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~-hpniv~l~~~~~~~~~  259 (360)
                      .++|...+.||+|+||.||+|+..      .+..||||.            +..|+++++++. |||||+++++|...+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            356788899999999999999752      234689974            346899999996 9999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-----------------------------------------------------------
Q 040294          260 RALVLEYMTNGSLEKVLYSSN-----------------------------------------------------------  280 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  280 (360)
                      .++|||||++|+|.++++...                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999886421                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC
Q 040294          281 ------------------------------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD  324 (360)
Q Consensus       281 ------------------------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~  324 (360)
                                                          ..+++..+..++.|+++||+|||   ..+|+||||||+||++++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                                13677788899999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          325 NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       325 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++.+||+|||+++...............+++.||||
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  308 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP  308 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence            999999999999876443322222344577889998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.95  E-value=5.1e-27  Score=220.87  Aligned_cols=149  Identities=30%  Similarity=0.370  Sum_probs=127.7

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+.. +++.||+|.+              ..|..++.++ +||||++++++|.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999864 6889999843              3467778777 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            9999988654 46889999999999999999999   9999999999999999999999999999997532221  1223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (329)
T cd05588         155 TFCGTPNYIAP  165 (329)
T ss_pred             cccCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.1e-27  Score=214.95  Aligned_cols=154  Identities=31%  Similarity=0.486  Sum_probs=133.8

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .|+..++||+|+||.||++.. .+++.||+|.+              .+|++++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            377789999999999999986 47889999743              348899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          266 YMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |+++|+|.+++... ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||+++.+.... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            99999999988654 345889999999999999999999   8999999999999999999999999999998754322 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......||+.||||
T Consensus       157 --~~~~~~~~~~y~aP  170 (285)
T cd05605         157 --TIRGRVGTVGYMAP  170 (285)
T ss_pred             --ccccccCCCCccCc
Confidence              12245789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=6.4e-27  Score=219.07  Aligned_cols=149  Identities=30%  Similarity=0.491  Sum_probs=129.5

Q ss_pred             CeeccCCCccEEEEEc----cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          206 NLIGRGSFGSVYKARL----QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      +.||+|+||.||+++.    .+|+.||+|.+             ..|++++++++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    36789999843             348899999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      +|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~  155 (318)
T cd05582          82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA  155 (318)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence            99999998654 35889999999999999999999   89999999999999999999999999999986543321  22


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....||+.||||
T Consensus       156 ~~~~g~~~y~aP  167 (318)
T cd05582         156 YSFCGTVEYMAP  167 (318)
T ss_pred             ecccCChhhcCH
Confidence            345799999998

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.2e-28  Score=216.31  Aligned_cols=157  Identities=30%  Similarity=0.398  Sum_probs=137.1

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhhHH--------------HHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDV--------------ECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ..++|+..+++|+|.||+|-+++.+ +++.||+|.+++              |-.+|+..+||.+..|-..|+..+++|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3568999999999999999999854 899999997765              3468888999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+.||.|.-+|.... .+++.....+-..|+.||.|||   +.+|+.||+|.+|.|+|++|++||+|||+++.--. 
T Consensus       246 VMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-  320 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-  320 (516)
T ss_pred             EEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence            999999999999987654 4666666778999999999999   89999999999999999999999999999996332 


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                       ......+.||||.|+||
T Consensus       321 -~g~t~kTFCGTPEYLAP  337 (516)
T KOG0690|consen  321 -YGDTTKTFCGTPEYLAP  337 (516)
T ss_pred             -ccceeccccCChhhcCc
Confidence             23345678999999998

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.94  E-value=8.8e-27  Score=218.72  Aligned_cols=154  Identities=29%  Similarity=0.324  Sum_probs=130.2

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCC-CeeEEEEEecCCCeEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHR-NLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lv~  264 (360)
                      +|+..+.||+|+||.||+|+.. +++.||||.+              ..|.+++..++|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999865 6788999843              3467788888765 6889999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            999999999998654 35788899999999999999999   8999999999999999999999999999987532221 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       .......||+.|+||
T Consensus       156 -~~~~~~~gt~~y~aP  170 (324)
T cd05587         156 -KTTRTFCGTPDYIAP  170 (324)
T ss_pred             -CceeeecCCccccCh
Confidence             122345799999998

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.94  E-value=1.1e-26  Score=211.62  Aligned_cols=158  Identities=28%  Similarity=0.527  Sum_probs=135.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC----CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD----GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..+.||+|+||.||+|+++.    ...||||.            |..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999998742    35788873            44689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++++|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999876667899999999999999999999   8999999999999999999999999999999875322


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .........+++.|+||
T Consensus       161 ~~~~~~~~~~~~~y~~P  177 (266)
T cd05033         161 ATYTTKGGKIPIRWTAP  177 (266)
T ss_pred             cceeccCCCCCccccCh
Confidence            22222233456789988

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=9.1e-27  Score=214.07  Aligned_cols=148  Identities=31%  Similarity=0.458  Sum_probs=128.2

Q ss_pred             eccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          208 IGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ||+|+||+||++... +++.||+|.+              ..|++++++++||||+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999864 7889999743              3588899999999999999999999999999999999999


Q ss_pred             HHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          273 EKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       273 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      ...+..   ....+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988753   2345889999999999999999999   89999999999999999999999999999987653321  123


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.|+||
T Consensus       156 ~~~g~~~y~aP  166 (280)
T cd05608         156 GYAGTPGFMAP  166 (280)
T ss_pred             ccCCCcCccCH
Confidence            45789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.94  E-value=4.8e-27  Score=216.22  Aligned_cols=156  Identities=27%  Similarity=0.397  Sum_probs=133.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|.             +..|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888899999999999999975 678899974             3468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |++++.+..+.. ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..... 
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            999887765543 3346888889999999999999999   89999999999999999999999999999987643321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      .......||+.|+||
T Consensus       156 ~~~~~~~~~~~y~aP  170 (287)
T cd07848         156 ANYTEYVATRWYRSP  170 (287)
T ss_pred             ccccccccccccCCc
Confidence            122345689999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=8.4e-27  Score=218.55  Aligned_cols=149  Identities=34%  Similarity=0.447  Sum_probs=125.3

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhhH--------------HHH-HHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VEC-EVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~-~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+.. +++.||+|.+.              .|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 68889998531              232 357789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|..++... ..+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            9999888654 35677788889999999999999   8999999999999999999999999999988642221  1223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (321)
T cd05603         155 TFCGTPEYLAP  165 (321)
T ss_pred             cccCCcccCCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=8.5e-27  Score=218.73  Aligned_cols=149  Identities=35%  Similarity=0.464  Sum_probs=126.2

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhhH--------------HHHH-HhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECE-VMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+.. +|+.||+|.+.              .|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999964 78999998542              1222 45789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|..++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            9999988754 35788888899999999999999   8999999999999999999999999999988643222  1223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (323)
T cd05575         155 TFCGTPEYLAP  165 (323)
T ss_pred             cccCChhhcCh
Confidence            45799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=7e-27  Score=219.39  Aligned_cols=152  Identities=30%  Similarity=0.437  Sum_probs=128.6

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehhhH--------------HHHH---HhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECE---VMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~~---~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      |+..+.||+|+||.||+|+.. +++.||||.+.              .|++   .++.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999864 78899998542              2333   34577899999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|...+..  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            999999999988864  35889999999999999999999   8999999999999999999999999999987643222


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                        ......+||+.||||
T Consensus       156 --~~~~~~~g~~~y~aP  170 (324)
T cd05589         156 --DRTSTFCGTPEFLAP  170 (324)
T ss_pred             --CcccccccCccccCH
Confidence              122346799999998

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=8.7e-27  Score=218.68  Aligned_cols=154  Identities=29%  Similarity=0.346  Sum_probs=130.2

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      +|+..+.||+|+||.||+|+.. +++.||+|.+              ..|..++..+ +||+|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999865 6788999843              2355666665 5899999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+.+... ..+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            999999999988654 35788899999999999999999   8999999999999999999999999999998643222 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       .......||+.||||
T Consensus       156 -~~~~~~~gt~~y~aP  170 (323)
T cd05616         156 -VTTKTFCGTPDYIAP  170 (323)
T ss_pred             -CccccCCCChhhcCH
Confidence             122346799999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=8.8e-27  Score=218.04  Aligned_cols=149  Identities=31%  Similarity=0.446  Sum_probs=125.6

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhhH--------------HHHHHhhc-CCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKS-IHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+.. +++.||+|.+.              .|..++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 67889998542              24445543 5899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++.... .+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999987543 5788888999999999999999   8999999999999999999999999999998653322  1223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05592         155 TFCGTPDYIAP  165 (316)
T ss_pred             cccCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=8.3e-27  Score=219.47  Aligned_cols=149  Identities=32%  Similarity=0.394  Sum_probs=126.6

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+.. +++.||+|.+              ..|+.++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 6788998743              3466666665 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|..++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (329)
T cd05618          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence            9999888654 35888899999999999999999   89999999999999999999999999999986432221  223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (329)
T cd05618         155 TFCGTPNYIAP  165 (329)
T ss_pred             cccCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=7.6e-27  Score=218.85  Aligned_cols=149  Identities=32%  Similarity=0.431  Sum_probs=126.8

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhhH--------------HHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+.+ +++.||||.+.              .|.+++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 68899998542              356666665 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            9999988754 35788889999999999999999   8999999999999999999999999999988643221  1223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (320)
T cd05590         155 TFCGTPDYIAP  165 (320)
T ss_pred             ccccCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=1.1e-26  Score=218.88  Aligned_cols=154  Identities=26%  Similarity=0.375  Sum_probs=134.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.            +.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367889999999999999999965 678888873            5578999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST-PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~-~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |+++|+|.+++.... .+++.....++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            999999999997643 5788888999999999999999   54 69999999999999999999999999998664321 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         .....||+.|+||
T Consensus       159 ---~~~~~g~~~y~aP  171 (331)
T cd06649         159 ---ANSFVGTRSYMSP  171 (331)
T ss_pred             ---cccCCCCcCcCCH
Confidence               2345699999998

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-27  Score=213.78  Aligned_cols=156  Identities=29%  Similarity=0.422  Sum_probs=132.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhhH-------------HHHHHhhcCCCCCeeEEEEEecC-----CCeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSFD-------------VECEVMKSIHHRNLVKIISSCSN-----EDFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~-------------~E~~~l~~l~hpniv~l~~~~~~-----~~~~  260 (360)
                      ..|...+.||+|+||.|..|.. ++|..||||++.             +|+++++.++|+||+.+.+.+..     -+.+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            3455568899999999999985 588999998653             59999999999999999999876     2468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |+|+|+| +-+|.+.++..+ .++......++.|+++||.|+|   +.+|+|||+||+|++++.+...||+|||+|+...
T Consensus       102 YiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             EEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeecc
Confidence            9999999 459999997654 4777788889999999999999   9999999999999999999999999999999876


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ........+..+.|.+|.||
T Consensus       177 ~~~~~~~mTeYVaTRWYRAP  196 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAP  196 (359)
T ss_pred             ccCcccchhcceeeeeecCH
Confidence            43222234567889999998

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=1e-26  Score=218.46  Aligned_cols=149  Identities=34%  Similarity=0.451  Sum_probs=126.1

Q ss_pred             CeeccCCCccEEEEEc-cCCcEEEehhhH--------------HHHH-HhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARL-QDGMEFAIKSFD--------------VECE-VMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+. .+|+.||+|.+.              .|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 478999998542              2332 46779999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|..++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (325)
T cd05604          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT  154 (325)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence            9999888654 45788899999999999999999   8999999999999999999999999999988643221  1223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05604         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCChhhCCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.94  E-value=4.2e-27  Score=223.53  Aligned_cols=150  Identities=31%  Similarity=0.518  Sum_probs=128.1

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +|+..+.||+|+||.||+|+.. +++.||||.            +.+|++++++++||||+++++++..++..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3555678999999999999864 789999984            356999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++|+|.+..     ..++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+.....  .
T Consensus       155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  224 (353)
T PLN00034        155 DGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P  224 (353)
T ss_pred             CCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence            999986532     3456677889999999999999   89999999999999999999999999999987643221  1


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....||..|+||
T Consensus       225 ~~~~~gt~~y~aP  237 (353)
T PLN00034        225 CNSSVGTIAYMSP  237 (353)
T ss_pred             ccccccCccccCc
Confidence            2345799999998

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=9.4e-27  Score=218.27  Aligned_cols=149  Identities=32%  Similarity=0.397  Sum_probs=126.8

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+.. +++.||+|.+              ..|.+++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 6789999854              2466777655 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|...+... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05591          81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT  154 (321)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence            9999988654 35788888999999999999999   8999999999999999999999999999988643222  1223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (321)
T cd05591         155 TFCGTPDYIAP  165 (321)
T ss_pred             ccccCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.94  E-value=5.3e-29  Score=219.22  Aligned_cols=154  Identities=31%  Similarity=0.431  Sum_probs=138.2

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCC
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGS  271 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  271 (360)
                      |++...+|+|+||.||+|.++ .|+.+|||.         +-+|+.+|++++.|++|++||.+.....+|+|||||..|+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            556678999999999999875 789999984         4579999999999999999999988888999999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecc
Q 040294          272 LEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT  351 (360)
Q Consensus       272 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~  351 (360)
                      ..+.++.++..+.+.....+....++||+|||   ...-||||||+.|||++-+|.+|++|||+|..+....  ....+.
T Consensus       115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTV  189 (502)
T KOG0574|consen  115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTV  189 (502)
T ss_pred             HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCcc
Confidence            99999988888999888899999999999999   7778999999999999999999999999999886543  234567


Q ss_pred             cccCcccCC
Q 040294          352 LATIGYMAP  360 (360)
Q Consensus       352 ~gt~~Y~aP  360 (360)
                      .||+.||||
T Consensus       190 IGTPFWMAP  198 (502)
T KOG0574|consen  190 IGTPFWMAP  198 (502)
T ss_pred             ccCcccccH
Confidence            899999998

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=1.2e-26  Score=217.90  Aligned_cols=149  Identities=34%  Similarity=0.445  Sum_probs=124.7

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhhH--------------HHH-HHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VEC-EVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~-~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      +.||+|+||.||+|+.. +++.||+|.+.              .|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 67789998542              122 246778999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++.... .+.+.....++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence            99999987643 4667777889999999999999   89999999999999999999999999999986432221  223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05602         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.94  E-value=1.6e-26  Score=209.57  Aligned_cols=156  Identities=28%  Similarity=0.454  Sum_probs=134.1

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      +|...+.||+|+||.||+|++.++..+|+|.          +..|++++++++||||+++++++...+..++||||+++|
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG   84 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence            4677789999999999999987777899873          456999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeec
Q 040294          271 SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ  350 (360)
Q Consensus       271 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~  350 (360)
                      +|.+++......+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||.++...... ......
T Consensus        85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~  160 (256)
T cd05113          85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVG  160 (256)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeecCC
Confidence            999999765556899999999999999999999   8999999999999999999999999999998754322 111222


Q ss_pred             ccccCcccCC
Q 040294          351 TLATIGYMAP  360 (360)
Q Consensus       351 ~~gt~~Y~aP  360 (360)
                      ..++..|+||
T Consensus       161 ~~~~~~y~~p  170 (256)
T cd05113         161 SKFPVRWSPP  170 (256)
T ss_pred             CccChhhCCH
Confidence            3456778887

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=1.9e-26  Score=216.80  Aligned_cols=149  Identities=31%  Similarity=0.386  Sum_probs=127.3

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+.. +++.||+|.+              ..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 6788998743              3567777777 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|..++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            9999888654 35889999999999999999999   8999999999999999999999999999998533221  1223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (327)
T cd05617         155 TFCGTPNYIAP  165 (327)
T ss_pred             cccCCcccCCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=1.7e-26  Score=216.20  Aligned_cols=149  Identities=29%  Similarity=0.441  Sum_probs=126.1

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhhH--------------HHHHHhhc-CCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKS-IHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+.+ +++.||+|.+.              .|..++.. .+||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 68899998542              35556654 5899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            9999988754 35788889999999999999999   8999999999999999999999999999987532221  1223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05620         155 TFCGTPDYIAP  165 (316)
T ss_pred             ccCCCcCccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.94  E-value=1.6e-26  Score=217.81  Aligned_cols=154  Identities=26%  Similarity=0.389  Sum_probs=133.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.            +..|++++++++||||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367889999999999999999975 678888863            4579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |+++|+|.+++.... .+++.....++.|++.||+|||   + .+|+||||||+||++++++.+||+|||++..+.... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            999999999997543 4788888899999999999999   5 479999999999999999999999999998654321 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         .....||..|+||
T Consensus       159 ---~~~~~~~~~y~aP  171 (333)
T cd06650         159 ---ANSFVGTRSYMSP  171 (333)
T ss_pred             ---cccCCCCccccCH
Confidence               2235689999998

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-27  Score=239.97  Aligned_cols=156  Identities=30%  Similarity=0.559  Sum_probs=133.9

Q ss_pred             CCCCCeeccCCCccEEEEEccC--Cc----EEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARLQD--GM----EFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~--~~----~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      -...+.||+|+||.||.|...+  +.    .||||            .|.+|..+|++++|||||+++|+|.+....+|+
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            3446889999999999998653  33    38887            467899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          264 LEYMTNGSLEKVLYSS------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      +|||++|||..+|++.      ...+...+-+.++.|||+|+.||+   ++++|||||..+|+|++....+||+|||+|+
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhH
Confidence            9999999999999877      456888899999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+...+.+.......-...||||
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~P  873 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPP  873 (1025)
T ss_pred             hhhhchheeccCccccceecCCH
Confidence            76655543332222344699998

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.8e-26  Score=209.01  Aligned_cols=156  Identities=30%  Similarity=0.471  Sum_probs=133.6

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      +|+..+.||+|+||.||+++++++..+|+|.          +..|++++++++||||+++++++...+..++||||++++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            4777889999999999999988777899874          446899999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeec
Q 040294          271 SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ  350 (360)
Q Consensus       271 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~  350 (360)
                      +|.+++......+++.....++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++...... ......
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~  160 (256)
T cd05059          85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQG  160 (256)
T ss_pred             CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccccCC
Confidence            999999765557899999999999999999999   8999999999999999999999999999998754322 111112


Q ss_pred             ccccCcccCC
Q 040294          351 TLATIGYMAP  360 (360)
Q Consensus       351 ~~gt~~Y~aP  360 (360)
                      ..++..|+||
T Consensus       161 ~~~~~~y~~P  170 (256)
T cd05059         161 TKFPVKWAPP  170 (256)
T ss_pred             CCCCccccCH
Confidence            2345678887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.94  E-value=1.5e-26  Score=217.13  Aligned_cols=154  Identities=29%  Similarity=0.349  Sum_probs=130.1

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIH-HRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~  264 (360)
                      +|+..++||+|+||.||+|+.. +++.||+|.+              ..|.++++.+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999854 7889999843              24667777775 577889999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++... ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            999999999998654 35889999999999999999999   8999999999999999999999999999998643222 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       .......||+.||||
T Consensus       156 -~~~~~~~gt~~y~aP  170 (323)
T cd05615         156 -VTTRTFCGTPDYIAP  170 (323)
T ss_pred             -ccccCccCCccccCH
Confidence             122345699999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.94  E-value=7.5e-27  Score=218.80  Aligned_cols=150  Identities=30%  Similarity=0.530  Sum_probs=131.7

Q ss_pred             CCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          205 NNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      .++||+|.||+||-|++ ++|+.||||.+             .+|+.+|++++||.||.+...|+..+.++.|||-+.|-
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999986 48999999843             56999999999999999999999999999999999765


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEeecccccccCCCCCcee
Q 040294          271 SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       271 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      =|+-+|....+.+++.....++.||+.||.|||   -++|+|+||||+|||+..   --.+||||||+|+++.+..   -
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence            566666666778998888899999999999999   899999999999999964   3479999999999987543   3


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      ..+.+||+.|+||
T Consensus       723 RrsVVGTPAYLaP  735 (888)
T KOG4236|consen  723 RRSVVGTPAYLAP  735 (888)
T ss_pred             hhhhcCCccccCH
Confidence            4568999999998

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1.1e-26  Score=221.10  Aligned_cols=156  Identities=23%  Similarity=0.315  Sum_probs=136.4

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCC
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGS  271 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  271 (360)
                      ...+|+..+.||+|+||.||+|+.. ++..||+|.     ...|+.++++++||||+++++++..++..++||||+. ++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~  142 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD  142 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence            4567999999999999999999965 577899984     3569999999999999999999999999999999995 68


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecc
Q 040294          272 LEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT  351 (360)
Q Consensus       272 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~  351 (360)
                      |.+++......+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++......   .....
T Consensus       143 l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~  216 (357)
T PHA03209        143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGL  216 (357)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---ccccc
Confidence            99988776667899999999999999999999   8999999999999999999999999999998543221   12345


Q ss_pred             cccCcccCC
Q 040294          352 LATIGYMAP  360 (360)
Q Consensus       352 ~gt~~Y~aP  360 (360)
                      .||+.|+||
T Consensus       217 ~gt~~y~aP  225 (357)
T PHA03209        217 AGTVETNAP  225 (357)
T ss_pred             cccccccCC
Confidence            699999998

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.94  E-value=2e-26  Score=211.80  Aligned_cols=158  Identities=28%  Similarity=0.520  Sum_probs=132.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-----cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-----QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|+..+.||+|+||.||+|..     .++..+|+|.            +..|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577789999999999999974     2457788864            4569999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC
Q 040294          263 VLEYMTNGSLEKVLYSSN----------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI  326 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~  326 (360)
                      ||||+++++|.+++....                ..+++.+...++.|++.||+|||   +.+|+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321                24678888999999999999999   88999999999999999999


Q ss_pred             cEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       327 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+||+|||+++...............++..|+||
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP  195 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecCh
Confidence            9999999999876543322222334567789987

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.94  E-value=2.3e-26  Score=211.26  Aligned_cols=157  Identities=27%  Similarity=0.426  Sum_probs=130.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCc----EEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGM----EFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|+..+.||+|+||.||+|.+. +++    .+++|.+            ..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46778899999999999999864 444    3666533            346667889999999999999865 45688


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ++||+++|+|.+++......+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876667899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..........++..|+||
T Consensus       163 ~~~~~~~~~~~~~~y~~p  180 (279)
T cd05111         163 DKKYFYSEHKTPIKWMAL  180 (279)
T ss_pred             CcccccCCCCCcccccCH
Confidence            322223345577889987

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.94  E-value=1.6e-27  Score=210.71  Aligned_cols=160  Identities=27%  Similarity=0.458  Sum_probs=134.7

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEcc---C--CcEEEehhhH-------------HHHHHhhcCCCCCeeEEEEEecC-C
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARLQ---D--GMEFAIKSFD-------------VECEVMKSIHHRNLVKIISSCSN-E  257 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~~---~--~~~vavK~~~-------------~E~~~l~~l~hpniv~l~~~~~~-~  257 (360)
                      .....|+....||+|.||.||+|..+   +  ...+|+|.|+             +|+.+++.++|||+|.|..+|.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            34456888899999999999999643   2  3379999885             48899999999999999999887 7


Q ss_pred             CeEEEEEEccCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC----CcEE
Q 040294          258 DFRALVLEYMTNGSLEKVLYSS----NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN----IVAH  329 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~----~~~k  329 (360)
                      ..+++++||.+. +|.+.++-.    ...++......|+.||+.|+.|||   +.-|+||||||+|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence            789999999986 999988633    235778888999999999999999   8889999999999999876    8999


Q ss_pred             EeecccccccCCCCCce-eeecccccCcccCC
Q 040294          330 LSDFGIAKLLTGEDQSM-TQTQTLATIGYMAP  360 (360)
Q Consensus       330 i~DFGla~~~~~~~~~~-~~~~~~gt~~Y~aP  360 (360)
                      |+|||+|+.+...-.+. .....+-|++|.||
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAP  208 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAP  208 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecCh
Confidence            99999999987654433 34456789999998

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.94  E-value=2.6e-26  Score=207.28  Aligned_cols=152  Identities=30%  Similarity=0.508  Sum_probs=128.3

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      +.||+|+||.||+|+.. +++.||+|.            +..|++++++++||||++++++|..++..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999864 788999983            45689999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeeccc
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL  352 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~  352 (360)
                      .+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|++|||+++...............
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999766666889999999999999999999   8999999999999999999999999999998654321111111112


Q ss_pred             ccCcccCC
Q 040294          353 ATIGYMAP  360 (360)
Q Consensus       353 gt~~Y~aP  360 (360)
                      ++..|+||
T Consensus       158 ~~~~y~aP  165 (252)
T cd05084         158 IPVKWTAP  165 (252)
T ss_pred             CceeecCc
Confidence            34568887

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.94  E-value=1.9e-26  Score=214.79  Aligned_cols=155  Identities=24%  Similarity=0.449  Sum_probs=133.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.+            .+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888899999999999999865 6788999843            4699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            975 888888766666888889999999999999999   89999999999999999999999999999986543221  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......+|+.|+||
T Consensus       160 ~~~~~~~~~~y~aP  173 (309)
T cd07872         160 TYSNEVVTLWYRPP  173 (309)
T ss_pred             ccccccccccccCC
Confidence            12234678999998

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.94  E-value=2.4e-26  Score=215.17  Aligned_cols=149  Identities=30%  Similarity=0.446  Sum_probs=126.1

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhc-CCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKS-IHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      +.||+|+||.||+|+.. +++.||||.+              ..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 6788999843              235566664 5899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++... ..+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence            9999998754 35788889999999999999999   89999999999999999999999999999875322211  223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05619         155 TFCGTPDYIAP  165 (316)
T ss_pred             eecCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=8.3e-27  Score=222.83  Aligned_cols=156  Identities=33%  Similarity=0.471  Sum_probs=139.4

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .+..|.+...||+|.|+.|..|++. ++.+||||.+             .+|+++|+.++|||||+++++...+..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4567888999999999999999964 7999999843             4699999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+.+|++++++...+...+ ..+..+..|+.+|++|||   ++.|+|||||++|+||+.++.+||+|||++..+....
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc
Confidence            999999999999987765555 677789999999999999   9999999999999999999999999999999876332


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                         ...+.+|++.|.||
T Consensus       210 ---~lqt~cgsppyAaP  223 (596)
T KOG0586|consen  210 ---MLQTFCGSPPYAAP  223 (596)
T ss_pred             ---cccccCCCCCccCh
Confidence               34567999999998

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.94  E-value=2e-26  Score=211.18  Aligned_cols=160  Identities=24%  Similarity=0.441  Sum_probs=133.0

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      .+++|+..+.||+|+||.||+|...      ++..||||.            +..|+.+++.++||||+++++++..+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567899999999999999998753      346789874            3468899999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEE
Q 040294          260 RALVLEYMTNGSLEKVLYSSN---------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL  330 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki  330 (360)
                      .++||||+++|+|.+++....         ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532         23577888999999999999999   889999999999999999999999


Q ss_pred             eecccccccCCCCCceeeecccccCcccCC
Q 040294          331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       331 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|||+++.+.............+++.||||
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSP  190 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcCh
Confidence            999999876443322222223467889998

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=2.4e-26  Score=209.60  Aligned_cols=151  Identities=26%  Similarity=0.391  Sum_probs=124.3

Q ss_pred             eeccCCCccEEEEEccC---CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCC
Q 040294          207 LIGRGSFGSVYKARLQD---GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGS  271 (360)
Q Consensus       207 ~iG~G~~g~Vy~~~~~~---~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  271 (360)
                      .||+|+||.||+|+..+   ...+|+|.            +.+|+++++.++||||++++++|...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   34677763            4568889999999999999999999999999999999999


Q ss_pred             HHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          272 LEKVLYSSNC----ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       272 L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      |.+++.....    ..++.....++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999975432    2456777889999999999999   89999999999999999999999999999876543321122


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....+++.|+||
T Consensus       159 ~~~~~~~~~y~aP  171 (269)
T cd05042         159 KDCHAVPLRWLAP  171 (269)
T ss_pred             cCCCCCcccccCH
Confidence            2334567789987

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.6e-26  Score=228.71  Aligned_cols=160  Identities=28%  Similarity=0.396  Sum_probs=134.5

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC-----
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED-----  258 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~-----  258 (360)
                      ..++|...+.||+|+||.||+|+. .+++.||||.+             ..|+..+..++|+||+++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346889999999999999999985 57899999853             45888899999999999988775432     


Q ss_pred             ---eEEEEEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEee
Q 040294          259 ---FRALVLEYMTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD  332 (360)
Q Consensus       259 ---~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~D  332 (360)
                         ..++||||+++|+|.+++...   ...+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence               368999999999999998643   245788889999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+++.+............+||+.||||
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aP  214 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAP  214 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCH
Confidence            9999876543222223346799999998

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=1.7e-26  Score=217.52  Aligned_cols=155  Identities=27%  Similarity=0.423  Sum_probs=129.5

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCC-----CeEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNE-----DFRA  261 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~  261 (360)
                      .|+..+.||+|+||.||+|+. .+++.||||.             +.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            367788999999999999985 4789999984             34689999999999999999988543     2579


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+. ++|.+++... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 6899988654 35888999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCc-eeeecccccCcccCC
Q 040294          342 EDQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~-~~~~~~~gt~~Y~aP  360 (360)
                      .... .......||+.|+||
T Consensus       156 ~~~~~~~~~~~~~t~~y~aP  175 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAP  175 (338)
T ss_pred             ccCccccccCCCCCCCcCCH
Confidence            2211 112345799999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-27  Score=194.48  Aligned_cols=154  Identities=29%  Similarity=0.431  Sum_probs=135.0

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      .|+..+.||+|.||+||+|+. .+++.||+|..             .+|+-+++.++|.|||++++....+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            355567899999999999995 57888999853             4799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      |. .+|.++....++.++...+..++.|+++||.|+|   +..++|||+||.|.|++.+|+.|++|||+|+...-..  .
T Consensus        83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--r  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R  156 (292)
T ss_pred             hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence            95 4999999888888999999999999999999999   9999999999999999999999999999999765332  2


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      .....+-|.+|.+|
T Consensus       157 cysaevvtlwyrpp  170 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPP  170 (292)
T ss_pred             eeeceeeeeeccCc
Confidence            33455678999887

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.94  E-value=5.3e-26  Score=208.62  Aligned_cols=147  Identities=32%  Similarity=0.504  Sum_probs=127.7

Q ss_pred             eccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          208 IGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ||+|+||.||+++.+ +|+.||+|.+              ..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 6889998743              2488999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecc
Q 040294          273 EKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT  351 (360)
Q Consensus       273 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~  351 (360)
                      .+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            98886533 35788888999999999999999   8999999999999999999999999999998764322   22345


Q ss_pred             cccCcccCC
Q 040294          352 LATIGYMAP  360 (360)
Q Consensus       352 ~gt~~Y~aP  360 (360)
                      .||..|+||
T Consensus       155 ~~~~~y~aP  163 (277)
T cd05607         155 AGTNGYMAP  163 (277)
T ss_pred             CCCCCccCH
Confidence            689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.94  E-value=2.5e-26  Score=208.43  Aligned_cols=157  Identities=24%  Similarity=0.487  Sum_probs=135.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|...+++.||+|.          +..|+.++++++||||+++++++...+..+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   85 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK   85 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence            56888899999999999999988888899974          34699999999999999999999999999999999999


Q ss_pred             CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      |+|.+++... ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....... ...
T Consensus        86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~  161 (261)
T cd05072          86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAR  161 (261)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-ecc
Confidence            9999998754 345788889999999999999999   89999999999999999999999999999987643221 112


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|+||
T Consensus       162 ~~~~~~~~y~aP  173 (261)
T cd05072         162 EGAKFPIKWTAP  173 (261)
T ss_pred             CCCccceecCCH
Confidence            233467789987

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.94  E-value=4.6e-26  Score=207.87  Aligned_cols=152  Identities=26%  Similarity=0.416  Sum_probs=126.2

Q ss_pred             CeeccCCCccEEEEEccC---CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          206 NLIGRGSFGSVYKARLQD---GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~---~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      +.||+|+||.||+|+..+   +..+|+|.            +.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998543   35678763            445889999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          271 SLEKVLYSSN----CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       271 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +|.+++....    ...++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997532    23567777889999999999999   8999999999999999999999999999998654333222


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......|+..|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (269)
T cd05087         158 TPDQLWVPLRWIAP  171 (269)
T ss_pred             cCCCcCCcccccCH
Confidence            23345678889998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.94  E-value=2.1e-26  Score=224.89  Aligned_cols=155  Identities=32%  Similarity=0.482  Sum_probs=128.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------HHHHHHhhcCCCCCeeEEEEEecCC--------CeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------DVECEVMKSIHHRNLVKIISSCSNE--------DFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------~~E~~~l~~l~hpniv~l~~~~~~~--------~~~~l  262 (360)
                      ..+|+..+.||+|+||.||+|... +++.||||.+       .+|+.+++.++|||||++++++...        ...++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            457889999999999999999864 6889999854       4699999999999999998876432        25779


Q ss_pred             EEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-CcEEEeecccccc
Q 040294          263 VLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKL  338 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-~~~ki~DFGla~~  338 (360)
                      ||||+++ ++.+++..   ....+++.....++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+.
T Consensus       145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            9999985 67666642   3456888899999999999999999   8999999999999999965 4799999999997


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.....   .....||+.||||
T Consensus       221 ~~~~~~---~~~~~~t~~y~aP  239 (440)
T PTZ00036        221 LLAGQR---SVSYICSRFYRAP  239 (440)
T ss_pred             ccCCCC---cccCCCCcCccCH
Confidence            654321   2345789999998

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.94  E-value=2.9e-26  Score=235.05  Aligned_cols=158  Identities=28%  Similarity=0.416  Sum_probs=132.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..++||+|+||.||+|+.. +++.||+|.              +.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888899999999999999864 688999984              446899999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecc
Q 040294          265 EYMTNGSLEKVLYSS----------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       265 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                      ||++||+|.+++...          ....++...+.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988631          123456678889999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCc----------------eeeecccccCcccCC
Q 040294          335 IAKLLTGEDQS----------------MTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~----------------~~~~~~~gt~~Y~aP  360 (360)
                      +++........                ......+||+.||||
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP  200 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP  200 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence            99876211100                011135699999998

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-26  Score=213.91  Aligned_cols=156  Identities=28%  Similarity=0.476  Sum_probs=130.7

Q ss_pred             CCCCCeeccCCCccEEEEEccCCcEEEehhh--------HHHHHHhh--cCCCCCeeEEEEEecCCC----eEEEEEEcc
Q 040294          202 FSANNLIGRGSFGSVYKARLQDGMEFAIKSF--------DVECEVMK--SIHHRNLVKIISSCSNED----FRALVLEYM  267 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~--------~~E~~~l~--~l~hpniv~l~~~~~~~~----~~~lv~e~~  267 (360)
                      ....+.||+|.||+||+|+|+ |..||||.|        .+|.++.+  .++|+||..+++.-..++    ++|||.||-
T Consensus       213 I~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  213 IVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             eEEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            445688999999999999996 789999977        34666655  579999999998865443    689999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF-----GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~-----~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      +.|||+|+|..  ..++....++++.-+|.||++||.     ...+.|.|||||+.|||+.+++.+.|+|+|+|-....+
T Consensus       292 e~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~  369 (513)
T KOG2052|consen  292 EHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD  369 (513)
T ss_pred             cCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence            99999999976  468888899999999999999994     24688999999999999999999999999999765544


Q ss_pred             CC--ceeeecccccCcccCC
Q 040294          343 DQ--SMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~--~~~~~~~~gt~~Y~aP  360 (360)
                      ..  .......+||.+||||
T Consensus       370 t~~idi~~N~rVGTKRYMAP  389 (513)
T KOG2052|consen  370 TDTIDIPPNPRVGTKRYMAP  389 (513)
T ss_pred             CCcccCCCCCccceeeccCh
Confidence            22  1233457899999999

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.94  E-value=5.8e-26  Score=209.26  Aligned_cols=153  Identities=28%  Similarity=0.459  Sum_probs=132.8

Q ss_pred             CCCCCeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          202 FSANNLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      |+..+.||+|+||.||+++. .+++.||+|.+              ..|++++++++|+||+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56678899999999999986 47889999843              3588999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999998886543 35899999999999999999999   8999999999999999999999999999997654322  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......|++.|+||
T Consensus       157 -~~~~~~g~~~~~aP  170 (285)
T cd05632         157 -SIRGRVGTVGYMAP  170 (285)
T ss_pred             -cccCCCCCcCccCh
Confidence             11234689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=3.6e-26  Score=211.52  Aligned_cols=158  Identities=26%  Similarity=0.481  Sum_probs=130.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC-------------C--cEEEehh------------hHHHHHHhhcCCCCCeeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD-------------G--MEFAIKS------------FDVECEVMKSIHHRNLVKIIS  252 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~-------------~--~~vavK~------------~~~E~~~l~~l~hpniv~l~~  252 (360)
                      ++|+..+.||+|+||.||+++...             +  ..||+|.            |..|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            468888999999999999987542             1  2478873            456999999999999999999


Q ss_pred             EecCCCeEEEEEEccCCCCHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcee
Q 040294          253 SCSNEDFRALVLEYMTNGSLEKVLYSSN-----------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVL  321 (360)
Q Consensus       253 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiL  321 (360)
                      ++...+..++||||+++++|.+++....           ..+++..++.++.|++.||+|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986432           13678888999999999999999   899999999999999


Q ss_pred             ecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          322 LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       322 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++++.+||+|||+++...............+++.|+||
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  200 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW  200 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecCh
Confidence            999999999999999875433221122233457789988

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.94  E-value=4.6e-26  Score=209.14  Aligned_cols=158  Identities=30%  Similarity=0.589  Sum_probs=132.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC------CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD------GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      ++|+..+.||+|+||.||+|....      ...||+|.            |.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            367788999999999999998542      24688873            456899999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC
Q 040294          262 LVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI  326 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~  326 (360)
                      ++|||+++|+|.+++....               ..+++.....++.|++.||+|||   +.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999986531               34778888999999999999999   89999999999999999999


Q ss_pred             cEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       327 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+||+|||+++...............+++.||||
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP  195 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCH
Confidence            9999999999875433322222344578889998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.94  E-value=3.9e-26  Score=220.12  Aligned_cols=157  Identities=25%  Similarity=0.468  Sum_probs=130.1

Q ss_pred             CCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIH-HRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~  261 (360)
                      +|...+.||+|+||.||+|++.      .+..||+|.            +..|++++.++. |||||+++++|..++..+
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~  117 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY  117 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence            4667789999999999999853      345799974            346899999997 999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC-------------------------------------------------------------
Q 040294          262 LVLEYMTNGSLEKVLYSSN-------------------------------------------------------------  280 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~-------------------------------------------------------------  280 (360)
                      +||||+++|+|.++++...                                                             
T Consensus       118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (401)
T cd05107         118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG  197 (401)
T ss_pred             EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence            9999999999999986431                                                             


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC
Q 040294          281 ------------------------------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD  324 (360)
Q Consensus       281 ------------------------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~  324 (360)
                                                          ..+++.....++.|++.||+|||   +.+|+||||||+|||+++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~  274 (401)
T cd05107         198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICE  274 (401)
T ss_pred             hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeC
Confidence                                                13567778889999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          325 NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       325 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++.+|++|||+++.+.............+++.||||
T Consensus       275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  310 (401)
T cd05107         275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP  310 (401)
T ss_pred             CCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence            999999999999875432211122234578889998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PHA02988 hypothetical protein; Provisional

Probab=99.94  E-value=4.7e-26  Score=209.82  Aligned_cols=146  Identities=24%  Similarity=0.325  Sum_probs=126.6

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecC----CCeEEEEEEc
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSN----EDFRALVLEY  266 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~  266 (360)
                      ...||+|++|.||+|++ +|+.||||.+              .+|++++++++|||||++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 6889999743              479999999999999999999876    3478999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++|+|.+++... ..+++.....++.|++.|+.|||   . .+++||||||+||++++++.+||+|||+++.+....  
T Consensus       104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            9999999999764 36788899999999999999999   5 478899999999999999999999999998764322  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                         ....||..|+||
T Consensus       178 ---~~~~~~~~y~aP  189 (283)
T PHA02988        178 ---FKNVNFMVYFSY  189 (283)
T ss_pred             ---ccccCcccccCH
Confidence               234688999998

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.94  E-value=7e-26  Score=208.78  Aligned_cols=153  Identities=29%  Similarity=0.483  Sum_probs=132.6

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      |+..++||+|+||.||++... +++.||+|.+              ..|+.++++++|++++.+++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999864 7889999743              3588999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999886432 35888899999999999999999   8999999999999999999999999999987654322  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.||||
T Consensus       157 -~~~~~~g~~~y~aP  170 (285)
T cd05630         157 -TIKGRVGTVGYMAP  170 (285)
T ss_pred             -cccCCCCCccccCh
Confidence             12235789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=5.8e-26  Score=206.14  Aligned_cols=158  Identities=27%  Similarity=0.475  Sum_probs=134.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .++|+..+.||+|+||.||+|...+++.||+|.          +..|++++++++||||+++++++...+..++||||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            346888899999999999999987778899974          4568999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          269 NGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       269 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +++|.+++.... ..+++.....++.|++.|+.|||   +.+|+||||||+||++++++.+||+|||+++....... ..
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~  160 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EA  160 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cc
Confidence            999999997643 45889999999999999999999   89999999999999999999999999999987653221 11


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....++..|+||
T Consensus       161 ~~~~~~~~~y~aP  173 (261)
T cd05068         161 REGAKFPIKWTAP  173 (261)
T ss_pred             cCCCcCceeccCc
Confidence            1122234578888

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=2.5e-26  Score=221.33  Aligned_cols=157  Identities=24%  Similarity=0.321  Sum_probs=134.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc---CCcEEEehhh------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ---DGMEFAIKSF------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ...|...+.||+|+||.||+|...   .+..||+|.+      .+|++++++++|||||++++++...+..++||||+. 
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  169 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-  169 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence            346889999999999999999743   4577898854      579999999999999999999999999999999996 


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      ++|.+++. ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..........
T Consensus       170 ~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~  245 (392)
T PHA03207        170 CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY  245 (392)
T ss_pred             CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccc
Confidence            68888884 3456899999999999999999999   8999999999999999999999999999998765433222233


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.|+||
T Consensus       246 ~~~gt~~y~aP  256 (392)
T PHA03207        246 GWSGTLETNSP  256 (392)
T ss_pred             ccccccCccCH
Confidence            46799999998

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.94  E-value=5.1e-26  Score=213.03  Aligned_cols=149  Identities=30%  Similarity=0.392  Sum_probs=127.0

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+++.. +++.||||.+              ..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 6789999854              2466777776 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|..++... ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (318)
T cd05570          81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS  154 (318)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence            9999988754 35889999999999999999999   8999999999999999999999999999987532222  1123


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ..+||+.||||
T Consensus       155 ~~~g~~~y~aP  165 (318)
T cd05570         155 TFCGTPDYIAP  165 (318)
T ss_pred             ceecCccccCH
Confidence            45699999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.7e-26  Score=214.27  Aligned_cols=147  Identities=30%  Similarity=0.399  Sum_probs=124.0

Q ss_pred             eccCCCccEEEEEcc-CCcEEEehhhH--------------HHHHHhhcC---CCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          208 IGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSI---HHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ||+|+||.||+|+.. +++.||||.+.              .|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999864 68899998542              234455444   699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~  154 (330)
T cd05586          81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN  154 (330)
T ss_pred             ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence            9999988754 45788889999999999999999   89999999999999999999999999999976432221  223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (330)
T cd05586         155 TFCGTTEYLAP  165 (330)
T ss_pred             CccCCccccCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.94  E-value=6e-26  Score=209.31  Aligned_cols=158  Identities=29%  Similarity=0.529  Sum_probs=132.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|...+.||+|+||.||++...      ++..+|+|.           +..|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46788899999999999999742      345678764           4569999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEE
Q 040294          263 VLEYMTNGSLEKVLYSSN------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL  330 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki  330 (360)
                      ||||+++++|.+++....            ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999986432            24889999999999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCCceeeecccccCcccCC
Q 040294          331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       331 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|||+++.+.............+++.|+||
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  191 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  191 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCH
Confidence            999999876443322222234467889998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.94  E-value=6.2e-26  Score=208.07  Aligned_cols=158  Identities=25%  Similarity=0.407  Sum_probs=131.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCc----EEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGM----EFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      .++|+..+.||+|+||.||+|++. ++.    .||+|.            +..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            456888899999999999999853 444    478874            34688899999999999999999764 468


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ++|||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999876667899999999999999999999   89999999999999999999999999999987653


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...........+++.|+||
T Consensus       162 ~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05109         162 DETEYHADGGKVPIKWMAL  180 (279)
T ss_pred             ccceeecCCCccchhhCCH
Confidence            3221112223456789987

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=220.60  Aligned_cols=155  Identities=35%  Similarity=0.458  Sum_probs=136.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ..|...+.||+|+||.||+|.. ++++.||+|.            +++|+.++..+++|||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            3567778999999999999984 5889999984            35689999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      |.||++.+.+.... .+++.....|++++..|+.|||   ..+.+|||||++|||+..+|.+|++|||++..+.....  
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            99999999997654 3466666778999999999999   89999999999999999999999999999998875542  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ...+++||+.||||
T Consensus       167 rr~tfvGTPfwMAP  180 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAP  180 (467)
T ss_pred             ccccccccccccch
Confidence            23678999999999

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.94  E-value=7.5e-26  Score=208.61  Aligned_cols=153  Identities=29%  Similarity=0.478  Sum_probs=126.3

Q ss_pred             CCCCCCeeccCCCccEEEEEcc--CCcEEEehhh-------------HHHHHHhhcC---CCCCeeEEEEEec-----CC
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ--DGMEFAIKSF-------------DVECEVMKSI---HHRNLVKIISSCS-----NE  257 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~-------------~~E~~~l~~l---~hpniv~l~~~~~-----~~  257 (360)
                      +|+..+.||+|+||.||+|+..  +++.||+|.+             .+|+++++.+   +||||++++++|.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            5788899999999999999863  4678998843             3466666554   6999999999985     34


Q ss_pred             CeEEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                      ...++||||+. ++|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            46899999996 5899988653 235788899999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCceeeecccccCcccCC
Q 040294          337 KLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +......   ......||+.|+||
T Consensus       158 ~~~~~~~---~~~~~~~~~~y~aP  178 (290)
T cd07862         158 RIYSFQM---ALTSVVVTLWYRAP  178 (290)
T ss_pred             EeccCCc---ccccccccccccCh
Confidence            8764321   22345689999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=2.6e-26  Score=210.09  Aligned_cols=135  Identities=29%  Similarity=0.420  Sum_probs=121.5

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .|+..+.||+|.-|+||+++.+ ++..+|+|.+              +.|.+||+.++||.++.||+.|+.++..|+|||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            4556678999999999999976 4588998744              348889999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          266 YMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ||+||+|....+.+. ..+++..+..+|.+|+-||+|||   -.|||.|||||+|||+.++|++-++||-++..
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            999999999998653 46888889999999999999999   99999999999999999999999999988744

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.93  E-value=7.1e-26  Score=208.83  Aligned_cols=160  Identities=23%  Similarity=0.427  Sum_probs=131.1

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.            +..|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3467888999999999999998743      245789973            3458889999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEE
Q 040294          260 RALVLEYMTNGSLEKVLYSSN---------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL  330 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki  330 (360)
                      .++||||+++|+|.+++....         ...++.....++.|++.||.|||   +++|+||||||+||++++++.+|+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996422         22456677889999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCCceeeecccccCcccCC
Q 040294          331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       331 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|||+++.+.............++..|+||
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p  190 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCH
Confidence            999999875433221122223456788887

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.93  E-value=4.6e-26  Score=215.11  Aligned_cols=158  Identities=27%  Similarity=0.471  Sum_probs=130.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehhh------------HHHHHHhhcC-CCCCeeEEEEEecCC-Ce
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKSF------------DVECEVMKSI-HHRNLVKIISSCSNE-DF  259 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~------------~~E~~~l~~l-~hpniv~l~~~~~~~-~~  259 (360)
                      ++|+..++||+|+||.||+|+..      +++.||+|.+            ..|++++.++ +||||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            35788899999999999999642      3578999853            3588999999 799999999988654 57


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-----------------------------------------------------------
Q 040294          260 RALVLEYMTNGSLEKVLYSSN-----------------------------------------------------------  280 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  280 (360)
                      .+++|||+++|+|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999999885421                                                           


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccC
Q 040294          281 -CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA  359 (360)
Q Consensus       281 -~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~a  359 (360)
                       ..+++..+..++.||+.||+|||   +.+|+||||||+||++++++.+||+|||+++.+.............++..|||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence             24788889999999999999999   89999999999999999999999999999987654332222334456788999


Q ss_pred             C
Q 040294          360 P  360 (360)
Q Consensus       360 P  360 (360)
                      |
T Consensus       244 P  244 (337)
T cd05054         244 P  244 (337)
T ss_pred             c
Confidence            8

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.93  E-value=1.3e-25  Score=202.34  Aligned_cols=151  Identities=29%  Similarity=0.499  Sum_probs=129.3

Q ss_pred             CeeccCCCccEEEEEccCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHH
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLE  273 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  273 (360)
                      ++||+|+||.||+|...+++.+|+|.            +..|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988888999974            456899999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccc
Q 040294          274 KVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA  353 (360)
Q Consensus       274 ~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~g  353 (360)
                      +++......+++..+..++.|++.||.|+|   +.+++||||||+||++++++.+|++|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            999766566889999999999999999999   89999999999999999999999999999876433221 11112234


Q ss_pred             cCcccCC
Q 040294          354 TIGYMAP  360 (360)
Q Consensus       354 t~~Y~aP  360 (360)
                      ++.|+||
T Consensus       157 ~~~y~aP  163 (250)
T cd05085         157 PIKWTAP  163 (250)
T ss_pred             cccccCH
Confidence            5678887

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.93  E-value=1.1e-25  Score=205.13  Aligned_cols=158  Identities=28%  Similarity=0.525  Sum_probs=132.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-C---CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-D---GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~---~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .+|+..+.||+|+||.||+|+.. +   +..+|+|.            +..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45778899999999999999863 2   33688863            45688999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++++|.+++......+++.+...++.|++.|++|||   +.+++||||||+||+++.++.++++|||+++.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876566889999999999999999999   8999999999999999999999999999998765432


Q ss_pred             Ccee-eecccccCcccCC
Q 040294          344 QSMT-QTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~-~~~~~gt~~Y~aP  360 (360)
                      .... .....++..|+||
T Consensus       161 ~~~~~~~~~~~~~~y~~p  178 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAP  178 (267)
T ss_pred             ceeeecCCCccceeecCH
Confidence            1111 1122335678887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.93  E-value=5.7e-26  Score=217.29  Aligned_cols=154  Identities=29%  Similarity=0.435  Sum_probs=131.0

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC-----eEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED-----FRA  261 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~  261 (360)
                      +|+..+.||+|+||.||+++. .+++.||||.+             .+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999985 47899999843             45899999999999999999998876     789


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+. ++|.+.+... ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999997 5888877543 35888899999999999999999   89999999999999999999999999999987543


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .. ........+|+.|+||
T Consensus       156 ~~-~~~~~~~~~~~~y~aP  173 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAP  173 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCH
Confidence            32 1122344688999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.93  E-value=4.8e-26  Score=206.96  Aligned_cols=153  Identities=37%  Similarity=0.611  Sum_probs=127.2

Q ss_pred             CCeeccCCCccEEEEEcc-----CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          205 NNLIGRGSFGSVYKARLQ-----DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~-----~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .+.||.|+||.||+|.+.     .+..|+||.            |.+|++.+++++||||++++++|...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999976     356788874            456899999999999999999999888899999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          268 TNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       268 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++|+|.+++... ...+++.++..|+.|+++||+|||   +.+++|+||+++||++++++.+||+|||+++.........
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            999999999886 567899999999999999999999   8899999999999999999999999999998874333222


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......+...|+||
T Consensus       161 ~~~~~~~~~~~~aP  174 (259)
T PF07714_consen  161 NDSSQQLPLRYLAP  174 (259)
T ss_dssp             ESTTSESGGGGS-H
T ss_pred             cccccccccccccc
Confidence            23344577888887

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=5.7e-26  Score=214.96  Aligned_cols=158  Identities=27%  Similarity=0.474  Sum_probs=128.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEc------cCCcEEEehhh------------HHHHHHhhcC-CCCCeeEEEEEecCC-Ce
Q 040294          200 NGFSANNLIGRGSFGSVYKARL------QDGMEFAIKSF------------DVECEVMKSI-HHRNLVKIISSCSNE-DF  259 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~------------~~E~~~l~~l-~hpniv~l~~~~~~~-~~  259 (360)
                      ++|+..+.||+|+||.||+|..      .+++.||||.+            ..|++++.++ +||||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            4688899999999999999973      35678999843            4589999999 689999999988654 46


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-----------------------------------------------------------
Q 040294          260 RALVLEYMTNGSLEKVLYSSN-----------------------------------------------------------  280 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  280 (360)
                      .++||||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999986421                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccc
Q 040294          281 -------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA  353 (360)
Q Consensus       281 -------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~g  353 (360)
                             ..+++.+...++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                   12577788899999999999999   89999999999999999999999999999987543322122222345


Q ss_pred             cCcccCC
Q 040294          354 TIGYMAP  360 (360)
Q Consensus       354 t~~Y~aP  360 (360)
                      ++.|+||
T Consensus       244 ~~~y~aP  250 (343)
T cd05103         244 PLKWMAP  250 (343)
T ss_pred             CcceECc
Confidence            6779988

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.93  E-value=9.2e-26  Score=209.69  Aligned_cols=159  Identities=28%  Similarity=0.488  Sum_probs=131.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc--------CCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNE  257 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~  257 (360)
                      .++|...+.||+|+||.||+|+..        ++..||+|.            +..|+++++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456778899999999999999741        244688874            34588999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL  322 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl  322 (360)
                      +..++||||+++|+|.+++....               ..+++.++..++.|++.||+|||   +.+|+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999987532               24678888999999999999999   8999999999999999


Q ss_pred             cCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          323 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       323 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++++.+||+|||+++.+.............+++.|+||
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP  208 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP  208 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence            99999999999999876543322122233467789998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=2e-25  Score=205.12  Aligned_cols=158  Identities=30%  Similarity=0.480  Sum_probs=130.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-----CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecC--CCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-----DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSN--EDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~  261 (360)
                      .+|+..+.||+|+||.||+++.+     ++..||+|.           +..|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46778899999999999999742     577899974           4569999999999999999998754  34689


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.+..
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999766556899999999999999999999   89999999999999999999999999999997654


Q ss_pred             CCCcee-eecccccCcccCC
Q 040294          342 EDQSMT-QTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~-~~~~~gt~~Y~aP  360 (360)
                      ...... .....++..|+||
T Consensus       161 ~~~~~~~~~~~~~~~~y~aP  180 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAP  180 (284)
T ss_pred             CCcceeecCCCCCceEeeCH
Confidence            332111 1112234558887

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.93  E-value=1.4e-25  Score=204.13  Aligned_cols=155  Identities=31%  Similarity=0.428  Sum_probs=134.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ++|+..+.||+|+||.||+|+. .+++.||+|.           +..|+.++++++||||+++++++..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4688899999999999999995 5788899873           346899999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|.+++... ..+++.++..++.|++.|++|||   +.+|+|||+||+||+++.++.+||+|||+++.+.....  .
T Consensus        89 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~  162 (267)
T cd06646          89 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K  162 (267)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence            999999998654 35788899999999999999999   89999999999999999999999999999987643221  1


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....|++.|+||
T Consensus       163 ~~~~~~~~~y~~P  175 (267)
T cd06646         163 RKSFIGTPYWMAP  175 (267)
T ss_pred             cCccccCccccCH
Confidence            2234688899987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.2e-25  Score=205.65  Aligned_cols=158  Identities=24%  Similarity=0.435  Sum_probs=132.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      ++|...+.||+|+||.||+|...      ++..||+|.            +..|+++++.++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            46788899999999999999864      236788874            456889999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEee
Q 040294          262 LVLEYMTNGSLEKVLYSSN---------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD  332 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~D  332 (360)
                      +||||+++|+|.+++....         ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence            9999999999999986432         23678889999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+++.+.............+|..|+||
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCH
Confidence            9999876543322222334567889988

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.93  E-value=1.6e-25  Score=206.95  Aligned_cols=158  Identities=25%  Similarity=0.420  Sum_probs=132.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC-----------------CcEEEehh------------hHHHHHHhhcCCCCCeeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD-----------------GMEFAIKS------------FDVECEVMKSIHHRNLVKI  250 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~------------~~~E~~~l~~l~hpniv~l  250 (360)
                      .+|+..+.||+|+||.||+|+...                 +..||+|.            +..|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            468888999999999999987542                 23577764            3458999999999999999


Q ss_pred             EEEecCCCeEEEEEEccCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCce
Q 040294          251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSN----------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV  320 (360)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~Ni  320 (360)
                      +++|..++..++||||+++++|.+++....          ..+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence            999999999999999999999999987543          25788899999999999999999   89999999999999


Q ss_pred             eecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          321 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       321 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++.++.++|+|||+++...............+++.||||
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW  201 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence            9999999999999999875433322222344567889998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=1.9e-25  Score=205.53  Aligned_cols=157  Identities=25%  Similarity=0.486  Sum_probs=131.9

Q ss_pred             CCCCCCeeccCCCccEEEEEc-----cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCC--CeEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-----QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNE--DFRA  261 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~  261 (360)
                      .|...+.||+|+||.||+++.     .++..||+|.            +.+|++++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            367788999999999999974     3577899874            45689999999999999999998875  5689


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++++|.+++......+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999999765556899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCce-eeecccccCcccCC
Q 040294          342 EDQSM-TQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~-~~~~~~gt~~Y~aP  360 (360)
                      ..... ......++..|+||
T Consensus       162 ~~~~~~~~~~~~~~~~y~ap  181 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAP  181 (284)
T ss_pred             CccceeecCCCCCCccccCH
Confidence            32211 11234567778887

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.8e-25  Score=205.06  Aligned_cols=157  Identities=27%  Similarity=0.436  Sum_probs=131.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCc----EEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGM----EFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      .+|+..+.||+|+||.||+|..+ +|.    .+|+|.            +.+|++++++++||||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45777899999999999999864 332    577763            4568999999999999999999987 67899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|.+++......+++.....++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999876666899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..........++..|+||
T Consensus       163 ~~~~~~~~~~~~~~y~~P  180 (279)
T cd05057         163 EKEYHAEGGKVPIKWMAL  180 (279)
T ss_pred             ccceecCCCcccccccCH
Confidence            322222222345678887

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-27  Score=226.49  Aligned_cols=151  Identities=30%  Similarity=0.422  Sum_probs=131.0

Q ss_pred             CCeeccCCCccEEEEEccCCcEE-Eeh-----------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEF-AIK-----------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~v-avK-----------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ...||.|+||.||+|..++.... |.|           .|..|++||+.++||+||+|++.|..++.+|+..|||.||..
T Consensus        37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV  116 (1187)
T KOG0579|consen   37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV  116 (1187)
T ss_pred             HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence            35689999999999987654433 334           355699999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeeccc
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL  352 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~  352 (360)
                      +.++-.-+..+.+.+...+++|++.||.|||   +..|||||||+.|||+.-+|.++++|||++......  .....++.
T Consensus       117 DaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRDsFI  191 (1187)
T KOG0579|consen  117 DAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRDSFI  191 (1187)
T ss_pred             hHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--Hhhhcccc
Confidence            9988877778999999999999999999999   999999999999999999999999999997654322  22345789


Q ss_pred             ccCcccCC
Q 040294          353 ATIGYMAP  360 (360)
Q Consensus       353 gt~~Y~aP  360 (360)
                      |||+||||
T Consensus       192 GTPYWMAP  199 (1187)
T KOG0579|consen  192 GTPYWMAP  199 (1187)
T ss_pred             CCcccccc
Confidence            99999999

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.93  E-value=9.2e-26  Score=206.74  Aligned_cols=158  Identities=30%  Similarity=0.531  Sum_probs=132.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      .+|...+.||+|+||.||+|+..      ++..||||.            +.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            35777889999999999999863      346789874            456999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcE
Q 040294          262 LVLEYMTNGSLEKVLYSSN-------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVA  328 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~  328 (360)
                      +||||+++++|.+++....             ..+++.+...++.|++.|++|||   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999996532             24678888999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeecccccCcccCC
Q 040294          329 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       329 ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|||+++.+.............+++.|+||
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP  193 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecCh
Confidence            99999999865433222222334567889998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=2e-25  Score=203.14  Aligned_cols=146  Identities=23%  Similarity=0.426  Sum_probs=123.6

Q ss_pred             CeeccCCCccEEEEEccC-------------CcEEEeh-----------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          206 NLIGRGSFGSVYKARLQD-------------GMEFAIK-----------SFDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~-------------~~~vavK-----------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      +.||+|+||.||+|++.+             ...||+|           .|..|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999998532             1247776           3456788999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc-------EEEeecc
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV-------AHLSDFG  334 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~-------~ki~DFG  334 (360)
                      +||||+++|+|..++......+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998766667899999999999999999999   999999999999999986654       8999999


Q ss_pred             cccccCCCCCceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++......      ....++..||||
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aP  177 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAP  177 (262)
T ss_pred             CCccccCc------ccccccccccCh
Confidence            98765322      234578889998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.93  E-value=1.2e-25  Score=206.12  Aligned_cols=145  Identities=22%  Similarity=0.396  Sum_probs=120.8

Q ss_pred             eeccCCCccEEEEEccC-------------------------CcEEEehh-----------hHHHHHHhhcCCCCCeeEE
Q 040294          207 LIGRGSFGSVYKARLQD-------------------------GMEFAIKS-----------FDVECEVMKSIHHRNLVKI  250 (360)
Q Consensus       207 ~iG~G~~g~Vy~~~~~~-------------------------~~~vavK~-----------~~~E~~~l~~l~hpniv~l  250 (360)
                      .||+|+||.||+|.+..                         ...||+|.           |..|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         12467763           4457889999999999999


Q ss_pred             EEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC----
Q 040294          251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI----  326 (360)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~----  326 (360)
                      +++|.++...++||||+++|+|..++......+++..+..++.|+++||+|||   +.+|+||||||+||++++.+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999999766667889999999999999999999   89999999999999997543    


Q ss_pred             ---cEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          327 ---VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       327 ---~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                         .+|++|||++......      ....++..|+||
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aP  189 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAP  189 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCc
Confidence               4899999998654321      123467788887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.93  E-value=6.4e-26  Score=205.66  Aligned_cols=158  Identities=26%  Similarity=0.510  Sum_probs=136.0

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEccCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ...+|+..+.||+|+||.||+|...++..+|+|.           +..|+++++.++||||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            3456888899999999999999988888999874           34688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++++|.+++... ...+++.+...++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++..+..... 
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            9999999999764 345789999999999999999999   89999999999999999999999999999987643321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......++..|+||
T Consensus       160 -~~~~~~~~~~~~~P  173 (261)
T cd05148         160 -LSSDKKIPYKWTAP  173 (261)
T ss_pred             -cccCCCCceEecCH
Confidence             11233466778887

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.93  E-value=1.3e-25  Score=208.79  Aligned_cols=158  Identities=27%  Similarity=0.471  Sum_probs=132.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEc------cCCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  260 (360)
                      ++|...+.||+|+||.||++..      .++..||||.            +..|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4688889999999999999973      1345788873            45699999999 799999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          261 ALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      ++||||+++|+|.+++.... ..+++.+...++.|++.||+|||   +.+|+|+||||+||+++.++.+|++|||+++.+
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999997543 34899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .............++..|+||
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aP  212 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAP  212 (302)
T ss_pred             cCCCceeecCCCCcccccCCH
Confidence            433221122233467789988

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.93  E-value=1.5e-25  Score=206.92  Aligned_cols=159  Identities=29%  Similarity=0.477  Sum_probs=132.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccC------CcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCe
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQD------GMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDF  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~  259 (360)
                      .++|+..+.||+|+||.||++....      ...+|+|.            +..|+++++++ +||||+++++++..++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            3467888999999999999998642      35788873            34688999999 79999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC
Q 040294          260 RALVLEYMTNGSLEKVLYSS---------------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD  324 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~  324 (360)
                      .+++|||+++|+|.+++...               ...+++..++.++.|++.||+|||   +.+|+||||||+||++++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence            99999999999999998642               235788899999999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          325 NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       325 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++.+|++|||+++.+.............+++.|+||
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  203 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP  203 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCH
Confidence            999999999999876543321122223456789988

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.93  E-value=1.8e-25  Score=208.24  Aligned_cols=153  Identities=27%  Similarity=0.361  Sum_probs=133.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||+|+||.||+++.. ++..+|+|.            +..|++++++++||||++++++|..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46888999999999999999864 677888763            44689999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++++|.+++... ..+++.....++.|+++||+|||   + .+++||||||+||+++.++.+||+|||++..+....  
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            9999999999765 45788888999999999999999   5 589999999999999999999999999987654321  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                        .....|++.|+||
T Consensus       155 --~~~~~~~~~~~aP  167 (308)
T cd06615         155 --ANSFVGTRSYMSP  167 (308)
T ss_pred             --cccCCCCcCccCh
Confidence              2345688899988

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.9e-25  Score=201.38  Aligned_cols=157  Identities=29%  Similarity=0.461  Sum_probs=134.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh----------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS----------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~----------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|+..++||+|+||.||+|.. .+++.||+|.                +.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999985 4688999873                3458899999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++++|.+++.... .+++.....++.|++.|++|||   +.+|+||||+|+||+++.++.++|+|||+++.+...
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999987543 4778888999999999999999   899999999999999999999999999999875432


Q ss_pred             CCcee-eecccccCcccCC
Q 040294          343 DQSMT-QTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~-~~~~~gt~~Y~aP  360 (360)
                      ..... .....|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~y~aP  176 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSP  176 (263)
T ss_pred             ccccccccCCCcCccccCc
Confidence            21111 1234678899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.93  E-value=1.1e-25  Score=207.07  Aligned_cols=166  Identities=27%  Similarity=0.395  Sum_probs=137.9

Q ss_pred             cCHHHHHHHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcC-CCCCeeEEEEEec--
Q 040294          190 FSYLELLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSI-HHRNLVKIISSCS--  255 (360)
Q Consensus       190 ~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l-~hpniv~l~~~~~--  255 (360)
                      +.++.+....++|+..+.||+|+||.||+++.. +++.+|+|.          +..|+.+++++ +||||+++++++.  
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            444556667889999999999999999999864 678899874          34588889998 6999999999884  


Q ss_pred             ---CCCeEEEEEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEE
Q 040294          256 ---NEDFRALVLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH  329 (360)
Q Consensus       256 ---~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~k  329 (360)
                         .++..++||||+++++|.+++..   ....+++..+..++.|+++||.|||   +.+|+||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence               44578999999999999998753   2345788888999999999999999   89999999999999999999999


Q ss_pred             EeecccccccCCCCCceeeecccccCcccCC
Q 040294          330 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       330 i~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+|||+++.+.....  ......|++.|+||
T Consensus       165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  193 (286)
T cd06638         165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAP  193 (286)
T ss_pred             EccCCceeecccCCC--ccccccCCCcccCh
Confidence            999999987643221  22334689999998

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.93  E-value=2e-25  Score=206.20  Aligned_cols=157  Identities=31%  Similarity=0.540  Sum_probs=132.0

Q ss_pred             CCCCCCeeccCCCccEEEEEcc------CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      +|...+.||+|+||.||+|+..      ++..+|+|.           +.+|++++++++||||+++++++...+..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            4677889999999999999742      345677763           56789999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcE
Q 040294          264 LEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVA  328 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~  328 (360)
                      |||+++++|.+++....               ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence            99999999999996432               23788999999999999999999   9999999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeecccccCcccCC
Q 040294          329 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       329 ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|||+++...............++..|+||
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  194 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  194 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecCh
Confidence            99999999876543222222334577889998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=1.3e-25  Score=204.97  Aligned_cols=151  Identities=22%  Similarity=0.386  Sum_probs=122.2

Q ss_pred             eeccCCCccEEEEEccCCc---EEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCC
Q 040294          207 LIGRGSFGSVYKARLQDGM---EFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGS  271 (360)
Q Consensus       207 ~iG~G~~g~Vy~~~~~~~~---~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  271 (360)
                      .||+|+||.||+++..++.   .+++|            .+.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5899999999999754332   34454            35568888999999999999999999999999999999999


Q ss_pred             HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          272 LEKVLYSSN---CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       272 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      |.+++....   ...++.....++.|+++||+|||   +.+++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997542   23566667889999999999999   889999999999999999999999999998653222111122


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....|+..|+||
T Consensus       159 ~~~~~~~~y~aP  170 (268)
T cd05086         159 DDKCVPLRWLAP  170 (268)
T ss_pred             cCCcCcccccCc
Confidence            345678889988

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.93  E-value=1.7e-25  Score=207.65  Aligned_cols=155  Identities=25%  Similarity=0.448  Sum_probs=133.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.+            ..|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888899999999999999865 6788999843            3589999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++ ++|.+++......+++.....++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            97 5999988776667888899999999999999999   89999999999999999999999999999986543221  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......+++.|+||
T Consensus       160 ~~~~~~~~~~y~~P  173 (301)
T cd07873         160 TYSNEVVTLWYRPP  173 (301)
T ss_pred             cccccceeecccCc
Confidence            12234578899998

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.93  E-value=2.2e-25  Score=203.18  Aligned_cols=160  Identities=31%  Similarity=0.459  Sum_probs=134.9

Q ss_pred             HHHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          196 LRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       196 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ..+++++.....||+|+||.||+|+.. ++..||+|.           +.+|++++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345677777789999999999999854 677899873           45789999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEEeecccccccC
Q 040294          264 LEYMTNGSLEKVLYSSNCIL--DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFGIAKLLT  340 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki~DFGla~~~~  340 (360)
                      |||+++++|.+++......+  ++..+..++.|++.|++|||   +.+|+||||||+||+++. ++.+||+|||++..+.
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999997654444  77888889999999999999   899999999999999986 6799999999998664


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  ......|++.|+||
T Consensus       161 ~~~~--~~~~~~~~~~~~aP  178 (268)
T cd06624         161 GINP--CTETFTGTLQYMAP  178 (268)
T ss_pred             cCCC--ccccCCCCccccCh
Confidence            3221  12234578899988

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.93  E-value=7.1e-26  Score=208.03  Aligned_cols=156  Identities=25%  Similarity=0.440  Sum_probs=129.5

Q ss_pred             CCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      |+..+.||+|+||.||+|+..      +++.||+|.            +..|+.++.+++||||+++++++...+..+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            555678999999999999853      346799974            34688899999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcE
Q 040294          264 LEYMTNGSLEKVLYSS---------------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVA  328 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~  328 (360)
                      +||+++++|.+++...               ...+++..+..++.|++.||+|+|   +.+|+||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence            9999999999998532               124778888999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeecccccCcccCC
Q 040294          329 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       329 ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|||+++.+.............+++.|+||
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSP  195 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCH
Confidence            99999999876433222222234567889998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.93  E-value=1.8e-25  Score=203.87  Aligned_cols=138  Identities=28%  Similarity=0.571  Sum_probs=123.4

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CC---cEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DG---MEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~---~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      +|+..+.||+|+||.||+|+.. ++   ..||||.            |..|++++++++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4677889999999999999865 23   3588874            445889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ||+++|+|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++.+..
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999876667899999999999999999999   89999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-26  Score=224.35  Aligned_cols=155  Identities=28%  Similarity=0.541  Sum_probs=135.0

Q ss_pred             CCCCCeeccCCCccEEEEEccC----CcEEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARLQD----GMEFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ..+.++||.|.||+||+|+++.    ...||||            .|..|+.||.+++||||++|.|+......++||.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            4457899999999999999752    3468987            46779999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      ||+||+|+.+|+...+.+.+.+...+.++||.|+.||-   +.+.+||||.+.|||++.+..+||+|||+++.+.++.. 
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~-  786 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-  786 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC-
Confidence            99999999999988888999999999999999999999   99999999999999999999999999999998865541 


Q ss_pred             eeeecccc--cCcccCC
Q 040294          346 MTQTQTLA--TIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~g--t~~Y~aP  360 (360)
                      ...++.-|  .++|.||
T Consensus       787 ~~ytt~GGKIPiRWTAP  803 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAP  803 (996)
T ss_pred             ccccccCCccceeecCh
Confidence            11122222  4578887

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.93  E-value=2e-25  Score=206.02  Aligned_cols=157  Identities=25%  Similarity=0.445  Sum_probs=129.7

Q ss_pred             CCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      +|...+.||+|+||.||+|+..      ....+|+|.            +..|+++++.++||||+++++.|..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3677889999999999999742      234677763            4568999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCc
Q 040294          263 VLEYMTNGSLEKVLYSSN-----------------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHN  319 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~N  319 (360)
                      +|||+.+|+|.+++....                       ..+++.+...++.|++.||+|||   +.+|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999886421                       23678889999999999999999   8999999999999


Q ss_pred             eeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          320 VLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       320 iLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |++++++.+||+|||+++...............++..|+||
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap  198 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI  198 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence            99999999999999999875433222222233466788887

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.93  E-value=1.8e-25  Score=203.29  Aligned_cols=156  Identities=28%  Similarity=0.512  Sum_probs=131.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|...+.||+|+||.||+|+..++..||+|.          +..|++++++++||||+++++++.. +..++||||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~   84 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   84 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence            45788899999999999999987767799873          4568999999999999999998754 457999999999


Q ss_pred             CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      |+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||.++.+..... ...
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~  160 (262)
T cd05071          85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR  160 (262)
T ss_pred             CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-ccc
Confidence            9999999753 335788999999999999999999   89999999999999999999999999999987653321 112


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|+||
T Consensus       161 ~~~~~~~~y~~P  172 (262)
T cd05071         161 QGAKFPIKWTAP  172 (262)
T ss_pred             cCCcccceecCH
Confidence            234467789988

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.3e-25  Score=206.07  Aligned_cols=156  Identities=29%  Similarity=0.413  Sum_probs=136.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ++|+..+.||+|+||.||+++.. ++..+|+|.           +..|++++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            45777888999999999999864 688899873           456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|.+++......+++.....++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++........  .
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~  159 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--K  159 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--c
Confidence            999999999776667899999999999999999999   89999999999999999999999999999876543221  2


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....||+.|+||
T Consensus       160 ~~~~~~~~~y~~P  172 (280)
T cd06611         160 RDTFIGTPYWMAP  172 (280)
T ss_pred             cceeecchhhcCH
Confidence            2335688889987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.93  E-value=2.4e-25  Score=208.02  Aligned_cols=152  Identities=24%  Similarity=0.425  Sum_probs=123.7

Q ss_pred             CCeeccCCCccEEEEEcc---CCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEecC--CCeEEEEEEccCCC
Q 040294          205 NNLIGRGSFGSVYKARLQ---DGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSN--EDFRALVLEYMTNG  270 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~g  270 (360)
                      .+.||+|+||.||+|+.+   +++.||+|.         +.+|++++++++||||+++++++..  +...++||||+. +
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence            467999999999999864   467899984         3569999999999999999998854  457899999996 4


Q ss_pred             CHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee----cCCCcEEEeecccccc
Q 040294          271 SLEKVLYSS--------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKL  338 (360)
Q Consensus       271 ~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl----~~~~~~ki~DFGla~~  338 (360)
                      +|.+++...        ...+++.....++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            888877532        124788888999999999999999   8999999999999999    4567899999999987


Q ss_pred             cCCCCCc-eeeecccccCcccCC
Q 040294          339 LTGEDQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~-~~~~~~~gt~~Y~aP  360 (360)
                      ....... .......||+.||||
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             cCCCCccccccCCccccccccCC
Confidence            6533211 122346789999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.93  E-value=2.6e-25  Score=200.79  Aligned_cols=155  Identities=30%  Similarity=0.447  Sum_probs=134.7

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||+|..+ +++.|++|.+             ..|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999864 6888998743             4588999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++++|.+++... ...+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999764 456888899999999999999999   89999999999999999999999999999987654321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......|++.|+||
T Consensus       157 -~~~~~~~~~~y~aP  170 (256)
T cd08529         157 -FANTIVGTPYYLSP  170 (256)
T ss_pred             -hhhccccCccccCH
Confidence             12334688899988

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.93  E-value=2.2e-25  Score=202.84  Aligned_cols=156  Identities=27%  Similarity=0.479  Sum_probs=134.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||||.              +..|+++++.++||||+++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999964 788999983              356899999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ||+++|+|.+++..   ....+++.....++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988853   2345788888999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...  ......|++.|+||
T Consensus       159 ~~~--~~~~~~~~~~~~aP  175 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSP  175 (267)
T ss_pred             hhH--HHhcCCCCccccCh
Confidence            221  12234688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.93  E-value=2.7e-25  Score=205.16  Aligned_cols=152  Identities=35%  Similarity=0.469  Sum_probs=134.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+++.. +++.+|+|.+              ..|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46788899999999999999865 6889999743              35889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||+|+||+++.++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999998765 46788889999999999999999   899999999999999999999999999999876533  


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         .....|++.|+||
T Consensus       155 ---~~~~~~~~~y~aP  167 (290)
T cd05580         155 ---TYTLCGTPEYLAP  167 (290)
T ss_pred             ---CCCCCCCccccCh
Confidence               2234688999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.93  E-value=2e-25  Score=202.94  Aligned_cols=156  Identities=31%  Similarity=0.547  Sum_probs=132.8

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      +|+..+.||+|+||.||+|..+ +++.||+|.          +..|++++++++||||+++++++..++..+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            4677889999999999999865 578899874          45689999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      ++|.+++.... ..+++..+..++.|+++||+|||   +.+++||||||+||++++++.+||+|||+++....... ...
T Consensus        87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~  162 (263)
T cd05052          87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAH  162 (263)
T ss_pred             CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-ecc
Confidence            99999987543 45889999999999999999999   89999999999999999999999999999987654321 111


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|+||
T Consensus       163 ~~~~~~~~y~aP  174 (263)
T cd05052         163 AGAKFPIKWTAP  174 (263)
T ss_pred             CCCCCccccCCH
Confidence            122346679887

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.93  E-value=3.1e-25  Score=202.34  Aligned_cols=155  Identities=28%  Similarity=0.487  Sum_probs=123.6

Q ss_pred             CCCCeeccCCCccEEEEEccC-Cc--EEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCC------CeE
Q 040294          203 SANNLIGRGSFGSVYKARLQD-GM--EFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNE------DFR  260 (360)
Q Consensus       203 ~~~~~iG~G~~g~Vy~~~~~~-~~--~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~------~~~  260 (360)
                      ...+.||+|+||.||+|+..+ +.  .+|+|.             +..|+++++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999998654 32  578863             34588999999999999999987532      246


Q ss_pred             EEEEEccCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccc
Q 040294          261 ALVLEYMTNGSLEKVLYSS-----NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGI  335 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGl  335 (360)
                      +++|||+++|+|.+++...     ...+++.....++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999887422     234788899999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCceeeecccccCcccCC
Q 040294          336 AKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       336 a~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++.+.............+++.|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~p  183 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAI  183 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCH
Confidence            9876533211111223456678876

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.93  E-value=2.5e-25  Score=205.98  Aligned_cols=158  Identities=24%  Similarity=0.443  Sum_probs=129.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-----------------CCcEEEehh------------hHHHHHHhhcCCCCCeeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-----------------DGMEFAIKS------------FDVECEVMKSIHHRNLVKI  250 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-----------------~~~~vavK~------------~~~E~~~l~~l~hpniv~l  250 (360)
                      ++|+..+.||+|+||.||+++..                 +...+|+|.            +..|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888899999999999998632                 233577763            4568999999999999999


Q ss_pred             EEEecCCCeEEEEEEccCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCce
Q 040294          251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSN----------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV  320 (360)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~Ni  320 (360)
                      ++++..++..++||||+++|+|.+++....          ..+++.+...++.|++.|++|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999987532          23677889999999999999999   88999999999999


Q ss_pred             eecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          321 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       321 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++++++.++++|||+++.+.............+++.|+||
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  201 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW  201 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence            9999999999999999876433211111223346678876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.93  E-value=1.9e-25  Score=208.01  Aligned_cols=158  Identities=28%  Similarity=0.465  Sum_probs=129.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc--------CCcEEEehhh------------HHHHHHhhcC-CCCCeeEEEEEecCCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKSF------------DVECEVMKSI-HHRNLVKIISSCSNED  258 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~------------~~E~~~l~~l-~hpniv~l~~~~~~~~  258 (360)
                      ++|.+.+.||+|+||.||+++..        +...+|+|.+            ..|+++++++ +||||++++++|...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            46888899999999999999752        2346888743            3588899998 7999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec
Q 040294          259 FRALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD  323 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~  323 (360)
                      ..++||||+++|+|.+++....               ..+++.+++.++.|++.||+|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999997532               24788899999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          324 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       324 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++.+||+|||+++...............+++.||||
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  211 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  211 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence            9999999999999865432211111122345689988

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.93  E-value=4.5e-25  Score=200.18  Aligned_cols=149  Identities=29%  Similarity=0.509  Sum_probs=124.0

Q ss_pred             eccCCCccEEEEEcc---CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          208 IGRGSFGSVYKARLQ---DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~---~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ||+|+||.||+|.++   ++..||+|.            +.+|++++++++||||+++++++.. +..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence            899999999999754   345688862            4578999999999999999999865 467999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce-eeecc
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM-TQTQT  351 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~-~~~~~  351 (360)
                      .+++......+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......... .....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            9999866667899999999999999999999   8899999999999999999999999999998654332211 11122


Q ss_pred             cccCcccCC
Q 040294          352 LATIGYMAP  360 (360)
Q Consensus       352 ~gt~~Y~aP  360 (360)
                      .+++.|+||
T Consensus       159 ~~~~~y~aP  167 (257)
T cd05115         159 KWPLKWYAP  167 (257)
T ss_pred             CCCcccCCH
Confidence            345789887

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.93  E-value=3.1e-25  Score=201.26  Aligned_cols=156  Identities=27%  Similarity=0.510  Sum_probs=131.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|...++..+|+|.          +..|++++++++|||++++++++.. +..+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~   84 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK   84 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence            35778899999999999999988888899874          4579999999999999999998864 557899999999


Q ss_pred             CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      ++|.+++... ...+++.++..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++..+..... ...
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~  160 (260)
T cd05070          85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TAR  160 (260)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-ccc
Confidence            9999999754 345789999999999999999999   88999999999999999999999999999987643221 111


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|+||
T Consensus       161 ~~~~~~~~y~aP  172 (260)
T cd05070         161 QGAKFPIKWTAP  172 (260)
T ss_pred             cCCCCCccccCh
Confidence            223456789988

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=7.1e-26  Score=224.57  Aligned_cols=159  Identities=30%  Similarity=0.421  Sum_probs=128.3

Q ss_pred             CCCCCCeeccCCCccEEEEEccCC-cEEEehh-----------hHHHHHHhhcCC-CCCeeEEEEEe-cC------CCeE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDG-MEFAIKS-----------FDVECEVMKSIH-HRNLVKIISSC-SN------EDFR  260 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~-----------~~~E~~~l~~l~-hpniv~l~~~~-~~------~~~~  260 (360)
                      ..++.++|.+|||+.||.|+...+ .+||+|+           +.+|+++|++++ |||||.+++.. ..      .-++
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            345678999999999999997655 9999984           467999999998 99999999932 21      1267


Q ss_pred             EEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          261 ALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      +|.||||+||.|-+++..+ ...+++.++++|+.|+++|+++|| .+.++|||||||.+||||+.++..||||||.|...
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            8999999999999999743 335899999999999999999999 45789999999999999999999999999998653


Q ss_pred             CCCC-Ccee------eecccccCcccCC
Q 040294          340 TGED-QSMT------QTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~-~~~~------~~~~~gt~~Y~aP  360 (360)
                      .... ....      .....-|+-|.||
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsP  224 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSP  224 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccCh
Confidence            2211 1100      0123468999988

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.93  E-value=3.8e-25  Score=200.68  Aligned_cols=156  Identities=26%  Similarity=0.497  Sum_probs=132.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|..++++.||+|.          +..|++++++++||||+++++++. .+..+++|||+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN   84 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence            46788899999999999999988899999983          467999999999999999999875 4568999999999


Q ss_pred             CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      ++|.+++... ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.++++|||++........ ...
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~  160 (260)
T cd05067          85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAR  160 (260)
T ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccc
Confidence            9999998653 345888899999999999999999   89999999999999999999999999999987653221 112


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|+||
T Consensus       161 ~~~~~~~~y~~p  172 (260)
T cd05067         161 EGAKFPIKWTAP  172 (260)
T ss_pred             cCCcccccccCH
Confidence            233466788887

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.93  E-value=3.9e-25  Score=199.93  Aligned_cols=157  Identities=28%  Similarity=0.487  Sum_probs=134.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||++.+.+++.+|+|.          |..|++++++++|||++++++++......++||||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            45777889999999999999987778899873          56799999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      ++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++...... .....
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~  159 (256)
T cd05112          84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSST  159 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccccC
Confidence            9999999876666889999999999999999999   8899999999999999999999999999988654322 11122


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...++.+|+||
T Consensus       160 ~~~~~~~~~aP  170 (256)
T cd05112         160 GTKFPVKWSSP  170 (256)
T ss_pred             CCccchhhcCH
Confidence            23456788887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.93  E-value=2.8e-25  Score=203.65  Aligned_cols=159  Identities=26%  Similarity=0.447  Sum_probs=130.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccC------CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQD------GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      +++|...+.||+|+||.||+|.+..      +..||+|.            |..|+.++++++||||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4568888999999999999998653      56788873            45688899999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC---cEEEe
Q 040294          261 ALVLEYMTNGSLEKVLYSSN------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI---VAHLS  331 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~---~~ki~  331 (360)
                      ++||||+++++|.+++....      ..+++.++..++.||+.|++|||   +.+++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999987543      24889999999999999999999   88999999999999998654   69999


Q ss_pred             ecccccccCCCCCceeeecccccCcccCC
Q 040294          332 DFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       332 DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |||+++.+..............+..||||
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPP  190 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCH
Confidence            99999876433211111122345678887

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.93  E-value=2.5e-25  Score=206.88  Aligned_cols=156  Identities=33%  Similarity=0.561  Sum_probs=128.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcE--EEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGME--FAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~--vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  262 (360)
                      .++|+..+.||+|+||.||+|+.+ ++..  +|+|.            +..|++++.++ +||||+++++++..++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888899999999999999864 4543  46652            44689999999 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc
Q 040294          263 VLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV  327 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~  327 (360)
                      ||||+++|+|.+++....               ..+++.+++.++.|++.|++|||   +.+|+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999997432               24788899999999999999999   899999999999999999999


Q ss_pred             EEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          328 AHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       328 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +||+|||+++......   ......++..|+||
T Consensus       163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aP  192 (303)
T cd05088         163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAI  192 (303)
T ss_pred             EEeCccccCcccchhh---hcccCCCcccccCH
Confidence            9999999987432111   11112345678887

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.93  E-value=4.5e-25  Score=201.14  Aligned_cols=156  Identities=27%  Similarity=0.504  Sum_probs=126.8

Q ss_pred             CCCCCeeccCCCccEEEEEccC----CcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCe-----
Q 040294          202 FSANNLIGRGSFGSVYKARLQD----GMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDF-----  259 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~-----  259 (360)
                      |...+.||+|+||.||+|....    +..||+|.             +..|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998642    36789874             3458899999999999999998876554     


Q ss_pred             -EEEEEEccCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeec
Q 040294          260 -RALVLEYMTNGSLEKVLYSS-----NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDF  333 (360)
Q Consensus       260 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DF  333 (360)
                       .+++|||+++|+|..++...     ...+++.....++.|++.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999988542     235788899999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCceeeecccccCcccCC
Q 040294          334 GIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       334 Gla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+++.+.............++..|+||
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             cceeeccccccccccccccCCccccCH
Confidence            999876543322122223356678877

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.93  E-value=4.8e-25  Score=202.37  Aligned_cols=148  Identities=27%  Similarity=0.380  Sum_probs=129.0

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +|+..++||+|+||.||+|+. .+++.||+|.            +..|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577788999999999999985 5788899974            346899999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|..+.     .+++.....++.|++.||+|||   +.+|+|+||||+||+++.++.+||+|||++..+....    
T Consensus        82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----  149 (279)
T cd06619          82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----  149 (279)
T ss_pred             CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence            999997642     3577788899999999999999   8999999999999999999999999999998754321    


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....||..|+||
T Consensus       150 ~~~~~~~~~y~aP  162 (279)
T cd06619         150 AKTYVGTNAYMAP  162 (279)
T ss_pred             ccCCCCChhhcCc
Confidence            2345789999998

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.93  E-value=4.3e-25  Score=202.82  Aligned_cols=154  Identities=30%  Similarity=0.429  Sum_probs=132.1

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      |+..+.||+|+||.||+|+.. ++..+|+|.           +..|+++++.++||||++++++|..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            445678999999999999965 567778763           45689999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      ++|..++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            9999988765567899999999999999999999   8999999999999999999999999999987654321  1223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.|+||
T Consensus       162 ~~~~~~~y~aP  172 (282)
T cd06643         162 SFIGTPYWMAP  172 (282)
T ss_pred             cccccccccCH
Confidence            35688999998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.93  E-value=4.8e-25  Score=200.78  Aligned_cols=159  Identities=26%  Similarity=0.523  Sum_probs=132.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCc---EEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGM---EFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~---~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      .++|+..+.||+|+||.||+|+.+ +++   .+|+|.            +..|++++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356788899999999999999865 333   688863            4468899999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++++|.+++......+++.++..++.|++.|++|||   +.+++|||+||+||++++++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999876667899999999999999999999   889999999999999999999999999999876433


Q ss_pred             CCce-eeecccccCcccCC
Q 040294          343 DQSM-TQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~-~~~~~~gt~~Y~aP  360 (360)
                      .... .......++.|+||
T Consensus       161 ~~~~~~~~~~~~~~~y~~P  179 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAP  179 (268)
T ss_pred             cccceeccCCCcCceecCH
Confidence            2111 11112234578887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=3e-25  Score=226.85  Aligned_cols=156  Identities=28%  Similarity=0.444  Sum_probs=134.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|.+.+.||+|+||.||+|+.. +++.||||.+              ..|+++++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            357888899999999999999965 7889999843              4577889999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++++|.+++.... .+++...+.|+.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~  158 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE  158 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCc
Confidence            99999999999997543 5788888999999999999999   8899999999999999999999999999999765332


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ......+|+.|+||
T Consensus       159 ~--~~~~~~~t~~~~~p  173 (669)
T cd05610         159 L--NMMDILTTPSMAKP  173 (669)
T ss_pred             c--cccccccCccccCc
Confidence            1  22345678888876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.93  E-value=2.7e-25  Score=206.64  Aligned_cols=158  Identities=28%  Similarity=0.474  Sum_probs=130.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCc----EEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGM----EFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      .++|+..+.||+|+||.||+|.+. ++.    .+|+|            .+..|+.++++++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            346778899999999999999853 444    46776            345688999999999999999999765 467


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +++||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.+..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999999876666888899999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...........++..|+||
T Consensus       162 ~~~~~~~~~~~~~~~y~~P  180 (303)
T cd05110         162 DEKEYNADGGKMPIKWMAL  180 (303)
T ss_pred             cccccccCCCccccccCCH
Confidence            3322222234467789987

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.93  E-value=6.4e-25  Score=202.76  Aligned_cols=156  Identities=29%  Similarity=0.401  Sum_probs=134.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +.|+..+.||+|+||.||+|+.. +++.+|+|.           +..|++++++++||||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            45778889999999999999965 578888874           346889999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|..++......+++..+..++.|++.|++|||   +.+++|||+||+||+++.++.+||+|||++.......  ..
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence            999999988765566899999999999999999999   8999999999999999999999999999987643221  11


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....+++.|+||
T Consensus       167 ~~~~~~~~~y~aP  179 (292)
T cd06644         167 RDSFIGTPYWMAP  179 (292)
T ss_pred             cceecCCccccCc
Confidence            2334578889988

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=7.6e-26  Score=216.58  Aligned_cols=150  Identities=30%  Similarity=0.484  Sum_probs=128.9

Q ss_pred             CCeeccCCCccEEEEEcc-CCcEEEe---h------------hhHHHHHHhhcCCCCCeeEEEEEecCCCe--EEEEEEc
Q 040294          205 NNLIGRGSFGSVYKARLQ-DGMEFAI---K------------SFDVECEVMKSIHHRNLVKIISSCSNEDF--RALVLEY  266 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~-~~~~vav---K------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~lv~e~  266 (360)
                      ..+||+|+|-+||||... +|.+||=   |            .|..|+++|+.++|||||+++.+|.+...  ..+|.|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            367999999999999864 6777772   2            46679999999999999999999988765  7789999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +..|+|..+..+.+ .++......+++||++||.|||. ..++|||||||-+||+++. .|.+||+|.|+|..+....  
T Consensus       125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--  200 (632)
T ss_pred             ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence            99999999997654 47778889999999999999994 5799999999999999975 5899999999999876432  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                        ..+.+|||.||||
T Consensus       201 --aksvIGTPEFMAP  213 (632)
T KOG0584|consen  201 --AKSVIGTPEFMAP  213 (632)
T ss_pred             --cceeccCccccCh
Confidence              2347899999999

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.93  E-value=2.8e-25  Score=204.66  Aligned_cols=159  Identities=29%  Similarity=0.502  Sum_probs=132.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      .++|+..+.||+|+||.||+++..      ++..||+|.            +..|++++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999853      467888873            45689999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCc
Q 040294          261 ALVLEYMTNGSLEKVLYSSN---------------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHN  319 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~N  319 (360)
                      ++||||+++|+|.+++....                     ..+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999996421                     23678888999999999999999   8999999999999


Q ss_pred             eeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          320 VLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       320 iLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |++++++.+||+|||+++.+.............+++.|+||
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP  201 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence            99999999999999998865433211112223456678887

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.93  E-value=5e-25  Score=199.01  Aligned_cols=152  Identities=36%  Similarity=0.617  Sum_probs=131.9

Q ss_pred             CeeccCCCccEEEEEccC----CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQD----GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~----~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      +.||+|+||.||+|....    +..||+|.            +..|++.++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998653    77888873            34588999999999999999999999999999999999


Q ss_pred             CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          270 GSLEKVLYSS--------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       270 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ++|.+++...        ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875        466899999999999999999999   89999999999999999999999999999988754


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...........+++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~y~aP  176 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAP  176 (262)
T ss_pred             ccccccccCCCcCccccCH
Confidence            4322223345678899998

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.93  E-value=6.4e-25  Score=198.50  Aligned_cols=155  Identities=24%  Similarity=0.402  Sum_probs=134.6

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..++||+|+||.||.++. .++..+++|.             +.+|++++++++|+||+++++++.+++..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477889999999999999885 4688888873             45699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++|+|.+++... ...+++.+...++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999764 345888999999999999999999   88999999999999999999999999999987643321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......|++.|+||
T Consensus       157 -~~~~~~~~~~y~ap  170 (256)
T cd08221         157 -MAETVVGTPYYMSP  170 (256)
T ss_pred             -cccccCCCccccCH
Confidence             22345688899987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.93  E-value=5.4e-25  Score=203.10  Aligned_cols=157  Identities=27%  Similarity=0.415  Sum_probs=132.7

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++++|...+.||+|+||.||+|.. .+++.||+|.+            .+|+++++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            457889999999999999999985 46889999843            46899999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+. +++.+.+......+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9996 6777777654455778888889999999999999   88999999999999999999999999999986433221


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......+++.|+||
T Consensus       159 --~~~~~~~~~~y~aP  172 (291)
T cd07870         159 --TYSSEVVTLWYRPP  172 (291)
T ss_pred             --CCCCccccccccCC
Confidence              12234578889998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.93  E-value=5.3e-25  Score=203.05  Aligned_cols=155  Identities=26%  Similarity=0.453  Sum_probs=133.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|.+            .+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999965 6889999853            4599999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +.+ +|.+++......+++.....++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--K  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--c
Confidence            985 999998766567888899999999999999999   8999999999999999999999999999987543221  1


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......++..|+||
T Consensus       159 ~~~~~~~~~~~~aP  172 (291)
T cd07844         159 TYSNEVVTLWYRPP  172 (291)
T ss_pred             cccccccccccCCc
Confidence            12223467888887

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.93  E-value=9.6e-26  Score=203.94  Aligned_cols=153  Identities=35%  Similarity=0.579  Sum_probs=131.7

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      |+..+.||+|+||.||+++.. +++.||+|.+             ..|+.++++++||||+++++++..++..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            345688999999999999965 5668999843             23888999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|.+++.. ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--EN  154 (260)
T ss_dssp             TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SE
T ss_pred             ccccccccccc-cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc--cc
Confidence            99999999972 345789999999999999999999   8899999999999999999999999999998642221  23


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....+|..|+||
T Consensus       155 ~~~~~~~~~y~aP  167 (260)
T PF00069_consen  155 FNPFVGTPEYMAP  167 (260)
T ss_dssp             BSSSSSSGGGSCH
T ss_pred             ccccccccccccc
Confidence            3456789999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.93  E-value=4.3e-25  Score=202.80  Aligned_cols=157  Identities=29%  Similarity=0.514  Sum_probs=130.9

Q ss_pred             CCCCCCeeccCCCccEEEEEcc------CCcEEEeh-----------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ------DGMEFAIK-----------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK-----------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      +|...+.||+|+||.||++...      ++..+|+|           .+..|+++++.++||||+++++++...+..+++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV   85 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence            4667789999999999999632      35577876           356799999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEE
Q 040294          264 LEYMTNGSLEKVLYSSN--------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH  329 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~k  329 (360)
                      |||+++|+|.+++....              ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+|
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~k  162 (280)
T cd05092          86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVK  162 (280)
T ss_pred             EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEE
Confidence            99999999999987542              24788899999999999999999   89999999999999999999999


Q ss_pred             EeecccccccCCCCCceeeecccccCcccCC
Q 040294          330 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       330 i~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+|||+++...............+++.|+||
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  193 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCH
Confidence            9999999866433221112233457789988

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.93  E-value=5.7e-25  Score=199.59  Aligned_cols=156  Identities=28%  Similarity=0.511  Sum_probs=130.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|.....||+|+||.||+|....+..+|+|.          +..|++++++++|||++++++++.. +..++||||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence            34777889999999999999987777888873          4569999999999999999998864 567899999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      |+|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++....... ...
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~  160 (260)
T cd05069          85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TAR  160 (260)
T ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-ccc
Confidence            99999997543 34788999999999999999999   89999999999999999999999999999987643221 111


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|+||
T Consensus       161 ~~~~~~~~y~~P  172 (260)
T cd05069         161 QGAKFPIKWTAP  172 (260)
T ss_pred             CCCccchhhCCH
Confidence            223466789887

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.93  E-value=4.7e-25  Score=206.01  Aligned_cols=158  Identities=28%  Similarity=0.480  Sum_probs=129.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc--------CCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNED  258 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~  258 (360)
                      ++|...+.||+|+||.||+++..        ....+|+|.            +..|+++++++ +||||++++++|..++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46778899999999999999742        245688863            44688999999 6999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec
Q 040294          259 FRALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD  323 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~  323 (360)
                      ..++||||+++|+|.+++....               ..+++.+...++.|++.||+|||   +.+|+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            9999999999999999996532               24788889999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          324 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       324 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++.+||+|||+++...............++..||||
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP  205 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCH
Confidence            9999999999999876432211111122345679987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.93  E-value=7.4e-25  Score=199.98  Aligned_cols=156  Identities=30%  Similarity=0.471  Sum_probs=132.7

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh---------------------hHHHHHHhhcCCCCCeeEEEEEecCCC
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS---------------------FDVECEVMKSIHHRNLVKIISSCSNED  258 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~---------------------~~~E~~~l~~l~hpniv~l~~~~~~~~  258 (360)
                      .|...+.||+|+||.||+|... +++.+|+|.                     +..|++++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3567789999999999999854 688899984                     345888999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            999999999999999999765 45788888999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..............|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~P  179 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAP  179 (272)
T ss_pred             ccccccccccccccCCccccCH
Confidence            5432211112334578889887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.93  E-value=2.3e-25  Score=202.84  Aligned_cols=155  Identities=32%  Similarity=0.429  Sum_probs=133.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ++|+..+.||+|+||.||+|+. .+++.||+|.           +.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            3566678899999999999985 4688899974           346889999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|.+++...+ .+++.+...++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||++.......  ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence            9999999986543 5788899999999999999999   8899999999999999999999999999987654321  12


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....|++.|+||
T Consensus       163 ~~~~~~~~~y~aP  175 (267)
T cd06645         163 RKSFIGTPYWMAP  175 (267)
T ss_pred             cccccCcccccCh
Confidence            2345689999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.93  E-value=2.4e-25  Score=203.12  Aligned_cols=158  Identities=30%  Similarity=0.434  Sum_probs=133.2

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcC-CCCCeeEEEEEecCC------Ce
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSI-HHRNLVKIISSCSNE------DF  259 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l-~hpniv~l~~~~~~~------~~  259 (360)
                      +++.|+..+.||+|+||.||+|+.. +++.||+|.          +..|++++.++ +||||++++++|...      ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            4556788889999999999999864 678899975          45688888888 699999999998753      46


Q ss_pred             EEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      .++||||+++|+|.+++... ...+++.....++.|++.|++|||   +.+|+|||+||+||++++++.+||+|||+++.
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            89999999999999998764 345888899999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....  .......|++.|+||
T Consensus       161 ~~~~~--~~~~~~~g~~~y~aP  180 (272)
T cd06637         161 LDRTV--GRRNTFIGTPYWMAP  180 (272)
T ss_pred             ccccc--ccCCcccccccccCH
Confidence            54322  122345689999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=4.8e-25  Score=199.42  Aligned_cols=145  Identities=26%  Similarity=0.456  Sum_probs=122.8

Q ss_pred             CeeccCCCccEEEEEccCCc-----------EEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          206 NLIGRGSFGSVYKARLQDGM-----------EFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~-----------~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      +.||+|+||.||+|...+..           .+++|.          |..|++++++++||||+++++++.. +..++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            36899999999999975432           466653          4568899999999999999999988 7789999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-------cEEEeeccccc
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-------VAHLSDFGIAK  337 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-------~~ki~DFGla~  337 (360)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++       .+||+|||++.
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            999999999999876557889999999999999999999   89999999999999999887       79999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....      ....++..|+||
T Consensus       157 ~~~~~------~~~~~~~~y~aP  173 (259)
T cd05037         157 TVLSR------EERVERIPWIAP  173 (259)
T ss_pred             ccccc------cccccCCCccCh
Confidence            75431      123466678887

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=4.8e-25  Score=199.87  Aligned_cols=158  Identities=30%  Similarity=0.549  Sum_probs=134.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .++|...+.||+|+||.||+|..++++.+|||.          +..|++++++++||||+++++++..+...++||||++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            357888899999999999999988788899974          4579999999999999999999999899999999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          269 NGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       269 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +++|.+++.... ..+++.++..++.|++.|++|||   +.+++|+||||+||++++++.+|++|||+++.+..... ..
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~  160 (261)
T cd05034          85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TA  160 (261)
T ss_pred             CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-hh
Confidence            999999997643 46889999999999999999999   88999999999999999999999999999987643211 11


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....++..|+||
T Consensus       161 ~~~~~~~~~y~~P  173 (261)
T cd05034         161 REGAKFPIKWTAP  173 (261)
T ss_pred             hhccCCCccccCH
Confidence            1122345678876

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=3e-25  Score=209.90  Aligned_cols=153  Identities=27%  Similarity=0.402  Sum_probs=130.8

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC-----
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE-----  257 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~-----  257 (360)
                      ...++|...+.||+|+||.||+|.. .+++.||||.+             .+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999985 47889999843             3589999999999999999987543     


Q ss_pred             -CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          258 -DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       258 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                       ...++++|++ +++|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence             3578999998 7899888754  35888899999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCceeeecccccCcccCC
Q 040294          337 KLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.....     .....||+.|+||
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aP  184 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAP  184 (343)
T ss_pred             eecCCC-----cCCccccccccCc
Confidence            876432     2345689999998

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.92  E-value=4e-25  Score=210.40  Aligned_cols=152  Identities=27%  Similarity=0.381  Sum_probs=127.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED------  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~------  258 (360)
                      .++|+..+.||+|+||.||+++. .++..||+|.+             .+|+.+++.++||||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46789999999999999999986 46889999854             35889999999999999999986543      


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..++||||+++ +|.+.+..   .+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence            57999999975 56666543   3677888889999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....   ......||+.|+||
T Consensus       173 ~~~~~---~~~~~~~t~~y~aP  191 (359)
T cd07876         173 ACTNF---MMTPYVVTRYYRAP  191 (359)
T ss_pred             cccCc---cCCCCcccCCCCCc
Confidence            53221   22345789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.92  E-value=6.8e-25  Score=201.46  Aligned_cols=154  Identities=29%  Similarity=0.444  Sum_probs=131.5

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||+|+.. ++..||+|.             +..|++++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999864 788999974             34689999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          267 MTNGSLEKVLYSSN--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       267 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ++ ++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 68888876432  45889999999999999999999   8999999999999999999999999999998654322 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       .......+++.|+||
T Consensus       156 -~~~~~~~~~~~y~aP  170 (285)
T cd07861         156 -RVYTHEVVTLWYRAP  170 (285)
T ss_pred             -ccccCCcccccccCh
Confidence             112234678889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.92  E-value=8.6e-25  Score=198.78  Aligned_cols=156  Identities=26%  Similarity=0.461  Sum_probs=133.4

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehh-----------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKS-----------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-----------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      +|...+.||+|+||.||+|...+++.+|+|.                 +..|++++++++|+||++++++|.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            3677889999999999999988888999983                 34588999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++++|.+++.... .+++.....++.|++.||+|||   +.+|+|+||+|+||++++++.+||+|||+++......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997543 5778888899999999999999   8899999999999999999999999999998653211


Q ss_pred             C----ceeeecccccCcccCC
Q 040294          344 Q----SMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~----~~~~~~~~gt~~Y~aP  360 (360)
                      .    ........|+..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~p  177 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAP  177 (265)
T ss_pred             ccccccccccccCCCccccCh
Confidence            0    1112234688899988

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.92  E-value=8.4e-25  Score=197.73  Aligned_cols=155  Identities=23%  Similarity=0.396  Sum_probs=133.2

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +|+..+.||+|+||.||++... +++.+|+|.            +..|+.+++.++||||+++++++.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677899999999999999864 688899874            345888999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          268 TNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       268 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++|+|.+++... ...+++.....++.|++.||.|||   +.+|+|+||||+||++++++.++++|||.+........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999988653 345788888999999999999999   89999999999999999999999999999987643321  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......|++.|+||
T Consensus       156 ~~~~~~~~~~~~aP  169 (255)
T cd08219         156 YACTYVGTPYYVPP  169 (255)
T ss_pred             ccccccCCccccCH
Confidence            12235688889987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.92  E-value=9.7e-25  Score=198.30  Aligned_cols=156  Identities=29%  Similarity=0.488  Sum_probs=135.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|... +++.||+|.              +.+|++++++++|+|++++++++..++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999976 889999973              345889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ||+++|+|.+++..   ....+++.++..++.+++.|++|||   +.+|+||||||+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998863   2345788899999999999999999   89999999999999999999999999999886543


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...  ......|++.|+||
T Consensus       159 ~~~--~~~~~~~~~~y~ap  175 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSP  175 (267)
T ss_pred             CCc--ccceecCCccccCH
Confidence            221  12234688889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.92  E-value=5.6e-25  Score=201.73  Aligned_cols=159  Identities=21%  Similarity=0.396  Sum_probs=133.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccC-----CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecC-CCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQD-----GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSN-EDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~-~~~~  260 (360)
                      .++|...++||+|+||.||+|....     +..||+|.            +..|+.++++++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4578888999999999999999765     67788873            4568899999999999999998766 4678


Q ss_pred             EEEEEccCCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeec
Q 040294          261 ALVLEYMTNGSLEKVLYSSN-------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDF  333 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DF  333 (360)
                      ++++||+++|+|.+++....       ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            99999999999999986532       35889999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCceeeecccccCcccCC
Q 040294          334 GIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       334 Gla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+++.+.............++..|+||
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~ap  188 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMAL  188 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCH
Confidence            999876544322222233467789887

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.92  E-value=5.9e-25  Score=200.96  Aligned_cols=157  Identities=21%  Similarity=0.437  Sum_probs=131.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      ++|+..+.||+|+||.||+|+.+      +.+.+|+|.            +..|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46788899999999999999864      245688863            456899999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeec
Q 040294          262 LVLEYMTNGSLEKVLYSSN--------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDF  333 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DF  333 (360)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997543        15789999999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCCceeeecccccCcccCC
Q 040294          334 GIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       334 Gla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+++...... ........++..|+||
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~P  187 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAP  187 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecCh
Confidence            9987643322 1122234567778887

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.92  E-value=9.5e-25  Score=203.81  Aligned_cols=152  Identities=24%  Similarity=0.433  Sum_probs=123.2

Q ss_pred             CCeeccCCCccEEEEEcc---CCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEec--CCCeEEEEEEccCCC
Q 040294          205 NNLIGRGSFGSVYKARLQ---DGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCS--NEDFRALVLEYMTNG  270 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~lv~e~~~~g  270 (360)
                      ...||+|+||.||+|+.+   ++..||+|.         +.+|++++++++||||+++++++.  .+...++||||+++ 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            357999999999999865   456899884         457999999999999999999885  35578999999975 


Q ss_pred             CHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee----cCCCcEEEeecccccc
Q 040294          271 SLEKVLYSS--------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKL  338 (360)
Q Consensus       271 ~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl----~~~~~~ki~DFGla~~  338 (360)
                      +|.+++...        ...+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            777776421        124788888999999999999999   8999999999999999    4667999999999987


Q ss_pred             cCCCCCc-eeeecccccCcccCC
Q 040294          339 LTGEDQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~-~~~~~~~gt~~Y~aP  360 (360)
                      ....... .......||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             cCCCcccccccCcceecccccCc
Confidence            6543221 122345789999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.92  E-value=6.8e-25  Score=206.72  Aligned_cols=157  Identities=28%  Similarity=0.475  Sum_probs=129.0

Q ss_pred             CCCCCCeeccCCCccEEEEEcc--------CCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCe
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDF  259 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~  259 (360)
                      +|.+.+.||+|+||.||+|+..        ++..||+|.            +..|+++++++ +||||++++++|..++.
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   92 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence            5778899999999999999742        123678863            44688999999 79999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC
Q 040294          260 RALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD  324 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~  324 (360)
                      .+++|||+++|+|.+++....               ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.
T Consensus        93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~  169 (334)
T cd05100          93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcC
Confidence            999999999999999986432               24778889999999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          325 NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       325 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++.+||+|||+++...............++..||||
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP  205 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence            999999999999876433211111223345679988

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.92  E-value=4.2e-25  Score=200.94  Aligned_cols=156  Identities=28%  Similarity=0.504  Sum_probs=134.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+++. .++..+|||.              +..|+++++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999995 5788999983              345889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ||+++++|.+++..   ....+++.+...++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998863   2345788999999999999999999   89999999999999999999999999999887643


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...  ......|+..|+||
T Consensus       159 ~~~--~~~~~~~~~~~~ap  175 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSP  175 (267)
T ss_pred             CCc--ccccccCCcCccCH
Confidence            321  12234688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=3.6e-25  Score=200.79  Aligned_cols=146  Identities=26%  Similarity=0.406  Sum_probs=123.7

Q ss_pred             CeeccCCCccEEEEEccC--------CcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          206 NLIGRGSFGSVYKARLQD--------GMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +.||+|+||.||+|..+.        ...+|+|.           +..|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999998642        23467764           34588899999999999999999998999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc--------EEEeecccccc
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV--------AHLSDFGIAKL  338 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~--------~ki~DFGla~~  338 (360)
                      +++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876667899999999999999999999   899999999999999987765        69999999876


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....      ....+++.|+||
T Consensus       158 ~~~~------~~~~~~~~y~aP  173 (258)
T cd05078         158 VLPK------EILLERIPWVPP  173 (258)
T ss_pred             cCCc------hhccccCCccCc
Confidence            5322      234578889988

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.92  E-value=1.2e-24  Score=197.99  Aligned_cols=157  Identities=27%  Similarity=0.401  Sum_probs=131.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------------hHHHHHHhhcCCCCCeeEEEEEecCC--CeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------------FDVECEVMKSIHHRNLVKIISSCSNE--DFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------------~~~E~~~l~~l~hpniv~l~~~~~~~--~~~  260 (360)
                      ++|+..+.||+|+||.||+++.. ++..||+|.                +..|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999864 688999974                23488999999999999999998764  468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||+++++|.+++.... .+++.....++.|++.||+|||   +.+|+|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987543 4678888999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCCc-eeeecccccCcccCC
Q 040294          341 GEDQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~-~~~~~~~gt~~Y~aP  360 (360)
                      ..... .......|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSP  178 (265)
T ss_pred             cccccccccccCCCCccccCh
Confidence            32111 112234688999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=8.6e-25  Score=200.77  Aligned_cols=155  Identities=30%  Similarity=0.453  Sum_probs=135.2

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||+|+.. +++.||+|.             +..|++++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999964 788999874             34689999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      + +++|.+++......+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999999766667899999999999999999999   89999999999999999999999999999987654321 1


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......|+.+|+||
T Consensus       156 ~~~~~~~~~~y~aP  169 (286)
T cd07832         156 LYSHQVATRWYRAP  169 (286)
T ss_pred             ccccccCcccccCc
Confidence            12335688999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.92  E-value=7.9e-25  Score=202.82  Aligned_cols=155  Identities=30%  Similarity=0.553  Sum_probs=126.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCc--EEEeh------------hhHHHHHHhhcC-CCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGM--EFAIK------------SFDVECEVMKSI-HHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK------------~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..++||+|+||.||+|..+ ++.  .+|+|            .+..|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46888899999999999999865 333  35654            245688999999 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcE
Q 040294          264 LEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVA  328 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~  328 (360)
                      |||+++|+|.+++....               ..+++.....++.|++.||+|||   +.+|+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999996532               24788889999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeecccccCcccCC
Q 040294          329 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       329 ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|||++......   ........+..|+||
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aP  187 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAI  187 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCc
Confidence            99999998743211   111112234568887

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.4e-24  Score=195.74  Aligned_cols=152  Identities=33%  Similarity=0.545  Sum_probs=128.5

Q ss_pred             CeeccCCCccEEEEEccCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHH
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLE  273 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  273 (360)
                      ++||+|+||.||++...+++.||+|.            +..|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36899999999999977789999973            456899999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccc
Q 040294          274 KVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA  353 (360)
Q Consensus       274 ~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~g  353 (360)
                      +++......+++.....++.+++.|++|||   +.+++||||||+||+++.++.+||+|||+++...............+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999765556788899999999999999999   89999999999999999999999999999986542221111111223


Q ss_pred             cCcccCC
Q 040294          354 TIGYMAP  360 (360)
Q Consensus       354 t~~Y~aP  360 (360)
                      +..|+||
T Consensus       158 ~~~y~~P  164 (251)
T cd05041         158 PIKWTAP  164 (251)
T ss_pred             eeccCCh
Confidence            5568877

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.7e-25  Score=215.49  Aligned_cols=150  Identities=32%  Similarity=0.504  Sum_probs=130.9

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhh-----------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHH
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSF-----------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLE  273 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~-----------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  273 (360)
                      -++|+|.||+||.|+.. +...+|||.+           ..|+.+.+.++|.|||+++|.|..+++.-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            47999999999999965 5567899865           45899999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec-CCCcEEEeecccccccCCCCCceeeec
Q 040294          274 KVLYSSNCIL--DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQ  350 (360)
Q Consensus       274 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~-~~~~~ki~DFGla~~~~~~~~~~~~~~  350 (360)
                      ++|...=+.+  .+.+.-.+..||++||.|||   ...|+|||||-.|||++ -.|.+||+|||.+|.+.+-..  ...+
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc--cccc
Confidence            9998654444  56677788999999999999   89999999999999997 579999999999999876542  3345


Q ss_pred             ccccCcccCC
Q 040294          351 TLATIGYMAP  360 (360)
Q Consensus       351 ~~gt~~Y~aP  360 (360)
                      +.||+.||||
T Consensus       736 FTGTLQYMAP  745 (1226)
T KOG4279|consen  736 FTGTLQYMAP  745 (1226)
T ss_pred             cccchhhhCh
Confidence            7799999998

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=4.6e-25  Score=202.95  Aligned_cols=155  Identities=28%  Similarity=0.422  Sum_probs=132.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||+|+||.||+++.. ++..||+|.            +.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35777889999999999999975 788999873            34588999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          267 MTNGSLEKVLYSS--NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       267 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      +++++|..++...  ...+++.....++.|++.||.|||.  ..+|+||||||+||+++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999999988754  2368899999999999999999993  2589999999999999999999999999998653221 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         .....|++.|+||
T Consensus       158 ---~~~~~~~~~y~aP  170 (286)
T cd06622         158 ---AKTNIGCQSYMAP  170 (286)
T ss_pred             ---cccCCCccCccCc
Confidence               1234578889888

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.92  E-value=1.2e-24  Score=197.00  Aligned_cols=152  Identities=32%  Similarity=0.489  Sum_probs=128.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEec-CCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCS-NEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~~  269 (360)
                      ++|...+.||+|+||.||++... +..+|+|.         +..|+.++++++|||++++++++. .++..++||||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            36788899999999999999765 67788873         557999999999999999999764 55678999999999


Q ss_pred             CCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      ++|.+++..... .+++.....++.|++.||+|||   +.+|+||||||+||++++++.+|++|||+++......     
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----  156 (256)
T cd05082          85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----  156 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence            999999976443 4788899999999999999999   8999999999999999999999999999988654322     


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|+||
T Consensus       157 ~~~~~~~~y~aP  168 (256)
T cd05082         157 DTGKLPVKWTAP  168 (256)
T ss_pred             CCCccceeecCH
Confidence            122345678887

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.92  E-value=9.6e-25  Score=202.38  Aligned_cols=154  Identities=32%  Similarity=0.454  Sum_probs=134.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .+|+..+.||+|+||.||++.. .+++.||+|.           +..|+.+++.++||||++++++|..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            4688889999999999999985 5789999984           346889999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|.+++...  .+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~  171 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--C
Confidence            999999998653  4788889999999999999999   89999999999999999999999999999987654321  1


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....+++.|+||
T Consensus       172 ~~~~~~~~~y~aP  184 (297)
T cd06656         172 RSTMVGTPYWMAP  184 (297)
T ss_pred             cCcccCCccccCH
Confidence            2234688889887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.5e-24  Score=196.20  Aligned_cols=152  Identities=32%  Similarity=0.553  Sum_probs=131.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|... ++.||+|.          +..|+.++++++||||+++++++...+..++||||+++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            46788899999999999999875 78899874          45688999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      ++|.+++.... ..+++.....++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||.++.......    
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----  157 (256)
T cd05039          85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----  157 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence            99999997654 25889999999999999999999   89999999999999999999999999999987632221    


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                       ...++..|+||
T Consensus       158 -~~~~~~~~~ap  168 (256)
T cd05039         158 -SGKLPVKWTAP  168 (256)
T ss_pred             -cCCCcccccCc
Confidence             22345567776

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.92  E-value=9.4e-25  Score=202.33  Aligned_cols=154  Identities=32%  Similarity=0.457  Sum_probs=133.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ..|+..+.||+|+||.||+|.. .+++.||+|.           +..|+.+++.++||||+++++.|..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            3677888999999999999985 4788999873           346889999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|.+++...  .+++.+...++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||++........  .
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~  172 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence            999999998643  4788899999999999999999   89999999999999999999999999999887543321  1


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....|++.|+||
T Consensus       173 ~~~~~~~~~y~aP  185 (296)
T cd06654         173 RSTMVGTPYWMAP  185 (296)
T ss_pred             cCcccCCccccCH
Confidence            2234688999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.92  E-value=1.1e-24  Score=200.61  Aligned_cols=153  Identities=31%  Similarity=0.493  Sum_probs=126.5

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcC---CCCCeeEEEEEecC-----CC
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSI---HHRNLVKIISSCSN-----ED  258 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l---~hpniv~l~~~~~~-----~~  258 (360)
                      .|+..+.||+|+||.||+|+.. +++.||+|.+             ..|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            3777889999999999999865 7889999843             3477766654   79999999998864     34


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            58999999985 8988886543 34788999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ......   ......||+.|+||
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aP  176 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAP  176 (288)
T ss_pred             cccCcc---cCCCccccccccCc
Confidence            764322   12335689999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.92  E-value=9.6e-25  Score=199.14  Aligned_cols=156  Identities=28%  Similarity=0.465  Sum_probs=129.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC----CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD----GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|...+.||+|+||.||+|...+    ...||||.            +..|+.++++++||||+++++++.++ ..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEE
Confidence            357778899999999999998643    24578763            45699999999999999999998764 57899


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+|++|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999876556899999999999999999999   8999999999999999999999999999998765432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      . .......++..|+||
T Consensus       162 ~-~~~~~~~~~~~y~aP  177 (270)
T cd05056         162 Y-YKASKGKLPIKWMAP  177 (270)
T ss_pred             c-eecCCCCccccccCh
Confidence            1 111223345678887

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=5.9e-25  Score=206.91  Aligned_cols=148  Identities=21%  Similarity=0.274  Sum_probs=117.4

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc--CCcEEEehh----------------hHHHHHHhhcCCCCCeeE-EEEEecCCC
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ--DGMEFAIKS----------------FDVECEVMKSIHHRNLVK-IISSCSNED  258 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~----------------~~~E~~~l~~l~hpniv~-l~~~~~~~~  258 (360)
                      ..++|...+.||+|+||+||+|+++  +++.+|||.                |.+|++++++++|+|++. ++++    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            4567999999999999999999864  577789974                467999999999999985 5442    3


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccC-CCCceeecCCCcEEEeeccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL-KPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdl-k~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ..++||||++|++|... ...    .   ...++.++++||+|||   +.+|+|||| ||+|||++.++.+||+|||+|+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            47999999999999732 111    1   1457889999999999   899999999 9999999999999999999999


Q ss_pred             ccCCCCCcee------eecccccCcccCC
Q 040294          338 LLTGEDQSMT------QTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~------~~~~~gt~~Y~aP  360 (360)
                      .+........      .+...+++.|+||
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~p  189 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAP  189 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCc
Confidence            7654321111      1345678888887

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.92  E-value=1.1e-24  Score=197.66  Aligned_cols=156  Identities=24%  Similarity=0.486  Sum_probs=132.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||++...++..+|+|.          +.+|++++++++|+||+++++++.. ...+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~   84 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK   84 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence            46788899999999999999987777899873          4569999999999999999999988 678999999999


Q ss_pred             CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      |+|.+++... ....++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||.+........ ...
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~  160 (260)
T cd05073          85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAR  160 (260)
T ss_pred             CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccc
Confidence            9999999763 345788889999999999999999   88999999999999999999999999999987643221 111


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|+||
T Consensus       161 ~~~~~~~~y~~P  172 (260)
T cd05073         161 EGAKFPIKWTAP  172 (260)
T ss_pred             cCCcccccccCH
Confidence            223456778887

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.92  E-value=1.4e-24  Score=199.32  Aligned_cols=155  Identities=31%  Similarity=0.435  Sum_probs=132.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|.             +..|++++++++|||++++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46788899999999999999975 688899873             3468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |++++.|..+.... ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++..+..... 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            99999888876543 35889999999999999999999   89999999999999999999999999999987654321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......++..|+||
T Consensus       156 -~~~~~~~~~~~~aP  169 (286)
T cd07847         156 -DYTDYVATRWYRAP  169 (286)
T ss_pred             -cccCcccccccCCH
Confidence             11234577788887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.92  E-value=1.3e-24  Score=197.25  Aligned_cols=152  Identities=28%  Similarity=0.503  Sum_probs=123.7

Q ss_pred             CeeccCCCccEEEEEcc----CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEec-CCCeEEEEEEccC
Q 040294          206 NLIGRGSFGSVYKARLQ----DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCS-NEDFRALVLEYMT  268 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~  268 (360)
                      +.||+|+||.||+|...    ++..+|+|.+            ..|+.+++.++||||+++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2356888743            35888999999999999999875 4556899999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc--e
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS--M  346 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~--~  346 (360)
                      +|+|.+++.......++.....++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++.+......  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999765555778888899999999999999   899999999999999999999999999999865432211  1


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......++..|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (262)
T cd05058         158 NHTGAKLPVKWMAL  171 (262)
T ss_pred             ccccCcCCccccCh
Confidence            11233467789987

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.3e-24  Score=196.80  Aligned_cols=156  Identities=33%  Similarity=0.450  Sum_probs=136.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ++|+..+.||+|+||.||+|... +++.+|+|.           +..|++++++++||||+++++++..++..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888899999999999999864 677888873           567899999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|.+++......+++.+...++.|++.|++|||   +.+|+|+||||+||++++++.+||+|||++........  .
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~  157 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K  157 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence            999999998776557889999999999999999999   89999999999999999999999999999987543221  1


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....++..|+||
T Consensus       158 ~~~~~~~~~y~~P  170 (262)
T cd06613         158 RKSFIGTPYWMAP  170 (262)
T ss_pred             cccccCCccccCc
Confidence            2235688889988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.92  E-value=1.7e-24  Score=201.29  Aligned_cols=135  Identities=30%  Similarity=0.480  Sum_probs=121.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+              ..|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888899999999999999865 5788998732              35888999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ||+++++|.+++... ..+++.....++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++.
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            999999999999765 35788888889999999999999   89999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.92  E-value=4.8e-25  Score=209.49  Aligned_cols=153  Identities=27%  Similarity=0.366  Sum_probs=128.0

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC------
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE------  257 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~------  257 (360)
                      ..++|...+.||+|+||.||+++.. +++.||||.+             .+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999854 6888999843             3588899999999999999988643      


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ...++||||+++ ++.+.+..   .+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            357999999975 66666643   3778888899999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ......   ......||+.|+||
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aP  187 (355)
T cd07874         168 TAGTSF---MMTPYVVTRYYRAP  187 (355)
T ss_pred             cCCCcc---ccCCccccCCccCH
Confidence            654321   22345789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.92  E-value=7.6e-25  Score=225.67  Aligned_cols=160  Identities=26%  Similarity=0.429  Sum_probs=131.0

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC--CCeEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN--EDFRA  261 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~  261 (360)
                      ..++|.+.+.||+|+||.||+|+.. ++..||+|.             |..|+.++++++|||||+++++|..  .+..|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4568999999999999999999965 567788763             4569999999999999999998854  45789


Q ss_pred             EEEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcC----CCCeEEccCCCCceeecCC---------
Q 040294          262 LVLEYMTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGF----STPIIHCDLKPHNVLLDDN---------  325 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~----~~~iiHrdlk~~NiLl~~~---------  325 (360)
                      |||||+++|+|.+++...   ...+++..++.|+.||+.||+|||...    ..+|+||||||+|||++.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999998642   245889999999999999999999321    1569999999999999642         


Q ss_pred             --------CcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          326 --------IVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       326 --------~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                              ..+||+|||+++.+....   ......||+.||||
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAP  210 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSP  210 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCH
Confidence                    358999999998764322   12345799999998

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.92  E-value=6.4e-25  Score=201.66  Aligned_cols=154  Identities=28%  Similarity=0.442  Sum_probs=132.4

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||+|+.. +|+.||+|.+             ..|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            3677789999999999999965 6888998743             4699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++ ++|.+++......+++.....++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            97 5888888765566899999999999999999999   89999999999999999999999999999986543221  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......+++.|+||
T Consensus       155 ~~~~~~~~~~y~aP  168 (284)
T cd07839         155 CYSAEVVTLWYRPP  168 (284)
T ss_pred             CcCCCccccCCcCh
Confidence            12234578899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.92  E-value=1.7e-24  Score=196.95  Aligned_cols=155  Identities=32%  Similarity=0.506  Sum_probs=131.8

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------------hHHHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------------FDVECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      |...+.||+|+||.||+|... +++.+|+|.                    +..|++++++++||||+++++++..++..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            567789999999999999864 678899873                    34688999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||+++++|.+++... ..+++.....++.|++.||+|||   +.+++||||+|+||++++++.+||+|||.++.+.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            9999999999999999754 45788888899999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCc----eeeecccccCcccCC
Q 040294          341 GEDQS----MTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~----~~~~~~~gt~~Y~aP  360 (360)
                      .....    .......|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~p  181 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAP  181 (267)
T ss_pred             cccccCCccccccccCCCcCccCh
Confidence            32111    111234588889987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.92  E-value=1.8e-24  Score=195.37  Aligned_cols=156  Identities=33%  Similarity=0.445  Sum_probs=137.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC-CcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|...+ +..+|+|.         +.+|++++++++||||+++++++..+...++++||+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            578888999999999999999764 78899873         56789999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      ++|.+++......+++.....++.|++.|+.|||   ..+++|||++|+||+++.++.+||+|||++........  ...
T Consensus        83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~  157 (256)
T cd06612          83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRN  157 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccc
Confidence            9999999876667899999999999999999999   88999999999999999999999999999987654321  122


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...|+..|+||
T Consensus       158 ~~~~~~~y~~P  168 (256)
T cd06612         158 TVIGTPFWMAP  168 (256)
T ss_pred             cccCCccccCH
Confidence            34578899987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.92  E-value=2.7e-24  Score=195.85  Aligned_cols=157  Identities=27%  Similarity=0.420  Sum_probs=131.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------------hHHHHHHhhcCCCCCeeEEEEEecC--CCeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------------FDVECEVMKSIHHRNLVKIISSCSN--EDFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------------~~~E~~~l~~l~hpniv~l~~~~~~--~~~~  260 (360)
                      .+|...++||+|+||.||+|... ++..||+|.                +.+|++++++++||||+++++++..  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999864 688898873                3458889999999999999999875  3578


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      +++|||+++++|.+++.... .+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999997543 4788888899999999999999   8999999999999999999999999999998654


Q ss_pred             CCCC-ceeeecccccCcccCC
Q 040294          341 GEDQ-SMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~-~~~~~~~~gt~~Y~aP  360 (360)
                      .... ........++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSP  178 (266)
T ss_pred             cccccCCccccCCccccccCH
Confidence            3211 1112234588899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.92  E-value=1.7e-24  Score=195.52  Aligned_cols=153  Identities=32%  Similarity=0.453  Sum_probs=132.9

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      +|+..+.||+|+||.||+|... ++..||+|.                +..|++++++++||||+++++++..++..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999975 788898872                45688999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++++|.+++... ..+++..+..++.|++.|++|||   +.+|+|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            9999999999998754 35788889999999999999999   8999999999999999999999999999988754332


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                         ......|+..|+||
T Consensus       157 ---~~~~~~~~~~y~~p  170 (258)
T cd06632         157 ---FAKSFKGSPYWMAP  170 (258)
T ss_pred             ---cccccCCCcceeCH
Confidence               12345688889887

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.92  E-value=9.6e-25  Score=208.20  Aligned_cols=153  Identities=27%  Similarity=0.358  Sum_probs=128.3

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC------
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE------  257 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~------  257 (360)
                      ..++|...+.||+|+||.||+++.. +++.||||.+             .+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3567999999999999999999854 6888999854             3588899999999999999987644      


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ...++||||+++ +|.+.+..   .+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999975 67776643   3678888899999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ......   ......||+.|+||
T Consensus       175 ~~~~~~---~~~~~~~t~~y~aP  194 (364)
T cd07875         175 TAGTSF---MMTPYVVTRYYRAP  194 (364)
T ss_pred             ccCCCC---cccCCcccCCcCCH
Confidence            754321   22345789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.92  E-value=1.6e-24  Score=195.94  Aligned_cols=151  Identities=26%  Similarity=0.431  Sum_probs=127.2

Q ss_pred             CeeccCCCccEEEEEccC--C--cEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQD--G--MEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~--~--~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|.+.+  +  ..||||.            +..|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  2  2588863            4568999999999999999999988 889999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce-e
Q 040294          270 GSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM-T  347 (360)
Q Consensus       270 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~-~  347 (360)
                      |+|.+++.... ..+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.+....... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997654 46889999999999999999999   8999999999999999999999999999998865432111 1


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....++..|+||
T Consensus       157 ~~~~~~~~~y~~p  169 (257)
T cd05040         157 EEHLKVPFAWCAP  169 (257)
T ss_pred             ccCCCCCceecCH
Confidence            1234577889987

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.92  E-value=1.4e-24  Score=200.96  Aligned_cols=154  Identities=32%  Similarity=0.521  Sum_probs=132.6

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh----------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF----------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~----------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      +|+..+.||+|+||.||+|... +++.||||.+                ..|++++++++||||+++++++.+++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3677789999999999999864 6889999743                3588999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+ +|+|.+++......+++..+..++.|+++||+|||   +.+|+|+||||+||+++.++.+||+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 89999999765546899999999999999999999   8999999999999999999999999999998765432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ......+++.|+||
T Consensus       157 ~--~~~~~~~~~~y~aP  171 (298)
T cd07841         157 R--KMTHQVVTRWYRAP  171 (298)
T ss_pred             c--cccccccceeeeCH
Confidence            1  11223467788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.92  E-value=2.7e-24  Score=194.12  Aligned_cols=155  Identities=33%  Similarity=0.603  Sum_probs=131.6

Q ss_pred             CCCCCeeccCCCccEEEEEccC-----CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARLQD-----GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      |+..+.||.|+||.||+++...     +..||+|.            +..|+++++.++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3456889999999999998653     37788873            346889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      ||+++++|.+++...... +++.+...++.|++.|++|||   +.+++||||||+||++++++.++++|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999765444 899999999999999999999   8999999999999999999999999999998765442


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      ... .....+++.|+||
T Consensus       158 ~~~-~~~~~~~~~y~~P  173 (258)
T smart00219      158 YYK-KKGGKLPIRWMAP  173 (258)
T ss_pred             ccc-cccCCCcccccCh
Confidence            211 1123377889987

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.92  E-value=1.2e-24  Score=200.71  Aligned_cols=165  Identities=30%  Similarity=0.413  Sum_probs=136.9

Q ss_pred             CHHHHHHHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh----------HHHHHHhhcC-CCCCeeEEEEEecCC-
Q 040294          191 SYLELLRATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF----------DVECEVMKSI-HHRNLVKIISSCSNE-  257 (360)
Q Consensus       191 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~----------~~E~~~l~~l-~hpniv~l~~~~~~~-  257 (360)
                      +..++..++++|+..+.||+|+||.||++.. .+++.+|+|.+          ..|+.+++++ +|||+++++++|... 
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            3345556688899999999999999999986 46888998743          3588888888 799999999998753 


Q ss_pred             ----CeEEEEEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEE
Q 040294          258 ----DFRALVLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL  330 (360)
Q Consensus       258 ----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki  330 (360)
                          +..++||||+++|+|.++++.   ....+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEE
Confidence                358999999999999998863   2345788899999999999999999   889999999999999999999999


Q ss_pred             eecccccccCCCCCceeeecccccCcccCC
Q 040294          331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       331 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|||+++.+.....  ......|+..|+||
T Consensus       170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  197 (291)
T cd06639         170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAP  197 (291)
T ss_pred             eecccchhcccccc--cccCccCCccccCh
Confidence            99999987643221  12234688889988

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2e-25  Score=212.70  Aligned_cols=157  Identities=30%  Similarity=0.539  Sum_probs=136.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEeh----------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK----------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .+......||-|.||.||.|.|+ ..-.||||          .|.+|+.+|+.++|||+|+|+|+|..+...|||.|||.
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            34556788999999999999986 45678987          46789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          269 NGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       269 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +|+|.++|.+.+. .++....+.+|.||+.|++||.   .+.+|||||...|+|+.++..+||+|||+++++.++.++ .
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-A  422 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-A  422 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-c
Confidence            9999999987653 3566667889999999999999   999999999999999999999999999999999877643 2


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....-.+.|.||
T Consensus       423 HAGAKFPIKWTAP  435 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAP  435 (1157)
T ss_pred             ccCccCcccccCc
Confidence            3334456788887

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.1e-25  Score=207.59  Aligned_cols=154  Identities=26%  Similarity=0.378  Sum_probs=137.4

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      -|+..+.||+|.|++|.+|++- +|..||||.+             .+|+..|+-++|||||+||++...+..+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            4677788999999999999864 8999999854             4699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec-CCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~-~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      -.+|+|++++-+....+.+....+++.||+.|+.|+|   ...++||||||+||.+- +-|-+|++|||++-.+.+..  
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--  173 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence            9999999999887778888889999999999999999   88899999999999875 57899999999997766544  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ..++.||++.|-||
T Consensus       174 -kL~TsCGSLAYSAP  187 (864)
T KOG4717|consen  174 -KLTTSCGSLAYSAP  187 (864)
T ss_pred             -hhhcccchhhccCc
Confidence             24567999999998

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.92  E-value=2.8e-24  Score=194.73  Aligned_cols=149  Identities=28%  Similarity=0.447  Sum_probs=123.8

Q ss_pred             eeccCCCccEEEEEc---cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          207 LIGRGSFGSVYKARL---QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       207 ~iG~G~~g~Vy~~~~---~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      .||+|+||.||+|.+   .++..+|+|.             +..|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999964   3577899874             3468899999999999999999865 4568999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce-eee
Q 040294          271 SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM-TQT  349 (360)
Q Consensus       271 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~-~~~  349 (360)
                      +|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.+....... ...
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999999654 35788899999999999999999   8999999999999999999999999999998765433211 112


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...+++.|+||
T Consensus       157 ~~~~~~~y~aP  167 (257)
T cd05116         157 HGKWPVKWYAP  167 (257)
T ss_pred             CCCCCccccCH
Confidence            22346789987

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.92  E-value=1.6e-24  Score=200.13  Aligned_cols=155  Identities=27%  Similarity=0.419  Sum_probs=133.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC--CeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE--DFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv  263 (360)
                      ++|+..+.||+|+||.||+|... +++.+|+|.+             .+|++++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999975 6788998743             4689999999999999999998877  889999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++ +|.+++......+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999974 999988765556899999999999999999999   8899999999999999999999999999998765432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ......+++.|+||
T Consensus       161 ~--~~~~~~~~~~~~aP  175 (293)
T cd07843         161 K--PYTQLVVTLWYRAP  175 (293)
T ss_pred             c--ccccccccccccCc
Confidence            1  12234578889998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.92  E-value=1.8e-24  Score=198.46  Aligned_cols=154  Identities=31%  Similarity=0.428  Sum_probs=127.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHH-hhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEV-MKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||.||+++.. +|+.||+|.+            ..|+.+ ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999865 6899999843            224443 566789999999999999999999999


Q ss_pred             ccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          266 YMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFST-PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       266 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~-~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      |++ |+|.+++..   ....+++.....++.|++.||+|||   +. +++||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 688877753   2345889999999999999999999   75 899999999999999999999999999987643


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..   ......|+..|+||
T Consensus       157 ~~---~~~~~~~~~~y~aP  172 (283)
T cd06617         157 SV---AKTIDAGCKPYMAP  172 (283)
T ss_pred             cc---ccccccCCccccCh
Confidence            21   12234578889987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.92  E-value=1.8e-24  Score=197.05  Aligned_cols=152  Identities=30%  Similarity=0.540  Sum_probs=125.3

Q ss_pred             CeeccCCCccEEEEEccC-------CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          206 NLIGRGSFGSVYKARLQD-------GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +.||+|+||.||+|+..+       +..+|+|.            +.+|+++++.++||||++++++|...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       24678774            34688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-----cEEEeeccc
Q 040294          267 MTNGSLEKVLYSS------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-----VAHLSDFGI  335 (360)
Q Consensus       267 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-----~~ki~DFGl  335 (360)
                      +++++|.+++...      ...+++.+++.++.|++.||+|||   +.+++|+||||+||+++.+.     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999742      234788899999999999999999   88999999999999999877     899999999


Q ss_pred             ccccCCCCCceeeecccccCcccCC
Q 040294          336 AKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       336 a~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++.+.............++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aP  182 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAP  182 (269)
T ss_pred             ccccccccccccCcccCCCccccCH
Confidence            9876433221122233456788887

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=2e-24  Score=202.90  Aligned_cols=153  Identities=21%  Similarity=0.299  Sum_probs=126.3

Q ss_pred             CCeeccC--CCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          205 NNLIGRG--SFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       205 ~~~iG~G--~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .++||+|  +|++||+++. .+|+.||+|.+             ..|+++++.++||||++++++|..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4679999  6789999986 47899999844             348889999999999999999999999999999999


Q ss_pred             CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce-
Q 040294          269 NGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM-  346 (360)
Q Consensus       269 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~-  346 (360)
                      +|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++|||.+.......... 
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            99999998653 235889999999999999999999   8999999999999999999999999998765432211100 


Q ss_pred             ----eeecccccCcccCC
Q 040294          347 ----TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ----~~~~~~gt~~Y~aP  360 (360)
                          ......++..|+||
T Consensus       160 ~~~~~~~~~~~~~~y~aP  177 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSP  177 (327)
T ss_pred             ccccccccccceecccCh
Confidence                01123467789988

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.92  E-value=2.4e-24  Score=198.65  Aligned_cols=155  Identities=29%  Similarity=0.406  Sum_probs=131.4

Q ss_pred             CCCCCCeeccCCCccEEEEEc----cCCcEEEehhh---------------HHHHHHhhcC-CCCCeeEEEEEecCCCeE
Q 040294          201 GFSANNLIGRGSFGSVYKARL----QDGMEFAIKSF---------------DVECEVMKSI-HHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~---------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~  260 (360)
                      +|+..+.||+|+||.||+++.    .+|..||+|.+               ..|+++++++ +||||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999999999985    36888999843               3488899999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||+++++|.+++... ..+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            9999999999999998754 35778888888999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .... .......|+..|+||
T Consensus       157 ~~~~-~~~~~~~~~~~y~aP  175 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAP  175 (290)
T ss_pred             cccc-cccccccCCcccCCh
Confidence            3321 112235688899988

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.92  E-value=2.8e-24  Score=196.25  Aligned_cols=149  Identities=34%  Similarity=0.593  Sum_probs=121.5

Q ss_pred             CeeccCCCccEEEEEcc-CCc--EEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGM--EFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~--~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++||+|+||.||+|+.+ ++.  .+|+|.            +..|++++.++ +||||++++++|...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999975 444  356653            34589999999 799999999999999999999999999


Q ss_pred             CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecc
Q 040294          270 GSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       270 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                      |+|.+++....               ..+++.+...++.|++.|++|||   +.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986432               24788899999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++......   .......+..|+||
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~ap  180 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAI  180 (270)
T ss_pred             Cccccchhh---hccCCCCccccCCh
Confidence            986422111   11112345678887

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=2.5e-24  Score=197.80  Aligned_cols=154  Identities=29%  Similarity=0.469  Sum_probs=126.3

Q ss_pred             CCCCCeeccCCCccEEEEEc-----cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCC--CeEEE
Q 040294          202 FSANNLIGRGSFGSVYKARL-----QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNE--DFRAL  262 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l  262 (360)
                      |+..+.||+|+||+||++..     .++..||+|.            +..|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            36778999999999988652     3577899874            34589999999999999999988653  46899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|.+++...  .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            99999999999999754  4899999999999999999999   899999999999999999999999999999876533


Q ss_pred             CCcee-eecccccCcccCC
Q 040294          343 DQSMT-QTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~-~~~~~gt~~Y~aP  360 (360)
                      ..... .....++..|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~P  179 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAV  179 (283)
T ss_pred             chhhccCCCCCCCceeeCH
Confidence            21111 1122355668887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.92  E-value=7.7e-25  Score=201.22  Aligned_cols=155  Identities=32%  Similarity=0.487  Sum_probs=133.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||.||+|..+ +++.||+|.+             ..|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36778899999999999999975 5889999843             468899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++++|..+.... ..+++.+...++.|++.||+|||   +.+|+|||++|+||++++++.++|+|||++..+..... 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            99999998876543 34889999999999999999999   88999999999999999999999999999987644321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......++..|+||
T Consensus       156 -~~~~~~~~~~y~aP  169 (286)
T cd07846         156 -VYTDYVATRWYRAP  169 (286)
T ss_pred             -ccCcccceeeccCc
Confidence             12234578889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.92  E-value=3.6e-24  Score=193.53  Aligned_cols=155  Identities=28%  Similarity=0.501  Sum_probs=131.7

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC-CCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN-EDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e  265 (360)
                      +|+..+.||+|+||.||+++.+ +++.||+|.             +..|++++++++|||++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999864 578899874             3458889999999999999998864 446899999


Q ss_pred             ccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          266 YMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |+++++|.+++... ...+++.++..++.+++.|++|||   +.+++||||||+||+++.++.++|+|||+++.+.....
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999763 345889999999999999999999   89999999999999999999999999999987643221


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......|++.|+||
T Consensus       158 --~~~~~~~~~~y~aP  171 (257)
T cd08223         158 --MASTLIGTPYYMSP  171 (257)
T ss_pred             --ccccccCCcCccCh
Confidence              22345688999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.92  E-value=3.4e-24  Score=196.47  Aligned_cols=157  Identities=29%  Similarity=0.501  Sum_probs=130.9

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-----CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecC--CCeEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-----DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSN--EDFRA  261 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~  261 (360)
                      .|...+.||+|+||.||++++.     ++..+|||.            |..|++++++++||||+++++++..  +...+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4666789999999999999853     367899973            4568899999999999999999887  55789


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||.+.....
T Consensus        85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            999999999999999876656899999999999999999999   89999999999999999999999999999987653


Q ss_pred             CCCcee-eecccccCcccCC
Q 040294          342 EDQSMT-QTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~-~~~~~gt~~Y~aP  360 (360)
                      ...... .....++..|+||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~P  181 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAP  181 (284)
T ss_pred             CCcceeccCCCCCcccccCc
Confidence            322111 1122345567776

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=9.6e-25  Score=216.46  Aligned_cols=157  Identities=22%  Similarity=0.298  Sum_probs=124.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCC--cEE------------------Eeh----------hhHHHHHHhhcCCCCCee
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDG--MEF------------------AIK----------SFDVECEVMKSIHHRNLV  248 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~--~~v------------------avK----------~~~~E~~~l~~l~hpniv  248 (360)
                      .++|++.+.||+|+||.||+|..+..  ..+                  +.|          .+.+|++++++++|||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            46899999999999999999865321  111                  111          356799999999999999


Q ss_pred             EEEEEecCCCeEEEEEEccCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC
Q 040294          249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSN----CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD  324 (360)
Q Consensus       249 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~  324 (360)
                      ++++++...+..|+|+|++. ++|.+++....    ......+...++.|++.||+|||   +.+|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence            99999999999999999995 57777765332    11234456779999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          325 NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       325 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++.+||+|||+++.+..... .......||+.|+||
T Consensus       303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aP  337 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSP  337 (501)
T ss_pred             CCCEEEEeCCCceecCcccc-cccccccCCcCCCCc
Confidence            99999999999987654321 122345799999998

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-25  Score=203.91  Aligned_cols=160  Identities=28%  Similarity=0.350  Sum_probs=134.3

Q ss_pred             HHHHHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhhHH--------------HHHHhhcC-CCCCeeEEEEEecCC
Q 040294          194 ELLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDV--------------ECEVMKSI-HHRNLVKIISSCSNE  257 (360)
Q Consensus       194 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------E~~~l~~l-~hpniv~l~~~~~~~  257 (360)
                      +..++ .+|....+||+|+||+|.+|..+ +...+|||.+++              |-++|+-. +-|.+|+++..|+.-
T Consensus       344 d~i~~-tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm  422 (683)
T KOG0696|consen  344 DRIKA-TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM  422 (683)
T ss_pred             cceee-cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence            33444 46888999999999999999876 456799986643              44555543 578999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      +++|+||||+.||+|.-+++.-+ .+.+..+..+|.+||-||-+||   +++||.||||..||++|.+|++||+|||+++
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccc
Confidence            99999999999999999887543 4667788889999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .---+.  .+..+.+|||.||||
T Consensus       499 Eni~~~--~TTkTFCGTPdYiAP  519 (683)
T KOG0696|consen  499 ENIFDG--VTTKTFCGTPDYIAP  519 (683)
T ss_pred             ccccCC--cceeeecCCCccccc
Confidence            743222  345578999999998

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=6.7e-25  Score=209.56  Aligned_cols=134  Identities=26%  Similarity=0.458  Sum_probs=119.8

Q ss_pred             CCCCCCCeeccCCCccEEEEE-ccCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .-|...+.||-|+||+|.+++ ..+...||.|.+              +.|-+||+.-+.+.||+|+..|++.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457788999999999999987 445667888743              45889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ||++||++..+|...+ .+++..+..++.++..|+++.|   ..++|||||||+|||||.+|++|++|||++.
T Consensus       709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccc
Confidence            9999999999997654 6777777788889999999999   9999999999999999999999999999984

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.92  E-value=2.6e-24  Score=199.41  Aligned_cols=153  Identities=33%  Similarity=0.480  Sum_probs=134.0

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      +|+..+.||.|+||.||+|.. .+++.||+|.           +..|+++++.++||||+++++++..++..++||||++
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   99 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA   99 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence            588889999999999999985 5788999974           3468999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      +++|.+++...  .+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++........  ..
T Consensus       100 ~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~  172 (296)
T cd06655         100 GGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KR  172 (296)
T ss_pred             CCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cC
Confidence            99999988643  4789999999999999999999   89999999999999999999999999999887654321  12


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....|+..|+||
T Consensus       173 ~~~~~~~~y~aP  184 (296)
T cd06655         173 STMVGTPYWMAP  184 (296)
T ss_pred             CCcCCCccccCc
Confidence            234688899998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.4e-24  Score=204.82  Aligned_cols=155  Identities=25%  Similarity=0.374  Sum_probs=138.5

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      .|++.+.||+||.+.||++...+.+.||+|.             |.+|++.|.+++ |.+||+|++|-..++.+|+||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            4777899999999999999998888999874             467999999997 99999999999999999999998


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      =+ -||.++|.......+...+..+..|++.++.++|   ..+|||.||||+|+|+.+ |.+||+|||+|..+..+....
T Consensus       442 Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  442 GD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             cc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccce
Confidence            64 5999999877665553367789999999999999   999999999999999984 789999999999999887777


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ...+.+||+.||+|
T Consensus       517 ~kdsQvGT~NYMsP  530 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSP  530 (677)
T ss_pred             eeccccCcccccCH
Confidence            77788999999998

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=2.8e-25  Score=197.27  Aligned_cols=161  Identities=25%  Similarity=0.462  Sum_probs=134.4

Q ss_pred             CHHHHHHHhCCCCCCCeeccCCCccEEEEE-ccCCcEEEehhhH-----------HHHHHhhcCC-CCCeeEEEEEecCC
Q 040294          191 SYLELLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFD-----------VECEVMKSIH-HRNLVKIISSCSNE  257 (360)
Q Consensus       191 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~-----------~E~~~l~~l~-hpniv~l~~~~~~~  257 (360)
                      ++.+..+-|+     ++||+|+|+.|-.+. ..+|.+||||.++           +|++++...+ |+||++|+++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            4566666653     679999999999887 6899999998653           5999999886 99999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC---CcEEEeecc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN---IVAHLSDFG  334 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~---~~~ki~DFG  334 (360)
                      ...|||||-|.||.|..+++.+. .+++..+.+++.+|+.||.|||   .++|.|||+||+|||-.+.   --+||+||-
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            99999999999999999998764 5778888899999999999999   9999999999999998654   358999998


Q ss_pred             cccccCCCC-----CceeeecccccCcccCC
Q 040294          335 IAKLLTGED-----QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~-----~~~~~~~~~gt~~Y~aP  360 (360)
                      +..-+.-..     .+....+.+|+..||||
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAP  255 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAP  255 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcch
Confidence            765432111     11123467899999998

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.91  E-value=2.1e-24  Score=201.11  Aligned_cols=156  Identities=28%  Similarity=0.508  Sum_probs=129.3

Q ss_pred             CCCCCCeeccCCCccEEEEEcc---CCcEEEehhhH--------------HHHHHhhcCCCCCeeEEEEEecCC--CeEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ---DGMEFAIKSFD--------------VECEVMKSIHHRNLVKIISSCSNE--DFRA  261 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~--------------~E~~~l~~l~hpniv~l~~~~~~~--~~~~  261 (360)
                      .|+..+.||+|+||.||+|...   ++..||+|.+.              .|++++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677789999999999999964   47899998553              388999999999999999999988  7899


Q ss_pred             EEEEccCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC----CCcEEEeec
Q 040294          262 LVLEYMTNGSLEKVLYSS----NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD----NIVAHLSDF  333 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~----~~~~ki~DF  333 (360)
                      +||||+++ ++.+.+...    ...+++.....++.|++.||+|||   +.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 676666422    225788888999999999999999   899999999999999999    999999999


Q ss_pred             ccccccCCCCC-ceeeecccccCcccCC
Q 040294          334 GIAKLLTGEDQ-SMTQTQTLATIGYMAP  360 (360)
Q Consensus       334 Gla~~~~~~~~-~~~~~~~~gt~~Y~aP  360 (360)
                      |+++....... ........+|+.|+||
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aP  184 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAP  184 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCH
Confidence            99987643322 1122345688899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.91  E-value=5.5e-24  Score=193.20  Aligned_cols=158  Identities=31%  Similarity=0.427  Sum_probs=136.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||+|+||.||+|... ++..+|+|.            +..|+++++.++||||+++++.+..++..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999854 677888873            35688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          267 MTNGSLEKVLYSSN--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       267 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      +++++|.+++....  ..+++.....++.|++.|++|||   +.+|+||||||+||++++++.+|++|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999997542  35788899999999999999999   89999999999999999999999999999987664432


Q ss_pred             ce--eeecccccCcccCC
Q 040294          345 SM--TQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~--~~~~~~gt~~Y~aP  360 (360)
                      ..  ......|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~y~~P  175 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAP  175 (267)
T ss_pred             ccccccccccCChhhcCh
Confidence            21  12334688999988

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.91  E-value=3.1e-24  Score=195.18  Aligned_cols=156  Identities=29%  Similarity=0.485  Sum_probs=132.2

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      +|+..+.||+|+||.||+++. .+++.||+|.                 +..|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 5788899863                 3458899999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-cEEEeecccccccCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTG  341 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-~~ki~DFGla~~~~~  341 (360)
                      ||||+++++|.+++... ..+++.....++.|++.||+|||   +.+++||||||+||+++.++ .+||+|||.+..+..
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            99999999999999754 35788889999999999999999   89999999999999998765 699999999987654


Q ss_pred             CCCc--eeeecccccCcccCC
Q 040294          342 EDQS--MTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~--~~~~~~~gt~~Y~aP  360 (360)
                      ....  .......||..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~P  177 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAP  177 (268)
T ss_pred             ccccCCccccccccccceeCH
Confidence            3211  112234688899997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.5e-24  Score=195.85  Aligned_cols=154  Identities=31%  Similarity=0.385  Sum_probs=134.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||.|+||.||+|+.. +++.||+|.            +..|++++++++||||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35777889999999999999865 688899874            45688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++++|.+++...  .+++.....++.|++.|+.|||   +.+++||||+|+||++++++.++|+|||+++.+....  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999999754  6788999999999999999999   8999999999999999999999999999998875432  1


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......|++.|+||
T Consensus       154 ~~~~~~~~~~y~~P  167 (274)
T cd06609         154 KRNTFVGTPFWMAP  167 (274)
T ss_pred             ccccccCCccccCh
Confidence            22345688899998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=1.4e-24  Score=196.65  Aligned_cols=153  Identities=35%  Similarity=0.486  Sum_probs=133.4

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      +|+..+.||.|+||.||+|+.. +++.||+|.              +..|++++++++||||+++++++..++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4777899999999999999975 688899873              3458899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++++|.+++... ..+++.....++.|+++||.|||   +.+++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999765 46888899999999999999999   8899999999999999999999999999988764332  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......|+..|+||
T Consensus       155 -~~~~~~~~~~y~~P  168 (258)
T cd05578         155 -LTTSTSGTPGYMAP  168 (258)
T ss_pred             -cccccCCChhhcCH
Confidence             12234578888887

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.91  E-value=3.6e-24  Score=196.61  Aligned_cols=165  Identities=29%  Similarity=0.429  Sum_probs=135.8

Q ss_pred             CHHHHHHHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh----------hHHHHHHhhcC-CCCCeeEEEEEecC--
Q 040294          191 SYLELLRATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS----------FDVECEVMKSI-HHRNLVKIISSCSN--  256 (360)
Q Consensus       191 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~----------~~~E~~~l~~l-~hpniv~l~~~~~~--  256 (360)
                      +..++......|+..+.||+|+||.||+|+. .+++.+|+|.          +..|+.+++++ +||||+++++++..  
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            4445555677889999999999999999996 4678899874          34577888888 69999999999853  


Q ss_pred             ----CCeEEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEe
Q 040294          257 ----EDFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLS  331 (360)
Q Consensus       257 ----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~  331 (360)
                          .+..+++|||+++|+|.+++... ...+++..+..++.|++.|++|||   +.+|+|||+||+||++++++.++|+
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEe
Confidence                45789999999999999998753 334778888889999999999999   8999999999999999999999999


Q ss_pred             ecccccccCCCCCceeeecccccCcccCC
Q 040294          332 DFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       332 DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |||++........  ......|++.|+||
T Consensus       164 dfg~~~~~~~~~~--~~~~~~~~~~y~aP  190 (282)
T cd06636         164 DFGVSAQLDRTVG--RRNTFIGTPYWMAP  190 (282)
T ss_pred             eCcchhhhhcccc--CCCcccccccccCH
Confidence            9999886542211  12345688899998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-25  Score=228.62  Aligned_cols=157  Identities=33%  Similarity=0.492  Sum_probs=134.3

Q ss_pred             CCCCCCCeeccCCCccEEEEE-ccCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      -++.....||.|.||.||.|. ..+|...|+|.             +..|+.++..++|||+|+++|+-.+++.++|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            356677889999999999998 56788888874             3579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      ||++|+|.+.+... ...++.....+..|++.|++|||   ..+||||||||+||+++.+|.+|.+|||.|..+.+..+.
T Consensus      1315 yC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            99999999999654 34555555668899999999999   999999999999999999999999999999987654322


Q ss_pred             ee--eecccccCcccCC
Q 040294          346 MT--QTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~--~~~~~gt~~Y~aP  360 (360)
                      ..  .....||+-||||
T Consensus      1391 ~~~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAP 1407 (1509)
T ss_pred             CCHHHHhhcCCchhcCc
Confidence            22  2356899999999

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.91  E-value=4.2e-24  Score=196.13  Aligned_cols=154  Identities=29%  Similarity=0.461  Sum_probs=131.5

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +|+..+.||.|++|.||+|+.. +|..||||.            +..|++++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999975 688899974            246899999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          268 TNGSLEKVLYSSN--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       268 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      ++ +|.+++....  ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.+|++|||+++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8888876543  45889999999999999999999   88999999999999999999999999999986543211 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......+++.|+||
T Consensus       156 -~~~~~~~~~~y~~P  169 (284)
T cd07836         156 -TFSNEVVTLWYRAP  169 (284)
T ss_pred             -ccccccccccccCh
Confidence             12234578889887

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=2e-24  Score=198.68  Aligned_cols=154  Identities=26%  Similarity=0.371  Sum_probs=131.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||+|+||.||+++.. +++.||+|            .+..|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45667788999999999999854 68888886            245789999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++++|.+++... ..+++.....++.+++.|+.|||+  ..+++||||||+||++++++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            9999999988754 357888999999999999999993  2579999999999999999999999999987653221   


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                       .....||..|+||
T Consensus       159 -~~~~~~~~~~~aP  171 (284)
T cd06620         159 -ADTFVGTSTYMSP  171 (284)
T ss_pred             -cCccccCcccCCH
Confidence             1234688899987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.9e-24  Score=193.36  Aligned_cols=157  Identities=27%  Similarity=0.421  Sum_probs=131.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh----------------hHHHHHHhhcCCCCCeeEEEEEecCC--CeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS----------------FDVECEVMKSIHHRNLVKIISSCSNE--DFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~----------------~~~E~~~l~~l~hpniv~l~~~~~~~--~~~  260 (360)
                      .+|+..+.||+|+||.||+|+. .++..||+|.                +.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999985 4688899873                34588999999999999999998764  468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      +++|||+++++|.+++.... .+++.....++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987543 4788888999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCC-ceeeecccccCcccCC
Q 040294          341 GEDQ-SMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~-~~~~~~~~gt~~Y~aP  360 (360)
                      .... ........|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSP  178 (264)
T ss_pred             cccccCccccccCCcccccCH
Confidence            2211 1112235688999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.91  E-value=4e-24  Score=193.26  Aligned_cols=151  Identities=30%  Similarity=0.573  Sum_probs=127.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      ++|...+.||+|+||.||++.. +++.||+|.         +..|+.++++++|||++++++++..+. .++||||++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~   83 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKG   83 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCC
Confidence            3577889999999999999875 577889873         467999999999999999999987654 69999999999


Q ss_pred             CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          271 SLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       271 ~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      +|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++......     .
T Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~  155 (254)
T cd05083          84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----D  155 (254)
T ss_pred             CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-----C
Confidence            9999997543 35788899999999999999999   8999999999999999999999999999987643211     1


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ....+..|+||
T Consensus       156 ~~~~~~~y~~p  166 (254)
T cd05083         156 NSKLPVKWTAP  166 (254)
T ss_pred             CCCCCceecCH
Confidence            12334567776

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PTZ00284 protein kinase; Provisional

Probab=99.91  E-value=2.1e-24  Score=212.54  Aligned_cols=154  Identities=25%  Similarity=0.360  Sum_probs=126.0

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh----------HHHHHHhhcCCC------CCeeEEEEEecCC-C
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF----------DVECEVMKSIHH------RNLVKIISSCSNE-D  258 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~----------~~E~~~l~~l~h------pniv~l~~~~~~~-~  258 (360)
                      ..+++|+..+.||+|+||.||+|+.. +++.||||.+          ..|++++++++|      +++++++++|..+ .
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~  205 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG  205 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence            45678999999999999999999864 6788999954          347777776654      4589999998765 4


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCCC-----------
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDNI-----------  326 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~~-----------  326 (360)
                      ..++|||++ +++|.+++... ..+++.....|+.||+.||+|||   . .+|+||||||+|||++.++           
T Consensus       206 ~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        206 HMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             eEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            789999998 77898888654 45888899999999999999999   6 5999999999999998665           


Q ss_pred             -----cEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          327 -----VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       327 -----~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                           .+||+|||.+.....     .....+||+.||||
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~AP  314 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSP  314 (467)
T ss_pred             CCCCceEEECCCCccccCcc-----ccccccCCccccCc
Confidence                 499999998864321     22356799999998

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.91  E-value=4.5e-24  Score=197.75  Aligned_cols=159  Identities=30%  Similarity=0.483  Sum_probs=133.1

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC----
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED----  258 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~----  258 (360)
                      ...++|+..+.||+|+||.||+|..+ +++.||+|.+             ..|++++++++||||+++++++.+.+    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34678999999999999999999975 6888998743             45889999999999999999987655    


Q ss_pred             ------eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEee
Q 040294          259 ------FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD  332 (360)
Q Consensus       259 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~D  332 (360)
                            ..++|+||+++ ++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999986 777777665556899999999999999999999   88999999999999999999999999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||++..+..... .......++..|+||
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~P  186 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPP  186 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccCh
Confidence            999987654321 111223467788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.91  E-value=7.3e-24  Score=197.28  Aligned_cols=151  Identities=32%  Similarity=0.414  Sum_probs=130.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ..|+..+.||+|+||.||+|+.. +++.||+|.              +..|+++++.++||||++++++|.+++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            34777889999999999999864 688899873              346888999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||++ |++.+.+......+++..+..++.|++.||.|||   +.+|+||||+|+||++++++.+||+|||+++.....  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9997 5777777654456889999999999999999999   899999999999999999999999999998865432  


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                          ....|++.|+||
T Consensus       169 ----~~~~~~~~y~aP  180 (307)
T cd06607         169 ----NSFVGTPYWMAP  180 (307)
T ss_pred             ----CCccCCccccCc
Confidence                124577888887

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.91  E-value=7.9e-24  Score=194.01  Aligned_cols=152  Identities=32%  Similarity=0.436  Sum_probs=131.5

Q ss_pred             CCCCCeeccCCCccEEEEEc-cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          202 FSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      |+..+.||+|+||.||+|.. .++..||+|.            +.+|++++++++||||+++++++..++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            66778899999999999985 4678899973            4468899999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      +++|.+++...  .+++.....++.|++.|+.|||   +.+++|+||||+||+++.++.++|+|||+++.+.....  ..
T Consensus        86 ~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~  158 (277)
T cd06641          86 GGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KR  158 (277)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hh
Confidence            99999998643  5788899999999999999999   89999999999999999999999999999887643221  12


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....|+..|+||
T Consensus       159 ~~~~~~~~y~~P  170 (277)
T cd06641         159 NTFVGTPFWMAP  170 (277)
T ss_pred             ccccCCccccCh
Confidence            234578889887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.91  E-value=6.4e-24  Score=191.93  Aligned_cols=155  Identities=27%  Similarity=0.465  Sum_probs=133.0

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||+++. .+++.||+|.             +..|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477789999999999999985 4788899873             44688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++++|.+.+.... ..+++.+...++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999987543 35788899999999999999999   89999999999999999999999999999987643321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......|++.|+||
T Consensus       157 -~~~~~~~~~~~~~p  170 (256)
T cd08218         157 -LARTCIGTPYYLSP  170 (256)
T ss_pred             -hhhhccCCccccCH
Confidence             11234578889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.91  E-value=6.2e-24  Score=195.19  Aligned_cols=146  Identities=28%  Similarity=0.420  Sum_probs=122.1

Q ss_pred             eeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHH---HhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          207 LIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECE---VMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       207 ~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~---~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      +||+|+||.||+++.. +++.+|+|.+              ..|..   ++...+||||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 6889999843              12222   3334579999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      +|+|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+||++++++.++++|||++.......    .
T Consensus        81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            99999988754 35889999999999999999999   8999999999999999999999999999987653221    1


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....||+.|+||
T Consensus       153 ~~~~~~~~y~aP  164 (279)
T cd05633         153 HASVGTHGYMAP  164 (279)
T ss_pred             cCcCCCcCccCH
Confidence            234689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=8.9e-24  Score=191.34  Aligned_cols=150  Identities=30%  Similarity=0.455  Sum_probs=123.1

Q ss_pred             CeeccCCCccEEEEEcc-C---CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-D---GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~---~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      +.||+|+||.||+|.+. .   +..+|+|.            +..|++++++++|||||++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            46999999999999753 2   26788874            3468899999999999999998875 457999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee-e
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT-Q  348 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~-~  348 (360)
                      |+|.+++.... .+++..+..++.|++.|++|||   ..+++||||||+||+++.++.+||+|||+++.+........ .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999997654 6889999999999999999999   88999999999999999999999999999987643332111 1


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|+||
T Consensus       156 ~~~~~~~~y~aP  167 (257)
T cd05060         156 TAGRWPLKWYAP  167 (257)
T ss_pred             cCccccccccCH
Confidence            122245678887

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6.7e-24  Score=194.18  Aligned_cols=153  Identities=27%  Similarity=0.450  Sum_probs=132.3

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh------------hHHHHHHhhcCC---CCCeeEEEEEecCCCeEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------FDVECEVMKSIH---HRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~------------~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .|+..+.||+|+||.||+|.. .+++.||+|.            +..|++++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467778899999999999996 5788999984            446888888886   999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++++|.+++...  .+++.....++.|++.||+|||   +.+|+|+||+|+||++++++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999998653  5788899999999999999999   89999999999999999999999999999987654331


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......|+..|+||
T Consensus       157 --~~~~~~~~~~y~aP  170 (277)
T cd06917         157 --KRSTFVGTPYWMAP  170 (277)
T ss_pred             --ccccccCCcceeCH
Confidence              12334688899987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.91  E-value=4.5e-24  Score=196.06  Aligned_cols=154  Identities=31%  Similarity=0.487  Sum_probs=131.6

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||+|+.. +++.||||.             +..|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999864 688999973             45699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +. ++|.+++... ...+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 6898888653 345889999999999999999999   89999999999999999999999999999986543221 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......+++.|+||
T Consensus       156 -~~~~~~~~~~y~aP  169 (284)
T cd07860         156 -TYTHEVVTLWYRAP  169 (284)
T ss_pred             -ccccccccccccCC
Confidence             12233568889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.91  E-value=5.8e-24  Score=195.48  Aligned_cols=156  Identities=32%  Similarity=0.449  Sum_probs=133.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||.||+|... +++.||+|.+             ..|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            35788899999999999999865 6788999843             468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |++++.+..+... ...+++.+...++.|++.||+|||   ..+++|||++|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            9998777665544 345788899999999999999999   88999999999999999999999999999987654432 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      .......++..|+||
T Consensus       156 ~~~~~~~~~~~~~~P  170 (288)
T cd07833         156 SPLTDYVATRWYRAP  170 (288)
T ss_pred             ccccCcccccCCcCC
Confidence            122335678899998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=5.1e-24  Score=210.36  Aligned_cols=159  Identities=30%  Similarity=0.443  Sum_probs=135.8

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh----------hHHHHHHhhcC-CCCCeeEEEEEecC-----CCe
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS----------FDVECEVMKSI-HHRNLVKIISSCSN-----EDF  259 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~----------~~~E~~~l~~l-~hpniv~l~~~~~~-----~~~  259 (360)
                      .-++-|++.++||.|.||.||+++. ++++.+|+|.          ++.|.++++.. .|||++.++++|..     ++.
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            3466788899999999999999995 5788888873          45566777765 59999999999863     568


Q ss_pred             EEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      +|||||||.+||..++++.. +..+.|.....|++.+++|+.+||   ...++|||+|-.|||+..++.+|++|||++..
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            99999999999999999754 345888899999999999999999   88999999999999999999999999999998


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++...  ....+.+||+.||||
T Consensus       173 ldsT~--grRnT~iGtP~WMAP  192 (953)
T KOG0587|consen  173 LDSTV--GRRNTFIGTPYWMAP  192 (953)
T ss_pred             eeccc--ccccCcCCCcccccc
Confidence            86543  233457899999998

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.91  E-value=1e-23  Score=192.19  Aligned_cols=154  Identities=29%  Similarity=0.486  Sum_probs=129.7

Q ss_pred             CCCCCCeeccCCCccEEEEEccC--CcEEEehhh---------------------HHHHHHhhc-CCCCCeeEEEEEecC
Q 040294          201 GFSANNLIGRGSFGSVYKARLQD--GMEFAIKSF---------------------DVECEVMKS-IHHRNLVKIISSCSN  256 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~---------------------~~E~~~l~~-l~hpniv~l~~~~~~  256 (360)
                      +|+..+.||+|+||.||++....  ++.+|+|.+                     ..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999764  677888742                     346676654 799999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCCCcEEEee
Q 040294          257 EDFRALVLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDNIVAHLSD  332 (360)
Q Consensus       257 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~~~~ki~D  332 (360)
                      ++..++||||+++++|.+++..   ....+++..+..++.|++.||.|||   . .+++|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3446888899999999999999999   5 6799999999999999999999999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||.+.......   ......|+..|+||
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~P  182 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCP  182 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcCh
Confidence            99998765432   22345688889988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6.9e-24  Score=198.09  Aligned_cols=138  Identities=33%  Similarity=0.467  Sum_probs=123.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|... +++.||+|.              +..|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36788899999999999999865 588999873              345889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          265 EYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       265 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ||+.+++|.+++... ...+++.....++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            999999999998754 345888899999999999999999   8999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.91  E-value=2.4e-24  Score=195.62  Aligned_cols=154  Identities=28%  Similarity=0.404  Sum_probs=134.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||+|+||.||++..+ +++.+|+|.            +.+|++++++++||||+++++++..++..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777789999999999999975 688899873            45688899999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++++|.+++......+++.....++.|++.|++|||   + .+++||||||+||++++++.+||+|||.+..+..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999999865466888888999999999999999   7 8999999999999999999999999999886643221 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                         ....++..|+||
T Consensus       157 ---~~~~~~~~y~~P  168 (265)
T cd06605         157 ---KTFVGTSSYMAP  168 (265)
T ss_pred             ---hcccCChhccCH
Confidence               115688889887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.91  E-value=9.3e-25  Score=221.73  Aligned_cols=162  Identities=31%  Similarity=0.486  Sum_probs=129.6

Q ss_pred             HHHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecC------
Q 040294          196 LRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSN------  256 (360)
Q Consensus       196 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~------  256 (360)
                      -+-.++|+..++||+||||.||+++.+ ||+.||||++            .+|+.++++++|||||+++..|.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345678899999999999999999976 9999999853            569999999999999999842100      


Q ss_pred             --------------------------------------------------------------------------------
Q 040294          257 --------------------------------------------------------------------------------  256 (360)
Q Consensus       257 --------------------------------------------------------------------------------  256 (360)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040294          257 -------------------------E--------DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH  303 (360)
Q Consensus       257 -------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH  303 (360)
                                               +        ..+||-||||+.-.+.+++......-......+++.+|++||+|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                     0        1358999999997777777654432134456778999999999999


Q ss_pred             hcCCCCeEEccCCCCceeecCCCcEEEeecccccccC----C-------C-----CCceeeecccccCcccCC
Q 040294          304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT----G-------E-----DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       304 ~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~----~-------~-----~~~~~~~~~~gt~~Y~aP  360 (360)
                         +.+||||||||.||++|.+..+||+|||+|....    .       .     ......++.+||.-|+||
T Consensus       715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence               9999999999999999999999999999998721    0       0     011245678999999998

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.91  E-value=1.4e-23  Score=191.68  Aligned_cols=158  Identities=25%  Similarity=0.349  Sum_probs=130.8

Q ss_pred             HHHHHHhCCCCCCCee--ccCCCccEEEEEc-cCCcEEEehhhHH------HHHHhhcC-CCCCeeEEEEEecCCCeEEE
Q 040294          193 LELLRATNGFSANNLI--GRGSFGSVYKARL-QDGMEFAIKSFDV------ECEVMKSI-HHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       193 ~~~~~~~~~f~~~~~i--G~G~~g~Vy~~~~-~~~~~vavK~~~~------E~~~l~~l-~hpniv~l~~~~~~~~~~~l  262 (360)
                      .+.....++|+..+.+  |+|+||.||+++. .++..+|+|.+..      |+.....+ +||||++++++|..++..++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            3444555677777776  9999999999985 4678899886532      33333323 69999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-cEEEeecccccccCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTG  341 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-~~ki~DFGla~~~~~  341 (360)
                      ||||+++|+|.+++.... .+++.+...++.|+++|++|||   +.+++||||||+||+++.++ .++|+|||+++....
T Consensus        87 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            999999999999997654 7899999999999999999999   89999999999999999888 999999999886542


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..      ...|+..|+||
T Consensus       163 ~~------~~~~~~~y~aP  175 (267)
T PHA03390        163 PS------CYDGTLDYFSP  175 (267)
T ss_pred             Cc------cCCCCCcccCh
Confidence            21      24588899998

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.91  E-value=7.3e-24  Score=194.53  Aligned_cols=146  Identities=29%  Similarity=0.447  Sum_probs=123.1

Q ss_pred             eeccCCCccEEEEEcc-CCcEEEehhhH--------------HHH---HHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          207 LIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VEC---EVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       207 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~---~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      +||+|+||.||+++.. +++.||+|.+.              .|.   +.++...||+|+++++++.+++..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 68899998431              122   33445689999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      ||+|.+++... ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++......    .
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            99999988654 46899999999999999999999   8999999999999999999999999999988654322    1


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....|+..|+||
T Consensus       153 ~~~~~~~~y~aP  164 (278)
T cd05606         153 HASVGTHGYMAP  164 (278)
T ss_pred             cCcCCCcCCcCc
Confidence            234689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.91  E-value=6.1e-24  Score=197.37  Aligned_cols=158  Identities=27%  Similarity=0.473  Sum_probs=132.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED------  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~------  258 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+             ..|++++++++||||++++++|...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            356888999999999999999864 6889999843             45899999999999999999987654      


Q ss_pred             --eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          259 --FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       259 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                        ..++||||+.+ +|.+.+......+++.+...++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              45999999964 888888766556899999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCCc--eeeecccccCcccCC
Q 040294          337 KLLTGEDQS--MTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~--~~~~~~~gt~~Y~aP  360 (360)
                      .........  .......++..|+||
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aP  192 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPP  192 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCc
Confidence            876432211  111234578889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.91  E-value=9.5e-24  Score=192.65  Aligned_cols=156  Identities=29%  Similarity=0.515  Sum_probs=124.7

Q ss_pred             CCCCCeeccCCCccEEEEEcc----CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCC------
Q 040294          202 FSANNLIGRGSFGSVYKARLQ----DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNED------  258 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~------  258 (360)
                      |...++||+|+||.||+|.++    +++.||||.             +.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556788999999999999853    467899973             346899999999999999999886542      


Q ss_pred             eEEEEEEccCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeec
Q 040294          259 FRALVLEYMTNGSLEKVLYSS-----NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDF  333 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DF  333 (360)
                      ..++++||+++|+|.+++...     ...+++.....++.|++.|++|||   +.+|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            347899999999999887532     124788888999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCCceeeecccccCcccCC
Q 040294          334 GIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       334 Gla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+++...............+++.|++|
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLAL  184 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCH
Confidence            999876433211112223455677776

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=4.4e-24  Score=194.54  Aligned_cols=158  Identities=29%  Similarity=0.421  Sum_probs=133.8

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcC-CCCCeeEEEEEecCCC------e
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSI-HHRNLVKIISSCSNED------F  259 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l-~hpniv~l~~~~~~~~------~  259 (360)
                      .+++|+..+.||+|+||.||+|+.+ +++.+|+|.          +..|+++++++ +||||+++++++....      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            4678999999999999999999975 677888874          45688999998 6999999999996544      5


Q ss_pred             EEEEEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          260 RALVLEYMTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                      .++||||+++++|.+++...   +..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+|++|||++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            89999999999999988643   356888899999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCCceeeecccccCcccCC
Q 040294          337 KLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .......  .......|+..|+||
T Consensus       161 ~~~~~~~--~~~~~~~~~~~y~aP  182 (275)
T cd06608         161 AQLDSTL--GRRNTFIGTPYWMAP  182 (275)
T ss_pred             eecccch--hhhcCccccccccCH
Confidence            8654322  112335688899988

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.91  E-value=8.3e-24  Score=197.02  Aligned_cols=157  Identities=31%  Similarity=0.450  Sum_probs=133.0

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC--CeEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE--DFRA  261 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~--~~~~  261 (360)
                      ..++|+..+.||+|+||.||+|... +|+.||+|.+             .+|++++++++||||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            3567899999999999999999964 6899999853             3699999999999999999998765  5689


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++ +|.+++......+++.+...++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            99999975 888888765566899999999999999999999   89999999999999999999999999999987653


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...  ......+++.|+||
T Consensus       161 ~~~--~~~~~~~~~~y~aP  177 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAP  177 (309)
T ss_pred             ccC--CCCcccccccccCh
Confidence            321  11223457889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.91  E-value=1e-23  Score=193.28  Aligned_cols=153  Identities=31%  Similarity=0.415  Sum_probs=131.9

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .|+..+.||+|+||.||+|... +++.||+|.            +..|++++++++||||+++++++.+++..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4666788999999999999865 678899873            456889999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++|+|.+++...  .+++.+...++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++........  .
T Consensus        85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06640          85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence            999999998653  4788888999999999999999   89999999999999999999999999999987654321  2


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....++..|+||
T Consensus       158 ~~~~~~~~~y~ap  170 (277)
T cd06640         158 RNTFVGTPFWMAP  170 (277)
T ss_pred             cccccCcccccCH
Confidence            2234578889887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.91  E-value=9.4e-24  Score=194.99  Aligned_cols=155  Identities=26%  Similarity=0.418  Sum_probs=128.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCC-CCCeeEEEEEecCCCe-----
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIH-HRNLVKIISSCSNEDF-----  259 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~-hpniv~l~~~~~~~~~-----  259 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.             +.+|++++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999964 788999984             346889999995 6999999999987665     


Q ss_pred             EEEEEEccCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEEeecc
Q 040294          260 RALVLEYMTNGSLEKVLYSSN----CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFG  334 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki~DFG  334 (360)
                      .++||||+++ +|.+++....    ..+++.....++.||+.||+|||   +.+|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 8888876432    34789999999999999999999   899999999999999998 8999999999


Q ss_pred             cccccCCCCCceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++.+.....  ......+++.|+||
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aP  180 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAP  180 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCCh
Confidence            9986543221  11223567888887

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.91  E-value=1e-23  Score=190.40  Aligned_cols=154  Identities=30%  Similarity=0.536  Sum_probs=132.0

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||++.. .+++.+|+|.             +..|+++++.++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            467788999999999999985 4678899873             45689999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-CcEEEeecccccccCCCCC
Q 040294          267 MTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       267 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-~~~ki~DFGla~~~~~~~~  344 (360)
                      +++++|.+++.... ..+++..+..++.+++.|++|||   +.+++||||||+||+++++ +.+|++|||.++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999997643 34788899999999999999999   8999999999999999854 5689999999987653321


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         .....|+..|+||
T Consensus       158 ---~~~~~~~~~y~aP  170 (256)
T cd08220         158 ---AYTVVGTPCYISP  170 (256)
T ss_pred             ---ccccccCCcccCc
Confidence               2234688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.91  E-value=1.4e-23  Score=190.13  Aligned_cols=155  Identities=31%  Similarity=0.482  Sum_probs=135.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||+|++|.||+|+.. +++.||+|.            +..|++.+.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888899999999999999976 588999874            45688899999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++++|.+++... ..+++.....++.|+++|++|||   + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999764 46888999999999999999999   8 99999999999999999999999999999876543321


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                        .....++..|+||
T Consensus       157 --~~~~~~~~~y~~p  169 (264)
T cd06623         157 --CNTFVGTVTYMSP  169 (264)
T ss_pred             --ccceeecccccCH
Confidence              1234578888887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.91  E-value=2.5e-24  Score=199.16  Aligned_cols=149  Identities=30%  Similarity=0.434  Sum_probs=128.7

Q ss_pred             CCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          205 NNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ...||+|+||.||++... ++..||||.           +..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            356999999999999864 688999974           44688999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeeccc
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL  352 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~  352 (360)
                      .+++...  .+++.+...++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++........  ......
T Consensus       107 ~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~  179 (292)
T cd06658         107 TDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLV  179 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceee
Confidence            9988543  4788889999999999999999   88999999999999999999999999999986543321  122356


Q ss_pred             ccCcccCC
Q 040294          353 ATIGYMAP  360 (360)
Q Consensus       353 gt~~Y~aP  360 (360)
                      |+..|+||
T Consensus       180 ~~~~y~aP  187 (292)
T cd06658         180 GTPYWMAP  187 (292)
T ss_pred             cCccccCH
Confidence            88999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.91  E-value=2.7e-24  Score=197.02  Aligned_cols=152  Identities=31%  Similarity=0.410  Sum_probs=130.2

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      |+..+.||+|+||.||+|... ++..||+|.            +..|++++++++||||+++++++..++..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            444567999999999999854 678899873            4568999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      +++|.+++..  ..+++..+..++.|+++|++|||   +.+++|+||+|+||++++++.++++|||+++.+.....  ..
T Consensus        86 ~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~  158 (277)
T cd06642          86 GGSALDLLKP--GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR  158 (277)
T ss_pred             CCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hh
Confidence            9999998864  35788889999999999999999   89999999999999999999999999999987653321  12


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....|+..|+||
T Consensus       159 ~~~~~~~~y~aP  170 (277)
T cd06642         159 NTFVGTPFWMAP  170 (277)
T ss_pred             hcccCcccccCH
Confidence            234578889987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.91  E-value=1.4e-23  Score=190.03  Aligned_cols=158  Identities=28%  Similarity=0.453  Sum_probs=132.4

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC--CCeEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN--EDFRALVL  264 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~  264 (360)
                      +|+..+.||.|+||.||++.. .+++.+|+|.             +..|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477788999999999999985 4778888873             3458899999999999999998754  45689999


Q ss_pred             EccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          265 EYMTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGF--STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       265 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~--~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      ||+++++|.+++...   ...+++.....++.|++.||+|||..+  +.+++|+||||+||+++.++.+|++|||+++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653   456889999999999999999999554  678999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....  ......|++.|+||
T Consensus       161 ~~~~~--~~~~~~~~~~~~~p  179 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSP  179 (265)
T ss_pred             cCCcc--cccccccCCCccCh
Confidence            54331  12234688999988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.91  E-value=1.1e-23  Score=192.94  Aligned_cols=147  Identities=31%  Similarity=0.472  Sum_probs=126.7

Q ss_pred             eccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          208 IGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ||+|+||.||+|... +|+.||+|.+              ..|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 6889998743              3588999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecc
Q 040294          273 EKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT  351 (360)
Q Consensus       273 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~  351 (360)
                      .+++.... ..+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.+||+|||++.......   .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            99987644 35888899999999999999999   8999999999999999999999999999998754321   12234


Q ss_pred             cccCcccCC
Q 040294          352 LATIGYMAP  360 (360)
Q Consensus       352 ~gt~~Y~aP  360 (360)
                      .++..|+||
T Consensus       155 ~~~~~y~~P  163 (277)
T cd05577         155 AGTPGYMAP  163 (277)
T ss_pred             cCCCCcCCH
Confidence            577888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.91  E-value=3.7e-24  Score=198.48  Aligned_cols=149  Identities=30%  Similarity=0.406  Sum_probs=128.9

Q ss_pred             CCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          205 NNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ...||+|+||.||+++.. +++.||+|.           +..|+.+++.++||||+++++++..++..++||||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            346999999999999864 788999974           34688999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeeccc
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL  352 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~  352 (360)
                      ..++..  ..+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++..+.....  ......
T Consensus       106 ~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~  178 (297)
T cd06659         106 TDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLV  178 (297)
T ss_pred             HHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccccee
Confidence            998754  34788899999999999999999   89999999999999999999999999999986543321  123456


Q ss_pred             ccCcccCC
Q 040294          353 ATIGYMAP  360 (360)
Q Consensus       353 gt~~Y~aP  360 (360)
                      |++.|+||
T Consensus       179 ~~~~y~aP  186 (297)
T cd06659         179 GTPYWMAP  186 (297)
T ss_pred             cCccccCH
Confidence            89999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.91  E-value=1.9e-23  Score=195.44  Aligned_cols=149  Identities=33%  Similarity=0.424  Sum_probs=129.2

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      |+..+.||+|+||.||+++.. ++..||+|.              +..|++++++++|||++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            666788999999999999854 688899874              34588999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +. |++.+.+......+++.++..++.|++.|+.|||   ..+|+||||+|+||+++.++.+||+|||++......    
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            97 4888877665566899999999999999999999   899999999999999999999999999998764322    


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                        ....|++.|+||
T Consensus       179 --~~~~~~~~y~aP  190 (317)
T cd06635         179 --NSFVGTPYWMAP  190 (317)
T ss_pred             --ccccCCccccCh
Confidence              234578889887

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.91  E-value=5.2e-24  Score=200.93  Aligned_cols=156  Identities=33%  Similarity=0.503  Sum_probs=131.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcC-CCCCeeEEEEEecCC--CeEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSI-HHRNLVKIISSCSNE--DFRA  261 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l-~hpniv~l~~~~~~~--~~~~  261 (360)
                      .++|+..+.||+|+||.||+|... +++.+|+|.+             ..|+.+++++ +||||++++++|...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            456888899999999999999865 6788999843             3489999999 999999999998654  3689


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||++ ++|..++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            9999997 5999888654  6788889999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCc---eeeecccccCcccCC
Q 040294          342 EDQS---MTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~---~~~~~~~gt~~Y~aP  360 (360)
                      ....   .......||..|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aP  181 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAP  181 (337)
T ss_pred             ccccccCcchhcccccccccCc
Confidence            3211   122335689999998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.91  E-value=1.2e-23  Score=192.86  Aligned_cols=151  Identities=28%  Similarity=0.437  Sum_probs=128.1

Q ss_pred             CCCCCeeccCCCccEEEEEc-cCCcEEEehhhH------------HHHHHhhcCC-CCCeeEEEEEecCC--CeEEEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARL-QDGMEFAIKSFD------------VECEVMKSIH-HRNLVKIISSCSNE--DFRALVLE  265 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~------------~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e  265 (360)
                      |+..+.||+|+||.||+|+. .+++.||+|.+.            .|+.+++++. |||++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            45678899999999999985 478899998542            4777888885 99999999999987  88999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |++ |++.+.+......+++.++..++.|++.||+|||   +.+++||||||+||+++. +.+||+|||+++.+..... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            997 5888888765567899999999999999999999   889999999999999999 9999999999987643321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                        .....++..|+||
T Consensus       155 --~~~~~~~~~y~aP  167 (282)
T cd07831         155 --YTEYISTRWYRAP  167 (282)
T ss_pred             --cCCCCCCcccCCh
Confidence              1234578889988

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.91  E-value=3e-24  Score=204.83  Aligned_cols=152  Identities=28%  Similarity=0.495  Sum_probs=132.8

Q ss_pred             CCCeeccCCCccEEEEEcc---CCc--EEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          204 ANNLIGRGSFGSVYKARLQ---DGM--EFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       204 ~~~~iG~G~~g~Vy~~~~~---~~~--~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ..+.||.|-||.||+|.+-   .|.  .||||            .|..|+-+|++++|||||+|+|+|.+. ..|||||.
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL  471 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL  471 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence            3578999999999999842   333  47776            478899999999999999999999865 68999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++-|.|..+|+..+..++......++.|+..||+|||   +..++||||...|||+....-+|++|||+++.+..+..+.
T Consensus       472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence            9999999999988888999899999999999999999   9999999999999999999999999999999988766443


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      . +...-.+.||||
T Consensus       549 a-S~~kLPIKWmaP  561 (974)
T KOG4257|consen  549 A-SRGKLPIKWMAP  561 (974)
T ss_pred             c-cccccceeecCc
Confidence            3 344456799998

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.91  E-value=1.2e-23  Score=194.76  Aligned_cols=154  Identities=34%  Similarity=0.468  Sum_probs=133.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-----------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-----------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-----------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ++|+..+.||+|+||.||++.. .+++.||+|.+           ..|+.++++++||||++++++|..++..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5678889999999999999985 46788998743           45888999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|.+++...  .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~  171 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence            999999998653  4678889999999999999999   89999999999999999999999999999876543321  1


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....|++.|+||
T Consensus       172 ~~~~~~~~~y~~P  184 (293)
T cd06647         172 RSTMVGTPYWMAP  184 (293)
T ss_pred             cccccCChhhcCc
Confidence            2234688889988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.90  E-value=2.1e-23  Score=192.80  Aligned_cols=155  Identities=30%  Similarity=0.461  Sum_probs=128.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|++|.||+|+.. +++.||+|.+             ..|++++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999865 7889999843             458999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEEeecccccccCCCC
Q 040294          266 YMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki~DFGla~~~~~~~  343 (360)
                      |++ ++|.+++.... ..+++.....++.|++.||+|||   +.+++||||+|+||+++. ++.+||+|||+++......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 58888775433 23577788889999999999999   899999999999999985 5679999999998654321


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ......+++.|+||
T Consensus       158 ~--~~~~~~~~~~y~~P  172 (294)
T PLN00009        158 R--TFTHEVVTLWYRAP  172 (294)
T ss_pred             c--ccccCceeecccCH
Confidence            1  11234578889887

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.90  E-value=2.8e-24  Score=189.46  Aligned_cols=157  Identities=30%  Similarity=0.384  Sum_probs=130.0

Q ss_pred             HhCCCCCC-CeeccCCCccEEEEEcc-CCcEEEehhh------HHHHHHhhcC-CCCCeeEEEEEecC----CCeEEEEE
Q 040294          198 ATNGFSAN-NLIGRGSFGSVYKARLQ-DGMEFAIKSF------DVECEVMKSI-HHRNLVKIISSCSN----EDFRALVL  264 (360)
Q Consensus       198 ~~~~f~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~------~~E~~~l~~l-~hpniv~l~~~~~~----~~~~~lv~  264 (360)
                      .|++|++. ++||-|-.|.|-.+.++ +++.+|+|.+      .+|+++.-.. .|||||+++++|+.    ...+.+||
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm  138 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM  138 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence            35566543 67999999999999864 8899999965      4677765444 59999999998764    34678999


Q ss_pred             EccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec---CCCcEEEeecccccccC
Q 040294          265 EYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~---~~~~~ki~DFGla~~~~  340 (360)
                      |+|+||+|...++.++ ..+++.++-.|+.||+.|+.|||   +.+|.||||||+|+|..   .+...|++|||+||.-.
T Consensus       139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            9999999999998764 46899999999999999999999   99999999999999995   46689999999999754


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .   .....+.+.|++|.||
T Consensus       216 ~---~~~L~TPc~TPyYvaP  232 (400)
T KOG0604|consen  216 E---PGDLMTPCFTPYYVAP  232 (400)
T ss_pred             C---CccccCCcccccccCH
Confidence            2   2234567899999998

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.90  E-value=1.9e-23  Score=189.60  Aligned_cols=146  Identities=32%  Similarity=0.486  Sum_probs=127.3

Q ss_pred             eccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          208 IGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ||.|+||.||+++.. +++.+|+|.              +..|+++++.++||||+++++++.+++..++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999965 588899874              34588999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeeccc
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL  352 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~  352 (360)
                      .+++.... .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||+++......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99997643 4788888999999999999999   8999999999999999999999999999998765432   112346


Q ss_pred             ccCcccCC
Q 040294          353 ATIGYMAP  360 (360)
Q Consensus       353 gt~~Y~aP  360 (360)
                      |+..|+||
T Consensus       154 ~~~~~~~P  161 (262)
T cd05572         154 GTPEYVAP  161 (262)
T ss_pred             CCcCccCh
Confidence            78889988

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.9e-24  Score=199.25  Aligned_cols=157  Identities=32%  Similarity=0.504  Sum_probs=130.4

Q ss_pred             CCCCCeeccCCCccEEEEE-ccCCcEEEehh------------------hHHHHHHhhcCCCCCeeEEEEEec-CCCeEE
Q 040294          202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKS------------------FDVECEVMKSIHHRNLVKIISSCS-NEDFRA  261 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~------------------~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~  261 (360)
                      |-...+||+|+|+.||+|. +...+-||||.                  ..+|..+.+.++||.||++|+||. +.+..|
T Consensus       465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC  544 (775)
T KOG1151|consen  465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC  544 (775)
T ss_pred             HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence            3345789999999999998 45667788863                  235888999999999999999997 456788


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEeecccccc
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKL  338 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~DFGla~~  338 (360)
                      -|+|||+|.+|+-+|+... .+++..+..|+.||+.||.||.. -.++|||-||||.|||+..   .|.+||+|||++++
T Consensus       545 TVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  545 TVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             eeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            9999999999999997543 57778888999999999999984 4789999999999999954   58999999999999


Q ss_pred             cCCCCCc----e-eeecccccCcccCC
Q 040294          339 LTGEDQS----M-TQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~----~-~~~~~~gt~~Y~aP  360 (360)
                      +.++...    + -....+||.||++|
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPP  649 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPP  649 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCc
Confidence            9876432    1 12356899999998

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.90  E-value=2.3e-23  Score=188.89  Aligned_cols=156  Identities=35%  Similarity=0.504  Sum_probs=133.2

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||+|... +++.||+|.             +..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            3677889999999999999854 688899873             34688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++++|.+++... ..+++..+..++.|++.|++|||   +.+|+|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            9999999999764 34778888999999999999999   8999999999999999999999999999998765433211


Q ss_pred             e--eecccccCcccCC
Q 040294          347 T--QTQTLATIGYMAP  360 (360)
Q Consensus       347 ~--~~~~~gt~~Y~aP  360 (360)
                      .  .....+++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~P  172 (264)
T cd06626         157 GEEVQSLAGTPAYMAP  172 (264)
T ss_pred             cccccCCcCCcCccCh
Confidence            1  1134578889987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.90  E-value=2e-23  Score=192.33  Aligned_cols=154  Identities=33%  Similarity=0.419  Sum_probs=129.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCC--CeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNE--DFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~  264 (360)
                      ++|+..+.||.|++|.||++... +++.+|+|.            +.+|++++++++||||++++++|...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46778899999999999999974 678899873            45799999999999999999998654  4689999


Q ss_pred             EccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ||+++++|.+++..   ....+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999987653   2345788888999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..    .....++..|+||
T Consensus       158 ~~----~~~~~~~~~y~~p  172 (287)
T cd06621         158 SL----AGTFTGTSFYMAP  172 (287)
T ss_pred             cc----cccccCCccccCH
Confidence            22    1134577788887

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.90  E-value=2.5e-23  Score=191.53  Aligned_cols=158  Identities=35%  Similarity=0.461  Sum_probs=136.6

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      .++.|+..+.||+|+||.||++... +++.||+|.          +..|++++++++|||++++++++..++..++|+||
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            4556777889999999999999976 688899873          45689999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++++|.+++......+++..+..++.|++.||+|||   ..+|+|+|++|+||+++.++.++|+|||++........  
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  171 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--  171 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence            9999999999876546899999999999999999999   89999999999999999999999999999876543221  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......++..|+||
T Consensus       172 ~~~~~~~~~~y~~P  185 (286)
T cd06614         172 KRNSVVGTPYWMAP  185 (286)
T ss_pred             hhccccCCcccCCH
Confidence            12234578889887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.90  E-value=4.7e-23  Score=184.75  Aligned_cols=154  Identities=37%  Similarity=0.519  Sum_probs=135.2

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      +|+..+.||+|++|.||++... ++..+++|.           +..|++++++++|||++++++++..++..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677889999999999999975 688888873           4568899999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      +++|.+++......+++.....++.|++.|++|||   ..+++||||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999776557899999999999999999999   89999999999999999999999999999987654331   2


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....|+..|+||
T Consensus       155 ~~~~~~~~~~~P  166 (253)
T cd05122         155 NTMVGTPYWMAP  166 (253)
T ss_pred             cceecCCcccCH
Confidence            334678888887

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=8.8e-24  Score=207.10  Aligned_cols=159  Identities=21%  Similarity=0.323  Sum_probs=122.6

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-----------------cCCcEEEehhhH-------------------------HH
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-----------------QDGMEFAIKSFD-------------------------VE  235 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-----------------~~~~~vavK~~~-------------------------~E  235 (360)
                      ..++|+..++||+|+||.||+|..                 ..++.||||.+.                         .|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999963                 235679998642                         25


Q ss_pred             HHHhhcCCCCCe-----eEEEEEecC--------CCeEEEEEEccCCCCHHHHHhcCCC---------------------
Q 040294          236 CEVMKSIHHRNL-----VKIISSCSN--------EDFRALVLEYMTNGSLEKVLYSSNC---------------------  281 (360)
Q Consensus       236 ~~~l~~l~hpni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  281 (360)
                      +.++.+++|.++     ++++++|..        ++..+|||||+++|+|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            556667766654     677777753        3468999999999999999874311                     


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccC
Q 040294          282 --ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA  359 (360)
Q Consensus       282 --~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~a  359 (360)
                        ..++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..... .......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence              2356678889999999999999   88999999999999999999999999999976543221 11112335789999


Q ss_pred             C
Q 040294          360 P  360 (360)
Q Consensus       360 P  360 (360)
                      |
T Consensus       379 P  379 (507)
T PLN03224        379 P  379 (507)
T ss_pred             h
Confidence            8

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.90  E-value=2.1e-23  Score=191.36  Aligned_cols=154  Identities=31%  Similarity=0.490  Sum_probs=131.2

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC--CeEEEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE--DFRALVLE  265 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e  265 (360)
                      |+..+.||+|+||.||+|+.. +++.+|+|.+             ..|+++++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556788999999999999865 5788998743             4588999999999999999999988  78999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++ +|.+++......+++.++..++.|++.||+|||   ..+++|+||||+||++++++.+||+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 899888766557899999999999999999999   88999999999999999999999999999987654321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      .......++..|+||
T Consensus       156 ~~~~~~~~~~~y~~P  170 (287)
T cd07840         156 ADYTNRVITLWYRPP  170 (287)
T ss_pred             ccccccccccccCCc
Confidence            112234567889988

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=4.1e-23  Score=185.94  Aligned_cols=154  Identities=34%  Similarity=0.502  Sum_probs=134.1

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|++|.||+++.. +++.||+|.             +..|++++++++|||++++++++..++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677889999999999999865 678899874             45688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++++|.+++... ..+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.++|+|||++........  
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--  154 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence            9999999998765 46889999999999999999999   89999999999999999999999999999987654332  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......++..|+||
T Consensus       155 ~~~~~~~~~~y~~p  168 (254)
T cd06627         155 DDASVVGTPYWMAP  168 (254)
T ss_pred             cccccccchhhcCH
Confidence            12335678889887

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.90  E-value=1.5e-23  Score=189.48  Aligned_cols=155  Identities=29%  Similarity=0.481  Sum_probs=131.9

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||++... +|..+|+|.+             ..|++++++++||||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677889999999999999965 6788888743             4688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-cEEEeecccccccCCCCC
Q 040294          267 MTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       267 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-~~ki~DFGla~~~~~~~~  344 (360)
                      +++++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+|+||+||++++++ .+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987543 35789999999999999999999   88999999999999999875 569999999987653321


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......|++.|+||
T Consensus       158 --~~~~~~~~~~~~ap  171 (257)
T cd08225         158 --LAYTCVGTPYYLSP  171 (257)
T ss_pred             --cccccCCCccccCH
Confidence              11234588899987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.90  E-value=1.2e-23  Score=190.54  Aligned_cols=149  Identities=34%  Similarity=0.500  Sum_probs=127.3

Q ss_pred             eccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          208 IGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ||+|+||.||+++.. +++.+|+|.+              ..|++++++++||||+++++.+..++..+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            589999999999976 5889999843              4578899999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC------ce
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ------SM  346 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~------~~  346 (360)
                      .+++.... .+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99997654 6888999999999999999999   89999999999999999999999999999886443211      11


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......++..|+||
T Consensus       157 ~~~~~~~~~~~~~P  170 (265)
T cd05579         157 EDKRIVGTPDYIAP  170 (265)
T ss_pred             cccCcccCccccCH
Confidence            22334578889887

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.90  E-value=1.8e-23  Score=192.60  Aligned_cols=155  Identities=28%  Similarity=0.435  Sum_probs=130.4

Q ss_pred             CCCCCCeeccCCCccEEEEEc----cCCcEEEehhh---------------HHHHHHhhcC-CCCCeeEEEEEecCCCeE
Q 040294          201 GFSANNLIGRGSFGSVYKARL----QDGMEFAIKSF---------------DVECEVMKSI-HHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~---------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~  260 (360)
                      +|+..+.||+|+||.||+++.    .+++.||||.+               ..|++++.++ +||||+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366778999999999999874    35678888743               3588899999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||+++|+|.+++... ..+++.....++.|+++||+|||   +.+++||||||+||+++.++.++|+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            9999999999999998754 35788888899999999999999   8999999999999999999999999999988754


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .... .......|+..|+||
T Consensus       157 ~~~~-~~~~~~~~~~~y~aP  175 (288)
T cd05583         157 AEEE-ERAYSFCGTIEYMAP  175 (288)
T ss_pred             cccc-cccccccCCccccCH
Confidence            3321 112234688899987

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.90  E-value=2.3e-23  Score=197.09  Aligned_cols=155  Identities=26%  Similarity=0.412  Sum_probs=131.3

Q ss_pred             HHHHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC--
Q 040294          195 LLRATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED--  258 (360)
Q Consensus       195 ~~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~--  258 (360)
                      +....++|+..+.||+|+||.||++.. .++..||||.+             ..|++++++++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            344567899999999999999999984 57889999843             35889999999999999999987654  


Q ss_pred             ----eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecc
Q 040294          259 ----FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       259 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                          ..++||||+ +++|.+++..  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+|++|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                358999999 7799888864  35788899999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++.......     ....+++.|+||
T Consensus       164 ~~~~~~~~~-----~~~~~~~~y~aP  184 (343)
T cd07880         164 LARQTDSEM-----TGYVVTRWYRAP  184 (343)
T ss_pred             cccccccCc-----cccccCCcccCH
Confidence            998654321     234578889887

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.90  E-value=1.8e-23  Score=198.55  Aligned_cols=153  Identities=28%  Similarity=0.388  Sum_probs=129.0

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC------
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE------  257 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~------  257 (360)
                      ..++|+..+.||+|+||.||+|+. .+++.||+|.+             ..|++++++++||||++++++|...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            346789999999999999999985 47899999854             2488999999999999999998644      


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ...++||||+. ++|.+.+...   +++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35799999996 4888877543   778888899999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ......   ......||..|+||
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aP  186 (353)
T cd07850         167 TAGTSF---MMTPYVVTRYYRAP  186 (353)
T ss_pred             eCCCCC---CCCCCcccccccCH
Confidence            764322   12234688899998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.90  E-value=6.8e-24  Score=200.97  Aligned_cols=155  Identities=25%  Similarity=0.366  Sum_probs=134.0

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhhH-------------------HHHHHhhcCC---CCCeeEEEEEe
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD-------------------VECEVMKSIH---HRNLVKIISSC  254 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~-------------------~E~~~l~~l~---hpniv~l~~~~  254 (360)
                      ...+|...+.+|+|+||.|+.|.++ +..+|+||.+.                   .|+++|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            3446888899999999999999976 56788888542                   3899999998   99999999999


Q ss_pred             cCCCeEEEEEEcc-CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeec
Q 040294          255 SNEDFRALVLEYM-TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDF  333 (360)
Q Consensus       255 ~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DF  333 (360)
                      +++++.||+||-- +|-+|.+++... ..+++..+..|..||+.|+++||   +.+|+|||||-+||.+|.+|-+|++||
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeec
Confidence            9999999999965 456899998654 46788889999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCceeeecccccCcccCC
Q 040294          334 GIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       334 Gla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |.|......    ....++||.+|.||
T Consensus       715 gsaa~~ksg----pfd~f~gtv~~aap  737 (772)
T KOG1152|consen  715 GSAAYTKSG----PFDVFVGTVDYAAP  737 (772)
T ss_pred             cchhhhcCC----Ccceeeeeccccch
Confidence            998875432    23467899999998

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.90  E-value=1.4e-23  Score=197.93  Aligned_cols=156  Identities=28%  Similarity=0.436  Sum_probs=129.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCC-----CeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNE-----DFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~-----~~~  260 (360)
                      +++|+..+.||+|+||.||+|+. .+++.||+|.+            ..|++++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46799999999999999999985 47899999843            3588999999999999999887654     357


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||+++ +|.+.+..  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            999999975 88887754  35788889999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCCce-eeecccccCcccCC
Q 040294          341 GEDQSM-TQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~-~~~~~~gt~~Y~aP  360 (360)
                      ...... ......||+.||||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAP  178 (336)
T ss_pred             ccccccCCcCCcCcCCCccCh
Confidence            322111 11235689999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.90  E-value=4.2e-23  Score=190.19  Aligned_cols=152  Identities=29%  Similarity=0.409  Sum_probs=131.1

Q ss_pred             CCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          202 FSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      |...+.||+|++|.||++.. .+++.+|+|.           +.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44567999999999999985 4788899874           35688999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      ++|.+++..  ..+++.....++.|++.|++|||   +.+|+||||+|+||+++.++.++++|||.+........  ...
T Consensus       101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~  173 (285)
T cd06648         101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK  173 (285)
T ss_pred             CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence            999999876  35788888999999999999999   89999999999999999999999999999876543221  122


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...|++.|+||
T Consensus       174 ~~~~~~~y~aP  184 (285)
T cd06648         174 SLVGTPYWMAP  184 (285)
T ss_pred             cccCCccccCH
Confidence            34688999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.90  E-value=3.1e-23  Score=190.40  Aligned_cols=153  Identities=32%  Similarity=0.486  Sum_probs=130.7

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      |+..+.||+|++|.||+|... +|..||+|.             +..|++++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999864 789999983             346899999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          268 TNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       268 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      + ++|.+++.... ..+++..+..++.|+++||+|||   +.+++||||+|+||+++.++.++|+|||+++.......  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68999887543 35889999999999999999999   88999999999999999999999999999986542221  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......++..|+||
T Consensus       155 ~~~~~~~~~~~~aP  168 (283)
T cd07835         155 TYTHEVVTLWYRAP  168 (283)
T ss_pred             ccCccccccCCCCC
Confidence            11233568889988

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.90  E-value=5.4e-23  Score=185.14  Aligned_cols=156  Identities=35%  Similarity=0.496  Sum_probs=134.9

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCC--CeEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNE--DFRALVL  264 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~  264 (360)
                      +|+..+.||+|++|.||+|... +++.|++|.             +..|++++++++||||+++++.+...  +..++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999976 788898873             45688999999999999999999988  8999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999997654 7889999999999999999999   89999999999999999999999999999987654432


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                      ........++..|+||
T Consensus       157 ~~~~~~~~~~~~y~~p  172 (260)
T cd06606         157 GEGTGSVRGTPYWMAP  172 (260)
T ss_pred             cccccCCCCCccccCH
Confidence            1112345678888887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.90  E-value=1.1e-23  Score=203.12  Aligned_cols=151  Identities=28%  Similarity=0.458  Sum_probs=128.4

Q ss_pred             CCCCCCeeccCCCccEEEEE-ccCCcEEEehhhH----------HHHHHhhcCC-C-----CCeeEEEEEecCCCeEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFD----------VECEVMKSIH-H-----RNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~----------~E~~~l~~l~-h-----pniv~l~~~~~~~~~~~lv  263 (360)
                      .|++.++||+|+||.|-+|. .++++.||||.++          .|+.+|..++ |     -|+|+++++|...++.|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            67888999999999999998 5689999998653          4888998887 3     3899999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC--CCcEEEeecccccccC
Q 040294          264 LEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD--NIVAHLSDFGIAKLLT  340 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~--~~~~ki~DFGla~~~~  340 (360)
                      +|.++. +|+++++..+ ..++......|+.||+.||.+||   ..+|||+||||+||||.+  ...+||+|||.|....
T Consensus       267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence            999954 9999998654 35888889999999999999999   999999999999999974  3489999999998754


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...     .+.+-+..|.||
T Consensus       343 q~v-----ytYiQSRfYRAP  357 (586)
T KOG0667|consen  343 QRV-----YTYIQSRFYRAP  357 (586)
T ss_pred             Ccc-----eeeeeccccccc
Confidence            322     134556788887

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.90  E-value=5.2e-23  Score=185.36  Aligned_cols=155  Identities=32%  Similarity=0.529  Sum_probs=134.5

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||++... ++..||+|.             +..|++++++++|||++++.+.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677889999999999999965 688899874             34688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          267 MTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       267 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      +++++|.+++...   ...+++.....++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999765   356899999999999999999999   8899999999999999999999999999998764432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                        .......|++.|+||
T Consensus       158 --~~~~~~~~~~~y~~p  172 (258)
T cd08215         158 --DLAKTVVGTPYYLSP  172 (258)
T ss_pred             --ceecceeeeecccCh
Confidence              122234688889987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.90  E-value=1.6e-23  Score=191.41  Aligned_cols=157  Identities=34%  Similarity=0.537  Sum_probs=134.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCC-CCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIH-HRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|...+.||+|+||.||+++.. +++.||+|.+              ..|++++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888899999999999999865 7889998743              34778899998 99999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++++|.+++.... .+++.....++.|++.||+|||   +.+++|+|++|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999997653 6899999999999999999999   8999999999999999999999999999998764432


Q ss_pred             Cc------------------eeeecccccCcccCC
Q 040294          344 QS------------------MTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~------------------~~~~~~~gt~~Y~aP  360 (360)
                      ..                  .......|+..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P  191 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP  191 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCH
Confidence            11                  112234578889887

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.90  E-value=1.6e-23  Score=197.46  Aligned_cols=157  Identities=27%  Similarity=0.399  Sum_probs=130.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC----CCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN----EDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~----~~~~  260 (360)
                      .++|+..+.||+|+||.||+|... ++..||+|.             +..|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888999999999999999854 688999974             2458999999999999999998763    3468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||+. |+|.+++.... .+++.....++.|++.||+|||   ..+|+||||||+||++++++.+||+|||+++.+.
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999996 68999886543 4889999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCCc--eeeecccccCcccCC
Q 040294          341 GEDQS--MTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~--~~~~~~~gt~~Y~aP  360 (360)
                      .....  .......|+..|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~P  180 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAP  180 (334)
T ss_pred             ccCcCCCcccccccccccccCh
Confidence            32211  111234688899988

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=2.1e-25  Score=192.28  Aligned_cols=156  Identities=27%  Similarity=0.503  Sum_probs=129.3

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC--------C
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE--------D  258 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~--------~  258 (360)
                      .|+....||+|.||+||+|+.+ +|+.||+|+.             .+|++++..++|+|++.+++.|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3455578999999999999965 6788898753             2589999999999999999888642        3


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..|+||++|+. +|..+|......++.....+++.++..||.|+|   +..|+|||+|++|+||+.++.+||+|||+|+.
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            58999999986 999999887777888899999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCCC--ceeeecccccCcccCC
Q 040294          339 LTGEDQ--SMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~--~~~~~~~~gt~~Y~aP  360 (360)
                      ......  ....+..+-|++|.+|
T Consensus       174 fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             eecccccCCCCcccceeeeecCCH
Confidence            543221  1122345568899876

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.89  E-value=1e-22  Score=190.19  Aligned_cols=149  Identities=31%  Similarity=0.404  Sum_probs=128.3

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      |...+.||+|+||.||+|+.. +++.||+|.              +..|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999864 678898873              34688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +. |++.+.+......+++.++..++.|++.|++|||   +.+++||||||+||++++++.+||+|||++......    
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----  174 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----  174 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence            96 5888888765566899999999999999999999   889999999999999999999999999998753221    


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                        ....|+..|+||
T Consensus       175 --~~~~~~~~y~aP  186 (313)
T cd06633         175 --NSFVGTPYWMAP  186 (313)
T ss_pred             --CCccccccccCh
Confidence              234688889988

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.89  E-value=2.6e-23  Score=190.77  Aligned_cols=152  Identities=30%  Similarity=0.464  Sum_probs=130.6

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEcc
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      |...+.||+|+||.||+|+.. +++.||||.+            .+|+..+++++ |||++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            556788999999999999975 5788999853            24778888999 999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          268 TNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       268 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                       +|+|.+.+.... ..+++.++..++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||+++.......  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             889999887654 46799999999999999999999   88999999999999999999999999999987653321  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                       .....++..|+||
T Consensus       155 -~~~~~~~~~~~aP  167 (283)
T cd07830         155 -YTDYVSTRWYRAP  167 (283)
T ss_pred             -cCCCCCcccccCc
Confidence             1234578888887

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.89  E-value=5.1e-23  Score=194.96  Aligned_cols=157  Identities=26%  Similarity=0.419  Sum_probs=132.4

Q ss_pred             HHHHHHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC-
Q 040294          193 LELLRATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE-  257 (360)
Q Consensus       193 ~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~-  257 (360)
                      .++...+++|...+.||+|+||.||+|.. .+++.||+|.+             .+|++++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            45667889999999999999999999985 57889999843             3488999999999999999988643 


Q ss_pred             -----CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEee
Q 040294          258 -----DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD  332 (360)
Q Consensus       258 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~D  332 (360)
                           ...++++|++ +++|.+++...  .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEec
Confidence                 3468888887 78998887643  4788899999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+++.....     .....||..|+||
T Consensus       164 fg~~~~~~~~-----~~~~~~~~~y~aP  186 (345)
T cd07877         164 FGLARHTDDE-----MTGYVATRWYRAP  186 (345)
T ss_pred             cccccccccc-----ccccccCCCccCH
Confidence            9998865322     2234678889987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.89  E-value=3.3e-23  Score=192.54  Aligned_cols=158  Identities=28%  Similarity=0.456  Sum_probs=131.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCC-------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNE-------  257 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~-------  257 (360)
                      .++|+..+.||+|+||.||+|+.. +++.+|+|.             +.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            568899999999999999999965 688899984             34699999999999999999887543       


Q ss_pred             -CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          258 -DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       258 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                       ...++||||+.+ ++...+......+++.++..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             356999999975 787777665567899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCc---------eeeecccccCcccCC
Q 040294          337 KLLTGEDQS---------MTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~---------~~~~~~~gt~~Y~aP  360 (360)
                      +........         ...+...|++.|+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP  195 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCCh
Confidence            865432211         111234578889998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.8e-23  Score=186.87  Aligned_cols=156  Identities=30%  Similarity=0.370  Sum_probs=134.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhhHHHH--------------HHhh-cCCCCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDVEC--------------EVMK-SIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~E~--------------~~l~-~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      .++|+..++||+|+|++|-.++++ +.+.||+|.+++|+              .+.. .-+||.+|.++.+|+.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            457999999999999999999965 78899999877653              3333 3479999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      |.||++||+|.-+++.. ..+++..+..+...|..||.|||   +++||.||+|..|+|+|..|++|++|+|.++.--.+
T Consensus       329 vieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            99999999998888654 45788888889999999999999   999999999999999999999999999999974322


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ....+.+|||.|+||
T Consensus       405 g--d~tstfcgtpnyiap  420 (593)
T KOG0695|consen  405 G--DTTSTFCGTPNYIAP  420 (593)
T ss_pred             C--cccccccCCCcccch
Confidence            2  234568999999998

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-24  Score=209.22  Aligned_cols=156  Identities=30%  Similarity=0.445  Sum_probs=137.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      .++|+....+|+|.||.|||++. ++++..|||.           +++|+-+++..+|||||.+++.+...+..+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            35788889999999999999995 4778888874           35688899999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      |.+|+|++..+..+ .+++.+...+++...+|++|||   +.+-+|||||-.|||+.+.+.+|++|||.+..+...-  .
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--A  167 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh--h
Confidence            99999999877543 5778888889999999999999   9999999999999999999999999999998876432  2


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      .+.+..||++||||
T Consensus       168 KrksfiGtpywmap  181 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAP  181 (829)
T ss_pred             hhhcccCCccccch
Confidence            34568899999998

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.89  E-value=4.8e-23  Score=190.60  Aligned_cols=148  Identities=29%  Similarity=0.414  Sum_probs=128.1

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHH
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLE  273 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  273 (360)
                      ..||+|+||.||++... +++.||||.           +..|+.+++.++||||+++++++..++..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            56999999999999864 788999974           345889999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccc
Q 040294          274 KVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA  353 (360)
Q Consensus       274 ~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~g  353 (360)
                      +++...  .+++.....++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++..+.....  ......|
T Consensus       106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~  178 (292)
T cd06657         106 DIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVG  178 (292)
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccccc
Confidence            987543  4788888999999999999999   88999999999999999999999999999876643321  1233568


Q ss_pred             cCcccCC
Q 040294          354 TIGYMAP  360 (360)
Q Consensus       354 t~~Y~aP  360 (360)
                      ++.|+||
T Consensus       179 ~~~y~~p  185 (292)
T cd06657         179 TPYWMAP  185 (292)
T ss_pred             CccccCH
Confidence            8899987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.3e-22  Score=183.94  Aligned_cols=145  Identities=31%  Similarity=0.455  Sum_probs=121.9

Q ss_pred             CeeccCCCccEEEEEcc-CCcEEEehhhH--------------HHHHH-hhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEV-MKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~E~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      +.||+|+||.||+|... +++.||+|.+.              .|..+ ....+|||++++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999864 68899998542              13233 3445899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      ++|.+++.... .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||+++....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999997543 5788888999999999999999   89999999999999999999999999999886432      12


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...|++.|+||
T Consensus       152 ~~~~~~~y~~p  162 (260)
T cd05611         152 KFVGTPDYLAP  162 (260)
T ss_pred             cCCCCcCccCh
Confidence            34577888887

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.89  E-value=5.5e-23  Score=190.32  Aligned_cols=154  Identities=29%  Similarity=0.432  Sum_probs=127.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIH-HRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+            ..|++++.+.. ||||++++++|.++...++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            56788899999999999999976 4889999854            23555565654 9999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |+. +++.+++......+++..+..++.|++.|++|||   + .+|+||||+|+||++++++.+||+|||++..+.....
T Consensus        95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            985 4787777665557889999999999999999999   6 5899999999999999999999999999987643221


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         .....++..|+||
T Consensus       171 ---~~~~~~~~~y~aP  183 (296)
T cd06618         171 ---KTRSAGCAAYMAP  183 (296)
T ss_pred             ---ccCCCCCccccCH
Confidence               1233577889887

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.89  E-value=7.4e-23  Score=192.53  Aligned_cols=156  Identities=28%  Similarity=0.430  Sum_probs=131.1

Q ss_pred             HHHHHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC-CC
Q 040294          194 ELLRATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN-ED  258 (360)
Q Consensus       194 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~-~~  258 (360)
                      ++...+++|+..+.||+|+||.||+++. .++..||+|.             +..|++++++++||||++++++|.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            3445678899999999999999999985 4788999984             3458999999999999999999865 55


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..++||||+ +++|.+++...  .+++.....++.|++.||+|||   +.+|+||||+|+||++++++.+||+|||.+..
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            789999999 56898888643  4677778889999999999999   89999999999999999999999999999886


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....     ....++..|+||
T Consensus       158 ~~~~~-----~~~~~~~~y~aP  174 (328)
T cd07856         158 QDPQM-----TGYVSTRYYRAP  174 (328)
T ss_pred             cCCCc-----CCCcccccccCc
Confidence            53221     234567888887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.89  E-value=7.4e-23  Score=184.59  Aligned_cols=153  Identities=30%  Similarity=0.491  Sum_probs=131.7

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|+..+.||+|+||.||+++.. +++.+|+|.+             ..|++++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4677889999999999999854 7788998743             3588899999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          267 MTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       267 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      +++++|.+++...   ...+++.....++.|++.||+|||   +.+++|+||+|+||++++++.+|++|||+++......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            9999999998652   245788889999999999999999   9999999999999999999999999999998765431


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                          .....|++.|+||
T Consensus       158 ----~~~~~~~~~~~~P  170 (256)
T cd08530         158 ----AKTQIGTPHYMAP  170 (256)
T ss_pred             ----cccccCCccccCH
Confidence                1224577888887

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.89  E-value=9.9e-23  Score=189.84  Aligned_cols=149  Identities=32%  Similarity=0.438  Sum_probs=128.2

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      |+..+.||+|+||.||+|+.. ++..+|+|.              +..|+++++.++|||++++++++..++..++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            555678999999999999964 677888874              23588999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +. |++.+.+......+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++......    
T Consensus        97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----  168 (308)
T cd06634          97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  168 (308)
T ss_pred             cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence            96 6888877655556888899999999999999999   889999999999999999999999999998875432    


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                        ....|++.|+||
T Consensus       169 --~~~~~~~~y~aP  180 (308)
T cd06634         169 --NXFVGTPYWMAP  180 (308)
T ss_pred             --ccccCCccccCH
Confidence              234578889887

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.89  E-value=5.6e-23  Score=189.24  Aligned_cols=154  Identities=31%  Similarity=0.405  Sum_probs=124.5

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +|...+.||+|+||.||+++.. +++.+|+|.+            ..|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999864 6889999844            35888888886 99999999999999999999999


Q ss_pred             cCCCCHHHHH---hc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          267 MTNGSLEKVL---YS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       267 ~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      +.. ++.++.   .. ....+++.....++.|++.||+|||+  ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 554432   22 23468888999999999999999993  258999999999999999999999999999875432


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .   ......|++.|+||
T Consensus       162 ~---~~~~~~~~~~y~aP  176 (288)
T cd06616         162 I---AKTRDAGCRPYMAP  176 (288)
T ss_pred             C---ccccccCccCccCH
Confidence            2   11234588889987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.89  E-value=1.5e-22  Score=190.66  Aligned_cols=152  Identities=28%  Similarity=0.425  Sum_probs=127.1

Q ss_pred             CCCeeccCCCccEEEEEcc-CCcEEEehh-------------------------hHHHHHHhhcCCCCCeeEEEEEecCC
Q 040294          204 ANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------------------FDVECEVMKSIHHRNLVKIISSCSNE  257 (360)
Q Consensus       204 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------------------~~~E~~~l~~l~hpniv~l~~~~~~~  257 (360)
                      ..+.||+|+||.||+|+.. +++.||||.                         +..|++++++++||||+++++++..+
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            3477999999999999854 788999983                         34688999999999999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      +..++||||+. |+|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+|++|||+++
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcccee
Confidence            99999999997 6999988653 35788889999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCC------------ceeeecccccCcccCC
Q 040294          338 LLTGEDQ------------SMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~------------~~~~~~~~gt~~Y~aP  360 (360)
                      .......            ........+++.|+||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  202 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAP  202 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCC
Confidence            6541110            0111233467889988

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.2e-24  Score=201.54  Aligned_cols=153  Identities=27%  Similarity=0.393  Sum_probs=133.1

Q ss_pred             CCCCCCeeccCCCccEEEEEccCC-cEEEehhhH--------------HHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDG-MEFAIKSFD--------------VECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~--------------~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      +++....||-|+||.|-+++.... ..+|+|.++              .|-.+|...+.|.||++|-.|.++.++|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            455667799999999998876432 347887553              37789999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      -|-||.+...+..++ .++..+...++..+++|++|||   +++||.|||||+|.++|.+|.+|+.|||+||.+..... 
T Consensus       501 aClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K-  575 (732)
T KOG0614|consen  501 ACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK-  575 (732)
T ss_pred             hhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence            999999999998764 5777788889999999999999   99999999999999999999999999999999875442 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                        .-++|||+.|.||
T Consensus       576 --TwTFcGTpEYVAP  588 (732)
T KOG0614|consen  576 --TWTFCGTPEYVAP  588 (732)
T ss_pred             --eeeecCCcccccc
Confidence              2358999999999

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.89  E-value=1.5e-22  Score=185.85  Aligned_cols=152  Identities=30%  Similarity=0.489  Sum_probs=126.2

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehhhH-------------HHHHHhhcC---CCCCeeEEEEEecCCCe-----
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD-------------VECEVMKSI---HHRNLVKIISSCSNEDF-----  259 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~-------------~E~~~l~~l---~hpniv~l~~~~~~~~~-----  259 (360)
                      |+..+.||+|+||.||+|+.+ +++.||+|.+.             .|+++++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999976 58899998542             466666554   69999999999988776     


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      .+++|||+.+ +|.+++.... ..+++..+..++.|++.||+|||   +.+++|+|++|+||++++++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            9999999974 8988886543 35899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.....   .....++..|+||
T Consensus       157 ~~~~~~---~~~~~~~~~~~~P  175 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAP  175 (287)
T ss_pred             ccCCcc---cccccccccccCh
Confidence            643321   1233477888887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.89  E-value=1e-22  Score=192.69  Aligned_cols=150  Identities=29%  Similarity=0.450  Sum_probs=126.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED------  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~------  258 (360)
                      .++|...+.||+|+||.||+|+. .+++.||||.+             ..|++++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999985 47889999743             35899999999999999999987543      


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..++|+||+.. +|..+..   ..+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+|++|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999964 7776652   34788889999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....     .....+|..|+||
T Consensus       167 ~~~~-----~~~~~~~~~y~aP  183 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAP  183 (342)
T ss_pred             CCCC-----CCCceeeecccCh
Confidence            5322     1234578889988

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.89  E-value=1.2e-22  Score=186.16  Aligned_cols=153  Identities=31%  Similarity=0.450  Sum_probs=131.3

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      |+..+.||+|++|.||+|... +++.+|+|.             +..|++++++++||||+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456788999999999999864 688899874             345889999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++ ++.+.+......+++.++..++.|++.||+|||   ..+|+|+||||+||+++.++.+||+|||.+........  .
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence            75 898888776567889999999999999999999   89999999999999999999999999999987654321  1


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~~P  167 (283)
T cd05118         155 YTHYVVTRWYRAP  167 (283)
T ss_pred             ccCccCcccccCc
Confidence            1234577888887

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-23  Score=182.64  Aligned_cols=151  Identities=27%  Similarity=0.397  Sum_probs=123.8

Q ss_pred             CCCeeccCCCccEEEEEcc-CCcEEEehhhH------------HHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          204 ANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD------------VECEVMKSIH-HRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       204 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~------------~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ....||.|+.|.|++++++ +|...|||.+.            ..++++.+.+ .|+||+.+|||..+..+++.||.|. 
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence            3456999999999999965 68999998552            3344444444 8999999999999999999999994 


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      -.+++++..-...+++.-.=.+..-++.||.||..  ..+|+|||+||+|||+|+.|.+|+||||++..+.+..   ..+
T Consensus       175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---Aht  249 (391)
T KOG0983|consen  175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHT  249 (391)
T ss_pred             HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---ccc
Confidence            36777776666667776666788889999999985  6789999999999999999999999999999886543   334


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ..+|.+.||||
T Consensus       250 rsAGC~~YMaP  260 (391)
T KOG0983|consen  250 RSAGCAAYMAP  260 (391)
T ss_pred             cccCCccccCc
Confidence            56799999998

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.88  E-value=1e-22  Score=192.14  Aligned_cols=154  Identities=28%  Similarity=0.423  Sum_probs=129.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC-----eE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED-----FR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~-----~~  260 (360)
                      +.|...+.||+|+||.||+|+. .+++.||||.+             ..|+++++.++||||+++++++....     ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4688889999999999999985 47889999843             34889999999999999999886543     47


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||+. ++|.+++... ..+++.....++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            99999996 6898888654 45888999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  ......++..|+||
T Consensus       160 ~~~~--~~~~~~~~~~y~aP  177 (337)
T cd07858         160 EKGD--FMTEYVVTRWYRAP  177 (337)
T ss_pred             CCcc--cccccccccCccCh
Confidence            3321  12234578889988

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.88  E-value=5.1e-23  Score=205.96  Aligned_cols=159  Identities=26%  Similarity=0.349  Sum_probs=116.9

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-C----CcEEEehhhH----HHHHHhhcCC---CCCeeEEEEE------ecCCCe
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-D----GMEFAIKSFD----VECEVMKSIH---HRNLVKIISS------CSNEDF  259 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~----~~~vavK~~~----~E~~~l~~l~---hpniv~l~~~------~~~~~~  259 (360)
                      ..++|+..+.||+|+||.||+|++. +    +..||||.+.    .|.....+++   +.+++.+...      +..++.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            4678999999999999999999975 4    6899999653    2333333332   2222222211      245668


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCC-------------------CCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCce
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCI-------------------LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV  320 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~Ni  320 (360)
                      .++||||+.+++|.+++......                   ........++.|++.||+|||   +.+|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHE
Confidence            89999999999999998754311                   112234568999999999999   89999999999999


Q ss_pred             eecC-CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          321 LLDD-NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       321 Ll~~-~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |++. ++.+||+|||+|+.+..... .......||+.||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~AP  326 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAP  326 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccCh
Confidence            9985 68999999999987643321 223356789999998

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.88  E-value=1.5e-22  Score=185.38  Aligned_cols=153  Identities=34%  Similarity=0.481  Sum_probs=130.8

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      |+..+.||+|+||.||+|+.. +++.||+|.+             ..|++++++++|||++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999975 5889999743             35889999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      + ++|.+++......+++..+..++.|++.||+|||   +.+|+||||+|+||++++++.+||+|||+++.......  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            8 5999999876456899999999999999999999   88999999999999999999999999999987643321  1


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~aP  167 (282)
T cd07829         155 YTHEVVTLWYRAP  167 (282)
T ss_pred             cCccccCcCcCCh
Confidence            2233457788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.88  E-value=2.3e-22  Score=189.04  Aligned_cols=129  Identities=22%  Similarity=0.312  Sum_probs=113.7

Q ss_pred             eeccC--CCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          207 LIGRG--SFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       207 ~iG~G--~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      .||+|  +||.||+++.. +|+.||+|.             +..|+.+++.++||||++++++|..++..++||||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999964 789999974             345788888899999999999999999999999999999


Q ss_pred             CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          271 SLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       271 ~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ++.+++.... ..+++.....++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+..
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            9999987542 34788888899999999999999   89999999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.88  E-value=2.5e-22  Score=189.17  Aligned_cols=155  Identities=25%  Similarity=0.352  Sum_probs=126.1

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-C--CcEEEehhh-------------HHHHHHhhcC-CCCCeeEEEEEecC----CCe
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-D--GMEFAIKSF-------------DVECEVMKSI-HHRNLVKIISSCSN----EDF  259 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~--~~~vavK~~-------------~~E~~~l~~l-~hpniv~l~~~~~~----~~~  259 (360)
                      +|+..+.||+|+||.||+++.. +  +..||+|.+             ..|+++++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677789999999999999964 4  778999843             3588899988 59999999987543    245


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .++++||+. ++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999986 6899988653 45888999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCc--eeeecccccCcccCC
Q 040294          340 TGEDQS--MTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~--~~~~~~~gt~~Y~aP  360 (360)
                      ......  .......||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aP  178 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAP  178 (332)
T ss_pred             ccccccccccccCcccCccccCc
Confidence            432211  111235689999998

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.88  E-value=2.7e-22  Score=185.75  Aligned_cols=156  Identities=24%  Similarity=0.375  Sum_probs=116.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC----CcEEEehh-------hHHH---------------HHHhhcCCCCCeeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD----GMEFAIKS-------FDVE---------------CEVMKSIHHRNLVKIISS  253 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~-------~~~E---------------~~~l~~l~hpniv~l~~~  253 (360)
                      +.|...++||+|+||.||+|+..+    +..+|+|.       +..|               ...+..++|++++++++.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            468889999999999999998654    34556552       1111               223456789999999987


Q ss_pred             ecCCC----eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEE
Q 040294          254 CSNED----FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH  329 (360)
Q Consensus       254 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~k  329 (360)
                      +....    ..++++|++.. ++.+.+... ...++.....++.|++.||+|||   +.+|+||||||+|||++.++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            66543    45788888743 666655432 23567778899999999999999   89999999999999999999999


Q ss_pred             EeecccccccCCCCCc-----eeeecccccCcccCC
Q 040294          330 LSDFGIAKLLTGEDQS-----MTQTQTLATIGYMAP  360 (360)
Q Consensus       330 i~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aP  360 (360)
                      |+|||+|+........     .......||+.|+||
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap  202 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL  202 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence            9999999876432211     112234699999997

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.88  E-value=5.8e-23  Score=172.48  Aligned_cols=153  Identities=27%  Similarity=0.423  Sum_probs=124.5

Q ss_pred             CCCCCeeccCCCccEEEEEc-cCCcEEEehhhH------------HHHHHh-hcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          202 FSANNLIGRGSFGSVYKARL-QDGMEFAIKSFD------------VECEVM-KSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~------------~E~~~l-~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ......||+|+||.|-+.++ .+|+..|+|.+.            +|+++. +....|.+|.++|.+.++..+++.||.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            33456799999999988886 489999998653            344433 3456999999999999999999999999


Q ss_pred             CCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          268 TNGSLEKVLY---SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       268 ~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      .. ||..+..   ..+...++.-.=+||..|+.||.|||.  ...+||||+||+|||++.+|.+||||||++..+.+.  
T Consensus       128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS--  202 (282)
T KOG0984|consen  128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS--  202 (282)
T ss_pred             hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh--
Confidence            65 7766543   345668887778899999999999995  678999999999999999999999999999987643  


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       ...+-..|...||||
T Consensus       203 -iAkt~daGCkpYmaP  217 (282)
T KOG0984|consen  203 -IAKTMDAGCKPYMAP  217 (282)
T ss_pred             -hHHHHhcCCCccCCh
Confidence             233446789999998

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.88  E-value=3.6e-23  Score=178.10  Aligned_cols=161  Identities=27%  Similarity=0.381  Sum_probs=132.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEE-ccCCcEEEehhh-----------HHHHHHhhcCCCCCeeEEEEEecCCC-----eEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF-----------DVECEVMKSIHHRNLVKIISSCSNED-----FRA  261 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~-----------~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~  261 (360)
                      .++|.+.+.+|+|||+-||.++ ..++..||+|++           .+|++.-++++|||++++++++..+.     ..|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            3568888999999999999998 568889999854           46899999999999999998876443     589


Q ss_pred             EEEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          262 LVLEYMTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      |++.|...|+|.+.+...   +..+++.+.+.|+.+|++||++||. ..++..||||||.|||+.+++.+++.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            999999999999988643   3468999999999999999999992 244599999999999999999999999999876


Q ss_pred             cCCC----CCc---eeeecccccCcccCC
Q 040294          339 LTGE----DQS---MTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~----~~~---~~~~~~~gt~~Y~aP  360 (360)
                      ..-.    .+.   ........|..|.||
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAP  207 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAP  207 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCc
Confidence            4311    100   111245678999998

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.88  E-value=1.5e-22  Score=190.22  Aligned_cols=155  Identities=28%  Similarity=0.418  Sum_probs=131.3

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCC-----eEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNED-----FRA  261 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~  261 (360)
                      +|+..+.||+|+||.||+|+.. +++.||+|.             +..|+++++.++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4777899999999999999965 588999873             345899999999999999999998775     789


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||++ ++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999998 48988886543 6889999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCc-eeeecccccCcccCC
Q 040294          342 EDQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~-~~~~~~~gt~~Y~aP  360 (360)
                      .... .......+|..|+||
T Consensus       156 ~~~~~~~~~~~~~~~~y~aP  175 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAP  175 (330)
T ss_pred             cccccccccccccccCcCCc
Confidence            3210 112334678889988

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.88  E-value=2.5e-22  Score=187.27  Aligned_cols=149  Identities=20%  Similarity=0.241  Sum_probs=120.0

Q ss_pred             eccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHHH
Q 040294          208 IGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEK  274 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~  274 (360)
                      +|.|+++.||+++. +++.||||.             +..|+++++.++||||+++++++..++..+++|||+++|+|.+
T Consensus        10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED   88 (314)
T ss_pred             hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence            34444444444444 688999974             3568999999999999999999999999999999999999999


Q ss_pred             HHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc-----eee
Q 040294          275 VLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS-----MTQ  348 (360)
Q Consensus       275 ~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~-----~~~  348 (360)
                      ++... ...+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+..+......     ...
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~  165 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP  165 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence            99753 335788888899999999999999   899999999999999999999999999998765432211     111


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|+||
T Consensus       166 ~~~~~~~~y~aP  177 (314)
T cd08216         166 KSSVKNLPWLSP  177 (314)
T ss_pred             ccccccccccCH
Confidence            234577789887

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-22  Score=199.36  Aligned_cols=155  Identities=31%  Similarity=0.535  Sum_probs=125.4

Q ss_pred             CCCCCCeeccCCCcc-EEEEEccCCcEEEehhh--------HHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          201 GFSANNLIGRGSFGS-VYKARLQDGMEFAIKSF--------DVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~-Vy~~~~~~~~~vavK~~--------~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      -|...+++|.|+-|+ ||+|.. +|++||||.+        .+|++.++.-+ |||||++++.-+++++.||..|.|. -
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~  587 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C  587 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence            355567889988775 699988 4789999965        46888888765 9999999999999999999999996 4


Q ss_pred             CHHHHHhcCCCCC---CHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-----CCcEEEeecccccccCCC
Q 040294          271 SLEKVLYSSNCIL---DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-----NIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       271 ~L~~~l~~~~~~~---~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-----~~~~ki~DFGla~~~~~~  342 (360)
                      +|++++.......   .......+..|++.||++||   +.+|+||||||.||||+.     ...++|+|||++|.+..+
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            9999997631111   11334668899999999999   899999999999999975     257999999999999876


Q ss_pred             CCceee-ecccccCcccCC
Q 040294          343 DQSMTQ-TQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~-~~~~gt~~Y~aP  360 (360)
                      ...... ....||-||+||
T Consensus       665 ~sS~~r~s~~sGt~GW~AP  683 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAP  683 (903)
T ss_pred             cchhhcccCCCCcccccCH
Confidence            544333 356799999998

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.88  E-value=4.9e-22  Score=178.13  Aligned_cols=141  Identities=23%  Similarity=0.175  Sum_probs=119.5

Q ss_pred             CCCccEEEEEc-cCCcEEEehhhH------HHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCC
Q 040294          211 GSFGSVYKARL-QDGMEFAIKSFD------VECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCIL  283 (360)
Q Consensus       211 G~~g~Vy~~~~-~~~~~vavK~~~------~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~  283 (360)
                      |.||.||+++. .+++.||+|.+.      .|...+....||||+++++++.+.+..++||||+++|+|.+++.... .+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l   82 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NI   82 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CC
Confidence            88999999986 478899998653      45555556679999999999999999999999999999999986543 48


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       284 ~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++.....++.|++.||+|||   +.+|+||||||+||+++.++.++++|||.+.......     ....++..|+||
T Consensus        83 ~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aP  151 (237)
T cd05576          83 PEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAP  151 (237)
T ss_pred             CHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCC
Confidence            88999999999999999999   8999999999999999999999999999887654321     223456778887

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.87  E-value=2.2e-22  Score=182.44  Aligned_cols=154  Identities=27%  Similarity=0.442  Sum_probs=125.4

Q ss_pred             CCCCCCeeccCCCccEEEEEccC-CcEEEe---h-------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQD-GMEFAI---K-------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~-~~~vav---K-------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .|...+.||+|+||.||+++... +..+++   |             .+..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36777899999999999998642 333322   2             133578899999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          264 LEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |||+++++|.+++..   ....+++..+..++.|++.|++|||   +.+++|+|+||+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864   2346889999999999999999999   899999999999999975 569999999998764


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  ......|++.|+||
T Consensus       157 ~~~~--~~~~~~~~~~~~~p  174 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSP  174 (260)
T ss_pred             CCcc--cccCCCCCcCccCH
Confidence            3321  12234578889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.87  E-value=6e-22  Score=178.14  Aligned_cols=147  Identities=36%  Similarity=0.484  Sum_probs=127.1

Q ss_pred             eccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          208 IGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ||+|+||.||++... +++.+|+|.              +..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 588899873              45688999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeeccc
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL  352 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~  352 (360)
                      .+++.... .+++.....++.|+++|+.|||   +.+++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence            99997653 5788899999999999999999   89999999999999999999999999999987643321  123345


Q ss_pred             ccCcccCC
Q 040294          353 ATIGYMAP  360 (360)
Q Consensus       353 gt~~Y~aP  360 (360)
                      ++..|+||
T Consensus       155 ~~~~~~~P  162 (250)
T cd05123         155 GTPEYLAP  162 (250)
T ss_pred             CCccccCh
Confidence            78888887

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.87  E-value=4.5e-23  Score=202.09  Aligned_cols=154  Identities=28%  Similarity=0.475  Sum_probs=131.3

Q ss_pred             CCCCCeeccCCCccEEEEEc-cCC----cEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARL-QDG----MEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~-~~~----~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ....++||+|+||.||+|.| ..|    .+||||.            +..|+-+|.+++|||+++|+++|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            44568999999999999986 333    3577763            456899999999999999999999876 78999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      +||+.|+|.++++..+..+.....+.+..|||+||.|||   ..+++||||-..|||+.....+||+|||+|+.+..+..
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999988888888889999999999999999   99999999999999999999999999999999887654


Q ss_pred             ceeeecccccCcccC
Q 040294          345 SMTQTQTLATIGYMA  359 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~a  359 (360)
                      ........-.+.|||
T Consensus       854 ey~~~~gK~pikwma  868 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMA  868 (1177)
T ss_pred             cccccccccCcHHHH
Confidence            433333334556665

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.87  E-value=2.8e-22  Score=189.70  Aligned_cols=152  Identities=27%  Similarity=0.415  Sum_probs=130.2

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCe----
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDF----  259 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~----  259 (360)
                      ..++|+..+.||+|+||.||+|+.. +++.||||.+             ..|+.++++++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4567888999999999999999975 6788999854             248899999999999999998876654    


Q ss_pred             --EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          260 --RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       260 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                        .++|+||+ +++|.+++..  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999999 6799998865  35888999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....     .....+|..|+||
T Consensus       167 ~~~~~-----~~~~~~~~~y~aP  184 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAP  184 (343)
T ss_pred             ccccc-----ccCCcccccccCH
Confidence            75432     1234578889887

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=5.3e-22  Score=171.84  Aligned_cols=128  Identities=20%  Similarity=0.241  Sum_probs=102.0

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEehhhH-------------------------------------HHHHHhhcCCCCCe
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIKSFD-------------------------------------VECEVMKSIHHRNL  247 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~-------------------------------------~E~~~l~~l~hpni  247 (360)
                      ...||+|+||.||+|...+|+.||||.+.                                     .|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999998899999998531                                     27888888887766


Q ss_pred             eEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeEEccCCCCceeecCCC
Q 040294          248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL-HFGFSTPIIHCDLKPHNVLLDDNI  326 (360)
Q Consensus       248 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yL-H~~~~~~iiHrdlk~~NiLl~~~~  326 (360)
                      .....+....  .+|||||++++++...... ...++......++.|++.+|+|+ |   +.+|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLKS--HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEecC--CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            4333222222  3899999999877654322 24578888999999999999999 6   77999999999999998 47


Q ss_pred             cEEEeeccccccc
Q 040294          327 VAHLSDFGIAKLL  339 (360)
Q Consensus       327 ~~ki~DFGla~~~  339 (360)
                      .++++|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.87  E-value=2.3e-22  Score=194.21  Aligned_cols=152  Identities=26%  Similarity=0.447  Sum_probs=126.0

Q ss_pred             CCeeccCCCccEEEEEcc--CCc--EEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          205 NNLIGRGSFGSVYKARLQ--DGM--EFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~--~~~--~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .++||+|.||+|++|.|.  .|+  .||||            .|.+|+.+|.+++|||+++|||...+ ....+|||.++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            468999999999999985  343  58888            46789999999999999999999988 67889999999


Q ss_pred             CCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          269 NGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       269 ~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      .|+|.+.|++ ....+-......++.|||.|+.||.   .++.|||||...|+|+-..-.+||+|||+.+.+...++...
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv  270 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV  270 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence            9999999987 3445666677889999999999999   99999999999999999999999999999998865543332


Q ss_pred             ee-cccccCcccCC
Q 040294          348 QT-QTLATIGYMAP  360 (360)
Q Consensus       348 ~~-~~~gt~~Y~aP  360 (360)
                      .. ...-.+.|-||
T Consensus       271 m~p~rkvPfAWCaP  284 (1039)
T KOG0199|consen  271 MAPQRKVPFAWCAP  284 (1039)
T ss_pred             ecCCCcCcccccCH
Confidence            21 22234455554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=1.1e-21  Score=170.21  Aligned_cols=130  Identities=22%  Similarity=0.269  Sum_probs=104.7

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEehhh-------------------------------------HHHHHHhhcCCCCCe
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIKSF-------------------------------------DVECEVMKSIHHRNL  247 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~-------------------------------------~~E~~~l~~l~hpni  247 (360)
                      ...||+|+||.||+|+..+|+.||||.+                                     ..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999878999999842                                     246788888999987


Q ss_pred             eEEEEEecCCCeEEEEEEccCCCCHHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCC
Q 040294          248 VKIISSCSNEDFRALVLEYMTNGSLEKV-LYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDN  325 (360)
Q Consensus       248 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~  325 (360)
                      .....+....  .++||||++|+++... +..  ..++......++.|++.++.++|   . .+|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            5444333332  4899999998865433 332  34667788899999999999999   7 8999999999999999 8


Q ss_pred             CcEEEeecccccccCCC
Q 040294          326 IVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       326 ~~~ki~DFGla~~~~~~  342 (360)
                      +.++|+|||+|+.+...
T Consensus       154 ~~~~liDFG~a~~~~~~  170 (190)
T cd05145         154 GKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCEEEEEcccceecCCC
Confidence            89999999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.86  E-value=8.6e-22  Score=186.31  Aligned_cols=155  Identities=27%  Similarity=0.413  Sum_probs=125.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCC----------
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNE----------  257 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~----------  257 (360)
                      .+|...+.||.|+||.||+|.. .+++.||+|.           +.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            5688889999999999999986 4688999873           45699999999999999999776543          


Q ss_pred             ----CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec-CCCcEEEee
Q 040294          258 ----DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSD  332 (360)
Q Consensus       258 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~-~~~~~ki~D  332 (360)
                          ...++||||++ ++|.+++..  ..+++.....++.|++.||+|||   +.+|+||||||+||+++ +++.+|++|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence                35789999997 589888754  34788899999999999999999   88999999999999997 456789999


Q ss_pred             cccccccCCCCCce-eeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSM-TQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~-~~~~~~gt~~Y~aP  360 (360)
                      ||.++.+....... ......|+..|+||
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aP  187 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSP  187 (342)
T ss_pred             cccceecCCccccccccccccccccccCH
Confidence            99998754321111 11223578889988

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-23  Score=182.14  Aligned_cols=150  Identities=34%  Similarity=0.422  Sum_probs=118.8

Q ss_pred             CCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHH-hhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          205 NNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEV-MKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      ...||.|+||+|+|..++ .|+..|||++            ..|.+. ++.-+.||||+++|++..++..|+.||.|.- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            457999999999999865 7999999854            334443 4445689999999999999999999999954 


Q ss_pred             CHHHHHh---c-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          271 SLEKVLY---S-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       271 ~L~~~l~---~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      |+..+..   . .+..+++.-.-.|+.-.+.||+||..  ...|||||+||+|||+|..|.+|+||||++..+.+   +.
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---Si  222 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SI  222 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---HH
Confidence            6655432   1 22345555555566777899999985  56799999999999999999999999999988753   33


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ..+..+|...||||
T Consensus       223 AkT~daGCrpYmAP  236 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAP  236 (361)
T ss_pred             HhhhccCCccccCh
Confidence            45667899999998

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=4.3e-21  Score=193.84  Aligned_cols=156  Identities=29%  Similarity=0.506  Sum_probs=129.6

Q ss_pred             CCCCCCeeccCCCccEEEEEcc----C----CcEEEehh------------hHHHHHHhhcCC-CCCeeEEEEEecCCCe
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ----D----GMEFAIKS------------FDVECEVMKSIH-HRNLVKIISSCSNEDF  259 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~----~----~~~vavK~------------~~~E~~~l~~l~-hpniv~l~~~~~~~~~  259 (360)
                      +....+.+|+|.||.|++|...    .    ...||||.            +..|+++|+.+. ||||+.++|+|..++.
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            3445569999999999999742    1    35688873            456899998875 9999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC
Q 040294          260 RALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD  324 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~  324 (360)
                      .++|+||++.|+|.++++..+               ..+...+.+.++.|||.|++||+   +.+++||||-+.|||+.+
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITK  453 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecC
Confidence            999999999999999998765               34778889999999999999999   999999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCceeeecccc--cCcccCC
Q 040294          325 NIVAHLSDFGIAKLLTGEDQSMTQTQTLA--TIGYMAP  360 (360)
Q Consensus       325 ~~~~ki~DFGla~~~~~~~~~~~~~~~~g--t~~Y~aP  360 (360)
                      +..+||+|||+|+........... ...|  ...||||
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmAp  490 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAP  490 (609)
T ss_pred             CCEEEEccccceeccCCCCceEec-CCCCccceeecCH
Confidence            999999999999976555433222 1222  4469998

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=4.4e-21  Score=171.57  Aligned_cols=156  Identities=24%  Similarity=0.382  Sum_probs=134.4

Q ss_pred             CCCCCCCeeccCCCccEEEEE-ccCCcEEEeh---------hhHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEccC
Q 040294          200 NGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK---------SFDVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK---------~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      -.|.+.+.||+|+||+.+.|+ +-+++.||||         .+..|....+.+. .++|..++.+.+++-+..||+|.+ 
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            368899999999999999998 6689999998         3456777666664 789999999999999999999988 


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-----CcEEEeecccccccCCCC
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-----IVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-----~~~ki~DFGla~~~~~~~  343 (360)
                      |.||++++.-++..++..++..+|.|++.-++|+|   ++.+|.|||||+|+||...     ..+.|+|||+||.+.+..
T Consensus       107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            88999999988889999999999999999999999   9999999999999999743     468999999999986554


Q ss_pred             Cc-----eeeecccccCcccC
Q 040294          344 QS-----MTQTQTLATIGYMA  359 (360)
Q Consensus       344 ~~-----~~~~~~~gt~~Y~a  359 (360)
                      ..     ....+..||.+||+
T Consensus       184 TkqHIPYrE~KSLsGTARYMS  204 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMS  204 (449)
T ss_pred             ccccCccccccccccceeeeE
Confidence            22     22346779999996

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-22  Score=177.44  Aligned_cols=151  Identities=27%  Similarity=0.467  Sum_probs=123.4

Q ss_pred             CCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC-----eEEEEE
Q 040294          204 ANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED-----FRALVL  264 (360)
Q Consensus       204 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~  264 (360)
                      ..+.||-|+||.||-... ++|+.||.|++             -+|++++..++|.|+...++..+-..     ++|.+.
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            347899999999998885 58999998754             46999999999999999988776553     467888


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |.|. .+|.+++-..+ .++.....-+..||++||.|||   +.+|+||||||.|.|++.+...||+|||+|+....++ 
T Consensus       137 ELmQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-  210 (449)
T KOG0664|consen  137 ELMQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-  210 (449)
T ss_pred             HHHH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhh-
Confidence            8885 48888776543 3555556668999999999999   9999999999999999999999999999999866543 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                      ....+..+-|.+|.||
T Consensus       211 ~~hMTqEVVTQYYRAP  226 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAP  226 (449)
T ss_pred             hhhhHHHHHHHHhccH
Confidence            3345566778888887

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.84  E-value=3.2e-20  Score=163.67  Aligned_cols=155  Identities=32%  Similarity=0.482  Sum_probs=131.0

Q ss_pred             CCCCCeeccCCCccEEEEEccC-CcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      |+..+.||+|++|.||++...+ ++.+|+|.+            .+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4566889999999999999764 788988743            348889999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      +++|.+++......+++.....++.+++.++.|||   ..+++|+|++++||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence            99999999765433788899999999999999999   889999999999999999999999999999876543200 12


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....++..|++|
T Consensus       157 ~~~~~~~~~~~p  168 (225)
T smart00221      157 KTVKGTPFYLAP  168 (225)
T ss_pred             cceeccCCcCCH
Confidence            234567778876

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.84  E-value=7.8e-22  Score=168.12  Aligned_cols=139  Identities=23%  Similarity=0.456  Sum_probs=118.6

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEeh--------hhHHHHHHhhcCC-CCCeeEEEEEecCCC--eEEEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIK--------SFDVECEVMKSIH-HRNLVKIISSCSNED--FRALVLE  265 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK--------~~~~E~~~l~~l~-hpniv~l~~~~~~~~--~~~lv~e  265 (360)
                      ..++|++.+.+|+|.|++||.|.. .+.+.++||        ++.+|+.+|+.++ ||||++|++...+..  ...||+|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE  115 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE  115 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence            456788889999999999999984 456666664        5778999999998 999999999998765  5679999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEEeecccccccCCCC
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki~DFGla~~~~~~~  343 (360)
                      |+.+-+...+..    .++......++.+++.||.|+|   +.||+|||+||.|+++|. .-..+++|+|+|..+.+..
T Consensus       116 ~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  116 YVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            999988776653    3555677889999999999999   999999999999999996 4689999999999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=1.3e-20  Score=161.90  Aligned_cols=157  Identities=26%  Similarity=0.372  Sum_probs=130.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEE-ccCCcEEEehh---------hHHHHHHhhcCCC-CCeeEEEEEecCCCeEEEEEEcc
Q 040294          199 TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKS---------FDVECEVMKSIHH-RNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~---------~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ...|...+.||+|+||.+|.|. ..+|.+||||.         +.-|..+.+.+++ ..|..+..+..++++-.+|||.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            3568889999999999999998 56899999983         4558888888875 67888888999999999999988


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEeecccccccCCCCC
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~DFGla~~~~~~~~  344 (360)
                       |.+|++++.-+...++..+++.+|-|++.-++|+|   .+++|||||||+|+|..-   ...+.++|||+|+.+.+...
T Consensus        94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence             88999999887778999999999999999999999   899999999999999974   35688999999998654321


Q ss_pred             c-----eeeecccccCcccC
Q 040294          345 S-----MTQTQTLATIGYMA  359 (360)
Q Consensus       345 ~-----~~~~~~~gt~~Y~a  359 (360)
                      .     .......||.+|.+
T Consensus       170 ~~HIpyre~r~ltGTaRYAS  189 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYAS  189 (341)
T ss_pred             cccCccccCCccceeeeehh
Confidence            1     11234567877753

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=2e-19  Score=155.91  Aligned_cols=148  Identities=42%  Similarity=0.658  Sum_probs=126.2

Q ss_pred             eccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHHH
Q 040294          208 IGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEK  274 (360)
Q Consensus       208 iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~  274 (360)
                      ||+|++|.||++... +++.+++|.            +.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999975 488888873            4578999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEEeecccccccCCCCCceeeecccc
Q 040294          275 VLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFGIAKLLTGEDQSMTQTQTLA  353 (360)
Q Consensus       275 ~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki~DFGla~~~~~~~~~~~~~~~~g  353 (360)
                      ++......+++..+..++.++++++.|||   ..+++|+|++|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            99765446788999999999999999999   889999999999999999 89999999999987653321  1122346


Q ss_pred             cCcccCC
Q 040294          354 TIGYMAP  360 (360)
Q Consensus       354 t~~Y~aP  360 (360)
                      ...|++|
T Consensus       156 ~~~~~~p  162 (215)
T cd00180         156 TPAYMAP  162 (215)
T ss_pred             CCCccCh
Confidence            6677766

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=1.6e-19  Score=158.06  Aligned_cols=128  Identities=16%  Similarity=0.312  Sum_probs=98.8

Q ss_pred             CCCCCeeccCCCccEEEEEccCCcEEEeh-----------hhHHHHHHhhcC-----CCCCeeEEEEEecCCC---eEE-
Q 040294          202 FSANNLIGRGSFGSVYKARLQDGMEFAIK-----------SFDVECEVMKSI-----HHRNLVKIISSCSNED---FRA-  261 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~~~~vavK-----------~~~~E~~~l~~l-----~hpniv~l~~~~~~~~---~~~-  261 (360)
                      .+..++||+|+||.||. .-.++.. +||           .+.+|+.+++.+     +||||++++++++++.   .++ 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999996 2223333 566           356799999998     6799999999998874   434 


Q ss_pred             EEEEc--cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeEEccCCCCceeecC----CCcEEEee-c
Q 040294          262 LVLEY--MTNGSLEKVLYSSNCILDILQRLNIMINVTSAL-EYLHFGFSTPIIHCDLKPHNVLLDD----NIVAHLSD-F  333 (360)
Q Consensus       262 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~yLH~~~~~~iiHrdlk~~NiLl~~----~~~~ki~D-F  333 (360)
                      +|+||  +.+|+|.+++...  .+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    +..++|+| |
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  6689999999653  35544  35677888788 9999   999999999999999974    34799999 5


Q ss_pred             ccccc
Q 040294          334 GIAKL  338 (360)
Q Consensus       334 Gla~~  338 (360)
                      |....
T Consensus       155 G~~~~  159 (210)
T PRK10345        155 GESTF  159 (210)
T ss_pred             CCcce
Confidence            55444

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=3.5e-20  Score=178.51  Aligned_cols=152  Identities=27%  Similarity=0.343  Sum_probs=126.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhhHH-------HHHHhhc-CCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSFDV-------ECEVMKS-IHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~-------E~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++.|.....+|.|+|+.|..+.. .+++..|||.+..       |+.++.. -+||||+++.+.+.++...|+|||++.|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG  400 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence            56777788899999999999885 4788999987753       5555544 4699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee-cCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL-DDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl-~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      |.+.+.+..... +. ..+..|+.+++.|+.|||   +.+|+|||+||+|||+ +..+.++|+|||.++.....     .
T Consensus       401 ~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~  470 (612)
T KOG0603|consen  401 GELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----C  470 (612)
T ss_pred             cHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----h
Confidence            999888865432 22 566679999999999999   8999999999999999 58899999999999987644     2


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      .+.+-|..|.||
T Consensus       471 ~tp~~t~~y~AP  482 (612)
T KOG0603|consen  471 DTPALTLQYVAP  482 (612)
T ss_pred             cccchhhcccCh
Confidence            234567788887

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.81  E-value=1.8e-19  Score=160.22  Aligned_cols=142  Identities=40%  Similarity=0.539  Sum_probs=123.1

Q ss_pred             CCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHHHHHhc
Q 040294          212 SFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS  278 (360)
Q Consensus       212 ~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  278 (360)
                      +||.||+|... +++.+|+|.+            ..|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 4888988743            4688999999999999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccccCccc
Q 040294          279 SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM  358 (360)
Q Consensus       279 ~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~  358 (360)
                      ... +++.....++.++++++.|||   ..+++|+|++|+||++++++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            443 788899999999999999999   8899999999999999999999999999998865432   223345788888


Q ss_pred             CC
Q 040294          359 AP  360 (360)
Q Consensus       359 aP  360 (360)
                      ||
T Consensus       154 ~p  155 (244)
T smart00220      154 AP  155 (244)
T ss_pred             CH
Confidence            87

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.79  E-value=5.1e-20  Score=160.68  Aligned_cols=136  Identities=21%  Similarity=0.402  Sum_probs=111.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhhHHHHHHhh----------cC-CCCCeeEEEE-EecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDVECEVMK----------SI-HHRNLVKIIS-SCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~E~~~l~----------~l-~hpniv~l~~-~~~~~~~~~lv~e  265 (360)
                      .+.|.+.+.+|+|.||.+-+++++ +.+.+++|.+.++...++          .+ .|.||+.-++ .|+..+...+++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            456788899999999999999986 577888886654433322          22 4899998776 4778888899999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec--CCCcEEEeeccccccc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD--DNIVAHLSDFGIAKLL  339 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~--~~~~~ki~DFGla~~~  339 (360)
                      |++.|+|.+-+...  .+.+.....++.|++.|++|||   ++.++|||||.+|||+-  +...+|+||||+.+..
T Consensus       103 ~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             cCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999988653  4677788899999999999999   99999999999999993  3458999999998753

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.79  E-value=5.6e-19  Score=160.74  Aligned_cols=153  Identities=25%  Similarity=0.373  Sum_probs=127.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhhH----------HHHHHhhcCCC--C----CeeEEEEEecCCCeEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSFD----------VECEVMKSIHH--R----NLVKIISSCSNEDFRA  261 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~----------~E~~~l~~l~h--p----niv~l~~~~~~~~~~~  261 (360)
                      ++.|.+.+.+|+|.||.|-++.. +.+..||||.++          -|+++++++.+  |    -+|++.++|.-.++.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC  167 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC  167 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence            67888999999999999999984 457889998764          38889999843  2    3789999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC----------------
Q 040294          262 LVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD----------------  324 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~----------------  324 (360)
                      ||+|.+ |-|+.+++...+ ..++......|+.|++++++|||   +..++|-||||+|||+.+                
T Consensus       168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCcccee
Confidence            999998 669999998754 35888899999999999999999   999999999999999831                


Q ss_pred             ----CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          325 ----NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       325 ----~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                          +..+||+|||.|..-....     ...+.|..|.||
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAP  278 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAP  278 (415)
T ss_pred             ccCCCcceEEEecCCcceeccCc-----ceeeeccccCCc
Confidence                2358999999998754333     345678899998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=4.6e-19  Score=154.67  Aligned_cols=134  Identities=25%  Similarity=0.237  Sum_probs=107.1

Q ss_pred             HHHHHhCCCCCCCeeccCCCccEEEEEccCCcEEEehh---------------------------------hHHHHHHhh
Q 040294          194 ELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS---------------------------------FDVECEVMK  240 (360)
Q Consensus       194 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~---------------------------------~~~E~~~l~  240 (360)
                      ++.+...-|...+.||+|+||.||++..++|+.||||.                                 +..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34444444777899999999999999988899999983                                 245777888


Q ss_pred             cCCCC--CeeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCC
Q 040294          241 SIHHR--NLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPH  318 (360)
Q Consensus       241 ~l~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~  318 (360)
                      ++.|+  .+++.++.    ...++||||++|++|......       .....++.+++.++.++|   ..+|+|||+||+
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~  154 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEF  154 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcc
Confidence            88777  44455442    345899999999999775431       234568899999999999   899999999999


Q ss_pred             ceeecCCCcEEEeecccccccCC
Q 040294          319 NVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       319 NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ||++++++.++|+|||.+.....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=4.5e-19  Score=156.07  Aligned_cols=124  Identities=25%  Similarity=0.370  Sum_probs=106.8

Q ss_pred             CeeccCCCccEEEEEccCCcEEEehh-------------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAIKS-------------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vavK~-------------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +.||+|++|.||+|++ +|..+++|.                   +..|++++..++|++++....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 567788763                   34588899999999988777777777778999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      ++|++|.+++....    + .+..++.+++.+|.++|   ..+++|||++|+||+++ ++.++|+|||.++..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99999999986532    2 67889999999999999   89999999999999999 789999999998864

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.2e-18  Score=148.84  Aligned_cols=122  Identities=19%  Similarity=0.229  Sum_probs=99.5

Q ss_pred             CCCCeeccCCCccEEEEEccCCcEEEeh---------------hhHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEc
Q 040294          203 SANNLIGRGSFGSVYKARLQDGMEFAIK---------------SFDVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       203 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK---------------~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      .....|++|+||+||.+.. .+..++.+               .+.+|+++|+++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999998766 45555532               3678999999996 5889999886    346999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccC-CCCceeecCCCcEEEeecccccccC
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL-KPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdl-k~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++|.+|.+.+..        ....++.|++++++++|   +.+|+|||| ||+|||++.++.++|+|||+|....
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            999999765421        12347789999999999   999999999 7999999999999999999998544

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=7.4e-19  Score=157.32  Aligned_cols=137  Identities=18%  Similarity=0.191  Sum_probs=107.4

Q ss_pred             HHHhCCCCCCCeeccCCCccEEEEE--ccCCcEEEehhh-----------------------------------HHHHHH
Q 040294          196 LRATNGFSANNLIGRGSFGSVYKAR--LQDGMEFAIKSF-----------------------------------DVECEV  238 (360)
Q Consensus       196 ~~~~~~f~~~~~iG~G~~g~Vy~~~--~~~~~~vavK~~-----------------------------------~~E~~~  238 (360)
                      ......|+..+.||+|+||.||+|.  ..+|+.||+|.+                                   ..|+++
T Consensus        24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            3333457788999999999999998  568999999842                                   257788


Q ss_pred             hhcCCCC--CeeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eEEccC
Q 040294          239 MKSIHHR--NLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP-IIHCDL  315 (360)
Q Consensus       239 l~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~-iiHrdl  315 (360)
                      +.++.+.  .+.+++++.    ..++||||+++++|....... ...+..+...++.|++.++.+||   ..+ |+|||+
T Consensus       104 L~~L~~~~i~~p~~~~~~----~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Di  175 (237)
T smart00090      104 LQRLYEAGVPVPKPIAWR----RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDL  175 (237)
T ss_pred             HHHHHhcCCCCCeeeEec----CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCC
Confidence            8888753  344555432    348999999998887654322 23455566789999999999999   888 999999


Q ss_pred             CCCceeecCCCcEEEeecccccccCC
Q 040294          316 KPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       316 k~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ||+||+++ ++.++++|||.|.....
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhccCC
Confidence            99999999 88999999999987554

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=2.5e-18  Score=161.34  Aligned_cols=156  Identities=29%  Similarity=0.438  Sum_probs=125.6

Q ss_pred             CCCCCCeeccCCCccEEEEEccCC--cEEEeh-----------hhHHHHHHhhcCCC----CCeeEEEEEe-cCCCeEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDG--MEFAIK-----------SFDVECEVMKSIHH----RNLVKIISSC-SNEDFRAL  262 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~--~~vavK-----------~~~~E~~~l~~l~h----pniv~l~~~~-~~~~~~~l  262 (360)
                      .|.+.+.||+|+||.||.+.....  ..+|+|           .+..|+.++..+..    +++.++++.. ..++..++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            788999999999999999996543  478876           25678888888873    6899999999 57889999


Q ss_pred             EEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-----CcEEEeecccc
Q 040294          263 VLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-----IVAHLSDFGIA  336 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-----~~~ki~DFGla  336 (360)
                      ||+.+ |.+|.++..... ..++..+.+.|+.|++.+|+++|   +.+++||||||+|++++..     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99987 889999875443 67889999999999999999999   9999999999999999854     46899999999


Q ss_pred             c--ccCCCCCc----e-e-eecccccCcccCC
Q 040294          337 K--LLTGEDQS----M-T-QTQTLATIGYMAP  360 (360)
Q Consensus       337 ~--~~~~~~~~----~-~-~~~~~gt~~Y~aP  360 (360)
                      +  ........    . . .....||..|.++
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~  206 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI  206 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccH
Confidence            8  43222211    1 1 1235699999764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=1.9e-18  Score=172.80  Aligned_cols=129  Identities=20%  Similarity=0.293  Sum_probs=107.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEe----h--------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAI----K--------------SFDVECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vav----K--------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      ...|...+.||+|+||.||++.+.+...++.    |              .+..|++++++++|++++....++...+..
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            3445667999999999999998754332211    1              245699999999999999888888777778


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||++|++|.+++.         ....++.+++++|.|||   +.+++|||+||+|||+ +++.++|+|||+++...
T Consensus       412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            99999999999999875         35678999999999999   8999999999999999 57899999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=2e-18  Score=150.55  Aligned_cols=121  Identities=22%  Similarity=0.377  Sum_probs=99.8

Q ss_pred             eeccCCCccEEEEEccCCcEEEehh-------------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          207 LIGRGSFGSVYKARLQDGMEFAIKS-------------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       207 ~iG~G~~g~Vy~~~~~~~~~vavK~-------------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +||+|+||.||+|.+ ++..+++|.                   +..|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 567777764                   225888999999887655555555566678999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      +|++|.+.+.....        .++.+++.+|.++|   +.+++|||++|.||+++ ++.+++.|||+++...
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            99999988754321        68999999999999   99999999999999999 8899999999988743

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.75  E-value=2.5e-18  Score=151.37  Aligned_cols=135  Identities=13%  Similarity=0.164  Sum_probs=110.0

Q ss_pred             HHHHHH--HhCCCCCCCeeccCCCccEEEEEccCCcEEEehhh--------------------HHHHHHhhcCCCCCeeE
Q 040294          192 YLELLR--ATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF--------------------DVECEVMKSIHHRNLVK  249 (360)
Q Consensus       192 ~~~~~~--~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~--------------------~~E~~~l~~l~hpniv~  249 (360)
                      |.++..  -.++|+..+++|.|+||.||.+.. ++..+|||.|                    ++|++.+.++.||+|..
T Consensus        21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~   99 (232)
T PRK10359         21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS   99 (232)
T ss_pred             HHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence            444433  356899999999999999999766 5678999843                    56788999999999999


Q ss_pred             EEEEecCC--------CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcee
Q 040294          250 IISSCSNE--------DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVL  321 (360)
Q Consensus       250 l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiL  321 (360)
                      +..++...        ...+|||||++|.+|.++..     .+.    ....+++.++..+|   +.+++|||+||+||+
T Consensus       100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nil  167 (232)
T PRK10359        100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFI  167 (232)
T ss_pred             ceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEE
Confidence            98886533        35789999999999988732     222    24568999999999   999999999999999


Q ss_pred             ecCCCcEEEeecccccccC
Q 040294          322 LDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       322 l~~~~~~ki~DFGla~~~~  340 (360)
                      +++++ ++++|||..+...
T Consensus       168 i~~~g-i~liDfg~~~~~~  185 (232)
T PRK10359        168 VSKNG-LRIIDLSGKRCTA  185 (232)
T ss_pred             EeCCC-EEEEECCCccccc
Confidence            99888 9999999887653

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.75  E-value=3.1e-18  Score=157.69  Aligned_cols=133  Identities=32%  Similarity=0.456  Sum_probs=116.8

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc----CCcEEEehhh---------HHHHHHhhcCC-CCCeeEEEEEecCCCeEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSF---------DVECEVMKSIH-HRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~---------~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv  263 (360)
                      ..+.|...+.||+|+|++||++...    ....||+|.+         ..|++.|..+. +.||+++.+++..++.+.+|
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv  113 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV  113 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence            4567888999999999999999854    3567999854         57999999886 99999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEEeeccccc
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFGIAK  337 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki~DFGla~  337 (360)
                      +||++.-+..++...    ++......+.+.+..||.++|   ..+|||||+||+|+|.+. .+.-.|.|||+|.
T Consensus       114 lp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  114 LPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             ecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            999999888888754    456777889999999999999   999999999999999984 5677899999997

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.73  E-value=5.1e-18  Score=151.31  Aligned_cols=149  Identities=29%  Similarity=0.395  Sum_probs=118.6

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC------eE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED------FR  260 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~------~~  260 (360)
                      .|...+.+|.|.- .|--+-. -.++.||+|+.             .+|..++..+.|+||++++.+|.-..      ..
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            3444566777765 4444432 25778888753             35899999999999999999997543      57


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |+|||||. .+|...++.   .++......|..|++.|+.|||   +.+|+||||||+||++..+..+||.|||+|+.-.
T Consensus        97 y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccC
Confidence            99999995 488887763   3677788889999999999999   9999999999999999999999999999998643


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+   ...+..+.|..|.||
T Consensus       170 ~~---~~mtpyVvtRyyrap  186 (369)
T KOG0665|consen  170 TD---FMMTPYVVTRYYRAP  186 (369)
T ss_pred             cc---cccCchhheeeccCc
Confidence            22   344556788889887

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.72  E-value=1.1e-16  Score=147.44  Aligned_cols=154  Identities=42%  Similarity=0.613  Sum_probs=128.5

Q ss_pred             CCCCCeeccCCCccEEEEEccCCcEEEeh--------------hhHHHHHHhhcCCCC-CeeEEEEEecCCCeEEEEEEc
Q 040294          202 FSANNLIGRGSFGSVYKARLQDGMEFAIK--------------SFDVECEVMKSIHHR-NLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~~~~vavK--------------~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~  266 (360)
                      |...+.||.|+||.||++...  ..+|+|              .+..|+.+++.+.|+ +++++...+......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556678999999999999876  566664              255688899999988 799999999888788999999


Q ss_pred             cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-cEEEeecccccccCCCC
Q 040294          267 MTNGSLEKVLYSSN--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTGED  343 (360)
Q Consensus       267 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-~~ki~DFGla~~~~~~~  343 (360)
                      +.++++.+++....  ..++......++.|++.++.|+|   +.+++|||+||+||+++... .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997776543  25788888999999999999999   88899999999999999888 79999999998665443


Q ss_pred             Cce----eeecccccCcccCC
Q 040294          344 QSM----TQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~----~~~~~~gt~~Y~aP  360 (360)
                      ...    ......||..|+||
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~p  177 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAP  177 (384)
T ss_pred             ccccccccccccccccccCCH
Confidence            221    23456799999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=8.4e-17  Score=138.81  Aligned_cols=126  Identities=22%  Similarity=0.254  Sum_probs=90.8

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEehhhH-----------------------------------HHHHHhhcCCCCC--e
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIKSFD-----------------------------------VECEVMKSIHHRN--L  247 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~-----------------------------------~E~~~l~~l~hpn--i  247 (360)
                      .+.||+|+||.||+|+..+++.||||.+.                                   .|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999998532                                   1233333333222  3


Q ss_pred             eEEEEEecCCCeEEEEEEccCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCC
Q 040294          248 VKIISSCSNEDFRALVLEYMTNGSLEK-VLYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDN  325 (360)
Q Consensus       248 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~  325 (360)
                      .+.++.    ...++||||++++++.. .+....  .. .....++.+++.++.++|   . .+|+|||+||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            333332    23589999999954321 111111  11 456778999999999999   7 8999999999999999 8


Q ss_pred             CcEEEeecccccccCC
Q 040294          326 IVAHLSDFGIAKLLTG  341 (360)
Q Consensus       326 ~~~ki~DFGla~~~~~  341 (360)
                      +.++++|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            9999999999986654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=3.5e-16  Score=129.01  Aligned_cols=126  Identities=21%  Similarity=0.329  Sum_probs=107.2

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEehh---------hHHHHHHhhcCCC--CCeeEEEEEecCCCeEEEEEEccCCCCHH
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHH--RNLVKIISSCSNEDFRALVLEYMTNGSLE  273 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK~---------~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L~  273 (360)
                      .+.||+|.++.||+++..+ ..+++|.         +..|+..++.++|  +.+++++.++..++..+++|||++++.+.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            4679999999999999754 6777762         5678899999987  59999999998888899999999998776


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          274 KVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       274 ~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      ..        +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++..
T Consensus        82 ~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          82 EV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            54        45567778999999999999544468999999999999999899999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=9.7e-16  Score=137.44  Aligned_cols=126  Identities=19%  Similarity=0.310  Sum_probs=98.7

Q ss_pred             CCeec-cCCCccEEEEEccCCcEEEehhh------------------------HHHHHHhhcCCCCCe--eEEEEEecCC
Q 040294          205 NNLIG-RGSFGSVYKARLQDGMEFAIKSF------------------------DVECEVMKSIHHRNL--VKIISSCSNE  257 (360)
Q Consensus       205 ~~~iG-~G~~g~Vy~~~~~~~~~vavK~~------------------------~~E~~~l~~l~hpni--v~l~~~~~~~  257 (360)
                      ..+|| .|+.|+||+++.. +..++||.+                        .+|++++.+++|+++  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35788 8999999998875 556666522                        348999999998885  6777764432


Q ss_pred             C----eEEEEEEccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEee
Q 040294          258 D----FRALVLEYMTN-GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD  332 (360)
Q Consensus       258 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~D  332 (360)
                      .    ..++||||++| .+|.+++...  .++..    .+.+++.++.+||   +.+|+|||+||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2    23599999997 6999888643  23332    3578999999999   99999999999999999988999999


Q ss_pred             cccccccC
Q 040294          333 FGIAKLLT  340 (360)
Q Consensus       333 FGla~~~~  340 (360)
                      ||.+....
T Consensus       186 fg~~~~~~  193 (239)
T PRK01723        186 FDRGELRT  193 (239)
T ss_pred             CCCcccCC
Confidence            99988754

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=6e-16  Score=144.90  Aligned_cols=123  Identities=28%  Similarity=0.389  Sum_probs=102.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh----------HHHHHHhhcCC-----C---CCeeEEEEEecC----
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF----------DVECEVMKSIH-----H---RNLVKIISSCSN----  256 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~----------~~E~~~l~~l~-----h---pniv~l~~~~~~----  256 (360)
                      .+|-+.+.||.|.|++||+|.. ++.+-||+|..          ..|+++|++++     |   ..||+|++.|..    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            4577889999999999999984 57788999854          35899998874     3   369999999975    


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC
Q 040294          257 EDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN  325 (360)
Q Consensus       257 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~  325 (360)
                      +.++++|+|++ |-+|..++.... ..++...+..|+.||+.||.|||..  .+|||-||||+|||+..+
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCST  224 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeecc
Confidence            45899999999 678888887543 4688899999999999999999974  489999999999999643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.61  E-value=3.4e-16  Score=163.76  Aligned_cols=117  Identities=17%  Similarity=0.257  Sum_probs=87.4

Q ss_pred             hcCCC-CCeeEEEEEe-------cCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 040294          240 KSIHH-RNLVKIISSC-------SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII  311 (360)
Q Consensus       240 ~~l~h-pniv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ii  311 (360)
                      +.++| +||++++++|       ...+..+.++||+ +++|.+++......+++.+++.++.||++||+|||   +.+|+
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            45566 6888888888       2334567788988 56999999766566899999999999999999999   99999


Q ss_pred             EccCCCCceeecC-------------------CCcEEEeecccccccCCCC--------------CceeeecccccCccc
Q 040294          312 HCDLKPHNVLLDD-------------------NIVAHLSDFGIAKLLTGED--------------QSMTQTQTLATIGYM  358 (360)
Q Consensus       312 Hrdlk~~NiLl~~-------------------~~~~ki~DFGla~~~~~~~--------------~~~~~~~~~gt~~Y~  358 (360)
                      ||||||+|||++.                   ++.+|++|||+++......              ........+||++||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   4556777777776432100              000112246899999


Q ss_pred             CC
Q 040294          359 AP  360 (360)
Q Consensus       359 aP  360 (360)
                      ||
T Consensus       183 AP  184 (793)
T PLN00181        183 SP  184 (793)
T ss_pred             Ch
Confidence            99

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.61  E-value=4e-16  Score=147.01  Aligned_cols=138  Identities=27%  Similarity=0.435  Sum_probs=117.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhhH----------HHHHHhhcCC------CCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD----------VECEVMKSIH------HRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~----------~E~~~l~~l~------hpniv~l~~~~~~~~~~~l  262 (360)
                      +.|.+....|+|-|+.|-+|+.. .|++||||.+.          .|+++|+++.      --++++++..|...+++||
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            46777778899999999999854 57899999763          5999999985      2478999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-CcEEEeeccccccc
Q 040294          263 VLEYMTNGSLEKVLYSSN--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKLL  339 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-~~~ki~DFGla~~~  339 (360)
                      |+|-+. -+|.++|+.-+  ..+....+..++.|+..||..|-   ..+|+|.||||.|||+++. ..+||||||.|...
T Consensus       512 VFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~  587 (752)
T KOG0670|consen  512 VFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASFA  587 (752)
T ss_pred             Eehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcccccc
Confidence            999885 48999987543  45777788889999999999999   8899999999999999865 57899999999876


Q ss_pred             CC
Q 040294          340 TG  341 (360)
Q Consensus       340 ~~  341 (360)
                      ..
T Consensus       588 ~e  589 (752)
T KOG0670|consen  588 SE  589 (752)
T ss_pred             cc
Confidence            53

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.59  E-value=2.3e-15  Score=137.73  Aligned_cols=164  Identities=20%  Similarity=0.307  Sum_probs=130.7

Q ss_pred             HHHHHhCCCCCCCeeccCCCccEEEEEccCC------cEEEehh------------hHHHHHHhhcCCCCCeeEEEEEec
Q 040294          194 ELLRATNGFSANNLIGRGSFGSVYKARLQDG------MEFAIKS------------FDVECEVMKSIHHRNLVKIISSCS  255 (360)
Q Consensus       194 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~------~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~  255 (360)
                      ++.....+++...++-+|.||.||+|-|++.      ++|-||.            +..|.-.+..+.|||+.++.+.+.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            3444455678888899999999999976543      3344443            345667778889999999999886


Q ss_pred             CC-CeEEEEEEccCCCCHHHHHhcC-----C--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc
Q 040294          256 NE-DFRALVLEYMTNGSLEKVLYSS-----N--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV  327 (360)
Q Consensus       256 ~~-~~~~lv~e~~~~g~L~~~l~~~-----~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~  327 (360)
                      ++ +..+.+|.++.-|+|..+|.-.     .  ..+.-.+...+|.|++.|++|||   +.+|||.||...|.+||+...
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence            54 4678889999999999999722     2  23566677889999999999999   999999999999999999999


Q ss_pred             EEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          328 AHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       328 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|++|=.+++.+.+.+...-.........||+|
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl  467 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSL  467 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCH
Confidence            999999999998877755444455567788875

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=1.9e-15  Score=155.15  Aligned_cols=138  Identities=31%  Similarity=0.437  Sum_probs=110.4

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEccCCcEEEehh--------hHHHHHHhhcCC---CCCeeEEEEEecCCCeEEEEEEc
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS--------FDVECEVMKSIH---HRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~--------~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ....|.+.+.||+|+||+||+|...+|+.||+|.        |--=.+++.+++   -+-|..+.......+.-+||+||
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey  775 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY  775 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence            3446777899999999999999988899999993        212234455555   23444455555566677899999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec-------CCCcEEEeeccccccc
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD-------DNIVAHLSDFGIAKLL  339 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~-------~~~~~ki~DFGla~~~  339 (360)
                      .+.|+|.+++. ....++|.-++.++.|+++-++.||   ..+|||+||||+|+||.       +...++|+|||-+--+
T Consensus       776 ~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  776 SPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             cccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            99999999997 4456889999999999999999999   99999999999999993       3457899999988654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=9.1e-15  Score=142.15  Aligned_cols=133  Identities=23%  Similarity=0.307  Sum_probs=94.4

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehhh--------H---------------------------------------
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKSF--------D---------------------------------------  233 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~--------~---------------------------------------  233 (360)
                      .|+ .+.||+|++|.||+|++++|+.||||..        .                                       
T Consensus       119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E  197 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE  197 (437)
T ss_pred             hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence            344 3689999999999999999999999831        1                                       


Q ss_pred             ----HHHHHhhcC----C-CCCeeEEEEE-ecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHh
Q 040294          234 ----VECEVMKSI----H-HRNLVKIISS-CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTS-ALEYL  302 (360)
Q Consensus       234 ----~E~~~l~~l----~-hpniv~l~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~yL  302 (360)
                          .|++.+.++    + ++++ .+-.. .......+|||||++|++|.+.........   .+..++..++. .+..+
T Consensus       198 ldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       198 LDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV  273 (437)
T ss_pred             HCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH
Confidence                133333332    2 3333 32222 222345689999999999988765322222   23456666665 46777


Q ss_pred             hhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       303 H~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      |   ..+++|+|++|.||++++++.++++|||++..+.+
T Consensus       274 ~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 L---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             H---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   88999999999999999999999999999988754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.8e-15  Score=146.16  Aligned_cols=144  Identities=29%  Similarity=0.386  Sum_probs=119.6

Q ss_pred             eeccCCCccEEEEEc----cCCcEEEehh-------------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEccC
Q 040294          207 LIGRGSFGSVYKARL----QDGMEFAIKS-------------FDVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       207 ~iG~G~~g~Vy~~~~----~~~~~vavK~-------------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      ++|+|+||.|+.++.    ..|..+|.|.             ...|..++..++ ||.+|+++..++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            368999999987642    2455566653             234788888888 9999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      ||++...+.... .++......+...++-+++++|   ..+|+|||+|++||+++.+|++++.|||+++......     
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----  151 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence            999999887654 4555566667778899999999   9999999999999999999999999999999865433     


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                       ..+||..||||
T Consensus       152 -~~cgt~eymAp  162 (612)
T KOG0603|consen  152 -IACGTYEYRAP  162 (612)
T ss_pred             -hcccchhhhhh
Confidence             12899999998

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=9.7e-15  Score=146.47  Aligned_cols=152  Identities=26%  Similarity=0.369  Sum_probs=118.0

Q ss_pred             CCCeeccCCCccEEEEEcc-CCcEEEehhhH-----------------HHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          204 ANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD-----------------VECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       204 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ..+++|.|++|.|+.+... ....++.|.|.                 .|..+-..++|||++..+..+.+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4678999999988776532 33334444332                 23334456899999888888777766666699


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      ||++ +|...+... ..+....+..+..|+..|+.|+|   ..+|.|||+|++|+++..++.+||+|||.+....-+...
T Consensus       402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 999998764 34666778889999999999999   999999999999999999999999999998764322222


Q ss_pred             --eeeecccccCcccCC
Q 040294          346 --MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 --~~~~~~~gt~~Y~aP  360 (360)
                        ......+|+-.|+||
T Consensus       477 ~~~~~~g~~gS~pY~ap  493 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAP  493 (601)
T ss_pred             hhhhhcCcccCCcCcCc
Confidence              445578899999998

>PLN03150 hypothetical protein; Provisional

Probab=99.51  E-value=4.1e-14  Score=143.56  Aligned_cols=119  Identities=37%  Similarity=0.600  Sum_probs=99.5

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccCCcccCeEEcCCCcccccCCccccCCCccceecccccccccCCCc
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN   84 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~   84 (360)
                      ++.|+|++|.|+|.+|..+.++++|+.|+|++               |+++|.+|..++.+++|+.|+|++|+|+|.+|+
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~---------------N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~  484 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSG---------------NSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE  484 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCC---------------CcccCcCChHHhCCCCCCEEECCCCCCCCCCch
Confidence            67888999999988888888888888777764               556778999999999999999999999999999


Q ss_pred             cccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCCCCCCCCCCCC
Q 040294           85 SFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCK  151 (360)
Q Consensus        85 ~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cgsp~~~~~~c~  151 (360)
                      .+++|++|+.|+|++|+|+|.+|..+..+.+           ......+.+|..+|+.|.  .++|.
T Consensus       485 ~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~-----------~~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLL-----------HRASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             HHhcCCCCCEEECcCCcccccCChHHhhccc-----------cCceEEecCCccccCCCC--CCCCc
Confidence            9999999999999999999999988765321           223456789999998664  35674

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.50  E-value=3.2e-14  Score=152.33  Aligned_cols=138  Identities=33%  Similarity=0.499  Sum_probs=95.7

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      ++|+.|+|++|++++.+|..+..+++|+.|++++|.+.+.        .|+.|++++|++++.+|..+.++++|+.|+|+
T Consensus       428 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls  507 (968)
T PLN00113        428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLS  507 (968)
T ss_pred             CCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECc
Confidence            3444444444444444444444445555555555544431        36788888999999999889999999999999


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccc-----------cccccCCC-CCCCCcccccccCCCCCC
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRG-GPFTKFSSKSFIGNDLLC  140 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~-----------~~~~~p~~-~~~~~~~~~~~~~n~~~c  140 (360)
                      +|+++|.+|..+..+++|++|+|++|+++|.+|..+..+.           ++|.+|.. ..+..+....+.+|...+
T Consensus       508 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        508 ENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             CCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence            9999999999999999999999999999999987665542           55666654 233445555666665443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.39  E-value=1.5e-13  Score=120.48  Aligned_cols=125  Identities=21%  Similarity=0.417  Sum_probs=105.9

Q ss_pred             CeeccCCCccEEEEEccCCcEEEe------------hhhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHH
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAI------------KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLE  273 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vav------------K~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  273 (360)
                      -.|.+...|+.|+|+|+.+..||-            +.|..|.-.++-+.||||..+++.|.....+.++..||+.|+|+
T Consensus       196 tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly  275 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY  275 (448)
T ss_pred             hhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence            346778899999999987665541            25778888999999999999999999999999999999999999


Q ss_pred             HHHhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEe
Q 040294          274 KVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLS  331 (360)
Q Consensus       274 ~~l~~~~~-~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~  331 (360)
                      ..+++... ..+..++.++|.++|+|++|||.- .+-|.---+.+..+++|++.++||+
T Consensus       276 nvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence            99997643 467889999999999999999942 4445555789999999999998876

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.38  E-value=1.6e-12  Score=109.98  Aligned_cols=118  Identities=21%  Similarity=0.260  Sum_probs=89.5

Q ss_pred             CeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCee-EEEEEecCCCeEEEEEEccCCCCHHH
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLV-KIISSCSNEDFRALVLEYMTNGSLEK  274 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~~~g~L~~  274 (360)
                      +.++.|.++.||+++.. +..|++|.          +..|+++++.+.+.+++ +++.+...  ..++||||++|.++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCCCcccc
Confidence            46788999999999865 66788873          46788888888655544 55555432  3479999999988764


Q ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-----eEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          275 VLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP-----IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       275 ~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~-----iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .-         .....++.+++++++.||   ..+     ++|+|++|.||+++ ++.++++|||.+..-
T Consensus        81 ~~---------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          81 ED---------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             cc---------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            30         112335678999999999   555     59999999999999 668999999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.36  E-value=3.3e-12  Score=126.03  Aligned_cols=137  Identities=20%  Similarity=0.248  Sum_probs=87.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC-CcEEEehhhH---------------------------------------------
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSFD---------------------------------------------  233 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~---------------------------------------------  233 (360)
                      .+|+. +.||+|++|.||+|++++ |++||||...                                             
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 789999999999999887 9999998321                                             


Q ss_pred             ------HHHHHhhcC----CCCCeeEEEEEecC-CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHh
Q 040294          234 ------VECEVMKSI----HHRNLVKIISSCSN-EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL  302 (360)
Q Consensus       234 ------~E~~~l~~l----~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yL  302 (360)
                            .|+..+.++    .+...+.+-.++.+ ....+|||||++|+.+.+.-.-.....+.   ..++...++.  |+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~---~~la~~~v~~--~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM---KLLAERGVEV--FF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH---HHHHHHHHHH--HH
Confidence                  122222222    23333333232221 33568999999999997743211111221   1222222221  22


Q ss_pred             hhcCCCCeEEccCCCCceeecCCC----cEEEeecccccccCCC
Q 040294          303 HFGFSTPIIHCDLKPHNVLLDDNI----VAHLSDFGIAKLLTGE  342 (360)
Q Consensus       303 H~~~~~~iiHrdlk~~NiLl~~~~----~~ki~DFGla~~~~~~  342 (360)
                      .+....+++|+|++|.||+++.++    .+++.|||++..+...
T Consensus       274 ~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        274 TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            222267999999999999999888    9999999999887543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1.4e-11  Score=113.58  Aligned_cols=90  Identities=27%  Similarity=0.393  Sum_probs=71.3

Q ss_pred             CCCCCeeEEEEEecC---------------------------CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHH
Q 040294          242 IHHRNLVKIISSCSN---------------------------EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMIN  294 (360)
Q Consensus       242 l~hpniv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~  294 (360)
                      -+|||||++.++|.+                           ...+|+||.-.+. +|.+++....  .+...+..|..|
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQ  349 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHH
Confidence            369999999988754                           2357899987754 8999887653  344456668999


Q ss_pred             HHHHHHHhhhcCCCCeEEccCCCCceee--cCCC--cEEEeeccccc
Q 040294          295 VTSALEYLHFGFSTPIIHCDLKPHNVLL--DDNI--VAHLSDFGIAK  337 (360)
Q Consensus       295 i~~~l~yLH~~~~~~iiHrdlk~~NiLl--~~~~--~~ki~DFGla~  337 (360)
                      +++|+.|||   ..+|.|||+|++|||+  |+|.  ...|+|||.+-
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence            999999999   9999999999999998  4444  46899999764

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.23  E-value=5.4e-13  Score=109.72  Aligned_cols=108  Identities=29%  Similarity=0.477  Sum_probs=87.5

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++.+++|-||+|+++ .+|+.+..+.+|+.|++++|+++.+        .|++|+++-|++. .+|..||.++.|+.|||
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence            467889999999999 7888999999999999999999875        4778888888876 56888888888888888


Q ss_pred             cccccc-cCCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           74 GHNRLQ-GSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        74 ~~N~l~-g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      ..|++. ..+|+.|..|+.|+.|.|++|.|. ++|..+++
T Consensus       110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~  148 (264)
T KOG0617|consen  110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGK  148 (264)
T ss_pred             cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhh
Confidence            888886 457888888888888888888886 34444443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=1.5e-10  Score=102.12  Aligned_cols=131  Identities=19%  Similarity=0.261  Sum_probs=101.9

Q ss_pred             CeeccCCCccEEEEEccCCcEEEehh------------hHHHHHHhhcCCC--CCeeEEEEEecCCC---eEEEEEEccC
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAIKS------------FDVECEVMKSIHH--RNLVKIISSCSNED---FRALVLEYMT  268 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vavK~------------~~~E~~~l~~l~h--pniv~l~~~~~~~~---~~~lv~e~~~  268 (360)
                      +.++.|.++.||+++..+|..+++|.            +..|.++++.+++  ..+.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887667888872            4578889998876  34577788776643   5689999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG-------------------------------------------  305 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-------------------------------------------  305 (360)
                      |.++.+.+..  ..++..++..++.++++.|.+||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888775431  2356667777888888888888832                                           


Q ss_pred             ----------CCCCeEEccCCCCceeecC--CCcEEEeecccccc
Q 040294          306 ----------FSTPIIHCDLKPHNVLLDD--NIVAHLSDFGIAKL  338 (360)
Q Consensus       306 ----------~~~~iiHrdlk~~NiLl~~--~~~~ki~DFGla~~  338 (360)
                                ....++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      1245799999999999998  66789999998875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.19  E-value=2.1e-12  Score=123.90  Aligned_cols=114  Identities=34%  Similarity=0.433  Sum_probs=68.1

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------------------------------ccCeEE
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------------------------------VLTRTD   48 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------------------------------~L~~l~   48 (360)
                      |++|++|+||+|.|....+.++..+.+|+.|+|+.|+|+.+                                 +|..||
T Consensus       292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~Ld  371 (873)
T KOG4194|consen  292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLD  371 (873)
T ss_pred             cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhc
Confidence            45555555555555555555555555555555555555432                                 355666


Q ss_pred             cCCCcccccCCc---cccCCCccceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcccc
Q 040294           49 FSRNNLLGDIPT---TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLL  115 (360)
Q Consensus        49 l~~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~  115 (360)
                      |++|.|++.|-+   .|.++++|+.|+|.+|++....-.+|..+.+|++|||.+|.+-.+-|.+++.+.+
T Consensus       372 Lr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~L  441 (873)
T KOG4194|consen  372 LRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMEL  441 (873)
T ss_pred             CcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchh
Confidence            666666665554   2455666666666666666333355666667777777777666666666665543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.19  E-value=2.9e-12  Score=122.89  Aligned_cols=99  Identities=28%  Similarity=0.433  Sum_probs=71.9

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccCCc------------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~------------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      |+.|.|++|.++..--..|..+++|+.|||++|.|+..            .|+.|.|.+|+|....-.+|.++.+|+.||
T Consensus       343 Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld  422 (873)
T KOG4194|consen  343 LEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD  422 (873)
T ss_pred             hhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence            33334444444333333344555666666666666532            589999999999876667999999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      |.+|.+-..-|.+|..+ .|+.|-+..-.|-.
T Consensus       423 L~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflC  453 (873)
T KOG4194|consen  423 LGDNAIASIQPNAFEPM-ELKELVMNSSSFLC  453 (873)
T ss_pred             CCCCcceeecccccccc-hhhhhhhcccceEE
Confidence            99999997889999999 99999887665543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.18  E-value=4e-11  Score=115.88  Aligned_cols=99  Identities=33%  Similarity=0.575  Sum_probs=91.8

Q ss_pred             hhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe-EEccCCC
Q 040294          239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI-IHCDLKP  317 (360)
Q Consensus       239 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~i-iHrdlk~  317 (360)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......++|.-...++++++.||+|+|   ..+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            46789999999999999999999999999999999999987778999999999999999999999   5555 9999999


Q ss_pred             CceeecCCCcEEEeecccccccC
Q 040294          318 HNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       318 ~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      +|.++|....+|++|||+.....
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             ccceeeeeEEEEechhhhccccc
Confidence            99999999999999999988764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.16  E-value=3.6e-10  Score=97.59  Aligned_cols=125  Identities=21%  Similarity=0.223  Sum_probs=89.9

Q ss_pred             CeeccCCCccEEEEEccC-------CcEEEehhh-------------------------------------HHHHHHhhc
Q 040294          206 NLIGRGSFGSVYKARLQD-------GMEFAIKSF-------------------------------------DVECEVMKS  241 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~-------------------------------------~~E~~~l~~  241 (360)
                      ..||.|.=+.||.|.-.+       +..+|||.+                                     ++|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468888888999997543       468888721                                     147777777


Q ss_pred             CCC--CCeeEEEEEecCCCeEEEEEEccCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeEEccCCC
Q 040294          242 IHH--RNLVKIISSCSNEDFRALVLEYMTNGSLEK-VLYSSNCILDILQRLNIMINVTSALEYL-HFGFSTPIIHCDLKP  317 (360)
Q Consensus       242 l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~yL-H~~~~~~iiHrdlk~  317 (360)
                      +..  -++.+.+++    ...+|||||+.+..+.. .+..  ..++..+...+..+++.++..+ |   ..+|+|+|+++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            653  355566654    34689999997754422 2222  1234445566789999999999 7   78999999999


Q ss_pred             CceeecCCCcEEEeecccccccC
Q 040294          318 HNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       318 ~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      .||+++ ++.+.|+|||-|-...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4679999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=2.3e-10  Score=96.05  Aligned_cols=120  Identities=22%  Similarity=0.347  Sum_probs=91.2

Q ss_pred             eeccCCCccEEEEEccCCcEEEeh-------------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          207 LIGRGSFGSVYKARLQDGMEFAIK-------------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       207 ~iG~G~~g~Vy~~~~~~~~~vavK-------------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .+++|+=+.+|.+.+.+ ..+.+|                   .-.+|+.++.+++--.|..-.=+..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            46788888888887643 334454                   1235888998877655554444555666678999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      +|..|.+.+...        +..++..|-.-+.-||   ..+|+|+|+.++||++..+. +.++|||++..-
T Consensus        82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999998888654        2456677777788899   99999999999999998665 999999999863

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.14  E-value=4.2e-12  Score=129.48  Aligned_cols=131  Identities=21%  Similarity=0.270  Sum_probs=107.9

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehhh------------HH---HHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKSF------------DV---ECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~------------~~---E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++...+.+|++.|=+|.+|+++.|. |+||.|            .+   |++ ....+|||.+.+--+-..+...|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4566788999999999999998887 777754            22   333 556789999998877777777788888


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      |+.. +|+|.+..+ ..+...+..-||.|++.|+.-+|   ..+|+|+|||.+|||+..-..+.++||..-|.
T Consensus       102 yvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCC
Confidence            8865 899988654 34556666779999999999999   99999999999999999999999999987765

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.12  E-value=4.5e-10  Score=94.00  Aligned_cols=132  Identities=18%  Similarity=0.220  Sum_probs=97.4

Q ss_pred             CCCeeccCCCccEEEEEccCCcEEEeh-------------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          204 ANNLIGRGSFGSVYKARLQDGMEFAIK-------------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       204 ~~~~iG~G~~g~Vy~~~~~~~~~vavK-------------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ...++-+|+=+.|+++.+. |+...||                   ...+|+..+.+++--.|..-.-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4567888998999998885 5555564                   2346899998877656655455565666668999


Q ss_pred             EccCC-CCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC---cEEEeeccccccc
Q 040294          265 EYMTN-GSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI---VAHLSDFGIAKLL  339 (360)
Q Consensus       265 e~~~~-g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~---~~ki~DFGla~~~  339 (360)
                      ||++| .++.+++...... .+......++..|-+.+.-||   ...|||+||..+||++..++   .+.+.|||++..-
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99987 4777777654322 222222568888999999999   99999999999999996544   4589999998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.10  E-value=5.9e-11  Score=120.97  Aligned_cols=129  Identities=30%  Similarity=0.476  Sum_probs=90.2

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhhHHHHHHhh----cCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDVECEVMK----SIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~E~~~l~----~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      ..++|+..++|..|+||.||..+++ +.+.+|+| +.+.--+++    ....|.+|                     ||-
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRnilt~a~npfvv---------------------gDc  138 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRNILTFAGNPFVV---------------------GDC  138 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhccccccCCccee---------------------chh
Confidence            4578999999999999999999986 56778884 333222332    22233333                     555


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC---------
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED---------  343 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~---------  343 (360)
                      ...++..+ .++.        +++.+++|+|   +.+|+|||+||+|.+|..-|++|++|||+++..-...         
T Consensus       139 ~tllk~~g-~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I  206 (1205)
T KOG0606|consen  139 ATLLKNIG-PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI  206 (1205)
T ss_pred             hhhcccCC-CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence            55554432 1221        1267899999   9999999999999999999999999999987632110         


Q ss_pred             ----CceeeecccccCcccCC
Q 040294          344 ----QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ----~~~~~~~~~gt~~Y~aP  360 (360)
                          ......+.+||+.|+||
T Consensus       207 ~k~t~Ef~dKqvcgTPeyiaP  227 (1205)
T KOG0606|consen  207 EKDTHEFQDKQVCGTPEYIAP  227 (1205)
T ss_pred             HHHHHHhhhccccCCccccCh
Confidence                00112356899999998

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.10  E-value=6.1e-12  Score=103.58  Aligned_cols=101  Identities=33%  Similarity=0.487  Sum_probs=80.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccc-cCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLG-DIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~-~~p~~~~~l~~L~~L~   72 (360)
                      |.+|+.|++++|+|+ .+|..++.+..|+.|+++-|++..+        .|+.|||+.|++.. .+|..|--++.|+.|+
T Consensus        55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly  133 (264)
T KOG0617|consen   55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY  133 (264)
T ss_pred             hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence            567888899999998 7888888899999999988887654        47888888888764 5777777777788888


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      |+.|.|+ .+|...+++++|+.|.+..|.|-.
T Consensus       134 l~dndfe-~lp~dvg~lt~lqil~lrdndll~  164 (264)
T KOG0617|consen  134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLLS  164 (264)
T ss_pred             hcCCCcc-cCChhhhhhcceeEEeeccCchhh
Confidence            8888887 777788888888888888887764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.09  E-value=2.5e-10  Score=97.11  Aligned_cols=73  Identities=26%  Similarity=0.239  Sum_probs=63.1

Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++...+..+++.++..++.|++.||+|||   +.+      ||+||+++.++.+|+  ||+++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            7899999876667999999999999999999999   544      999999999999999  99998764322      


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                       ..||+.||||
T Consensus        64 -~~g~~~y~aP   73 (176)
T smart00750       64 -SRVDPYFMAP   73 (176)
T ss_pred             -CCCcccccCh
Confidence             2689999998

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.08  E-value=2.4e-11  Score=122.18  Aligned_cols=158  Identities=27%  Similarity=0.368  Sum_probs=124.4

Q ss_pred             CCCCCCeeccCCCccEEEEEccC--CcEEEehh-------------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQD--GMEFAIKS-------------FDVECEVMKSIH-HRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~-------------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .|...+.||+|+|+.|-......  ...+|+|.             ...|..+-..+. |+|++++++.....+..+++.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            45566779999999998776533  23344432             234666666776 999999999999999999999


Q ss_pred             EccCCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-cEEEeecccccccCC-
Q 040294          265 EYMTNGSLEKVL-YSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTG-  341 (360)
Q Consensus       265 e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-~~ki~DFGla~~~~~-  341 (360)
                      ||..+|++...+ +......+......+..|+..++.|+|.  ..++.|||+||+|.+++..+ ..+++|||+|..... 
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            999999999988 4443245555667789999999999994  56799999999999999999 999999999988765 


Q ss_pred             CCCceeeecccc-cCcccCC
Q 040294          342 EDQSMTQTQTLA-TIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~g-t~~Y~aP  360 (360)
                      ..........+| ++.|+||
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~  198 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAP  198 (601)
T ss_pred             CCcceeeecccCCCCCCCCc
Confidence            333344456778 9999997

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.07  E-value=3.8e-11  Score=110.70  Aligned_cols=100  Identities=31%  Similarity=0.452  Sum_probs=89.3

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++.|+.|+|++|-+. .+|.+++.+..|+.|++|.|+|..+        .++.+..++|++...-|+.++++.+|..|||
T Consensus       434 l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL  512 (565)
T KOG0472|consen  434 LQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDL  512 (565)
T ss_pred             hhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceecc
Confidence            578999999999998 7999999999999999999999875        2555566678887666666999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccC
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~  103 (360)
                      .+|.+. .+|..+++|++|++|+|++|+|.
T Consensus       513 ~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  513 QNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             CCCchh-hCChhhccccceeEEEecCCccC
Confidence            999998 89999999999999999999998

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.05  E-value=1.5e-09  Score=98.90  Aligned_cols=133  Identities=26%  Similarity=0.385  Sum_probs=83.6

Q ss_pred             CCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCC----------CCeeEEEEE----
Q 040294          203 SANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHH----------RNLVKIISS----  253 (360)
Q Consensus       203 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~h----------pniv~l~~~----  253 (360)
                      ...+.||.|+++.||.++.. +++++|||.|              ++|.-....+.+          -.++--++.    
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            34578999999999999965 6899999744              233322222211          111111111    


Q ss_pred             -----ecCC---Ce-----EEEEEEccCCCCHHHHHh---cCCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEcc
Q 040294          254 -----CSNE---DF-----RALVLEYMTNGSLEKVLY---SSNC---ILDILQRLNIMINVTSALEYLHFGFSTPIIHCD  314 (360)
Q Consensus       254 -----~~~~---~~-----~~lv~e~~~~g~L~~~l~---~~~~---~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrd  314 (360)
                           +...   ..     .+++|+-+ .+||.+++.   ....   ......++.+..|+++.+++||   ..+++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence                 1111   11     25677777 458888754   2221   2344566777899999999999   99999999


Q ss_pred             CCCCceeecCCCcEEEeeccccccc
Q 040294          315 LKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       315 lk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      |||+|++++.+|.++++||+.....
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~  195 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRA  195 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEET
T ss_pred             cceeeEEEcCCCCEEEcChHHHeec
Confidence            9999999999999999999877653

>PLN03150 hypothetical protein; Provisional

Probab=99.02  E-value=3.5e-10  Score=115.04  Aligned_cols=88  Identities=31%  Similarity=0.534  Sum_probs=77.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCcccCeEEcCCCcccccCCccccCCCccceecccccccccC
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS   81 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~   81 (360)
                      |++|+.|+|++|+|+|.+|..++++++|+.|+|++|               +++|.+|..++++++|+.|+|++|+|+|.
T Consensus       441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N---------------~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~  505 (623)
T PLN03150        441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN---------------SFNGSIPESLGQLTSLRILNLNGNSLSGR  505 (623)
T ss_pred             CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCC---------------CCCCCCchHHhcCCCCCEEECcCCccccc
Confidence            688999999999999999999999999988877654               55678899999999999999999999999


Q ss_pred             CCccccCC-CCCCeEeCcCCccCc
Q 040294           82 IPNSFDDL-VSLESLDLSNNNLSE  104 (360)
Q Consensus        82 ~p~~~~~l-~~L~~l~ls~N~l~~  104 (360)
                      +|..+..+ .++..+++++|....
T Consensus       506 iP~~l~~~~~~~~~l~~~~N~~lc  529 (623)
T PLN03150        506 VPAALGGRLLHRASFNFTDNAGLC  529 (623)
T ss_pred             CChHHhhccccCceEEecCCcccc
Confidence            99998774 477889999997544

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.01  E-value=2.7e-11  Score=117.20  Aligned_cols=107  Identities=34%  Similarity=0.555  Sum_probs=94.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      |.+|..+|||.|.|. ..|..+.++.+|+.|+||+|+|+.+        .|+.|++|.|+++ .+|+.+..++.|+.|++
T Consensus       221 l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~  298 (1255)
T KOG0444|consen  221 LHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYA  298 (1255)
T ss_pred             hhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHh
Confidence            567889999999998 8999999999999999999999986        4889999999998 68999999999999999


Q ss_pred             cccccc-cCCCccccCCCCCCeEeCcCCccCcccchhhh
Q 040294           74 GHNRLQ-GSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE  111 (360)
Q Consensus        74 ~~N~l~-g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~  111 (360)
                      .+|+++ .-||+.++.|.+|+.+..++|.|. .+|..+.
T Consensus       299 n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglc  336 (1255)
T KOG0444|consen  299 NNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLC  336 (1255)
T ss_pred             ccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhh
Confidence            999986 348999999999999999999886 5665443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.01  E-value=3.7e-10  Score=115.63  Aligned_cols=80  Identities=31%  Similarity=0.378  Sum_probs=55.9

Q ss_pred             cCeeeccccccCCc-----ccCeEEcCCCcccccCCccccCCCccceecccccccccCCCccccCCCCCCeEeCcCCccC
Q 040294           29 LRNLHLDSNELRHL-----VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        29 L~~L~l~~N~l~~~-----~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~  103 (360)
                      |+.|++++|.|+.+     .|+.|++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+
T Consensus       384 L~~LdLs~N~Lt~LP~l~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls  458 (788)
T PRK15387        384 LKELIVSGNRLTSLPVLPSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS  458 (788)
T ss_pred             cceEEecCCcccCCCCcccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence            44455555555443     25556666666653 4532   245777888888887 78888999999999999999999


Q ss_pred             cccchhhhcc
Q 040294          104 EIIPLSLEKL  113 (360)
Q Consensus       104 ~~~p~~l~~l  113 (360)
                      +.+|..+..+
T Consensus       459 ~~~~~~L~~l  468 (788)
T PRK15387        459 ERTLQALREI  468 (788)
T ss_pred             chHHHHHHHH
Confidence            9888877554

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.99  E-value=6e-11  Score=114.87  Aligned_cols=101  Identities=35%  Similarity=0.435  Sum_probs=84.3

Q ss_pred             CCCCcEeeCCCCcccc-cCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSG-SIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      |+.|+.+++.+|+|.. -+|+.+-.+..|..||||+|+|++.        ++-.|+||+|+|.....+-|-+++.|-.||
T Consensus        77 Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLD  156 (1255)
T KOG0444|consen   77 LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLD  156 (1255)
T ss_pred             chhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhc
Confidence            5677788888888864 4788888899999999999999875        466889999999854444567899999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccC
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~  103 (360)
                      ||+|++. .+|..+..|..|++|+||+|+|.
T Consensus       157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~  186 (1255)
T KOG0444|consen  157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN  186 (1255)
T ss_pred             cccchhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence            9999998 78889999999999999999774

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.95  E-value=4.6e-10  Score=95.05  Aligned_cols=99  Identities=31%  Similarity=0.459  Sum_probs=33.9

Q ss_pred             CCCcEeeCCCCcccccCCcccc-CCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccc-cCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFS-NLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTI-QGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~-~~l~~L~~L~l   73 (360)
                      ..++.|+|++|+|+ .+. .++ .+++|+.|+|++|.++.+       .|+.|++++|+|+. ++..+ ..+++|++|+|
T Consensus        19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L   95 (175)
T PF14580_consen   19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKLEGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYL   95 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S--TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-
T ss_pred             cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccccCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEEC
Confidence            35678888888887 343 465 577888888888887764       47777888888774 33334 35777888888


Q ss_pred             cccccccCC-CccccCCCCCCeEeCcCCccCc
Q 040294           74 GHNRLQGSI-PNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        74 ~~N~l~g~~-p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      ++|++...- =..++.+++|+.|+|.+|+++.
T Consensus        96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             cCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            888876321 1345667777788888887763

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.92  E-value=7.9e-09  Score=88.83  Aligned_cols=114  Identities=26%  Similarity=0.315  Sum_probs=74.8

Q ss_pred             EEEEEccCCcEEEehh-------------------------------------hHHHHHHhhcCCCC--CeeEEEEEecC
Q 040294          216 VYKARLQDGMEFAIKS-------------------------------------FDVECEVMKSIHHR--NLVKIISSCSN  256 (360)
Q Consensus       216 Vy~~~~~~~~~vavK~-------------------------------------~~~E~~~l~~l~hp--niv~l~~~~~~  256 (360)
                      ||.|...+|..+|||.                                     .++|.+.|.++..-  ++.+.+++-  
T Consensus         2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~--   79 (188)
T PF01163_consen    2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN--   79 (188)
T ss_dssp             EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred             EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence            7888877788888862                                     13588999988765  456666553  


Q ss_pred             CCeEEEEEEccC--CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeEEccCCCCceeecCCCcEEEeec
Q 040294          257 EDFRALVLEYMT--NGSLEKVLYSSNCILDILQRLNIMINVTSALEY-LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDF  333 (360)
Q Consensus       257 ~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~y-LH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DF  333 (360)
                        ...|||||++  |..+..+....   ++......++.+++..+.. +|   ..+|+|+|+.+.||+++++ .+.|+||
T Consensus        80 --~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 --RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             --TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--G
T ss_pred             --CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEec
Confidence              2479999998  54443332221   1122345567777775555 57   8899999999999999987 9999999


Q ss_pred             ccccccC
Q 040294          334 GIAKLLT  340 (360)
Q Consensus       334 Gla~~~~  340 (360)
                      |-+....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.92  E-value=4.7e-10  Score=103.39  Aligned_cols=36  Identities=31%  Similarity=0.510  Sum_probs=21.2

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccC
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR   40 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~   40 (360)
                      .+.++|..|+|+...|..|+.+++|+.||||+|.|+
T Consensus        69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is  104 (498)
T KOG4237|consen   69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS  104 (498)
T ss_pred             ceEEEeccCCcccCChhhccchhhhceecccccchh
Confidence            345566666666544555666666666666666553

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.90  E-value=1.2e-10  Score=117.14  Aligned_cols=100  Identities=39%  Similarity=0.507  Sum_probs=88.1

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      +.|+.|+|.+|.|+-..-+.|.++.+|+.|+|++|+|...         .|++|+||+|+|+ .+|+++.+|..|++|..
T Consensus       359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a  437 (1081)
T KOG0618|consen  359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA  437 (1081)
T ss_pred             HHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence            4578889999999987777788999999999999998864         4889999999998 67899999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      .+|++. .+| ++.++++|+.+|||.|+|+..
T Consensus       438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~  467 (1081)
T KOG0618|consen  438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEV  467 (1081)
T ss_pred             cCCcee-ech-hhhhcCcceEEecccchhhhh
Confidence            999998 788 899999999999999999865

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=1.1e-09  Score=76.36  Aligned_cols=59  Identities=41%  Similarity=0.571  Sum_probs=41.3

Q ss_pred             cCeEEcCCCcccccCCccccCCCccceecccccccccCCCccccCCCCCCeEeCcCCcc
Q 040294           44 LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL  102 (360)
Q Consensus        44 L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l  102 (360)
                      |+.|++++|+++...+..|.++++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            44555555556555556777777777777777777766667777788888888877764

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.87  E-value=2.3e-08  Score=90.95  Aligned_cols=104  Identities=16%  Similarity=0.142  Sum_probs=77.0

Q ss_pred             hHHHHHHhhcCCCCCe--eEEEEEecC-----CCeEEEEEEccCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHh
Q 040294          232 FDVECEVMKSIHHRNL--VKIISSCSN-----EDFRALVLEYMTNG-SLEKVLYSS-NCILDILQRLNIMINVTSALEYL  302 (360)
Q Consensus       232 ~~~E~~~l~~l~hpni--v~l~~~~~~-----~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yL  302 (360)
                      +.+|...+.++..-+|  ++.+++...     ...-+||+|++++- +|.+++... ....+...+..++.+++..+.-|
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L  154 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM  154 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            4567777776643333  333444432     23578999999986 898887532 22344556678999999999999


Q ss_pred             hhcCCCCeEEccCCCCceeecC-------CCcEEEeecccccc
Q 040294          303 HFGFSTPIIHCDLKPHNVLLDD-------NIVAHLSDFGIAKL  338 (360)
Q Consensus       303 H~~~~~~iiHrdlk~~NiLl~~-------~~~~ki~DFGla~~  338 (360)
                      |   ..+|+|+|++++|||++.       +..+.++||+.++.
T Consensus       155 H---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        155 H---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             H---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9   999999999999999975       46899999998864

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.83  E-value=2.6e-09  Score=74.43  Aligned_cols=61  Identities=39%  Similarity=0.608  Sum_probs=53.0

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCcccCeEEcCCCcccccCCccccCCCccceeccccccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRL   78 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   78 (360)
                      ++|+.|+|++|+|+...+..|.++++|+.|++++|.++.+               .|..|.++++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i---------------~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSI---------------PPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEE---------------ETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCcc---------------CHHHHcCCCCCCEEeCcCCcC
Confidence            5799999999999976667899999999999987776543               477899999999999999986

...

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.82  E-value=2.1e-10  Score=105.94  Aligned_cols=107  Identities=36%  Similarity=0.479  Sum_probs=87.5

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCcccc-CCCccceeccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQ-GLKSLQFLSLG   74 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~-~l~~L~~L~l~   74 (360)
                      +.|+.||.-.|-+. ++|+.++.+.+|..|+|..|.+..+       .|..+.++.|+++ .+|.+.+ .+.+|..|||.
T Consensus       183 ~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLR  260 (565)
T KOG0472|consen  183 KRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLR  260 (565)
T ss_pred             HHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecc
Confidence            45677788888876 7888888888888899988888765       3777888888886 5777776 88999999999


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      +|+++ +.|+++.-+.+|..||||+|.+++..+ +++++
T Consensus       261 dNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~-sLgnl  297 (565)
T KOG0472|consen  261 DNKLK-EVPDEICLLRSLERLDLSNNDISSLPY-SLGNL  297 (565)
T ss_pred             ccccc-cCchHHHHhhhhhhhcccCCccccCCc-ccccc
Confidence            99998 889999999999999999999997654 44444

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.81  E-value=7.2e-10  Score=105.84  Aligned_cols=96  Identities=26%  Similarity=0.459  Sum_probs=80.0

Q ss_pred             eEEEEEEccCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSS--NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                      ..|+.|++|+-.+|.+|+..+  ....++...+.++.|++.|++|      ++.+|||+||.||....+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999643  3346777888999999999998      67899999999999999999999999998


Q ss_pred             cccCCCC----CceeeecccccCcccCC
Q 040294          337 KLLTGED----QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~----~~~~~~~~~gt~~Y~aP  360 (360)
                      .......    .....+..+||.+||+|
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsP  431 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSP  431 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCH
Confidence            7765443    12334567899999998

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.78  E-value=1.4e-08  Score=104.30  Aligned_cols=34  Identities=35%  Similarity=0.411  Sum_probs=19.7

Q ss_pred             ccceecccccccccCCCccccCCCCCCeEeCcCCccCc
Q 040294           67 SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        67 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      +|+.|+|++|+|+ .+|...   ++|+.|++++|+|++
T Consensus       383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss  416 (788)
T PRK15387        383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS  416 (788)
T ss_pred             ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC
Confidence            4556666666665 344332   456666777776665

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.76  E-value=1.6e-08  Score=104.15  Aligned_cols=94  Identities=24%  Similarity=0.466  Sum_probs=71.8

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc------ccCeEEcCCCcccccCCccccCCCccceeccccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHN   76 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N   76 (360)
                      ++|+.|+|++|+|+ .+|..+.  ++|+.|++++|+|+.+      .|+.|+|++|++. .+|..+.  .+|+.|+|++|
T Consensus       199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N  272 (754)
T PRK15370        199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLPDTIQEMELSINRIT-ELPERLP--SALQSLDLFHN  272 (754)
T ss_pred             cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhhccccEEECcCCccC-cCChhHh--CCCCEEECcCC
Confidence            35788888888888 4666553  4788888888888765      4778888888887 5676654  47888888888


Q ss_pred             ccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           77 RLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        77 ~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      +|+ .+|..+.  .+|+.|+|++|+|++.
T Consensus       273 ~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L  298 (754)
T PRK15370        273 KIS-CLPENLP--EELRYLSVYDNSIRTL  298 (754)
T ss_pred             ccC-ccccccC--CCCcEEECCCCccccC
Confidence            888 5777664  4788888888888864

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.69  E-value=1.8e-08  Score=103.76  Aligned_cols=90  Identities=34%  Similarity=0.530  Sum_probs=38.2

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccCCc------ccCeEEcCCCcccccCCccccCCCccceeccccccc
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRL   78 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   78 (360)
                      |+.|+|++|+|+ .+|..+.  ++|+.|++++|+|+.+      .|+.|++++|+++. +|..+  .++|+.|++++|.|
T Consensus       264 L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~L  337 (754)
T PRK15370        264 LQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENAL  337 (754)
T ss_pred             CCEEECcCCccC-ccccccC--CCCcEEECCCCccccCcccchhhHHHHHhcCCcccc-CCccc--cccceeccccCCcc
Confidence            444555555554 2443332  2455555555554432      13334444444432 22221  13444444444444


Q ss_pred             ccCCCccccCCCCCCeEeCcCCccC
Q 040294           79 QGSIPNSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        79 ~g~~p~~~~~l~~L~~l~ls~N~l~  103 (360)
                      ++ +|..+.  ++|+.|+|++|+|+
T Consensus       338 t~-LP~~l~--~sL~~L~Ls~N~L~  359 (754)
T PRK15370        338 TS-LPASLP--PELQVLDVSKNQIT  359 (754)
T ss_pred             cc-CChhhc--CcccEEECCCCCCC
Confidence            42 343332  34455555555444

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.68  E-value=9.7e-09  Score=99.72  Aligned_cols=137  Identities=27%  Similarity=0.346  Sum_probs=111.0

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc--cCCcEEEehhhH-------------HHHHHhhcC-CCCCeeEEEEEecCCCeEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL--QDGMEFAIKSFD-------------VECEVMKSI-HHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~~~-------------~E~~~l~~l-~hpniv~l~~~~~~~~~~~  261 (360)
                      -+.+|.....||.|.|+.|+....  .++..|++|...             .|+.+...+ .|.+++.....|...+..|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            345788889999999999998764  467889998532             255454444 4889999888888888888


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-CcEEEeecccccc
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKL  338 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-~~~ki~DFGla~~  338 (360)
                      +--|||+++++...... ...++...++++..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||.+..
T Consensus       343 ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            99999999998776622 234666778889999999999999   9999999999999999875 8889999998863

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.67  E-value=9e-08  Score=85.22  Aligned_cols=124  Identities=23%  Similarity=0.266  Sum_probs=88.9

Q ss_pred             CCCCCeeccCCCccEEEEEccCCcEEEehh---------------------------------hHHHHHHhhcCCCC--C
Q 040294          202 FSANNLIGRGSFGSVYKARLQDGMEFAIKS---------------------------------FDVECEVMKSIHHR--N  246 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~---------------------------------~~~E~~~l~~l~hp--n  246 (360)
                      ......||-|.=+.||.|..+.|.++|||.                                 -++|.+.|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345678999999999999999999999971                                 13578888887654  5


Q ss_pred             eeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC
Q 040294          247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI  326 (360)
Q Consensus       247 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~  326 (360)
                      +.+.+++    +...+||||++|-.|...-      ++....-.++..|++-+.-.-   ..+++|+|+.+=||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            5555543    4568999999996665432      111222334444444444444   67899999999999999999


Q ss_pred             cEEEeecccccc
Q 040294          327 VAHLSDFGIAKL  338 (360)
Q Consensus       327 ~~ki~DFGla~~  338 (360)
                      .+.++||--+-.
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999965543

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.64  E-value=3.2e-08  Score=83.90  Aligned_cols=92  Identities=28%  Similarity=0.339  Sum_probs=46.7

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccC-CccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDI-PTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~-p~~~~~l~~L~~L   71 (360)
                      |++|+.|+|++|.|+. ++ .+..++.|+.|++++|+++.+         .|+.|++++|+|...- -..+..+++|+.|
T Consensus        41 l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             -TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred             hcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence            5789999999999994 54 588899999999999999864         5899999999997521 2456789999999


Q ss_pred             cccccccccCCCc----cccCCCCCCeEe
Q 040294           72 SLGHNRLQGSIPN----SFDDLVSLESLD   96 (360)
Q Consensus        72 ~l~~N~l~g~~p~----~~~~l~~L~~l~   96 (360)
                      +|.+|+++. .+.    -+..+++|+.||
T Consensus       119 ~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen  119 SLEGNPVCE-KKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             E-TT-GGGG-STTHHHHHHHH-TT-SEET
T ss_pred             eccCCcccc-hhhHHHHHHHHcChhheeC
Confidence            999999983 343    256789999987

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.63  E-value=4.5e-08  Score=95.16  Aligned_cols=155  Identities=27%  Similarity=0.310  Sum_probs=121.4

Q ss_pred             CCCCCeecc--CCCccEEEEEc---cCCcEEEehhh-------------HHHHHHhhcCC-CCCeeEEEEEecCCCeEEE
Q 040294          202 FSANNLIGR--GSFGSVYKARL---QDGMEFAIKSF-------------DVECEVMKSIH-HRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       202 f~~~~~iG~--G~~g~Vy~~~~---~~~~~vavK~~-------------~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l  262 (360)
                      |....-+|.  |.+|.||.++.   .++..+|+|.=             .+|.....+++ |++.|+.+..+...+..++
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi  195 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI  195 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence            445677899  99999999886   36778888741             24666666665 9999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeEEccCCCCceeecCC-CcEEEeeccccc
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTS----ALEYLHFGFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAK  337 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~yLH~~~~~~iiHrdlk~~NiLl~~~-~~~ki~DFGla~  337 (360)
                      -.|++. .+|..+.+.....++......+..+..+    |+.++|   ...|+|-|+||+||....+ ..++..|||+..
T Consensus       196 qtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  196 QTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             eecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcceeE
Confidence            999995 7888888776655777777778888888    999999   9999999999999999988 899999999998


Q ss_pred             ccCCCCCc---eeeecccccCcccCC
Q 040294          338 LLTGEDQS---MTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~---~~~~~~~gt~~Y~aP  360 (360)
                      .+.+..-.   .......|-..|++|
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~k  297 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAK  297 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeCh
Confidence            87654311   111222455667765

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.63  E-value=7.5e-09  Score=104.53  Aligned_cols=96  Identities=33%  Similarity=0.481  Sum_probs=82.4

Q ss_pred             CCCCcEeeCCCCcccccCCc-cccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      ...|+.|+|++|+|. .+|. .+.++..|+.|+||+|+|+.+        .|..|...+|++. ..| .+..+++|+.+|
T Consensus       382 ~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD  458 (1081)
T KOG0618|consen  382 FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD  458 (1081)
T ss_pred             ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence            567999999999998 5665 689999999999999999986        4788889999997 456 899999999999


Q ss_pred             ccccccc-cCCCccccCCCCCCeEeCcCCc
Q 040294           73 LGHNRLQ-GSIPNSFDDLVSLESLDLSNNN  101 (360)
Q Consensus        73 l~~N~l~-g~~p~~~~~l~~L~~l~ls~N~  101 (360)
                      ++.|+|+ +.+|...-+ ++|++|||++|.
T Consensus       459 lS~N~L~~~~l~~~~p~-p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  459 LSCNNLSEVTLPEALPS-PNLKYLDLSGNT  487 (1081)
T ss_pred             cccchhhhhhhhhhCCC-cccceeeccCCc
Confidence            9999998 445555444 899999999996

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.62  E-value=5.7e-09  Score=93.28  Aligned_cols=97  Identities=32%  Similarity=0.428  Sum_probs=77.9

Q ss_pred             CCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccccc
Q 040294            4 ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHN   76 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N   76 (360)
                      .|+.||||+|.|+ .+..+..-++.++.|++|+|.+..+       +|+.||||+|.++ .+-.+-..+.+.+.|.|+.|
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N  362 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN  362 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence            4788999999998 6777888888899999999988764       6888999999886 34445567888889999999


Q ss_pred             ccccCCCccccCCCCCCeEeCcCCccCc
Q 040294           77 RLQGSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        77 ~l~g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      .+.. + +.+..|-+|..||+++|++..
T Consensus       363 ~iE~-L-SGL~KLYSLvnLDl~~N~Ie~  388 (490)
T KOG1259|consen  363 KIET-L-SGLRKLYSLVNLDLSSNQIEE  388 (490)
T ss_pred             hHhh-h-hhhHhhhhheeccccccchhh
Confidence            9873 2 457888889999999998863

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.60  E-value=1.6e-07  Score=92.55  Aligned_cols=136  Identities=21%  Similarity=0.270  Sum_probs=91.1

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehh-------------------------------------------------
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------------------------------------------  231 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------------------------------------------  231 (360)
                      .|+. ..|+.++-|.||+|++++|++||||.                                                 
T Consensus       127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E  205 (517)
T COG0661         127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE  205 (517)
T ss_pred             HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence            3443 67999999999999999999999972                                                 


Q ss_pred             --hHHHHHHhhcC----C-CCCeeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040294          232 --FDVECEVMKSI----H-HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF  304 (360)
Q Consensus       232 --~~~E~~~l~~l----~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~  304 (360)
                        +..|+..+.++    + .|++.--.=|++-.....|+|||++|-.+.+.........+   +..++..++++.  +-+
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f--~~q  280 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAF--LRQ  280 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHH--HHH
Confidence              11244433333    2 34443222333334556899999999888877433323344   233444443332  111


Q ss_pred             cCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       305 ~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ...-++.|.|..|-||+++.++.+...|||+...+.+.
T Consensus       281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            22568999999999999999999999999998876543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.52  E-value=4.1e-07  Score=89.45  Aligned_cols=129  Identities=24%  Similarity=0.339  Sum_probs=87.0

Q ss_pred             CeeccCCCccEEEEEccCCcEEEehh------------------------------------------------hHHHHH
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAIKS------------------------------------------------FDVECE  237 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vavK~------------------------------------------------~~~E~~  237 (360)
                      +.||.-+.|.||+|++++|+.||||.                                                |.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            67899999999999999999999971                                                123443


Q ss_pred             Hhh----cCCCCC------eeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 040294          238 VMK----SIHHRN------LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS  307 (360)
Q Consensus       238 ~l~----~l~hpn------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~  307 (360)
                      -..    .++|-+      |.+++..+..  ...|+||||+|..+.+.-.-....++..   .++..+.++  |++.-..
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~--~~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEA--YLEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHH--HHHHHHh
Confidence            322    233444      4555544433  4689999999987766544333345443   333333333  2222225


Q ss_pred             CCeEEccCCCCceeecC----CCcEEEeecccccccCC
Q 040294          308 TPIIHCDLKPHNVLLDD----NIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       308 ~~iiHrdlk~~NiLl~~----~~~~ki~DFGla~~~~~  341 (360)
                      .|++|.|-.|-||++..    ++.+.+-|||+.+.+..
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            67999999999999983    67899999999887643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.52  E-value=4.8e-07  Score=79.33  Aligned_cols=105  Identities=20%  Similarity=0.233  Sum_probs=79.0

Q ss_pred             hHHHHHHhhcCCCCC--eeEEEEEecCC----CeEEEEEEccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040294          232 FDVECEVMKSIHHRN--LVKIISSCSNE----DFRALVLEYMTN-GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF  304 (360)
Q Consensus       232 ~~~E~~~l~~l~hpn--iv~l~~~~~~~----~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~  304 (360)
                      ..+|...+..+..-.  ..+.+++.+..    ...++|+|++++ .+|.+++..... .+......++.++++.++-|| 
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH-  135 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLH-  135 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHH-
Confidence            445776666554332  34445554432    245899999998 489998875322 445567789999999999999 


Q ss_pred             cCCCCeEEccCCCCceeecCCC---cEEEeecccccccC
Q 040294          305 GFSTPIIHCDLKPHNVLLDDNI---VAHLSDFGIAKLLT  340 (360)
Q Consensus       305 ~~~~~iiHrdlk~~NiLl~~~~---~~ki~DFGla~~~~  340 (360)
                        ..+|+|+|+++.|||++.+.   .+.++||+-++...
T Consensus       136 --~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  136 --DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             --HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence              99999999999999999876   89999999887644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.48  E-value=8e-07  Score=85.31  Aligned_cols=127  Identities=21%  Similarity=0.282  Sum_probs=103.0

Q ss_pred             ccEEEEEc-cCCcEEEehhhH-----------HHHHHhhcCCCCCeeEEEEEecC----CCeEEEEEEccCC-CCHHHHH
Q 040294          214 GSVYKARL-QDGMEFAIKSFD-----------VECEVMKSIHHRNLVKIISSCSN----EDFRALVLEYMTN-GSLEKVL  276 (360)
Q Consensus       214 g~Vy~~~~-~~~~~vavK~~~-----------~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~l  276 (360)
                      .+.||+.. .||..|..|++.           .-++..+++.|+|+|++.++|..    +..+++||+|.++ ++|.+..
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            46788884 488899988761           23678899999999999999873    3478999999997 6787765


Q ss_pred             hcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          277 YSS--------------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       277 ~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ...              +...++...+.++.|+..||.++|   +.|..-+-|.+.+||++.+.+++|+..|+...+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            321              123567778899999999999999   888888999999999999999999999988877655


Q ss_pred             C
Q 040294          343 D  343 (360)
Q Consensus       343 ~  343 (360)
                      .
T Consensus       447 ~  447 (655)
T KOG3741|consen  447 P  447 (655)
T ss_pred             C
Confidence            4

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.43  E-value=3.2e-08  Score=88.54  Aligned_cols=102  Identities=25%  Similarity=0.318  Sum_probs=84.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++.++.|++|+|.|. .+. ++..+.+|+.||||+|.++.+        +.+.|.|+.|.+..  -+.++.+.+|..||+
T Consensus       306 ~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl  381 (490)
T KOG1259|consen  306 APKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDL  381 (490)
T ss_pred             ccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccc
Confidence            467899999999998 343 488899999999999999865        67899999999864  346788999999999


Q ss_pred             cccccccCC-CccccCCCCCCeEeCcCCccCcccc
Q 040294           74 GHNRLQGSI-PNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        74 ~~N~l~g~~-p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      .+|++...- -..+++|+-|+.+.|.+|++.+++-
T Consensus       382 ~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  382 SSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             cccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            999998321 2458899999999999999997643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.41  E-value=1.1e-06  Score=86.88  Aligned_cols=119  Identities=18%  Similarity=0.247  Sum_probs=92.7

Q ss_pred             cCCCccEEEEEccCCcEEEehhhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHH
Q 040294          210 RGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL  289 (360)
Q Consensus       210 ~G~~g~Vy~~~~~~~~~vavK~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  289 (360)
                      .|++-.|+....+++ ++ .....+-++.++.++||||++++..++.+...|||+|-+.  -|...+....    .....
T Consensus        36 ~~~~vsVF~~~~~~~-~~-~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~  107 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG-EV-TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC  107 (690)
T ss_pred             cCCceEEEEEeCCCc-hh-hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence            466667777666665 21 1224556788999999999999999999999999999884  4555554432    23344


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          290 NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       290 ~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      --+.||+.||.|||+  +.+++|++|.-+.|.++..|+-||++|-++..
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~  154 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSK  154 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence            468899999999985  56799999999999999999999999987754

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.41  E-value=2.8e-07  Score=85.36  Aligned_cols=89  Identities=31%  Similarity=0.418  Sum_probs=63.2

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCcccCeEEcCCCcccccCCccccCCCccceecccccccccC
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS   81 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~   81 (360)
                      |++|+.|+|++|+|+++-+.+|.++.+++.|.|..|+|..               .-...|.++..|+.|+|.+|+|+-.
T Consensus       273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~---------------v~~~~f~~ls~L~tL~L~~N~it~~  337 (498)
T KOG4237|consen  273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEF---------------VSSGMFQGLSGLKTLSLYDNQITTV  337 (498)
T ss_pred             cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHH---------------HHHHhhhccccceeeeecCCeeEEE
Confidence            4566666666666666666666666666666666655543               3345677788888888888888877


Q ss_pred             CCccccCCCCCCeEeCcCCccCcc
Q 040294           82 IPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        82 ~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      -|.+|..+.+|.+|+|-.|+|.--
T Consensus       338 ~~~aF~~~~~l~~l~l~~Np~~Cn  361 (498)
T KOG4237|consen  338 APGAFQTLFSLSTLNLLSNPFNCN  361 (498)
T ss_pred             ecccccccceeeeeehccCcccCc
Confidence            788888888888888888887654

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.40  E-value=6.5e-08  Score=93.26  Aligned_cols=97  Identities=31%  Similarity=0.448  Sum_probs=65.9

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceeccccc
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHN   76 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N   76 (360)
                      |+.|-+++|+++ .+|..++.+..|..||.+.|++..+        .|+.|++..|++. .+|..+. .-.|..||++.|
T Consensus       145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScN  221 (722)
T KOG0532|consen  145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCN  221 (722)
T ss_pred             ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccC
Confidence            444445555554 4455555555555555555555433        3556666677766 3566666 446788999999


Q ss_pred             ccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           77 RLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        77 ~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      +++ .||-.|..|+.|++|-|.+|+|..+
T Consensus       222 kis-~iPv~fr~m~~Lq~l~LenNPLqSP  249 (722)
T KOG0532|consen  222 KIS-YLPVDFRKMRHLQVLQLENNPLQSP  249 (722)
T ss_pred             cee-ecchhhhhhhhheeeeeccCCCCCC
Confidence            998 8999999999999999999999864

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.40  E-value=6.1e-08  Score=90.41  Aligned_cols=102  Identities=26%  Similarity=0.367  Sum_probs=63.9

Q ss_pred             CCCcEeeCCCCcccc------cCCccccCCcccCeeeccccccCCc---------c---cCeEEcCCCcccc----cCCc
Q 040294            3 AALFQLDLRGNKLSG------SIPTCFSNLTALRNLHLDSNELRHL---------V---LTRTDFSRNNLLG----DIPT   60 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g------~~p~~~~~l~~L~~L~l~~N~l~~~---------~---L~~l~l~~N~l~~----~~p~   60 (360)
                      ++|+.|++++|.+.+      .++..+..+++|+.|++++|.+...         .   |+.|++++|++++    .+..
T Consensus        51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~  130 (319)
T cd00116          51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK  130 (319)
T ss_pred             CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence            457777777776652      2333456677777777777776531         3   7777777777763    2333


Q ss_pred             cccCC-CccceecccccccccC----CCccccCCCCCCeEeCcCCccCc
Q 040294           61 TIQGL-KSLQFLSLGHNRLQGS----IPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        61 ~~~~l-~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      .+..+ ++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++
T Consensus       131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~  179 (319)
T cd00116         131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD  179 (319)
T ss_pred             HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence            44555 6777777777777632    23345566677777777777764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PLN03210 Resistant to P

Probab=98.39  E-value=7.9e-07  Score=96.92  Aligned_cols=103  Identities=28%  Similarity=0.414  Sum_probs=72.5

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccc-cCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE-LRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      .+|+.|+|++|++. .+|..+..+++|+.|+|+++. +..+       +|+.|+|++|.....+|.+++++++|+.|+++
T Consensus       611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~  689 (1153)
T PLN03210        611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS  689 (1153)
T ss_pred             cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence            56777778777776 566667778888888887653 3322       57778888777777778888888888888887


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|.....+|..+ ++++|+.|+|++|...+.+|
T Consensus       690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p  721 (1153)
T PLN03210        690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFP  721 (1153)
T ss_pred             CCCCcCccCCcC-CCCCCCEEeCCCCCCccccc
Confidence            765444677655 67777777777765544444

syringae 6; Provisional

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.38  E-value=1.6e-07  Score=85.16  Aligned_cols=93  Identities=27%  Similarity=0.390  Sum_probs=78.4

Q ss_pred             HhhcCCCCCeeEEEEEecCCC-----eEEEEEEccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 040294          238 VMKSIHHRNLVKIISSCSNED-----FRALVLEYMTNGSLEKVLYSSN---CILDILQRLNIMINVTSALEYLHFGFSTP  309 (360)
Q Consensus       238 ~l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~yLH~~~~~~  309 (360)
                      .+-.+.|.|||+++.||.+..     +..++.|||+.|++.++|++..   ..+......+++.||..||.||| .|+++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCc
Confidence            445667999999999987654     5788999999999999997542   33555666789999999999999 67999


Q ss_pred             eEEccCCCCceeecCCCcEEEe
Q 040294          310 IIHCDLKPHNVLLDDNIVAHLS  331 (360)
Q Consensus       310 iiHrdlk~~NiLl~~~~~~ki~  331 (360)
                      |+|+++...-|.+..++-+||.
T Consensus       199 iihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cccCCcchhheeecCCceEEec
Confidence            9999999999999999988875

>PRK09902 hypothetical protein; Provisional

Probab=98.37  E-value=6e-06  Score=71.81  Aligned_cols=126  Identities=17%  Similarity=0.110  Sum_probs=89.5

Q ss_pred             ccCCCccEEEEEccCCcEEEeh-----------------hhHHHHHHhhcCCCCC--eeEEEEEecC----CCeEEEEEE
Q 040294          209 GRGSFGSVYKARLQDGMEFAIK-----------------SFDVECEVMKSIHHRN--LVKIISSCSN----EDFRALVLE  265 (360)
Q Consensus       209 G~G~~g~Vy~~~~~~~~~vavK-----------------~~~~E~~~l~~l~hpn--iv~l~~~~~~----~~~~~lv~e  265 (360)
                      |+||-+-|++-.+.+. .+=+|                 .|.+|...+.++..-+  +.+...+...    ...-+||+|
T Consensus        27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            5567777777655332 34444                 4678988888775332  4444422211    124679999


Q ss_pred             ccCC-CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc--EEEeecccccc
Q 040294          266 YMTN-GSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV--AHLSDFGIAKL  338 (360)
Q Consensus       266 ~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~--~ki~DFGla~~  338 (360)
                      -++| -+|.+++.... ...+...+..+..++++.++-||   +.++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            8765 68999886532 23466667889999999999999   999999999999999986666  99999987664

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.36  E-value=1.1e-07  Score=88.74  Aligned_cols=105  Identities=28%  Similarity=0.380  Sum_probs=79.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcc---cCeeeccccccCC--------------cccCeEEcCCCccccc----CCc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTA---LRNLHLDSNELRH--------------LVLTRTDFSRNNLLGD----IPT   60 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~---L~~L~l~~N~l~~--------------~~L~~l~l~~N~l~~~----~p~   60 (360)
                      +++|+.|+|++|.+.+..+..+..+.+   |+.|++++|.++.              ..|+.|++++|.+++.    ++.
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            468899999999998766666666665   9999999988872              1568889999998853    334


Q ss_pred             cccCCCccceecccccccccC----CCccccCCCCCCeEeCcCCccCccc
Q 040294           61 TIQGLKSLQFLSLGHNRLQGS----IPNSFDDLVSLESLDLSNNNLSEII  106 (360)
Q Consensus        61 ~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~~~~  106 (360)
                      .+..+.+|++|+|++|.+++.    ++..+..+++|+.|+|++|.+++.-
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~  209 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG  209 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHH
Confidence            456677899999999988742    3445566678999999999887543

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.32  E-value=7.2e-06  Score=72.92  Aligned_cols=129  Identities=13%  Similarity=0.185  Sum_probs=78.3

Q ss_pred             CeeccCCCccEEEEEccCCcEEEeh---------hhHHHHHHhhcCCCCC--eeEEEEEecCCCeEEEEEEccCCCC-HH
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHRN--LVKIISSCSNEDFRALVLEYMTNGS-LE  273 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vavK---------~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~~g~-L~  273 (360)
                      ..||+|..+.||+..   +..+++|         ...+|.++++.+..-.  +.+.++++...+...+|||+++|.+ +.
T Consensus         7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~   83 (226)
T TIGR02172         7 TQTGEGGNGESYTHK---TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS   83 (226)
T ss_pred             eeecCCCCcceeEec---CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence            568999999999842   3345554         3467888888876433  4677888877778889999999963 21


Q ss_pred             HH---------------------HhcCC-CCCCHHHHH-HHHH----------HHHH-HHHHhh-hcCCCCeEEccCCCC
Q 040294          274 KV---------------------LYSSN-CILDILQRL-NIMI----------NVTS-ALEYLH-FGFSTPIIHCDLKPH  318 (360)
Q Consensus       274 ~~---------------------l~~~~-~~~~~~~~~-~i~~----------~i~~-~l~yLH-~~~~~~iiHrdlk~~  318 (360)
                      ..                     +|.-. ...+..... .+..          .+.+ ...+|. ......++|+|+.|.
T Consensus        84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~  163 (226)
T TIGR02172        84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG  163 (226)
T ss_pred             hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence            11                     11110 001111000 0000          0011 112221 122445789999999


Q ss_pred             ceeecCCCcEEEeecccccc
Q 040294          319 NVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       319 NiLl~~~~~~ki~DFGla~~  338 (360)
                      ||++++++ +.|.||+.+..
T Consensus       164 Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       164 NLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cEEEcCCC-cEEEechhcCc
Confidence            99999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.23  E-value=3.5e-08  Score=95.12  Aligned_cols=93  Identities=38%  Similarity=0.491  Sum_probs=56.5

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecccccc
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR   77 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   77 (360)
                      |..+.|..|+|. .+|..+.++..|..|||+.|+++.+       .|+.|-+++|+++ .+|..++.+..|..||.+.|.
T Consensus       100 Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lpLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ne  177 (722)
T KOG0532|consen  100 LESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLPLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNE  177 (722)
T ss_pred             HHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCcceeEEEecCccc-cCCcccccchhHHHhhhhhhh
Confidence            444556666666 6677777777777777777777753       4666777777765 455566655556666666666


Q ss_pred             cccCCCccccCCCCCCeEeCcCC
Q 040294           78 LQGSIPNSFDDLVSLESLDLSNN  100 (360)
Q Consensus        78 l~g~~p~~~~~l~~L~~l~ls~N  100 (360)
                      +. .+|..++.+.+|+.|++..|
T Consensus       178 i~-slpsql~~l~slr~l~vrRn  199 (722)
T KOG0532|consen  178 IQ-SLPSQLGYLTSLRDLNVRRN  199 (722)
T ss_pred             hh-hchHHhhhHHHHHHHHHhhh
Confidence            55 45555555544433333333

>PLN03210 Resistant to P

Probab=98.19  E-value=3.7e-06  Score=91.79  Aligned_cols=102  Identities=27%  Similarity=0.366  Sum_probs=85.2

Q ss_pred             CCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            4 ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      +|+.|++.+|.++ .+|..| ...+|+.|+|++|++..+        .|+.++|++|+..+.+|. ++.+++|+.|+|++
T Consensus       590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~  666 (1153)
T PLN03210        590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD  666 (1153)
T ss_pred             ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence            5788888888887 677777 578999999999988754        589999998877777874 88999999999999


Q ss_pred             cccccCCCccccCCCCCCeEeCcCCccCcccch
Q 040294           76 NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        76 N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      |.....+|.++.++++|+.|++++|...+.+|.
T Consensus       667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~  699 (1153)
T PLN03210        667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPT  699 (1153)
T ss_pred             CCCccccchhhhccCCCCEEeCCCCCCcCccCC
Confidence            877678999999999999999999765556664

syringae 6; Provisional

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.18  E-value=1.1e-06  Score=56.58  Aligned_cols=39  Identities=41%  Similarity=0.701  Sum_probs=28.2

Q ss_pred             CccceecccccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           66 KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        66 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ++|++|+|++|+|+ .+|..+++|++|+.|++++|+++..
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~i   39 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISDI   39 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSBE
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCCC
Confidence            46778888888887 5676778888888888888887743

...

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.15  E-value=1.7e-05  Score=69.37  Aligned_cols=68  Identities=22%  Similarity=0.345  Sum_probs=52.9

Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ...+++|||++|..|.+...     ++.    .++..+++++.-+|   ..|+.|+|..|.|+++.+++ +++.||+-.+
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             eEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            35578999999988765432     221    24566778899999   99999999999999998654 9999998765


Q ss_pred             c
Q 040294          338 L  338 (360)
Q Consensus       338 ~  338 (360)
                      .
T Consensus       183 ~  183 (229)
T PF06176_consen  183 M  183 (229)
T ss_pred             c
Confidence            4

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.15  E-value=1.3e-05  Score=70.84  Aligned_cols=143  Identities=20%  Similarity=0.205  Sum_probs=89.6

Q ss_pred             ccCHHHHHHHhCCCCCCCeecc---CCCccEEEEEccCCcEEEehhhH--------------------------------
Q 040294          189 RFSYLELLRATNGFSANNLIGR---GSFGSVYKARLQDGMEFAIKSFD--------------------------------  233 (360)
Q Consensus       189 ~~~~~~~~~~~~~f~~~~~iG~---G~~g~Vy~~~~~~~~~vavK~~~--------------------------------  233 (360)
                      ..+...+.+..+...+..+.|.   |.=+.||+|...++..+|||.+.                                
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            3444555555555555566555   44456999998889999998542                                


Q ss_pred             ---HHHHHhhcCC--CCCeeEEEEEecCCCeEEEEEEccCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 040294          234 ---VECEVMKSIH--HRNLVKIISSCSNEDFRALVLEYMTNG-SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS  307 (360)
Q Consensus       234 ---~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~  307 (360)
                         +|..-|.++.  +-.+.+-+++.    ...|||||+... .-.-.|..-  ..+......+..++++.+.-|-.  .
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~--~  185 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYK--E  185 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHH--h
Confidence               2444444432  22223333332    246999999653 111122211  12222455567777777777762  4


Q ss_pred             CCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       308 ~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      .+++|+||..=|||+. ++.+.|+|||-|-...
T Consensus       186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            7899999999999999 8899999999876654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.13  E-value=1.4e-05  Score=68.96  Aligned_cols=102  Identities=24%  Similarity=0.292  Sum_probs=80.7

Q ss_pred             HHHHHHhhcCCC-CCeeEEEEEecCCCeEEEEEEccCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 040294          233 DVECEVMKSIHH-RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS--SNCILDILQRLNIMINVTSALEYLHFGFSTP  309 (360)
Q Consensus       233 ~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~  309 (360)
                      ..|.-+++.+++ +++++++|+|-+    ++|.||...+++...-..  .-...+|..|.+||.++++.++++++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            347778888876 699999999943    678999987766422000  0123689999999999999999999765566


Q ss_pred             eEEccCCCCceeecCCCcEEEeecccccc
Q 040294          310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       310 iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      +.-.|++++|+-+++++++|++|..-+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            77899999999999999999999876654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.12  E-value=1.6e-06  Score=55.94  Aligned_cols=38  Identities=34%  Similarity=0.572  Sum_probs=26.9

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCC
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH   41 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~   41 (360)
                      ++|+.|+|++|+|+ .+|+.|.+|++|+.|++++|.++.
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~   38 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD   38 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence            46778888888887 566667788888888887777664

...

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.10  E-value=1.6e-06  Score=83.63  Aligned_cols=98  Identities=39%  Similarity=0.590  Sum_probs=67.8

Q ss_pred             CCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            4 ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      +|+.|++++|++. .+|..+.++++|+.|++++|+++.+        .|+.|++++|++. .+|..++.+..|++|++++
T Consensus       141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~  218 (394)
T COG4886         141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN  218 (394)
T ss_pred             hcccccccccchh-hhhhhhhccccccccccCCchhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcC
Confidence            6788888888887 6666778888888888888887654        3667777777776 4555555555677777777


Q ss_pred             cccccCCCccccCCCCCCeEeCcCCccCc
Q 040294           76 NRLQGSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        76 N~l~g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      |++. .++..+.++.++..+.+++|++..
T Consensus       219 N~~~-~~~~~~~~~~~l~~l~l~~n~~~~  246 (394)
T COG4886         219 NSII-ELLSSLSNLKNLSGLELSNNKLED  246 (394)
T ss_pred             Ccce-ecchhhhhcccccccccCCceeee
Confidence            7543 455566666666666666666544

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.07  E-value=1.2e-07  Score=93.83  Aligned_cols=99  Identities=34%  Similarity=0.313  Sum_probs=65.6

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      |+.|+.|+|++|+++..-  .+..|+.|+.|||+.|+|..+        .|..|.|++|-++..  ..+.++++|..|||
T Consensus       186 l~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lrnN~l~tL--~gie~LksL~~LDl  261 (1096)
T KOG1859|consen  186 LPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLRNNALTTL--RGIENLKSLYGLDL  261 (1096)
T ss_pred             HHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheeeeecccHHHhh--hhHHhhhhhhccch
Confidence            355677777777777332  667777777778877777654        467777777777642  34567777777777


Q ss_pred             cccccccCCC-ccccCCCCCCeEeCcCCccCc
Q 040294           74 GHNRLQGSIP-NSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        74 ~~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      +.|-|++.-. .-++.|.+|..|+|.+|++--
T Consensus       262 syNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  262 SYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             hHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            7777764311 224455677777777777653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.07  E-value=4.7e-05  Score=68.40  Aligned_cols=130  Identities=15%  Similarity=0.177  Sum_probs=78.3

Q ss_pred             eccCCC-ccEEEEEccCCcEEEeh--------hhHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEccCCCCHHHHH-
Q 040294          208 IGRGSF-GSVYKARLQDGMEFAIK--------SFDVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL-  276 (360)
Q Consensus       208 iG~G~~-g~Vy~~~~~~~~~vavK--------~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l-  276 (360)
                      |-.|.+ ..||+....+ ..+.||        .+..|+++++.+. +--+.+++++...++..++|||+++|.++.... 
T Consensus         6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~   84 (244)
T cd05150           6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWE   84 (244)
T ss_pred             cCCCCCcCeEEEEcCCC-CcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhc
Confidence            334444 6788887643 556665        2567888888774 344567788877766789999999997776431 


Q ss_pred             ------------------hcCC---CCCC-H-HHHHHHHH--------------------HHHHHHHHhh----hcCCCC
Q 040294          277 ------------------YSSN---CILD-I-LQRLNIMI--------------------NVTSALEYLH----FGFSTP  309 (360)
Q Consensus       277 ------------------~~~~---~~~~-~-~~~~~i~~--------------------~i~~~l~yLH----~~~~~~  309 (360)
                                        +...   .... . ..+.....                    .+...+..|-    ....+.
T Consensus        85 ~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  164 (244)
T cd05150          85 ELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLV  164 (244)
T ss_pred             ccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceE
Confidence                              1110   0111 0 00000000                    0111112221    012456


Q ss_pred             eEEccCCCCceeecCCCcEEEeecccccc
Q 040294          310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       310 iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ++|+|+.|.||+++++....|+||+.|..
T Consensus       165 l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         165 VTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             EECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            89999999999999987788999998864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.04  E-value=1.4e-06  Score=84.62  Aligned_cols=102  Identities=37%  Similarity=0.523  Sum_probs=74.9

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|++.+|+|.. +...+..+++|+.|++++|.|+.+       .|+.|++++|.++.  ...+..+++|+.++++
T Consensus        94 ~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~  170 (414)
T KOG0531|consen   94 LKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGNLISD--ISGLESLKSLKLLDLS  170 (414)
T ss_pred             ccceeeeeccccchhh-cccchhhhhcchheeccccccccccchhhccchhhheeccCcchh--ccCCccchhhhcccCC
Confidence            5678888888888884 443477788888888888888764       47788888888864  2345667888888888


Q ss_pred             ccccccCCCcc-ccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNS-FDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|.++. ++.. ...+.+|+.+++++|.+..+-.
T Consensus       171 ~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~i~~  203 (414)
T KOG0531|consen  171 YNRIVD-IENDELSELISLEELDLGGNSIREIEG  203 (414)
T ss_pred             cchhhh-hhhhhhhhccchHHHhccCCchhcccc
Confidence            888873 3332 4777888888888887765543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.02  E-value=4.5e-05  Score=67.39  Aligned_cols=132  Identities=20%  Similarity=0.293  Sum_probs=76.2

Q ss_pred             CeeccCCCccEEEEEccCCcEEEehh---------hHHHHHHhhcCCCC--CeeEEEEEec---CCCeEEEEEEccCCCC
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHHR--NLVKIISSCS---NEDFRALVLEYMTNGS  271 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vavK~---------~~~E~~~l~~l~hp--niv~l~~~~~---~~~~~~lv~e~~~~g~  271 (360)
                      +.++.|..+.||+....+ ..+++|.         +..|..+++.+...  .+.+++.++.   .....+++|++++|..
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~   81 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP   81 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence            568899999999999877 5888873         34577777766533  3456666443   3335789999999987


Q ss_pred             HHH----------------HH---hcC---CCCCCHHH---------HHHH------------HHHHHH-HHHHhhh---
Q 040294          272 LEK----------------VL---YSS---NCILDILQ---------RLNI------------MINVTS-ALEYLHF---  304 (360)
Q Consensus       272 L~~----------------~l---~~~---~~~~~~~~---------~~~i------------~~~i~~-~l~yLH~---  304 (360)
                      +..                .+   +..   .....+..         ....            ...+.+ .++.++.   
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (239)
T PF01636_consen   82 LDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP  161 (239)
T ss_dssp             HHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence            777                11   111   01111110         0000            011222 2333331   


Q ss_pred             -cCCCCeEEccCCCCceeec-CCCcEEEeecccccc
Q 040294          305 -GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKL  338 (360)
Q Consensus       305 -~~~~~iiHrdlk~~NiLl~-~~~~~ki~DFGla~~  338 (360)
                       .....++|+|+.+.||+++ +++.+.|.||+.+..
T Consensus       162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             cCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence             2356799999999999999 566668999998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.00  E-value=4.8e-06  Score=80.34  Aligned_cols=104  Identities=40%  Similarity=0.630  Sum_probs=76.7

Q ss_pred             CCCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            1 YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         1 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      .+++|+.|++++|+++ .+|...+.+++|+.|++++|+++.+        .|+.+.+++|.+. .++..+.++.++..|.
T Consensus       161 ~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~  238 (394)
T COG4886         161 NLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE  238 (394)
T ss_pred             ccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccc
Confidence            3678899999999998 6777666888999999999988764        2677788888533 3455667777777777


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +++|++. .+|..++.++++++|++++|+++.+.+
T Consensus       239 l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~  272 (394)
T COG4886         239 LSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS  272 (394)
T ss_pred             cCCceee-eccchhccccccceecccccccccccc
Confidence            7777776 446667777777777777777765543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=97.99  E-value=3.5e-07  Score=90.61  Aligned_cols=97  Identities=34%  Similarity=0.393  Sum_probs=81.0

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecccccc
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR   77 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   77 (360)
                      |...+.++|+|. .+..++.-++.|+.|+|++|+++.+       .|++|||+.|.|.-..--....|. |+.|.|.+|.
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~  243 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVDNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNA  243 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhHHHHhcccccccccccchhccccccchhhhh-heeeeecccH
Confidence            556788999998 6777888899999999999999864       699999999999854333445666 9999999999


Q ss_pred             cccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           78 LQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        78 l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ++. + ..+.+|.+|+.|||+.|-|++-
T Consensus       244 l~t-L-~gie~LksL~~LDlsyNll~~h  269 (1096)
T KOG1859|consen  244 LTT-L-RGIENLKSLYGLDLSYNLLSEH  269 (1096)
T ss_pred             HHh-h-hhHHhhhhhhccchhHhhhhcc
Confidence            983 3 4588999999999999988765

>PLN02876 acyl-CoA dehydrogenase

Probab=97.93  E-value=0.00011  Score=77.51  Aligned_cols=67  Identities=15%  Similarity=0.444  Sum_probs=49.9

Q ss_pred             CCeeccCCCccEEEEEccCC---cEEEeh------------hhHHHHHHhhcCC-CCCe--eEEEEEecCC---CeEEEE
Q 040294          205 NNLIGRGSFGSVYKARLQDG---MEFAIK------------SFDVECEVMKSIH-HRNL--VKIISSCSNE---DFRALV  263 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~---~~vavK------------~~~~E~~~l~~l~-hpni--v~l~~~~~~~---~~~~lv  263 (360)
                      .+.++.|.+..+|+....++   ..+++|            .+.+|.++++.+. |+++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45678899999998876543   245543            3568999999886 6665  7888888765   357899


Q ss_pred             EEccCCCC
Q 040294          264 LEYMTNGS  271 (360)
Q Consensus       264 ~e~~~~g~  271 (360)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.89  E-value=5.7e-05  Score=63.43  Aligned_cols=118  Identities=18%  Similarity=0.273  Sum_probs=79.9

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEeh---------hhHHHHHHhhcCCCCCee-EEEEEecCCCeEEEEEEccCCCCHHH
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHRNLV-KIISSCSNEDFRALVLEYMTNGSLEK  274 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK---------~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~~~g~L~~  274 (360)
                      .+.|++|.+|.||++.++. .++|+|         .++.|++++..+.-.++. +++.|-.+    ++.|||+.|-.|.+
T Consensus        27 ~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~  101 (201)
T COG2112          27 EKELAKGTTSVVYLGEWRG-GEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGK  101 (201)
T ss_pred             hhhhhcccccEEEEeeccC-ceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhh
Confidence            4679999999999999974 477776         467899999988876664 45554332    45599999988877


Q ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCC-CceeecCCCcEEEeecccccc
Q 040294          275 VLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP-HNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       275 ~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~-~NiLl~~~~~~ki~DFGla~~  338 (360)
                      +-...    +...    ...+++.---|-   ..+|-|..+.- ...++..+..+.|+||--|..
T Consensus       102 ~~~~~----~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         102 LEIGG----DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhcc----cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            65321    1222    223344422233   67788888764 444444455999999998874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.89  E-value=0.00011  Score=63.45  Aligned_cols=114  Identities=26%  Similarity=0.455  Sum_probs=83.8

Q ss_pred             CCCCCCCeeccCCC-ccEEEEEccCCcEEEehhh--------------------------------HHHHHHhhcCC---
Q 040294          200 NGFSANNLIGRGSF-GSVYKARLQDGMEFAIKSF--------------------------------DVECEVMKSIH---  243 (360)
Q Consensus       200 ~~f~~~~~iG~G~~-g~Vy~~~~~~~~~vavK~~--------------------------------~~E~~~l~~l~---  243 (360)
                      .+++..+.||.|.- |.||+++.. |+.||+|.|                                ..|+....+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888899999999 999999984 679999852                                24666655554   


Q ss_pred             CCCe--eEEEEEecCC------------------CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040294          244 HRNL--VKIISSCSNE------------------DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH  303 (360)
Q Consensus       244 hpni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH  303 (360)
                      +.++  |+.+||..-.                  ....||.||++...          .+    ...-+.+|.+-+..+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~----~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL----QIRDIPQMLRDLKILH  181 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc----chhHHHHHHHHHHHHH
Confidence            5566  9999987211                  12468899887643          11    1223556777788899


Q ss_pred             hcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       304 ~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                         ..+|+-+|+++.|..     .-||+|||.+
T Consensus       182 ---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 ---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ---HCCeeeccCcccccc-----CCEEEecccC
Confidence               999999999999986     4589999864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	360
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-25
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-24
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-22
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-21
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-16
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-16
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-13
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-06
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-06
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-06
3soa_A	444	Full-Length Human Camkii Length = 444		4e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-06
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-06
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		5e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-06
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		5e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-06
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-06
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		9e-06
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		8e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-05
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		7e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-04
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		5e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-04
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		6e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 71/188 (37%), Positives = 95/188 (50%), Gaps = 16/188 (8%)
Query: 188 RRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK------------SFDVE 235
           +RFS  EL  A++ FS  N++GRG FG VYK RL DG   A+K             F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY---SSNCILDILQRLNIM 292
            E++    HRNL+++   C     R LV  YM NGS+   L     S   LD  +R  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 293 INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
           +     L YLH      IIH D+K  N+LLD+   A + DFG+AKL+  +D  +      
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 204
Query: 353 ATIGYMAP 360
            TIG++AP
Sbjct: 205 GTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/188 (36%), Positives = 93/188 (49%), Gaps = 16/188 (8%)
Query: 188 RRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK------------SFDVE 235
           +RFS  EL  A++ F   N++GRG FG VYK RL DG   A+K             F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY---SSNCILDILQRLNIM 292
            E++    HRNL+++   C     R LV  YM NGS+   L     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 293 INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
           +     L YLH      IIH D+K  N+LLD+   A + DFG+AKL+  +D  +      
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 196
Query: 353 ATIGYMAP 360
             IG++AP
Sbjct: 197 GXIGHIAP 204

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/186 (36%), Positives = 93/186 (50%), Gaps = 17/186 (9%)
Query: 189 RFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECE----------- 237
           R   ++L  ATN F    LIG G FG VYK  L+DG + A+K    E             
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 238 VMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSN---CILDILQRLNIMIN 294
            +    H +LV +I  C   +   L+ +YM NG+L++ LY S+     +   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
               L YLH   +  IIH D+K  N+LLD+N V  ++DFGI+K  T  DQ+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 355 IGYMAP 360
           +GY+ P
Sbjct: 205 LGYIDP 210

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/186 (35%), Positives = 92/186 (49%), Gaps = 17/186 (9%)
Query: 189 RFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECE----------- 237
           R   ++L  ATN F    LIG G FG VYK  L+DG + A+K    E             
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 238 VMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSN---CILDILQRLNIMIN 294
            +    H +LV +I  C   +   L+ +YM NG+L++ LY S+     +   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
               L YLH   +  IIH D+K  N+LLD+N V  ++DFGI+K  T   Q+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 355 IGYMAP 360
           +GY+ P
Sbjct: 205 LGYIDP 210

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 89/197 (45%), Gaps = 33/197 (16%)
Query: 190 FSYLELLRATNGFS------ANNLIGRGSFGSVYKARLQDGMEFAIKS------------ 231
           FS+ EL   TN F         N +G G FG VYK  + +    A+K             
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 232 ---FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI-----L 283
              FD E +VM    H NLV+++   S+ D   LV  YM NGSL   L   +C+     L
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGTPPL 130
Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
               R  I     + + +LH       IH D+K  N+LLD+   A +SDFG+A+      
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 344 QSMTQTQTLATIGYMAP 360
           Q++  ++ + T  YMAP
Sbjct: 188 QTVMXSRIVGTTAYMAP 204

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 88/197 (44%), Gaps = 33/197 (16%)
Query: 190 FSYLELLRATNGFS------ANNLIGRGSFGSVYKARLQDGMEFAIKS------------ 231
           FS+ EL   TN F         N +G G FG VYK  + +    A+K             
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 232 ---FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI-----L 283
              FD E +VM    H NLV+++   S+ D   LV  YM NGSL   L   +C+     L
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGTPPL 130
Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
               R  I     + + +LH       IH D+K  N+LLD+   A +SDFG+A+      
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 344 QSMTQTQTLATIGYMAP 360
           Q++   + + T  YMAP
Sbjct: 188 QTVMXXRIVGTTAYMAP 204

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 190 FSYLELLRATNGFS------ANNLIGRGSFGSVYKARLQDGMEFAIKS------------ 231
           FS+ EL   TN F         N +G G FG VYK  + +    A+K             
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 232 ---FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI-----L 283
              FD E +VM    H NLV+++   S+ D   LV  YM NGSL   L   +C+     L
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGTPPL 124
Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
               R  I     + + +LH       IH D+K  N+LLD+   A +SDFG+A+      
Sbjct: 125 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 344 QSMTQTQTLATIGYMAP 360
           Q +   + + T  YMAP
Sbjct: 182 QXVMXXRIVGTTAYMAP 198

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 19/168 (11%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIISSC 254
           IG GSFG+V++A    G + A+K              F  E  +MK + H N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           +     ++V EY++ GSL ++L+ S     LD  +RL++  +V   + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLK  N+L+D      + DFG+++L       +       T  +MAP
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAP 208

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 19/168 (11%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIISSC 254
           IG GSFG+V++A    G + A+K              F  E  +MK + H N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           +     ++V EY++ GSL ++L+ S     LD  +RL++  +V   + YLH   + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +LK  N+L+D      + DFG+++L       ++      T  +MAP
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAP 208

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 183 PQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV------- 234
           PQ  ++R            F    ++G GSF +V  AR L    E+AIK  +        
Sbjct: 2   PQPRKKR---------PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN 52
Query: 235 -------ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQ 287
                  E +VM  + H   VK+  +  +++     L Y  NG L K +       +   
Sbjct: 53  KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT 112
Query: 288 RLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
           R      + SALEYLH      IIH DLKP N+LL++++   ++DFG AK+L+ E +   
Sbjct: 113 RF-YTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 168
Query: 348 QTQTLATIGYMAP 360
               + T  Y++P
Sbjct: 169 ANXFVGTAQYVSP 181

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 183 PQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV------- 234
           PQ  ++R            F    ++G GSF +V  AR L    E+AIK  +        
Sbjct: 1   PQPRKKR---------PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN 51
Query: 235 -------ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQ 287
                  E +VM  + H   VK+  +  +++     L Y  NG L K +       +   
Sbjct: 52  KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT 111
Query: 288 RLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
           R      + SALEYLH      IIH DLKP N+LL++++   ++DFG AK+L+ E +   
Sbjct: 112 RF-YTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 167
Query: 348 QTQTLATIGYMAP 360
               + T  Y++P
Sbjct: 168 ANXFVGTAQYVSP 180

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 125
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 124
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 152
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 153 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 206

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 150
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 204

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 150
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 131
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 132 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 146
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 146
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 87/176 (49%), Gaps = 22/176 (12%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------E 235
           + + L ATN  S + ++G G FG V   RL+      +  AIK+  V            E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             +M    H N++++    +      +V EYM NGSL+  L   +    ++Q + ++  +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 296 TSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            S ++YL   G+    +H DL   N+L++ N+V  +SDFG+A++L  + ++   T+
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 87/176 (49%), Gaps = 22/176 (12%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------E 235
           + + L ATN  S + ++G G FG V   RL+      +  AIK+  V            E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             +M    H N++++    +      +V EYM NGSL+  L   +    ++Q + ++  +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 296 TSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            S ++YL   GF    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 157 ASGMKYLSDMGF----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +V  AR L    E+AIK  +               E +VM  + H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+     +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 154
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 155 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 84/197 (42%), Gaps = 33/197 (16%)
Query: 190 FSYLELLRATNGFS------ANNLIGRGSFGSVYKARLQDGMEFAIKS------------ 231
           FS+ EL   TN F         N  G G FG VYK  + +    A+K             
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 232 ---FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI-----L 283
              FD E +V     H NLV+++   S+ D   LV  Y  NGSL   L   +C+     L
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL---SCLDGTPPL 121
Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
               R  I     + + +LH       IH D+K  N+LLD+   A +SDFG+A+      
Sbjct: 122 SWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 344 QSMTQTQTLATIGYMAP 360
           Q +  ++ + T  Y AP
Sbjct: 179 QXVXXSRIVGTTAYXAP 195

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 80/174 (45%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F    ++G GSF +   AR L    E+AIK  +               E +VM  + H  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            VK+  +  +++     L Y  NG L K +       +   R      + SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 182 QPQASRRRFSYLELLRATNGFSAN---------NLIGRGSFGSVYKARL----QDGMEFA 228
           +PQ      +Y E  RA   F+            +IG G  G V   RL    Q  +  A
Sbjct: 22  EPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA 81
Query: 229 IKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL 276
           IK+            F  E  +M    H N++++    +      +V EYM NGSL+  L
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 277 YSSNCILDILQRLNIMINVTSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGI 335
            + +    I+Q + ++  V + + YL   G+    +H DL   NVL+D N+V  +SDFG+
Sbjct: 142 RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 336 AKLLTGE-DQSMTQTQTLATIGYMAP 360
           +++L  + D + T T     I + AP
Sbjct: 198 SRVLEDDPDAAXTTTGGKIPIRWTAP 223

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 182 QPQASRRRFSYLELLRATNGFSAN---------NLIGRGSFGSVYKARL----QDGMEFA 228
           +PQ      +Y E  RA   F+            +IG G  G V   RL    Q  +  A
Sbjct: 22  EPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA 81
Query: 229 IKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL 276
           IK+            F  E  +M    H N++++    +      +V EYM NGSL+  L
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 277 YSSNCILDILQRLNIMINVTSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGI 335
            + +    I+Q + ++  V + + YL   G+    +H DL   NVL+D N+V  +SDFG+
Sbjct: 142 RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 336 AKLLTGE-DQSMTQTQTLATIGYMAP 360
           +++L  + D + T T     I + AP
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAP 223

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------ECEVM 239
           L ATN  S + ++G G FG V   RL+      +  AIK+  V            E  +M
Sbjct: 30  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
               H N++++    +      +V EYM NGSL+  L   +    ++Q + ++  + S +
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 148
Query: 300 EYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
           +YL   G+    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 149 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 87/176 (49%), Gaps = 22/176 (12%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------E 235
           + + L ATN  S + ++G G FG V   RL+      +  AIK+  V            E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             +M    H N++++    +      +V EYM NGSL+  L   +    ++Q + ++  +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 296 TSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            S ++YL   G+    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 87/176 (49%), Gaps = 22/176 (12%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------E 235
           + + L ATN  S + ++G G FG V   RL+      +  AIK+  V            E
Sbjct: 9   FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             +M    H N++++    +      +V EYM NGSL+  L   +    ++Q + ++  +
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 127
Query: 296 TSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            S ++YL   G+    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 128 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 87/176 (49%), Gaps = 22/176 (12%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------E 235
           + + L ATN  S + ++G G FG V   RL+      +  AIK+  V            E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             +M    H N++++    +      +V EYM NGSL+  L   +    ++Q + ++  +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 296 TSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            S ++YL   G+    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 87/176 (49%), Gaps = 22/176 (12%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------E 235
           + + L ATN  S + ++G G FG V   RL+      +  AIK+  V            E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             +M    H N++++    +      +V EYM NGSL+  L   +    ++Q + ++  +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 296 TSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            S ++YL   G+    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------ECEVM 239
           L ATN  S + ++G G FG V   RL+      +  AIK+  V            E  +M
Sbjct: 40  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
               H N++++    +      +V EYM NGSL+  L   +    ++Q + ++  + S +
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 158
Query: 300 EYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
           +YL   G+    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 159 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------ECEVM 239
           L ATN  S + ++G G FG V   RL+      +  AIK+  V            E  +M
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
               H N++++    +      +V EYM NGSL+  L   +    ++Q + ++  + S +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 300 EYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
           +YL   G+    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 161 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 86/176 (48%), Gaps = 22/176 (12%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------E 235
           + + L ATN  S + ++G G FG V   RL+      +  AIK+  V            E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             +M    H N++++    +      +V EYM NGSL+  L   +    ++Q + ++  +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 296 TSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            S ++YL   G+    +H DL   N+L++ N+V  +SDFG+ ++L  + ++   T+
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 87/192 (45%), Gaps = 17/192 (8%)
Query: 180 NMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAI---------- 229
            ++P+  R    Y E+  +    S    IG GSFG+VYK +    +   I          
Sbjct: 18  KIRPRGQRDSSYYWEIEASEVMLSTR--IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQ 75
Query: 230 -KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR 288
            ++F  E  V++   H N++  +   + ++  A+V ++    SL K L+       + Q 
Sbjct: 76  FQAFRNEVAVLRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQL 134
Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           ++I       ++YLH   +  IIH D+K +N+ L + +   + DFG+A + +    S   
Sbjct: 135 IDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191
Query: 349 TQTLATIGYMAP 360
            Q   ++ +MAP
Sbjct: 192 EQPTGSVLWMAP 203

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    +++E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 136
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAP 182

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    +++E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 140
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 186

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G FG VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 133
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAP 179

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 20/162 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG-----MEFAIKSFDV------------ECEVMKSIHHRNL 247
             +IG G FG VYK  L+       +  AIK+               E  +M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           +++    S      ++ EYM NG+L+K L   +    +LQ + ++  + + ++YL    +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---N 165
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 349
              +H DL   N+L++ N+V  +SDFG++++L  + ++   T
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    +++E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 133
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAP 179

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    +++E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 140
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAP 186

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    +++E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 139
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 185

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK I H  LV++ +  S E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEE 85
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 141
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 142 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 75
Query: 258 DFRALVLEYMTNGSLEKVLY-SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L   +   L + Q +++   + S + Y+        +H DL+
Sbjct: 76  PI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 131
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 132 AANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAP 174

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 80  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 136
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           DL   N L+ +N +  ++DFG+++L+TG+
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V+EYM+ GSL   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 86  PI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 141
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 142 AANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAP 184

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 140
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 186

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 140
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 186

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 92  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 148
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 149 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 194

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 137
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 183

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 258 DFRALVLEYMTNGSLEKVLY-SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L   +   L + Q +++   + S + Y+        +H DL+
Sbjct: 335 PI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 390
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 391 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 433

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 137
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 183

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V+EYM+ GSL   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 86  PI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 141
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 142 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 137
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           DL   N L+ +N +  ++DFG+++L+TG+
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 22/176 (12%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------E 235
           + + L ATN  S + ++G G FG V   RL+      +  AIK+  V            E
Sbjct: 9   FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             +M    H N++++    +      +V E M NGSL+  L   +    ++Q + ++  +
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGI 127
Query: 296 TSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            S ++YL   G+    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 128 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 140
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 186

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 22/176 (12%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------E 235
           + + L ATN  S + ++G G FG V   RL+      +  AIK+  V            E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             +M    H N++++    +      +V E M NGSL+  L   +    ++Q + ++  +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 296 TSALEYL-HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            S ++YL   G+    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 78
Query: 258 DFRALVLEYMTNGSLEKVLY-SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L   +   L + Q +++   + S + Y+        +H DL+
Sbjct: 79  PI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 134
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 135 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 177

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 258 DFRALVLEYMTNGSLEKVLY-SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L   +   L + Q +++   + S + Y+        +H DL+
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 307
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 308 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 350

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 258 DFRALVLEYMTNGSLEKVLY-SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L   +   L + Q +++   + S + Y+        +H DL+
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 307
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 308 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 350

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 19/149 (12%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 133
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           DL   N L+ +N +  ++DFG+++L+TG+
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 206 NLIGRGSFGSVYKARLQDGMEFAI------------KSFDVECEVMKSIHHRNLVKIISS 253
            ++G+G FG   K   ++  E  +            ++F  E +VM+ + H N++K I  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              +     + EY+  G+L  ++ S +      QR++   ++ S + YLH   S  IIH 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
           DL  HN L+ +N    ++DFG+A+L+  E    TQ + L ++
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEK---TQPEGLRSL 171

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------E 235
           + + L ATN  S + ++G G FG V   RL+      +  AIK+  V            E
Sbjct: 38  FAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             +M    H N++++    +      +V E M NGSL+  L   +    ++Q + ++  +
Sbjct: 97  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            S ++YL        +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 157 ASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 258 DFRALVLEYMTNGSLEKVLY-SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM  GSL   L   +   L + Q +++   + S + Y+        +H DL+
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDLR 138
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 139 AANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAP 181

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 79/167 (47%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    +V EYM  G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHR 154
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DL   N L+ +N V  ++DFG+++L+TG D           I + AP
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 200

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 74
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 75  PI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 130
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 131 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 173

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 141
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 142 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 86  PI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 141
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 142 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 76
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 77  PI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 132
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 133 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 175

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 258 DFRALVLEYMTNGSLEKVLY-SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM  GSL   L   +   L + Q +++   + S + Y+        +H DL+
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDLR 138
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 139 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 181

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 258 DFRALVLEYMTNGSLEKVLY-SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L   +   L + Q +++   + S + Y+        +H DL+
Sbjct: 252 PI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 307
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 308 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 350

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   ++ +  L +   ++SA+EYL        IH 
Sbjct: 325 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 381
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 382 NLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 427

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 87/172 (50%), Gaps = 23/172 (13%)
Query: 206 NLIGRGSFGSVYKARLQDGMEF-AIKSFDV----------------ECEVMKSIHHRNLV 248
           + +G G F +VYKAR ++  +  AIK   +                E ++++ + H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
            ++ +  ++   +LV ++M    LE ++  ++ +L        M+     LEYLH  +  
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            I+H DLKP+N+LLD+N V  L+DFG+AK     +++      + T  Y AP
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTRWYRAP 181

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 202 FSANNLIGRGSFGSVYKA-RLQDGMEFAIKSFDVECE---------VMKSIHHRNLVKII 251
           F     +G GS+GSVYKA   + G   AIK   VE +         +M+     ++VK  
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            S        +V+EY   GS+  ++   N  L   +   I+ +    LEYLHF      I
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---I 147
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H D+K  N+LL+    A L+DFG+A  LT  D    +   + T  +MAP
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAP 194

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V+EYM+ G L   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 86  PI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 141
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 142 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVY-------------KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
           +G G +G VY             K   +D ME  ++ F  E  VMK I H NLV+++  C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 342
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L   N L+ +N +  ++DFG+++L+TG D           I + AP
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 388

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L       L + Q +++   + S + Y+        +H DL 
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLA 141
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 142 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 30/179 (16%)
Query: 205 NNLIGRGSFGSVYKARLQDGMEFAIKSF------DV---------ECEVMKSIHHRNLVK 249
             +IG G FG VY+A    G E A+K+       D+         E ++   + H N++ 
Sbjct: 12  EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +   C  E    LV+E+   G L +VL       DIL  +N  + +   + YLH     P
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVP 128
Query: 310 IIHCDLKPHNVLLDDNI--------VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           IIH DLK  N+L+   +        +  ++DFG+A+    E    T+        +MAP
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAP 183

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 252
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ GSL   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 253 PI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 308
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+ +L+  ED   T  Q     I + AP
Sbjct: 309 AANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAP 351

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 37/191 (19%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DG--MEFAIK------------SFDVECEVM-KSIH 243
           N     ++IG G+FG V KAR++ DG  M+ AIK             F  E EV+ K  H
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI---------------LDILQR 288
           H N++ ++ +C +  +  L +EY  +G+L   L  S  +               L   Q 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           L+   +V   ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +
Sbjct: 145 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 198
Query: 349 TQTLATIGYMA 359
           T     + +MA
Sbjct: 199 TMGRLPVRWMA 209

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 21/161 (13%)
Query: 207 LIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------ECEVMKSIHHRNLVKI 250
           +IG G FG V   RL+      +  AIK+  V            E  +M    H N++ +
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL-HFGFSTP 309
               +      +V EYM NGSL+  L  ++    ++Q + ++  +++ ++YL   G+   
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY--- 145
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 146 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 185

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 37/191 (19%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DG--MEFAIK------------SFDVECEVM-KSIH 243
           N     ++IG G+FG V KAR++ DG  M+ AIK             F  E EV+ K  H
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI---------------LDILQR 288
           H N++ ++ +C +  +  L +EY  +G+L   L  S  +               L   Q 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           L+   +V   ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +
Sbjct: 135 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 188
Query: 349 TQTLATIGYMA 359
           T     + +MA
Sbjct: 189 TMGRLPVRWMA 199

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 258 DFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM+ G L   L       L + Q +++   + S + Y+        +H DL+
Sbjct: 86  PI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 141
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 142 AANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 22/175 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDGME----FAIKS------------FDVECEVMKSIHHRNLV 248
             +IG G FG V + RL+   +     AIK+            F  E  +M    H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           ++    +N     ++ E+M NG+L+  L  ++    ++Q + ++  + S + YL      
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 137
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAP 360
             +H DL   N+L++ N+V  +SDFG+++ L       T+T +L     I + AP
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 205 NNLIGRGSFGSVYKARL--------QDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSN 256
             ++GRG+FG V KA+         Q   E   K+F VE   +  ++H N+VK+  +C N
Sbjct: 14  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCI--LDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
                LV+EY   GSL  VL+ +  +        ++  +  +  + YLH      +IH D
Sbjct: 74  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 315 LKPHNVLL-DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LKP N+LL     V  + DFG     T  D     T    +  +MAP
Sbjct: 132 LKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAP 173

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 205 NNLIGRGSFGSVYKARL--------QDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSN 256
             ++GRG+FG V KA+         Q   E   K+F VE   +  ++H N+VK+  +C N
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCI--LDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
                LV+EY   GSL  VL+ +  +        ++  +  +  + YLH      +IH D
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 315 LKPHNVLL-DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LKP N+LL     V  + DFG     T  D     T    +  +MAP
Sbjct: 131 LKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAP 172

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVL 195

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 141
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 142 YIHRDLATRNILVENENRVKIGDFGLTKVL 171

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 133
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 134 YIHRDLATRNILVENENRVKIGDFGLTKVL 163

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 132
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 133 YIHRDLATRNILVENENRVKIGDFGLTKVL 162

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 139
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 140 YIHRDLATRNILVENENRVKIGDFGLTKVL 169

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 33/187 (17%)
Query: 190 FSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGME-FAIKSFDV-------------- 234
           F + E+LRA         IG+GSFG V   +  D  + +A+K  +               
Sbjct: 14  FDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 235 ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMIN 294
           E ++M+ + H  LV +  S  +E+   +V++ +  G L   L  +    +   +L I   
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI-CE 123
Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA- 353
           +  AL+YL    +  IIH D+KP N+LLD++   H++DF IA +L  E    TQ  T+A 
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAG 176
Query: 354 TIGYMAP 360
           T  YMAP
Sbjct: 177 TKPYMAP 183

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 140
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 141 YIHRDLATRNILVENENRVKIGDFGLTKVL 170

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 138
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 139 YIHRDLATRNILVENENRVKIGDFGLTKVL 168

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 19/166 (11%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISSC 254
           +G G++G VYKA+   G   A+K   ++ E             ++K +HH N+V +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            +E    LV E+M    L+KVL  +   L   Q   I I +   L  +       I+H D
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAP 188

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L +    +D ++ L     +   +EYL    +  
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 19/166 (11%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISSC 254
           +G G++G VYKA+   G   A+K   ++ E             ++K +HH N+V +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            +E    LV E+M    L+KVL  +   L   Q   I I +   L  +       I+H D
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAP 188

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 27/166 (16%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF--------DVECEVM--KSIHH 244
           LR  + F    ++G+G+FG V KAR   D   +AIK           +  EVM   S++H
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 245 -------------RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI 291
                        RN VK +++   +    + +EY  NG+L  +++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
              +  AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 18/194 (9%)
Query: 179 ANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS------- 231
           ++MQ Q  ++ +   E             +G G FG V+        + A+KS       
Sbjct: 2   SHMQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS 61
Query: 232 ---FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQ 287
              F  E  +MK + H+ LV++ +  + E    ++ EYM NGSL   L + + I L I +
Sbjct: 62  PDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINK 120
Query: 288 RLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
            L++   +   + ++        IH DL+  N+L+ D +   ++DFG+A+L+  ED   T
Sbjct: 121 LLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYT 175
Query: 348 QTQTLA-TIGYMAP 360
             +     I + AP
Sbjct: 176 AREGAKFPIKWTAP 189

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 30/183 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKS------------FDVECEVMKSIHHRNLV 248
           +     +G G FG V +   QD G + AIK             + +E ++MK ++H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 249 KI------ISSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSALE 300
                   +   +  D   L +EY   G L K L  + + C L       ++ +++SAL 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 301 YLHFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
           YLH      IIH DLKP N++L      ++  + D G AK L   DQ    T+ + T+ Y
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQY 189
Query: 358 MAP 360
           +AP
Sbjct: 190 LAP 192

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 30/183 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKS------------FDVECEVMKSIHHRNLV 248
           +     +G G FG V +   QD G + AIK             + +E ++MK ++H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 249 KI------ISSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSALE 300
                   +   +  D   L +EY   G L K L  + + C L       ++ +++SAL 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 301 YLHFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
           YLH      IIH DLKP N++L      ++  + D G AK L   DQ    T+ + T+ Y
Sbjct: 137 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQY 190
Query: 358 MAP 360
           +AP
Sbjct: 191 LAP 193

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 22/175 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDGME----FAIKS------------FDVECEVMKSIHHRNLV 248
             +IG G FG V + RL+   +     AIK+            F  E  +M    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           ++    +N     ++ E+M NG+L+  L  ++    ++Q + ++  + S + YL      
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 135
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAP 360
             +H DL   N+L++ N+V  +SDFG+++ L       T T +L     I + AP
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + AIK           F  E +VM ++ H  LV++   C+ +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               ++ EYM NG L   L          Q L +  +V  A+EYL    S   +H DL  
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAA 148
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
            N L++D  V  +SDFG+++ +  ++++
Sbjct: 149 RNCLVNDQGVVKVSDFGLSRYVLDDEET 176

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++E++  GSL + L      +D ++ L     +   +EYL    +  
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH DL   N+L+++     + DFG+ K+L
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 37/191 (19%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DG--MEFAIK------------SFDVECEVM-KSIH 243
           N     ++IG G+FG V KAR++ DG  M+ AIK             F  E EV+ K  H
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI---------------LDILQR 288
           H N++ ++ +C +  +  L +EY  +G+L   L  S  +               L   Q 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           L+   +V   ++YL        IH +L   N+L+ +N VA ++DFG+++   G++  + +
Sbjct: 142 LHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKK 195
Query: 349 TQTLATIGYMA 359
           T     + +MA
Sbjct: 196 TMGRLPVRWMA 206

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 89
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 90  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 145
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 146 AANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 188

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 88
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 89  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 144
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 145 AANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 187

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF-------------DVECEVMKSIHHRNLVKIIS 252
           L+G GS+G V K R +D G   AIK F               E +++K + H NLV ++ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 253 SCSNEDFRALVLEYMTNGSLEKV-LYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            C  +    LV E++ +  L+ + L+ +     ++Q+   +  + + + + H   S  II
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKY--LFQIINGIGFCH---SHNII 146
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H D+KP N+L+  + V  L DFG A+ L    +       +AT  Y AP
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAP 193

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 142
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 143 AANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 185

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 169 QKRATELPNVANMQPQ-ASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKAR-LQDGME 226
           Q +  + P V   QPQ A R    Y  L      F     IGRG F  VY+A  L DG+ 
Sbjct: 4   QSQGMQGPPVPQFQPQKALRPDMGYNTLA----NFRIEKKIGRGQFSEVYRAACLLDGVP 59
Query: 227 FAIKS---FDV-----------ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL 272
            A+K    FD+           E +++K ++H N++K  +S   ++   +VLE    G L
Sbjct: 60  VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119
Query: 273 EKVLYSSNCILDILQRLNIM---INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH 329
            +++        ++    +    + + SALE++H   S  ++H D+KP NV +    V  
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK 176
Query: 330 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L D G+ +  +   ++      + T  YM+P
Sbjct: 177 LGDLGLGRFFSS--KTTAAHSLVGTPYYMSP 205

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 30/181 (16%)
Query: 202 FSANNLIGRGSFGSVYK-ARLQDGMEFAIKSFDVECEVM-------------KSIH---- 243
           +   ++IGRG    V +      G EFA+K  +V  E +             +  H    
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 244 ---HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALE 300
              H +++ +I S  +  F  LV + M  G L   L +    L   +  +IM ++  A+ 
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVS 214
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMA 359
           +LH   +  I+H DLKP N+LLDDN+   LSDFG +  L  GE       +   T GY+A
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLA 267
Query: 360 P 360
           P
Sbjct: 268 P 268

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 82
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 83  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 138
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 139 AANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 181

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L++S    ++ + ++I       ++YLH   +  IIH DLK
Sbjct: 80  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 135
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L ++    + DFG+A + +    S    Q   +I +MAP
Sbjct: 136 SNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 136
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 137 AANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 179

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           IG G FG V+     +  + AIK+          F  E EVM  + H  LV++   C  +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               LV E+M +G L   L +   +      L + ++V   + YL       +IH DL  
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLAA 131
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +P
Sbjct: 132 RNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 173

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 81
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 82  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 137
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 138 AANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 180

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 142
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 143 AANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 185

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 136
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 137 AANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 179

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + A+K           F  E + M  + H  LVK    CS E
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               +V EY++NG L   L S    L+  Q L +  +V   + +L    S   IH DL  
Sbjct: 76  YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAA 132
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            N L+D ++   +SDFG+ + +  +DQ ++   T   + + AP
Sbjct: 133 RNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAP 174

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 136
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 137 AANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 179

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 85
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 86  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 141
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 142 AANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 184

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 80/185 (43%), Gaps = 35/185 (18%)
Query: 208 IGRGSFGSVYKAR------LQDGMEFAIKS-----------FDVECEVMKSIHHRNLVKI 250
           +G G+FG V+ A        +D M  A+K+           F  E E++ ++ H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYS---------------SNCILDILQRLNIMINV 295
              C + D   +V EYM +G L K L +               +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
            S + YL    S   +H DL   N L+  N++  + DFG+++ +   D       T+  I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 356 GYMAP 360
            +M P
Sbjct: 200 RWMPP 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 71/136 (52%), Gaps = 7/136 (5%)
Query: 226 EFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI 285
           E  +K F+ E      + H+N+V +I     +D   LV+EY+   +L + +  S+  L +
Sbjct: 52  EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSV 110
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              +N    +   +++ H      I+H D+KP N+L+D N    + DFGIAK L+  + S
Sbjct: 111 DTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETS 165
Query: 346 MTQT-QTLATIGYMAP 360
           +TQT   L T+ Y +P
Sbjct: 166 LTQTNHVLGTVQYFSP 181

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L+      ++++ ++I       ++YLH   +  IIH DLK
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 159
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L +++   + DFG+A + +    S    Q   +I +MAP
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L+      ++++ ++I       ++YLH   +  IIH DLK
Sbjct: 103 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 158
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L +++   + DFG+A + +    S    Q   +I +MAP
Sbjct: 159 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 75
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 76  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 131
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 132 AANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 174

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L+      ++++ ++I       ++YLH   +  IIH DLK
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 136
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L +++   + DFG+A + +    S    Q   +I +MAP
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           IG G FG V+     +  + AIK+          F  E EVM  + H  LV++   C  +
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               LV E+M +G L   L +   +      L + ++V   + YL       +IH DL  
Sbjct: 78  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAA 134
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +P
Sbjct: 135 RNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 176

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 252 SSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 135
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            IH +L   N+L+++     + DFG+ K+L
Sbjct: 136 YIHRNLATRNILVENENRVKIGDFGLTKVL 165

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L+      ++++ ++I       ++YLH   +  IIH DLK
Sbjct: 78  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 133
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L +++   + DFG+A + +    S    Q   +I +MAP
Sbjct: 134 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L+      ++++ ++I       ++YLH   +  IIH DLK
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 136
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L +++   + DFG+A + +    S    Q   +I +MAP
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           IG G FG V+     +  + AIK+          F  E EVM  + H  LV++   C  +
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               LV E+M +G L   L +   +      L + ++V   + YL       +IH DL  
Sbjct: 95  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAA 151
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +P
Sbjct: 152 RNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 193

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 18/147 (12%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG+G+F  V  AR +  G E A+K  D              E  +MK ++H N+VK+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    LV+EY + G +   L +   + +   R      + SA++Y H  F   I+H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 130
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           DLK  N+LLD ++   ++DFG +   T
Sbjct: 131 DLKAENLLLDADMNIKIADFGFSNEFT 157

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L+      ++++ ++I       ++YLH   +  IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L +++   + DFG+A + +    S    Q   +I +MAP
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 32/182 (17%)
Query: 208 IGRGSFGSVYKAR-----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKI 250
           +G G+FG V+ A                  L+D  + A K F  E E++ ++ H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL------------QRLNIMINVTSA 298
              C   D   +V EYM +G L K L +      ++            Q L+I   + + 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           + YL    S   +H DL   N L+ +N++  + DFG+++ +   D       T+  I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 359 AP 360
            P
Sbjct: 198 PP 199

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           IG G FG V+     +  + AIK+          F  E EVM  + H  LV++   C  +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               LV E+M +G L   L +   +      L + ++V   + YL       +IH DL  
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAA 131
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +P
Sbjct: 132 RNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 173

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           IG G FG V+     +  + AIK+          F  E EVM  + H  LV++   C  +
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               LV E+M +G L   L +   +      L + ++V   + YL       +IH DL  
Sbjct: 73  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAA 129
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +P
Sbjct: 130 RNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 171

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 119
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 179
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 180 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 215

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 176 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 117
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 177
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 178 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 213

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 13/146 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + AIK           F  E +VM ++ H  LV++   C+ +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               ++ EYM NG L   L          Q L +  +V  A+EYL    S   +H DL  
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAA 148
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGED 343
            N L++D  V  +SDFG+++ +  ++
Sbjct: 149 RNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 176 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 16/143 (11%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSC 254
           IGRG+FG V+  RL+ D    A+KS            F  E  ++K   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
           + +    +V+E +  G     L +    L +   L ++ +  + +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 315 LKPHNVLLDDNIVAHLSDFGIAK 337
           L   N L+ +  V  +SDFG+++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 86
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 146
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 147 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 182

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 160
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 220
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 221 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 256

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 109
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 169
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 170 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 205

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 16/143 (11%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSC 254
           IGRG+FG V+  RL+ D    A+KS            F  E  ++K   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
           + +    +V+E +  G     L +    L +   L ++ +  + +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 315 LKPHNVLLDDNIVAHLSDFGIAK 337
           L   N L+ +  V  +SDFG+++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L+      ++++ ++I       ++YLH   +  IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L +++   + DFG+A + +    S    Q   +I +MAP
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + AIK           F  E +VM ++ H  LV++   C+ +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               ++ EYM NG L   L          Q L +  +V  A+EYL    S   +H DL  
Sbjct: 83  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAA 139
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
            N L++D  V  +SDFG+++ +  ++ +
Sbjct: 140 RNCLVNDQGVVKVSDFGLSRYVLDDEYT 167

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + AIK           F  E +VM ++ H  LV++   C+ +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               ++ EYM NG L   L          Q L +  +V  A+EYL    S   +H DL  
Sbjct: 77  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAA 133
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
            N L++D  V  +SDFG+++ +  ++ +
Sbjct: 134 RNCLVNDQGVVKVSDFGLSRYVLDDEYT 161

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 100
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 160
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 161 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 196

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + AIK           F  E +VM ++ H  LV++   C+ +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               ++ EYM NG L   L          Q L +  +V  A+EYL    S   +H DL  
Sbjct: 77  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAA 133
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
            N L++D  V  +SDFG+++ +  ++ +
Sbjct: 134 RNCLVNDQGVVKVSDFGLSRYVLDDEYT 161

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 83/174 (47%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQ----DGMEFAIKSFDV------------ECEVMKSIHHRNLV 248
             +IG G FG V   RL+      +  AIK+  V            E  +M    H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL-HFGFS 307
            +    +      +V+E+M NG+L+  L   +    ++Q + ++  + + + YL   G+ 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY- 166
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM-TQTQTLATIGYMAP 360
              +H DL   N+L++ N+V  +SDFG+++++  + +++ T T     + + AP
Sbjct: 167 ---VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 154 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 82
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 142
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 143 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 178

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 18/147 (12%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG+G+F  V  AR +  G E A+K  D              E  +MK ++H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    LV+EY + G +   L +   + +   R      + SA++Y H  F   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           DLK  N+LLD ++   ++DFG +   T
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 142 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 142 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 85
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 145
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 146 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 181

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + AIK          SF  E ++MK + H  LV++ +  S E
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEE 76
Query: 258 DFRALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM  GSL   L       L +   +++   V + + Y+        IH DL+
Sbjct: 77  PI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLR 132
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ + ++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 133 SANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAP 175

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 89
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 149
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 150 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 185

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 18/147 (12%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG+G+F  V  AR +  G E A+K  D              E  +MK ++H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    LV+EY + G +   L +   + +   R      + SA++Y H  F   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           DLK  N+LLD ++   ++DFG +   T
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFAI-----------KSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +   +           ++F  E  V++   H N++  +   + 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L++S    ++ + ++I       ++YLH   +  IIH DLK
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L ++    + DFG+A   +    S    Q   +I +MAP
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + AIK           F  E +VM ++ H  LV++   C+ +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               ++ EYM NG L   L          Q L +  +V  A+EYL    S   +H DL  
Sbjct: 76  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAA 132
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
            N L++D  V  +SDFG+++ +  ++ +
Sbjct: 133 RNCLVNDQGVVKVSDFGLSRYVLDDEYT 160

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 94
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 154
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 155 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 190

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 142 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 18/147 (12%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG+G+F  V  AR +  G E A+K  D              E  +MK ++H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    LV+EY + G +   L +   + +   R      + SA++Y H  F   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           DLK  N+LLD ++   ++DFG +   T
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 142 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 154 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 142 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + AIK           F  E +VM ++ H  LV++   C+ +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               ++ EYM NG L   L          Q L +  +V  A+EYL    S   +H DL  
Sbjct: 72  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAA 128
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
            N L++D  V  +SDFG+++ +  ++ +
Sbjct: 129 RNCLVNDQGVVKVSDFGLSRYVLDDEYT 156

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 142 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           IG G FG V+     +  + AIK+          F  E EVM  + H  LV++   C  +
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               LV E+M +G L   L +   +      L + ++V   + YL       +IH DL  
Sbjct: 76  APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAA 132
Query: 318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +P
Sbjct: 133 RNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 174

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 23/160 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------DVECEVMKSIHHRNLVKI--- 250
           ++   +IG GSFG VY+A+L D  E  AIK         + E ++M+ + H N+V++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 251 -ISSCSNED--FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLH-F 304
             SS   +D  +  LVL+Y+         + S     L ++     M  +  +L Y+H F
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 305 GFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK-LLTGE 342
           G    I H D+KP N+LLD D  V  L DFG AK L+ GE
Sbjct: 142 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L+      ++++ ++I       ++YLH   +  IIH DLK
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 159
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L +++   + DFG+A   +    S    Q   +I +MAP
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFAI-----------KSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +   +           ++F  E  V++   H N++  +   + 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L++S    ++ + ++I       ++YLH   +  IIH DLK
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L ++    + DFG+A   +    S    Q   +I +MAP
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L+      ++++ ++I       ++YLH   +  IIH DLK
Sbjct: 96  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 151
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L +++   + DFG+A   +    S    Q   +I +MAP
Sbjct: 152 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 81/183 (44%), Gaps = 34/183 (18%)
Query: 207 LIGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKS--IHHRNLVKIISSCSN 256
           LIGRG +G+VYK  L D    A+K F          E  + +   + H N+ + I    +
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFI--VGD 76
Query: 257 EDFRA-------LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG---- 305
           E   A       LV+EY  NGSL K  Y S    D +    +  +VT  L YLH      
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 306 --FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE------DQSMTQTQTLATIGY 357
             +   I H DL   NVL+ ++    +SDFG++  LTG       ++       + TI Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 358 MAP 360
           MAP
Sbjct: 195 MAP 197

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 208 IGRGSFGSVYKARLQDGMEFA-----------IKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK +    +              +++F  E  V++   H N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L+      ++++ ++I       ++YLH   +  IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L +++   + DFG+A   +    S    Q   +I +MAP
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 76
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH +L+
Sbjct: 77  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNLR 132
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 133 AANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 175

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 27/166 (16%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF--------DVECEVM--KSIHH 244
           LR  + F    ++G+G+FG V KAR   D   +AIK           +  EVM   S++H
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 245 -------------RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI 291
                        RN VK +++   +    + +EY  N +L  +++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
              +  AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 18/147 (12%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG+G+F  V  AR +  G E A++  D              E  +MK ++H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    LV+EY + G +   L +   + +   R      + SA++Y H  F   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           DLK  N+LLD ++   ++DFG +   T
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 18/147 (12%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG+G+F  V  AR +  G E A++  D              E  +MK ++H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    LV+EY + G +   L +   + +   R      + SA++Y H  F   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           DLK  N+LLD ++   ++DFG +   T
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFT 164

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 26/179 (14%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDVECEVMK-----SIHHRNLVKIISS 253
           N FS + +IGRG FG VY  R  D G  +A+K  D +   MK     +++ R ++ ++S+
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 254 -------CSNEDFR-----ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
                  C +  F      + +L+ M  G L   L       +   R      +   LE+
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 306
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +H  F   +++ DLKP N+LLD++    +SD G+A   + +        ++ T GYMAP
Sbjct: 307 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 358

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 26/179 (14%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDVECEVMK-----SIHHRNLVKIISS 253
           N FS + +IGRG FG VY  R  D G  +A+K  D +   MK     +++ R ++ ++S+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 254 -------CSNEDFR-----ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
                  C +  F      + +L+ M  G L   L       +   R      +   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +H  F   +++ DLKP N+LLD++    +SD G+A   + +        ++ T GYMAP
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 359

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSF------------DVECEVMKSIHHRNLVKIISSC 254
           +G G+FG V+    +  G+E  IK+             + E EV+KS+ H N++KI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR---LNIMINVTSALEYLHFGFSTPII 311
            +     +V+E    G L + + S+      L       +M  + +AL Y H   S  ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 312 HCDLKPHNVLLDD---NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H DLKP N+L  D   +    + DFG+A+L   ++ S   T    T  YMAP
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAP 195

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDVECE-----------VMKSIHHRNLVKIISSCS 255
           IG+G+ G+VY A  +  G E AI+  +++ +           VM+   + N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+EY+  GSL  V+ +  C +D  Q   +      ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+LL  +    L+DFG    +T E     +++ + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAP 185

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 26/179 (14%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDVECEVMK-----SIHHRNLVKIISS 253
           N FS + +IGRG FG VY  R  D G  +A+K  D +   MK     +++ R ++ ++S+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 254 -------CSNEDFR-----ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
                  C +  F      + +L+ M  G L   L       +   R      +   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +H  F   +++ DLKP N+LLD++    +SD G+A   + +        ++ T GYMAP
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 359

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 26/179 (14%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDVECEVMK-----SIHHRNLVKIISS 253
           N FS + +IGRG FG VY  R  D G  +A+K  D +   MK     +++ R ++ ++S+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 254 -------CSNEDFR-----ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
                  C +  F      + +L+ M  G L   L       +   R      +   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +H  F   +++ DLKP N+LLD++    +SD G+A   + +        ++ T GYMAP
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 359

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 18/153 (11%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNL 247
           +     IG+G+F  V  AR +  G E A+K  D              E  +MK ++H N+
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK+      E    LV+EY + G +   L +   + +   R      + SA++Y H  + 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY- 134
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT 340
             I+H DLK  N+LLD ++   ++DFG +   T
Sbjct: 135 --IVHRDLKAENLLLDGDMNIKIADFGFSNEFT 165

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHRNLVKIISSCSNED 258
           IG+G FG V     + G + A+K         +F  E  VM  + H NLV+++     E 
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 78
Query: 259 FR-ALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM  GSL   L S    +L     L   ++V  A+EYL        +H DL 
Sbjct: 79  GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLA 135
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 136 ARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 174

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISSC 254
           IG G++G VYKA+   G  FA+K   +E E             ++K + H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
             +    LV E++ +  L+K+L      L+ +   + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAP 169

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 27/167 (16%)
Query: 201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKSF-------DVECEVMKSIHHRNLVKIIS- 252
            ++   +IG GSFG V++A+L +  E AIK         + E ++M+ + H N+V + + 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 253 -----SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI------MINVTSALEY 301
                   +E F  LVLEY+     E V  +S     + Q + +      M  +  +L Y
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 302 LHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMT 347
           +H   S  I H D+KP N+LLD  + V  L DFG AK+L   + +++
Sbjct: 157 IH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHRNLVKIISSCSNED 258
           IG+G FG V     + G + A+K         +F  E  VM  + H NLV+++     E 
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87
Query: 259 FR-ALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM  GSL   L S    +L     L   ++V  A+EYL        +H DL 
Sbjct: 88  GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLA 144
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 145 ARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 183

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 205 NNLIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLV 248
             +IG G FG V   RL+      +  AIK+            F  E  +M    H N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
            +    +      ++ EYM NGSL+  L  ++    ++Q + ++  + S ++YL      
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 150
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
             +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 192

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G  G V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + + I L I + L++   +   + ++        IH DL+
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 136
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 137 AANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWTAP 179

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISSC 254
           IG G++G VYKA+   G  FA+K   +E E             ++K + H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
             +    LV E++ +  L+K+L      L+ +   + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAP 169

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISSC 254
           IG G++G VYKA+   G  FA+K   +E E             ++K + H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
             +    LV E++ +  L+K+L      L+ +   + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAP 169

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 17/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+     +  + A+K+          F  E  +MK++ H  LV++ +  + E
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRL-NIMINVTSALEYLHFGFSTPIIHCDLK 316
           +   ++ EYM  GSL   L S      +L +L +    +   + Y+        IH DL+
Sbjct: 81  EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLR 137
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             NVL+ ++++  ++DFG+A+++  ED   T  +     I + AP
Sbjct: 138 AANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 180

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHRNLVKIISSCSNED 258
           IG+G FG V     + G + A+K         +F  E  VM  + H NLV+++     E 
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 259 FR-ALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM  GSL   L S    +L     L   ++V  A+EYL        +H DL 
Sbjct: 73  GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLA 129
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 130 ARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 168

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 205 NNLIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLV 248
             +IG G FG V   RL+      +  AIK+            F  E  +M    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
            +    +      ++ EYM NGSL+  L  ++    ++Q + ++  + S ++YL      
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 129
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
             +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 205 NNLIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLV 248
             +IG G FG V   RL+      +  AIK+            F  E  +M    H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
            +    +      ++ EYM NGSL+  L  ++    ++Q + ++  + S ++YL      
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 135
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
             +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDVECE-----------VMKSIHHRNLVKIISSCS 255
           IG+G+ G+VY A  +  G E AI+  +++ +           VM+   + N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+EY+  GSL  V+ +  C +D  Q   +      ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+LL  +    L+DFG    +T E QS   T  + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAP 185

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDVECE-----------VMKSIHHRNLVKIISSCS 255
           IG+G+ G+VY A  +  G E AI+  +++ +           VM+   + N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+EY+  GSL  V+ +  C +D  Q   +      ALE+LH   S  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+LL  +    L+DFG    +T E     ++  + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAP 185

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 29/179 (16%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ------------------DGMEFAIKSFDVECEVMKS 241
           + F     +G+G FG+VY AR +                  +G+E  ++    E E+   
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRR---EIEIQAH 79
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           +HH N++++ +   +     L+LEY   G L K L  S C  D  +   IM  +  AL Y
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMY 138
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            H      +IH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ P
Sbjct: 139 CH---GKKVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPP 190

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDVECE-----------VMKSIHHRNLVKIISSCS 255
           IG+G+ G+VY A  +  G E AI+  +++ +           VM+   + N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+EY+  GSL  V+ +  C +D  Q   +      ALE+LH   S  +IH D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+LL  +    L+DFG    +T E     ++  + T  +MAP
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAP 186

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 18/147 (12%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG+G+F  V  AR +  G E AIK  D              E  +MK ++H N+VK+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    L++EY + G +   L +   + +   R      + SA++Y H      I+H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           DLK  N+LLD ++   ++DFG +   T
Sbjct: 136 DLKAENLLLDADMNIKIADFGFSNEFT 162

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 84/169 (49%), Gaps = 20/169 (11%)
Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSC 254
           ++G+G++G VY  R L + +  AIK               E  + K + H+N+V+ + S 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCIL-DILQRLNIMI-NVTSALEYLHFGFSTPIIH 312
           S   F  + +E +  GSL  +L S    L D  Q +      +   L+YLH      I+H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 131
Query: 313 CDLKPHNVLLDD-NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ YMAP
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAP 178

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 24/184 (13%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVYKA---RLQDGMEFAIKSFDVECEVMKSIHHRNLV 248
           Y + +     F+    IG+GSFG V+K    R Q  +  AIK  D+E    +    +  +
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVV--AIKIIDLEEAEDEIEDIQQEI 76
Query: 249 KIISSCSN-----------EDFR-ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVT 296
            ++S C +           +D +  +++EY+  GS   +L      LD  Q   I+  + 
Sbjct: 77  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREIL 134
Query: 297 SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
             L+YLH   S   IH D+K  NVLL ++    L+DFG+A  LT  D  + +   + T  
Sbjct: 135 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPF 189
Query: 357 YMAP 360
           +MAP
Sbjct: 190 WMAP 193

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 66/144 (45%), Gaps = 19/144 (13%)
Query: 205 NNLIGRGSFGSVYKARLQDGMEFAIKSFDVEC-----------EVM--KSIHHRNLVKII 251
             LIG+G FG VY  R     E AI+  D+E            EVM  +   H N+V  +
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            +C +    A++       +L  V+  +  +LD+ +   I   +   + YLH   +  I+
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGI 335
           H DLK  NV  D+  V  ++DFG+
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHRNLVKIISSCSNED 258
           IG+G FG V     + G + A+K         +F  E  VM  + H NLV+++     E 
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259
Query: 259 FR-ALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM  GSL   L S    +L     L   ++V  A+EYL        +H DL 
Sbjct: 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLA 316
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 355

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 84/169 (49%), Gaps = 20/169 (11%)
Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSC 254
           ++G+G++G VY  R L + +  AIK               E  + K + H+N+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCIL-DILQRLNIMI-NVTSALEYLHFGFSTPIIH 312
           S   F  + +E +  GSL  +L S    L D  Q +      +   L+YLH      I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 313 CDLKPHNVLLDD-NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ YMAP
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAP 192

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 18/147 (12%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG+G+F  V  AR +  G E AIK  D              E  +MK ++H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    L++EY + G +   L +   + +   R      + SA++Y H      I+H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           DLK  N+LLD ++   ++DFG +   T
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFT 165

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 22/170 (12%)
Query: 207 LIGRGSFGSVYKARLQ-DGMEFAIKSFDVEC---------------EVMKSIHHRNLVKI 250
           +IG+GSFG V  AR + + + +A+K    +                 ++K++ H  LV +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             S    D    VL+Y+  G L   L    C L+   R      + SAL YLH   S  I
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 160
Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           ++ DLKP N+LLD      L+DFG+ K     + + T +    T  Y+AP
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAP 208

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKA---RLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSN-- 256
           F+    IG+GSFG V+K    R Q  +  AIK  D+E    +    +  + ++S C +  
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVV--AIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 257 ---------EDFR-ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
                    +D +  +++EY+  GS   +L      LD  Q   I+  +   L+YLH   
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 136
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S   IH D+K  NVLL ++    L+DFG+A  LT  D  + +   + T  +MAP
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 188

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKA---RLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSN-- 256
           F+    IG+GSFG V+K    R Q  +  AIK  D+E    +    +  + ++S C +  
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVV--AIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 257 ---------EDFR-ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
                    +D +  +++EY+  GS   +L      LD  Q   I+  +   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 121
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S   IH D+K  NVLL ++    L+DFG+A  LT  D  + +   + T  +MAP
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 173

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 80/171 (46%), Gaps = 28/171 (16%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG GS+G V+K R +D G   AIK F               E  ++K + H NLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR---LNIMINVT-SALEYLHFGFSTP 309
              +    LV EY  +  L +        LD  QR    +++ ++T   L+ ++F     
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IH D+KP N+L+  + V  L DFG A+LLTG   S      +AT  Y +P
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDYYDDEVATRWYRSP 171

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKA---RLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSN-- 256
           F+    IG+GSFG V+K    R Q  +  AIK  D+E    +    +  + ++S C +  
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVV--AIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 257 ---------EDFR-ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
                    +D +  +++EY+  GS   +L      LD  Q   I+  +   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 121
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S   IH D+K  NVLL ++    L+DFG+A  LT  D  + +   + T  +MAP
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 173

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 40/187 (21%)
Query: 208 IGRGSFGSVYKARL------QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKI 250
           +G G+FG V+ A        QD M  A+K+           F  E E++  + H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL--------------QRLNIMINVT 296
              C+      +V EYM +G L + L S      +L              Q L +   V 
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 297 SALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 353
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 354 TIGYMAP 360
            I +M P
Sbjct: 223 PIRWMPP 229

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 52/238 (21%)
Query: 135 GNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRATELPNVANMQPQASRRRFSYLE 194
           GND LC   ++   PC S+KP             +K A E+P                  
Sbjct: 157 GNDGLCQKLSV---PCMSSKPQ---------KPWEKDAWEIPR----------------- 187
Query: 195 LLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHH 244
                        +G G FG V+ A      + A+K+          F  E  VMK++ H
Sbjct: 188 -----ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH 242
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL-EYLH 303
             LVK+ +  + E    ++ E+M  GSL   L S       L +L   I+ ++ + E + 
Sbjct: 243 DKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMA 298
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
           F      IH DL+  N+L+  ++V  ++DFG+A+++  ED   T  +     I + AP
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 354

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 40/187 (21%)
Query: 208 IGRGSFGSVYKARL------QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKI 250
           +G G+FG V+ A        QD M  A+K+           F  E E++  + H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL--------------QRLNIMINVT 296
              C+      +V EYM +G L + L S      +L              Q L +   V 
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 297 SALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 353
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 354 TIGYMAP 360
            I +M P
Sbjct: 194 PIRWMPP 200

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 17/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+     +  + A+K          +F  E  +MK++ H  LV++ +  + E
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 79
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRL-NIMINVTSALEYLHFGFSTPIIHCDLK 316
           +   ++ E+M  GSL   L S      +L +L +    +   + Y+        IH DL+
Sbjct: 80  EPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLR 136
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             NVL+ ++++  ++DFG+A+++  ED   T  +     I + AP
Sbjct: 137 AANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 179

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 40/187 (21%)
Query: 208 IGRGSFGSVYKARL------QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKI 250
           +G G+FG V+ A        QD M  A+K+           F  E E++  + H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL--------------QRLNIMINVT 296
              C+      +V EYM +G L + L S      +L              Q L +   V 
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 297 SALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 353
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 354 TIGYMAP 360
            I +M P
Sbjct: 200 PIRWMPP 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 150
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 78/174 (44%), Gaps = 22/174 (12%)
Query: 206 NLIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
            +IG G FG V    L+      +  AIK+            F  E  +M    H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +    +      ++ E+M NGSL+  L  ++    ++Q + ++  + + ++YL       
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 155
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAP 360
            +H DL   N+L++ N+V  +SDFG+++ L  +    T T  L     I + AP
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   ++YL    S
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 143
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 94/190 (49%), Gaps = 23/190 (12%)
Query: 180 NMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVECEV 238
           +MQ    R+ F ++E+L  +  FS   L+ +   G ++  + ++    F   S + E  V
Sbjct: 1   SMQTTNIRKTFIFMEVL-GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGS-----LEKVLYSSNCILDILQRLNIMI 293
           +K I H N+V +     +     LV++ ++ G      LE+ +Y+      ++Q+     
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----- 114
Query: 294 NVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            V SA++YLH      I+H DLKP N+L    ++N    ++DFG++K+    +Q+   + 
Sbjct: 115 -VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMST 166
Query: 351 TLATIGYMAP 360
              T GY+AP
Sbjct: 167 ACGTPGYVAP 176

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   ++YL    S
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 169
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 151
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 23/173 (13%)
Query: 208 IGRGSFGSVYKARLQ-----DGMEFAIKSFDVEC------------EVMKSIHHRNLVKI 250
           +G G FG V   R        G + A+KS   E             E++++++H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 251 ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              C+ +      L++E++ +GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAP 360
             +H DL   NVL++      + DFG+ K + T ++    +    + + + AP
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   ++YL    S
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 170
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 23/173 (13%)
Query: 208 IGRGSFGSVYKARLQ-----DGMEFAIKSFDVEC------------EVMKSIHHRNLVKI 250
           +G G FG V   R        G + A+KS   E             E++++++H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 251 ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              C+ +      L++E++ +GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT-QTQTLATIGYMAP 360
             +H DL   NVL++      + DFG+ K +  + +  T +    + + + AP
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 29/195 (14%)
Query: 189 RFSYLELLRAT----NGFSANNLIGRGSFGSVYKARLQ-DGMEFA--------------I 229
           RF   + L A     + F    ++GRG FG V+  +++  G  +A               
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 230 KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY---SSNCILDIL 286
           +   VE +++  +H R +V +  +   +    LV+  M  G +   +Y     N      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           + +     + S LE+LH      II+ DLKP NVLLDD+    +SD G+A  L       
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQ 343
Query: 347 TQTQTLA-TIGYMAP 360
           T+T+  A T G+MAP
Sbjct: 344 TKTKGYAGTPGFMAP 358

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 29/195 (14%)
Query: 189 RFSYLELLRA----TNGFSANNLIGRGSFGSVYKARLQ-DGMEFA--------------I 229
           RF   + L A     + F    ++GRG FG V+  +++  G  +A               
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 230 KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY---SSNCILDIL 286
           +   VE +++  +H R +V +  +   +    LV+  M  G +   +Y     N      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           + +     + S LE+LH      II+ DLKP NVLLDD+    +SD G+A  L       
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQ 343
Query: 347 TQTQTLA-TIGYMAP 360
           T+T+  A T G+MAP
Sbjct: 344 TKTKGYAGTPGFMAP 358

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   ++YL    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 149
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   ++YL    S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 148
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   ++YL    S
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 146
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 29/195 (14%)
Query: 189 RFSYLELLRA----TNGFSANNLIGRGSFGSVYKARLQ-DGMEFA--------------I 229
           RF   + L A     + F    ++GRG FG V+  +++  G  +A               
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 230 KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY---SSNCILDIL 286
           +   VE +++  +H R +V +  +   +    LV+  M  G +   +Y     N      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           + +     + S LE+LH      II+ DLKP NVLLDD+    +SD G+A  L       
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQ 343
Query: 347 TQTQTLA-TIGYMAP 360
           T+T+  A T G+MAP
Sbjct: 344 TKTKGYAGTPGFMAP 358

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 150
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 29/195 (14%)
Query: 189 RFSYLELLRA----TNGFSANNLIGRGSFGSVYKARLQ-DGMEFA--------------I 229
           RF   + L A     + F    ++GRG FG V+  +++  G  +A               
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 230 KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY---SSNCILDIL 286
           +   VE +++  +H R +V +  +   +    LV+  M  G +   +Y     N      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           + +     + S LE+LH      II+ DLKP NVLLDD+    +SD G+A  L       
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQ 343
Query: 347 TQTQTLA-TIGYMAP 360
           T+T+  A T G+MAP
Sbjct: 344 TKTKGYAGTPGFMAP 358

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFD----------VECEVMKSIHH 244
           LR  + F    ++G+G+FG V KAR   D   +AIK              E  ++ S++H
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNH 61
Query: 245 -------------RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI 291
                        RN VK  ++   +    +  EY  N +L  +++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
              +  AL Y+H   S  IIH +LKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 151
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+ A      + A+K+          F  E  VMK++ H  LVK+ +  + E
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 82
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL-EYLHFGFSTPIIHCDLK 316
               ++ E+M  GSL   L S       L +L   I+ ++ + E + F      IH DL+
Sbjct: 83  PI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFIEQRNYIHRDLR 138
Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             N+L+  ++V  ++DFG+A+++  ED   T  +     I + AP
Sbjct: 139 AANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 181

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 32/187 (17%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------------FDVECEV 238
           A N       IG+G FG V+K RL +D    AIKS                  F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           M +++H N+VK+     N     +V+E++  G L   L      +    +L +M+++   
Sbjct: 77  MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 299 LEYLHFGFSTPIIHCDLKPHNVL---LDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTLA 353
           +EY+    + PI+H DL+  N+    LD+N  + A ++DFG     T +    + +  L 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-----TSQQSVHSVSGLLG 188
Query: 354 TIGYMAP 360
              +MAP
Sbjct: 189 NFQWMAP 195

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVEC------EVM---KSIHHRNLVKIIS 252
           F   +++G G+ G++    + D  + A+K    EC      EV    +S  H N+++   
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFC 85
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           +  +  F+ + +E +   +L++ +   +     L+ + ++   TS L +LH   S  I+H
Sbjct: 86  TEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVH 141
Query: 313 CDLKPHNVLLD-----DNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
            DLKPHN+L+        I A +SDFG+ K L     S ++   +  T G++AP
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 35/192 (18%)
Query: 195 LLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEF-AIKSFDVEC-----------EV--- 238
           L RA   +     IG G++G V+KAR L++G  F A+K   V+            EV   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 239 --MKSIHHRNLVKIISSCS-----NEDFRALVLEYMTNG---SLEKVLYSSNCILDILQR 288
             +++  H N+V++   C+      E    LV E++       L+KV         I   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
            ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A++ + +   M  
Sbjct: 124 -DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 176
Query: 349 TQTLATIGYMAP 360
           T  + T+ Y AP
Sbjct: 177 TSVVVTLWYRAP 188

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDVECE-----------VMKSIHHRNLVKIISSCS 255
           IG+G+ G+VY A  +  G E AI+  +++ +           VM+   + N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+EY+  GSL  V+ +  C +D  Q   +      ALE+LH   S  +IH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+LL  +    L+DFG    +T E QS   T  + T  +MAP
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAP 186

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 18/153 (11%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F   NL+G+GSF  VY+A  +  G+E AIK  D               E ++   + H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           ++++ +   + ++  LVLE   NG + + L +        +  + M  + + + YLH   
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH--- 129
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
           S  I+H DL   N+LL  N+   ++DFG+A  L
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 35/192 (18%)
Query: 195 LLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEF-AIKSFDVEC-----------EV--- 238
           L RA   +     IG G++G V+KAR L++G  F A+K   V+            EV   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 239 --MKSIHHRNLVKIISSCS-----NEDFRALVLEYMTNG---SLEKVLYSSNCILDILQR 288
             +++  H N+V++   C+      E    LV E++       L+KV         I   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
            ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A++ + +   M  
Sbjct: 124 -DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 176
Query: 349 TQTLATIGYMAP 360
           T  + T+ Y AP
Sbjct: 177 TSVVVTLWYRAP 188

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 88/188 (46%), Gaps = 34/188 (18%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------------FDVECEV 238
           A N       IG+G FG V+K RL +D    AIKS                  F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           M +++H N+VK+     N     +V+E++  G L   L      +    +L +M+++   
Sbjct: 77  MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 299 LEYLHFGFSTPIIHCDLKPHNVL---LDDN--IVAHLSDFGIAKLLTGEDQSM-TQTQTL 352
           +EY+    + PI+H DL+  N+    LD+N  + A ++DFG+++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLL 187
Query: 353 ATIGYMAP 360
               +MAP
Sbjct: 188 GNFQWMAP 195

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 35/192 (18%)
Query: 195 LLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEF-AIKSFDVEC-----------EV--- 238
           L RA   +     IG G++G V+KAR L++G  F A+K   V+            EV   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 239 --MKSIHHRNLVKIISSCS-----NEDFRALVLEYMTNG---SLEKVLYSSNCILDILQR 288
             +++  H N+V++   C+      E    LV E++       L+KV         I   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
            ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A++ + +   M  
Sbjct: 124 -DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 176
Query: 349 TQTLATIGYMAP 360
           T  + T+ Y AP
Sbjct: 177 TSVVVTLWYRAP 188

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 27/175 (15%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIK----SFDV---------ECEVMKSIHHRNLVKIIS- 252
           IG G++G V  AR +  G + AIK    +FDV         E +++K   H N++ I   
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 253 ---SCSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
              +    +F+++  VL+ M +  L ++++SS   L +      +  +   L+Y+H   S
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQP-LTLEHVRYFLYQLLRGLKYMH---S 176
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL--TGEDQSMTQTQTLATIGYMAP 360
             +IH DLKP N+L+++N    + DFG+A+ L  +  +     T+ +AT  Y AP
Sbjct: 177 AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 27/175 (15%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIK----SFDV---------ECEVMKSIHHRNLVKIIS- 252
           IG G++G V  AR +  G + AIK    +FDV         E +++K   H N++ I   
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 253 ---SCSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
              +    +F+++  VL+ M +  L ++++SS   L +      +  +   L+Y+H   S
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQP-LTLEHVRYFLYQLLRGLKYMH---S 177
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL--TGEDQSMTQTQTLATIGYMAP 360
             +IH DLKP N+L+++N    + DFG+A+ L  +  +     T+ +AT  Y AP
Sbjct: 178 AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLSFCHS 121
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 172

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 128
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 179

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 128
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 179

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 173

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 171

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 125
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 176

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 172

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 172

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 171

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 172

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKA---RLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNED 258
           F+    IG+GSFG V+K    R Q  +  AIK  D+E    +    +  + ++S C +  
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVV--AIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 259 FRA------------LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
                          +++EY+  GS   +L +     D  Q   ++  +   L+YLH   
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH--- 137
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S   IH D+K  NVLL +     L+DFG+A  LT  D  + +   + T  +MAP
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 189

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 49/215 (22%)
Query: 135 GNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRATELPNVANMQPQASRRRFSYLE 194
           GND LC   ++   PC S+KP             +K A E+P                  
Sbjct: 151 GNDGLCQKLSV---PCMSSKPQ---------KPWEKDAWEIPR----------------- 181
Query: 195 LLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHH 244
                        +G G FG V+ A      + A+K+          F  E  VMK++ H
Sbjct: 182 -----ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH 236
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL-EYLH 303
             LVK+ +  + E    ++ E+M  GSL   L S       L +L   I+ ++ + E + 
Sbjct: 237 DKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMA 292
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL 338
           F      IH DL+  N+L+  ++V  ++DFG+A++
Sbjct: 293 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 327

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 66/147 (44%), Gaps = 18/147 (12%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG+G+F  V  AR +  G E A+K  D              E  + K ++H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    LV EY + G +   L +     +   R      + SA++Y H  F   I+H 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           DLK  N+LLD +    ++DFG +   T
Sbjct: 138 DLKAENLLLDADXNIKIADFGFSNEFT 164

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 25/188 (13%)
Query: 193 LELLRATNG-FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV----ECEVMKSI---- 242
           L  LR   G F    L+G G++G VYK R ++ G   AIK  DV    E E+ + I    
Sbjct: 16  LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK 75
Query: 243 ---HHRNLVKIISSCSN------EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMI 293
              HHRN+     +         +D   LV+E+   GS+  ++   N   + L+   I  
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAY 133
Query: 294 NVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-L 352
                L  L       +IH D+K  NVLL +N    L DFG++  L   D+++ +  T +
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFI 190
Query: 353 ATIGYMAP 360
            T  +MAP
Sbjct: 191 GTPYWMAP 198

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECEV-MKSIHHRN-------------LVKIIS 252
           +G GSFG V+  R   +G  +A+K    E  V +K + H N             ++++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           +  +     ++++Y+  G L  +L  S    + + +      V  ALEYLH   S  II+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            DLKP N+LLD N    ++DFG AK +
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYV 156

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   +++L    S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 210
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 23/152 (15%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEFA-------------IKSFDVECEVMKSIHHRNLV 248
           ++  N IGRGS+G V K  +Q G                 +  F  E E+MKS+ H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 249 KIISSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           ++  +  +     LV+E  T G L E+V++    +        IM +V SA+ Y H    
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---K 124
Query: 308 TPIIHCDLKPHNVL-LDDNIVAHLS--DFGIA 336
             + H DLKP N L L D+  + L   DFG+A
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 23/152 (15%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEFA-------------IKSFDVECEVMKSIHHRNLV 248
           ++  N IGRGS+G V K  +Q G                 +  F  E E+MKS+ H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 249 KIISSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           ++  +  +     LV+E  T G L E+V++    +        IM +V SA+ Y H    
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---K 141
Query: 308 TPIIHCDLKPHNVL-LDDNIVAHLS--DFGIA 336
             + H DLKP N L L D+  + L   DFG+A
Sbjct: 142 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 173

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 151
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 152
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 41/188 (21%)
Query: 199 TNGFSANNLIGRGSFGSVYKA-RLQDGMEFAIK-------------SFDVECEVMKSIHH 244
           T+ +     +G+G+F  V +  ++  G E+A K               + E  + + + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINV 295
            N+V++  S S E F  LV + +T G L      +  YS    S+CI  IL+ +N     
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----- 117
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
                + H      I+H DLKP N+LL          L+DFG+A  + G+ Q+       
Sbjct: 118 -----HCHL---NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 353 ATIGYMAP 360
            T GY++P
Sbjct: 168 GTPGYLSP 175

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   +++L    S
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 156
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 31/184 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------DVECEVMKSIHHRNLVKIISS 253
           F    LIG G FG V+KA+ + DG  + IK         + E + +  + H N+V     
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 254 CSNEDFRA----------------LVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVT 296
               D+                  + +E+   G+LE+ +       LD +  L +   +T
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 297 SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
             ++Y+H   S  +I+ DLKP N+ L D     + DFG+   L  + +   + ++  T+ 
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRSKGTLR 186
Query: 357 YMAP 360
           YM+P
Sbjct: 187 YMSP 190

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 152
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   +++L    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 149
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 249 KIISSC-SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C  +E    +VL YM +G L   + +      +   +   + V   +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 151
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMA 359
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 41/188 (21%)
Query: 199 TNGFSANNLIGRGSFGSVYKA-RLQDGMEFAIK-------------SFDVECEVMKSIHH 244
           T+ +     +G+G+F  V +  ++  G E+A K               + E  + + + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINV 295
            N+V++  S S E F  LV + +T G L      +  YS    S+CI  IL+ +N     
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----- 117
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
                + H      I+H DLKP N+LL          L+DFG+A  + G+ Q+       
Sbjct: 118 -----HCHL---NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 353 ATIGYMAP 360
            T GY++P
Sbjct: 168 GTPGYLSP 175

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++      K    ++ +  I   L I   +   L+ L F  S
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDL--KTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 171

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 18/147 (12%)
Query: 208 IGRGSFG-SVYKARLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG GSFG ++     +DG ++ IK  ++             E  V+ ++ H N+V+   S
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCIL-DILQRLNIMINVTSALEYLHFGFSTPIIH 312
                   +V++Y   G L K + +   +L    Q L+  + +  AL+++H      I+H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILH 148
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLL 339
            D+K  N+ L  +    L DFGIA++L
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 33/181 (18%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGME----FAIKSFD-------------VECEVMKSIHH 244
           F    ++G+GSFG V+  +   G +    +A+K                +E +++  ++H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSAL 299
             +VK+  +   E    L+L+++  G L     ++V+++   +   L  L +      AL
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------AL 139
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           ++LH   S  II+ DLKP N+LLD+     L+DFG++K     D          T+ YMA
Sbjct: 140 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMA 194
Query: 360 P 360
           P
Sbjct: 195 P 195

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 33/181 (18%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGME----FAIKSFD-------------VECEVMKSIHH 244
           F    ++G+GSFG V+  +   G +    +A+K                +E +++  ++H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSAL 299
             +VK+  +   E    L+L+++  G L     ++V+++   +   L  L +      AL
Sbjct: 87  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------AL 140
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           ++LH   S  II+ DLKP N+LLD+     L+DFG++K     D          T+ YMA
Sbjct: 141 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMA 195
Query: 360 P 360
           P
Sbjct: 196 P 196

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKS 241
           L +   F     IG G++G VYKAR +  G   A+K    D E E           ++K 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           ++H N+VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQG 118
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L F  S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 33/181 (18%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGME----FAIKSFD-------------VECEVMKSIHH 244
           F    ++G+GSFG V+  +   G +    +A+K                +E +++  ++H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSAL 299
             +VK+  +   E    L+L+++  G L     ++V+++   +   L  L +      AL
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------AL 139
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           ++LH   S  II+ DLKP N+LLD+     L+DFG++K     D          T+ YMA
Sbjct: 140 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMA 194
Query: 360 P 360
           P
Sbjct: 195 P 195

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKS 241
           L +   F     IG G++G VYKAR +  G   A+K    D E E           ++K 
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           ++H N+VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQG 119
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L F  S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 176

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKS 241
           L +   F     IG G++G VYKAR +  G   A+K    D E E           ++K 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           ++H N+VK++     E+   LV E+++   L+K +  ++ +  I   L I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFM-DASALTGIPLPL-IKSYLFQLLQG 118
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L F  S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 119 LAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 208 IGRGSFGSVYKAR------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCS 255
           +G G+FG VYKA+            +    E  ++ + VE +++ S  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            E+   +++E+   G+++ V+      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 316 KPHNVL--LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+L  LD +I   L+DFG++   T   Q   +   + T  +MAP
Sbjct: 162 KAGNILFTLDGDI--KLADFGVSAKNTRXIQR--RDSFIGTPYWMAP 204

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 208 IGRGSFGSVYKAR------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCS 255
           +G G+FG VYKA+            +    E  ++ + VE +++ S  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            E+   +++E+   G+++ V+      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 316 KPHNVL--LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+L  LD +I   L+DFG++   T   Q   +   + T  +MAP
Sbjct: 162 KAGNILFTLDGDI--KLADFGVSAKNTRXIQR--RDXFIGTPYWMAP 204

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 206 NLIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
            +IG G FG V    L+      +  AIK+            F  E  +M    H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +    +      ++ E+M NGSL+  L  ++    ++Q + ++  + + ++YL       
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 129
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAP 360
            +H  L   N+L++ N+V  +SDFG+++ L  +    T T  L     I + AP
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 123
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 174

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 173

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 16/170 (9%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGMEF-AIKSFDVECEVMKSIHHRNLVKIISSCSNEDFR 260
           F+  + IG+GSFG VYK       E  AIK  D+E    +    +  + ++S C +    
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 261 ALVLEYMTNGSLEKVL--YSSNCILDILQR--------LNIMINVTSALEYLHFGFSTPI 310
                Y+ +  L  ++        LD+L+           I+  +   L+YLH   S   
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH---SERK 137
Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           IH D+K  NVLL +     L+DFG+A  LT  D  + +   + T  +MAP
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 185

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 173 TELPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKA-RLQDG----MEF 227
           TEL  V  + P  +    + L +L+ T       ++G G+FG+VYK   + +G    +  
Sbjct: 14  TEL--VEPLTPSGTAPNQAQLRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPV 70
Query: 228 AIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKV 275
           AIK             F  E  +M S+ H +LV+++  C +   + LV + M +G L + 
Sbjct: 71  AIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEY 129
Query: 276 LYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGI 335
           ++     +     LN  + +   + YL       ++H DL   NVL+       ++DFG+
Sbjct: 130 VHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGL 186
Query: 336 AKLLTGEDQSMTQTQTLATIGYMA 359
           A+LL G+++          I +MA
Sbjct: 187 ARLLEGDEKEYNADGGKMPIKWMA 210

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 123
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 174

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 172

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 208 IGRGSFGSVYKAR------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCS 255
           +G G+FG VYKA+            +    E  ++ + VE +++ S  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            E+   +++E+   G+++ V+      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 316 KPHNVL--LDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  N+L  LD +I   L+DFG++   T   Q   +   + T  +MAP
Sbjct: 162 KAGNILFTLDGDI--KLADFGVSAKNTRTIQR--RDSFIGTPYWMAP 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 172

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 171

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 33/181 (18%)
Query: 202 FSANNLIGRGSFGSVYKARL----QDGMEFAIKSFD-------------VECEVMKSIHH 244
           F    ++G+GSFG V+  R       G  +A+K                +E +++  ++H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSAL 299
             +VK+  +   E    L+L+++  G L     ++V+++   +   L  L +       L
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------GL 143
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           ++LH   S  II+ DLKP N+LLD+     L+DFG++K     D          T+ YMA
Sbjct: 144 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMA 198
Query: 360 P 360
           P
Sbjct: 199 P 199

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 80/173 (46%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++      K    ++ +  I   L I   +   L+ L F  S
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDL--KTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  A     G + A+K  D+           E  +M+  HH N+V + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+E++  G+L  ++  ++  ++  Q   + ++V  AL YLH   +  +IH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAP
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMAP 210

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 172

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 34/188 (18%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------------FDVECEV 238
           A N       IG+G FG V+K RL +D    AIKS                  F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           M +++H N+VK+     N     +V+E++  G L   L      +    +L +M+++   
Sbjct: 77  MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 299 LEYLHFGFSTPIIHCDLKPHNVL---LDDN--IVAHLSDFGIAKLLTGEDQSM-TQTQTL 352
           +EY+    + PI+H DL+  N+    LD+N  + A ++DF +++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLL 187
Query: 353 ATIGYMAP 360
               +MAP
Sbjct: 188 GNFQWMAP 195

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 123
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 174

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 23/179 (12%)
Query: 197 RATNGFSANNLIGRGSFGSV-----YKARLQDGMEFA----IKSFD----VECEV--MKS 241
           R    +     +G GSFG V     YK + +  ++F     +K  D    VE E+  +K 
Sbjct: 6   RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL 65
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           + H +++K+    +      +V+EY      + ++       D  +R      +  A+EY
Sbjct: 66  LRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--FQQIICAIEY 123
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            H      I+H DLKP N+LLDDN+   ++DFG++ ++T  D +  +T +  +  Y AP
Sbjct: 124 CH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 176

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 171

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 172

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 173

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E+++   L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSM-DLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 173

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+     D E E           ++K ++H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 172

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+     D E E           ++K ++H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 171

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 39/189 (20%)
Query: 208 IGRGSFGSVYKARL--------------------QDGMEFAIKSFDVECEVMKSI-HHRN 246
           +G G+FG V  A                       D  E  +     E E+MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL-----------YSSNCILDILQRLNIMINV 295
           ++ ++ +C+ +    +++EY + G+L + L           Y  N + +       +++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 296 T----SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           T      +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 83/190 (43%), Gaps = 41/190 (21%)
Query: 197 RATNGFSANNLIGRGSFGSVYK-ARLQDGMEFAIK-------------SFDVECEVMKSI 242
           R T+ +     +G+G+F  V +  +     E+A K               + E  + + +
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 243 HHRNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMI 293
            H N+V++  S S E F  LV + +T G L      +  YS    S+CI  IL+ +N   
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVN--- 144
Query: 294 NVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN---IVAHLSDFGIAKLLTGEDQSMTQTQ 350
                  ++H      I+H DLKP N+LL          L+DFG+A  + GE Q+     
Sbjct: 145 -------HIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA 194
Query: 351 TLATIGYMAP 360
              T GY++P
Sbjct: 195 --GTPGYLSP 202

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 39/189 (20%)
Query: 208 IGRGSFGSVYKARL--------------------QDGMEFAIKSFDVECEVMKSI-HHRN 246
           +G G+FG V  A                       D  E  +     E E+MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL-----------YSSNCILDILQRLNIMINV 295
           ++ ++ +C+ +    +++EY + G+L + L           Y  N + +       +++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 296 T----SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           T      +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 173

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 22/172 (12%)
Query: 208 IGRGSFGSVYKARLQD-----GMEFAIKS-----------FDVECEVMKSIHHRNLVKI- 250
           +G+G+FGSV   R        G   A+K            F  E +++K++H   +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 251 -ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
            +S         LV+EY+ +G L   L      LD  + L     +   +EYL    S  
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 131
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGYMAP 360
            +H DL   N+L++      ++DFG+AKLL   +D  + +    + I + AP
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAP 183

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 81/197 (41%), Gaps = 44/197 (22%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------DVECEVMKSIHHRNLVKIISS 253
           F    LIG G FG V+KA+ + DG  + I+         + E + +  + H N+V     
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGC 73
Query: 254 CSNEDFRA-----------------------------LVLEYMTNGSLEKVLYSSNC-IL 283
               D+                               + +E+   G+LE+ +       L
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           D +  L +   +T  ++Y+H   S  +IH DLKP N+ L D     + DFG+   L  + 
Sbjct: 134 DKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 344 QSMTQTQTLATIGYMAP 360
           +   +T++  T+ YM+P
Sbjct: 191 K---RTRSKGTLRYMSP 204

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++ +  L+K +  ++ +  I   L I   +   L+ L F  S
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 27/197 (13%)
Query: 182 QPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEF-AIKSF-------- 232
           +P+ ++ R S L++      F  + ++G+GSFG V+ A  +   +F AIK+         
Sbjct: 1   EPELNKERPS-LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD 59
Query: 233 -DVECEVMK------SIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNC-ILD 284
            DVEC +++      +  H  L  +  +   ++    V+EY+  G L  + +  +C   D
Sbjct: 60  DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFD 117
Query: 285 ILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL-LTGED 343
           + +       +   L++LH   S  I++ DLK  N+LLD +    ++DFG+ K  + G+ 
Sbjct: 118 LSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 174
Query: 344 QSMTQTQTLATIGYMAP 360
           ++    +   T  Y+AP
Sbjct: 175 KT---NEFCGTPDYIAP 188

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 41/188 (21%)
Query: 199 TNGFSANNLIGRGSFGSVYK-ARLQDGMEFAIK-------------SFDVECEVMKSIHH 244
           T+ +     IG+G+F  V +  +L  G E+A K               + E  + + + H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINV 295
            N+V++  S S E F  LV + +T G L      +  YS    S+CI  IL+        
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------- 114
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNI---VAHLSDFGIAKLLTGEDQSMTQTQTL 352
             A+ + H      ++H DLKP N+LL          L+DFG+A  + G+ Q+       
Sbjct: 115 --AVLHCH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 353 ATIGYMAP 360
            T GY++P
Sbjct: 168 GTPGYLSP 175

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 19/179 (10%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKS 241
           L +   F     IG G++G VYKAR +  G   A+K    D E E           ++K 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           ++H N+VK++     E+   LV E+++     K    ++ +  I   L I   +   L+ 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSMDL--KDFMDASALTGIPLPL-IKSYLFQLLQG 118
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L F  S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 175

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 19/179 (10%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKS 241
           L +   F     IG G++G VYKAR +  G   A+K    D E E           ++K 
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           ++H N+VK++     E+   LV E+++     K    ++ +  I   L I   +   L+ 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLSMDL--KDFMDASALTGIPLPL-IKSYLFQLLQG 117
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L F  S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 118 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 174

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 23/189 (12%)
Query: 189 RFSYLELLRAT-NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ 234
           ++ +LE    T N F    ++G+G FG V   +++  G  +A K  +             
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 235 --ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNI 291
             E ++++ ++ R +V +  +   +D   LVL  M  G L+  +Y          + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
              +   LE LH      I++ DLKP N+LLDD+    +SD G+A  +    +  T    
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGR 345
Query: 352 LATIGYMAP 360
           + T+GYMAP
Sbjct: 346 VGTVGYMAP 354

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 39/189 (20%)
Query: 208 IGRGSFGSVYKARL--------------------QDGMEFAIKSFDVECEVMKSI-HHRN 246
           +G G+FG V  A                       D  E  +     E E+MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL-----------YSSNCILDILQRLNIMINV 295
           ++ ++ +C+ +    +++EY + G+L + L           Y  N + +       +++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 296 T----SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           T      +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 18/144 (12%)
Query: 208 IGRGSFGSVYKA--------------RLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISS 253
           IG G++G+V+KA              RL D  E    S   E  ++K + H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
             ++    LV E+  +  L+K   S N  LD     + +  +   L + H   S  ++H 
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAK 337
           DLKP N+L++ N    L+DFG+A+
Sbjct: 126 DLKPQNLLINRNGELKLADFGLAR 149

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 39/189 (20%)
Query: 208 IGRGSFGSVYKARL--------------------QDGMEFAIKSFDVECEVMKSI-HHRN 246
           +G G+FG V  A                       D  E  +     E E+MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL-----------YSSNCILDILQRLNIMINV 295
           ++ ++ +C+ +    +++EY + G+L + L           Y  N + +       +++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 296 T----SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           T      +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 23/189 (12%)
Query: 189 RFSYLELLRAT-NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ 234
           ++ +LE    T N F    ++G+G FG V   +++  G  +A K  +             
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 235 --ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNI 291
             E ++++ ++ R +V +  +   +D   LVL  M  G L+  +Y          + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
              +   LE LH      I++ DLKP N+LLDD+    +SD G+A  +    +  T    
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGR 345
Query: 352 LATIGYMAP 360
           + T+GYMAP
Sbjct: 346 VGTVGYMAP 354

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 22/172 (12%)
Query: 208 IGRGSFGSVYKARLQD-----GMEFAIKS-----------FDVECEVMKSIHHRNLVKI- 250
           +G+G+FGSV   R        G   A+K            F  E +++K++H   +VK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 251 -ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
            +S         LV+EY+ +G L   L      LD  + L     +   +EYL    S  
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 135
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGYMAP 360
            +H DL   N+L++      ++DFG+AKLL   +D  + +    + I + AP
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 187

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 31/188 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVE-------------------CE 237
           AT+ +     IG G++G+VYKAR    G   A+KS  V                      
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 238 VMKSIHHRNLVKIISSCSN-----EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIM 292
            +++  H N+V+++  C+      E    LV E++       +  +    L      ++M
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 293 INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
                 L++LH   +  I+H DLKP N+L+       L+DFG+A++ + +   M  T  +
Sbjct: 127 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVV 180
Query: 353 ATIGYMAP 360
            T+ Y AP
Sbjct: 181 VTLWYRAP 188

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 39/189 (20%)
Query: 208 IGRGSFGSVYKARL--------------------QDGMEFAIKSFDVECEVMKSI-HHRN 246
           +G G+FG V  A                       D  E  +     E E+MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL-----------YSSNCILDILQRLNIMINV 295
           ++ ++ +C+ +    +++EY + G+L + L           Y  N + +       +++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 296 T----SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           T      +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 47/215 (21%)
Query: 176 PNVANMQPQASRRRFSYLELLRATNGFSAN----NLIGRGSFGSVYK-ARLQDGMEFAIK 230
           P++A+M       R S   ++ A+  FS N      +G+G+F  V +      G+EFA K
Sbjct: 2   PHMASMTGGQQMGRGSEF-MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 231 -------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL----- 272
                          + E  + + + H N+V++  S   E F  LV + +T G L     
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 273 EKVLYS----SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN--- 325
            +  YS    S+CI  IL+          ++ Y H   S  I+H +LKP N+LL      
Sbjct: 121 AREFYSEADASHCIQQILE----------SIAYCH---SNGIVHRNLKPENLLLASKAKG 167
Query: 326 IVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
               L+DFG+A  +   + S        T GY++P
Sbjct: 168 AAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSP 199

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 22/172 (12%)
Query: 208 IGRGSFGSVYKARLQD-----GMEFAIKS-----------FDVECEVMKSIHHRNLVKI- 250
           +G+G+FGSV   R        G   A+K            F  E +++K++H   +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 251 -ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
            +S         LV+EY+ +G L   L      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGYMAP 360
            +H DL   N+L++      ++DFG+AKLL   +D  + +    + I + AP
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 39/189 (20%)
Query: 208 IGRGSFGSVYKARL--------------------QDGMEFAIKSFDVECEVMKSI-HHRN 246
           +G G+FG V  A                       D  E  +     E E+MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL-----------YSSNCILDILQRLNIMINV 295
           ++ ++ +C+ +    +++EY + G+L + L           Y  N + +       +++ 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 296 T----SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           T      +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 22/172 (12%)
Query: 208 IGRGSFGSVYKARLQD-----GMEFAIKS-----------FDVECEVMKSIHHRNLVKI- 250
           +G+G+FGSV   R        G   A+K            F  E +++K++H   +VK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 251 -ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
            +S         LV+EY+ +G L   L      LD  + L     +   +EYL    S  
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 134
Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGYMAP 360
            +H DL   N+L++      ++DFG+AKLL   +D  + +    + I + AP
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 186

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 39/189 (20%)
Query: 208 IGRGSFGSVYKARL--------------------QDGMEFAIKSFDVECEVMKSI-HHRN 246
           +G G+FG V  A                       D  E  +     E E+MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL-----------YSSNCILDILQRLNIMINV 295
           ++ ++ +C+ +    +++EY + G+L + L           Y  N + +       +++ 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 296 T----SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           T      +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 64/128 (50%), Gaps = 9/128 (7%)
Query: 235 ECEVMKSIHHRNLVKIISSCS--NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIM 292
           E  ++K + H N+VK++      NED   +V E +  G + +V        D  Q     
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--QARFYF 143
Query: 293 INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
            ++   +EYLH+     IIH D+KP N+L+ ++    ++DFG++    G D  +  + T+
Sbjct: 144 QDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTV 198
Query: 353 ATIGYMAP 360
            T  +MAP
Sbjct: 199 GTPAFMAP 206

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 22/174 (12%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIK--------SFDV------ECEVMKSIHHRN 246
           +   + +G G+FG V     Q  G + A+K        S DV      E + +K   H +
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           ++K+    S      +V+EY++ G L   +     + ++  R  +   + SA++Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH--- 128
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              ++H DLKP NVLLD ++ A ++DFG++ +++  D    +T +  +  Y AP
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRT-SCGSPNYAAP 179

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 19/150 (12%)
Query: 206 NLIGRGSFGSVYKARLQ-DGMEFAIK--------SFDV------ECEVMKSIHHRNLVKI 250
           + +G G+FG V   + +  G + A+K        S DV      E + +K   H +++K+
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
               S      +V+EY++ G L   +   N  LD  +   +   + S ++Y H      +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLT 340
           +H DLKP NVLLD ++ A ++DFG++ +++
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMS 167

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 23/160 (14%)
Query: 206 NLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE 265
           ++ G GSF +     +Q+  E  +K  D+   + K   H N++++  +     F  LV +
Sbjct: 38  DVTGGGSFSA---EEVQELREATLKEVDI---LRKVSGHPNIIQLKDTYETNTFFFLVFD 91
Query: 266 YMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV 320
            M  G L     EKV  S      I++ L   + V  AL  L+      I+H DLKP N+
Sbjct: 92  LMKKGELFDYLTEKVTLSEKETRKIMRAL---LEVICALHKLN------IVHRDLKPENI 142
Query: 321 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LLDD++   L+DFG +  L   D      +   T  Y+AP
Sbjct: 143 LLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAP 179

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 233 DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL------EKVLYSSNCILDIL 286
           + E E++K ++H  ++KI +    ED+  +VLE M  G L       K L  + C L   
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGED 343
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 344 QSMTQTQTL-ATIGYMAP 360
             M   +TL  T  Y+AP
Sbjct: 171 SLM---RTLCGTPTYLAP 185

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 80/173 (46%), Gaps = 19/173 (10%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--FDVECE-----------VMKSIHHRNL 247
           F     IG G++G VYKAR +  G   A+K    D E E           ++K ++H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           VK++     E+   LV E++      K    ++ +  I   L I   +   L+ L F  S
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDL--KDFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAP 172

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 233 DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL------EKVLYSSNCILDIL 286
           + E E++K ++H  ++KI +    ED+  +VLE M  G L       K L  + C L   
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGED 343
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 121 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 169
Query: 344 QSMTQTQTL-ATIGYMAP 360
             M   +TL  T  Y+AP
Sbjct: 170 SLM---RTLCGTPTYLAP 184

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 233 DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL------EKVLYSSNCILDIL 286
           + E E++K ++H  ++KI +    ED+  +VLE M  G L       K L  + C L   
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGED 343
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 344 QSMTQTQTL-ATIGYMAP 360
             M   +TL  T  Y+AP
Sbjct: 171 SLM---RTLCGTPTYLAP 185

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 233 DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL------EKVLYSSNCILDIL 286
           + E E++K ++H  ++KI +    ED+  +VLE M  G L       K L  + C L   
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGED 343
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 261 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 309
Query: 344 QSMTQTQTL-ATIGYMAP 360
             M   +TL  T  Y+AP
Sbjct: 310 SLM---RTLCGTPTYLAP 324

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 75/144 (52%), Gaps = 9/144 (6%)
Query: 221 LQDGMEFAIKS-FDVECEVMKSIHHRNLVKIISSCSNEDFRA--LVLEYMTNGSLEKVLY 277
           L++G    ++S +  E E++++++H ++VK    C ++  ++  LV+EY+  GSL   L 
Sbjct: 46  LKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL- 104
Query: 278 SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
             +C+  + Q L     +   + YLH   +   IH  L   NVLLD++ +  + DFG+AK
Sbjct: 105 PRHCV-GLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAK 160
Query: 338 LL-TGEDQSMTQTQTLATIGYMAP 360
            +  G +    +    + + + AP
Sbjct: 161 AVPEGHEYYRVREDGDSPVFWYAP 184

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 76/175 (43%), Gaps = 25/175 (14%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG GS+G   K R + DG     K  D              E  +++ + H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 254 CSNEDFRAL--VLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHF---G 305
             +     L  V+EY   G L  V+         LD    L +M  +T AL+  H    G
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             T ++H DLKP NV LD      L DFG+A++L   D S  +T  + T  YM+P
Sbjct: 134 GHT-VLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKT-FVGTPYYMSP 185

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 75/144 (52%), Gaps = 9/144 (6%)
Query: 221 LQDGMEFAIKS-FDVECEVMKSIHHRNLVKIISSCSNEDFRA--LVLEYMTNGSLEKVLY 277
           L++G    ++S +  E E++++++H ++VK    C ++  ++  LV+EY+  GSL   L 
Sbjct: 45  LKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL- 103
Query: 278 SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
             +C+  + Q L     +   + YLH   +   IH  L   NVLLD++ +  + DFG+AK
Sbjct: 104 PRHCV-GLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAK 159
Query: 338 LL-TGEDQSMTQTQTLATIGYMAP 360
            +  G +    +    + + + AP
Sbjct: 160 AVPEGHEYYRVREDGDSPVFWYAP 183

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 233 DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL------EKVLYSSNCILDIL 286
           + E E++K ++H  ++KI +    ED+  +VLE M  G L       K L  + C L   
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGED 343
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 247 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 295
Query: 344 QSMTQTQTL-ATIGYMAP 360
             M   +TL  T  Y+AP
Sbjct: 296 SLM---RTLCGTPTYLAP 310

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 233 DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL------EKVLYSSNCILDIL 286
           + E E++K ++H  ++KI +    ED+  +VLE M  G L       K L  + C L   
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGED 343
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 344 QSMTQTQTL-ATIGYMAP 360
             M   +TL  T  Y+AP
Sbjct: 171 SLM---RTLCGTPTYLAP 185

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 19/154 (12%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIK--------SFDV------ECEVMKSIHHRN 246
           +   + +G G+FG V     Q  G + A+K        S DV      E + +K   H +
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           ++K+    S      +V+EY++ G L   +     + ++  R  +   + SA++Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH--- 128
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT 340
              ++H DLKP NVLLD ++ A ++DFG++ +++
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 124 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 277 ------YSSNCILDILQRLNIMINVT----SALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
                 Y  N + +       +++ T      +EYL    S   IH DL   NVL+ +N 
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENN 240
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 72/138 (52%), Gaps = 25/138 (18%)
Query: 233 DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL------EKVLYSSNCILDIL 286
           + E E++K ++H  ++KI +    ED+  +VLE M  G L       K L  + C L   
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGED 343
           Q L        A++YLH      IIH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 128 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 176
Query: 344 QSMTQTQTL-ATIGYMAP 360
             M   +TL  T  Y+AP
Sbjct: 177 SLM---RTLCGTPTYLAP 191

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 67  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 126
Query: 277 ------YSSNCILDILQRLNIMINVT----SALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
                 Y  N + +       +++ T      +EYL    S   IH DL   NVL+ +N 
Sbjct: 127 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENN 183
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 184 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 217

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 23/160 (14%)
Query: 206 NLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE 265
           ++ G GSF +     +Q+  E  +K  D+   + K   H N++++  +     F  LV +
Sbjct: 51  DVTGGGSFSA---EEVQELREATLKEVDI---LRKVSGHPNIIQLKDTYETNTFFFLVFD 104
Query: 266 YMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV 320
            M  G L     EKV  S      I++ L   + V  AL  L+      I+H DLKP N+
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRAL---LEVICALHKLN------IVHRDLKPENI 155
Query: 321 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LLDD++   L+DFG +  L   D      +   T  Y+AP
Sbjct: 156 LLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAP 192

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 70  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 129
Query: 277 ------YSSNCILDILQRLNIMINVT----SALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
                 Y  N + +       +++ T      +EYL    S   IH DL   NVL+ +N 
Sbjct: 130 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENN 186
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 187 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 220

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 65  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 124
Query: 277 ------YSSNCILDILQRLNIMINVT----SALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
                 Y  N + +       +++ T      +EYL    S   IH DL   NVL+ +N 
Sbjct: 125 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENN 181
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 182 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 215

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 28/185 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVE----------------CEVMK 240
           AT+ +     IG G++G+VYKAR    G   A+KS  V                    ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 241 SIHHRNLVKIISSCSN-----EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
           +  H N+V+++  C+      E    LV E++       +  +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
              L++LH   +  I+H DLKP N+L+       L+DFG+A++ + +   M     + T+
Sbjct: 122 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVTL 175
Query: 356 GYMAP 360
            Y AP
Sbjct: 176 WYRAP 180

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 184 QASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKA-RLQDG----MEFAIK-------- 230
           QA  R     EL R         ++G G+FG+VYK   + +G    +  AIK        
Sbjct: 6   QAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP 58
Query: 231 ----SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL 286
                F  E  +M S+ H +LV+++  C +   + LV + M +G L + ++     +   
Sbjct: 59  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQ 117
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
             LN  + +   + YL       ++H DL   NVL+       ++DFG+A+LL G+++  
Sbjct: 118 LLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 174
Query: 347 TQTQTLATIGYMA 359
                   I +MA
Sbjct: 175 NADGGKMPIKWMA 187

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 17/142 (11%)
Query: 208 IGRGSFGSVYKAR------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCS 255
           +G G+FG VYKA+            ++   E  ++ + VE E++ +  H  +VK++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDI-LQRLNIMINVTSALEYLHFGFSTPIIHCD 314
           ++    +++E+   G+++ ++      LD  L    I +     LE L+F  S  IIH D
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRD 134
Query: 315 LKPHNVLLDDNIVAHLSDFGIA 336
           LK  NVL+       L+DFG++
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVS 156

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 17/142 (11%)
Query: 208 IGRGSFGSVYKAR------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCS 255
           +G G+FG VYKA+            ++   E  ++ + VE E++ +  H  +VK++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDI-LQRLNIMINVTSALEYLHFGFSTPIIHCD 314
           ++    +++E+   G+++ ++      LD  L    I +     LE L+F  S  IIH D
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRD 142
Query: 315 LKPHNVLLDDNIVAHLSDFGIA 336
           LK  NVL+       L+DFG++
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS 164

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 28/185 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVE----------------CEVMK 240
           AT+ +     IG G++G+VYKAR    G   A+KS  V                    ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 241 SIHHRNLVKIISSCSN-----EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
           +  H N+V+++  C+      E    LV E++       +  +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
              L++LH   +  I+H DLKP N+L+       L+DFG+A++ + +   M     + T+
Sbjct: 122 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVTL 175
Query: 356 GYMAP 360
            Y AP
Sbjct: 176 WYRAP 180

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 84/161 (52%), Gaps = 24/161 (14%)
Query: 205 NNLIGRGSFGSVYKARLQD-GMEFAIKSF---------DV---ECEVMKSIHHRNLVKI- 250
           ++++G+G+  +V++ R +  G  FAIK F         DV   E EV+K ++H+N+VK+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 251 -ISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCI-LDILQRLNIMINVTSALEYLHFGFS 307
            I   +    + L++E+   GSL  VL   SN   L   + L ++ +V   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 308 TPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTGEDQ 344
             I+H ++KP N++     D   V  L+DFG A+ L  ++Q
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 112 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 171
Query: 277 ----YSSNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
               YS N   +  ++L+          V   +EYL    S   IH DL   NVL+ ++ 
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 228
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 84/161 (52%), Gaps = 24/161 (14%)
Query: 205 NNLIGRGSFGSVYKARLQD-GMEFAIKSF---------DV---ECEVMKSIHHRNLVKI- 250
           ++++G+G+  +V++ R +  G  FAIK F         DV   E EV+K ++H+N+VK+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 251 -ISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCI-LDILQRLNIMINVTSALEYLHFGFS 307
            I   +    + L++E+   GSL  VL   SN   L   + L ++ +V   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 308 TPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTGEDQ 344
             I+H ++KP N++     D   V  L+DFG A+ L  ++Q
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 23/168 (13%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIK--------------SFDVECEVMKSIHHRNLVKIIS 252
           +G GSFG V  A     G + A+K                + E   ++ + H +++K+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
              ++D   +V+EY  N   + ++          +R      + SA+EY H      I+H
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 136
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+LLD+++   ++DFG++ ++T  D +  +T +  +  Y AP
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 181

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 63  DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 122
Query: 277 ----YSSNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
               YS N   +  ++L+          V   +EYL    S   IH DL   NVL+ ++ 
Sbjct: 123 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDN 179
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 180 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 23/168 (13%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIK--------------SFDVECEVMKSIHHRNLVKIIS 252
           +G GSFG V  A     G + A+K                + E   ++ + H +++K+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
              ++D   +V+EY  N   + ++          +R      + SA+EY H      I+H
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 126
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+LLD+++   ++DFG++ ++T  D +  +T +  +  Y AP
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 171

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 71  DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 130
Query: 277 ----YSSNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
               YS N   +  ++L+          V   +EYL    S   IH DL   NVL+ ++ 
Sbjct: 131 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 187
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 188 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 221

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 23/168 (13%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIK--------------SFDVECEVMKSIHHRNLVKIIS 252
           +G GSFG V  A     G + A+K                + E   ++ + H +++K+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
              ++D   +V+EY  N   + ++          +R      + SA+EY H      I+H
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 135
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+LLD+++   ++DFG++ ++T  D +  +T +  +  Y AP
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 180

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 60  DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 119
Query: 277 ----YSSNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
               YS N   +  ++L+          V   +EYL    S   IH DL   NVL+ ++ 
Sbjct: 120 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDN 176
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 177 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 210

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 28/185 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVE----------------CEVMK 240
           AT+ +     IG G++G+VYKAR    G   A+KS  V                    ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 241 SIHHRNLVKIISSCSN-----EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
           +  H N+V+++  C+      E    LV E++       +  +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
              L++LH   +  I+H DLKP N+L+       L+DFG+A++ + +   M     + T+
Sbjct: 122 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALFPVVVTL 175
Query: 356 GYMAP 360
            Y AP
Sbjct: 176 WYRAP 180

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 18/144 (12%)
Query: 208 IGRGSFGSVYKA--------------RLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISS 253
           IG G++G+V+KA              RL D  E    S   E  ++K + H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
             ++    LV E+  +  L+K   S N  LD     + +  +   L + H   S  ++H 
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAK 337
           DLKP N+L++ N    L++FG+A+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLAR 149

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 23/160 (14%)
Query: 206 NLIGRGSFGSVYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE 265
           ++ G GSF +     +Q+  E  +K  D+   + K   H N++++  +     F  LV +
Sbjct: 51  DVTGGGSFSA---EEVQELREATLKEVDI---LRKVSGHPNIIQLKDTYETNTFFFLVFD 104
Query: 266 YMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV 320
            M  G L     EKV  S      I++ L   + V  AL  L+      I+H DLKP N+
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRAL---LEVICALHKLN------IVHRDLKPENI 155
Query: 321 LLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LLDD++   L+DFG +  L   D          T  Y+AP
Sbjct: 156 LLDDDMNIKLTDFGFSCQL---DPGEKLRSVCGTPSYLAP 192

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 23/168 (13%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIK--------------SFDVECEVMKSIHHRNLVKIIS 252
           +G GSFG V  A     G + A+K                + E   ++ + H +++K+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
              ++D   +V+EY  N   + ++          +R      + SA+EY H      I+H
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 130
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+LLD+++   ++DFG++ ++T  D +  +T +  +  Y AP
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 175

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 76/175 (43%), Gaps = 25/175 (14%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG GS+G   K R + DG     K  D              E  +++ + H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 254 CSNEDFRAL--VLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHF---G 305
             +     L  V+EY   G L  V+         LD    L +M  +T AL+  H    G
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             T ++H DLKP NV LD      L DFG+A++L   D+   + + + T  YM+P
Sbjct: 134 GHT-VLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDEDFAK-EFVGTPYYMSP 185

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 71  DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREP 130
Query: 277 ----YSSNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
               YS N   +  ++L+          V   +EYL    S   IH DL   NVL+ ++ 
Sbjct: 131 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 187
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 188 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 221

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 64  DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 123
Query: 277 ----YSSNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
               YS N   +  ++L+          V   +EYL    S   IH DL   NVL+ ++ 
Sbjct: 124 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDN 180
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 181 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 214

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 25/178 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGME----FAIKSFD---------------VECEVMKSI 242
           F    ++G+G +G V++ R   G      FA+K                   E  +++ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 243 HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL 302
            H  +V +I +        L+LEY++ G L   L      ++       +  ++ AL +L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHL 137
Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H      II+ DLKP N++L+      L+DFG+ K  +  D ++T T    TI YMAP
Sbjct: 138 H---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHT-FCGTIEYMAP 190

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 195 LLRATNGFSANNLIGRGSFGSV----YKAR----------LQDGMEFA-IKSFDVECEVM 239
            L+  N   A+  +G G+FGSV    Y+ R          L+ G E A  +    E ++M
Sbjct: 5   FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 64
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + +  +V++I  C  E    LV+E    G L K L      + +     ++  V+  +
Sbjct: 65  HQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
           +YL        +H DL   NVLL +   A +SDFG++K L  +D   T
Sbjct: 124 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 42/188 (22%)
Query: 199 TNGFSANNLIGRGSFGSVYK-ARLQDGMEFAIK-------------SFDVECEVMKSIHH 244
           ++ +     +G+G+F  V +      G+EFA K               + E  + + + H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINV 295
            N+V++  S   E F  LV + +T G L      +  YS    S+CI  IL+        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 116
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDN---IVAHLSDFGIAKLLTGEDQSMTQTQTL 352
             ++ Y H   S  I+H +LKP N+LL          L+DFG+A  +   + S       
Sbjct: 117 --SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFA 168
Query: 353 ATIGYMAP 360
            T GY++P
Sbjct: 169 GTPGYLSP 176

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 29/179 (16%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ------------------DGMEFAIKSFDVECEVMKS 241
           + F     +G+G FG+VY AR +                  +G+E  ++    E E+   
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR---EIEIQSH 71
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           + H N++++ +   +     L+LE+   G L K L   +   D  +    M  +  AL Y
Sbjct: 72  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHY 130
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            H      +IH D+KP N+L+       ++DFG     +    S+ +     T+ Y+ P
Sbjct: 131 CH---ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPP 182

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAIKSFDVECE------------VMKSI 242
           + +++ F     +G G++ +VYK      G+  A+K   ++ E            +MK +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 243 HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY- 301
            H N+V++      E+   LV E+M N  L+K +  S  + +  + L +  N+    ++ 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLEL--NLVKYFQWQ 116
Query: 302 ----LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
               L F     I+H DLKP N+L++      L DFG+A+       +   +  + T+ Y
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWY 174
Query: 358 MAP 360
            AP
Sbjct: 175 RAP 177

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 29/182 (15%)
Query: 199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIK--------------SFDVECEVMKSIH 243
           ++ +    ++G+GSFG V   + +  G E A+K              S   E +++K + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++K+     ++ +  LV E  T G L   + S     ++     I+  V S + Y+H
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMH 149
Query: 304 FGFSTPIIHCDLKPHNVLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
                 I+H DLKP N+LL     D NI   + DFG++   T  + S      + T  Y+
Sbjct: 150 ---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLS---THFEASKKMKDKIGTAYYI 201
Query: 359 AP 360
           AP
Sbjct: 202 AP 203

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 83/172 (48%), Gaps = 23/172 (13%)
Query: 183 PQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEF-AIKSF--------- 232
           P+ ++ R S L++      F  + ++G+GSFG V+ A  +   +F AIK+          
Sbjct: 1   PELNKERPS-LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59
Query: 233 DVECEVMK------SIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNC-ILDI 285
           DVEC +++      +  H  L  +  +   ++    V+EY+  G L  + +  +C   D+
Sbjct: 60  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDL 117
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
            +       +   L++LH   S  I++ DLK  N+LLD +    ++DFG+ K
Sbjct: 118 SRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK 166

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 75/175 (42%), Gaps = 25/175 (14%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           IG GS+G   K R + DG     K  D              E  +++ + H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 254 CSNEDFRAL--VLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHF---G 305
             +     L  V+EY   G L  V+         LD    L +M  +T AL+  H    G
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             T ++H DLKP NV LD      L DFG+A++L   D S  +   + T  YM+P
Sbjct: 134 GHT-VLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKA-FVGTPYYMSP 185

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 39/189 (20%)
Query: 208 IGRGSFGSVYKARL--------------------QDGMEFAIKSFDVECEVMKSI-HHRN 246
           +G G+FG V  A                       D  E  +     E E+MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL-----------YSSNCILDILQRLNIMINV 295
           ++ ++ +C+ +    +++ Y + G+L + L           Y  N + +       +++ 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 296 T----SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           T      +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 79/173 (45%), Gaps = 25/173 (14%)
Query: 208 IGRGSFGSVY-----KARLQDGMEFAIKSFDVEC------------EVMKSIHHRNLVKI 250
           +G G FG V            G   A+K+   +C            +++++++H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 251 ISSCSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              C ++  ++L  V+EY+  GSL   L   +  + + Q L     +   + YLH   S 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAP 360
             IH +L   NVLLD++ +  + DFG+AK +  G +    +    + + + AP
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 42/188 (22%)
Query: 199 TNGFSANNLIGRGSFGSVYK-ARLQDGMEFAIK-------------SFDVECEVMKSIHH 244
           ++ +     +G+G+F  V +      G+EFA K               + E  + + + H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINV 295
            N+V++  S   E F  LV + +T G L      +  YS    S+CI  IL+        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 116
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDN---IVAHLSDFGIAKLLTGEDQSMTQTQTL 352
             ++ Y H   S  I+H +LKP N+LL          L+DFG+A  +   + S       
Sbjct: 117 --SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFA 168
Query: 353 ATIGYMAP 360
            T GY++P
Sbjct: 169 GTPGYLSP 176

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 85/189 (44%), Gaps = 34/189 (17%)
Query: 199 TNGFSANNLIGRGSFGSVYKARLQDGMEFA----IKSFDV---------ECEVMKSIHHR 245
           ++ F   +L+G G++G V  A  +   E      I+ FD          E +++K   H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 246 NLVKIISSCSNEDFR----ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           N++ I +    + F       +++ +    L +V+ +     D +Q    +     A++ 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAVKV 127
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL----------TGEDQSMTQTQT 351
           LH    + +IH DLKP N+L++ N    + DFG+A+++          TG+   M  T+ 
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM--TEX 182
Query: 352 LATIGYMAP 360
           +AT  Y AP
Sbjct: 183 VATRWYRAP 191

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 67
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G + K L       D  +    +  + +AL
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANAL 126
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 179
Query: 360 P 360
           P
Sbjct: 180 P 180

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 42/188 (22%)
Query: 199 TNGFSANNLIGRGSFGSVYK-ARLQDGMEFAIK-------------SFDVECEVMKSIHH 244
           ++ +     +G+G+F  V +      G+EFA K               + E  + + + H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINV 295
            N+V++  S   E F  LV + +T G L      +  YS    S+CI  IL+        
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 115
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDN---IVAHLSDFGIAKLLTGEDQSMTQTQTL 352
             ++ Y H   S  I+H +LKP N+LL          L+DFG+A  +   + S       
Sbjct: 116 --SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFA 167
Query: 353 ATIGYMAP 360
            T GY++P
Sbjct: 168 GTPGYLSP 175

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     IG GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EYM  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     IG GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EYM  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 82/196 (41%), Gaps = 36/196 (18%)
Query: 183 PQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQD------------------G 224
           P  S+R+++          F     +G+G FG+VY AR +                   G
Sbjct: 2   PLGSKRQWT-------LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG 54
Query: 225 MEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD 284
           +E  ++    E E+   + H N++++     +     L+LEY   G++ + L       D
Sbjct: 55  VEHQLRR---EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFD 110
Query: 285 ILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ 344
             +    +  + +AL Y H   S  +IH D+KP N+LL  N    ++DFG     +    
Sbjct: 111 EQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAP 163
Query: 345 SMTQTQTLATIGYMAP 360
           S  +T    T+ Y+ P
Sbjct: 164 SSRRTTLCGTLDYLPP 179

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/181 (20%), Positives = 81/181 (44%), Gaps = 27/181 (14%)
Query: 203 SANNLIGRGSFGSVYKARLQDGMEFA-IKSFDVECEVMKSIHHRNLVKIISSCSNEDFRA 261
           +A +L GR  + +V    L++    + ++    E  V+K ++H +++K+  +CS +    
Sbjct: 43  TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102
Query: 262 LVLEYMTNGSLEKVLYSSNCI-----------------------LDILQRLNIMINVTSA 298
           L++EY   GSL   L  S  +                       L +   ++    ++  
Sbjct: 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           ++YL       ++H DL   N+L+ +     +SDFG+++ +  ED  + ++Q    + +M
Sbjct: 163 MQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWM 219
Query: 359 A 359
           A
Sbjct: 220 A 220

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 209 GRGSFGSVYKARLQDGMEFAIKSFDV--------ECEV--MKSIHHRNLVKIISS----C 254
            RG FG V+KA+L +    A+K F +        E EV  +  + H N+++ I +     
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF-------GFS 307
           S +    L+  +   GSL   L ++  ++   +  +I   +   L YLH        G  
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAP 360
             I H D+K  NVLL +N+ A ++DFG+A K   G+    T  Q + T  YMAP
Sbjct: 150 PAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAP 202

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 32/178 (17%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGME--FAIKSFD---------VECEVMKSIHHRNLVKI 250
           F   + +GRG+   VY+ + Q G +  +A+K             E  V+  + H N++K+
Sbjct: 55  FEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 251 ISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
                     +LVLE +T G L     EK  YS     D +++      +  A+ YLH  
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVAYLH-- 165
Query: 306 FSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
               I+H DLKP N+L      +    ++DFG++K++  E Q + +T    T GY AP
Sbjct: 166 -ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYCAP 219

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 39/189 (20%)
Query: 208 IGRGSFGSVYKARL--------------------QDGMEFAIKSFDVECEVMKSI-HHRN 246
           +G G+FG V  A                       D  E  +     E E+MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL-----------YSSNCILDILQRLNIMINV 295
           ++ ++ +C+ +    +++ Y + G+L + L           Y  N + +       +++ 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 296 T----SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           T      +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 85/189 (44%), Gaps = 34/189 (17%)
Query: 199 TNGFSANNLIGRGSFGSVYKARLQDGMEFA----IKSFDV---------ECEVMKSIHHR 245
           ++ F   +L+G G++G V  A  +   E      I+ FD          E +++K   H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 246 NLVKIISSCSNEDFR----ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           N++ I +    + F       +++ +    L +V+ +     D +Q    +     A++ 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAVKV 127
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL----------TGEDQSMTQTQT 351
           LH    + +IH DLKP N+L++ N    + DFG+A+++          TG+   M  T+ 
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM--TEY 182
Query: 352 LATIGYMAP 360
           +AT  Y AP
Sbjct: 183 VATRWYRAP 191

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/181 (20%), Positives = 81/181 (44%), Gaps = 27/181 (14%)
Query: 203 SANNLIGRGSFGSVYKARLQDGMEFA-IKSFDVECEVMKSIHHRNLVKIISSCSNEDFRA 261
           +A +L GR  + +V    L++    + ++    E  V+K ++H +++K+  +CS +    
Sbjct: 43  TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102
Query: 262 LVLEYMTNGSLEKVLYSSNCI-----------------------LDILQRLNIMINVTSA 298
           L++EY   GSL   L  S  +                       L +   ++    ++  
Sbjct: 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           ++YL       ++H DL   N+L+ +     +SDFG+++ +  ED  + ++Q    + +M
Sbjct: 163 MQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWM 219
Query: 359 A 359
           A
Sbjct: 220 A 220

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 199 TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVMKSIH 243
           ++ +    ++G G    V+ AR L+D  + A+K               F  E +   +++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 244 HRNLVKIISSCSNED----FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
           H  +V +  +   E        +V+EY+   +L  ++++   +     +  I + +  A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYM 358
           + L+F     IIH D+KP N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 359 AP 360
           +P
Sbjct: 187 SP 188

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 199 TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVMKSIH 243
           ++ +    ++G G    V+ AR L+D  + A+K               F  E +   +++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 244 HRNLVKIISSCSNED----FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
           H  +V +  +   E        +V+EY+   +L  ++++   +     +  I + +  A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYM 358
           + L+F     IIH D+KP N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 359 AP 360
           +P
Sbjct: 187 SP 188

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 231 SFDVECEVMKSIHHRNLVKIISSCSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDILQR 288
            +  E +++++++H +++K    C +    +L  V+EY+  GSL   L   +  + + Q 
Sbjct: 79  GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQL 136
Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSMT 347
           L     +   + YLH   +   IH DL   NVLLD++ +  + DFG+AK +  G +    
Sbjct: 137 LLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRV 193
Query: 348 QTQTLATIGYMAP 360
           +    + + + AP
Sbjct: 194 REDGDSPVFWYAP 206

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 76/194 (39%), Gaps = 44/194 (22%)
Query: 208 IGRGSFGSVYKARLQDGMEF------AIK------------SFDVECEVMKSIHHRNLVK 249
           IG G+FG V++AR    + +      A+K             F  E  +M    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSN----C-------------------ILDIL 286
           ++  C+      L+ EYM  G L + L S +    C                    L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           ++L I   V + + YL        +H DL   N L+ +N+V  ++DFG+++ +   D   
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 347 TQTQTLATIGYMAP 360
                   I +M P
Sbjct: 232 ADGNDAIPIRWMPP 245

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/181 (20%), Positives = 81/181 (44%), Gaps = 27/181 (14%)
Query: 203 SANNLIGRGSFGSVYKARLQDGMEFA-IKSFDVECEVMKSIHHRNLVKIISSCSNEDFRA 261
           +A +L GR  + +V    L++    + ++    E  V+K ++H +++K+  +CS +    
Sbjct: 43  TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102
Query: 262 LVLEYMTNGSLEKVLYSSNCI-----------------------LDILQRLNIMINVTSA 298
           L++EY   GSL   L  S  +                       L +   ++    ++  
Sbjct: 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           ++YL       ++H DL   N+L+ +     +SDFG+++ +  ED  + ++Q    + +M
Sbjct: 163 MQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM 219
Query: 359 A 359
           A
Sbjct: 220 A 220

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 76/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 62
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 121
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T+   T+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLP 174
Query: 360 P 360
           P
Sbjct: 175 P 175

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 78/177 (44%), Gaps = 22/177 (12%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------DVECEVMK------SIH 243
           + F    ++G+GSFG V  AR+++ G  +A+K           DVEC + +      + +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H  L ++       D    V+E++  G L   +  S    +   R      + SAL +LH
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH 141
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                 II+ DLK  NVLLD      L+DFG+ K   G    +T      T  Y+AP
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAP 193

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 35/193 (18%)
Query: 189 RFSYLELLRATNGFSANNLIGRGSFGSVYKAR-------------LQDGMEFAIKSFDVE 235
           R+   E +R    F   +++G G+F  V  A               ++ +E    S + E
Sbjct: 9   RWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLN 290
             V+  I H N+V +     +     L+++ ++ G L     EK  Y+            
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASR 120
Query: 291 IMINVTSALEYLHFGFSTPIIHCDLKPHNVL---LDDNIVAHLSDFGIAKLLTGEDQSMT 347
           ++  V  A++YLH      I+H DLKP N+L   LD++    +SDFG++K+   ED    
Sbjct: 121 LIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 348 QTQTLATIGYMAP 360
            +    T GY+AP
Sbjct: 175 LSTACGTPGYVAP 187

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 35/193 (18%)
Query: 189 RFSYLELLRATNGFSANNLIGRGSFGSVYKAR-------------LQDGMEFAIKSFDVE 235
           R+   E +R    F   +++G G+F  V  A               ++ +E    S + E
Sbjct: 9   RWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLN 290
             V+  I H N+V +     +     L+++ ++ G L     EK  Y+            
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASR 120
Query: 291 IMINVTSALEYLHFGFSTPIIHCDLKPHNVL---LDDNIVAHLSDFGIAKLLTGEDQSMT 347
           ++  V  A++YLH      I+H DLKP N+L   LD++    +SDFG++K+   ED    
Sbjct: 121 LIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 348 QTQTLATIGYMAP 360
            +    T GY+AP
Sbjct: 175 LSTACGTPGYVAP 187

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 204 ANNLIGRGSFGSVYKA----RLQDGMEFAIKS------------FDVECEVMKSIHHRNL 247
           ++ +IG+G FG VY      + Q+ ++ AIKS            F  E  +M+ ++H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 248 VKIIS-SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           + +I      E    ++L YM +G L + + S      +   ++  + V   +EYL    
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---A 141
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAK-LLTGEDQSMTQ 348
               +H DL   N +LD++    ++DFG+A+ +L  E  S+ Q
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ 184

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 35/193 (18%)
Query: 189 RFSYLELLRATNGFSANNLIGRGSFGSVYKAR-------------LQDGMEFAIKSFDVE 235
           R+   E +R    F   +++G G+F  V  A               ++ +E    S + E
Sbjct: 9   RWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLN 290
             V+  I H N+V +     +     L+++ ++ G L     EK  Y+            
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASR 120
Query: 291 IMINVTSALEYLHFGFSTPIIHCDLKPHNVL---LDDNIVAHLSDFGIAKLLTGEDQSMT 347
           ++  V  A++YLH      I+H DLKP N+L   LD++    +SDFG++K+   ED    
Sbjct: 121 LIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 348 QTQTLATIGYMAP 360
            +    T GY+AP
Sbjct: 175 LSTACGTPGYVAP 187

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 29/179 (16%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ------------------DGMEFAIKSFDVECEVMKS 241
           + F     +G+G FG+VY AR +                  +G+E  ++    E E+   
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR---EIEIQSH 70
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           + H N++++ +   +     L+LE+   G L K L   +   D  +    M  +  AL Y
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHY 129
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            H      +IH D+KP N+L+       ++DFG     +    S+ +     T+ Y+ P
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPP 181

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 79/173 (45%), Gaps = 25/173 (14%)
Query: 208 IGRGSFGSVY-----KARLQDGMEFAIKSFDVEC------------EVMKSIHHRNLVKI 250
           +G G FG V            G   A+K+   +C            +++++++H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 251 ISSCSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              C ++  ++L  V+EY+  GSL   L   +  + + Q L     +   + YLH   + 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAP 360
             IH +L   NVLLD++ +  + DFG+AK +  G +    +    + + + AP
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 21/176 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHH 244
           N F    L+G+G+FG V   R +  G  +A+K                  E  V+++  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  +    D    V+EY   G L   L       +   R      + SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     M  AIK+            F  E   M+   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIKWMAP 181

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 77/175 (44%), Gaps = 26/175 (14%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAP 208

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 41/179 (22%)
Query: 208 IGRGSFGSVYK-ARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIISS 253
           +G+G+F  V +  ++  G E+A K               + E  + + + H N+V++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 254 CSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALEYLHF 304
            S E    L+ + +T G L      +  YS    S+CI  IL+          A+ + H 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE----------AVLHCH- 138
Query: 305 GFSTPIIHCDLKPHNVLLDDNI---VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                ++H DLKP N+LL   +      L+DFG+A  + GE Q+        T GY++P
Sbjct: 139 --QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSP 193

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 78/195 (40%), Gaps = 33/195 (16%)
Query: 181 MQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD------ 233
           M P+ +   F YL+LL            G+G+FG V   R +  G  +A+K         
Sbjct: 3   MDPKVTMNDFDYLKLL------------GKGTFGKVILVREKATGRYYAMKILRKEVIIA 50
Query: 234 --------VECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI 285
                    E  V+++  H  L  +  +    D    V+EY   G L   L       + 
Sbjct: 51  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE 110
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
             R      + SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K   G    
Sbjct: 111 RARF-YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG 164
Query: 346 MTQTQTLATIGYMAP 360
            T      T  Y+AP
Sbjct: 165 ATMKXFCGTPEYLAP 179

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 21/176 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHH 244
           N F    L+G+G+FG V   R +  G  +A+K                  E  V+++  H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  +    D    V+EY   G L   L       +   R      + SALEYLH 
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 125
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 126 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 177

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 39/189 (20%)
Query: 208 IGRGSFGSVYKARL--------------------QDGMEFAIKSFDVECEVMKSI-HHRN 246
           +G G+FG V  A                       D  E  +     E E+MK I  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVL---------YSSNCILDILQRLN------I 291
           ++ ++ +C+ +    +++EY + G+L + L         +S N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
              V   +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 29/182 (15%)
Query: 199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIK--------------SFDVECEVMKSIH 243
           ++ +    ++G+GSFG V   + +  G E A+K              S   E +++K + 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++K+     ++ +  LV E  T G L   + S     ++     I+  V S + Y+H
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMH 167
Query: 304 FGFSTPIIHCDLKPHNVLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
                 I+H DLKP N+LL     D NI   + DFG++   T  + S      + T  Y+
Sbjct: 168 ---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLS---THFEASKKMKDKIGTAYYI 219
Query: 359 AP 360
           AP
Sbjct: 220 AP 221

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 26/177 (14%)
Query: 200 NGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHH 244
           + F     +G GSFG V   + ++ G  +A+K  D               E  ++++++ 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
             S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T  Y+AP
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAP 193

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 21/176 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHH 244
           N F    L+G+G+FG V   R +  G  +A+K                  E  V+++  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  +    D    V+EY   G L   L       +   R      + SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 174

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 195 LLRATNGFSANNLIGRGSFGSV----YKAR----------LQDGMEFA-IKSFDVECEVM 239
            L+  N   A+  +G G+FGSV    Y+ R          L+ G E A  +    E ++M
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 390
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + +  +V++I  C  E    LV+E    G L K L      + +     ++  V+  +
Sbjct: 391 HQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
           +YL        +H +L   NVLL +   A +SDFG++K L  +D   T
Sbjct: 450 KYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 21/176 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHH 244
           N F    L+G+G+FG V   R +  G  +A+K                  E  V+++  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  +    D    V+EY   G L   L       +   R      + SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 29/182 (15%)
Query: 199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIK--------------SFDVECEVMKSIH 243
           ++ +    ++G+GSFG V   + +  G E A+K              S   E +++K + 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++K+     ++ +  LV E  T G L   + S     ++     I+  V S + Y+H
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMH 166
Query: 304 FGFSTPIIHCDLKPHNVLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
                 I+H DLKP N+LL     D NI   + DFG++   T  + S      + T  Y+
Sbjct: 167 ---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLS---THFEASKKMKDKIGTAYYI 218
Query: 359 AP 360
           AP
Sbjct: 219 AP 220

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 21/176 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHH 244
           N F    L+G+G+FG V   R +  G  +A+K                  E  V+++  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  +    D    V+EY   G L   L       +   R      + SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 174

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 21/163 (12%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQDG--MEFAIKSFDV-------ECEVM-KSIHHR 245
           ++ T+G+     IG GS+ SV K  +     MEFA+K  D        E E++ +   H 
Sbjct: 18  IQFTDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHP 76
Query: 246 NLVKIISSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
           N++ +     +  +  +V E M  G L +K+L          +   ++  +T  +EYLH 
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLH- 133
Query: 305 GFSTPIIHCDLKPHNVLLDDNI----VAHLSDFGIAKLLTGED 343
             +  ++H DLKP N+L  D         + DFG AK L  E+
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 13/136 (9%)
Query: 235 ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-------SNCILDILQ 287
           E + M   HH N+V   +S   +D   LV++ ++ GS+  ++          + +LD   
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 288 RLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSM 346
              I+  V   LEYLH       IH D+K  N+LL ++    ++DFG++  L TG D + 
Sbjct: 118 IATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 174
Query: 347 TQTQT--LATIGYMAP 360
            + +   + T  +MAP
Sbjct: 175 NKVRKTFVGTPCWMAP 190

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 83/193 (43%), Gaps = 35/193 (18%)
Query: 189 RFSYLELLRATNGFSANNLIGRGSFGSVYKAR-------------LQDGMEFAIKSFDVE 235
           R+   E +R    F   +++G G+F  V  A               +  +E    S + E
Sbjct: 9   RWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLN 290
             V+  I H N+V +     +     L+++ ++ G L     EK  Y+            
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASR 120
Query: 291 IMINVTSALEYLHFGFSTPIIHCDLKPHNVL---LDDNIVAHLSDFGIAKLLTGEDQSMT 347
           ++  V  A++YLH      I+H DLKP N+L   LD++    +SDFG++K+   ED    
Sbjct: 121 LIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 348 QTQTLATIGYMAP 360
            +    T GY+AP
Sbjct: 175 LSTACGTPGYVAP 187

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 29/182 (15%)
Query: 199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIK--------------SFDVECEVMKSIH 243
           ++ +    ++G+GSFG V   + +  G E A+K              S   E +++K + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++K+     ++ +  LV E  T G L   + S     ++     I+  V S + Y+H
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMH 143
Query: 304 FGFSTPIIHCDLKPHNVLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
                 I+H DLKP N+LL     D NI   + DFG++   T  + S      + T  Y+
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLS---THFEASKKMKDKIGTAYYI 195
Query: 359 AP 360
           AP
Sbjct: 196 AP 197

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 25/157 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 67
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G + K L       D  +    +  + +AL
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANAL 126
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
            Y H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 20/157 (12%)
Query: 198 ATNGF---SANNLIGRGSFGSVYK-ARLQDGMEFAIKSFDV-----------ECEVMKSI 242
           A N F   S   ++G G FG V+K      G++ A K               E  VM  +
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 243 HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL 302
            H NL+++  +  +++   LV+EY+  G L   +   +  L  L  +  M  +   + ++
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLS--DFGIAK 337
           H  +   I+H DLKP N+L  +     +   DFG+A+
Sbjct: 204 HQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 208 IGRGSFGSVYKARLQ---------------DGMEFAIK-SFDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q               +  + A+K     E  VM+ + +  +V++I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E +  LV+E    G L K L  +  + D    + ++  V+  ++YL     +  +
Sbjct: 437 GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 491
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
           H DL   NVLL     A +SDFG++K L   E+    QT     + + AP
Sbjct: 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 541

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 13/136 (9%)
Query: 235 ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-------SNCILDILQ 287
           E + M   HH N+V   +S   +D   LV++ ++ GS+  ++          + +LD   
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 288 RLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSM 346
              I+  V   LEYLH       IH D+K  N+LL ++    ++DFG++  L TG D + 
Sbjct: 123 IATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 347 TQTQT--LATIGYMAP 360
            + +   + T  +MAP
Sbjct: 180 NKVRKTFVGTPCWMAP 195

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 81/175 (46%), Gaps = 27/175 (15%)
Query: 209 GRGSFGSVYKARLQDGMEFAIK--------SFDVECEVMKS--IHHRNLVKIISS---CS 255
            RG FG V+KA+L +    A+K        S+  E E+  +  + H NL++ I++    S
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 256 NEDFR-ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF--------GF 306
           N +    L+  +   GSL   L  +  I+   +  ++   ++  L YLH         G 
Sbjct: 83  NLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRGEGH 140
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAP 360
              I H D K  NVLL  ++ A L+DFG+A +   G+    T  Q + T  YMAP
Sbjct: 141 KPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-VGTRRYMAP 194

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 21/176 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD--------------VECEVMKSIHH 244
           N F    L+G+G+FG V   R +  G  +A+K                  E  V+++  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  +    D    V+EY   G L   L       +   R      + SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 56  DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 115
Query: 277 ----YSSNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
               Y  N   +  ++L+          V   +EYL    S   IH DL   NVL+ ++ 
Sbjct: 116 PGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDN 172
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 208 IGRGSFGSVYKARLQ---------------DGMEFAIK-SFDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q               +  + A+K     E  VM+ + +  +V++I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E +  LV+E    G L K L  +  + D    + ++  V+  ++YL     +  +
Sbjct: 438 GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 492
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
           H DL   NVLL     A +SDFG++K L   E+    QT     + + AP
Sbjct: 493 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 542

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     M  AIK+            F  E   M+   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 181

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVEC----EVMK--SIHHRNLVKIISSCSNEDFR 260
           +GRGSFG V++    Q G + A+K   +E     E+M    +    +V +  +     + 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWV 141
Query: 261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV 320
            + +E +  GSL +++    C+ +  + L  +      LEYLH   S  I+H D+K  NV
Sbjct: 142 NIFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALEGLEYLH---SRRILHGDVKADNV 197
Query: 321 LL-DDNIVAHLSDFGIA----------KLLTGEDQSMTQTQTLATIGYMAP 360
           LL  D   A L DFG A           LLTG+    T+T       +MAP
Sbjct: 198 LLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET-------HMAP 241

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVEC----EVMK--SIHHRNLVKIISSCSNEDFR 260
           +GRGSFG V++    Q G + A+K   +E     E+M    +    +V +  +     + 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWV 160
Query: 261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV 320
            + +E +  GSL +++    C+ +  + L  +      LEYLH   S  I+H D+K  NV
Sbjct: 161 NIFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALEGLEYLH---SRRILHGDVKADNV 216
Query: 321 LL-DDNIVAHLSDFGIA----------KLLTGEDQSMTQTQTLATIGYMAP 360
           LL  D   A L DFG A           LLTG+    T+T       +MAP
Sbjct: 217 LLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET-------HMAP 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 62
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 121
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLP 174
Query: 360 P 360
           P
Sbjct: 175 P 175

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 33/180 (18%)
Query: 202 FSANNLIGRGSFGSVYKARLQ-DGMEFAIK------------SFDVECEVMKSIHHRNLV 248
           F     +G G+F  V  A  +  G  FA+K            S + E  V++ I H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 249 KIISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSALEYLH 303
            +     + +   LV++ ++ G L     EK  Y+      ++++      V  A+ YLH
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ------VLDAVYYLH 137
Query: 304 FGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                 I+H DLKP N+L    D+     +SDFG++K+   E +    +    T GY+AP
Sbjct: 138 ---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAP 191

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 25/178 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGME----FAIKSFD---------------VECEVMKSI 242
           F    ++G+G +G V++ R   G      FA+K                   E  +++ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 243 HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL 302
            H  +V +I +        L+LEY++ G L   L      ++       +  ++ AL +L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHL 137
Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H      II+ DLKP N++L+      L+DFG+ K  +  D ++T      TI YMAP
Sbjct: 138 H---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHX-FCGTIEYMAP 190

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 223 DGMEFAIKSFDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL----- 276
           D  E  +     E E+MK I  H+N++ ++ +C+ +    +++EY + G+L + L     
Sbjct: 71  DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 130
Query: 277 ----YSSNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI 326
               Y  N   +  ++L+          V   +EYL    S   IH DL   NVL+ ++ 
Sbjct: 131 PGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 187
Query: 327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           V  ++DFG+A+ +   D     T     + +MAP
Sbjct: 188 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 221

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 74/172 (43%), Gaps = 32/172 (18%)
Query: 183 PQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQD------------------G 224
           P  S+R+++          F     +G+G FG+VY AR +                   G
Sbjct: 2   PLGSKRQWT-------LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG 54
Query: 225 MEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD 284
           +E  ++    E E+   + H N++++     +     L+LEY   G++ + L       D
Sbjct: 55  VEHQLRR---EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFD 110
Query: 285 ILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
             +    +  + +AL Y H   S  +IH D+KP N+LL  N    ++DFG +
Sbjct: 111 EQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 62
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 121
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLP 174
Query: 360 P 360
           P
Sbjct: 175 P 175

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 63/130 (48%), Gaps = 12/130 (9%)
Query: 235 ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMI 293
           E  ++KS+ H N++K+     ++ +  LV E+   G L E+++       D     NIM 
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMK 153
Query: 294 NVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN---IVAHLSDFGIAKLLTGEDQSMTQTQ 350
            + S + YLH      I+H D+KP N+LL++    +   + DFG++   +   +      
Sbjct: 154 QILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRD 207
Query: 351 TLATIGYMAP 360
            L T  Y+AP
Sbjct: 208 RLGTAYYIAP 217

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 81/182 (44%), Gaps = 24/182 (13%)
Query: 199 TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVMKSIH 243
           ++ +    ++G G    V+ AR L+D  + A+K               F  E +   +++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 244 HRNLVKIISSCSNED----FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
           H  +V +  +   E        +V+EY+   +L  ++++   +     +  I + +  A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYM 358
           + L+F     IIH D+KP N+L+       + DFGIA+ +     S+ QT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 359 AP 360
           +P
Sbjct: 187 SP 188

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 61
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 120
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 121 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 173
Query: 360 P 360
           P
Sbjct: 174 P 174

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 63
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 122
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLP 175
Query: 360 P 360
           P
Sbjct: 176 P 176

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  FA+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  FA+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 62
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 121
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLP 174
Query: 360 P 360
           P
Sbjct: 175 P 175

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 26/169 (15%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRNLVKIIS 252
           +G GSFG V   + ++ G  +A+K  D               E  ++++++   LVK+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           S  +     +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
            DLKP N+L+D      ++DFG AK + G      +T  LA T  Y+AP
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLAGTPEYLAP 207

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 59
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 118
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 119 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 171
Query: 360 P 360
           P
Sbjct: 172 P 172

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 62
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 121
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 174
Query: 360 P 360
           P
Sbjct: 175 P 175

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     IG GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 66
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 125
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 126 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 178
Query: 360 P 360
           P
Sbjct: 179 P 179

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  FA+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 88
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 147
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 148 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 200
Query: 360 P 360
           P
Sbjct: 201 P 201

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     M  AIK+            F  E   M+   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 561

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 67
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 126
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLP 179
Query: 360 P 360
           P
Sbjct: 180 P 180

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 65
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 124
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 177
Query: 360 P 360
           P
Sbjct: 178 P 178

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 65
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 124
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 177
Query: 360 P 360
           P
Sbjct: 178 P 178

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 21/167 (12%)
Query: 208 IGRGSFGSVYK--ARLQDGMEFAIKSFDVECE------------VMKSIHHRNLVKIISS 253
           +G G++ +VYK  ++L D +  A+K   +E E            ++K + H N+V +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E    LV EY+ +  L++ L     I+++      +  +   L Y H      ++H 
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DLKP N+L+++     L+DFG+A+       + T    + T+ Y  P
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPP 169

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 67
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 126
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 179
Query: 360 P 360
           P
Sbjct: 180 P 180

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 76/176 (43%), Gaps = 24/176 (13%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHH 244
           + F     +G GSFG V   + ++ G  +A+K  D               E  ++++++ 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +I+ DLKP N+L+D+     ++DFG AK + G    +       T  Y+AP
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 194

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 26/175 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 179
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G       T TL  T  Y+AP
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ATWTLCGTPEYLAP 228

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 35/180 (19%)
Query: 194 ELLRATNGFSANNLIGRGSFGSVYKARL--QDG--MEFAIK-------------SFDVEC 236
           ++L     F+   ++G+G FGSV +A+L  +DG  ++ A+K              F  E 
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 237 EVMKSIHHRNLVKIISSCSNEDFRA------LVLEYMTNGSLEKVLYSS-------NCIL 283
             MK   H ++ K++        +       ++L +M +G L   L +S       N  L
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
             L R   M+++   +EYL    S   IH DL   N +L +++   ++DFG+++ +   D
Sbjct: 137 QTLVRF--MVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 21/182 (11%)
Query: 194 ELLRATNGFSANNLIGRGSFGSV-----------YKARLQDGMEFAIKS----FDVECEV 238
           +L      +    +IGRG+FG V           Y  +L    E   +S    F  E ++
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           M   +   +V++  +  ++ +  +V+EYM  G L  ++ S+  + +   R      V  A
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARF-YTAEVVLA 180
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           L+ +H   S   IH D+KP N+LLD +    L+DFG    +  E      T  + T  Y+
Sbjct: 181 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYI 236
Query: 359 AP 360
           +P
Sbjct: 237 SP 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 179
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 228

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 63
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 122
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLP 175
Query: 360 P 360
           P
Sbjct: 176 P 176

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 21/182 (11%)
Query: 194 ELLRATNGFSANNLIGRGSFGSV-----------YKARLQDGMEFAIKS----FDVECEV 238
           +L      +    +IGRG+FG V           Y  +L    E   +S    F  E ++
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           M   +   +V++  +  ++ +  +V+EYM  G L  ++ S+  + +   R      V  A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARF-YTAEVVLA 185
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           L+ +H   S   IH D+KP N+LLD +    L+DFG    +  E      T  + T  Y+
Sbjct: 186 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYI 241
Query: 359 AP 360
           +P
Sbjct: 242 SP 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 67
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 126
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 179
Query: 360 P 360
           P
Sbjct: 180 P 180

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 23/145 (15%)
Query: 197 RATNGFSANNLIGRGSFGSVYK-ARLQDGMEFAIK--------SFDVECEVMKSIH---- 243
           R T  F     IG G FGSV+K  +  DG  +AIK        S D E   ++ ++    
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAV 62
Query: 244 ---HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL---NIMINVTS 297
              H ++V+  S+ + +D   +  EY   GSL   +  +  I+   +     ++++ V  
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLL 322
            L Y+H   S  ++H D+KP N+ +
Sbjct: 123 GLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 24/176 (13%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHH 244
           + F     +G GSFG V   + ++ G  +A+K  D               E  ++++++ 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 202

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 30/185 (16%)
Query: 196 LRATNGFSANNLIGRGSFGSVY-KARLQDGMEFAIK---------SFDVECEVMKSIHHR 245
           LR  N +     IG GSFG +Y  A +  G E AIK            +E +  K +   
Sbjct: 5   LRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGG 64
Query: 246 NLVKIISSCSNE-DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             +  I  C  E D+  +V+E +   SLE +    +    +   L +   + S +EY+H 
Sbjct: 65  VGIPSIKWCGAEGDYNVMVME-LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH- 122
Query: 305 GFSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTG----------EDQSMTQTQ 350
             S   IH D+KP N L+      N+V ++ DFG+AK              E++++T T 
Sbjct: 123 --SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 351 TLATI 355
             A+I
Sbjct: 180 RYASI 184

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 21/182 (11%)
Query: 194 ELLRATNGFSANNLIGRGSFGSV-----------YKARLQDGMEFAIKS----FDVECEV 238
           +L      +    +IGRG+FG V           Y  +L    E   +S    F  E ++
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           M   +   +V++  +  ++ +  +V+EYM  G L  ++ S+  + +   R      V  A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARF-YTAEVVLA 185
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 358
           L+ +H   S   IH D+KP N+LLD +    L+DFG    +  E      T  + T  Y+
Sbjct: 186 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYI 241
Query: 359 AP 360
           +P
Sbjct: 242 SP 243

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 23/145 (15%)
Query: 197 RATNGFSANNLIGRGSFGSVYK-ARLQDGMEFAIK--------SFDVECEVMKSIH---- 243
           R T  F     IG G FGSV+K  +  DG  +AIK        S D E   ++ ++    
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAV 64
Query: 244 ---HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL---NIMINVTS 297
              H ++V+  S+ + +D   +  EY   GSL   +  +  I+   +     ++++ V  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLL 322
            L Y+H   S  ++H D+KP N+ +
Sbjct: 125 GLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 23/145 (15%)
Query: 197 RATNGFSANNLIGRGSFGSVYK-ARLQDGMEFAIK--------SFDVECEVMKSIH---- 243
           R T  F     IG G FGSV+K  +  DG  +AIK        S D E   ++ ++    
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAV 66
Query: 244 ---HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL---NIMINVTS 297
              H ++V+  S+ + +D   +  EY   GSL   +  +  I+   +     ++++ V  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLL 322
            L Y+H   S  ++H D+KP N+ +
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 35/174 (20%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVE---------CEVMKSIHHRNLVKIISSCSNE 257
           +GRGSFG V++ +  Q G + A+K   +E         C  + S     +V +  +    
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSP---RIVPLYGAVREG 122
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
            +  + +E +  GSL +++    C+ +  + L  +      LEYLH   +  I+H D+K 
Sbjct: 123 PWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRRILHGDVKA 178
Query: 318 HNVLL-DDNIVAHLSDFGIA----------KLLTGEDQSMTQTQTLATIGYMAP 360
            NVLL  D   A L DFG A           LLTG+    T+T       +MAP
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET-------HMAP 225

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 25/157 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR ++                  G+E  ++    E E+ 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 62
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 121
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
            Y H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 122 SYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 79
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 138
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ 
Sbjct: 139 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 191
Query: 360 P 360
           P
Sbjct: 192 P 192

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 208 IGRGSFGSVYKARLQ---------------DGMEFAIK-SFDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q               +  + A+K     E  VM+ + +  +V++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E +  LV+E    G L K L  +  + D    + ++  V+  ++YL     +  +
Sbjct: 79  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFV 133
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
           H DL   NVLL     A +SDFG++K L   E+    QT     + + AP
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAP 183

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 84/189 (44%), Gaps = 34/189 (17%)
Query: 199 TNGFSANNLIGRGSFGSVYKARLQDGMEFA----IKSFDV---------ECEVMKSIHHR 245
           ++ F   +L+G G++G V  A  +   E      I+ FD          E +++K   H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 246 NLVKIISSCSNEDFR----ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           N++ I +    + F       +++ +    L +V+ +     D +Q    +     A++ 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAVKV 127
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL----------TGEDQSMTQTQT 351
           LH    + +IH DLKP N+L++ N    + DFG+A+++          TG+   M   + 
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM--VEF 182
Query: 352 LATIGYMAP 360
           +AT  Y AP
Sbjct: 183 VATRWYRAP 191

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 23/145 (15%)
Query: 197 RATNGFSANNLIGRGSFGSVYK-ARLQDGMEFAIK--------SFDVECEVMKSIH---- 243
           R T  F     IG G FGSV+K  +  DG  +AIK        S D E   ++ ++    
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAV 64
Query: 244 ---HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL---NIMINVTS 297
              H ++V+  S+ + +D   +  EY   GSL   +  +  I+   +     ++++ V  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLL 322
            L Y+H   S  ++H D+KP N+ +
Sbjct: 125 GLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 24/168 (14%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRNLVKIIS 252
           +G GSFG V   + ++ G  +A+K  D               E  ++++++   LVK+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           S  +     +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAP 207

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 35/174 (20%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVE---------CEVMKSIHHRNLVKIISSCSNE 257
           +GRGSFG V++ +  Q G + A+K   +E         C  + S     +V +  +    
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSP---RIVPLYGAVREG 138
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
            +  + +E +  GSL +++    C+ +  + L  +      LEYLH   +  I+H D+K 
Sbjct: 139 PWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRRILHGDVKA 194
Query: 318 HNVLL-DDNIVAHLSDFGIA----------KLLTGEDQSMTQTQTLATIGYMAP 360
            NVLL  D   A L DFG A           LLTG+    T+T       +MAP
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET-------HMAP 241

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 21/171 (12%)
Query: 206 NLIGRGSFGSVYKA-RLQDGMEFAI-------------KSFDVECEVM---KSIHHRNLV 248
            ++G G FG+V+K   + +G    I             +SF    + M    S+ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           +++  C     + LV +Y+  GSL   +      L     LN  + +   + YL      
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            ++H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +MA
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 208 IGRGSFGSVYKARLQ---------------DGMEFAIK-SFDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q               +  + A+K     E  VM+ + +  +V++I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E +  LV+E    G L K L  +  + D    + ++  V+  ++YL     +  +
Sbjct: 93  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFV 147
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
           H DL   NVLL     A +SDFG++K L   E+    QT     + + AP
Sbjct: 148 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 197

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     +  AIK+            F  E   M+   H ++VK+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 106 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 31/183 (16%)
Query: 199 TNGFSANNLIGRGSFGSVY--KARLQDGMEFAIK--------------SFDVECEVMKSI 242
           ++ +    ++G+GSFG V   K ++  G E A+K              S   E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 243 HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL 302
            H N+ K+     ++ +  LV E  T G L   + S     ++     I+  V S + Y 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYX 142
Query: 303 HFGFSTPIIHCDLKPHNVLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
           H      I+H DLKP N+LL     D NI   + DFG++   T  + S      + T  Y
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANI--RIIDFGLS---THFEASKKXKDKIGTAYY 194
Query: 358 MAP 360
           +AP
Sbjct: 195 IAP 197

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 79/193 (40%), Gaps = 34/193 (17%)
Query: 202 FSANNL-----IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------------ECEV 238
           F  NNL     +G G+FG V +A     G E A+    V                 E ++
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 239 MKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTS 297
           M  +  H N+V ++ +C++     ++ EY   G L   L   + +L+      I  +  S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 298 ALEYLHFG----------FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
             + LHF            S   IH D+   NVLL +  VA + DFG+A+ +  +   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 348 QTQTLATIGYMAP 360
           +      + +MAP
Sbjct: 223 KGNARLPVKWMAP 235

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 24/176 (13%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHH 244
           + F     +G GSFG V   + ++ G  +A+K  D               E  ++++++ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 200

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 21/171 (12%)
Query: 206 NLIGRGSFGSVYKA-RLQDGMEFAI-------------KSFDVECEVM---KSIHHRNLV 248
            ++G G FG+V+K   + +G    I             +SF    + M    S+ H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           +++  C     + LV +Y+  GSL   +      L     LN  + +   + YL      
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 152
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            ++H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +MA
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     +  AIK+            F  E   M+   H ++VK+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 80  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 183

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 27/177 (15%)
Query: 202 FSANNLIGRGSFGSV-----------YKARLQDGMEFAIKS----FDVECEVMKSIHHRN 246
           +    +IGRG+FG V           Y  +L    E   +S    F  E ++M   +   
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 136
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN--IMINVTSALEYLHF 304
           +V++  +  ++ +  +V+EYM  G L  ++  SN   D+ ++        V  AL+ +H 
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SN--YDVPEKWAKFYTAEVVLALDAIH- 191
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
             S  +IH D+KP N+LLD +    L+DFG    +  ++  M    T + T  Y++P
Sbjct: 192 --SMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAVGTPDYISP 244

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     +  AIK+            F  E   M+   H ++VK+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 81  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 184

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 208 IGRGSFGSVYKARLQ---------------DGMEFAIK-SFDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q               +  + A+K     E  VM+ + +  +V++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E +  LV+E    G L K L  +  + D    + ++  V+  ++YL     +  +
Sbjct: 79  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFV 133
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
           H DL   NVLL     A +SDFG++K L   E+    QT     + + AP
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 183

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     +  AIK+            F  E   M+   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 83  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 186

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 21/172 (12%)
Query: 205 NNLIGRGSFGSVYKARLQ----DGMEFAIKSFDVECE------------VMKSIHHRNLV 248
           N ++G G FG VY+        + +  A+K+   +C             +MK++ H ++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           K+I     E    +++E    G L   L  +   L +L  +   + +  A+ YL    S 
Sbjct: 89  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 195

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 208 IGRGSFGSVYKARLQ---------------DGMEFAIK-SFDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q               +  + A+K     E  VM+ + +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E +  LV+E    G L K L  +  + D    + ++  V+  ++YL     +  +
Sbjct: 85  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFV 139
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
           H DL   NVLL     A +SDFG++K L   E+    QT     + + AP
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 208 IGRGSFGSVYKARLQ---------------DGMEFAIK-SFDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q               +  + A+K     E  VM+ + +  +V++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E +  LV+E    G L K L  +  + D    + ++  V+  ++YL     +  +
Sbjct: 73  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFV 127
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
           H DL   NVLL     A +SDFG++K L   E+    QT     + + AP
Sbjct: 128 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 177

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 24/168 (14%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRNLVKIIS 252
           +G GSFG V   + ++ G  +A+K  D               E  ++++++   LVK+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           S  +     +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     +  AIK+            F  E   M+   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 181

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 21/172 (12%)
Query: 205 NNLIGRGSFGSVYKARLQ----DGMEFAIKSFDVECE------------VMKSIHHRNLV 248
           N ++G G FG VY+        + +  A+K+   +C             +MK++ H ++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           K+I     E    +++E    G L   L  +   L +L  +   + +  A+ YL    S 
Sbjct: 73  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 179

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 21/172 (12%)
Query: 205 NNLIGRGSFGSVYKARLQ----DGMEFAIKSFDVECE------------VMKSIHHRNLV 248
           N ++G G FG VY+        + +  A+K+   +C             +MK++ H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           K+I     E    +++E    G L   L  +   L +L  +   + +  A+ YL    S 
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 183

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 24/168 (14%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRNLVKIIS 252
           +G GSFG V   + ++ G  +A+K  D               E  ++++++   LVK+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           S  +     +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 208 IGRGSFGSVYKARLQ---------------DGMEFAIK-SFDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q               +  + A+K     E  VM+ + +  +V++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E +  LV+E    G L K L  +  + D    + ++  V+  ++YL     +  +
Sbjct: 95  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 149
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
           H DL   NVLL     A +SDFG++K L   E+    QT     + + AP
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 208 IGRGSFGSVYKARLQ---------------DGMEFAIK-SFDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q               +  + A+K     E  VM+ + +  +V++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E +  LV+E    G L K L  +  + D    + ++  V+  ++YL     +  +
Sbjct: 95  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 149
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
           H DL   NVLL     A +SDFG++K L   E+    QT     + + AP
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 40/184 (21%)
Query: 206 NLIGRGSFGSVYKA-RLQDGMEFAIKSFDV----------------ECEVMKSIHHRNLV 248
            +IG+G+F  V +    + G +FA+K  DV                E  +   + H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA---------L 299
           +++ + S++    +V E+M    L           +I++R +     + A         L
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 300 EYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
           E L +     IIH D+KP NVLL   +++    L DFG+A  L   +  +     + T  
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGGRVGTPH 198
Query: 357 YMAP 360
           +MAP
Sbjct: 199 FMAP 202

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 72/150 (48%), Gaps = 10/150 (6%)
Query: 216 VYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNED----FRALVLEYMTNGS 271
           V +A L     F ++ F  E +   +++H  +V + ++   E        +V+EY+   +
Sbjct: 44  VLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVT 102
Query: 272 LEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLS 331
           L  ++++   +     +  I + +  A + L+F     IIH D+KP N+++       + 
Sbjct: 103 LRDIVHTEGPMT---PKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 332 DFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
           DFGIA+ +     S+TQT   + T  Y++P
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 62
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 121
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
            Y H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 35/174 (20%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVE---------CEVMKSIHHRNLVKIISSCSNE 257
           +GRGSFG V++ +  Q G + A+K   +E         C  + S     +V +  +    
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSP---RIVPLYGAVREG 136
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
            +  + +E +  GSL +++    C+ +  + L  +      LEYLH   +  I+H D+K 
Sbjct: 137 PWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRRILHGDVKA 192
Query: 318 HNVLL-DDNIVAHLSDFGIA----------KLLTGEDQSMTQTQTLATIGYMAP 360
            NVLL  D   A L DFG A           LLTG+    T+T       +MAP
Sbjct: 193 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET-------HMAP 239

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 65
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 124
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
            Y H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 179
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +  T       Y+AP
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAP 228

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     +  AIK+            F  E   M+   H ++VK+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 75  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 178

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 41/190 (21%)
Query: 197 RATNGFSANNLIGRGSFGSVYK-ARLQDGMEFAI-------------KSFDVECEVMKSI 242
           R T  +     +G+G+F  V +  ++  G E+A              +  + E  + + +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 243 HHRNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMI 293
            H N+V++  S S E    L+ + +T G L      +  YS    S+CI  IL+      
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE------ 121
Query: 294 NVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI---VAHLSDFGIAKLLTGEDQSMTQTQ 350
               A+ + H      ++H +LKP N+LL   +      L+DFG+A  + GE Q+     
Sbjct: 122 ----AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 351 TLATIGYMAP 360
              T GY++P
Sbjct: 175 --GTPGYLSP 182

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 208 IGRGSFGSVYKARLQ---------------DGMEFAIK-SFDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q               +  + A+K     E  VM+ + +  +V++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  E +  LV+E    G L K L  +  + D    + ++  V+  ++YL     +  +
Sbjct: 75  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFV 129
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
           H DL   NVLL     A +SDFG++K L   E+    QT     + + AP
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 33/174 (18%)
Query: 208 IGRGSFGSV---YKARLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII 251
           +G G++GSV   Y ARL+   + A+K                 E  ++K + H N++ ++
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 252 S----SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMI-NVTSALEYLHFGF 306
                + S EDF  + L     G+    +  S  + D  + +  ++  +   L+Y+H   
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSD--EHVQFLVYQLLRGLKYIH--- 148
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  IIH DLKP NV ++++    + DFG+A+     D+ M  T  +AT  Y AP
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEM--TGYVATRWYRAP 197

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 84/205 (40%), Gaps = 48/205 (23%)
Query: 197 RATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIH 243
           R    F     +GRG FG V++A+ + D   +AIK   +            E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY---------------SSNCILDILQR 288
           H  +V+  ++   ++      E +   S +  LY               +  C ++  +R
Sbjct: 62  HPGIVRYFNAWLEKN----TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              L+I + +  A+E+LH   S  ++H DLKP N+    + V  + DFG+   +  +++ 
Sbjct: 118 SVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 346 MT----------QTQTLATIGYMAP 360
            T           T  + T  YM+P
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSP 199

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 62
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 121
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
            Y H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 74/167 (44%), Gaps = 20/167 (11%)
Query: 208 IGRGSFGSVYK-ARLQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           +G G+FG V++      G  F  K  +            E  +M  +HH  L+ +  +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
           ++    L+LE+++ G L   + + +  +   + +N M      L+++H      I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175
Query: 316 KPHNVLLDDNIVAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           KP N++ +    + +   DFG+A  L  ++       T AT  + AP
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAP 219

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  A ++  G   A+K  D+           E  +M+   H N+V++ +S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+E++  G+L  ++  ++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAP
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 88
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 147
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
            Y H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 148 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  A ++  G   A+K  D+           E  +M+   H N+V++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+E++  G+L  ++  ++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAP
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 316

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 65
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 124
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
            Y H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D+            E  + K ++H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 129
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 65
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 124
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
            Y H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D+            E  + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 64
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 123
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
            Y H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 124 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 63
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 122
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
            Y H   S  +IH D+KP N+LL       ++DFG +
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+++ M  G          C+LD ++        
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFG----------CLLDYVREHKDNIGS 120
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 121 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 177
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 178 YHAEGGKVPIKWMA 191

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY   G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+++D      ++DFG+AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 79/193 (40%), Gaps = 34/193 (17%)
Query: 202 FSANNL-----IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------------ECEV 238
           F  NNL     +G G+FG V +A     G E A+    V                 E ++
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 239 MKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTS 297
           M  +  H N+V ++ +C++     ++ EY   G L   L   + +L+      I  +  S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 298 ALEYLHFG----------FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
             + LHF            S   IH D+   NVLL +  VA + DFG+A+ +  +   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 348 QTQTLATIGYMAP 360
           +      + +MAP
Sbjct: 223 KGNARLPVKWMAP 235

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 33/178 (18%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           FS    IG GSFG+VY AR +++    AIK                  E   ++ + H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI----LQRLNIMINVTSALEYL 302
            ++       E    LV+EY         L S++ +L++    LQ + I      AL+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +  S  +IH D+K  N+LL +  +  L DFG A ++            + T  +MAP
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAP 219

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  A ++  G   A+K  D+           E  +M+   H N+V++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+E++  G+L  ++  ++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAP
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 196

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 24/176 (13%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHH 244
           + F     +G GSFG V   + ++ G  +A+K  D               E  ++++++ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 200

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+++ M  G          C+LD ++        
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFG----------CLLDYVREHKDNIGS 117
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 118 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 175 YHAEGGKVPIKWMA 188

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 30/185 (16%)
Query: 196 LRATNGFSANNLIGRGSFGSVY-KARLQDGMEFAIK---------SFDVECEVMKSIHHR 245
           LR  N +     IG GSFG +Y    +  G E AIK            +E ++ K +   
Sbjct: 5   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 64
Query: 246 NLVKIISSCSNE-DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             +  I  C  E D+  +V+E +   SLE +    +    +   L +   + S +EY+H 
Sbjct: 65  VGIPTIRWCGAEGDYNVMVME-LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH- 122
Query: 305 GFSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTG----------EDQSMTQTQ 350
             S   IH D+KP N L+      N+V ++ DFG+AK              E++++T T 
Sbjct: 123 --SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 351 TLATI 355
             A+I
Sbjct: 180 RYASI 184

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+++ M  G          C+LD ++        
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFG----------CLLDYVREHKDNIGS 118
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 119 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 176 YHAEGGKVPIKWMA 189

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+++ M  G          C+LD ++        
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFG----------CLLDYVREHKDNIGS 116
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 174 YHAEGGKVPIKWMA 187

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+++ M  G          C+LD ++        
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFG----------CLLDYVREHKDNIGS 119
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 120 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 177 YHAEGGKVPIKWMA 190

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D+            E  + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 30/177 (16%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISSCSNE 257
           +G+G +G V++   Q G   A+K F          E E+  ++   H N++  I+S    
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 103
Query: 258 DFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH---FGF--ST 308
              +    L+  Y   GSL   L  +   LD +  L I++++ S L +LH   FG     
Sbjct: 104 RHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 161
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-----LATIGYMAP 360
            I H DLK  N+L+  N    ++D G+A +     QS  Q        + T  YMAP
Sbjct: 162 AIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 216 VYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNED----FRALVLEYMTNGS 271
           V +A L     F ++ F  E +   +++H  +V +  +   E        +V+EY+   +
Sbjct: 44  VLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT 102
Query: 272 LEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLS 331
           L  ++++   +     +  I + +  A + L+F     IIH D+KP N+++       + 
Sbjct: 103 LRDIVHTEGPMT---PKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 158
Query: 332 DFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
           DFGIA+ +     S+TQT   + T  Y++P
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY   G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 30/185 (16%)
Query: 196 LRATNGFSANNLIGRGSFGSVY-KARLQDGMEFAIK---------SFDVECEVMKSIHHR 245
           LR  N +     IG GSFG +Y    +  G E AIK            +E ++ K +   
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 62
Query: 246 NLVKIISSCSNE-DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             +  I  C  E D+  +V+E +   SLE +    +    +   L +   + S +EY+H 
Sbjct: 63  VGIPTIRWCGAEGDYNVMVME-LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH- 120
Query: 305 GFSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTG----------EDQSMTQTQ 350
             S   IH D+KP N L+      N+V ++ DFG+AK              E++++T T 
Sbjct: 121 --SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 351 TLATI 355
             A+I
Sbjct: 178 RYASI 182

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  A ++  G   A+K  D+           E  +M+   H N+V++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+E++  G+L  ++  ++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 97  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAP
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 194

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 22/184 (11%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             VM S+ + ++ +++  C     + L+++ M  G L   +      +     LN  + +
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
              + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 356 GYMA 359
            +MA
Sbjct: 185 KWMA 188

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 129
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  A ++  G   A+K  D+           E  +M+   H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+E++  G+L  ++  ++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAP
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 185

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY   G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY   G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+++D      ++DFG+AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  A ++  G   A+K  D+           E  +M+   H N+V++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             D   +V+E++  G+L  ++  ++  ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 92  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAP
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 189

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 30/177 (16%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISSCSNE 257
           +G+G +G V++   Q G   A+K F          E E+  ++   H N++  I+S    
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 258 DFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG-FST---- 308
              +    L+  Y   GSL   L  +   LD +  L I++++ S L +LH   F T    
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-----LATIGYMAP 360
            I H DLK  N+L+  N    ++D G+A +     QS  Q        + T  YMAP
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 186

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 30/177 (16%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISSCSNE 257
           +G+G +G V++   Q G   A+K F          E E+  ++   H N++  I+S    
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 258 DFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG-FST---- 308
              +    L+  Y   GSL   L  +   LD +  L I++++ S L +LH   F T    
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-----LATIGYMAP 360
            I H DLK  N+L+  N    ++D G+A +     QS  Q        + T  YMAP
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 186

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 65
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 124
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       +++FG     +    S  +T    T+ Y+ 
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLP 177
Query: 360 P 360
           P
Sbjct: 178 P 178

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 129
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 129
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 129
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     M  AIK+            F  E   M+   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 181

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 127
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 24/168 (14%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRNLVKIIS 252
           +G GSFG V   + ++ G  +A+K  D               E  ++++++   LVK+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           S  +     +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 165 RDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 235 ECEVMKSIHHRNLVKIISSCSNEDFRAL--VLEYMTNGSLEKVLYSSNCILDILQRLNIM 292
           E ++++ + H+N+++++    NE+ + +  V+EY   G  E +         + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 293 INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
             +   LEYLH   S  I+H D+KP N+LL       +S  G+A+ L
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 42/184 (22%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG+G+FG V+KAR  + G + A+K   +E E             +++ + H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 254 CSNE---------------DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           C  +               DF     E+   G L  VL     + +I + + +++N    
Sbjct: 86  CRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFT-LSEIKRVMQMLLN---G 137
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL--LTGEDQSMTQTQTLATIG 356
           L Y+H      I+H D+K  NVL+  + V  L+DFG+A+   L    Q       + T+ 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 357 YMAP 360
           Y  P
Sbjct: 195 YRPP 198

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 216 VYKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNED----FRALVLEYMTNGS 271
           V +A L     F ++ F  E +   +++H  +V +  +   E        +V+EY+   +
Sbjct: 61  VLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT 119
Query: 272 LEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLS 331
           L  ++++   +     +  I + +  A + L+F     IIH D+KP N+++       + 
Sbjct: 120 LRDIVHTEGPMT---PKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 175
Query: 332 DFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
           DFGIA+ +     S+TQT   + T  Y++P
Sbjct: 176 DFGIARAIADSGNSVTQTAAVIGTAQYLSP 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 198 ATNGFSANNLIGRGSFGSVYKARLQD------------------GMEFAIKSFDVECEVM 239
           A   F     +G+G FG+VY AR +                   G+E  ++    E E+ 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR---EVEIQ 64
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
             + H N++++     +     L+LEY   G++ + L       D  +    +  + +AL
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANAL 123
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            Y H   S  +IH D+KP N+LL       +++FG     +    S  +T    T+ Y+ 
Sbjct: 124 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLP 176
Query: 360 P 360
           P
Sbjct: 177 P 177

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 129
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 32/178 (17%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISSCSNE 257
           IG+G FG V++ + + G E A+K F          E E+ +++   H N++  I++ + +
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 95
Query: 258 DFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF-----ST 308
           +       LV +Y  +GSL   L      ++ +  + + ++  S L +LH          
Sbjct: 96  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 153
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 360
            I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 154 AIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 207

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 32/178 (17%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISSCSNE 257
           IG+G FG V++ + + G E A+K F          E E+ +++   H N++  I++ + +
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 258 DFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF-----ST 308
           +       LV +Y  +GSL   L      ++ +  + + ++  S L +LH          
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 166
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 360
            I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 167 AIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 220

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 24/168 (14%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDVECEV-MKSIHHR-------------NLVKIIS 252
           +G GSFG V   + ++ G  +A+K  D +  V +K I H               LVK+  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           S  +     +VLEY   G +   L       +   R      +    EYLH   S  +I+
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 165
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 166 RDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 19/149 (12%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRNLVKIIS 252
           +G GSFG V   + ++ G  +A+K  D               E  ++++++   LVK+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           S  +     +V+EY+  G +   L       +   R      +    EYLH   S  +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTG 341
            DLKP N+L+D      ++DFG AK + G
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 84/209 (40%), Gaps = 42/209 (20%)
Query: 178 VANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI------- 229
           V  + P       + L +L+ T  F    ++G G+FG+VYK   + +G +  I       
Sbjct: 28  VEPLTPSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMEL 86
Query: 230 ---------KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSN 280
                    K    E  VM S+ + ++ +++  C     + L+ + M  G          
Sbjct: 87  REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG---------- 135
Query: 281 CILDILQR----------LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL 330
           C+LD ++           LN  + +   + YL       ++H DL   NVL+       +
Sbjct: 136 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKI 192
Query: 331 SDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           +DFG+AKLL  E++          I +MA
Sbjct: 193 TDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 128
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 32/178 (17%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISSCSNE 257
           IG+G FG V++ + + G E A+K F          E E+ +++   H N++  I++ + +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 72
Query: 258 DFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF-----ST 308
           +       LV +Y  +GSL   L      ++ +  + + ++  S L +LH          
Sbjct: 73  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 130
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 360
            I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 131 AIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 184

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY   G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 33/178 (18%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           FS    IG GSFG+VY AR +++    AIK                  E   ++ + H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI----LQRLNIMINVTSALEYL 302
            ++       E    LV+EY         L S++ +L++    LQ + I      AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +  S  +IH D+K  N+LL +  +  L DFG A ++            + T  +MAP
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAP 180

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VECE--------VMKSIHHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C         + K ++H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 129
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 44/215 (20%)
Query: 174 ELPNVANMQPQASRR--RFSYLELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI- 229
           ++P   N+  Q S      + L +L+ T  F    ++G G+FG+VYK   + +G +  I 
Sbjct: 13  DIPTTENLYFQGSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP 71
Query: 230 ---------------KSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEK 274
                          K    E  VM S+ + ++ +++  C     + L+ + M  G    
Sbjct: 72  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG---- 126
Query: 275 VLYSSNCILDILQR----------LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD 324
                 C+LD ++           LN  + +   + YL       ++H DL   NVL+  
Sbjct: 127 ------CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKT 177
Query: 325 NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
                ++DFG+AKLL  E++          I +MA
Sbjct: 178 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 32/178 (17%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISSCSNE 257
           IG+G FG V++ + + G E A+K F          E E+ +++   H N++  I++ + +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 75
Query: 258 DFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF-----ST 308
           +       LV +Y  +GSL   L      ++ +  + + ++  S L +LH          
Sbjct: 76  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 133
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 360
            I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 134 AIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 187

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 19/165 (11%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           IG GS G V  AR +  G + A+K  D+           E  +M+   H N+V++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             +   +++E++  G+L  ++  S   L+  Q   +   V  AL YLH   +  +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           K  ++LL  +    LSDFG    ++ +     +   + T  +MAP
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAP 210

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 32/178 (17%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISSCSNE 257
           IG+G FG V++ + + G E A+K F          E E+ +++   H N++  I++ + +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 70
Query: 258 DFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF-----ST 308
           +       LV +Y  +GSL   L      ++ +  + + ++  S L +LH          
Sbjct: 71  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 128
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 360
            I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 129 AIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 182

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 13/92 (14%)
Query: 3   AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNEL-----RHLVLTRT------DFSR 51
           + L  L L  N LSG+IP+   +L+ LR+L L  N L     + L+  +T      DF  
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF-- 475
Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 83
           N+L G+IP+ +    +L ++SL +NRL G IP
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 44/114 (38%), Gaps = 14/114 (12%)
Query: 48  DFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNXXXXXXXXXXXXXXXXXXXEIIP 107
           D S N L G IP  I  +  L  L+LGHN + GSIP+                     IP
Sbjct: 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP 697
Query: 108 LSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPC 150
            ++  L            L G IP  G F  F    F+ N  LCG P   +P C
Sbjct: 698 QAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRC 748

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 42/184 (22%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG+G+FG V+KAR  + G + A+K   +E E             +++ + H N+V +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 254 CSNE---------------DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           C  +               DF     E+   G L  VL     + +I + + +++N    
Sbjct: 85  CRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFT-LSEIKRVMQMLLN---G 136
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL--LTGEDQSMTQTQTLATIG 356
           L Y+H      I+H D+K  NVL+  + V  L+DFG+A+   L    Q       + T+ 
Sbjct: 137 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 193
Query: 357 YMAP 360
           Y  P
Sbjct: 194 YRPP 197

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 42/184 (22%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG+G+FG V+KAR  + G + A+K   +E E             +++ + H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 254 CSNE---------------DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           C  +               DF     E+   G L  VL     + +I + + +++N    
Sbjct: 86  CRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFT-LSEIKRVMQMLLN---G 137
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL--LTGEDQSMTQTQTLATIG 356
           L Y+H      I+H D+K  NVL+  + V  L+DFG+A+   L    Q       + T+ 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 357 YMAP 360
           Y  P
Sbjct: 195 YRPP 198

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 25/169 (14%)
Query: 192 YLELLRATNGFSANNLIGRGSFGS----VYKARLQDGMEFAIKSFDV-------ECEVM- 239
           Y + +  ++G+     IG GS+      V+KA     ME+A+K  D        E E++ 
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIEILL 75
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSA 298
           +   H N++ +     +     LV E M  G L +K+L          +   ++  +   
Sbjct: 76  RYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKT 133
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNI----VAHLSDFGIAKLLTGED 343
           +EYLH   S  ++H DLKP N+L  D         + DFG AK L  E+
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 23/170 (13%)
Query: 208 IGRGSFGSV----YKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V    Y +     M  AIK+            F  E   M+   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
              + E+   +++E  T G L   L      LD+   +     +++AL YL    S   +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 561

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 13/92 (14%)
Query: 3   AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNEL-----RHLVLTRT------DFSR 51
           + L  L L  N LSG+IP+   +L+ LR+L L  N L     + L+  +T      DF  
Sbjct: 415 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF-- 472
Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIP 83
           N+L G+IP+ +    +L ++SL +NRL G IP
Sbjct: 473 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 504

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 44/114 (38%), Gaps = 14/114 (12%)
Query: 48  DFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNXXXXXXXXXXXXXXXXXXXEIIP 107
           D S N L G IP  I  +  L  L+LGHN + GSIP+                     IP
Sbjct: 635 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP 694
Query: 108 LSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPC 150
            ++  L            L G IP  G F  F    F+ N  LCG P   +P C
Sbjct: 695 QAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRC 745

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 42/184 (22%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG+G+FG V+KAR  + G + A+K   +E E             +++ + H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 254 CSNE---------------DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           C  +               DF     E+   G L  VL     + +I + + +++N    
Sbjct: 86  CRTKASPYNRCKASIYLVFDF----CEHDLAGLLSNVLVKFT-LSEIKRVMQMLLN---G 137
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL--LTGEDQSMTQTQTLATIG 356
           L Y+H      I+H D+K  NVL+  + V  L+DFG+A+   L    Q       + T+ 
Sbjct: 138 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 357 YMAP 360
           Y  P
Sbjct: 195 YRPP 198

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 32/178 (17%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISSCSNE 257
           IG+G FG V++ + + G E A+K F          E E+ +++   H N++  I++ + +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 258 DFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF-----ST 308
           +       LV +Y  +GSL   L      ++ +  + + ++  S L +LH          
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQGKP 127
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 360
            I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 181

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 123
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 124 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 181 YHAEGGKVPIKWMA 194

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 119
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 120 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 177 YHAEGGKVPIKWMA 190

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 118
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 119 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 176 YHAEGGKVPIKWMA 189

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 19  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 77
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 78  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 126
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 127 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 183
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 184 YHAEGGKVPIKWMA 197

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 32/178 (17%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISSCSNE 257
           IG+G +G V+  + + G + A+K F          E E+ +++   H N++  I++    
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA---- 99
Query: 258 DFRA--------LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG-FST 308
           D +         L+ +Y  NGSL   L S+   LD    L +  +  S L +LH   FST
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 309 ----PIIHCDLKPHNVLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQT-LATIGYMAP 360
                I H DLK  N+L+  N    ++D G+A K ++  ++      T + T  YM P
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 6   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 64
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 65  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 113
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 114 QYLLNWCVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 170
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 171 YHAEGGKVPIKWMA 184

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 119
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 120 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 177 YHAEGGKVPIKWMA 190

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 116
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 174 YHAEGGKVPIKWMA 187

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+++ M  G          C+LD ++        
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFG----------CLLDYVREHKDNIGS 118
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG AKLL  E++ 
Sbjct: 119 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 176 YHAEGGKVPIKWMA 189

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 119
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 120 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 177 YHAEGGKVPIKWMA 190

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 22/184 (11%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             VM S+ + ++ +++  C     + L+ + M  G L   +      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
              + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 356 GYMA 359
            +MA
Sbjct: 184 KWMA 187

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 116
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 174 YHAEGGKVPIKWMA 187

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+++ M  G          C+LD ++        
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFG----------CLLDYVREHKDNIGS 118
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG AKLL  E++ 
Sbjct: 119 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 176 YHAEGGKVPIKWMA 189

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 83/190 (43%), Gaps = 30/190 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVY----KARLQDGME--FAIKS------------FDVECEVM 239
           A    + +  +G+GSFG VY    K  ++D  E   AIK+            F  E  VM
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DILQRLN 290
           K  +  ++V+++   S      +++E MT G L+  L S      +N +L    + + + 
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 291 IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
           +   +   + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 351 TLATIGYMAP 360
            L  + +M+P
Sbjct: 185 GLLPVRWMSP 194

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 15  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 73
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 74  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 122
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 123 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 179
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 180 YHAEGGKVPIKWMA 193

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           L K+  S  +     +V+EY   G +   L       +   R      +    EYLH   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY   G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 33/174 (18%)
Query: 208 IGRGSFGSV---YKARLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII 251
           +G G++GSV   Y ARL+   + A+K                 E  ++K + H N++ ++
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 252 S----SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMI-NVTSALEYLHFGF 306
                + S EDF  + L     G+    +     + D  + +  ++  +   L+Y+H   
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD--EHVQFLVYQLLRGLKYIH--- 140
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  IIH DLKP NV ++++    + DFG+A+     D+ M  T  +AT  Y AP
Sbjct: 141 SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEM--TGYVATRWYRAP 189

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 110
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 111 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 168 YHAEGGKVPIKWMA 181

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 30/165 (18%)
Query: 206 NLIGRGSFGSVYKARL--QDG--MEFAIKS-------------FDVECEVMKSIHHRNLV 248
            ++G G FGSV +  L  +DG  ++ A+K+             F  E   MK   H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 249 KIISSCSNEDFRAL-----VLEYMTNGSLEKVLYSSNCI-----LDILQRLNIMINVTSA 298
           +++  C     + +     +L +M  G L   L  S        + +   L  M+++   
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           +EYL    +   +H DL   N +L D++   ++DFG++K +   D
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 80/180 (44%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVY----KARLQDGME--FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY    K  ++D  E   AIK+            F  E  VMK  +  ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DILQRLNIMINVTSALE 300
           ++   S      +++E MT G L+  L S      +N +L    + + + +   +   + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+++ M  G          C+LD ++        
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFG----------CLLDYVREHKDNIGS 120
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG AKLL  E++ 
Sbjct: 121 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 177
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 178 YHAEGGKVPIKWMA 191

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 33/174 (18%)
Query: 208 IGRGSFGSV---YKARLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII 251
           +G G++GSV   Y ARL+   + A+K                 E  ++K + H N++ ++
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 252 S----SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMI-NVTSALEYLHFGF 306
                + S EDF  + L     G+    +     + D  + +  ++  +   L+Y+H   
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD--EHVQFLVYQLLRGLKYIH--- 148
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  IIH DLKP NV ++++    + DFG+A+     D+ M  T  +AT  Y AP
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEM--TGYVATRWYRAP 197

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 77/195 (39%), Gaps = 32/195 (16%)
Query: 181 MQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDVEC--- 236
           M P+ +   F YL+LL            G+G+FG V   + +  G  +A+K    E    
Sbjct: 3   MDPRVTMNEFEYLKLL------------GKGTFGKVILVKEKATGRYYAMKILKKEVIVA 50
Query: 237 -----------EVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI 285
                       V+++  H  L  +  S    D    V+EY   G L   L       + 
Sbjct: 51  KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED 110
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
             R      + SAL+YLH      +++ DLK  N++LD +    ++DFG+ K   G    
Sbjct: 111 RARF-YGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDG 165
Query: 346 MTQTQTLATIGYMAP 360
            T      T  Y+AP
Sbjct: 166 ATMKXFCGTPEYLAP 180

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 80/172 (46%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  +  ++ G++ A+K                 E  ++K + H N++ ++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 173
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 174 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 220

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 26/172 (15%)
Query: 189 RFSYLELLRATNGFSANNLIGRGSFGS----VYKARLQDGMEFAIKSFDV-------ECE 237
           R S++ L+  ++G+     IG GS+      V+KA     ME+A+K  D        E E
Sbjct: 17  RGSHMNLV-FSDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDPSEEIE 72
Query: 238 VM-KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINV 295
           ++ +   H N++ +     +     LV E M  G L +K+L          +   ++  +
Sbjct: 73  ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTI 130
Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNI----VAHLSDFGIAKLLTGED 343
              +EYLH   S  ++H DLKP N+L  D         + DFG AK L  E+
Sbjct: 131 GKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 40/179 (22%)
Query: 207 LIGRGSFGSVYKARLQ-DGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS 252
           ++G+GSFG V K + +    E+A+K  +              E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR--------LNIMINVTSALEYLHF 304
              +     +V E  T G L           +I++R          I+  V S + Y+H 
Sbjct: 89  ILEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYMH- 138
Query: 305 GFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                I+H DLKP N+LL   + +    + DFG++   T   Q+      + T  Y+AP
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAP 192

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 21/163 (12%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQDGM--EFAIKSFDV-------ECEVM-KSIHHR 245
           ++ T+G+     IG GS+ SV K  +      EFA+K  D        E E++ +   H 
Sbjct: 18  IQFTDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHP 76
Query: 246 NLVKIISSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
           N++ +     +  +  +V E    G L +K+L          +   ++  +T  +EYLH 
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLH- 133
Query: 305 GFSTPIIHCDLKPHNVLLDDNI----VAHLSDFGIAKLLTGED 343
             +  ++H DLKP N+L  D         + DFG AK L  E+
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 26/151 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIK-----------------SFDVECEVMKSIHHRNLVK 249
           +G G F  V K R +  G E+A K                   + E  +++ I H N++ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +     N+    L+LE ++ G L   L     + +  +    +  +   + YLH   S  
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLH---SKR 135
Query: 310 IIHCDLKPHNVLLDDNIVAH----LSDFGIA 336
           I H DLKP N++L D  V +    L DFGIA
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 166

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           L K+  S  +     +V+EY   G +   L       +   R      +    EYLH   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 40/179 (22%)
Query: 207 LIGRGSFGSVYKARLQ-DGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS 252
           ++G+GSFG V K + +    E+A+K  +              E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR--------LNIMINVTSALEYLHF 304
              +     +V E  T G L           +I++R          I+  V S + Y+H 
Sbjct: 89  ILEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYMH- 138
Query: 305 GFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                I+H DLKP N+LL   + +    + DFG++   T   Q+      + T  Y+AP
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAP 192

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           IG G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 196

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 34/176 (19%)
Query: 207 LIGRGSFGSVYKARLQ-DGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS 252
           ++G+GSFG V K + +    E+A+K  +              E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 253 SCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
              +     +V E  T G L     ++  +S +    I+++      V S + Y+H    
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ------VFSGITYMH---K 139
Query: 308 TPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             I+H DLKP N+LL   + +    + DFG++       Q+      + T  Y+AP
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAP 192

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 6/124 (4%)
Query: 238 VMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVT 296
           + K ++H N+VK        + + L LEY + G L +++           QR      + 
Sbjct: 57  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLM 114
Query: 297 SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
           + + YLH      I H D+KP N+LLD+     +SDFG+A +    ++     +   T+ 
Sbjct: 115 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 171
Query: 357 YMAP 360
           Y+AP
Sbjct: 172 YVAP 175

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 26/151 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIK-----------------SFDVECEVMKSIHHRNLVK 249
           +G G F  V K R +  G E+A K                   + E  +++ I H N++ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +     N+    L+LE ++ G L   L     + +  +    +  +   + YLH   S  
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLH---SKR 149
Query: 310 IIHCDLKPHNVLLDDNIVAH----LSDFGIA 336
           I H DLKP N++L D  V +    L DFGIA
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 180

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 26/151 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIK-----------------SFDVECEVMKSIHHRNLVK 249
           +G G F  V K R +  G E+A K                   + E  +++ I H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +     N+    L+LE ++ G L   L     + +  +    +  +   + YLH   S  
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLH---SKR 128
Query: 310 IIHCDLKPHNVLLDDNIVAH----LSDFGIA 336
           I H DLKP N++L D  V +    L DFGIA
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 208 IGRGSFGSVYKARLQDGME-FAIKSFD----VEC--EVMKSI------HHRNLVKIISSC 254
           +G G++G V  A  +   E  A+K  D    V+C   + K I      +H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 255 SNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              + + L LEY + G L +++           QR      + + + YLH      I H 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 129
Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 24/174 (13%)
Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K  D               E  ++++++   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           L K+  S  +     +V+EY   G +   L       +   R      +    EYLH   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 78/177 (44%), Gaps = 21/177 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIK--------------SFDVECEVMKSIHH 244
           + F    +IGRG+F  V   ++ Q G  +A+K               F  E +V+ +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH- 303
           R + ++  +  +E++  LV+EY   G L  +L      +        +  +  A++ +H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            G+    +H D+KP N+LLD      L+DFG    L   D ++     + T  Y++P
Sbjct: 181 LGY----VHRDIKPDNILLDRCGHIRLADFGSCLKLRA-DGTVRSLVAVGTPDYLSP 232

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 26/162 (16%)
Query: 197 RATNGFSANNLIGRGSFGSVYKARLQD-GMEFAIK-----------------SFDVECEV 238
           +  + +     +G G F  V K R +  G+E+A K                   + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           ++ + H N++ +     N     L+LE ++ G L   L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-EEATSFIKQILDG 127
Query: 299 LEYLHFGFSTPIIHCDLKPHNV-LLDDNI-VAHLS--DFGIA 336
           + YLH   +  I H DLKP N+ LLD NI + H+   DFG+A
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 40/184 (21%)
Query: 206 NLIGRGSFGSVYKA-RLQDGMEFAIKSFDV----------------ECEVMKSIHHRNLV 248
            +IG+G F  V +    + G +FA+K  DV                E  +   + H ++V
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA---------L 299
           +++ + S++    +V E+M    L           +I++R +     + A         L
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 300 EYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
           E L +     IIH D+KPH VLL   +++    L  FG+A  L   +  +     + T  
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPH 200
Query: 357 YMAP 360
           +MAP
Sbjct: 201 FMAP 204

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++  G+FG+VYK   + +G +  I                K    E
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+++ M  G          C+LD ++        
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFG----------CLLDYVREHKDNIGS 123
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 124 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 181 YHAEGGKVPIKWMA 194

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 194 ELLRATNGFSANNLIGRGSFGSVY----KARLQDGME--FAIKS------------FDVE 235
           E   A    + +  +G+GSFG VY    K  ++D  E   AIK+            F  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DIL 286
             VMK  +  ++V+++   S      +++E MT G L+  L S      +N +L    + 
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           + + +   +   + YL+   +   +H DL   N ++ ++    + DFG+ + +   D   
Sbjct: 126 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 347 TQTQTLATIGYMAP 360
              + L  + +M+P
Sbjct: 183 KGGKGLLPVRWMSP 196

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 118
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG AKLL  E++ 
Sbjct: 119 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 176 YHAEGGKVPIKWMA 189

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 155
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 156 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 202

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAP 191

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 26/162 (16%)
Query: 197 RATNGFSANNLIGRGSFGSVYKARLQD-GMEFAIK-----------------SFDVECEV 238
           +  + +     +G G F  V K R +  G+E+A K                   + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           ++ + H N++ +     N     L+LE ++ G L   L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-EEATSFIKQILDG 127
Query: 299 LEYLHFGFSTPIIHCDLKPHNV-LLDDNI-VAHLS--DFGIA 336
           + YLH   +  I H DLKP N+ LLD NI + H+   DFG+A
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 196

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 203

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 36/203 (17%)
Query: 179 ANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGME----FAIKSFDV 234
           AN+   A +      ELL+         ++G G++G V+  R   G +    +A+K    
Sbjct: 42  ANLTGHAEKVGIENFELLK---------VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK 92
Query: 235 ECEVMKSI---HHRN-------------LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS 278
              V K+    H R              LV +  +   E    L+L+Y+  G L   L  
Sbjct: 93  ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 152
Query: 279 SNCILDILQRLNIMI-NVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
                +    + I +  +  ALE+LH      II+ D+K  N+LLD N    L+DFG++K
Sbjct: 153 RERFTE--HEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207
Query: 338 LLTGEDQSMTQTQTLATIGYMAP 360
                D++        TI YMAP
Sbjct: 208 EFVA-DETERAYDFCGTIEYMAP 229

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 194 ELLRATNGFSANNLIGRGSFGSVY----KARLQDGME--FAIKS------------FDVE 235
           E   A    + +  +G+GSFG VY    K  ++D  E   AIK+            F  E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DIL 286
             VMK  +  ++V+++   S      +++E MT G L+  L S      +N +L    + 
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           + + +   +   + YL+   +   +H DL   N ++ ++    + DFG+ + +   D   
Sbjct: 130 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 186
Query: 347 TQTQTLATIGYMAP 360
              + L  + +M+P
Sbjct: 187 KGGKGLLPVRWMSP 200

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 26/162 (16%)
Query: 197 RATNGFSANNLIGRGSFGSVYKARLQD-GMEFAIK-----------------SFDVECEV 238
           +  + +     +G G F  V K R +  G+E+A K                   + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           ++ + H N++ +     N     L+LE ++ G L   L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-EEATSFIKQILDG 127
Query: 299 LEYLHFGFSTPIIHCDLKPHNV-LLDDNI-VAHLS--DFGIA 336
           + YLH   +  I H DLKP N+ LLD NI + H+   DFG+A
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 80/180 (44%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVY----KARLQDGME--FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY    K  ++D  E   AIK+            F  E  VMK  +  ++V+
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DILQRLNIMINVTSALE 300
           ++   S      +++E MT G L+  L S      +N +L    + + + +   +   + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 175 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 194 ELLRATNGFSANNLIGRGSFGSVY----KARLQDGME--FAIKS------------FDVE 235
           E   A    + +  +G+GSFG VY    K  ++D  E   AIK+            F  E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DIL 286
             VMK  +  ++V+++   S      +++E MT G L+  L S      +N +L    + 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           + + +   +   + YL+   +   +H DL   N ++ ++    + DFG+ + +   D   
Sbjct: 139 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 347 TQTQTLATIGYMAP 360
              + L  + +M+P
Sbjct: 196 KGGKGLLPVRWMSP 209

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 142
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 143 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 189

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 163
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 210

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 20/176 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDVEC--------------EVMKSIHH 244
           N F    L+G+G+FG V   + +  G  +A+K    E                V+++  H
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  S    D    V+EY   G L   L       +   R      + SAL+YLH 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 269
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                +++ DLK  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 270 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 321

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 123
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG AKLL  E++ 
Sbjct: 124 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 180
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 181 YHAEGGKVPIKWMA 194

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 20/176 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDVEC--------------EVMKSIHH 244
           N F    L+G+G+FG V   + +  G  +A+K    E                V+++  H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  S    D    V+EY   G L   L       +   R      + SAL+YLH 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 266
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                +++ DLK  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 318

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 211

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 193

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 26/162 (16%)
Query: 197 RATNGFSANNLIGRGSFGSVYKARLQD-GMEFAIK-----------------SFDVECEV 238
           +  + +     +G G F  V K R +  G+E+A K                   + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           ++ + H N++ +     N     L+LE ++ G L   L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-EEATSFIKQILDG 127
Query: 299 LEYLHFGFSTPIIHCDLKPHNV-LLDDNI-VAHLS--DFGIA 336
           + YLH   +  I H DLKP N+ LLD NI + H+   DFG+A
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 80/180 (44%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVY----KARLQDGME--FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY    K  ++D  E   AIK+            F  E  VMK  +  ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DILQRLNIMINVTSALE 300
           ++   S      +++E MT G L+  L S      +N +L    + + + +   +   + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 193

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 194 ELLRATNGFSANNLIGRGSFGSVY----KARLQDGME--FAIKS------------FDVE 235
           E   A    + +  +G+GSFG VY    K  ++D  E   AIK+            F  E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DIL 286
             VMK  +  ++V+++   S      +++E MT G L+  L S      +N +L    + 
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           + + +   +   + YL+   +   +H DL   N ++ ++    + DFG+ + +   D   
Sbjct: 129 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 185
Query: 347 TQTQTLATIGYMAP 360
              + L  + +M+P
Sbjct: 186 KGGKGLLPVRWMSP 199

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 187

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 116
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG AKLL  E++ 
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 173
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 174 YHAEGGKVPIKWMA 187

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 20/176 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDVEC--------------EVMKSIHH 244
           N F    L+G+G+FG V   + +  G  +A+K    E                V+++  H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  S    D    V+EY   G L   L       +   R      + SAL+YLH 
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 126
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                +++ DLK  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 127 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 178

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 194 ELLRATNGFSANNLIGRGSFGSVY----KARLQDGME--FAIKS------------FDVE 235
           E   A    + +  +G+GSFG VY    K  ++D  E   AIK+            F  E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DIL 286
             VMK  +  ++V+++   S      +++E MT G L+  L S      +N +L    + 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           + + +   +   + YL+   +   +H DL   N ++ ++    + DFG+ + +   D   
Sbjct: 132 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 347 TQTQTLATIGYMAP 360
              + L  + +M+P
Sbjct: 189 KGGKGLLPVRWMSP 202

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 194 ELLRATNGFSANNLIGRGSFGSVY----KARLQDGME--FAIKS------------FDVE 235
           E   A    + +  +G+GSFG VY    K  ++D  E   AIK+            F  E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DIL 286
             VMK  +  ++V+++   S      +++E MT G L+  L S      +N +L    + 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 138
Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
           + + +   +   + YL+   +   +H DL   N ++ ++    + DFG+ + +   D   
Sbjct: 139 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 347 TQTQTLATIGYMAP 360
              + L  + +M+P
Sbjct: 196 KGGKGLLPVRWMSP 209

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 193

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 155
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 156 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 202

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 167
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 214

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 203

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 141
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 188

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 26/162 (16%)
Query: 197 RATNGFSANNLIGRGSFGSVYKARLQD-GMEFAIK-----------------SFDVECEV 238
           +  + +     +G G F  V K R +  G+E+A K                   + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 239 MKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           ++ + H N++ +     N     L+LE ++ G L   L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-EEATSFIKQILDG 127
Query: 299 LEYLHFGFSTPIIHCDLKPHNV-LLDDNI-VAHLS--DFGIA 336
           + YLH   +  I H DLKP N+ LLD NI + H+   DFG+A
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 203

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 80/180 (44%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVY----KARLQDGME--FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY    K  ++D  E   AIK+            F  E  VMK  +  ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DILQRLNIMINVTSALE 300
           ++   S      +++E MT G L+  L S      +N +L    + + + +   +   + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 196

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 141
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 188

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 20/176 (11%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFDVEC--------------EVMKSIHH 244
           N F    L+G+G+FG V   + +  G  +A+K    E                V+++  H
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  S    D    V+EY   G L   L       +   R      + SAL+YLH 
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 127
Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                +++ DLK  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 128 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 179

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 143
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 190

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 198

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 197

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 196

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 40/184 (21%)
Query: 206 NLIGRGSFGSVYKA-RLQDGMEFAIKSFDV----------------ECEVMKSIHHRNLV 248
            +IG+G F  V +    + G +FA+K  DV                E  +   + H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA---------L 299
           +++ + S++    +V E+M    L           +I++R +     + A         L
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 300 EYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
           E L +     IIH D+KPH VLL   +++    L  FG+A  L   +  +     + T  
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPH 198
Query: 357 YMAP 360
           +MAP
Sbjct: 199 FMAP 202

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 130
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 131 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGME-FAIK--------------SFDVECEVMKSIHHRN 246
           F    +IGRG+FG V   ++++    +A+K               F  E +V+ +   + 
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 135
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNI--MINVTSALEYLH 303
           +  +  +  +E+   LV++Y   G L  +L    + + + + R  I  M+    ++  LH
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +      +H D+KP NVLLD N    L+DFG + L   +D ++  +  + T  Y++P
Sbjct: 196 Y------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 245

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 130
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 131 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGME-FAIK--------------SFDVECEVMKSIHHRN 246
           F    +IGRG+FG V   ++++    +A+K               F  E +V+ +   + 
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 151
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNI--MINVTSALEYLH 303
           +  +  +  +E+   LV++Y   G L  +L    + + + + R  I  M+    ++  LH
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +      +H D+KP NVLLD N    L+DFG + L   +D ++  +  + T  Y++P
Sbjct: 212 Y------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 261

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++ S     D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+ +    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAP 191

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA----HLSDFGIA 336
              S  I H DLKP N++L D  V      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 147 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAP 193

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 151 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAP 197

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 197

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVYKARLQDGME------FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY+   +D ++       A+K+            F  E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD---------ILQRLNIMINVTSALE 300
           ++   S      +V+E M +G L+  L S     +         + + + +   +   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVYKARLQDGME------FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY+   +D ++       A+K+            F  E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD---------ILQRLNIMINVTSALE 300
           ++   S      +V+E M +G L+  L S     +         + + + +   +   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 72/179 (40%), Gaps = 21/179 (11%)
Query: 197 RATNGFSANNLIGRGSFGSVYKARLQDGME-FAIK--------------SFDVECEVMKS 241
           R    +     +G+G F   Y+    D  E FA K                  E  + KS
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           + + ++V       ++DF  +VLE     SL ++      + +   R   M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 141
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LH   +  +IH DLK  N+ L+D++   + DFG+A  +  E     +     T  Y+AP
Sbjct: 142 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAP 195

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVYKARLQDGME------FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY+   +D ++       A+K+            F  E  VMK     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD---------ILQRLNIMINVTSALE 300
           ++   S      +V+E M +G L+  L S     +         + + + +   +   + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 77/180 (42%), Gaps = 25/180 (13%)
Query: 202 FSANNL-----IGRGSFGSVYK-ARLQDGMEFAIKSFDVECE-------------VMKSI 242
           F+A +L     IGRG++GSV K      G   A+K      +             VM+S 
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78
Query: 243 HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL 302
               +V+   +   E    + +E M+  S +K       +LD +    I+  +T A    
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 303 --HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             H   +  IIH D+KP N+LLD +    L DFGI+  L     S+ +T+      YMAP
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAP 194

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 26/151 (17%)
Query: 208 IGRGSFGSVYKARLQD-GMEFAIK-----------------SFDVECEVMKSIHHRNLVK 249
           +G G F  V K R +  G+E+A K                   + E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +     N     L+LE ++ G L   L     + +  +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-EEATSFIKQILDGVNYLH---TKK 135
Query: 310 IIHCDLKPHNV-LLDDNI-VAHLS--DFGIA 336
           I H DLKP N+ LLD NI + H+   DFG+A
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 202 FSANNLIGRGSFGSVYKARLQDGME-FAIK--------------SFDVECEVMKSIHHRN 246
           F    +IGRG+FG V   +L++  + FA+K               F  E +V+ +   + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNI--MINVTSALEYLH 303
           +  +  +  +++   LV++Y   G L  +L    + + + + R  +  M+    ++  LH
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAP 360
           +      +H D+KP N+L+D N    L+DFG   KL+  ED ++  +  + T  Y++P
Sbjct: 196 Y------VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISP 245

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++  +    D +Q L  +  +   L+Y+H   S 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 187

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+LE +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 76/180 (42%), Gaps = 23/180 (12%)
Query: 197 RATNGFSANNLIGRGSFGSVYKARLQDGME-FAIK--------------SFDVECEVMKS 241
           R    +     +G+G F   Y+    D  E FA K                  E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           + + ++V       ++DF  +VLE     SL ++      + +   R   M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 157
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           LH   +  +IH DLK  N+ L+D++   + DFG+A  +  + +   + +TL  T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKTLCGTPNYIAP 211

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++  G+FG+VYK   + +G +  I                K    E
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 123
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 124 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 181 YHAEGGKVPIKWMA 194

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 42/194 (21%)
Query: 193 LELLRATNGFSANNLIGRGSFGSVYKA-RLQDGMEFAI----------------KSFDVE 235
           L +L+ T  F    ++  G+FG+VYK   + +G +  I                K    E
Sbjct: 9   LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR------- 288
             VM S+ + ++ +++  C     + L+ + M  G          C+LD ++        
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 116
Query: 289 ---LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              LN  + +   + YL       ++H DL   NVL+       ++DFG+AKLL  E++ 
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 346 MTQTQTLATIGYMA 359
                    I +MA
Sbjct: 174 YHAEGGKVPIKWMA 187

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 72/179 (40%), Gaps = 21/179 (11%)
Query: 197 RATNGFSANNLIGRGSFGSVYKARLQDGME-FAIK--------------SFDVECEVMKS 241
           R    +     +G+G F   Y+    D  E FA K                  E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           + + ++V       ++DF  +VLE     SL ++      + +   R   M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 157
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LH   +  +IH DLK  N+ L+D++   + DFG+A  +  E     +     T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAP 211

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 82/190 (43%), Gaps = 30/190 (15%)
Query: 198 ATNGFSANNLIGRGSFGSVY----KARLQDGME--FAIKS------------FDVECEVM 239
           A    + +  +G+GSFG VY    K  ++D  E   AIK+            F  E  VM
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYS------SNCIL---DILQRLN 290
           K  +  ++V+++   S      +++E MT G L+  L S      +N +L    + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 291 IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
           +   +   + YL+   +   +H DL   N  + ++    + DFG+ + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 351 TLATIGYMAP 360
            L  + +M+P
Sbjct: 187 GLLPVRWMSP 196

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 200 NGFSANNLIGRGSFGSVYKARLQDGME---FAIKS----FD--VECE-------VMKSIH 243
           + +   +LIG GS+G V +A   D +E    AIK     F+  ++C+       ++  ++
Sbjct: 53  DRYEIRHLIGTGSYGHVCEA--YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 244 HRNLVKIISSCSNED---FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALE 300
           H ++VK++     +D   F  L +      S  K L+ +   L  L    ++ N+   ++
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           Y+H   S  I+H DLKP N L++ +    + DFG+A+ +   +   +Q
Sbjct: 171 YVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 163
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 210

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 72/179 (40%), Gaps = 21/179 (11%)
Query: 197 RATNGFSANNLIGRGSFGSVYKARLQDGME-FAIK--------------SFDVECEVMKS 241
           R    +     +G+G F   Y+    D  E FA K                  E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
           + + ++V       ++DF  +VLE     SL ++      + +   R   M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 157
Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LH   +  +IH DLK  N+ L+D++   + DFG+A  +  E     +     T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAP 211

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + D+G+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 31/193 (16%)
Query: 193 LELLRATNG-----FSANNLIGRGSFGSVYKARLQDGMEFAIKSF--------------- 232
           LE L A  G     +S  + +G G+FG V+ A  ++  +  +  F               
Sbjct: 12  LEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDP 71
Query: 233 -----DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQ 287
                 +E  ++  + H N++K++    N+ F  LV+E   +G         +  LD   
Sbjct: 72  KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131
Query: 288 RLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
              I   + SA+ YL       IIH D+K  N+++ ++    L DFG A  L   ++   
Sbjct: 132 ASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKL 185
Query: 348 QTQTLATIGYMAP 360
                 TI Y AP
Sbjct: 186 FYTFCGTIEYCAP 198

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 211

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVYKARLQDGME------FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY+   +D ++       A+K+            F  E  VMK     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD---------ILQRLNIMINVTSALE 300
           ++   S      +V+E M +G L+  L S     +         + + + +   +   + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/172 (22%), Positives = 76/172 (44%), Gaps = 26/172 (15%)
Query: 208 IGRGSFGSVYKA--------------RLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISS 253
           +G G++G VYKA              RL+   E    +   E  ++K + HRN++++ S 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
             +     L+ EY  N   + +  + +  + +++  + +  + + + + H   S   +H 
Sbjct: 102 IHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIK--SFLYQLINGVNFCH---SRRCLHR 156
Query: 314 DLKPHNVLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DLKP N+LL      +  V  + DFG+A+      +    T  + T+ Y  P
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPP 206

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 82/228 (35%), Gaps = 67/228 (29%)
Query: 195 LLRATNGFSANNLIGRGSFGSVY-----------------KARLQDGMEFAIKSFDVECE 237
           LL     +     IG+GS+G V                  K +++      ++    E  
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 238 VMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL------YSSNCILDILQRL-- 289
           +MK +HH N+ ++     +E +  LV+E    G L   L       +  C +D+++    
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 290 -------------------------------NIMINVTSALEYLHFGFSTPIIHCDLKPH 318
                                          NIM  + SAL YLH   +  I H D+KP 
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPE 197
Query: 319 NVLLDDN--IVAHLSDFGIA----KLLTGEDQSMTQTQTLATIGYMAP 360
           N L   N      L DFG++    KL  GE   MT      T  ++AP
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA--GTPYFVAP 243

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 187

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 154
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 155 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 201

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 36/183 (19%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++  ++H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 173 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 358 MAP 360
           M P
Sbjct: 227 MPP 229

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 36/160 (22%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++  ++H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAK 337
             HF      IH D+   N LL       VA + DFG+A+
Sbjct: 159 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 4/78 (5%)
Query: 283 LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           +D  +R +   N+  A+  +H      I+H DLKP N L+ D ++  L DFGIA  +  +
Sbjct: 152 IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPD 207
Query: 343 DQSMTQTQTLATIGYMAP 360
             S+ +   + T+ YM P
Sbjct: 208 TTSVVKDSQVGTVNYMPP 225

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 4/78 (5%)
Query: 283 LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           +D  +R +   N+  A+  +H      I+H DLKP N L+ D ++  L DFGIA  +  +
Sbjct: 105 IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPD 160
Query: 343 DQSMTQTQTLATIGYMAP 360
             S+ +   + T+ YM P
Sbjct: 161 TTSVVKDSQVGTVNYMPP 178

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 150 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 358 MAP 360
           M P
Sbjct: 204 MPP 206

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/186 (21%), Positives = 75/186 (40%), Gaps = 36/186 (19%)
Query: 208 IGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G   FG VYK  L      +     AIK+            F  E  +   + H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY---------------SSNCILDILQRLNIMIN 294
           ++   + +   +++  Y ++G L + L                +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
           + + +EYL    S  ++H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 137 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 355 IGYMAP 360
           I +MAP
Sbjct: 194 IRWMAP 199

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 79/174 (45%), Gaps = 31/174 (17%)
Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNED-------- 258
           +GRG++G V K R +  G   A+K   +   V      R L+ +  S    D        
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKR--IRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 259 ---FRA----LVLEYMTNGSLEK----VLYSSNCIL-DILQRLNIMINVTSALEYLHFGF 306
              FR     + +E M + SL+K    V+     I  DIL +  I +++  ALE+LH   
Sbjct: 117 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHSKL 173
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +IH D+KP NVL++      + DFGI+  L     S+ +T       YMAP
Sbjct: 174 S--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKTIDAGCKPYMAP 222

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/186 (21%), Positives = 75/186 (40%), Gaps = 36/186 (19%)
Query: 208 IGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G   FG VYK  L      +     AIK+            F  E  +   + H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY---------------SSNCILDILQRLNIMIN 294
           ++   + +   +++  Y ++G L + L                +    L+    ++++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
           + + +EYL    S  ++H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 154 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 355 IGYMAP 360
           I +MAP
Sbjct: 211 IRWMAP 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 19/166 (11%)
Query: 208 IGRGSFGSVYK-ARLQDGMEFAIK--SFDVECEVMKSIH-------HRNLVKIISSCSNE 257
           +G GSF    K    +    FA+K  S  +E    K I        H N+VK+     ++
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
               LV+E +  G L + +       +  +   IM  + SA+ ++H      ++H DLKP
Sbjct: 79  LHTFLVMELLNGGELFERIKKKKHFSET-EASYIMRKLVSAVSHMH---DVGVVHRDLKP 134
Query: 318 HNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            N+L    +DN+   + DFG A+L   ++Q +       T+ Y AP
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAP 178

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/180 (21%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVYKARLQDGME------FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY+   +D ++       A+K+            F  E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD---------ILQRLNIMINVTSALE 300
           ++   S      +V+E M +G L+  L S     +         + + + +   +   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 36/160 (22%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAK 337
             HF      IH D+   N LL       VA + DFG+A+
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 197

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 36/160 (22%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAK 337
             HF      IH D+   N LL       VA + DFG+A+
Sbjct: 176 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N+VK++    ++  +  +L+ EY+ N    KVLY +    DI      +  +  AL+Y H
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRY---YIYELLKALDYCH 163
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D  +    L D+G+A+ 
Sbjct: 164 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 196

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 58/144 (40%), Gaps = 25/144 (17%)
Query: 217 YKARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL 276
           Y  +LQ   +  I+ +D E            + ++  C N D  + + +  +    E+  
Sbjct: 63  YLNKLQQHSDKIIRLYDYEIT-------DQYIYMVMECGNIDLNSWLKKKKSIDPWERKS 115
Query: 277 YSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
           Y  N                  LE +H      I+H DLKP N L+ D ++  L DFGIA
Sbjct: 116 YWKN-----------------MLEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIA 157
Query: 337 KLLTGEDQSMTQTQTLATIGYMAP 360
             +  +  S+ +   + T+ YM P
Sbjct: 158 NQMQPDTTSVVKDSQVGTVNYMPP 181

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 12/132 (9%)
Query: 235 ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN---- 290
           E +++    H N++ I          A+   Y+    +E  LY    +L   Q  N    
Sbjct: 91  EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK---LLKSQQLSNDHIC 147
Query: 291 -IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQ 348
             +  +   L+Y+H   S  ++H DLKP N+L++      + DFG+A++   E D +   
Sbjct: 148 YFLYQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFL 204
Query: 349 TQTLATIGYMAP 360
           T+ +AT  Y AP
Sbjct: 205 TEXVATRWYRAP 216

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 358 MAP 360
           M P
Sbjct: 212 MPP 214

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 173 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 358 MAP 360
           M P
Sbjct: 227 MPP 229

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N+VK++    ++  +  +L+ EY+ N    KVLY +    DI      +  +  AL+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRY---YIYELLKALDYCH 142
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D  +    L D+G+A+ 
Sbjct: 143 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 36/160 (22%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAK 337
             HF      IH D+   N LL       VA + DFG+A+
Sbjct: 159 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 36/160 (22%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAK 337
             HF      IH D+   N LL       VA + DFG+A+
Sbjct: 175 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 4/78 (5%)
Query: 283 LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           +D  +R +   N+  A+  +H      I+H DLKP N L+ D ++  L DFGIA  +  +
Sbjct: 152 IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPD 207
Query: 343 DQSMTQTQTLATIGYMAP 360
             S+ +   + T+ YM P
Sbjct: 208 TTSVVKDSQVGTVNYMPP 225

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 4/78 (5%)
Query: 283 LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           +D  +R +   N+  A+  +H      I+H DLKP N L+ D ++  L DFGIA  +  +
Sbjct: 104 IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPD 159
Query: 343 DQSMTQTQTLATIGYMAP 360
             S+ +   + T+ YM P
Sbjct: 160 TTSVVKDSQVGTVNYMPP 177

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N+VK++    ++  +  +L+ EY+ N    KVLY +    DI      +  +  AL+Y H
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRY---YIYELLKALDYCH 143
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D  +    L D+G+A+ 
Sbjct: 144 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 176

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N+VK++    ++  +  +L+ EY+ N    KVLY +    DI      +  +  AL+Y H
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRY---YIYELLKALDYCH 144
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D  +    L D+G+A+ 
Sbjct: 145 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 177

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 36/160 (22%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 303 --HFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAK 337
             HF      IH D+   N LL       VA + DFG+A+
Sbjct: 185 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 167
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E         +AT  Y AP
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRWYRAP 214

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 165 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 358 MAP 360
           M P
Sbjct: 219 MPP 221

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N+VK++    ++  +  +L+ EY+ N    KVLY +    DI      +  +  AL+Y H
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRY---YIYELLKALDYCH 143
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D  +    L D+G+A+ 
Sbjct: 144 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 176

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 4/78 (5%)
Query: 283 LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           +D  +R +   N+  A+  +H      I+H DLKP N L+ D ++  L DFGIA  +  +
Sbjct: 124 IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPD 179
Query: 343 DQSMTQTQTLATIGYMAP 360
             S+ +   + T+ YM P
Sbjct: 180 TTSVVKDSQVGTVNYMPP 197

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N+VK++    ++  +  +L+ EY+ N    KVLY +    DI      +  +  AL+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRY---YIYELLKALDYCH 142
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D  +    L D+G+A+ 
Sbjct: 143 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N+VK++    ++  +  +L+ EY+ N    KVLY +    DI      +  +  AL+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRY---YIYELLKALDYCH 142
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D  +    L D+G+A+ 
Sbjct: 143 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N+VK++    ++  +  +L+ EY+ N    KVLY +    DI      +  +  AL+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRY---YIYELLKALDYCH 142
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D  +    L D+G+A+ 
Sbjct: 143 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 36/160 (22%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAK 337
             HF      IH D+   N LL       VA + DFG+A+
Sbjct: 159 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N+VK++    ++  +  +L+ EY+ N    KVLY +    DI      +  +  AL+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRY---YIYELLKALDYCH 142
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D  +    L D+G+A+ 
Sbjct: 143 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N+VK++    ++  +  +L+ EY+ N    KVLY +    DI      +  +  AL+Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRY---YIYELLKALDYCH 142
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D  +    L D+G+A+ 
Sbjct: 143 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 175

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N++K+I +  +   +  ALV EY+ N    K LY      DI  R   M  +  AL+Y H
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDF-KQLYQILTDFDI--RF-YMYELLKALDYCH 154
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D       L D+G+A+ 
Sbjct: 155 ---SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEF 187

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 65/150 (43%), Gaps = 21/150 (14%)
Query: 208 IGRGSFGSVYKA------------RLQDG--MEFAIKSFDVECEVMKSIHHRNLVKII-- 251
           IGRGSF +VYK              LQD    +   + F  E E +K + H N+V+    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 252 --SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             S+   +    LV E  T+G+L+  L     +  I    +    +   L++LH   + P
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGLQFLH-TRTPP 151
Query: 310 IIHCDLKPHNVLLDDNI-VAHLSDFGIAKL 338
           IIH DLK  N+ +        + D G+A L
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATL 181

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R +++E M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 173 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 358 MAP 360
           M P
Sbjct: 227 MPP 229

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 208 IGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++         ++ A+K+            F +E  ++   +H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYL- 302
            I        R +++E M  G L+  L       S    L +L  L++  ++    +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 303 --HFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 358 MAP 360
           M P
Sbjct: 212 MPP 214

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++ +  H N++ I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 143
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 10/96 (10%)
Query: 246 NLVKIISSCSNEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           N++K+I +  +   +  ALV EY+ N    K LY      DI  R   M  +  AL+Y H
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDF-KQLYQILTDFDI--RF-YMYELLKALDYCH 149
Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVA-HLSDFGIAKL 338
              S  I+H D+KPHNV++D       L D+G+A+ 
Sbjct: 150 ---SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEF 182

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 9/101 (8%)
Query: 261 ALVLEYMTNGSLEKVLYSSNCILD-ILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHN 319
           ++ +E+M  GSL++VL  +  I + IL +++I   V   L YL       I+H D+KP N
Sbjct: 83  SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 138
Query: 320 VLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L++      L DFG++  L  E       + + T  YM+P
Sbjct: 139 ILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSP 175

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 75/147 (51%), Gaps = 23/147 (15%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIK----SFDVECEVMKSIH----------HRNLVKIIS 252
           +G+G++G V+K+   + G   A+K    +F    +  ++            H N+V +++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 253 SCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
               ++ R   LV +YM    L  V+ ++  IL+ + +  ++  +   ++YLH G    +
Sbjct: 77  VLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG---GL 130
Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAK 337
           +H D+KP N+LL+      ++DFG+++
Sbjct: 131 LHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E         +AT  Y AP
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRAP 211

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 26/157 (16%)
Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------------DVECEV--MKSIH 243
           +     +G G F  V K R +  G+++A K                 D+E EV  +K I 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++ +     N+    L+ E +  G L   L     + +  +    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 304 FGFSTPIIHCDLKPHNV-LLDDNIVA---HLSDFGIA 336
              S  I H DLKP N+ LLD N+      + DFG+A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 261 ALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHN 319
           ++ +E+M  GSL++VL  +  I  +IL +++I   V   L YL       I+H D+KP N
Sbjct: 90  SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSN 145
Query: 320 VLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L++      L DFG++  L     SM  +  + T  YMAP
Sbjct: 146 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMAP 182

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/139 (22%), Positives = 58/139 (41%), Gaps = 25/139 (17%)
Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSL-------------EKVLYSSNCILDILQRLN 290
           H N+V ++ +C+      L+ EY   G L             +++ Y +   L+  + LN
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 291 IM---------INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG 341
           ++           V   +E+L F      +H DL   NVL+    V  + DFG+A+ +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 342 EDQSMTQTQTLATIGYMAP 360
           +   + +      + +MAP
Sbjct: 225 DSNYVVRGNARLPVKWMAP 243

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    +  FG+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 196 LRATNGFSANNLIGRGSFGSVYKARLQDGME-FAIKSFD------VECE-------VMKS 241
           ++  + +   +LIGRGS+G VY A  ++  +  AIK  +      ++C+       ++  
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 242 IHHRNLVKIISSCSNED---FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSA 298
           +    ++++      ED   F  L +      S  K L+ +   L       I+ N+   
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
            +++H    + IIH DLKP N LL+ +    + DFG+A+ +  +
Sbjct: 144 EKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSD 184

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 22/174 (12%)
Query: 202 FSANNLIGRGSFGSVYK-ARLQDGMEFAIK-----------SFDVECEVMKSIHHRNLVK 249
           +  +  +G G+FG V++      G  FA K           +   E + M  + H  LV 
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 250 IISSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           +  +  +++   ++ E+M+ G L EKV    N + +  + +  M  V   L ++H     
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-EAVEYMRQVCKGLCHMH---EN 168
Query: 309 PIIHCDLKPHNVLLDDNIVAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             +H DLKP N++        L   DFG+   L   D   +   T  T  + AP
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAP 219

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 77/182 (42%), Gaps = 40/182 (21%)
Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV--------ECEVMKSI--HHRNLVKIISS---C 254
           +G+G +G V++  L  G   A+K F          E E+  ++   H N++  I+S    
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTS 74
Query: 255 SNEDFR-ALVLEYMTNGSLEKVLYSSNCILDILQR--------LNIMINVTSALEYLH-- 303
            N   +  L+  Y  +GSL           D LQR        L + ++    L +LH  
Sbjct: 75  RNSSTQLWLITHYHEHGSL----------YDFLQRQTLEPHLALRLAVSAACGLAHLHVE 124
Query: 304 -FGFS--TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT-GEDQ-SMTQTQTLATIGYM 358
            FG      I H D K  NVL+  N+   ++D G+A + + G D   +     + T  YM
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYM 184
Query: 359 AP 360
           AP
Sbjct: 185 AP 186

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 23/171 (13%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLV---KII 251
           IG G++G V  A    + +  AIK                E +++    H N++    II
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 252 SSCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
            + + E  + + L  ++    L K+L + +   D +     +  +   L+Y+H   S  +
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHI--CYFLYQILRGLKYIH---SANV 165
Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           +H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 22/174 (12%)
Query: 202 FSANNLIGRGSFGSVYK-ARLQDGMEFAIK-----------SFDVECEVMKSIHHRNLVK 249
           +  +  +G G+FG V++      G  FA K           +   E + M  + H  LV 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 250 IISSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           +  +  +++   ++ E+M+ G L EKV    N + +  + +  M  V   L ++H     
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-EAVEYMRQVCKGLCHMH---EN 274
Query: 309 PIIHCDLKPHNVLLDDNIVAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             +H DLKP N++        L   DFG+   L   D   +   T  T  + AP
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAP 325

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 30/189 (15%)
Query: 202 FSANNL-----IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------------ECEV 238
           F  NNL     +G G+FG V +A     G E A+    V                 E ++
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 239 MKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY-SSNCILDI-----LQRLNI 291
           M  +  H N+V ++ +C++     ++ EY   G L   L   +   LD      L+  ++
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           +   +   + + F  S   IH D+   NVLL +  VA + DFG+A+ +  +   + +   
Sbjct: 155 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 215 RLPVKWMAP 223

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++ +  H N++ I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 143
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 144 SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 146
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 93  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 147
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 148 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 84  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 138
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 139 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 29/174 (16%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLN------IMINVTSALEYLHFGFS 307
            N+  RA  +E M +  + + L  ++   L   Q L+       +  +   L+Y+H   S
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
             ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 30/189 (15%)
Query: 202 FSANNL-----IGRGSFGSVYKA-RLQDGMEFAIKSFDV-----------------ECEV 238
           F  NNL     +G G+FG V +A     G E A+    V                 E ++
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 239 MKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY-SSNCILDI-----LQRLNI 291
           M  +  H N+V ++ +C++     ++ EY   G L   L   +   LD      L+  ++
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           +   +   + + F  S   IH D+   NVLL +  VA + DFG+A+ +  +   + +   
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 223 RLPVKWMAP 231

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 139
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 139
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 4/78 (5%)
Query: 283 LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           +D  +R +   N+  A+  +H      I+H DLKP N L+ D ++  L DFGIA  +  +
Sbjct: 152 IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPD 207
Query: 343 DQSMTQTQTLATIGYMAP 360
             S+ +   +  + YM P
Sbjct: 208 TTSVVKDSQVGAVNYMPP 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 29/174 (16%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLN------IMINVTSALEYLHFGFS 307
            N+  RA  +E M +  + + L  ++   L   Q L+       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
             ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 107 -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 161
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 162 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 29/174 (16%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI---- 90
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLN------IMINVTSALEYLHFGFS 307
            N+  RA  +E M +  + + L  ++   L   Q L+       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
             ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 141
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 202 FSANNL-----IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------------ECEV 238
           F  NNL     +G G+FG V +A     G E A+    V                 E ++
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 239 MKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL---------YSSNCILDILQR 288
           M  +  H N+V ++ +C++     ++ EY   G L   L         YS N   +  ++
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 289 L---NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
           L   +++   +   + + F  S   IH D+   NVLL +  VA + DFG+A+ +  +   
Sbjct: 163 LSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 346 MTQTQTLATIGYMAP 360
           + +      + +MAP
Sbjct: 223 IVKGNARLPVKWMAP 237

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 94
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 95  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 149
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 150 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 141
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 141
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + D G+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E         +AT  Y AP
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAP 187

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 9/136 (6%)
Query: 228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDI 285
           A+  F  E   M S+ HRNL+++         + +V E    GSL   L  +  + +L  
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQ 344
           L R    + V   + YL    S   IH DL   N+LL    +  + DFG+ + L   +D 
Sbjct: 123 LSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 345 SMTQTQTLATIGYMAP 360
            + Q        + AP
Sbjct: 178 XVMQEHRKVPFAWCAP 193

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 192 YLELLRATNGFSANNLIGRGSFGSVY--KARLQDGMEFAIK-------------SFDVEC 236
           Y  + + +N F   + IG G+F SVY   A+LQ G E  I              + +++C
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQC 72
Query: 237 EVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVT 296
             +      N++ +       D   + + Y+ + S   +L S    L   +    M+N+ 
Sbjct: 73  LTVAG-GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS----LSFQEVREYMLNLF 127
Query: 297 SALEYLH-FGFSTPIIHCDLKPHNVLLDDNIVAH-LSDFGIAK 337
            AL+ +H FG    I+H D+KP N L +  +  + L DFG+A+
Sbjct: 128 KALKRIHQFG----IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 31/175 (17%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 88
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--------MINVTSALEYLHFGF 306
            N+  RA  +E M +  + + L  ++ +  +L+  ++        +  +   L+Y+H   
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 143
Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
           S  ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E         +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAP 191

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 4/78 (5%)
Query: 283 LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           +D  +R +   N+  A+  +H      I+H DLKP N L+ D ++  L DFGIA  +  +
Sbjct: 124 IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPD 179
Query: 343 DQSMTQTQTLATIGYMAP 360
              + +   + T+ YM P
Sbjct: 180 XXXVVKDSQVGTVNYMPP 197

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G   A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + DFG+A+    E         +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAP 191

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 29/174 (16%)
Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG G++G V  A    + +  AIK                E +++    H N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLN------IMINVTSALEYLHFGFS 307
            N+  RA  +E M +  + + L  ++   L   Q L+       +  +   L+Y+H   S
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAP 360
             ++H DLKP N+LL+      + DFG+A++   + D +   T+ +AT  Y AP
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + D G+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 197 RATNGFSANNLIGRGSFGSVY-KARLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCS 255
           R  N F     IG GSFG +Y    +Q   E AIK  +V+ +  + ++   + +I+   +
Sbjct: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGT 63
Query: 256 ----------NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
                       D+  LV++ +   SLE +    +  L +   L +   + + +E++H  
Sbjct: 64  GIPNVRWFGVEGDYNVLVMD-LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-- 120
Query: 306 FSTPIIHCDLKPHNVLLDDNIVA---HLSDFGIAK 337
            S   +H D+KP N L+     A   ++ DFG+AK
Sbjct: 121 -SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/180 (20%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVYKARLQDGME------FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY+   +D ++       A+K+            F  E  VMK     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD---------ILQRLNIMINVTSALE 300
           ++   S      +V+E M +G L+  L S     +         + + + +   +   + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H +L   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 9/136 (6%)
Query: 228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDI 285
           A+  F  E   M S+ HRNL+++         + +V E    GSL   L  +  + +L  
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQ 344
           L R    + V   + YL    S   IH DL   N+LL    +  + DFG+ + L   +D 
Sbjct: 123 LSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 345 SMTQTQTLATIGYMAP 360
            + Q        + AP
Sbjct: 178 YVMQEHRKVPFAWCAP 193

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 9/136 (6%)
Query: 228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDI 285
           A+  F  E   M S+ HRNL+++         + +V E    GSL   L  +  + +L  
Sbjct: 54  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT 112
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQ 344
           L R    + V   + YL    S   IH DL   N+LL    +  + DFG+ + L   +D 
Sbjct: 113 LSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 345 SMTQTQTLATIGYMAP 360
            + Q        + AP
Sbjct: 168 XVMQEHRKVPFAWCAP 183

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 208 IGRGSFGSVYKA-RLQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS- 252
           +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 253 ---SCSNEDFRALVL-EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              + S E+F  + L  ++    L  ++       D +Q L  +  +   L+Y+H   S 
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            IIH DLKP N+ ++++    + D G+A+    E      T  +AT  Y AP
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAP 191

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/180 (20%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 208 IGRGSFGSVYKARLQDGME------FAIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY+   +D ++       A+K+            F  E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD---------ILQRLNIMINVTSALE 300
           ++   S      +V+E M +G L+  L S     +         + + + +   +   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H +L   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 261 ALVLEYMTNGSLEKVLYSSNCILD-ILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHN 319
           ++ +E+M  GSL++VL  +  I + IL +++I   V   L YL       I+H D+KP N
Sbjct: 142 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 197
Query: 320 VLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L++      L DFG++  L     SM  +  + T  YM+P
Sbjct: 198 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 234

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/56 (42%), Positives = 32/56 (57%), Gaps = 6/56 (10%)
Query: 290 NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTGE 342
            IM ++  A++YLH   S  I H D+KP N+L      N +  L+DFG AK  TGE
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/134 (22%), Positives = 62/134 (46%), Gaps = 18/134 (13%)
Query: 214 GSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIISSCSNE--D 258
           G ++K R Q G +  +K              F+ EC  ++   H N++ ++ +C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 259 FRALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP 317
              L+  +M  GSL  VL+  +N ++D  Q +   +++   + +LH      I    L  
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNS 141
Query: 318 HNVLLDDNIVAHLS 331
            +V++D+++ A +S
Sbjct: 142 RSVMIDEDMTARIS 155

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 261 ALVLEYMTNGSLEKVLYSSNCILD-ILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHN 319
           ++ +E+M  GSL++VL  +  I + IL +++I   V   L YL       I+H D+KP N
Sbjct: 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 162
Query: 320 VLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L++      L DFG++  L     SM  +  + T  YM+P
Sbjct: 163 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 199

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 67/135 (49%), Gaps = 18/135 (13%)
Query: 235 ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI--- 291
           E +++    H N++ I     N+  RA  +E M +  + + L  ++ +  +L+  ++   
Sbjct: 75  EIKILLRFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSND 128
Query: 292 -----MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE-DQS 345
                +  +   L+Y+H   S  ++H DLKP N+LL+      + DFG+A++   + D +
Sbjct: 129 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 346 MTQTQTLATIGYMAP 360
              T+ +AT  Y AP
Sbjct: 186 GFLTEYVATRWYRAP 200

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 44/79 (55%), Gaps = 8/79 (10%)
Query: 261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV 320
           ALV E++ N    K LY +    DI  R   M  +  AL+Y H   S  I+H D+KPHNV
Sbjct: 110 ALVFEHVNNTDF-KQLYQTLTDYDI--RF-YMYEILKALDYCH---SMGIMHRDVKPHNV 162
Query: 321 LLD-DNIVAHLSDFGIAKL 338
           L+D ++    L D+G+A+ 
Sbjct: 163 LIDHEHRKLRLIDWGLAEF 181

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 9/136 (6%)
Query: 228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDI 285
           A+  F  E   M S+ HRNL+++         + +V E    GSL   L  +  + +L  
Sbjct: 58  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT 116
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQ 344
           L R    + V   + YL    S   IH DL   N+LL    +  + DFG+ + L   +D 
Sbjct: 117 LSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 345 SMTQTQTLATIGYMAP 360
            + Q        + AP
Sbjct: 172 YVMQEHRKVPFAWCAP 187

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 9/136 (6%)
Query: 228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDI 285
           A+  F  E   M S+ HRNL+++         + +V E    GSL   L  +  + +L  
Sbjct: 54  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT 112
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQ 344
           L R    + V   + YL    S   IH DL   N+LL    +  + DFG+ + L   +D 
Sbjct: 113 LSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 345 SMTQTQTLATIGYMAP 360
            + Q        + AP
Sbjct: 168 YVMQEHRKVPFAWCAP 183

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 261 ALVLEYMTNGSLEKVLYSSNCILD-ILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHN 319
           ++ +E+M  GSL++VL  +  I + IL +++I   V   L YL       I+H D+KP N
Sbjct: 99  SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE--KHKIMHRDVKPSN 154
Query: 320 VLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L++      L DFG++  L     SM  +  + T  YM+P
Sbjct: 155 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 191

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 9/136 (6%)
Query: 228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDI 285
           A+  F  E   M S+ HRNL+++         + +V E    GSL   L  +  + +L  
Sbjct: 54  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT 112
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQ 344
           L R    + V   + YL    S   IH DL   N+LL    +  + DFG+ + L   +D 
Sbjct: 113 LSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 345 SMTQTQTLATIGYMAP 360
            + Q        + AP
Sbjct: 168 YVMQEHRKVPFAWCAP 183

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 9/136 (6%)
Query: 228 AIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDI 285
           A+  F  E   M S+ HRNL+++         + +V E    GSL   L  +  + +L  
Sbjct: 58  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGT 116
Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQ 344
           L R    + V   + YL    S   IH DL   N+LL    +  + DFG+ + L   +D 
Sbjct: 117 LSRY--AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 345 SMTQTQTLATIGYMAP 360
            + Q        + AP
Sbjct: 172 YVMQEHRKVPFAWCAP 187

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 26/137 (18%)
Query: 235 ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN---- 290
           E  V+K + H N++K+     ++    LV+E    G L           +I+ R+     
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL---------FDEIIHRMKFNEV 136
Query: 291 ----IMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGED 343
               I+  V S + YLH      I+H DLKP N+LL   + + +  + DFG++ +   E+
Sbjct: 137 DAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--EN 191
Query: 344 QSMTQTQTLATIGYMAP 360
           Q   + + L T  Y+AP
Sbjct: 192 QKKMK-ERLGTAYYIAP 207

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 59/131 (45%), Gaps = 14/131 (10%)
Query: 235 ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL--EKVLYSSNCILDILQRLNIM 292
           E  V+K + H N++K+     ++    LV+E    G L  E +L      +D      IM
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IM 127
Query: 293 INVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTGEDQSMTQT 349
             V S   YLH      I+H DLKP N+LL+    + +  + DFG++      +      
Sbjct: 128 KQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMK 181
Query: 350 QTLATIGYMAP 360
           + L T  Y+AP
Sbjct: 182 ERLGTAYYIAP 192

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 208 IGRGSFGSVYKAR-----------------LQDGMEFAI-KSFDVECEVMKSI-HHRNLV 248
           +GRG+FG V +A                  L++G   +  ++   E +++  I HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 249 KIISSCSNEDFRALVL-EYMTNGSLEKVLYSS--------NCILDILQRLNIMINVTSAL 299
            ++ +C+      +V+ E+   G+L   L S         +   D L   +++       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           + + F  S   IH DL   N+LL +  V  + DFG+A+ +  +   + +      + +MA
Sbjct: 155 KGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMA 214
Query: 360 P 360
           P
Sbjct: 215 P 215

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	360
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-61
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-59
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-50
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-43
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-41
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-41
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-22
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-20
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-08
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-39
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-39
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-38
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-09
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-36
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-35
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-35
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-26
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-24
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-14
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-22
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-09
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-21
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-20
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-20
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-20
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-19
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-19
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-08
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-07
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-17
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-12
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-05
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-06
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-17
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-16
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-15
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-07
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-16
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-16
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-04
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-15
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-15
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-14
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-10
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-15
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-15
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-08
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-04
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-07
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-09
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-07
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-09
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-12
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-12
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-05
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-04
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-05
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-10
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-10
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-11
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-10
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-10
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	6e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	7e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  198 bits (506), Expect = 2e-61
 Identities = 78/204 (38%), Positives = 102/204 (50%), Gaps = 20/204 (9%)

Query: 172 ATELPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS 231
           A E P V   Q     +RFS  EL  A++ FS  N++GRG FG VYK RL DG   A+K 
Sbjct: 6   AEEDPEVHLGQL----KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR 61

Query: 232 ------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY-- 277
                       F  E E++    HRNL+++   C     R LV  YM NGS+   L   
Sbjct: 62  LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121

Query: 278 -SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA 336
             S   LD  +R  I +     L YLH      IIH D+K  N+LLD+   A + DFG+A
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181

Query: 337 KLLTGEDQSMTQTQTLATIGYMAP 360
           KL+  +D  +T T    TIG++AP
Sbjct: 182 KLMDYKDTHVT-TAVRGTIGHIAP 204

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  192 bits (491), Expect = 5e-59
 Identities = 70/187 (37%), Positives = 96/187 (51%), Gaps = 17/187 (9%)

Query: 188 RRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-----------FDVEC 236
            R   ++L  ATN F    LIG G FG VYK  L+DG + A+K            F+ E 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 237 EVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSN---CILDILQRLNIMI 293
           E +    H +LV +I  C   +   L+ +YM NG+L++ LY S+     +   QRL I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 294 NVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 353
                L YLH      IIH D+K  N+LLD+N V  ++DFGI+K  T  DQ+   T    
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 354 TIGYMAP 360
           T+GY+ P
Sbjct: 204 TLGYIDP 210

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  170 bits (432), Expect = 1e-50
 Identities = 62/196 (31%), Positives = 86/196 (43%), Gaps = 27/196 (13%)

Query: 188 RRFSYLELLRATNGFS------ANNLIGRGSFGSVYKARLQDGMEFAIKS---------- 231
             FS+ EL   TN F         N +G G FG VYK  + +    A+K           
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 232 -----FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY--SSNCILD 284
                FD E +VM    H NLV+++   S+ D   LV  YM NGSL   L        L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 285 ILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ 344
              R  I     + + +LH       IH D+K  N+LLD+   A +SDFG+A+      Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 345 SMTQTQTLATIGYMAP 360
           ++  ++ + T  YMAP
Sbjct: 189 TVMTSRIVGTTAYMAP 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  150 bits (380), Expect = 8e-43
 Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 24/200 (12%)

Query: 182 QPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK--------SFD 233
              +S        L   +       +  RG FG V+KA+L      A+K        S+ 
Sbjct: 6   HHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ 64

Query: 234 VECEV--MKSIHHRNLVKIISSCSNEDFRA----LVLEYMTNGSLEKVLYSSNCILDILQ 287
            E EV  +  + H N+++ I +            L+  +   GSL   L ++  ++   +
Sbjct: 65  NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNE 122

Query: 288 RLNIMINVTSALEYLH------FGFSTP-IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT 340
             +I   +   L YLH           P I H D+K  NVLL +N+ A ++DFG+A    
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 341 GEDQSMTQTQTLATIGYMAP 360
               +      + T  YMAP
Sbjct: 183 AGKSAGDTHGQVGTRRYMAP 202

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  147 bits (372), Expect = 1e-41
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)

Query: 208 IGRGSFGSVYKA------------RLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCS 255
           IG GSFG+V++A              QD     +  F  E  +MK + H N+V  + + +
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCI--LDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
                ++V EY++ GSL ++L+ S     LD  +RL++  +V   + YLH   + PI+H 
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHR 163

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +LK  N+L+D      + DFG+++L      S        T  +MAP
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAP 208

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  146 bits (372), Expect = 1e-41
 Identities = 49/169 (28%), Positives = 72/169 (42%), Gaps = 24/169 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTAL-RNLHLDSN--------ELRHLVLTRTDFSRN 52
           L  L  +   GN++SG+IP  + + + L  ++ +  N           +L L   D SRN
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRN 207

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 112
            L GD        K+ Q + L  N L   +        +L  LDL NN +   +P  L +
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266

Query: 113 L-----------LLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPC 150
           L            L GEIP+GG   +F   ++  N  LCGSP   +P C
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 36/133 (27%), Positives = 52/133 (39%), Gaps = 28/133 (21%)

Query: 2   LAALFQLDLRG-NKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
           L  L  L + G N L G IP   + LT L  L++               +  N+ G IP 
Sbjct: 75  LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI---------------THTNVSGAIPD 119

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL------- 113
            +  +K+L  L   +N L G++P S   L +L  +    N +S  IP S           
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179

Query: 114 -----LLEGEIPR 121
                 L G+IP 
Sbjct: 180 TISRNRLTGKIPP 192

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 38/130 (29%), Positives = 55/130 (42%), Gaps = 27/130 (20%)

Query: 5   LFQLDLRGNKLSGS--IPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTI 62
           +  LDL G  L     IP+  +NL  L  L++                 NNL+G IP  I
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI--------------GGINNLVGPIPPAI 97

Query: 63  QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL--------- 113
             L  L +L + H  + G+IP+    + +L +LD S N LS  +P S+  L         
Sbjct: 98  AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157

Query: 114 --LLEGEIPR 121
              + G IP 
Sbjct: 158 GNRISGAIPD 167

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 54.8 bits (133), Expect = 1e-08
 Identities = 24/90 (26%), Positives = 32/90 (35%), Gaps = 14/90 (15%)

Query: 45  TRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGS--IPNSFDDLVSLESLDLSN-NN 101
             TD      LG +  T      +  L L    L     IP+S  +L  L  L +   NN
Sbjct: 29  PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88

Query: 102 LSEIIPLSLEKL-----------LLEGEIP 120
           L   IP ++ KL            + G IP
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  141 bits (357), Expect = 1e-39
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)

Query: 208 IGRGSFGSVYKA-----------RLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSCSN 256
           IG GSFG+VYK             +       +++F  E  V++   H N++  +   + 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91

Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               A+V ++    SL   L++S    ++ + ++I       ++YLH   +  IIH DLK
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147

Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            +N+ L ++    + DFG+A   +    S    Q   +I +MAP
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  142 bits (359), Expect = 1e-39
 Identities = 57/198 (28%), Positives = 80/198 (40%), Gaps = 30/198 (15%)

Query: 190 FSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK--------SFDVECEVMK- 240
            +  E     +      LIGRG +G+VYK  L D    A+K        +F  E  + + 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRV 61

Query: 241 -SIHHRNLVKIISSCSNEDFRA-----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMIN 294
             + H N+ + I               LV+EY  NGSL K L       D +    +  +
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHS 119

Query: 295 VTSALEYLH------FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           VT  L YLH        +   I H DL   NVL+ ++    +SDFG++  LTG       
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 349 TQTLA------TIGYMAP 360
            +  A      TI YMAP
Sbjct: 180 EEDNAAISEVGTIRYMAP 197

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  140 bits (356), Expect = 2e-39
 Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 20/165 (12%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHRNLVKIISSCSNED 258
           +GRG+FG V KA+ +   + AIK         +F VE   +  ++H N+VK+  +C N  
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP- 73

Query: 259 FRALVLEYMTNGSLEKVLYSSN--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
              LV+EY   GSL  VL+ +           ++  +  +  + YLH      +IH DLK
Sbjct: 74  -VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132

Query: 317 PHNVLLDDN-IVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           P N+LL     V  + DFG A      D     T    +  +MAP
Sbjct: 133 PPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 172

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  139 bits (353), Expect = 7e-39
 Identities = 39/169 (23%), Positives = 71/169 (42%), Gaps = 18/169 (10%)

Query: 206 NLIGRGSFGSVYKA-----------RLQDGMEFAIKSFDVECEVMKSIHHRNLVKIISSC 254
            LIG+G FG VY              ++   E  +K+F  E    +   H N+V  + +C
Sbjct: 39  ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            +    A++       +L  V+  +  +LD+ +   I   +   + YLH   +  I+H D
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKD 155

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAP 360
           LK  NV  D+  V  ++DFG+  +         + +       + ++AP
Sbjct: 156 LKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  137 bits (348), Expect = 2e-38
 Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 32/177 (18%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIK------------------SFDVECEVMKSIHHRNLV 248
           IG+G FG V+K RL  D    AIK                   F  E  +M +++H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           K+     N     +V+E++  G L   L      +    +L +M+++   +EY+    + 
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 309 PIIHCDLKPHNVLLD-----DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           PI+H DL+  N+ L        + A ++DFG+++         + +  L    +MAP
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  136 bits (344), Expect = 5e-38
 Identities = 32/169 (18%), Positives = 67/169 (39%), Gaps = 25/169 (14%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIISSC 254
           +     G ++K R Q G +  +K              F+ EC  ++   H N++ ++ +C
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 255 SNEDFR--ALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPII 311
            +       L+  +M  GSL  VL+      +D  Q +   +++   + +LH      I 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              L   +V++D+++ A +S   +         S      +    ++AP
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAP 177

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  135 bits (341), Expect = 1e-37
 Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 30/176 (17%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIK---------------SFDVECEVMKSIHHRNLVKIIS 252
           IG G FG VY+A    G E A+K               +   E ++   + H N++ +  
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
            C  E    LV+E+   G L +VL      +     +N  + +   + YLH     PIIH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 313 CDLKPHNVLLD--------DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLK  N+L+          N +  ++DFG+A+        M+         +MAP
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAA---GAYAWMAP 183

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  139 bits (352), Expect = 2e-36
 Identities = 50/163 (30%), Positives = 65/163 (39%), Gaps = 29/163 (17%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           L+     ++      G     F N  ++  L               D S N L G IP  
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFL---------------DMSYNMLSGYIPKE 651

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL------- 114
           I  +  L  L+LGHN + GSIP+   DL  L  LDLS+N L   IP ++  L        
Sbjct: 652 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711

Query: 115 ----LEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSN 153
               L G IP  G F  F    F+ N  LCG P   +P C  +
Sbjct: 712 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS 751

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  107 bits (270), Expect = 9e-26
 Identities = 44/154 (28%), Positives = 60/154 (38%), Gaps = 16/154 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN--------ELRHLV-LTRTDFSRN 52
           L+ L  L L  N L G IP     +  L  L LD N         L +   L     S N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 112
            L G+IP  I  L++L  L L +N   G+IP    D  SL  LDL+ N  +  IP ++ K
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560

Query: 113 L-------LLEGEIPRGGPFTKFSSKSFIGNDLL 139
                    + G+            +     +LL
Sbjct: 561 QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  100 bits (252), Expect = 2e-23
 Identities = 45/139 (32%), Positives = 63/139 (45%), Gaps = 20/139 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
            +AL  LD+ GNKLSG      S  T L+ L++ SN+    +       L     + N  
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKF 281

Query: 55  LGDIPTTIQG-LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL----- 108
            G+IP  + G   +L  L L  N   G++P  F     LESL LS+NN S  +P+     
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341

Query: 109 --SLEKLLL-----EGEIP 120
              L+ L L      GE+P
Sbjct: 342 MRGLKVLDLSFNEFSGELP 360

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 40/131 (30%), Positives = 55/131 (41%), Gaps = 26/131 (19%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
               L +L L+ N  +G IP   SN + L +L                 S N L G IP+
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSL---------------HLSFNYLSGTIPS 436

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL------- 113
           ++  L  L+ L L  N L+G IP     + +LE+L L  N+L+  IP  L          
Sbjct: 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS 496

Query: 114 ----LLEGEIP 120
                L GEIP
Sbjct: 497 LSNNRLTGEIP 507

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 37/138 (26%), Positives = 55/138 (39%), Gaps = 20/138 (14%)

Query: 2   LAALFQLDLRGNKLSGSIP---TCFSNLTALRNLHLDSNELRHLV-------LTRTDFSR 51
           L +L  LDL  N +SG+             L++L +  N++   V       L   D S 
Sbjct: 150 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSS 209

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS-- 109
           NN    IP  +    +LQ L +  N+L G    +      L+ L++S+N     IP    
Sbjct: 210 NNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPL 268

Query: 110 --LEKL-----LLEGEIP 120
             L+ L        GEIP
Sbjct: 269 KSLQYLSLAENKFTGEIP 286

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 42/145 (28%), Positives = 57/145 (39%), Gaps = 25/145 (17%)

Query: 2   LAALFQLDLRGNKLSGSIPTC-FSNLTALRNLHLDSN--------ELRHLV-LTRTDFSR 51
           L +L  L L  NK +G IP         L  L L  N               L     S 
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327

Query: 52  NNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDL-VSLESLDLSNNNLSEIIPLS 109
           NN  G++P  T+  ++ L+ L L  N   G +P S  +L  SL +LDLS+NN S  I  +
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387

Query: 110 LEKLL-------------LEGEIPR 121
           L +                 G+IP 
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPP 412

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 83.0 bits (206), Expect = 2e-17
 Identities = 29/129 (22%), Positives = 49/129 (37%), Gaps = 19/129 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
              L  + L  N+L+G IP     L  L  L L               S N+  G+IP  
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKL---------------SNNSFSGNIPAE 533

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPR 121
           +   +SL +L L  N   G+IP +        S  ++ N ++    + ++   ++ E   
Sbjct: 534 LGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHG 589

Query: 122 GGPFTKFSS 130
            G   +F  
Sbjct: 590 AGNLLEFQG 598

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 33/143 (23%), Positives = 51/143 (35%), Gaps = 25/143 (17%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN----------ELRHLV-LTRTDFS 50
           L  L  L L  + ++GS+   F    +L +L L  N           L     L   + S
Sbjct: 76  LTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVS 134

Query: 51  RNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDD---LVSLESLDLSNNNLSEII 106
            N L      +    L SL+ L L  N + G+    +        L+ L +S N +S  +
Sbjct: 135 SNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV 194

Query: 107 PL----SLEKL-----LLEGEIP 120
            +    +LE L          IP
Sbjct: 195 DVSRCVNLEFLDVSSNNFSTGIP 217

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 14/120 (11%)

Query: 8   LDLRGNKLS---GSIPTCFSNLTALRNLHLDSNELRHLV--------LTRTDFSRNNLLG 56
           +DL    L+    ++ +   +LT L +L L ++ +   V        LT  D SRN+L G
Sbjct: 55  IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSG 114

Query: 57  DIPT--TIQGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEIIPLSLEKL 113
            + T  ++     L+FL++  N L      S    L SLE LDLS N++S    +     
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS 174

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 56.8 bits (138), Expect = 4e-09
 Identities = 19/77 (24%), Positives = 35/77 (45%), Gaps = 3/77 (3%)

Query: 35  DSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES 94
             +++  + L+      N     + +++  L  L+ L L ++ + GS+   F    SL S
Sbjct: 48  RDDKVTSIDLSSKPL--NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTS 104

Query: 95  LDLSNNNLSEIIPLSLE 111
           LDLS N+LS  +     
Sbjct: 105 LDLSRNSLSGPVTTLTS 121

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  131 bits (331), Expect = 7e-36
 Identities = 45/176 (25%), Positives = 73/176 (41%), Gaps = 24/176 (13%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK--------SFDVECEV--MKSIHHRNLVKIISSCS 255
             +G+G +G V++   Q G   A+K        S+  E E+     + H N++  I+S  
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72

Query: 256 NEDFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-----FGF 306
                +    L+  Y   GSL   L      LD +  L I++++ S L +LH        
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA--TIGYMAP 360
              I H DLK  N+L+  N    ++D G+A + +     +         T  YMAP
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  130 bits (328), Expect = 3e-35
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 27/177 (15%)

Query: 208 IGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCS 255
           +G+G FG   K    + G    +K            F  E +VM+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            +     + EY+  G+L  ++ S +      QR++   ++ S + YLH   S  IIH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA------------TIGYMAP 360
             HN L+ +N    ++DFG+A+L+  E       ++L                +MAP
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  130 bits (329), Expect = 3e-35
 Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 24/176 (13%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK--------SFDVECEV--MKSIHHRNLVKIISSCS 255
             IG+G +G V+  + + G + A+K        S+  E E+     + H N++  I++  
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101

Query: 256 NEDFR----ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-----FGF 306
                     L+ +Y  NGSL   L S+   LD    L +  +  S L +LH        
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA--TIGYMAP 360
              I H DLK  N+L+  N    ++D G+A     +   +         T  YM P
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  127 bits (321), Expect = 5e-34
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 24/176 (13%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK--------SFDVECEV--MKSIHHRNLVKIISSCS 255
             IG+G FG V++ + + G E A+K        S+  E E+     + H N++  I++ +
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106

Query: 256 NEDFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-----FGF 306
            ++       LV +Y  +GSL   L      + +   + + ++  S L +LH        
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQG 164

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA--TIGYMAP 360
              I H DLK  N+L+  N    ++D G+A        ++         T  YMAP
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  125 bits (316), Expect = 1e-32
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 19/174 (10%)

Query: 202 FSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVEC------EV---MKSIHHRNLVKIIS 252
           F   +++G G+ G++    + D  + A+K    EC      EV    +S  H N+++   
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFC 85

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
           +  +  F+ + +E     +L++ +   +     L+ + ++   TS L +LH   S  I+H
Sbjct: 86  TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVH 141

Query: 313 CDLKPHNVLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
            DLKPHN+L+        I A +SDFG+ K L     S ++   +  T G++AP
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  122 bits (307), Expect = 4e-32
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 15/166 (9%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDVEC------EVMKSIHHRNLVKIISSCSNED 258
             +GRGSFG V++ +  Q G + A+K   +E            +    +V +  +     
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGP 123

Query: 259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPH 318
           +  + +E +  GSL +++    C L   + L  +      LEYLH   +  I+H D+K  
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHGDVKAD 179

Query: 319 NVLLDDN-IVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
           NVLL  +   A L DFG A  L  +    +        G   +MAP
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  116 bits (292), Expect = 2e-30
 Identities = 52/175 (29%), Positives = 73/175 (41%), Gaps = 23/175 (13%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS 252
            IG GS+G   K R   DG     K  D              E  +++ + H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 253 SCSNEDFRAL--VLEYMTNGSLEKVL---YSSNCILDILQRLNIMINVTSALEYLH--FG 305
              +     L  V+EY   G L  V+         LD    L +M  +T AL+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
               ++H DLKP NV LD      L DFG+A++L   D S  +T  + T  YM+P
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTF-VGTPYYMSP 185

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  116 bits (293), Expect = 2e-30
 Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 22/170 (12%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSC 254
           ++G+G++G VY  R L + +  AIK               E  + K + H+N+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL--NIMINVTSALEYLHFGFSTPIIH 312
           S   F  + +E +  GSL  +L S    L   ++        +   L+YLH      I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 313 CDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
            D+K  NVL++  + V  +SDFG +K L G       T+T   T+ YMAP
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAP 192

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  115 bits (291), Expect = 5e-30
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)

Query: 167 RCQKRATELPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKAR-LQDGM 225
             Q +  + P V   QPQ + R       L     F     IGRG F  VY+A  L DG+
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTL---ANFRIEKKIGRGQFSEVYRAACLLDGV 58

Query: 226 EFAIKSFDV--------------ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGS 271
             A+K   +              E +++K ++H N++K  +S   ++   +VLE    G 
Sbjct: 59  PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 118

Query: 272 LEKVL---YSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVA 328
           L +++        ++         + + SALE++H   S  ++H D+KP NV +    V 
Sbjct: 119 LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVV 175

Query: 329 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            L D G+ +  + +  +   +    T  YM+P
Sbjct: 176 KLGDLGLGRFFSSKT-TAAHSLV-GTPYYMSP 205

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  115 bits (291), Expect = 5e-30
 Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 29/180 (16%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSC 254
            +G G F  V     L DG  +A+K               E ++ +  +H N++++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 255 SNEDFRA----LVLEYMTNGSLEKVLYSSNCILDIL---QRLNIMINVTSALEYLHFGFS 307
             E        L+L +   G+L   +       + L   Q L +++ +   LE +H   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-------TIGYMAP 360
               H DLKP N+LL D     L D G         +   Q  TL        TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  115 bits (289), Expect = 2e-29
 Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 20/169 (11%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS 252
            IG GSFG     +  +DG ++ IK  ++             E  V+ ++ H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 253 SCSNEDFRALVLEYMTNGSLEKVL-YSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
           S        +V++Y   G L K +      +    Q L+  + +  AL+++H      I+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H D+K  N+ L  +    L DFGIA++L      + +     T  Y++P
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACI-GTPYYLSP 194

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  114 bits (287), Expect = 2e-29
 Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 21/170 (12%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNL--VKI 250
             IG G    V++   +    +AIK             S+  E   +  +   +   +++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
                 + +  +V+E   N  L   L      +D  +R +   N+  A+  +H      I
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +H DLKP N L+ D ++  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  114 bits (286), Expect = 4e-29
 Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 21/170 (12%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSI--HHRNLVKI 250
             IG G    V++   +    +AIK             S+  E   +  +  H   ++++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
                 + +  +V+E   N  L   L      +D  +R +   N+  A+  +H      I
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +H DLKP N L+ D ++  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  114 bits (288), Expect = 5e-29
 Identities = 42/209 (20%), Positives = 80/209 (38%), Gaps = 23/209 (11%)

Query: 169 QKRATELPNVANMQPQASRRRFSYLELLRATNG--FSANNLIGRGSFGSVYKARLQDGME 226
            K   +  +  ++      +  S      +  G  +S    IG G    V++   +    
Sbjct: 23  AKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQI 82

Query: 227 FAIK-------------SFDVECEVMKSIHHRNL--VKIISSCSNEDFRALVLEYMTNGS 271
           +AIK             S+  E   +  +   +   +++      + +  +V+E   N  
Sbjct: 83  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNID 141

Query: 272 LEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLS 331
           L   L      +D  +R +   N+  A+  +H      I+H DLKP N L+ D ++  L 
Sbjct: 142 LNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLI 196

Query: 332 DFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DFGIA  +  +  S+ +   +  + YM P
Sbjct: 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  112 bits (282), Expect = 6e-29
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 31/180 (17%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------ECEVMKSIHHRNLVKIISSCSNE 257
            LIG G FG V+KA+   DG  + IK           E + +  + H N+V         
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76

Query: 258 DFRA----------------LVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALE 300
           D+                  + +E+   G+LE+ +       LD +  L +   +T  ++
Sbjct: 77  DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVD 136

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           Y+H   S  +I+ DLKP N+ L D     + DFG+   L  + +      TL    YM+P
Sbjct: 137 YIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR---YMSP 190

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (283), Expect = 4e-28
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 34/189 (17%)

Query: 202 FSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVEC------EV---MKSIHHRNLVKIIS 252
             +  ++G GS G+V       G   A+K   ++       E+    +S  H N+++   
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYC 76

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRL------NIMINVTSALEYLHFGF 306
           S + + F  + LE   N +L+ ++ S N   + L+        +++  + S + +LH   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132

Query: 307 STPIIHCDLKPHNVLLD-------------DNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 353
           S  IIH DLKP N+L+              +N+   +SDFG+ K L     S        
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 354 --TIGYMAP 360
             T G+ AP
Sbjct: 193 SGTSGWRAP 201

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  108 bits (273), Expect = 1e-27
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 39/201 (19%)

Query: 196 LRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV----------ECEVMKSIHH 244
           LR  + F    ++G+G+FG V KAR   D   +AIK              E  ++ S++H
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61

Query: 245 RNLVKIISSCSNEDFRA-------------LVLEYMTNGSLEKVLYSSNCILDILQRLNI 291
           + +V+  ++                     + +EY  NG+L  +++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
              +  AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK +      +     
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 352 LAT---------IG---YMAP 360
                       IG   Y+A 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVAT 199

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  106 bits (268), Expect = 4e-27
 Identities = 46/166 (27%), Positives = 73/166 (43%), Gaps = 20/166 (12%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           IG G FG V+     +  + AIK+          F  E EVM  + H  LV++   C  +
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFSTPIIHCD 314
               LV E+M +G L   L +   +      L + ++V   + YL           IH D
Sbjct: 76  APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHRD 129

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L   N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +P
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 174

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  107 bits (268), Expect = 6e-27
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 31/178 (17%)

Query: 205 NNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKI 250
           +  IGRGSF +VYK    +  +E A                   E E++K + H N+V+ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 251 ISSCSNEDFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
             S  +         LV E MT+G+L+  L     ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 307 STPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
           + PIIH DLK  N+ +        + D G+A L          +   A IG   +MAP
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFMAP 199

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  106 bits (267), Expect = 1e-26
 Identities = 40/170 (23%), Positives = 64/170 (37%), Gaps = 24/170 (14%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSI-HHRNLVKII 251
            +G GS+G V+K R  +DG  +A+K                 E    + +  H   V++ 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            +        L  E     SL++   +    L   Q    + +   AL +LH   S  ++
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLV 179

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
           H D+KP N+ L       L DFG+   L     +    +       YMAP
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELG----TAGAGEVQEGDPRYMAP 225

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  105 bits (264), Expect = 2e-26
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 20/166 (12%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + A+K           F  E + M  + H  LVK    CS E
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFSTPIIHCD 314
               +V EY++NG L   L S    L+  Q L +  +V   + +L    F      IH D
Sbjct: 76  YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHRD 129

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L   N L+D ++   +SDFG+ + +  +DQ ++   T   + + AP
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAP 174

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  108 bits (272), Expect = 2e-26
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 43/180 (23%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           +G+G+F  V +   +  G E+A    +              E  + + + H N+V++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 254 CSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALEYLHF 304
            S E    L+ + +T G L      +  YS    S+CI  IL           A+ + H 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLHCH- 127

Query: 305 GFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
                ++H +LKP N+LL          L+DFG+A  + GE Q+       A T GY++P
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSP 182

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  105 bits (265), Expect = 2e-26
 Identities = 36/191 (18%), Positives = 76/191 (39%), Gaps = 40/191 (20%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISS 253
            +GRG FG V++A+   D   +AIK   +            E + +  + H  +V+  ++
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 254 CSNEDFRA------------LVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSAL 299
              ++               + ++     +L+  +    +    +    L+I + +  A+
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG--- 356
           E+LH   S  ++H DLKP N+    + V  + DFG+   +  +++  T    +       
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 357 -------YMAP 360
                  YM+P
Sbjct: 189 GQVGTKLYMSP 199

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  105 bits (264), Expect = 2e-26
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 20/166 (12%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V   + +   + AIK           F  E +VM ++ H  LV++   C+ +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91

Query: 258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFSTPIIHCD 314
               ++ EYM NG L   L          Q L +  +V  A+EYL    F      +H D
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHRD 145

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L   N L++D  V  +SDFG+++ +  +D+  +   +   + +  P
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPP 190

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  105 bits (265), Expect = 3e-26
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 27/175 (15%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD------------VECEVMKSIHHRNLVKI--I 251
           ++G+G+  +V++ R  + G  FAIK F+             E EV+K ++H+N+VK+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYS--SNCILDILQRLNIMINVTSALEYLHFGFSTP 309
              +    + L++E+   GSL  VL    +   L   + L ++ +V   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 310 IIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           I+H ++KP N++     D   V  L+DFG A+ L  ++Q ++      T  Y+ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHP 184

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (265), Expect = 4e-26
 Identities = 47/186 (25%), Positives = 74/186 (39%), Gaps = 48/186 (25%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV----------------ECEVMKSIHHRNLVKI 250
           IG+G F  V +    + G +FA+K  DV                E  +   + H ++V++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 251 ISSCSNEDFRALVLEYMTNGSL---------EKVLYS----SNCILDILQRLNIMINVTS 297
           + + S++    +V E+M    L            +YS    S+ +  IL           
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
           AL Y H      IIH D+KPH VLL   +++    L  FG+A  L            + T
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 355 IGYMAP 360
             +MAP
Sbjct: 197 PHFMAP 202

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  106 bits (266), Expect = 5e-26
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 16/166 (9%)

Query: 208 IGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSC 254
           IGRG+FG V+  RL+ D    A+KS            F  E  ++K   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
           + +    +V+E +  G     L +    L +   L ++ +  + +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L   N L+ +  V  +SDFG+++       + +       + + AP
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  107 bits (268), Expect = 6e-26
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 16/166 (9%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCS 255
             +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            E    +V EYM+ GSL   L       L + Q +++   + S + Y+        +H D
Sbjct: 250 EEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L+  N+L+ +N+V  ++DFG+A+L+   + +  Q      I + AP
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAP 350

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  106 bits (266), Expect = 1e-25
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 16/166 (9%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCS 255
             +G+G FG V+          AIK+          F  E +VMK + H  LV++ +  S
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            E    +V EYM+ GSL   L       L + Q +++   + S + Y+        +H D
Sbjct: 333 EEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L+  N+L+ +N+V  ++DFG+A+L+   + +  Q      I + AP
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAP 433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  103 bits (258), Expect = 2e-25
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 42/179 (23%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           +G+G+F  V +      G+EFA K  +              E  + + + H N+V++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 254 CSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALEYLHF 304
              E F  LV + +T G L      +  YS    S+CI  IL           ++ Y H 
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCH- 122

Query: 305 GFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  I+H +LKP N+LL          L+DFG+A  +  + ++        T GY++P
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYLSP 176

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  105 bits (264), Expect = 2e-25
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 16/166 (9%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCS 255
             +G G FG V+ A      + A+K+          F  E  VMK++ H  LVK+ +  +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 256 NEDFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            E    ++ E+M  GSL   L S       + + ++    +   + ++        IH D
Sbjct: 254 KEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 309

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L+  N+L+  ++V  ++DFG+A+++  +++   +      I + AP
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 354

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  104 bits (261), Expect = 2e-25
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 42/179 (23%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           +G+G+F  V +      G+EFA K  +              E  + + + H N+V++  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 254 CSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALEYLHF 304
              E F  LV + +T G L      +  YS    S+CI  IL           ++ Y H 
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCH- 145

Query: 305 GFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  I+H +LKP N+LL          L+DFG+A  +  + ++        T GY++P
Sbjct: 146 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYLSP 199

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  103 bits (258), Expect = 2e-25
 Identities = 42/174 (24%), Positives = 81/174 (46%), Gaps = 23/174 (13%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-----------VMKSIHHRNLVK 249
           +     +G G+FG VYKA+  + G   A K  + + E           ++ +  H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           ++ +  ++    +++E+   G+++ ++   +  L   Q   +   +  AL +LH   S  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
           IIH DLK  NVL+       L+DFG++       +++ +  +   IG   +MAP
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKRDSF--IGTPYWMAP 186

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  104 bits (261), Expect = 3e-25
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 27/175 (15%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV------------ECEVMKSIHHRNLVKI--I 251
           ++G+G+  +V++ R  + G  FAIK F+             E EV+K ++H+N+VK+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYS--SNCILDILQRLNIMINVTSALEYLHFGFSTP 309
              +    + L++E+   GSL  VL    +   L   + L ++ +V   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 310 IIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           I+H ++KP N++     D   V  L+DFG A+ L  ++Q ++      T  Y+ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHP 184

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  103 bits (258), Expect = 4e-25
 Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 39/176 (22%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------ECEVM-KSIHHRNLVKIISSCSNED 258
           IG GS+    +       MEFA+K  D        E E++ +   H N++ +     +  
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGK 89

Query: 259 FRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +  +V E M  G L      +  +S    S  +  I             +EYLH   +  
Sbjct: 90  YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT----------KTVEYLH---AQG 136

Query: 310 IIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
           ++H DLKP N+L      +     + DFG AK L  E+  +    T   T  ++AP
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYTANFVAP 189

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  102 bits (257), Expect = 4e-25
 Identities = 55/172 (31%), Positives = 80/172 (46%), Gaps = 21/172 (12%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVECE---------VMKSIHHRNLVKII 251
           F     +G GS+GSVYKA   + G   AIK   VE +         +M+     ++VK  
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            S        +V+EY   GS+  ++   N  L   +   I+ +    LEYLH       I
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKI 147

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
           H D+K  N+LL+    A L+DFG+A  LT    +M +  T+  IG   +MAP
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLT---DTMAKRNTV--IGTPFWMAP 194

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  101 bits (255), Expect = 5e-25
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 47/181 (25%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD-----------VECEVMKSIHHRNLVKIISSC 254
           ++G G+F  V+  +    G  FA+K               E  V+K I H N+V +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 255 SNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALEYLHFG 305
            +     LV++ ++ G L     E+ +Y+    S  I  +L          SA++YLH  
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----------SAVKYLH-- 123

Query: 306 FSTPIIHCDLKPHNVLL-----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMA 359
               I+H DLKP N+L      +  I+  ++DFG++K+   ++  M+   T   T GY+A
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIM--ITDFGLSKME--QNGIMS---TACGTPGYVA 175

Query: 360 P 360
           P
Sbjct: 176 P 176

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  101 bits (255), Expect = 5e-25
 Identities = 44/177 (24%), Positives = 74/177 (41%), Gaps = 28/177 (15%)

Query: 206 NLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLVK 249
            +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 250 IISSCSNEDFRAL-VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFG 305
           ++  C   +   L VL YM +G L   + +      +   +   + V   ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED--QSMTQTQTLATIGYMAP 360
                +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA 
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  104 bits (261), Expect = 5e-25
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 16/167 (9%)

Query: 206 NLIGRGSFGSVYKARLQD-GMEFAIKS----------FDVECEVMKSIHHRNLVKIISSC 254
           + +G G +G VY+   +   +  A+K+          F  E  VMK I H NLV+++  C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           + E    ++ E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH 
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 342

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +L   N L+ +N +  ++DFG+++L+T  D           I + AP
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 388

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  101 bits (255), Expect = 5e-25
 Identities = 45/184 (24%), Positives = 73/184 (39%), Gaps = 47/184 (25%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------------ECEVMKSI-HHR 245
           +GRG    V +        E+A+K  DV                    E ++++ +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 246 NLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVT 296
           N++++  +     F  LV + M  G L     EKV  S       +  +L          
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL---------- 134

Query: 297 SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
             +  LH      I+H DLKP N+LLDD++   L+DFG +  L    + +   +   T  
Sbjct: 135 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKL--REVCGTPS 188

Query: 357 YMAP 360
           Y+AP
Sbjct: 189 YLAP 192

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  102 bits (255), Expect = 6e-25
 Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 25/174 (14%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVK 249
           ++    IG+G+ G+VY A  +  G E AI+  ++           E  VM+   + N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
            + S    D   +V+EY+  GSL  V+  +   +D  Q   +      ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
           +IH D+K  N+LL  +    L+DFG    +T      ++  T+  +G   +MAP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---PEQSKRSTM--VGTPYWMAP 185

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  102 bits (256), Expect = 6e-25
 Identities = 49/173 (28%), Positives = 79/173 (45%), Gaps = 26/173 (15%)

Query: 208 IGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G  G V   RL+      +  AIK+            F  E  +M    H N++++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFST 308
              +      +V EYM NGSL+  L + +    I+Q + ++  V + + YL    +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAP 360
             +H DL   NVL+D N+V  +SDFG++++L    D + T T     I + AP
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  102 bits (255), Expect = 7e-25
 Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 25/174 (14%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVK 249
             +   IG GS G V  AR    G + A+K  D+           E  +M+   H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +  S    +   +++E++  G+L  ++  S   L+  Q   +   V  AL YLH   +  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQG 161

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
           +IH D+K  ++LL  +    LSDFG    ++   + + + ++L  +G   +MAP
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKSL--VGTPYWMAP 210

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  101 bits (255), Expect = 7e-25
 Identities = 44/175 (25%), Positives = 73/175 (41%), Gaps = 37/175 (21%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFD--------VECEVMKSI-HHRNLVKIISSCSNE 257
           +G GSF    K    +    FA+K            E   +K    H N+VK+     ++
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78

Query: 258 DFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALEYLHFGFST 308
               LV+E +  G L     +K  +S    S  +  ++          SA+ ++H     
Sbjct: 79  LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV----------SAVSHMH---DV 125

Query: 309 PIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            ++H DLKP N+L    +DN+   + DFG A+L   ++Q +       T+ Y AP
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAP 178

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  101 bits (253), Expect = 7e-25
 Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 16/164 (9%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNE 257
           +G G FG V+        + A+KS          F  E  +MK + H+ LV++ +  + E
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80

Query: 258 DFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               ++ EYM NGSL   L + +   L I + L++   +   + ++        IH DL+
Sbjct: 81  PIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 136

Query: 317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             N+L+ D +   ++DFG+A+L+  +++   +      I + AP
Sbjct: 137 AANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 179

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  102 bits (256), Expect = 9e-25
 Identities = 61/255 (23%), Positives = 94/255 (36%), Gaps = 52/255 (20%)

Query: 141 GSPNLQVPPCKSNKPIILALKFGLISRCQKRATELPNVANMQPQASRRRFSYLELLRATN 200
                Q      +     +    L++  +K     P         S      L    A  
Sbjct: 31  NLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK 90

Query: 201 GFSAN----NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------------EC 236
            F       ++IGRG    V +      G EFA+K  +V                   E 
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150

Query: 237 EVMKSIH-HRNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDIL 286
            +++ +  H +++ +I S  +  F  LV + M  G L     EKV  S     + +  +L
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210

Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
                      A+ +LH   +  I+H DLKP N+LLDDN+   LSDFG +  L    + +
Sbjct: 211 ----------EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKL 256

Query: 347 TQTQTLA-TIGYMAP 360
                L  T GY+AP
Sbjct: 257 R---ELCGTPGYLAP 268

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  101 bits (255), Expect = 9e-25
 Identities = 41/173 (23%), Positives = 67/173 (38%), Gaps = 27/173 (15%)

Query: 208 IGRGSFGSVYKARLQDGMEF-----AIKS------------FDVECEVMKSIHHRNLVKI 250
           +G G+FG+VYK       E      AIK                E  VM S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFS 307
           +  C     + L+ + M  G L   +      +     LN  + +   + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              +H DL   NVL+       ++DFG+AKLL  E++          I +MA 
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  104 bits (260), Expect = 1e-24
 Identities = 49/177 (27%), Positives = 77/177 (43%), Gaps = 30/177 (16%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFD------------VECEVMKSIHHRNLVKII--- 251
           +G G FG V +      G + AIK               +E ++MK ++H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 252 ---SSCSNEDFRALVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSALEYLHFGF 306
                 +  D   L +EY   G L K L  + + C L       ++ +++SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 307 STPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              IIH DLKP N++L      ++  + D G AK L  +   +     + T+ Y+AP
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAP 192

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  100 bits (252), Expect = 1e-24
 Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 23/173 (13%)

Query: 208 IGRGSFGSVYKARL-----QDGMEFAIKS------------FDVECEVMKSIHHRNLVKI 250
           +G G FG V   R        G + A+KS               E E++++++H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 251 ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              C+ +      L++E++ +GSL++ L  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAP 360
             +H DL   NVL++      + DFG+ K + T ++    +    + + + AP
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  100 bits (251), Expect = 1e-24
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 25/154 (16%)

Query: 208 IGRGSFGSVYKARLQDGMEF---AIKS------------FDVECEVMKSIHHRNLVKIIS 252
           +G G+FGSV +   +   +    AIK                E ++M  + +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFSTP 309
            C  E    LV+E    G L K L      + +     ++  V+  ++YL   +F     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
            +H DL   NVLL +   A +SDFG++K L  +D
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  100 bits (252), Expect = 2e-24
 Identities = 40/177 (22%), Positives = 72/177 (40%), Gaps = 28/177 (15%)

Query: 206 NLIGRGSFGSVYKARLQDGMEF----AIKS------------FDVECEVMKSIHHRNLVK 249
            +IG+G FG VY     D  +     AIKS            F  E  +M+ ++H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 250 IISSCSNEDFRAL-VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFG 305
           +I      +     +L YM +G L + + S      +   ++  + V   +EYL    F 
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF- 145

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED--QSMTQTQTLATIGYMAP 360
                +H DL   N +LD++    ++DFG+A+ +   +             + + A 
Sbjct: 146 -----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  100 bits (250), Expect = 2e-24
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 16/165 (9%)

Query: 208 IGRGSFGSVYKARLQDG-MEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSN 256
           +G G +G VY+   +   +  A+K+          F  E  VMK I H NLV+++  C+ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80

Query: 257 EDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
           E    ++ E+MT G+L   L   N   +  +  L +   ++SA+EYL        IH DL
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              N L+ +N +  ++DFG+++L+T  D           I + AP
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  100 bits (252), Expect = 2e-24
 Identities = 48/186 (25%), Positives = 70/186 (37%), Gaps = 33/186 (17%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSI-HHRNLVKIISS 253
           ++  G F  VY+A+ +  G E+A+K               E   MK +  H N+V+  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 254 CS-------NEDFRALVLEYMTNGSLEKVL--YSSNCILDILQRLNIMINVTSALEYLHF 304
            S             L+L  +  G L + L    S   L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA----------T 354
               PIIH DLK  N+LL +     L DFG A  ++         Q  A          T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 355 IGYMAP 360
             Y  P
Sbjct: 214 PMYRTP 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (252), Expect = 2e-24
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 28/173 (16%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IGRG++GSV K      G   A+K      +             VM+S     +V+   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCIL------DILQRLNIMINVTSALEYLHFGFS 307
              E    + +E M + S +K       +L      +IL +  I +    AL +L     
Sbjct: 90  LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLKENLK 146

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             IIH D+KP N+LLD +    L DFGI+  L     S+ +T+      YMAP
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAP 194

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  101 bits (253), Expect = 2e-24
 Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 28/177 (15%)

Query: 206 NLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLVK 249
            +IGRG FG VY   L D     +  A+KS            F  E  +MK   H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 250 IISSCSNEDF-RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFG 305
           ++  C   +    +VL YM +G L   + +      +   +   + V   +++L    F 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAP 360
                +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA 
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  100 bits (251), Expect = 3e-24
 Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 58/243 (23%)

Query: 139 LCGSPNLQVPPCKSNKPIILALKFGLISRCQKRATELPNVANMQPQASRRRFSYLELLRA 198
           +  + NL       + P    LKF          TE+               S +   + 
Sbjct: 14  IPTTENLYFQGAMGSDPNQAVLKF---------TTEIHP-------------SCVTRQK- 50

Query: 199 TNGFSANNLIGRGSFGSVYKARLQDGMEF-----AIKS------------FDVECEVMKS 241
                   +IG G FG VYK  L+          AIK+            F  E  +M  
Sbjct: 51  --------VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ 102

Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
             H N++++    S      ++ EYM NG+L+K L   +    +LQ + ++  + + ++Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 302 L---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGY 357
           L   ++      +H DL   N+L++ N+V  +SDFG++++L  + ++   T      I +
Sbjct: 163 LANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216

Query: 358 MAP 360
            AP
Sbjct: 217 TAP 219

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  103 bits (257), Expect = 3e-24
 Identities = 37/175 (21%), Positives = 69/175 (39%), Gaps = 36/175 (20%)

Query: 207 LIGRGSFGSVYKA---RLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
            I  G  G +Y A    + +G    +K                E + +  + H ++V+I 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 252 SSCSNEDFRA-----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           +   + D        +V+EY+   SL++        L + + +  ++ +  AL YLH   
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
           S  +++ DLKP N++L +  +  L D G           +        T G+ AP
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAP 246

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  100 bits (250), Expect = 3e-24
 Identities = 40/170 (23%), Positives = 69/170 (40%), Gaps = 21/170 (12%)

Query: 208 IGRGSFGSVYKARLQDGMEF-----AIKS------------FDVECEVMKSIHHRNLVKI 250
           +G G FG+V+K       E       IK                    + S+ H ++V++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
           +  C     + LV +Y+  GSL   +      L     LN  + +   + YL       +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +MA 
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  100 bits (252), Expect = 3e-24
 Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 26/173 (15%)

Query: 208 IGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLVKII 251
           +G G FG V   RL+      +  AIK+            F  E  +M    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFST 308
              +      +V EYM NGSL+  L   +    ++Q + ++  + S ++YL    +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGYMAP 360
             +H DL   N+L++ N+V  +SDFG+ ++L    + + T       I + +P
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 99.3 bits (248), Expect = 4e-24
 Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 22/172 (12%)

Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 252 SSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAP 360
            IH DL   N+L+++     + DFG+ K+L   ++    +    + I + AP
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  102 bits (255), Expect = 5e-24
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 25/154 (16%)

Query: 208 IGRGSFGSVYKARLQDG---MEFAIKS------------FDVECEVMKSIHHRNLVKIIS 252
           +G G+FGSV +   +     ++ AIK                E ++M  + +  +V++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFSTP 309
            C  E    LV+E    G L K L      + +     ++  V+  ++YL   +F     
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
            +H +L   NVLL +   A +SDFG++K L  +D
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 99.4 bits (248), Expect = 7e-24
 Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 22/172 (12%)

Query: 208 IGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R                LQ   E  ++ F+ E E++KS+ H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 252 SSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
             C +   R   L++EY+  GSL   L      +D ++ L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAP 360
            IH DL   N+L+++     + DFG+ K+L   ++    +    + I + AP
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 99.3 bits (248), Expect = 9e-24
 Identities = 52/212 (24%), Positives = 83/212 (39%), Gaps = 44/212 (20%)

Query: 176 PNVANMQPQASRRRFSYLELLRATNGFSAN----NLIGRGSFGSVYKAR-LQDGMEFAIK 230
              A+  P  +     Y       +  S      + +GRG+   VY+ +       +A+K
Sbjct: 25  SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK 84

Query: 231 SFD---------VECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL-----EKVL 276
                        E  V+  + H N++K+          +LVLE +T G L     EK  
Sbjct: 85  VLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY 144

Query: 277 YS----SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAH 329
           YS    ++ +  IL           A+ YLH      I+H DLKP N+L      +    
Sbjct: 145 YSERDAADAVKQIL----------EAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLK 191

Query: 330 LSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
           ++DFG++K++      M    T+  T GY AP
Sbjct: 192 IADFGLSKIV-EHQVLMK---TVCGTPGYCAP 219

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  100 bits (251), Expect = 1e-23
 Identities = 47/141 (33%), Positives = 66/141 (46%), Gaps = 15/141 (10%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSNED 258
           IG+G FG V     + G + A+K          F  E  VM  + H NLV+++     E 
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259

Query: 259 FRA-LVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
               +V EYM  GSL   L S    +L     L   ++V  A+EYL        +H DL 
Sbjct: 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLA 316

Query: 317 PHNVLLDDNIVAHLSDFGIAK 337
             NVL+ ++ VA +SDFG+ K
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTK 337

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 47/184 (25%), Positives = 74/184 (40%), Gaps = 43/184 (23%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSI-HHRNLVKIISS 253
           ++G G+   V     L    E+A+K  +            E E++     HRN++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 254 CSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALEYLHF 304
              ED   LV E M  GS+     ++  ++    S  + D+           SAL++LH 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVA----------SALDFLH- 128

Query: 305 GFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLATI----G 356
             +  I H DLKP N+L    +      + DF +   +    D S   T  L T      
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 357 YMAP 360
           YMAP
Sbjct: 187 YMAP 190

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 24/171 (14%)

Query: 207 LIGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKI 250
            +G G   +VY A                  ++  E  +K F+ E      + H+N+V +
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEET-LKRFEREVHNSSQLSHQNIVSM 76

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
           I     +D   LV+EY+   +L + +  S+  L +   +N    +   +++ H      I
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
           +H D+KP N+L+D N    + DFGIAK L+  + S+TQT   L T+ Y +P
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSP 181

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  100 bits (252), Expect = 1e-23
 Identities = 30/123 (24%), Positives = 45/123 (36%), Gaps = 10/123 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRT----------DFSR 51
           L  L  LD+       +    F+ L++L  L +  N  +   L             D S+
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
             L    PT    L SLQ L++ HN         +  L SL+ LD S N++       L+
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539

Query: 112 KLL 114
              
Sbjct: 540 HFP 542

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 92.8 bits (231), Expect = 8e-21
 Identities = 34/122 (27%), Positives = 52/122 (42%), Gaps = 10/122 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
              L  LDL   ++       + +L+ L  L L  N ++ L          L +      
Sbjct: 51  FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
           NL       I  LK+L+ L++ HN +Q   +P  F +L +LE LDLS+N +  I    L 
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170

Query: 112 KL 113
            L
Sbjct: 171 VL 172

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 25/106 (23%), Positives = 36/106 (33%), Gaps = 15/106 (14%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           LDL  N L       F +   L+ L L   E++ +                    Q L  
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI---------------EDGAYQSLSH 77

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           L  L L  N +Q     +F  L SL+ L     NL+ +    +  L
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 32/129 (24%), Positives = 52/129 (40%), Gaps = 14/129 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
           L+ L  L L GN +       FS L++L+ L      L  L          L   + + N
Sbjct: 75  LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134

Query: 53  NLLG-DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLE----SLDLSNNNLSEIIP 107
            +    +P     L +L+ L L  N++Q         L  +     SLDLS N ++ I P
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194

Query: 108 LSLEKLLLE 116
            + +++ L 
Sbjct: 195 GAFKEIRLH 203

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 31/117 (26%), Positives = 49/117 (41%), Gaps = 11/117 (9%)

Query: 2   LAALFQLDLRGNKLS--GSIPTCFSNLTALRNLHLDSNELRHLV--------LTRTDFSR 51
           L +L  LDL  N LS  G         T+L+ L L  N +  +         L   DF  
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQH 405

Query: 52  NNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
           +NL      ++   L++L +L + H   + +    F+ L SLE L ++ N+  E   
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 28/113 (24%), Positives = 41/113 (36%), Gaps = 11/113 (9%)

Query: 2   LAALFQLDLRGNKLSGSIPTC-FSNLTALRNLHLDSNELRHLV---------LTRTDFSR 51
           L++L  L + GN    +     F+ L  L  L L   +L  L          L   + S 
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV-SLESLDLSNNNLS 103
           NN         + L SLQ L    N +  S          SL  L+L+ N+ +
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 29/116 (25%), Positives = 43/116 (37%), Gaps = 7/116 (6%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV----LTRTDFSRNNL-- 54
           Y      L+L   K          +L  L             V    L   D SRN L  
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
            G    +  G  SL++L L  N +   + ++F  L  LE LD  ++NL ++   S+
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 24/114 (21%), Positives = 39/114 (34%), Gaps = 13/114 (11%)

Query: 5   LFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQ 63
           L +L LR N  S ++  TC   L  L    L   E           +  NL     + ++
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF---------RNEGNLEKFDKSALE 252

Query: 64  GLKSLQFLSLGHNRLQGS---IPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           GL +L         L      I + F+ L ++ S  L +  +  +   S     
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGW 306

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 15/70 (21%), Positives = 24/70 (34%)

Query: 44  LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 103
               D S N L      +      LQ L L    +Q     ++  L  L +L L+ N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 104 EIIPLSLEKL 113
            +   +   L
Sbjct: 90  SLALGAFSGL 99

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 12/121 (9%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
           L  L  LDL   +L    PT F++L++L+ L++  N    L          L   D+S N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528

Query: 53  NLLGDIPTTIQGL-KSLQFLSLGHNRLQGSIPNS--FDDLVSLESLDLSNNNLSEIIPLS 109
           +++      +Q    SL FL+L  N    +  +      +     L +    +    P  
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588

Query: 110 L 110
            
Sbjct: 589 K 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 24/116 (20%), Positives = 38/116 (32%), Gaps = 14/116 (12%)

Query: 2   LAALFQLDLRGNKLSGSI---PTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDI 58
           LA L    L   +            S L  L NL ++   L +L         +  L DI
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL---------DYYLDDI 274

Query: 59  PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
                 L ++   SL    ++     S+      + L+L N    +   L L+ L 
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLK 328

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 28/124 (22%), Positives = 36/124 (29%), Gaps = 17/124 (13%)

Query: 2   LAALFQLDLRGNKLSGS---IPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSR 51
           L  L   + R   L      I   F+ LT + +  L S  +  +            +   
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVN 313

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS--EIIPLS 109
                        LK      L     +G    S  DL SLE LDLS N LS       S
Sbjct: 314 CKF-----GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 110 LEKL 113
               
Sbjct: 369 DFGT 372

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 36/155 (23%), Positives = 65/155 (41%), Gaps = 26/155 (16%)

Query: 208 IGRGSFGSVYKARLQDGMEF----AIKS------------FDVECEVMKSIHHRNLVKII 251
           +G G FG VY+    +        A+K+            F  E  +MK++ H ++VK+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFST 308
                E    +++E    G L   L  +   L +L  +   + +  A+ YL   +     
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
             +H D+   N+L+       L DFG+++ +  ED
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 34/187 (18%), Positives = 66/187 (35%), Gaps = 35/187 (18%)

Query: 206 NLIGRGSFGSVYKAR------LQDGMEFAIKSFD-----------VECEVMKSIHHRNLV 248
           +L+G G+F  VY+A        ++  +F +K                 E +K       +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 249 KIISSCSNEDFRALVLEYMTNGSL----EKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
           K  S+   ++   LV E  + G+L         +   ++     ++  + +   +E +H 
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH- 189

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAH-----------LSDFGIAKLLTGEDQSMTQTQTLA 353
                IIH D+KP N +L +  +             L D G +  +    +    T    
Sbjct: 190 --DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247

Query: 354 TIGYMAP 360
           T G+   
Sbjct: 248 TSGFQCV 254

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.8 bits (246), Expect = 2e-23
 Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 22/167 (13%)

Query: 208 IGRGSFGSVYKARL-QDGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           +G G+ G V+K      G+  A K   +            E +V+   +   +V    + 
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCIL-DILQRLNIMINVTSALEYLHFGFSTPIIHC 313
            ++   ++ +E+M  GSL++VL  +  I   IL +  + I V   L YL       I+H 
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLREKHK--IMHR 156

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+L++      L DFG++  L     SM  +  + T  YM+P
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 199

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 96.9 bits (242), Expect = 2e-23
 Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 27/172 (15%)

Query: 208 IGRGSFGSVYKARLQDGMEF----AIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V++             AIK+            F  E   M+   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFST 308
              +      +++E  T G L   L      LD+   +     +++AL YL    F    
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             +H D+   NVL+  N    L DFG+++ +  +      ++    I +MAP
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAP 186

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 50/169 (29%), Positives = 74/169 (43%), Gaps = 26/169 (15%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISSC 254
           IG+GSFG V+K    +     AIK  D+            E  V+       + K   S 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
             +    +++EY+  GS   +L      LD  Q   I+  +   L+YLH   S   IH D
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH---SEKKIHRD 144

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
           +K  NVLL ++    L+DFG+A  LT    +  +  T   +G   +MAP
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTF--VGTPFWMAP 188

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 208 IGRGSFGSVYKARL-----QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKII 251
           +G+G+FGSV   R        G   A+K            F  E +++K++H   +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 252 SSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
                   ++  LV+EY+ +G L   L      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
            +H DL   N+L++      ++DFG+AKLL  + 
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 24/171 (14%)

Query: 207 LIGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKI 250
           L+GRG  G VY+A                 L     F       E      +   ++V I
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVF-RTRMQREARTAGRLQEPHVVPI 99

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
                 +    + +  +    L  +L      L   + + I+  + SAL+  H   +   
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGA 155

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
            H D+KP N+L+  +  A+L DFGIA   T  D+ +TQ    + T+ YMAP
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAP 204

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 38/164 (23%), Positives = 57/164 (34%), Gaps = 28/164 (17%)

Query: 208 IGRGSFGSVYKARLQ----DGMEFAIKS--------------FDVECEVMKSIHHRNLVK 249
           +G GSFG V +          +  A+K               F  E   M S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGF 306
           +         + +V E    GSL   L        +       + V   + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
               IH DL   N+LL    +  + DFG+ + L   D      +
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 27/155 (17%)

Query: 208 IGRGSFGSVYKARLQDGMEF---AIKS-------------FDVECEVMKSIHHRNLVKII 251
           +G G+FG+V K   Q        A+K                 E  VM+ + +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFST 308
             C  E +  LV+E    G L K L   N  +     + ++  V+  ++YL   +F    
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF---- 138

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
             +H DL   NVLL     A +SDFG++K L  ++
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 41/173 (23%), Positives = 67/173 (38%), Gaps = 27/173 (15%)

Query: 208 IGRGSFGSVYKARLQDGMEF-----AIKS------------FDVECEVMKSIHHRNLVKI 250
           +G G+FG+VYK       E      AIK                E  VM S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFS 307
           +  C     + L+ + M  G L   +      +     LN  + +   + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              +H DL   NVL+       ++DFG+AKLL  E++          I +MA 
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 95.8 bits (239), Expect = 7e-23
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 42/179 (23%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIISS 253
           +G+GSFG V K +      E+A+K  +              E E++K + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 254 CSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALEYLHF 304
             +     +V E  T G L     ++  +S    +  I  +           S + Y+H 
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----------SGITYMH- 138

Query: 305 GFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                I+H DLKP N+LL   + +    + DFG++     ++  M     + T  Y+AP
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYIAP 192

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 96.2 bits (240), Expect = 8e-23
 Identities = 52/186 (27%), Positives = 77/186 (41%), Gaps = 51/186 (27%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFD-------------------VECEVMKSIHHRNL 247
           +G G+ G V  A   +   + AIK                       E E++K ++H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 248 VKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSA 298
           +KI +    ED+  +VLE M  G L                     +L           A
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML----------LA 126

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-T 354
           ++YLH      IIH DLKP NVLL   +++ +  ++DFG +K+L GE   M    TL  T
Sbjct: 127 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMR---TLCGT 179

Query: 355 IGYMAP 360
             Y+AP
Sbjct: 180 PTYLAP 185

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 95.8 bits (239), Expect = 9e-23
 Identities = 39/183 (21%), Positives = 73/183 (39%), Gaps = 36/183 (19%)

Query: 208 IGRGSFGSVYKARLQDGMEF----AIKS-------------FDVECEVMKSIHHRNLVKI 250
           +G G FGSV +  L+         A+K+             F  E   MK   H N++++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 251 ISSCSNEDFRA-----LVLEYMTNGSLEKVL-----YSSNCILDILQRLNIMINVTSALE 300
           +  C     +      ++L +M  G L   L      +    + +   L  M+++   +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 301 YL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
           YL   +F      +H DL   N +L D++   ++DFG++K +   D           + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 358 MAP 360
           +A 
Sbjct: 216 IAI 218

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 96.3 bits (240), Expect = 1e-22
 Identities = 52/216 (24%), Positives = 79/216 (36%), Gaps = 40/216 (18%)

Query: 172 ATELPNVANMQPQASRRRFSYLELLRATNGFSANN---------LIGRGSFGSVYKAR-L 221
              L     M P  +  R   L+       F  ++          IG GSFG+VY AR +
Sbjct: 17  TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV 76

Query: 222 QDGMEFAIKSFDVECE--------------VMKSIHHRNLVKIISSCSNEDFRALVLEYM 267
           ++    AIK      +               ++ + H N ++       E    LV+EY 
Sbjct: 77  RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136

Query: 268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV 327
             GS   +L      L  ++   +       L YLH   S  +IH D+K  N+LL +  +
Sbjct: 137 -LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 192

Query: 328 AHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
             L DFG A         M    +   +G   +MAP
Sbjct: 193 VKLGDFGSA-------SIMAPANSF--VGTPYWMAP 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 26/176 (14%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE------------VMKSIHHRNLVKIISSC 254
           IG G+   V  A       + AIK  ++E               M   HH N+V   +S 
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 255 SNEDFRALVLEYMTNGSLEKVL-YSSNCILDILQRLN------IMINVTSALEYLHFGFS 307
             +D   LV++ ++ GS+  ++ +           L+      I+  V   LEYLH    
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAP 360
              IH D+K  N+LL ++    ++DFG++  L               +G   +MAP
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 29/173 (16%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           +GRG++G V K R +  G   A+K                     M+++     V    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN------IMINVTSALEYLHFGFS 307
              E    + +E M + SL+K       ++D  Q +       I +++  ALE+LH   S
Sbjct: 75  LFREGDVWICMELM-DTSLDKFYKQ---VIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             +IH D+KP NVL++      + DFGI+  L      + +        YMAP
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAP 178

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 39/184 (21%), Positives = 76/184 (41%), Gaps = 37/184 (20%)

Query: 208 IGRGSFGSVYKARLQDGMEF----AIKS-------------FDVECEVMKSIHHRNLVKI 250
           +G+G FGSV +A+L+         A+K              F  E   MK   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 251 ISSCSNEDFRA------LVLEYMTNGSLEKVLYSS-----NCILDILQRLNIMINVTSAL 299
           +        +       ++L +M +G L   L +S        L +   +  M+++   +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 300 EYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
           EYL   +F      IH DL   N +L +++   ++DFG+++ +   D       +   + 
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 357 YMAP 360
           ++A 
Sbjct: 205 WLAL 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 52/166 (31%), Positives = 74/166 (44%), Gaps = 20/166 (12%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSN 256
             IG+G FG V     + G + A+K          F  E  VM  + H NLV+++     
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85

Query: 257 EDFRA-LVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
           E     +V EYM  GSL   L S    +L     L   ++V  A+EYL        +H D
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 183

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 22/168 (13%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           +G G+ G V+K R  + G   A+K                    V+KS     +V+   +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCIL-DILQRLNIMINVTSALEYLHFGFSTPIIH 312
                   + +E M   + +        I   IL +  + + +  AL YL       +IH
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKEKHG--VIH 148

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            D+KP N+LLD+     L DFGI+  L        + ++     YMAP
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAP 193

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 94.3 bits (235), Expect = 3e-22
 Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 36/166 (21%)

Query: 208 IGRGSFGSVYKARLQD--------GMEFAIK-----------SFDVECEVMKSIHHRNLV 248
           +G+G+F  ++K   ++          E  +K           SF     +M  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFG 305
                C   D   LV E++  GSL+  L  +   ++IL +L +   + +A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 306 FSTPIIHCDLKPHNVLLD--------DNIVAHLSDFGIAKLLTGED 343
                IH ++   N+LL         +     LSD GI+  +  +D
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 43/184 (23%), Positives = 68/184 (36%), Gaps = 47/184 (25%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------------ECEVMKSIHHRNLVK 249
           +G G F  V K R    G+E+A K                     E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 250 IISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALE 300
           +     N     L+LE ++ G L     +K   S    ++ I  IL            + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL----------DGVN 129

Query: 301 YLHFGFSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
           YLH   +  I H DLKP N++L           L DFG+A  +  +           T  
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPE 183

Query: 357 YMAP 360
           ++AP
Sbjct: 184 FVAP 187

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 42/172 (24%), Positives = 68/172 (39%), Gaps = 27/172 (15%)

Query: 208 IGRGSFGSVYKARLQDGMEF----AIKS------------FDVECEVMKSIHHRNLVKII 251
           IG G FG V++             AIK+            F  E   M+   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYL---HFGFST 308
              +      +++E  T G L   L      LD+   +     +++AL YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             +H D+   NVL+  N    L DFG+++ +         ++    I +MAP
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAP 561

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 95.2 bits (237), Expect = 4e-22
 Identities = 40/177 (22%), Positives = 71/177 (40%), Gaps = 40/177 (22%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           +G G+FG V++      G  F  K  +            E  +M  +HH  L+ +  +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 256 NEDFRALVLEYMTNGSL------EKVLYS----SNCILDILQRLNIMINVTSALEYLHFG 305
           ++    L+LE+++ G L      E    S     N +                L+++H  
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC----------EGLKHMH-- 166

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHL--SDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
               I+H D+KP N++ +    + +   DFG+A  L   D+ +    T AT  + AP
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIV--KVTTATAEFAAP 219

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 93.5 bits (233), Expect = 4e-22
 Identities = 39/191 (20%), Positives = 70/191 (36%), Gaps = 46/191 (24%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSI-HHRNLVKII 251
            IG G FGSV+K     DG  +AIK                 E      +  H ++V+  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL---QRLNIMINVTSALEYLHFGFST 308
           S+ + +D   +  EY   GSL   +  +  I+      +  ++++ V   L Y+H   S 
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134

Query: 309 PIIHCDLKPHNVLLDDN-------------------IVAHLSDFGIAKLLTGEDQSMTQT 349
            ++H D+KP N+ +                      ++  + D G    +     S  Q 
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-----SSPQV 189

Query: 350 QTLATIGYMAP 360
           +      ++A 
Sbjct: 190 EE-GDSRFLAN 199

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.8 bits (234), Expect = 5e-22
 Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 25/172 (14%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSFD---------VEC-----EVMKSIHHRNLVKII 251
           ++G GSF +V  AR      E+AIK  +         V       +VM  + H   VK+ 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            +  +++     L Y  NG L K +       +   R      + SALEYLH      II
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH---GKGII 152

Query: 312 HCDLKPHNVLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           H DLKP N+LL+++   H  ++DFG AK+L+ E +      +   T  Y++P
Sbjct: 153 HRDLKPENILLNED--MHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYVSP 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.1 bits (237), Expect = 6e-22
 Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 51/186 (27%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFD-------------------VECEVMKSIHHRNL 247
           +G G+ G V  A   +   + AI+                       E E++K ++H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 248 VKIISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSA 298
           +KI +    ED+  +VLE M  G L                     +L           A
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML----------LA 251

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-T 354
           ++YLH      IIH DLKP NVLL   +++ +  ++DFG +K+L GE   M    TL  T
Sbjct: 252 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMR---TLCGT 304

Query: 355 IGYMAP 360
             Y+AP
Sbjct: 305 PTYLAP 310

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 94.8 bits (236), Expect = 6e-22
 Identities = 41/185 (22%), Positives = 70/185 (37%), Gaps = 44/185 (23%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVK 249
            S   ++G G FG V+K      G++ A K               E  VM  + H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 250 IISSCSNEDFRALVLEYMTNGSL------EKVLYS----SNCILDILQRLNIMINVTSAL 299
           +  +  +++   LV+EY+  G L      E    +       +  I             +
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC----------EGI 200

Query: 300 EYLHFGFSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
            ++H      I+H DLKP N+L        I   + DFG+A+      + +       T 
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIK--IIDFGLARRY-KPREKL--KVNFGTP 252

Query: 356 GYMAP 360
            ++AP
Sbjct: 253 EFLAP 257

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 93.6 bits (233), Expect = 7e-22
 Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 25/173 (14%)

Query: 208 IGRGSFGSVYKARLQD-----GMEFAIKS------------FDVECEVMKSIHHRNLVKI 250
           +G G FG V            G   A+K+            +  E +++++++H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 251 ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              C +    +  LV+EY+  GSL   L   +  + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAP 360
             IH DL   NVLLD++ +  + DFG+AK +  G +    +    + + + AP
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 93.5 bits (233), Expect = 7e-22
 Identities = 38/175 (21%), Positives = 73/175 (41%), Gaps = 26/175 (14%)

Query: 207 LIGRGSFGSVYKAR----------------LQDGMEFAIKSFDVECEVMKSIHHRNLVKI 250
           ++G G    V+ AR                L     F    F  E +   +++H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSF-YLRFRREAQNAAALNHPAIVAV 77

Query: 251 ISSCSNEDFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
             +   E        +V+EY+   +L  ++  +   +   + + ++ +   AL + H   
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH--- 133

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAP 360
              IIH D+KP N+++       + DFGIA+ +     S+TQT   + T  Y++P
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 92.7 bits (231), Expect = 8e-22
 Identities = 41/171 (23%), Positives = 70/171 (40%), Gaps = 25/171 (14%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFD--------------VECEVMKSIHHRNLVKI 250
             +G+G FG+VY AR  Q     A+K                  E E+   + H N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
                +     L+LEY   G++ + L   +   +       +  + +AL Y H   S  +
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRV 130

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           IH D+KP N+LL       ++DFG +           +   L  T+ Y+ P
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPP 176

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 33/176 (18%), Positives = 55/176 (31%), Gaps = 34/176 (19%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-----------------L 44
           L  L  LDL  N ++         L  L  L L  N L  L                  L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538

Query: 45  TRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 104
              +   N          + L  L+ + LG N L     + F++ VSL+SL+L  N ++ 
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598

Query: 105 IIPLSLEKLL------------LEGEIPRGGPFTKFSSKS-----FIGNDLLCGSP 143
           +                      +        F  + +++      + +  LC +P
Sbjct: 599 VEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 32/123 (26%), Positives = 47/123 (38%), Gaps = 9/123 (7%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
            + L  LD+  N +S   P     L  L+ L+L  NEL  L          LT      N
Sbjct: 48  YSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN 107

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 112
           ++           K+L  L L HN L  +   +   L +L+ L LSNN +  +    L+ 
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167

Query: 113 LLL 115
              
Sbjct: 168 FAN 170

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 29/115 (25%), Positives = 44/115 (38%), Gaps = 9/115 (7%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGDI 58
           L+L  N+L       F+  + L +L +  N +  L          L   +   N L    
Sbjct: 30  LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLS 89

Query: 59  PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
             T     +L  L L  N +Q    N F    +L +LDLS+N LS     +  +L
Sbjct: 90  DKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 33/131 (25%), Positives = 51/131 (38%), Gaps = 19/131 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-----------LTRTDFS 50
           L  +F++ L  NK        F+ + +L+ L L    L+++            LT  D S
Sbjct: 429 LENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488

Query: 51  RNNLLGDIPTTIQGLKSLQFLSLGHNRLQ--------GSIPNSFDDLVSLESLDLSNNNL 102
            NN+       ++GL+ L+ L L HN L         G        L  L  L+L +N  
Sbjct: 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGF 548

Query: 103 SEIIPLSLEKL 113
            EI     + L
Sbjct: 549 DEIPVEVFKDL 559

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 30/118 (25%), Positives = 49/118 (41%), Gaps = 12/118 (10%)

Query: 2   LAALFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSNELRHL---------VLTRTDFSR 51
           L  L  LDL  N++   +    +  L  +  ++L  N+   L          L R    R
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463

Query: 52  NNL--LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
             L  +   P+  Q L++L  L L +N +     +  + L  LE LDL +NNL+ +  
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWK 521

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 27/124 (21%), Positives = 38/124 (30%), Gaps = 11/124 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
              L +L L  N +       F     L  L L  N L             L     S N
Sbjct: 96  CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155

Query: 53  NLLGDIPTTIQ--GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
            +       +      SL+ L L  N+++   P  F  +  L  L L+N  L   +   L
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215

Query: 111 EKLL 114
              L
Sbjct: 216 CLEL 219

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 27/103 (26%), Positives = 43/103 (41%), Gaps = 6/103 (5%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
           +L  L    L  N +          L  +R L+L  +       T+   S  +L      
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS------FTKQSISLASLPKIDDF 323

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 103
           + Q LK L+ L++  N + G   N F  L++L+ L LSN+  S
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 31/115 (26%), Positives = 45/115 (39%), Gaps = 12/115 (10%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGDI 58
            D    KL+  +P      T +  L+L  N+LR L          LT  D   N +    
Sbjct: 9   ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65

Query: 59  PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           P   Q L  L+ L+L HN L      +F    +L  L L +N++ +I      K 
Sbjct: 66  PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 32/135 (23%), Positives = 53/135 (39%), Gaps = 23/135 (17%)

Query: 2   LAALFQLDLRGNKLSGSIP---TCFSNLTALRNLHLDSNELRHLV-----------LTRT 47
           +  LF L L   +L  S+          T++RNL L +++L               LT  
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253

Query: 48  DFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN------- 100
           D S NNL      +   L  L++  L +N +Q    +S   L ++  L+L  +       
Sbjct: 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS 313

Query: 101 --NLSEIIPLSLEKL 113
             +L +I   S + L
Sbjct: 314 LASLPKIDDFSFQWL 328

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.7 bits (192), Expect = 8e-16
 Identities = 25/102 (24%), Positives = 40/102 (39%), Gaps = 16/102 (15%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIP-TTIQ 63
           L  L+L  NK+S      FS L  L  L               D   N +  ++     +
Sbjct: 383 LHILNLTKNKISKIESDAFSWLGHLEVL---------------DLGLNEIGQELTGQEWR 427

Query: 64  GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
           GL+++  + L +N+      NSF  + SL+ L L    L  +
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 25/106 (23%), Positives = 40/106 (37%), Gaps = 11/106 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           L  L  L++  N + G     F+ L  L+ L L ++      LT   F            
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL--------- 378

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
                 L  L+L  N++     ++F  L  LE LDL  N + + + 
Sbjct: 379 --AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 19/70 (27%), Positives = 32/70 (45%), Gaps = 3/70 (4%)

Query: 44  LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 103
               D S   L   +P  +    ++  L+L HN+L+     +F     L SLD+  N +S
Sbjct: 6   HEVADCSHLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 104 EIIPLSLEKL 113
           ++ P   +KL
Sbjct: 63  KLEPELCQKL 72

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 93.5 bits (233), Expect = 9e-22
 Identities = 31/176 (17%), Positives = 63/176 (35%), Gaps = 39/176 (22%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV----------ECEVMKSIHHRNLVKIISSCSN 256
           +GRG FG V++         +  K   V          E  ++    HRN++ +  S  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72

Query: 257 EDFRALVLEYMTNGSL------EKVLYS----SNCILDILQRLNIMINVTSALEYLHFGF 306
            +   ++ E+++   +           +     + +  +            AL++LH   
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC----------EALQFLH--- 119

Query: 307 STPIIHCDLKPHNVLLDDNIVAHL--SDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  I H D++P N++      + +   +FG A+ L     +           Y AP
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF--RLLFTAPEYYAP 172

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 95.7 bits (238), Expect = 9e-22
 Identities = 39/177 (22%), Positives = 64/177 (36%), Gaps = 40/177 (22%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISSCS 255
           +G G+FG V++      G  FA K               E + M  + H  LV +  +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 256 NEDFRALVLEYMTNGSL------EKVLYS----SNCILDILQRLNIMINVTSALEYLHFG 305
           +++   ++ E+M+ G L      E    S       +  +             L ++H  
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC----------KGLCHMH-- 272

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHL--SDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                +H DLKP N++        L   DFG+   L    QS+    T  T  + AP
Sbjct: 273 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSV--KVTTGTAEFAAP 325

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 43/184 (23%), Positives = 68/184 (36%), Gaps = 47/184 (25%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------------ECEVMKSIHHRNLVK 249
           +G G F  V K R    G+E+A K                     E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 250 IISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALE 300
           +     N     L+LE ++ G L     +K   S    ++ I  IL            + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL----------DGVN 129

Query: 301 YLHFGFSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 356
           YLH   +  I H DLKP N++L           L DFG+A  +  +           T  
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPE 183

Query: 357 YMAP 360
           ++AP
Sbjct: 184 FVAP 187

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 92.2 bits (230), Expect = 1e-21
 Identities = 47/184 (25%), Positives = 69/184 (37%), Gaps = 47/184 (25%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------------ECEVMKSIHHRNLVK 249
           +G G F  V K R    G E+A K                     E  +++ I H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 250 IISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALE 300
           +     N+    L+LE ++ G L     EK   +    +  +  IL            + 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL----------DGVH 122

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAH----LSDFGIAKLLTGEDQSMTQTQTLATIG 356
           YLH   S  I H DLKP N++L D  V +    L DFGIA  +              T  
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGTPE 176

Query: 357 YMAP 360
           ++AP
Sbjct: 177 FVAP 180

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 36/180 (20%), Positives = 74/180 (41%), Gaps = 30/180 (16%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS------------FDVECEVMKSIHHRNLVK 249
           +G+GSFG VY+   +  ++       AIK+            F  E  VMK  +  ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVL---------YSSNCILDILQRLNIMINVTSALE 300
           ++   S      +++E MT G L+  L                 + + + +   +   + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 47/177 (26%), Positives = 71/177 (40%), Gaps = 40/177 (22%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCS 255
           IGRGS+G V  A      +  A K            F  E E+MKS+ H N++++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 256 NEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALEYLHFGF 306
           +     LV+E  T G L      K ++     +  + D+L          SA+ Y H   
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL----------SAVAYCH--- 123

Query: 307 STPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              + H DLKP N L      +    L DFG+A       + M     + T  Y++P
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMM--RTKVGTPYYVSP 177

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 42/179 (23%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISS 253
           +G+GSFG V K +      E+A+K                 E E++K + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILD-ILQR--------LNIMINVTSALEYLHF 304
             +     +V E  T G L           D I++R          I+  V S + Y+H 
Sbjct: 90  LEDSSSFYIVGELYTGGEL----------FDEIIKRKRFSEHDAARIIKQVFSGITYMH- 138

Query: 305 GFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                I+H DLKP N+LL   + +    + DFG++     ++  M     + T  Y+AP
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYIAP 192

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 34/175 (19%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISS 253
           +G G++G V   R     +E AIK                 E  V+K + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 254 CSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
             ++    LV+E    G L      ++ ++            I+  V S + YLH     
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEV------DAAVIIKQVLSGVTYLH---KH 155

Query: 309 PIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            I+H DLKP N+LL   + + +  + DFG++ +     + M   + L T  Y+AP
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKM--KERLGTAYYIAP 207

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 36/173 (20%), Positives = 68/173 (39%), Gaps = 29/173 (16%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD--------------VECEVMKSIHHRNLVKII 251
            +G+G F   ++         FA K                 +E  + +S+ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
               + DF  +VLE     SL ++      + +   R   +  +    +YLH      +I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI-G---YMAP 360
           H DLK  N+ L++++   + DFG+A  +          +    + G   Y+AP
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAP 184

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 30/206 (14%)

Query: 177 NVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVE 235
           ++A+  P  S        L      F    L+G G++G VYK R ++ G   AIK  DV 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 236 CEVMKSI-----------HHRNLVKIISS------CSNEDFRALVLEYMTNGSLEKVLYS 278
            +  + I           HHRN+     +         +D   LV+E+   GS+  ++ +
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 279 SNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
           +    L       I   +   L +LH      +IH D+K  NVLL +N    L DFG++ 
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177

Query: 338 LLTGEDQSMTQTQTLATIG---YMAP 360
            L    +++ +  T   IG   +MAP
Sbjct: 178 QLD---RTVGRRNTF--IGTPYWMAP 198

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 92.7 bits (230), Expect = 4e-21
 Identities = 32/175 (18%), Positives = 69/175 (39%), Gaps = 25/175 (14%)

Query: 208 IGRG--SFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII 251
           IG+G     +V  AR    G    ++  ++             E  V K  +H N+V   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVL-YSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
           ++   ++   +V  +M  GS + ++       ++ L    I+  V  AL+Y+H       
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLL--TGEDQSMTQTQTLATIG---YMAP 360
           +H  +K  ++L+  +   +LS       +   G+ Q +       ++    +++P
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 36/173 (20%), Positives = 68/173 (39%), Gaps = 29/173 (16%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD--------------VECEVMKSIHHRNLVKII 251
            +G+G F   ++         FA K                 +E  + +S+ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
               + DF  +VLE     SL ++      + +   R   +  +    +YLH      +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI-G---YMAP 360
           H DLK  N+ L++++   + DFG+A  +          +    + G   Y+AP
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAP 210

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 44/176 (25%), Positives = 72/176 (40%), Gaps = 35/176 (19%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRNLVKIIS 252
           +G+GSFG V   +    G E A+K                  E +++K + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 253 SCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
              ++ +  LV E  T G L      +  +S            I+  V S + Y+H    
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV------DAARIIRQVLSGITYMH---K 144

Query: 308 TPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             I+H DLKP N+LL     +    + DFG++       + M     + T  Y+AP
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKM--KDKIGTAYYIAP 197

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.6 bits (228), Expect = 7e-21
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 36/202 (17%)

Query: 175 LPNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSF- 232
           +P V +     +   F   E+LRA         IG+GSFG V   +  D    +A+K   
Sbjct: 2   MPPVFDENEDVNFDHF---EILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMN 49

Query: 233 --------DVEC-----EVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSS 279
                   +V       ++M+ + H  LV +  S  +E+   +V++ +  G L   L  +
Sbjct: 50  KQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN 109

Query: 280 NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
               +   +L I   +  AL+YL    +  IIH D+KP N+LLD++   H++DF IA +L
Sbjct: 110 VHFKEETVKLFIC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165

Query: 340 TGEDQSMTQTQTLA-TIGYMAP 360
             E    TQ  T+A T  YMAP
Sbjct: 166 PRE----TQITTMAGTKPYMAP 183

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 90.9 bits (226), Expect = 8e-21
 Identities = 41/237 (17%), Positives = 84/237 (35%), Gaps = 57/237 (24%)

Query: 163 GLISRCQKRATELPNVANMQPQASRRRFS---YLELLRATNGFSANNLIGRGSFGSVYKA 219
           G +   +   +   N+  +      +      Y  ++R          + +G F  +   
Sbjct: 1   GPLGSMKDILSNYSNLIYLNKYVKEKDKYINDY-RIIR---------TLNQGKFNKIILC 50

Query: 220 RLQDGMEFAIKSFD----------------------------VECEVMKSIHHRNLVKII 251
             +D   +A+K ++                             E +++  I +   +   
Sbjct: 51  E-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109

Query: 252 SSCSNEDFRALVLEYMTNGSL-------EKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
              +N D   ++ EYM N S+         +  +  C + I     I+ +V ++  Y+H 
Sbjct: 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN 169

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             +  I H D+KP N+L+D N    LSDFG ++ +  +       +    T  +M P
Sbjct: 170 EKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGSRGTYEFMPP 219

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 90.4 bits (225), Expect = 9e-21
 Identities = 45/184 (24%), Positives = 69/184 (37%), Gaps = 47/184 (25%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------------ECEVMKSIHHRNLVK 249
           +G G F  V K R    G+++A K                     E  ++K I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 250 IISSCSNEDFRALVLEYMTNGSL-----EKVLYS----SNCILDILQRLNIMINVTSALE 300
           +     N+    L+LE +  G L     EK   +    +  +  IL          + + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL----------NGVY 128

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAH----LSDFGIAKLLTGEDQSMTQTQTLATIG 356
           YLH   S  I H DLKP N++L D  V      + DFG+A  +              T  
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEF--KNIFGTPE 182

Query: 357 YMAP 360
           ++AP
Sbjct: 183 FVAP 186

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 50/213 (23%), Positives = 74/213 (34%), Gaps = 63/213 (29%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV----------------ECEVMKSIHHRNLVKI 250
           IG+GS+G V  A   Q     AIK  +                 E  +MK +HH N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 251 ISSCSNEDFRALVLEYMTNGSL-----EKVLYSSNCILDILQRL---------------- 289
                +E +  LV+E    G L       +  S+      + +                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 290 ------------------NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL- 330
                             NIM  + SAL YLH   +  I H D+KP N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 331 -SDFGIAKLLTGEDQSMTQT-QTLA-TIGYMAP 360
             DFG++K     +        T A T  ++AP
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 38/178 (21%), Positives = 68/178 (38%), Gaps = 37/178 (20%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSI-HHRNLVKIIS 252
           +GRG F  V +      G E+A K                 E  V++       ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 253 SCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRL------NIMINVTSALEYLHFG 305
              N     L+LEY   G +         C+ ++ + +       ++  +   + YLH  
Sbjct: 97  VYENTSEIILILEYAAGGEIFSL------CLPELAEMVSENDVIRLIKQILEGVYYLH-- 148

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAH---LSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
               I+H DLKP N+LL          + DFG+++ + G    +   + + T  Y+AP
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACEL--REIMGTPEYLAP 202

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 89.1 bits (222), Expect = 1e-20
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 22/170 (12%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD--------------VECEVMKSIHHRNLVKII 251
           L+G+GSF  VY+A  +  G+E AIK  D               E ++   + H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
           +   + ++  LVLE   NG + + L +        +  + M  + + + YLH   S  I+
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           H DL   N+LL  N+   ++DFG+A  L    +      TL  T  Y++P
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISP 181

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 41/183 (22%), Positives = 74/183 (40%), Gaps = 36/183 (19%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++            A+K+            F +E  ++   +H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSS------NCILDILQRLNIMINVTSALEYL- 302
            I        R +++E M  G L+  L  +         L +L  L++  ++    +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 303 --HFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 358 MAP 360
           M P
Sbjct: 212 MPP 214

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 42/179 (23%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSF----DVECEV---MKSIHHRNLVKII----SSCS 255
           +G G  G V +    +   +FA+K          EV    ++    ++V+I+    +  +
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 129

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILD-ILQRLN----------IMINVTSALEYLHF 304
                 +V+E +  G L             I  R +          IM ++  A++YLH 
Sbjct: 130 GRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 178

Query: 305 GFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  I H D+KP N+L      N +  L+DFG AK  T  +   T      T  Y+AP
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAP 232

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 88.8 bits (221), Expect = 2e-20
 Identities = 40/189 (21%), Positives = 73/189 (38%), Gaps = 42/189 (22%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS------------FDVECEVMKSIHHRNLVK 249
           +G   FG VYK  L            AIK+            F  E  +   + H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVL---------------YSSNCILDILQRLNIMIN 294
           ++   + +   +++  Y ++G L + L                +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 295 VTSALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           + + +EYL   H       +H DL   NVL+ D +   +SD G+ + +   D       +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 352 LATIGYMAP 360
           L  I +MAP
Sbjct: 191 LLPIRWMAP 199

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 88.8 bits (221), Expect = 2e-20
 Identities = 51/208 (24%), Positives = 80/208 (38%), Gaps = 47/208 (22%)

Query: 182 QPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF-------- 232
              + R    +   +     F     +G G+FG V+       G+E  IK+         
Sbjct: 6   HHSSGRENLYFQGTIDDL--FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63

Query: 233 --DV--ECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD-ILQ 287
              +  E EV+KS+ H N++KI     +     +V+E    G L          L+ I+ 
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----------LERIVS 113

Query: 288 RL------------NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSD 332
                          +M  + +AL Y H   S  ++H DLKP N+L      +    + D
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIID 170

Query: 333 FGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           FG+A+L    D+    T    T  YMAP
Sbjct: 171 FGLAELF-KSDEHS--TNAAGTALYMAP 195

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 88.0 bits (219), Expect = 4e-20
 Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 25/170 (14%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD--------------VECEVMKSIHHRNLVKII 251
            +G+G FG+VY AR  Q+    A+K                  E E+   + H N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
           +   +     L+LE+   G L K L       +       M  +  AL Y H      +I
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCH---ERKVI 136

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           H D+KP N+L+       ++DFG +           + +T+  T+ Y+ P
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPP 181

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 42/183 (22%), Positives = 74/183 (40%), Gaps = 36/183 (19%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS------------FDVECEVMKSIHHRNLVK 249
           +G G+FG VY+ ++            A+K+            F +E  ++   +H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSS------NCILDILQRLNIMINVTSALEYL- 302
            I        R ++LE M  G L+  L  +         L +L  L++  ++    +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 303 --HFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 357
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 358 MAP 360
           M P
Sbjct: 253 MPP 255

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 45/192 (23%), Positives = 74/192 (38%), Gaps = 53/192 (27%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFD------------------------VECEVMK 240
             +G G++G V   +      E AIK                            E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 241 SIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD-ILQR--------LNI 291
           S+ H N++K+     ++ +  LV E+   G L           + I+ R         NI
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----------FEQIINRHKFDECDAANI 151

Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           M  + S + YLH      I+H D+KP N+LL   +  +   + DFG++     +D  +  
Sbjct: 152 MKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKL-- 205

Query: 349 TQTLATIGYMAP 360
              L T  Y+AP
Sbjct: 206 RDRLGTAYYIAP 217

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 88.1 bits (219), Expect = 5e-20
 Identities = 47/188 (25%), Positives = 78/188 (41%), Gaps = 41/188 (21%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS-----------FDVECEVMKSIHHRNLVKI 250
           +G G+FG V+ A   +          A+K+           F  E E++ ++ H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVL---------------YSSNCILDILQRLNIMINV 295
              C + D   +V EYM +G L K L                 +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 296 TSALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
            S + YL   HF      +H DL   N L+  N++  + DFG+++ +   D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 353 ATIGYMAP 360
             I +M P
Sbjct: 197 LPIRWMPP 204

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 41/180 (22%), Positives = 73/180 (40%), Gaps = 43/180 (23%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSF----DVECEV---MKSIHHRNLVKII----SSC 254
           ++G G  G V +    + G + A+K          EV    ++    ++V I+    +  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH 95

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILD-ILQRLN----------IMINVTSALEYLH 303
             +    +++E M  G L             I +R +          IM ++ +A+++LH
Sbjct: 96  HGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 304 FGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              S  I H D+KP N+L    + + V  L+DFG AK       ++       T  Y+AP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCYTPYYVAP 198

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 87.7 bits (218), Expect = 8e-20
 Identities = 44/187 (23%), Positives = 77/187 (41%), Gaps = 40/187 (21%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS-----------FDVECEVMKSIHHRNLVKI 250
           +G G+FG V+ A   + +        A+K+           F  E E++  + H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSS--------------NCILDILQRLNIMINVT 296
              C+      +V EYM +G L + L S                  L + Q L +   V 
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 297 SALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 353
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 354 TIGYMAP 360
            I +M P
Sbjct: 223 PIRWMPP 229

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 25/121 (20%), Positives = 40/121 (33%), Gaps = 9/121 (7%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
           L  L  LDL   ++       F +   L  L L +N L  +          L    F + 
Sbjct: 56  LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT 115

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 112
            +       +   K+L+ L LG N +             L+ LD  NN +  +    +  
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175

Query: 113 L 113
           L
Sbjct: 176 L 176

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 29/125 (23%), Positives = 46/125 (36%), Gaps = 13/125 (10%)

Query: 2   LAALFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSNELRHLV---------LTRTDFSR 51
              L  LDL   +L      + F NL  L+ L+L  + L             L   +   
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458

Query: 52  NNLLGDI---PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 108
           N+          ++Q L  L+ L L    L     ++F  L  +  +DLS+N L+     
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518

Query: 109 SLEKL 113
           +L  L
Sbjct: 519 ALSHL 523

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 22/106 (20%), Positives = 31/106 (29%), Gaps = 15/106 (14%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           L+   N L     T FS L  L  L L   ++  +                  T Q    
Sbjct: 38  LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI---------------HEDTFQSQHR 82

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           L  L L  N L      +     +L+ L      +S I  + L   
Sbjct: 83  LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQ 128

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 34/124 (27%), Positives = 51/124 (41%), Gaps = 12/124 (9%)

Query: 2   LAALFQLDLRGNKL--SGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFS 50
           L  L +LDL  + +  S        NL+ L++L+L  NE   L          L   D +
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408

Query: 51  RNNLLG-DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
              L   D  +  Q L  L+ L+L H+ L  S    FD L +L+ L+L  N+  +     
Sbjct: 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK 468

Query: 110 LEKL 113
              L
Sbjct: 469 TNSL 472

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 29/121 (23%), Positives = 45/121 (37%), Gaps = 12/121 (9%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRT----------DFSR 51
           L+ L +L L  NK         SN  +L +L +  N  R  + T            D S 
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359

Query: 52  NNL--LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
           +++         ++ L  LQ L+L +N        +F +   LE LDL+   L      S
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419

Query: 110 L 110
            
Sbjct: 420 P 420

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 33/124 (26%), Positives = 49/124 (39%), Gaps = 13/124 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV------------LTRTDF 49
           L  L  L+L  + L  S    F  L AL++L+L  N                  L     
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483

Query: 50  SRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
           S  +L          LK +  + L HNRL  S   +   L  +  L+L++N++S I+P  
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSL 542

Query: 110 LEKL 113
           L  L
Sbjct: 543 LPIL 546

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 22/126 (17%), Positives = 41/126 (32%), Gaps = 11/126 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
              L  L L  N L     T  S   AL++L      +  +          L       N
Sbjct: 80  QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLE--SLDLSNNNLSEIIPLSL 110
           ++           + L+ L   +N +          L      SL+L+ N+++ I P + 
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF 199

Query: 111 EKLLLE 116
           +  + +
Sbjct: 200 DSAVFQ 205

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 18/103 (17%), Positives = 36/103 (34%), Gaps = 16/103 (15%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQG 64
           +  ++L+ +         F   + L+ L L +  L                  +P+ + G
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE----------------LPSGLVG 299

Query: 65  LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
           L +L+ L L  N+ +     S  +  SL  L +  N     + 
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 18/112 (16%), Positives = 32/112 (28%), Gaps = 14/112 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           + +L+             P  F  L  +    +             +  ++        T
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI-------------NLQKHYFFNISSNT 273

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
                 LQ L L    L   +P+    L +L+ L LS N    +  +S    
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 26/114 (22%), Positives = 40/114 (35%), Gaps = 13/114 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTC---FSNLTALRNLHLDSNELRHLV---------LTRTDF 49
           L AL  L+L+GN               L  L  L L   +L  +          +   D 
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDL 507

Query: 50  SRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 103
           S N L       +  LK +  L+L  N +   +P+    L    +++L  N L 
Sbjct: 508 SHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLD 560

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 22/111 (19%), Positives = 44/111 (39%), Gaps = 14/111 (12%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-----------LTRTDFSRNNLLG 56
           L+L GN ++  I     +    ++L+    +   ++           L    F   +   
Sbjct: 184 LNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242

Query: 57  DIPTTIQGLK--SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
             P   +GL   S++ ++L  +       N+F     L+ LDL+  +LSE+
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL 293

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 21/106 (19%), Positives = 34/106 (32%), Gaps = 18/106 (16%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
            +     L+  IP    N      L    N L  +                 TT   L +
Sbjct: 17  YNCENLGLN-EIPGTLPNS--TECLEFSFNVLPTI---------------QNTTFSRLIN 58

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           L FL L   ++     ++F     L++L L+ N L  +   +L   
Sbjct: 59  LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 26/132 (19%), Positives = 50/132 (37%), Gaps = 17/132 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLTRTDFSR 51
              L  L+L  N+++            + NL    N+L+++          V++  DFS 
Sbjct: 352 EIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSY 411

Query: 52  NNL-------LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 104
           N +          +  T     ++  ++L +N++       F     L S++L  N L+E
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

Query: 105 IIPLSLEKLLLE 116
           I   SL+     
Sbjct: 472 IPKNSLKDENEN 483

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 26/124 (20%), Positives = 50/124 (40%), Gaps = 19/124 (15%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-----------------L 44
           L  L  +++        +PT    L  ++ +++  N                       +
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307

Query: 45  TRTDFSRNNLL-GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 103
                  NNL    + T++Q +K L  L   +N+L+G +P +F   + L SL+L+ N ++
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT 366

Query: 104 EIIP 107
           EI  
Sbjct: 367 EIPA 370

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 24/113 (21%), Positives = 40/113 (35%), Gaps = 13/113 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           L  L  +DL  N  S   PT   N + L+   + +           D   N  L + P  
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR---------DAQGNRTLREWPEG 561

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           I    SL  L +G N ++  +        ++  LD+ +N    I    +   +
Sbjct: 562 ITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYI 611

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 26/135 (19%), Positives = 44/135 (32%), Gaps = 24/135 (17%)

Query: 2   LAALFQLDLRGNKLSG-------SIPTCFSNLTALRNLHLDSNELRHL----------VL 44
            + L  ++L GN L+             F N   L ++ L  N+L  L           L
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYL 515

Query: 45  TRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH------NRLQGSIPNSFDDLVSLESLDLS 98
              D S  N     PT      +L+   + +      NR     P       SL  L + 
Sbjct: 516 VGIDLS-YNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574

Query: 99  NNNLSEIIPLSLEKL 113
           +N++ ++       +
Sbjct: 575 SNDIRKVNEKITPNI 589

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 19/125 (15%), Positives = 38/125 (30%), Gaps = 13/125 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN---ELRHLV-LTRTDFSRNNLLGD 57
           L  L Q  +  +                           +  +L  LT  +      L  
Sbjct: 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264

Query: 58  IPTTIQGLKSLQFLSLGHNRL--------QGSIPNSFDDLVSLESLDLSNNNLSEI-IPL 108
           +PT ++ L  +Q +++  NR                      ++ + +  NNL    +  
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324

Query: 109 SLEKL 113
           SL+K+
Sbjct: 325 SLQKM 329

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 14/113 (12%), Positives = 35/113 (30%), Gaps = 5/113 (4%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTR----TDFSRNNLLGDIPTTI 62
           Q+    N ++  +      LT LR  ++ ++      +       +              
Sbjct: 187 QIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245

Query: 63  QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLL 115
             LK L  + + +      +P     L  ++ ++++ N       L  +   L
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 19/130 (14%), Positives = 39/130 (30%), Gaps = 24/130 (18%)

Query: 2   LAALFQLDLRGNKLSG-SIPTCFSNLTALRNLHLDSNELRHLV----------------L 44
              +  L    NKL          +++ +  +    NE+  +                 +
Sbjct: 376 TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435

Query: 45  TRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG-------SIPNSFDDLVSLESLDL 97
           +  + S N +             L  ++L  N L             +F +   L S+DL
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495

Query: 98  SNNNLSEIIP 107
             N L+++  
Sbjct: 496 RFNKLTKLSD 505

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 19/104 (18%), Positives = 34/104 (32%), Gaps = 17/104 (16%)

Query: 5   LFQLDLRGNKL-SGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQ 63
           +  + +  N L +  + T    +  L  L                   N L G +P    
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLEC---------------LYNQLEGKLPA-FG 350

Query: 64  GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
               L  L+L +N++     N       +E+L  ++N L  I  
Sbjct: 351 SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPN 394

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 21/122 (17%), Positives = 38/122 (31%), Gaps = 16/122 (13%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH-------------LVLTRTDFSRNN 53
            L L G   SG +P     LT L  L L S+  +              +   +    R +
Sbjct: 85  GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMH 144

Query: 54  LLGDIPTTIQGLK--SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
                           L    +  +  Q SI  S    +    +   +NN++  +  ++ 
Sbjct: 145 YQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVM 203

Query: 112 KL 113
           +L
Sbjct: 204 RL 205

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 15/128 (11%), Positives = 34/128 (26%), Gaps = 35/128 (27%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQG 64
           L +  +  +    SI            +   SN +                  +   +  
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF----------------VSKAVMR 204

Query: 65  LKSLQFLSLGHNRLQG-------------------SIPNSFDDLVSLESLDLSNNNLSEI 105
           L  L+   +G++                       +    +D+L  L  +++ N      
Sbjct: 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264

Query: 106 IPLSLEKL 113
           +P  L+ L
Sbjct: 265 LPTFLKAL 272

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 15/105 (14%), Positives = 30/105 (28%), Gaps = 18/105 (17%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
                 Q D +GN+     P   +   +L  L + SN++R                 +  
Sbjct: 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK----------------VNE 583

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
            I    ++  L +  N       +     +      L  +   +I
Sbjct: 584 KI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDI 626

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 12/76 (15%), Positives = 22/76 (28%), Gaps = 4/76 (5%)

Query: 44  LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQG----SIPNSFDDLVSLESLDLSN 99
           +T          G +P  I  L  L+ L+LG +  +       P      +S E      
Sbjct: 83  VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142

Query: 100 NNLSEIIPLSLEKLLL 115
            +  +       +   
Sbjct: 143 MHYQKTFVDYDPREDF 158

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 38/190 (20%), Positives = 71/190 (37%), Gaps = 41/190 (21%)

Query: 206 NLIGRGSFGSVYKARLQDGMEF------AIKS------------FDVECEVMKSI-HHRN 246
             +G G+FG V +A      +       A+K                E ++M  +  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSL-------------EKVLYSSNCILDILQRLNIMI 293
           +V ++ +C++     ++ EY   G L             +     +N        L+   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 294 NVTSALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
            V   + +L   +       IH D+   NVLL +  VA + DFG+A+ +  +   + +  
Sbjct: 172 QVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 351 TLATIGYMAP 360
               + +MAP
Sbjct: 226 ARLPVKWMAP 235

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 37/186 (19%)

Query: 206 NLIGRGSFGSVYKARLQDG---MEFAIKS------------FDVECEVMKSI-HHRNLVK 249
           ++IG G+FG V KAR++     M+ AIK             F  E EV+  + HH N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVL---------------YSSNCILDILQRLNIMIN 294
           ++ +C +  +  L +EY  +G+L   L                S+   L   Q L+   +
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
           V   ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +T     
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204

Query: 355 IGYMAP 360
           + +MA 
Sbjct: 205 VRWMAI 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 87.6 bits (217), Expect = 5e-19
 Identities = 44/178 (24%), Positives = 73/178 (41%), Gaps = 28/178 (15%)

Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------DVEC--------EVMKSIH 243
           FS + +IGRG FG VY  R  D G  +A+K                        ++ +  
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
              +V +  +    D  + +L+ M  G L   L       +   R      +   LE++H
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMH 309

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
              +  +++ DLKP N+LLD++    +SD G+A   + +     +      T GYMAP
Sbjct: 310 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 86.3 bits (213), Expect = 6e-19
 Identities = 26/201 (12%), Positives = 57/201 (28%), Gaps = 51/201 (25%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK----------------------------------- 230
           ++G+    +  +A   + G  F +                                    
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 231 ----SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM-TNGSLEKVL------YSS 279
                F    +++K    + ++++     +    +    Y     +L+          S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 280 NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
           +  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 340 TGEDQSMTQTQTLATIGYMAP 360
            G        +  A     A 
Sbjct: 262 -GASAVSPIGRGFAPPETTAE 281

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 28/122 (22%), Positives = 42/122 (34%), Gaps = 10/122 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRT----------DFSR 51
           L  L  LD+            F  LT+L  L +  N  +   L+            D S+
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
             L          L  LQ L++ HN L     + ++ L SL +LD S N +     +   
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542

Query: 112 KL 113
             
Sbjct: 543 FP 544

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 29/122 (23%), Positives = 46/122 (37%), Gaps = 10/122 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
            + L  LDL   ++       +  L  L NL L  N ++            L        
Sbjct: 55  FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
            L       I  L +L+ L++ HN +    +P  F +L +L  +DLS N +  I    L+
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174

Query: 112 KL 113
            L
Sbjct: 175 FL 176

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 28/106 (26%), Positives = 39/106 (36%), Gaps = 15/106 (14%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           +DL  N L       FSN + L+ L L   E+  +                     GL  
Sbjct: 37  IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI---------------EDKAWHGLHH 81

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           L  L L  N +Q   P SF  L SLE+L      L+ +    + +L
Sbjct: 82  LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQL 127

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 35/133 (26%), Positives = 51/133 (38%), Gaps = 19/133 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
           L  L  L L GN +    P  FS LT+L NL     +L  L          L + + + N
Sbjct: 79  LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN 138

Query: 53  NLLG-DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDL----VSLESLDLSNNNLSEIIP 107
            +    +P     L +L  + L +N +Q    N    L        SLD+S N +  I  
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQD 198

Query: 108 -----LSLEKLLL 115
                + L +L L
Sbjct: 199 QAFQGIKLHELTL 211

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 74.7 bits (184), Expect = 8e-15
 Identities = 29/124 (23%), Positives = 48/124 (38%), Gaps = 11/124 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNL--TALRNLHLDSNELRHLV--------LTRTDFSR 51
           L +L  LDL  N LS S    +S+L   +LR+L L  N    +         L   DF  
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQH 408

Query: 52  NNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
           + L           L+ L +L + +   +      F  L SL +L ++ N+  +    ++
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468

Query: 111 EKLL 114
               
Sbjct: 469 FANT 472

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 28/117 (23%), Positives = 38/117 (32%), Gaps = 10/117 (8%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFS------RNNLLGDI 58
           + +  L            F  L  +  + L    +++L      F           L   
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQF 322

Query: 59  PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLL 115
           PT    L  L+ L+L  N+   SI      L SL  LDLS N LS     S   L  
Sbjct: 323 PT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 26/133 (19%), Positives = 46/133 (34%), Gaps = 16/133 (12%)

Query: 5   LFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQ 63
           L +L LRGN  S +I  TC  NL  L    L   E +            NL    P+ ++
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE---------RNLEIFEPSIME 256

Query: 64  GLKSLQF--LSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL----SLEKLLLEG 117
           GL  +      L +          F  L ++ ++ L+  ++  +  +      + L +  
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIR 316

Query: 118 EIPRGGPFTKFSS 130
              +  P      
Sbjct: 317 CQLKQFPTLDLPF 329

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 32/173 (18%), Positives = 50/173 (28%), Gaps = 31/173 (17%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV------LTRTDFSRNNLL 55
           LA +  + L G  +              ++L +   +L+         L     + N   
Sbjct: 284 LANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKG- 340

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDL--VSLESLDLSNNNLSEIIPL----- 108
             I      L SL +L L  N L  S   S+ DL   SL  LDLS N    +        
Sbjct: 341 -SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLE 399

Query: 109 SLEKLLLEG----EIPRGGPFTKFSS----------KSFIGNDLLCGSPNLQV 147
            L+ L  +      +     F                    + +  G  +L  
Sbjct: 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT 452

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 2/63 (3%)

Query: 51  RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
            +  L  +P  I    S + + L  N L+     SF +   L+ LDLS   +  I   + 
Sbjct: 19  MDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAW 76

Query: 111 EKL 113
             L
Sbjct: 77  HGL 79

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 50/197 (25%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS------------FDVECEVMKSIHHRNLVK 249
           IG G+FG V++AR    + +      A+K             F  E  +M    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSS-----------------------NCILDIL 286
           ++  C+      L+ EYM  G L + L S                           L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 287 QRLNIMINVTSALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           ++L I   V + + YL    F      +H DL   N L+ +N+V  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 344 QSMTQTQTLATIGYMAP 360
                      I +M P
Sbjct: 229 YYKADGNDAIPIRWMPP 245

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 25/178 (14%)

Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------DVEC-----EVMKSIHHRN 246
           F    ++GRG FG V+  +++  G  +A K             +      +++  +H R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL--QRLNIMIN-VTSALEYLH 303
           +V +  +   +    LV+  M  G +   +Y+ +         R       + S LE+LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
                 II+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G+MAP
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFMAP 358

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 41/197 (20%), Positives = 75/197 (38%), Gaps = 50/197 (25%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS------------FDVECEVMKSIHHRNLVK 249
           +G G FG V KA              A+K                E  V+K ++H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSS-----------------------NCILDIL 286
           +  +CS +    L++EY   GSL   L  S                          L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 287 QRLNIMINVTSALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
             ++    ++  ++YL           +H DL   N+L+ +     +SDFG+++ +  ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 344 QSMTQTQTLATIGYMAP 360
             + ++Q    + +MA 
Sbjct: 205 SYVKRSQGRIPVKWMAI 221

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 43/154 (27%), Positives = 64/154 (41%), Gaps = 18/154 (11%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG GS+G V+K R    G   AIK F    +             ++K + H NLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              +    LV EY  + ++   L      +      +I      A+ + H       IH 
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT 347
           D+KP N+L+  + V  L DFG A+LLTG      
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 39/161 (24%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSF----DVECEV---MKSIHHRNLVKII----SSCS 255
           +G G  G V +    +   +FA+K          EV    ++    ++V+I+    +  +
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 85

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILD-ILQRLN----------IMINVTSALEYLHF 304
                 +V+E +  G L             I  R +          IM ++  A++YLH 
Sbjct: 86  GRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 134

Query: 305 GFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGE 342
             S  I H D+KP N+L      N +  L+DFG AK  TGE
Sbjct: 135 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 27/181 (14%), Positives = 55/181 (30%), Gaps = 35/181 (19%)

Query: 2   LAALFQLDLRGNKLS-------GSIPTCFSNLTALRNLHLDSNELRHL----------VL 44
            + +  + L  N ++             + N   L  + L  N+L  L           L
Sbjct: 696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYL 755

Query: 45  TRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH------NRLQGSIPNSFDDLVSLESLDLS 98
           +  D S  N     PT       L+   + H      NR+    P       SL  L + 
Sbjct: 756 SNMDVS-YNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814

Query: 99  NNNLSEIIPLSLEKL---------LLEGEIPRGGPFTKFSSKSFIGND--LLCGSPNLQV 147
           +N++ ++      +L          +  ++    P+ +      + +    + G   L +
Sbjct: 815 SNDIRKVDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGI 874

Query: 148 P 148
            
Sbjct: 875 E 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 19/117 (16%), Positives = 42/117 (35%), Gaps = 5/117 (4%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----VLTRTDFSRNNLLGDIPTTI 62
           Q+    N+++  I      LT L+ ++  ++   +          +        +   + 
Sbjct: 429 QIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487

Query: 63  QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEI 119
             LK L  + L +      +P+   DL  L+SL+++ N       L  +   L  + 
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 80.7 bits (199), Expect = 9e-17
 Identities = 21/119 (17%), Positives = 38/119 (31%), Gaps = 11/119 (9%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           L  L  ++L        +P    +L  L++L++  N                    +   
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA------AQLKADWTRLADD 543

Query: 62  IQGLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIPL----SLEKLLL 115
                 +Q   +G+N L+      S   +V L  LD  +N +  +        L  L L
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEAFGTNVKLTDLKL 602

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 23/127 (18%), Positives = 45/127 (35%), Gaps = 15/127 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLTRTDFSR 51
              L  L L  N++        +    +  L    N+L+++          V+   DFS 
Sbjct: 594 NVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSY 653

Query: 52  NNLLGDIPTT-----IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII 106
           N +  +              +   ++L +N +Q      F     + ++ LSNN ++ I 
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713

Query: 107 PLSLEKL 113
             SL+  
Sbjct: 714 ENSLKPK 720

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 21/119 (17%), Positives = 38/119 (31%), Gaps = 25/119 (21%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQG 64
               +    K   +    +SNL  L ++ L                    +  +P  +  
Sbjct: 469 WEDANSDYAKQYENEELSWSNLKDLTDVEL---------------YNCPNMTQLPDFLYD 513

Query: 65  LKSLQFLSLGHNRLQG---------SIPNSFDDLVSLESLDLSNNNLSEI-IPLSLEKL 113
           L  LQ L++  NR             + +  D    ++   +  NNL E     SL+K+
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKM 572

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 19/123 (15%), Positives = 35/123 (28%), Gaps = 21/123 (17%)

Query: 2   LAALFQLDLRGNKLSG---------SIPTCFSNLTALRNLHLDSNELRHLV--------- 43
           L  L  L++  N+             +         ++  ++  N L             
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573

Query: 44  -LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 102
            L   D   N +             L  L L +N+++    +       +E L  S+N L
Sbjct: 574 KLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL 631

Query: 103 SEI 105
             I
Sbjct: 632 KYI 634

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 16/147 (10%), Positives = 36/147 (24%), Gaps = 38/147 (25%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNEL---------RHLVLTRTDFSRNNLLGD 57
            L L G    G +P     LT L+ L   ++             L    ++  ++ +   
Sbjct: 327 GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386

Query: 58  I-PTTIQGLKSLQFLSLGHNRLQG----------------------------SIPNSFDD 88
                +   + L    L  + +                               I  +   
Sbjct: 387 YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQR 446

Query: 89  LVSLESLDLSNNNLSEIIPLSLEKLLL 115
           L  L+ +  +N+  +        +   
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDAN 473

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 17/113 (15%), Positives = 31/113 (27%), Gaps = 18/113 (15%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
                 Q D  GN++    PT  +   +L  L + SN++R                 +  
Sbjct: 780 AFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK----------------VDE 823

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
            +     L  L +  N        S    +      L  +   +I       +
Sbjct: 824 KL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGI 874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 16/112 (14%), Positives = 33/112 (29%), Gaps = 4/112 (3%)

Query: 36  SNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESL 95
            N   H +    +   +         +     +  LSL     +G +P++   L  L+ L
Sbjct: 293 INNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVL 352

Query: 96  DLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQV 147
               ++ +    L  ++ L     P      K   +       L     L +
Sbjct: 353 SFGTHSETVSGRLFGDEELT----PDMSEERKHRIRMHYKKMFLDYDQRLNL 400

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 17/129 (13%), Positives = 38/129 (29%), Gaps = 13/129 (10%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE------LRHLVLTRTDFSR-NNLLGD 57
             ++ +   K+        +    L++    + E         + L  T      N +  
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF 439

Query: 58  IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN------NLSEIIPLSLE 111
           I   IQ L  LQ +   ++           +  + +      N      NL ++  + L 
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499

Query: 112 KLLLEGEIP 120
                 ++P
Sbjct: 500 NCPNMTQLP 508

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.9 bits (119), Expect = 8e-07
 Identities = 19/149 (12%), Positives = 37/149 (24%), Gaps = 28/149 (18%)

Query: 13  NKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLS 72
           +           N   +  L L               +     G +P  I  L  L+ LS
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSL---------------AGFGAKGRVPDAIGQLTELKVLS 353

Query: 73  LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP------------LSLEKLLLEGEIP 120
            G +    S     D+ ++ +  +   + +                   L +  +    P
Sbjct: 354 FGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNP 412

Query: 121 RGGPFTKFSSKSFIGNDLLCGSPNLQVPP 149
              P  K S  S     +   +  +    
Sbjct: 413 EMKPIKKDSRISLKDTQIGNLTNRITFIS 441

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 43/184 (23%), Positives = 77/184 (41%), Gaps = 41/184 (22%)

Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------DVEC-----EVMKSIHHRN 246
           +    +IGRG+FG V   R +     +A+K           D        ++M   +   
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMIN--------VTSA 298
           +V++  +  ++ +  +V+EYM  G L          ++++   ++           V  A
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLA 180

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTLATIG 356
           L+ +H   S   IH D+KP N+LLD +   H  L+DFG    +  E      T  + T  
Sbjct: 181 LDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDT-AVGTPD 234

Query: 357 YMAP 360
           Y++P
Sbjct: 235 YISP 238

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 38/189 (20%), Positives = 72/189 (38%), Gaps = 39/189 (20%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS------------FDVECEVMKSI-HHRNLV 248
           +G G+FG V +A     ++       A+K                E +V+  + +H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 249 KIISSCSNEDFRALVLEYMTNGSL-----------------EKVLYSSNCILDILQRLNI 291
            ++ +C+      ++ EY   G L                   ++      LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
              V   + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 208 RLPVKWMAP 216

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 42/189 (22%), Positives = 75/189 (39%), Gaps = 39/189 (20%)

Query: 208 IGRGSFGSVYKARLQDGMEF--------AIKS------------FDVECEVMKSI-HHRN 246
           +G G+FG V  A      +         A+K                E E+MK I  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSL---------------EKVLYSSNCILDILQRLNI 291
           ++ ++ +C+ +    +++EY + G+L                 +       +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
              +   +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 38/188 (20%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS------------FDVECEVMKSI-HHRNLV 248
           +GRG+FG V +A      +       A+K                E +++  I HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 249 KIISSCSNEDF-RALVLEYMTNGSLEKVLYSS---------------NCILDILQRLNIM 292
            ++ +C+       +++E+   G+L   L S                   L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 293 INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
             V   +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   + +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 353 ATIGYMAP 360
             + +MAP
Sbjct: 212 LPLKWMAP 219

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 26/201 (12%), Positives = 60/201 (29%), Gaps = 56/201 (27%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK----------------------------------- 230
           ++G+    +  +A   + G  F +                                    
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 231 ----SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM-TNGSLEKVL------YSS 279
                F    +++K    + ++++     +    +    Y     +L+          S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 280 NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL 339
           +  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 340 TGEDQSMTQTQTLATIGYMAP 360
              D +   +    + G+  P
Sbjct: 255 --RDGARVVSSV--SRGFEPP 271

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 22/157 (14%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDV-------ECEVMKSIHHRNLVK----IISSCSN 256
           IG GSFG V++A+L +  E AIK           E ++M+ + H N+V       S+   
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107

Query: 257 EDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNI---MINVTSALEYLHFGFSTPII 311
           +D     LVLEY+   ++ +       +   +  L I   M  +  +L Y+H   S  I 
Sbjct: 108 KDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGIC 163

Query: 312 HCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMT 347
           H D+KP N+LLD  + V  L DFG AK+L    +   
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNV 199

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 40/186 (21%), Positives = 76/186 (40%), Gaps = 43/186 (23%)

Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------DVEC-----EVMKSIHHRN 246
           F    +IGRG+FG V   +L++    FA+K           +  C     +V+ +   + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMIN----------VT 296
           +  +  +  +++   LV++Y   G L          L +L +    +           + 
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAEMV 185

Query: 297 SALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTLAT 354
            A++ +H       +H D+KP N+L+D N   H  L+DFG    L  +    +    + T
Sbjct: 186 IAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGT 239

Query: 355 IGYMAP 360
             Y++P
Sbjct: 240 PDYISP 245

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 24/171 (14%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF---------DVEC-----EVMKSIHHRNLVKII 251
           ++G+G FG V   +++  G  +A K                    ++++ ++ R +V + 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMIN-VTSALEYLHFGFSTPI 310
            +   +D   LVL  M  G L+  +Y          R       +   LE LH      I
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERI 307

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
           ++ DLKP N+LLDD+    +SD G+A  +          +    T+GYMAP
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAP 354

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 43/189 (22%), Positives = 76/189 (40%), Gaps = 39/189 (20%)

Query: 208 IGRGSFGSVYKARLQDGMEF--------AIKS------------FDVECEVMKSI-HHRN 246
           +G G+FG V  A      +         A+K                E E+MK I  H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSL---------------EKVLYSSNCILDILQRLNI 291
           ++ ++ +C+ +    +++EY + G+L                   ++    L     ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 292 MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
              V   +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 352 LATIGYMAP 360
              + +MAP
Sbjct: 254 RLPVKWMAP 262

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 83.2 bits (206), Expect = 7e-18
 Identities = 42/181 (23%), Positives = 76/181 (41%), Gaps = 43/181 (23%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF---------DVEC-----EVMKSIHHRNLVKII 251
           +IGRG+F  V   +++  G  +A+K           +V C     +V+ +   R + ++ 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMIN----------VTSALEY 301
            +  +E++  LV+EY   G L          L +L +    I           +  A++ 
Sbjct: 128 FAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           +H       +H D+KP N+LLD     H  L+DFG    L  +    +    + T  Y++
Sbjct: 178 VH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLS 231

Query: 360 P 360
           P
Sbjct: 232 P 232

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 82.8 bits (205), Expect = 7e-18
 Identities = 42/192 (21%), Positives = 75/192 (39%), Gaps = 45/192 (23%)

Query: 208 IGRGSFGSVYKARLQDGMEF--------AIKS------------FDVECEVMKSI-HHRN 246
           +G G FG V  A      +         A+K                E E+MK I  H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSS---------------NCILDILQRLNI 291
           ++ ++ +C+ +    +++EY + G+L + L +                   +     ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 292 MINVTSALEYL---HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
              +   +EYL           IH DL   NVL+ +N V  ++DFG+A+ +   D     
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 349 TQTLATIGYMAP 360
           T     + +MAP
Sbjct: 263 TNGRLPVKWMAP 274

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 81.5 bits (202), Expect = 9e-18
 Identities = 46/205 (22%), Positives = 78/205 (38%), Gaps = 69/205 (33%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV------------------------------- 234
            IG+GS+G V  A    D   +A+K                                   
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 235 ------ECEVMKSIHHRNLVKIIS--SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL 286
                 E  ++K + H N+VK++      NED   +V E +  G +          +++ 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----------MEVP 129

Query: 287 Q--RLNI---------MINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGI 335
               L+          +I     +EYLH      IIH D+KP N+L+ ++    ++DFG+
Sbjct: 130 TLKPLSEDQARFYFQDLI---KGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 336 AKLLTGEDQSMTQTQTLATIGYMAP 360
           +    G D ++    T+ T  +MAP
Sbjct: 184 SNEFKGSD-ALLSN-TVGTPAFMAP 206

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 19/180 (10%)

Query: 182 QPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSFDVECE---- 237
              +S R   Y +       +     +G G++G VYKA+   G   A+K   ++ E    
Sbjct: 5   HHHSSGRENLYFQ--GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI 62

Query: 238 ---------VMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQR 288
                    ++K +HH N+V +I    +E    LV E+M    L+KVL  +   L   Q 
Sbjct: 63  PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQI 121

Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
              +  +   + + H      I+H DLKP N+L++ +    L+DFG+A+      +S T 
Sbjct: 122 KIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 47/169 (27%), Positives = 73/169 (43%), Gaps = 20/169 (11%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKII 251
            L+G GS+G V K R    G   AIK F    +             ++K + H NLV ++
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
             C  +    LV E++ + ++   L      LD       +  + + + + H   S  II
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H D+KP N+L+  + V  L DFG A+ L    +       +AT  Y AP
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAP 193

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 23/200 (11%), Positives = 48/200 (24%), Gaps = 55/200 (27%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------ECEVMKSIHHRNLVKII 251
            +  G    V+  R ++   +FA+K F +                     +   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 252 SSC----------------------SNEDFRA----LVLEYM-----TNGSLEKVLYSSN 280
                                      +D+      L++           S    +Y   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 281 CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT 340
               IL    +   +      L    S  ++H    P N+ +  +    L D      + 
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 341 GEDQSMTQTQTLATIGYMAP 360
                 T+    +     AP
Sbjct: 246 ------TRGPASSVPVTYAP 259

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 29/117 (24%), Positives = 41/117 (35%), Gaps = 11/117 (9%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSR----------NNLLGD 57
           L+L  NKL       F  LT L  L L SN L                       N +  
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 92

Query: 58  IPTTIQGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           + +   GL+ L+ L   H+ L+     S F  L +L  LD+S+ +           L
Sbjct: 93  MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 149

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 79.7 bits (197), Expect = 5e-17
 Identities = 32/139 (23%), Positives = 45/139 (32%), Gaps = 29/139 (20%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN---------------ELRHLVLTR 46
           L  L  LD+       +    F+ L++L  L +  N                L  L L  
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL-- 182

Query: 47  TDFSRNNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
                   L  +       L SLQ L++ HN         +  L SL+ LD S N++   
Sbjct: 183 ----SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238

Query: 106 -------IPLSLEKLLLEG 117
                   P SL  L L  
Sbjct: 239 KKQELQHFPSSLAFLNLTQ 257

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 78.9 bits (195), Expect = 7e-17
 Identities = 29/124 (23%), Positives = 48/124 (38%), Gaps = 11/124 (8%)

Query: 1   YLAALFQLDLRGNKLSGSIPTC-FSNLTALRNLHLDSNELRHL---------VLTRTDFS 50
            L  L  LD + + L        F +L  L  L +     R            L     +
Sbjct: 99  GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 158

Query: 51  RNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
            N+   +    I   L++L FL L   +L+   P +F+ L SL+ L++S+NN   +    
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218

Query: 110 LEKL 113
            + L
Sbjct: 219 YKCL 222

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 30/117 (25%), Positives = 48/117 (41%), Gaps = 11/117 (9%)

Query: 2   LAALFQLDLRGNKLS--GSIPTCFSNLTALRNLHLDSNELRHLV--------LTRTDFSR 51
           L  L +L L  N LS  G         T+L+ L L  N +  +         L   DF  
Sbjct: 51  LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQH 110

Query: 52  NNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
           +NL      ++   L++L +L + H   + +    F+ L SLE L ++ N+  E   
Sbjct: 111 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 29/113 (25%), Positives = 42/113 (37%), Gaps = 11/113 (9%)

Query: 2   LAALFQLDLRGNKLSGSI-PTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSR 51
           L++L  L + GN    +  P  F+ L  L  L L   +L  L          L   + S 
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV-SLESLDLSNNNLS 103
           NN         + L SLQ L    N +  S          SL  L+L+ N+ +
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 20/54 (37%), Positives = 24/54 (44%), Gaps = 2/54 (3%)

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
           +  L  +PT I    S   L L  N+LQ      FD L  L  L LS+N LS  
Sbjct: 16  SKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 17/154 (11%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISSC 254
           IG G++G VYKA+   G  FA+K   +E E             ++K + H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
             +    LV E++    L+K+L      L+ +   + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           LKP N+L++      ++DFG+A+      +  T 
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 34/122 (27%), Positives = 52/122 (42%), Gaps = 10/122 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRN 52
              L  LDL   ++       + +L+ L  L L  N ++ L          L +      
Sbjct: 51  FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQ-GSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
           NL       I  LK+L+ L++ HN +Q   +P  F +L +LE LDLS+N +  I    L 
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170

Query: 112 KL 113
            L
Sbjct: 171 VL 172

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 25/106 (23%), Positives = 36/106 (33%), Gaps = 15/106 (14%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           LDL  N L       F +   L+ L L   E++ +                    Q L  
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI---------------EDGAYQSLSH 77

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           L  L L  N +Q     +F  L SL+ L     NL+ +    +  L
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 31/117 (26%), Positives = 49/117 (41%), Gaps = 11/117 (9%)

Query: 2   LAALFQLDLRGNKLS--GSIPTCFSNLTALRNLHLDSNELRHLV--------LTRTDFSR 51
           L +L  LDL  N LS  G         T+L+ L L  N +  +         L   DF  
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQH 405

Query: 52  NNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
           +NL      ++   L++L +L + H   + +    F+ L SLE L ++ N+  E   
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 28/123 (22%), Positives = 49/123 (39%), Gaps = 11/123 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTC-FSNLTALRNLHLDSNELRHLV---------LTRTDFSR 51
           L  L  LD + + L        F +L  L  L +     R            L     + 
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454

Query: 52  NNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
           N+   +    I   L++L FL L   +L+   P +F+ L SL+ L++++N L  +     
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514

Query: 111 EKL 113
           ++L
Sbjct: 515 DRL 517

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 29/112 (25%), Positives = 43/112 (38%), Gaps = 10/112 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRT----------DFSR 51
           L  L  LD+       +    F+ L++L  L +  N  +   L             D S+
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 103
             L    PT    L SLQ L++  N+L+      FD L SL+ + L  N   
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 25/120 (20%), Positives = 44/120 (36%), Gaps = 15/120 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRT----------DFSR 51
           L++L +L      L+        +L  L+ L++  N ++   L             D S 
Sbjct: 99  LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158

Query: 52  NNLLGDIPTTIQGLKSLQF----LSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
           N +     T ++ L  +      L L  N +    P +F ++  L  L L NN  S  + 
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVM 217

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 21/105 (20%), Positives = 32/105 (30%), Gaps = 18/105 (17%)

Query: 9   DLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSL 68
                     IP       + +NL L  N LRHL                  +      L
Sbjct: 13  QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHL---------------GSYSFFSFPEL 54

Query: 69  QFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           Q L L    +Q     ++  L  L +L L+ N +  +   +   L
Sbjct: 55  QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 23/93 (24%), Positives = 32/93 (34%), Gaps = 10/93 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHL---------VLTRTDFSR 51
           L++L  L + GN    +     F+ L  L  L L   +L  L          L   + + 
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN 84
           N L          L SLQ + L  N    S P 
Sbjct: 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 32/114 (28%), Positives = 43/114 (37%), Gaps = 15/114 (13%)

Query: 2   LAALFQLDLRGNKLSGS---IPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSR 51
           L  L   + R   L      I   F+ LT + +  L S  +  +            +   
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVN 313

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
               G  PT    LKSL+ L+   N+   +   S  DL SLE LDLS N LS  
Sbjct: 314 CKF-GQFPT--LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFK 362

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 30/140 (21%), Positives = 55/140 (39%), Gaps = 19/140 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
           L+ L +LD+  NK+   +   F +L  L++L +  N+L ++          L +    + 
Sbjct: 103 LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP----- 107
           NL       +  L  L  L L H  +      SF  L  L+ L++S+    + +      
Sbjct: 163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222

Query: 108 -LSLEKLLLEG----EIPRG 122
            L+L  L +       +P  
Sbjct: 223 GLNLTSLSITHCNLTAVPYL 242

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 27/122 (22%), Positives = 47/122 (38%), Gaps = 9/122 (7%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE---------LRHLVLTRTDFSR 51
           +L  L  L LR   ++      F  L  L+ L +             L  L LT    + 
Sbjct: 174 HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
            NL       ++ L  L+FL+L +N +     +   +L+ L+ + L    L+ + P +  
Sbjct: 234 CNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFR 293

Query: 112 KL 113
            L
Sbjct: 294 GL 295

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 34/127 (26%), Positives = 53/127 (41%), Gaps = 17/127 (13%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGD 57
            LDL  N++       F++   L  L L+ N +  +          L       N L   
Sbjct: 36  LLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL-KL 94

Query: 58  IPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP------LSL 110
           IP     GL +L  L +  N++   +   F DL +L+SL++ +N+L  I         SL
Sbjct: 95  IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSL 154

Query: 111 EKLLLEG 117
           E+L LE 
Sbjct: 155 EQLTLEK 161

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 22/106 (20%), Positives = 39/106 (36%), Gaps = 18/106 (16%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           +     +   ++P      T  R L L  N ++ L   + +F+                 
Sbjct: 16  VLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTL--NQDEFA-------------SFPH 57

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           L+ L L  N +    P +F++L +L +L L +N L  I       L
Sbjct: 58  LEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGL 103

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 40/167 (23%), Positives = 78/167 (46%), Gaps = 20/167 (11%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKIISS 253
           IG G++G+V+KA+  +     A+K   ++ +             ++K + H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
             ++    LV E+     L+K   S N  LD     + +  +   L + H   S  ++H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPP 170

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 79.9 bits (198), Expect = 5e-17
 Identities = 49/181 (27%), Positives = 77/181 (42%), Gaps = 48/181 (26%)

Query: 207 LIGRGSFGSVYKARLQDGME-FAIKSF---------DVEC-----EVMKSIHHRNLVKII 251
            +G GSFG V+  R +     +A+K            VE       ++  + H  ++++ 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMIN---------VTSALEYL 302
            +  +     ++++Y+  G L            +L++     N         V  ALEYL
Sbjct: 73  GTFQDAQQIFMIMDYIEGGEL----------FSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTL-ATIGYMA 359
           H   S  II+ DLKP N+LLD N   H  ++DFG AK +         T TL  T  Y+A
Sbjct: 123 H---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP------DVTYTLCGTPDYIA 171

Query: 360 P 360
           P
Sbjct: 172 P 172

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 50/158 (31%), Positives = 75/158 (47%), Gaps = 23/158 (14%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-------ECEVMKSIHHRNLVKII------SS 253
           IG GSFG VY+A+L D G   AIK           E ++M+ + H N+V++         
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             +E +  LVL+Y+   ++ +V      +   L ++     M  +  +L Y+H   S  I
Sbjct: 122 KKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGI 177

Query: 311 IHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMT 347
            H D+KP N+LLD D  V  L DFG AK L    +   
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNV 214

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 26/175 (14%)

Query: 202 FSANNLIGRGSFGSVYKARLQD-GMEFAIKSF---------DVEC-----EVMKSIHHRN 246
           F     +G GSFG V   + ++ G  +A+K            +E       ++++++   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           LVK+  S  +     +V+EY+  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH--- 158

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T   +AP
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAP 207

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 79.7 bits (197), Expect = 6e-17
 Identities = 39/194 (20%), Positives = 66/194 (34%), Gaps = 44/194 (22%)

Query: 208 IGRGSFGSVYKARLQDGMEF------AIKS------------FDVECEVMKSI-HHRNLV 248
           +G G+FG V  A      +       A+K                E ++M  +  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVL----------------------YSSNCILDIL 286
            ++ +C+      L+ EY   G L   L                           +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM 346
             L     V   +E+L        +H DL   NVL+    V  + DFG+A+ +  +   +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 347 TQTQTLATIGYMAP 360
            +      + +MAP
Sbjct: 230 VRGNARLPVKWMAP 243

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 79.2 bits (196), Expect = 7e-17
 Identities = 38/177 (21%), Positives = 68/177 (38%), Gaps = 31/177 (17%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD---------------VECEVMKSIHHRNLVK- 249
           L+G GS+G V +    +     A+K                   E ++++ + H+N+++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 250 --IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
             ++ +   +    +V+EY   G  E +         + Q       +   LEYLH   S
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---S 127

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI----GYMAP 360
             I+H D+KP N+LL       +S  G+A+ L           T  T      +  P
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQGSPAFQPP 180

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 21/158 (13%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK--SFDVECE--------------VMKSIHHRNLVKI 250
           +G G F +VYKAR        AIK        E              +++ + H N++ +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
           + +  ++   +LV ++M    LE ++  ++ +L        M+     LEYLH  +   I
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---I 133

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           +H DLKP+N+LLD+N V  L+DFG+AK     +++ T 
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 37/123 (30%), Positives = 49/123 (39%), Gaps = 12/123 (9%)

Query: 2   LAALFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSNELRHL---------VLTRTDFSR 51
           LA L QLDL  N    S+    F  L  L  LHLD   L+ L          L       
Sbjct: 79  LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138

Query: 52  NNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
           N L   +P    + L +L  L L  NR+      +F  L SL+ L L  N ++ + P + 
Sbjct: 139 NAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 111 EKL 113
             L
Sbjct: 198 RDL 200

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 75.8 bits (187), Expect = 8e-16
 Identities = 38/139 (27%), Positives = 55/139 (39%), Gaps = 30/139 (21%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE---------------LRHLVLTR 46
              L  L L  N L+      F+ L  L  L L  N                L  L L  
Sbjct: 55  CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL-- 112

Query: 47  TDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSE 104
                   L ++   + +GL +LQ+L L  N LQ ++P ++F DL +L  L L  N +S 
Sbjct: 113 ----DRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS 167

Query: 105 IIPL------SLEKLLLEG 117
           +         SL++LLL  
Sbjct: 168 VPERAFRGLHSLDRLLLHQ 186

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 20/100 (20%), Positives = 33/100 (33%), Gaps = 18/100 (18%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
                  L  ++P       A + + L  N + H+                  + +  ++
Sbjct: 16  TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVP---------------AASFRACRN 57

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
           L  L L  N L      +F  L  LE LDLS+N     + 
Sbjct: 58  LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 36/115 (31%), Positives = 45/115 (39%), Gaps = 10/115 (8%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIP 59
            L L  N L           T L  L+LD  EL  L       VL   D S +N L  +P
Sbjct: 35  ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLS-HNQLQSLP 93

Query: 60  TTIQGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
              Q L +L  L +  NRL  S+P  +   L  L+ L L  N L  + P  L   
Sbjct: 94  LLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 75.9 bits (187), Expect = 7e-16
 Identities = 34/105 (32%), Positives = 45/105 (42%), Gaps = 18/105 (17%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           L  L  LDL  N+L  S+P     L AL  L +  N L  L                   
Sbjct: 76  LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP---------------LGA 119

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEI 105
           ++GL  LQ L L  N L+ ++P         LE L L+NNNL+E+
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTEL 163

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 62.0 bits (151), Expect = 4e-11
 Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 14/110 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHL---------VLTRTDFSR 51
           L AL  LD+  N+L+ S+P      L  L+ L+L  NEL+ L          L +   + 
Sbjct: 99  LPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157

Query: 52  NNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 100
           NNL  ++P  +  GL++L  L L  N L  +IP  F     L    L  N
Sbjct: 158 NNL-TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 40.5 bits (95), Expect = 4e-04
 Identities = 15/87 (17%), Positives = 26/87 (29%), Gaps = 19/87 (21%)

Query: 20  PTC-FSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRL 78
           P C  S + +   ++ D   L                  +P  +   K    L L  N L
Sbjct: 2   PICEVSKVASHLEVNCDKRNLT----------------ALPPDL--PKDTTILHLSENLL 43

Query: 79  QGSIPNSFDDLVSLESLDLSNNNLSEI 105
                 +      L  L+L    L+++
Sbjct: 44  YTFSLATLMPYTRLTQLNLDRAELTKL 70

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 26/160 (16%), Positives = 50/160 (31%), Gaps = 20/160 (12%)

Query: 2   LAALFQLDLRGNKLSGSI--PTCFSNLTALRNLHLDSNELRHLV------LTRTDFSRNN 53
           L  +  ++L  N L  S      F  +  L  + +    +  +       LT      N 
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNK 203

Query: 54  LLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI-----IP 107
           +   +   +++GL +L  L L  N +      S  +   L  L L+NN L ++       
Sbjct: 204 I-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 262

Query: 108 LSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQV 147
             ++ + L          +   S  F          +   
Sbjct: 263 KYIQVVYLH-----NNNISAIGSNDFCPPGYNTKKASYSG 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 21/101 (20%), Positives = 39/101 (38%), Gaps = 12/101 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
              L +L L  NKL   +P   ++   ++ ++L +N +  +     DF         P  
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI--GSNDFCP-------PGY 288

Query: 62  IQGLKSLQFLSLGHNRLQGSI--PNSFDDLVSLESLDLSNN 100
                S   +SL  N +Q     P++F  +    ++ L N 
Sbjct: 289 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 23/119 (19%), Positives = 44/119 (36%), Gaps = 20/119 (16%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHLV---------LTRTDFSR 51
             +L +L L GNK++  +       L  L  L L  N +  +          L     + 
Sbjct: 191 PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 249

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS-------FDDLVSLESLDLSNNNLS 103
           N L+  +P  +   K +Q + L +N +  +I ++            S   + L +N + 
Sbjct: 250 NKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 64.3 bits (157), Expect = 9e-12
 Identities = 28/108 (25%), Positives = 46/108 (42%), Gaps = 12/108 (11%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGD 57
            LDL+ NK++      F NL  L  L L +N++  +          L R   S  N L +
Sbjct: 56  LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS-KNQLKE 114

Query: 58  IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
           +P  +   K+LQ L +  N +     + F+ L  +  ++L  N L   
Sbjct: 115 LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 28/122 (22%), Positives = 48/122 (39%), Gaps = 25/122 (20%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           +      L   +P           L L +N++  +     DF               LK+
Sbjct: 36  VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEI--KDGDFK-------------NLKN 77

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI---IPLSLEKLLLEG----EIP 120
           L  L L +N++    P +F  LV LE L LS N L E+   +P +L++L +      ++ 
Sbjct: 78  LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVR 137

Query: 121 RG 122
           + 
Sbjct: 138 KS 139

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 37/181 (20%), Positives = 76/181 (41%), Gaps = 33/181 (18%)

Query: 208 IGRGSFGSVYKARLQD---GMEFAIKSFDVE-------CEV--MKSIHHRNLVK---IIS 252
           +GRG++G VYKA+ +D     ++A+K  +          E+  ++ + H N++    +  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 253 SCSNEDFRALVLEYMTNGSLEKVL--------YSSNCILDILQRLNIMINVTSALEYLHF 304
           S ++     L+ +Y  +  L  ++              L      +++  +   + YLH 
Sbjct: 89  SHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH- 145

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAH----LSDFGIAKLLTGEDQSMTQ-TQTLATIGYMA 359
             +  ++H DLKP N+L+           ++D G A+L     + +      + T  Y A
Sbjct: 146 --ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203

Query: 360 P 360
           P
Sbjct: 204 P 204

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 8/120 (6%)

Query: 2   LAALFQLDL-RGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNN 53
           + +L +LDL    KL       F  L  L+ L+L    ++ +        L   + S N+
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNH 229

Query: 54  LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
                P +  GL SL+ L + ++++     N+FD L SL  L+L++NNLS +       L
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 38/141 (26%), Positives = 57/141 (40%), Gaps = 22/141 (15%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFS----------R 51
           L  L  L L  N +       F+ L +L  L L  N L  +      F           R
Sbjct: 98  LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVI--PSGAFEYLSKLRELWLR 155

Query: 52  NNLLGDIPTTI-QGLKSLQFLSLGH-NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL- 108
           NN +  IP+     + SL  L LG   +L+     +F+ L +L+ L+L   N+ ++  L 
Sbjct: 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLT 215

Query: 109 ---SLEKLLLEG----EIPRG 122
               LE+L + G    EI  G
Sbjct: 216 PLVGLEELEMSGNHFPEIRPG 236

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 30/117 (25%), Positives = 46/117 (39%), Gaps = 12/117 (10%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGDI 58
           L+L  N +       F +L  L  L L  N +R +          L   +   N L   I
Sbjct: 80  LNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL-TVI 138

Query: 59  PT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN-LSEIIPLSLEKL 113
           P+   + L  L+ L L +N ++     +F+ + SL  LDL     L  I   + E L
Sbjct: 139 PSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 25/110 (22%), Positives = 37/110 (33%), Gaps = 11/110 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
           L  L  L+L    +   +P   + L  L  L +  N    +          L +     +
Sbjct: 195 LFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 102
            +         GL SL  L+L HN L     + F  L  L  L L +N  
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 25/106 (23%), Positives = 43/106 (40%), Gaps = 18/106 (16%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           +      LS  +P      +  R L+L  N ++ +                  T + L  
Sbjct: 59  VVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQ---------------ADTFRHLHH 100

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           L+ L LG N ++     +F+ L SL +L+L +N L+ I   + E L
Sbjct: 101 LEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYL 146

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 52.8 bits (127), Expect = 8e-08
 Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 9/87 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRN 52
           L  L +L++ GN      P  F  L++L+ L + ++++  +          L   + + N
Sbjct: 217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQ 79
           NL          L+ L  L L HN   
Sbjct: 277 NLSSLPHDLFTPLRYLVELHLHHNPWN 303

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 75.5 bits (186), Expect = 4e-16
 Identities = 31/117 (26%), Positives = 50/117 (42%), Gaps = 13/117 (11%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR--------HLV-LTRTDFSRNNLLGDI 58
           + L  N +    P  FS    LR + L +N++          L  L       N +  ++
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI-TEL 95

Query: 59  PTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           P ++ +GL SLQ L L  N++   +   +F DL +L  L L +N L  I   +   L
Sbjct: 96  PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.9 bits (156), Expect = 4e-12
 Identities = 27/110 (24%), Positives = 48/110 (43%), Gaps = 13/110 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHL---------VLTRTDFSR 51
              L ++DL  N++S  +    F  L +L +L L  N++  L          L     + 
Sbjct: 55  YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNA 113

Query: 52  NNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 100
           N +   +     Q L +L  LSL  N+LQ     +F  L +++++ L+ N
Sbjct: 114 NKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 54.3 bits (131), Expect = 8e-09
 Identities = 28/122 (22%), Positives = 47/122 (38%), Gaps = 28/122 (22%)

Query: 11  RGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQF 70
           RG  L+  IPT       +  + L+ N ++ +                P      K L+ 
Sbjct: 19  RGKGLT-EIPTNLP--ETITEIRLEQNTIKVIP---------------PGAFSPYKKLRR 60

Query: 71  LSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP------LSLEKLLLEG----EIP 120
           + L +N++    P++F  L SL SL L  N ++E+         SL+ LLL       + 
Sbjct: 61  IDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLR 120

Query: 121 RG 122
             
Sbjct: 121 VD 122

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 39/132 (29%), Positives = 53/132 (40%), Gaps = 18/132 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFS----------R 51
           L  L  L L  N +       F+ L  L  L L  N L    +    F           R
Sbjct: 87  LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT--IPNGAFVYLSKLKELWLR 144

Query: 52  NNLLGDIPT-TIQGLKSLQFLSLGH-NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL- 108
           NN +  IP+     + SL+ L LG   RL      +F+ L +L  L+L+  NL EI  L 
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLT 204

Query: 109 ---SLEKLLLEG 117
               L++L L G
Sbjct: 205 PLIKLDELDLSG 216

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 34/123 (27%), Positives = 55/123 (44%), Gaps = 14/123 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHL-DSNELRHL---------VLTRTDFS 50
           L+ L +L LR N +  SIP+  F+ + +LR L L +   L ++          L   + +
Sbjct: 135 LSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193

Query: 51  RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
             NL  +IP  +  L  L  L L  N L    P SF  L+ L+ L +  + +  I   + 
Sbjct: 194 MCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251

Query: 111 EKL 113
           + L
Sbjct: 252 DNL 254

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 30/130 (23%), Positives = 47/130 (36%), Gaps = 17/130 (13%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           L+L  N++       F +L  L  L L  N +R +                     GL +
Sbjct: 69  LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE---------------IGAFNGLAN 113

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL--LLEGEIPRGGPF 125
           L  L L  NRL      +F  L  L+ L L NN +  I   +  ++  L   ++      
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173

Query: 126 TKFSSKSFIG 135
           +  S  +F G
Sbjct: 174 SYISEGAFEG 183

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 52.8 bits (127), Expect = 8e-08
 Identities = 24/116 (20%), Positives = 46/116 (39%), Gaps = 24/116 (20%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           +      L   +P   S  T  R L+L  N+++ +                  + + L+ 
Sbjct: 48  VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIK---------------VNSFKHLRH 89

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP------LSLEKLLLEG 117
           L+ L L  N ++     +F+ L +L +L+L +N L+ I          L++L L  
Sbjct: 90  LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRN 145

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 33/159 (20%), Positives = 52/159 (32%), Gaps = 22/159 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFS----------R 51
              L  L L+ N L+        N   L  + L  NEL  +      F            
Sbjct: 225 NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKI--MYHPFVKMQRLERLYIS 280

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI---IPL 108
           NN L  +    Q + +L+ L L HN L   +  +      LE+L L +N++  +      
Sbjct: 281 NNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHH 339

Query: 109 SLEKLLLEG----EIPRGGPFTKFSSKSFIGNDLLCGSP 143
           +L+ L L             F   +  +    D  C   
Sbjct: 340 TLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID 378

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 26/121 (21%), Positives = 50/121 (41%), Gaps = 9/121 (7%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRN 52
              +  L+L   ++       F+    ++ L++  N +R+L         +LT     RN
Sbjct: 68  FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 112
           +L             L  LS+ +N L+    ++F    SL++L LS+N L+ +    +  
Sbjct: 128 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS 187

Query: 113 L 113
           L
Sbjct: 188 L 188

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 20/122 (16%), Positives = 40/122 (32%), Gaps = 9/122 (7%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSR 51
            L     +  + + +         +   +  L+L+  ++  +          + +     
Sbjct: 43  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
           N +    P   Q +  L  L L  N L       F +   L +L +SNNNL  I   + +
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162

Query: 112 KL 113
             
Sbjct: 163 AT 164

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 25/110 (22%), Positives = 43/110 (39%), Gaps = 13/110 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV------LTRTDFSRNNLL 55
           + +LF  ++  N L     +  +   A+  L    N +  +       LT      NNL 
Sbjct: 185 IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT 239

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
            D    +     L  + L +N L+  + + F  +  LE L +SNN L  +
Sbjct: 240 -DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL 287

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 26/121 (21%), Positives = 46/121 (38%), Gaps = 17/121 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRN 52
           +  L  L L  N LS      F N   L  L + +N L  +          L     S N
Sbjct: 116 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 112
            L   +   +  + SL   ++ +N L      +    +++E LD S+N+++ +      +
Sbjct: 176 RLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVE 227

Query: 113 L 113
           L
Sbjct: 228 L 228

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 10/105 (9%), Positives = 33/105 (31%), Gaps = 9/105 (8%)

Query: 18  SIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGDIPTTIQGLKSL 68
            I +         ++H+D                      F  + +       +   + +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 69  QFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           + L+L   +++     +F    +++ L +  N +  + P   + +
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 116

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 41/180 (22%), Positives = 64/180 (35%), Gaps = 34/180 (18%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIK-------------SFDV---------ECEVMKSIHHR 245
           I  GS+G+V      +G+  AIK                          E  ++   HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 246 NLVK---IISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALE 300
           N++    I             LV E M    L +V++    ++        M ++   L 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLH 148

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            LH      ++H DL P N+LL DN    + DF +A+     D +   T  +    Y AP
Sbjct: 149 VLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANK--THYVTHRWYRAP 202

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 38/179 (21%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFD-------------------VECEVMKSIHHRNL 247
           +G G+FG V+ A   +   E  +K                      +E  ++  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN------IMINVTSALEY 301
           +K++    N+ F  LV+E   +G L+  L++    +D   RL+      I   + SA+ Y
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LD--LFA---FIDRHPRLDEPLASYIFRQLVSAVGY 145

Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L       IIH D+K  N+++ ++    L DFG A  L  E   +  T    TI Y AP
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEYCAP 198

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 44/178 (24%), Positives = 66/178 (37%), Gaps = 42/178 (23%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV----------ECEVMKSIHHRNLVKIISSCS 255
            IG G+FG     R        A+K  +           E    +S+ H N+V+      
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 256 NEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLN----------IMINVTSALEYLHF 304
                A+++EY + G L E++  +         R +          ++    S + Y H 
Sbjct: 87  TPTHLAIIMEYASGGELYERICNA--------GRFSEDEARFFFQQLL----SGVSYCH- 133

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHL--SDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  I H DLK  N LLD +    L   DFG +K      Q  +   T A   Y+AP
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAP 186

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 75.8 bits (187), Expect = 7e-16
 Identities = 35/115 (30%), Positives = 50/115 (43%), Gaps = 20/115 (17%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
           L+ L  L L GN +  S+    FS L++L+ L      L  L                  
Sbjct: 75  LSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLE---------------NF 118

Query: 61  TIQGLKSLQFLSLGHNRLQGSIP--NSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
            I  LK+L+ L++ HN +Q S      F +L +LE LDLS+N +  I    L  L
Sbjct: 119 PIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.9 bits (164), Expect = 8e-13
 Identities = 29/132 (21%), Positives = 44/132 (33%), Gaps = 29/132 (21%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTI-QGLK 66
           LDL  N L       F +   L+ L L   E++                 I     Q L 
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ----------------TIEDGAYQSLS 76

Query: 67  SLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEI------IPLSLEKLLLEG-- 117
            L  L L  N +Q S+   +F  L SL+ L     NL+ +         +L++L +    
Sbjct: 77  HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135

Query: 118 --EIPRGGPFTK 127
                    F+ 
Sbjct: 136 IQSFKLPEYFSN 147

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 30/113 (26%), Positives = 48/113 (42%), Gaps = 15/113 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPT--CFSNLTALRNLHLDSNELRHL---------VLTRTDFS 50
           L  L +L++  N +  S      FSNLT L +L L SN+++ +          +   + S
Sbjct: 123 LKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181

Query: 51  ---RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 100
                N +  I         L+ L+L  N+L+      FD L SL+ + L  N
Sbjct: 182 LDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 40.0 bits (94), Expect = 6e-04
 Identities = 14/49 (28%), Positives = 20/49 (40%), Gaps = 6/49 (12%)

Query: 57  DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
           ++P       S + L L  N L+     SF     L+ LDLS   +  I
Sbjct: 25  NLPF------STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 76.0 bits (188), Expect = 8e-16
 Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 19/158 (12%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDVECE-------------VMKSIHHRNLVKII 251
             IG G++G VYKAR    G   A+K   ++ E             ++K ++H N+VK++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPI 310
                E+   LV E++    L+K + +S    + +    + +  +   L + H   S  +
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRV 124

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           +H DLKP N+L++      L+DFG+A+      ++ T 
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 37/161 (22%), Positives = 64/161 (39%), Gaps = 37/161 (22%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD------------VECEVMKSIHHRNLVKIISS 253
            +G G++G V  A         A+K  D             E  + K ++H N+VK    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 254 CSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNI---------MINVTSALEYLH 303
               + + L LEY + G L +++             +           ++   + + YLH
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD--------IGMPEPDAQRFFHQLM---AGVVYLH 122

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ 344
                 I H D+KP N+LLD+     +SDFG+A +    ++
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 17/154 (11%)

Query: 208 IGRGSFGSVYKARLQDGMEF-AIKSFDVECE------------VMKSIHHRNLVKIISSC 254
           +G G++ +VYK + +      A+K   +E E            ++K + H N+V +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
             E    LV EY+    L++ L     I+++      +  +   L Y H      ++H D
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRD 125

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           LKP N+L+++     L+DFG+A+  +   ++   
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 30/122 (24%), Positives = 46/122 (37%), Gaps = 11/122 (9%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRN 52
            L  L  L L    +  S+P   +NL  L++L + ++ L  L         L   D    
Sbjct: 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGC 239

Query: 53  NLLGDIPTTIQGLKSLQFLSL-GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
             L + P    G   L+ L L   + L  ++P     L  LE LDL        +P  + 
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298

Query: 112 KL 113
           +L
Sbjct: 299 QL 300

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 27/115 (23%), Positives = 42/115 (36%), Gaps = 18/115 (15%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQG 64
              L+LR   L    P     L+ L+++ +D+  L  L                P T+Q 
Sbjct: 83  RVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL----------------PDTMQQ 125

Query: 65  LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEI 119
              L+ L+L  N L+ ++P S   L  L  L +        +P  L      GE 
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 28/131 (21%), Positives = 47/131 (35%), Gaps = 21/131 (16%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN-----------------ELRHLV 43
             A L  L L  N L  ++P   ++L  LR L + +                  E + LV
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183

Query: 44  -LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 102
            L         +   +P +I  L++L+ L + ++ L  ++  +   L  LE LDL     
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTA 241

Query: 103 SEIIPLSLEKL 113
               P      
Sbjct: 242 LRNYPPIFGGR 252

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 67.3 bits (165), Expect = 9e-13
 Identities = 25/121 (20%), Positives = 43/121 (35%), Gaps = 13/121 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHL-DSNELRHL--------VLTRTDFSRN 52
           L  L  L +R + LS ++     +L  L  L L     LR+          L R      
Sbjct: 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN---NLSEIIPLS 109
           + L  +P  I  L  L+ L L        +P+    L +   + +  +    L +  P++
Sbjct: 264 SNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVA 323

Query: 110 L 110
            
Sbjct: 324 R 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 14/119 (11%), Positives = 33/119 (27%), Gaps = 8/119 (6%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN----ELRHLVLTRTDFSRNNLLG 56
           + +    L  +G+          S      N   +         +    + +      L 
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK 69

Query: 57  DIPTTIQGLKS--LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
                ++         L L    L    P+    L  L+ + +    L E +P ++++ 
Sbjct: 70  ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQF 126

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 22/159 (13%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDVECE------------VMKSIHHRNLVKIISSC 254
           +G G++ +VYK      G+  A+K   ++ E            +MK + H N+V++    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCI-----LDILQRLNIMINVTSALEYLHFGFSTP 309
             E+   LV E+M N  L+K + S         L++         +   L + H      
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           I+H DLKP N+L++      L DFG+A+       + + 
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 16/113 (14%)

Query: 8   LDLRGNKLSGSIP--TCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLG 56
           LDL  N LS  +      + LT L +L L  N L  +          L   D S N+L  
Sbjct: 44  LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL-H 101

Query: 57  DIPT-TIQGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIP 107
            +       L++L+ L L +N +   +  N+F+D+  L+ L LS N +S    
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPV 153

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 37/127 (29%), Positives = 50/127 (39%), Gaps = 18/127 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTC-FSNLTALRNLHLDSNELRHLVLTRTDFSR--------- 51
           L  L  L L  N L+  I +  F  +  LR L L SN L    L    FS          
Sbjct: 63  LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH--TLDEFLFSDLQALEVLLL 119

Query: 52  -NNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDD---LVSLESLDLSNNNLSEII 106
            NN +  +     + +  LQ L L  N++         D   L  L  LDLS+N L ++ 
Sbjct: 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLP 179

Query: 107 PLSLEKL 113
              L+KL
Sbjct: 180 LTDLQKL 186

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 44/205 (21%), Positives = 62/205 (30%), Gaps = 41/205 (20%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHLV---------LTRTDFSR 51
           +  L  LDL  N L  ++    FS+L AL  L L +N +  +          L +   S 
Sbjct: 87  VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS- 144

Query: 52  NNLLGDIP----TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSL--ESLDLSNNNLS-- 103
            N +   P         L  L  L L  N+L+         L +     L L NN L   
Sbjct: 145 QNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD 204

Query: 104 -EIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSP-------NLQVPPCKSNKP 155
            ++  L                  + SS      DL C          +L    C   K 
Sbjct: 205 CKLYQL-FSHWQYR----------QLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKE 253

Query: 156 IILALKFG--LISRCQKRATELPNV 178
                  G  L  RC  +   +  V
Sbjct: 254 SAWEAHLGDTLTIRCDTKQQGMTKV 278

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 58.3 bits (141), Expect = 9e-10
 Identities = 26/107 (24%), Positives = 38/107 (35%), Gaps = 19/107 (17%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           L     +L  ++P    + T    L L  N L  L       +              L +
Sbjct: 23  LSCSKQQLP-NVPQSLPSYT--ALLDLSHNNLSRL-RAEWTPT-------------RLTN 65

Query: 68  LQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           L  L L HN L   I   +F  + +L  LDLS+N+L  +       L
Sbjct: 66  LHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL 111

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 40/192 (20%), Positives = 75/192 (39%), Gaps = 24/192 (12%)

Query: 176 PNVANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDV 234
             +            S      + + +     +G G++G VYKA         AIK   +
Sbjct: 10  GTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL 69

Query: 235 ECE-------------VMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNC 281
           E E             ++K + HRN++++ S   +     L+ EY  N  L+K +   N 
Sbjct: 70  EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNP 127

Query: 282 ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH-----LSDFGIA 336
            + +    + +  + + + + H   S   +H DLKP N+LL  +  +      + DFG+A
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184

Query: 337 KLLTGEDQSMTQ 348
           +      +  T 
Sbjct: 185 RAFGIPIRQFTH 196

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 13/124 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHLV----------LTRTDFS 50
           L +L  LDL  N LS ++ +  F  L++L  L+L  N  + L           L      
Sbjct: 99  LGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVG 157

Query: 51  RNNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
             +    I      GL  L+ L +  + LQ   P S   + ++  L L       ++ + 
Sbjct: 158 NMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF 217

Query: 110 LEKL 113
           ++  
Sbjct: 218 VDVT 221

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 34/141 (24%), Positives = 53/141 (37%), Gaps = 20/141 (14%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLK 66
            LDL  N+++    +       L+ L L SN +  +                  +   L 
Sbjct: 56  SLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE---------------EDSFSSLG 100

Query: 67  SLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPF 125
           SL+ L L +N L  ++ +S F  L SL  L+L  N    +   SL   L + +I R G  
Sbjct: 101 SLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159

Query: 126 TKFSSKSFIGNDLLCGSPNLQ 146
             F+    I      G   L+
Sbjct: 160 DTFTK---IQRKDFAGLTFLE 177

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 32/123 (26%), Positives = 49/123 (39%), Gaps = 11/123 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRN 52
              L  L L  N ++      FS+L +L +L L  N L +L          LT  +   N
Sbjct: 75  CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGN 134

Query: 53  NLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIPLSL 110
                  T++   L  LQ L +G+      I    F  L  LE L++  ++L    P SL
Sbjct: 135 PYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL 194

Query: 111 EKL 113
           + +
Sbjct: 195 KSI 197

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 15/121 (12%), Positives = 38/121 (31%), Gaps = 18/121 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRN 52
           L  L +L++  + L    P    ++  + +L L   +   L          +   +    
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232

Query: 53  NLLGDIPTTIQ--------GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 104
           +L     + +            + + + +    L   +    + +  L  L+ S N L  
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291

Query: 105 I 105
           +
Sbjct: 292 V 292

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 21/110 (19%), Positives = 37/110 (33%), Gaps = 26/110 (23%)

Query: 2   LAALFQLDLRGNKLSG----SIPTC----FSNLTALRNLHLDSNELRHLVLTRTDFSRNN 53
            +++  L+LR   L       + T            RN+ +    L              
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ------------ 268

Query: 54  LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNL 102
               +   +  +  L  L    N+L+ S+P+  FD L SL+ + L  N  
Sbjct: 269 ----VMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 15/63 (23%), Positives = 32/63 (50%), Gaps = 2/63 (3%)

Query: 51  RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
            +  L  IP+ +   ++++ L L +NR+     +     V+L++L L++N ++ I   S 
Sbjct: 39  SSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSF 96

Query: 111 EKL 113
             L
Sbjct: 97  SSL 99

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 31/152 (20%), Positives = 55/152 (36%), Gaps = 15/152 (9%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLL 55
           +  LDL    +       F  L  L+ L+L  N++  +          L   + S N L 
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL-SLEKLL 114
               +   GL  + ++ L  N +      +F  L  L++LDL +N L+ I  + S+  + 
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIF 387

Query: 115 LEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQ 146
           L G              +   N +      L+
Sbjct: 388 LSGN-----KLVTLPKINLTANLIHLSENRLE 414

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 34/125 (27%), Positives = 51/125 (40%), Gaps = 13/125 (10%)

Query: 2   LAALFQLDLRGNKLSGSI-PTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSR 51
           L  L  L+L       +I    F NL  LR L L S+++  L          L       
Sbjct: 47  LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYF 106

Query: 52  NNLLGDI--PTTIQGLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIPL 108
             L   +      + LK+L  L L  N+++   +  SF  L SL+S+D S+N +  +   
Sbjct: 107 CGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH 166

Query: 109 SLEKL 113
            LE L
Sbjct: 167 ELEPL 171

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 39/147 (26%), Positives = 53/147 (36%), Gaps = 18/147 (12%)

Query: 2   LAALFQLDLRGNKLSG-SIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
           +  L  L L  N+ S  S     S   +L  L L  N L+    T               
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC----------WD 474

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI----IPLSLEKLLLE 116
             +GL  LQ L L HN L    P  F  L +L  L L++N L+ +    +P +LE L + 
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDIS 534

Query: 117 G---EIPRGGPFTKFSSKSFIGNDLLC 140
                 P    F   S      N  +C
Sbjct: 535 RNQLLAPNPDVFVSLSVLDITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 23/109 (21%), Positives = 38/109 (34%), Gaps = 14/109 (12%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDI 58
              R   L+  +P     L     L L  N +R +          L   +         I
Sbjct: 9   AFYRFCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64

Query: 59  -PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII 106
                + L +L+ L LG +++    P++F  L  L  L L    LS+ +
Sbjct: 65  DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 27/132 (20%), Positives = 47/132 (35%), Gaps = 23/132 (17%)

Query: 5   LFQLDLRGNKLSGSIPTCFSN------------LTALRNLHLDSNELRHL---------- 42
           L  LD+ GN  +  I   FSN               +       + ++            
Sbjct: 206 LEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR 265

Query: 43  -VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN 101
             +   D S   +        + LK L+ L+L +N++      +F  L +L+ L+LS N 
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325

Query: 102 LSEIIPLSLEKL 113
           L E+   +   L
Sbjct: 326 LGELYSSNFYGL 337

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 36/159 (22%), Positives = 57/159 (35%), Gaps = 24/159 (15%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----VLTRTDFSRNNLLGD 57
           L  +  +DL+ N ++      F  L  L+ L L  N L  +     +     S N L   
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKL--- 393

Query: 58  IPTTIQGLK-SLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEII-------PL 108
              T+  +  +   + L  NRL+   I      +  L+ L L+ N  S            
Sbjct: 394 --VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451

Query: 109 SLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQV 147
           SLE+L L   + +    T+     F G        +LQV
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGL------SHLQV 484

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 40/172 (23%), Positives = 64/172 (37%), Gaps = 20/172 (11%)

Query: 2   LAALFQLDLRGNKLSGSI--PTCFSNLTALRNLHLDSNELRHLVLTRT----------DF 49
           L  LF+L L    LS ++     F NL AL  L L  N++R L L  +          DF
Sbjct: 96  LFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDF 155

Query: 50  SRNNLLGDIPTTIQGL--KSLQFLSLGHNRLQGSIPNSFDDL------VSLESLDLSNNN 101
           S N +       ++ L  K+L F SL  N L   +   +         + LE LD+S N 
Sbjct: 156 SSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNG 215

Query: 102 LSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSN 153
            +  I  +    + + +              F  +++     N      +S+
Sbjct: 216 WTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS 267

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 25/115 (21%), Positives = 41/115 (35%), Gaps = 20/115 (17%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
            L  L  L+L  N L     + F  L  +  + L  N +  +                  
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ---------------DQ 356

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLL 115
           T + L+ LQ L L  N L      +   + S+  + LS N L  +  ++L   L+
Sbjct: 357 TFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINLTANLI 406

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 22/170 (12%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF---------DVEC-----EVMKSIHHRNLVKII 251
           L+G+G+FG V   + +  G  +A+K           +V        V+++  H  L  + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
            S    D    V+EY   G L   L       +   R      + SAL+YLH   +  ++
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN--VV 271

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           + DLK  N++LD +    ++DFG+ K    +  +    +T   T  Y+AP
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAP 318

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 53/185 (28%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF---------DVEC-----EVMKSIHHRNLVKII 251
           L+G+G+FG V   R +  G  +A+K           +V        V+++  H  L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 252 SSCSNEDFRALVLEYMTNGSL-----------EK--VLYSSNCILDILQRLNIMINVTSA 298
            +    D    V+EY   G L           E+    Y +  I+             SA
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIV-------------SA 117

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTL-ATI 355
           LEYLH   S  +++ D+K  N++LD +   H  ++DFG+ K    +  +    +T   T 
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGAT---MKTFCGTP 169

Query: 356 GYMAP 360
            Y+AP
Sbjct: 170 EYLAP 174

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 28/177 (15%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKS--FDVECE-----------VMKSIHHRNLVK---I 250
           IG+G+FG V+KAR  + G + A+K    + E E           +++ + H N+V    I
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 251 ISSCSNEDFRA-----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
             + ++   R      LV ++  +  L  +L +      + +   +M  + + L Y+H  
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 141

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ--TQTLATIGYMAP 360
               I+H D+K  NVL+  + V  L+DFG+A+  +    S     T  + T+ Y  P
Sbjct: 142 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 197

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 37/161 (22%), Positives = 64/161 (39%), Gaps = 37/161 (22%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD------------VECEVMKSIHHRNLVKIISS 253
            +G G++G V  A         A+K  D             E  + K ++H N+VK    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 254 CSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNI---------MINVTSALEYLH 303
               + + L LEY + G L +++             +           ++   + + YLH
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD--------IGMPEPDAQRFFHQLM---AGVVYLH 122

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ 344
                 I H D+KP N+LLD+     +SDFG+A +    ++
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 38/171 (22%), Positives = 70/171 (40%), Gaps = 25/171 (14%)

Query: 199 TNGFSANNLIGRGSFGSVYKARLQD-GMEFAIKS-FDV---------ECEVMKSIHHRNL 247
            + F    + G+G+FG+V   + +  GM  AIK                + +  +HH N+
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81

Query: 248 VKII-------SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNI---MINVTS 297
           V++             + +  +V+EY+   +L +   +          + I   +  +  
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMT 347
           ++  LH   S  + H D+KPHNVL++  +    L DFG AK L    +   
Sbjct: 141 SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNV 189

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 73.9 bits (182), Expect = 6e-15
 Identities = 35/127 (27%), Positives = 55/127 (43%), Gaps = 12/127 (9%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV------LTRTDFSRNNLL 55
           L  L+ L L  NK+S      FS L  L+ L++  N L  +       L       N + 
Sbjct: 77  LQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIR 136

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSI--PNSFDDLVSLESLDLSNNNLSEI---IPLSL 110
                   GL+++  + +G N L+ S   P +FD L  L  L +S   L+ I   +P +L
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLPETL 195

Query: 111 EKLLLEG 117
            +L L+ 
Sbjct: 196 NELHLDH 202

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 70.8 bits (174), Expect = 7e-14
 Identities = 31/181 (17%), Positives = 54/181 (29%), Gaps = 41/181 (22%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE---------------LRHLVLTR 46
            ++L +L +  N++       FS L  +  + +  N                L +L ++ 
Sbjct: 122 PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181

Query: 47  TDFSR---------------NNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLV 90
              +                +N +  I    +     L  L LGHN+++     S   L 
Sbjct: 182 AKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP 241

Query: 91  SLESLDLSNNNLSEI-----IPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNL 145
           +L  L L NN LS +         L+ + L          TK     F            
Sbjct: 242 TLRELHLDNNKLSRVPAGLPDLKLLQVVYLH-----TNNITKVGVNDFCPVGFGVKRAYY 296

Query: 146 Q 146
            
Sbjct: 297 N 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 32/138 (23%), Positives = 53/138 (38%), Gaps = 23/138 (16%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGD 57
            LDL+ N +S      F  L  L  L L +N++  +          L +   S+N+ L +
Sbjct: 58  LLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH-LVE 116

Query: 58  IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII-------PLSL 110
           IP  +    SL  L +  NR++      F  L ++  +++  N L            L L
Sbjct: 117 IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKL 174

Query: 111 EKLLLEG----EIPRGGP 124
             L +       IP+  P
Sbjct: 175 NYLRISEAKLTGIPKDLP 192

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 26/108 (24%), Positives = 40/108 (37%), Gaps = 22/108 (20%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
            + L++L L  N++        S L  LR LHLD+N+L                  +P  
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR----------------VPAG 259

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDL------VSLESLDLSNNNLS 103
           +  LK LQ + L  N +     N F  +           + L NN + 
Sbjct: 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 12/101 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           L  L +L L  NKLS  +P    +L  L+ ++L +N +  +     DF            
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV--GVNDFCPVGFGV----- 291

Query: 62  IQGLKSLQFLSLGHNRLQGSI--PNSFDDLVSLESLDLSNN 100
                    +SL +N +      P +F  +    ++   N 
Sbjct: 292 --KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 30/122 (24%), Positives = 51/122 (41%), Gaps = 25/122 (20%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           +      L  ++P   S       L L +N++  L   + DF              GL+ 
Sbjct: 38  VQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISEL--RKDDFK-------------GLQH 79

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI---IPLSLEKLLLEG----EIP 120
           L  L L +N++      +F  L  L+ L +S N+L EI   +P SL +L +      ++P
Sbjct: 80  LYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVP 139

Query: 121 RG 122
           +G
Sbjct: 140 KG 141

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 33/159 (20%), Positives = 52/159 (32%), Gaps = 22/159 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFS----------R 51
              L  L L+ N L+        N   L  + L  NEL  +      F            
Sbjct: 231 NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKI--MYHPFVKMQRLERLYIS 286

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI---IPL 108
           NN L  +    Q + +L+ L L HN L   +  +      LE+L L +N++  +      
Sbjct: 287 NNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHH 345

Query: 109 SLEKLLLEG----EIPRGGPFTKFSSKSFIGNDLLCGSP 143
           +L+ L L             F   +  +    D  C   
Sbjct: 346 TLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID 384

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 26/121 (21%), Positives = 50/121 (41%), Gaps = 9/121 (7%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRN 52
              +  L+L   ++       F+    ++ L++  N +R+L         +LT     RN
Sbjct: 74  FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 112
           +L             L  LS+ +N L+    ++F    SL++L LS+N L+ +    +  
Sbjct: 134 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS 193

Query: 113 L 113
           L
Sbjct: 194 L 194

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 20/122 (16%), Positives = 40/122 (32%), Gaps = 9/122 (7%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSR 51
            L     +  + + +         +   +  L+L+  ++  +          + +     
Sbjct: 49  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
           N +    P   Q +  L  L L  N L       F +   L +L +SNNNL  I   + +
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 168

Query: 112 KL 113
             
Sbjct: 169 AT 170

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 25/110 (22%), Positives = 43/110 (39%), Gaps = 13/110 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV------LTRTDFSRNNLL 55
           + +LF  ++  N L     +  +   A+  L    N +  +       LT      NNL 
Sbjct: 191 IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT 245

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
            D    +     L  + L +N L+  + + F  +  LE L +SNN L  +
Sbjct: 246 -DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL 293

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 26/121 (21%), Positives = 46/121 (38%), Gaps = 17/121 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
           +  L  L L  N LS      F N   L  L + +N L  +          L     S N
Sbjct: 122 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 112
            L   +   +  + SL   ++ +N L      +    +++E LD S+N+++ +      +
Sbjct: 182 RLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVE 233

Query: 113 L 113
           L
Sbjct: 234 L 234

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 10/105 (9%), Positives = 33/105 (31%), Gaps = 9/105 (8%)

Query: 18  SIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGDIPTTIQGLKSL 68
            I +         ++H+D                      F  + +       +   + +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 69  QFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           + L+L   +++     +F    +++ L +  N +  + P   + +
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 73.5 bits (181), Expect = 7e-15
 Identities = 46/156 (29%), Positives = 69/156 (44%), Gaps = 36/156 (23%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFD-----------VECEV--MKSIHHRNLVKIISS 253
           IG+G+F  V  AR +  G E AIK  D           +  EV  MK ++H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL---QRLN------IMINVTSALEYLHF 304
              E    L++EY + G +           D L    R+           + SA++Y H 
Sbjct: 83  IETEKTLYLIMEYASGGEV----------FDYLVAHGRMKEKEARSKFRQIVSAVQYCH- 131

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT 340
                I+H DLK  N+LLD ++   ++DFG +   T
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 73.0 bits (180), Expect = 7e-15
 Identities = 36/153 (23%), Positives = 74/153 (48%), Gaps = 21/153 (13%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD--------------VECEVMKSIHHRNLVKII 251
            +G G+FG V        G + A+K  +               E + +K   H +++K+ 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 252 SSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
              S      +V+EY++ G L + +    +  ++ ++   +   + SA++Y H      +
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVDYCH---RHMV 132

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           +H DLKP NVLLD ++ A ++DFG++ +++  +
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.5 bits (183), Expect = 8e-15
 Identities = 39/163 (23%), Positives = 75/163 (46%), Gaps = 24/163 (14%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK----SFDV---------ECEVMKSIHHRNLVK---I 250
           IG GS+G V +A    +    AIK     F+          E  ++  ++H ++VK   I
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120

Query: 251 ISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           +     E F    +VLE   +   +K+  +   + ++  +  ++ N+   ++Y+H   S 
Sbjct: 121 VIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH---SA 175

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
            I+H DLKP N L++ +    + DFG+A+ +   +   +Q   
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 73.3 bits (181), Expect = 9e-15
 Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 12/120 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           +  L  L +  NK++   P   +NL+ L  L + +N++  +        L   +   N +
Sbjct: 220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQI 277

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS-LEKL 113
             DI   +  L  L  L L +N+L          L +L +L LS N++++I PL+ L K+
Sbjct: 278 -SDISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKM 335

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 71.8 bits (177), Expect = 3e-14
 Identities = 29/128 (22%), Positives = 56/128 (43%), Gaps = 16/128 (12%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNN 53
           YL  L  L+L GN+++   P   SNL  L NL++ +N++  +        L     + +N
Sbjct: 64  YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDN 121

Query: 54  LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS---- 109
           +    P  +  L  +  L+LG N     +     ++  L  L ++ + + ++ P++    
Sbjct: 122 ISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTPIANLTD 178

Query: 110 LEKLLLEG 117
           L  L L  
Sbjct: 179 LYSLSLNY 186

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 71.8 bits (177), Expect = 3e-14
 Identities = 28/120 (23%), Positives = 51/120 (42%), Gaps = 14/120 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNL 54
           +  L  L +  +K+    P   +NLT L +L L+ N++  +        L       N +
Sbjct: 154 MTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQI 211

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS-LEKL 113
               P  +  +  L  L +G+N++    P    +L  L  L++  N +S+I  +  L KL
Sbjct: 212 TDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLTKL 267

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 71.8 bits (177), Expect = 3e-14
 Identities = 30/128 (23%), Positives = 52/128 (40%), Gaps = 18/128 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV--------LTRTDFSRNN 53
           L  L +L L  + +S   P   +NLT + +L+L +N     +        L     + + 
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESK 166

Query: 54  LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL----S 109
           +  D+   I  L  L  LSL +N+++   P     L SL       N +++I P+     
Sbjct: 167 V-KDVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTR 222

Query: 110 LEKLLLEG 117
           L  L +  
Sbjct: 223 LNSLKIGN 230

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 26/127 (20%), Positives = 53/127 (41%), Gaps = 16/127 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L  ++ L+L  N     +    SN+T L  L +  ++++ +        L     + N +
Sbjct: 131 LTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQI 189

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
               P  +  L SL + +   N++    P    ++  L SL + NN ++++ PL+    L
Sbjct: 190 EDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQL 245

Query: 111 EKLLLEG 117
             L +  
Sbjct: 246 TWLEIGT 252

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 69.1 bits (170), Expect = 2e-13
 Identities = 24/125 (19%), Positives = 53/125 (42%), Gaps = 17/125 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           LA   +  L+   ++  +      L ++  L +   ++  +        L   + + N +
Sbjct: 21  LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQI 78

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
               P  +  L  L  L +G N++  +  ++  +L +L  L L+ +N+S+I PL+    +
Sbjct: 79  TDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPLANLTKM 134

Query: 111 EKLLL 115
             L L
Sbjct: 135 YSLNL 139

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 57.9 bits (141), Expect = 1e-09
 Identities = 24/122 (19%), Positives = 48/122 (39%), Gaps = 17/122 (13%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNLLGDIP 59
            L      ++   P   ++L       L    +  +V       +T+   +    +  I 
Sbjct: 4   TLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEK-VASIQ 60

Query: 60  TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----LEKLLL 115
             I+ L +L++L+L  N++    P    +LV L +L +  N +++I  L     L +L L
Sbjct: 61  -GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQNLTNLRELYL 117

Query: 116 EG 117
             
Sbjct: 118 NE 119

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 13/78 (16%), Positives = 22/78 (28%), Gaps = 17/78 (21%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           L+ L  L L  N+L          LT L  L L  N +  +                   
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI-----------------RP 328

Query: 62  IQGLKSLQFLSLGHNRLQ 79
           +  L  +      +  ++
Sbjct: 329 LASLSKMDSADFANQVIK 346

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 26/133 (19%), Positives = 52/133 (39%), Gaps = 18/133 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRT------------DF 49
           L  + ++ +  +K+     +   +L +L  L L  N +    L  +              
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368

Query: 50  SRNNL--LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI-- 105
           S+N+L  +      +  LK+L  L +  N     +P+S      +  L+LS+  +  +  
Sbjct: 369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKT 427

Query: 106 -IPLSLEKLLLEG 117
            IP +LE L +  
Sbjct: 428 CIPQTLEVLDVSN 440

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 28/123 (22%), Positives = 47/123 (38%), Gaps = 11/123 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
            A L  L L+ ++++      F +L +L +L L  N L  L          L   +   N
Sbjct: 49  CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN 108

Query: 53  NLLG-DIPTTIQGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIPLSL 110
                 + +    L +LQ L +G+      I    F  L SL  L++   +L      SL
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168

Query: 111 EKL 113
           + +
Sbjct: 169 KSI 171

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 27/143 (18%), Positives = 51/143 (35%), Gaps = 23/143 (16%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLL 55
           + +L +    L   + T +S L  ++ + ++++++  +          L   D S N ++
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

Query: 56  GDIPTT---IQGLKSLQFLSLGHNRLQ--GSIPNSFDDLVSLESLDLSNNNLSEI----- 105
            +            SLQ L L  N L+           L +L SLD+S N    +     
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQ 407

Query: 106 IPLSLEKLLLEG----EIPRGGP 124
            P  +  L L       +    P
Sbjct: 408 WPEKMRFLNLSSTGIRVVKTCIP 430

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 25/125 (20%), Positives = 50/125 (40%), Gaps = 11/125 (8%)

Query: 2   LAALFQLDLRGNKLSG-SIPTCFSNLTALRNLHLDSNELRHLV----------LTRTDFS 50
           L++L  L+L GN      + + F NLT L+ L + + E    +          L   +  
Sbjct: 97  LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156

Query: 51  RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
             +L      +++ ++ +  L+L  +     +    D L S+  L+L + NL+      L
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216

Query: 111 EKLLL 115
               +
Sbjct: 217 PVDEV 221

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 29/118 (24%), Positives = 43/118 (36%), Gaps = 13/118 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLL 55
           L  L  LD+  N     +P        +R L+L S  +R +       L   D S NN L
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVS-NNNL 443

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
                    L  LQ L +  N+L+     S      L  + +S N L  +     ++L
Sbjct: 444 DSFSL---FLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRL 496

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 33/137 (24%), Positives = 56/137 (40%), Gaps = 28/137 (20%)

Query: 4   ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQ 63
           A    D R    + SIP+      A+++L L  N++ ++                   ++
Sbjct: 6   ASGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYI---------------GHGDLR 47

Query: 64  GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL------SLEKLLLEG 117
              +LQ L L  +R+     ++F  L SLE LDLS+N+LS +         SL+ L L G
Sbjct: 48  ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMG 107

Query: 118 ----EIPRGGPFTKFSS 130
                +     F   ++
Sbjct: 108 NPYQTLGVTSLFPNLTN 124

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 21/102 (20%), Positives = 42/102 (41%), Gaps = 7/102 (6%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
            D   N L    P+    ++ L  +   +  +R L        +  L  D+ T    L+ 
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVT--IRRL-----HIPQFYLFYDLSTVYSLLEK 311

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
           ++ +++ ++++     +    L SLE LDLS N + E    +
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 20/123 (16%), Positives = 37/123 (30%), Gaps = 10/123 (8%)

Query: 2   LAALFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSNELRHLV---------LTRTDFSR 51
           L  L  L +   +    I    F+ LT+L  L + +  LR+           +       
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
           +     +      L S+++L L    L     +          +       S +   S  
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241

Query: 112 KLL 114
           +LL
Sbjct: 242 ELL 244

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 24/140 (17%), Positives = 42/140 (30%), Gaps = 29/140 (20%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------------------- 42
           +  +  L L  ++ +  +      L+++R L L    L                      
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230

Query: 43  -VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFD--------DLVSLE 93
                TD S N LL  +   I  L  ++F     N L    P+  D        + V++ 
Sbjct: 231 RGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289

Query: 94  SLDLSNNNLSEIIPLSLEKL 113
            L +    L   +      L
Sbjct: 290 RLHIPQFYLFYDLSTVYSLL 309

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 24/119 (20%), Positives = 44/119 (36%), Gaps = 15/119 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
              + +LDL GN LS       +  T L  L+L SN L   +       L   D + N +
Sbjct: 33  AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYV 92

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
                  +    S++ L   +N +   +          +++ L+NN ++ +  L     
Sbjct: 93  -----QELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCR 143

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 21/114 (18%), Positives = 38/114 (33%), Gaps = 13/114 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLTRTDFSR 51
                 + L  NK++          + ++ L L  NE+  +           L   +   
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
           N +  D+   +     L+ L L  N+L   +   F     +  + L NN L  I
Sbjct: 179 NFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLI 229

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 21/117 (17%), Positives = 41/117 (35%), Gaps = 18/117 (15%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
                   +  + L  ++ +   +   ++ L L  N L  +                   
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQI---------------SAAD 53

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL-SLEKLLLEG 117
           +     L+ L+L  N L        + L +L +LDL+NN + E++   S+E L    
Sbjct: 54  LAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQELLVGPSIETLHAAN 108

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 21/117 (17%), Positives = 44/117 (37%), Gaps = 9/117 (7%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV----LTRTDFSRNNLLGD 57
              L  L+L  N L         +L+ LR L L++N ++ L+    +     + NN+   
Sbjct: 57  FTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI-SR 113

Query: 58  IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           +  +    +  + + L +N++             ++ LDL  N +  +    L    
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 20/104 (19%), Positives = 34/104 (32%), Gaps = 19/104 (18%)

Query: 18  SIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR 77
           +I     N    +   +  + L+                 + +  Q   +++ L L  N 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQA---------------LASLRQSAWNVKELDLSGNP 45

Query: 78  LQGSIPNSFDDLVSLESLDLSNNNLSEIIPL----SLEKLLLEG 117
           L             LE L+LS+N L E + L    +L  L L  
Sbjct: 46  LSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNN 89

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 13/105 (12%), Positives = 24/105 (22%), Gaps = 4/105 (3%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLL---GDI 58
            A +  + LR NKL   I         L +  L  N      L         +       
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 59  PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 103
              + G    +                     +   + L +++  
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 40/115 (34%), Positives = 51/115 (44%), Gaps = 13/115 (11%)

Query: 2   LAALFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSNEL--------RHLVLTRTDFSRN 52
           L  L  L L  NKL  ++P   F  L  L  L +  N+L          LV         
Sbjct: 60  LTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDR 118

Query: 53  NLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEI 105
           N L  +P  +   L  L +LSLG+N LQ S+P   FD L SL+ L L NN L  +
Sbjct: 119 NQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRV 172

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.4 bits (173), Expect = 5e-14
 Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 13/110 (11%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGD 57
           +LDL+ NKLS      F  LT LR L+L+ N+L+ L          L     + +N L  
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT-DNKLQA 99

Query: 58  IPTTI-QGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEI 105
           +P  +   L +L  L L  N+L+ S+P   FD L  L  L L  N L  +
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSL 148

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 25/121 (20%)

Query: 2   LAALFQLDLRGNKLSGSIPTC-FSNLTALRNLHLDSN--------------ELRHLVLTR 46
           L  L  L +  NKL  ++P   F  L  L  L LD N              +L +L L  
Sbjct: 84  LKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL-- 140

Query: 47  TDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSE 104
                 N L  +P  +   L SL+ L L +N+L+  +P  +FD L  L++L L NN L  
Sbjct: 141 ----GYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR 195

Query: 105 I 105
           +
Sbjct: 196 V 196

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 36/123 (29%), Positives = 49/123 (39%), Gaps = 15/123 (12%)

Query: 1   YLAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNEL--------RHLV-LTRTDFS 50
            L  L +L L  N+L  S+P   F +LT L  L L  NEL          L  L      
Sbjct: 107 QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLY 165

Query: 51  RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL----SEII 106
            N L          L  L+ L L +N+L+     +FD L  L+ L L  N      + II
Sbjct: 166 NNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNGII 225

Query: 107 PLS 109
            ++
Sbjct: 226 YMA 228

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 49.2 bits (118), Expect = 7e-07
 Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 22/99 (22%)

Query: 9   DLRGNKLSGSIPTCFSNL-TALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           D    KL+ +IP   SN+    + L L SN+L  L                      L  
Sbjct: 22  DCSSKKLT-AIP---SNIPADTKKLDLQSNKLSSLP---------------SKAFHRLTK 62

Query: 68  LQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEI 105
           L+ L L  N+LQ ++P   F +L +LE+L +++N L  +
Sbjct: 63  LRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQAL 100

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 29/147 (19%), Positives = 60/147 (40%), Gaps = 15/147 (10%)

Query: 226 EFAIKSFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI--L 283
              + +  V+   M     +N V  +   S + +  + ++     +L+  +     +   
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 284 DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED 343
           +    L+I I +  A+E+LH   S  ++H DLKP N+    + V  + DFG+   +  ++
Sbjct: 162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218

Query: 344 QSMTQTQTLA----------TIGYMAP 360
           +  T    +           T  YM+P
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSP 245

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 13/66 (19%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV------------ECEVMKSIHHRNLVKIISS 253
            +GRG FG V++A+   D   +AIK   +            E + +  + H  +V+  ++
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 254 CSNEDF 259
                 
Sbjct: 73  WLETPP 78

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 40/158 (25%), Positives = 56/158 (35%), Gaps = 26/158 (16%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSR----------NNLLG 56
            +DL  N ++    T FS L  L+ L ++      LV+    F             N   
Sbjct: 34  YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPG-LVIRNNTFRGLSSLIILKLDYNQFL 92

Query: 57  DIPTTI-QGLKSLQFLSLGHNRLQGSI--PNSFDDLVSLESLDLSNNNLSEIIPL----- 108
            + T    GL +L+ L+L    L G++   N F  L SLE L L +NN+ +I P      
Sbjct: 93  QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152

Query: 109 --SLEKLLLEG----EIPRGGPFTKFSSKSFIGNDLLC 140
                 L L       I        F  K F    L  
Sbjct: 153 MRRFHVLDLTFNKVKSICEED-LLNFQGKHFTLLRLSS 189

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 29/111 (26%), Positives = 44/111 (39%), Gaps = 15/111 (13%)

Query: 3   AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTI 62
           + +   DL  +K+   + + FS+ T L  L L  NE+  +                    
Sbjct: 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI---------------DDNAF 319

Query: 63  QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
            GL  L  L+L  N L       F++L  LE LDLS N++  +   S   L
Sbjct: 320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL 370

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 33/188 (17%), Positives = 56/188 (29%), Gaps = 22/188 (11%)

Query: 2   LAALFQLDLRGNKLSGSI--PTCFSNLTALRNLHLDSNELRHLV----------LTRTDF 49
           LA L  L L    L G++     F  LT+L  L L  N ++ +               D 
Sbjct: 102 LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDL 161

Query: 50  SRNNL----------LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 99
           + N +                T+  L S+    +    L      +     S+ +LDLS 
Sbjct: 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSG 221

Query: 100 NNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILA 159
           N   E +       +   +I        ++  S  G+       N      +++      
Sbjct: 222 NGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCD 281

Query: 160 LKFGLISR 167
           L    I  
Sbjct: 282 LSKSKIFA 289

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 33/103 (32%), Positives = 47/103 (45%), Gaps = 19/103 (18%)

Query: 2   LAALFQLDLRGNKLSGSIPTC-FSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
           L  L +L+L  N L  SI +  F NL  L  L L  N +R L                  
Sbjct: 322 LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALG---------------DQ 365

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNL 102
           +  GL +L+ L+L  N+L+ S+P+  FD L SL+ + L  N  
Sbjct: 366 SFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 23/115 (20%), Positives = 45/115 (39%), Gaps = 6/115 (5%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
             ++  LDL GN    S+   F +   +    + S  L +     + F   N       T
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDA--IAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268

Query: 62  IQGLK--SLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
            +GL+   ++   L  +++  ++    F     LE L L+ N +++I   +   L
Sbjct: 269 FKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGL 322

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 32/174 (18%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD--------------VECEVMKSIHHRNLVKII 251
            +G G+FG V   +    G + A+K  +               E + +K   H +++K+ 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 252 SSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
              S      +V+EY++ G L + +    N  LD  +   +   + S ++Y H      +
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQQILSGVDYCH---RHMV 137

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI----GYMAP 360
           +H DLKP NVLLD ++ A ++DFG++ +       M+  + L T      Y AP
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAAP 184

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 71.4 bits (176), Expect = 4e-14
 Identities = 46/189 (24%), Positives = 75/189 (39%), Gaps = 57/189 (30%)

Query: 207 LIGRGSFGSVYKARLQDGME----FAIKSF----------DVEC-----EVMKSIHHRNL 247
           ++G+G +G V++ R   G      FA+K            D         +++ + H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 248 VKIISSCSNEDFRALVLEYMTNGSL------EKVL-------YSSNCILDILQRLNIMIN 294
           V +I +        L+LEY++ G L      E +        Y +   +           
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM----------- 132

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTL 352
              AL +LH      II+ DLKP N++L+    +   L+DFG+ K    +      T T 
Sbjct: 133 ---ALGHLH---QKGIIYRDLKPENIMLNHQGHVK--LTDFGLCKESIHDGTV---THTF 181

Query: 353 A-TIGYMAP 360
             TI YMAP
Sbjct: 182 CGTIEYMAP 190

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 24/119 (20%), Positives = 44/119 (36%), Gaps = 15/119 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
              + +LDL GN LS       +  T L  L+L SN L   +       L   D + N +
Sbjct: 33  AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYV 92

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
                  +    S++ L   +N +     +        +++ L+NN ++ +  L     
Sbjct: 93  -----QELLVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKITMLRDLDEGCR 143

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 21/117 (17%), Positives = 46/117 (39%), Gaps = 9/117 (7%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV----LTRTDFSRNNLLGD 57
              L  L+L  N L  ++     +L+ LR L L++N ++ L+    +     + NN+   
Sbjct: 57  FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI-SR 113

Query: 58  IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           +  +    +  + + L +N++             ++ LDL  N +  +    L    
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 21/117 (17%), Positives = 41/117 (35%), Gaps = 18/117 (15%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
                   +  + L  ++ +   +   ++ L L  N L  +                   
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQI---------------SAAD 53

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL-SLEKLLLEG 117
           +     L+ L+L  N L        + L +L +LDL+NN + E++   S+E L    
Sbjct: 54  LAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAAN 108

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 21/114 (18%), Positives = 38/114 (33%), Gaps = 13/114 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLTRTDFSR 51
                 + L  NK++          + ++ L L  NE+  +           L   +   
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ- 177

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
            N + D+   +     L+ L L  N+L   +   F     +  + L NN L  I
Sbjct: 178 YNFIYDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLI 229

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 20/104 (19%), Positives = 34/104 (32%), Gaps = 19/104 (18%)

Query: 18  SIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR 77
           +I     N    +   +  + L+                 + +  Q   +++ L L  N 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQA---------------LASLRQSAWNVKELDLSGNP 45

Query: 78  LQGSIPNSFDDLVSLESLDLSNNNLSEIIPL----SLEKLLLEG 117
           L             LE L+LS+N L E + L    +L  L L  
Sbjct: 46  LSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNN 89

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 17/124 (13%), Positives = 31/124 (25%), Gaps = 9/124 (7%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTR--------TDFSRNN 53
            A +  + LR NKL   I         L +  L  N      L             ++  
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 54  LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           +        +          G    +       D L++L+  + +  +        LE  
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331

Query: 114 LLEG 117
               
Sbjct: 332 RENQ 335

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 7/113 (6%), Positives = 20/113 (17%), Gaps = 11/113 (9%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
                                   L AL+         +            +    +   
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ-----------GSETERLECE 331

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
            +     + +     + +  I        +  +L+     L E +        
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.1 bits (175), Expect = 6e-14
 Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 54/186 (29%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF---------DVECEVM------KSIHHRNLVKI 250
           +IG+GSFG V  AR +   + +A+K           + +  +       K++ H  LV +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 251 ISSCSNEDFRALVLEYMTNGSL-----------EK--VLYSSNCILDILQRLNIMINVTS 297
             S    D    VL+Y+  G L           E     Y++               + S
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE--------------IAS 150

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTL-AT 354
           AL YLH   S  I++ DLKP N+LLD    IV  L+DFG+ K     + +   T T   T
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIV--LTDFGLCKENIEHNST---TSTFCGT 202

Query: 355 IGYMAP 360
             Y+AP
Sbjct: 203 PEYLAP 208

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 38/148 (25%), Positives = 63/148 (42%), Gaps = 24/148 (16%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK---------SFDVECEVMKSIHH-RNLVKIISSCSN 256
           IG G+FG +   + L      AIK            +E    K +     + ++      
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76

Query: 257 EDFRALVLEYMTNG-SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
             + A+VLE +  G SLE +    +    +   L I I + S +EY+H   S  +I+ D+
Sbjct: 77  GKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDV 131

Query: 316 KPHNVLL------DDNIVAHLSDFGIAK 337
           KP N L+         ++ H+ DF +AK
Sbjct: 132 KPENFLIGRPGNKTQQVI-HIIDFALAK 158

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 70.7 bits (174), Expect = 8e-14
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 55/187 (29%)

Query: 207 LIGRGSFGSVYKARLQDGME----FAIKSF---------DVEC----EVMKSIHHRNLVK 249
           ++G+GSFG V+  +   G +    +A+K            V      +++  ++H  +VK
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 250 IISSCSNEDFRALVLEYMTNGSL-----------EK--VLYSSNCILDILQRLNIMINVT 296
           +  +   E    L+L+++  G L           E+    Y +               + 
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE--------------LA 136

Query: 297 SALEYLHFGFSTPIIHCDLKPHNVLLDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTL-A 353
            AL++LH   S  II+ DLKP N+LLD+   I   L+DFG++K     ++      +   
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIK--LTDFGLSKESIDHEKK---AYSFCG 188

Query: 354 TIGYMAP 360
           T+ YMAP
Sbjct: 189 TVEYMAP 195

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 30/148 (20%), Positives = 59/148 (39%), Gaps = 24/148 (16%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK---------SFDVECEVMKSIHH-RNLVKIISSCSN 256
           IG GSFG +++   L +  + AIK             E    K +     +  +      
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77

Query: 257 EDFRALVLEYMTNG-SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
                LV++ +  G SLE +L        +         + + ++ +H      +++ D+
Sbjct: 78  GLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDI 132

Query: 316 KPHNVLL------DDNIVAHLSDFGIAK 337
           KP N L+      + N++ ++ DFG+ K
Sbjct: 133 KPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 22/146 (15%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK---------SFDVECEVMKSIHH-RNLVKIISSCSN 256
           IG GSFG +Y    +  G E AIK            +E ++ K +     +  I    + 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76

Query: 257 EDFRALVLEYMTNG-SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            D+  +V+E +  G SLE +    +    +   L +   + S +EY+H   S   IH D+
Sbjct: 77  GDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDV 131

Query: 316 KPHNVLL----DDNIVAHLSDFGIAK 337
           KP N L+      N+V ++ DFG+AK
Sbjct: 132 KPDNFLMGLGKKGNLV-YIIDFGLAK 156

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 27/110 (24%), Positives = 51/110 (46%), Gaps = 14/110 (12%)

Query: 8   LDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGD 57
           L L  N+ +    T  F  L  LR ++  +N++  +          +     + +N L +
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT-SNRLEN 95

Query: 58  IPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNLSEI 105
           +   + +GL+SL+ L L  NR+   + N SF  L S+  L L +N ++ +
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTV 144

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.5 bits (155), Expect = 6e-12
 Identities = 26/111 (23%), Positives = 49/111 (44%), Gaps = 15/111 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSR---------- 51
           L  L +++   NK++      F   + +  + L SN L ++      F            
Sbjct: 56  LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV--QHKMFKGLESLKTLMLR 113

Query: 52  NNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNN 100
           +N +  +   +  GL S++ LSL  N++  ++   +FD L SL +L+L  N
Sbjct: 114 SNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 46/185 (24%), Positives = 74/185 (40%), Gaps = 47/185 (25%)

Query: 207 LIGRGSFGSVYKARLQDGME----FAIKSF----------DVEC-----EVMKSI-HHRN 246
           ++G G++G V+  R   G +    +A+K              E      +V++ I     
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMIN---------VTS 297
           LV +  +   E    L+L+Y+  G L             L +               +  
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGEL----------FTHLSQRERFTEHEVQIYVGEIVL 170

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
           ALE+LH      II+ D+K  N+LLD N  +V  L+DFG++K    ++          TI
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVV--LTDFGLSKEFVADETERAYD-FCGTI 224

Query: 356 GYMAP 360
            YMAP
Sbjct: 225 EYMAP 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 34/180 (18%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV------------ECEVMKSIHHRNLVK---II 251
           +G G++G V  A     G   AIK  +             E +++K   H N++    I 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78

Query: 252 SSCSNEDFRA--LVLEYM-TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
              S E+F    ++ E M T+  L +V+  S  +L        +     A++ LH    +
Sbjct: 79  RPDSFENFNEVYIIQELMQTD--LHRVI--STQMLSDDHIQYFIYQTLRAVKVLH---GS 131

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ--------TQTLATIGYMAP 360
            +IH DLKP N+L++ N    + DFG+A+++       ++         + +AT  Y AP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 50/184 (27%), Positives = 76/184 (41%), Gaps = 50/184 (27%)

Query: 207 LIGRGSFGSVYKARLQDGME-FAIKSF---------DVECEVM------KSIHHRNLVKI 250
           ++G+GSFG V  AR+++  + +A+K           DVEC +        + +H  L ++
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 251 ISSCSNEDFRALVLEYMTNGSL-----------EK--VLYSSNCILDILQRLNIMINVTS 297
                  D    V+E++  G L           E     Y++  I+             S
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA-EII-------------S 135

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIG 356
           AL +LH      II+ DLK  NVLLD      L+DFG+ K       +   T T   T  
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPD 189

Query: 357 YMAP 360
           Y+AP
Sbjct: 190 YIAP 193

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 31/198 (15%)

Query: 183 PQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQD-GMEFAIKSF--------- 232
           P+ ++ R S    L+  + F  + ++G+GSFG V+ A  +     FAIK+          
Sbjct: 1   PELNKERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59

Query: 233 DVECEVM-------KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDI 285
           DVEC  M        +  H  L  +  +   ++    V+EY+  G L   + S +     
Sbjct: 60  DVEC-TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS 118

Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN--IVAHLSDFGIAKLLTGED 343
                    +   L++LH   S  I++ DLK  N+LLD +  I   ++DFG+ K     D
Sbjct: 119 RATFYAA-EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIK--IADFGMCKENMLGD 172

Query: 344 QSMTQTQTL-ATIGYMAP 360
                T T   T  Y+AP
Sbjct: 173 AK---TNTFCGTPDYIAP 187

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 18/127 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L  L  L L  N+++   P    NLT L  L L SN +  +        L +  F  N +
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG-NQV 167

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
               P  +  L +L+ L +  N++  S  +    L +LESL  +NN +S+I PL     L
Sbjct: 168 TDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLGILTNL 223

Query: 111 EKLLLEG 117
           ++L L G
Sbjct: 224 DELSLNG 230

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 36/127 (28%), Positives = 55/127 (43%), Gaps = 17/127 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L  L  LDL  N++S   P   S LT L  L L +N++ ++        LT  + + N L
Sbjct: 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 299

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
               P  I  LK+L +L+L  N +    P     L  L+ L   NN +S++  L+    +
Sbjct: 300 EDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNI 355

Query: 111 EKLLLEG 117
             L    
Sbjct: 356 NWLSAGH 362

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 29/127 (22%), Positives = 55/127 (43%), Gaps = 17/127 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           LA   +  L    ++ ++    ++L  +  L  D   ++ +        LT+ +FS N L
Sbjct: 23  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQL 80

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
               P  ++ L  L  + + +N++    P    +L +L  L L NN +++I PL     L
Sbjct: 81  TDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNL 136

Query: 111 EKLLLEG 117
            +L L  
Sbjct: 137 NRLELSS 143

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 17/127 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L  L +L L GN+L   I T  ++LT L +L L +N++ +L        LT      N +
Sbjct: 220 LTNLDELSLNGNQLK-DIGT-LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQI 277

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
               P  + GL +L  L L  N+L+   P    +L +L  L L  NN+S+I P+S    L
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKL 333

Query: 111 EKLLLEG 117
           ++L    
Sbjct: 334 QRLFFYN 340

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L +L QL   GN+++   P   +NLT L  L + SN++  +        L     + N +
Sbjct: 155 LTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQI 211

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
               P  +  L +L  LSL  N+L+     +   L +L  LDL+NN +S + PLS    L
Sbjct: 212 SDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKL 267

Query: 111 EKLLLEG 117
            +L L  
Sbjct: 268 TELKLGA 274

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 32/134 (23%), Positives = 62/134 (46%), Gaps = 25/134 (18%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
           YL  L Q++   N+L+   P    NLT L ++ +++N++  +                 T
Sbjct: 66  YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-----------------T 106

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----LEKLLLE 116
            +  L +L  L+L +N++    P    +L +L  L+LS+N +S+I  LS    L++L   
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG 164

Query: 117 GEIPRGGPFTKFSS 130
            ++    P    ++
Sbjct: 165 NQVTDLKPLANLTT 178

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 31/122 (25%), Positives = 51/122 (41%), Gaps = 13/122 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L AL  L+L  N+L    P   SNL  L  L L  N +  +        L R  F  NN 
Sbjct: 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFY-NNK 342

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           + D+ + +  L ++ +LS GHN++    P    +L  +  L L++   +         + 
Sbjct: 343 VSDVSS-LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399

Query: 115 LE 116
           + 
Sbjct: 400 IP 401

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 22/132 (16%), Positives = 39/132 (29%), Gaps = 11/132 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L  L +L    NK+S    +  +NLT +  L    N++  L        +T+   +    
Sbjct: 330 LTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAW 387

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
                     +     +      L    P +  D  S    D++ N  S    +S     
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQ 445

Query: 115 LEGEIPRGGPFT 126
                     F+
Sbjct: 446 PVTIGKGTTTFS 457

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 37/158 (23%), Positives = 63/158 (39%), Gaps = 26/158 (16%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD-----------------VECEVMKSIHHR--N 246
           L+G G FGSVY    + D +  AIK  +                 +E  ++K +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 247 LVKIISSCSNEDFRALVLEYMTN-GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
           +++++      D   L+LE       L   +     + + L R +    V  A+ + H  
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 166

Query: 306 FSTPIIHCDLKPHNVLLDDNIV-AHLSDFGIAKLLTGE 342
            +  ++H D+K  N+L+D N     L DFG   LL   
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 39/179 (21%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV------------ECEVMKSIHHRNLVK---II 251
           IG G++G V  A    + +  AIK                E +++    H N++    II
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94

Query: 252 SSCSNEDFRA--LVLEYM-TNGSLEKVLYSSNCILDILQRLN------IMINVTSALEYL 302
            + + E  +   +V + M T+  L K+L +        Q L+       +  +   L+Y+
Sbjct: 95  RAPTIEQMKDVYIVQDLMETD--LYKLLKT--------QHLSNDHICYFLYQILRGLKYI 144

Query: 303 HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 360
           H   S  ++H DLKP N+LL+      + DFG+A++   +       T+ +AT  Y AP
Sbjct: 145 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 49/215 (22%)

Query: 178 VANMQPQASRRR--FSYLELLRA----TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK 230
           +A+     S+ R  F   EL +        +   + +G G++GSV  A   + G+  A+K
Sbjct: 1   MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60

Query: 231 ----SFDV---------ECEVMKSIHHRNLVKI----ISSCSNEDFRA--LVLEYMTNGS 271
                F           E  ++K + H N++ +      + S E+F    LV   M    
Sbjct: 61  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GAD 119

Query: 272 LEKVLYSSNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN 325
           L  ++          Q+L       ++  +   L+Y+H   S  IIH DLKP N+ ++++
Sbjct: 120 LNNIVKC--------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNED 168

Query: 326 IVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
               + DFG+A+        M  T  +AT  Y AP
Sbjct: 169 CELKILDFGLAR---HTADEM--TGYVATRWYRAP 198

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 37/160 (23%), Positives = 66/160 (41%), Gaps = 28/160 (17%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD-----------------VECEVMKSIH----H 244
           L+G+G FG+V+    L D ++ AIK                    +E  ++  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGS-LEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
             +++++     ++   LVLE       L   +     + +   R      V +A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156

Query: 304 FGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGE 342
              S  ++H D+K  N+L+D     A L DFG   LL  E
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 49/174 (28%), Positives = 72/174 (41%), Gaps = 30/174 (17%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF---------DVECEVM-------KSIHHRNLVK 249
           +IGRGS+  V   RL+     +A+K           D++  V        ++ +H  LV 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQASNHPFLVG 74

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           + S    E     V+EY+  G L   +     + +   R      ++ AL YLH      
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH---ERG 130

Query: 310 IIHCDLKPHNVLLDDN--IVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 360
           II+ DLK  NVLLD    I   L+D+G+ K           T T   T  Y+AP
Sbjct: 131 IIYRDLKLDNVLLDSEGHIK--LTDYGMCKEGLRPGD---TTSTFCGTPNYIAP 179

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 33/190 (17%)

Query: 197 RATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFDVECE------------------ 237
            AT+ +     IG G++G+VYKAR    G   A+KS  V                     
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 238 -VMKSIHHRNLVK---IISSCSNEDFRA--LVLEYMTNGSLEKVLYSSNCI-LDILQRLN 290
             +++  H N+V+   + ++   +      LV E++    L   L  +    L      +
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 291 IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
           +M      L++LH   +  I+H DLKP N+L+       L+DFG+A++ + +   M  T 
Sbjct: 125 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTP 178

Query: 351 TLATIGYMAP 360
            + T+ Y AP
Sbjct: 179 VVVTLWYRAP 188

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 26/173 (15%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK----SFDV---------ECEVMKSIHHRNLVK---I 250
           IGRGS+G VY A         AIK     F+          E  ++  +    +++   +
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93

Query: 251 ISSCSNEDFRA--LVLEYM-TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
           I       F    +VLE   ++  L+K+  +   + +   +  I+ N+     ++H    
Sbjct: 94  IIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH---E 147

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           + IIH DLKP N LL+ +    + DFG+A+ +  E  +               
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 44/184 (23%), Positives = 69/184 (37%), Gaps = 50/184 (27%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF---------DVECEVM------KSIHHRNLVKI 250
           ++G+GSFG V  +  +     +A+K           DVEC ++             L ++
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 251 ISSCSNEDFRALVLEYMTNGSL-------------EKVLYSSNCILDILQRLNIMINVTS 297
            S     D    V+EY+  G L               V Y++   +              
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI-------------- 453

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIG 356
            L +L    S  II+ DLK  NV+LD      ++DFG+ K    +      T+T   T  
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPD 507

Query: 357 YMAP 360
           Y+AP
Sbjct: 508 YIAP 511

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 44/174 (25%), Positives = 71/174 (40%), Gaps = 33/174 (18%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFD--------------VECEVMKSIHHRNLVKII 251
            +G GSFG V  A   +   + A+K                  E   +K + H +++K+ 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 252 SSCSNEDFRALVLEYMTNGSL-EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
              +      +V+EY   G L + +       +   +       +  A+EY H      I
Sbjct: 76  DVITTPTDIVMVIEY-AGGELFDYI--VEKKRMTEDEGRRFFQQIICAIEYCH---RHKI 129

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI----GYMAP 360
           +H DLKP N+LLDDN+   ++DFG++ +       MT    L T      Y AP
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNI-------MTDGNFLKTSCGSPNYAAP 176

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 68.2 bits (166), Expect = 9e-13
 Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 17/127 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L ++ Q+    + +  S+      L  +  L L+ N+L  +        L       N +
Sbjct: 42  LNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKI 99

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
             D+ ++++ LK L+ LSL HN +   I      L  LESL L NN +++I  LS    L
Sbjct: 100 K-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLSRLTKL 155

Query: 111 EKLLLEG 117
           + L LE 
Sbjct: 156 DTLSLED 162

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 66.3 bits (161), Expect = 4e-12
 Identities = 28/127 (22%), Positives = 61/127 (48%), Gaps = 17/127 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
            A   + +L+   ++ ++    + L ++  +  ++++++ +        +T+   + N L
Sbjct: 20  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKL 77

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
             DI   +  LK+L +L L  N+++  + +   DL  L+SL L +N +S+I  L     L
Sbjct: 78  T-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDINGLVHLPQL 133

Query: 111 EKLLLEG 117
           E L L  
Sbjct: 134 ESLYLGN 140

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 66.3 bits (161), Expect = 4e-12
 Identities = 37/126 (29%), Positives = 58/126 (46%), Gaps = 15/126 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE------LRHLVLTRTDFSRNNLL 55
           L  L  L L  NK+   + +   +L  L++L L+ N       L HL    + +  NN +
Sbjct: 86  LKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKI 143

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----LE 111
            DI T +  L  L  LSL  N++   I      L  L++L LS N++S++  L+    L+
Sbjct: 144 TDI-TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDLRALAGLKNLD 200

Query: 112 KLLLEG 117
            L L  
Sbjct: 201 VLELFS 206

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 58.6 bits (141), Expect = 1e-09
 Identities = 21/124 (16%), Positives = 42/124 (33%), Gaps = 17/124 (13%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNLLGD 57
           + +       +    P            +L    +   V       + +   + ++ +  
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSD-IKS 57

Query: 58  IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----LEKL 113
           +   IQ L ++  L L  N+L   I     +L +L  L L  N + ++  L     L+ L
Sbjct: 58  V-QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDLSSLKDLKKLKSL 114

Query: 114 LLEG 117
            LE 
Sbjct: 115 SLEH 118

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 29/121 (23%), Positives = 47/121 (38%), Gaps = 13/121 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L  L  L L  N +S  I     +L  L +L+L +N++  +        L       N +
Sbjct: 108 LKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQI 165

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
             DI   + GL  LQ L L  N +  S   +   L +L+ L+L +             L+
Sbjct: 166 -SDIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 115 L 115
           +
Sbjct: 222 V 222

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 18/147 (12%), Positives = 43/147 (29%), Gaps = 25/147 (17%)

Query: 207 LIGRGSFGSVYKARLQD---GMEFAIKS--------------FDVECEVMKSIHHRNLVK 249
             G       ++A   D     + A+                       +  I    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           ++          +V E++  GSL++V  +S      +  +  M ++ +A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIA 336
           +      P  V +  +    L+     
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATM 176

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.4 bits (160), Expect = 1e-12
 Identities = 26/130 (20%), Positives = 44/130 (33%), Gaps = 16/130 (12%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE--------LRHLV-LTRTDFSR 51
           Y   +  L +     +   P   S L+ L  L +   +        L  L  LT  D S 
Sbjct: 64  YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS-- 109
           +     I T I  L  +  + L +N     I      L  L+SL++  + + +   +   
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIEDF 180

Query: 110 --LEKLLLEG 117
             L +L    
Sbjct: 181 PKLNQLYAFS 190

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.0 bits (159), Expect = 1e-12
 Identities = 20/113 (17%), Positives = 41/113 (36%), Gaps = 12/113 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
           L+ L +L + G  ++       S LT+L  L +  +     +         +   D S N
Sbjct: 87  LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
             + DI   ++ L  L+ L++  + +        +D   L  L   +  +   
Sbjct: 147 GAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 64.6 bits (158), Expect = 2e-12
 Identities = 24/116 (20%), Positives = 49/116 (42%), Gaps = 10/116 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           + +L  + L    ++  + T       +++L +++    +         L R      ++
Sbjct: 43  MNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDV 100

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN-LSEIIPLS 109
             D    + GL SL  L + H+    SI    + L  + S+DLS N  +++I+PL 
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLK 156

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 55.7 bits (135), Expect = 2e-09
 Identities = 19/119 (15%), Positives = 40/119 (33%), Gaps = 12/119 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
             A     L  +  +       + + +L  + L +  +  L        +     + N  
Sbjct: 22  FKAYLNGLLGQSSTANITE---AQMNSLTYITLANINVTDLTGIEYAHNIKDLTIN-NIH 77

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
             +    I GL +L+ L +    +      +   L SL  LD+S++   + I   +  L
Sbjct: 78  ATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 35/205 (17%)

Query: 181 MQPQASRRR-FSYLELLRAT----NGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK---- 230
           M  ++ R   F  +E+  +T      +     IG G+ G V  A         AIK    
Sbjct: 1   MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60

Query: 231 SFDV---------ECEVMKSIHHRNLVKI----ISSCSNEDFRA--LVLEYMTNGSLEKV 275
            F           E  +MK ++H+N++ +        S E+F+   +V+E M + +L +V
Sbjct: 61  PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQV 119

Query: 276 LYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGI 335
           +      LD  +   ++  +   +++LH   S  IIH DLKP N+++  +    + DFG+
Sbjct: 120 IQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 173

Query: 336 AKLLTGEDQSMTQTQTLATIGYMAP 360
           A+       S   T  + T  Y AP
Sbjct: 174 AR---TAGTSFMMTPYVVTRYYRAP 195

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 46/186 (24%), Positives = 71/186 (38%), Gaps = 54/186 (29%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF---------DVECEVM------KSIHHRNLVKI 250
           ++G+GSFG V  +  +     +A+K           DVEC ++             L ++
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 251 ISSCSNEDFRALVLEYMTNGSL-----------EK--VLYSSNCILDILQRLNIMINVTS 297
            S     D    V+EY+  G L           E   V Y++               +  
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE--------------IAI 132

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTL-AT 354
            L +L    S  II+ DLK  NV+LD     H  ++DFG+ K    +      T+T   T
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV---TTKTFCGT 184

Query: 355 IGYMAP 360
             Y+AP
Sbjct: 185 PDYIAP 190

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 66.7 bits (162), Expect = 2e-12
 Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 21/111 (18%)

Query: 13  NKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT-TIQGLKSLQFL 71
              +            L  L++++                  L  +    ++GL  L+ L
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQ---------------QHLQHLELRDLRGLGELRNL 61

Query: 72  SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI-----IPLSLEKLLLEG 117
           ++  + L+   P++F     L  L+LS N L  +       LSL++L+L G
Sbjct: 62  TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSG 112

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 23/103 (22%), Positives = 34/103 (33%), Gaps = 17/103 (16%)

Query: 1   YLAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIP 59
               L +L +   +    +       L  LRNL +  + LR +                P
Sbjct: 29  GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA---------------P 73

Query: 60  TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 102
                   L  L+L  N L+     +   L SL+ L LS N L
Sbjct: 74  DAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 50/186 (26%), Positives = 71/186 (38%), Gaps = 54/186 (29%)

Query: 207 LIGRGSFGSVYKARLQD-GMEFAIKSF---------DVECEVM------KSIHHRNLVKI 250
           +IGRGS+  V   RL+     +A++           D++          ++ +H  LV +
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 251 ISSCSNEDFRALVLEYMTNGSL-----------EK--VLYSSNCILDILQRLNIMINVTS 297
            S    E     V+EY+  G L           E+    YS+  I               
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EIS-------------L 164

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTL-AT 354
           AL YLH      II+ DLK  NVLLD     H  L+D+G+ K           T T   T
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGD---TTSTFCGT 216

Query: 355 IGYMAP 360
             Y+AP
Sbjct: 217 PNYIAP 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 34/216 (15%)

Query: 169 QKRATELPNVANMQPQASRRRFSYLELLRAT----NGFSANNLIGRGSFGSVYKAR-LQD 223
           Q   + +    NM       +F  +E+  +T      +     IG G+ G V  A     
Sbjct: 27  QVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL 86

Query: 224 GMEFAIK----SFDV---------ECEVMKSIHHRNLVKII----SSCSNEDFRA--LVL 264
               AIK     F           E  +MK ++H+N++ ++       + E+F+   LV+
Sbjct: 87  DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146

Query: 265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD 324
           E M + +L +V+      LD  +   ++  +   +++LH   S  IIH DLKP N+++  
Sbjct: 147 ELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 199

Query: 325 NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +    + DFG+A+   G    M  T  + T  Y AP
Sbjct: 200 DCTLKILDFGLAR-TAGTSFMM--TPYVVTRYYRAP 232

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.1 bits (159), Expect = 3e-12
 Identities = 37/109 (33%), Positives = 50/109 (45%), Gaps = 11/109 (10%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNEL--------RHLVLTRTDFSRNNLLGDI 58
           +LDL+   L+      F  LT L  L+LD N+L          L    T    NN L  +
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98

Query: 59  PTTI-QGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEI 105
           P  +   L  L  L LG N+L+ S+P+  FD L  L+ L L+ N L  I
Sbjct: 99  PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSI 146

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 43/124 (34%), Positives = 58/124 (46%), Gaps = 19/124 (15%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNEL--------RHLV-LTRTDFSR 51
           L  L  L L  N+L+ S+P   F +LT L  L+L  N+L          L  L     + 
Sbjct: 82  LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLN- 139

Query: 52  NNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNL----SEI 105
            N L  IP      L +LQ LSL  N+LQ S+P  +FD L  L+++ L  N       EI
Sbjct: 140 TNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFDCSRCEI 198

Query: 106 IPLS 109
           + LS
Sbjct: 199 LYLS 202

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 23/72 (31%), Positives = 35/72 (48%), Gaps = 3/72 (4%)

Query: 45  TRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 104
            + D     L      T +GL  L +L+L +N+LQ      FDDL  L +L L+NN L+ 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 105 I---IPLSLEKL 113
           +   +   L +L
Sbjct: 98  LPLGVFDHLTQL 109

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 44/208 (21%), Positives = 87/208 (41%), Gaps = 48/208 (23%)

Query: 183 PQASRRRFSYLELLRA----TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK----SFD 233
               ++ F   ++ +        + +   +G G++GSV  A   + G + AIK     F 
Sbjct: 3   SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62

Query: 234 V---------ECEVMKSIHHRNLVKI----ISSCSNEDFRA--LVLEYMTNGSLEKVLYS 278
                     E  ++K + H N++ +      + S  +F    LV+ +M    L+K+   
Sbjct: 63  SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKI--- 118

Query: 279 SNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD 332
                 +  + +      ++  +   L+Y+H   S  ++H DLKP N+ ++++    + D
Sbjct: 119 ------MGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILD 169

Query: 333 FGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           FG+A+     D  M  T  + T  Y AP
Sbjct: 170 FGLAR---HADAEM--TGYVVTRWYRAP 192

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 31/124 (25%), Positives = 49/124 (39%), Gaps = 15/124 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-----LTRTDFSRNNLLG 56
            A L  ++   N+L+  +P      T+L  L + +N+L  L      L   D S  NLL 
Sbjct: 139 PALLEYINADNNQLT-MLP---ELPTSLEVLSVRNNQLTFLPELPESLEALDVS-TNLLE 193

Query: 57  DIPTTIQGLKSLQ----FLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK 112
            +P         +    F     NR+   IP +   L    ++ L +N LS  I  SL +
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252

Query: 113 LLLE 116
              +
Sbjct: 253 QTAQ 256

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 31/123 (25%), Positives = 48/123 (39%), Gaps = 18/123 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----VLTRTDFSRNNLLG 56
           +    +L L    LS S+P        +  L +  N L  L      L   D   +N L 
Sbjct: 58  INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALISLPELPASLEYLDAC-DNRLS 113

Query: 57  DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI--IPLSLEKLL 114
            +P     LK L    + +N+L   +P        LE ++  NN L+ +  +P SLE L 
Sbjct: 114 TLPELPASLKHLD---VDNNQLT-MLPEL---PALLEYINADNNQLTMLPELPTSLEVLS 166

Query: 115 LEG 117
           +  
Sbjct: 167 VRN 169

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 27/124 (21%), Positives = 48/124 (38%), Gaps = 18/124 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLL 55
                      N+    +  C   +     L L+   L  L       +T  + ++N L 
Sbjct: 36  WEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLSSLPDNLPPQITVLEITQNAL- 92

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI--IPLSLEKL 113
             +P       SL++L    NRL  ++P   +   SL+ LD+ NN L+ +  +P  LE +
Sbjct: 93  ISLPELP---ASLEYLDACDNRLS-TLP---ELPASLKHLDVDNNQLTMLPELPALLEYI 145

Query: 114 LLEG 117
             + 
Sbjct: 146 NADN 149

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 24/117 (20%), Positives = 36/117 (30%), Gaps = 15/117 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFS--- 50
             +L  L +R N+L+  +P    +L     L + +N L  L            T+     
Sbjct: 159 PTSLEVLSVRNNQLT-FLPELPESL---EALDVSTNLLESLPAVPVRNHHSEETEIFFRC 214

Query: 51  RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
           R N +  IP  I  L     + L  N L   I  S     +           S    
Sbjct: 215 RENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 24/114 (21%), Positives = 42/114 (36%), Gaps = 16/114 (14%)

Query: 13  NKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNLLGDIPTTIQGL 65
           +       + +           + NE   L+        +    +R NL   +P  +   
Sbjct: 23  SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNL-SSLPDNL--P 79

Query: 66  KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI--IPLSLEKLLLEG 117
             +  L +  N L  S+P       SLE LD  +N LS +  +P SL+ L ++ 
Sbjct: 80  PQITVLEITQNALI-SLPELPA---SLEYLDACDNRLSTLPELPASLKHLDVDN 129

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 12/87 (13%), Positives = 23/87 (26%), Gaps = 5/87 (5%)

Query: 34  LDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLE 93
           L  N    L       + +    D  +     +         N     +      +    
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62

Query: 94  SLDLSNNNLSEI---IPLSLEKLLLEG 117
            L L+  NLS +   +P  +  L +  
Sbjct: 63  ELQLNRLNLSSLPDNLPPQITVLEITQ 89

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 36/182 (19%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK--SFDV---------ECEVMKSIHHRNLVKII---- 251
           +G G  G V+ A         AIK               E ++++ + H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78

Query: 252 --------SSCSNEDFRA--LVLEYM-TNGSLEKVLYSSNCILDILQRLNIMINVTSALE 300
                      S  +  +  +V EYM T+  L  VL     + +  +    M  +   L+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHAR--LFMYQLLRGLK 134

Query: 301 YLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYM 358
           Y+H   S  ++H DLKP N+ ++ +++V  + DFG+A+++          ++ L T  Y 
Sbjct: 135 YIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191

Query: 359 AP 360
           +P
Sbjct: 192 SP 193

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 65.3 bits (160), Expect = 4e-12
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 31/188 (16%)

Query: 197 RATNGFSANNLIGRGSFGSVYKAR-LQDGMEF-AIKSFDVECE----------------V 238
           RA   +     IG G++G V+KAR L++G  F A+K   V+                   
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67

Query: 239 MKSIHHRNLVKIISSCSNEDFRA-----LVLEYMTNGSLEKVLYS-SNCILDILQRLNIM 292
           +++  H N+V++   C+           LV E++    L   L       +      ++M
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 293 INVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTL 352
             +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A++ + +   M  T  +
Sbjct: 127 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVV 180

Query: 353 ATIGYMAP 360
            T+ Y AP
Sbjct: 181 VTLWYRAP 188

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 11/110 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTC-FSNLTALRNLHLDSNELRHLV-------LTRTDFSRNN 53
           + +L QLD+  N +S        S   +L +L++ SN L   +       +   D   N 
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNK 432

Query: 54  LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNL 102
           +   IP  +  L++LQ L++  N+L+ S+P+  FD L SL+ + L  N  
Sbjct: 433 IK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 26/125 (20%), Positives = 43/125 (34%), Gaps = 12/125 (9%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
            + +   +   +        C S ++   +L   +N L   V         L       N
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358

Query: 53  NL--LGDIPTTIQGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIPLS 109
            L  L  I      +KSLQ L +  N +             SL SL++S+N L++ I   
Sbjct: 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418

Query: 110 LEKLL 114
           L   +
Sbjct: 419 LPPRI 423

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 23/114 (20%), Positives = 41/114 (35%), Gaps = 21/114 (18%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           L+ L  L +  N++     + F     L  L L  N+L  +                  +
Sbjct: 44  LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI------------------S 85

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNS--FDDLVSLESLDLSNNNLSEIIPLSLEKL 113
                +L+ L L  N    ++P    F ++  L+ L LS  +L +   L +  L
Sbjct: 86  CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 33/132 (25%), Positives = 49/132 (37%), Gaps = 25/132 (18%)

Query: 6   FQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGL 65
           F +D   N L   +P   S       L++  N +  L                 + I  L
Sbjct: 3   FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISEL---------------WTSDILSL 44

Query: 66  KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP---LSLEKLLLEG----E 118
             L+ L + HNR+Q    + F     LE LDLS+N L +I     ++L+ L L       
Sbjct: 45  SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDA 104

Query: 119 IPRGGPFTKFSS 130
           +P    F   S 
Sbjct: 105 LPICKEFGNMSQ 116

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 18/114 (15%), Positives = 38/114 (33%), Gaps = 9/114 (7%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLL 55
           +  + L+G           ++L AL    + S+               +   +F+ +   
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
                    +     L   +N L  ++  +   L  LE+L L  N L E+  ++
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA 367

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 13/113 (11%), Positives = 37/113 (32%), Gaps = 10/113 (8%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
           +   ++   +   KL G +     + +      L +  +  +V     F ++ +      
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYS---GTSLKALSIHQVVSDVFGFPQSYIY----- 296

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
             +   ++   +   +  +         +     LD SNN L++ +  +   L
Sbjct: 297 --EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 47/208 (22%)

Query: 183 PQASRRRFSYLELLRA----TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK----SFD 233
           P  +R  F   E+ +        +     +G G++G+V  A   + G + AIK     F 
Sbjct: 4   PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 63

Query: 234 V---------ECEVMKSIHHRNLVKII----SSCSNEDFRA--LVLEYMTNGSLEKVLYS 278
                     E  ++K + H N++ ++       + +DF    LV+ +M    L K++  
Sbjct: 64  SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH 122

Query: 279 SNCILDILQRLN------IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD 332
                   ++L       ++  +   L Y+H   +  IIH DLKP N+ ++++    + D
Sbjct: 123 --------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILD 171

Query: 333 FGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           FG+A+     D  M  T  + T  Y AP
Sbjct: 172 FGLAR---QADSEM--TGYVVTRWYRAP 194

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 42/190 (22%), Positives = 72/190 (37%), Gaps = 55/190 (28%)

Query: 208 IGRGSFGSVYKARLQD-GMEFAIKSFDV-------ECEVMKSIHHRNLVKII-------- 251
           +G GSFG V +    + G  FA+K           E ++MK + H N++K++        
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGD 74

Query: 252 ------------------------------SSCSNEDFRALVLEYMTNGSLEKVLYSSNC 281
                                          + S   +  +++EY+   +L KVL S   
Sbjct: 75  EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIR 133

Query: 282 ILDILQRLNI---MINVTSALEYLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAK 337
               +    I   +  +  A+ ++H   S  I H D+KP N+L++  +    L DFG AK
Sbjct: 134 SGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190

Query: 338 LLTGEDQSMT 347
            L    +   
Sbjct: 191 KLI-PSEPSV 199

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 29/167 (17%), Positives = 60/167 (35%), Gaps = 42/167 (25%)

Query: 207 LIGRGSFGSVYKAR------LQDGMEFAIK-------SFDVECEVMKSIHHRNLVKIISS 253
            IG+G FG +Y A       +       +K           E +  +       ++    
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 254 -------------------CSNEDFRALVLEYMTNG-SLEKVLYSSNCILDILQRLNIMI 293
                               + + +R ++++    G  L+K+  ++         L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 294 NVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAK 337
            +   LEY+H       +H D+K  N+LL   + + V +L D+G+A 
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 33/119 (27%), Positives = 53/119 (44%), Gaps = 14/119 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----VLTRTDFSRNNLLG 56
            + L++L    N+L+ S+P   +  + L+ L +  N L  L      L     S  N L 
Sbjct: 200 PSELYKLWAYNNRLT-SLP---ALPSGLKELIVSGNRLTSLPVLPSELKELMVS-GNRLT 254

Query: 57  DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLL 115
            +P    GL SL   S+  N+L   +P S   L S  +++L  N LSE    +L ++  
Sbjct: 255 SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS 309

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 25/120 (20%), Positives = 41/120 (34%), Gaps = 18/120 (15%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-----LTRTDFSRNNLLGDIP 59
              L++  + L+ ++P C      +  L +  N L  L      L   + S  N L  +P
Sbjct: 42  NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTSLPALPPELRTLEVS-GNQLTSLP 97

Query: 60  TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL--SLEKLLLEG 117
               GL  L   S     L             L  L +  N L+ +  L   L++L +  
Sbjct: 98  VLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLTSLPVLPPGLQELSVSD 150

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 30/123 (24%), Positives = 48/123 (39%), Gaps = 19/123 (15%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----VLTRTDFSRNNLLG 56
              L +L +  N+L+ S+P   S L     L   +N+L  L      L     S +N L 
Sbjct: 140 PPGLQELSVSDNQLA-SLPALPSELC---KLWAYNNQLTSLPMLPSGLQELSVS-DNQLA 194

Query: 57  DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL--SLEKLL 114
            +PT    L  L   +     L             L+ L +S N L+ +  L   L++L+
Sbjct: 195 SLPTLPSELYKLWAYNNRLTSLPALPSG-------LKELIVSGNRLTSLPVLPSELKELM 247

Query: 115 LEG 117
           + G
Sbjct: 248 VSG 250

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 22/106 (20%), Positives = 37/106 (34%), Gaps = 14/106 (13%)

Query: 18  SIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL 71
            +  C         L++  + L  L       +T      NNL   +P     L++   L
Sbjct: 33  KMRACL--NNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLT-SLPALPPELRT---L 86

Query: 72  SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEG 117
            +  N+L  S+P     L+ L        +L  +    L KL + G
Sbjct: 87  EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-GLCKLWIFG 130

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 22/111 (19%), Positives = 39/111 (35%), Gaps = 10/111 (9%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----VLTRTDFSRNNLLG 56
            + L +L + GN+L+ S+P      + L+ L +  N L  L      L        N L 
Sbjct: 220 PSGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLTSLPMLPSGLLSLSVY-RNQLT 274

Query: 57  DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
            +P ++  L S   ++L  N L      +  ++ S                
Sbjct: 275 RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 62/367 (16%), Positives = 102/367 (27%), Gaps = 66/367 (17%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           +D     L+  +P         + L L  N +  L     D S              L  
Sbjct: 36  VDYSNRNLT-HVPKDLP--PRTKALSLSQNSISEL--RMPDISF-------------LSE 77

Query: 68  LQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEI--IPL-SLEKLLLEG----EI 119
           L+ L L HNR++ S+    F     LE LD+S+N L  I   P+ SL  L L       +
Sbjct: 78  LRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVL 136

Query: 120 PRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRATELPNVA 179
           P    F   +  +F+G                + K     L    ++        L  V+
Sbjct: 137 PVCKEFGNLTKLTFLGLS--------------AAK--FRQLDLLPVAHLHLSCILLDLVS 180

Query: 180 NMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKAR------LQDGMEFAIKSFD 233
                                 F  N+L       SV          ++   E   +   
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240

Query: 234 VECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMI 293
              E+ +     N+       + +    L  ++     +E  L   N  +          
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKL-FQFFWPRPVEY-LNIYNLTITERIDREEFT 298

Query: 294 NVTSALEYL--------HFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              +AL+ L         F FS   ++      N+         LS      +      S
Sbjct: 299 YSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK-------MLSISDTPFIHMVCPPS 351

Query: 346 MTQTQTL 352
            +    L
Sbjct: 352 PSSFTFL 358

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 25/117 (21%), Positives = 44/117 (37%), Gaps = 17/117 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------------LTRTD 48
           L  L  L L+ N L  +          + +L      L  L              +   +
Sbjct: 376 LKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434

Query: 49  FSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
            S N L G +   +     ++ L L +NR+  SIP     L +L+ L++++N L  +
Sbjct: 435 LSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSV 488

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 31/109 (28%), Positives = 55/109 (50%), Gaps = 11/109 (10%)

Query: 2   LAALFQLDLRGNKL-SGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNN 53
           +++L  LD+  N L S +     +   ++  L+L SN L   V       +   D   N 
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNR 461

Query: 54  LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNN 101
           ++  IP  +  L++LQ L++  N+L+ S+P+  FD L SL+ + L +N 
Sbjct: 462 IM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 25/142 (17%), Positives = 45/142 (31%), Gaps = 22/142 (15%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRN 52
            A +    L  +        C  + ++   L+   N     V         L      RN
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV----SLESLDLSNNNLSEI--- 105
            L  +        K++  L      L     +++D       S+  L+LS+N L+     
Sbjct: 388 GL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446

Query: 106 -IPLSLEKLLLEG----EIPRG 122
            +P  ++ L L       IP+ 
Sbjct: 447 CLPPKVKVLDLHNNRIMSIPKD 468

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 18/116 (15%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
              L  LD+  N+L  +I      + +LR+L L  N+   L               +   
Sbjct: 99  NQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVL--------------PVCKE 141

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDL-VSLESLDLSNNNLSEIIPLSLEKLLLE 116
              L  L FL L   + +         L +S   LDL + ++      SL+     
Sbjct: 142 FGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTT 197

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 17/119 (14%), Positives = 32/119 (26%), Gaps = 20/119 (16%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           L +L    ++      S    +S    +    L  ++   +                   
Sbjct: 304 LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH---------------MVC 348

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI-----IPLSLEKLLL 115
                S  FL+   N    S+      L  L++L L  N L        +  ++  L  
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 61.2 bits (149), Expect = 2e-11
 Identities = 32/104 (30%), Positives = 47/104 (45%), Gaps = 14/104 (13%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR--------HLV-LTRTDFSRNNLLGDI 58
           L L GN+ +  +P   SN   L  + L +N +         ++  L     S N  L  I
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR-LRCI 93

Query: 59  PTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNN 100
           P     GLKSL+ LSL  N +   +P  +F+DL +L  L +  N
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.1 bits (123), Expect = 6e-08
 Identities = 24/81 (29%), Positives = 33/81 (40%), Gaps = 10/81 (12%)

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL--- 108
            N    +P  +   K L  + L +NR+      SF ++  L +L LS N L  I P    
Sbjct: 40  GNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFD 99

Query: 109 ---SLEKLLLEG----EIPRG 122
              SL  L L G     +P G
Sbjct: 100 GLKSLRLLSLHGNDISVVPEG 120

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.9 bits (151), Expect = 3e-11
 Identities = 25/151 (16%), Positives = 50/151 (33%), Gaps = 40/151 (26%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHL----------VLTRTDFS 50
           L+ +  +++R  +    I       L  L+ L + +  L+            +    + +
Sbjct: 79  LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEIT 138

Query: 51  RNNLLGDIPT-TIQGLKS-LQFLSLGHNRLQGSIP------------------------- 83
            N  +  IP    QGL +    L L +N    S+                          
Sbjct: 139 DNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK 197

Query: 84  NSFDDLVS-LESLDLSNNNLSEIIPLSLEKL 113
           ++F  + S    LD+S  +++ +    LE L
Sbjct: 198 DAFGGVYSGPSLLDVSQTSVTALPSKGLEHL 228

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.4 bits (147), Expect = 9e-11
 Identities = 22/114 (19%), Positives = 41/114 (35%), Gaps = 14/114 (12%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSN-ELRHL---------VLTRTDFSRNNLLG 56
            L L    L       FSNL  +  +++  +  L+ L          +T  +      L 
Sbjct: 35  TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT 94

Query: 57  DIPT-TIQGLKSLQFLSLGHNRLQGSIPN--SFDDLVSLESLDLSNNNLSEIIP 107
            I    ++ L  L+FL + +  L+   P+            L++++N     IP
Sbjct: 95  YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 19/118 (16%), Positives = 39/118 (33%), Gaps = 15/118 (12%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDI 58
             +    +   IP   S   + + L L    LR +          ++R   S +  L  +
Sbjct: 16  FRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQL 71

Query: 59  PTTI-QGLKSLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
            +     L  +  + + + R    I  ++  +L  L+ L + N  L     L+     
Sbjct: 72  ESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYST 129

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 25/171 (14%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK----SFDV---------ECEVMKSIH-HRNLVKIIS 252
           +G+G++G V+K+   + G   A+K    +F           E  ++  +  H N+V +++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76

Query: 253 SCSNEDFRA--LVLEYM-TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
               ++ R   LV +YM T+  L  V+ ++  IL+ + +  ++  +   ++YLH   S  
Sbjct: 77  VLRADNDRDVYLVFDYMETD--LHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGG 129

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           ++H D+KP N+LL+      ++DFG+++      +                
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 22/146 (15%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIK---------SFDVECEVMKSIHHRNLV-KIISSCSN 256
           IG GSFG +Y    +Q   E AIK             E ++ + +     +  +      
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74

Query: 257 EDFRALVLEYMTNG-SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            D+  LV++ +  G SLE +    +  L +   L +   + + +E++H   S   +H D+
Sbjct: 75  GDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDI 129

Query: 316 KPHNVLL----DDNIVAHLSDFGIAK 337
           KP N L+      N V ++ DFG+AK
Sbjct: 130 KPDNFLMGLGRRANQV-YIIDFGLAK 154

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 30/167 (17%), Positives = 58/167 (34%), Gaps = 44/167 (26%)

Query: 208 IGRGSFGSVYKAR---------LQDGMEFAIK----------------------SFDVEC 236
             R + G +Y+A               +F++K                        +   
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 237 EVMKSIHHRNLVKIISSCSNED-FRALVLEYMTNG-SLEKVL-YSSNCILDILQRLNIMI 293
           ++        +   +    ++D +R LVL  +  G SL+  L  S   +L     L +  
Sbjct: 110 KLYS-TPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVAC 166

Query: 294 NVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAK 337
            +  ALE+LH       +H ++   N+ +   D + V  L+ +G A 
Sbjct: 167 RLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 36/165 (21%), Positives = 62/165 (37%), Gaps = 41/165 (24%)

Query: 207 LIGRGSFGSVYKA-RLQDGMEFAIKSFDVE--------------------CEVMKSIHHR 245
            IG G FG +Y A       + A     VE                      + K I  +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 246 NLVKI---------ISSCSNEDFRALVLEYMTNG-SLEKVLYSSNCILDILQRLNIMINV 295
            L  +         ++      +R +V+E +  G  L+K +   N        L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160

Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAK 337
              LEY+H       +H D+K  N+LL   + + V +L+D+G++ 
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 62.2 bits (151), Expect = 6e-11
 Identities = 26/130 (20%), Positives = 47/130 (36%), Gaps = 17/130 (13%)

Query: 1   YLAALFQLDLRGNKLSGSIPT-CFSNLTA-LRNLHLDSNELR--------HLVLTRTDFS 50
           +      LD++ N    +I    F  L+     L L+ N ++           L   + S
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185

Query: 51  RNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL- 108
            NN L ++P  +  G      L +   R+        ++L  L +   S  NL ++  L 
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLKKLPTLE 243

Query: 109 ---SLEKLLL 115
              +L +  L
Sbjct: 244 KLVALMEASL 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 18/124 (14%), Positives = 37/124 (29%), Gaps = 13/124 (10%)

Query: 2   LAALFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSN-ELRHL---------VLTRTDFS 50
           L  L  L +    +   +P     +      L +  N  +  +           +   + 
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161

Query: 51  RNNLLGDIPT-TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
             N + +I      G +  +     +N L+    + F        LD+S   +  +    
Sbjct: 162 NKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 221

Query: 110 LEKL 113
           LE L
Sbjct: 222 LENL 225

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 58.7 bits (142), Expect = 7e-10
 Identities = 29/152 (19%), Positives = 48/152 (31%), Gaps = 44/152 (28%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV----------LTRTDFSRNNLLG 56
           +L     KL       FS    L  + +  N++  ++          L      + N L 
Sbjct: 34  ELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 93

Query: 57  DIPTTI-QGLKSLQFLSLGHNRLQGSIP--------------------------NSFDDL 89
            I     Q L +LQ+L + +  ++  +P                          NSF  L
Sbjct: 94  YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152

Query: 90  VS-LESLDLSNNNLSEIIP-----LSLEKLLL 115
                 L L+ N + EI         L++L L
Sbjct: 153 SFESVILWLNKNGIQEIHNSAFNGTQLDELNL 184

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 42.9 bits (101), Expect = 8e-05
 Identities = 13/74 (17%), Positives = 33/74 (44%), Gaps = 9/74 (12%)

Query: 51  RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL-- 108
           + + + +IP+ +   ++   L     +L+     +F     LE +++S N++ E+I    
Sbjct: 17  QESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74

Query: 109 -----SLEKLLLEG 117
                 L ++ +E 
Sbjct: 75  FSNLPKLHEIRIEK 88

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 32/128 (25%), Positives = 59/128 (46%), Gaps = 17/128 (13%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNN 53
           YL  L  L+L+ N+++  +     NLT +  L L  N L+++        +   D +   
Sbjct: 61  YLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ 118

Query: 54  LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS---- 109
           +  D+   + GL +LQ L L  N++  +I      L +L+ L + N  +S++ PL+    
Sbjct: 119 I-TDVTP-LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTPLANLSK 174

Query: 110 LEKLLLEG 117
           L  L  + 
Sbjct: 175 LTTLKADD 182

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 22/127 (17%), Positives = 56/127 (44%), Gaps = 17/127 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           LA   ++    + ++ ++    ++L  +  L      +  +        L   +   +N 
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELK-DNQ 74

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
           + D+   ++ L  +  L L  N L+ ++      L S+++LDL++  ++++ PL+    L
Sbjct: 75  ITDLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 111 EKLLLEG 117
           + L L+ 
Sbjct: 132 QVLYLDL 138

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 30/127 (23%), Positives = 61/127 (48%), Gaps = 17/127 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L  + +L+L GN L  ++    + L +++ L L S ++  +        L       N +
Sbjct: 84  LTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQI 141

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
             +I   + GL +LQ+LS+G+ ++   +     +L  L +L   +N +S+I PL+    L
Sbjct: 142 -TNISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISPLASLPNL 197

Query: 111 EKLLLEG 117
            ++ L+ 
Sbjct: 198 IEVHLKN 204

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 32/151 (21%), Positives = 63/151 (41%), Gaps = 15/151 (9%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L+ L  L L  N+++   P   + LT L+ L + + ++  L        LT      +N 
Sbjct: 128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD-DNK 184

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           + DI   +  L +L  + L +N++    P    +  +L  + L+N  ++         L+
Sbjct: 185 ISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLV 241

Query: 115 LEGEIPRGGPFTKFSSKSFIGNDLLCGSPNL 145
           +   +   GP     + + I ++    SPNL
Sbjct: 242 VPNVV--KGPSGAPIAPATISDNGTYASPNL 270

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 18/103 (17%), Positives = 36/103 (34%), Gaps = 15/103 (14%)

Query: 24  SNLTALRNLHLDSNELRHLV-------LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHN 76
             L     +    + +   V       +T         +  I   +Q L +L  L L  N
Sbjct: 16  PALANAIKIAAGKSNVTDTVTQADLDGITTLSAF-GTGVTTIE-GVQYLNNLIGLELKDN 73

Query: 77  RLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----LEKLLL 115
           ++   +     +L  +  L+LS N L  +  ++    ++ L L
Sbjct: 74  QIT-DLAP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDL 114

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 61.7 bits (149), Expect = 1e-10
 Identities = 26/106 (24%), Positives = 39/106 (36%), Gaps = 19/106 (17%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
            L  +  LDL  N+L  ++P   + L  L  L    N L ++                  
Sbjct: 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-----------------D 502

Query: 61  TIQGLKSLQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEI 105
            +  L  LQ L L +NRLQ  +          L  L+L  N+L + 
Sbjct: 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 61.3 bits (148), Expect = 2e-10
 Identities = 28/118 (23%), Positives = 43/118 (36%), Gaps = 27/118 (22%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLK 66
            L L    L+  +      L  + +L L  N LR                 +P  +  L+
Sbjct: 445 VLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR----------------ALPPALAALR 486

Query: 67  SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN---NLSEIIPL----SLEKLLLEG 117
            L+ L    N L+ ++     +L  L+ L L NN     + I PL     L  L L+G
Sbjct: 487 CLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 53.2 bits (127), Expect = 7e-08
 Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 8/111 (7%)

Query: 13  NKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDF--SRNNLLGDIPTTIQGLKSLQF 70
           + L    P   + L  LR+  L  N +  +           +  L  +   ++ L  +  
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH-LEQLLLVTH 467

Query: 71  LSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL----SLEKLLLEG 117
           L L HNRL+ ++P +   L  LE L  S+N L  +  +     L++LLL  
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCN 517

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 27/116 (23%), Positives = 47/116 (40%), Gaps = 13/116 (11%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--VLTRTDFSRNNLLGDIPTTIQGL 65
           L    N L+  +P    +L +L   + +   L  L  +L     S N L   +P  +Q  
Sbjct: 96  LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQL-EKLPE-LQNS 152

Query: 66  KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL----SLEKLLLEG 117
             L+ + + +N L+  +P+      SLE +   NN L E+  L     L  +  + 
Sbjct: 153 SFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLEELPELQNLPFLTAIYADN 204

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 30/121 (24%), Positives = 46/121 (38%), Gaps = 17/121 (14%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----VLTRTDFSRNNLLG 56
             +L  +    N L         NL  L  ++ D+N L+ L      L   +   +N L 
Sbjct: 214 PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVR-DNYLT 270

Query: 57  DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL--SLEKLL 114
           D+P   Q L  L       + L    PN       L  L+ S+N +  +  L  SLE+L 
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIRSLCDLPPSLEELN 323

Query: 115 L 115
           +
Sbjct: 324 V 324

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 20/114 (17%), Positives = 37/114 (32%), Gaps = 8/114 (7%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           + +  +     ++   + P        +    L     R       + +    L  +P  
Sbjct: 33  VKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ--AHELELNNLG-LSSLPEL 89

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLL 115
              L+S   L    N L   +P     L SL   + +   LS++ P  LE L +
Sbjct: 90  PPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-LLEYLGV 138

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 13/120 (10%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV--LTRTDFSRNNLLGDIP 59
             +L  L++R N L+  +P    +LT L       + L  L   L   + S +N +  + 
Sbjct: 256 PPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS-SNEIRSLC 313

Query: 60  TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL--SLEKLLLEG 117
                  SL+ L++ +N+L   +P        LE L  S N+L+E+  L  +L++L +E 
Sbjct: 314 DL---PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAEVPELPQNLKQLHVEY 366

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 25/109 (22%), Positives = 46/109 (42%), Gaps = 14/109 (12%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---VLTRTDFSRNNLLGDIPTTIQG 64
           L    N L+  +P    NL   + LH++ N LR       +  D   N+ L ++P   Q 
Sbjct: 342 LIASFNHLA-EVPELPQNL---KQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQ- 396

Query: 65  LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
             +L+ L +  N L+   P+      S+E L +++  + +    + E  
Sbjct: 397 --NLKQLHVETNPLR-EFPDI---PESVEDLRMNSERVVDPYEFAHETT 439

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 25/119 (21%), Positives = 41/119 (34%), Gaps = 18/119 (15%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
            + L  +D+  N L   +P       +L  +   +N+L  L        LT      N+L
Sbjct: 152 SSFLKIIDVDNNSLK-KLP---DLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 207

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
                       SL+ +  G+N L         +L  L ++   NN L   +P     L
Sbjct: 208 ----KKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDLPPSL 259

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 21/112 (18%), Positives = 40/112 (35%), Gaps = 8/112 (7%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
              L +     + L+  +P    N+ +    +   +E            R   +  +   
Sbjct: 10  NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           +   +    L L +  L  S+P   +    LESL  S N+L+E +P   + L
Sbjct: 69  L--DRQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLTE-LPELPQSL 113

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 14/84 (16%), Positives = 29/84 (34%), Gaps = 15/84 (17%)

Query: 49  FSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV-------------SLESL 95
              ++ L ++P   + +KS        +  + + P    +                   L
Sbjct: 17  LRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76

Query: 96  DLSNNNLSEI--IPLSLEKLLLEG 117
           +L+N  LS +  +P  LE L+   
Sbjct: 77  ELNNLGLSSLPELPPHLESLVASC 100

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 31/122 (25%), Positives = 40/122 (32%), Gaps = 20/122 (16%)

Query: 2   LAALFQLDLRGNKLSGSIP----TCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGD 57
             AL  LDL  N   G        C      L+ L L +  +                G 
Sbjct: 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM------------ETPSGV 219

Query: 58  IPTTIQGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNLSEI---IPLSLEKL 113
                     LQ L L HN L+ +    S D    L SL+LS   L ++   +P  L  L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL 279

Query: 114 LL 115
            L
Sbjct: 280 DL 281

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 26/126 (20%), Positives = 43/126 (34%), Gaps = 20/126 (15%)

Query: 5   LFQLDLRGNKLSG---SIPTCFSNL-TALRNLHLDSNELRHL---------VLTRTDFSR 51
           L  L+LR    +     +      L   L+ L +      +           L+  D S 
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182

Query: 52  NNLLGDIPTTIQ----GLKSLQFLSLGHNRLQ---GSIPNSFDDLVSLESLDLSNNNLSE 104
           N  LG+             +LQ L+L +  ++   G         V L+ LDLS+N+L +
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242

Query: 105 IIPLSL 110
                 
Sbjct: 243 AAGAPS 248

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 16/127 (12%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR------HLVLTRTDFSRNNL 54
           +   L +L L  N++S  + +   +LT L  L ++ N L+         L+R     N L
Sbjct: 61  FFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNEL 118

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
             D   ++  LK+L+ LS+ +N+L+ SI      L  LE LDL  N ++    L+    +
Sbjct: 119 R-DT-DSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGGLTRLKKV 174

Query: 111 EKLLLEG 117
             + L G
Sbjct: 175 NWIDLTG 181

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 52.7 bits (127), Expect = 4e-08
 Identities = 21/112 (18%), Positives = 43/112 (38%), Gaps = 21/112 (18%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           LA   + +L    ++         L+ ++N + D++ ++ L                   
Sbjct: 18  LANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSL-----------------AG 58

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           +Q   +L+ L L HN++   +     DL  LE L ++ N L  +  +    L
Sbjct: 59  MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACL 108

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 52.3 bits (126), Expect = 6e-08
 Identities = 35/129 (27%), Positives = 52/129 (40%), Gaps = 22/129 (17%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE------LRHLV-LTRTDFSRNNL 54
           L+ +   +   + +  S+       T L+ LHL  N+      L+ L  L     +RN L
Sbjct: 40  LSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRL 97

Query: 55  LGDIPTTIQGLK--SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS--- 109
                  + G+    L  L L +N L     +S   L +LE L + NN L  I+ L    
Sbjct: 98  -----KNLNGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLKSIVMLGFLS 150

Query: 110 -LEKLLLEG 117
            LE L L G
Sbjct: 151 KLEVLDLHG 159

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 17/127 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L ++ Q+    + +  S+      L  +  L L+ N+L  +        L       N +
Sbjct: 45  LNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKV 102

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
             D+ ++++ LK L+ LSL HN +   I      L  LESL L NN +++I  LS    L
Sbjct: 103 K-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLSRLTKL 158

Query: 111 EKLLLEG 117
           + L LE 
Sbjct: 159 DTLSLED 165

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 28/127 (22%), Positives = 61/127 (48%), Gaps = 17/127 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
            A   + +L+   ++ ++    + L ++  +  ++++++ +        +T+   +  N 
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLN-GNK 79

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----L 110
           L DI   +  LK+L +L L  N+++  + +   DL  L+SL L +N +S+I  L     L
Sbjct: 80  LTDI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDINGLVHLPQL 136

Query: 111 EKLLLEG 117
           E L L  
Sbjct: 137 ESLYLGN 143

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 30/125 (24%), Positives = 50/125 (40%), Gaps = 11/125 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNL 54
           L  L  L L  NK++  I    S LT L  L L+ N++  +V       L     S  N 
Sbjct: 133 LPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLS-KNH 189

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           + D+   + GLK+L  L L          N   +LV   ++  ++ +L     +S +   
Sbjct: 190 ISDL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDY 248

Query: 115 LEGEI 119
            +  +
Sbjct: 249 EKPNV 253

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 20/105 (19%), Positives = 38/105 (36%), Gaps = 15/105 (14%)

Query: 24  SNLTALRNLHLDSNELRHLV-------LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHN 76
                    +L    +   V       + +   + ++ +  +   IQ L ++  L L  N
Sbjct: 21  DAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSD-IKSV-QGIQYLPNVTKLFLNGN 78

Query: 77  RLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS----LEKLLLEG 117
           +L   I     +L +L  L L  N + ++  L     L+ L LE 
Sbjct: 79  KLT-DIKP-LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEH 121

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 58.5 bits (142), Expect = 6e-10
 Identities = 36/111 (32%), Positives = 48/111 (43%), Gaps = 11/111 (9%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR--------HLVLTRTDFSRNN 53
           L  L  L L GN+L       F  LT L+ L L  N+L+         L         +N
Sbjct: 84  LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHN 143

Query: 54  LLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNL 102
            L  +P  +   L +L  L L +N+LQ S+P   FD L  L+ L L  N L
Sbjct: 144 QLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 41/114 (35%), Positives = 53/114 (46%), Gaps = 13/114 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSR--NN 53
           L  +  L L GNKL   I      LT L  L L  N+L+ L       LT         N
Sbjct: 62  LPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN 119

Query: 54  LLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEI 105
            L  +P  +   L +L +L+L HN+LQ S+P   FD L +L  LDLS N L  +
Sbjct: 120 QLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSL 172

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.2 bits (110), Expect = 7e-06
 Identities = 18/99 (18%), Positives = 45/99 (45%), Gaps = 21/99 (21%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLK 66
           + +L+   ++    T  + L ++  +  ++++++ +                   IQ L 
Sbjct: 23  KANLKKKSVT-DAVT-QNELNSIDQIIANNSDIKSV-----------------QGIQYLP 63

Query: 67  SLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI 105
           ++++L+LG N+L   I  +  +L +L  L L+ N L  +
Sbjct: 64  NVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSL 100

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 38/110 (34%), Positives = 53/110 (48%), Gaps = 14/110 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELR--------HLV-LTRTDFSR 51
           L  L +L L  N+L  ++P   F +LT L  L L +N+L          LV L       
Sbjct: 63  LINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC- 120

Query: 52  NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNN 100
            N L ++P  I+ L  L  L+L  N+L+ SIP+ +FD L SL    L  N
Sbjct: 121 CNKLTELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 20/108 (18%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTI-QGLK 66
           L L  N+++   P  F +L  L+ L+L SN+L  L                P  +   L 
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL----------------PVGVFDSLT 88

Query: 67  SLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEIIPLSLEKL 113
            L  L LG N+L   +P++ FD LV L+ L +  N L+E +P  +E+L
Sbjct: 89  QLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERL 134

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 25/89 (28%), Positives = 38/89 (42%), Gaps = 12/89 (13%)

Query: 45  TRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLS 103
                  N +    P     L +L+ L LG N+L  ++P   FD L  L  LDL  N L+
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 104 EIIP------LSLEKLLLEG----EIPRG 122
            +        + L++L +      E+PRG
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLTELPRG 130

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 30/118 (25%), Positives = 44/118 (37%), Gaps = 14/118 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLL 55
              L +LD   NK    +    +  T L  L    N++  L      +L R +   NN+ 
Sbjct: 147 NTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNNIT 204

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
             +   +     L FL    N+L   I      L  L   D S N L+E+   +L KL
Sbjct: 205 -KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKL 256

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 28/118 (23%), Positives = 44/118 (37%), Gaps = 13/118 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTR----TDFS-RNNLLG 56
              L  LD   NK++  +    S    L  L+ D+N +  L L +    T     +N L 
Sbjct: 169 QTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLT 225

Query: 57  DIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           +I   +  L  L +     N L   +  S   L  L +L     +L EI      +L+
Sbjct: 226 EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLEIDLTHNTQLI 278

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 14/118 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV------LTRTDFSRNNLL 55
              L  L    NKL+ ++    + LT L  L+ D+N+L  L       LT  + +RN L 
Sbjct: 84  NTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTL- 139

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
            +I   +     L  L    N+    +         L +LD S N ++E+     + L
Sbjct: 140 TEID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQNKLL 193

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 24/118 (20%), Positives = 34/118 (28%), Gaps = 14/118 (11%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLL 55
              L  LD   NKL+  I    + LT L       N L  L       LT     + +L 
Sbjct: 211 NIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDL- 266

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
                 I    + Q +       +            L  LD     ++E+      KL
Sbjct: 267 ----LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKL 320

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 27/115 (23%), Positives = 41/115 (35%), Gaps = 15/115 (13%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNL 54
            L  L +L    N ++ ++    S  T L  L  DSN+L +L       LT  +   N L
Sbjct: 62  KLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKL 118

Query: 55  LGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
                  +     L +L+   N L   I  S      L  LD   N     + ++
Sbjct: 119 ---TKLDVSQNPLLTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKITKLDVT 167

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 17/118 (14%), Positives = 40/118 (33%), Gaps = 13/118 (11%)

Query: 3   AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV-------LTRTDFSRNNLL 55
                      ++  +       L  L +L   ++ +  +        LT+   + NN +
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNN-I 76

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
             +   +    +L +L+   N+L  ++      L  L  L+   N L+++       L
Sbjct: 77  TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLL 129

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 22/140 (15%), Positives = 39/140 (27%), Gaps = 31/140 (22%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLL 55
           L  L   D   N L+  +    S L+ L  LH    +L  +       L          +
Sbjct: 232 LTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKI 288

Query: 56  GDIPTT-------------------IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLD 96
            ++  T                   +     L +L L +  L   +         L+SL 
Sbjct: 289 KELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLS 345

Query: 97  LSNNNLSEIIPLSLEKLLLE 116
             N ++ +   +     L  
Sbjct: 346 CVNAHIQDFSSVGKIPALNN 365

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.0 bits (133), Expect = 4e-09
 Identities = 27/100 (27%), Positives = 41/100 (41%), Gaps = 18/100 (18%)

Query: 8   LDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLK 66
           L L  N+L        F  L  L  L L  N+L  +                P   +G  
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE---------------PNAFEGAS 78

Query: 67  SLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNLSEI 105
            +Q L LG N+++  I N  F  L  L++L+L +N +S +
Sbjct: 79  HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCV 117

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 54.6 bits (132), Expect = 4e-09
 Identities = 27/101 (26%), Positives = 49/101 (48%), Gaps = 19/101 (18%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
           L  L +L+L+ N+L+G  P  F   + ++ L L  N+++ +                   
Sbjct: 53  LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI----------------SNK 96

Query: 62  I-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNN 100
           +  GL  L+ L+L  N++   +   SF+ L SL SL+L++N
Sbjct: 97  MFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.1 bits (128), Expect = 1e-08
 Identities = 29/123 (23%), Positives = 44/123 (35%), Gaps = 25/123 (20%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTT 61
                +LDLRG K+   I    + L     +    NE+R L                   
Sbjct: 18  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-----------------DG 59

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN---LSEIIPL----SLEKLL 114
              L+ L+ L + +NR+          L  L  L L+NN+   L ++ PL    SL  L 
Sbjct: 60  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 119

Query: 115 LEG 117
           +  
Sbjct: 120 ILR 122

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 4e-05
 Identities = 15/81 (18%), Positives = 29/81 (35%), Gaps = 8/81 (9%)

Query: 33  HLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSL 92
           + ++   R L L      R   +  I      L     +    N ++  +   F  L  L
Sbjct: 15  YTNAVRDRELDL------RGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRL 66

Query: 93  ESLDLSNNNLSEIIPLSLEKL 113
           ++L ++NN +  I     + L
Sbjct: 67  KTLLVNNNRICRIGEGLDQAL 87

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 53.0 bits (128), Expect = 1e-08
 Identities = 33/104 (31%), Positives = 47/104 (45%), Gaps = 13/104 (12%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR--------HLV-LTRTDFSRNNLLGDI 58
           L+L  NKL       F  LT L  L L  N+++         L  LT       N L  +
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH-ENKLQSL 91

Query: 59  PTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNN 100
           P  +   L  L+ L+L  N+L+ S+P+  FD L SL+ + L  N
Sbjct: 92  PNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 23/80 (28%), Positives = 33/80 (41%), Gaps = 17/80 (21%)

Query: 27  TALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNS- 85
           ++   L L+SN+L+ L                      L  L  LSL  N++Q S+P+  
Sbjct: 28  SSATRLELESNKLQSLP---------------HGVFDKLTQLTKLSLSQNQIQ-SLPDGV 71

Query: 86  FDDLVSLESLDLSNNNLSEI 105
           FD L  L  L L  N L  +
Sbjct: 72  FDKLTKLTILYLHENKLQSL 91

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 34/129 (26%), Positives = 53/129 (41%), Gaps = 26/129 (20%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE------LRHLV-LTRTDFSRNNLLGDIP 59
           +L      +   +    S L A ++L L +N       L  +  L      RN +     
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLI----- 82

Query: 60  TTIQGL----KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN---NLSEIIPL---- 108
             I+ L     +L+ L + +N++  S+    + LV+L  L +SNN   N  EI  L    
Sbjct: 83  KKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALD 140

Query: 109 SLEKLLLEG 117
            LE LLL G
Sbjct: 141 KLEDLLLAG 149

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 29/120 (24%), Positives = 48/120 (40%), Gaps = 15/120 (12%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNN 53
           L A   L L  N +   I +  S +  LR L L  N ++ +         L     S  N
Sbjct: 47  LKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWIS-YN 103

Query: 54  LLGDIPTTIQGLKSLQFLSLGHNRLQ--GSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE 111
            +  + + I+ L +L+ L + +N++   G I +    L  LE L L+ N L      +  
Sbjct: 104 QIASL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNA 161

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 37/161 (22%)

Query: 208 IGRGSFGSVYKAR-LQDGMEFAIKSFDV--------ECEVMKSI-HHRNLVKII----SS 253
           +GRG +  V++A  + +  +  +K            E ++++++    N++ +       
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP 103

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLN------IMINVTSALEYLHFGFS 307
            S     ALV E++ N   ++          + Q L        M  +  AL+Y H   S
Sbjct: 104 VSRTP--ALVFEHVNNTDFKQ----------LYQTLTDYDIRFYMYEILKALDYCH---S 148

Query: 308 TPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMT 347
             I+H D+KPHNV++D ++    L D+G+A+      Q   
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYN 188

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 51.7 bits (124), Expect = 4e-08
 Identities = 30/125 (24%), Positives = 47/125 (37%), Gaps = 25/125 (20%)

Query: 1   YLAALFQLDLRGNKLS-GSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIP 59
             AA+ +L L   K + G I    +    L  L L +  L  +                 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV----------------- 64

Query: 60  TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN---LSEIIPL----SLEK 112
           + +  L  L+ L L  NR+ G +    + L +L  L+LS N    +S + PL     L+ 
Sbjct: 65  SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKS 124

Query: 113 LLLEG 117
           L L  
Sbjct: 125 LDLFN 129

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 32/157 (20%), Positives = 56/157 (35%), Gaps = 28/157 (17%)

Query: 208 IGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSI-HHRNLV 248
           +GRG+FG V +A              A+K                E +++  I HH N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 249 KIISSCSNEDFRALV-LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++ +C+      +V +E+   G+L   L S         R   +   T    +      
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--------RNEFVPYKTKGARFRQGKDY 141

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ 344
              I  DLK     +  +  +  S F   K L+  ++
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 3/95 (3%)

Query: 266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN 325
                  E         L +   +     V   +E+L    S   IH DL   N+LL + 
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 229

Query: 326 IVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            V  + DFG+A+ +  +   + +      + +MAP
Sbjct: 230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 51.6 bits (124), Expect = 6e-08
 Identities = 34/101 (33%), Positives = 46/101 (45%), Gaps = 19/101 (18%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTI-QGL 65
            LDL  N L       F  LT+L  L+L  N+L+ L                P  +   L
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL----------------PNGVFNKL 75

Query: 66  KSLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEI 105
            SL +L+L  N+LQ S+PN  FD L  L+ L L+ N L  +
Sbjct: 76  TSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSL 115

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 37/108 (34%), Positives = 52/108 (48%), Gaps = 23/108 (21%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---VLTRTDFSRNNLLGDI 58
           L +L QL L GNKL       F+ LT+L  L+L +N+L+ L   V     F +       
Sbjct: 51  LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGV-----FDK------- 98

Query: 59  PTTIQGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNLSEI 105
                 L  L+ L+L  N+LQ S+P+  FD L  L+ L L  N L  +
Sbjct: 99  ------LTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSV 139

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.4 bits (108), Expect = 7e-06
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 25/104 (24%)

Query: 2   LAALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHL---VLTRTDFSRNNLLGD 57
           L +L  L+L  N+L  S+P   F  LT L+ L L++N+L+ L   V     F +      
Sbjct: 75  LTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGV-----FDK------ 122

Query: 58  IPTTIQGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNN 100
                  L  L+ L L  N+L+ S+P+  FD L SL+ + L +N
Sbjct: 123 -------LTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.7 bits (101), Expect = 5e-05
 Identities = 22/61 (36%), Positives = 27/61 (44%)

Query: 45  TRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 104
           T  D   N+L          L SL  L LG N+LQ      F+ L SL  L+LS N L  
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 105 I 105
           +
Sbjct: 91  L 91

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 29/165 (17%), Positives = 63/165 (38%), Gaps = 40/165 (24%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK----------SFDVECEVMKSI--------HHRNL 247
            +G G F +V+ A+ + +    A+K          + + E ++++ +             
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 248 VKIISSCSNEDFRA-------LVLEYMTNGSLEKVLYSSN---CILDILQRLNIMINVTS 297
             I+    + + +        +V E +   +L  ++         L  +++  I   +  
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLLL 142

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAH------LSDFGIA 336
            L+Y+H      IIH D+KP NVL++            ++D G A
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 38/150 (25%), Positives = 67/150 (44%), Gaps = 28/150 (18%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK------SF----DVECEVMKSIHHR---NLVKIIS 252
           +IG+GSFG V KA   +     A+K       F      E  +++ +  +   N + +I 
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 253 SCSNEDFRA---LVLEYMTNGSLEKVLYSSNCI---LDILQRLNIMINVTSALEYLHFGF 306
              N  FR    +  E ++  +L +++  +      L ++++     ++   L+ LH   
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALH--- 217

Query: 307 STPIIHCDLKPHNVLLDDNIVAH--LSDFG 334
              IIHCDLKP N+LL     +   + DFG
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 3e-07
 Identities = 26/119 (21%), Positives = 42/119 (35%), Gaps = 25/119 (21%)

Query: 7   QLDLRGNKLS-GSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGL 65
           +L L  ++ + G +         L  L   +  L  +                   +  L
Sbjct: 21  ELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-----------------ANLPKL 63

Query: 66  KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN---LSEIIPL----SLEKLLLEG 117
             L+ L L  NR+ G +    +   +L  L+LS N    LS I PL    +L+ L L  
Sbjct: 64  NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 49.9 bits (118), Expect = 6e-07
 Identities = 36/213 (16%), Positives = 56/213 (26%), Gaps = 68/213 (31%)

Query: 184 QASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIK------------- 230
           Q     FS+      T        IG G FG V++    D    AIK             
Sbjct: 7   QKGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGS 62

Query: 231 ------SFDVECEVMKSIH---------HRNLVKIISSC--------------------- 254
                     E  + K +              + + S                       
Sbjct: 63  HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122

Query: 255 ---------SNEDFRALVLEYMTNG-SLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
                      +D   +VLE+   G  LE++      +  +    +I+  +T++L     
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEA 179

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
                  H DL   NVLL    +  L      K
Sbjct: 180 SLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 48.0 bits (115), Expect = 6e-07
 Identities = 30/97 (30%), Positives = 44/97 (45%), Gaps = 23/97 (23%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---VLTRTDFSRNNLLGDIPTTIQG 64
           L L  N+++   P  F +L  L+ L+ +SN+L  +   V     F +             
Sbjct: 38  LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGV-----FDK------------- 79

Query: 65  LKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNN 100
           L  L  L L  N L+ SIP  +FD+L SL  + L NN
Sbjct: 80  LTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 40.3 bits (95), Expect = 2e-04
 Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 20/100 (20%)

Query: 7   QLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLK 66
            ++ +  +L+ S+P      T  + L L++N++  L                P     L 
Sbjct: 16  LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLE---------------PGVFDHLV 57

Query: 67  SLQFLSLGHNRLQGSIPNS-FDDLVSLESLDLSNNNLSEI 105
           +LQ L    N+L  +IP   FD L  L  LDL++N+L  I
Sbjct: 58  NLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLKSI 96

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 47.6 bits (114), Expect = 7e-07
 Identities = 34/97 (35%), Positives = 45/97 (46%), Gaps = 23/97 (23%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---VLTRTDFSRNNLLGDIPTTIQG 64
           L L  N+++   P  F  LT L  L LD+N+L  L   V     F +             
Sbjct: 35  LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGV-----FDK------------- 76

Query: 65  LKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNN 100
           L  L  LSL  N+L+ SIP  +FD+L SL  + L NN
Sbjct: 77  LTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 32/145 (22%), Positives = 57/145 (39%), Gaps = 39/145 (26%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK------SF----DVECEVMKSI-----HHRNLVKI 250
            +G G+FG V   + + +   +A+K       +     +E +++K I     ++ N+VK 
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101

Query: 251 ISSCSNEDFRA---LVLEYMTNGSLEKVL-------YSSNCILDILQRLNIMINVTSALE 300
                   +     L+ E +   SL +++       +    I      +        AL 
Sbjct: 102 HGKF---MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEI------LKALN 151

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDN 325
           YL       + H DLKP N+LLDD 
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDP 173

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 1e-05
 Identities = 59/358 (16%), Positives = 106/358 (29%), Gaps = 108/358 (30%)

Query: 26  LTALRNL--HLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS-LQFLSLGHNRLQGSI 82
           L  L+ L   +D N       +R+D S N     I   I  +++ L+ L L         
Sbjct: 199 LEMLQKLLYQIDPN-----WTSRSDHSSN-----IKLRIHSIQAELRRL-LKSKPY---- 243

Query: 83  PNSF---DDLVS----LESLDLS--------NNNLSEIIPLSLEKLLLEGEIPRGGPFTK 127
            N      + V       + +LS           +++ +  +    +           T 
Sbjct: 244 ENCLLVLLN-VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT--LTP 300

Query: 128 FSSKSFIGNDLLCGSPNLQVPP--CKSNKPIILALKFGLISR-------------CQKRA 172
              KS +   L C   +L  P     +N P  L++      R             C K  
Sbjct: 301 DEVKSLLLKYLDCRPQDL--PREVLTTN-PRRLSI-IAESIRDGLATWDNWKHVNCDKLT 356

Query: 173 TELPN-VANMQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS 231
           T + + +  ++P   R+ F  L +      F  +  I       ++         F +  
Sbjct: 357 TIIESSLNVLEPAEYRKMFDRLSV------FPPSAHIPTILLSLIW---------FDVIK 401

Query: 232 FDVECEVMKSIHHRNLVKIISSCSNEDFR----ALVLEYMTNGSLEKVLYSSNCILDILQ 287
            DV   V+  +H  +LV+       ++      ++ LE       E  L+ S     I+ 
Sbjct: 402 SDVM-VVVNKLHKYSLVE----KQPKESTISIPSIYLELKVKLENEYALHRS-----IVD 451

Query: 288 RLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-----IVAHLSDFGIAKLLT 340
             NI         +       P              D      I  HL +    + +T
Sbjct: 452 HYNI------PKTFDSDDLIPPY------------LDQYFYSHIGHHLKNIEHPERMT 491

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 28/147 (19%), Positives = 52/147 (35%), Gaps = 41/147 (27%)

Query: 207 LIGRGSFGSVYKA--RLQDGMEFAIK------SF----DVECEVMKSIHHR------NLV 248
            +G G+FG V +     +   + A+K       +     +E  V+K I  +        V
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85

Query: 249 KIISSCSNEDFRA---LVLEYMTNGSLEKVL-------YSSNCILDILQRLNIMINVTSA 298
            +       +F     +  E +   +  + L       Y    +  +  +L        A
Sbjct: 86  LMSDWF---NFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQL------CHA 135

Query: 299 LEYLHFGFSTPIIHCDLKPHNVLLDDN 325
           L +LH      + H DLKP N+L  ++
Sbjct: 136 LRFLH---ENQLTHTDLKPENILFVNS 159

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 34/164 (20%)

Query: 199 TNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK------SF----DVECEVMKSIHHR-- 245
            + +  ++LIG+GSFG V KA    +    AIK      +F     +E  +++ ++    
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 246 ----NLVKIISSCSNEDFRALVLEYMTNGSLEKVL-------YSSNCILDILQRLNIMIN 294
                +V +       +   LV E ++  +L  +L        S N      Q++     
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQM----- 166

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLL--DDNIVAHLSDFGIA 336
             +AL +L       IIHCDLKP N+LL         + DFG +
Sbjct: 167 -CTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 26/143 (18%), Positives = 57/143 (39%), Gaps = 33/143 (23%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEF-AIK------SF----DVECEVMKSIHHR------NLV 248
            +G G+FG V +    + G    A+K       +      E +V++ ++          V
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80

Query: 249 KIISSCSNEDFRA---LVLEYMTNGSLEKVLYSSNCI---LDILQRLNIMINVTSALEYL 302
           +++      +      +V E +   S    +  +  +   LD +++  +   +  ++ +L
Sbjct: 81  QMLEWF---EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK--MAYQICKSVNFL 134

Query: 303 HFGFSTPIIHCDLKPHNVLLDDN 325
           H   S  + H DLKP N+L   +
Sbjct: 135 H---SNKLTHTDLKPENILFVQS 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	360
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.98
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.97
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.97
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.97
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.97
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.97
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.96
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.96
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.96
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.96
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.96
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.96
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.96
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.96
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.96
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.96
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.96
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.96
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.96
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.96
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.96
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.96
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.96
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.96
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.96
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.96
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.96
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.96
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.95
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.95
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.95
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.95
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.95
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.95
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.95
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.95
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.95
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.95
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.95
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.95
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.95
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.95
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.95
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.95
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.95
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.95
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.95
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.95
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.95
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.95
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.95
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.95
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.95
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.95
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.95
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.95
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.95
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.95
3bhy_A	283	Death-associated protein kinase 3; death associate	99.95
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.95
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.95
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.95
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.95
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.95
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.95
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.95
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.95
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.95
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.95
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.95
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.95
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.95
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.95
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.94
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.94
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.94
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.94
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.94
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.94
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.94
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.94
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.94
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.94
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.94
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.94
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.94
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.94
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.94
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.94
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.94
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.94
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.94
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.94
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.94
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.94
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.94
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.94
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.94
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.94
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.94
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.94
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.94
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.94
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.94
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.94
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.94
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.94
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.94
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.93
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.93
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.93
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.93
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.93
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.93
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.93
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.93
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.92
3uqc_A	286	Probable conserved transmembrane protein; structur	99.92
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.92
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.76
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.68
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.68
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.68
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.67
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.66
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.65
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.65
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.65
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.64
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.63
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.62
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.62
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.61
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.61
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.61
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.6
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.6
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.6
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.6
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.59
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.59
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.58
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.57
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.57
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.56
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.56
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.56
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.55
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.55
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.55
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.54
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.54
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.54
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.53
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.53
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.53
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.53
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.52
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.52
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.52
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.51
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.5
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.5
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.5
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.49
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.49
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.48
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.48
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.47
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.47
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.46
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.46
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.45
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.44
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.43
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.43
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.43
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.42
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.42
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.42
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.41
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.41
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.41
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.41
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.41
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.4
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.4
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.4
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.4
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.4
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.4
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.4
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.4
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.39
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.39
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.39
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.39
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.38
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.38
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.38
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.38
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.38
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.38
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.37
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.37
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.37
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.36
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.35
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.35
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.35
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.33
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.33
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.33
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.33
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.32
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.31
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.31
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.3
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.3
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.3
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.29
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.28
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.28
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.28
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.26
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.24
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.24
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.22
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.21
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.21
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.2
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.2
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.18
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.01
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.01
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.0
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.99
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.98
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.96
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.89
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.76
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.66
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.66
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.57
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.56
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.56
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.51
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.5
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.49
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.45
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.44
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.35
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.29
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.27
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.27
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.1
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.88
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.85
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.85
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.82
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.75
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.74
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.71
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.69
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.61
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.5
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.32
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.31
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.23
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.14
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.07
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.76
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.71
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.67
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.54
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.5
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.48
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.43
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.4
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.39
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.26
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.24
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.09
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.0
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	95.83
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	95.48
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	95.41
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.91
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.9
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	94.46
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.75
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.48
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.97

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.4e-40  Score=302.16  Aligned_cols=155  Identities=28%  Similarity=0.506  Sum_probs=131.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEeh-------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK-------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +++...+.||+|+||+||+|++++  .||||             .|.+|++++++++|||||+++++|.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            567778999999999999999764  58886             35689999999999999999999875 457999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      |+||+|.++++.....++|.++..|+.|||+||+|||   +.+||||||||+|||+++++.+||+|||+|+.........
T Consensus       113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            9999999999887778999999999999999999999   8899999999999999999999999999999865443333


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      .....+||+.||||
T Consensus       190 ~~~~~~GT~~ymAP  203 (307)
T 3omv_A          190 QVEQPTGSVLWMAP  203 (307)
T ss_dssp             ----CCCCTTSCCH
T ss_pred             eecccccCCCccCH
Confidence            34567899999998

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6e-40  Score=302.84  Aligned_cols=157  Identities=33%  Similarity=0.506  Sum_probs=141.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..++||+|+||+||+|+. .+|+.||||.              +.+|++++++++|||||+++++|++++..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5699999999999999999996 4799999984              356999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |||+||+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999999764 36889999999999999999999   89999999999999999999999999999998765443


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                      .....+.+||+.||||
T Consensus       188 ~~~~~~~~GTp~YmAP  203 (311)
T 4aw0_A          188 QARANSFVGTAQYVSP  203 (311)
T ss_dssp             CCCBCCCCSCGGGCCH
T ss_pred             cccccCcccCcccCCH
Confidence            3344567899999998

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.7e-40  Score=303.42  Aligned_cols=158  Identities=29%  Similarity=0.524  Sum_probs=136.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|...+.||+|+||.||+|++.      ++..||||.           |.+|++++++++|||||+++++|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45677789999999999999864      477899973           6789999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEE
Q 040294          263 VLEYMTNGSLEKVLYSS------------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL  330 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki  330 (360)
                      |||||++|+|.++|+..            ...++|.+++.|+.|||+||+|||   +++|+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            99999999999999753            245899999999999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCCceeeecccccCcccCC
Q 040294          331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       331 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|||+|+...............||+.||||
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  199 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  199 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCH
Confidence            999999987554433333445799999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=304.35  Aligned_cols=158  Identities=28%  Similarity=0.506  Sum_probs=129.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|...+.||+|+||.||+|+++      +++.||||.           |.+|+++|++++|||||+++++|.+++..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            35666789999999999999864      478899983           6789999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcE
Q 040294          263 VLEYMTNGSLEKVLYSSN--------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVA  328 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~  328 (360)
                      |||||++|+|.++++...              ..++|.+++.|+.|||+||+|||   +++|+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997532              35899999999999999999999   8899999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeecccccCcccCC
Q 040294          329 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       329 ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|||+|+.+............+||+.||||
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  229 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  229 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCH
T ss_pred             EEcccccceeccCCCcceecCcccccccccCh
Confidence            99999999987654433344557899999998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.5e-39  Score=301.27  Aligned_cols=156  Identities=26%  Similarity=0.452  Sum_probs=136.6

Q ss_pred             CCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++..+.||+|+||+||+|++.      +++.||||.            |.+|+.++++++|||||+++++|.+++..+||
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            455678999999999999863      467899973            67899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcE
Q 040294          264 LEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVA  328 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~  328 (360)
                      ||||++|+|.++|....               ..++|.+++.|+.|||+||+|||   +.+||||||||+|||+++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence            99999999999996432               35899999999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeecccccCcccCC
Q 040294          329 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       329 ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|||+|+.+...+........+||++||||
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  216 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAP  216 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCH
Confidence            99999999987554433334456899999998

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.4e-39  Score=302.49  Aligned_cols=156  Identities=27%  Similarity=0.455  Sum_probs=133.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||+||+|+. .+|+.||||.             +.+|++++++++|||||+++++|++++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5788999999999999999996 4799999984             4579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          266 YMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+||+|.+++...+ ..+++.++..|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            999999999997543 45788899999999999999999   8999999999999999999999999999999764321 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       ......+||+.||||
T Consensus       180 -~~~~~~~GT~~YmAP  194 (350)
T 4b9d_A          180 -ELARACIGTPYYLSP  194 (350)
T ss_dssp             -HHHHHHHSCCTTCCH
T ss_pred             -ccccccCCCccccCH
Confidence             122456899999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.5e-39  Score=299.37  Aligned_cols=154  Identities=28%  Similarity=0.390  Sum_probs=139.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ..|+..+.||+|+||+||+|+.+ +|+.||||.           +.+|+++|++++|||||+++++|.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            35888899999999999999964 799999984           568999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +||+|.+++...  .+++.++..|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.....  .
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence            999999999763  5899999999999999999999   89999999999999999999999999999998754432  2


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      ..+.+||+.||||
T Consensus       227 ~~~~~GTp~YmAP  239 (346)
T 4fih_A          227 RKSLVGTPYWMAP  239 (346)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             ccccccCcCcCCH
Confidence            3457899999998

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.9e-38  Score=296.17  Aligned_cols=157  Identities=27%  Similarity=0.379  Sum_probs=135.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      +.|+..+.||+|+||.||+|+.+ +|+.||||.+      .+|++++++++|||||+++++|.+++..|||||||+||+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            45777789999999999999964 7999999964      4799999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-cEEEeecccccccCCCCCc---eee
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTGEDQS---MTQ  348 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-~~ki~DFGla~~~~~~~~~---~~~  348 (360)
                      .+++... ..+++..+..|+.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+|+.+......   ...
T Consensus       138 ~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~  213 (336)
T 4g3f_A          138 GQLIKQM-GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG  213 (336)
T ss_dssp             HHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecC
Confidence            9999764 36899999999999999999999   99999999999999999887 6999999999987643211   122


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ...+||+.||||
T Consensus       214 ~~~~GT~~YmAP  225 (336)
T 4g3f_A          214 DYIPGTETHMAP  225 (336)
T ss_dssp             CCCCCCGGGCCH
T ss_pred             CccccCccccCH
Confidence            346899999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.5e-38  Score=301.57  Aligned_cols=154  Identities=28%  Similarity=0.390  Sum_probs=139.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +.|+..+.||+|+||.||+|+.+ +|+.||||.           +.+|+++|++++|||||+++++|.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            45888999999999999999964 799999984           568999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +||+|.+++...  .+++.++..|+.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+.+.....  .
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  303 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  303 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence            999999999754  4889999999999999999999   89999999999999999999999999999998754432  2


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      ..+.+||+.||||
T Consensus       304 ~~~~~GTp~YmAP  316 (423)
T 4fie_A          304 RKSLVGTPYWMAP  316 (423)
T ss_dssp             BCCCEECTTTCCH
T ss_pred             ccccccCcCcCCH
Confidence            3467899999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.4e-38  Score=287.04  Aligned_cols=150  Identities=31%  Similarity=0.450  Sum_probs=130.1

Q ss_pred             CCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC----CCeEEEEE
Q 040294          203 SANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN----EDFRALVL  264 (360)
Q Consensus       203 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~  264 (360)
                      +..+.||+|+||.||+|++. ++..||||.             |.+|++++++++|||||+++++|.+    ++..||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            44567999999999999964 788999973             5679999999999999999999864    35689999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCceeec-CCCcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP--IIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--iiHrdlk~~NiLl~-~~~~~ki~DFGla~~~~~  341 (360)
                      |||+||+|.+++... ..+++..+..++.||+.||+|||   +.+  |+||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999764 46889999999999999999999   666  99999999999998 479999999999986543


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .    ...+.+||+.||||
T Consensus       185 ~----~~~~~~GTp~YmAP  199 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAP  199 (290)
T ss_dssp             T----SBEESCSSCCCCCG
T ss_pred             C----ccCCcccCccccCH
Confidence            2    23457899999999

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.4e-38  Score=284.39  Aligned_cols=154  Identities=26%  Similarity=0.467  Sum_probs=125.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||+||+|+. .+|+.||||.              +.+|++++++++|||||++++++.+++..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            36899999999999999999996 4799999984              45799999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||| +|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus        92 mEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            9999 68999999765 46899999999999999999999   8999999999999999999999999999998765432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                         ...+.+||+.||||
T Consensus       167 ---~~~~~~GT~~Y~AP  180 (275)
T 3hyh_A          167 ---FLKTSCGSPNYAAP  180 (275)
T ss_dssp             -----------CTTSCH
T ss_pred             ---ccCCeeECcccCCh
Confidence               23457899999998

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-37  Score=288.86  Aligned_cols=157  Identities=27%  Similarity=0.437  Sum_probs=130.0

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehhh----------HHHHHHhhcCCCCCeeEEEEEecCCC----eEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKSF----------DVECEVMKSIHHRNLVKIISSCSNED----FRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~----------~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e~  266 (360)
                      +|...+.||+|+||+||+|++ +|+.||||.+          +.|+..+.+++|||||+++++|.+++    ..+|||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            355678999999999999998 5899999853          34666677899999999999998654    57999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG-----FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      |++|+|.++++..  .++|..+.+++.|+++||+|||..     ..++|+||||||+|||++.++.+||+|||+|+....
T Consensus        83 ~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  160 (303)
T 3hmm_A           83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             CCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence            9999999999764  488999999999999999999932     234999999999999999999999999999998765


Q ss_pred             CCCce--eeecccccCcccCC
Q 040294          342 EDQSM--TQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~--~~~~~~gt~~Y~aP  360 (360)
                      .....  .....+||++||||
T Consensus       161 ~~~~~~~~~~~~~GT~~ymAP  181 (303)
T 3hmm_A          161 ATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             TTTEESCC-----CCGGGCCH
T ss_pred             CCCceeeecccccccccccCH
Confidence            43221  22346899999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-38  Score=292.33  Aligned_cols=155  Identities=28%  Similarity=0.429  Sum_probs=132.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc----CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|+..+.||+|+||+||+|+..    +++.||||.             +.+|++++++++|||||++++++++++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46899999999999999999852    577899984             4579999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      |||||+||+|.+++...+ .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999997643 5889999999999999999999   899999999999999999999999999999875433


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ....+.+||+.||||
T Consensus       180 ~--~~~~~~~GT~~YmAP  195 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAP  195 (304)
T ss_dssp             ---CCCCSCCCCGGGCCH
T ss_pred             C--ccccccccCcccCCH
Confidence            2  123457899999998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9e-38  Score=288.38  Aligned_cols=158  Identities=24%  Similarity=0.477  Sum_probs=125.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCC--------
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNED--------  258 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~--------  258 (360)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||.            +.+|++++++++|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46888999999999999999964 789999984            457999999999999999999987544        


Q ss_pred             ----eEEEEEEccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEee
Q 040294          259 ----FRALVLEYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD  332 (360)
Q Consensus       259 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~D  332 (360)
                          ..|+|||||++|+|.+++.....  ..++..+..|+.||++||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                47999999999999999976542  2456678889999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCc----------eeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQS----------MTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~----------~~~~~~~gt~~Y~aP  360 (360)
                      ||+|+.+......          ...++.+||+.||||
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP  199 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP  199 (299)
T ss_dssp             CCCC--------------------------CCCTTSCH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCH
Confidence            9999987543211          112346899999998

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.4e-37  Score=288.53  Aligned_cols=160  Identities=25%  Similarity=0.437  Sum_probs=137.9

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCC-CCeeEEEEEecCC-
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHH-RNLVKIISSCSNE-  257 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~h-pniv~l~~~~~~~-  257 (360)
                      ..++|+..+.||+|+||.||+|++.      +++.||||.            |.+|+++|.+++| ||||+++++|.+. 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            3467888999999999999999854      235799973            5679999999975 8999999999764 


Q ss_pred             CeEEEEEEccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee
Q 040294          258 DFRALVLEYMTNGSLEKVLYSS---------------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL  322 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl  322 (360)
                      +..+||||||++|+|.++|+..               ...++|..++.++.|||+||+|||   +++||||||||+|||+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL  218 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceee
Confidence            5789999999999999999753               234889999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          323 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       323 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++++.+||+|||+|+.+............+||+.||||
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  256 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  256 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence            99999999999999987655444445567899999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.5e-35  Score=293.37  Aligned_cols=154  Identities=29%  Similarity=0.454  Sum_probs=137.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhhH-----------------HHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSFD-----------------VECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      .++|+..++||+|+||.||+|+.+ +|+.||||.+.                 .++.+++.++|||||+++++|++++.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999965 79999998541                 235677788999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |||||||+||+|.+++... ..+++..+..|+.||+.||+|||   +.+||||||||+|||++.+|.+||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999999764 45889999999999999999999   9999999999999999999999999999999875


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...    ..+.+||+.||||
T Consensus       344 ~~~----~~t~~GTp~YmAP  359 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAP  359 (689)
T ss_dssp             SCC----CCSCCSCGGGCCH
T ss_pred             CCC----CCCccCCcCccCH
Confidence            432    2356899999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=277.82  Aligned_cols=156  Identities=30%  Similarity=0.447  Sum_probs=133.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecC------CCe
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSN------EDF  259 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~------~~~  259 (360)
                      ++|+..+.||+|+||+||+|+. .+|+.||||.+             .+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5688899999999999999996 47999999853             469999999999999999998764      357


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      +|||||||+ |+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 6899999764 46899999999999999999999   899999999999999999999999999999976


Q ss_pred             CCCCC--ceeeecccccCcccCC
Q 040294          340 TGEDQ--SMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~--~~~~~~~~gt~~Y~aP  360 (360)
                      .....  .....+.+||+.||||
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~AP  231 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAP  231 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCH
T ss_pred             ccCccccccccccceeChHhcCH
Confidence            43321  1223457899999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.5e-34  Score=273.64  Aligned_cols=136  Identities=27%  Similarity=0.415  Sum_probs=123.2

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc----CCcEEEehh---------hHHHHHHhhcC-CCCCeeEEEEEecCCCeEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKS---------FDVECEVMKSI-HHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~---------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ..+.|+..+.||+|+||+||+|+.+    +++.||||.         +.+|+++++.+ +|||||+++++|.+++..|+|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv   98 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA   98 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence            4578999999999999999999753    567899984         45799999988 699999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-CcEEEeecccccccC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKLLT  340 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-~~~ki~DFGla~~~~  340 (360)
                      ||||++|+|.+++.    .+++.++..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+...
T Consensus        99 mE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           99 MPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             EeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            99999999999984    3788899999999999999999   8999999999999999876 799999999998654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.8e-34  Score=284.54  Aligned_cols=156  Identities=24%  Similarity=0.407  Sum_probs=140.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|.           +.+|+++|+.++|||||+++++|.+++..||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            357899999999999999999964 799999984           45799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC--CcEEEeecccccccCCCCC
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN--IVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~--~~~ki~DFGla~~~~~~~~  344 (360)
                      |+||+|.+++......+++.++..++.||+.||+|||   +.+|+||||||+|||++.+  +.+||+|||+|+.+.... 
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            9999999999776667899999999999999999999   8999999999999999854  899999999999876543 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        .....+||+.||||
T Consensus       312 --~~~~~~GT~~y~AP  325 (573)
T 3uto_A          312 --SVKVTTGTAEFAAP  325 (573)
T ss_dssp             --EEEEECSSGGGCCH
T ss_pred             --ceeeeEECccccCH
Confidence              23456899999998

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.98  E-value=1.7e-32  Score=266.00  Aligned_cols=163  Identities=25%  Similarity=0.385  Sum_probs=144.5

Q ss_pred             HHHHHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCC
Q 040294          194 ELLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNED  258 (360)
Q Consensus       194 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~  258 (360)
                      ++...+++|+..++||+|+||.||+|+.+ +++.||+|.              +..|+.++..++|||||+++++|.+++
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            34445678999999999999999999975 578899984              456899999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..++|||||++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            999999999999999999876667999999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..... .......+||++||||
T Consensus       225 ~~~~~-~~~~~~~~GT~~Y~AP  245 (437)
T 4aw2_A          225 LMEDG-TVQSSVAVGTPDYISP  245 (437)
T ss_dssp             CCTTS-CEECCSCCSCGGGCCH
T ss_pred             cccCC-CcccccccCCcCeeCh
Confidence            65443 2233456899999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=4.3e-32  Score=261.40  Aligned_cols=163  Identities=25%  Similarity=0.411  Sum_probs=143.9

Q ss_pred             HHHHHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCC
Q 040294          194 ELLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNED  258 (360)
Q Consensus       194 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~  258 (360)
                      +.....++|+..++||+|+||.||+|+.+ +++.||||.              +..|.+++..++||||++++++|++++
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            33445678999999999999999999974 789999984              346889999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..|+||||+++|+|.+++...+..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence            999999999999999999875557899999999999999999999   89999999999999999999999999999998


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.... .......+||+.||||
T Consensus       212 ~~~~~-~~~~~~~~Gt~~Y~AP  232 (412)
T 2vd5_A          212 LRADG-TVRSLVAVGTPDYLSP  232 (412)
T ss_dssp             CCTTS-CEECSSCCSCGGGCCH
T ss_pred             ccCCC-ccccceeccccCcCCH
Confidence            75433 2223356899999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=2.4e-31  Score=247.85  Aligned_cols=173  Identities=41%  Similarity=0.628  Sum_probs=152.2

Q ss_pred             CCccCHHHHHHHhCCCCCCCeeccCCCccEEEEEccCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEe
Q 040294          187 RRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSC  254 (360)
Q Consensus       187 ~~~~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~  254 (360)
                      ...+++.++...+++|+..+.||+|+||.||+|+..+++.||||.            +.+|++++++++||||++++++|
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            456788899999999999999999999999999988899999983            46799999999999999999999


Q ss_pred             cCCCeEEEEEEccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEe
Q 040294          255 SNEDFRALVLEYMTNGSLEKVLYSSN---CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLS  331 (360)
Q Consensus       255 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~  331 (360)
                      ...+..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||..+..+|+||||||+||+++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999998643   348999999999999999999994333499999999999999999999999


Q ss_pred             ecccccccCCCCCceeeecccccCcccCC
Q 040294          332 DFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       332 DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |||+++...... ........||+.|+||
T Consensus       177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aP  204 (326)
T 3uim_A          177 DFGLAKLMDYKD-THVTTAVRGTIGHIAP  204 (326)
T ss_dssp             CCSSCEECCSSS-SCEECCCCSCGGGCCH
T ss_pred             cCccccccCccc-ccccccccCCcCccCH
Confidence            999999765433 2233445699999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.97  E-value=1.1e-31  Score=258.34  Aligned_cols=160  Identities=27%  Similarity=0.405  Sum_probs=141.4

Q ss_pred             HHHHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          195 LLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       195 ~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      +....++|+..++||+|+||.||+|+.+ +++.||+|.              +..|+++++.++|||||+++++|.+++.
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3345678999999999999999999965 688999984              3469999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .|+|||||+||+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            99999999999999999754  4788899999999999999999   899999999999999999999999999999887


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .... .......+||+.||||
T Consensus       219 ~~~~-~~~~~~~~gt~~Y~AP  238 (410)
T 3v8s_A          219 NKEG-MVRCDTAVGTPDYISP  238 (410)
T ss_dssp             CTTS-EEECCSCCSCGGGCCH
T ss_pred             ccCC-cccccCCcCCccccCH
Confidence            5433 2233467899999998

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=1.2e-31  Score=249.55  Aligned_cols=165  Identities=42%  Similarity=0.687  Sum_probs=144.6

Q ss_pred             HHHHHHhCCCCCCCeeccCCCccEEEEEccCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          193 LELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       193 ~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      .++...+++|+..+.||+|+||.||+|+.++++.||||.           +.+|++++++++||||++++++|..++..+
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            344456789999999999999999999988899999983           567999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          262 LVLEYMTNGSLEKVLYSSN---CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      +||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999999997543   24899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..............||+.|+||
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aP  210 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDP  210 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCH
T ss_pred             cccccccccccccCCCccccCH
Confidence            5543322233445699999998

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=7.8e-31  Score=242.82  Aligned_cols=158  Identities=28%  Similarity=0.509  Sum_probs=138.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ++|...+.||+|+||.||+|+.. +++.||+|.           +.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            56778899999999999999964 688999983           467999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce-
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM-  346 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~-  346 (360)
                      ++|+|.+++......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......... 
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            999999999886677999999999999999999999   8999999999999999999999999999998765432110 


Q ss_pred             -----------eeecccccCcccCC
Q 040294          347 -----------TQTQTLATIGYMAP  360 (360)
Q Consensus       347 -----------~~~~~~gt~~Y~aP  360 (360)
                                 ......||+.|+||
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aP  191 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAP  191 (310)
T ss_dssp             -------------CCCCSCGGGCCH
T ss_pred             ccccccccccccccccCCCcceeCH
Confidence                       11145799999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=4.7e-31  Score=250.12  Aligned_cols=159  Identities=21%  Similarity=0.322  Sum_probs=137.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEE------ccCCcEEEehh--------hHHHHHHhhcCC---CCCeeEEEEEecCCCeEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKAR------LQDGMEFAIKS--------FDVECEVMKSIH---HRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~------~~~~~~vavK~--------~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~  261 (360)
                      .++|...+.||+|+||.||+|.      ..+++.||||.        +..|+++++.++   |+||+++++++..++..+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~  143 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV  143 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence            4668888999999999999994      45788999984        456788887777   999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-----------CC
Q 040294          262 LVLEYMTNGSLEKVLYS----SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-----------NI  326 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-----------~~  326 (360)
                      +|||||++|+|.+++..    ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.           ++
T Consensus       144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccC
Confidence            99999999999999974    3456999999999999999999999   899999999999999998           89


Q ss_pred             cEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       327 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+||+|||+|+.+............+||++||||
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP  254 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV  254 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCCh
Confidence            9999999999876433323344567899999998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.97  E-value=7.5e-31  Score=245.51  Aligned_cols=155  Identities=29%  Similarity=0.429  Sum_probs=138.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .++|+..+.||+|+||.||+|+. .+|+.||||.             +.+|+++++.++||||+++++++..++..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45788999999999999999996 5899999984             346999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            999999999999764 35888999999999999999999   8899999999999999999999999999998765432 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        .....+||++|+||
T Consensus       169 --~~~~~~gt~~y~aP  182 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAP  182 (328)
T ss_dssp             --GGGTTSSSGGGCCH
T ss_pred             --ccccccCCcceeCc
Confidence              23456799999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.97  E-value=1.1e-30  Score=245.24  Aligned_cols=156  Identities=29%  Similarity=0.411  Sum_probs=137.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+.+ +|+.||+|.+              ..|+++++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357888999999999999999965 7899999843              4588999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            9999999999998754 35788899999999999999999   8899999999999999999999999999998643322


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                        ......+||+.||||
T Consensus       160 --~~~~~~~gt~~y~aP  174 (337)
T 1o6l_A          160 --ATMKTFCGTPEYLAP  174 (337)
T ss_dssp             --CCBCCCEECGGGCCG
T ss_pred             --CcccccccChhhCCh
Confidence              123456899999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.97  E-value=9.4e-31  Score=247.27  Aligned_cols=157  Identities=30%  Similarity=0.411  Sum_probs=132.8

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  261 (360)
                      ..++|+..++||+|+||.||+|+.+ +++.||||.+              ..|.++++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3568999999999999999999965 6899999843              3578888887 6999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            999999999999999764 35889999999999999999999   88999999999999999999999999999986433


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..  ......+||+.||||
T Consensus       177 ~~--~~~~~~~gt~~y~aP  193 (353)
T 3txo_A          177 NG--VTTATFCGTPDYIAP  193 (353)
T ss_dssp             -----------CCGGGCCH
T ss_pred             CC--ccccccCCCcCeECh
Confidence            22  233456899999998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=4.3e-30  Score=237.23  Aligned_cols=170  Identities=36%  Similarity=0.557  Sum_probs=149.8

Q ss_pred             CCccCHHHHHHHhCCCCCC------CeeccCCCccEEEEEccCCcEEEehh---------------hHHHHHHhhcCCCC
Q 040294          187 RRRFSYLELLRATNGFSAN------NLIGRGSFGSVYKARLQDGMEFAIKS---------------FDVECEVMKSIHHR  245 (360)
Q Consensus       187 ~~~~~~~~~~~~~~~f~~~------~~iG~G~~g~Vy~~~~~~~~~vavK~---------------~~~E~~~l~~l~hp  245 (360)
                      ...+++.++..++++|+..      +.||+|+||.||+|+. +++.||||.               +.+|++++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4568999999999999988      8999999999999997 578899873               45799999999999


Q ss_pred             CeeEEEEEecCCCeEEEEEEccCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec
Q 040294          246 NLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSS--NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD  323 (360)
Q Consensus       246 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~  323 (360)
                      ||+++++++.+++..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998743  345899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          324 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       324 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .++.+||+|||+++...............||+.|+||
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP  204 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP  204 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCCh
Confidence            9999999999999876544333333446799999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=9.8e-31  Score=248.69  Aligned_cols=159  Identities=27%  Similarity=0.487  Sum_probs=136.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc--------CCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNE  257 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~  257 (360)
                      .++|+..+.||+|+||.||+|+..        ++..||||.            +.+|+++++++ +|||||+++++|..+
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            356888899999999999999852        345799974            45799999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL  322 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl  322 (360)
                      +..++||||+++|+|.+++....               ..+++..+..++.|++.||+|||   +.+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999997643               24788999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          323 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       323 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.++.+||+|||+++.+.............||+.||||
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  274 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  274 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence            99999999999999976544322223345678999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=2.7e-30  Score=238.18  Aligned_cols=155  Identities=32%  Similarity=0.454  Sum_probs=138.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.           +.+|+.++++++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            35789999999999999999985 5789999984           45799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            9999999999764  4888999999999999999999   88999999999999999999999999999987654432  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.|+||
T Consensus       172 ~~~~~~gt~~y~aP  185 (297)
T 3fxz_A          172 KRSTMVGTPYWMAP  185 (297)
T ss_dssp             CBCCCCSCGGGCCH
T ss_pred             ccCCccCCcCccCh
Confidence            23456799999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.97  E-value=1.6e-30  Score=248.13  Aligned_cols=154  Identities=31%  Similarity=0.457  Sum_probs=138.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.              +.+|+++++.++|||||+++++|.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888999999999999999864 688999984              346999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-  169 (384)
T ss_dssp             CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred             ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence            999999999999764 45889999999999999999999   8999999999999999999999999999999765432 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        .....+||+.|+||
T Consensus       170 --~~~~~~gt~~Y~aP  183 (384)
T 4fr4_A          170 --QITTMAGTKPYMAP  183 (384)
T ss_dssp             --CBCCCCSCGGGCCG
T ss_pred             --ceeccCCCccccCC
Confidence              23456899999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2e-30  Score=241.83  Aligned_cols=156  Identities=22%  Similarity=0.369  Sum_probs=139.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.          +.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            357888999999999999999965 688899974          467999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC--CCcEEEeecccccccCCCCCc
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD--NIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~--~~~~ki~DFGla~~~~~~~~~  345 (360)
                      ++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++.+....  
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--  158 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--  158 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence            999999999876667899999999999999999999   899999999999999987  7899999999999875433  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.|+||
T Consensus       159 -~~~~~~gt~~y~aP  172 (321)
T 1tki_A          159 -NFRLLFTAPEYYAP  172 (321)
T ss_dssp             -EEEEEESCGGGSCH
T ss_pred             -ccccccCChhhcCc
Confidence             23446799999998

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=1.3e-30  Score=243.04  Aligned_cols=156  Identities=28%  Similarity=0.443  Sum_probs=135.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehhh----------HHHHHHhhcCCCCCeeEEEEEecCCC----eEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF----------DVECEVMKSIHHRNLVKIISSCSNED----FRALVL  264 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~----------~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv~  264 (360)
                      .++|+..+.||+|+||.||+|+.. ++.||||.+          ..|+.++++++|||||++++++....    ..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            356888899999999999999875 789999854          45888899999999999999998754    479999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC----------CeEEccCCCCceeecCCCcEEEeecc
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST----------PIIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~----------~iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                      ||+++|+|.+++...  .+++..+..++.|++.||+|||   +.          +|+||||||+|||++.++.+||+|||
T Consensus       102 e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            999999999999764  4899999999999999999999   77          99999999999999999999999999


Q ss_pred             cccccCCCCCceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++.+.............||+.|+||
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aP  202 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAP  202 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCH
T ss_pred             cccccccccCccccccCccCccccCH
Confidence            99887654433333446799999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.97  E-value=2.8e-30  Score=240.64  Aligned_cols=153  Identities=30%  Similarity=0.438  Sum_probs=136.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+.+ +|+.||+|.+              ..|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            356888999999999999999965 7899999843              3588899999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            9999999999999764 35888899999999999999999   999999999999999999999999999999876432 


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                          ....+||+.|+||
T Consensus       160 ----~~~~~gt~~y~aP  172 (318)
T 1fot_A          160 ----TYTLCGTPDYIAP  172 (318)
T ss_dssp             ----BCCCCSCTTTCCH
T ss_pred             ----cccccCCccccCH
Confidence                2346799999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.97  E-value=1.4e-30  Score=249.52  Aligned_cols=156  Identities=30%  Similarity=0.375  Sum_probs=136.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSI-HHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  262 (360)
                      .++|+..++||+|+||.||+|+.+ +++.||+|.              +..|..++.++ +|||||+++++|.+++..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            457889999999999999999965 678899974              34688888776 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|..++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            99999999999999764 35889999999999999999999   899999999999999999999999999999864322


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ......+||+.||||
T Consensus       207 ~--~~~~~~~gt~~Y~aP  222 (396)
T 4dc2_A          207 G--DTTSTFCGTPNYIAP  222 (396)
T ss_dssp             T--CCBCCCCBCGGGCCH
T ss_pred             C--CccccccCCcccCCc
Confidence            2  223457899999998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=8.2e-31  Score=249.79  Aligned_cols=159  Identities=28%  Similarity=0.478  Sum_probs=137.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|...+.||+|+||.||+|++. +++.||||.            |.+|++++++++|||||+++++|..++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            346778899999999999999975 789999983            4569999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++|+|.+++......+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999876566899999999999999999999   899999999999999999999999999999875432211


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      .......+++.|+||
T Consensus       270 ~~~~~~~~~~~y~aP  284 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAP  284 (377)
T ss_dssp             CCSSCCEEEGGGSCH
T ss_pred             ecCCCCCCCcCcCCH
Confidence            111123467889998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.97  E-value=1.3e-30  Score=243.19  Aligned_cols=158  Identities=25%  Similarity=0.398  Sum_probs=139.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.            +.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            467889999999999999999865 789999984            4579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999998654 45889999999999999999999   899999999999999999999999999999876533322


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      ......+||+.|+||
T Consensus       162 ~~~~~~~gt~~y~aP  176 (323)
T 3tki_A          162 RLLNKMCGTLPYVAP  176 (323)
T ss_dssp             CCBCSCCSCGGGSCH
T ss_pred             cccCCCccCcCccCc
Confidence            233456799999998

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=2.8e-30  Score=241.19  Aligned_cols=158  Identities=30%  Similarity=0.537  Sum_probs=134.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc----CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..+.||+|+||.||+|+..    .+..||||.            +.+|++++++++||||++++++|.+++..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            45777899999999999999974    344699974            45699999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999999999877677999999999999999999999   8999999999999999999999999999999875432


Q ss_pred             C-ceeeecccccCcccCC
Q 040294          344 Q-SMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~-~~~~~~~~gt~~Y~aP  360 (360)
                      . ........+|+.|+||
T Consensus       206 ~~~~~~~~~~~t~~y~aP  223 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAP  223 (325)
T ss_dssp             -CCEECC---CCGGGSCH
T ss_pred             cceeeccCCCCcccccCH
Confidence            2 1222334578899998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=2.8e-30  Score=243.25  Aligned_cols=158  Identities=28%  Similarity=0.428  Sum_probs=136.8

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeE
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~  260 (360)
                      ...++|...++||+|+||.||+|+.+ +++.||||.+              ..|.+++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            35678999999999999999999975 6889999854              3477778766 899999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            9999999999999999764 35889999999999999999999   8899999999999999999999999999998653


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...  ......+||+.|+||
T Consensus       170 ~~~--~~~~~~~gt~~y~aP  187 (345)
T 1xjd_A          170 LGD--AKTNTFCGTPDYIAP  187 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCH
T ss_pred             cCC--CcccCCCCCcccCCh
Confidence            322  123456899999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=1.5e-30  Score=235.97  Aligned_cols=157  Identities=28%  Similarity=0.466  Sum_probs=139.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|+..+++.||+|.          +.+|++++++++||||+++++++.+++..++||||+++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   89 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence            46778899999999999999988888999984          56799999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  165 (269)
T 4hcu_A           90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSST  165 (269)
T ss_dssp             CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTT
T ss_pred             CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccccc
Confidence            9999999877777899999999999999999999   8999999999999999999999999999998764322 11223


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...+|+.|+||
T Consensus       166 ~~~~~~~y~aP  176 (269)
T 4hcu_A          166 GTKFPVKWASP  176 (269)
T ss_dssp             STTCCGGGCCH
T ss_pred             CcccccccCCH
Confidence            44578889998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=5.4e-30  Score=238.83  Aligned_cols=166  Identities=27%  Similarity=0.351  Sum_probs=143.4

Q ss_pred             CccCHHHHHHHhCC----------CCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCC
Q 040294          188 RRFSYLELLRATNG----------FSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHR  245 (360)
Q Consensus       188 ~~~~~~~~~~~~~~----------f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hp  245 (360)
                      ..+++.++..+++.          |+..+.||+|+||.||+|+.. +|+.||||.           +.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34677777766653          556678999999999999975 799999984           45799999999999


Q ss_pred             CeeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC
Q 040294          246 NLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN  325 (360)
Q Consensus       246 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~  325 (360)
                      ||++++++|...+..++||||+++|+|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            999999999999999999999999999999864  35899999999999999999999   8899999999999999999


Q ss_pred             CcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          326 IVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       326 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.+||+|||+++.......  ......||+.|+||
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  210 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAP  210 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCH
T ss_pred             CcEEEeeeeeeeecccCcc--ccccccCCccccCH
Confidence            9999999999987654321  23356799999998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=3.4e-30  Score=239.95  Aligned_cols=159  Identities=25%  Similarity=0.463  Sum_probs=132.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCC-------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNED-------  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~-------  258 (360)
                      .++|+..+.||+|+||.||+|+.+ +++.||||.            +.+|++++++++|||||+++++|.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356888899999999999999975 889999984            457999999999999999999985443       


Q ss_pred             --------------------------------------------------eEEEEEEccCCCCHHHHHhcCCC--CCCHH
Q 040294          259 --------------------------------------------------FRALVLEYMTNGSLEKVLYSSNC--ILDIL  286 (360)
Q Consensus       259 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~  286 (360)
                                                                        ..++||||+++|+|.+++.....  ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999986532  35666


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc----------eeeecccccCc
Q 040294          287 QRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS----------MTQTQTLATIG  356 (360)
Q Consensus       287 ~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~----------~~~~~~~gt~~  356 (360)
                      .+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78899999999999999   899999999999999999999999999999987654211          12234579999


Q ss_pred             ccCC
Q 040294          357 YMAP  360 (360)
Q Consensus       357 Y~aP  360 (360)
                      |+||
T Consensus       242 y~aP  245 (332)
T 3qd2_B          242 YMSP  245 (332)
T ss_dssp             GSCH
T ss_pred             ccCh
Confidence            9998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=3.2e-30  Score=233.47  Aligned_cols=158  Identities=28%  Similarity=0.450  Sum_probs=140.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .++|+..+.||+|+||.||+|+.+++..||+|.          +.+|++++++++||||+++++++.+++..++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            356788899999999999999998888999984          4679999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~  162 (268)
T 3sxs_A           87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSS  162 (268)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEEC
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhcc
Confidence            99999999876666899999999999999999999   8899999999999999999999999999998765443 2223


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....+|+.|+||
T Consensus       163 ~~~~~~~~y~aP  174 (268)
T 3sxs_A          163 VGTKFPVKWSAP  174 (268)
T ss_dssp             CSCCCCGGGCCH
T ss_pred             cCCCcCcccCCH
Confidence            345577889998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=4.3e-30  Score=238.39  Aligned_cols=156  Identities=30%  Similarity=0.458  Sum_probs=137.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||.||+|+..+++.||+|.             +.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            356888899999999999999998899999984             3469999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++ +|.+.+......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  174 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-  174 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence            9985 898888877667899999999999999999999   88999999999999999999999999999987653321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.|+||
T Consensus       175 -~~~~~~~t~~y~aP  188 (311)
T 3niz_A          175 -SYTHEVVTLWYRAP  188 (311)
T ss_dssp             ----CCCCCCTTCCH
T ss_pred             -cccCCcccCCcCCH
Confidence             23345789999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=3.2e-30  Score=245.39  Aligned_cols=158  Identities=28%  Similarity=0.553  Sum_probs=126.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc----CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..+.||+|+||.||+|+..    ++..||||.            |.+|++++++++||||++++++|..++..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47889999999999999999865    567899983            45799999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++......+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            9999999999999877667999999999999999999999   8899999999999999999999999999998765432


Q ss_pred             Cc-eeeecccccCcccCC
Q 040294          344 QS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~-~~~~~~~gt~~Y~aP  360 (360)
                      .. .......+|+.|+||
T Consensus       202 ~~~~~~~~~~~~~~y~aP  219 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSP  219 (373)
T ss_dssp             ------------CTTSCH
T ss_pred             ccceeccCCCcCCCccCh
Confidence            11 112223467889998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=3.8e-30  Score=236.75  Aligned_cols=156  Identities=28%  Similarity=0.484  Sum_probs=132.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+. .+++.||+|.              +.+|++++++++||||+++++++..++..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            5688889999999999999985 4788999984              457999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        91 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  165 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-  165 (294)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-
Confidence            9999999999997643 5889999999999999999999   8899999999999999999999999999998765332 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                      ........||+.|+||
T Consensus       166 ~~~~~~~~gt~~y~aP  181 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSP  181 (294)
T ss_dssp             ---------CCSSCCH
T ss_pred             ccccCccccCccccCH
Confidence            1223345799999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=4e-30  Score=242.23  Aligned_cols=155  Identities=31%  Similarity=0.381  Sum_probs=135.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|.+              ..|..+++++ +|||||++++++.+++..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56888899999999999999965 6889999843              4588888887 899999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            9999999999999754 35889999999999999999999   8899999999999999999999999999998643222


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                        ......+||+.|+||
T Consensus       165 --~~~~~~~gt~~y~aP  179 (345)
T 3a8x_A          165 --DTTSTFCGTPNYIAP  179 (345)
T ss_dssp             --CCBCCCCSCGGGCCH
T ss_pred             --CcccccCCCccccCc
Confidence              123456899999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=6.7e-30  Score=242.13  Aligned_cols=155  Identities=26%  Similarity=0.441  Sum_probs=137.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------------hHHHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------------FDVECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      .+.|+..+.||+|+||.||+|+.+ +|+.||+|.                 +.+|++++++++||||++++++|.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            456888999999999999999965 789999973                 45799999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC----cEEEeecccc
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI----VAHLSDFGIA  336 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~----~~ki~DFGla  336 (360)
                      ++||||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            9999999999999999654 46889999999999999999999   88999999999999998776    7999999999


Q ss_pred             cccCCCCCceeeecccccCcccCC
Q 040294          337 KLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.+....   .....+||+.|+||
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aP  187 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAP  187 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCH
T ss_pred             eEcCCCC---ccccCCCCccEECc
Confidence            9865432   22346799999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=5.3e-30  Score=241.84  Aligned_cols=152  Identities=28%  Similarity=0.404  Sum_probs=136.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.. +|+.||||.+              .+|+++++.++||||+++++++.+++..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999965 7899999843              45889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            9999999999997643 5888999999999999999999   899999999999999999999999999999976432  


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         ....+||+.|+||
T Consensus       195 ---~~~~~gt~~y~aP  207 (350)
T 1rdq_E          195 ---TWTLCGTPEALAP  207 (350)
T ss_dssp             ---BCCCEECGGGCCH
T ss_pred             ---cccccCCccccCH
Confidence               2345799999998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.96  E-value=6.5e-30  Score=254.57  Aligned_cols=156  Identities=29%  Similarity=0.478  Sum_probs=139.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..++||+|+||.||+|+.. +|+.||||.+              ..|++++++++|||||++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            456888999999999999999965 7899999843              4689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          264 LEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      |||++||+|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999997653 34899999999999999999999   889999999999999999999999999999987543


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .   .....+||+.||||
T Consensus       340 ~---~~~~~~GT~~Y~AP  354 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAP  354 (576)
T ss_dssp             C---CEECCCSCGGGCCH
T ss_pred             c---cccccCCCccccCH
Confidence            3   23346899999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=5.4e-30  Score=242.06  Aligned_cols=157  Identities=26%  Similarity=0.324  Sum_probs=136.8

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  261 (360)
                      ..++|+..++||+|+||.||+|+.+ +++.||||.+              ..|..++..+ +||+|+++++++++.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3568999999999999999999975 5788999843              3578888887 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||++||+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999997543 5889999999999999999999   88999999999999999999999999999986432


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..  ......+||+.||||
T Consensus       174 ~~--~~~~~~~gt~~y~aP  190 (353)
T 2i0e_A          174 DG--VTTKTFCGTPDYIAP  190 (353)
T ss_dssp             TT--CCBCCCCSCGGGCCH
T ss_pred             CC--cccccccCCccccCh
Confidence            22  123456899999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.96  E-value=5e-30  Score=235.02  Aligned_cols=155  Identities=28%  Similarity=0.468  Sum_probs=134.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||+|+||.||+|+..+++.||+|.             +.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46788899999999999999988899999984             34799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            985 999999876667899999999999999999999   8899999999999999999999999999998765322  1


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.|+||
T Consensus       156 ~~~~~~~t~~y~aP  169 (288)
T 1ob3_A          156 KYTHEIVTLWYRAP  169 (288)
T ss_dssp             ------CCCTTCCH
T ss_pred             ccccccccccccCc
Confidence            22345789999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=5.3e-30  Score=237.66  Aligned_cols=156  Identities=31%  Similarity=0.539  Sum_probs=127.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||.||+|+. +++.||||.             +.+|++++++++||||+++++++...+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            35678889999999999999987 578899974             4579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          266 YMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLHFGFSTP--IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~yLH~~~~~~--iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      |+++|+|.+++.....  .+++..+..++.|++.||+|||   +.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            9999999999976532  3889999999999999999999   778  99999999999999999999999999986543


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..  .......||+.|+||
T Consensus       192 ~~--~~~~~~~gt~~y~aP  208 (309)
T 3p86_A          192 TF--LSSKSAAGTPEWMAP  208 (309)
T ss_dssp             ------------CCTTSCH
T ss_pred             cc--cccccCCCCccccCh
Confidence            22  123356799999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.96  E-value=1.4e-29  Score=242.07  Aligned_cols=156  Identities=24%  Similarity=0.432  Sum_probs=138.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      .+.|+..+.||+|+||.||+|+.. +++.||+|.           +.+|++++++++|||||++++++.+++..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            457889999999999999999864 788999974           45799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC--CCcEEEeecccccccCCCCC
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD--NIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~--~~~~ki~DFGla~~~~~~~~  344 (360)
                      +++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++.+.... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999876667899999999999999999999   889999999999999974  5789999999999875433 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......||+.|+||
T Consensus       206 --~~~~~~gt~~y~aP  219 (387)
T 1kob_A          206 --IVKVTTATAEFAAP  219 (387)
T ss_dssp             --CEEEECSSGGGCCH
T ss_pred             --ceeeeccCCCccCc
Confidence              22345799999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=3.4e-30  Score=243.10  Aligned_cols=166  Identities=25%  Similarity=0.423  Sum_probs=139.4

Q ss_pred             HHHHHHHhCCCCCCCeeccCCCccEEEEEc------cCCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEE
Q 040294          192 YLELLRATNGFSANNLIGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSI-HHRNLVKIIS  252 (360)
Q Consensus       192 ~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~  252 (360)
                      ..+.....++|+..+.||+|+||.||+|++      .+++.||||.            +.+|+++++++ +|||||++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            344444567899999999999999999973      3567899984            56799999999 7999999999


Q ss_pred             EecCCC-eEEEEEEccCCCCHHHHHhcCCC--------------------------------------------------
Q 040294          253 SCSNED-FRALVLEYMTNGSLEKVLYSSNC--------------------------------------------------  281 (360)
Q Consensus       253 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------  281 (360)
                      +|...+ ..++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            998765 48999999999999999976432                                                  


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          282 ---------------ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       282 ---------------~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                                     .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.......
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                           1888899999999999999999   8899999999999999999999999999999765444333


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.|+||
T Consensus       251 ~~~~~~~t~~y~aP  264 (359)
T 3vhe_A          251 RKGDARLPLKWMAP  264 (359)
T ss_dssp             EC--CEECGGGCCH
T ss_pred             hccccCCCceeECh
Confidence            44556789999998

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.96  E-value=5.1e-30  Score=240.30  Aligned_cols=160  Identities=29%  Similarity=0.486  Sum_probs=137.3

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      ..++|+..+.||+|+||.||+|+..      +++.||||.            +.+|++++++++||||++++++|..++.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            4567899999999999999999864      347899984            4579999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCC
Q 040294          260 RALVLEYMTNGSLEKVLYSSN-----------------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK  316 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk  316 (360)
                      .++||||+++|+|.+++....                       ..+++.++..++.|++.||+|||   +.+|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            999999999999999997632                       45889999999999999999999   8899999999


Q ss_pred             CCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       317 ~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+||+++.++.+||+|||+++...............||+.|+||
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  245 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  245 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence            99999999999999999999876533222223345689999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.96  E-value=1.1e-29  Score=237.43  Aligned_cols=158  Identities=25%  Similarity=0.359  Sum_probs=138.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh---------hHHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS---------FDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~---------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.         +..|+++++++ +||||+++++++..++..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            35788899999999999999995 5789999983         56899999999 9999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc-----EEEeecccccccCCC
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV-----AHLSDFGIAKLLTGE  342 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~-----~ki~DFGla~~~~~~  342 (360)
                       +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++.+...
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence             99999999876667999999999999999999999   889999999999999998887     999999999976543


Q ss_pred             CCce-----eeecccccCcccCC
Q 040294          343 DQSM-----TQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~-----~~~~~~gt~~Y~aP  360 (360)
                      ....     ......||+.|+||
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aP  186 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSI  186 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             CCCccccccccCCcCCCccccCh
Confidence            2211     12356799999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=1.6e-29  Score=231.93  Aligned_cols=155  Identities=26%  Similarity=0.426  Sum_probs=135.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+             .+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888899999999999999964 7889999843             469999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++ ++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence            9975 676666665667999999999999999999999   88999999999999999999999999999987653321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.|+||
T Consensus       157 -~~~~~~~t~~y~aP  170 (292)
T 3o0g_A          157 -CYSAEVVTLWYRPP  170 (292)
T ss_dssp             -CCCSCCSCGGGCCH
T ss_pred             -cccCCccccCCcCh
Confidence             23345789999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=8e-30  Score=242.60  Aligned_cols=156  Identities=33%  Similarity=0.432  Sum_probs=132.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHH-hhcCCCCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEV-MKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~-l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      .++|+..++||+|+||.||+|+.+ +++.||||.+              ..|..+ ++.++|||||+++++|.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357889999999999999999965 6888999854              234444 567899999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||++||+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999999764 35788888999999999999999   899999999999999999999999999999874332


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ......+||+.||||
T Consensus       193 ~--~~~~~~~gt~~y~aP  208 (373)
T 2r5t_A          193 N--STTSTFCGTPEYLAP  208 (373)
T ss_dssp             C--CCCCSBSCCCCCCCH
T ss_pred             C--CccccccCCccccCH
Confidence            2  123456899999998

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=4.4e-30  Score=234.44  Aligned_cols=158  Identities=27%  Similarity=0.465  Sum_probs=136.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .++|+..+.||+|+||.||+|++.++..||||.          +.+|++++++++||||+++++++.+++..++||||++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            346778899999999999999998888999984          4679999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      +|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~  178 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSS  178 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHST
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cccc
Confidence            99999999875567899999999999999999999   8999999999999999999999999999998764322 1122


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....+|+.|+||
T Consensus       179 ~~~~~~~~y~aP  190 (283)
T 3gen_A          179 VGSKFPVRWSPP  190 (283)
T ss_dssp             TSTTSCGGGCCH
T ss_pred             cCCccCcccCCH
Confidence            234578889998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=7.6e-30  Score=238.42  Aligned_cols=156  Identities=29%  Similarity=0.451  Sum_probs=131.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc----cCCcEEEehhh---------------HHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL----QDGMEFAIKSF---------------DVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~---------------~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      .++|+..+.||+|+||.||+++.    .+++.||+|.+               ..|++++++++||||+++++++..++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35688899999999999999986    47889999843               358999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .++||||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999754 35788889999999999999999   889999999999999999999999999999865


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  ......+||+.|+||
T Consensus       172 ~~~~--~~~~~~~gt~~y~aP  190 (327)
T 3a62_A          172 IHDG--TVTHTFCGTIEYMAP  190 (327)
T ss_dssp             ---------CTTSSCCTTSCH
T ss_pred             ccCC--ccccccCCCcCccCH
Confidence            3322  123356799999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.96  E-value=1.7e-29  Score=250.61  Aligned_cols=157  Identities=31%  Similarity=0.471  Sum_probs=138.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|...++||+|+||.||+|+.+ +|+.||+|.+              ..|++++++++|||||+++++|.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            357888899999999999999975 7899999843              4589999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          264 LEYMTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |||++||+|.+++...   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999998754   245899999999999999999999   8999999999999999999999999999999865


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  .....+||+.||||
T Consensus       341 ~~~~--~~~~~~GT~~Y~AP  358 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAP  358 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCH
T ss_pred             CCCc--ccccccCCccccCh
Confidence            4331  22345899999998

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=1.4e-29  Score=233.16  Aligned_cols=155  Identities=30%  Similarity=0.483  Sum_probs=133.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------------------------------hHHHHHHhh
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------------------------------FDVECEVMK  240 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------------------------------~~~E~~~l~  240 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.                                     +.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46788899999999999999985 4788899984                                     346999999


Q ss_pred             cCCCCCeeEEEEEecC--CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCC
Q 040294          241 SIHHRNLVKIISSCSN--EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPH  318 (360)
Q Consensus       241 ~l~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~  318 (360)
                      +++||||+++++++.+  ++..++||||+++++|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999986  5689999999999999886543  35889999999999999999999   889999999999


Q ss_pred             ceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          319 NVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       319 NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+++.++.+||+|||+++.......  ......||+.|+||
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP  206 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAP  206 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCG
T ss_pred             HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccCh
Confidence            99999999999999999987654332  23346799999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.96  E-value=2.5e-29  Score=233.75  Aligned_cols=156  Identities=28%  Similarity=0.442  Sum_probs=122.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.            +.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467889999999999999999864 689999984            4579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          266 YMTNGSLEKVLYSSN-----CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |++ |+|.+++....     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999886432     35888899999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  ......||+.|+||
T Consensus       160 ~~~~--~~~~~~~t~~y~aP  177 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAP  177 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCH
T ss_pred             CCcc--cCCCCcccccccCc
Confidence            3321  22345789999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.96  E-value=9e-30  Score=237.52  Aligned_cols=157  Identities=25%  Similarity=0.421  Sum_probs=132.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcE----EEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGME----FAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|+..+.||+|+||.||+|++. +++.    ||+|.            +..|+.++++++||||++++++|.. +..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence            46788899999999999999864 4444    67763            4579999999999999999999974 55889


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999876667888899999999999999999   889999999999999999999999999999987655


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..........||+.|+||
T Consensus       169 ~~~~~~~~~~~~~~y~aP  186 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMAL  186 (325)
T ss_dssp             TTCCC-----CCTTTSCH
T ss_pred             cccccccCCCCcccccCh
Confidence            433334456788999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.96  E-value=8e-30  Score=236.50  Aligned_cols=154  Identities=27%  Similarity=0.333  Sum_probs=131.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhc-CCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKS-IHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+             ..|+..+.+ .+||||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            46888999999999999999975 7999999853             224444444 48999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 67999998877667999999999999999999999   8899999999999999999999999999998764332 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......||++|+||
T Consensus       212 --~~~~~~gt~~y~aP  225 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAP  225 (311)
T ss_dssp             -----CCCCCGGGCCG
T ss_pred             --CCcccCCCccccCH
Confidence              22345699999998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.96  E-value=3.3e-30  Score=244.76  Aligned_cols=158  Identities=25%  Similarity=0.454  Sum_probs=134.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      ++|+..+.||+|+||.||+|++.      ++..||||.            +.+|+.++++++|||||++++++..++..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            46778899999999999999843      466899985            456999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC---cEEEee
Q 040294          262 LVLEYMTNGSLEKVLYSSN------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI---VAHLSD  332 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~---~~ki~D  332 (360)
                      +||||+++|+|.+++....      ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997543      35889999999999999999999   89999999999999999554   599999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+++.+.............||+.|+||
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aP  255 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPP  255 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred             CccccccccccccccCCCcCCcccEECH
Confidence            9999865432222223345789999998

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=1.3e-29  Score=237.82  Aligned_cols=154  Identities=27%  Similarity=0.455  Sum_probs=136.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|...+.||+|+||.||+|+. .+++.||||.              +.+|+++++.++||||+++++++..++..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35788899999999999999996 5789999983              45799999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+ +|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus        88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 78999988654 35889999999999999999999   8899999999999999999999999999998765432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                         .....+||+.|+||
T Consensus       163 ---~~~~~~gt~~y~aP  176 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAP  176 (336)
T ss_dssp             ---TTCCCTTSTTTSCG
T ss_pred             ---ccccccCCcCcCCH
Confidence               22345799999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=1.6e-29  Score=239.57  Aligned_cols=155  Identities=26%  Similarity=0.509  Sum_probs=136.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .++|+..+.||+|+||.||+|..+ +++.||+|.             +.+|++++++++|||||++++++.+++..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456888999999999999999864 789999984             346999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC---CcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN---IVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~---~~~ki~DFGla~~~~~  341 (360)
                      ||+++|+|.+.+... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+|||+++....
T Consensus       108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            999999999998754 45889999999999999999999   8899999999999999864   4599999999987653


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..   ......||+.|+||
T Consensus       184 ~~---~~~~~~gt~~y~aP  199 (362)
T 2bdw_A          184 SE---AWHGFAGTPGYLSP  199 (362)
T ss_dssp             CC---SCCCSCSCTTTCCH
T ss_pred             Cc---ccccCCCCccccCH
Confidence            32   22346799999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=245.72  Aligned_cols=157  Identities=25%  Similarity=0.422  Sum_probs=136.2

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ..++|+..+.||+|+||.||+|.. .+|+.||+|.             +.+|++++++++|||||++++++.+++..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            345788899999999999999985 4788999873             45799999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec---CCCcEEEeecccccccC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~---~~~~~ki~DFGla~~~~  340 (360)
                      |||+++|+|.+.+.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++   +++.+||+|||+++...
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999987653 5889999999999999999999   89999999999999998   56889999999998765


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  ......||++|+||
T Consensus       165 ~~~~--~~~~~~gt~~Y~AP  182 (444)
T 3soa_A          165 GEQQ--AWFGFAGTPGYLSP  182 (444)
T ss_dssp             TTCC--BCCCSCSCGGGCCH
T ss_pred             CCCc--eeecccCCcccCCH
Confidence            4432  22356799999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=6.4e-30  Score=248.93  Aligned_cols=156  Identities=29%  Similarity=0.390  Sum_probs=132.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.+              ..|+++++.++||||++++++|...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            45788899999999999999985 47899999853              3478889999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            9999999999999764 35889999999999999999999   7 89999999999999999999999999999864432


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ......+||++||||
T Consensus       303 ~--~~~~~~~gt~~y~aP  318 (446)
T 4ejn_A          303 G--ATMKTFCGTPEYLAP  318 (446)
T ss_dssp             ------CCSSSCGGGCCH
T ss_pred             C--cccccccCCccccCH
Confidence            2  223457899999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.96  E-value=3.2e-29  Score=245.47  Aligned_cols=155  Identities=26%  Similarity=0.473  Sum_probs=138.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|...+.||+|+||.||+|+.. +|+.||||.              +.+|+++++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            356888899999999999999965 799999984              34689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        95 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            9999999999999754 46899999999999999999999   8999999999999999999999999999999865432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                         .....+||+.|+||
T Consensus       171 ---~~~~~~gt~~y~aP  184 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAP  184 (476)
T ss_dssp             ---CBCCCCSCSTTCCH
T ss_pred             ---cccccCCCcCeECh
Confidence               22346799999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=1.6e-29  Score=238.58  Aligned_cols=156  Identities=26%  Similarity=0.449  Sum_probs=135.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      +.|+..+.||+|+||.||+|+.+ +++.||||.                +.+|+++++.++|||||++++++.+++..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            45888899999999999999864 789999984                3579999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc---EEEeecccc
Q 040294          263 VLEYMTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV---AHLSDFGIA  336 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~---~ki~DFGla  336 (360)
                      ||||+++|+|.+.+...   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998887542   335789999999999999999999   899999999999999986554   999999999


Q ss_pred             cccCCCCCceeeecccccCcccCC
Q 040294          337 KLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +......  ......+||+.|+||
T Consensus       181 ~~~~~~~--~~~~~~~gt~~y~aP  202 (351)
T 3c0i_A          181 IQLGESG--LVAGGRVGTPHFMAP  202 (351)
T ss_dssp             EECCTTS--CBCCCCCSCGGGCCH
T ss_pred             eEecCCC--eeecCCcCCcCccCH
Confidence            8875432  123346799999998

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=240.59  Aligned_cols=150  Identities=27%  Similarity=0.480  Sum_probs=128.4

Q ss_pred             CCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          205 NNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      .+.||+|+||.||+|+. .+|+.||+|.           +.+|++++++++|||||+++++|...+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56799999999999986 4789999983           46799999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee--cCCCcEEEeecccccccCCCCCceeeec
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL--DDNIVAHLSDFGIAKLLTGEDQSMTQTQ  350 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl--~~~~~~ki~DFGla~~~~~~~~~~~~~~  350 (360)
                      .+++......+++..+..++.|++.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++.+....   ....
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~  247 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKV  247 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cccc
Confidence            9999776667899999999999999999999   8899999999999999  567899999999999875433   2234


Q ss_pred             ccccCcccCC
Q 040294          351 TLATIGYMAP  360 (360)
Q Consensus       351 ~~gt~~Y~aP  360 (360)
                      ..||++|+||
T Consensus       248 ~~gt~~y~aP  257 (373)
T 2x4f_A          248 NFGTPEFLAP  257 (373)
T ss_dssp             CCSSCTTCCH
T ss_pred             ccCCCcEeCh
Confidence            5799999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.6e-29  Score=237.19  Aligned_cols=159  Identities=25%  Similarity=0.456  Sum_probs=137.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc------cCCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCe
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDF  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~  259 (360)
                      .++|...+.||+|+||.||+|+.      .++..||||.            +.+|+++++++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            45788889999999999999985      2456799974            45799999999 89999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCC
Q 040294          260 RALVLEYMTNGSLEKVLYSSNC----------------------ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP  317 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~  317 (360)
                      .++||||+++|+|.+++.....                      .+++..+..++.|++.||+|||   +.+|+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence            9999999999999999976532                      3788899999999999999999   89999999999


Q ss_pred             CceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       318 ~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +||+++.++.+||+|||+++...............||+.|+||
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  243 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  243 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence            9999999999999999999876544433334456688999998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.96  E-value=2e-29  Score=238.84  Aligned_cols=155  Identities=26%  Similarity=0.351  Sum_probs=128.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .++|+..+.||+|+||.||+++.. +++.||||.          +.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            457888999999999999999965 789999984          457999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc--EEEeecccccccCCCCCc
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV--AHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~--~ki~DFGla~~~~~~~~~  345 (360)
                      ++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||+++......  
T Consensus        99 ~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--  172 (361)
T 3uc3_A           99 SGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  172 (361)
T ss_dssp             CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence            9999999987543 5889999999999999999999   899999999999999987765  9999999998543222  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       .....+||+.|+||
T Consensus       173 -~~~~~~gt~~y~aP  186 (361)
T 3uc3_A          173 -QPKSTVGTPAYIAP  186 (361)
T ss_dssp             ---------CTTSCH
T ss_pred             -CCCCCcCCCCcCCh
Confidence             22345799999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.4e-29  Score=241.68  Aligned_cols=158  Identities=28%  Similarity=0.460  Sum_probs=136.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc--------CCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ--------DGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNED  258 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~  258 (360)
                      ++|...+.||+|+||.||+|+..        ++..||||.            +.+|+++++++ +|||||+++++|..++
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            56778899999999999999852        235799974            45799999999 8999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec
Q 040294          259 FRALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD  323 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~  323 (360)
                      ..++||||+++|+|.+++....               ..+++..+..++.|++.||+|||   +.+|+||||||+|||++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEc
Confidence            9999999999999999997643               34899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          324 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       324 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .++.+||+|||+++...............||+.|+||
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  262 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  262 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence            9999999999999977544322333445688999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.96  E-value=2.1e-29  Score=233.09  Aligned_cols=159  Identities=26%  Similarity=0.450  Sum_probs=137.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc------cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      .++|...+.||+|+||.||+|+.      .+++.||||.            +.+|++++++++||||+++++++..++..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            35677889999999999999985      2457899984            35699999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCC
Q 040294          261 ALVLEYMTNGSLEKVLYSSN-----------------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKP  317 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~  317 (360)
                      ++||||+++|+|.+++....                       ..+++..+..++.|++.||+|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            99999999999999997643                       23788899999999999999999   88999999999


Q ss_pred             CceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          318 HNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       318 ~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +||+++.++.+||+|||+++...............+|+.|+||
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  221 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI  221 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence            9999999999999999999877554433333445678899998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=4.1e-29  Score=233.38  Aligned_cols=154  Identities=27%  Similarity=0.441  Sum_probs=136.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      +.|+..+.||+|+||.||+|+.. +++.||+|.                 +.+|++++++++||||+++++++.+++..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45788899999999999999965 688999973                 457999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC----cEEEeeccccc
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI----VAHLSDFGIAK  337 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~----~~ki~DFGla~  337 (360)
                      +||||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||+++
T Consensus        91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            999999999999999654 46889999999999999999999   89999999999999999877    89999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+....   ......||+.|+||
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aP  186 (326)
T 2y0a_A          167 KIDFGN---EFKNIFGTPEFVAP  186 (326)
T ss_dssp             ECCTTS---CCCCCCSCTTTCCH
T ss_pred             ECCCCC---ccccccCCcCcCCc
Confidence            865332   12345799999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.96  E-value=2.5e-29  Score=233.77  Aligned_cols=155  Identities=29%  Similarity=0.473  Sum_probs=135.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCC--eEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNED--FRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~  264 (360)
                      +.|...+.||+|+||.||+|+.. +++.||||.            +.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            45788899999999999999965 689999984            347999999999999999999987655  789999


Q ss_pred             EccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee----cCCCcEEEeecccccc
Q 040294          265 EYMTNGSLEKVLYSSNC--ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKL  338 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl----~~~~~~ki~DFGla~~  338 (360)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976432  3899999999999999999999   8899999999999999    7888999999999998


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ......   .....||+.|+||
T Consensus       166 ~~~~~~---~~~~~gt~~y~aP  184 (319)
T 4euu_A          166 LEDDEQ---FVSLYGTEEYLHP  184 (319)
T ss_dssp             CCTTCC---BCCCCSCGGGCCH
T ss_pred             cCCCCc---eeecccCCCccCH
Confidence            754432   2345799999998

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.96  E-value=1e-29  Score=237.38  Aligned_cols=157  Identities=27%  Similarity=0.446  Sum_probs=131.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcE----EEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGME----FAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|+..+.||+|+||.||+|++. +++.    ||+|.            +.+|++++++++||||++++++|..++ .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            46888899999999999999854 4443    57763            456999999999999999999998865 789


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      |+||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999999999887778999999999999999999999   889999999999999999999999999999987655


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..........||+.|+||
T Consensus       171 ~~~~~~~~~~~t~~y~aP  188 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             CC-------CCCGGGSCH
T ss_pred             cccccccCCCccccccCh
Confidence            433334455678899998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.96  E-value=1.7e-29  Score=249.12  Aligned_cols=158  Identities=29%  Similarity=0.524  Sum_probs=138.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .++|+..+.||+|+||.||+|++. ++..||||.          |.+|++++++++|||||+++++|..++..++|||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            346778899999999999999976 488999984          567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          268 TNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       268 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.... ..
T Consensus       299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~  374 (495)
T 1opk_A          299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YT  374 (495)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EE
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-ee
Confidence            999999999864 345889999999999999999999   8999999999999999999999999999999875433 22


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......+|+.|+||
T Consensus       375 ~~~~~~~~~~y~aP  388 (495)
T 1opk_A          375 AHAGAKFPIKWTAP  388 (495)
T ss_dssp             CCTTCCCCGGGCCH
T ss_pred             ecCCCcCCcceeCH
Confidence            22345578899998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.96  E-value=2.6e-29  Score=245.30  Aligned_cols=157  Identities=27%  Similarity=0.442  Sum_probs=122.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC-----CCe
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN-----EDF  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~-----~~~  259 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.             +.+|++++++++|||||+++++|..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367899999999999999999864 789999984             3469999999999999999999943     357


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .|+||||+ +|+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 57999998754 46889999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCc-------------------------eeeecccccCcccCC
Q 040294          340 TGEDQS-------------------------MTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~-------------------------~~~~~~~gt~~Y~aP  360 (360)
                      ......                         ...+..+||++||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP  252 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP  252 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCH
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccCh
Confidence            432110                         122456789999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.96  E-value=4e-29  Score=234.43  Aligned_cols=156  Identities=28%  Similarity=0.417  Sum_probs=137.7

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------------hHHHHHHhhcCCCCCeeEEEEEecCC
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------------FDVECEVMKSIHHRNLVKIISSCSNE  257 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------------~~~E~~~l~~l~hpniv~l~~~~~~~  257 (360)
                      ..++|+..+.||+|+||.||+|+. .+++.||||.                   +..|++++++++||||++++++|.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            345788999999999999999985 5788999984                   34599999999999999999999999


Q ss_pred             CeEEEEEEccCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          258 DFRALVLEYMTNG-SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       258 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                      +..++||||+.+| +|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 999999764 35889999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCCceeeecccccCcccCC
Q 040294          337 KLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.+.....   .....||+.|+||
T Consensus       178 ~~~~~~~~---~~~~~gt~~y~aP  198 (335)
T 3dls_A          178 AYLERGKL---FYTFCGTIEYCAP  198 (335)
T ss_dssp             EECCTTCC---BCEECSCGGGCCH
T ss_pred             eECCCCCc---eeccCCCccccCh
Confidence            98754332   2345799999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=1.5e-29  Score=232.48  Aligned_cols=158  Identities=29%  Similarity=0.496  Sum_probs=131.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-----cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCC--CeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-----QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNE--DFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~  261 (360)
                      ++|+..+.||+|+||.||+|++     .+++.||||.           +.+|++++++++||||++++++|...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            4677889999999999999984     3688999984           46799999999999999999998653  4589


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            999999999999999876666899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCc-eeeecccccCcccCC
Q 040294          342 EDQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~-~~~~~~~gt~~Y~aP  360 (360)
                      .... .......+|..|+||
T Consensus       167 ~~~~~~~~~~~~~~~~y~aP  186 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAP  186 (295)
T ss_dssp             ---------CTTCGGGGCCH
T ss_pred             CcceeeeccCCCCccceeCc
Confidence            3321 122334578889998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.96  E-value=6.5e-29  Score=253.30  Aligned_cols=157  Identities=26%  Similarity=0.324  Sum_probs=137.1

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhhcC-CCCCeeEEEEEecCCCeEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMKSI-HHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  261 (360)
                      ..++|+..++||+|+||.||+|+.+ +++.||||.+              ..|..++..+ +||+|+++++++++.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4567899999999999999999965 6888999853              3477788877 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999997643 5889999999999999999999   89999999999999999999999999999996443


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..  ......+||+.||||
T Consensus       495 ~~--~~~~~~~GT~~Y~AP  511 (674)
T 3pfq_A          495 DG--VTTKTFCGTPDYIAP  511 (674)
T ss_dssp             TT--CCBCCCCSCSSSCCH
T ss_pred             CC--cccccccCCCcccCH
Confidence            32  223457899999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.96  E-value=5.8e-29  Score=228.74  Aligned_cols=159  Identities=28%  Similarity=0.444  Sum_probs=132.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehhh--------HHHHHHhhc--CCCCCeeEEEEEecC----CCeEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF--------DVECEVMKS--IHHRNLVKIISSCSN----EDFRALVL  264 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~--------~~E~~~l~~--l~hpniv~l~~~~~~----~~~~~lv~  264 (360)
                      .++|+..+.||+|+||.||+|+. +++.||||.+        ..|.+++..  ++||||+++++++..    ....++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence            45788899999999999999988 6889999854        346666655  899999999998653    35689999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG-----FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      ||+++|+|.+++..  ..+++..+..++.|++.||+|||..     ++.+|+||||||+|||++.++.+||+|||+++..
T Consensus        86 e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  163 (301)
T 3q4u_A           86 HYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH  163 (301)
T ss_dssp             CCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             hhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence            99999999999954  3589999999999999999999932     2678999999999999999999999999999876


Q ss_pred             CCCCCce--eeecccccCcccCC
Q 040294          340 TGEDQSM--TQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~--~~~~~~gt~~Y~aP  360 (360)
                      .......  ......||+.|+||
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aP  186 (301)
T 3q4u_A          164 SQSTNQLDVGNNPRVGTKRYMAP  186 (301)
T ss_dssp             ETTTTEEECCCCCCCCCGGGCCH
T ss_pred             ccccccccccccccccccceeCh
Confidence            5443221  12234799999998

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.96  E-value=2.5e-29  Score=232.52  Aligned_cols=158  Identities=27%  Similarity=0.468  Sum_probs=137.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEc------cCCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  260 (360)
                      ++|+..+.||+|+||.||+|+.      .+++.||||.            +.+|+++++++ +||||+++++++..++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            5678889999999999999984      3567899984            45799999999 899999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec
Q 040294          261 ALVLEYMTNGSLEKVLYSSNC-----------------ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD  323 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~  323 (360)
                      ++||||+++|+|.+++.....                 .+++..+..++.|++.||+|||   +.+|+||||||+||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEc
Confidence            999999999999999976532                 3889999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          324 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       324 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .++.+||+|||+++...............||+.|+||
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  216 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence            9999999999999887654433333445688899998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.96  E-value=5.8e-29  Score=232.80  Aligned_cols=159  Identities=27%  Similarity=0.496  Sum_probs=135.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc--------cCCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL--------QDGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNE  257 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~--------~~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~  257 (360)
                      .++|...+.||+|+||.||+|+.        .++..||||.            +.+|+++++++ +||||++++++|..+
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            35688889999999999999985        3467899984            45689999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL  322 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl  322 (360)
                      +..++||||+++|+|.+++....               ..+++..+..++.|++.||+|||   +.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            99999999999999999997643               23788999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          323 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       323 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.++.+||+|||+++...............+|+.|+||
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  228 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  228 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence            99999999999999877654332233345678899998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.96  E-value=6.8e-29  Score=225.96  Aligned_cols=157  Identities=29%  Similarity=0.494  Sum_probs=128.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.              +.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35688899999999999999986 5789999984              34689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999876667899999999999999999999   8899999999999999999999999999998765332


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ......||+.|+||
T Consensus       167 ~--~~~~~~~~~~y~aP  181 (278)
T 3cok_A          167 E--KHYTLCGTPNYISP  181 (278)
T ss_dssp             -----------------
T ss_pred             C--cceeccCCCCcCCc
Confidence            1  12345789999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.96  E-value=1.3e-29  Score=247.22  Aligned_cols=157  Identities=24%  Similarity=0.484  Sum_probs=135.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .++|+..+.||+|+||.||+|++.++..||||.          |.+|++++++++|||||++++++. .+..++||||++
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            456788899999999999999998888999983          568999999999999999999987 556899999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          269 NGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       269 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~  341 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTA  341 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHT
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eec
Confidence            999999997542 25788889999999999999999   8899999999999999999999999999999764321 111


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....+|+.|+||
T Consensus       342 ~~~~~~~~~y~aP  354 (454)
T 1qcf_A          342 REGAKFPIKWTAP  354 (454)
T ss_dssp             TCSSSSCGGGSCH
T ss_pred             cCCCcccccccCH
Confidence            2334578899998

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.96  E-value=6.1e-29  Score=228.85  Aligned_cols=157  Identities=25%  Similarity=0.488  Sum_probs=136.1

Q ss_pred             CCCCCCeeccCCCccEEEEEc-----cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCC--CeEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-----QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNE--DFRA  261 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~  261 (360)
                      .|+..+.||+|+||.||+|++     .+++.||||.            +.+|++++++++||||+++++++...  +..+
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  101 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK  101 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence            467789999999999999983     4688999984            45799999999999999999999877  6689


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  178 (302)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence            999999999999999766667899999999999999999999   89999999999999999999999999999998765


Q ss_pred             CCCc-eeeecccccCcccCC
Q 040294          342 EDQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~-~~~~~~~gt~~Y~aP  360 (360)
                      .... .......||..|+||
T Consensus       179 ~~~~~~~~~~~~~~~~y~aP  198 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAP  198 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCH
T ss_pred             CCcceeccCCCCCCccccCC
Confidence            4322 223345688899998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.96  E-value=3.8e-29  Score=235.85  Aligned_cols=155  Identities=26%  Similarity=0.438  Sum_probs=125.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .+.|+..+.||+|+||.||+|+.. +++.||||.         +.+|++++++++||||++++++|...+..++||||++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            467888999999999999999975 678899984         4569999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEeecccccccCCCCCc
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++......  
T Consensus       132 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--  205 (349)
T 2w4o_A          132 GGELFDRIVEK-GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--  205 (349)
T ss_dssp             SCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--
Confidence            99999999754 45889999999999999999999   889999999999999975   8899999999998764322  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.|+||
T Consensus       206 -~~~~~~gt~~y~aP  219 (349)
T 2w4o_A          206 -LMKTVCGTPGYCAP  219 (349)
T ss_dssp             --------CGGGSCH
T ss_pred             -ccccccCCCCccCH
Confidence             22346799999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=3.5e-29  Score=228.43  Aligned_cols=156  Identities=27%  Similarity=0.444  Sum_probs=123.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC----CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD----GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..+.||+|+||.||+|+...    +..||+|.            +.+|+.++++++||||+++++++.+ +..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccEEE
Confidence            467788999999999999998642    45688874            4579999999999999999999854 568999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence            9999999999999877667899999999999999999999   8899999999999999999999999999998765432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      . .......+|+.|+||
T Consensus       171 ~-~~~~~~~~~~~y~aP  186 (281)
T 1mp8_A          171 Y-YKASKGKLPIKWMAP  186 (281)
T ss_dssp             ---------CCGGGCCH
T ss_pred             c-cccccCCCcccccCh
Confidence            1 122334578899998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=2.7e-29  Score=226.96  Aligned_cols=157  Identities=28%  Similarity=0.459  Sum_probs=138.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|+..+++.||+|.          +.+|++++++++||||+++++++.+++..++||||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH   87 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence            46778899999999999999988888999984          46799999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      ++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus        88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~  163 (267)
T 3t9t_A           88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSST  163 (267)
T ss_dssp             CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTT
T ss_pred             CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccccc
Confidence            9999999877667899999999999999999999   8899999999999999999999999999998764321 11222


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.|+||
T Consensus       164 ~~~~~~~y~aP  174 (267)
T 3t9t_A          164 GTKFPVKWASP  174 (267)
T ss_dssp             STTCCGGGCCH
T ss_pred             cccccccccCh
Confidence            34578889998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.96  E-value=1.3e-28  Score=229.87  Aligned_cols=150  Identities=28%  Similarity=0.408  Sum_probs=119.5

Q ss_pred             CCeeccCCCccEEEEEcc-CCcEEEehh--------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEccCCCCHHH
Q 040294          205 NNLIGRGSFGSVYKARLQ-DGMEFAIKS--------FDVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEYMTNGSLEK  274 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~  274 (360)
                      .+.||+|+||.||+|+.. +++.||||.        +.+|+++++.+. ||||+++++++.+++..++||||+++|+|.+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE   95 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence            478999999999999965 789999984        356899999997 9999999999999999999999999999999


Q ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC---cEEEeecccccccCCCCCceeeecc
Q 040294          275 VLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI---VAHLSDFGIAKLLTGEDQSMTQTQT  351 (360)
Q Consensus       275 ~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~---~~ki~DFGla~~~~~~~~~~~~~~~  351 (360)
                      ++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||+++.......  .....
T Consensus        96 ~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~  169 (325)
T 3kn6_A           96 RIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTP  169 (325)
T ss_dssp             HHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--ccccc
Confidence            99765 46899999999999999999999   89999999999999997665   899999999987654322  23456


Q ss_pred             cccCcccCC
Q 040294          352 LATIGYMAP  360 (360)
Q Consensus       352 ~gt~~Y~aP  360 (360)
                      +||+.|+||
T Consensus       170 ~~t~~y~aP  178 (325)
T 3kn6_A          170 CFTLHYAAP  178 (325)
T ss_dssp             ---------
T ss_pred             CCCcCccCH
Confidence            789999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.96  E-value=1.4e-29  Score=234.60  Aligned_cols=158  Identities=23%  Similarity=0.462  Sum_probs=127.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCC----e
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNED----F  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~----~  259 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.              +.+|++++++++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            35788899999999999999995 5789999984              357889999999999999999987654    3


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .++||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999997543 5889999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCc-eeeecccccCcccCC
Q 040294          340 TGEDQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~-~~~~~~~gt~~Y~aP  360 (360)
                      ...... .......||+.|+||
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aP  188 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSP  188 (311)
T ss_dssp             ---------------CCTTCCH
T ss_pred             cccccccccccccCcCcccCCH
Confidence            543221 122345799999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.4e-29  Score=237.78  Aligned_cols=157  Identities=29%  Similarity=0.426  Sum_probs=137.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc----cCCcEEEehhh---------------HHHHHHhhcC-CCCCeeEEEEEecCCC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL----QDGMEFAIKSF---------------DVECEVMKSI-HHRNLVKIISSCSNED  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~---------------~~E~~~l~~l-~hpniv~l~~~~~~~~  258 (360)
                      .++|+..+.||+|+||.||+|+.    .+++.||||.+               ..|+++++++ +||||+++++++..++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35788899999999999999986    37889999853               3599999999 6999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999997643 5888999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.... .......+||+.|+||
T Consensus       209 ~~~~~-~~~~~~~~gt~~y~aP  229 (355)
T 1vzo_A          209 FVADE-TERAYDFCGTIEYMAP  229 (355)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCH
T ss_pred             cccCC-CCcccCcccCcCccCh
Confidence            64322 1223346799999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.96  E-value=6.1e-29  Score=233.83  Aligned_cols=156  Identities=28%  Similarity=0.477  Sum_probs=135.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------HHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------DVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      .++|+..+.||+|+||.||+|+.+ +++.||||.+       ..|++++.++ +||||+++++++.+++..++||||+++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g  100 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG  100 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence            456888999999999999999965 7889999854       5789988887 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC----CcEEEeecccccccCCCCCc
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN----IVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~----~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+.++    +.+||+|||+++....... 
T Consensus       101 g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-  175 (342)
T 2qr7_A          101 GELLDKILRQ-KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-  175 (342)
T ss_dssp             CBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-
Confidence            9999999764 45889999999999999999999   8899999999999998432    3599999999997654332 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       .....+||+.|+||
T Consensus       176 -~~~~~~gt~~y~aP  189 (342)
T 2qr7_A          176 -LLMTPCYTANFVAP  189 (342)
T ss_dssp             -CBCCSSCCSSCCCH
T ss_pred             -ceeccCCCccccCH
Confidence             22346799999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.96  E-value=8e-29  Score=236.75  Aligned_cols=159  Identities=19%  Similarity=0.284  Sum_probs=137.2

Q ss_pred             hCCCCCCCeeccC--CCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSANNLIGRG--SFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G--~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      .++|+..+.||+|  +||.||+|+.. +++.||||.             +.+|+++++.++|||||+++++|.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4568889999999  99999999965 789999984             3459999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          263 VLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      |||||++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999764 245899999999999999999999   89999999999999999999999999999876432


Q ss_pred             CCCc-----eeeecccccCcccCC
Q 040294          342 EDQS-----MTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~-----~~~~~~~gt~~Y~aP  360 (360)
                      ....     ......+||+.|+||
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aP  204 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSP  204 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCH
T ss_pred             ccccccccccccccccccccccCH
Confidence            2110     111234789999998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.95  E-value=5.9e-29  Score=234.50  Aligned_cols=150  Identities=32%  Similarity=0.432  Sum_probs=134.1

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .|+..+.||+|+||.||+|+. .+++.||||.              +.+|++++++++|||||+++++|..++..++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            477889999999999999995 5789999984              3579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+. |+|.+.+......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            997 6888888765667899999999999999999999   889999999999999999999999999999876432   


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                         ....||+.|+||
T Consensus       208 ---~~~~gt~~y~aP  219 (348)
T 1u5q_A          208 ---NSFVGTPYWMAP  219 (348)
T ss_dssp             ---CCCCSCGGGCCH
T ss_pred             ---CcccCCcceeCH
Confidence               235799999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=7.4e-29  Score=240.51  Aligned_cols=157  Identities=28%  Similarity=0.445  Sum_probs=132.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCC-----Ce
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNE-----DF  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~-----~~  259 (360)
                      .++|...+.||+|+||.||+|+.. +++.||||.             +.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            467888999999999999999864 688899984             34799999999999999999999876     57


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .|+||||++ |+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 5999999754 45899999999999999999999   889999999999999999999999999999986


Q ss_pred             CCCCCc--------------------eeeecccccCcccCC
Q 040294          340 TGEDQS--------------------MTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~--------------------~~~~~~~gt~~Y~aP  360 (360)
                      ......                    ...+..+||++|+||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  220 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP  220 (432)
T ss_dssp             -------------------------------CCCCCTTCCH
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCH
Confidence            543211                    112456899999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=6.3e-29  Score=233.87  Aligned_cols=157  Identities=31%  Similarity=0.520  Sum_probs=135.1

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh----------------HHHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF----------------DVECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~----------------~~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||.+                .+|++++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4567999999999999999999975 6899999854                3689999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||+++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999999986 899998876667888889999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  ......||+.|+||
T Consensus       164 ~~~~--~~~~~~~t~~y~aP  181 (346)
T 1ua2_A          164 SPNR--AYTHQVVTRWYRAP  181 (346)
T ss_dssp             SCCC--CCCCSCCCCTTCCH
T ss_pred             CCcc--cCCcccccccccCc
Confidence            3321  23346799999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=4.3e-29  Score=232.91  Aligned_cols=155  Identities=25%  Similarity=0.446  Sum_probs=131.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|...+.||+|+||.||+|+.. +++.||||.+            .+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888899999999999999965 7899999854            3589999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++ |+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            97 5999999877777899999999999999999999   8999999999999999999999999999998654332  1


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.|+||
T Consensus       156 ~~~~~~~t~~y~aP  169 (324)
T 3mtl_A          156 TYDNEVVTLWYRPP  169 (324)
T ss_dssp             -------CGGGCCH
T ss_pred             ccccccCcccccCh
Confidence            23345789999998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.95  E-value=5.4e-29  Score=234.02  Aligned_cols=155  Identities=25%  Similarity=0.396  Sum_probs=130.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCCC--CCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIHH--RNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~  264 (360)
                      +.|+..+.||+|+||.||++...+++.||||.             +.+|++++++++|  |||+++++++..++..++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            45888899999999999999988899999984             4569999999987  99999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      | +.+|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus        89 e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             C-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             e-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            9 5688999999865 46888899999999999999999   88999999999999997 57899999999998754433


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                      .......+||+.|+||
T Consensus       163 ~~~~~~~~gt~~y~aP  178 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPP  178 (343)
T ss_dssp             -------CCCCSSCCH
T ss_pred             cccCCCCcCCcCcCCH
Confidence            3333456799999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.95  E-value=3.7e-29  Score=237.08  Aligned_cols=158  Identities=20%  Similarity=0.312  Sum_probs=130.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccC------CcEEEehhh-------HH---------------HHHHhhcCCCCCeeEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQD------GMEFAIKSF-------DV---------------ECEVMKSIHHRNLVKI  250 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~-------~~---------------E~~~l~~l~hpniv~l  250 (360)
                      .++|+..+.||+|+||.||+|++..      ++.||||.+       ..               |+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578899999999999999998754      478999852       22               3445667889999999


Q ss_pred             EEEecCC----CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec--C
Q 040294          251 ISSCSNE----DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD--D  324 (360)
Q Consensus       251 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~--~  324 (360)
                      ++++...    ...++||||+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9998764    4689999999 99999999877677999999999999999999999   88999999999999999  8


Q ss_pred             CCcEEEeecccccccCCCCCc-----eeeecccccCcccCC
Q 040294          325 NIVAHLSDFGIAKLLTGEDQS-----MTQTQTLATIGYMAP  360 (360)
Q Consensus       325 ~~~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aP  360 (360)
                      ++.+||+|||+++.+......     .......||+.||||
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  230 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI  230 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCH
Confidence            899999999999876533211     111345699999998

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.95  E-value=4.3e-29  Score=232.28  Aligned_cols=159  Identities=25%  Similarity=0.482  Sum_probs=121.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCC-c---EEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeE-
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDG-M---EFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFR-  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~-~---~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~-  260 (360)
                      .++|+..+.||+|+||.||+|+.... .   .||||.             +.+|++++++++||||+++++++...+.. 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            45788999999999999999997533 2   789984             45699999999999999999999887655 


Q ss_pred             -----EEEEEccCCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEE
Q 040294          261 -----ALVLEYMTNGSLEKVLYSSN-----CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL  330 (360)
Q Consensus       261 -----~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki  330 (360)
                           ++||||+++|+|.+++....     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999986421     25889999999999999999999   889999999999999999999999


Q ss_pred             eecccccccCCCCCceeeecccccCcccCC
Q 040294          331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       331 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|||+++...............+|+.|+||
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  208 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLAL  208 (323)
T ss_dssp             CCCCC-----------------CCGGGCCH
T ss_pred             eeccccccccccccccccccccCcccccCc
Confidence            999999876544332333345678899998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.95  E-value=2.7e-28  Score=223.90  Aligned_cols=158  Identities=19%  Similarity=0.273  Sum_probs=138.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh---------hHHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS---------FDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~---------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.         +.+|+++++++ +|+|++++++++..+...++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            35688899999999999999995 5789999984         56799999999 7999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc-----EEEeecccccccCCC
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV-----AHLSDFGIAKLLTGE  342 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~-----~ki~DFGla~~~~~~  342 (360)
                       +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||+++.....
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence             99999999876667999999999999999999999   899999999999999987776     999999999887544


Q ss_pred             CCc-----eeeecccccCcccCC
Q 040294          343 DQS-----MTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~-----~~~~~~~gt~~Y~aP  360 (360)
                      ...     .......||+.|+||
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aP  187 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSI  187 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             cccccccccCccCCCCCcccCCc
Confidence            221     123456799999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.95  E-value=3.4e-29  Score=244.24  Aligned_cols=157  Identities=28%  Similarity=0.508  Sum_probs=130.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .++|+..+.||+|+||.||+|++.++..||||.          |.+|++++++++||||+++++++.+ +..++||||++
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            356778899999999999999998888899983          5689999999999999999999977 66899999999


Q ss_pred             CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          269 NGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       269 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~  337 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA  337 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eec
Confidence            99999999753 245889999999999999999999   8999999999999999999999999999998765432 122


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....+|+.|+||
T Consensus       338 ~~~~~~~~~y~aP  350 (452)
T 1fmk_A          338 RQGAKFPIKWTAP  350 (452)
T ss_dssp             -----CCGGGSCH
T ss_pred             ccCCcccccccCH
Confidence            2345578899998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.95  E-value=1.1e-28  Score=236.31  Aligned_cols=154  Identities=24%  Similarity=0.398  Sum_probs=131.1

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCC--CCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIH--HRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .|+..+.||+|+||.||+|...+++.||||.             +.+|++++++++  |||||++++++..++..++|||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            4888899999999999999988899999984             357999999997  5999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                       +.+++|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++ ++.+||+|||+++.+......
T Consensus       137 -~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          137 -CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             -CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             -cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence             56889999998654 6788889999999999999999   89999999999999996 589999999999987544322


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      ......+||+.||||
T Consensus       211 ~~~~~~~gt~~y~aP  225 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPP  225 (390)
T ss_dssp             ---CCSCCCGGGCCH
T ss_pred             ccCCCCCcCCCccCh
Confidence            233456799999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=7.3e-29  Score=227.03  Aligned_cols=155  Identities=32%  Similarity=0.493  Sum_probs=131.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +.|...+.||+|+||.||+|+. .++..+|+|.            +.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            4578889999999999999986 4688999873            46799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee---cCCCcEEEeecccccccC
Q 040294          267 MTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       267 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl---~~~~~~ki~DFGla~~~~  340 (360)
                      +++|+|.+.+...   ...+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988542   356899999999999999999999   8899999999999999   456889999999998765


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...   ......||+.|+||
T Consensus       179 ~~~---~~~~~~~t~~y~aP  195 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAP  195 (285)
T ss_dssp             -----------CTTGGGCCH
T ss_pred             Ccc---cCcCcccccCcCCh
Confidence            432   23345799999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.95  E-value=6e-29  Score=227.96  Aligned_cols=156  Identities=28%  Similarity=0.472  Sum_probs=122.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .+.|+..+.||+|+||.||+|+...  .||||.             +.+|++++++++||||+++++++.. +..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-CccEEEEE
Confidence            3568888999999999999998753  588863             5679999999999999999997654 45799999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999877777999999999999999999999   889999999999999999999999999999876543322


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      .......||+.|+||
T Consensus       177 ~~~~~~~gt~~y~aP  191 (289)
T 3og7_A          177 HQFEQLSGSILWMAP  191 (289)
T ss_dssp             -------CCCTTCCH
T ss_pred             ccccccCCCccccCc
Confidence            233456799999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.95  E-value=4.6e-29  Score=231.89  Aligned_cols=160  Identities=24%  Similarity=0.442  Sum_probs=136.4

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      ..++|+..+.||+|+||.||+|+..      +++.||||.            +.+|++++++++||||+++++++.+++.
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            3457888899999999999999854      367899984            4579999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEE
Q 040294          260 RALVLEYMTNGSLEKVLYSSN---------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL  330 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki  330 (360)
                      .++||||+++|+|.+++....         ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEE
Confidence            999999999999999987421         34688899999999999999999   889999999999999999999999


Q ss_pred             eecccccccCCCCCceeeecccccCcccCC
Q 040294          331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       331 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|||+++...............||+.|+||
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSP  209 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             CcCccccccccccccccccCCCCCCCccCh
Confidence            999999876543322222344678899998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.95  E-value=7.7e-29  Score=238.05  Aligned_cols=155  Identities=28%  Similarity=0.431  Sum_probs=125.3

Q ss_pred             CCCCCC-CeeccCCCccEEEEEcc-CCcEEEehhh------HHHHHHh-hcCCCCCeeEEEEEecC----CCeEEEEEEc
Q 040294          200 NGFSAN-NLIGRGSFGSVYKARLQ-DGMEFAIKSF------DVECEVM-KSIHHRNLVKIISSCSN----EDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~------~~E~~~l-~~l~hpniv~l~~~~~~----~~~~~lv~e~  266 (360)
                      ++|... ++||+|+||.||+|+.. +++.||||.+      .+|++++ +..+||||++++++|..    .+..++||||
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~  140 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC  140 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence            455554 68999999999999864 7889999854      5788876 45689999999998865    5678999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEeecccccccCCC
Q 040294          267 MTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       267 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~DFGla~~~~~~  342 (360)
                      |++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            99999999998653 35899999999999999999999   889999999999999997   789999999999976532


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .   .....+||+.|+||
T Consensus       218 ~---~~~~~~gt~~y~aP  232 (400)
T 1nxk_A          218 N---SLTTPCYTPYYVAP  232 (400)
T ss_dssp             ------------CTTCCG
T ss_pred             C---ccccCCCCCCccCH
Confidence            2   23456799999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.95  E-value=3.1e-28  Score=222.60  Aligned_cols=152  Identities=30%  Similarity=0.517  Sum_probs=133.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh------------------hHHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------------FDVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~------------------~~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||+|.                  +.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            35688889999999999999996 4789999984                  346999999999999999999998776 


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCceeecCCCc-----EEEee
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP--IIHCDLKPHNVLLDDNIV-----AHLSD  332 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--iiHrdlk~~NiLl~~~~~-----~ki~D  332 (360)
                       ++||||+++|+|.+.+......+++..+..++.|++.||+|||   +.+  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             6999999999999999877778999999999999999999999   778  999999999999987776     99999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+++....     ......||+.|+||
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aP  195 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAP  195 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCG
T ss_pred             CCccccccc-----cccccCCCccccCc
Confidence            999985432     23346799999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=1.3e-28  Score=224.29  Aligned_cols=154  Identities=27%  Similarity=0.471  Sum_probs=133.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+.. ++..||||.              +.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467888999999999999999865 677899984              34689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            9999999999998754 35888999999999999999999   8999999999999999999999999999987644322


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                          .....||+.|+||
T Consensus       164 ----~~~~~~~~~y~aP  176 (279)
T 3fdn_A          164 ----RTDLCGTLDYLPP  176 (279)
T ss_dssp             --------CCCCTTCCH
T ss_pred             ----ccccCCCCCccCH
Confidence                2345799999998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.95  E-value=1.2e-28  Score=230.53  Aligned_cols=156  Identities=35%  Similarity=0.508  Sum_probs=127.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehhh--------HH--HHHHhhcCCCCCeeEEEEEec-----CCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF--------DV--ECEVMKSIHHRNLVKIISSCS-----NEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~--------~~--E~~~l~~l~hpniv~l~~~~~-----~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+. +++.||||.+        ..  |+..+..++||||+++++.+.     .....++|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            45788899999999999999987 6889999854        23  344455689999999997542     33467899


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC---------CeEEccCCCCceeecCCCcEEEeecc
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST---------PIIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~---------~iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                      |||+++|+|.+++....  .++..+..++.|++.||+|||   +.         +|+||||||+|||++.++.+||+|||
T Consensus        91 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             ECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            99999999999997643  488889999999999999999   77         99999999999999999999999999


Q ss_pred             cccccCCCCC------ceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQ------SMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~------~~~~~~~~gt~~Y~aP  360 (360)
                      +++.+.....      ........||+.|+||
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP  197 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCH
T ss_pred             ceeecccccccCccccccccccCCCccceeCc
Confidence            9987654321      1122345799999998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.95  E-value=2.7e-28  Score=225.54  Aligned_cols=156  Identities=31%  Similarity=0.488  Sum_probs=132.2

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh----------------HHHHHHhhcCC---CCCeeEEEEEecCC
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF----------------DVECEVMKSIH---HRNLVKIISSCSNE  257 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~----------------~~E~~~l~~l~---hpniv~l~~~~~~~  257 (360)
                      ..++|+..+.||+|+||.||+|+. .+++.||||.+                .+|++++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            356899999999999999999996 57899999853                46777777665   99999999999875


Q ss_pred             C-----eEEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEe
Q 040294          258 D-----FRALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLS  331 (360)
Q Consensus       258 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~  331 (360)
                      .     ..++||||+. |+|.+++..... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     5899999997 599999976543 4899999999999999999999   8899999999999999999999999


Q ss_pred             ecccccccCCCCCceeeecccccCcccCC
Q 040294          332 DFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       332 DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |||+++......   ......||+.|+||
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aP  188 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAP  188 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCH
T ss_pred             eCccccccCCCc---ccCCccccccccCc
Confidence            999998765332   23456799999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.95  E-value=8.7e-29  Score=239.08  Aligned_cols=155  Identities=29%  Similarity=0.403  Sum_probs=128.1

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------------hHHHHHHhhcCCCCCeeEEEEEecCC
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------------FDVECEVMKSIHHRNLVKIISSCSNE  257 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------------~~~E~~~l~~l~hpniv~l~~~~~~~  257 (360)
                      ..++|...+.||+|+||.||+|+. .+++.||||.                   +.+|++++++++|||||++++++..+
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  212 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE  212 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            457899999999999999999985 4788999974                   45799999999999999999998654


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC---CcEEEeecc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN---IVAHLSDFG  334 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~---~~~ki~DFG  334 (360)
                       ..++||||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+|||
T Consensus       213 -~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          213 -DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             -EEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             -ceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence             579999999999999988654 46889999999999999999999   8899999999999999754   459999999


Q ss_pred             cccccCCCCCceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++......   .....+||+.|+||
T Consensus       288 ~a~~~~~~~---~~~~~~gt~~y~aP  310 (419)
T 3i6u_A          288 HSKILGETS---LMRTLCGTPTYLAP  310 (419)
T ss_dssp             TTTSCC--------------CTTCCT
T ss_pred             cceecCCCc---cccccCCCCCccCc
Confidence            999765332   23356799999999

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=1.5e-28  Score=223.54  Aligned_cols=154  Identities=31%  Similarity=0.443  Sum_probs=136.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +.|+..+.||+|+||.||+|+.. ++..||+|.           +.+|++++++++||||+++++++.+++..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            45888899999999999999965 577889873           567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee---cCCCcEEEeecccccccCCCCC
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl---~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||++....... 
T Consensus        89 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-  163 (277)
T 3f3z_A           89 TGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-  163 (277)
T ss_dssp             CSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence            999999988764 35889999999999999999999   8999999999999999   788999999999998765433 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......||+.|+||
T Consensus       164 --~~~~~~~t~~y~aP  177 (277)
T 3f3z_A          164 --MMRTKVGTPYYVSP  177 (277)
T ss_dssp             --CBCCCCSCTTTCCH
T ss_pred             --chhccCCCCCccCh
Confidence              22345799999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.95  E-value=1.2e-28  Score=233.04  Aligned_cols=163  Identities=26%  Similarity=0.370  Sum_probs=134.4

Q ss_pred             CHHHHHHHhCCCCCCCeeccCCCccEEEEEccCCcEEEehh----------------------hHHHHHHhhcCCCCCee
Q 040294          191 SYLELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------------------FDVECEVMKSIHHRNLV  248 (360)
Q Consensus       191 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------------------~~~E~~~l~~l~hpniv  248 (360)
                      ...++....++|...+.||+|+||.||+|...+++.||||.                      +.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            44567778899999999999999999999988899999984                      35799999999999999


Q ss_pred             EEEEEec-----CCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec
Q 040294          249 KIISSCS-----NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD  323 (360)
Q Consensus       249 ~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~  323 (360)
                      ++++++.     .....++||||++ |+|.+.+......+++..+..++.|++.||+|||   +.+|+||||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence            9999983     3447899999998 6999988877667999999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          324 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       324 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .++.+||+|||+++......   ......||+.|+||
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aP  202 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAP  202 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCH
T ss_pred             CCCCEEEEecCccccccccc---ccceecccceecCc
Confidence            99999999999998654332   23345789999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=1.3e-28  Score=239.92  Aligned_cols=153  Identities=33%  Similarity=0.493  Sum_probs=131.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEecCCC-eEEEEEEccC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSNED-FRALVLEYMT  268 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~  268 (360)
                      .++|+..+.||+|+||.||+|++. ++.||||.         |.+|++++++++|||||++++++...+ ..++||||++
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~  270 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA  270 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence            356778899999999999999985 67999983         568999999999999999999987665 7899999999


Q ss_pred             CCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          269 NGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       269 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +|+|.+++..... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....     
T Consensus       271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----  342 (450)
T 1k9a_A          271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----  342 (450)
T ss_dssp             TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----
Confidence            9999999986543 3688999999999999999999   899999999999999999999999999999864322     


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....+|+.|+||
T Consensus       343 ~~~~~~~~~y~aP  355 (450)
T 1k9a_A          343 QDTGKLPVKWTAP  355 (450)
T ss_dssp             ----CCCTTTSCH
T ss_pred             ccCCCCCcceeCH
Confidence            1223578899998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=6.6e-29  Score=238.14  Aligned_cols=155  Identities=29%  Similarity=0.491  Sum_probs=134.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCC--eEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNED--FRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~  264 (360)
                      +.|...+.||+|+||.||+|+.. +++.||||.+            .+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            45788899999999999999965 6899999843            47999999999999999999998755  789999


Q ss_pred             EccCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee----cCCCcEEEeecccccc
Q 040294          265 EYMTNGSLEKVLYSSN--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL----DDNIVAHLSDFGIAKL  338 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl----~~~~~~ki~DFGla~~  338 (360)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999997543  23899999999999999999999   8899999999999999    7788899999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....   ......||+.|+||
T Consensus       166 ~~~~~---~~~~~~gt~~y~aP  184 (396)
T 4eut_A          166 LEDDE---QFVSLYGTEEYLHP  184 (396)
T ss_dssp             CCCGG---GSSCSSSCCTTCCH
T ss_pred             ccCCC---ccccccCCccccCH
Confidence            65432   22346799999998

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=2.9e-29  Score=229.51  Aligned_cols=152  Identities=26%  Similarity=0.413  Sum_probs=133.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CC-------cEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DG-------MEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~-------~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      ++|...+.||+|+||.||+|+.. ++       ..||+|.           +.+|++++++++||||+++++++.+++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            46778899999999999999865 33       4688873           45799999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc--------EEEee
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV--------AHLSD  332 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~--------~ki~D  332 (360)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.        +||+|
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence            9999999999999999876666899999999999999999999   899999999999999998876        99999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+++.....      ....||+.|+||
T Consensus       165 fg~~~~~~~~------~~~~~~~~y~aP  186 (289)
T 4fvq_A          165 PGISITVLPK------DILQERIPWVPP  186 (289)
T ss_dssp             CCSCTTTSCH------HHHHHTTTTSCH
T ss_pred             CcccccccCc------cccCCcCcccCH
Confidence            9998765321      234688999998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=1.4e-28  Score=235.05  Aligned_cols=157  Identities=25%  Similarity=0.473  Sum_probs=124.9

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCC-CCCeeEEEEEecCCC--eE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIH-HRNLVKIISSCSNED--FR  260 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~-hpniv~l~~~~~~~~--~~  260 (360)
                      ..++|+..+.||+|+||.||+|+. .+++.||||.+             .+|+.+++++. |||||++++++..++  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            356799999999999999999985 57899999843             36889999997 999999999997544  78


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |+|||||+ |+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999997 5999998763  5888899999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCC-------------------ceeeecccccCcccCC
Q 040294          341 GEDQ-------------------SMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~-------------------~~~~~~~~gt~~Y~aP  360 (360)
                      ....                   ....+..+||++|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  199 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP  199 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCH
Confidence            3110                   1122346899999998

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.95  E-value=8.9e-29  Score=226.19  Aligned_cols=158  Identities=30%  Similarity=0.537  Sum_probs=138.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .++|+..+.||+|+||.||+|+.. ++..||+|.          +.+|++++++++||||+++++++.+++..++||||+
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   91 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   91 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence            456888899999999999999975 588899974          567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          268 TNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       268 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  167 (288)
T 3kfa_A           92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YT  167 (288)
T ss_dssp             TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SE
T ss_pred             CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cc
Confidence            9999999997643 45899999999999999999999   8899999999999999999999999999999876443 22


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......+|+.|+||
T Consensus       168 ~~~~~~~~~~y~aP  181 (288)
T 3kfa_A          168 AHAGAKFPIKWTAP  181 (288)
T ss_dssp             EETTEEECGGGCCH
T ss_pred             cccCCccccCcCCh
Confidence            33445678899998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=2e-28  Score=233.61  Aligned_cols=157  Identities=29%  Similarity=0.479  Sum_probs=132.1

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------HHHHHHhhcCCCCCeeEEEEEecC------------
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------DVECEVMKSIHHRNLVKIISSCSN------------  256 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------~~E~~~l~~l~hpniv~l~~~~~~------------  256 (360)
                      ...++|+..+.||+|+||.||+|+. .+|+.||||.+       .+|+++++.++|||||+++++|..            
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            3467899999999999999999985 58999999954       579999999999999999999843            


Q ss_pred             --------------------------CCeEEEEEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 040294          257 --------------------------EDFRALVLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFS  307 (360)
Q Consensus       257 --------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~  307 (360)
                                                ....++||||++ |+|.+.+..   ....+++..+..++.|+++||+|||   +
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~  159 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---S  159 (383)
T ss_dssp             --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence                                      345889999998 588777653   3456899999999999999999999   9


Q ss_pred             CCeEEccCCCCceeec-CCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          308 TPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       308 ~~iiHrdlk~~NiLl~-~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+|+||||||+||+++ .++.+||+|||+|+.+....   ......||+.|+||
T Consensus       160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aP  210 (383)
T 3eb0_A          160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAP  210 (383)
T ss_dssp             TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCH
T ss_pred             CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCH
Confidence            9999999999999998 68999999999999765433   22345789999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.7e-28  Score=226.90  Aligned_cols=155  Identities=30%  Similarity=0.429  Sum_probs=131.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||||.             +.+|++++++++||||+++++++..++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            56888899999999999999965 689999984             3469999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            99999999887654 45889999999999999999999   88999999999999999999999999999987653321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.|+||
T Consensus       158 -~~~~~~~~~~y~aP  171 (311)
T 4agu_A          158 -YYDDEVATRWYRSP  171 (311)
T ss_dssp             ---------GGGCCH
T ss_pred             -ccCCCcCCccccCh
Confidence             22345789999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.7e-28  Score=227.85  Aligned_cols=157  Identities=28%  Similarity=0.457  Sum_probs=130.9

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEccCCcEEEehhh--------HHHHHHhhc--CCCCCeeEEEEEecCC----CeEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF--------DVECEVMKS--IHHRNLVKIISSCSNE----DFRALV  263 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~--------~~E~~~l~~--l~hpniv~l~~~~~~~----~~~~lv  263 (360)
                      ..++|+..+.||+|+||.||+|+.. ++.||||.+        ..|.+++..  ++||||+++++++...    ...++|
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  113 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI  113 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence            3457999999999999999999975 889999854        345555544  4899999999999877    789999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC--------CeEEccCCCCceeecCCCcEEEeeccc
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST--------PIIHCDLKPHNVLLDDNIVAHLSDFGI  335 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~--------~iiHrdlk~~NiLl~~~~~~ki~DFGl  335 (360)
                      |||+++|+|.+++...  .+++..+..++.|++.||+|||   +.        +|+||||||+|||++.++.+||+|||+
T Consensus       114 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~  188 (337)
T 3mdy_A          114 TDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  188 (337)
T ss_dssp             ECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence            9999999999999764  5889999999999999999999   66        999999999999999999999999999


Q ss_pred             ccccCCCCCc--eeeecccccCcccCC
Q 040294          336 AKLLTGEDQS--MTQTQTLATIGYMAP  360 (360)
Q Consensus       336 a~~~~~~~~~--~~~~~~~gt~~Y~aP  360 (360)
                      ++.+......  .......||+.|+||
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aP  215 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPP  215 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCH
T ss_pred             ceeeccccccccCCCCCCccCcceeCh
Confidence            9876543221  112245799999998

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=6.6e-29  Score=229.92  Aligned_cols=167  Identities=25%  Similarity=0.414  Sum_probs=139.8

Q ss_pred             CHHHHHHHhCCCCCCCeeccCCCccEEEEEc------cCCcEEEehh------------hHHHHHHhhcC-CCCCeeEEE
Q 040294          191 SYLELLRATNGFSANNLIGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSI-HHRNLVKII  251 (360)
Q Consensus       191 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~  251 (360)
                      ...+.....++|+..+.||+|+||.||+|+.      .+++.||||.            +.+|+++++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3334444567899999999999999999974      3567899984            45689999999 799999999


Q ss_pred             EEecCCC-eEEEEEEccCCCCHHHHHhcCCCC---------------CCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccC
Q 040294          252 SSCSNED-FRALVLEYMTNGSLEKVLYSSNCI---------------LDILQRLNIMINVTSALEYLHFGFSTPIIHCDL  315 (360)
Q Consensus       252 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdl  315 (360)
                      +++...+ ..++||||+++|+|.+++......               +++..+..++.|++.||+|||   +.+|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence            9988755 589999999999999999765432               788899999999999999999   889999999


Q ss_pred             CCCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       316 k~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+||+++.++.+||+|||+++...............||+.|+||
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  219 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence            999999999999999999999877554433334456789999998

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.95  E-value=1.5e-28  Score=223.87  Aligned_cols=155  Identities=30%  Similarity=0.549  Sum_probs=135.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------hHHHHHHhhcCCCCCeeEEEEEecC---------------
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------FDVECEVMKSIHHRNLVKIISSCSN---------------  256 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------~~~E~~~l~~l~hpniv~l~~~~~~---------------  256 (360)
                      .+|+..+.||+|+||.||+|+.. +++.||+|.       +.+|++++++++||||+++++++..               
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   90 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS   90 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence            46888899999999999999975 789999984       5789999999999999999998854               


Q ss_pred             -CCeEEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecc
Q 040294          257 -EDFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       257 -~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                       ....++||||+++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  167 (284)
T 2a19_B           91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFG  167 (284)
T ss_dssp             EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcch
Confidence             34589999999999999999754 346889999999999999999999   8899999999999999999999999999


Q ss_pred             cccccCCCCCceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++......   ......||+.|+||
T Consensus       168 ~~~~~~~~~---~~~~~~~~~~y~aP  190 (284)
T 2a19_B          168 LVTSLKNDG---KRTRSKGTLRYMSP  190 (284)
T ss_dssp             TCEESSCCS---CCCCCCSCCTTSCH
T ss_pred             hheeccccc---cccccCCcccccCh
Confidence            998875432   12345699999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.95  E-value=3.8e-30  Score=241.05  Aligned_cols=149  Identities=21%  Similarity=0.240  Sum_probs=124.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------------hHHHHHHhhcCC---------CCCeeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------------FDVECEVMKSIH---------HRNLVKII  251 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------------~~~E~~~l~~l~---------hpniv~l~  251 (360)
                      ++|+..+.||+|+||.||+|+. +|+.||||.                   +.+|+++++.++         |||||++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4577889999999999999998 689999974                   346888888775         77777777


Q ss_pred             EEe-----------------c-------------CCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 040294          252 SSC-----------------S-------------NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY  301 (360)
Q Consensus       252 ~~~-----------------~-------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~y  301 (360)
                      +.+                 .             .++..++||||+++|++.+.+..  ..+++..+..++.|++.||+|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence            653                 2             26789999999999977666643  457899999999999999999


Q ss_pred             hhhcCCCCeEEccCCCCceeecCCC--------------------cEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          302 LHFGFSTPIIHCDLKPHNVLLDDNI--------------------VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       302 LH~~~~~~iiHrdlk~~NiLl~~~~--------------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+  +.+|+||||||+|||++.++                    .+||+|||+|+.....       ..+||+.||||
T Consensus       177 lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP  246 (336)
T 2vuw_A          177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE  246 (336)
T ss_dssp             HHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred             HHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence            993  36799999999999999876                    8999999999976432       34799999999

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.95  E-value=6.6e-29  Score=232.05  Aligned_cols=158  Identities=27%  Similarity=0.443  Sum_probs=127.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcE----EEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGME----FAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      .++|+..+.||+|+||.||+|++. +++.    ||+|            .+.+|++++++++||||++++++|..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            357888999999999999999854 4544    4665            3567999999999999999999998765 78


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +|+||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887777999999999999999999999   88999999999999999999999999999998754


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...........||+.|+||
T Consensus       170 ~~~~~~~~~~~~t~~y~aP  188 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             ----------CCCGGGSCH
T ss_pred             ccccccccCCCccccccCH
Confidence            4333333445678899998

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=1.1e-28  Score=231.54  Aligned_cols=162  Identities=31%  Similarity=0.423  Sum_probs=132.1

Q ss_pred             HHHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh----------------hHHHHHHhhcCCCCCeeEEEEEecCCC
Q 040294          196 LRATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS----------------FDVECEVMKSIHHRNLVKIISSCSNED  258 (360)
Q Consensus       196 ~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~----------------~~~E~~~l~~l~hpniv~l~~~~~~~~  258 (360)
                      ....++|+..+.||+|+||.||+|+. .++..||+|.                +..|++++++++||||++++++|.+++
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            34456789999999999999999986 4788899984                346999999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcC---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 040294          259 FRALVLEYMTNGSLEKVLYSS---------------------------------------NCILDILQRLNIMINVTSAL  299 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~l  299 (360)
                      ..++||||+++|+|.+++...                                       ...+++.....++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998520                                       11134566788999999999


Q ss_pred             HHhhhcCCCCeEEccCCCCceeecCCC--cEEEeecccccccCCCCC--ceeeecccccCcccCC
Q 040294          300 EYLHFGFSTPIIHCDLKPHNVLLDDNI--VAHLSDFGIAKLLTGEDQ--SMTQTQTLATIGYMAP  360 (360)
Q Consensus       300 ~yLH~~~~~~iiHrdlk~~NiLl~~~~--~~ki~DFGla~~~~~~~~--~~~~~~~~gt~~Y~aP  360 (360)
                      +|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+||
T Consensus       182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  243 (345)
T 3hko_A          182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP  243 (345)
T ss_dssp             HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred             HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence            9999   88999999999999998766  899999999987643221  1123456799999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.95  E-value=2.7e-28  Score=229.77  Aligned_cols=158  Identities=27%  Similarity=0.471  Sum_probs=135.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC--------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN--------  256 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~--------  256 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.             +.+|++++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35688899999999999999996 5789999983             3579999999999999999999876        


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       257 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                      .+..++||||+++ +|.+.+......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            4468999999985 888888776667999999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCC--ceeeecccccCcccCC
Q 040294          337 KLLTGEDQ--SMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~--~~~~~~~~gt~~Y~aP  360 (360)
                      +.+.....  ........||+.|+||
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPP  197 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCH
T ss_pred             ccccccccccccccCCcccccCccCc
Confidence            87653221  1223456789999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.95  E-value=1.9e-28  Score=228.55  Aligned_cols=158  Identities=28%  Similarity=0.449  Sum_probs=136.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-----cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEec--CCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-----QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCS--NEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~  261 (360)
                      ++|+..+.||+|+||.||+|++     .+++.||||.           +.+|++++++++||||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4678889999999999999983     4678899984           567999999999999999999886  456789


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999875556899999999999999999999   89999999999999999999999999999998754


Q ss_pred             CCCce-eeecccccCcccCC
Q 040294          342 EDQSM-TQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~-~~~~~~gt~~Y~aP  360 (360)
                      ..... ......||+.|+||
T Consensus       180 ~~~~~~~~~~~~~~~~y~aP  199 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAP  199 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCH
T ss_pred             CCccceeeccCCccccccCH
Confidence            43221 22345688899998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.95  E-value=7.1e-29  Score=231.82  Aligned_cols=159  Identities=26%  Similarity=0.469  Sum_probs=136.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CC-----cEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCe
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DG-----MEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDF  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~-----~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~  259 (360)
                      .++|+..+.||+|+||.||+|+.. ++     ..||+|.            +.+|+++++++ +||||++++++|..++.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            467888999999999999999854 23     4789873            45799999999 89999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC
Q 040294          260 RALVLEYMTNGSLEKVLYSS-------------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI  326 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~  326 (360)
                      .++||||+++|+|.+++...             ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCC
Confidence            99999999999999998643             234788999999999999999999   88999999999999999999


Q ss_pred             cEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          327 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       327 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+||+|||+++...............||+.|+||
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  235 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP  235 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCH
Confidence            9999999999876544333333445678899998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.95  E-value=1.5e-28  Score=225.98  Aligned_cols=158  Identities=28%  Similarity=0.494  Sum_probs=131.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC----CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEec-CCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD----GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCS-NEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~l  262 (360)
                      ..|+..+.||+|+||.||+|+..+    ...+|+|.            +.+|++++++++||||++++++|. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            357778999999999999998642    23578763            457999999999999999999864 5567899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999999999877677899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CC--ceeeecccccCcccCC
Q 040294          343 DQ--SMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~--~~~~~~~~gt~~Y~aP  360 (360)
                      ..  ........||+.|+||
T Consensus       182 ~~~~~~~~~~~~~~~~y~aP  201 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMAL  201 (298)
T ss_dssp             GGCBC-----CCBCGGGSCH
T ss_pred             chhccccccCCCCCccccCh
Confidence            21  1123345688899998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.95  E-value=1e-28  Score=233.39  Aligned_cols=162  Identities=30%  Similarity=0.444  Sum_probs=138.9

Q ss_pred             cCHHHHHHHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh----------HHHHHHhhcCC-----CCCeeEEEEE
Q 040294          190 FSYLELLRATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF----------DVECEVMKSIH-----HRNLVKIISS  253 (360)
Q Consensus       190 ~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~----------~~E~~~l~~l~-----hpniv~l~~~  253 (360)
                      +++.+.....++|...+.||+|+||.||+|+. .+++.||||.+          ..|++++++++     |||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            34344444567899999999999999999996 47889999854          45888898886     9999999999


Q ss_pred             ecCCCeEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC--------
Q 040294          254 CSNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD--------  324 (360)
Q Consensus       254 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~--------  324 (360)
                      +...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.        
T Consensus       105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred             eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccccc
Confidence            99999999999999 999999997654 35889999999999999999999   899999999999999975        


Q ss_pred             -----------------CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          325 -----------------NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       325 -----------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                                       ++.+||+|||+++......     ....||+.|+||
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aP  228 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAP  228 (360)
T ss_dssp             EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCH
T ss_pred             chhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCc
Confidence                             7899999999998754322     345799999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=3.4e-28  Score=221.90  Aligned_cols=155  Identities=26%  Similarity=0.505  Sum_probs=135.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .++|+..+.||+|+||.||+|... +++.||+|.             +.+|++++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467889999999999999999864 688999984             356999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc---EEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV---AHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~---~ki~DFGla~~~~~  341 (360)
                      ||+++++|.+.+... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            999999999888754 35889999999999999999999   889999999999999986654   99999999987654


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..   ......||+.|+||
T Consensus       161 ~~---~~~~~~~~~~y~aP  176 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSP  176 (284)
T ss_dssp             SC---BCCCSCSCGGGCCH
T ss_pred             Cc---cccCCCCCcCCcCc
Confidence            32   22346799999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=2e-28  Score=223.13  Aligned_cols=153  Identities=25%  Similarity=0.453  Sum_probs=133.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSI-HHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.             +.+|+..+.++ +||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456888999999999999999975 789999984             34578888888 999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC----------------
Q 040294          264 LEYMTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD----------------  324 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~----------------  324 (360)
                      |||+++|+|.+++...   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999753   245889999999999999999999   889999999999999984                


Q ss_pred             ---CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          325 ---NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       325 ---~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                         ...+||+|||.+.......      ...||+.|+||
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aP  199 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLAN  199 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCH
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccCh
Confidence               4479999999998765332      23589999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.95  E-value=1.8e-28  Score=222.63  Aligned_cols=158  Identities=25%  Similarity=0.398  Sum_probs=137.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.            +.+|+++++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            456888899999999999999965 789999974            3579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            99999999998643 45889999999999999999999   889999999999999999999999999999876433222


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      .......||+.|+||
T Consensus       162 ~~~~~~~~~~~y~aP  176 (276)
T 2yex_A          162 RLLNKMCGTLPYVAP  176 (276)
T ss_dssp             CCBCCCCSCGGGCCG
T ss_pred             hcccCCccccCccCh
Confidence            223346799999998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=2.3e-28  Score=227.47  Aligned_cols=154  Identities=27%  Similarity=0.445  Sum_probs=136.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      +.|+..+.||+|+||.||+|+.. +++.||||.                 +.+|++++++++||||+++++++.+++..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            45888899999999999999965 688999973                 467999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC----cEEEeeccccc
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI----VAHLSDFGIAK  337 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~----~~ki~DFGla~  337 (360)
                      +||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||+++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            999999999999999754 45888999999999999999999   88999999999999999887    79999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ......   ......||+.|+||
T Consensus       168 ~~~~~~---~~~~~~gt~~y~aP  187 (321)
T 2a2a_A          168 EIEDGV---EFKNIFGTPEFVAP  187 (321)
T ss_dssp             ECCTTC---CCCCCCSCGGGCCH
T ss_pred             ecCccc---cccccCCCCCccCc
Confidence            765432   22345799999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.95  E-value=1.7e-28  Score=223.40  Aligned_cols=156  Identities=27%  Similarity=0.506  Sum_probs=134.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|+..++..||||.          +.+|++++++++||||+++++++..+ ..++||||+++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~   91 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMEN   91 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCC-CcEEEEecCCC
Confidence            46778899999999999999988888999984          46799999999999999999998754 58999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      ++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus        92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  167 (279)
T 1qpc_A           92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAR  167 (279)
T ss_dssp             CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECC
T ss_pred             CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cccc
Confidence            99999996532 25888999999999999999999   8999999999999999999999999999998765432 1222


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....+|+.|+||
T Consensus       168 ~~~~~~~~y~aP  179 (279)
T 1qpc_A          168 EGAKFPIKWTAP  179 (279)
T ss_dssp             TTCCCCTTTSCH
T ss_pred             cCCCCccCccCh
Confidence            344578899998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.95  E-value=3.5e-28  Score=239.70  Aligned_cols=154  Identities=28%  Similarity=0.459  Sum_probs=132.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      +.|+..+.||+|+||.||+|+.. ++..||+|.             +.+|+++++.++|||||+++++|.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            35888899999999999999965 788999984             3579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEeecccccccCCC
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~DFGla~~~~~~  342 (360)
                      ||++|+|.+.+... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            99999999988654 35888999999999999999999   889999999999999975   456999999999876543


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .   .....+||+.|+||
T Consensus       193 ~---~~~~~~gt~~y~aP  207 (494)
T 3lij_A          193 K---KMKERLGTAYYIAP  207 (494)
T ss_dssp             B---CBCCCCSCTTTCCH
T ss_pred             c---cccccCCCcCeeCH
Confidence            2   23346799999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.95  E-value=1.9e-28  Score=225.03  Aligned_cols=159  Identities=30%  Similarity=0.458  Sum_probs=131.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecC-----------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSN-----------  256 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~-----------  256 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.          +.+|++++++++||||++++++|.+           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            45688889999999999999996 4789999984          4579999999999999999998754           


Q ss_pred             --CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecc
Q 040294          257 --EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       257 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                        .+..++||||+++|+|.+++......+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence              35789999999999999999876667888889999999999999999   8899999999999999999999999999


Q ss_pred             cccccCCCCC------------ceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQ------------SMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~------------~~~~~~~~gt~~Y~aP  360 (360)
                      +++.......            ........||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT  199 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCc
Confidence            9987643210            1122345699999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.4e-28  Score=228.82  Aligned_cols=158  Identities=29%  Similarity=0.550  Sum_probs=128.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC-----CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD-----GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      +.|...+.||+|+||.||+|+...     +..||||.            +.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            346667899999999999998642     23589874            4579999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999877667999999999999999999999   889999999999999999999999999999876543


Q ss_pred             CC-ceeeecccccCcccCC
Q 040294          343 DQ-SMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~-~~~~~~~~gt~~Y~aP  360 (360)
                      .. ........+|+.|+||
T Consensus       201 ~~~~~~~~~~~~~~~y~aP  219 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAP  219 (333)
T ss_dssp             ----------CCCGGGSCH
T ss_pred             cccccccCCCCccccccCc
Confidence            21 1122234568899998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=3.4e-28  Score=219.91  Aligned_cols=150  Identities=21%  Similarity=0.439  Sum_probs=132.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCC--CeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNE--DFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.. ++.||||.             +.+|++++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            46888899999999999999985 78899974             45789999999999999999999887  7889999


Q ss_pred             EccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTP--IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~yLH~~~~~~--iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ||+++|+|.+++..... .+++..+..++.|++.||+|||   +.+  |+||||||+||+++.++.++|+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            99999999999986543 5899999999999999999999   777  99999999999999999999999998765322


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                             ....||+.|+||
T Consensus       166 -------~~~~~t~~y~aP  177 (271)
T 3kmu_A          166 -------PGRMYAPAWVAP  177 (271)
T ss_dssp             -------TTCBSCGGGSCH
T ss_pred             -------cCccCCccccCh
Confidence                   234689999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.1e-28  Score=234.88  Aligned_cols=156  Identities=29%  Similarity=0.527  Sum_probs=121.8

Q ss_pred             CCCCCeeccCCCccEEEEEcc--CC--cEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecC-CCeEEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARLQ--DG--MEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSN-EDFRALVL  264 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~--~~--~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~  264 (360)
                      |...+.||+|+||.||+|++.  ++  ..||||.            |.+|+.++++++||||++++++|.. ++..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            556689999999999999864  22  3578873            4579999999999999999998754 45789999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            999999999999877777889999999999999999999   88999999999999999999999999999987643321


Q ss_pred             c--eeeecccccCcccCC
Q 040294          345 S--MTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~--~~~~~~~gt~~Y~aP  360 (360)
                      .  .......+|+.|+||
T Consensus       248 ~~~~~~~~~~~~~~y~aP  265 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMAL  265 (373)
T ss_dssp             ----------CCGGGSCH
T ss_pred             ccccccCCCCCcccccCh
Confidence            1  122345678899998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.95  E-value=4.1e-28  Score=239.75  Aligned_cols=155  Identities=28%  Similarity=0.477  Sum_probs=134.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------------------hHHHHHHhhcCCCCCeeEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------------------FDVECEVMKSIHHRNLVKIISS  253 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------------------~~~E~~~l~~l~hpniv~l~~~  253 (360)
                      .+.|...+.||+|+||.||+|+.. +++.||||.                        +.+|++++++++|||||+++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467888999999999999999965 678999974                        2368999999999999999999


Q ss_pred             ecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC---cEEE
Q 040294          254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI---VAHL  330 (360)
Q Consensus       254 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~---~~ki  330 (360)
                      |.+++..++|||||++|+|.+.+... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++   .+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            99999999999999999999988754 35889999999999999999999   88999999999999998765   6999


Q ss_pred             eecccccccCCCCCceeeecccccCcccCC
Q 040294          331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       331 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|||+++......   .....+||+.|+||
T Consensus       191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aP  217 (504)
T 3q5i_A          191 VDFGLSSFFSKDY---KLRDRLGTAYYIAP  217 (504)
T ss_dssp             CCCTTCEECCTTS---CBCCCCSCTTTCCH
T ss_pred             EECCCCEEcCCCC---ccccccCCcCCCCH
Confidence            9999998775432   23346799999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=3.5e-28  Score=239.19  Aligned_cols=154  Identities=27%  Similarity=0.461  Sum_probs=134.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      +.|+..+.||+|+||.||+|+.. +++.||||.             +.+|++++++++|||||++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            46888999999999999999965 789999985             3469999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec---CCCcEEEeecccccccCCC
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~---~~~~~ki~DFGla~~~~~~  342 (360)
                      |+++|+|.+.+... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++   .++.+||+|||+++.....
T Consensus       102 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            99999999988654 35889999999999999999999   89999999999999995   4568999999999876543


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      .   .....+||+.|+||
T Consensus       178 ~---~~~~~~gt~~y~aP  192 (486)
T 3mwu_A          178 T---KMKDRIGTAYYIAP  192 (486)
T ss_dssp             -------CCTTGGGGCCG
T ss_pred             C---ccCCCcCCCCCCCH
Confidence            2   23346799999998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=3.6e-28  Score=230.52  Aligned_cols=157  Identities=32%  Similarity=0.527  Sum_probs=138.7

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------------hHHHHHHhhcC-CCCCeeEEEEEec
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------------FDVECEVMKSI-HHRNLVKIISSCS  255 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------------~~~E~~~l~~l-~hpniv~l~~~~~  255 (360)
                      ...++|+..+.||+|+||.||+|+.. +|+.||||.                   +..|+++++++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            34567888999999999999999975 799999983                   34688899998 7999999999999


Q ss_pred             CCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccc
Q 040294          256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGI  335 (360)
Q Consensus       256 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGl  335 (360)
                      ..+..++||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence            999999999999999999999754 35889999999999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCCceeeecccccCcccCC
Q 040294          336 AKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       336 a~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +..+....   ......||+.|+||
T Consensus       247 ~~~~~~~~---~~~~~~gt~~y~aP  268 (365)
T 2y7j_A          247 SCHLEPGE---KLRELCGTPGYLAP  268 (365)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCH
T ss_pred             ccccCCCc---ccccCCCCCCccCh
Confidence            98876433   22346799999998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=5.1e-28  Score=222.05  Aligned_cols=155  Identities=23%  Similarity=0.385  Sum_probs=136.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|...+.||+|+||.||+|+.. +++.||+|.              +.+|++++++++||||+++++++.+++..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            46778899999999999999965 678899873              356899999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        95 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           95 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             ECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            999999999988654 35889999999999999999999   88999999999999999999999999999987653321


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......||+.|+||
T Consensus       171 --~~~~~~~~~~y~aP  184 (294)
T 2rku_A          171 --RKKVLCGTPNYIAP  184 (294)
T ss_dssp             --CBCCCCSCCSSCCH
T ss_pred             --ccccccCCCCcCCc
Confidence              22345799999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.95  E-value=1.8e-28  Score=241.08  Aligned_cols=154  Identities=28%  Similarity=0.490  Sum_probs=136.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      +.|+..+.||+|+||.||+|+.. +++.||||.              +.+|++++++++|||||+++++|.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            45888899999999999999965 789999984              457999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee---cCCCcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl---~~~~~~ki~DFGla~~~~~  341 (360)
                      ||+.+|+|.+.+... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++....
T Consensus       106 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          106 EVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            999999999998764 35889999999999999999999   8899999999999999   4678999999999988754


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..   .....+||+.|+||
T Consensus       182 ~~---~~~~~~gt~~y~aP  197 (484)
T 3nyv_A          182 SK---KMKDKIGTAYYIAP  197 (484)
T ss_dssp             CC---SHHHHTTGGGTCCH
T ss_pred             cc---ccccCCCCccccCc
Confidence            33   22346799999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=4.9e-28  Score=226.74  Aligned_cols=156  Identities=23%  Similarity=0.382  Sum_probs=136.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|...+.||+|+||.||+++.. +++.||+|.              +.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            346788899999999999999965 678899874              35689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            9999999999988654 35889999999999999999999   8899999999999999999999999999998765332


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .  ......||+.|+||
T Consensus       196 ~--~~~~~~gt~~y~aP  210 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAP  210 (335)
T ss_dssp             C--CBCCCCSCCSSCCH
T ss_pred             c--cccccCCCccccCH
Confidence            1  22345799999998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.95  E-value=3.1e-28  Score=220.63  Aligned_cols=151  Identities=29%  Similarity=0.521  Sum_probs=123.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh---------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS---------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~---------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|++. ++.||||.               +.+|+++++.++||||+++++++..++..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            56888899999999999999975 78899974               346899999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC---eEEccCCCCceeecC--------CCcEEEeec
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP---IIHCDLKPHNVLLDD--------NIVAHLSDF  333 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~---iiHrdlk~~NiLl~~--------~~~~ki~DF  333 (360)
                      ||+++++|.+++..  ..+++..+..++.|++.||+|||   +.+   |+||||||+||+++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999864  35889999999999999999999   666   999999999999986        678999999


Q ss_pred             ccccccCCCCCceeeecccccCcccCC
Q 040294          334 GIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       334 Gla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+++......    .....||+.|+||
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aP  183 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAP  183 (271)
T ss_dssp             CC-----------------CCGGGSCH
T ss_pred             Cccccccccc----ccCCCCccceeCH
Confidence            9998765332    2245799999998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.95  E-value=2.6e-28  Score=224.46  Aligned_cols=160  Identities=28%  Similarity=0.407  Sum_probs=125.7

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ..++|+..+.||+|+||.||+|+.. +++.||||.+            .+|++++++++||||+++++++..++..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3568999999999999999999864 7889999853            36888999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          265 EYMTNGSLEKVLYS-------SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       265 e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ||+++++|.+++..       ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999864       2345899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCC---ceeeecccccCcccCC
Q 040294          338 LLTGEDQ---SMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~---~~~~~~~~gt~~Y~aP  360 (360)
                      .......   ........||+.|+||
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAP  195 (303)
T ss_dssp             HCC---------------CCCTTCCH
T ss_pred             eeccCCCccchhhhcccCCCccccCH
Confidence            7653321   1112345799999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=6.5e-28  Score=223.49  Aligned_cols=157  Identities=26%  Similarity=0.385  Sum_probs=128.2

Q ss_pred             CCCCC-CCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhc-CCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSA-NNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKS-IHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~-~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      +.|.+ .+.||+|+||.||+|+. .+++.||||.           +.+|++++.+ .+||||+++++++.+++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            45666 37899999999999995 4789999984           4579999988 479999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc---EEEeecccccccCCC
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV---AHLSDFGIAKLLTGE  342 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~---~ki~DFGla~~~~~~  342 (360)
                      |+++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||+++.....
T Consensus        92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999764 35888999999999999999999   889999999999999988765   999999999875422


Q ss_pred             CC-----ceeeecccccCcccCC
Q 040294          343 DQ-----SMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~-----~~~~~~~~gt~~Y~aP  360 (360)
                      ..     .......+||+.|+||
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aP  190 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAP  190 (316)
T ss_dssp             --------------CCSGGGCCH
T ss_pred             CccccccccccccccCCcCccCh
Confidence            11     1112245699999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.95  E-value=2.7e-28  Score=238.57  Aligned_cols=152  Identities=28%  Similarity=0.365  Sum_probs=124.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC------C
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE------D  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~------~  258 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.+             .+|+++++.++|||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46788899999999999999985 47889999843             4699999999999999999999654      4


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            67999999976 46666643   3788899999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....   ..+..+||++|+||
T Consensus       214 ~~~~~---~~~~~~gt~~y~aP  232 (464)
T 3ttj_A          214 AGTSF---MMTPYVVTRYYRAP  232 (464)
T ss_dssp             ---CC---CC----CCCTTCCH
T ss_pred             cCCCc---ccCCCcccccccCH
Confidence            65332   23456899999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.95  E-value=2.6e-28  Score=227.65  Aligned_cols=159  Identities=25%  Similarity=0.455  Sum_probs=130.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc------cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      .++|+..+.||+|+||.||+|++      .++..||||.            +.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            35688889999999999999984      2567899984            35689999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEe
Q 040294          261 ALVLEYMTNGSLEKVLYSSN------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLS  331 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~  331 (360)
                      ++||||+++|+|.+++....      ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998643      34888999999999999999999   889999999999999984   4569999


Q ss_pred             ecccccccCCCCCceeeecccccCcccCC
Q 040294          332 DFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       332 DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |||+++...............||+.|+||
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  214 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPP  214 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred             ccccccccccccccccCCCcCCCcceeCH
Confidence            99999876543322233445689999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=6.7e-28  Score=220.19  Aligned_cols=154  Identities=27%  Similarity=0.462  Sum_probs=136.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.              +.+|++++++++||||+++++++.+++..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            356888899999999999999965 678899984              34689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            99999999999997643 5888999999999999999999   8999999999999999999999999999997654322


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                          .....||+.|+||
T Consensus       169 ----~~~~~~~~~y~aP  181 (284)
T 2vgo_A          169 ----RRTMCGTLDYLPP  181 (284)
T ss_dssp             ----BCCCCSCGGGCCH
T ss_pred             ----cccccCCCCcCCH
Confidence                2345799999998

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.4e-28  Score=224.28  Aligned_cols=156  Identities=24%  Similarity=0.438  Sum_probs=131.6

Q ss_pred             CCCCCeeccCCCccEEEEEcc-CC---cEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeE-EEEE
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-DG---MEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFR-ALVL  264 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-~~---~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~lv~  264 (360)
                      |...++||+|+||.||+|++. ++   ..||+|.            +.+|++++++++||||+++++++.+.+.. ++||
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            445688999999999999853 22   3688873            45799999999999999999999876654 9999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+.+|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            999999999999887777899999999999999999999   88999999999999999999999999999987643321


Q ss_pred             --ceeeecccccCcccCC
Q 040294          345 --SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 --~~~~~~~~gt~~Y~aP  360 (360)
                        ........+|+.|+||
T Consensus       180 ~~~~~~~~~~~~~~y~aP  197 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTAL  197 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCH
T ss_pred             cccccCcCCCCCccccCh
Confidence              1122345688899997

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.95  E-value=3.3e-28  Score=245.76  Aligned_cols=150  Identities=27%  Similarity=0.468  Sum_probs=125.3

Q ss_pred             eeccCCCccEEEEEcc---CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCCC
Q 040294          207 LIGRGSFGSVYKARLQ---DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGS  271 (360)
Q Consensus       207 ~iG~G~~g~Vy~~~~~---~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~  271 (360)
                      .||+|+||.||+|.++   ++..||||.            |.+|++++++++|||||+++++|.. +..++|||||++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   456799973            4679999999999999999999987 45899999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc-eeeec
Q 040294          272 LEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS-MTQTQ  350 (360)
Q Consensus       272 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~-~~~~~  350 (360)
                      |.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... .....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999876667999999999999999999999   889999999999999999999999999999986543221 11223


Q ss_pred             ccccCcccCC
Q 040294          351 TLATIGYMAP  360 (360)
Q Consensus       351 ~~gt~~Y~aP  360 (360)
                      ..+|+.||||
T Consensus       499 ~~~~~~y~AP  508 (613)
T 2ozo_A          499 GKWPLKWYAP  508 (613)
T ss_dssp             ---CCTTSCH
T ss_pred             CCCccceeCH
Confidence            3467899998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.95  E-value=7.6e-29  Score=246.68  Aligned_cols=157  Identities=28%  Similarity=0.508  Sum_probs=135.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .++|+..+.||+|+||.||+|++.++..||||.          |.+|++++++++|||||++++++.+ +..++|||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            356778899999999999999998888899983          5689999999999999999999977 66899999999


Q ss_pred             CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          269 NGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       269 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +|+|.+++... ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.... ...
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~  420 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA  420 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eec
Confidence            99999999753 245889999999999999999999   8999999999999999999999999999998764321 111


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....+|+.|+||
T Consensus       421 ~~~~~~~~~y~aP  433 (535)
T 2h8h_A          421 RQGAKFPIKWTAP  433 (535)
T ss_dssp             TCSTTSCGGGSCH
T ss_pred             ccCCcCcccccCH
Confidence            2234578899998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.95  E-value=6.8e-28  Score=218.96  Aligned_cols=155  Identities=26%  Similarity=0.477  Sum_probs=129.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|...+.||+|+||.||+|+.. +++.||||.              +.+|+++++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357888899999999999999975 789999984              34689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999997543 5788999999999999999999   8899999999999999999999999999998765432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                         ......||+.|+||
T Consensus       166 ---~~~~~~~~~~y~aP  179 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAP  179 (276)
T ss_dssp             --------------CCT
T ss_pred             ---ceecccCCccccCH
Confidence               12345689999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.95  E-value=6e-28  Score=223.57  Aligned_cols=158  Identities=32%  Similarity=0.414  Sum_probs=134.5

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ..+.|+..+.||+|+||.||+|+.. +|+.||||.         +.+|++++++++||||+++++++...+..++||||+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            3467888999999999999999865 689999984         467999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++++|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......  ..
T Consensus       107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~  181 (314)
T 3com_A          107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AK  181 (314)
T ss_dssp             TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SC
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cc
Confidence            999999999765567899999999999999999999   8999999999999999999999999999998765432  12


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....||+.|+||
T Consensus       182 ~~~~~~~~~y~aP  194 (314)
T 3com_A          182 RNTVIGTPFWMAP  194 (314)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             cCccCCCCCccCh
Confidence            2345799999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.95  E-value=5.1e-28  Score=223.94  Aligned_cols=153  Identities=32%  Similarity=0.518  Sum_probs=124.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      ++|+..+.||+|+||.||+|++. ++.||||.         |.+|++++++++||||+++++++.+.  .++||||+++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~~~   84 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGG   84 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCTTC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCCCC
Confidence            45778899999999999999975 68899984         46799999999999999999998844  78999999999


Q ss_pred             CHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc-EEEeecccccccCCCCCcee
Q 040294          271 SLEKVLYSSNC--ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV-AHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       271 ~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~-~ki~DFGla~~~~~~~~~~~  347 (360)
                      +|.+++.....  .+++...+.++.|+++||+|||..+..+|+||||||+||+++.++. +||+|||+++.....     
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----  159 (307)
T 2eva_A           85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----  159 (307)
T ss_dssp             BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred             CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence            99999986543  3678889999999999999999333389999999999999988876 799999999865422     


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      .....||+.|+||
T Consensus       160 ~~~~~gt~~y~aP  172 (307)
T 2eva_A          160 MTNNKGSAAWMAP  172 (307)
T ss_dssp             -----CCTTSSCH
T ss_pred             cccCCCCCceECh
Confidence            1234699999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.95  E-value=4.5e-28  Score=224.43  Aligned_cols=160  Identities=24%  Similarity=0.469  Sum_probs=124.8

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc----CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCC--
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNED--  258 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~--  258 (360)
                      ..++|...+.||+|+||.||+|+..    ++..||||.             +.+|++++++++||||+++++++...+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4567888899999999999999854    345799984             446899999999999999999998765  


Q ss_pred             ---eEEEEEEccCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEE
Q 040294          259 ---FRALVLEYMTNGSLEKVLYS-----SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL  330 (360)
Q Consensus       259 ---~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki  330 (360)
                         ..++||||+++|+|.+++..     ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence               34999999999999999853     2345899999999999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCCceeeecccccCcccCC
Q 040294          331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       331 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|||+++...............+++.|+||
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  218 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  218 (313)
T ss_dssp             CSCSCC----------------CCGGGSCH
T ss_pred             eecCcceecccccccCcccccCCCccccCc
Confidence            999999876544322233345678899998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.95  E-value=4e-28  Score=221.36  Aligned_cols=157  Identities=27%  Similarity=0.478  Sum_probs=130.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccC----CcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQD----GMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      .++|...+.||+|+||.||+|+...    +..||+|.            +.+|++++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4568888999999999999998542    33589874            45699999999999999999998765 4689


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999876667899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      . ........+|+.|+||
T Consensus       167 ~-~~~~~~~~~~~~y~aP  183 (281)
T 3cc6_A          167 D-YYKASVTRLPIKWMSP  183 (281)
T ss_dssp             -------CCCCCGGGCCH
T ss_pred             c-ccccccCCCCcceeCc
Confidence            2 1122345678899998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=5.9e-28  Score=223.61  Aligned_cols=157  Identities=27%  Similarity=0.350  Sum_probs=130.0

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.              +.+|++++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            467999999999999999999964 788999984              34689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            9999999999999754 35889999999999999999999   8899999999999999999999999999998765432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      . .......||+.|+||
T Consensus       189 ~-~~~~~~~~~~~y~aP  204 (309)
T 2h34_A          189 L-TQLGNTVGTLYYMAP  204 (309)
T ss_dssp             ---------CCGGGCCG
T ss_pred             c-ccccccCCCcCccCH
Confidence            1 122345799999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.95  E-value=1.9e-27  Score=219.12  Aligned_cols=158  Identities=24%  Similarity=0.401  Sum_probs=132.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh---------------hHHHHHHhhcCCCCCeeEEEEEe--cCCCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS---------------FDVECEVMKSIHHRNLVKIISSC--SNEDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~---------------~~~E~~~l~~l~hpniv~l~~~~--~~~~~~  260 (360)
                      .++|...+.||+|+||.||+|+.. +++.||+|.               +.+|++++++++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            467999999999999999999964 788999974               34689999999999999999998  445578


Q ss_pred             EEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          261 ALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      ++||||++++ |.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999887 76666543 446899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .............||+.|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aP  180 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPP  180 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCH
T ss_pred             CccccccccccCCCCCCCcCh
Confidence            543322333456799999998

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.95  E-value=2.8e-28  Score=230.46  Aligned_cols=153  Identities=26%  Similarity=0.399  Sum_probs=133.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.            +.+|++++++++||||+++++++..++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            46888899999999999999965 788999974            45799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST-PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~-~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++|+|.+++.... .+++..+..++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||+++.+...   
T Consensus       113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  185 (360)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence            99999999997643 5888899999999999999999   64 8999999999999999999999999999865322   


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.|+||
T Consensus       186 -~~~~~~gt~~y~aP  199 (360)
T 3eqc_A          186 -MANSFVGTRSYMSP  199 (360)
T ss_dssp             -C----CCCCTTCCH
T ss_pred             -cccCCCCCCCeECH
Confidence             12345799999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.95  E-value=6.4e-28  Score=219.96  Aligned_cols=154  Identities=29%  Similarity=0.466  Sum_probs=132.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.                 +.+|++++++++||||+++++++.+++..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            45788899999999999999975 789999873                 467999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC----cEEEeeccccc
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI----VAHLSDFGIAK  337 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~----~~ki~DFGla~  337 (360)
                      +||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            999999999999999753 35889999999999999999999   88999999999999998877    89999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ......   ......||+.|+||
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aP  180 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAP  180 (283)
T ss_dssp             ECC-----------CCCGGGCCH
T ss_pred             eccCCC---cccccCCCcCccCc
Confidence            765332   12345699999998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=6.6e-28  Score=220.66  Aligned_cols=156  Identities=26%  Similarity=0.460  Sum_probs=132.1

Q ss_pred             CCCCCC-eeccCCCccEEEEEcc---CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          201 GFSANN-LIGRGSFGSVYKARLQ---DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       201 ~f~~~~-~iG~G~~g~Vy~~~~~---~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      +|...+ .||+|+||.||+|...   ++..||||.            +.+|++++++++||||+++++++. .+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEE
Confidence            344444 8999999999999853   577899974            457999999999999999999995 45689999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  165 (287)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence            999999999999876667999999999999999999999   88999999999999999999999999999998754332


Q ss_pred             ce-eeecccccCcccCC
Q 040294          345 SM-TQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~-~~~~~~gt~~Y~aP  360 (360)
                      .. ......||+.|+||
T Consensus       166 ~~~~~~~~~~~~~y~aP  182 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAP  182 (287)
T ss_dssp             EECCCCSSCCCGGGCCH
T ss_pred             eeeccccccccccccCH
Confidence            11 12234578999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.95  E-value=1.2e-27  Score=222.48  Aligned_cols=154  Identities=27%  Similarity=0.470  Sum_probs=131.8

Q ss_pred             CCCCCeeccCCCccEEEEEcc-----CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecC--CCeEEE
Q 040294          202 FSANNLIGRGSFGSVYKARLQ-----DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSN--EDFRAL  262 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l  262 (360)
                      |+..+.||+|+||.||++.+.     +++.||||.            +.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            477889999999999988643     678899984            4679999999999999999999987  467899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997653  889999999999999999999   889999999999999999999999999999987654


Q ss_pred             CCc-eeeecccccCcccCC
Q 040294          343 DQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~-~~~~~~~gt~~Y~aP  360 (360)
                      ... .......||+.|+||
T Consensus       188 ~~~~~~~~~~~~~~~y~aP  206 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAP  206 (318)
T ss_dssp             CSEEEC---CCCCGGGCCH
T ss_pred             ccccccccCCCCCceeeCh
Confidence            322 122345688899998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.95  E-value=3.6e-28  Score=227.11  Aligned_cols=156  Identities=26%  Similarity=0.435  Sum_probs=129.4

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ..++|+..+.||+|+||.||+|+. .+++.||||.+             .+|++++++++||||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            456799999999999999999985 47889999843             4799999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee-----cCCCcEEEeecccccc
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL-----DDNIVAHLSDFGIAKL  338 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl-----~~~~~~ki~DFGla~~  338 (360)
                      |||+++ +|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||+     +.++.+||+|||+++.
T Consensus       112 ~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            999985 9999997653 5889999999999999999999   8899999999999999     4555699999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....  .......||+.|+||
T Consensus       187 ~~~~~--~~~~~~~~t~~y~aP  206 (329)
T 3gbz_A          187 FGIPI--RQFTHEIITLWYRPP  206 (329)
T ss_dssp             HC-------------CCTTCCH
T ss_pred             cCCcc--cccCCCcCCccccCH
Confidence            65332  123345789999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=8.2e-28  Score=224.25  Aligned_cols=158  Identities=29%  Similarity=0.502  Sum_probs=135.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-----cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCC--eEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-----QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNED--FRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~  261 (360)
                      ++|+..+.||+|+||.||+|++     .+++.||||.           +.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4577789999999999999983     3688999984           567999999999999999999987654  689


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            999999999999999877667899999999999999999999   88999999999999999999999999999998754


Q ss_pred             CCCcee-eecccccCcccCC
Q 040294          342 EDQSMT-QTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~-~~~~~gt~~Y~aP  360 (360)
                      ...... .....+|..|+||
T Consensus       198 ~~~~~~~~~~~~~~~~y~aP  217 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAP  217 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCH
T ss_pred             cccccccccCCCCceeEECc
Confidence            432211 2234578889998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.5e-28  Score=230.04  Aligned_cols=151  Identities=26%  Similarity=0.427  Sum_probs=126.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED------  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~------  258 (360)
                      .+.|+..+.||+|+||.||+|+. .+|+.||||.+             .+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            35688889999999999999996 57899999853             46999999999999999999998763      


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..++||||+ +++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 88999999763  5788899999999999999999   89999999999999999999999999999997


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....     ....+||++|+||
T Consensus       178 ~~~~-----~~~~~~t~~y~aP  194 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAP  194 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCT
T ss_pred             cccc-----cCcCcCCCCcCCH
Confidence            6432     2345789999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.1e-28  Score=246.66  Aligned_cols=144  Identities=19%  Similarity=0.175  Sum_probs=113.3

Q ss_pred             eccCCCccEEEEE-ccCCcEEEehh---------------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEE
Q 040294          208 IGRGSFGSVYKAR-LQDGMEFAIKS---------------------FDVECEVMKSI-HHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       208 iG~G~~g~Vy~~~-~~~~~~vavK~---------------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .+.|+.|.++.++ ...|+.||+|.                     |.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            3455555555544 33577777763                     56799999999 6999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||++||+|.+++...+ .++..   .|+.||+.||+|+|   +.+||||||||+|||+++++.+||+|||+|+...... 
T Consensus       322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred             ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence            9999999999997654 45543   48999999999999   9999999999999999999999999999999765432 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                       ....+.+||++||||
T Consensus       394 -~~~~t~vGTp~YmAP  408 (569)
T 4azs_A          394 -SWPTNLVQSFFVFVN  408 (569)
T ss_dssp             -CCSHHHHHHHHHHHH
T ss_pred             -ccccCceechhhccH
Confidence             223457899999997

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.95  E-value=5.9e-28  Score=225.68  Aligned_cols=156  Identities=30%  Similarity=0.486  Sum_probs=131.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.             +.+|++++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            346788899999999999999965 689999984             346999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       104 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            999999998876544 35889999999999999999999   88999999999999999999999999999987654321


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......||+.|+||
T Consensus       180 --~~~~~~~t~~y~aP  193 (331)
T 4aaa_A          180 --VYDDEVATRWYRAP  193 (331)
T ss_dssp             ------CCCCCTTCCH
T ss_pred             --ccCCCcCCccccCc
Confidence              22345799999998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.95  E-value=2.3e-27  Score=217.43  Aligned_cols=155  Identities=30%  Similarity=0.469  Sum_probs=132.6

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      .|....+||+|+||.||+|+. .+++.||||.           +..|+.++++++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455567999999999999995 5788999984           4579999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEEeecccccccCCCCCc
Q 040294          269 NGSLEKVLYSSN--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       269 ~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++. ++.+||+|||+++....... 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            999999997653  24568888889999999999999   889999999999999987 89999999999987654321 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.|+||
T Consensus       179 -~~~~~~~~~~y~aP  192 (295)
T 2clq_A          179 -CTETFTGTLQYMAP  192 (295)
T ss_dssp             ---CCCCCCGGGCCH
T ss_pred             -cccccCCCccccCh
Confidence             22345799999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.95  E-value=2.7e-28  Score=224.48  Aligned_cols=157  Identities=27%  Similarity=0.396  Sum_probs=133.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      .+.|+..+.||+|+||.||+|+.. +++.||+|.           +..|++++++++||||+++++++..++..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            456888899999999999999975 688999974           45699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......  ..
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ  172 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence            9999999998765567899999999999999999999   889999999999999999999999999998643211  11


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.|+||
T Consensus       173 ~~~~~~~~~~y~aP  186 (302)
T 2j7t_A          173 KRDSFIGTPYWMAP  186 (302)
T ss_dssp             C-----CCGGGCCH
T ss_pred             ccccccCChhhcCC
Confidence            12345689999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.95  E-value=7e-28  Score=224.69  Aligned_cols=155  Identities=33%  Similarity=0.590  Sum_probs=131.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEE--Eehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEF--AIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~v--avK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..+.||+|+||.||+|+.. ++..+  |+|.            +.+|+++++++ +||||+++++++.+++..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56888899999999999999865 56544  7763            46799999999 899999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcE
Q 040294          264 LEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVA  328 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~  328 (360)
                      |||+++|+|.+++....               ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997643               36899999999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeecccccCcccCC
Q 040294          329 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       329 ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|||+++.....   .......+|+.|+||
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aP  210 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAI  210 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCH
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccCh
Confidence            99999999853321   112334578899998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.95  E-value=1.2e-27  Score=219.70  Aligned_cols=156  Identities=27%  Similarity=0.455  Sum_probs=137.5

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------------HHHHHHhhcCC-CCCeeEEEEEec
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------------DVECEVMKSIH-HRNLVKIISSCS  255 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------------~~E~~~l~~l~-hpniv~l~~~~~  255 (360)
                      ..++|+..+.||+|+||.||+|+.. +++.||||.+                    .+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3567888999999999999999965 7889999853                    35888999996 999999999999


Q ss_pred             CCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccc
Q 040294          256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGI  335 (360)
Q Consensus       256 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGl  335 (360)
                      .++..++||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            999999999999999999999764 35889999999999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCCceeeecccccCcccCC
Q 040294          336 AKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       336 a~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++......   ......||+.|+||
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aP  192 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAP  192 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCH
T ss_pred             hhhcCCCc---ccccccCCccccCH
Confidence            98765432   22345789999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.95  E-value=4.5e-28  Score=232.24  Aligned_cols=155  Identities=32%  Similarity=0.489  Sum_probs=129.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehhh-------HHHHHHhhcCCCCCeeEEEEEecCC------CeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF-------DVECEVMKSIHHRNLVKIISSCSNE------DFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~-------~~E~~~l~~l~hpniv~l~~~~~~~------~~~~lv~e~  266 (360)
                      ..|+..++||+|+||.||+|+...+..+|+|.+       .+|+++++.++|||||+++++|...      ...++||||
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~  119 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY  119 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence            357888999999999999999877777998754       4799999999999999999998543      348899999


Q ss_pred             cCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec-CCCcEEEeecccccccCCCC
Q 040294          267 MTNGSLEKVLY--SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       267 ~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~-~~~~~ki~DFGla~~~~~~~  343 (360)
                      ++++.+.....  .....+++..+..++.|+++||+|||   +.+|+||||||+|||++ .++.+||+|||+|+.+....
T Consensus       120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~  196 (394)
T 4e7w_A          120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE  196 (394)
T ss_dssp             CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence            98754443332  23456889999999999999999999   89999999999999999 79999999999999865433


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                         ......||+.|+||
T Consensus       197 ---~~~~~~~t~~y~aP  210 (394)
T 4e7w_A          197 ---PNVSYICSRYYRAP  210 (394)
T ss_dssp             ---CCCSSCSCGGGCCH
T ss_pred             ---CCcccccCcCccCH
Confidence               22346789999998

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.95  E-value=7.2e-28  Score=232.70  Aligned_cols=154  Identities=33%  Similarity=0.529  Sum_probs=128.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------HHHHHHhhcCCCCCeeEEEEEecC------CCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------DVECEVMKSIHHRNLVKIISSCSN------EDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------~~E~~~l~~l~hpniv~l~~~~~~------~~~~~lv~e  265 (360)
                      ..|+..++||+|+||.||+|+.. +++.||||.+       .+|++++++++|||||+++++|..      ....++|||
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  133 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD  133 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence            35778899999999999999975 6899999854       469999999999999999998843      224679999


Q ss_pred             ccCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-CcEEEeecccccccCC
Q 040294          266 YMTNGSLEKVLY---SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKLLTG  341 (360)
Q Consensus       266 ~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-~~~ki~DFGla~~~~~  341 (360)
                      |+++ ++.+.+.   .....+++..+..++.|+++||+|||   +.+|+||||||+|||++.+ +.+||+|||+++.+..
T Consensus       134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            9986 6666554   23456899999999999999999999   8999999999999999955 6789999999997654


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..   .....+||++|+||
T Consensus       210 ~~---~~~~~~~t~~y~aP  225 (420)
T 1j1b_A          210 GE---PNVSYICSRYYRAP  225 (420)
T ss_dssp             TC---CCCSCCSCTTSCCH
T ss_pred             CC---CceeeeeCCCcCCH
Confidence            33   12346799999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.95  E-value=2.1e-27  Score=217.55  Aligned_cols=151  Identities=30%  Similarity=0.450  Sum_probs=130.0

Q ss_pred             CCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC----CCeEEEE
Q 040294          202 FSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN----EDFRALV  263 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv  263 (360)
                      |...+.||+|+||.||+|.. .++..||+|.             +.+|++++++++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            56677899999999999986 4678899863             4579999999999999999998864    4568999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCceeec-CCCcEEEeecccccccC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP--IIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--iiHrdlk~~NiLl~-~~~~~ki~DFGla~~~~  340 (360)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||   +.+  |+||||||+||+++ .++.+||+|||++....
T Consensus       108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            9999999999999754 35888999999999999999999   777  99999999999998 78999999999998654


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...    .....||+.|+||
T Consensus       184 ~~~----~~~~~~t~~y~aP  199 (290)
T 1t4h_A          184 ASF----AKAVIGTPEFMAP  199 (290)
T ss_dssp             TTS----BEESCSSCCCCCG
T ss_pred             ccc----cccccCCcCcCCH
Confidence            332    2345799999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.95  E-value=1.4e-27  Score=222.68  Aligned_cols=151  Identities=23%  Similarity=0.418  Sum_probs=132.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------hHHHHHHhhcCC-CCCeeEEEEEecC--CCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------FDVECEVMKSIH-HRNLVKIISSCSN--EDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lv~e~~  267 (360)
                      ++|+..+.||+|+||.||+|+. .+++.||||.        +.+|++++++++ ||||+++++++.+  ....++||||+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~  115 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  115 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence            5688889999999999999985 5789999984        467999999997 9999999999987  66789999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-cEEEeecccccccCCCCCce
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++++|.+++..    +++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++......   
T Consensus       116 ~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---  185 (330)
T 3nsz_A          116 NNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---  185 (330)
T ss_dssp             CCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---
T ss_pred             CchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---
Confidence            99999998853    778889999999999999999   89999999999999999766 89999999998765433   


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||..|+||
T Consensus       186 ~~~~~~~~~~y~aP  199 (330)
T 3nsz_A          186 EYNVRVASRYFKGP  199 (330)
T ss_dssp             CCCSCCSCGGGCCH
T ss_pred             ccccccccccccCh
Confidence            22345789999998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.95  E-value=2.7e-27  Score=221.66  Aligned_cols=160  Identities=27%  Similarity=0.450  Sum_probs=136.4

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEccCCcEEEehhh--------HHHHHHhhc--CCCCCeeEEEEEecCCC----eEEEE
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF--------DVECEVMKS--IHHRNLVKIISSCSNED----FRALV  263 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~--------~~E~~~l~~--l~hpniv~l~~~~~~~~----~~~lv  263 (360)
                      ..++|...+.||+|+||.||+|+. +++.||||.+        ..|++++..  ++||||+++++++...+    ..++|
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv  118 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV  118 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence            456799999999999999999998 5889999854        467788776  78999999999998876    78999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG-----FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      |||+++|+|.+++...  .+++..+..++.|++.||+|||..     .+.+|+||||||+||+++.++.+||+|||+++.
T Consensus       119 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  196 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  196 (342)
T ss_dssp             ECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCcee
Confidence            9999999999999764  588999999999999999999932     157899999999999999999999999999987


Q ss_pred             cCCCCCce--eeecccccCcccCC
Q 040294          339 LTGEDQSM--TQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~--~~~~~~gt~~Y~aP  360 (360)
                      ........  ......||+.|+||
T Consensus       197 ~~~~~~~~~~~~~~~~gt~~y~aP  220 (342)
T 1b6c_B          197 HDSATDTIDIAPNHRVGTKRYMAP  220 (342)
T ss_dssp             EETTTTEEEECCCSCCCCGGGCCH
T ss_pred             ccccccccccccccCCcCcccCCH
Confidence            65443221  22345799999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.95  E-value=2e-27  Score=219.02  Aligned_cols=154  Identities=32%  Similarity=0.427  Sum_probs=136.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +.|+..+.||+|+||.||+|+. .+++.||||.            +.+|+.++++++||||+++++++..++..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            4578889999999999999985 4788999984            46799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +++++|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  .
T Consensus       102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  174 (303)
T 3a7i_A          102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I  174 (303)
T ss_dssp             CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence            999999999864  35889999999999999999999   8899999999999999999999999999998765432  1


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.|+||
T Consensus       175 ~~~~~~~~~~y~aP  188 (303)
T 3a7i_A          175 KRNTFVGTPFWMAP  188 (303)
T ss_dssp             CBCCCCSCGGGCCH
T ss_pred             ccCccCCCcCccCH
Confidence            22345799999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.95  E-value=5.1e-28  Score=225.16  Aligned_cols=153  Identities=31%  Similarity=0.421  Sum_probs=132.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------------hHHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------------FDVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------------~~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      ++|...+.||+|+||.||+|+.. +++.||||.                   +.+|++++++++||||+++++++..++ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            46888999999999999999864 688999984                   457999999999999999999998766 


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc---EEEeecccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV---AHLSDFGIA  336 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~---~ki~DFGla  336 (360)
                      .++||||+++|+|.+++... ..+++.....++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            79999999999999988654 46889999999999999999999   889999999999999987654   999999999


Q ss_pred             cccCCCCCceeeecccccCcccCC
Q 040294          337 KLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +......   ......||+.|+||
T Consensus       165 ~~~~~~~---~~~~~~gt~~y~aP  185 (322)
T 2ycf_A          165 KILGETS---LMRTLCGTPTYLAP  185 (322)
T ss_dssp             EECCCCH---HHHHHHSCCTTCCH
T ss_pred             eeccccc---ccccccCCcCccCc
Confidence            8764321   12345799999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.95  E-value=1.7e-27  Score=220.29  Aligned_cols=157  Identities=28%  Similarity=0.497  Sum_probs=125.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.              +.+|++++++++||||+++++++..++..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            34688899999999999999985 5789999984              34699999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          264 LEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864   3456889999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....  ......||+.|+||
T Consensus       188 ~~~~--~~~~~~~~~~y~aP  205 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSP  205 (310)
T ss_dssp             -------------CCSSCCH
T ss_pred             CCCc--cccccCCCeeEeCh
Confidence            3321  22345689999998

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.94  E-value=1.4e-27  Score=219.36  Aligned_cols=155  Identities=30%  Similarity=0.497  Sum_probs=135.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+             .+|++++++++||||+++++++..++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            57888899999999999999965 7899999843             468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          266 YMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |++ |+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  158 (299)
T 2r3i_A           83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  158 (299)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCcc
Confidence            998 69999987653 45888899999999999999999   88999999999999999999999999999987653321


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                        ......||+.|+||
T Consensus       159 --~~~~~~~~~~y~aP  172 (299)
T 2r3i_A          159 --TYTHEVVTLWYRAP  172 (299)
T ss_dssp             --CTTSCBCCCTTCCH
T ss_pred             --ccCcccccccccCc
Confidence              22345689999998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.94  E-value=7.3e-28  Score=220.19  Aligned_cols=155  Identities=27%  Similarity=0.343  Sum_probs=123.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhhH-------------HHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSFD-------------VECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~-------------~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.+.             .+...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            35688889999999999999996 578999998541             2334578889999999999999999999999


Q ss_pred             EccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          265 EYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFST-PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       265 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~-~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ||++ |+|.+++..   ....+++..+..++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 488777653   4557899999999999999999999   76 99999999999999999999999999998765


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...   ......||+.|+||
T Consensus       162 ~~~---~~~~~~~t~~y~aP  178 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAP  178 (290)
T ss_dssp             -----------CCCCCCSCH
T ss_pred             ccc---cccccCCCccccCh
Confidence            432   22334799999998

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.94  E-value=4.1e-28  Score=228.20  Aligned_cols=156  Identities=21%  Similarity=0.281  Sum_probs=125.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc----CCcEEEehhh----------------------HHHHHHhhcCCCCCeeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKSF----------------------DVECEVMKSIHHRNLVKIISS  253 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~----------------------~~E~~~l~~l~hpniv~l~~~  253 (360)
                      ++|...+.||+|+||.||+|+..    ++..+|||.+                      ..|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            56888899999999999999975    5678898732                      246677788899999999999


Q ss_pred             ecC----CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC--c
Q 040294          254 CSN----EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI--V  327 (360)
Q Consensus       254 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~--~  327 (360)
                      +..    ....++||||+ +++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++  .
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence            987    67899999999 999999997654 6899999999999999999999   88999999999999999877  9


Q ss_pred             EEEeecccccccCCCCCc-----eeeecccccCcccCC
Q 040294          328 AHLSDFGIAKLLTGEDQS-----MTQTQTLATIGYMAP  360 (360)
Q Consensus       328 ~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aP  360 (360)
                      +||+|||+++.+......     .......||+.|+||
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  229 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSL  229 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCH
Confidence            999999999876432111     111345799999998

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=1.3e-27  Score=224.49  Aligned_cols=154  Identities=27%  Similarity=0.442  Sum_probs=137.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh----------------------------hHHHHHHhhcCCCCCeeEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------------------------FDVECEVMKSIHHRNLVKI  250 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------------------------~~~E~~~l~~l~hpniv~l  250 (360)
                      .++|...+.||+|+||.||+|+. +++.||||.                            +.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788999999999999999999 899999973                            3568999999999999999


Q ss_pred             EEEecCCCeEEEEEEccCCCCHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCceee
Q 040294          251 ISSCSNEDFRALVLEYMTNGSLEKV------LYSS-NCILDILQRLNIMINVTSALEYLHFGFS-TPIIHCDLKPHNVLL  322 (360)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~-~~iiHrdlk~~NiLl  322 (360)
                      ++++.+.+..++||||+++|+|.++      +... ...+++..+..++.|++.||+|||   + .+|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5442 456899999999999999999999   7 899999999999999


Q ss_pred             cCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          323 DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       323 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.++.+||+|||+++.....    ......||+.|+||
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aP  219 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPP  219 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCG
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCc
Confidence            99999999999999876433    23456799999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.94  E-value=2.4e-27  Score=217.20  Aligned_cols=159  Identities=27%  Similarity=0.434  Sum_probs=133.5

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEe-cCCCeEEEEEEc
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSC-SNEDFRALVLEY  266 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e~  266 (360)
                      ..++|+..+.||+|+||.||+|+. .+++.||||.         +..|+++++.++|++++..+.++ ..++..++||||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            457899999999999999999995 5788999983         57899999999988877666555 667788999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee---cCCCcEEEeecccccccCCCC
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl---~~~~~~ki~DFGla~~~~~~~  343 (360)
                      + +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9 99999999866667999999999999999999999   8899999999999999   788999999999998865443


Q ss_pred             Cc-----eeeecccccCcccCC
Q 040294          344 QS-----MTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~-----~~~~~~~gt~~Y~aP  360 (360)
                      ..     .......||+.|+||
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCH
T ss_pred             cCccCCCCcccccCCCccccch
Confidence            21     122356799999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.94  E-value=1.3e-27  Score=220.57  Aligned_cols=153  Identities=29%  Similarity=0.501  Sum_probs=134.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ++|...+.||+|+||.||+|+.. +|+.||+|.           +.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            45788899999999999999965 789999984           457999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee---cCCCcEEEeecccccccCCCCC
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl---~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++...... 
T Consensus        89 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-  163 (304)
T 2jam_A           89 SGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-  163 (304)
T ss_dssp             CSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred             CCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence            9999999986543 5788899999999999999999   8899999999999999   788999999999998643221 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         .....||+.|+||
T Consensus       164 ---~~~~~~~~~y~aP  176 (304)
T 2jam_A          164 ---MSTACGTPGYVAP  176 (304)
T ss_dssp             ---THHHHSCCCBCCT
T ss_pred             ---cccccCCCCccCh
Confidence               2345699999998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.94  E-value=3.8e-28  Score=226.09  Aligned_cols=159  Identities=30%  Similarity=0.441  Sum_probs=132.0

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh----------hHHHHHHhhcC-CCCCeeEEEEEecC------CC
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS----------FDVECEVMKSI-HHRNLVKIISSCSN------ED  258 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~----------~~~E~~~l~~l-~hpniv~l~~~~~~------~~  258 (360)
                      ...+.|+..+.||+|+||.||+|+. .+++.||||.          +.+|+++++++ +||||+++++++..      .+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            3567788999999999999999996 4789999984          46799999998 79999999999976      46


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ..++||||+++|+|.+++.... ..+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence            8899999999999999997643 45888899999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ......  .......||+.|+||
T Consensus       178 ~~~~~~--~~~~~~~~~~~y~aP  198 (326)
T 2x7f_A          178 QLDRTV--GRRNTFIGTPYWMAP  198 (326)
T ss_dssp             ---------------CCGGGCCH
T ss_pred             ecCcCc--cccccccCCccccCh
Confidence            764322  122345799999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.94  E-value=2e-28  Score=233.13  Aligned_cols=151  Identities=17%  Similarity=0.238  Sum_probs=124.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHH---HHhhcCCCCCeeEEE-------EEe
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVEC---EVMKSIHHRNLVKII-------SSC  254 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~---~~l~~l~hpniv~l~-------~~~  254 (360)
                      ++|...+.||+|+||.||+|+. .+|+.||||.+              .+|+   +++++++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            4677789999999999999996 57899999853              4788   556667899999998       666


Q ss_pred             cCCC-----------------eEEEEEEccCCCCHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 040294          255 SNED-----------------FRALVLEYMTNGSLEKVLYSSNC------ILDILQRLNIMINVTSALEYLHFGFSTPII  311 (360)
Q Consensus       255 ~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~yLH~~~~~~ii  311 (360)
                      ..++                 ..++||||+ +|+|.+++.....      .+++..+..|+.|++.||+|||   +.+|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            5543                 278999999 6899999975322      2335788889999999999999   88999


Q ss_pred             EccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       312 Hrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||||||+|||++.++.+||+|||+|+....     .....+| +.|+||
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aP  271 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPP  271 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccCh
Confidence            999999999999999999999999986432     2345568 999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.94  E-value=1.4e-27  Score=242.65  Aligned_cols=157  Identities=27%  Similarity=0.441  Sum_probs=130.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc----CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ----DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      .++|+..+.||+|+||.||+|++.    .+..||||.            +..|+.++++++|||||++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            346777899999999999999864    245688873            4579999999999999999999964 56899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            99999999999999877667899999999999999999999   889999999999999999999999999999976543


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      . ........+|+.||||
T Consensus       545 ~-~~~~~~~~~t~~y~aP  561 (656)
T 2j0j_A          545 T-YYKASKGKLPIKWMAP  561 (656)
T ss_dssp             ----------CCGGGCCH
T ss_pred             c-ceeccCCCCCcceeCH
Confidence            2 1222344678899998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.94  E-value=9e-28  Score=222.65  Aligned_cols=159  Identities=25%  Similarity=0.355  Sum_probs=132.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEec----CCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCS----NEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~----~~~~~~l  262 (360)
                      .++|+..+.||+|+||.||+++. .+++.||||.           +.+|++++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            34688889999999999999996 5789999984           457999999999999999999986    3457899


Q ss_pred             EEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          263 VLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      ||||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999875   3456899999999999999999999   889999999999999999999999999998865


Q ss_pred             CCCCCc-------eeeecccccCcccCC
Q 040294          340 TGEDQS-------MTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~-------~~~~~~~gt~~Y~aP  360 (360)
                      ......       .......||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  212 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAP  212 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred             ccccccccccccccccccccCCcccCCH
Confidence            321100       001234579999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.94  E-value=5.1e-28  Score=220.13  Aligned_cols=157  Identities=30%  Similarity=0.473  Sum_probs=132.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEec--CCCeEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCS--NEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~l  262 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.             +.+|++++++++||||+++++++.  .++..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357888899999999999999965 788999974             456999999999999999999874  4678999


Q ss_pred             EEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-----eEEccCCCCceeecCCCcEEEeecc
Q 040294          263 VLEYMTNGSLEKVLYSS---NCILDILQRLNIMINVTSALEYLHFGFSTP-----IIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~-----iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999743   334899999999999999999999   666     9999999999999999999999999


Q ss_pred             cccccCCCCCceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++.......  ......||+.|+||
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aP  185 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSP  185 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCH
T ss_pred             hheeeccccc--cccccCCCccccCh
Confidence            9987653321  12245689999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.94  E-value=1.1e-27  Score=244.87  Aligned_cols=148  Identities=25%  Similarity=0.426  Sum_probs=128.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc--CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCe-----E
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ--DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDF-----R  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~-----~  260 (360)
                      ++|++.+.||+|+||.||+|+..  +++.||||.            +..|++++++++|||||+++++|...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67889999999999999999964  688999984            3568999999999999999999987654     7


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |+||||++|++|.+++..   .+++.++..++.||+.||+|||   +.+|+||||||+|||++.+ .+||+|||+++...
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            999999999999987754   5899999999999999999999   8899999999999999986 89999999998765


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..      ....||++||||
T Consensus       233 ~~------~~~~gt~~y~aP  246 (681)
T 2pzi_A          233 SF------GYLYGTPGFQAP  246 (681)
T ss_dssp             CC------SCCCCCTTTSCT
T ss_pred             cC------CccCCCccccCH
Confidence            32      345799999999

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.94  E-value=2.8e-27  Score=224.86  Aligned_cols=152  Identities=27%  Similarity=0.347  Sum_probs=122.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCC------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNED------  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~------  258 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.             +.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            35788899999999999999985 4788999984             346999999999999999999997665      


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..++||||+++ +|.+.+..   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 78888853   4788899999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....   ......||+.|+||
T Consensus       177 ~~~~~---~~~~~~gt~~y~aP  195 (371)
T 2xrw_A          177 AGTSF---MMTPYVVTRYYRAP  195 (371)
T ss_dssp             ----------------CTTCCH
T ss_pred             ccccc---ccCCceecCCccCH
Confidence            64321   23346799999998

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.94  E-value=1.7e-27  Score=241.26  Aligned_cols=150  Identities=29%  Similarity=0.447  Sum_probs=123.8

Q ss_pred             CeeccCCCccEEEEEcc---CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ---DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~---~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      +.||+|+||.||+|.+.   +++.||||.             +.+|++++++++|||||+++++|..+ ..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence            47999999999999653   467899973             45799999999999999999999755 47899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc-eee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS-MTQ  348 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~-~~~  348 (360)
                      |+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus       454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            9999999754 46889999999999999999999   889999999999999999999999999999987544321 222


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....||+.|+||
T Consensus       530 ~~~~~t~~y~AP  541 (635)
T 4fl3_A          530 THGKWPVKWYAP  541 (635)
T ss_dssp             -----CGGGSCH
T ss_pred             cCCCCceeeeCh
Confidence            344578899998

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.94  E-value=2.4e-27  Score=227.80  Aligned_cols=155  Identities=24%  Similarity=0.429  Sum_probs=116.7

Q ss_pred             CCC-CCeeccCCCccEEEEEcc---CCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEe--cCCCeEEEEEEc
Q 040294          202 FSA-NNLIGRGSFGSVYKARLQ---DGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSC--SNEDFRALVLEY  266 (360)
Q Consensus       202 f~~-~~~iG~G~~g~Vy~~~~~---~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~--~~~~~~~lv~e~  266 (360)
                      |+. .++||+|+||.||+|+++   +++.||||.         +.+|++++++++|||||+++++|  ..+...++||||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~  101 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY  101 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence            444 468999999999999965   578899984         45799999999999999999999  457789999999


Q ss_pred             cCCCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee----cCCCcEEEeecc
Q 040294          267 MTNGSLEKVLYSS--------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL----DDNIVAHLSDFG  334 (360)
Q Consensus       267 ~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl----~~~~~~ki~DFG  334 (360)
                      ++ |+|.+++...        ...+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||
T Consensus       102 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A          102 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             CS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             CC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            97 4888877521        124889999999999999999999   8899999999999999    678999999999


Q ss_pred             cccccCCCCCc-eeeecccccCcccCC
Q 040294          335 IAKLLTGEDQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~-~~~~~~~gt~~Y~aP  360 (360)
                      +|+........ ......+||++|+||
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aP  204 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAP  204 (405)
T ss_dssp             CCC----------------CCCTTCCH
T ss_pred             CceecCCCCcccccCCCceecCcccCc
Confidence            99876543211 223456799999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.94  E-value=2.1e-27  Score=217.29  Aligned_cols=157  Identities=26%  Similarity=0.399  Sum_probs=126.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc--CCc--EEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ--DGM--EFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~--~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      ++|+..+.||+|+||.||+|++.  +++  .||||.+              .+|++++++++||||+++++++..++ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            46888899999999999999853  333  5888743              46899999999999999999998876 78


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999999999876566889999999999999999999   88999999999999999999999999999988754


Q ss_pred             CCCce-eeecccccCcccCC
Q 040294          342 EDQSM-TQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~-~~~~~~gt~~Y~aP  360 (360)
                      ..... ......+|+.|+||
T Consensus       174 ~~~~~~~~~~~~~~~~y~aP  193 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAP  193 (291)
T ss_dssp             -CCEEEC-----CCGGGCCH
T ss_pred             cccchhhhccCCCCceeeCc
Confidence            43221 22345688899998

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.94  E-value=4.1e-28  Score=228.74  Aligned_cols=157  Identities=18%  Similarity=0.288  Sum_probs=132.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC---------CcEEEehh------hHHHHHHhhcCCCCCeeE---------------
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD---------GMEFAIKS------FDVECEVMKSIHHRNLVK---------------  249 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~---------~~~vavK~------~~~E~~~l~~l~hpniv~---------------  249 (360)
                      ++|...+.||+|+||.||+|+...         ++.||||.      +.+|++++++++||||++               
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~  121 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT  121 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence            578888999999999999999753         78899984      578999999999999987               


Q ss_pred             EEEEecC-CCeEEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-
Q 040294          250 IISSCSN-EDFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-  326 (360)
Q Consensus       250 l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-  326 (360)
                      +++++.. ++..++||||+ +++|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++ 
T Consensus       122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~  197 (352)
T 2jii_A          122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQ  197 (352)
T ss_dssp             CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEE
T ss_pred             hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCC
Confidence            5667665 67899999999 99999999865 356899999999999999999999   88999999999999999988 


Q ss_pred             -cEEEeecccccccCCCCCc-----eeeecccccCcccCC
Q 040294          327 -VAHLSDFGIAKLLTGEDQS-----MTQTQTLATIGYMAP  360 (360)
Q Consensus       327 -~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aP  360 (360)
                       .+||+|||+++.+......     .......||+.|+||
T Consensus       198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  237 (352)
T 2jii_A          198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM  237 (352)
T ss_dssp             EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH
T ss_pred             ceEEEecCcceeeccCCCccccccccccccccCCccccCH
Confidence             9999999999876532211     112345799999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.94  E-value=7.5e-27  Score=229.10  Aligned_cols=158  Identities=25%  Similarity=0.374  Sum_probs=136.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh---------hHHHHHHhhcCCC-CCeeEEEEEecCCCeEEEEEEcc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS---------FDVECEVMKSIHH-RNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~---------~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.         +..|+++++.++| ++++.+..++...+..++||||+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            46789999999999999999995 5789999983         5789999999987 56667777778888999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee---cCCCcEEEeecccccccCCCCC
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl---~~~~~~ki~DFGla~~~~~~~~  344 (360)
                       +++|.+++......+++..++.|+.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.+.....
T Consensus        86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence             99999999876667999999999999999999999   8899999999999999   6889999999999998764432


Q ss_pred             c-----eeeecccccCcccCC
Q 040294          345 S-----MTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~-----~~~~~~~gt~~Y~aP  360 (360)
                      .     .......||+.|+||
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aP  182 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASV  182 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCH
T ss_pred             ccccccccccccCCCccccCH
Confidence            1     112356799999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.94  E-value=4.8e-27  Score=219.26  Aligned_cols=156  Identities=24%  Similarity=0.383  Sum_probs=130.5

Q ss_pred             hCCCCCC-CeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEEE
Q 040294          199 TNGFSAN-NLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIH-HRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       199 ~~~f~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l  262 (360)
                      .+.|... +.||+|+||.||+|+.. +++.||+|.             +.+|+.++++++ ||||+++++++...+..++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            3445555 78999999999999865 789999984             456899999885 6999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEeecccccc
Q 040294          263 VLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKL  338 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~DFGla~~  338 (360)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++.
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            99999999999998643 346899999999999999999999   889999999999999987   78999999999997


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .....   ......||+.|+||
T Consensus       184 ~~~~~---~~~~~~gt~~y~aP  202 (327)
T 3lm5_A          184 IGHAC---ELREIMGTPEYLAP  202 (327)
T ss_dssp             C------------CCCGGGCCH
T ss_pred             cCCcc---ccccccCCcCccCC
Confidence            65332   22346799999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.94  E-value=2.7e-27  Score=224.26  Aligned_cols=156  Identities=26%  Similarity=0.380  Sum_probs=133.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCC-----CeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNE-----DFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~  260 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.            +.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457888999999999999999854 788899984            34799999999999999999998755     368


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||++ |+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999997 5999998754  4889999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCce-eeecccccCcccCC
Q 040294          341 GEDQSM-TQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~-~~~~~~gt~~Y~aP  360 (360)
                      ...... .....+||+.|+||
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aP  200 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAP  200 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCH
T ss_pred             CCCCccccccccccccCCCCC
Confidence            332111 12345799999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.94  E-value=1.9e-27  Score=230.45  Aligned_cols=157  Identities=27%  Similarity=0.480  Sum_probs=127.2

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehhh--------HHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEccCCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF--------DVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~--------~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g  270 (360)
                      .+|+..++||+|+||.||.....+++.||||.+        .+|+++++++ +|||||++++++.+.+..++|||||. |
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g  102 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A  102 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence            457788999999999976555567899999853        6799999999 79999999999999999999999996 5


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-----CCcEEEeecccccccCCCCCc
Q 040294          271 SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-----NIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       271 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-----~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +|.+++........+..+..++.|++.||+|||   +.+|+||||||+|||++.     ...+||+|||+|+.+......
T Consensus       103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~  179 (432)
T 3p23_A          103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS  179 (432)
T ss_dssp             EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred             CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence            999999876655555566789999999999999   889999999999999943     346889999999987543211


Q ss_pred             -eeeecccccCcccCC
Q 040294          346 -MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 -~~~~~~~gt~~Y~aP  360 (360)
                       ......+||++|+||
T Consensus       180 ~~~~~~~~gt~~y~AP  195 (432)
T 3p23_A          180 FSRRSGVPGTEGWIAP  195 (432)
T ss_dssp             ------CCSCTTSCCG
T ss_pred             eeeccccCCCcCccCh
Confidence             223456799999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.94  E-value=4.5e-27  Score=221.19  Aligned_cols=156  Identities=27%  Similarity=0.445  Sum_probs=131.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCC-----CeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNE-----DFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~-----~~~  260 (360)
                      .++|+..+.||+|+||.||+|+.. +|+.||||.+            .+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467888999999999999999965 7889999853            4799999999999999999998764     678


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      ++||||++ |+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 5999998763  5889999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCce--------eeecccccCcccCC
Q 040294          341 GEDQSM--------TQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~--------~~~~~~gt~~Y~aP  360 (360)
                      ......        .....+||+.|+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAP  191 (353)
T ss_dssp             ----------------CCCCCCGGGCCH
T ss_pred             cccccccCccccccchhhccccccccCC
Confidence            322110        11235789999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.94  E-value=5.6e-27  Score=214.95  Aligned_cols=158  Identities=27%  Similarity=0.436  Sum_probs=134.6

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEe-cCCCeEEEEEEcc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSC-SNEDFRALVLEYM  267 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e~~  267 (360)
                      .++|+..+.||+|+||.||+|+. .+++.||||.         +..|+++++.++|++++..+.++ ..++..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            46788999999999999999995 5889999983         57899999999988866555554 6677889999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee---cCCCcEEEeecccccccCCCCC
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL---DDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl---~~~~~~ki~DFGla~~~~~~~~  344 (360)
                       +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++.......
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence             99999999866667999999999999999999999   8899999999999999   4889999999999988654432


Q ss_pred             c-----eeeecccccCcccCC
Q 040294          345 S-----MTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~-----~~~~~~~gt~~Y~aP  360 (360)
                      .     .......||+.|+||
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCH
T ss_pred             ccccccccccccccccccCCh
Confidence            1     112346799999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.94  E-value=1.4e-27  Score=217.31  Aligned_cols=153  Identities=32%  Similarity=0.488  Sum_probs=125.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEecCC-CeEEEEEEccC
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSNE-DFRALVLEYMT  268 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~~~  268 (360)
                      .++|+..+.||+|+||.||+|+.. ++.||||.         +.+|++++++++||||+++++++... +..++||||++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            356888899999999999999874 78899984         56799999999999999999997654 47899999999


Q ss_pred             CCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          269 NGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       269 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +|+|.+++..... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......    
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----  171 (278)
T 1byg_A           99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----  171 (278)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence            9999999975432 3788889999999999999999   8899999999999999999999999999998654321    


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                       ....+|+.|+||
T Consensus       172 -~~~~~~~~y~aP  183 (278)
T 1byg_A          172 -DTGKLPVKWTAP  183 (278)
T ss_dssp             -----CCTTTSCH
T ss_pred             -cCCCccccccCH
Confidence             233578899998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.94  E-value=5.7e-27  Score=218.54  Aligned_cols=157  Identities=28%  Similarity=0.362  Sum_probs=121.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCC-CCCeeEEEEEe--------cCCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIH-HRNLVKIISSC--------SNED  258 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~-hpniv~l~~~~--------~~~~  258 (360)
                      .+|+..+.||+|+||.||+|+. .+++.||||.           +.+|+.+++++. ||||+++++++        ....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            4678889999999999999996 4789999984           356889999996 99999999998        3445


Q ss_pred             eEEEEEEccCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCceeecCCCcEEEeecc
Q 040294          259 FRALVLEYMTNGSLEKVLYS--SNCILDILQRLNIMINVTSALEYLHFGFSTP--IIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                      ..++||||+. |+|.+++..  ....+++..+..++.|++.||+|||   +.+  |+||||||+|||++.++.+||+|||
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            6899999996 799998864  3456899999999999999999999   777  9999999999999999999999999


Q ss_pred             cccccCCCCCce----------eeecccccCcccCC
Q 040294          335 IAKLLTGEDQSM----------TQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~~----------~~~~~~gt~~Y~aP  360 (360)
                      +++.........          ......||+.|+||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP  219 (337)
T ss_dssp             TCBCCSSCC---------------------------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCCh
Confidence            998765432110          11245699999998

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.94  E-value=1.8e-27  Score=226.09  Aligned_cols=150  Identities=12%  Similarity=0.110  Sum_probs=112.4

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHH---HHHhhcCCCCCeeEEEE-------Eec
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVE---CEVMKSIHHRNLVKIIS-------SCS  255 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E---~~~l~~l~hpniv~l~~-------~~~  255 (360)
                      .|...+.||+|+||.||+|+.. +++.||||.+              ..|   ++.++. +||||++++.       ++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            4778899999999999999964 7899999843              356   445556 7999988653       332


Q ss_pred             CC-----------------CeEEEEEEccCCCCHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHhhhcCCCCeEE
Q 040294          256 NE-----------------DFRALVLEYMTNGSLEKVLYSSNCILDILQR------LNIMINVTSALEYLHFGFSTPIIH  312 (360)
Q Consensus       256 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~yLH~~~~~~iiH  312 (360)
                      .+                 ...++||||++ |+|.+++...+..+++..+      ..++.|++.||+|||   +.+|+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCcc
Confidence            22                 34799999999 8999999865434455556      778899999999999   899999


Q ss_pred             ccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       313 rdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |||||+|||++.++.+||+|||+|+....     ......||+.|+||
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aP  260 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPR  260 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCH
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcCh
Confidence            99999999999999999999999997532     12245678999998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.94  E-value=5.8e-27  Score=214.81  Aligned_cols=156  Identities=27%  Similarity=0.433  Sum_probs=129.9

Q ss_pred             CCCCCCC-eeccCCCccEEEEEc---cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANN-LIGRGSFGSVYKARL---QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~-~iG~G~~g~Vy~~~~---~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|...+ .||+|+||.||+|.+   .+++.||||.             +.+|++++++++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4566666 899999999999964   3467899874             45689999999999999999999 4566899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      ||||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        95 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            99999999999999764 35889999999999999999999   889999999999999999999999999999887544


Q ss_pred             CCce-eeecccccCcccCC
Q 040294          343 DQSM-TQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~-~~~~~~gt~~Y~aP  360 (360)
                      .... ......+|+.|+||
T Consensus       171 ~~~~~~~~~~~~~~~y~aP  189 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAP  189 (291)
T ss_dssp             CSEEEC----CCCGGGCCH
T ss_pred             CCcccccccCCCCceeeCh
Confidence            3221 12234577899998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.94  E-value=9.4e-27  Score=219.61  Aligned_cols=163  Identities=25%  Similarity=0.399  Sum_probs=123.4

Q ss_pred             HHHHHHhCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh----------HHHHHHhhcCCCCCeeEEEEEecCCC---
Q 040294          193 LELLRATNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF----------DVECEVMKSIHHRNLVKIISSCSNED---  258 (360)
Q Consensus       193 ~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~----------~~E~~~l~~l~hpniv~l~~~~~~~~---  258 (360)
                      .+.....++|+..+.||+|+||.||+|+.. +++.||||.+          ..|++.++.++||||++++++|...+   
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            345567789999999999999999999964 7899999843          45677788899999999999986533   


Q ss_pred             ----eEEEEEEccCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEE
Q 040294          259 ----FRALVLEYMTNGSLEKVLY---SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHL  330 (360)
Q Consensus       259 ----~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki  330 (360)
                          ..++||||+++ +|.+.+.   .....+++..+..++.|++.||.||| .++.+|+||||||+|||++. ++.+||
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                37899999986 5544443   23456888899999999999999999 34689999999999999996 899999


Q ss_pred             eecccccccCCCCCceeeecccccCcccCC
Q 040294          331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       331 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +|||+++.+....   ......||+.|+||
T Consensus       174 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aP  200 (360)
T 3e3p_A          174 CDFGSAKKLSPSE---PNVAYICSRYYRAP  200 (360)
T ss_dssp             CCCTTCBCCCTTS---CCCSTTSCGGGCCH
T ss_pred             eeCCCceecCCCC---CcccccCCcceeCH
Confidence            9999999765433   22345789999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.94  E-value=1.6e-27  Score=226.21  Aligned_cols=151  Identities=27%  Similarity=0.430  Sum_probs=114.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC------C
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE------D  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~------~  258 (360)
                      .++|+..+.||+|+||.||+|+. .+|+.||||.+             .+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46788899999999999999985 57899999853             3699999999999999999998754      5


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..++||||+ +++|.+++..  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 7899988865  35889999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....     ....+||++|+||
T Consensus       182 ~~~~-----~~~~~~t~~y~aP  198 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAP  198 (367)
T ss_dssp             --------------CCCTTCCH
T ss_pred             cccc-----CCCcCcCcCccCh
Confidence            5432     2346799999998

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.94  E-value=7.7e-27  Score=226.10  Aligned_cols=152  Identities=23%  Similarity=0.364  Sum_probs=130.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh----------HHHHHHhhcC------CCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF----------DVECEVMKSI------HHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~----------~~E~~~l~~l------~hpniv~l~~~~~~~~~~~l  262 (360)
                      .+|+..+.||+|+||.||+|+.. +++.||||.+          ..|+++++.+      .|+||+++++++...+..++
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            46888899999999999999854 6889999854          4577777765      67899999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc--EEEeeccccccc
Q 040294          263 VLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV--AHLSDFGIAKLL  339 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~--~ki~DFGla~~~  339 (360)
                      ||||+. ++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||+++..
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            999996 69999887654 35899999999999999999999   889999999999999999887  999999999865


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...     ....+||+.||||
T Consensus       253 ~~~-----~~~~~gt~~y~aP  268 (429)
T 3kvw_A          253 HQR-----VYTYIQSRFYRAP  268 (429)
T ss_dssp             TCC-----CCSSCSCGGGCCH
T ss_pred             CCc-----ccccCCCCCccCh
Confidence            432     2345799999998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.94  E-value=6.4e-27  Score=217.61  Aligned_cols=156  Identities=29%  Similarity=0.472  Sum_probs=132.8

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc--cCCcEEEehh-------------hHHHHHHhhcC---CCCCeeEEEEEec----
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL--QDGMEFAIKS-------------FDVECEVMKSI---HHRNLVKIISSCS----  255 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~-------------~~~E~~~l~~l---~hpniv~l~~~~~----  255 (360)
                      ..++|+..+.||+|+||.||+|+.  .+++.||+|.             +.+|+++++.+   +||||++++++|.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999996  4678899984             34677777665   8999999999987    


Q ss_pred             -CCCeEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeec
Q 040294          256 -NEDFRALVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDF  333 (360)
Q Consensus       256 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DF  333 (360)
                       .....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5567899999998 69999987643 34889999999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCCceeeecccccCcccCC
Q 040294          334 GIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       334 Gla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+++......   ......||+.|+||
T Consensus       165 g~~~~~~~~~---~~~~~~~~~~y~aP  188 (326)
T 1blx_A          165 GLARIYSFQM---ALTSVVVTLWYRAP  188 (326)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCH
T ss_pred             cccccccCCC---CccccccccceeCH
Confidence            9998754221   22345789999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.94  E-value=2e-27  Score=220.32  Aligned_cols=156  Identities=26%  Similarity=0.431  Sum_probs=129.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||.||+|+..+  .+|+|.             +.+|++++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4678889999999999999998754  477763             4579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC-
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ-  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~-  344 (360)
                      |+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++ ++.+||+|||+++....... 
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred             cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence            99999999999876667889999999999999999999   88999999999999998 67999999999876532111 


Q ss_pred             --ceeeecccccCcccCC
Q 040294          345 --SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 --~~~~~~~~gt~~Y~aP  360 (360)
                        ........||+.|+||
T Consensus       186 ~~~~~~~~~~g~~~y~aP  203 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAP  203 (319)
T ss_dssp             --CCSCBCCSGGGGTSCH
T ss_pred             ccccccccCCCcccccCh
Confidence              1122334689999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.94  E-value=1.3e-26  Score=214.66  Aligned_cols=155  Identities=26%  Similarity=0.400  Sum_probs=123.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEec------------
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCS------------  255 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~------------  255 (360)
                      ++|...+.||+|+||.||+|+.. +++.||||.           +.+|++++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            56888899999999999999975 588999984           457999999999999999999874            


Q ss_pred             --CCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec-CCCcEEEee
Q 040294          256 --NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSD  332 (360)
Q Consensus       256 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~-~~~~~ki~D  332 (360)
                        ..+..++||||++ |+|.+++..  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++ +++.+||+|
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence              4467899999998 699999864  35788899999999999999999   88999999999999997 567999999


Q ss_pred             cccccccCCCCC-ceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQ-SMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~-~~~~~~~~gt~~Y~aP  360 (360)
                      ||+++....... ........||..|+||
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSP  193 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCH
T ss_pred             CccccccCCCcccccccccccccccccCc
Confidence            999987653221 1122345689999998

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.94  E-value=5.5e-27  Score=217.21  Aligned_cols=156  Identities=25%  Similarity=0.393  Sum_probs=128.8

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCC--CCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIH--HRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+++..+++.||||.             +.+|++++++++  ||||+++++++..++..++|
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            456888899999999999999988899999984             356899999997  59999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      || +.+++|.+++... ..+++..+..++.|+++||+|||   +.+|+||||||+||++++ +.+||+|||+++.+....
T Consensus       107 ~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred             Ee-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence            99 5688999999765 36788899999999999999999   889999999999999974 899999999998765443


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .........||+.|+||
T Consensus       181 ~~~~~~~~~gt~~y~aP  197 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPP  197 (313)
T ss_dssp             ---------CCGGGCCH
T ss_pred             ccccccCCCCCCCcCCH
Confidence            22223355799999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.94  E-value=8.3e-27  Score=218.60  Aligned_cols=155  Identities=26%  Similarity=0.392  Sum_probs=117.6

Q ss_pred             hCCCCCC-CeeccCCCccEEEEEcc-CCcEEEehhh------HHHH-HHhhcCCCCCeeEEEEEecC----CCeEEEEEE
Q 040294          199 TNGFSAN-NLIGRGSFGSVYKARLQ-DGMEFAIKSF------DVEC-EVMKSIHHRNLVKIISSCSN----EDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~------~~E~-~~l~~l~hpniv~l~~~~~~----~~~~~lv~e  265 (360)
                      .++|... ++||+|+||.||+|+.. +++.||||.+      ..|+ ..++.++||||+++++++..    +...++|||
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  106 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME  106 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence            4567774 57999999999999965 7899999964      2333 34667899999999999876    456899999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEeecccccccCC
Q 040294          266 YMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~DFGla~~~~~  341 (360)
                      |+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++....
T Consensus       107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            999999999998654 36899999999999999999999   889999999999999976   45699999999987643


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..    .....||+.|+||
T Consensus       184 ~~----~~~~~~t~~y~aP  198 (336)
T 3fhr_A          184 NA----LQTPCYTPYYVAP  198 (336)
T ss_dssp             -------------------
T ss_pred             cc----cccCCCCcCccCh
Confidence            22    2345789999998

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.94  E-value=5.2e-27  Score=223.89  Aligned_cols=152  Identities=26%  Similarity=0.349  Sum_probs=128.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh----------HHHHHHhhcCC--------CCCeeEEEEEec----C
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF----------DVECEVMKSIH--------HRNLVKIISSCS----N  256 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~----------~~E~~~l~~l~--------hpniv~l~~~~~----~  256 (360)
                      ++|+..+.||+|+||.||+|+. .+++.||||.+          .+|+++++.++        ||||+++++++.    .
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~  116 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN  116 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence            5688899999999999999985 57889999853          46888988885        788999999987    5


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCceeecCCC--------
Q 040294          257 EDFRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFST-PIIHCDLKPHNVLLDDNI--------  326 (360)
Q Consensus       257 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~-~iiHrdlk~~NiLl~~~~--------  326 (360)
                      ....++||||+ ++++.+.+... ...+++..+..++.|++.||+|||   +. +|+||||||+|||++.++        
T Consensus       117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            66899999999 55666665543 356899999999999999999999   77 999999999999999775        


Q ss_pred             -----------------------------------------cEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          327 -----------------------------------------VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       327 -----------------------------------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                                                               .+||+|||+++.....     ....+||+.|+||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP  262 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence                                                     7999999999876432     2345799999998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.94  E-value=5.7e-27  Score=222.70  Aligned_cols=150  Identities=26%  Similarity=0.435  Sum_probs=127.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeE----
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFR----  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~----  260 (360)
                      .++|...+.||+|+||.||+|+. .+|+.||||.+             .+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            45788889999999999999985 47899999843             4699999999999999999999887654    


Q ss_pred             --EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          261 --ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       261 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                        ++||||++ ++|.+.+..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 688888743   4889999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....     .....||+.|+||
T Consensus       194 ~~~~-----~~~~~~t~~y~aP  210 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAP  210 (371)
T ss_dssp             -----------CTTCCCTTSCH
T ss_pred             cccC-----cCCcccCccccCH
Confidence            5432     2346789999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.93  E-value=9.5e-27  Score=225.78  Aligned_cols=155  Identities=27%  Similarity=0.414  Sum_probs=120.1

Q ss_pred             CCCCCeeccCCCccEEEEEccCCcEEEehh--------hHHHHHHhhcC-CCCCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          202 FSANNLIGRGSFGSVYKARLQDGMEFAIKS--------FDVECEVMKSI-HHRNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~--------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      |...++||+|+||+||.+...+|+.||||.        +.+|+++++++ +|||||++++++.+++..++|||||. |+|
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL   95 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL   95 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence            445688999999999877666899999984        35799999876 89999999999999999999999996 699


Q ss_pred             HHHHhcCCCCC------CHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-------------CcEEEeec
Q 040294          273 EKVLYSSNCIL------DILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-------------IVAHLSDF  333 (360)
Q Consensus       273 ~~~l~~~~~~~------~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-------------~~~ki~DF  333 (360)
                      .+++.......      ++..+..++.|++.||+|||   +.+|+||||||+|||++.+             +.+||+||
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             HHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            99997643211      22235679999999999999   8899999999999999754             48999999


Q ss_pred             ccccccCCCCCce--eeecccccCcccCC
Q 040294          334 GIAKLLTGEDQSM--TQTQTLATIGYMAP  360 (360)
Q Consensus       334 Gla~~~~~~~~~~--~~~~~~gt~~Y~aP  360 (360)
                      |+++.+.......  ......||++|+||
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aP  201 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAP  201 (434)
T ss_dssp             TTCEECCC--------------CCTTSCH
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCH
Confidence            9999876433211  12345799999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.93  E-value=1.7e-26  Score=215.38  Aligned_cols=152  Identities=22%  Similarity=0.360  Sum_probs=131.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEc--cCCcEEEehhh----------HHHHHHhhcCCCC------CeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL--QDGMEFAIKSF----------DVECEVMKSIHHR------NLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~~----------~~E~~~l~~l~hp------niv~l~~~~~~~~~~~  261 (360)
                      ++|+..+.||+|+||.||+|..  .+++.||||.+          ..|+++++.++|+      +++++++++...+..+
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            5788899999999999999985  36889999843          4688888887665      4999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC----------------
Q 040294          262 LVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD----------------  324 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~----------------  324 (360)
                      +||||+ +++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.                
T Consensus        94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~  169 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER  169 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence            999999 889999997654 35788999999999999999999   889999999999999987                


Q ss_pred             ---CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          325 ---NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       325 ---~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                         ++.+||+|||+++.....     .....||+.|+||
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aP  203 (339)
T 1z57_A          170 TLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAP  203 (339)
T ss_dssp             EESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCH
T ss_pred             cccCCCceEeeCcccccCccc-----cccccCCccccCh
Confidence               668999999999875432     2345799999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=1.8e-26  Score=211.11  Aligned_cols=155  Identities=27%  Similarity=0.464  Sum_probs=134.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.             +.+|++++++++||||+++++++...+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            457889999999999999999965 788999984             357999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC---CcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN---IVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~---~~~ki~DFGla~~~~~  341 (360)
                      ||+++++|.+.+.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.+   +.+||+|||+++....
T Consensus       101 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            9999999999886543 5889999999999999999999   8899999999999999754   4799999999987654


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..   ......||+.|+||
T Consensus       177 ~~---~~~~~~~~~~y~aP  192 (287)
T 2wei_A          177 NT---KMKDRIGTAYYIAP  192 (287)
T ss_dssp             CS---SCSCHHHHHTTCCH
T ss_pred             CC---ccccccCcccccCh
Confidence            32   12234689999998

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.93  E-value=1.5e-26  Score=215.24  Aligned_cols=155  Identities=25%  Similarity=0.354  Sum_probs=135.4

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-----------------HHHHHHhhcCC--CCCeeEEEEEecCC
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-----------------DVECEVMKSIH--HRNLVKIISSCSNE  257 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-----------------~~E~~~l~~l~--hpniv~l~~~~~~~  257 (360)
                      ..++|+..+.||+|+||.||+|+. .+++.||||.+                 ..|++++++++  ||||+++++++..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            346788899999999999999985 57889999853                 35899999996  59999999999999


Q ss_pred             CeEEEEEEccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec-CCCcEEEeeccc
Q 040294          258 DFRALVLEYMTN-GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGI  335 (360)
Q Consensus       258 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~-~~~~~ki~DFGl  335 (360)
                      +..++||||+.+ ++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++ +++.+||+|||+
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            999999999986 8999998764 35888999999999999999999   89999999999999999 789999999999


Q ss_pred             ccccCCCCCceeeecccccCcccCC
Q 040294          336 AKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       336 a~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++......    .....||+.|+||
T Consensus       197 ~~~~~~~~----~~~~~gt~~y~aP  217 (320)
T 3a99_A          197 GALLKDTV----YTDFDGTRVYSPP  217 (320)
T ss_dssp             CEECCSSC----BCCCCSCGGGSCH
T ss_pred             cccccccc----ccCCCCCccCCCh
Confidence            98765332    2345699999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.93  E-value=2.3e-26  Score=214.30  Aligned_cols=155  Identities=29%  Similarity=0.383  Sum_probs=118.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHH-HhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECE-VMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+            ..|+. +++.++||||+++++++..++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            357888899999999999999974 7899999843            23444 677889999999999999999999999


Q ss_pred             EccCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          265 EYMTNGSLEKVLYS----SNCILDILQRLNIMINVTSALEYLHFGFST-PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       265 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~-~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      ||+++ +|.+++..    ....+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 88777652    2456889999999999999999999   77 9999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....   ......||+.|+||
T Consensus       177 ~~~~---~~~~~~gt~~y~aP  194 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAP  194 (327)
T ss_dssp             ---------------------
T ss_pred             cccc---ccccCCCCccccCc
Confidence            5332   22334799999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.93  E-value=9.3e-27  Score=215.44  Aligned_cols=156  Identities=26%  Similarity=0.373  Sum_probs=129.3

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-----------------HHHHHHhhcC----CCCCeeEEEEEe
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-----------------DVECEVMKSI----HHRNLVKIISSC  254 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-----------------~~E~~~l~~l----~hpniv~l~~~~  254 (360)
                      ...++|+..+.||+|+||.||+|+. .+++.||||.+                 ..|++++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3456899999999999999999986 47889999854                 2488888888    899999999999


Q ss_pred             cCCCeEEEEEEc-cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec-CCCcEEEee
Q 040294          255 SNEDFRALVLEY-MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSD  332 (360)
Q Consensus       255 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~-~~~~~ki~D  332 (360)
                      ...+..++|||| +.+++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++ .++.+||+|
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEE
Confidence            999999999999 78999999997643 5889999999999999999999   88999999999999999 889999999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+++......    .....||+.|+||
T Consensus       184 fg~~~~~~~~~----~~~~~~~~~y~aP  207 (312)
T 2iwi_A          184 FGSGALLHDEP----YTDFDGTRVYSPP  207 (312)
T ss_dssp             CSSCEECCSSC----BCCCCSCTTTSCH
T ss_pred             cchhhhcccCc----ccccCCcccccCc
Confidence            99998765432    2345699999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.93  E-value=1.1e-26  Score=219.00  Aligned_cols=150  Identities=26%  Similarity=0.433  Sum_probs=126.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCe-----
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDF-----  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~-----  259 (360)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+             .+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            356888899999999999999864 7899999843             468999999999999999999987654     


Q ss_pred             -EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          260 -RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       260 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                       .++||||++ ++|.+++..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588887743   4889999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....     .....||+.|+||
T Consensus       176 ~~~~-----~~~~~~t~~y~aP  192 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAP  192 (353)
T ss_dssp             -------------CCSBCCSCH
T ss_pred             CCCC-----ccccccCcCcCCH
Confidence            5422     2345789999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.93  E-value=2.2e-26  Score=213.13  Aligned_cols=155  Identities=26%  Similarity=0.372  Sum_probs=117.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+             ..+..+++.++||||+++++++..++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356778899999999999999975 7899999854             12344678889999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST-PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~-~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      ||+ ++.+..+.......+++..+..++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 56676666554566899999999999999999999   74 89999999999999999999999999998764332


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                         ......||+.|+||
T Consensus       180 ---~~~~~~~~~~y~aP  193 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAP  193 (318)
T ss_dssp             ----------CCTTCCH
T ss_pred             ---cccccCCCccccCh
Confidence               22345699999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.93  E-value=2.8e-26  Score=231.06  Aligned_cols=155  Identities=32%  Similarity=0.509  Sum_probs=132.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecC------CCeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSN------EDFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~------~~~~  260 (360)
                      ++|+..+.||+|+||.||+|+. .+|+.||||.            +..|++++++++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6799999999999999999986 4789999984            4569999999999999999999876      6678


Q ss_pred             EEEEEccCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCc---EEEeeccc
Q 040294          261 ALVLEYMTNGSLEKVLYSSN--CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV---AHLSDFGI  335 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~---~ki~DFGl  335 (360)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999998643  25788889999999999999999   889999999999999997664   99999999


Q ss_pred             ccccCCCCCceeeecccccCcccCC
Q 040294          336 AKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       336 a~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++......   ......||+.|+||
T Consensus       171 a~~~~~~~---~~~~~~gt~~Y~AP  192 (676)
T 3qa8_A          171 AKELDQGE---LCTEFVGTLQYLAP  192 (676)
T ss_dssp             CCBTTSCC---CCCCCCSCCTTCSS
T ss_pred             cccccccc---ccccccCCcccCCh
Confidence            99865432   22346799999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.93  E-value=8.7e-26  Score=215.28  Aligned_cols=155  Identities=28%  Similarity=0.399  Sum_probs=130.7

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh----------HHHHHHhhcCC-CC-----CeeEEEEEecCCCeEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF----------DVECEVMKSIH-HR-----NLVKIISSCSNEDFRA  261 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~----------~~E~~~l~~l~-hp-----niv~l~~~~~~~~~~~  261 (360)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+          ..|+++++.++ |+     +|+++++++...+..+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            568889999999999999999864 7889999854          35777777775 44     4999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec--CCCcEEEeecccccc
Q 040294          262 LVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD--DNIVAHLSDFGIAKL  338 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~--~~~~~ki~DFGla~~  338 (360)
                      +||||++ |+|.+++.... ..+++..+..++.|++.||+|||. +..+|+||||||+|||++  .++.+||+|||+++.
T Consensus       133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~  210 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ  210 (382)
T ss_dssp             EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence            9999996 59999997654 458899999999999999999992 247899999999999994  578899999999987


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....     .....||+.|+||
T Consensus       211 ~~~~-----~~~~~~t~~y~aP  227 (382)
T 2vx3_A          211 LGQR-----IYQYIQSRFYRSP  227 (382)
T ss_dssp             TTCC-----CCSSCSCGGGCCH
T ss_pred             cccc-----cccccCCccccCh
Confidence            6432     2346799999998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.93  E-value=8.2e-26  Score=212.17  Aligned_cols=152  Identities=24%  Similarity=0.384  Sum_probs=129.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CC-cEEEehhh----------HHHHHHhhcCCCCC------eeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DG-MEFAIKSF----------DVECEVMKSIHHRN------LVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~-~~vavK~~----------~~E~~~l~~l~hpn------iv~l~~~~~~~~~~~  261 (360)
                      ++|+..+.||+|+||.||+|+.. ++ +.||+|.+          ..|++++++++|++      ++.+++++...+..+
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            57888999999999999999864 44 68999853          46888888887766      999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceee------------------
Q 040294          262 LVLEYMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLL------------------  322 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl------------------  322 (360)
                      +||||+ ++++.+.+.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+                  
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccccc
Confidence            999999 567777665543 46899999999999999999999   8999999999999999                  


Q ss_pred             -cCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          323 -DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       323 -~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                       +.++.+||+|||+++.....     .....||+.|+||
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aP  208 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPP  208 (355)
T ss_dssp             EESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCH
T ss_pred             ccCCCcEEEeecCcccccccc-----ccCCcCCCcccCC
Confidence             56789999999999875432     2345799999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=8e-27  Score=232.00  Aligned_cols=142  Identities=18%  Similarity=0.281  Sum_probs=111.6

Q ss_pred             CCCeeccCCCccEEEEEccCCcEEEehh-------------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          204 ANNLIGRGSFGSVYKARLQDGMEFAIKS-------------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       204 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ..++||+|+||.||+|+. .++.+|+|.                   +.+|++++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            457899999999999965 456777752                   568999999999999995555555666779999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+++++|.+++..         +..++.|+++||+|||   +.+|+||||||+|||++.  .+||+|||+|+.......
T Consensus       419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred             ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence            99999999999865         4578999999999999   899999999999999998  999999999998754321


Q ss_pred             ce-----eeecccccCcccCC
Q 040294          345 SM-----TQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~-----~~~~~~gt~~Y~aP  360 (360)
                      ..     .....+||+.||||
T Consensus       485 ~~~~~~~~~~~~~GT~~y~AP  505 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFD  505 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHH
T ss_pred             cccchhhhhhhhcCCCCcCCH
Confidence            11     12356899999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.92  E-value=5.3e-26  Score=215.36  Aligned_cols=152  Identities=22%  Similarity=0.395  Sum_probs=129.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh----------HHHHHHhhcCC-----------CCCeeEEEEEecCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF----------DVECEVMKSIH-----------HRNLVKIISSCSNE  257 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~----------~~E~~~l~~l~-----------hpniv~l~~~~~~~  257 (360)
                      ++|...+.||+|+||.||+|+. .+++.||||.+          ..|++++++++           ||||+++++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            5688899999999999999995 57899999853          46888888776           89999999998765


Q ss_pred             C----eEEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCceeec------CC
Q 040294          258 D----FRALVLEYMTNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFST-PIIHCDLKPHNVLLD------DN  325 (360)
Q Consensus       258 ~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~-~iiHrdlk~~NiLl~------~~  325 (360)
                      +    ..++||||+ +++|.+++... ...+++..+..++.|++.||+|||   +. +|+||||||+|||++      ..
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCc
Confidence            4    789999999 89999999764 345889999999999999999999   77 999999999999994      44


Q ss_pred             CcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          326 IVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       326 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.+||+|||+++.....     .....||+.|+||
T Consensus       175 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aP  204 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEH-----YTNSIQTREYRSP  204 (373)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCH
T ss_pred             ceEEEcccccccccCCC-----CCCCCCCccccCc
Confidence            58999999999876432     2345799999998

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.92  E-value=3.1e-25  Score=203.32  Aligned_cols=132  Identities=13%  Similarity=0.064  Sum_probs=118.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      +.|+..+.||+|+||.||+|+.. +++.||||.              +.+|++++++++||||+++++++..++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888899999999999999965 589999984              456889999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      ||++|++|.+++...   ....+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+++|...
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence            999999999999542   345577889999999999999   8999999999999999999999999887654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.92  E-value=3.4e-25  Score=204.00  Aligned_cols=140  Identities=29%  Similarity=0.450  Sum_probs=122.6

Q ss_pred             CCCCCC-CeeccCCCccEEEEEc-cCCcEEEehh------hHHHHHHh-hcCCCCCeeEEEEEecC----CCeEEEEEEc
Q 040294          200 NGFSAN-NLIGRGSFGSVYKARL-QDGMEFAIKS------FDVECEVM-KSIHHRNLVKIISSCSN----EDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~-~~iG~G~~g~Vy~~~~-~~~~~vavK~------~~~E~~~l-~~l~hpniv~l~~~~~~----~~~~~lv~e~  266 (360)
                      ++|... ++||+|+||.||+|+. .+++.||+|.      +.+|++++ +..+||||+++++++..    +...++||||
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~   96 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC   96 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence            456655 7899999999999986 5789999985      45688887 66799999999999876    6688999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEeecccccccCCC
Q 040294          267 MTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       267 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~DFGla~~~~~~  342 (360)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++...+.
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  173 (299)
T 3m2w_A           97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE  173 (299)
T ss_dssp             CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTC
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccccc
Confidence            99999999998653 36899999999999999999999   899999999999999997   789999999999876543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.90  E-value=2.5e-24  Score=207.44  Aligned_cols=150  Identities=19%  Similarity=0.247  Sum_probs=113.9

Q ss_pred             CCCCCCeeccCCCccEEEEE-ccCCcEEEehhh--------------HHHHHHhhcCCC-CCe-----------------
Q 040294          201 GFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSF--------------DVECEVMKSIHH-RNL-----------------  247 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~--------------~~E~~~l~~l~h-pni-----------------  247 (360)
                      .|...++||+|+||.||+|+ ..+|+.||||.+              .+|+.+++.++| +|.                 
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            46667899999999999999 457999999854              479999999987 211                 


Q ss_pred             ----eEEEEEecCC-----CeEEEEEEccCCCCHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEE
Q 040294          248 ----VKIISSCSNE-----DFRALVLEYMTNGSLEKVLY------SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH  312 (360)
Q Consensus       248 ----v~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiH  312 (360)
                          ..+..++...     ...+++|+++ +++|.+++.      .....+++..++.++.|+++||+|||   +.+|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence                1111112211     2356777765 689999884      22334778889999999999999999   899999


Q ss_pred             ccCCCCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       313 rdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |||||+|||++.++.+||+|||+++....     .....+| +.||||
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aP  276 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPP  276 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCc
Confidence            99999999999999999999999986532     1345678 999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=4.9e-23  Score=188.35  Aligned_cols=132  Identities=17%  Similarity=0.182  Sum_probs=108.0

Q ss_pred             HHHHHhCCCCCCCeeccCCCccEEEEEccCCcEEEehhh-----------------------------HHHHHHhhcCCC
Q 040294          194 ELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF-----------------------------DVECEVMKSIHH  244 (360)
Q Consensus       194 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~-----------------------------~~E~~~l~~l~h  244 (360)
                      .+......|+..+.||+|+||.||+|+..+|+.||||.+                             .+|++++++++|
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            344455567777999999999999999977999999854                             479999999985


Q ss_pred             CCeeEEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC
Q 040294          245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD  324 (360)
Q Consensus       245 pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~  324 (360)
                      +++..   ++.. +..++||||++||+|.+ +..       .....++.|++.||+|||   +.+|+||||||+|||++ 
T Consensus       164 ~~v~~---~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          164 LAVPK---VYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             SSSCC---EEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred             CCcCe---EEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence            44444   4433 45699999999999988 422       123469999999999999   89999999999999999 


Q ss_pred             CCcEEEeecccccccCC
Q 040294          325 NIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       325 ~~~~ki~DFGla~~~~~  341 (360)
                      ++.+||+|||+|+....
T Consensus       228 ~~~vkl~DFG~a~~~~~  244 (282)
T 1zar_A          228 EEGIWIIDFPQSVEVGE  244 (282)
T ss_dssp             TTEEEECCCTTCEETTS
T ss_pred             CCcEEEEECCCCeECCC
Confidence            99999999999986543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.85  E-value=1.1e-21  Score=203.15  Aligned_cols=149  Identities=39%  Similarity=0.611  Sum_probs=127.9

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------------------------------------
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------------------------------------   42 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------------------------------------   42 (360)
                      +++|+.|+|++|+++|.+|..+.++++|+.|++++|.+++.                                       
T Consensus       513 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (768)
T 3rgz_A          513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN  592 (768)
T ss_dssp             CTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEE
T ss_pred             CCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccc
Confidence            46677777777777777777777788888888887766520                                       


Q ss_pred             ----------------------------------------ccCeEEcCCCcccccCCccccCCCccceecccccccccCC
Q 040294           43 ----------------------------------------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSI   82 (360)
Q Consensus        43 ----------------------------------------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~   82 (360)
                                                              .|+.|++++|+++|.+|.+|+++++|+.|+|++|+++|.+
T Consensus       593 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i  672 (768)
T 3rgz_A          593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI  672 (768)
T ss_dssp             EEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred             ccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCC
Confidence                                                    2567999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCeEeCcCCccCcccchhhhccc-----------cccccCCCCCCCCcccccccCCCCCCCCCCCCCCCCC
Q 040294           83 PNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCK  151 (360)
Q Consensus        83 p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~-----------~~~~~p~~~~~~~~~~~~~~~n~~~cgsp~~~~~~c~  151 (360)
                      |.+|+++++|+.|||++|+|+|.+|..+..+.           ++|.||..+.|..++..+|.||+.+||.|.   ++|.
T Consensus       673 p~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~  749 (768)
T 3rgz_A          673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCD  749 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCC
T ss_pred             ChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCC
Confidence            99999999999999999999999998876653           789999999999999999999999999773   3676


Q ss_pred             CC
Q 040294          152 SN  153 (360)
Q Consensus       152 ~~  153 (360)
                      ..
T Consensus       750 ~~  751 (768)
T 3rgz_A          750 PS  751 (768)
T ss_dssp             SC
T ss_pred             CC
Confidence            43

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=1.2e-20  Score=170.13  Aligned_cols=128  Identities=20%  Similarity=0.244  Sum_probs=101.4

Q ss_pred             CCCCCeeccCCCccEEEEEc-cCCcE--EEehh-----------------------------------hHHHHHHhhcCC
Q 040294          202 FSANNLIGRGSFGSVYKARL-QDGME--FAIKS-----------------------------------FDVECEVMKSIH  243 (360)
Q Consensus       202 f~~~~~iG~G~~g~Vy~~~~-~~~~~--vavK~-----------------------------------~~~E~~~l~~l~  243 (360)
                      |+..+.||+|+||.||+|+. .+|+.  ||||.                                   +.+|++++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999997 68888  99983                                   356888999888


Q ss_pred             CCCe--eEEEEEecCCCeEEEEEEccCC-C----CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCC
Q 040294          244 HRNL--VKIISSCSNEDFRALVLEYMTN-G----SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK  316 (360)
Q Consensus       244 hpni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk  316 (360)
                      |+++  +.++++    +..+|||||+.+ |    +|.+....    .++.....++.|++.||.|||.  +.+|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            7754  344443    246899999942 4    77776532    1233567799999999999994  4689999999


Q ss_pred             CCceeecCCCcEEEeecccccccCC
Q 040294          317 PHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       317 ~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      |+|||+++  .++|+|||+|.....
T Consensus       199 p~NILl~~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEETTS
T ss_pred             HHHEEEcC--cEEEEECcccccCCC
Confidence            99999998  999999999987643

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.76  E-value=1.5e-18  Score=160.81  Aligned_cols=142  Identities=33%  Similarity=0.548  Sum_probs=100.3

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCc-ccCeeeccccccCC--------cccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLT-ALRNLHLDSNELRH--------LVLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~l~~N~l~~--------~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|+|+|.+|..+.+++ +|+.|++++|.+++        +.|+.|++++|++++.+|..|+.+++|+.|+
T Consensus       148 l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  227 (313)
T 1ogq_A          148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH  227 (313)
T ss_dssp             CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred             CCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEE
Confidence            34455555555555555555555554 55555555555442        1366777777777777777777888888888


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccc-----------cccccCCCCCCCCcccccccCCCCCCC
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~-----------~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      |++|++++.+|. +..+++|++|+|++|++++.+|..+..+.           +.|.+|..+.+..+....+.+|+.+|+
T Consensus       228 L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          228 LAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             CCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred             CCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccC
Confidence            888888766555 77888888888999998888887665542           678888877777888889999999999


Q ss_pred             CCC
Q 040294          142 SPN  144 (360)
Q Consensus       142 sp~  144 (360)
                      .|.
T Consensus       307 ~p~  309 (313)
T 1ogq_A          307 SPL  309 (313)
T ss_dssp             TTS
T ss_pred             CCC
Confidence            764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=1.2e-17  Score=157.70  Aligned_cols=130  Identities=15%  Similarity=0.192  Sum_probs=95.9

Q ss_pred             HHHHhCCCCCCCeeccCCCccEEEEEccCCcEEEehhh---------------------------------HHHHHHhhc
Q 040294          195 LLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKSF---------------------------------DVECEVMKS  241 (360)
Q Consensus       195 ~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~---------------------------------~~E~~~l~~  241 (360)
                      +.....-|++.+.||+|+||.||+|...+|+.||||.+                                 .+|...|.+
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            33334458889999999999999999989999999842                                 124445555


Q ss_pred             CCCCCee--EEEEEecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCc
Q 040294          242 IHHRNLV--KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHN  319 (360)
Q Consensus       242 l~hpniv--~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~N  319 (360)
                      +.+.++.  ..++..    ..+|||||++|++|.++...     +  ....++.|++.+|.|||   ..+||||||||.|
T Consensus       170 L~~~gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~~-----~--~~~~l~~qll~~l~~lH---~~gIVHrDLKp~N  235 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQS----RHTIVMSLVDALPMRQVSSV-----P--DPASLYADLIALILRLA---KHGLIHGDFNEFN  235 (397)
T ss_dssp             HHHTTCSCCCEEEEE----TTEEEEECCSCEEGGGCCCC-----S--CHHHHHHHHHHHHHHHH---HTTEECSCCSTTS
T ss_pred             HHhcCCCCCeeeecc----CceEEEEecCCccHhhhccc-----H--HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHH
Confidence            5443331  222221    23799999999888765422     1  23457899999999999   8899999999999


Q ss_pred             eeecCCC----------cEEEeecccccc
Q 040294          320 VLLDDNI----------VAHLSDFGIAKL  338 (360)
Q Consensus       320 iLl~~~~----------~~ki~DFGla~~  338 (360)
                      ||+++++          .+.|+||+-+-.
T Consensus       236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          236 ILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EEEeCCCCcccccccccceEEEEeCCccc
Confidence            9998776          389999997654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.68  E-value=2.3e-16  Score=141.27  Aligned_cols=110  Identities=32%  Similarity=0.371  Sum_probs=85.6

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|++..|..|.++++|+.|+|++|.++++         .|+.|++++|++++..+..|..+++|+.|+|
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  114 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL  114 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence            4577888888888877777788888888888888887763         4778888888888777777788888888888


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      ++|+|++..+..|..+++|+.|+|++|+|++..|..+..
T Consensus       115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  153 (251)
T 3m19_A          115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDK  153 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCc
Confidence            888888666666788888888888888888777655443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.68  E-value=2.1e-16  Score=139.76  Aligned_cols=126  Identities=28%  Similarity=0.377  Sum_probs=109.4

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+.+         .|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus        40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L  119 (229)
T 3e6j_A           40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM  119 (229)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence            5799999999999998899999999999999999999764         5899999999999888888899999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      ++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+            ..+....+.+|+..|.
T Consensus       120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------------~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A          120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL------------SSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTC------------TTCCEEECTTSCBCTT
T ss_pred             cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCC------------CCCCEEEeeCCCccCC
Confidence            999999 889999999999999999999998776555433            3445566777876664

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.68  E-value=1.5e-16  Score=139.72  Aligned_cols=127  Identities=25%  Similarity=0.374  Sum_probs=108.0

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|++..+..|..+++|+.|+|++|+++.+         .|+.|+|++|+|+...+..|..+++|+.|+|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            4689999999999987777899999999999999998764         5899999999999776667899999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      ++|++++..|..|..+++|+.|+|++|+|++..+..+..+            ..+....+.+|+..|.
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------------~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL------------RAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC------------TTCCEEECCSSCEECS
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCC------------CCCCEEEeCCCCcCCC
Confidence            9999998889999999999999999999998877655443            3444566777877664

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.67  E-value=1.7e-16  Score=139.40  Aligned_cols=127  Identities=24%  Similarity=0.361  Sum_probs=105.7

Q ss_pred             CCCcEeeCCCCcccccCC-ccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            3 AALFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      ..++.|+|++|+|++..| ..|.++++|+.|+|++|+++++         .|+.|+|++|++++..|..|..+++|++|+
T Consensus        32 ~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  111 (220)
T 2v70_A           32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLM  111 (220)
T ss_dssp             TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEE
T ss_pred             CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEE
Confidence            357899999999998755 4588999999999999998764         588999999999988888899999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      |++|+|++..|..|..+++|+.|+|++|+|++..|..+..+            ..+....+.+|+..|.
T Consensus       112 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------------~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A          112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL------------HSLSTLNLLANPFNCN  168 (220)
T ss_dssp             CTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTC------------TTCCEEECCSCCEECS
T ss_pred             CCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCC------------CCCCEEEecCcCCcCC
Confidence            99999998889999999999999999999999888766543            2344456667766554

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.66  E-value=1.4e-16  Score=164.81  Aligned_cols=48  Identities=33%  Similarity=0.497  Sum_probs=29.9

Q ss_pred             CccceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           66 KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        66 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      ++|+.|+|++|+++|.+|.+|+++++|+.|+|++|+|+|.+|..+..+
T Consensus       632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L  679 (768)
T 3rgz_A          632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL  679 (768)
T ss_dssp             BCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred             ccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCC
Confidence            455566666666666666666666666666666666666666555443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.65  E-value=8.8e-18  Score=165.04  Aligned_cols=30  Identities=13%  Similarity=0.174  Sum_probs=25.9

Q ss_pred             ehhhHHHHHHhhcCCCCCeeEEEEEecCCC
Q 040294          229 IKSFDVECEVMKSIHHRNLVKIISSCSNED  258 (360)
Q Consensus       229 vK~~~~E~~~l~~l~hpniv~l~~~~~~~~  258 (360)
                      -+.|..|++.+.+++|+|+|+++|||....
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            367999999999999999999999998754

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.65  E-value=4e-16  Score=137.09  Aligned_cols=107  Identities=26%  Similarity=0.356  Sum_probs=100.6

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|+|++..|..|.++++|+.|+|++|.++++         .|+.|+|++|++++..|..|..+++|+.|+
T Consensus        56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  135 (220)
T 2v70_A           56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS  135 (220)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred             CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence            67899999999999988888999999999999999999874         589999999999999999999999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccch
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      |++|+|++..|..|..+++|+.|+|++|++++..+.
T Consensus       136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  171 (220)
T 2v70_A          136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL  171 (220)
T ss_dssp             CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred             CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence            999999988899999999999999999999987763

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.65  E-value=1.1e-15  Score=138.61  Aligned_cols=138  Identities=31%  Similarity=0.366  Sum_probs=95.5

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|++++ + +.+.++++|+.|++++|.++++         .|+.|++++|++++..|..|+.+++|+.|+
T Consensus        62 l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  139 (272)
T 3rfs_A           62 LPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN  139 (272)
T ss_dssp             CTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence            5678888888888875 3 3677888888888888877653         477788888888877777778888888888


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccc-----------cccccCCC-CCCCCcccccccCCCCCC
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRG-GPFTKFSSKSFIGNDLLC  140 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~-----------~~~~~p~~-~~~~~~~~~~~~~n~~~c  140 (360)
                      |++|++++..|..|..+++|+.|+|++|++++..|..+..+.           +.+..|.. ..+..+....+.+|+..|
T Consensus       140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  219 (272)
T 3rfs_A          140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  219 (272)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence            888888866666677888888888888888877665443321           22222221 233455556667776655


Q ss_pred             C
Q 040294          141 G  141 (360)
Q Consensus       141 g  141 (360)
                      .
T Consensus       220 ~  220 (272)
T 3rfs_A          220 T  220 (272)
T ss_dssp             C
T ss_pred             c
Confidence            4

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.64  E-value=1.1e-15  Score=131.43  Aligned_cols=105  Identities=28%  Similarity=0.355  Sum_probs=90.5

Q ss_pred             CCcEeeCCCCcccccCCc-cccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            4 ALFQLDLRGNKLSGSIPT-CFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      +|+.|+|++|+|++..+. .|.++++|+.|+|++|+|+++         .|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            688899999999866654 488899999999999988875         4888999999999888888889999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccch
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      ++|+|++.+|..|..+++|++|+|++|+|++..+.
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  144 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence            99999988888899999999999999999888763

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.63  E-value=2.1e-15  Score=130.92  Aligned_cols=110  Identities=32%  Similarity=0.367  Sum_probs=93.5

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|++..+..|.++++|+.|++++|+++.+         .|+.|++++|++++..+..|+.+++|+.|+|
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  107 (208)
T 2o6s_A           28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL  107 (208)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence            5689999999999976666788999999999999988764         5889999999999777777889999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      ++|++++..+..|..+++|+.|+|++|++++..+..+..
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  146 (208)
T 2o6s_A          108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDR  146 (208)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred             CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhcc
Confidence            999999776777899999999999999999876654443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.62  E-value=3.6e-16  Score=144.72  Aligned_cols=113  Identities=33%  Similarity=0.523  Sum_probs=101.9

Q ss_pred             CCCCcEeeCCC-CcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            2 LAALFQLDLRG-NKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      +++|+.|+|++ |++++.+|..|+++++|++|+|++|.+++.         .|+.|++++|++++.+|..++.+++|++|
T Consensus        75 l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  154 (313)
T 1ogq_A           75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI  154 (313)
T ss_dssp             CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred             CCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeE
Confidence            67899999995 999999999999999999999999998742         58999999999999999999999999999


Q ss_pred             cccccccccCCCccccCCC-CCCeEeCcCCccCcccchhhhccc
Q 040294           72 SLGHNRLQGSIPNSFDDLV-SLESLDLSNNNLSEIIPLSLEKLL  114 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~-~L~~l~ls~N~l~~~~p~~l~~l~  114 (360)
                      +|++|+++|.+|..+..++ +|++|+|++|++++.+|..+..+.
T Consensus       155 ~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~  198 (313)
T 1ogq_A          155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN  198 (313)
T ss_dssp             ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC
T ss_pred             ECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc
Confidence            9999999999999999998 999999999999999888776653

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.62  E-value=7.3e-16  Score=143.65  Aligned_cols=109  Identities=23%  Similarity=0.297  Sum_probs=58.9

Q ss_pred             CCCCcEeeCCCCcccccCCccccC---------CcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccC
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSN---------LTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQG   64 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~---------l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~   64 (360)
                      +++|+.|+|++|++.+.+|..+..         +++|+.|+|++|.++.+        .|+.|++++|++++ +|..++.
T Consensus       149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~  227 (328)
T 4fcg_A          149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHH  227 (328)
T ss_dssp             CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGG
T ss_pred             CcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-Cchhhcc
Confidence            345555555555555555554433         55555555555555432        35555555555553 3444555


Q ss_pred             CCccceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhh
Q 040294           65 LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE  111 (360)
Q Consensus        65 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~  111 (360)
                      +++|+.|+|++|++.+.+|..|+.+++|+.|+|++|++.+.+|..+.
T Consensus       228 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~  274 (328)
T 4fcg_A          228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH  274 (328)
T ss_dssp             CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGG
T ss_pred             CCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhh
Confidence            55555555555555555555555555555555555555555554433

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.61  E-value=3e-15  Score=129.93  Aligned_cols=121  Identities=31%  Similarity=0.307  Sum_probs=104.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|+|++..+..|.++++|+.|+|++|.++.+         .|+.|++++|++++..+..|..+++|+.|+
T Consensus        51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  130 (208)
T 2o6s_A           51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR  130 (208)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence            67899999999999976666789999999999999999864         589999999999988887899999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccch----hhhccccccccCCC
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL----SLEKLLLEGEIPRG  122 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~----~l~~l~~~~~~p~~  122 (360)
                      |++|++++..+..|..+++|+.|+|++|++.+..|.    .+....+.|.+|..
T Consensus       131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l~~L~~~~n~~~g~ip~~  184 (208)
T 2o6s_A          131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINKHSGVVRNS  184 (208)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTTTHHHHHHHHHCTTTBBCT
T ss_pred             CCCCccceeCHHHhccCCCccEEEecCCCeecCCCCHHHHHHHHHhCCceeecc
Confidence            999999977777799999999999999999998873    12223477888863

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.61  E-value=1.7e-15  Score=133.11  Aligned_cols=106  Identities=26%  Similarity=0.335  Sum_probs=98.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|+|++..|..|.++++|+.|+|++|.|+.+         .|+.|+|++|++++..|..|..+++|+.|+
T Consensus        55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  134 (220)
T 2v9t_B           55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS  134 (220)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence            67899999999999998899999999999999999999864         589999999999999999999999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      |++|+|++..+..|..+++|+.|+|++|++.....
T Consensus       135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B          135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            99999998877889999999999999999987544

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.61  E-value=6.8e-15  Score=133.09  Aligned_cols=106  Identities=33%  Similarity=0.351  Sum_probs=69.7

Q ss_pred             CCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            4 ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +|+.|+|++|+|++..+..|.++++|+.|++++|.++.+         .|+.|++++|++++..+..|..+++|+.|+|+
T Consensus        38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  117 (270)
T 2o6q_A           38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD  117 (270)
T ss_dssp             TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred             CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence            467777777777755555677777777777777766543         36666777777666555556666667777777


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccchh
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS  109 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~  109 (360)
                      +|++++..|..|..+++|++|+|++|++++..+..
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~  152 (270)
T 2o6q_A          118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGV  152 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred             CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhH
Confidence            67666555556666666666666666666655443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.60  E-value=3.2e-15  Score=128.39  Aligned_cols=120  Identities=30%  Similarity=0.472  Sum_probs=102.6

Q ss_pred             cEeeCCCCcccccCCccccCCcccCeeeccccccCCc----------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            6 FQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         6 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~----------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      +.+++++|+|+ .+|..+..  +|+.|++++|.++++          .|+.|+|++|++++.+|..|+++++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            68999999997 78877754  899999999998764          488999999999999999999999999999999


Q ss_pred             cccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCC
Q 040294           76 NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLC  140 (360)
Q Consensus        76 N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~c  140 (360)
                      |+|++..|..|..+++|++|+|++|+|++.+|..+..+            ..+....+.+|+..|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------------~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL------------NSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTC------------TTCCEEECTTCCBCC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcC------------CCCCEEEeCCCCccC
Confidence            99999888889999999999999999999988766543            233444556666554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.60  E-value=3.7e-15  Score=135.03  Aligned_cols=111  Identities=32%  Similarity=0.370  Sum_probs=83.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|+|++..|..|.++++|+.|++++|.++++         .|+.|++++|++++..|..++.+++|+.|+
T Consensus        84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  163 (272)
T 3rfs_A           84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD  163 (272)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence            56788888888888876666678888888888888877653         477778888888776666677788888888


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      |++|++++..|..|..+++|+.|+|++|++++..|..+..
T Consensus       164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  203 (272)
T 3rfs_A          164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDR  203 (272)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred             CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhC
Confidence            8888887666666777788888888888887777654443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.60  E-value=8.1e-15  Score=131.10  Aligned_cols=128  Identities=30%  Similarity=0.418  Sum_probs=104.6

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|+|++..|..|.++++|+.|+|++|.++.+         .|+.|++++|++++..+..|..+++|+.|+
T Consensus        58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  137 (251)
T 3m19_A           58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR  137 (251)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence            67899999999999988788889999999999999988764         588899999999977777788999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      |++|+|++..|..|..+++|+.|+|++|+|++..|..+..+            ..+....+.+|+..|.
T Consensus       138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------------~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRL------------GKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC------------TTCCEEECCSCCBCTT
T ss_pred             CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCC------------CCCCEEEeeCCceeCC
Confidence            99999997666689999999999999999998777655443            3444556667766554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.60  E-value=3.1e-15  Score=136.26  Aligned_cols=112  Identities=34%  Similarity=0.415  Sum_probs=88.3

Q ss_pred             CCCCcEeeCCCCc-ccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            2 LAALFQLDLRGNK-LSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      +++|+.|+|++|. ++...|..|.++++|+.|++++|.++++         .|+.|++++|++++..+..|+.+++|+.|
T Consensus        79 l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  158 (285)
T 1ozn_A           79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL  158 (285)
T ss_dssp             CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence            5778888888887 7766577788888888888888887753         47888888888887776778888888888


Q ss_pred             cccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           72 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      +|++|++++..+..|..+++|+.|+|++|++++..|..+..+
T Consensus       159 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  200 (285)
T 1ozn_A          159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL  200 (285)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCc
Confidence            888888886555668888888888888888888777665543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.59  E-value=1.3e-15  Score=125.09  Aligned_cols=106  Identities=20%  Similarity=0.275  Sum_probs=97.2

Q ss_pred             CCCCcEeeCCCCccc-ccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLS-GSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      .++|+.|++++|.++ +.+|..+..+++|+.|++++|.++.+       .|+.|++++|++++.+|..++.+++|+.|+|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l   95 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL   95 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCCTTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCchhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence            467999999999999 88999999999999999999999874       5899999999999989998899999999999


Q ss_pred             cccccccC-CCccccCCCCCCeEeCcCCccCcccc
Q 040294           74 GHNRLQGS-IPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        74 ~~N~l~g~-~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      ++|++++. .|..+..+++|++|++++|++++..+
T Consensus        96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  130 (149)
T 2je0_A           96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND  130 (149)
T ss_dssp             TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred             CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence            99999963 45889999999999999999998776

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.59  E-value=4.2e-15  Score=125.72  Aligned_cols=105  Identities=30%  Similarity=0.344  Sum_probs=88.9

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|++..+..|.++++|+.|++++|.++.+         .|+.|++++|++++..+..+..+++|+.|+|
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            5788999999999876666788899999999999988764         4788999999998877777888999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      ++|++++..+..|..+++|++|+|++|++++..|
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            9999986655667889999999999999988776

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.58  E-value=1.3e-14  Score=132.74  Aligned_cols=107  Identities=32%  Similarity=0.332  Sum_probs=77.8

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      ++|+.|+|++|+|++..|..|.++++|+.|+|++|.++.+       .|+.|++++|+++ .+|..+..+++|+.|+|++
T Consensus        31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~  109 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF  109 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred             CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCC
Confidence            4678888888888877777788888888888888877653       4677777777776 5566667777777777777


Q ss_pred             cccccCCCccccCCCCCCeEeCcCCccCcccchhh
Q 040294           76 NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL  110 (360)
Q Consensus        76 N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l  110 (360)
                      |+|++..|..|..+++|++|+|++|+|++..+..+
T Consensus       110 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  144 (290)
T 1p9a_G          110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL  144 (290)
T ss_dssp             SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred             CcCcccCHHHHcCCCCCCEEECCCCCCCccChhhc
Confidence            77776555667777777777777777776655443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.57  E-value=7.9e-15  Score=126.12  Aligned_cols=121  Identities=26%  Similarity=0.347  Sum_probs=76.4

Q ss_pred             cEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecccccc
Q 040294            6 FQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR   77 (360)
Q Consensus         6 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   77 (360)
                      +.+++++|+|+ .+|..+.  ++|+.|+|++|.++.+        .|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            45667777766 4555443  4667777777766653        36667777777776666667777777777777777


Q ss_pred             cccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294           78 LQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        78 l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      |++..|..|..+++|+.|+|++|+|++..+..+..+            ..+....+.+|+..|.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l------------~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDL------------SALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTC------------TTCCEEECCSSCEECS
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcC------------ccccEEEeCCCCeecC
Confidence            776666667777777777777777776555443322            2333445556665554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.57  E-value=3.9e-15  Score=140.48  Aligned_cols=106  Identities=30%  Similarity=0.281  Sum_probs=75.7

Q ss_pred             CCcEeeCCCCcccccCCcccc-CCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            4 ALFQLDLRGNKLSGSIPTCFS-NLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      .++.|+|++|+|++..+..|. ++++|+.|+|++|+|+.+         .|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  119 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL  119 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence            466777777777766666666 777777777777777653         4677777777777666666777777777777


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchh
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS  109 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~  109 (360)
                      ++|+|++..|..|..+++|+.|+|++|+|++..+..
T Consensus       120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~  155 (361)
T 2xot_A          120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVEL  155 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGG
T ss_pred             CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHH
Confidence            777777666777777777777777777777654443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.56  E-value=1.2e-14  Score=128.44  Aligned_cols=106  Identities=31%  Similarity=0.336  Sum_probs=96.4

Q ss_pred             CCCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            1 YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         1 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      .+++|+.|+|++|+|+...+..|.++++|+.|+|++|+|+.+         .|+.|++++|+|+ .+|..+..+++|+.|
T Consensus        62 ~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L  140 (229)
T 3e6j_A           62 SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL  140 (229)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE
T ss_pred             CccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE
Confidence            367899999999999866667789999999999999999874         5899999999999 789999999999999


Q ss_pred             cccccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           72 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus       141 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          141 ALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             ECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            999999997767789999999999999999998765

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.56  E-value=9.6e-15  Score=141.53  Aligned_cols=129  Identities=26%  Similarity=0.341  Sum_probs=110.3

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|++++.+|..|.++++|+.|++++|+++++         .|+.|++++|++++..|..|+++++|++|+|
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            5799999999999999999999999999999999998764         5899999999999988999999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCCCC
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGSP  143 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cgsp  143 (360)
                      ++|++++..|.+|..+++|++|+|++|++++..+..+..+            ..+....+.+|+..|..+
T Consensus       355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------------~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL------------TSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC------------TTCCEEECCSSCBCCCTT
T ss_pred             CCCcccccChhhccccccccEEECCCCccccCCHhHhccC------------CcccEEEccCCCcccCCC
Confidence            9999998889999999999999999999998766554432            344556667777666543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.56  E-value=7.2e-15  Score=123.12  Aligned_cols=106  Identities=26%  Similarity=0.329  Sum_probs=96.3

Q ss_pred             CCCCcEeeCCCCccc-ccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLS-GSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      .++|+.|+|++|+++ +.+|..+..+++|+.|++++|.++.+       .|+.|++++|++++.+|..+..+++|+.|+|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCCSSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCChhhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            467999999999998 78999999999999999999998864       5899999999999988988889999999999


Q ss_pred             cccccccC-CCccccCCCCCCeEeCcCCccCcccc
Q 040294           74 GHNRLQGS-IPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        74 ~~N~l~g~-~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      ++|++++. .+..+..+++|+.|+|++|++++..+
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~  137 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND  137 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence            99999963 22789999999999999999998766

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.55  E-value=2.1e-14  Score=123.48  Aligned_cols=104  Identities=32%  Similarity=0.378  Sum_probs=95.5

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|.|+.+         .|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            47999999999998 7889999999999999999999875         5899999999999999999999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      ++|+|++..+..|..+++|+.|+|++|++.....
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A          110 HGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            9999997666679999999999999999987554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.55  E-value=2.9e-14  Score=129.72  Aligned_cols=109  Identities=32%  Similarity=0.376  Sum_probs=74.3

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCc-ccccCCccccCCCccceec
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNN-LLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~-l~~~~p~~~~~l~~L~~L~   72 (360)
                      ++|+.|+|++|++++..+..|.++++|+.|++++|.++++         .|+.|++++|+ +....|..+..+++|++|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            4567777777777765556677777777777777766543         36677777776 5555566677777777777


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhhh
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE  111 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~  111 (360)
                      |++|++++..|..|..+++|++|+|++|++++..+..+.
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  150 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR  150 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhc
Confidence            777777766666677777777777777777766554443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.55  E-value=1e-14  Score=135.83  Aligned_cols=109  Identities=23%  Similarity=0.334  Sum_probs=96.7

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCC------------------cccCeEEcCCCcccccCCcccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH------------------LVLTRTDFSRNNLLGDIPTTIQ   63 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~------------------~~L~~l~l~~N~l~~~~p~~~~   63 (360)
                      +++|+.|+|++|+|+ .+|..|+++++|+.|++++|.+.+                  ..|+.|++++|+++ .+|..++
T Consensus       126 l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~  203 (328)
T 4fcg_A          126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA  203 (328)
T ss_dssp             GTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGG
T ss_pred             cCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhc
Confidence            678999999999999 789999999999999999976543                  15889999999998 8899999


Q ss_pred             CCCccceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           64 GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        64 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      .+++|+.|+|++|++++ +|..|..+++|++|+|++|++.+.+|..+..+
T Consensus       204 ~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l  252 (328)
T 4fcg_A          204 NLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGR  252 (328)
T ss_dssp             GCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCC
T ss_pred             CCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCC
Confidence            99999999999999995 77789999999999999999999999766543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.54  E-value=1.2e-14  Score=146.08  Aligned_cols=108  Identities=22%  Similarity=0.231  Sum_probs=75.1

Q ss_pred             CCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            4 ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++.|||++|+|++..|..|.++++|++|+|++|+|+++         .|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus        53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls  132 (635)
T 4g8a_A           53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  132 (635)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred             CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence            567777777777766666777777777777777777653         46777777777776666667777777777777


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcc-cchhhh
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEI-IPLSLE  111 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~-~p~~l~  111 (360)
                      +|++++..|..|+++++|++|+|++|.+++. +|..+.
T Consensus       133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~  170 (635)
T 4g8a_A          133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS  170 (635)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGG
T ss_pred             CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhc
Confidence            7777765555677777777777777777653 444433

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.54  E-value=2e-14  Score=132.10  Aligned_cols=110  Identities=25%  Similarity=0.390  Sum_probs=86.5

Q ss_pred             CCCCcEeeCCCCcccccCC-ccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccc-cCCccccCCCccce
Q 040294            2 LAALFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLG-DIPTTIQGLKSLQF   70 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~-~~p~~~~~l~~L~~   70 (360)
                      +++|+.|+|++|++++..+ ..+.++++|+.|++++|.++..         .|+.|++++|.+++ .+|..+..+++|+.
T Consensus       100 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~  179 (306)
T 2z66_A          100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF  179 (306)
T ss_dssp             CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence            5778888888888886554 5688888888888888877542         57888888888876 57778888888888


Q ss_pred             ecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhh
Q 040294           71 LSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE  111 (360)
Q Consensus        71 L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~  111 (360)
                      |+|++|++++..|..|..+++|+.|+|++|++++..+..+.
T Consensus       180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  220 (306)
T 2z66_A          180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK  220 (306)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGT
T ss_pred             EECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhcc
Confidence            88888888877788888888888888888888877665443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.54  E-value=1.1e-14  Score=149.46  Aligned_cols=108  Identities=24%  Similarity=0.323  Sum_probs=100.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++.|+.|+|++|+|+ .+|..+.++++|+.|+|++|.|+.+        .|+.|+|++|+|+ .+|..|++|++|++|+|
T Consensus       223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L  300 (727)
T 4b8c_D          223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF  300 (727)
T ss_dssp             CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred             CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence            578999999999999 7888888999999999999999865        5899999999999 78999999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      ++|.|+ .+|.+|+.|++|+.|+|++|+|++.+|..+..
T Consensus       301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  338 (727)
T 4b8c_D          301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE  338 (727)
T ss_dssp             CSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred             CCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence            999998 88999999999999999999999999976644

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.53  E-value=2.3e-14  Score=143.98  Aligned_cols=129  Identities=27%  Similarity=0.346  Sum_probs=108.4

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCC---------c-ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH---------L-VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~---------~-~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      +++++.++++.|.+++..|..+..+++|+.|++++|.+..         + .|+.|+|++|+|++.+|..|+++++|++|
T Consensus       444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L  523 (635)
T 4g8a_A          444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  523 (635)
T ss_dssp             CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence            5678889999999998888888999999999999987432         1 58899999999999999999999999999


Q ss_pred             cccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294           72 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      +|++|+|++..|..|..+++|+.|||++|+|++.+|..+..+.           ..+....+.+|+..|.
T Consensus       524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-----------~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP-----------SSLAFLNLTQNDFACT  582 (635)
T ss_dssp             ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCC-----------TTCCEEECTTCCBCCS
T ss_pred             ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhh-----------CcCCEEEeeCCCCccc
Confidence            9999999988888899999999999999999998887765431           2345567788988775

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.53  E-value=3.9e-14  Score=128.03  Aligned_cols=111  Identities=35%  Similarity=0.442  Sum_probs=97.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|+|+...+..|.++++|+.|++++|.++.+         .|+.|++++|++++..|..|+.+++|+.|+
T Consensus        60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  139 (270)
T 2o6q_A           60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS  139 (270)
T ss_dssp             CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence            67899999999999966666679999999999999998764         588999999999998888899999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      |++|++++..+..|..+++|+.|+|++|++++..+..+..
T Consensus       140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  179 (270)
T 2o6q_A          140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDK  179 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred             CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhcc
Confidence            9999999766667899999999999999999887765544

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.53  E-value=4.4e-14  Score=129.25  Aligned_cols=109  Identities=34%  Similarity=0.336  Sum_probs=86.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      +++|+.|+|++|+|++..+  .+.+++|+.|++++|+++.+        .|+.|++++|++++..|..|..+++|+.|+|
T Consensus        54 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L  131 (290)
T 1p9a_G           54 YTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL  131 (290)
T ss_dssp             CTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred             CCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence            5778888888888885433  27788888888888888754        4788888888888777778888888888888


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      ++|++++..|..|..+++|+.|+|++|+|++..+..+..
T Consensus       132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~  170 (290)
T 1p9a_G          132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG  170 (290)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTT
T ss_pred             CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcC
Confidence            888888766677888888888888888888766654443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.53  E-value=3.4e-14  Score=128.67  Aligned_cols=111  Identities=30%  Similarity=0.386  Sum_probs=98.4

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|++++..+..|.++++|+.|+|++|.++++         .|+.|++++|++++..+..++.+++|+.|+
T Consensus        51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  130 (276)
T 2z62_A           51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN  130 (276)
T ss_dssp             CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred             ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence            67899999999999987777899999999999999998753         588999999999988777899999999999


Q ss_pred             cccccccc-CCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           73 LGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        73 l~~N~l~g-~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      |++|++++ .+|..|..+++|++|+|++|++++..+..+..
T Consensus       131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  171 (276)
T 2z62_A          131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV  171 (276)
T ss_dssp             CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred             CcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhh
Confidence            99999986 36999999999999999999999887765544

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.52  E-value=4.5e-14  Score=118.81  Aligned_cols=100  Identities=32%  Similarity=0.347  Sum_probs=89.1

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      .+.|++++|+|+ .+|..+.  ++|+.|+|++|+|+++         .|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            578999999999 5777664  8899999999999875         588999999999988787889999999999999


Q ss_pred             cccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           76 NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        76 N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      |+|++..|..|..+++|+.|+|++|+++...+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            99997777789999999999999999998765

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.52  E-value=3.5e-14  Score=128.58  Aligned_cols=111  Identities=23%  Similarity=0.233  Sum_probs=99.6

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|++..+..|.++++|+.|++++|.++.+         .|+.|++++|++++..|..|.++++|++|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            3699999999999987777899999999999999998753         5899999999999998899999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcc-cchhhhcc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI-IPLSLEKL  113 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~-~p~~l~~l  113 (360)
                      ++|++++..+..+..+++|++|+|++|++++. +|..+..+
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l  148 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL  148 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGC
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccC
Confidence            99999987777899999999999999999885 57766654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.52  E-value=3.7e-14  Score=137.22  Aligned_cols=138  Identities=27%  Similarity=0.375  Sum_probs=80.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeecccc-ccCC--------c-ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN-ELRH--------L-VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~~--------~-~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      +++|+.|+|++|+|+...+..|.++++|+.|+|++| .++.        + .|+.|++++|+++. +| .+..+++|+.|
T Consensus       135 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L  212 (440)
T 3zyj_A          135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDEL  212 (440)
T ss_dssp             CSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEE
T ss_pred             cccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEE
Confidence            567888888888888666666777777777777763 2221        1 45666666666653 33 35566666666


Q ss_pred             cccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccc------cccc----cCCC--CCCCCcccccccCCCCC
Q 040294           72 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL------LEGE----IPRG--GPFTKFSSKSFIGNDLL  139 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~------~~~~----~p~~--~~~~~~~~~~~~~n~~~  139 (360)
                      +|++|++++..|..|..+++|+.|+|++|++++..|..+..+.      +++.    +|..  ..+..+....+.+|+..
T Consensus       213 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            6666666655566666666666666666666665554433221      1111    1111  12234455667777776


Q ss_pred             CC
Q 040294          140 CG  141 (360)
Q Consensus       140 cg  141 (360)
                      |.
T Consensus       293 Cd  294 (440)
T 3zyj_A          293 CN  294 (440)
T ss_dssp             CS
T ss_pred             CC
Confidence            64

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.51  E-value=3.3e-14  Score=137.71  Aligned_cols=106  Identities=30%  Similarity=0.322  Sum_probs=99.6

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|++++..|..|.++++|+.|+|++|.++++         .|+.|++++|++++..|.+|..+++|++|+
T Consensus       298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  377 (455)
T 3v47_A          298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA  377 (455)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence            67899999999999998899999999999999999998764         589999999999999999999999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      |++|++++..+..|..+++|++|+|++|++++.+|
T Consensus       378 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            99999997666778999999999999999999988

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.51  E-value=4e-14  Score=142.19  Aligned_cols=141  Identities=21%  Similarity=0.247  Sum_probs=102.7

Q ss_pred             CCCCcEeeCCCCcccccCC-ccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccc-cCCccccCCCccce
Q 040294            2 LAALFQLDLRGNKLSGSIP-TCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLG-DIPTTIQGLKSLQF   70 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~-~~p~~~~~l~~L~~   70 (360)
                      +++|+.|+|++|++++..| ..|.++++|+.|++++|.+++.         .|+.|++++|++++ .+|..++.+++|+.
T Consensus       398 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~  477 (606)
T 3vq2_A          398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF  477 (606)
T ss_dssp             CTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             CCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCE
Confidence            5778888888888887776 5788888888888888877652         57888888888887 36777888888888


Q ss_pred             ecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccc------ccc----ccCCC-CCCC-CcccccccCCCC
Q 040294           71 LSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL------LEG----EIPRG-GPFT-KFSSKSFIGNDL  138 (360)
Q Consensus        71 L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~------~~~----~~p~~-~~~~-~~~~~~~~~n~~  138 (360)
                      |+|++|++++..|..|..+++|++|+|++|++++.+|..+..+.      +++    .+|.. ..+. .+....+.+|+.
T Consensus       478 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~  557 (606)
T 3vq2_A          478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV  557 (606)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCC
T ss_pred             EECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCc
Confidence            88888888887788888888888888888888888777665442      221    23332 1111 244556777877


Q ss_pred             CCCC
Q 040294          139 LCGS  142 (360)
Q Consensus       139 ~cgs  142 (360)
                      .|..
T Consensus       558 ~c~c  561 (606)
T 3vq2_A          558 ACIC  561 (606)
T ss_dssp             CCSS
T ss_pred             ccCC
Confidence            7653

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.50  E-value=5.4e-14  Score=136.56  Aligned_cols=108  Identities=26%  Similarity=0.315  Sum_probs=70.4

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeecccc-ccCCc---------ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN-ELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      +++|+.|+|++|+|++..+..|.++++|+.|++++| .++.+         .|+.|++++|++++. | .+..+++|+.|
T Consensus       146 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L  223 (452)
T 3zyi_A          146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEEL  223 (452)
T ss_dssp             CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEE
T ss_pred             cCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEE
Confidence            678888888888888666667777777777777763 33221         466666666666643 3 35666666666


Q ss_pred             cccccccccCCCccccCCCCCCeEeCcCCccCcccchhhh
Q 040294           72 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE  111 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~  111 (360)
                      +|++|++++..|..|..+++|+.|+|++|++++..|..+.
T Consensus       224 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  263 (452)
T 3zyi_A          224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD  263 (452)
T ss_dssp             ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred             ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhc
Confidence            6666666666666666666666666666666666554443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.50  E-value=5.7e-14  Score=132.49  Aligned_cols=130  Identities=28%  Similarity=0.269  Sum_probs=103.6

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+.+         .|+.|+|++|++++..|..|..+++|+.|+
T Consensus        63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  142 (361)
T 2xot_A           63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY  142 (361)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence            67899999999999987778899999999999999998764         588999999999998899999999999999


Q ss_pred             ccccccccCCCccc---cCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294           73 LGHNRLQGSIPNSF---DDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        73 l~~N~l~g~~p~~~---~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      |++|+|++..+..|   ..+++|+.|||++|+|++..+..+..+...          ......+.+|+..|.
T Consensus       143 L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~----------~l~~l~l~~N~~~C~  204 (361)
T 2xot_A          143 LSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW----------VKNGLYLHNNPLECD  204 (361)
T ss_dssp             CCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHH----------HHTTEECCSSCEECC
T ss_pred             CCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHh----------hcceEEecCCCccCC
Confidence            99999995433444   679999999999999998776666554200          012345677877764

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.50  E-value=4.4e-14  Score=141.90  Aligned_cols=112  Identities=26%  Similarity=0.290  Sum_probs=76.7

Q ss_pred             CCCCcEeeCCCCcccccCCcc-ccCCcccCeeeccccccCCc---------ccCeEEcCCCccccc---CCccccCCCcc
Q 040294            2 LAALFQLDLRGNKLSGSIPTC-FSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGD---IPTTIQGLKSL   68 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~---~p~~~~~l~~L   68 (360)
                      +++|+.|+|++|++++..|.. |.++++|+.|++++|.+++.         .|+.|++++|++++.   .+..+..+++|
T Consensus       399 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L  478 (606)
T 3t6q_A          399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL  478 (606)
T ss_dssp             CTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred             CccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCc
Confidence            466777777777777665543 67777777777777776542         467777777777652   23456777777


Q ss_pred             ceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           69 QFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        69 ~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      +.|+|++|++++..|..|..+++|+.|+|++|++++.+|..+..+
T Consensus       479 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l  523 (606)
T 3t6q_A          479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL  523 (606)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTC
T ss_pred             cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcc
Confidence            777777777776667777777777777777777777776655543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.49  E-value=1e-13  Score=141.13  Aligned_cols=129  Identities=24%  Similarity=0.303  Sum_probs=66.3

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-----------------ccCeEEcCCCcccccCCccccCC
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----------------VLTRTDFSRNNLLGDIPTTIQGL   65 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-----------------~L~~l~l~~N~l~~~~p~~~~~l   65 (360)
                      ++|+.|+|++|+|++..|..|.++++|+.|++++|.++.+                 .|+.|++++|+++...+..|.++
T Consensus       480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l  559 (680)
T 1ziw_A          480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL  559 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence            4455555555555544444455555555555555544421                 24455555555553222345555


Q ss_pred             CccceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCCC
Q 040294           66 KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCGS  142 (360)
Q Consensus        66 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cgs  142 (360)
                      ++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..|..+..           .+..+....+.+|+..|..
T Consensus       560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----------~~~~L~~l~l~~N~~~c~c  625 (680)
T 1ziw_A          560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP-----------AFRNLTELDMRFNPFDCTC  625 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHH-----------HHTTCSEEECTTCCCCBCC
T ss_pred             cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcc-----------cccccCEEEccCCCcccCC
Confidence            55555555555555443444555555555555555555554443320           1234455677888888763

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.49  E-value=6.2e-14  Score=139.95  Aligned_cols=101  Identities=29%  Similarity=0.290  Sum_probs=92.8

Q ss_pred             CCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            4 ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      .|+.|+|++|+|++ +|. |+++++|+.|+|++|.|+.+        .|+.|+|++|+|++ +| .++.+++|+.|+|++
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~  517 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN  517 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence            58899999999996 676 99999999999999999875        58999999999997 67 899999999999999


Q ss_pred             cccccCC-CccccCCCCCCeEeCcCCccCcccch
Q 040294           76 NRLQGSI-PNSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        76 N~l~g~~-p~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      |+|++.. |..|+.+++|+.|+|++|+|++.+|.
T Consensus       518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            9999876 99999999999999999999998763

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.48  E-value=8.4e-14  Score=139.87  Aligned_cols=106  Identities=25%  Similarity=0.303  Sum_probs=51.4

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|++++..|..|.++++|+.|+|++|.++++         .|+.|++++|++++..|..++++++|++|+|
T Consensus        56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  135 (606)
T 3vq2_A           56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV  135 (606)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred             ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence            3444444444444444444444444444444444444432         2444555555554444444555555555555


Q ss_pred             ccccccc-CCCccccCCCCCCeEeCcCCccCcccch
Q 040294           74 GHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        74 ~~N~l~g-~~p~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      ++|++++ .+|..|+++++|++|+|++|++++..|.
T Consensus       136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~  171 (606)
T 3vq2_A          136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN  171 (606)
T ss_dssp             CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred             CCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence            5555543 3455555555555555555555554443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.48  E-value=1.6e-13  Score=115.87  Aligned_cols=100  Identities=26%  Similarity=0.316  Sum_probs=86.3

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      -+.+++++|+|+ .+|..+.  ++|+.|+|++|+|+++         .|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            368999999997 6887765  8899999999999875         488999999999987676789999999999999


Q ss_pred             cccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           76 NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        76 N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      |+|++..+..|..+++|+.|+|++|++....+
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            99996666669999999999999999987654

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.47  E-value=3.4e-14  Score=143.97  Aligned_cols=109  Identities=18%  Similarity=0.260  Sum_probs=96.1

Q ss_pred             CCcEeeCCCCcccccCCccccCCcccCeeecccccc--------------------------------------------
Q 040294            4 ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNEL--------------------------------------------   39 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l--------------------------------------------   39 (360)
                      .++.|+|++|.++|.+|++|++|++|+.|+|++|.+                                            
T Consensus        82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~  161 (636)
T 4eco_A           82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL  161 (636)
T ss_dssp             CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred             CEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHH
Confidence            578999999999999999999999999999999954                                            


Q ss_pred             ----------------------------------CCc--------ccCeEEcCCCccccc-----------------CCc
Q 040294           40 ----------------------------------RHL--------VLTRTDFSRNNLLGD-----------------IPT   60 (360)
Q Consensus        40 ----------------------------------~~~--------~L~~l~l~~N~l~~~-----------------~p~   60 (360)
                                                        +++        .|+.|+|++|+++|.                 +|.
T Consensus       162 ~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~  241 (636)
T 4eco_A          162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE  241 (636)
T ss_dssp             HHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred             HHHHhhcCccccccccccccchhhhhhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCch
Confidence                                              111        478899999999986                 899


Q ss_pred             ccc--CCCccceecccccccccCCCccccCCCCCCeEeCcCCc-cCc-ccchhhhc
Q 040294           61 TIQ--GLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN-LSE-IIPLSLEK  112 (360)
Q Consensus        61 ~~~--~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~-l~~-~~p~~l~~  112 (360)
                      .++  ++++|++|+|++|++.|.+|..|+++++|++|+|++|+ ++| .+|..+..
T Consensus       242 ~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~  297 (636)
T 4eco_A          242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA  297 (636)
T ss_dssp             CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHH
T ss_pred             hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHh
Confidence            988  99999999999999999999999999999999999998 998 88876654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.47  E-value=3.2e-13  Score=114.08  Aligned_cols=121  Identities=27%  Similarity=0.362  Sum_probs=98.7

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      .+.+++++|+++ .+|..+.  ++|+.|++++|.++++         .|+.|++++|++++..+..|+.+++|+.|+|++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            568999999998 5675553  7899999999998764         589999999999987777889999999999999


Q ss_pred             cccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCC
Q 040294           76 NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLC  140 (360)
Q Consensus        76 N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~c  140 (360)
                      |++++..+..|..+++|++|+|++|++++..+..+..+            ..+....+.+|+..|
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l------------~~L~~L~l~~N~~~~  138 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRL------------TSLQKIWLHTNPWDC  138 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC------------TTCCEEECCSSCBCC
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCC------------cccCEEEecCCCeec
Confidence            99998777778999999999999999997766544332            334445566676554

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.46  E-value=1e-13  Score=135.25  Aligned_cols=107  Identities=36%  Similarity=0.424  Sum_probs=59.5

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|.+++..|..|.++++|+.|+|++|.++.+         .|+.|++++|++++..|..|..+++|+.|+
T Consensus        55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~  134 (477)
T 2id5_A           55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE  134 (477)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence            34555555555555555555555555555555555555432         355555555555555555555555555555


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccch
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      |++|.+++..|..|..+++|+.|+|++|++++..+.
T Consensus       135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  170 (477)
T 2id5_A          135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE  170 (477)
T ss_dssp             ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred             CCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence            555555555555555555666666666655554443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.46  E-value=8.1e-14  Score=128.71  Aligned_cols=103  Identities=18%  Similarity=0.232  Sum_probs=93.8

Q ss_pred             CCCCcEeeCCCCcccccCCccc--cCCcccCeeeccccccCC-------------cccCeEEcCCCcccccCCccccCCC
Q 040294            2 LAALFQLDLRGNKLSGSIPTCF--SNLTALRNLHLDSNELRH-------------LVLTRTDFSRNNLLGDIPTTIQGLK   66 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~--~~l~~L~~L~l~~N~l~~-------------~~L~~l~l~~N~l~~~~p~~~~~l~   66 (360)
                      +++|+.|+|++|++++.+|..+  ..+++|+.|+|++|++++             ..|+.|++++|++++..|..|+.++
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~  173 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP  173 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence            6889999999999999999886  999999999999999987             3689999999999999889999999


Q ss_pred             ccceecccccccccC--CCccc--cCCCCCCeEeCcCCccCc
Q 040294           67 SLQFLSLGHNRLQGS--IPNSF--DDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        67 ~L~~L~l~~N~l~g~--~p~~~--~~l~~L~~l~ls~N~l~~  104 (360)
                      +|+.|+|++|++.|.  +|..+  ..+++|++|+|++|++++
T Consensus       174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~  215 (312)
T 1wwl_A          174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET  215 (312)
T ss_dssp             SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCC
T ss_pred             CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcc
Confidence            999999999999875  34455  899999999999999995

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.46  E-value=1.5e-13  Score=136.82  Aligned_cols=139  Identities=25%  Similarity=0.319  Sum_probs=95.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc----------ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~----------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      +++|+.|+|++|.+++..+ .+..+++|+.|++++|.+++.          .|+.|++++|.+++.+|..+..+++|+.|
T Consensus       372 ~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  450 (570)
T 2z63_A          372 TTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL  450 (570)
T ss_dssp             CSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred             cCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence            5678888888888875443 477788888888888776542          46777888888877777777788888888


Q ss_pred             cccccccc-cCCCccccCCCCCCeEeCcCCccCcccchhhhccc-----------cccccCCC-CCCCCcccccccCCCC
Q 040294           72 SLGHNRLQ-GSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRG-GPFTKFSSKSFIGNDL  138 (360)
Q Consensus        72 ~l~~N~l~-g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~-----------~~~~~p~~-~~~~~~~~~~~~~n~~  138 (360)
                      +|++|+++ +.+|..|..+++|++|+|++|++++..|..+..+.           +.+..|.. ..+..+....+.+|+.
T Consensus       451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~  530 (570)
T 2z63_A          451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW  530 (570)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcc
Confidence            88888876 56777788888888888888888777776554432           22222221 1234455556677766


Q ss_pred             CCC
Q 040294          139 LCG  141 (360)
Q Consensus       139 ~cg  141 (360)
                      .|.
T Consensus       531 ~~~  533 (570)
T 2z63_A          531 DCS  533 (570)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.45  E-value=1.6e-13  Score=126.12  Aligned_cols=111  Identities=28%  Similarity=0.418  Sum_probs=98.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc----------ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~----------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      +++|+.|+|++|.++ .+|..+.++++|+.|++++|.++++          .|+.|++++|.+++..|..+..+++|++|
T Consensus        77 ~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  155 (306)
T 2z66_A           77 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL  155 (306)
T ss_dssp             CSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred             ccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence            578999999999998 5777899999999999999988753          58899999999999999999999999999


Q ss_pred             ccccccccc-CCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           72 SLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        72 ~l~~N~l~g-~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      +|++|.+++ .+|..|..+++|++|+|++|++++..|..+..+
T Consensus       156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  198 (306)
T 2z66_A          156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL  198 (306)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCC
Confidence            999999987 588999999999999999999999888766543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.44  E-value=3.1e-13  Score=135.90  Aligned_cols=110  Identities=23%  Similarity=0.270  Sum_probs=92.3

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|.|++..|..|+++++|+.|+|++|.++++         .|+.|+|++|.+++..+..|+++++|+.|+
T Consensus        74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  153 (597)
T 3oja_B           74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  153 (597)
T ss_dssp             CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence            57889999999999987778899999999999999988764         488899999999876666678899999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhhh
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE  111 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~  111 (360)
                      |++|.+++..|..|..+++|++|+|++|.+++..+..+.
T Consensus       154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~  192 (597)
T 3oja_B          154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP  192 (597)
T ss_dssp             CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCT
T ss_pred             eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhh
Confidence            999999988888899999999999999998886544433

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.43  E-value=1.7e-13  Score=117.90  Aligned_cols=104  Identities=20%  Similarity=0.305  Sum_probs=91.1

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|++++|.++ .+| .+..+++|+.|++++|.++.+       .|+.|++++|++++..|..++.+++|+.|+|+
T Consensus        43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls  120 (197)
T 4ezg_A           43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS  120 (197)
T ss_dssp             HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred             cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence            457899999999998 667 689999999999999987754       58999999999998888899999999999999


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|++++..|..|..+++|++|+|++|++.+.+|
T Consensus       121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~  153 (197)
T 4ezg_A          121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIM  153 (197)
T ss_dssp             SSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG
T ss_pred             CCccCcHhHHHHhhCCCCCEEEccCCCCccccH
Confidence            999998888999999999999999998444444

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.43  E-value=6.4e-13  Score=130.98  Aligned_cols=107  Identities=28%  Similarity=0.373  Sum_probs=87.3

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-----------ccCeEEcCCCcccccCCcc-ccCCCccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----------VLTRTDFSRNNLLGDIPTT-IQGLKSLQ   69 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-----------~L~~l~l~~N~l~~~~p~~-~~~l~~L~   69 (360)
                      +++|+.|+|++|++++.+|..+.++++|+.|++++|+++++           .|+.|++++|++++.+|.. +..+++|+
T Consensus       323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~  402 (520)
T 2z7x_B          323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL  402 (520)
T ss_dssp             CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred             CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence            56788999999999988888899999999999999988852           5888999999998866764 77888888


Q ss_pred             eecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhh
Q 040294           70 FLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE  111 (360)
Q Consensus        70 ~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~  111 (360)
                      .|+|++|++++.+|..+.  ++|+.|+|++|+++ .+|..+.
T Consensus       403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~  441 (520)
T 2z7x_B          403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV  441 (520)
T ss_dssp             EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG
T ss_pred             EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh
Confidence            888888888877777664  68888888888888 5555443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.43  E-value=6.5e-14  Score=141.86  Aligned_cols=108  Identities=24%  Similarity=0.385  Sum_probs=99.1

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccc-cCC----------------cccCeEEcCCCcccccCCc--cc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE-LRH----------------LVLTRTDFSRNNLLGDIPT--TI   62 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~----------------~~L~~l~l~~N~l~~~~p~--~~   62 (360)
                      +++|+.|+|++|++.|.+|..|+++++|+.|++++|+ +++                ..|+.|++++|+++ .+|.  .+
T Consensus       248 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l  326 (636)
T 4eco_A          248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSL  326 (636)
T ss_dssp             CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHH
T ss_pred             cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhh
Confidence            6889999999999999999999999999999999998 886                46899999999999 8998  99


Q ss_pred             cCCCccceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           63 QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        63 ~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      +++++|+.|+|++|+++|.+| .|+.+++|+.|+|++|+++ .+|..+..
T Consensus       327 ~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~  374 (636)
T 4eco_A          327 QKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCG  374 (636)
T ss_dssp             TTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEE
T ss_pred             ccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhh
Confidence            999999999999999999999 9999999999999999998 66654443

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.42  E-value=9.6e-13  Score=131.21  Aligned_cols=104  Identities=29%  Similarity=0.342  Sum_probs=84.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-----------ccCeEEcCCCcccccCCc-cccCCCccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----------VLTRTDFSRNNLLGDIPT-TIQGLKSLQ   69 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-----------~L~~l~l~~N~l~~~~p~-~~~~l~~L~   69 (360)
                      +++|+.|+|++|++++.+|..|.++++|+.|++++|+++++           .|+.|++++|++++.+|. .+..+++|+
T Consensus       352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~  431 (562)
T 3a79_B          352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL  431 (562)
T ss_dssp             CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred             CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence            56889999999999988888899999999999999988853           478899999999886665 477888888


Q ss_pred             eecccccccccCCCccccCCCCCCeEeCcCCccCcccch
Q 040294           70 FLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        70 ~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      .|+|++|++++.+|..+.  ++|+.|+|++|+++. +|.
T Consensus       432 ~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~  467 (562)
T 3a79_B          432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPK  467 (562)
T ss_dssp             EEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC-CCT
T ss_pred             EEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc-cCh
Confidence            888888888877766654  678888888888874 444

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.42  E-value=8.8e-13  Score=122.48  Aligned_cols=108  Identities=22%  Similarity=0.343  Sum_probs=69.1

Q ss_pred             CCCCcEeeCCCCcccc--cCCccccCCcccCeeeccccccCCc------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSG--SIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      +++|+.|+|++|.++.  ..+..|.++++|+.|++++|.++.+      .|+.|++++|++++..|..+..+++|+.|+|
T Consensus       144 l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  223 (330)
T 1xku_A          144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL  223 (330)
T ss_dssp             CTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred             CccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            3455555565555542  4455556666666666666665543      4666777777777666677777777777777


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhh
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL  110 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l  110 (360)
                      ++|++++..|..|..+++|+.|+|++|+++ .+|..+
T Consensus       224 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l  259 (330)
T 1xku_A          224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL  259 (330)
T ss_dssp             CSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT
T ss_pred             CCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhh
Confidence            777777666666777777777777777776 344433

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.42  E-value=3.9e-13  Score=133.74  Aligned_cols=107  Identities=30%  Similarity=0.386  Sum_probs=54.8

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|++++..|..|.++++|++|+|++|.++.+         .|+.|++++|++++..+..++++++|++|+|
T Consensus        52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  131 (570)
T 2z63_A           52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV  131 (570)
T ss_dssp             SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred             CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence            4455555555555544444455555555555555544321         3455555555555443334555555555555


Q ss_pred             ccccccc-CCCccccCCCCCCeEeCcCCccCcccchh
Q 040294           74 GHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIPLS  109 (360)
Q Consensus        74 ~~N~l~g-~~p~~~~~l~~L~~l~ls~N~l~~~~p~~  109 (360)
                      ++|.+++ .+|..|+++++|++|++++|++++..|..
T Consensus       132 ~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~  168 (570)
T 2z63_A          132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD  168 (570)
T ss_dssp             CSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG
T ss_pred             CCCccceecChhhhcccCCCCEEeCcCCccceecHHH
Confidence            5555554 24555555555555555555555554443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.41  E-value=8e-14  Score=145.16  Aligned_cols=104  Identities=20%  Similarity=0.262  Sum_probs=62.9

Q ss_pred             CCCCcEeeCCCCcccc-----------------cCCcccc--CCcccCeeeccccccCCc---------ccCeEEcCCCc
Q 040294            2 LAALFQLDLRGNKLSG-----------------SIPTCFS--NLTALRNLHLDSNELRHL---------VLTRTDFSRNN   53 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g-----------------~~p~~~~--~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~   53 (360)
                      |++|+.|+|++|+|+|                 .+|..++  ++++|+.|+|++|.+.+.         .|+.|++++|+
T Consensus       447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~  526 (876)
T 4ecn_A          447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR  526 (876)
T ss_dssp             CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred             CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence            4556666666666665                 2566555  666666666666655431         45666666665


Q ss_pred             -ccc-cCCccccCCC-------ccceecccccccccCCCc--cccCCCCCCeEeCcCCccCcccc
Q 040294           54 -LLG-DIPTTIQGLK-------SLQFLSLGHNRLQGSIPN--SFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        54 -l~~-~~p~~~~~l~-------~L~~L~l~~N~l~g~~p~--~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                       ++| .+|..++++.       +|+.|+|++|+++ .+|.  .|+++++|+.|+|++|+++ .+|
T Consensus       527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp  589 (876)
T 4ecn_A          527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE  589 (876)
T ss_dssp             TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC
T ss_pred             CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch
Confidence             666 5665555444       6666666666666 5665  6666666666666666666 455

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.41  E-value=2.2e-13  Score=127.81  Aligned_cols=110  Identities=26%  Similarity=0.309  Sum_probs=91.2

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|++..+..|.++++|+.|++++|.++++         .|+.|++++|++++..+..|+++++|++|+|
T Consensus        52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  131 (353)
T 2z80_A           52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL  131 (353)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred             ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence            4789999999999976666899999999999999988764         4889999999998766666899999999999


Q ss_pred             cccccccCCCc--cccCCCCCCeEeCcCC-ccCcccchhhhcc
Q 040294           74 GHNRLQGSIPN--SFDDLVSLESLDLSNN-NLSEIIPLSLEKL  113 (360)
Q Consensus        74 ~~N~l~g~~p~--~~~~l~~L~~l~ls~N-~l~~~~p~~l~~l  113 (360)
                      ++|++++ +|.  .|..+++|++|++++| .+++..|..+..+
T Consensus       132 ~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l  173 (353)
T 2z80_A          132 LGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL  173 (353)
T ss_dssp             TTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred             CCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCC
Confidence            9999984 554  7899999999999999 4666666555443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.41  E-value=4.4e-13  Score=115.29  Aligned_cols=102  Identities=20%  Similarity=0.198  Sum_probs=89.3

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|++++|.++  .++.+..+++|+.|++++|.++..         .|+.|++++|++++..|..++.+++|+.|+
T Consensus        65 l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~  142 (197)
T 4ezg_A           65 AHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID  142 (197)
T ss_dssp             CTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred             CCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence            678999999999776  445799999999999999999851         589999999999998899999999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCccc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEII  106 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~  106 (360)
                      |++|++.+.+| .+..+++|+.|++++|++++..
T Consensus       143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~  175 (197)
T 4ezg_A          143 LSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR  175 (197)
T ss_dssp             CCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCT
T ss_pred             ccCCCCccccH-hhcCCCCCCEEECCCCCCcChH
Confidence            99998434676 6999999999999999998753

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.41  E-value=3.3e-13  Score=131.67  Aligned_cols=111  Identities=24%  Similarity=0.293  Sum_probs=101.1

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|++..|..|.++++|+.|+|++|.++++         .|+.|+|++|++++..+..|.++++|+.|+|
T Consensus        32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  111 (477)
T 2id5_A           32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI  111 (477)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred             CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence            4789999999999988889999999999999999998764         5899999999999877778899999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      ++|++++..|..|..+++|++|+|++|++++..|..+..+
T Consensus       112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  151 (477)
T 2id5_A          112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGL  151 (477)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTC
T ss_pred             CCCccccCChhHccccccCCEEECCCCccceeChhhccCC
Confidence            9999998889999999999999999999999888665543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.41  E-value=9.5e-13  Score=132.29  Aligned_cols=81  Identities=35%  Similarity=0.350  Sum_probs=71.8

Q ss_pred             CCCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            1 YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         1 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      .+++|+.|+|++|.|++..|..|+++++|+.|+|++|.++.+         .|+.|++++|.+++..|..|+.+++|+.|
T Consensus        97 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  176 (597)
T 3oja_B           97 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL  176 (597)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE
T ss_pred             CCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEE
Confidence            367899999999999988888899999999999999998764         58899999999999888889999999999


Q ss_pred             cccccccccC
Q 040294           72 SLGHNRLQGS   81 (360)
Q Consensus        72 ~l~~N~l~g~   81 (360)
                      +|++|.+++.
T Consensus       177 ~L~~N~l~~~  186 (597)
T 3oja_B          177 QLSSNRLTHV  186 (597)
T ss_dssp             ECTTSCCSBC
T ss_pred             ECcCCCCCCc
Confidence            9999988854

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.41  E-value=8.9e-13  Score=125.32  Aligned_cols=104  Identities=24%  Similarity=0.311  Sum_probs=56.7

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|.+++..|..|.++++|+.|+|++|.++++         .|+.|++++|+++...+..|+++++|++|+
T Consensus        68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  147 (390)
T 3o6n_A           68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  147 (390)
T ss_dssp             CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence            34555555555555554444555555555555555555442         255555555555533333345555555555


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      |++|++++..|..|..+++|++|+|++|++++.
T Consensus       148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  180 (390)
T 3o6n_A          148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  180 (390)
T ss_dssp             CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred             CCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence            555555554455555555555555555555544

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.40  E-value=4e-13  Score=136.78  Aligned_cols=106  Identities=29%  Similarity=0.302  Sum_probs=59.4

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|++++..|..|.++++|+.|+|++|.++.+         .|+.|++++|++++..|..|+++++|++|+|
T Consensus        49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  128 (680)
T 1ziw_A           49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL  128 (680)
T ss_dssp             TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred             CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence            4455555555555554455555555555555555554432         3555566666655555555566666666666


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccch
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      ++|.+++..|..|.++++|++|+|++|++++..|.
T Consensus       129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  163 (680)
T 1ziw_A          129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE  163 (680)
T ss_dssp             CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred             CCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence            66666655555556666666666666666555544

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.40  E-value=3.8e-13  Score=133.39  Aligned_cols=105  Identities=28%  Similarity=0.287  Sum_probs=84.8

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|++..|..|.++++|++|+|++|+++++         .|+.|++++|++++..|..|+++++|++|+|
T Consensus        26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  105 (549)
T 2z81_A           26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL  105 (549)
T ss_dssp             TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred             CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence            4688888888888887788888888888888888887653         4788888888888877777888888888888


Q ss_pred             ccccccc-CCCccccCCCCCCeEeCcCCccCcccc
Q 040294           74 GHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        74 ~~N~l~g-~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      ++|++++ .+|..|+++++|++|+|++|++.+.+|
T Consensus       106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~  140 (549)
T 2z81_A          106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR  140 (549)
T ss_dssp             TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred             CCCcccccchhhhhhccCCccEEECCCCccccccC
Confidence            8888875 356778888888888888888555554

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.40  E-value=4.4e-13  Score=113.19  Aligned_cols=101  Identities=25%  Similarity=0.250  Sum_probs=87.2

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCc-ccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLT-ALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      +++|+.|+|++|+|+. +|. +..+. +|+.|++++|.++++       .|+.|++++|++++..|..++.+++|+.|+|
T Consensus        18 ~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   95 (176)
T 1a9n_A           18 AVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL   95 (176)
T ss_dssp             TTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred             cCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcccccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence            5789999999999994 554 55555 999999999999864       5899999999999765566699999999999


Q ss_pred             cccccccCCCc--cccCCCCCCeEeCcCCccCcc
Q 040294           74 GHNRLQGSIPN--SFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        74 ~~N~l~g~~p~--~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ++|+++ .+|.  .+..+++|+.|+|++|+++..
T Consensus        96 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~  128 (176)
T 1a9n_A           96 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK  128 (176)
T ss_dssp             CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred             CCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCc
Confidence            999996 6776  899999999999999999854

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.40  E-value=3e-13  Score=124.66  Aligned_cols=102  Identities=19%  Similarity=0.144  Sum_probs=74.3

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCC------------c-ccCeEEcCCCcccccCCc----cccC
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH------------L-VLTRTDFSRNNLLGDIPT----TIQG   64 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~------------~-~L~~l~l~~N~l~~~~p~----~~~~   64 (360)
                      +++|+.|+|++|+|++..|..|+++++|+.|+|++|++.+            + .|+.|++++|+++. +|.    .+++
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~  222 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA  222 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence            5677888888888877777778888888888888887542            1 47778888888762 222    2467


Q ss_pred             CCccceecccccccccCCCccccCC---CCCCeEeCcCCccCc
Q 040294           65 LKSLQFLSLGHNRLQGSIPNSFDDL---VSLESLDLSNNNLSE  104 (360)
Q Consensus        65 l~~L~~L~l~~N~l~g~~p~~~~~l---~~L~~l~ls~N~l~~  104 (360)
                      +++|++|+|++|++++..|..+..+   ++|++|+|++|+|+.
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~  265 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ  265 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc
Confidence            7788888888888887767777666   578888888888873

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.40  E-value=1.1e-12  Score=121.90  Aligned_cols=103  Identities=27%  Similarity=0.429  Sum_probs=63.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      +++|+.|+|++|++++..|..|.++++|+.|++++|.++.+      .|+.|++++|++++..+..|.++++|+.|+|++
T Consensus        75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  154 (330)
T 1xku_A           75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT  154 (330)
T ss_dssp             CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCS
T ss_pred             CCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhhcccccEEECCCCcccccCHhHhcCCccccEEECCC
Confidence            45566666666666655565666666666666666665543      356666666666665555566666666666666


Q ss_pred             cccc--cCCCccccCCCCCCeEeCcCCccCc
Q 040294           76 NRLQ--GSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        76 N~l~--g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      |.++  +..|..|..+++|++|++++|.++.
T Consensus       155 n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~  185 (330)
T 1xku_A          155 NPLKSSGIENGAFQGMKKLSYIRIADTNITT  185 (330)
T ss_dssp             SCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             CcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence            6664  2455666666666666666666654

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.40  E-value=1.6e-12  Score=120.94  Aligned_cols=107  Identities=25%  Similarity=0.367  Sum_probs=64.7

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccC-------------------------Cc------ccCeEEcCC
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR-------------------------HL------VLTRTDFSR   51 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-------------------------~~------~L~~l~l~~   51 (360)
                      ++|+.|+|++|++++..+..|.++++|+.|++++|.++                         .+      .|+.|++++
T Consensus       123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~  202 (332)
T 2ft3_A          123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDH  202 (332)
T ss_dssp             TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCS
T ss_pred             ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCC
Confidence            45677777777777554555677777777777777664                         21      245555555


Q ss_pred             CcccccCCccccCCCccceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhh
Q 040294           52 NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL  110 (360)
Q Consensus        52 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l  110 (360)
                      |++++..|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+++ .+|..+
T Consensus       203 n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l  260 (332)
T 2ft3_A          203 NKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL  260 (332)
T ss_dssp             SCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence            5655555555666666666666666666555555666666666666666665 344333

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.40  E-value=3.9e-13  Score=112.48  Aligned_cols=102  Identities=25%  Similarity=0.214  Sum_probs=90.4

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCC-c--------ccCeEEcCCCcccccC-CccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH-L--------VLTRTDFSRNNLLGDI-PTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~--------~L~~l~l~~N~l~~~~-p~~~~~l~~L~~L   71 (360)
                      +++|+.|+|++|.|++.  ..|..+++|+.|+|++|.+++ +        .|+.|++++|++++.. +..+..+++|+.|
T Consensus        48 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L  125 (168)
T 2ell_A           48 FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL  125 (168)
T ss_dssp             GGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEE
T ss_pred             CCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEE
Confidence            57899999999999975  789999999999999999987 3        5899999999998753 3789999999999


Q ss_pred             cccccccccCCC---ccccCCCCCCeEeCcCCccCcc
Q 040294           72 SLGHNRLQGSIP---NSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        72 ~l~~N~l~g~~p---~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      +|++|++++..+   ..|..+++|++|++++|.+...
T Consensus       126 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A          126 DLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             ECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             EeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            999999996544   4899999999999999998754

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.40  E-value=2.8e-13  Score=134.36  Aligned_cols=113  Identities=25%  Similarity=0.314  Sum_probs=101.1

Q ss_pred             CCCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccc-cCCccccCCCccce
Q 040294            1 YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLG-DIPTTIQGLKSLQF   70 (360)
Q Consensus         1 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~-~~p~~~~~l~~L~~   70 (360)
                      .+++|+.|+|++|+|++..|..|.++++|+.|+|++|.++++         .|+.|++++|++++ .+|..++++++|++
T Consensus        48 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~  127 (549)
T 2z81_A           48 ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT  127 (549)
T ss_dssp             SCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCE
T ss_pred             cCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccE
Confidence            368899999999999998889999999999999999999874         58999999999997 46788999999999


Q ss_pred             ecccccccccCCC-ccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           71 LSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        71 L~l~~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      |+|++|++.+.+| ..|..+++|++|+|++|++++.+|..+..+
T Consensus       128 L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l  171 (549)
T 2z81_A          128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI  171 (549)
T ss_dssp             EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTC
T ss_pred             EECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcc
Confidence            9999999655665 689999999999999999999988776554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.39  E-value=4.2e-13  Score=123.90  Aligned_cols=101  Identities=23%  Similarity=0.140  Sum_probs=45.8

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCC-------------cccCeEEcCCCcccc--cCC-ccccCCC
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH-------------LVLTRTDFSRNNLLG--DIP-TTIQGLK   66 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-------------~~L~~l~l~~N~l~~--~~p-~~~~~l~   66 (360)
                      ++|+.|+|++|+|++..|..|+++++|+.|+|++|++.+             ..|+.|++++|++++  .++ ..+..++
T Consensus       149 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~  228 (312)
T 1wwl_A          149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV  228 (312)
T ss_dssp             TTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC
T ss_pred             CCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCC
Confidence            344445555555544444445555555555555554321             034445555555442  111 1223444


Q ss_pred             ccceecccccccccCCC-ccccCCCCCCeEeCcCCccC
Q 040294           67 SLQFLSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        67 ~L~~L~l~~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~  103 (360)
                      +|+.|+|++|++++.+| ..+..+++|+.|+|++|+|+
T Consensus       229 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (312)
T 1wwl_A          229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK  266 (312)
T ss_dssp             CCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred             CCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence            55555555555554433 23344455555555555554

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.39  E-value=1.2e-12  Score=126.96  Aligned_cols=105  Identities=25%  Similarity=0.248  Sum_probs=83.8

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|+|++..|..|.++++|+.|+|++|.++++         .|+.|+|++|++++..+..|..+++|++|+|
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  154 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL  154 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence            4688899999999888888888999999999999888753         5888899999888777777888888999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      ++|+++...+..|..+++|+.|+|++|+..+.+|
T Consensus       155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~  188 (452)
T 3zyi_A          155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS  188 (452)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC
T ss_pred             CCCCcceeCHhHHhcCCcccEEeCCCCCCccccC
Confidence            9988886666677888888888888744333333

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.39  E-value=3e-13  Score=119.82  Aligned_cols=108  Identities=21%  Similarity=0.318  Sum_probs=93.1

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccc-cCCc---------ccCeEEcCC-CcccccCCccccCCCcccee
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE-LRHL---------VLTRTDFSR-NNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~---------~L~~l~l~~-N~l~~~~p~~~~~l~~L~~L   71 (360)
                      ++|+.|+|++|+|++..+..|.++++|+.|++++|. ++.+         .|+.|++++ |++++..+..|.++++|+.|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            468999999999997777789999999999999996 7653         589999998 99998877889999999999


Q ss_pred             cccccccccCCCccccCCCCCC---eEeCcCC-ccCcccchhhhc
Q 040294           72 SLGHNRLQGSIPNSFDDLVSLE---SLDLSNN-NLSEIIPLSLEK  112 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~~L~---~l~ls~N-~l~~~~p~~l~~  112 (360)
                      +|++|++++ +|. |..+++|+   +|++++| +++++.+..+..
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~  153 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQG  153 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTT
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccc
Confidence            999999985 777 88888888   9999999 888877665544

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.39  E-value=4.2e-13  Score=109.93  Aligned_cols=97  Identities=24%  Similarity=0.223  Sum_probs=86.5

Q ss_pred             CCCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCC-c--------ccCeEEcCCCccccc-CCccccCCCccce
Q 040294            1 YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH-L--------VLTRTDFSRNNLLGD-IPTTIQGLKSLQF   70 (360)
Q Consensus         1 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~--------~L~~l~l~~N~l~~~-~p~~~~~l~~L~~   70 (360)
                      .+++|+.|+|++|+|++.  ..+.++++|+.|++++|.+++ +        .|+.|++++|++++. .|..++.+++|+.
T Consensus        40 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~  117 (149)
T 2je0_A           40 EFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS  117 (149)
T ss_dssp             TCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred             hcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence            367899999999999976  789999999999999999998 3        599999999999984 4588999999999


Q ss_pred             ecccccccccCCC---ccccCCCCCCeEeCcC
Q 040294           71 LSLGHNRLQGSIP---NSFDDLVSLESLDLSN   99 (360)
Q Consensus        71 L~l~~N~l~g~~p---~~~~~l~~L~~l~ls~   99 (360)
                      |++++|++++..+   ..+..+++|+.||+++
T Consensus       118 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A          118 LDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             EECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             EeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            9999999997655   5799999999999874

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.38  E-value=2.3e-13  Score=133.53  Aligned_cols=104  Identities=19%  Similarity=0.151  Sum_probs=81.9

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc----------ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~----------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      +++|+.|+|++|.|++..|..|+++++|+.|+|++|.+++.          .|+.|+|++|.+++..  .+..+++|+.|
T Consensus       119 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~L~~L  196 (487)
T 3oja_A          119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTL  196 (487)
T ss_dssp             CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEE
T ss_pred             cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccc--ccccCCCCCEE
Confidence            56788889999999888888888888888999988888752          4788888888888762  24458888888


Q ss_pred             cccccccccCCCccccCCCCCCeEeCcCCccCcccchh
Q 040294           72 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS  109 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~  109 (360)
                      +|++|+|++ +|..|..+++|+.|+|++|+|++ +|..
T Consensus       197 ~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~  232 (487)
T 3oja_A          197 DLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKA  232 (487)
T ss_dssp             ECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTT
T ss_pred             ECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchh
Confidence            888888886 44458888888888888888886 3433

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.38  E-value=2.4e-12  Score=119.71  Aligned_cols=98  Identities=27%  Similarity=0.397  Sum_probs=58.9

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|++++..|..|.++++|+.|++++|.++++         .|+.|++++|+++ .+|..+.  ++|++|++
T Consensus        54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l  130 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI  130 (332)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred             CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence            3466666666666655555666666666666666666543         3566666666665 3444443  56666666


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccC
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~  103 (360)
                      ++|++++..+..|..+++|+.|++++|+++
T Consensus       131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~  160 (332)
T 2ft3_A          131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLE  160 (332)
T ss_dssp             CSSCCCCCCSGGGSSCSSCCEEECCSCCCB
T ss_pred             CCCccCccCHhHhCCCccCCEEECCCCccc
Confidence            666666444445666666666666666664

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.38  E-value=8.4e-13  Score=123.83  Aligned_cols=107  Identities=27%  Similarity=0.295  Sum_probs=48.7

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCC-ccccCCCccceec
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIP-TTIQGLKSLQFLS   72 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p-~~~~~l~~L~~L~   72 (360)
                      ++|+.|+|++|++++..|..|.++++|+.|++++|.++++         .|+.|++++|++++..+ ..+..+++|+.|+
T Consensus        76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~  155 (353)
T 2z80_A           76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR  155 (353)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred             CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEE
Confidence            4444455555544444444444444455555554444432         24444555444443222 2344444455555


Q ss_pred             cccc-ccccCCCccccCCCCCCeEeCcCCccCcccchh
Q 040294           73 LGHN-RLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS  109 (360)
Q Consensus        73 l~~N-~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~  109 (360)
                      +++| .+++..|..|..+++|++|++++|++++..|..
T Consensus       156 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  193 (353)
T 2z80_A          156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS  193 (353)
T ss_dssp             EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred             CCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHH
Confidence            5444 233333344444444555555555444444433

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.38  E-value=8.8e-13  Score=121.55  Aligned_cols=102  Identities=27%  Similarity=0.396  Sum_probs=88.6

Q ss_pred             CCCCCcEeeCCCCccccc--C--CccccCCcccCeeeccccccCCc------------ccCeEEcCCCcccccCCccccC
Q 040294            1 YLAALFQLDLRGNKLSGS--I--PTCFSNLTALRNLHLDSNELRHL------------VLTRTDFSRNNLLGDIPTTIQG   64 (360)
Q Consensus         1 ~l~~L~~L~L~~N~l~g~--~--p~~~~~l~~L~~L~l~~N~l~~~------------~L~~l~l~~N~l~~~~p~~~~~   64 (360)
                      .+++|+.|+|++|++.+.  +  +..++++++|+.|+|++|+++.+            .|+.|++++|++++.+|..++.
T Consensus       167 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~  246 (310)
T 4glp_A          167 AFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR  246 (310)
T ss_dssp             CCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS
T ss_pred             cCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh
Confidence            367899999999998763  2  23357899999999999999752            5899999999999998988888


Q ss_pred             C---CccceecccccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           65 L---KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        65 l---~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      +   ++|+.|+|++|+|+ .+|..+.  ++|+.|||++|++++.
T Consensus       247 ~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~  287 (310)
T 4glp_A          247 CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA  287 (310)
T ss_dssp             CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC
T ss_pred             ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC
Confidence            7   69999999999999 7888775  8999999999999984

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.38  E-value=8.9e-13  Score=132.36  Aligned_cols=102  Identities=25%  Similarity=0.228  Sum_probs=67.6

Q ss_pred             CCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            4 ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      .++.|+|++|+|++..|..|.++++|++|+|++|.++.+         .|+.|++++|++++..|..|+++++|++|+|+
T Consensus        34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  113 (606)
T 3t6q_A           34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI  113 (606)
T ss_dssp             TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred             cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence            466777777777766666677777777777777766542         46666777776666666666666666666666


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      +|++++..|..|+++++|++|+|++|++++.
T Consensus       114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~  144 (606)
T 3t6q_A          114 QTGISSIDFIPLHNQKTLESLYLGSNHISSI  144 (606)
T ss_dssp             TSCCSCGGGSCCTTCTTCCEEECCSSCCCCC
T ss_pred             ccCcccCCcchhccCCcccEEECCCCccccc
Confidence            6666654456666666666666666666653

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.38  E-value=3.1e-13  Score=125.07  Aligned_cols=100  Identities=19%  Similarity=0.154  Sum_probs=69.5

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc----------ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~----------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      +++|+.|+|++|++++..|..+..+++|+.|++++|.++.+          .|+.|++++|++++. | ....+++|+.|
T Consensus       119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L  196 (317)
T 3o53_A          119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTL  196 (317)
T ss_dssp             CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEE
T ss_pred             cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEE
Confidence            45677788888888776666777777788888887777642          467777777777654 2 23346777777


Q ss_pred             cccccccccCCCccccCCCCCCeEeCcCCccCc
Q 040294           72 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      +|++|++++ +|..|..+++|+.|+|++|++++
T Consensus       197 ~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~  228 (317)
T 3o53_A          197 DLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL  228 (317)
T ss_dssp             ECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE
T ss_pred             ECCCCcCCc-chhhhcccCcccEEECcCCcccc
Confidence            777777774 44457777777777777777764

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.37  E-value=6e-13  Score=117.87  Aligned_cols=104  Identities=18%  Similarity=0.266  Sum_probs=90.9

Q ss_pred             CCCCcEeeCCCCc-ccccCCccccCCcccCeeeccc-cccCCc---------ccCeEEcCCCcccccCCccccCCCccc-
Q 040294            2 LAALFQLDLRGNK-LSGSIPTCFSNLTALRNLHLDS-NELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQ-   69 (360)
Q Consensus         2 l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~l~~-N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~-   69 (360)
                      +++|+.|+|++|+ +++..+..|.++++|+.|++++ |.++.+         .|+.|++++|++++ +|. ++.+++|+ 
T Consensus        54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~  131 (239)
T 2xwt_C           54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI  131 (239)
T ss_dssp             CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred             CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence            6789999999997 8876667899999999999998 988764         58999999999987 676 88888888 


Q ss_pred             --eeccccc-ccccCCCccccCCCCCC-eEeCcCCccCcccc
Q 040294           70 --FLSLGHN-RLQGSIPNSFDDLVSLE-SLDLSNNNLSEIIP  107 (360)
Q Consensus        70 --~L~l~~N-~l~g~~p~~~~~l~~L~-~l~ls~N~l~~~~p  107 (360)
                        .|++++| ++++..+..|..+++|+ .|+|++|+++.+.+
T Consensus       132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~  173 (239)
T 2xwt_C          132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQG  173 (239)
T ss_dssp             EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECT
T ss_pred             ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCH
Confidence              9999999 99976677799999999 99999999984443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.37  E-value=2e-12  Score=124.94  Aligned_cols=105  Identities=24%  Similarity=0.247  Sum_probs=81.4

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++++.|+|++|+|++..+..|.++++|+.|+|++|.++.+         .|+.|+|++|++++..+..|..+++|++|+|
T Consensus        64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  143 (440)
T 3zyj_A           64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL  143 (440)
T ss_dssp             TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred             CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence            4578888888888877778888888888888888887653         4788888888888766667888888888888


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      ++|+++...+..|..+++|++|+|++|+..+.+|
T Consensus       144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~  177 (440)
T 3zyj_A          144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS  177 (440)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC
T ss_pred             CCCcccccCHHHhhhCcccCEeCCCCCCCcceeC
Confidence            8888886666677888888888888754333333

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.37  E-value=9.1e-13  Score=137.67  Aligned_cols=108  Identities=29%  Similarity=0.334  Sum_probs=54.4

Q ss_pred             CCCcEeeCCCCcccccC-CccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCcc--ccCCCccce
Q 040294            3 AALFQLDLRGNKLSGSI-PTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTT--IQGLKSLQF   70 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~--~~~l~~L~~   70 (360)
                      ++|+.|+|++|.+.+.+ |..|.++++|++|+|++|.++++         .|+.|+|++|++++.+|..  |+++++|+.
T Consensus        48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~  127 (844)
T 3j0a_A           48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR  127 (844)
T ss_dssp             CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred             ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence            34444444444333333 33444444555555554444432         3555555555555544443  555555555


Q ss_pred             ecccccccccCCC-ccccCCCCCCeEeCcCCccCcccchhh
Q 040294           71 LSLGHNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIPLSL  110 (360)
Q Consensus        71 L~l~~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~~~~p~~l  110 (360)
                      |+|++|.+++..| ..|+++++|++|+|++|.+++..|..+
T Consensus       128 L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l  168 (844)
T 3j0a_A          128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL  168 (844)
T ss_dssp             EEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGG
T ss_pred             EECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHc
Confidence            5555555554433 345556666666666666655555444

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.36  E-value=1.8e-12  Score=116.80  Aligned_cols=96  Identities=27%  Similarity=0.384  Sum_probs=49.2

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      ++|+.|++++|+|+ .+| .+..+++|+.|+|++|+++++       .|+.|++++|++++ +|.. .. ++|+.|+|++
T Consensus        41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~  115 (263)
T 1xeu_A           41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDN  115 (263)
T ss_dssp             TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCS
T ss_pred             CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChhhccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccC
Confidence            45555555555555 233 455555555555555555543       25555555555554 2221 11 5555555555


Q ss_pred             cccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           76 NRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        76 N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      |++++ +| .+..+++|+.|+|++|++++.
T Consensus       116 N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~  143 (263)
T 1xeu_A          116 NELRD-TD-SLIHLKNLEILSIRNNKLKSI  143 (263)
T ss_dssp             SCCSB-SG-GGTTCTTCCEEECTTSCCCBC
T ss_pred             CccCC-Ch-hhcCcccccEEECCCCcCCCC
Confidence            55553 22 355555555555555555543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.36  E-value=7.9e-13  Score=122.30  Aligned_cols=101  Identities=21%  Similarity=0.194  Sum_probs=79.5

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccc-cCCCccceec
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTI-QGLKSLQFLS   72 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~-~~l~~L~~L~   72 (360)
                      ++|+.|++++|+|++..+.   .+++|+.|++++|.++.+         .|+.|++++|.+++..|..+ ..+++|+.|+
T Consensus        99 ~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~  175 (317)
T 3o53_A           99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN  175 (317)
T ss_dssp             TTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred             CCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence            4667777777777755443   357799999999998864         48889999999998877777 4789999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccch
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      |++|++++. |. ...+++|++|+|++|++++..+.
T Consensus       176 L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~  209 (317)
T 3o53_A          176 LQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE  209 (317)
T ss_dssp             CTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG
T ss_pred             CCCCcCccc-cc-ccccccCCEEECCCCcCCcchhh
Confidence            999999854 43 34589999999999999987554

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.35  E-value=6.9e-14  Score=143.64  Aligned_cols=113  Identities=27%  Similarity=0.304  Sum_probs=96.2

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      +++|+.|+|++|+|+ .+|..|++|++|+.|+|++|.|+.+        .|+.|+|++|.|+ .+|..|+++++|+.|+|
T Consensus       246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L  323 (727)
T 4b8c_D          246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV  323 (727)
T ss_dssp             CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred             CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence            688999999999999 8999999999999999999999875        5899999999997 78999999999999999


Q ss_pred             cccccccCCCccccCCCC-CCeEeCcCCccCcccchhhhccccc
Q 040294           74 GHNRLQGSIPNSFDDLVS-LESLDLSNNNLSEIIPLSLEKLLLE  116 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~-L~~l~ls~N~l~~~~p~~l~~l~~~  116 (360)
                      ++|+|+|.+|..+..+.. +..|+|++|.++|.+|..+..+.++
T Consensus       324 ~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~l~  367 (727)
T 4b8c_D          324 EGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIEIN  367 (727)
T ss_dssp             TTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-------
T ss_pred             CCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeEee
Confidence            999999999998876532 2358999999999999988777544

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.35  E-value=1.4e-12  Score=136.27  Aligned_cols=112  Identities=29%  Similarity=0.274  Sum_probs=99.1

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCC---------c-ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH---------L-VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~---------~-~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      .++|+.|||++|+|++..|..|.++++|++|+|++|.+.+         + .|+.|+|++|++++..|.+|+++++|++|
T Consensus        23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  102 (844)
T 3j0a_A           23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL  102 (844)
T ss_dssp             CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred             CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence            3679999999999999889999999999999999994332         2 59999999999999999999999999999


Q ss_pred             cccccccccCCCcc--ccCCCCCCeEeCcCCccCcccc-hhhhcc
Q 040294           72 SLGHNRLQGSIPNS--FDDLVSLESLDLSNNNLSEIIP-LSLEKL  113 (360)
Q Consensus        72 ~l~~N~l~g~~p~~--~~~l~~L~~l~ls~N~l~~~~p-~~l~~l  113 (360)
                      +|++|.+++.+|..  |.++++|++|||++|.+++..| ..+..+
T Consensus       103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L  147 (844)
T 3j0a_A          103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL  147 (844)
T ss_dssp             ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTC
T ss_pred             eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhC
Confidence            99999999877765  9999999999999999998865 344443

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.35  E-value=7.8e-13  Score=130.39  Aligned_cols=100  Identities=26%  Similarity=0.336  Sum_probs=75.2

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|++++..|..|.++++|+.|+|++|+++++         .|+.|++++|+++ .+|..  .+++|++|+|
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L   97 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL   97 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence            4677888888888776667778888888888888877653         4777888888877 45655  6778888888


Q ss_pred             ccccccc-CCCccccCCCCCCeEeCcCCccCcc
Q 040294           74 GHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        74 ~~N~l~g-~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ++|++++ .+|..|+++++|++|+|++|++++.
T Consensus        98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~  130 (520)
T 2z7x_B           98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS  130 (520)
T ss_dssp             CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG
T ss_pred             cCCccccccchhhhccCCcceEEEecCcccchh
Confidence            8888876 4677788888888888888877764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.35  E-value=2.2e-12  Score=115.73  Aligned_cols=135  Identities=14%  Similarity=0.113  Sum_probs=106.6

Q ss_pred             HHhCCCCCCCeeccCCCccEEEEEccCCcEEEehh-----------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEE
Q 040294          197 RATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-----------FDVECEVMKSIH-HRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       197 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-----------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ...++|.....++.|+.+.||++... ++.+++|.           +..|+++++.+. +..+.++++++...+..|+||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            34467877777888888999998864 57888874           568999998885 677889999998888999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG---------------------------------------  305 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~---------------------------------------  305 (360)
                      ||++|.+|.+.+..      ......++.+++++++.||..                                       
T Consensus        90 e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           90 SEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             ECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999876321      112346788999999999951                                       


Q ss_pred             -----------------CCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          306 -----------------FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       306 -----------------~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                                       ....++|+|+++.||+++++..+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                             014589999999999998766677999998754

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.35  E-value=9.4e-13  Score=137.14  Aligned_cols=107  Identities=24%  Similarity=0.385  Sum_probs=98.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccc-cCC--c---------------ccCeEEcCCCcccccCCc--c
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNE-LRH--L---------------VLTRTDFSRNNLLGDIPT--T   61 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~--~---------------~L~~l~l~~N~l~~~~p~--~   61 (360)
                      +++|+.|+|++|++.|.+|..|+++++|+.|+|++|+ +++  +               .|+.|++++|+++ .+|.  .
T Consensus       490 L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~  568 (876)
T 4ecn_A          490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASAS  568 (876)
T ss_dssp             CTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHH
T ss_pred             CCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhh
Confidence            6889999999999999999999999999999999998 775  1               5899999999999 8998  9


Q ss_pred             ccCCCccceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           62 IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        62 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      |+++++|+.|+|++|+++ .+| .|+.+++|+.|+|++|+++ .+|..+..
T Consensus       569 l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~  616 (876)
T 4ecn_A          569 LQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCA  616 (876)
T ss_dssp             HTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCE
T ss_pred             hhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhh
Confidence            999999999999999999 889 8999999999999999999 67755443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.33  E-value=3e-12  Score=117.03  Aligned_cols=100  Identities=32%  Similarity=0.511  Sum_probs=58.6

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|+|++|++++..|  +.++++|+.|++++|.++.+       .|+.|++++|++++.  +.+..+++|+.|+|+
T Consensus        67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~  142 (291)
T 1h6t_A           67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLG  142 (291)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECC
T ss_pred             CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEcc
Confidence            4556666666666664332  56666666666666665543       356666666666542  345566666666666


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|++++.  ..+..+++|+.|+|++|++++..|
T Consensus       143 ~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~  173 (291)
T 1h6t_A          143 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVP  173 (291)
T ss_dssp             SSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred             CCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence            6666643  455666666666666666665544

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.33  E-value=4e-12  Score=106.83  Aligned_cols=102  Identities=21%  Similarity=0.262  Sum_probs=87.0

Q ss_pred             ccCeeeccccccCCc------ccCeEEcCCCcccccCCccccCCCccceecccccccccCCCccccCCCCCCeEeCcCCc
Q 040294           28 ALRNLHLDSNELRHL------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN  101 (360)
Q Consensus        28 ~L~~L~l~~N~l~~~------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~  101 (360)
                      +.+.+++++|.|+.+      .++.|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..|..+++|++|+|++|+
T Consensus        10 ~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           10 SGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            467899999999876      58999999999999999999999999999999999998777788999999999999999


Q ss_pred             cCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294          102 LSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus       102 l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      |+++.|..+..+            ..+....+.+|+..|.
T Consensus        90 l~~~~~~~~~~l------------~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           90 LKSIPRGAFDNL------------KSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             CCCCCTTTTTTC------------TTCCEEECCSSCBCTT
T ss_pred             cCEeCHHHhcCC------------CCCCEEEeCCCCCCCC
Confidence            998877655543            3445566777776664

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.33  E-value=2.3e-12  Score=120.49  Aligned_cols=99  Identities=23%  Similarity=0.239  Sum_probs=86.0

Q ss_pred             cEeeCCCC-cccccCCccccCCcccCeeeccc-cccCCc---------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            6 FQLDLRGN-KLSGSIPTCFSNLTALRNLHLDS-NELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         6 ~~L~L~~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      ..++++++ +|+ .+|. |..+++|+.|+|++ |.|+++         .|+.|+|++|+|++.+|..|+++++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35788988 898 5888 99999999999996 998764         58999999999999999999999999999999


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|+|++..|..|..+. |+.|+|++|+|.....
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~  120 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCA  120 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence            9999976666676665 9999999999987654

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.33  E-value=1.6e-12  Score=123.59  Aligned_cols=112  Identities=18%  Similarity=0.227  Sum_probs=97.7

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|++++|.++...+..|.++++|+.|++++|.++.+         .|+.|++++|++++..|..|+++++|+.|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            57899999999999965555589999999999999998764         589999999999999899999999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      |++|+++...+..|..+++|++|+|++|++++..|..+..+
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  164 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT  164 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSC
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCC
Confidence            99999995444557999999999999999999888666543

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.32  E-value=1.7e-12  Score=129.38  Aligned_cols=100  Identities=30%  Similarity=0.359  Sum_probs=79.1

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ++|+.|+|++|.|++..|..|.++++|+.|+|++|+++++         .|+.|++++|+++ .+|..  .+++|+.|+|
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence            4688888888888877677888888888888888887754         4788888888887 46655  7888888888


Q ss_pred             ccccccc-CCCccccCCCCCCeEeCcCCccCcc
Q 040294           74 GHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        74 ~~N~l~g-~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ++|++++ .+|..|+++++|++|+|++|++++.
T Consensus       129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~  161 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL  161 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT
T ss_pred             CCCCccccCchHhhcccCcccEEecCCCccccC
Confidence            8888876 3567888888888888888888764

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.31  E-value=4.5e-12  Score=118.32  Aligned_cols=104  Identities=26%  Similarity=0.411  Sum_probs=58.5

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|++++|.+++..+  +..+++|+.|++++|.++.+       .|+.|++++|.+++.  +.+..+++|+.|+++
T Consensus       198 l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~  273 (347)
T 4fmz_A          198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVG  273 (347)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECC
T ss_pred             CCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEcc
Confidence            3456666666666654322  55566666666666665543       355666666665542  345556666666666


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccchhhh
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLE  111 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~  111 (360)
                      +|++++ + ..+..+++|+.|+|++|++++..|..+.
T Consensus       274 ~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~  308 (347)
T 4fmz_A          274 SNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIG  308 (347)
T ss_dssp             SSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHH
T ss_pred             CCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhh
Confidence            666653 2 2355566666666666666555554443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.31  E-value=1.7e-12  Score=109.48  Aligned_cols=98  Identities=21%  Similarity=0.344  Sum_probs=87.4

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCc--cccCCCcccee
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPT--TIQGLKSLQFL   71 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~--~~~~l~~L~~L   71 (360)
                      ++|+.|+|++|+|++.  ..|.++++|+.|++++|.++.+         .|+.|++++|+++ .+|.  .+..+++|+.|
T Consensus        42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L  118 (176)
T 1a9n_A           42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL  118 (176)
T ss_dssp             TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred             CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence            4899999999999975  6799999999999999999864         5899999999995 5666  88999999999


Q ss_pred             cccccccccCCCcc----ccCCCCCCeEeCcCCccCc
Q 040294           72 SLGHNRLQGSIPNS----FDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        72 ~l~~N~l~g~~p~~----~~~l~~L~~l~ls~N~l~~  104 (360)
                      +|++|+++ .+|..    +..+++|+.||+++|.+..
T Consensus       119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A          119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            99999998 56775    9999999999999998764

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.30  E-value=6.6e-12  Score=114.76  Aligned_cols=99  Identities=28%  Similarity=0.423  Sum_probs=88.6

Q ss_pred             CCCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            1 YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         1 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      .+++|+.|+|++|++++ +| .+..+++|+.|++++|.++.+       .|+.|++++|++++.  +.++.+++|+.|+|
T Consensus        88 ~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L  163 (291)
T 1h6t_A           88 NLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL  163 (291)
T ss_dssp             TCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred             cCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCChhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEc
Confidence            36889999999999986 44 499999999999999999875       589999999999975  67999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ++|++++..|  +..+++|+.|+|++|++++.
T Consensus       164 ~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l  193 (291)
T 1h6t_A          164 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL  193 (291)
T ss_dssp             CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred             cCCccccchh--hcCCCccCEEECCCCcCCCC
Confidence            9999996544  99999999999999999874

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.30  E-value=3e-12  Score=127.57  Aligned_cols=104  Identities=29%  Similarity=0.320  Sum_probs=75.7

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-----ccCeEEcCCCcccccCCccccCCCcc-------c
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----VLTRTDFSRNNLLGDIPTTIQGLKSL-------Q   69 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-----~L~~l~l~~N~l~~~~p~~~~~l~~L-------~   69 (360)
                      +++|+.|+|++|+|++ +|.   .+++|+.|+|++|.|+++     .|+.|++++|+|+ .+|. |..  +|       +
T Consensus       139 l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~l~~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~  210 (571)
T 3cvr_A          139 PALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEI  210 (571)
T ss_dssp             CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCC-CC----------CCE
T ss_pred             CccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcchhhCCCCEEECcCCCCC-chhh-HHH--hhhcccccce
Confidence            4566677777777764 554   456777777777777664     4777888888877 5666 544  66       8


Q ss_pred             eecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccc
Q 040294           70 FLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL  114 (360)
Q Consensus        70 ~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~  114 (360)
                      .|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+.
T Consensus       211 ~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             EEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred             EEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence            8888888888 6788888888899999999999888888877764

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.30  E-value=5.8e-12  Score=126.56  Aligned_cols=100  Identities=32%  Similarity=0.516  Sum_probs=66.6

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      |++|+.|+|++|+|++..|  +..+++|+.|+|++|.|+.+       .|+.|+|++|++++.  +.+..+++|+.|+|+
T Consensus        64 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls  139 (605)
T 1m9s_A           64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLG  139 (605)
T ss_dssp             CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCTTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECC
T ss_pred             CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCChhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECC
Confidence            5667777777777775433  66777777777777776653       466777777777652  346667777777777


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|+|++.  ..|..+++|+.|+|++|+|++.+|
T Consensus       140 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~  170 (605)
T 1m9s_A          140 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVP  170 (605)
T ss_dssp             SSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred             CCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence            7777643  456667777777777777766655

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.29  E-value=6.3e-12  Score=115.84  Aligned_cols=98  Identities=26%  Similarity=0.472  Sum_probs=48.5

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|+|++|++++. +. +.++++|+.|+|++|.++.+       .|+.|++++|++++. | .+..+++|+.|+|+
T Consensus        62 l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~  137 (308)
T 1h6u_A           62 LNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLD  137 (308)
T ss_dssp             CTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECC
T ss_pred             cCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCCchhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECC
Confidence            34455555555555532 22 55555555555555555442       345555555555442 2 25555555555555


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      +|++++. |. +..+++|+.|+|++|++++.
T Consensus       138 ~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~  166 (308)
T 1h6u_A          138 LNQITNI-SP-LAGLTNLQYLSIGNAQVSDL  166 (308)
T ss_dssp             SSCCCCC-GG-GGGCTTCCEEECCSSCCCCC
T ss_pred             CCccCcC-cc-ccCCCCccEEEccCCcCCCC
Confidence            5555532 22 45555555555555555543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.28  E-value=8.2e-12  Score=115.06  Aligned_cols=101  Identities=27%  Similarity=0.523  Sum_probs=84.3

Q ss_pred             CCCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            1 YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         1 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      .+++|+.|+|++|+|++ +| .+..+++|+.|++++|.++.+       .|+.|++++|++++..+  ++.+++|+.|+|
T Consensus        83 ~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l  158 (308)
T 1h6u_A           83 NLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSI  158 (308)
T ss_dssp             TCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred             cCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCchhhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEc
Confidence            36789999999999985 33 688899999999999998764       58899999999987544  888999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      ++|++++ +|. +..+++|+.|+|++|++++..+
T Consensus       159 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~  190 (308)
T 1h6u_A          159 GNAQVSD-LTP-LANLSKLTTLKADDNKISDISP  190 (308)
T ss_dssp             CSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG
T ss_pred             cCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh
Confidence            9999985 444 8889999999999999987665

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.28  E-value=1.2e-11  Score=104.36  Aligned_cols=101  Identities=23%  Similarity=0.276  Sum_probs=84.6

Q ss_pred             cCeeeccccccCCc------ccCeEEcCCCcccccCCccccCCCccceecccccccccCCCccccCCCCCCeEeCcCCcc
Q 040294           29 LRNLHLDSNELRHL------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL  102 (360)
Q Consensus        29 L~~L~l~~N~l~~~------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l  102 (360)
                      -+.+++++|.++.+      .|+.|+|++|+|++.+|..|+++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus        14 ~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l   93 (174)
T 2r9u_A           14 QTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL   93 (174)
T ss_dssp             SSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence            47899999999875      589999999999999999999999999999999999976666789999999999999999


Q ss_pred             CcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294          103 SEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus       103 ~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      ++..+..+..+            ..+....+.+|+..|.
T Consensus        94 ~~l~~~~~~~l------------~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           94 KSIPRGAFDNL------------KSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCCTTTTTTC------------TTCSEEECCSSCBCTT
T ss_pred             ceeCHHHhccc------------cCCCEEEeCCCCcccc
Confidence            98776555443            3445566677776554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.28  E-value=8.1e-14  Score=120.05  Aligned_cols=101  Identities=26%  Similarity=0.314  Sum_probs=47.4

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      ++|+.|+|++|+|++ +| .+.++++|+.|++++|.++.+        .|+.|++++|++++ +| .++.+++|+.|+|+
T Consensus        48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~  123 (198)
T 1ds9_A           48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMS  123 (198)
T ss_dssp             TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEES
T ss_pred             CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECC
Confidence            344555555555543 33 444455555555555544432        24455555555544 22 34445555555555


Q ss_pred             ccccccCCC-ccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|++++..+ ..+..+++|++|++++|++++.+|
T Consensus       124 ~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A          124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             EEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             CCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence            555542111 244455555555555555544433

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.28  E-value=7.5e-12  Score=111.63  Aligned_cols=122  Identities=14%  Similarity=0.105  Sum_probs=93.3

Q ss_pred             ccCCCccEEEEEccCCcEEEehh--------hHHHHHHhhcCCCCC--eeEEEEEecCCCeEEEEEEccCCCCHHHHHhc
Q 040294          209 GRGSFGSVYKARLQDGMEFAIKS--------FDVECEVMKSIHHRN--LVKIISSCSNEDFRALVLEYMTNGSLEKVLYS  278 (360)
Q Consensus       209 G~G~~g~Vy~~~~~~~~~vavK~--------~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  278 (360)
                      +.|..+.||+....+|..+++|.        +..|+++++.+.+.+  +.++++++..++..++||||++|.++.  ...
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~  106 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH  106 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc
Confidence            35566999999877788898883        468999998886544  556888888888889999999998884  211


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------------------
Q 040294          279 SNCILDILQRLNIMINVTSALEYLHFGF----------------------------------------------------  306 (360)
Q Consensus       279 ~~~~~~~~~~~~i~~~i~~~l~yLH~~~----------------------------------------------------  306 (360)
                          .+   ...++.++++.+..||...                                                    
T Consensus       107 ----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  179 (264)
T 1nd4_A          107 ----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP  179 (264)
T ss_dssp             ----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred             ----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcC
Confidence                11   2356778888888888421                                                    


Q ss_pred             ---CCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          307 ---STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       307 ---~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                         ...++|+|++|.||+++++..+.|+|||.+...
T Consensus       180 ~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          180 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             CCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence               112999999999999988766789999998753

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.26  E-value=1.5e-11  Score=123.52  Aligned_cols=98  Identities=29%  Similarity=0.435  Sum_probs=85.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|+|++|+|++ +| .|..+++|+.|+|++|.++.+       .|+.|+|++|++++.  ..++.+++|+.|+|+
T Consensus        86 l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls  161 (605)
T 1m9s_A           86 LKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLE  161 (605)
T ss_dssp             CTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCCGGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECC
T ss_pred             CCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCCccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECc
Confidence            6789999999999985 44 789999999999999998875       588999999999875  678899999999999


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      +|+|++..|  +..+++|+.|+|++|+|++.
T Consensus       162 ~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l  190 (605)
T 1m9s_A          162 DNQISDIVP--LAGLTKLQNLYLSKNHISDL  190 (605)
T ss_dssp             SSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred             CCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence            999997666  88999999999999999875

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.26  E-value=6.7e-12  Score=117.10  Aligned_cols=102  Identities=25%  Similarity=0.399  Sum_probs=92.9

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|+|++|++++..+  +..+++|+.|++++|.++.+       .|+.|++++|++++.  +.+..+++|+.|+|+
T Consensus       220 ~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~  295 (347)
T 4fmz_A          220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLN  295 (347)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECC
T ss_pred             CCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCChhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECc
Confidence            5789999999999996443  89999999999999998874       589999999999875  468999999999999


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|++++..|..|..+++|+.|+|++|++++..|
T Consensus       296 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~  328 (347)
T 4fmz_A          296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP  328 (347)
T ss_dssp             SSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred             CCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence            999998889999999999999999999999877

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.24  E-value=1.9e-11  Score=121.71  Aligned_cols=89  Identities=37%  Similarity=0.509  Sum_probs=44.9

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-----ccCeEEcCCCcccccCCccccCCCccceecccccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR   77 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-----~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   77 (360)
                      ++|+.|+|++|+|++ +|. |.+  +|+.|+|++|.|+++     .|+.|++++|+|++ +|.   .+++|+.|+|++|+
T Consensus       100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~lp~~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~  171 (571)
T 3cvr_A          100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTMLPELPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQ  171 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred             CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCCCCCcCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCC
Confidence            445555555555554 444 333  455555555555443     24555555555554 333   34455555555555


Q ss_pred             cccCCCccccCCCCCCeEeCcCCccC
Q 040294           78 LQGSIPNSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        78 l~g~~p~~~~~l~~L~~l~ls~N~l~  103 (360)
                      |++ +|. |.  ++|+.|+|++|+|+
T Consensus       172 L~~-lp~-l~--~~L~~L~Ls~N~L~  193 (571)
T 3cvr_A          172 LTF-LPE-LP--ESLEALDVSTNLLE  193 (571)
T ss_dssp             CSC-CCC-CC--TTCCEEECCSSCCS
T ss_pred             CCC-cch-hh--CCCCEEECcCCCCC
Confidence            553 444 43  55555555555555

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.24  E-value=4.4e-11  Score=116.32  Aligned_cols=97  Identities=28%  Similarity=0.298  Sum_probs=52.1

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeecccc----------------------ccCCc------ccCeEEcCCCc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN----------------------ELRHL------VLTRTDFSRNN   53 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N----------------------~l~~~------~L~~l~l~~N~   53 (360)
                      +++|+.|+|++|+|++. |  ++++++|+.|++++|                      +++++      .|+.|++++|+
T Consensus       126 l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~l~l~~l~~L~~L~l~~N~  202 (457)
T 3bz5_A          126 NPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNN  202 (457)
T ss_dssp             CTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCCCCCTTCTTCCEEECCSSC
T ss_pred             CCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccceeccccCCCCCEEECcCCc
Confidence            46677777777777753 2  555555555555555                      33332      24444444444


Q ss_pred             ccccCCccccCCCccceecccccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           54 LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        54 l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +++.   .++.+++|+.|+|++|++++ +|  ++.+++|+.|++++|+|++..+
T Consensus       203 l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~  250 (457)
T 3bz5_A          203 ITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV  250 (457)
T ss_dssp             CSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC
T ss_pred             CCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH
Confidence            4442   24455555555555555554 34  5555555555555555555443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.24  E-value=1e-11  Score=123.87  Aligned_cols=95  Identities=24%  Similarity=0.265  Sum_probs=85.2

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccC-CccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDI-PTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~-p~~~~~l~~L~~L~l   73 (360)
                      +++|+.|+|++|+|+ .+|..|+++++|+.|+|++|.|+++       .|+.|+|++|+|++.+ |..++.+++|+.|+|
T Consensus       462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L  540 (567)
T 1dce_A          462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL  540 (567)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEEC
T ss_pred             cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCCcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEe
Confidence            678999999999999 8899999999999999999999875       5899999999999987 999999999999999


Q ss_pred             cccccccCCCcc---ccCCCCCCeEeC
Q 040294           74 GHNRLQGSIPNS---FDDLVSLESLDL   97 (360)
Q Consensus        74 ~~N~l~g~~p~~---~~~l~~L~~l~l   97 (360)
                      ++|+|++.+|..   +..+++|+.|||
T Consensus       541 ~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          541 QGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             TTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             cCCcCCCCccHHHHHHHHCcccCccCC
Confidence            999999765532   344889999875

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.23  E-value=5.9e-11  Score=115.30  Aligned_cols=93  Identities=30%  Similarity=0.397  Sum_probs=69.2

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-----ccCeEEcCCCcccccCCccccCCCccceecccccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR   77 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-----~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   77 (360)
                      ++|+.|+|++|++++ +| .|+++++|+.|++++|+++++     .|+.|++++|++++ +| .++++++|+.|++++|+
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~  206 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNS  206 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCcccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCc
Confidence            478888888888886 77 588999999999999988875     58888999998887 56 58888888888887777


Q ss_pred             cccCCCccccCCCCCCeEeCcCCccC
Q 040294           78 LQGSIPNSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        78 l~g~~p~~~~~l~~L~~l~ls~N~l~  103 (360)
                      +++ +|...   ++|++|++++|+++
T Consensus       207 l~~-l~~~~---~~L~~L~l~~n~l~  228 (454)
T 1jl5_A          207 LKK-LPDLP---LSLESIVAGNNILE  228 (454)
T ss_dssp             CSS-CCCCC---TTCCEEECCSSCCS
T ss_pred             CCc-CCCCc---CcccEEECcCCcCC
Confidence            774 34322   24555555555554

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.22  E-value=3.6e-11  Score=116.89  Aligned_cols=100  Identities=27%  Similarity=0.310  Sum_probs=82.9

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      +++|+.|+|++|+|++ +|  +..+++|+.|++++|.++++      .|+.|++++|++++ +|  ++.+++|+.|++++
T Consensus       169 l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~  242 (457)
T 3bz5_A          169 QTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSV  242 (457)
T ss_dssp             CTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCCCCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCS
T ss_pred             CCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCeeccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeC
Confidence            5789999999999997 55  88999999999999999875      58899999999998 66  88999999999999


Q ss_pred             cccccCCCccccCCC-------CCCeEeCcCCccCcccc
Q 040294           76 NRLQGSIPNSFDDLV-------SLESLDLSNNNLSEIIP  107 (360)
Q Consensus        76 N~l~g~~p~~~~~l~-------~L~~l~ls~N~l~~~~p  107 (360)
                      |++++..+..+.++.       +|+.|++++|++.|.+|
T Consensus       243 N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~  281 (457)
T 3bz5_A          243 NPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ  281 (457)
T ss_dssp             SCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred             CcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence            999987655555554       55666667776666665

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.21  E-value=2.5e-11  Score=109.27  Aligned_cols=98  Identities=33%  Similarity=0.499  Sum_probs=88.4

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      +++|+.|+|++|+|++..|  +.++++|+.|+|++|+++++      .|+.|++++|++++.  +.++.+++|+.|+|++
T Consensus        62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~~~~~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~  137 (263)
T 1xeu_A           62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRN  137 (263)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTTCCCSSCCEEECCSSCCSBS--GGGTTCTTCCEEECTT
T ss_pred             CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCccccCcccEEEccCCccCCC--hhhcCcccccEEECCC
Confidence            6789999999999996544  99999999999999999875      589999999999973  4699999999999999


Q ss_pred             cccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           76 NRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        76 N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      |++++ +| .+..+++|+.|+|++|++++.
T Consensus       138 N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A          138 NKLKS-IV-MLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             SCCCB-CG-GGGGCTTCCEEECTTSCCCBC
T ss_pred             CcCCC-Ch-HHccCCCCCEEECCCCcCcch
Confidence            99996 45 699999999999999999987

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.21  E-value=3.2e-11  Score=117.38  Aligned_cols=98  Identities=35%  Similarity=0.540  Sum_probs=70.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|+|++|++++..|  +..+++|+.|++++|.++++       .|+.|++++|++++..|  ++.+++|+.|+|+
T Consensus       242 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~  317 (466)
T 1o6v_A          242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY  317 (466)
T ss_dssp             CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECC
T ss_pred             CCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECc
Confidence            5677888888888876544  77777788888888777654       46777777777776443  6677777777777


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      +|++++..|  +..+++|+.|++++|++++.
T Consensus       318 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          318 FNNISDISP--VSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             SSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             CCcCCCchh--hccCccCCEeECCCCccCCc
Confidence            777776544  66777777777777777765

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.20  E-value=3.7e-11  Score=116.96  Aligned_cols=100  Identities=36%  Similarity=0.539  Sum_probs=86.2

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|+|++|++++ + +.+..+++|+.|++++|.++++       .|+.|++++|++++..|  +..+++|+.|+|+
T Consensus       220 l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~  295 (466)
T 1o6v_A          220 LTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELN  295 (466)
T ss_dssp             CTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred             cCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchhhhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcC
Confidence            5789999999999985 3 4688899999999999998874       58999999999987544  8899999999999


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|++++..|  +..+++|+.|+|++|++++..|
T Consensus       296 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~  326 (466)
T 1o6v_A          296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISP  326 (466)
T ss_dssp             SSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG
T ss_pred             CCcccCchh--hcCCCCCCEEECcCCcCCCchh
Confidence            999996544  8899999999999999998877

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.20  E-value=1.7e-11  Score=119.10  Aligned_cols=102  Identities=30%  Similarity=0.358  Sum_probs=60.6

Q ss_pred             cccCeeeccccccCCc-----ccCeEEcCCCcccccCCccccCCCccceecccccccccCCCccccCCCCCCeEeCcCCc
Q 040294           27 TALRNLHLDSNELRHL-----VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN  101 (360)
Q Consensus        27 ~~L~~L~l~~N~l~~~-----~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~  101 (360)
                      ++|+.|++++|+++++     .|+.|++++|++++ +|..   +++|+.|+|++|+++ .+|.   .+++|++|+|++|+
T Consensus       297 ~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~  368 (454)
T 1jl5_A          297 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNP  368 (454)
T ss_dssp             TTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSC
T ss_pred             CcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCC
Confidence            3455566666655542     57788888888876 5654   588999999999998 5777   57899999999999


Q ss_pred             cCc--ccchhhhccc---cccccCCCCCCCCcccccccCCCC
Q 040294          102 LSE--IIPLSLEKLL---LEGEIPRGGPFTKFSSKSFIGNDL  138 (360)
Q Consensus       102 l~~--~~p~~l~~l~---~~~~~p~~~~~~~~~~~~~~~n~~  138 (360)
                      +++  .+|..+..+.   +.|.+|..  ...+....+.+|..
T Consensus       369 l~~l~~ip~~l~~L~~n~~~~~i~~~--~~~L~~L~ls~N~l  408 (454)
T 1jl5_A          369 LREFPDIPESVEDLRMNSHLAEVPEL--PQNLKQLHVETNPL  408 (454)
T ss_dssp             CSSCCCCCTTCCEEECCC------------------------
T ss_pred             CCcCCCChHHHHhhhhcccccccccc--cCcCCEEECCCCcC
Confidence            999  7888776663   44555542  23344445555543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.18  E-value=3.4e-11  Score=121.27  Aligned_cols=106  Identities=30%  Similarity=0.373  Sum_probs=76.1

Q ss_pred             CCCcEeeCCCCcccccCCccccC-----------------CcccCeeeccccccCCc-----ccCeEEcCCCcccccCCc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSN-----------------LTALRNLHLDSNELRHL-----VLTRTDFSRNNLLGDIPT   60 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~-----------------l~~L~~L~l~~N~l~~~-----~L~~l~l~~N~l~~~~p~   60 (360)
                      ++|+.|+|++|+|++ +|..+.+                 +++|+.|+|++|.|+++     .|+.|++++|+|+ .+|.
T Consensus       181 ~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~lp~~l~~L~~L~Ls~N~L~-~lp~  258 (622)
T 3g06_A          181 SGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPM  258 (622)
T ss_dssp             TTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCS-CCCC
T ss_pred             CCCcEEECCCCCCCC-CCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCcCCCCCCcCcEEECCCCCCC-cCCc
Confidence            566677777777764 3332221                 15566777777777664     4777777777777 3554


Q ss_pred             cccCCCccceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccc
Q 040294           61 TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL  114 (360)
Q Consensus        61 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~  114 (360)
                         .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|++++.+|..+..+.
T Consensus       259 ---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          259 ---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             ---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             ---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence               5678888888888888 7788888888899999999998888888776654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.14  E-value=9e-13  Score=113.44  Aligned_cols=103  Identities=23%  Similarity=0.328  Sum_probs=91.9

Q ss_pred             CCCCcEeeCCCCcccccCCc------cccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCcc
Q 040294            2 LAALFQLDLRGNKLSGSIPT------CFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSL   68 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~------~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L   68 (360)
                      ...++.++++.|.|+|.+|.      .|.++++|+.|++++|.++.+       .|+.|++++|+++ .+|..+..+++|
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L   95 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTL   95 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccccccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence            35788899999999999887      899999999999999999885       5899999999998 678888888999


Q ss_pred             ceecccccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           69 QFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        69 ~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +.|+|++|++++ +| .+..+++|+.|+|++|++++..+
T Consensus        96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~  132 (198)
T 1ds9_A           96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGE  132 (198)
T ss_dssp             SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHH
T ss_pred             CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhH
Confidence            999999999996 56 68999999999999999987543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.08  E-value=3.9e-10  Score=105.89  Aligned_cols=130  Identities=15%  Similarity=0.237  Sum_probs=99.5

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEehh--------------hHHHHHHhhcCC--CCCeeEEEEEecCC---CeEEEEEE
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIKS--------------FDVECEVMKSIH--HRNLVKIISSCSNE---DFRALVLE  265 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK~--------------~~~E~~~l~~l~--hpniv~l~~~~~~~---~~~~lv~e  265 (360)
                      .+.++.|.++.||+.+..+ ..+++|.              +..|.++++.+.  +..+++++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4678899999999988765 4555542              345888888887  45678899998876   35799999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF---------------------------------------  306 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------  306 (360)
                      |++|..+.+..   ...++..++..++.++++.|+.||...                                       
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99998774321   123567778889999999999999520                                       


Q ss_pred             ----------------CCCeEEccCCCCceeecCCCc--EEEeecccccc
Q 040294          307 ----------------STPIIHCDLKPHNVLLDDNIV--AHLSDFGIAKL  338 (360)
Q Consensus       307 ----------------~~~iiHrdlk~~NiLl~~~~~--~ki~DFGla~~  338 (360)
                                      ...++|+|+++.||+++.++.  +.|.||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            256999999999999997653  68999998865

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.07  E-value=2.1e-11  Score=113.11  Aligned_cols=99  Identities=19%  Similarity=0.246  Sum_probs=61.5

Q ss_pred             CCCCcEeeCCCCccccc-CCccccCCcccCeeeccccccCC---------cccCeEEcCCC-cccc-cCCccccCCCccc
Q 040294            2 LAALFQLDLRGNKLSGS-IPTCFSNLTALRNLHLDSNELRH---------LVLTRTDFSRN-NLLG-DIPTTIQGLKSLQ   69 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~---------~~L~~l~l~~N-~l~~-~~p~~~~~l~~L~   69 (360)
                      +++|+.|+|++|.+++. +|..+..+++|+.|++++|.++.         -.|+.|++++| .+++ .+|..+.++++|+
T Consensus        92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~  171 (336)
T 2ast_B           92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD  171 (336)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred             CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence            45666777777766654 56566666677777777666553         14666666666 4554 2455566666666


Q ss_pred             eeccccc-ccccC-CCccccCCC-CCCeEeCcCC
Q 040294           70 FLSLGHN-RLQGS-IPNSFDDLV-SLESLDLSNN  100 (360)
Q Consensus        70 ~L~l~~N-~l~g~-~p~~~~~l~-~L~~l~ls~N  100 (360)
                      +|+|++| .+++. +|..+..++ +|++|+|++|
T Consensus       172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~  205 (336)
T 2ast_B          172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY  205 (336)
T ss_dssp             EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred             EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence            6666666 66543 455566666 6666666666

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.05  E-value=2.6e-11  Score=115.05  Aligned_cols=38  Identities=26%  Similarity=0.495  Sum_probs=17.9

Q ss_pred             Cccceecccccccc-cCCC---ccccCCCCCCeEeCcCCccC
Q 040294           66 KSLQFLSLGHNRLQ-GSIP---NSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        66 ~~L~~L~l~~N~l~-g~~p---~~~~~l~~L~~l~ls~N~l~  103 (360)
                      ++|+.|+|++|+++ +.+|   ..|..+++|++|+|++|+++
T Consensus       159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~  200 (386)
T 2ca6_A          159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR  200 (386)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred             CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence            45555555555554 2233   23444445555555555444

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.04  E-value=8e-10  Score=111.24  Aligned_cols=35  Identities=31%  Similarity=0.373  Sum_probs=18.2

Q ss_pred             CccceecccccccccCCCccccCCCCCCeEeCcCCccCc
Q 040294           66 KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        66 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      ++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+.
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~  255 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS  255 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc
Confidence            445555555555553 44   233455555555555553

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.04  E-value=3.8e-10  Score=105.33  Aligned_cols=84  Identities=24%  Similarity=0.250  Sum_probs=73.6

Q ss_pred             Ceeecccc-ccCCc-------ccCeEEcCC-CcccccCCccccCCCccceecccccccccCCCccccCCCCCCeEeCcCC
Q 040294           30 RNLHLDSN-ELRHL-------VLTRTDFSR-NNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN  100 (360)
Q Consensus        30 ~~L~l~~N-~l~~~-------~L~~l~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N  100 (360)
                      ..++.+++ .|+.+       .|+.|+|++ |+|++..|..|+++++|+.|+|++|+|++..|..|.+|++|+.|||++|
T Consensus        11 ~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           11 SGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             SCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             CEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            35677777 77664       489999996 9999998899999999999999999999999999999999999999999


Q ss_pred             ccCcccchhhhcc
Q 040294          101 NLSEIIPLSLEKL  113 (360)
Q Consensus       101 ~l~~~~p~~l~~l  113 (360)
                      +|+++.|..+..+
T Consensus        91 ~l~~~~~~~~~~~  103 (347)
T 2ifg_A           91 ALESLSWKTVQGL  103 (347)
T ss_dssp             CCSCCCSTTTCSC
T ss_pred             ccceeCHHHcccC
Confidence            9998877665543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.01  E-value=3.9e-10  Score=105.57  Aligned_cols=64  Identities=20%  Similarity=0.281  Sum_probs=34.7

Q ss_pred             CeEEcCCCcccccCCccccCCCccceecccc-cccccCCC-ccccCCCCCCeEeCcCCccCcccchhh
Q 040294           45 TRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH-NRLQGSIP-NSFDDLVSLESLDLSNNNLSEIIPLSL  110 (360)
Q Consensus        45 ~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~g~~p-~~~~~l~~L~~l~ls~N~l~~~~p~~l  110 (360)
                      +.|++++|+|+. +|..+....+|+.|++++ |.++ .+| +.|..+++|+.|||++|+|+.+.+..+
T Consensus       157 ~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~  222 (350)
T 4ay9_X          157 VILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGL  222 (350)
T ss_dssp             EEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSSC
T ss_pred             hhhccccccccC-CChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhhh
Confidence            345566666653 333333445566666653 4444 344 346666666666666666665544333

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.01  E-value=4.6e-11  Score=113.33  Aligned_cols=61  Identities=20%  Similarity=0.287  Sum_probs=27.6

Q ss_pred             cCeEEcCCCccc--c---cCCccccCCCccceecccccccc----cCCCccccCCCCCCeEeCcCCccCc
Q 040294           44 LTRTDFSRNNLL--G---DIPTTIQGLKSLQFLSLGHNRLQ----GSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        44 L~~l~l~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      |+.|++++|+++  |   .+|..+..+++|+.|+|++|.++    +.+|..+..+++|+.|+|++|.+++
T Consensus       189 L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~  258 (386)
T 2ca6_A          189 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  258 (386)
T ss_dssp             CCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             cCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCch
Confidence            444444444444  1   22224444444444444444443    3344444444444444444444443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.00  E-value=2.8e-10  Score=106.60  Aligned_cols=97  Identities=21%  Similarity=0.194  Sum_probs=62.9

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc----------ccC-eEEcCCCcccccCCccccCCCcccee
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLT-RTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~----------~L~-~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      ++++.|+|++|+|+...+..|.++++|+.|+|++|++.+.          .+. .+.+++|+++...|..|..+++|+.|
T Consensus        30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L  109 (350)
T 4ay9_X           30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  109 (350)
T ss_dssp             TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred             CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence            4577788888888754445677788888888887776431          122 35556677777667777777777777


Q ss_pred             cccccccccCCCccccCCCCCCeEeCcC
Q 040294           72 SLGHNRLQGSIPNSFDDLVSLESLDLSN   99 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~~L~~l~ls~   99 (360)
                      ++++|++++..+..+....++..|++++
T Consensus       110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~  137 (350)
T 4ay9_X          110 LISNTGIKHLPDVHKIHSLQKVLLDIQD  137 (350)
T ss_dssp             EEEEECCSSCCCCTTCCBSSCEEEEEES
T ss_pred             cccccccccCCchhhcccchhhhhhhcc
Confidence            7777777755444454444555555533

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.99  E-value=1.3e-10  Score=109.31  Aligned_cols=104  Identities=25%  Similarity=0.317  Sum_probs=73.1

Q ss_pred             CCCcEeeCCCCcccccCC----ccccCCc-ccCeeeccccccCC--------------cccCeEEcCCCcccccCCcccc
Q 040294            3 AALFQLDLRGNKLSGSIP----TCFSNLT-ALRNLHLDSNELRH--------------LVLTRTDFSRNNLLGDIPTTIQ   63 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p----~~~~~l~-~L~~L~l~~N~l~~--------------~~L~~l~l~~N~l~~~~p~~~~   63 (360)
                      ++|+.|+|++|+|++..+    ..|..++ +|+.|+|++|.++.              -.|+.|++++|++++..+..+.
T Consensus        22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~  101 (362)
T 3goz_A           22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV  101 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred             CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence            347888888888876555    5667777 78888888887765              2477888888888776666443


Q ss_pred             C----C-CccceecccccccccCCCcccc----C-CCCCCeEeCcCCccCccc
Q 040294           64 G----L-KSLQFLSLGHNRLQGSIPNSFD----D-LVSLESLDLSNNNLSEII  106 (360)
Q Consensus        64 ~----l-~~L~~L~l~~N~l~g~~p~~~~----~-l~~L~~l~ls~N~l~~~~  106 (360)
                      .    + ++|+.|+|++|++++..+..+.    . .++|++|+|++|+++...
T Consensus       102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  154 (362)
T 3goz_A          102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKS  154 (362)
T ss_dssp             HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSC
T ss_pred             HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHH
Confidence            3    3 7788888888888765554433    3 257888888888877543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.98  E-value=1.2e-10  Score=109.69  Aligned_cols=110  Identities=22%  Similarity=0.263  Sum_probs=85.7

Q ss_pred             CC-CCcEeeCCCCcccccCCccccCC-----cccCeeeccccccCC--------------cccCeEEcCCCcccccCCcc
Q 040294            2 LA-ALFQLDLRGNKLSGSIPTCFSNL-----TALRNLHLDSNELRH--------------LVLTRTDFSRNNLLGDIPTT   61 (360)
Q Consensus         2 l~-~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~~--------------~~L~~l~l~~N~l~~~~p~~   61 (360)
                      ++ +|+.|+|++|+|++..+..|..+     ++|+.|+|++|.++.              -.|+.|++++|++++..+..
T Consensus        49 ~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~  128 (362)
T 3goz_A           49 TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSE  128 (362)
T ss_dssp             CCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHH
T ss_pred             CCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHH
Confidence            45 79999999999998777777765     899999999998874              15889999999998776665


Q ss_pred             cc----C-CCccceecccccccccC----CCccccCCC-CCCeEeCcCCccCcccchhhh
Q 040294           62 IQ----G-LKSLQFLSLGHNRLQGS----IPNSFDDLV-SLESLDLSNNNLSEIIPLSLE  111 (360)
Q Consensus        62 ~~----~-l~~L~~L~l~~N~l~g~----~p~~~~~l~-~L~~l~ls~N~l~~~~p~~l~  111 (360)
                      +.    . .++|++|+|++|.+++.    ++..+..+. +|++|+|++|++++..+..+.
T Consensus       129 l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~  188 (362)
T 3goz_A          129 FKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELA  188 (362)
T ss_dssp             HHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             HHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHH
Confidence            54    3 36899999999999853    334455565 899999999999887765443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.96  E-value=1.5e-10  Score=107.33  Aligned_cols=107  Identities=13%  Similarity=0.182  Sum_probs=89.3

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCC--c--------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRH--L--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~--~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      ++++.|++++|.+++.++. +..+++|+.|++++|.++.  +        .|+.|++++|++++..|..++.+++|+.|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            6788999999999976665 5679999999999998764  1        589999999999988888999999999999


Q ss_pred             cccc-cccc-CCCccccCCCCCCeEeCcCC-ccCcc-cchhh
Q 040294           73 LGHN-RLQG-SIPNSFDDLVSLESLDLSNN-NLSEI-IPLSL  110 (360)
Q Consensus        73 l~~N-~l~g-~~p~~~~~l~~L~~l~ls~N-~l~~~-~p~~l  110 (360)
                      |++| .+++ .+|..+..+++|++|+|++| .+++. ++..+
T Consensus       149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~  190 (336)
T 2ast_B          149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV  190 (336)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH
Confidence            9999 6875 37777889999999999999 88864 44433

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.89  E-value=1.4e-10  Score=112.14  Aligned_cols=103  Identities=22%  Similarity=0.206  Sum_probs=48.2

Q ss_pred             CCCcEeeCCCCcccccC-----CccccCCcccCeeeccccccCC-----c--------ccCeEEcCCCcccccCCccccC
Q 040294            3 AALFQLDLRGNKLSGSI-----PTCFSNLTALRNLHLDSNELRH-----L--------VLTRTDFSRNNLLGDIPTTIQG   64 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~-----p~~~~~l~~L~~L~l~~N~l~~-----~--------~L~~l~l~~N~l~~~~p~~~~~   64 (360)
                      ++|+.|+|++|.++..-     +..+..+++|+.|++++|.++.     +        .|+.|++++|.++...+..+..
T Consensus       227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~  306 (461)
T 1z7x_W          227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE  306 (461)
T ss_dssp             TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence            45555555555554321     1112235555555555555543     1        3555555555554332222221


Q ss_pred             -----CCccceecccccccccC----CCccccCCCCCCeEeCcCCccCcc
Q 040294           65 -----LKSLQFLSLGHNRLQGS----IPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        65 -----l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                           .++|+.|+|++|.+++.    +|..+..+++|++|+|++|++++.
T Consensus       307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~  356 (461)
T 1z7x_W          307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA  356 (461)
T ss_dssp             HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred             HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccc
Confidence                 13555555555555433    334444445555555555555443

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.76  E-value=5.6e-10  Score=107.93  Aligned_cols=112  Identities=17%  Similarity=0.146  Sum_probs=92.0

Q ss_pred             CCCCcEeeCCCCccccc----CCccccCCcccCeeeccccccCC--------------cccCeEEcCCCccccc----CC
Q 040294            2 LAALFQLDLRGNKLSGS----IPTCFSNLTALRNLHLDSNELRH--------------LVLTRTDFSRNNLLGD----IP   59 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~--------------~~L~~l~l~~N~l~~~----~p   59 (360)
                      +++|+.|+|++|+++..    ++..+.++++|+.|++++|.++.              ..|+.|++++|.+++.    +|
T Consensus       255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  334 (461)
T 1z7x_W          255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS  334 (461)
T ss_dssp             TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence            57899999999999964    67778889999999999998863              1689999999999876    56


Q ss_pred             ccccCCCccceecccccccccCCCccccC-----CCCCCeEeCcCCccCc----ccchhhhcc
Q 040294           60 TTIQGLKSLQFLSLGHNRLQGSIPNSFDD-----LVSLESLDLSNNNLSE----IIPLSLEKL  113 (360)
Q Consensus        60 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~l~ls~N~l~~----~~p~~l~~l  113 (360)
                      ..+..+++|+.|+|++|++++..+..+..     .++|++|+|++|++++    .+|..+..+
T Consensus       335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~  397 (461)
T 1z7x_W          335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN  397 (461)
T ss_dssp             HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred             HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhC
Confidence            77788899999999999998655554443     6799999999999986    667665543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.66  E-value=1.4e-09  Score=102.81  Aligned_cols=103  Identities=23%  Similarity=0.249  Sum_probs=79.2

Q ss_pred             CCCcEeeCCCCcccccCCccc-cCCcccCeeeccccccCC--------------cccCeEEcCCCcccc----cCCcccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCF-SNLTALRNLHLDSNELRH--------------LVLTRTDFSRNNLLG----DIPTTIQ   63 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~~--------------~~L~~l~l~~N~l~~----~~p~~~~   63 (360)
                      ++|+.|+|++|.|+..-...+ ..+++|+.|+|++|.|+.              ..|+.|+|++|.|+.    .++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            578999999999875433333 356789999999998864              148899999999864    3445557


Q ss_pred             CCCccceeccccccccc----CCCccccCCCCCCeEeCcCCccCcc
Q 040294           64 GLKSLQFLSLGHNRLQG----SIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        64 ~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      .+++|++|+|++|.|+.    .++..+...++|++|+|++|.++..
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~  226 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT  226 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHH
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHH
Confidence            78889999999999874    2356677888999999999998764

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.57  E-value=1.3e-07  Score=87.48  Aligned_cols=111  Identities=14%  Similarity=0.123  Sum_probs=69.4

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcc------------------
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNL------------------   54 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l------------------   54 (360)
                      +++|+.|+|++ .++..-+..|.+|++|+.|++++|.+..+         .+..+.+..+..                  
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L  178 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL  178 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence            67889999988 88865566799999999999998876432         122222211100                  


Q ss_pred             c--------ccCCcc---------------------------c-cCCCccceecccccccccCCCccccCCCCCCeEeCc
Q 040294           55 L--------GDIPTT---------------------------I-QGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS   98 (360)
Q Consensus        55 ~--------~~~p~~---------------------------~-~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls   98 (360)
                      .        +.+|..                           + ..+++|+.|+|++|+++...+..|.++++|+.|+|.
T Consensus       179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~  258 (329)
T 3sb4_A          179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP  258 (329)
T ss_dssp             EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred             ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence            0        000000                           0 026778888888888875445568888888888888


Q ss_pred             CCccCcccchhhhccc
Q 040294           99 NNNLSEIIPLSLEKLL  114 (360)
Q Consensus        99 ~N~l~~~~p~~l~~l~  114 (360)
                      +| ++.+-+.++..+.
T Consensus       259 ~n-i~~I~~~aF~~~~  273 (329)
T 3sb4_A          259 HN-LKTIGQRVFSNCG  273 (329)
T ss_dssp             TT-CCEECTTTTTTCT
T ss_pred             cc-cceehHHHhhCCh
Confidence            87 6666556666554

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.56  E-value=1.3e-07  Score=86.45  Aligned_cols=128  Identities=20%  Similarity=0.285  Sum_probs=91.3

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEeh---------hhHHHHHHhhcCC-CCC--eeEEEEEecCCC---eEEEEEEccCC
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIH-HRN--LVKIISSCSNED---FRALVLEYMTN  269 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK---------~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lv~e~~~~  269 (360)
                      .+.++.|.+..||+..    ..+++|         .+..|.++++.+. +..  +.+++......+   ..|+||||++|
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            4568999999999753    346665         3567999888773 322  445666654443   35899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------------
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG--------------------------------------------  305 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~--------------------------------------------  305 (360)
                      .++......   .++..++..++.++++.++.||..                                            
T Consensus       101 ~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  177 (304)
T 3sg8_A          101 VPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY  177 (304)
T ss_dssp             EECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred             eECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence            887653321   245666777888888888888841                                            


Q ss_pred             -----------CCCCeEEccCCCCceeecC--CCcEEEeeccccccc
Q 040294          306 -----------FSTPIIHCDLKPHNVLLDD--NIVAHLSDFGIAKLL  339 (360)
Q Consensus       306 -----------~~~~iiHrdlk~~NiLl~~--~~~~ki~DFGla~~~  339 (360)
                                 ....++|+|+++.||++++  +..+.|.||+.+..-
T Consensus       178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                       1245799999999999998  566789999998753

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.56  E-value=3.4e-08  Score=88.58  Aligned_cols=85  Identities=28%  Similarity=0.411  Sum_probs=62.0

Q ss_pred             eeCCCCccc---ccCCccccCCcccCeeeccccccCCcccCeEEcCCCcccccCCccccCCCccceecccccccccCCCc
Q 040294            8 LDLRGNKLS---GSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPN   84 (360)
Q Consensus         8 L~L~~N~l~---g~~p~~~~~l~~L~~L~l~~N~l~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~   84 (360)
                      ++++.|+..   +.++-...++++|+.|+|++|+|+++.             .+|..+..+++|+.|+|++|+|++.  .
T Consensus       148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~-------------~l~~~~~~l~~L~~L~Ls~N~i~~~--~  212 (267)
T 3rw6_A          148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLD-------------DMSSIVQKAPNLKILNLSGNELKSE--R  212 (267)
T ss_dssp             CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCG-------------GGTTHHHHSTTCCEEECTTSCCCSG--G
T ss_pred             ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCc-------------cchhHHhhCCCCCEEECCCCccCCc--h
Confidence            677888533   222222356788888888888776542             3567778899999999999999864  3


Q ss_pred             cccCCC--CCCeEeCcCCccCcccc
Q 040294           85 SFDDLV--SLESLDLSNNNLSEIIP  107 (360)
Q Consensus        85 ~~~~l~--~L~~l~ls~N~l~~~~p  107 (360)
                      ++..+.  +|++|+|++|++++.+|
T Consensus       213 ~l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          213 ELDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             GGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hhhhcccCCcceEEccCCcCccccC
Confidence            455555  89999999999998776

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.51  E-value=2.1e-08  Score=85.13  Aligned_cols=102  Identities=14%  Similarity=0.154  Sum_probs=79.0

Q ss_pred             CCCCcEeeCCCC-ccccc----CCccccCCcccCeeeccccccCC-------------cccCeEEcCCCccccc----CC
Q 040294            2 LAALFQLDLRGN-KLSGS----IPTCFSNLTALRNLHLDSNELRH-------------LVLTRTDFSRNNLLGD----IP   59 (360)
Q Consensus         2 l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~~-------------~~L~~l~l~~N~l~~~----~p   59 (360)
                      .++|+.|+|++| .|...    +...+...++|+.|+|++|.+..             ..|+.|+|++|.|...    +.
T Consensus        35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~  114 (185)
T 1io0_A           35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV  114 (185)
T ss_dssp             CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred             CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence            467999999999 88632    34456778899999999999864             1589999999998753    45


Q ss_pred             ccccCCCccceecc--cccccccC----CCccccCCCCCCeEeCcCCccC
Q 040294           60 TTIQGLKSLQFLSL--GHNRLQGS----IPNSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        60 ~~~~~l~~L~~L~l--~~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~  103 (360)
                      ..+...++|++|+|  ++|.++..    +-..+...++|++|+|++|.+.
T Consensus       115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            56777888999999  88998742    3345666689999999999875

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.50  E-value=1.6e-08  Score=90.66  Aligned_cols=59  Identities=24%  Similarity=0.278  Sum_probs=43.9

Q ss_pred             EEcCCCcc---cccCCccccCCCccceeccccccccc--CCCccccCCCCCCeEeCcCCccCcc
Q 040294           47 TDFSRNNL---LGDIPTTIQGLKSLQFLSLGHNRLQG--SIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        47 l~l~~N~l---~~~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ++++.|+.   .+.++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.
T Consensus       148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~  211 (267)
T 3rw6_A          148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE  211 (267)
T ss_dssp             CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred             ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence            55666632   22222223568899999999999997  5667788899999999999999876

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.49  E-value=7.7e-09  Score=97.68  Aligned_cols=103  Identities=20%  Similarity=0.229  Sum_probs=81.6

Q ss_pred             CCCcEeeCCCCcccccCCccccC-----CcccCeeeccccccCCc----------ccCeEEcCCCcccccCCccc-----
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSN-----LTALRNLHLDSNELRHL----------VLTRTDFSRNNLLGDIPTTI-----   62 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~-----l~~L~~L~l~~N~l~~~----------~L~~l~l~~N~l~~~~p~~~-----   62 (360)
                      +.|+.|+|++|.|+......|..     .++|+.|+|++|.++..          .|+.|+|++|+++..-...+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            57999999999998654444433     37999999999999741          58999999999976544444     


Q ss_pred             cCCCccceeccccccccc----CCCccccCCCCCCeEeCcCCccCcc
Q 040294           63 QGLKSLQFLSLGHNRLQG----SIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        63 ~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ...++|+.|+|++|.|+.    .++..+..+++|++|||++|.|+..
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~  198 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDE  198 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcH
Confidence            356889999999999974    3556668899999999999998753

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.45  E-value=2.7e-07  Score=85.33  Aligned_cols=95  Identities=14%  Similarity=0.116  Sum_probs=64.2

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCcccCeEEcCCCcccccCCccccCCCccc-eeccccccccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQ-FLSLGHNRLQG   80 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~g   80 (360)
                      +++|+.|+|++|+++...+..|.+|++|+.|+|++| ++.+               -+.+|.+|.+|+ .++|.+ .++.
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I---------------~~~aF~~~~~L~~~l~l~~-~l~~  287 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTI---------------GQRVFSNCGRLAGTLELPA-SVTA  287 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEE---------------CTTTTTTCTTCCEEEEECT-TCCE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-ccee---------------hHHHhhCChhccEEEEEcc-cceE
Confidence            578899999999998655567899999999988876 4332               244566666666 666665 5553


Q ss_pred             CCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           81 SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        81 ~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      .-+..|.++++|+.|++++|+++.+-+.++..+
T Consensus       288 I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~  320 (329)
T 3sb4_A          288 IEFGAFMGCDNLRYVLATGDKITTLGDELFGNG  320 (329)
T ss_dssp             ECTTTTTTCTTEEEEEECSSCCCEECTTTTCTT
T ss_pred             EchhhhhCCccCCEEEeCCCccCccchhhhcCC
Confidence            444666666666666666666666555555443

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.44  E-value=1.4e-06  Score=77.83  Aligned_cols=127  Identities=18%  Similarity=0.137  Sum_probs=88.8

Q ss_pred             eeccCCCc-cEEEEEcc-CCcEEEeh--------hhHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEccCCCCHHHH
Q 040294          207 LIGRGSFG-SVYKARLQ-DGMEFAIK--------SFDVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEYMTNGSLEKV  275 (360)
Q Consensus       207 ~iG~G~~g-~Vy~~~~~-~~~~vavK--------~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~  275 (360)
                      .+..|..| .||+.... ++..+.+|        .+..|...|+.+. +--+.++++++.+++..++|||+++|.++.+.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~  110 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV  110 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence            34556555 58987754 45678887        3567888887764 33467888999988999999999999887765


Q ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------------------
Q 040294          276 LYSSNCILDILQRLNIMINVTSALEYLHFG--------------------------------------------------  305 (360)
Q Consensus       276 l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~--------------------------------------------------  305 (360)
                      .....     .....++.+++..|.-||..                                                  
T Consensus       111 ~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  185 (272)
T 4gkh_A          111 LEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK  185 (272)
T ss_dssp             HHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred             ccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence            43211     12233455555555555521                                                  


Q ss_pred             -----CCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          306 -----FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       306 -----~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                           ....++|+|+.+.||++++++.+-|.||+.+..
T Consensus       186 ~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          186 LLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                 011379999999999999887778999998865

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.41  E-value=1.1e-06  Score=80.53  Aligned_cols=126  Identities=13%  Similarity=0.178  Sum_probs=84.3

Q ss_pred             CeeccCCCccEEEEEccCCcEEEeh---------hhHHHHHHhhcCCCC---CeeEEEEEec-CCCeEEEEEEccCCCCH
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHR---NLVKIISSCS-NEDFRALVLEYMTNGSL  272 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vavK---------~~~~E~~~l~~l~hp---niv~l~~~~~-~~~~~~lv~e~~~~g~L  272 (360)
                      +.++.|....||+.    +..+++|         .+..|.++++.+.+.   .+.+.+.++. ..+..++||||++|..+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l  100 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL  100 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence            56788888889987    4556665         356799999988752   3556666664 45567899999999877


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------------------
Q 040294          273 EKVLYSSNCILDILQRLNIMINVTSALEYLHFG-----------------------------------------------  305 (360)
Q Consensus       273 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-----------------------------------------------  305 (360)
                      ......   .++..++..++.++++.|+.||..                                               
T Consensus       101 ~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  177 (306)
T 3tdw_A          101 GEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ  177 (306)
T ss_dssp             HHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred             chhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence            653211   123333344444444444444421                                               


Q ss_pred             ----------CCCCeEEccCCCCceeecC---CCc-EEEeecccccc
Q 040294          306 ----------FSTPIIHCDLKPHNVLLDD---NIV-AHLSDFGIAKL  338 (360)
Q Consensus       306 ----------~~~~iiHrdlk~~NiLl~~---~~~-~ki~DFGla~~  338 (360)
                                ....++|+|+.+.||+++.   ++. +.|.||+.+..
T Consensus       178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                      2446799999999999987   455 48999998775

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.29  E-value=2.4e-07  Score=92.33  Aligned_cols=72  Identities=14%  Similarity=0.146  Sum_probs=39.5

Q ss_pred             CCCCcEeeCCCCccccc----CCccccCCcccCeeeccccccCCc-------------ccCeEEcCCCcccccCCccccC
Q 040294            2 LAALFQLDLRGNKLSGS----IPTCFSNLTALRNLHLDSNELRHL-------------VLTRTDFSRNNLLGDIPTTIQG   64 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~-------------~L~~l~l~~N~l~~~~p~~~~~   64 (360)
                      +++|+.|+|++|.+++.    ++..+.++++|+.|++++|.++++             .|+.|++++|.+.+ +|..+.+
T Consensus       163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~  241 (592)
T 3ogk_B          163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA  241 (592)
T ss_dssp             CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred             CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence            45666666666666544    222344566666666666666521             36666666666554 3444444


Q ss_pred             CCccceeccc
Q 040294           65 LKSLQFLSLG   74 (360)
Q Consensus        65 l~~L~~L~l~   74 (360)
                      +++|+.|+++
T Consensus       242 ~~~L~~L~l~  251 (592)
T 3ogk_B          242 AANLEEFCGG  251 (592)
T ss_dssp             CTTCCEEEEC
T ss_pred             hhHHHhhccc
Confidence            4444444443

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.27  E-value=5.2e-08  Score=97.14  Aligned_cols=103  Identities=16%  Similarity=0.135  Sum_probs=64.9

Q ss_pred             CCCCcEeeCCCCcccccCCccccCC--cccCeeeccccc-cCC----------cccCeEEcCCCccccc----CCccccC
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNL--TALRNLHLDSNE-LRH----------LVLTRTDFSRNNLLGD----IPTTIQG   64 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l--~~L~~L~l~~N~-l~~----------~~L~~l~l~~N~l~~~----~p~~~~~   64 (360)
                      +++|+.|+|++|.+++..+..+...  ++|+.|+|++|. ++.          -.|+.|++++|.+++.    ++..+..
T Consensus       111 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~  190 (592)
T 3ogk_B          111 LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQH  190 (592)
T ss_dssp             CTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHH
T ss_pred             CCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhc
Confidence            4566777777776665555555443  337777776654 211          1477777777777655    3334456


Q ss_pred             CCccceecccccccc----cCCCccccCCCCCCeEeCcCCccCc
Q 040294           65 LKSLQFLSLGHNRLQ----GSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        65 l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      +++|+.|+|++|.++    +.++..+.++++|++|+|++|.+.+
T Consensus       191 ~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~  234 (592)
T 3ogk_B          191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE  234 (592)
T ss_dssp             CCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG
T ss_pred             CCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH
Confidence            777777777777776    2344455667777888887777766

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.10  E-value=3.5e-06  Score=78.55  Aligned_cols=68  Identities=7%  Similarity=0.081  Sum_probs=47.5

Q ss_pred             Cee-ccCCCccEEEEEcc-------CCcEEEeh--------------hhHHHHHHhhcCCC---CCeeEEEEEecCC---
Q 040294          206 NLI-GRGSFGSVYKARLQ-------DGMEFAIK--------------SFDVECEVMKSIHH---RNLVKIISSCSNE---  257 (360)
Q Consensus       206 ~~i-G~G~~g~Vy~~~~~-------~~~~vavK--------------~~~~E~~~l~~l~h---pniv~l~~~~~~~---  257 (360)
                      +.| +.|....+|+....       ++..+++|              .+..|+.+++.+..   -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 77888899987654       24566665              24678888887752   3567788887665   


Q ss_pred             CeEEEEEEccCCCCHH
Q 040294          258 DFRALVLEYMTNGSLE  273 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~  273 (360)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999986654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.88  E-value=8.7e-07  Score=88.17  Aligned_cols=59  Identities=14%  Similarity=0.042  Sum_probs=24.9

Q ss_pred             cCeEEcCCCcccccCCccc-cCCCccceecccccccccCCCc-cccCCCCCCeEeCcCCcc
Q 040294           44 LTRTDFSRNNLLGDIPTTI-QGLKSLQFLSLGHNRLQGSIPN-SFDDLVSLESLDLSNNNL  102 (360)
Q Consensus        44 L~~l~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~ls~N~l  102 (360)
                      |+.|++++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|+|++|++
T Consensus       458 L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          458 MEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             CCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             ccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence            4444444444443322222 3344455555555544322111 223344455555555444

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.85  E-value=2.5e-06  Score=84.83  Aligned_cols=99  Identities=14%  Similarity=0.114  Sum_probs=55.7

Q ss_pred             CCCCcEeeCCCCcccccCCcccc-CCcccCeeecccc-ccCC----------cccCeEEcCCCcccccCCcccc----CC
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFS-NLTALRNLHLDSN-ELRH----------LVLTRTDFSRNNLLGDIPTTIQ----GL   65 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l~~N-~l~~----------~~L~~l~l~~N~l~~~~p~~~~----~l   65 (360)
                      +++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.          -.|+.|++++|.+++..+..+.    .+
T Consensus       104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~  183 (594)
T 2p1m_B          104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY  183 (594)
T ss_dssp             CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred             CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence            34666677776666655555554 4666777777666 3322          1466777777766654443332    45


Q ss_pred             Cccceecccccc--ccc-CCCccccCCCCCCeEeCcCC
Q 040294           66 KSLQFLSLGHNR--LQG-SIPNSFDDLVSLESLDLSNN  100 (360)
Q Consensus        66 ~~L~~L~l~~N~--l~g-~~p~~~~~l~~L~~l~ls~N  100 (360)
                      ++|+.|+|++|.  ++. .++.-+..+++|+.|+|++|
T Consensus       184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~  221 (594)
T 2p1m_B          184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA  221 (594)
T ss_dssp             CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred             CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence            567777776665  210 01111234567777777766

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.85  E-value=2.4e-05  Score=72.08  Aligned_cols=32  Identities=25%  Similarity=0.314  Sum_probs=28.8

Q ss_pred             CCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       307 ~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            57899999999999998888999999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.82  E-value=4.2e-05  Score=72.37  Aligned_cols=64  Identities=17%  Similarity=0.208  Sum_probs=43.2

Q ss_pred             CCeeccCCCccEEEEEcc-CCcEEEehh------------------hHHHHHHhhcCCC--C-CeeEEEEEecCCCeEEE
Q 040294          205 NNLIGRGSFGSVYKARLQ-DGMEFAIKS------------------FDVECEVMKSIHH--R-NLVKIISSCSNEDFRAL  262 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------------~~~E~~~l~~l~h--p-niv~l~~~~~~~~~~~l  262 (360)
                      .+.+|.|.++.||+++.. +++.++||.                  +..|.++++.+..  | .+.+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            457899999999999754 467888872                  2458888876642  3 344666553  334589


Q ss_pred             EEEccCCC
Q 040294          263 VLEYMTNG  270 (360)
Q Consensus       263 v~e~~~~g  270 (360)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.75  E-value=2.9e-06  Score=79.56  Aligned_cols=100  Identities=22%  Similarity=0.260  Sum_probs=68.7

Q ss_pred             CCCCcEeeCCCCc-ccccCCccccCCcccCeeeccccccCC-----------cccCeEEcCC--Cccccc-----CCccc
Q 040294            2 LAALFQLDLRGNK-LSGSIPTCFSNLTALRNLHLDSNELRH-----------LVLTRTDFSR--NNLLGD-----IPTTI   62 (360)
Q Consensus         2 l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~l~~N~l~~-----------~~L~~l~l~~--N~l~~~-----~p~~~   62 (360)
                      +++|+.|+|++|. +  .++. +. +++|+.|+|..+.++.           .+|+.|+|+.  |...|.     +...+
T Consensus       171 ~P~L~~L~L~g~~~l--~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l  246 (362)
T 2ra8_A          171 MPLLNNLKIKGTNNL--SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF  246 (362)
T ss_dssp             CTTCCEEEEECCBTC--BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred             CCCCcEEEEeCCCCc--eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence            5789999999883 3  2443 43 7899999998887752           2588888753  332222     11122


Q ss_pred             --cCCCccceecccccccccCCCcccc---CCCCCCeEeCcCCccCcc
Q 040294           63 --QGLKSLQFLSLGHNRLQGSIPNSFD---DLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        63 --~~l~~L~~L~l~~N~l~g~~p~~~~---~l~~L~~l~ls~N~l~~~  105 (360)
                        +.+++|+.|+|.+|.+....+..+.   .+++|++|||+.|.++..
T Consensus       247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~  294 (362)
T 2ra8_A          247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE  294 (362)
T ss_dssp             CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred             hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence              3578999999999988754333332   578999999999998874

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.74  E-value=0.00012  Score=69.45  Aligned_cols=70  Identities=10%  Similarity=0.080  Sum_probs=35.8

Q ss_pred             CCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            4 ALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         4 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      +|+.+.|.. .++..-+..|.+|++|+.++|++|.++.+        .|+.+.+.+| ++..-..+|.+|.+|+.++|..
T Consensus       158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~  235 (401)
T 4fdw_A          158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE  235 (401)
T ss_dssp             CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred             CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence            345555543 44433344566666666666666555432        3455555432 4433344555555565555554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.71  E-value=0.00012  Score=67.02  Aligned_cols=128  Identities=13%  Similarity=0.131  Sum_probs=85.0

Q ss_pred             CCeeccCCCccEEEEEccCCcEEEeh--------hhHHHHHHhhcCC---CCCeeEEEEEecCCCeEEEEEEccCCCCHH
Q 040294          205 NNLIGRGSFGSVYKARLQDGMEFAIK--------SFDVECEVMKSIH---HRNLVKIISSCSNEDFRALVLEYMTNGSLE  273 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~~~vavK--------~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  273 (360)
                      .+.|+.|.+..+|+... ++..+++|        .+..|.+.|+.+.   ...+++++.++...+..++||||+++..+.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~  119 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK  119 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence            45688999999999886 45677887        3577888887764   356788888888888899999999987541


Q ss_pred             --------H---HHhcCCC---------------------CCCHHHHH---HHHH----------------HHHHHH-HH
Q 040294          274 --------K---VLYSSNC---------------------ILDILQRL---NIMI----------------NVTSAL-EY  301 (360)
Q Consensus       274 --------~---~l~~~~~---------------------~~~~~~~~---~i~~----------------~i~~~l-~y  301 (360)
                              .   .+|....                     .-+|....   ++..                .++..+ ..
T Consensus       120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~  199 (312)
T 3jr1_A          120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT  199 (312)
T ss_dssp             TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence                    1   2232111                     12454321   1111                111111 23


Q ss_pred             hh-hcCCCCeEEccCCCCceeecCCCcEEEeecc
Q 040294          302 LH-FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       302 LH-~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                      |. ....+.++|+|+.+.|++++.++ +.|.||.
T Consensus       200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            32 12357899999999999999887 8899984

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.69  E-value=1.1e-05  Score=68.24  Aligned_cols=84  Identities=14%  Similarity=0.182  Sum_probs=67.4

Q ss_pred             cccCCcccCeeecccc-ccCC-------------cccCeEEcCCCccccc----CCccccCCCccceecccccccccC--
Q 040294           22 CFSNLTALRNLHLDSN-ELRH-------------LVLTRTDFSRNNLLGD----IPTTIQGLKSLQFLSLGHNRLQGS--   81 (360)
Q Consensus        22 ~~~~l~~L~~L~l~~N-~l~~-------------~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~--   81 (360)
                      .+...++|+.|+|++| .+..             ..|+.|+|++|++...    +...+...++|++|+|++|.|+..  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            4567899999999999 8864             1589999999999642    334455678999999999999842  


Q ss_pred             --CCccccCCCCCCeEeC--cCCccCcc
Q 040294           82 --IPNSFDDLVSLESLDL--SNNNLSEI  105 (360)
Q Consensus        82 --~p~~~~~l~~L~~l~l--s~N~l~~~  105 (360)
                        +...+...++|++|+|  ++|.+...
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~  138 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNN  138 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence              4567888899999999  88998754

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.61  E-value=8.2e-05  Score=70.68  Aligned_cols=107  Identities=12%  Similarity=0.150  Sum_probs=71.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCccc-----ccCCccccCCCc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLL-----GDIPTTIQGLKS   67 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~-----~~~p~~~~~l~~   67 (360)
                      +++|+.++|+.| ++..-...|.+ ++|+.+.+. |.++.+         .|+.+++.+|.+.     ..-+..|.+|.+
T Consensus       225 ~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~  301 (401)
T 4fdw_A          225 TSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPK  301 (401)
T ss_dssp             CTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTT
T ss_pred             CCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCcc
Confidence            567888888875 55444456766 678888874 334322         5788888777664     234567888888


Q ss_pred             cceecccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           68 LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        68 L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      |+.+.|. |.++-.-...|.++++|+.++|.+| ++.+-+.++..+
T Consensus       302 L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~  345 (401)
T 4fdw_A          302 LARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT  345 (401)
T ss_dssp             CCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS
T ss_pred             CCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC
Confidence            9998888 4476444577888888998888655 554444444433

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.50  E-value=0.00036  Score=66.52  Aligned_cols=31  Identities=19%  Similarity=0.336  Sum_probs=27.8

Q ss_pred             CCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       307 ~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ...++|+|+++.||+++.++ ++|.||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            67899999999999998776 99999988765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.32  E-value=0.0011  Score=59.48  Aligned_cols=65  Identities=18%  Similarity=0.286  Sum_probs=48.6

Q ss_pred             CCCCeeccCCCccEEEEEccCCcEEEehh-----------hHHHHHHhhcCCC---CCeeEEEEEecCCCeEEEEEEccC
Q 040294          203 SANNLIGRGSFGSVYKARLQDGMEFAIKS-----------FDVECEVMKSIHH---RNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       203 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-----------~~~E~~~l~~l~h---pniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      ...+.+|.|..+.||+.+..+|+.|.+|.           |..|++.|+.+.-   --+.+++++..    -++||||++
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~lv~e~l~   93 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RTLAMEWVD   93 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TEEEEECCC
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC----ceEEEEeec
Confidence            33467899999999999999999999983           6789988877642   23455555532    378999998


Q ss_pred             CCC
Q 040294          269 NGS  271 (360)
Q Consensus       269 ~g~  271 (360)
                      ++.
T Consensus        94 ~~~   96 (288)
T 3f7w_A           94 ERP   96 (288)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.31  E-value=0.00034  Score=55.33  Aligned_cols=58  Identities=26%  Similarity=0.263  Sum_probs=44.9

Q ss_pred             eEEcCCCccc-ccCCccccCCCccceecccccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           46 RTDFSRNNLL-GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        46 ~l~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      .++.++++|+ ..+|..+  -.+|+.|+|++|+|+...+..|..+++|+.|+|++|++.-.
T Consensus        12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~Cd   70 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCD   70 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred             EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeecc
Confidence            5666777775 3556543  24699999999999966667789999999999999988643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.23  E-value=0.0011  Score=60.87  Aligned_cols=32  Identities=28%  Similarity=0.338  Sum_probs=27.9

Q ss_pred             CCCeEEccCCCCceeecCC----CcEEEeecccccc
Q 040294          307 STPIIHCDLKPHNVLLDDN----IVAHLSDFGIAKL  338 (360)
Q Consensus       307 ~~~iiHrdlk~~NiLl~~~----~~~ki~DFGla~~  338 (360)
                      ...++|+|+.+.||+++.+    ..+.|.||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            5679999999999999874    6899999998765

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.14  E-value=0.00026  Score=66.24  Aligned_cols=107  Identities=16%  Similarity=0.171  Sum_probs=72.1

Q ss_pred             CCCCcEeeCCCCccc---------ccCCccccCCcccCeeeccccc-cC-----CcccCeEEcCCCcccccCCcccc--C
Q 040294            2 LAALFQLDLRGNKLS---------GSIPTCFSNLTALRNLHLDSNE-LR-----HLVLTRTDFSRNNLLGDIPTTIQ--G   64 (360)
Q Consensus         2 l~~L~~L~L~~N~l~---------g~~p~~~~~l~~L~~L~l~~N~-l~-----~~~L~~l~l~~N~l~~~~p~~~~--~   64 (360)
                      +++|+.|.+..+...         +.++..+..+++|+.|+|++|. ++     ..+|+.|+|..+.+....-..+.  .
T Consensus       138 l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~l~~~~~~~L~~L~L~~~~l~~~~l~~l~~~~  217 (362)
T 2ra8_A          138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD  217 (362)
T ss_dssp             HTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCBCCSCBCTTCSEEEEECSBCCHHHHHHHHHSB
T ss_pred             cchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCceeccccCCCCcEEEEecCCCChHHHHHHHHcc
Confidence            578999998766432         1244456778999999998873 21     23689999998887654334444  7


Q ss_pred             CCccceecccc--cccccC-----CCccc--cCCCCCCeEeCcCCccCcccch
Q 040294           65 LKSLQFLSLGH--NRLQGS-----IPNSF--DDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        65 l~~L~~L~l~~--N~l~g~-----~p~~~--~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      +++|+.|+|+.  |...|.     +...+  ..+++|+.|+|++|.+....+.
T Consensus       218 lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~  270 (362)
T 2ra8_A          218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVE  270 (362)
T ss_dssp             CTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHH
T ss_pred             CCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHH
Confidence            89999999853  332221     11122  3578999999999998765443

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.07  E-value=0.0014  Score=59.27  Aligned_cols=31  Identities=23%  Similarity=0.333  Sum_probs=25.9

Q ss_pred             CCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       307 ~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ...++|+|+.+.||+ ..++.+.++||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            445899999999999 5667789999988764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.76  E-value=0.00032  Score=59.55  Aligned_cols=100  Identities=14%  Similarity=0.175  Sum_probs=54.6

Q ss_pred             CCCcEeeCCCC-cccc----cCCccccCCcccCeeeccccccCCc-------------ccCeEEcCCCccccc----CCc
Q 040294            3 AALFQLDLRGN-KLSG----SIPTCFSNLTALRNLHLDSNELRHL-------------VLTRTDFSRNNLLGD----IPT   60 (360)
Q Consensus         3 ~~L~~L~L~~N-~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~-------------~L~~l~l~~N~l~~~----~p~   60 (360)
                      +.|+.|+|++| +|..    .+-..+..-+.|+.|+|++|++..-             .|+.|+|++|.|...    +-.
T Consensus        41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~  120 (197)
T 1pgv_A           41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR  120 (197)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence            45777777774 6542    1223345556677777777777531             467777777776531    112


Q ss_pred             cccCCCccceecccccc---ccc----CCCccccCCCCCCeEeCcCCcc
Q 040294           61 TIQGLKSLQFLSLGHNR---LQG----SIPNSFDDLVSLESLDLSNNNL  102 (360)
Q Consensus        61 ~~~~l~~L~~L~l~~N~---l~g----~~p~~~~~l~~L~~l~ls~N~l  102 (360)
                      .+..-+.|++|+|++|.   +..    .+-..+..-+.|+.|+|+.|..
T Consensus       121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            23334457777776442   221    1222344445666777666543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.73  E-value=0.0033  Score=60.55  Aligned_cols=63  Identities=19%  Similarity=0.284  Sum_probs=42.8

Q ss_pred             CeeccCCCccEEEEEccC-CcEEEehhh----------HHHHHHhhcCCCCCe-eEEEEEecCCCeEEEEEEccCCCCH
Q 040294          206 NLIGRGSFGSVYKARLQD-GMEFAIKSF----------DVECEVMKSIHHRNL-VKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~----------~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      +.|+.|-...+|+....+ +..+.+|..          ..|..+++.+...++ .++++.+..    .+||||++|.++
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            467778888999988764 467777632          578888888865444 577777742    259999987443

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.71  E-value=0.0038  Score=56.79  Aligned_cols=148  Identities=14%  Similarity=0.129  Sum_probs=79.8

Q ss_pred             cCHHHHHHHhCCCCCC-----CeeccCCCccEEEEEccCCcEEEehh---------hHHHHHHhhcCCCCC--eeEEEEE
Q 040294          190 FSYLELLRATNGFSAN-----NLIGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHHRN--LVKIISS  253 (360)
Q Consensus       190 ~~~~~~~~~~~~f~~~-----~~iG~G~~g~Vy~~~~~~~~~vavK~---------~~~E~~~l~~l~hpn--iv~l~~~  253 (360)
                      ++..++......|...     +.|+.|....+|+....+| .+++|.         +..|.++++.+....  +.+++..
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~   85 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR   85 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence            3445555544555542     3456677788999887655 566663         345777766554222  2233321


Q ss_pred             e------cCCCeEEEEEEccCCCCHHH--------------HHhcC--C--CC-------CCHHHHHH------------
Q 040294          254 C------SNEDFRALVLEYMTNGSLEK--------------VLYSS--N--CI-------LDILQRLN------------  290 (360)
Q Consensus       254 ~------~~~~~~~lv~e~~~~g~L~~--------------~l~~~--~--~~-------~~~~~~~~------------  290 (360)
                      .      ...+..+++|||++|..+..              .+|..  .  ..       ..|.....            
T Consensus        86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~  165 (322)
T 2ppq_A           86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  165 (322)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence            1      12356789999999854310              12211  0  00       11222110            


Q ss_pred             HHHHHHHHHHHhhhc----CCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          291 IMINVTSALEYLHFG----FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       291 i~~~i~~~l~yLH~~----~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      +...+.+.++++...    ....++|+|+.+.||+++++..+.|.||+.+..
T Consensus       166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            011133445555421    245789999999999999876668999988754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.67  E-value=0.004  Score=58.45  Aligned_cols=129  Identities=12%  Similarity=0.137  Sum_probs=73.8

Q ss_pred             CeeccCCCccEEEEEccC--------CcEEEehh----------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEc
Q 040294          206 NLIGRGSFGSVYKARLQD--------GMEFAIKS----------FDVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~----------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +.+..|-...+|+....+        ++.+.+|.          +.+|.++++.+. +.-..++++++.+    .+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            456667778888887642        35677753          346888877664 2223566777764    289999


Q ss_pred             cCCCCHHH-----------------HHhcCCC----CCC--HHHHHHHHHHHH-------------------HHHHHhh-
Q 040294          267 MTNGSLEK-----------------VLYSSNC----ILD--ILQRLNIMINVT-------------------SALEYLH-  303 (360)
Q Consensus       267 ~~~g~L~~-----------------~l~~~~~----~~~--~~~~~~i~~~i~-------------------~~l~yLH-  303 (360)
                      ++|..+..                 .+|....    ...  |.+..++..++.                   ..+++|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            99854421                 1122111    122  233333333221                   1223332 


Q ss_pred             ----hcCCCCeEEccCCCCceeecCC----CcEEEeecccccc
Q 040294          304 ----FGFSTPIIHCDLKPHNVLLDDN----IVAHLSDFGIAKL  338 (360)
Q Consensus       304 ----~~~~~~iiHrdlk~~NiLl~~~----~~~ki~DFGla~~  338 (360)
                          ......++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                1224568999999999999876    7899999988764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.54  E-value=0.0013  Score=63.01  Aligned_cols=62  Identities=18%  Similarity=0.297  Sum_probs=41.0

Q ss_pred             CeeccCCCccEEEEEccC--------CcEEEehhh---------HHHHHHhhcCCCCCe-eEEEEEecCCCeEEEEEEcc
Q 040294          206 NLIGRGSFGSVYKARLQD--------GMEFAIKSF---------DVECEVMKSIHHRNL-VKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~---------~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~  267 (360)
                      +.|+.|....+|+....+        +..+.+|..         ..|..+++.+...++ .++++.+.+    .+||||+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l  154 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  154 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence            457778888999988653        466776643         247777776643333 567776653    3899999


Q ss_pred             CCCC
Q 040294          268 TNGS  271 (360)
Q Consensus       268 ~~g~  271 (360)
                      +|.+
T Consensus       155 ~G~~  158 (429)
T 1nw1_A          155 PSRP  158 (429)
T ss_dssp             CEEE
T ss_pred             CCcc
Confidence            8743

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.50  E-value=0.0029  Score=49.92  Aligned_cols=57  Identities=30%  Similarity=0.390  Sum_probs=38.3

Q ss_pred             cEeeCCCCccc-ccCCccccCCcccCeeeccccccCCcccCeEEcCCCcccccCCccccCCCccceecccccccc
Q 040294            6 FQLDLRGNKLS-GSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ   79 (360)
Q Consensus         6 ~~L~L~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   79 (360)
                      +.++.+++.|+ ..+|..+.  .+|+.|+|++|               +|+...+..|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N---------------~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGN---------------NLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTS---------------CCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCC---------------cCCccChhhhhhccccCEEEecCCCee
Confidence            35677777776 34554433  24555555554               555444667889999999999999986

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.48  E-value=0.00078  Score=56.08  Aligned_cols=58  Identities=12%  Similarity=0.091  Sum_probs=36.0

Q ss_pred             cCeEEcCCCc-ccccCCccccCC----Cccceecccccc-cccCCCccccCCCCCCeEeCcCCc
Q 040294           44 LTRTDFSRNN-LLGDIPTTIQGL----KSLQFLSLGHNR-LQGSIPNSFDDLVSLESLDLSNNN  101 (360)
Q Consensus        44 L~~l~l~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~l~ls~N~  101 (360)
                      |+.|+|+++. ++..--..+..+    ++|+.|+|+++. ++..-=..+..+++|++|+|++..
T Consensus        87 L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A           87 VEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred             CCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence            5555555553 332211234443    479999999875 763222346788999999999874

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.43  E-value=0.0041  Score=57.91  Aligned_cols=31  Identities=23%  Similarity=0.394  Sum_probs=25.2

Q ss_pred             CCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       307 ~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ...++|+|+.+.||+++++. +.|+||..+..
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            45689999999999998654 89999987753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.40  E-value=0.016  Score=52.78  Aligned_cols=130  Identities=12%  Similarity=0.163  Sum_probs=72.5

Q ss_pred             CeeccCCCccEEEEEccCCcEEEehhh----------HHHHHHhhcCCCCC--eeEEEEE-----ecCCCeEEEEEEccC
Q 040294          206 NLIGRGSFGSVYKARLQDGMEFAIKSF----------DVECEVMKSIHHRN--LVKIISS-----CSNEDFRALVLEYMT  268 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~~~vavK~~----------~~E~~~l~~l~hpn--iv~l~~~-----~~~~~~~~lv~e~~~  268 (360)
                      ..++ |....||+....+|+.+++|..          ..|..+++.+....  +++++..     ...++..+++|||++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            4566 7778899988777777888743          34666666554212  3334332     112446688999998


Q ss_pred             CCCHH-----H---------HHhc----C----CCCCCHHHH----HHH---------------HHHHHHHHHHhhh---
Q 040294          269 NGSLE-----K---------VLYS----S----NCILDILQR----LNI---------------MINVTSALEYLHF---  304 (360)
Q Consensus       269 ~g~L~-----~---------~l~~----~----~~~~~~~~~----~~i---------------~~~i~~~l~yLH~---  304 (360)
                      |..+.     .         .+|.    .    ....++...    ..+               ...+...++.+..   
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            85421     1         1111    0    011222110    000               0011112222221   


Q ss_pred             -cCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          305 -GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       305 -~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                       .....++|+|+++.||+++ + .+.|.||+.+..
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence             1245689999999999999 4 899999987764

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.39  E-value=0.02  Score=53.20  Aligned_cols=107  Identities=17%  Similarity=0.236  Sum_probs=64.3

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      .+|+.+.+..+ ++..-...|.++..|+.+.+..+ ++.+         .|+.+.+..+ +...-...|.+|.+|+.+.+
T Consensus       217 ~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l  293 (379)
T 4h09_A          217 KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM  293 (379)
T ss_dssp             SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred             cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence            34555555443 33233445667777777777554 2221         4666666543 44333456778888888888


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      .++.++..-+..|.++.+|+.++|..+ ++.+-..++..+
T Consensus       294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C  332 (379)
T 4h09_A          294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNC  332 (379)
T ss_dssp             CCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred             cccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCC
Confidence            888777444567888888888888654 554444455543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.26  E-value=0.012  Score=55.28  Aligned_cols=38  Identities=16%  Similarity=0.331  Sum_probs=19.0

Q ss_pred             ccccCCCccceecccccccccCCCccccCCCCCCeEeCc
Q 040294           60 TTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLS   98 (360)
Q Consensus        60 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls   98 (360)
                      .+|.+|.+|+.+.|..| ++-.-..+|.++++|+.+.|.
T Consensus       305 ~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip  342 (394)
T 4gt6_A          305 SVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP  342 (394)
T ss_dssp             TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred             eeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence            34555555555555433 332223445555555555554

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.24  E-value=0.01  Score=55.18  Aligned_cols=100  Identities=16%  Similarity=0.172  Sum_probs=75.3

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeecccc-------ccCC-cccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN-------ELRH-LVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-------~l~~-~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      .+.|+.+.+..+ ++..-...|.++.+|+.+.+..+       .+.+ -.|+.+.+.++.++..-..+|.+|.+|+.+.|
T Consensus       239 ~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l  317 (379)
T 4h09_A          239 MKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAKVKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL  317 (379)
T ss_dssp             CSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCCCSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred             CccceEEEcCCC-ccEeCccccceeehhccccccccceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence            457888888776 66445567889999999988654       1222 26899999988887666778999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      ..+ ++-.-..+|.++++|+.+.+..| ++.
T Consensus       318 p~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~  346 (379)
T 4h09_A          318 PTA-LKTIQVYAFKNCKALSTISYPKS-ITL  346 (379)
T ss_dssp             CTT-CCEECTTTTTTCTTCCCCCCCTT-CCE
T ss_pred             Ccc-ccEEHHHHhhCCCCCCEEEECCc-cCE
Confidence            765 66334567999999999988654 443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.09  E-value=0.014  Score=53.70  Aligned_cols=32  Identities=22%  Similarity=0.317  Sum_probs=28.1

Q ss_pred             CCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       307 ~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ...++|+|+.+.||++++++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45789999999999999888899999987765

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.00  E-value=0.0098  Score=55.84  Aligned_cols=97  Identities=15%  Similarity=0.263  Sum_probs=71.5

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccC--------C-cccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR--------H-LVLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~--------~-~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      ++.|+.+.+..+..+ .-...|.++++|+.+.+.. .++        + ..|+.+.|..+ ++..-..+|.+|.+|+.+.
T Consensus       264 c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~-~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~  340 (394)
T 4gt6_A          264 CAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSS-RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIA  340 (394)
T ss_dssp             CSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred             cccccEEecccccce-ecCcccccccccccccCCC-cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEE
Confidence            467888888766554 4456788899999988863 333        2 26888888754 5544456889999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCcc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNL  102 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l  102 (360)
                      |..+ ++-.-..+|.++++|+.+++.+|..
T Consensus       341 ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          341 IPSS-VTKIPESAFSNCTALNNIEYSGSRS  369 (394)
T ss_dssp             ECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred             ECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence            9765 6634457799999999999998754

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=95.83  E-value=0.012  Score=55.31  Aligned_cols=92  Identities=15%  Similarity=0.189  Sum_probs=51.0

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccC--------C-cccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR--------H-LVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~--------~-~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      ..|+.+.+..+.+   ....|..+.+|+.+.+..+ ++        + ..|+.+++.++ ++..-..+|.+|.+|+.+.|
T Consensus       276 ~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~l  350 (394)
T 4fs7_A          276 SGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINF  350 (394)
T ss_dssp             TTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECC
T ss_pred             cccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEE
Confidence            3445555544332   2235677777777777543 22        1 13555555432 33333456677777777777


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCC
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNN  100 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N  100 (360)
                      ..| ++-.-..+|.++++|+.+++..|
T Consensus       351 p~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          351 PLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             CTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             Ccc-ccEehHHHhhCCCCCCEEEECCC
Confidence            665 55333456777777777776543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=95.48  E-value=0.041  Score=51.50  Aligned_cols=91  Identities=20%  Similarity=0.230  Sum_probs=42.0

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccC-------C-cccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR-------H-LVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-------~-~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      ++|+.+.+..+ ++..-...|.++..|+.+.+..+..+       . ..++.+.+..+.+.   ...|..+.+|+.+.+.
T Consensus       230 ~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~  305 (394)
T 4fs7_A          230 TGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLL  305 (394)
T ss_dssp             CCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEEC
T ss_pred             CCCceEEECCC-ceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeec---cccccccccccccccc
Confidence            34556655433 22223345666777777766655321       0 12333333333221   2234455555555554


Q ss_pred             ccccccCCCccccCCCCCCeEeCc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLS   98 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls   98 (360)
                      .+ ++..-+..|.++++|+.++|.
T Consensus       306 ~~-i~~I~~~aF~~c~~L~~i~lp  328 (394)
T 4fs7_A          306 DS-VKFIGEEAFESCTSLVSIDLP  328 (394)
T ss_dssp             TT-CCEECTTTTTTCTTCCEECCC
T ss_pred             cc-cceechhhhcCCCCCCEEEeC
Confidence            33 332223445555555555554

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=95.41  E-value=0.0026  Score=52.87  Aligned_cols=61  Identities=10%  Similarity=0.190  Sum_probs=33.1

Q ss_pred             ccCeEEcCCCcccccCCccccCCCccceecccccc-cccCCCccccCC----CCCCeEeCcCCc-cC
Q 040294           43 VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR-LQGSIPNSFDDL----VSLESLDLSNNN-LS  103 (360)
Q Consensus        43 ~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~l~ls~N~-l~  103 (360)
                      .|+.||++++.++..=-..+..|++|+.|+|+++. ++..-=..+..+    ++|++|+|+++. +|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT  128 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT  128 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence            34445555554443222345677778888887775 542211223443    357788887763 54

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.91  E-value=0.035  Score=52.79  Aligned_cols=31  Identities=23%  Similarity=0.358  Sum_probs=26.8

Q ss_pred             CCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       307 ~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ...++|+|+.+.||+ +.++.+.++||..|..
T Consensus       261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            346899999999999 8888999999988764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=94.46  E-value=0.012  Score=49.69  Aligned_cols=77  Identities=14%  Similarity=0.176  Sum_probs=49.7

Q ss_pred             cCCcccCeeecccc-ccCC-------------cccCeEEcCCCccccc----CCccccCCCccceecccccccccC----
Q 040294           24 SNLTALRNLHLDSN-ELRH-------------LVLTRTDFSRNNLLGD----IPTTIQGLKSLQFLSLGHNRLQGS----   81 (360)
Q Consensus        24 ~~l~~L~~L~l~~N-~l~~-------------~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~----   81 (360)
                      .+-+.|+.|+|++| .+..             ..|+.|+|++|++...    +-..+..-+.|+.|+|+.|.|...    
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a  117 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR  117 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence            34567888888875 6642             1578888888887531    222334556788888888888631    


Q ss_pred             CCccccCCCCCCeEeCcCC
Q 040294           82 IPNSFDDLVSLESLDLSNN  100 (360)
Q Consensus        82 ~p~~~~~l~~L~~l~ls~N  100 (360)
                      +-..+..-+.|++|+|++|
T Consensus       118 la~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          118 LLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHhhCCceeEEECCCC
Confidence            2233555567888888765

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.75  E-value=0.1  Score=49.16  Aligned_cols=30  Identities=27%  Similarity=0.351  Sum_probs=25.0

Q ss_pred             CeEEccCCCCceee------cCCCcEEEeecccccc
Q 040294          309 PIIHCDLKPHNVLL------DDNIVAHLSDFGIAKL  338 (360)
Q Consensus       309 ~iiHrdlk~~NiLl------~~~~~~ki~DFGla~~  338 (360)
                      .++|+|+.+.||++      +++..+.++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4467799999988764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.48  E-value=4.3  Score=34.49  Aligned_cols=88  Identities=13%  Similarity=0.154  Sum_probs=62.7

Q ss_pred             CCCCCeeEEEEEecCCCeEEEEEEccCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCCeEEccCCCCc
Q 040294          242 IHHRNLVKIISSCSNEDFRALVLEYMTNG-SLEKVLYSSNCILDILQRLNIMINVTSALE-YLHFGFSTPIIHCDLKPHN  319 (360)
Q Consensus       242 l~hpniv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~-yLH~~~~~~iiHrdlk~~N  319 (360)
                      -.||++  -..+-.+++.+.+.++.-+++ ++. .+.    ..+...+++++..++.-.. +++     .-+|--+.|+|
T Consensus        47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N  114 (219)
T 4ano_A           47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN  114 (219)
T ss_dssp             GSCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred             ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence            368888  334446777777777765333 343 332    3567788888888877655 333     35788899999


Q ss_pred             eeecCCCcEEEeecccccccCC
Q 040294          320 VLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       320 iLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +.+|.++.++|.-.|+-..+.+
T Consensus       115 L~f~~~~~p~i~hRGi~~~lpP  136 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESLPP  136 (219)
T ss_dssp             EEECTTCCEEESCCEETTTBSS
T ss_pred             EEEeCCCcEEEEEcCCcccCCC
Confidence            9999999999999998776644

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.97  E-value=2.8  Score=35.60  Aligned_cols=90  Identities=10%  Similarity=0.141  Sum_probs=64.0

Q ss_pred             CCCCCeeEEEEEecCCCeEEEEEEccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCce
Q 040294          242 IHHRNLVKIISSCSNEDFRALVLEYMTN-GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNV  320 (360)
Q Consensus       242 l~hpniv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~Ni  320 (360)
                      -.||+.+.. .+-.+++.+.+.|+.-+. -++.. +.    ..+...+++++..|+.-..+++   .  -+|--+.|+|+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~---~--r~tf~L~P~NL  110 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR---T--RYTFVLAPDEL  110 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG---S--SEECCCSGGGE
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc---C--ceEEEEecceE
Confidence            468888876 566666766666665432 22322 22    3567788999999888775555   2  36888999999


Q ss_pred             eecCCCcEEEeecccccccCCC
Q 040294          321 LLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       321 Ll~~~~~~ki~DFGla~~~~~~  342 (360)
                      .++.++.+++.-.|+...+.+.
T Consensus       111 ~f~~~~~p~i~~RGik~~l~P~  132 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVDPL  132 (215)
T ss_dssp             EECTTSCEEESCCEETTTBSCC
T ss_pred             EEcCCCCEEEEEccCccCCCCC
Confidence            9999999999999987665543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	360
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-42
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-40
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-38
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-38
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-37
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-37
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-37
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-36
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-36
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-35
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-35
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-34
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-34
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-33
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-32
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-30
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-29
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-29
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-28
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-27
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-27
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-27
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-26
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-25
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-24
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-24
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-21
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-19
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.002
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	9e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	7e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 5e-44
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 19/168 (11%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIIS 252
             IG GSFG+VYK +     + A+K             +F  E  V++   H N++  + 
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
             +     A+V ++    SL   L+      ++++ ++I       ++YLH      IIH
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLK +N+ L +++   + DFG+A + +    S    Q   +I +MAP
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  146 bits (369), Expect = 6e-42
 Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 31/199 (15%)

Query: 190 FSYLELLRATNGFSAN---------NLIGRGSFGSVYKARL----QDGMEFAIK------ 230
           F++ +   A   F+            +IG G FG V    L    +  +  AIK      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 231 ------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILD 284
                  F  E  +M    H N++ +    +      ++ E+M NGSL+  L  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 285 ILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ 344
           ++Q + ++  + + ++YL        +H DL   N+L++ N+V  +SDFG+++ L  +  
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 345 SMTQTQTL---ATIGYMAP 360
             T T  L     I + AP
Sbjct: 184 DPTYTSALGGKIPIRWTAP 202

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-40
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 16/166 (9%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCS 255
             +G G FG V+        + A+K          +F  E  +MK + H+ LV++ +  +
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCI-LDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            E    ++ EYM NGSL   L + + I L I + L++   +   + ++        IH D
Sbjct: 79  QEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L+  N+L+ D +   ++DFG+A+L+  +++   +      I + AP
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 179

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-39
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 14/165 (8%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCS 255
             +G G FG V   + +   + AIK           F  E +VM ++ H  LV++   C+
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            +    ++ EYM NG L   L          Q L +  +V  A+EYL        +H DL
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 126

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              N L++D  V  +SDFG+++ +  +D+  +   +   + +  P
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPP 170

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-38
 Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 21/184 (11%)

Query: 194 ELLRATNGFSANNL-IGRGSFGSVYKARLQ---DGMEFAIK------------SFDVECE 237
           +L    +     ++ +G G+FGSV +   +     ++ AIK                E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 238 VMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTS 297
           +M  + +  +V++I  C  E    LV+E    G L K L      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 298 ALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIG 356
            ++YL        +H DL   NVLL +   A +SDFG++K L  +D   T        + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 357 YMAP 360
           + AP
Sbjct: 178 WYAP 181

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 2e-38
 Identities = 44/181 (24%), Positives = 76/181 (41%), Gaps = 22/181 (12%)

Query: 193 LELLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK------------SFDVECEVM 239
           +EL    + F   + +G G+ G V+K      G+  A K                E +V+
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 240 KSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSAL 299
              +   +V    +  ++   ++ +E+M  GSL++VL  +   +       + I V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 300 EYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
            YL       I+H D+KP N+L++      L DFG++  L     SM  +    T  YM+
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFV-GTRSYMS 171

Query: 360 P 360
           P
Sbjct: 172 P 172

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-38
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 14/165 (8%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCS 255
             IG G FG V+     +  + AIK           F  E EVM  + H  LV++   C 
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
            +    LV E+M +G L   L +   +      L + ++V   + YL       +IH DL
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDL 127

Query: 316 KPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
              N L+ +N V  +SDFG+ + +  +  + +   T   + + +P
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASP 171

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 6e-38
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 17/167 (10%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIK-----------SFDVECEVMKSIHHRNLVKIISS 253
             +G G+FG VYKA+  +  +  A K            + VE +++ S  H N+VK++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
              E+   +++E+   G+++ V+      L   Q   +      AL YLH      IIH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           DLK  N+L   +    L+DFG++   T   Q         T  +MAP
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAP 179

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (338), Expect = 2e-37
 Identities = 45/174 (25%), Positives = 70/174 (40%), Gaps = 25/174 (14%)

Query: 202 FSANNLIGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVMKSIHHRN 246
           FS    IG GSFG+VY AR +++    AIK                  E   ++ + H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
            ++       E    LV+EY    + + +       L  ++   +       L YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH--- 132

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  +IH D+K  N+LL +  +  L DFG A ++            + T  +MAP
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAP 180

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-37
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 16/170 (9%)

Query: 202 FSANNLIGRGSFGSVYKARLQDGMEFAIK----------SFDVECEVMKSIHHRNLVKII 251
                 +G+G FG V+          AIK          +F  E +VMK + H  LV++ 
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY 78

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDIL-QRLNIMINVTSALEYLHFGFSTPI 310
           +  S E    +V EYM+ GSL   L         L Q +++   + S + Y+        
Sbjct: 79  AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 134

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +H DL+  N+L+ +N+V  ++DFG+A+L+  +++   +      I + AP
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAP 183

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 3e-37
 Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 17/168 (10%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV------------ECEVMKSIHHRNLVKIIS 252
             +G G++G V  A         A+K  D+            E  + K ++H N+VK   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
                + + L LEY + G L   +   +  +           + + + YLH      I H
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITH 126

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  132 bits (333), Expect = 7e-37
 Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 20/192 (10%)

Query: 181 MQPQASRRRFSYLELLRATNGFSANNLIGRGSFGSVYKARLQD-GMEFAIK--------- 230
           M P       +Y +        +  + +G G +G VY+   +   +  A+K         
Sbjct: 2   MDPS----SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV 57

Query: 231 -SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSN-CILDILQR 288
             F  E  VMK I H NLV+++  C+ E    ++ E+MT G+L   L   N   +  +  
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117

Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           L +   ++SA+EYL        IH DL   N L+ +N +  ++DFG+++L+TG D     
Sbjct: 118 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH 173

Query: 349 TQTLATIGYMAP 360
                 I + AP
Sbjct: 174 AGAKFPIKWTAP 185

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-36
 Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 19/170 (11%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVMKSIHHRNLVKI 250
            ++G GSF +V  AR L    E+AIK                  E +VM  + H   VK+
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             +  +++     L Y  NG L K +       D          + SALEYLH      I
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGI 129

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           IH DLKP N+LL++++   ++DFG AK+L+ E +       + T  Y++P
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 3e-36
 Identities = 49/176 (27%), Positives = 69/176 (39%), Gaps = 23/176 (13%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII 251
             IG GS+G   K R   DG     K  D              E  +++ + H N+V+  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 252 SSCSNEDFRAL--VLEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLH--F 304
               +     L  V+EY   G L  V+         LD    L +M  +T AL+  H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                ++H DLKP NV LD      L DFG+A++L  +           T  YM+P
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYMSP 183

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 6e-36
 Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 22/173 (12%)

Query: 205 NNLIGRGSFGSVYKARLQD---GMEFAIK-------------SFDVECEVMKSIHHRNLV 248
           +  +G G+FG+V K   Q        A+K                 E  VM+ + +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
           ++I  C  E +  LV+E    G L K L  +   +     + ++  V+  ++YL     +
Sbjct: 72  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE---S 126

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             +H DL   NVLL     A +SDFG++K L  ++            + + AP
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 7e-36
 Identities = 52/166 (31%), Positives = 73/166 (43%), Gaps = 20/166 (12%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK---------SFDVECEVMKSIHHRNLVKIISSCSN 256
             IG+G FG V       G + A+K         +F  E  VM  + H NLV+++     
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71

Query: 257 EDFR-ALVLEYMTNGSLEKVLYSSNC-ILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
           E     +V EYM  GSL   L S    +L     L   ++V  A+EYL        +H D
Sbjct: 72  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 128

Query: 315 LKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           L   NVL+ ++ VA +SDFG+ K       S TQ      + + AP
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAP 169

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-35
 Identities = 40/195 (20%), Positives = 70/195 (35%), Gaps = 44/195 (22%)

Query: 207 LIGRGSFGSVYKARLQD------GMEFAIK------------SFDVECEVMKSI-HHRNL 247
           ++G G+FG V  A           ++ A+K            +   E ++M  +  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 248 VKIISSCSNEDFRALVLEYMTNGSLEKVLYSSN----------------------CILDI 285
           V ++ +C+      L+ EY   G L   L S                         +L  
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 286 LQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS 345
              L     V   +E+L        +H DL   NVL+    V  + DFG+A+ +  +   
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 346 MTQTQTLATIGYMAP 360
           + +      + +MAP
Sbjct: 221 VVRGNARLPVKWMAP 235

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-35
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 21/177 (11%)

Query: 202 FSANNLIGRGSFGSVYKARLQDG-----MEFAIK------------SFDVECEVMKSIHH 244
            +   +IG G FG VYK  L+       +  AIK             F  E  +M    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
            N++++    S      ++ EYM NG+L+K L   +    +LQ + ++  + + ++YL  
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAP 360
             +   +H DL   N+L++ N+V  +SDFG++++L    + + T +     I + AP
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  130 bits (327), Expect = 2e-35
 Identities = 37/168 (22%), Positives = 68/168 (40%), Gaps = 20/168 (11%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK-----------SFDVECEVMKSIHHRNLVKIISSC 254
            +G G+FG V++      G  FA K           +   E + M  + H  LV +  + 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            +++   ++ E+M+ G L + +   +  +   + +  M  V   L ++H       +H D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149

Query: 315 LKPHNVLL--DDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           LKP N++     +    L DFG+   L  +      T T     + AP
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAP 194

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 4e-35
 Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 23/170 (13%)

Query: 206 NLIGRGSFGSVYKARL-QDGMEFAIK--------------SFDVECEVMKSIHHRNLVKI 250
             +G+G FG+VY AR  Q     A+K                  E E+   + H N++++
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
                +     L+LEY   G++ + L   +   D  +    +  + +AL Y H   S  +
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRV 127

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           IH D+KP N+LL       ++DFG +       ++        T+ Y+ P
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPP 173

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 7e-35
 Identities = 47/175 (26%), Positives = 73/175 (41%), Gaps = 25/175 (14%)

Query: 205 NNLIGRGSFGSVYKARL-QDGMEFAIK-------------SFDVECEVMKSIHHRNLVKI 250
           +  IGRGSF +VYK    +  +E A                F  E E++K + H N+V+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 251 ISSC----SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
             S       +    LV E MT+G+L+  L     ++ I    +    +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR- 131

Query: 307 STPIIHCDLKPHNVLLDD-NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           + PIIH DLK  N+ +        + D G+A L             + T  +MAP
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (313), Expect = 6e-34
 Identities = 49/213 (23%), Positives = 79/213 (37%), Gaps = 46/213 (21%)

Query: 189 RFSYLELLRATNGFSANNLIGRGSFGSVYKARL------QDGMEFAIK------------ 230
           +   LE  R  N       IG G+FG V++AR       +     A+K            
Sbjct: 4   KLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 231 SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNC--------- 281
            F  E  +M    + N+VK++  C+      L+ EYM  G L + L S +          
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 282 --------------ILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIV 327
                          L   ++L I   V + + YL        +H DL   N L+ +N+V
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMV 178

Query: 328 AHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             ++DFG+++ +   D           I +M P
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 7e-34
 Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 24/174 (13%)

Query: 208 IGRGSFGSVYKARLQDGMEFAIKSFD----------VECEVMKSIHHRNLVKIISSCSNE 257
           IG+G FG V++ +   G E A+K F            E      + H N++  I++ + +
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69

Query: 258 DFRA----LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH-----FGFST 308
           +       LV +Y  +GSL   L      + +   + + ++  S L +LH          
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT--QTQTLATIGYMAP 360
            I H DLK  N+L+  N    ++D G+A        ++       + T  YMAP
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 8e-34
 Identities = 43/185 (23%), Positives = 76/185 (41%), Gaps = 22/185 (11%)

Query: 193 LELLRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK----------------SFDVE 235
           L +L+ T  F    ++G G+FG+VYK   + +G +  I                     E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 236 CEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINV 295
             VM S+ + ++ +++  C     + L+ + M  G L   +      +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 296 TSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATI 355
              + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 356 GYMAP 360
            +MA 
Sbjct: 178 KWMAL 182

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 8e-34
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 19/167 (11%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-----------ECEVMKSIHHRNLVKIISS 253
             IG+G+ G+VY A  +  G E AI+  ++           E  VM+   + N+V  + S
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
               D   +V+EY+  GSL  V+  +    D  Q   +      ALE+LH   S  +IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140

Query: 314 DLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+K  N+LL  +    L+DFG    +T E    +      T  +MAP
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAP 185

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-33
 Identities = 40/191 (20%), Positives = 71/191 (37%), Gaps = 39/191 (20%)

Query: 206 NLIGRGSFGSVYKARL------QDGMEFAIK------------SFDVECEVMKSI-HHRN 246
             +G G+FG V +A           M  A+K            +   E +V+  + +H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSS-----------------NCILDILQRL 289
           +V ++ +C+      ++ EY   G L   L                       LD+   L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 290 NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 349
           +    V   + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + + 
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 350 QTLATIGYMAP 360
                + +MAP
Sbjct: 206 NARLPVKWMAP 216

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 2e-33
 Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 21/169 (12%)

Query: 207 LIGRGSFGSVYKARL----QDGMEFAIKS------------FDVECEVMKSIHHRNLVKI 250
            IG G FG V++          +  AIK+            F  E   M+   H ++VK+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
           I   + E+   +++E  T G L   L      LD+   +     +++AL YL    S   
Sbjct: 74  IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           +H D+   NVL+  N    L DFG+++ +            L  I +MA
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMA 177

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  124 bits (312), Expect = 3e-33
 Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 20/168 (11%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK-----------SFDVECEVMKSIHHRNLVKIISSC 254
            +G G+FG V++      G  F  K           +   E  +M  +HH  L+ +  + 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 255 SNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCD 314
            ++    L+LE+++ G L   + + +  +   + +N M      L+++H      I+H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 315 LKPHNVLLDDNIVAH--LSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +KP N++ +    +   + DFG+A  L  ++     T   AT  + AP
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAP 197

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 3e-33
 Identities = 41/172 (23%), Positives = 62/172 (36%), Gaps = 23/172 (13%)

Query: 208 IGRGSFGSVYKARL----QDGMEFAIK--------------SFDVECEVMKSIHHRNLVK 249
           +G GSFG V +          +  A+K               F  E   M S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +         + +V E    GSL   L        +       + V   + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGYMAP 360
            IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 2e-32
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 37/192 (19%)

Query: 200 NGFSANNLIGRGSFGSVYKARLQDG---MEFAIK------------SFDVECEVMKSI-H 243
           N     ++IG G+FG V KAR++     M+ AIK             F  E EV+  + H
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCI---------------LDILQR 288
           H N++ ++ +C +  +  L +EY  +G+L   L  S  +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 289 LNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ 348
           L+   +V   ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 349 TQTLATIGYMAP 360
           T     + +MA 
Sbjct: 184 TMGRLPVRWMAI 195

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 5e-32
 Identities = 41/175 (23%), Positives = 73/175 (41%), Gaps = 22/175 (12%)

Query: 205 NNLIGRGSFGSVYKARLQD----GMEFAIK------------SFDVECEVMKSIHHRNLV 248
           N +IGRG FG VY   L D     +  A+K             F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 249 KIISSCSNEDFRA-LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            ++  C   +    +VL YM +G L   + +      +   +   + V   +++L     
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED--QSMTQTQTLATIGYMAP 360
              +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 4e-31
 Identities = 32/158 (20%), Positives = 67/158 (42%), Gaps = 16/158 (10%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV----------ECEVMKSIHHRNLVKIISSCS 255
            +GRG FG V++         +  K   V          E  ++    HRN++ +  S  
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 256 NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDL 315
           + +   ++ E+++   + + + +S   L+  + ++ +  V  AL++LH   S  I H D+
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128

Query: 316 KPHNVLLD--DNIVAHLSDFGIAKLLTGEDQSMTQTQT 351
           +P N++     +    + +FG A+ L   D        
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 7e-31
 Identities = 36/186 (19%), Positives = 73/186 (39%), Gaps = 30/186 (16%)

Query: 202 FSANNLIGRGSFGSVYKARL------QDGMEFAIK------------SFDVECEVMKSIH 243
            + +  +G+GSFG VY+         +     AIK             F  E  VMK  +
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLY---------SSNCILDILQRLNIMIN 294
             ++V+++   S      +++E MT G L+  L                 + + + +   
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 295 VTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLAT 354
           +   + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 355 IGYMAP 360
           + +M+P
Sbjct: 199 VRWMSP 204

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  114 bits (287), Expect = 3e-30
 Identities = 39/174 (22%), Positives = 78/174 (44%), Gaps = 24/174 (13%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVMKSIHHRNLVKII 251
           ++G G    V+ AR L+   + A+K               F  E +   +++H  +V + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 252 SSCSNED----FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFS 307
            +   E        +V+EY+   +L  ++++    +   + + ++ +   AL + H    
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---Q 129

Query: 308 TPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 360
             IIH D+KP N+++       + DFGIA+ +     S+TQT  +  T  Y++P
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (287), Expect = 4e-30
 Identities = 37/168 (22%), Positives = 65/168 (38%), Gaps = 17/168 (10%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIK------------SFDVECEVMKSIHHRNLVKIIS 252
           +++G G+F  V  A   +     AIK            S + E  V+  I H N+V +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
              +     L+++ ++ G L   +              ++  V  A++YLH         
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDL 133

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                    LD++    +SDFG++K+   ED     +    T GY+AP
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 178

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  115 bits (290), Expect = 5e-30
 Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 26/178 (14%)

Query: 200 NGFSANNLIGRGSFGSVYKAR-LQDGMEFAIKSFD-----------------VECEVMKS 241
           N FS + +IGRG FG VY  R    G  +A+K  D                 +   ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 242 IHHRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEY 301
                +V +  +    D  + +L+ M  G L   L S + +            +   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122

Query: 302 LHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           +H   +  +++ DLKP N+LLD++    +SD G+A   + +    +      T GYMA
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG----THGYMA 173

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-29
 Identities = 40/171 (23%), Positives = 68/171 (39%), Gaps = 19/171 (11%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIK------------SFDVECEVMKSIHHRNLVKIIS 252
           + IG G++G V  A    + +  AIK                E +++    H N++ I  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYS--SNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
                    +   Y+    +   LY       L        +  +   L+Y+H   S  +
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGYMAP 360
           +H DLKP N+LL+      + DFG+A++     D +   T+ +AT  Y AP
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  112 bits (281), Expect = 2e-29
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 29/177 (16%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------------------ECEVMKSIH- 243
            ++GRG    V +        E+A+K  DV                    E ++++ +  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 244 HRNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
           H N++++  +     F  LV + M  G L   L +    L   +   IM  +   +  LH
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH 127

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
                 I+H DLKP N+LLDD++   L+DFG +  L   D      +   T  Y+AP
Sbjct: 128 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAP 178

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 6e-29
 Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 23/172 (13%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV----------------ECEVMKSIHHRNLV 248
           + +G G F +VYKAR        AIK   +                E ++++ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
            ++ +  ++   +LV ++M    LE ++  ++ +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 309 PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            I+H DLKP+N+LLD+N V  L+DFG+AK       +   T  + T  Y AP
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAP 169

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  111 bits (277), Expect = 7e-29
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 19/168 (11%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKIIS 252
             IG G++G VYKA+   G  FA+K             +   E  ++K + H N+VK+  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 253 SCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIH 312
               +    LV E++ +  L+K+L      L+ +   + ++ + + + Y H      ++H
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 313 CDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            DLKP N+L++      ++DFG+A+           T  + T+ Y AP
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAP 169

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 1e-28
 Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 23/176 (13%)

Query: 202 FSANNLIGRGSFGSVYKARL-QDGMEFAIK-------SFDVECEVMKSIHHRNLVKIISS 253
           ++   +IG GSFG VY+A+L   G   AIK         + E ++M+ + H N+V++   
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 81

Query: 254 C------SNEDFRALVLEYMTNGSLEKVLY--SSNCILDILQRLNIMINVTSALEYLHFG 305
                   +E +  LVL+Y+         +   +   L ++     M  +  +L Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139

Query: 306 FSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            S  I H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 191

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (277), Expect = 1e-28
 Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 24/170 (14%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVMKSIHHRNLVKI 250
             +G GSFG V+  R   +G  +A+K                + E  ++  + H  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 251 ISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPI 310
             +  +     ++++Y+  G L   L   +              V  ALEYLH   S  I
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 311 IHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           I+ DLKP N+LLD N    ++DFG AK +     ++       T  Y+AP
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAP 170

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 2e-28
 Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 22/170 (12%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK------SFDVECEVM-KSIHHRNLVKIISSC---- 254
           ++G G  G V +    +   +FA+K          E E+  ++    ++V+I+       
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY 78

Query: 255 SNEDFRALVLEYMTNGSLEKVLYS-SNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           +      +V+E +  G L   +    +      +   IM ++  A++YLH   S  I H 
Sbjct: 79  AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHR 135

Query: 314 DLKPHNVLLD---DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KP N+L      N +  L+DFG AK  T  +   T      T  Y+AP
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAP 182

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-27
 Identities = 44/171 (25%), Positives = 72/171 (42%), Gaps = 22/171 (12%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVM-KSIHHRNLVK 249
            ++G+GSFG V+ A   +    FAIK                 VE  V+  +  H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 250 IISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP 309
           +  +   ++    V+EY+  G L   + S +   D+ +       +   L++LH   S  
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKG 123

Query: 310 IIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           I++ DLK  N+LLD +    ++DFG+ K     D          T  Y+AP
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAP 172

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 2e-27
 Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 39/191 (20%)

Query: 206 NLIGRGSFGSVYKARL--------QDGMEFAIK------------SFDVECEVMKSI-HH 244
             +G G+FG V  A              + A+K                E E+MK I  H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVL---------------YSSNCILDILQRL 289
           +N++ ++ +C+ +    +++EY + G+L + L               ++    L     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 290 NIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT 349
           +    V   +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 350 QTLATIGYMAP 360
                + +MAP
Sbjct: 196 NGRLPVKWMAP 206

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 6e-27
 Identities = 41/190 (21%), Positives = 74/190 (38%), Gaps = 38/190 (20%)

Query: 206 NLIGRGSFGSVYKAR------LQDGMEFAIK------------SFDVECEVMKSI-HHRN 246
             +GRG+FG V +A              A+K            +   E +++  I HH N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 247 LVKIISSCSNEDFR-ALVLEYMTNGSLEKVLYSSNC---------------ILDILQRLN 290
           +V ++ +C+       +++E+   G+L   L S                   L +   + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 291 IMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQ 350
               V   +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   + +  
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 351 TLATIGYMAP 360
               + +MAP
Sbjct: 196 ARLPLKWMAP 205

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 7e-27
 Identities = 38/175 (21%), Positives = 62/175 (35%), Gaps = 28/175 (16%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK-----------------SFDVECEVMKSIH--HRN 246
           L+G G FGSVY    + D +  AIK                    +E  ++K +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 247 LVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
           +++++      D   L+LE            +    L      +    V  A+ + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127

Query: 307 STPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +  ++H D+K  N+L+D +     L DFG   LL         T    T  Y  P
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPP 178

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  104 bits (261), Expect = 1e-26
 Identities = 43/183 (23%), Positives = 68/183 (37%), Gaps = 21/183 (11%)

Query: 196 LRATNGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK---------SFDVECEVMKSIHHR 245
           LR  N +     IG GSFG +Y    +  G E AIK            +E ++ K +   
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 62

Query: 246 NLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
             +  I  C  E    +++  +   SLE +    +    +   L +   + S +EY+H  
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-- 120

Query: 306 FSTPIIHCDLKPHNVL---LDDNIVAHLSDFGIAKLLTGED-----QSMTQTQTLATIGY 357
            S   IH D+KP N L        + ++ DFG+AK                     T  Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 358 MAP 360
            + 
Sbjct: 180 ASI 182

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-26
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 19/169 (11%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKII 251
             IG G++G VYKAR    G   A+K   +             E  ++K ++H N+VK++
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
                E+   LV E++     + +  S+   + +    + +  +   L + H   S  ++
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVL 124

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H DLKP N+L++      L+DFG+A+      ++ T      T+ Y AP
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 171

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-25
 Identities = 42/176 (23%), Positives = 68/176 (38%), Gaps = 29/176 (16%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK-----------------SFDVECEVMKSIHHRNLV 248
            +G G F  V K R    G+++A K                   + E  ++K I H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 249 KIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST 308
            +     N+    L+LE +  G L     +    L   +    +  + + + YLH   S 
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH---SL 132

Query: 309 PIIHCDLKPHNVLLDDN----IVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
            I H DLKP N++L D         + DFG+A  +   D          T  ++AP
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 185

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  102 bits (255), Expect = 1e-25
 Identities = 32/174 (18%), Positives = 64/174 (36%), Gaps = 23/174 (13%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK---------SFDVECEVMKSIHHRNLVKIISSCSN 256
            IG GSFG +++   L +  + AIK             E    K +     +  +     
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71

Query: 257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK 316
           E    +++  +   SLE +L        +         + + ++ +H      +++ D+K
Sbjct: 72  EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIK 128

Query: 317 PHNVLLDDNIVAH-----LSDFGIAKLL----TGEDQSMTQTQTLA-TIGYMAP 360
           P N L+      +     + DFG+ K      T +     + + L+ T  YM+ 
Sbjct: 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 6e-25
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 21/176 (11%)

Query: 200 NGFSANNLIGRGSFGSVYKAR-LQDGMEFAIK--------------SFDVECEVMKSIHH 244
           N F    L+G+G+FG V   R    G  +A+K                  E  V+++  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 245 RNLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHF 304
             L  +  +    D    V+EY   G L   L S   +    +       + SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122

Query: 305 GFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
             S  +++ D+K  N++LD +    ++DFG+ K    +  +M       T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 174

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.9 bits (245), Expect = 2e-24
 Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 20/169 (11%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKII 251
             IG G++G+V+KA+  +     A+K             S   E  ++K + H+N+V++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 252 SSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPII 311
               ++    LV E+      +     +  +       + +  +   L + H      ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLKGLGFCHS---RNVL 123

Query: 312 HCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPP 170

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 3e-24
 Identities = 41/179 (22%), Positives = 76/179 (42%), Gaps = 28/179 (15%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKII 251
             IG+G+FG V+KAR  + G + A+K             +   E ++++ + H N+V +I
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 252 SSCSNEDFRA--------LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLH 303
             C  +            LV ++  +     +         + +   +M  +   L  L+
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQML---LNGLY 131

Query: 304 FGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQT--LATIGYMAP 360
           +     I+H D+K  NVL+  + V  L+DFG+A+  +    S     T  + T+ Y  P
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 98.7 bits (245), Expect = 6e-24
 Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 28/210 (13%)

Query: 170 KRATELPNVANMQPQASRRRFSYLELLRAT----NGFSANNLIGRGSFGSVYKAR-LQDG 224
           K+ +E  +V     +A        E         + F     +G GSFG V   +  + G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 225 MEFAIK--------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTNG 270
             +A+K                  E  ++++++   LVK+  S  +     +V+EY+  G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 271 SLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHL 330
            +   L                  +    EYLH   S  +I+ DLKP N+L+D      +
Sbjct: 127 EMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV 182

Query: 331 SDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           +DFG AK + G   ++       T   +AP
Sbjct: 183 TDFGFAKRVKGRTWTLCG-----TPEALAP 207

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 98.4 bits (244), Expect = 6e-24
 Identities = 36/168 (21%), Positives = 74/168 (44%), Gaps = 23/168 (13%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIKSFDV--------ECEVMKSI-HHRNLVKIISSCS 255
             +GRG +  V++A  + +  +  +K            E ++++++    N++ +     
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 100

Query: 256 NEDFR--ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHC 313
           +   R  ALV E++ N   +++  +    L        M  +  AL+Y H   S  I+H 
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHR 153

Query: 314 DLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           D+KPHNV++D ++    L D+G+A+              +A+  +  P
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGP 198

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.6 bits (242), Expect = 8e-24
 Identities = 47/187 (25%), Positives = 79/187 (42%), Gaps = 29/187 (15%)

Query: 197 RATNGFSANNLIGRGSFGSVYKAR--LQDGMEFAIK-------------SFDVECEVMK- 240
           RA   +     IG G++G V+KAR     G   A+K             S   E  V++ 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 241 --SIHHRNLVKIISSCS-----NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMI 293
             +  H N+V++   C+      E    LV E++       +       +      ++M 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 294 NVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLA 353
            +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A++       M  T  + 
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 177

Query: 354 TIGYMAP 360
           T+ Y AP
Sbjct: 178 TLWYRAP 184

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 3e-21
 Identities = 42/174 (24%), Positives = 67/174 (38%), Gaps = 25/174 (14%)

Query: 206 NLIGRGSFGSVYKARL----QDGMEFAIK---------------SFDVECEVMKSI-HHR 245
            ++G G++G V+  R       G  +A+K                   E +V++ I    
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 246 NLVKIISSCSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG 305
            LV +  +   E    L+L+Y+  G L   L              + I V   +  L   
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145

Query: 306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
               II+ D+K  N+LLD N    L+DFG++K    ++          TI YMA
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 198

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 9e-21
 Identities = 42/198 (21%), Positives = 79/198 (39%), Gaps = 35/198 (17%)

Query: 187 RRRFSYLELLRATNGFSAN----NLIGRGSFGSVYKAR-LQDGMEFAIK----------- 230
           R  F   E+ +      A       +G G++G+V  A   + G + AIK           
Sbjct: 1   RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60

Query: 231 --SFDVECEVMKSIHHRNLVKIISSCSNEDFRA------LVLEYMTNGSLEKVLYSSNCI 282
                 E  ++K + H N++ ++   + ++         LV+ +M     +      +  
Sbjct: 61  AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEK 117

Query: 283 LDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE 342
           L   +   ++  +   L Y+H   +  IIH DLKP N+ ++++    + DFG+A+    E
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174

Query: 343 DQSMTQTQTLATIGYMAP 360
                 T  + T  Y AP
Sbjct: 175 -----MTGYVVTRWYRAP 187

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.5 bits (213), Expect = 1e-19
 Identities = 40/174 (22%), Positives = 70/174 (40%), Gaps = 30/174 (17%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIKSFDV-------------ECEVMKSIHHRNLVKIIS 252
            IG G+ G V  A         AIK                 E  +MK ++H+N++ +++
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 253 SCSNEDFR------ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
             + +          LV+E M     + +        D  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  IIH DLKP N+++  +    + DFG+A+       S   T  + T  Y AP
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAP 187

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 85.1 bits (209), Expect = 4e-19
 Identities = 35/181 (19%), Positives = 71/181 (39%), Gaps = 29/181 (16%)

Query: 207 LIGRGSFGSVYKAR-LQDGMEFAIK----------SFDVECEVMKSIHHRNLVKIISSCS 255
            +G G F +V+ A+ + +    A+K          + + E ++++ ++  +  K  S  +
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 256 NEDFR---------------ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALE 300
           N   +                +V E +    L  +    +  + ++    I   +   L+
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 301 YLHFGFSTPIIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 359
           Y+H      IIH D+KP NVL++  +   +L    IA L          T ++ T  Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 360 P 360
           P
Sbjct: 198 P 198

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 6e-19
 Identities = 22/157 (14%), Positives = 48/157 (30%), Gaps = 37/157 (23%)

Query: 206 NLIGRGSFGSVYKARLQDGMEFAIK---------------------SFDVECEVMKSIHH 244
            L+G G   +V+    +   E  +K                      F V          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 245 RNLVKIISSCSNEDF----RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALE 300
           R L K+      + +     A+++E +               + +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEVA 117

Query: 301 YLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK 337
             +      I+H DL  +NVL+ +  +  + DF  + 
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 2e-18
 Identities = 37/174 (21%), Positives = 69/174 (39%), Gaps = 29/174 (16%)

Query: 206 NLIGRGSFGSVYKAR-LQDGMEFAIK-------------SFDVECEVMKSIHHRNLVKII 251
           + +G G++GSV  A   + G+  A+K                 E  ++K + H N++ ++
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 252 SSCS-----NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF 306
              +      E     ++ ++    L          L       ++  +   L+Y+H   
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIH--- 138

Query: 307 STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 360
           S  IIH DLKP N+ ++++    + DFG+A+    E           T  Y AP
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAP 187

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.6 bits (171), Expect = 2e-14
 Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 16/85 (18%)

Query: 66  KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPF 125
           K+L  L L +NR+ G++P     L  L SL++S NNL              GEIP+GG  
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-------------GEIPQGGNL 290

Query: 126 TKFSSKSFIGNDLLCGSPNLQVPPC 150
            +F   ++  N  LCGSP   +P C
Sbjct: 291 QRFDVSAYANNKCLCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.8 bits (143), Expect = 1e-10
 Identities = 18/62 (29%), Positives = 26/62 (41%), Gaps = 1/62 (1%)

Query: 48  DFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
           D   N + G +P  +  LK L  L++  N L G IP    +L   +    +NN      P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

Query: 108 LS 109
           L 
Sbjct: 309 LP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 52.8 bits (125), Expect = 2e-08
 Identities = 19/75 (25%), Positives = 32/75 (42%), Gaps = 16/75 (21%)

Query: 9   DLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSL 68
           DLR N++ G++P   + L  L +L++               S NNL G+IP     L+  
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNV---------------SFNNLCGEIPQGGN-LQRF 293

Query: 69  QFLSLGHNRLQGSIP 83
              +  +N+     P
Sbjct: 294 DVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 37.4 bits (85), Expect = 0.002
 Identities = 11/36 (30%), Positives = 14/36 (38%), Gaps = 1/36 (2%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN 37
           L  L  L++  N L G IP    NL         +N
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 63.9 bits (154), Expect = 7e-12
 Identities = 34/149 (22%), Positives = 56/149 (37%), Gaps = 39/149 (26%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------------------- 42
           L  L  LDL  N++S   P   S LT L  L L +N++ ++                   
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297

Query: 43  ----------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSL 92
                      LT      NN+    P  +  L  LQ L   +N++     +S  +L ++
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353

Query: 93  ESLDLSNNNLSEIIPL----SLEKLLLEG 117
             L   +N +S++ PL     + +L L  
Sbjct: 354 NWLSAGHNQISDLTPLANLTRITQLGLND 382

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 60.8 bits (146), Expect = 6e-11
 Identities = 23/100 (23%), Positives = 41/100 (41%), Gaps = 21/100 (21%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
            L  L  L L  N +S   P   S+LT L+ L   +N++                    +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-----------------VS 345

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNN 100
           ++  L ++ +LS GHN++    P    +L  +  L L++ 
Sbjct: 346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 7e-05
 Identities = 15/66 (22%), Positives = 29/66 (43%), Gaps = 4/66 (6%)

Query: 44  LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLS 103
             +T   + N+   +  +   L  +  L      ++ SI    + L +L  ++ SNN L+
Sbjct: 24  KMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLT 79

Query: 104 EIIPLS 109
           +I PL 
Sbjct: 80  DITPLK 85

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.4 bits (88), Expect = 9e-04
 Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 4/62 (6%)

Query: 48  DFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
             + N +    P  I    +L  LSL  N+L+     +   L +L  LDL+NN +S + P
Sbjct: 203 IATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 258

Query: 108 LS 109
           LS
Sbjct: 259 LS 260

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 1e-07
 Identities = 23/108 (21%), Positives = 37/108 (34%), Gaps = 25/108 (23%)

Query: 10  LRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQ 69
              N  S  I +      +L  L++ +N+L                  +P        L+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE----------------LPA---LPPRLE 307

Query: 70  FLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI--IPLSLEKLLL 115
            L    N L   +P       +L+ L +  N L E   IP S+E L +
Sbjct: 308 RLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 3e-06
 Identities = 19/71 (26%), Positives = 35/71 (49%), Gaps = 6/71 (8%)

Query: 49  FSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 108
           +  N    +I +      SL+ L++ +N+L   +P        LE L  S N+L+E+  L
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAEVPEL 322

Query: 109 --SLEKLLLEG 117
             +L++L +E 
Sbjct: 323 PQNLKQLHVEY 333

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 6e-06
 Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 27/99 (27%)

Query: 1   YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPT 60
              +L +L++  NKL   +P        L  L                    N L ++P 
Sbjct: 282 LPPSLEELNVSNNKLI-ELPALPPR---LERLIAS----------------FNHLAEVPE 321

Query: 61  TIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 99
             Q   +L+ L + +N L+   P+  +   S+E L +++
Sbjct: 322 LPQ---NLKQLHVEYNPLR-EFPDIPE---SVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 36.3 bits (82), Expect = 0.004
 Identities = 15/48 (31%), Positives = 23/48 (47%), Gaps = 5/48 (10%)

Query: 66  KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
           +    L L +  L  S+P   +    LESL  S N+L+E +P   + L
Sbjct: 38  RQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLTE-LPELPQSL 80

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.3 bits (116), Expect = 3e-07
 Identities = 35/127 (27%), Positives = 56/127 (44%), Gaps = 11/127 (8%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL------VLTRTDFSRNNLL 55
           L  L  L L  NK+S   P  F+ L  L  L+L  N+L+ L       L       N + 
Sbjct: 54  LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT 113

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQ--GSIPNSFDDLVSLESLDLSNNNLSEI---IPLSL 110
               +   GL  +  + LG N L+  G    +F  +  L  + +++ N++ I   +P SL
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSL 173

Query: 111 EKLLLEG 117
            +L L+G
Sbjct: 174 TELHLDG 180

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 47.3 bits (111), Expect = 1e-06
 Identities = 29/147 (19%), Positives = 45/147 (30%), Gaps = 21/147 (14%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           LDL+ NK++      F NL  L  L L                 N +    P     L  
Sbjct: 36  LDLQNNKITEIKDGDFKNLKNLHTLIL---------------INNKISKISPGAFAPLVK 80

Query: 68  LQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTK 127
           L+ L L  N+L+  +P      +  + L +  N ++++       L     +  G    K
Sbjct: 81  LERLYLSKNQLK-ELPEKMPKTL--QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 137

Query: 128 FSSKSFIGNDLLCGSPNLQVPPCKSNK 154
            S      N    G   L         
Sbjct: 138 SSGIE---NGAFQGMKKLSYIRIADTN 161

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.8 bits (107), Expect = 3e-06
 Identities = 25/135 (18%), Positives = 45/135 (33%), Gaps = 18/135 (13%)

Query: 2   LAALFQLDLRGNKLSGSIPTCFSNLTALRNL---------HLDSNELRHLVLTRTDFSRN 52
             +L +L L GNK++         L  L  L           + +      L     + N
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSF------DDLVSLESLDLSNNNLS--E 104
             L  +P  +   K +Q + L +N +     N F          S   + L +N +   E
Sbjct: 230 K-LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288

Query: 105 IIPLSLEKLLLEGEI 119
           I P +   + +   +
Sbjct: 289 IQPSTFRCVYVRAAV 303

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 41.9 bits (97), Expect = 6e-05
 Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 2/63 (3%)

Query: 51  RNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL 110
            +  L  +P  +        L L +N++       F +L +L +L L NN +S+I P + 
Sbjct: 18  SDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75

Query: 111 EKL 113
             L
Sbjct: 76  APL 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 5e-07
 Identities = 20/100 (20%), Positives = 34/100 (34%), Gaps = 16/100 (16%)

Query: 20  PTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQ 79
                  + LR L L   ++            ++    +  T+    SL+ L L +N L 
Sbjct: 362 QGLGQPGSVLRVLWLADCDVS-----------DSSCSSLAATLLANHSLRELDLSNNCLG 410

Query: 80  GSIPNSFDDLV-----SLESLDLSNNNLSEIIPLSLEKLL 114
            +      + V      LE L L +   SE +   L+ L 
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 4e-06
 Identities = 15/84 (17%), Positives = 30/84 (35%), Gaps = 10/84 (11%)

Query: 36  SNELRHLVLTRTDFSRNNLL-GDIPTTIQGLKSLQFLSLGHNRLQG----SIPNSFDDLV 90
           S +++ L     D     L        +  L+  Q + L    L       I ++     
Sbjct: 1   SLDIQSL-----DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNP 55

Query: 91  SLESLDLSNNNLSEIIPLSLEKLL 114
           +L  L+L +N L ++    + + L
Sbjct: 56  ALAELNLRSNELGDVGVHCVLQGL 79

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 1e-05
 Identities = 18/100 (18%), Positives = 33/100 (33%), Gaps = 17/100 (17%)

Query: 8   LDLRGNKLSGS-IPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLK 66
           LD++  +LS +        L   + + LD   L                 DI + ++   
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT-----------EARCKDISSALRVNP 55

Query: 67  SLQFLSLGHNRLQGSIPNSFDDLV-----SLESLDLSNNN 101
           +L  L+L  N L     +     +      ++ L L N  
Sbjct: 56  ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 1e-06
 Identities = 27/116 (23%), Positives = 42/116 (36%), Gaps = 11/116 (9%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKS 67
           L L    L+  +      L  + +L L  N LR L           +L      ++ +  
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 68  ------LQFLSLGHNRLQG-SIPNSFDDLVSLESLDLSNNNLSEI--IPLSLEKLL 114
                 LQ L L +NRLQ  +          L  L+L  N+L +   I   L ++L
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.7 bits (109), Expect = 2e-06
 Identities = 30/108 (27%), Positives = 40/108 (37%), Gaps = 9/108 (8%)

Query: 15  LSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLLGDIPTTIQGL 65
           L    P  F  L  L  LHLD   L+ L          L       N L      T + L
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152

Query: 66  KSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
            +L  L L  NR+      +F  L SL+ L L  N ++ + P +   L
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.5 bits (98), Expect = 4e-05
 Identities = 31/149 (20%), Positives = 47/149 (31%), Gaps = 9/149 (6%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLV---------LTRTDFSRNNLL 55
           L  L L+ N L       F +L  L +L L  N +  +          L R    +N + 
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190

Query: 56  GDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLL 115
              P   + L  L  L L  N L      +   L +L+ L L++N              L
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL 250

Query: 116 EGEIPRGGPFTKFSSKSFIGNDLLCGSPN 144
           +              +   G DL   + N
Sbjct: 251 QKFRGSSSEVPCSLPQRLAGRDLKRLAAN 279

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 6e-04
 Identities = 39/203 (19%), Positives = 61/203 (30%), Gaps = 15/203 (7%)

Query: 8   LDLRGNKLSGSIPTCFSNLTALR---------NLHLDSNELRHLVLTRTDFSRNNLLGDI 58
           + L GN++S      F     L               +      +L + D S N  L  +
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 59  -PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEG 117
            P T  GL  L  L L    LQ   P  F  L +L+ L L +N L  +   +   L    
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156

Query: 118 EIPRGGPFTKFSSKSFIGNDLLCGSPNLQVPPCKSNKPIILALKFGLISRCQKRATELPN 177
            +     F   +  S +      G  +L       N+   +                  N
Sbjct: 157 HL-----FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 178 VANMQPQASRRRFSYLELLRATN 200
             +  P  +      L+ LR  +
Sbjct: 212 NLSALPTEALAPLRALQYLRLND 234

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.5 bits (99), Expect = 1e-05
 Identities = 21/114 (18%), Positives = 41/114 (35%), Gaps = 9/114 (7%)

Query: 9   DLRGNKLSGSIPTCFSNLTALRNLHLDSN------ELRHLVLTRTDFSRNNLLGDIPTTI 62
           +L+  ++   +    S         LD        +L    +      R+++   +    
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIE 61

Query: 63  QGLKSLQFLSLGHNRLQG--SIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           + +  L  L+L +NRL     + +      +L+ L+LS N L     L   K L
Sbjct: 62  ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL 115

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 9e-04
 Identities = 22/103 (21%), Positives = 43/103 (41%), Gaps = 13/103 (12%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQG 64
           +  +  R + ++ ++     N+  L +L+L +N L  L              D+ + +Q 
Sbjct: 43  IDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRL-------------DDMSSIVQK 89

Query: 65  LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP 107
             +L+ L+L  N L+          + LE L L  N+LS+   
Sbjct: 90  APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 2e-05
 Identities = 9/51 (17%), Positives = 16/51 (31%), Gaps = 2/51 (3%)

Query: 58  IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL 108
                 G      L +   R+        ++L  L +   S  NL ++  L
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLKKLPTL 241

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (84), Expect = 0.002
 Identities = 7/32 (21%), Positives = 11/32 (34%)

Query: 82  IPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL 113
             + F        LD+S   +  +    LE L
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 4e-05
 Identities = 12/56 (21%), Positives = 23/56 (41%), Gaps = 4/56 (7%)

Query: 44  LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN 99
           LT      N +    P  +  L +L  + L +N++    P    +  +L  + L+N
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 3e-04
 Identities = 15/59 (25%), Positives = 25/59 (42%), Gaps = 6/59 (10%)

Query: 62  IQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL----SLEKLLLE 116
           +  L  L  L    N++    P     L +L  + L NN +S++ PL    +L  + L 
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 4e-05
 Identities = 16/54 (29%), Positives = 21/54 (38%), Gaps = 1/54 (1%)

Query: 49  FSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNL 102
            + NNL       + GL++L  L L  N L  +IP  F     L    L  N  
Sbjct: 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 1e-04
 Identities = 11/58 (18%), Positives = 17/58 (29%), Gaps = 3/58 (5%)

Query: 44  LTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNN 101
               +  + NL   +P  +   K    L L  N L      +      L  L+L    
Sbjct: 12  HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 9e-05
 Identities = 9/57 (15%), Positives = 22/57 (38%), Gaps = 2/57 (3%)

Query: 53  NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLS 109
            L+         ++  + L L   ++   I N    L   +++D S+N + ++    
Sbjct: 6   ELIEQAAQYTNAVR-DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP 60

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.001
 Identities = 27/110 (24%), Positives = 40/110 (36%), Gaps = 18/110 (16%)

Query: 5   LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQG 64
             +LDLRG K+   I    + L     +    NE+R L                      
Sbjct: 20  DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-----------------DGFPL 61

Query: 65  LKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL 114
           L+ L+ L + +NR+          L  L  L L+NN+L E+  L     L
Sbjct: 62  LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL 111

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 7e-04
 Identities = 19/69 (27%), Positives = 28/69 (40%), Gaps = 3/69 (4%)

Query: 31  NLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLV 90
           N   D   L  L    T    +N + DI   + GL  LQ L L  N +      +   L 
Sbjct: 144 NKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD--LRALAGLK 200

Query: 91  SLESLDLSN 99
           +L+ L+L +
Sbjct: 201 NLDVLELFS 209

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 8e-04
 Identities = 9/66 (13%), Positives = 22/66 (33%), Gaps = 2/66 (3%)

Query: 45  TRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSE 104
              D +  NL  D+   +     +       + +   +   F     ++ +DLSN+ +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60

Query: 105 IIPLSL 110
                +
Sbjct: 61  STLHGI 66

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	360
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.98
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.98
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.98
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.98
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.98
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.97
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.97
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.89
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.64
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.59
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.54
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.51
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.46
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.45
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.43
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.4
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.39
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.24
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.24
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.23
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.22
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.21
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.19
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.18
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.14
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.13
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.06
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.95
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.95
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.91
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.89
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.89
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.7
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.68
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.49
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.48
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.29
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.24
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.24
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.24
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.18
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.06
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.97
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.92
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.9
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.47
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.36
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.33
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.55
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.43
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.74
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.23
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.98
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	92.17

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=288.36  Aligned_cols=158  Identities=25%  Similarity=0.398  Sum_probs=141.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||+||+|+.+ +|+.||||.            +.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            467889999999999999999964 789999984            4679999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      ||++|+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+......
T Consensus        84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999999653 46899999999999999999999   899999999999999999999999999999987544333


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      ......+||+.||||
T Consensus       160 ~~~~~~~GT~~Y~AP  174 (271)
T d1nvra_         160 RLLNKMCGTLPYVAP  174 (271)
T ss_dssp             CCBCCCCSCGGGSCT
T ss_pred             ccccceeeCcCccCH
Confidence            334567899999999

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-38  Score=283.11  Aligned_cols=156  Identities=28%  Similarity=0.490  Sum_probs=132.1

Q ss_pred             hCCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||.||+|+++.  .||||.             |.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            3578889999999999999998753  699873             5679999999999999999999865 45799999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      ||++|+|.+++...+..+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877777999999999999999999999   889999999999999999999999999999887644333


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      .......||+.||||
T Consensus       161 ~~~~~~~gt~~y~AP  175 (276)
T d1uwha_         161 HQFEQLSGSILWMAP  175 (276)
T ss_dssp             -----CCCCGGGCCH
T ss_pred             ccccccccCcccCCH
Confidence            344567899999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-38  Score=282.04  Aligned_cols=157  Identities=28%  Similarity=0.466  Sum_probs=131.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|++.+++.||||.          |.+|++++++++|||||+++++|..++..++|||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            46788899999999999999998889999984          56899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++......+++..+..++.|+|.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....... ....
T Consensus        85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~  160 (263)
T d1sm2a_          85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSST  160 (263)
T ss_dssp             CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eeec
Confidence            9999999887777999999999999999999999   89999999999999999999999999999998754432 2233


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.||||
T Consensus       161 ~~~gt~~y~aP  171 (263)
T d1sm2a_         161 GTKFPVKWASP  171 (263)
T ss_dssp             ----CTTSCCH
T ss_pred             ceecCcccCCh
Confidence            46799999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-36  Score=277.84  Aligned_cols=154  Identities=32%  Similarity=0.457  Sum_probs=138.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +.|+..+.||+|+||.||+|+. .+|+.||||.           +.+|++++++++|||||+++++|.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            3689999999999999999995 5799999984           467999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +||+|.+++...  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.....  .
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence            999999988653  5889999999999999999999   89999999999999999999999999999998754432  2


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      ....+||+.||||
T Consensus       173 ~~~~~gt~~Y~aP  185 (293)
T d1yhwa1         173 RSTMVGTPYWMAP  185 (293)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             ccccccCCCccCh
Confidence            3456799999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-37  Score=281.23  Aligned_cols=157  Identities=33%  Similarity=0.506  Sum_probs=136.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||+||+|+. .+++.||||.              +.+|++++++++|||||+++++|.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5689999999999999999996 4789999984              456999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |||+||+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            999999999988764 35889999999999999999999   89999999999999999999999999999998764433


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                      .......+||+.||||
T Consensus       164 ~~~~~~~~GT~~Y~AP  179 (288)
T d1uu3a_         164 QARANSFVGTAQYVSP  179 (288)
T ss_dssp             ------CCCCGGGCCH
T ss_pred             ccccccccCCccccCc
Confidence            3334456899999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-37  Score=276.28  Aligned_cols=153  Identities=27%  Similarity=0.475  Sum_probs=138.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|.              +.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57888999999999999999975 789999984              346999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |||++|+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            999999999999754 35889999999999999999999   8999999999999999999999999999998765432 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         .....||+.||||
T Consensus       161 ---~~~~~Gt~~Y~AP  173 (263)
T d2j4za1         161 ---RTTLCGTLDYLPP  173 (263)
T ss_dssp             ---CEETTEEGGGCCH
T ss_pred             ---ccccCCCCcccCH
Confidence               2346799999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-37  Score=280.94  Aligned_cols=158  Identities=30%  Similarity=0.529  Sum_probs=140.2

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .++|+..+.||+|+||.||+|+++ +++.||||.          |.+|++++++++|||||+++++|.+++..++|||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            356778899999999999999975 688999984          567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          268 TNGSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       268 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++|+|.+++... ...+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus        96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~  171 (287)
T d1opja_          96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YT  171 (287)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SE
T ss_pred             cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-ce
Confidence            999999999754 456899999999999999999999   8899999999999999999999999999999876543 23


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.||||
T Consensus       172 ~~~~~~g~~~y~aP  185 (287)
T d1opja_         172 AHAGAKFPIKWTAP  185 (287)
T ss_dssp             EETTEEECGGGCCH
T ss_pred             eeccccccccccCh
Confidence            33455689999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-37  Score=282.52  Aligned_cols=157  Identities=26%  Similarity=0.504  Sum_probs=124.5

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCc---EEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGM---EFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~---~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      +|+..++||+|+||.||+|+++ +++   .||||            .|.+|++++++++|||||+++++|..++..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            4556689999999999999975 332   57886            3668999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |||++|+|.+++......++|.++..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            999999999999877777999999999999999999999   89999999999999999999999999999998764432


Q ss_pred             ce---eeecccccCcccCC
Q 040294          345 SM---TQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~---~~~~~~gt~~Y~aP  360 (360)
                      ..   ......||+.||||
T Consensus       184 ~~~~~~~~~~~~t~~y~aP  202 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAP  202 (299)
T ss_dssp             ------------CGGGSCH
T ss_pred             cceeeecccccCCccccCH
Confidence            11   12234689999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-37  Score=277.74  Aligned_cols=156  Identities=27%  Similarity=0.506  Sum_probs=137.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|++++++.||||.          |.+|++++++++|||||++++++.++ ..++||||+++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~iv~Ey~~~   91 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMEN   91 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccC-CeEEEEEeCCC
Confidence            46777899999999999999998889999984          56899999999999999999998654 57999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      |+|.+++.... ..+++..++.|+.||++||.|||   +.+|+||||||+|||+++++.+||+|||+|+.+.... ....
T Consensus        92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~  167 (272)
T d1qpca_          92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAR  167 (272)
T ss_dssp             CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECC
T ss_pred             CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cccc
Confidence            99999876443 24899999999999999999999   8999999999999999999999999999999876443 2333


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....||+.||||
T Consensus       168 ~~~~gt~~y~AP  179 (272)
T d1qpca_         168 EGAKFPIKWTAP  179 (272)
T ss_dssp             TTCCCCTTTSCH
T ss_pred             cccCCcccccCh
Confidence            456799999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-37  Score=280.87  Aligned_cols=156  Identities=29%  Similarity=0.408  Sum_probs=138.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +.|+..+.||+|+||.||+|+. .+++.||||.           +.+|++++++++|||||++++++.+++..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4578889999999999999996 4789999973           567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      ++|+|.+++......+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+......  ..
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence            999999998766667999999999999999999999   8999999999999999999999999999998654221  12


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      ....+||+.||||
T Consensus       167 ~~~~~Gt~~y~AP  179 (288)
T d2jfla1         167 RDSFIGTPYWMAP  179 (288)
T ss_dssp             HTCCCSCCTTCCH
T ss_pred             ccccccccccCCH
Confidence            2346799999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-36  Score=271.71  Aligned_cols=157  Identities=27%  Similarity=0.468  Sum_probs=142.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|++++++.||||.          |.+|++++++++|||||+++++|.+++..++||||+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            68999999999999999999999899999983          56899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceeee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQT  349 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~  349 (360)
                      |+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+.... .....
T Consensus        84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~  159 (258)
T d1k2pa_          84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSV  159 (258)
T ss_dssp             EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCC
T ss_pred             CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceeec
Confidence            9999998877777899999999999999999999   8899999999999999999999999999998765443 22334


Q ss_pred             cccccCcccCC
Q 040294          350 QTLATIGYMAP  360 (360)
Q Consensus       350 ~~~gt~~Y~aP  360 (360)
                      ...||+.||||
T Consensus       160 ~~~~t~~y~aP  170 (258)
T d1k2pa_         160 GSKFPVRWSPP  170 (258)
T ss_dssp             CSCCCGGGCCH
T ss_pred             ccCCCCCcCCc
Confidence            56799999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-37  Score=285.12  Aligned_cols=154  Identities=26%  Similarity=0.388  Sum_probs=136.4

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .++|+..+.||+|+||+||+|+. .+|+.||+|.            +.+|++++++++|||||+++++|.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46799999999999999999996 4789999984            4579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFST-PIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~-~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+||+|.+++...+ .+++..+..++.|++.||.|||   +. +|+||||||+|||+++++.+||+|||+|+.+.... 
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence            999999999997643 5889999999999999999999   54 89999999999999999999999999999764322 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         ..+.+||++||||
T Consensus       160 ---~~~~~GT~~Y~AP  172 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSP  172 (322)
T ss_dssp             ---C---CCSSCCCCH
T ss_pred             ---cccccCCccccCc
Confidence               2356899999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-36  Score=275.11  Aligned_cols=159  Identities=30%  Similarity=0.452  Sum_probs=124.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC--CCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN--EDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv  263 (360)
                      ++|+..+.||+|+||.||+|+. .+|+.||||.             +.+|++++++++|||||++++++.+  ++..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5788999999999999999986 4789999984             4579999999999999999999865  4568999


Q ss_pred             EEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          264 LEYMTNGSLEKVLYS---SNCILDILQRLNIMINVTSALEYLHFGF--STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~--~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ||||++|+|.+++..   ....+++..+..++.|++.||+|||...  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864   2456899999999999999999999421  24599999999999999999999999999998


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +.....  .....+||+.||||
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~AP  183 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSP  183 (269)
T ss_dssp             C-------------CCCSCCCH
T ss_pred             cccCCC--ccccCCCCcccCCH
Confidence            754321  23456899999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-36  Score=278.44  Aligned_cols=158  Identities=25%  Similarity=0.467  Sum_probs=136.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC-C-----cEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD-G-----MEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  260 (360)
                      ++|+..++||+|+||+||+|++.. +     ..||||.            +.+|+.++.++ +|||||+++++|.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            568888999999999999998642 2     3688873            45799999988 899999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCC
Q 040294          261 ALVLEYMTNGSLEKVLYSSN----------------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPH  318 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~  318 (360)
                      ++|||||++|+|.++++...                      ..+++..++.++.||++||+|||   +.+|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            99999999999999997543                      24788999999999999999999   889999999999


Q ss_pred             ceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          319 NVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       319 NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |||++.++.+||+|||+|+...............||+.||||
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  235 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  235 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence            999999999999999999987655444444456789999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.5e-36  Score=279.63  Aligned_cols=155  Identities=24%  Similarity=0.408  Sum_probs=139.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ++|++.+.||+|+||.||+|+. .+|+.||||.           +.+|++++++++|||||+++++|.+++..|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5789999999999999999996 4789999984           457999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec--CCCcEEEeecccccccCCCCCc
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD--DNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~--~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +||+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|+.+....  
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--  180 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  180 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence            999999999776667999999999999999999999   89999999999999995  46889999999999876443  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.||||
T Consensus       181 -~~~~~~gT~~Y~aP  194 (350)
T d1koaa2         181 -SVKVTTGTAEFAAP  194 (350)
T ss_dssp             -CEEEECSCTTTCCH
T ss_pred             -ccceecCcccccCH
Confidence             23456899999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-36  Score=273.04  Aligned_cols=158  Identities=29%  Similarity=0.553  Sum_probs=130.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCC-----cEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDG-----MEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~-----~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      +.|+..++||+|+||.||+|++++.     ..||||.            |.+|++++++++|||||+++++|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999987642     3689973            5679999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      |||||.+|++.+.+......++|.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999998877778999999999999999999999   899999999999999999999999999999987543


Q ss_pred             CC-ceeeecccccCcccCC
Q 040294          343 DQ-SMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~-~~~~~~~~gt~~Y~aP  360 (360)
                      .. ........||+.||||
T Consensus       164 ~~~~~~~~~~~gt~~Y~AP  182 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAP  182 (283)
T ss_dssp             ----------CCCGGGSCH
T ss_pred             CccceEeccCCCCccccCH
Confidence            32 2223345689999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-36  Score=277.65  Aligned_cols=156  Identities=29%  Similarity=0.405  Sum_probs=139.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      .++|+..+.||+|+||.||+|+. .+|+.||||.              +.+|++++++++|||||+++++|++++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36789999999999999999996 5899999984              34689999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      ||||+||+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999987654 5788888999999999999999   9999999999999999999999999999999765433


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                      .  .....+||+.||||
T Consensus       160 ~--~~~~~~GT~~Y~aP  174 (337)
T d1o6la_         160 A--TMKTFCGTPEYLAP  174 (337)
T ss_dssp             C--CBCCCEECGGGCCG
T ss_pred             c--ccccceeCHHHhhh
Confidence            2  23457899999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-35  Score=273.58  Aligned_cols=152  Identities=30%  Similarity=0.440  Sum_probs=137.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||+||+|+. .+|+.||||.              +.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5688899999999999999996 5799999984              346999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |||+||+|..++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999999887654 5778888889999999999999   999999999999999999999999999999986532  


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                         ....+||+.||||
T Consensus       158 ---~~~~~Gt~~Y~AP  170 (316)
T d1fota_         158 ---TYTLCGTPDYIAP  170 (316)
T ss_dssp             ---BCCCCSCTTTCCH
T ss_pred             ---cccccCcccccCH
Confidence               2346899999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-36  Score=275.20  Aligned_cols=150  Identities=30%  Similarity=0.404  Sum_probs=134.4

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      .|+..+.||+|+||.||+|+. .+++.||||.              +.+|++++++++|||||+++++|.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            378889999999999999985 5788999983              4579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      ||++|+|..++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....   
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence            99999998766543 46899999999999999999999   899999999999999999999999999999875432   


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                         ...+||+.||||
T Consensus       169 ---~~~~GT~~Y~AP  180 (309)
T d1u5ra_         169 ---NSFVGTPYWMAP  180 (309)
T ss_dssp             ---CCCCSCGGGCCH
T ss_pred             ---CccccCccccCH
Confidence               245799999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.5e-35  Score=277.44  Aligned_cols=155  Identities=25%  Similarity=0.436  Sum_probs=140.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      ++|+..+.||+|+||.||+|+. .+|+.||||.           +.+|++++++++|||||+++++|.+++..|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5688999999999999999996 5799999984           457999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec--CCCcEEEeecccccccCCCCCc
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD--DNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~--~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +||+|.+.+......+++.++..|+.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|+.+....  
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--  183 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--  183 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence            999999988776667999999999999999999999   89999999999999998  67899999999999876543  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.||||
T Consensus       184 -~~~~~~gt~~y~aP  197 (352)
T d1koba_         184 -IVKVTTATAEFAAP  197 (352)
T ss_dssp             -CEEEECSSGGGCCH
T ss_pred             -ceeeccCcccccCH
Confidence             23446799999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-35  Score=270.77  Aligned_cols=156  Identities=27%  Similarity=0.472  Sum_probs=134.1

Q ss_pred             CCCCCCe-eccCCCccEEEEEcc---CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          201 GFSANNL-IGRGSFGSVYKARLQ---DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       201 ~f~~~~~-iG~G~~g~Vy~~~~~---~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      +|...+. ||+|+||.||+|.++   ++..||||.            |.+|++++++++|||||+++++|.++ ..++||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEE
Confidence            4555564 999999999999764   355799973            56799999999999999999999765 579999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      |||++|+|.+++...+..+++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus        88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            999999999998777677999999999999999999999   89999999999999999999999999999998765432


Q ss_pred             c-eeeecccccCcccCC
Q 040294          345 S-MTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~-~~~~~~~gt~~Y~aP  360 (360)
                      . .......||+.||||
T Consensus       165 ~~~~~~~~~gt~~y~aP  181 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAP  181 (285)
T ss_dssp             EECCCCSSCCCGGGCCH
T ss_pred             ccccccccccCccccCh
Confidence            2 222345689999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-35  Score=266.98  Aligned_cols=150  Identities=31%  Similarity=0.445  Sum_probs=129.3

Q ss_pred             CCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC----CCeEEEEE
Q 040294          203 SANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN----EDFRALVL  264 (360)
Q Consensus       203 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~  264 (360)
                      +..+.||+|+||+||+|+.. +++.||+|.             |.+|++++++++|||||+++++|.+    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            44567999999999999964 788999973             4679999999999999999999864    34689999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCceeec-CCCcEEEeecccccccCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTP--IIHCDLKPHNVLLD-DNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--iiHrdlk~~NiLl~-~~~~~ki~DFGla~~~~~  341 (360)
                      |||++|+|.+++... ..+++..+..++.||++||+|||   +.+  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            999999999999764 35889999999999999999999   666  99999999999996 578999999999987543


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..    ....+||+.||||
T Consensus       168 ~~----~~~~~GT~~Y~aP  182 (270)
T d1t4ha_         168 SF----AKAVIGTPEFMAP  182 (270)
T ss_dssp             TS----BEESCSSCCCCCG
T ss_pred             Cc----cCCcccCccccCH
Confidence            22    2356899999999

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-36  Score=274.24  Aligned_cols=154  Identities=26%  Similarity=0.423  Sum_probs=125.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      +.|+..++||+|+||+||+|+.+ +++.||||.+            .+|++++++++|||||++++++.+++..|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            56888999999999999999964 7899999853            4699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec---CCCcEEEeecccccccCCCC
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~---~~~~~ki~DFGla~~~~~~~  343 (360)
                      |+||+|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+.   +++.+||+|||+|+......
T Consensus        89 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          89 VSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             CCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             cCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            9999999999764 46899999999999999999999   89999999999999994   57899999999998765332


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                         .....+||+.||||
T Consensus       165 ---~~~~~~GT~~y~AP  178 (307)
T d1a06a_         165 ---VLSTACGTPGYVAP  178 (307)
T ss_dssp             -----------CTTSCH
T ss_pred             ---eeeeeeeCccccCc
Confidence               23356799999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-35  Score=269.19  Aligned_cols=156  Identities=28%  Similarity=0.511  Sum_probs=130.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|++++++.||||.          |.+|+.++++++|||||+++++|.+ +..++|||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~   95 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   95 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence            46888899999999999999998888999984          6789999999999999999999965 457899999999


Q ss_pred             CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSS-NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      |+|...+... ...++|.+++.++.||+.||+|||   +.+|+||||||+|||+|+++.+||+|||+|+...... ....
T Consensus        96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~  171 (285)
T d1fmka3          96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTAR  171 (285)
T ss_dssp             CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ceee
Confidence            9999988653 345899999999999999999999   8899999999999999999999999999998765433 2233


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....||+.||||
T Consensus       172 ~~~~gt~~y~aP  183 (285)
T d1fmka3         172 QGAKFPIKWTAP  183 (285)
T ss_dssp             ----CCGGGSCH
T ss_pred             ccccccccccCh
Confidence            456799999998

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-35  Score=266.12  Aligned_cols=154  Identities=27%  Similarity=0.447  Sum_probs=137.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      +.|+..+.||+|+||+||+|+. .+|+.||||.                 +.+|++++++++|||||+++++|.+++..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5688999999999999999996 4789999983                 467999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC----cEEEeeccccc
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI----VAHLSDFGIAK  337 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~----~~ki~DFGla~  337 (360)
                      +|||||++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++    .+|++|||+|+
T Consensus        90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            9999999999999997643 6899999999999999999999   89999999999999998776    49999999999


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ......   ......||+.||||
T Consensus       166 ~~~~~~---~~~~~~~t~~y~AP  185 (293)
T d1jksa_         166 KIDFGN---EFKNIFGTPEFVAP  185 (293)
T ss_dssp             ECTTSC---BCSCCCCCGGGCCH
T ss_pred             hcCCCc---cccccCCCCcccCH
Confidence            875433   23346799999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.3e-35  Score=273.23  Aligned_cols=154  Identities=28%  Similarity=0.435  Sum_probs=136.3

Q ss_pred             hCCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------H---HHHHHhhcCCCCCeeEEEEEecCCCeE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------D---VECEVMKSIHHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~---~E~~~l~~l~hpniv~l~~~~~~~~~~  260 (360)
                      .++|+..++||+|+||.||+|+.. +|+.||||.+              .   .|+++++.++|||||+++++|.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999964 7999999853              1   236678888999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |+|||||+||+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999999999764 45788899999999999999999   8999999999999999999999999999999765


Q ss_pred             CCCCceeeecccccCcccCC
Q 040294          341 GEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...    ....+||+.||||
T Consensus       159 ~~~----~~~~~GT~~y~AP  174 (364)
T d1omwa3         159 KKK----PHASVGTHGYMAP  174 (364)
T ss_dssp             SSC----CCSCCSCGGGCCH
T ss_pred             CCc----ccccccccccchh
Confidence            432    2346799999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-34  Score=263.17  Aligned_cols=150  Identities=29%  Similarity=0.450  Sum_probs=128.2

Q ss_pred             CeeccCCCccEEEEEcc---CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccCC
Q 040294          206 NLIGRGSFGSVYKARLQ---DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMTN  269 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~---~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  269 (360)
                      +.||+|+||.||+|.++   +++.||||.             |.+|++++++++|||||+++++|..+ ..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999864   346799973             55799999999999999999999765 46899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce-ee
Q 040294          270 GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM-TQ  348 (360)
Q Consensus       270 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~-~~  348 (360)
                      |+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+....... ..
T Consensus        92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9999998764 45899999999999999999999   8899999999999999999999999999999876543222 22


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....||+.||||
T Consensus       168 ~~~~gt~~y~AP  179 (277)
T d1xbba_         168 THGKWPVKWYAP  179 (277)
T ss_dssp             ---CCCGGGCCH
T ss_pred             cccCCCceecCc
Confidence            345799999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-34  Score=262.68  Aligned_cols=154  Identities=27%  Similarity=0.460  Sum_probs=138.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------------hHHHHHHhhcCC-CCCeeEEEEEecCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------------FDVECEVMKSIH-HRNLVKIISSCSNE  257 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------------~~~E~~~l~~l~-hpniv~l~~~~~~~  257 (360)
                      ++|+..+.||+|+||+||+|+. .+|+.||||.                    +.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788899999999999999996 5789999984                    456999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccc
Q 040294          258 DFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAK  337 (360)
Q Consensus       258 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~  337 (360)
                      +..|+|||||++|+|.+++... ..+++.++..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            9999999999999999999764 46899999999999999999999   8999999999999999999999999999999


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .+....   ......||+.|+||
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~P  178 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAP  178 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCH
T ss_pred             EccCCC---ceeeeeccCCCCCH
Confidence            875433   23446799999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=267.06  Aligned_cols=155  Identities=22%  Similarity=0.375  Sum_probs=138.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh----------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEccC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS----------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~----------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      ++|+..+.||+|+||+||+|+.+ +++.||||.          +.+|+++|+.++|||||++++++.+++..|+|||||+
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            56888899999999999999965 788999984          4589999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC--CCcEEEeecccccccCCCCCce
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD--NIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~--~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ||+|.+++...+..+++.++..++.||+.||+|||   +.+|+||||||+|||++.  ...+||+|||+++......   
T Consensus        85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---  158 (321)
T d1tkia_          85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---  158 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC---
Confidence            99999999877667899999999999999999999   899999999999999984  4589999999999875433   


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.||||
T Consensus       159 ~~~~~~~t~~y~ap  172 (321)
T d1tkia_         159 NFRLLFTAPEYYAP  172 (321)
T ss_dssp             EEEEEESCGGGSCH
T ss_pred             cccccccccccccc
Confidence            23446799999997

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-34  Score=270.11  Aligned_cols=152  Identities=28%  Similarity=0.404  Sum_probs=137.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh--------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF--------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVL  264 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~--------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  264 (360)
                      ++|+..+.||+|+||.||+|+. .+|+.||||.+              .+|+++++.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5788999999999999999996 47999999843              46999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCC
Q 040294          265 EYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQ  344 (360)
Q Consensus       265 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~  344 (360)
                      ||+.+|+|.+++...+ .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence            9999999999997654 5889999999999999999999   8999999999999999999999999999999875332 


Q ss_pred             ceeeecccccCcccCC
Q 040294          345 SMTQTQTLATIGYMAP  360 (360)
Q Consensus       345 ~~~~~~~~gt~~Y~aP  360 (360)
                          ....||+.||||
T Consensus       196 ----~~~~Gt~~Y~AP  207 (350)
T d1rdqe_         196 ----WTLCGTPEALAP  207 (350)
T ss_dssp             ----CCCEECGGGCCH
T ss_pred             ----ccccCccccCCH
Confidence                346799999998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-34  Score=266.34  Aligned_cols=160  Identities=29%  Similarity=0.486  Sum_probs=138.2

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCe
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDF  259 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~  259 (360)
                      ..++|+..+.||+|+||.||+|+++      +++.||||.            |.+|++++++++||||++++++|...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            3567999999999999999999864      457899973            5679999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCC
Q 040294          260 RALVLEYMTNGSLEKVLYSSN-----------------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLK  316 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk  316 (360)
                      .++||||+++|+|.++++...                       ..+++..++.|+.|++.||+|||   +.+|+|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence            999999999999999986432                       23788899999999999999999   8999999999


Q ss_pred             CCceeecCCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          317 PHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       317 ~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      |+|||+|.++.+||+|||+|+.+.+...........||+.||||
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP  211 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  211 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence            99999999999999999999987654433344456799999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-34  Score=266.95  Aligned_cols=157  Identities=27%  Similarity=0.442  Sum_probs=132.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCc----EEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGM----EFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRAL  262 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  262 (360)
                      ++|+..++||+|+||.||+|++. +|+    .||||            .|.+|++++++++|||||+++++|.+++ .++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            46889999999999999999864 444    57876            3567999999999999999999998764 678


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCC
Q 040294          263 VLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGE  342 (360)
Q Consensus       263 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~  342 (360)
                      +|||+.+|+|.+.+......+++..++.++.|||.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999999887778999999999999999999999   889999999999999999999999999999987655


Q ss_pred             CCceeeecccccCcccCC
Q 040294          343 DQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       343 ~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..........||+.||||
T Consensus       165 ~~~~~~~~~~gt~~y~AP  182 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMAL  182 (317)
T ss_dssp             CC--------CCTTTSCH
T ss_pred             cccccccccccCccccCh
Confidence            444344456799999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-34  Score=260.49  Aligned_cols=156  Identities=27%  Similarity=0.441  Sum_probs=124.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC----CcEEEeh------------hhHHHHHHhhcCCCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD----GMEFAIK------------SFDVECEVMKSIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vavK------------~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..+.||+|+||.||+|++..    +..||||            .|.+|++++++++|||||+++++|.+ +..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence            467888999999999999998642    3468886            35679999999999999999999964 568999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      |||+++|+|.+++......+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+....
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999999998877778999999999999999999999   8999999999999999999999999999999765433


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                       ........||+.||||
T Consensus       163 -~~~~~~~~gt~~y~ap  178 (273)
T d1mp8a_         163 -YYKASKGKLPIKWMAP  178 (273)
T ss_dssp             ---------CCGGGCCH
T ss_pred             -ceeccceecCcccchh
Confidence             2233455789999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=261.06  Aligned_cols=155  Identities=29%  Similarity=0.448  Sum_probs=135.4

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehhh--------------HHHHHHhh-cCCCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF--------------DVECEVMK-SIHHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~--------------~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..+.||+|+||+||+|+.+ +++.||||.+              ..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999964 7899999854              23555554 68999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCC
Q 040294          264 LEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~  343 (360)
                      ||||++|+|.+++... ..+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            9999999999999754 35788899999999999999999   8999999999999999999999999999999765432


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                        .......||+.||||
T Consensus       158 --~~~~~~~gt~~y~aP  172 (320)
T d1xjda_         158 --AKTNTFCGTPDYIAP  172 (320)
T ss_dssp             --CCBCCCCSCGGGCCH
T ss_pred             --ccccccCCCCCcCCH
Confidence              223456799999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-34  Score=260.06  Aligned_cols=157  Identities=27%  Similarity=0.437  Sum_probs=130.3

Q ss_pred             CCCCCCeeccCCCccEEEEEccCCcEEEehhh----------HHHHHHhhcCCCCCeeEEEEEecCCC----eEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQDGMEFAIKSF----------DVECEVMKSIHHRNLVKIISSCSNED----FRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~----------~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e~  266 (360)
                      +|...+.||+|+||.||+|++ +|+.||||.+          +.|+..+.+++|||||+++++|.+++    ..++||||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            355668899999999999997 5889999854          33555666889999999999997654    68999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFG-----FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-----~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      |++|+|.++++..  .++|.++..++.|+|.||+|+|..     .+++|+||||||+|||+++++.+||+|||+++....
T Consensus        83 ~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~  160 (303)
T d1vjya_          83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             ccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence            9999999999864  588999999999999999999942     247999999999999999999999999999998765


Q ss_pred             CCCce--eeecccccCcccCC
Q 040294          342 EDQSM--TQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~--~~~~~~gt~~Y~aP  360 (360)
                      .....  .....+||++||||
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aP  181 (303)
T d1vjya_         161 ATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             TTTEECC----CCSCGGGCCH
T ss_pred             CCcceeccccceecccCcCCh
Confidence            43221  23456799999998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-34  Score=260.48  Aligned_cols=156  Identities=29%  Similarity=0.443  Sum_probs=136.3

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||+||+|+. .+|+.||||.+             .+|++++++++|||||+++++|.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999995 57999999853             469999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+.++.+..........+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....... 
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence            99765555444455567999999999999999999999   89999999999999999999999999999998754332 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......||+.|+||
T Consensus       158 -~~~~~~gt~~y~ap  171 (298)
T d1gz8a_         158 -TYTHEVVTLWYRAP  171 (298)
T ss_dssp             -CTTCCBCCCTTCCH
T ss_pred             -cceeecccceeeeh
Confidence             23345799999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-34  Score=260.59  Aligned_cols=158  Identities=26%  Similarity=0.456  Sum_probs=126.5

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehhh------------HHHHHHhhcC-CCCCeeEEEEEecCC-Ce
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKSF------------DVECEVMKSI-HHRNLVKIISSCSNE-DF  259 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~------------~~E~~~l~~l-~hpniv~l~~~~~~~-~~  259 (360)
                      ++|+..+.||+|+||.||+|++.      +++.||||.+            ..|...+.++ +|||||.+++++..+ +.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            56888999999999999999853      3468999854            3456666665 689999999998764 46


Q ss_pred             EEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC
Q 040294          260 RALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD  324 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~  324 (360)
                      .++|||||++|+|.++++...               ..+++.++..++.||++||+|||   +.+|+||||||+|||+++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence            899999999999999997432               24789999999999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          325 NIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       325 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ++.+||+|||+|+...............||+.||||
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  205 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  205 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccch
Confidence            999999999999986654433344456799999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=262.28  Aligned_cols=156  Identities=28%  Similarity=0.402  Sum_probs=133.1

Q ss_pred             hCCCCCC-CeeccCCCccEEEEEc-cCCcEEEehh------hHHHHHHhhc-CCCCCeeEEEEEecC----CCeEEEEEE
Q 040294          199 TNGFSAN-NLIGRGSFGSVYKARL-QDGMEFAIKS------FDVECEVMKS-IHHRNLVKIISSCSN----EDFRALVLE  265 (360)
Q Consensus       199 ~~~f~~~-~~iG~G~~g~Vy~~~~-~~~~~vavK~------~~~E~~~l~~-l~hpniv~l~~~~~~----~~~~~lv~e  265 (360)
                      .++|.+. ++||+|+||.||+|+. .+++.||||.      +.+|++++.+ .+|||||+++++|++    +...|+|||
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE   89 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   89 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence            3567765 5699999999999985 5789999984      5679988655 589999999999865    457899999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC---CCcEEEeecccccccCC
Q 040294          266 YMTNGSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD---NIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~---~~~~ki~DFGla~~~~~  341 (360)
                      ||+||+|.+++...+ ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+|+....
T Consensus        90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccC
Confidence            999999999998653 46899999999999999999999   899999999999999985   56799999999998754


Q ss_pred             CCCceeeecccccCcccCC
Q 040294          342 EDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ..   .....+||+.||||
T Consensus       167 ~~---~~~~~~gt~~y~aP  182 (335)
T d2ozaa1         167 HN---SLTTPCYTPYYVAP  182 (335)
T ss_dssp             CC---CCCCCSCCCSSCCC
T ss_pred             CC---ccccccCCcccCCc
Confidence            43   23456799999999

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-33  Score=259.31  Aligned_cols=150  Identities=31%  Similarity=0.486  Sum_probs=131.0

Q ss_pred             CCeeccCCCccEEEEEcc-CCcEEEehhh----------------HHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEcc
Q 040294          205 NNLIGRGSFGSVYKARLQ-DGMEFAIKSF----------------DVECEVMKSIHHRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~----------------~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      .++||+|+||+||+|+.+ +|+.||||.+                .+|++++++++|||||++++++.+++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            478999999999999964 7899999843                46999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCcee
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMT  347 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~  347 (360)
                      +++++..+.. ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.......  .
T Consensus        83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~  156 (299)
T d1ua2a_          83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A  156 (299)
T ss_dssp             SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred             cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--c
Confidence            9887776654 3456788888999999999999999   89999999999999999999999999999987654332  2


Q ss_pred             eecccccCcccCC
Q 040294          348 QTQTLATIGYMAP  360 (360)
Q Consensus       348 ~~~~~gt~~Y~aP  360 (360)
                      ....+||+.||||
T Consensus       157 ~~~~~gt~~y~aP  169 (299)
T d1ua2a_         157 YTHQVVTRWYRAP  169 (299)
T ss_dssp             CCCSCCCCTTCCH
T ss_pred             ccceecChhhccH
Confidence            3346799999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-34  Score=261.44  Aligned_cols=158  Identities=23%  Similarity=0.443  Sum_probs=137.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc------CCcEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ------DGMEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      ++|...+.||+|+||.||+|++.      +++.||||.            |.+|++++++++|||||+++++|..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            56778899999999999999863      357899983            467999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEee
Q 040294          262 LVLEYMTNGSLEKVLYSSN---------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSD  332 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~D  332 (360)
                      +|||||++|+|.+++....         ..+++..+..++.|+|+||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence            9999999999999886321         34688899999999999999999   88999999999999999999999999


Q ss_pred             cccccccCCCCCceeeecccccCcccCC
Q 040294          333 FGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       333 FGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|+.+.............||+.||||
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aP  204 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSP  204 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             cccceeccCCcceeeccceecccccCCH
Confidence            9999987554433333455799999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.2e-33  Score=258.33  Aligned_cols=155  Identities=33%  Similarity=0.577  Sum_probs=132.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCc--EEEeh------------hhHHHHHHhhcC-CCCCeeEEEEEecCCCeEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGM--EFAIK------------SFDVECEVMKSI-HHRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK------------~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv  263 (360)
                      ++|+..++||+|+||.||+|+++ ++.  .||||            .|.+|++++.++ +|||||+++++|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888899999999999999975 444  46676            356899999998 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcE
Q 040294          264 LEYMTNGSLEKVLYSS---------------NCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVA  328 (360)
Q Consensus       264 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~  328 (360)
                      |||+++|+|.++++..               ...+++..+..++.|||+||.|+|   +.+|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999753               346899999999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeecccccCcccCC
Q 040294          329 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       329 ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ||+|||+|+......   ......||..|+||
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aP  195 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAI  195 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCH
T ss_pred             EEccccccccccccc---cccceecCCcccch
Confidence            999999998654222   22345689999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.9e-33  Score=254.14  Aligned_cols=157  Identities=27%  Similarity=0.410  Sum_probs=128.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc--CC--cEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ--DG--MEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~--~~--~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  261 (360)
                      ++|+..+.||+|+||.||+|++.  ++  ..||||.              |.+|++++++++|||||+++++|.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            45888899999999999999853  23  3688873              45799999999999999999999765 568


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      +||||+++|++.+.+......+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.+..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988876667999999999999999999999   89999999999999999999999999999998765


Q ss_pred             CCCce-eeecccccCcccCC
Q 040294          342 EDQSM-TQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~~-~~~~~~gt~~Y~aP  360 (360)
                      ..... ......||+.||||
T Consensus       164 ~~~~~~~~~~~~~~~~~~aP  183 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAP  183 (273)
T ss_dssp             -CCEEEC-----CCGGGCCH
T ss_pred             CCCcceecCccccCcccCCH
Confidence            43322 22345688899998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.98  E-value=2.4e-33  Score=254.19  Aligned_cols=157  Identities=22%  Similarity=0.436  Sum_probs=128.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------------hHHHHHHhhcCCCCCeeEEEEEecCCC----eE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------------FDVECEVMKSIHHRNLVKIISSCSNED----FR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------------~~~E~~~l~~l~hpniv~l~~~~~~~~----~~  260 (360)
                      ++|+..+.||+|+||.||+|+. .+|+.||||.              |.+|+++++.++|||||++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5688999999999999999995 5899999984              457999999999999999999987654    47


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccC
Q 040294          261 ALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLT  340 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~  340 (360)
                      |+||||++||+|.+++...+ .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||.++...
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             EEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhc
Confidence            99999999999999887653 5889999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCC-ceeeecccccCcccCC
Q 040294          341 GEDQ-SMTQTQTLATIGYMAP  360 (360)
Q Consensus       341 ~~~~-~~~~~~~~gt~~Y~aP  360 (360)
                      .... .......+||+.||||
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aP  183 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSP  183 (277)
T ss_dssp             ----------------TTCCH
T ss_pred             cccccccccccccCcccccCH
Confidence            3321 2233456899999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.3e-33  Score=258.40  Aligned_cols=158  Identities=27%  Similarity=0.471  Sum_probs=138.6

Q ss_pred             CCCCCCCeeccCCCccEEEEEc------cCCcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCCeE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL------QDGMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNEDFR  260 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  260 (360)
                      ++|+..+.||+|+||.||+|++      .+++.||||.            |.+|+.+++++ +|||||+++++|.+++..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            5677889999999999999975      2456899984            45789999998 699999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec
Q 040294          261 ALVLEYMTNGSLEKVLYSSN-----------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD  323 (360)
Q Consensus       261 ~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~  323 (360)
                      ++|||||++|+|.++++...                 ..+++..+..++.||++||+|||   +.+|+||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence            99999999999999997542                 24888999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          324 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       324 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .++.+|++|||+++...............||+.||||
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP  216 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence            9999999999999987655444455567899999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=6e-33  Score=255.48  Aligned_cols=153  Identities=29%  Similarity=0.529  Sum_probs=131.8

Q ss_pred             CCeeccCCCccEEEEEccCC----cEEEehh------------hHHHHHHhhcCCCCCeeEEEEEecC-CCeEEEEEEcc
Q 040294          205 NNLIGRGSFGSVYKARLQDG----MEFAIKS------------FDVECEVMKSIHHRNLVKIISSCSN-EDFRALVLEYM  267 (360)
Q Consensus       205 ~~~iG~G~~g~Vy~~~~~~~----~~vavK~------------~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~  267 (360)
                      .++||+|+||+||+|++..+    ..||||.            |.+|++++++++|||||+++++|.+ +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            36899999999999996532    3588873            5689999999999999999999865 56899999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc--
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS--  345 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~--  345 (360)
                      ++|+|.+++.......++..++.++.|++.||.|+|   +.+|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999887777889999999999999999999   899999999999999999999999999999987544321  


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                      .......||+.|+||
T Consensus       189 ~~~~~~~gt~~y~aP  203 (311)
T d1r0pa_         189 HNKTGAKLPVKWMAL  203 (311)
T ss_dssp             TCTTCSSCCGGGSCH
T ss_pred             eecccccccccccCh
Confidence            122345789999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.9e-33  Score=252.59  Aligned_cols=152  Identities=32%  Similarity=0.496  Sum_probs=125.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh---------hHHHHHHhhcCCCCCeeEEEEEecC-CCeEEEEEEccCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS---------FDVECEVMKSIHHRNLVKIISSCSN-EDFRALVLEYMTN  269 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~---------~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~~  269 (360)
                      ++|+..+.||+|+||.||+|+++ |+.||||.         |.+|++++++++|||||+++++|.+ .+..++||||+++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~   85 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   85 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence            45777889999999999999985 77899984         5679999999999999999999865 4568999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCceee
Q 040294          270 GSLEKVLYSSN-CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSMTQ  348 (360)
Q Consensus       270 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~~~  348 (360)
                      |+|.+++.... ..++|..++.++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||+++.....     .
T Consensus        86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~  157 (262)
T d1byga_          86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q  157 (262)
T ss_dssp             EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC-----C
Confidence            99999997543 34899999999999999999999   899999999999999999999999999999976432     2


Q ss_pred             ecccccCcccCC
Q 040294          349 TQTLATIGYMAP  360 (360)
Q Consensus       349 ~~~~gt~~Y~aP  360 (360)
                      ....+|+.||||
T Consensus       158 ~~~~~~~~y~aP  169 (262)
T d1byga_         158 DTGKLPVKWTAP  169 (262)
T ss_dssp             ----CCTTTSCH
T ss_pred             ccccccccCCCh
Confidence            234689999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.2e-33  Score=252.82  Aligned_cols=153  Identities=25%  Similarity=0.348  Sum_probs=133.9

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-----------------hHHHHHHhhcCC--CCCeeEEEEEecCCCe
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-----------------FDVECEVMKSIH--HRNLVKIISSCSNEDF  259 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-----------------~~~E~~~l~~l~--hpniv~l~~~~~~~~~  259 (360)
                      ++|++.++||+|+||.||+|+. .+|+.||||.                 +.+|++++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5688899999999999999996 5789999984                 347999999987  8999999999999999


Q ss_pred             EEEEEEccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-CCcEEEeeccccc
Q 040294          260 RALVLEYMTN-GSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-NIVAHLSDFGIAK  337 (360)
Q Consensus       260 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-~~~~ki~DFGla~  337 (360)
                      .++||||+.+ +++.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++. ++.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999986 6888877654 46889999999999999999999   899999999999999985 5799999999998


Q ss_pred             ccCCCCCceeeecccccCcccCC
Q 040294          338 LLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       338 ~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ......    .+..+||+.||||
T Consensus       160 ~~~~~~----~~~~~GT~~y~aP  178 (273)
T d1xwsa_         160 LLKDTV----YTDFDGTRVYSPP  178 (273)
T ss_dssp             ECCSSC----BCCCCSCGGGSCH
T ss_pred             eccccc----ccccccCCCcCCH
Confidence            754322    3456799999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-32  Score=252.63  Aligned_cols=158  Identities=28%  Similarity=0.461  Sum_probs=131.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEccC--------CcEEEehh------------hHHHHHHhhcC-CCCCeeEEEEEecCCC
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQD--------GMEFAIKS------------FDVECEVMKSI-HHRNLVKIISSCSNED  258 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~--------~~~vavK~------------~~~E~~~l~~l-~hpniv~l~~~~~~~~  258 (360)
                      ++|...+.||+|+||.||+|+..+        +..||||.            +..|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            467788999999999999998532        24799984            34577778777 7999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec
Q 040294          259 FRALVLEYMTNGSLEKVLYSSN---------------CILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD  323 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~  323 (360)
                      ..++|||||++|+|.+++....               ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            9999999999999999997543               34799999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCceeeecccccCcccCC
Q 040294          324 DNIVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       324 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .++.+||+|||+++...............||+.||||
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  206 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  206 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence            9999999999999987655433344556799999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.8e-32  Score=249.33  Aligned_cols=155  Identities=26%  Similarity=0.433  Sum_probs=133.0

Q ss_pred             CCCCCCCeeccCCCccEEEEEccCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEEc
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLEY  266 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  266 (360)
                      ++|+..+.||+|+||+||+|+.++|+.||||.             +.+|+.++++++|||||+++++|.+++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57888899999999999999999999999984             45799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCce
Q 040294          267 MTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       267 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~~  346 (360)
                      +.++.+..+.. ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||.|........  
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--  155 (286)
T d1ob3a_          82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (286)
T ss_dssp             CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence            98776666654 4457899999999999999999999   88999999999999999999999999999998754332  


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      ......||+.|+||
T Consensus       156 ~~~~~~~~~~y~~p  169 (286)
T d1ob3a_         156 KYTHEIVTLWYRAP  169 (286)
T ss_dssp             ------CCCTTCCH
T ss_pred             ccceecccchhhhH
Confidence            23345689999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.3e-32  Score=252.79  Aligned_cols=154  Identities=32%  Similarity=0.510  Sum_probs=129.3

Q ss_pred             CCCCCCeeccCCCccEEEEEcc-CCcEEEehhh-------HHHHHHhhcCCCCCeeEEEEEecC------CCeEEEEEEc
Q 040294          201 GFSANNLIGRGSFGSVYKARLQ-DGMEFAIKSF-------DVECEVMKSIHHRNLVKIISSCSN------EDFRALVLEY  266 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~-------~~E~~~l~~l~hpniv~l~~~~~~------~~~~~lv~e~  266 (360)
                      +|+..++||+|+||+||+|+.. +|+.||||.+       .+|++++++++|||||+++++|..      ....++||||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            4777889999999999999964 7999999853       579999999999999999999843      3367999999


Q ss_pred             cCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC-cEEEeecccccccCCCC
Q 040294          267 MTNGSLEKVLY--SSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI-VAHLSDFGIAKLLTGED  343 (360)
Q Consensus       267 ~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~-~~ki~DFGla~~~~~~~  343 (360)
                      |+++.+..+..  .....+++.++..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++......
T Consensus       101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_         101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            98765444432  34456899999999999999999999   99999999999999999765 89999999999875433


Q ss_pred             CceeeecccccCcccCC
Q 040294          344 QSMTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~~~~~~~~gt~~Y~aP  360 (360)
                         .....+||+.|+||
T Consensus       178 ---~~~~~~gt~~y~aP  191 (350)
T d1q5ka_         178 ---PNVSYICSRYYRAP  191 (350)
T ss_dssp             ---CCCSCCSCTTSCCH
T ss_pred             ---ccccccccccccCh
Confidence               22346799999998

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=5e-31  Score=240.68  Aligned_cols=157  Identities=19%  Similarity=0.285  Sum_probs=136.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh---------hHHHHHHhhcCCC-CCeeEEEEEecCCCeEEEEEEccC
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS---------FDVECEVMKSIHH-RNLVKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~---------~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~  268 (360)
                      ++|++.+.||+|+||.||+|+. .+|+.||||.         +..|++.++.++| +|++.+++++..+...++||||+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            4688899999999999999995 4789999984         4679999999976 89999999999999999999999 


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecC-----CCcEEEeecccccccCCCC
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDD-----NIVAHLSDFGIAKLLTGED  343 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~-----~~~~ki~DFGla~~~~~~~  343 (360)
                      +|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||+|+......
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            78999999877777999999999999999999999   999999999999999974     5789999999999865432


Q ss_pred             Cc-----eeeecccccCcccCC
Q 040294          344 QS-----MTQTQTLATIGYMAP  360 (360)
Q Consensus       344 ~~-----~~~~~~~gt~~Y~aP  360 (360)
                      ..     ......+||+.||||
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aP  182 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSI  182 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCH
T ss_pred             cccceeecccCceEEchhhcCH
Confidence            11     123356799999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-31  Score=246.45  Aligned_cols=157  Identities=28%  Similarity=0.453  Sum_probs=132.4

Q ss_pred             HhCCCCCCCeeccCCCccEEEEEc-cC-CcEEEehh-------------hHHHHHHhhcC---CCCCeeEEEEEec----
Q 040294          198 ATNGFSANNLIGRGSFGSVYKARL-QD-GMEFAIKS-------------FDVECEVMKSI---HHRNLVKIISSCS----  255 (360)
Q Consensus       198 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~-~~~vavK~-------------~~~E~~~l~~l---~hpniv~l~~~~~----  255 (360)
                      ..++|++.+.||+|+||+||+|+. ++ ++.||||.             +.+|+++++.+   +|||||+++++|.    
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            356899999999999999999986 44 56789984             34688777655   7999999999985    


Q ss_pred             -CCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecc
Q 040294          256 -NEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFG  334 (360)
Q Consensus       256 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFG  334 (360)
                       .....+++|||++++++..........+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence             334789999999998887776666667899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCceeeecccccCcccCC
Q 040294          335 IAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       335 la~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++......   ......||+.||||
T Consensus       162 ~~~~~~~~~---~~~~~~gT~~Y~AP  184 (305)
T d1blxa_         162 LARIYSFQM---ALTSVVVTLWYRAP  184 (305)
T ss_dssp             SCCCCCGGG---GGCCCCCCCTTCCH
T ss_pred             hhhhhcccc---cCCCcccChhhcCc
Confidence            998654322   23456899999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.97  E-value=3.3e-31  Score=245.65  Aligned_cols=151  Identities=23%  Similarity=0.412  Sum_probs=130.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh--------hHHHHHHhhcCC-CCCeeEEEEEecC--CCeEEEEEEcc
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS--------FDVECEVMKSIH-HRNLVKIISSCSN--EDFRALVLEYM  267 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~--------~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lv~e~~  267 (360)
                      ++|++.+.||+|+||+||+|+. .+|+.||||.        +.+|+++|++++ ||||++++++|..  ....++|||||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            5788999999999999999996 5789999984        467999999996 9999999999874  45689999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCC-CcEEEeecccccccCCCCCce
Q 040294          268 TNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDN-IVAHLSDFGIAKLLTGEDQSM  346 (360)
Q Consensus       268 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~-~~~ki~DFGla~~~~~~~~~~  346 (360)
                      ++++|....    ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.+ ..+||+|||+|+......   
T Consensus       115 ~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---  184 (328)
T d3bqca1         115 NNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---  184 (328)
T ss_dssp             CSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---
T ss_pred             CCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC---
Confidence            999997764    35888999999999999999999   9999999999999999865 469999999999765443   


Q ss_pred             eeecccccCcccCC
Q 040294          347 TQTQTLATIGYMAP  360 (360)
Q Consensus       347 ~~~~~~gt~~Y~aP  360 (360)
                      .....+||+.|+||
T Consensus       185 ~~~~~~~t~~y~aP  198 (328)
T d3bqca1         185 EYNVRVASRYFKGP  198 (328)
T ss_dssp             CCCSCCSCGGGCCH
T ss_pred             cccccccCccccCc
Confidence            23456799999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.2e-31  Score=246.03  Aligned_cols=157  Identities=25%  Similarity=0.371  Sum_probs=128.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh------------HHHHHHhhcCCCCCeeEEEEEecCCC----eEE
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF------------DVECEVMKSIHHRNLVKIISSCSNED----FRA  261 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~------------~~E~~~l~~l~hpniv~l~~~~~~~~----~~~  261 (360)
                      ++.|+..+.||+|+||+||+|+. .+|+.||||.+            .+|+++|++++|||||++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35688889999999999999985 58999999853            46999999999999999999987643    234


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCC
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTG  341 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~  341 (360)
                      ++++|+.+|+|.+++...  .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            555667799999999754  5889999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCc-eeeecccccCcccCC
Q 040294          342 EDQS-MTQTQTLATIGYMAP  360 (360)
Q Consensus       342 ~~~~-~~~~~~~gt~~Y~aP  360 (360)
                      .... ......+||+.|+||
T Consensus       162 ~~~~~~~~~~~~gt~~y~aP  181 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAP  181 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCG
T ss_pred             CCccceeeccccccceechH
Confidence            3211 122346799999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.9e-31  Score=245.26  Aligned_cols=151  Identities=26%  Similarity=0.427  Sum_probs=126.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCCC------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNED------  258 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~~------  258 (360)
                      .+.|+..+.||+|+||+||+|+. .+|+.||||.+             .+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            35788889999999999999995 57999999853             46999999999999999999998655      


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          259 FRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       259 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ..++||||+ +.+|..+.+..  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            579999999 66888877643  5899999999999999999999   89999999999999999999999999999997


Q ss_pred             cCCCCCceeeecccccCcccCC
Q 040294          339 LTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       339 ~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....     .+...||+.|+||
T Consensus       171 ~~~~-----~~~~~~t~~y~aP  187 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAP  187 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCT
T ss_pred             cCCc-----cccccccccccCH
Confidence            6533     2346799999998

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.6e-31  Score=243.96  Aligned_cols=156  Identities=29%  Similarity=0.432  Sum_probs=135.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEc----cCCcEEEehhh---------------HHHHHHhhcCCC-CCeeEEEEEecCCCe
Q 040294          200 NGFSANNLIGRGSFGSVYKARL----QDGMEFAIKSF---------------DVECEVMKSIHH-RNLVKIISSCSNEDF  259 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~---------------~~E~~~l~~l~h-pniv~l~~~~~~~~~  259 (360)
                      ++|+..+.||+|+||+||+|+.    .+|+.||||.+               .+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999974    25789999853               369999999977 899999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .++||||+.+|+|.+++.... .++......++.|++.||+|+|   +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999997654 4567788889999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      .... ........||+.|+||
T Consensus       180 ~~~~-~~~~~~~~g~~~~~~p  199 (322)
T d1vzoa_         180 VADE-TERAYDFCGTIEYMAP  199 (322)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCH
T ss_pred             cccc-cccccccccccccchh
Confidence            5432 2223456799999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-30  Score=240.15  Aligned_cols=158  Identities=27%  Similarity=0.451  Sum_probs=130.9

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecC--------
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSN--------  256 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~--------  256 (360)
                      .++|++.+.||+|+||+||+|+. ++|+.||||.+             .+|+++|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            35788899999999999999996 58999999853             479999999999999999998855        


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccc
Q 040294          257 EDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIA  336 (360)
Q Consensus       257 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla  336 (360)
                      ++..++||||++++.+.... .....++......++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34589999999887666544 34456888889999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCc--eeeecccccCcccCC
Q 040294          337 KLLTGEDQS--MTQTQTLATIGYMAP  360 (360)
Q Consensus       337 ~~~~~~~~~--~~~~~~~gt~~Y~aP  360 (360)
                      +........  ......+||++|+||
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aP  190 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPP  190 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCH
T ss_pred             eecccccccccccccceecCHHHhhH
Confidence            876543211  122345799999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.9e-30  Score=235.03  Aligned_cols=155  Identities=24%  Similarity=0.373  Sum_probs=134.7

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecCCCeEEEEEE
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSNEDFRALVLE  265 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  265 (360)
                      ++|+..+.||+|+||+||+|+. .+++.||||.             +.+|+.++++++|||||+++++|.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4688899999999999999995 5789999984             3579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeecccccccCCCCCc
Q 040294          266 YMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       266 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      |+.++++..++... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            99999988877644 46788889999999999999999   89999999999999999999999999999998754332 


Q ss_pred             eeeecccccCcccCC
Q 040294          346 MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 ~~~~~~~gt~~Y~aP  360 (360)
                       ......+++.|+||
T Consensus       157 -~~~~~~~~~~~~~p  170 (292)
T d1unla_         157 -CYSAEVVTLWYRPP  170 (292)
T ss_dssp             -CCCSCCSCGGGCCH
T ss_pred             -cceeeccccchhhh
Confidence             22234567777775

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=3.9e-30  Score=235.27  Aligned_cols=157  Identities=27%  Similarity=0.405  Sum_probs=130.8

Q ss_pred             CCCCCCCeeccCCCccEEEEEc-cCCcEEEeh---------hhHHHHHHhhcCCCCCe-eEEEEEecCCCeEEEEEEccC
Q 040294          200 NGFSANNLIGRGSFGSVYKARL-QDGMEFAIK---------SFDVECEVMKSIHHRNL-VKIISSCSNEDFRALVLEYMT  268 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK---------~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~  268 (360)
                      +.|+..+.||+|+||.||+|+. .+|+.||||         .+..|+++++.++|+++ +.+.+++.+++..++||||+ 
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            4688899999999999999985 578999998         35679999999987765 55566667888999999999 


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeec---CCCcEEEeecccccccCCCCCc
Q 040294          269 NGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLD---DNIVAHLSDFGIAKLLTGEDQS  345 (360)
Q Consensus       269 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~---~~~~~ki~DFGla~~~~~~~~~  345 (360)
                      +|++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+|||++   .+..+||+|||+|+.+......
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            56777777666667999999999999999999999   89999999999999975   4567999999999987543321


Q ss_pred             -----eeeecccccCcccCC
Q 040294          346 -----MTQTQTLATIGYMAP  360 (360)
Q Consensus       346 -----~~~~~~~gt~~Y~aP  360 (360)
                           ......+||+.||||
T Consensus       163 ~~~~~~~~~~~~gt~~y~aP  182 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASI  182 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCH
T ss_pred             cceeccccCCcCCCccccCH
Confidence                 123456799999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.8e-30  Score=237.79  Aligned_cols=152  Identities=25%  Similarity=0.413  Sum_probs=127.5

Q ss_pred             hCCCCCCCeeccCCCccEEEEEc-cCCcEEEehhh-------------HHHHHHhhcCCCCCeeEEEEEecCC-----Ce
Q 040294          199 TNGFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF-------------DVECEVMKSIHHRNLVKIISSCSNE-----DF  259 (360)
Q Consensus       199 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~-------------~~E~~~l~~l~hpniv~l~~~~~~~-----~~  259 (360)
                      .++|+..+.||+|+||+||+|+. .+|+.||||.+             .+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46788899999999999999995 58999999853             4699999999999999999998643     33


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .+++|||+.+|+|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||+|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            46777888899999998653  5899999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ...     .....||+.|+||
T Consensus       172 ~~~-----~~~~~g~~~y~ap  187 (348)
T d2gfsa1         172 DDE-----MTGYVATRWYRAP  187 (348)
T ss_dssp             TGG-----GSSSCHHHHTSCH
T ss_pred             Ccc-----cccccccccccCc
Confidence            322     2345789999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3e-29  Score=234.92  Aligned_cols=151  Identities=27%  Similarity=0.342  Sum_probs=119.1

Q ss_pred             CCCCCCCeeccCCCccEEEEEcc-CCcEEEehh-------------hHHHHHHhhcCCCCCeeEEEEEecC------CCe
Q 040294          200 NGFSANNLIGRGSFGSVYKARLQ-DGMEFAIKS-------------FDVECEVMKSIHHRNLVKIISSCSN------EDF  259 (360)
Q Consensus       200 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~-------------~~~E~~~l~~l~hpniv~l~~~~~~------~~~  259 (360)
                      +.|++.++||+|+||+||+|+.. +|+.||||.             +.+|++++++++|||||+++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            56888999999999999999964 799999984             3479999999999999999999964      368


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeeccccccc
Q 040294          260 RALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKLL  339 (360)
Q Consensus       260 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~~  339 (360)
                      .|+|||||.++.+. .+.   ..+++.....++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999765544 443   34788999999999999999999   899999999999999999999999999998875


Q ss_pred             CCCCCceeeecccccCcccCC
Q 040294          340 TGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       340 ~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      ....   .....+||+.|+||
T Consensus       170 ~~~~---~~~~~~~t~~y~aP  187 (355)
T d2b1pa1         170 GTSF---MMTPYVVTRYYRAP  187 (355)
T ss_dssp             --------------CCTTCCH
T ss_pred             cccc---ccccccccccccCh
Confidence            4332   23456799999998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.89  E-value=2.6e-24  Score=201.16  Aligned_cols=153  Identities=20%  Similarity=0.316  Sum_probs=119.8

Q ss_pred             CCCCCCeeccCCCccEEEEEc-cCCcEEEehhh----------HHHHHHhhcCC-----------CCCeeEEEEEecC--
Q 040294          201 GFSANNLIGRGSFGSVYKARL-QDGMEFAIKSF----------DVECEVMKSIH-----------HRNLVKIISSCSN--  256 (360)
Q Consensus       201 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~----------~~E~~~l~~l~-----------hpniv~l~~~~~~--  256 (360)
                      .|++.++||+|+||+||+|+. .+|+.||||.+          .+|+++++.++           |+|||++++++..  
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            388899999999999999996 58999999854          45888887765           5789999988764  


Q ss_pred             CCeEEEEEEccCCCCHHH--HHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCC------cE
Q 040294          257 EDFRALVLEYMTNGSLEK--VLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNI------VA  328 (360)
Q Consensus       257 ~~~~~lv~e~~~~g~L~~--~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~------~~  328 (360)
                      ....+++|+++..+....  ........+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++      .+
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence            346677777766544322  223334567888899999999999999993  37899999999999998654      49


Q ss_pred             EEeecccccccCCCCCceeeecccccCcccCC
Q 040294          329 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  360 (360)
Q Consensus       329 ki~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  360 (360)
                      +++|||.|......     ....+||+.|+||
T Consensus       172 kl~dfg~s~~~~~~-----~~~~~gt~~y~aP  198 (362)
T d1q8ya_         172 KIADLGNACWYDEH-----YTNSIQTREYRSP  198 (362)
T ss_dssp             EECCCTTCEETTBC-----CCSCCSCGGGCCH
T ss_pred             eEeecccccccccc-----cccccccccccCh
Confidence            99999999865422     2346799999998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1.6e-23  Score=178.51  Aligned_cols=122  Identities=16%  Similarity=0.229  Sum_probs=100.6

Q ss_pred             CCCCeeccCCCccEEEEEccCCcEEEehhh-----------------------------HHHHHHhhcCCCCCeeEEEEE
Q 040294          203 SANNLIGRGSFGSVYKARLQDGMEFAIKSF-----------------------------DVECEVMKSIHHRNLVKIISS  253 (360)
Q Consensus       203 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~-----------------------------~~E~~~l~~l~hpniv~l~~~  253 (360)
                      .+.+.||+|+||.||+|+..+|+.||||.+                             ..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            346889999999999999888999999832                             236778889999999998876


Q ss_pred             ecCCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCceeecCCCcEEEeec
Q 040294          254 CSNEDFRALVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGFSTPIIHCDLKPHNVLLDDNIVAHLSDF  333 (360)
Q Consensus       254 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iiHrdlk~~NiLl~~~~~~ki~DF  333 (360)
                      ..    .+++|||+++..+.+        ++......++.|++++++|||   +.+|+||||||+|||++++ .++|+||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            43    279999999866543        222334678999999999999   8999999999999999965 5899999


Q ss_pred             ccccccC
Q 040294          334 GIAKLLT  340 (360)
Q Consensus       334 Gla~~~~  340 (360)
                      |.|+...
T Consensus       147 G~a~~~~  153 (191)
T d1zara2         147 PQSVEVG  153 (191)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9998764

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.76  E-value=2.6e-19  Score=163.44  Aligned_cols=147  Identities=37%  Similarity=0.641  Sum_probs=107.0

Q ss_pred             CCCCCcEeeCCC-CcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccce
Q 040294            1 YLAALFQLDLRG-NKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQF   70 (360)
Q Consensus         1 ~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~   70 (360)
                      .|++|+.|+|++ |+|+|.+|.+|+++++|++|+|++|++.++         .|+.++++.|++.+.+|.+++++++|+.
T Consensus        74 ~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~  153 (313)
T d1ogqa_          74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG  153 (313)
T ss_dssp             GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred             cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccce
Confidence            378899999987 899999999999999999999999988753         2455555555555555555555555555


Q ss_pred             ecccccccccCCCccc----------------------------------------------------------------
Q 040294           71 LSLGHNRLQGSIPNSF----------------------------------------------------------------   86 (360)
Q Consensus        71 L~l~~N~l~g~~p~~~----------------------------------------------------------------   86 (360)
                      +++++|.++|.+|+.+                                                                
T Consensus       154 l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l  233 (313)
T d1ogqa_         154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL  233 (313)
T ss_dssp             EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred             eecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            5555555444444333                                                                


Q ss_pred             -------cCCCCCCeEeCcCCccCcccchhhhccc-----------cccccCCCCCCCCcccccccCCCCCCCCCCCCCC
Q 040294           87 -------DDLVSLESLDLSNNNLSEIIPLSLEKLL-----------LEGEIPRGGPFTKFSSKSFIGNDLLCGSPNLQVP  148 (360)
Q Consensus        87 -------~~l~~L~~l~ls~N~l~~~~p~~l~~l~-----------~~~~~p~~~~~~~~~~~~~~~n~~~cgsp~~~~~  148 (360)
                             ..+++|+.|+|++|+|+|.+|..+..+.           ++|.+|..+.+..+....+.+|+.+||.|.   |
T Consensus       234 ~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl---p  310 (313)
T d1ogqa_         234 AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL---P  310 (313)
T ss_dssp             CCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS---S
T ss_pred             cccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC---C
Confidence                   2356678888888888888887766543           678889877778888889999999999763   5


Q ss_pred             CC
Q 040294          149 PC  150 (360)
Q Consensus       149 ~c  150 (360)
                      +|
T Consensus       311 ~c  312 (313)
T d1ogqa_         311 AC  312 (313)
T ss_dssp             CC
T ss_pred             CC
Confidence            66

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.64  E-value=6.8e-16  Score=130.61  Aligned_cols=105  Identities=27%  Similarity=0.332  Sum_probs=91.3

Q ss_pred             CCCcEeeCCCCcccccC-CccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            3 AALFQLDLRGNKLSGSI-PTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      ++++.|+|++|+|++.+ +..|.++++|+.|+|++|.+..+         .|+.|+|++|+|++..|.+|.++++|++|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence            46889999999998755 45688999999999999988764         588999999999988888899999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      |++|+|++..|+.|..+++|++|+|++|++....+
T Consensus       109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~  143 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             cCCccccccCHHHhcCCcccccccccccccccccc
Confidence            99999998778889999999999999999987655

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.59  E-value=2.9e-15  Score=126.64  Aligned_cols=122  Identities=30%  Similarity=0.458  Sum_probs=103.8

Q ss_pred             CcEeeCCCCcccccCCccccCCcccCeeeccccccCCc----------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            5 LFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL----------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         5 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~----------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      .+.++.++|+|+ .+|..+.  ++++.|+|++|+|+..          .|+.|++++|++.+.++..|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            568999999999 7887775  6899999999999752          58999999999999999999999999999999


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      +|+|++..|+.|.++++|++|+|++|+|+++.|..+..+            ..+....+.+|+..|.
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l------------~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL------------NSLTSLNLASNPFNCN  141 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTC------------TTCCEEECTTCCBCCS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCC------------cccccccccccccccc
Confidence            999998888899999999999999999999888776554            2334455666665543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=2.1e-14  Score=127.44  Aligned_cols=138  Identities=33%  Similarity=0.373  Sum_probs=71.1

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      +++|+.|+|++|+|+. +| .++.+++|+.|+|++|+++..        .|+.|++++|.+.+..+..+..+.++..|++
T Consensus        54 l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l  131 (266)
T d1p9ag_          54 YTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL  131 (266)
T ss_dssp             CTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred             cccccccccccccccc-cc-cccccccccccccccccccccccccccccccccccccccccceeeccccccccccccccc
Confidence            5667777777777763 33 345677777777777766542        3445555555554444444444444444444


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccc------ccc----ccCCC-CCCCCcccccccCCCCCCC
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLL------LEG----EIPRG-GPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~------~~~----~~p~~-~~~~~~~~~~~~~n~~~cg  141 (360)
                      ++|.++...+..+..+++|+.|++++|+|++..+..+..+.      +++    .+|.+ .....+....+.||+..|.
T Consensus       132 ~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             cccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCC
Confidence            44444433334444444444444444444444443322211      111    22322 1223455677888888775

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=2.6e-14  Score=128.05  Aligned_cols=128  Identities=32%  Similarity=0.365  Sum_probs=87.1

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.|+|++|.+....+..+..+++|+.+++++|+|+.+         .|+.|++++|++++..|.+|.++++|+.++
T Consensus       104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~  183 (284)
T d1ozna_         104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL  183 (284)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence            45677777777777655555666677777777777776653         366777777777766666777777777777


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      +++|++++..|..|..+++|++||+++|++++..|..+..+            ..+....+.+|+..|.
T Consensus       184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~------------~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL------------RALQYLRLNDNPWVCD  240 (284)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC------------TTCCEEECCSSCEECS
T ss_pred             hhhccccccChhHhhhhhhcccccccccccccccccccccc------------cccCEEEecCCCCCCC
Confidence            77777776667777777777777777777777666655433            2345566778877664

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=5.2e-14  Score=115.56  Aligned_cols=102  Identities=25%  Similarity=0.253  Sum_probs=86.7

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      ...|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+.+       .|+.|++++|+++...+..+..+++|+.|+|+
T Consensus        17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~   95 (162)
T d1a9na_          17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT   95 (162)
T ss_dssp             TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred             cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCccCCcccCcchhhhhcccccccCCCccccccccccccceec
Confidence            457899999999998 5677778899999999999998864       58899999999987666667789999999999


Q ss_pred             ccccccCCC--ccccCCCCCCeEeCcCCccCcc
Q 040294           75 HNRLQGSIP--NSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        75 ~N~l~g~~p--~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      +|+++ .++  ..+..+++|++|++++|+++..
T Consensus        96 ~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~  127 (162)
T d1a9na_          96 NNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK  127 (162)
T ss_dssp             SCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred             ccccc-ccccccccccccccchhhcCCCccccc
Confidence            99998 344  4688899999999999988754

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.45  E-value=1.3e-13  Score=107.81  Aligned_cols=96  Identities=30%  Similarity=0.309  Sum_probs=79.5

Q ss_pred             cEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecccccc
Q 040294            6 FQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR   77 (360)
Q Consensus         6 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   77 (360)
                      +.|+|++|+|+ .+| .+..+++|+.|++++|+|+.+        .|+.|++++|.++. +| .++.+++|+.|++++|+
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            57999999998 555 489999999999999999875        48889999999885 44 58889999999999999


Q ss_pred             cccCC-CccccCCCCCCeEeCcCCccCcc
Q 040294           78 LQGSI-PNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        78 l~g~~-p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ++... ...+..+++|++|++++|+++..
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            98432 25688889999999999988754

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.43  E-value=4.6e-14  Score=128.02  Aligned_cols=110  Identities=30%  Similarity=0.451  Sum_probs=98.8

Q ss_pred             CCcEeeCCCCcccc--cCCccccCCcccCeeeccc-cccCC-c--------ccCeEEcCCCcccccCCccccCCCcccee
Q 040294            4 ALFQLDLRGNKLSG--SIPTCFSNLTALRNLHLDS-NELRH-L--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFL   71 (360)
Q Consensus         4 ~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~l~~-N~l~~-~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L   71 (360)
                      .++.|+|++|.++|  .+|++|+++++|++|+|++ |++++ +        .|+.|++++|++.+..|..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            48899999999998  5899999999999999986 78874 2        58999999999999999999999999999


Q ss_pred             cccccccccCCCccccCCCCCCeEeCcCCccCcccchhhhcc
Q 040294           72 SLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEKL  113 (360)
Q Consensus        72 ~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~l  113 (360)
                      +++.|.+.+.+|.+|++++.|+.+++++|.++|.+|..+..+
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l  172 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF  172 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCC
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccc
Confidence            999999999999999999999999999999999998776554

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=5.9e-13  Score=117.94  Aligned_cols=109  Identities=31%  Similarity=0.303  Sum_probs=92.1

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGH   75 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~   75 (360)
                      ++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+.+       .|+.|++++|++++. |..+..+++|+.|++++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~  109 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSF  109 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEECCS
T ss_pred             cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence            4688999999999976667899999999999999988864       588999999998854 66788899999999999


Q ss_pred             cccccCCCccccCCCCCCeEeCcCCccCcccchhhhc
Q 040294           76 NRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSLEK  112 (360)
Q Consensus        76 N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l~~  112 (360)
                      |.+.+..+..+..+.+++.|++++|.++...+..+..
T Consensus       110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~  146 (266)
T d1p9ag_         110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP  146 (266)
T ss_dssp             SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred             cccceeeccccccccccccccccccccceeccccccc
Confidence            9998777788889999999999999998877655443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.39  E-value=2.7e-13  Score=121.24  Aligned_cols=107  Identities=27%  Similarity=0.267  Sum_probs=98.7

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.+++++|+|++..+..|..+++|+.|++++|+++.+         .|+.+++++|++++..|..|..+++|+.|+
T Consensus       128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~  207 (284)
T d1ozna_         128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY  207 (284)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence            56799999999999977778899999999999999999764         589999999999999999999999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccch
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      +++|++++..|..|..+.+|++|+|++|++.+..+.
T Consensus       208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~  243 (284)
T d1ozna_         208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA  243 (284)
T ss_dssp             CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred             ccccccccccccccccccccCEEEecCCCCCCCccc
Confidence            999999988889999999999999999999987653

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=1.4e-11  Score=100.08  Aligned_cols=99  Identities=22%  Similarity=0.189  Sum_probs=75.6

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeecccc-ccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSN-ELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      ...+.++.+++.++ ..|..+..+++|+.|++++| .|+.+         .|+.|++++|+|+...|.+|..+++|++|+
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            34667889999988 57888999999999999766 46643         577888888888877777788888888888


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccC
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLS  103 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~  103 (360)
                      |++|+|+ .+|.......+|+.|+|++|+|.
T Consensus        87 Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          87 LSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ccCCCCc-ccChhhhccccccccccCCCccc
Confidence            8888888 44444334447888888888875

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.24  E-value=3.8e-11  Score=107.90  Aligned_cols=39  Identities=38%  Similarity=0.495  Sum_probs=28.9

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccC
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELR   40 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~   40 (360)
                      +++|+.|++++|.++...|..|.++++|+.|++++|+++
T Consensus        54 l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~   92 (305)
T d1xkua_          54 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK   92 (305)
T ss_dssp             CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS
T ss_pred             cccccccccccccccccchhhhhCCCccCEecccCCccC
Confidence            567777777777777666667777777888887777654

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.23  E-value=8.2e-12  Score=97.39  Aligned_cols=93  Identities=26%  Similarity=0.323  Sum_probs=76.9

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccC-CccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDI-PTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~-p~~~~~l~~L~~L~l   73 (360)
                      +++|+.|+|++|+|+ .+|+.|+.+++|+.|++++|.++.+       .|+.+++++|+++... ...++.+++|+.|++
T Consensus        19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l   97 (124)
T d1dcea3          19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL   97 (124)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEEC
T ss_pred             CCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccCccccccccCeEECCCCccCCCCCchhhcCCCCCCEEEC
Confidence            678999999999998 6788899999999999999999875       5899999999998653 357899999999999


Q ss_pred             cccccccC--CCc-cccCCCCCCeE
Q 040294           74 GHNRLQGS--IPN-SFDDLVSLESL   95 (360)
Q Consensus        74 ~~N~l~g~--~p~-~~~~l~~L~~l   95 (360)
                      ++|+++..  ++. -+..+++|+.|
T Consensus        98 ~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          98 QGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             TTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCcCCcCccHHHHHHHHCcCcceE
Confidence            99999842  122 23446677655

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.22  E-value=1.9e-11  Score=103.28  Aligned_cols=100  Identities=27%  Similarity=0.486  Sum_probs=77.1

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|+|++|+|++..|  ++++++|+.|++++|.+..+       .|+.+++++|.+...  ..+..+++|+.|+++
T Consensus        61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~  136 (199)
T d2omxa2          61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELS  136 (199)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECC
T ss_pred             CCCcCcCccccccccCccc--ccCCcccccccccccccccccccccccccccccccccccccc--cccchhhhhHHhhhh
Confidence            6788999999999986433  88889999999998887654       477788888777653  347778888888888


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|++.. +| .+..+++|+.|++++|++++..|
T Consensus       137 ~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~  167 (199)
T d2omxa2         137 SNTISD-IS-ALSGLTSLQQLNFSSNQVTDLKP  167 (199)
T ss_dssp             SSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGG
T ss_pred             hhhhcc-cc-cccccccccccccccccccCCcc
Confidence            888873 43 57788888888888888877543

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.21  E-value=2.6e-11  Score=109.01  Aligned_cols=105  Identities=24%  Similarity=0.372  Sum_probs=87.1

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCCccccCCCccceec
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLS   72 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~   72 (360)
                      +++|+.+++++|+++ .+|..+  +++|+.|++++|..+..         .++.|++++|.+++..|..+.++++|++|+
T Consensus       149 l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~  225 (305)
T d1xkua_         149 MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH  225 (305)
T ss_dssp             CTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred             ccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeee
Confidence            567889999999988 566543  57889999999877642         478899999999988888899999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEeCcCCccCcccchhh
Q 040294           73 LGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIPLSL  110 (360)
Q Consensus        73 l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p~~l  110 (360)
                      |++|+|+ .+|.+|..+++|+.|+|++|+|+.+-...+
T Consensus       226 L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f  262 (305)
T d1xkua_         226 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF  262 (305)
T ss_dssp             CCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred             ccccccc-ccccccccccCCCEEECCCCccCccChhhc
Confidence            9999998 678899999999999999999986544443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.19  E-value=4.3e-13  Score=113.67  Aligned_cols=102  Identities=26%  Similarity=0.338  Sum_probs=83.9

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc--------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL--------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      |++|+.|+|++|+|+ .++ .|.++++|+.|+|++|.++.+        .|+.|++++|+++. + +.+..+++|+.|+|
T Consensus        47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L  122 (198)
T d1m9la_          47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLYM  122 (198)
T ss_dssp             TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEEE
T ss_pred             ccccceeECcccCCC-Ccc-cccCCccccChhhcccccccccccccccccccccccccccccc-c-cccccccccccccc
Confidence            678999999999998 455 588899999999999988865        48899999999885 3 35788899999999


Q ss_pred             cccccccCCC--ccccCCCCCCeEeCcCCccCcccch
Q 040294           74 GHNRLQGSIP--NSFDDLVSLESLDLSNNNLSEIIPL  108 (360)
Q Consensus        74 ~~N~l~g~~p--~~~~~l~~L~~l~ls~N~l~~~~p~  108 (360)
                      ++|+++. ++  ..|..+++|+.|+|++|++....+.
T Consensus       123 ~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  158 (198)
T d1m9la_         123 SNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             SEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred             ccchhcc-ccccccccCCCccceeecCCCccccCccc
Confidence            9999984 44  4688899999999999988765543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.18  E-value=3.5e-11  Score=102.45  Aligned_cols=100  Identities=32%  Similarity=0.501  Sum_probs=70.1

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.|+|++|+|++ ++ .++++++|+.|++++|+++.+       .|+.|++++|.+..  ...+..+++|+.++++
T Consensus        67 l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l~~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~  142 (210)
T d1h6ta2          67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLG  142 (210)
T ss_dssp             CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECC
T ss_pred             CCCCCEEeCCCccccC-cc-ccccCccccccccccccccccccccccccccccccccccccc--cccccccccccccccc
Confidence            6788888888888885 33 367888888888888888764       46777777777653  2346666667777777


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      .|.+++  +..+..+++|+.+++++|+++++.|
T Consensus       143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~  173 (210)
T d1h6ta2         143 NNKITD--ITVLSRLTKLDTLSLEDNQISDIVP  173 (210)
T ss_dssp             SSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG
T ss_pred             cccccc--ccccccccccccccccccccccccc
Confidence            777663  2346667777777777777776543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.14  E-value=4.3e-11  Score=110.39  Aligned_cols=100  Identities=30%  Similarity=0.467  Sum_probs=58.8

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-----------------------------ccCeEEcCCC
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----------------------------VLTRTDFSRN   52 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-----------------------------~L~~l~l~~N   52 (360)
                      +++|+.|++++|++++..|  +..+++|+.|++++|.++++                             .++.|++++|
T Consensus       240 l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n  317 (384)
T d2omza2         240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN  317 (384)
T ss_dssp             CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSS
T ss_pred             ccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCC
Confidence            3456666666666654322  55566666666666655432                             2455666666


Q ss_pred             cccccCCccccCCCccceecccccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           53 NLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        53 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      ++++..  .+..+++|++|+|++|+|++ +| .|.++++|++|+|++|++++.+|
T Consensus       318 ~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~  368 (384)
T d2omza2         318 NISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP  368 (384)
T ss_dssp             CCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred             CCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence            666532  25666666666666666663 33 46666666666666666666544

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.13  E-value=6.7e-11  Score=101.75  Aligned_cols=100  Identities=27%  Similarity=0.532  Sum_probs=51.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccC----------------
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDI----------------   58 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~----------------   58 (360)
                      +++|+.|+|++|++++..|  +.++++|+.+++++|.++.+       .|+.++++++...+..                
T Consensus        62 l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~  139 (227)
T d1h6ua2          62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN  139 (227)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             CCCCcEeecCCceeecccc--ccccccccccccccccccccccccccccccccccccccccccchhccccchhhhhchhh
Confidence            5566666666666664322  55666666666666654432       1333333333322110                


Q ss_pred             ----CccccCCCccceecccccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           59 ----PTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        59 ----p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                          ...+..+++|+.|++++|.+++.  ..+.++++|+.|||++|+++++
T Consensus       140 ~~~~~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l  188 (227)
T d1h6ua2         140 QITNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI  188 (227)
T ss_dssp             CCCCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC
T ss_pred             hhchhhhhccccccccccccccccccc--hhhcccccceecccCCCccCCC
Confidence                11234455566666666665532  1255666666666666666553

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.06  E-value=8.5e-11  Score=95.91  Aligned_cols=92  Identities=22%  Similarity=0.315  Sum_probs=78.4

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCC-ccccCCCcccee
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIP-TTIQGLKSLQFL   71 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p-~~~~~l~~L~~L   71 (360)
                      +++|+.|+|++|+|+. ++ .|..+++|+.|++++|+++.+         .|+.|++++|+++.... ..+..+++|+.|
T Consensus        40 l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L  117 (162)
T d1a9na_          40 LDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL  117 (162)
T ss_dssp             TTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEE
T ss_pred             cccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccccccchh
Confidence            5789999999999994 54 589999999999999999864         58999999999975322 467899999999


Q ss_pred             cccccccccCCCc----cccCCCCCCeEe
Q 040294           72 SLGHNRLQGSIPN----SFDDLVSLESLD   96 (360)
Q Consensus        72 ~l~~N~l~g~~p~----~~~~l~~L~~l~   96 (360)
                      ++++|+++ ..|.    .+..+++|+.||
T Consensus       118 ~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_         118 CILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             ECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             hcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            99999998 4554    478899999998

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.95  E-value=1.2e-09  Score=88.26  Aligned_cols=104  Identities=21%  Similarity=0.213  Sum_probs=79.9

Q ss_pred             CCcccCeeeccccccCCc--------ccCeEEcCCCc-ccccCCccccCCCccceecccccccccCCCccccCCCCCCeE
Q 040294           25 NLTALRNLHLDSNELRHL--------VLTRTDFSRNN-LLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESL   95 (360)
Q Consensus        25 ~l~~L~~L~l~~N~l~~~--------~L~~l~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l   95 (360)
                      .+.....++.+++.+...        .|+.|++++|+ ++...+.+|.++++|+.|+|++|+|+...|..|..+++|++|
T Consensus         6 ~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L   85 (156)
T d2ifga3           6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL   85 (156)
T ss_dssp             CCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred             CcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence            344556677777766542        58899998765 887777889999999999999999998778899999999999


Q ss_pred             eCcCCccCcccchhhhccccccccCCCCCCCCcccccccCCCCCCC
Q 040294           96 DLSNNNLSEIIPLSLEKLLLEGEIPRGGPFTKFSSKSFIGNDLLCG  141 (360)
Q Consensus        96 ~ls~N~l~~~~p~~l~~l~~~~~~p~~~~~~~~~~~~~~~n~~~cg  141 (360)
                      +|++|+|+.+.+..+..+             .+....+.+|+.-|.
T Consensus        86 ~Ls~N~l~~l~~~~~~~~-------------~l~~L~L~~Np~~C~  118 (156)
T d2ifga3          86 NLSFNALESLSWKTVQGL-------------SLQELVLSGNPLHCS  118 (156)
T ss_dssp             ECCSSCCSCCCSTTTCSC-------------CCCEEECCSSCCCCC
T ss_pred             eccCCCCcccChhhhccc-------------cccccccCCCcccCC
Confidence            999999997665554332             233456677776553

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.95  E-value=7.8e-10  Score=101.70  Aligned_cols=76  Identities=28%  Similarity=0.483  Sum_probs=66.9

Q ss_pred             cccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecccccccccCCCccccCCCCCCe
Q 040294           22 CFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLES   94 (360)
Q Consensus        22 ~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~   94 (360)
                      .+..+++++.|++++|+++++       .|+.|++++|++++ +| .++++++|++|+|++|++++..|  +.++++|+.
T Consensus       302 ~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~  377 (384)
T d2omza2         302 PISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQ  377 (384)
T ss_dssp             GGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSE
T ss_pred             ccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCE
Confidence            466778899999999999885       58999999999986 44 69999999999999999997654  899999999


Q ss_pred             EeCcCCc
Q 040294           95 LDLSNNN  101 (360)
Q Consensus        95 l~ls~N~  101 (360)
                      |+|++|.
T Consensus       378 L~L~~Na  384 (384)
T d2omza2         378 LGLNDQA  384 (384)
T ss_dssp             EECCCEE
T ss_pred             eeCCCCc
Confidence            9999983

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.91  E-value=1.8e-09  Score=90.73  Aligned_cols=98  Identities=23%  Similarity=0.374  Sum_probs=81.4

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +.+|+.|++++|.++. ++ .+..+++|++|++++|+++.+       .|+.|++++|.+.. +| .+.++++|+.|+++
T Consensus        39 l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~  114 (199)
T d2omxa2          39 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLF  114 (199)
T ss_dssp             HTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECC
T ss_pred             hcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCcccccCCccccccccccccccc-cc-cccccccccccccc
Confidence            4678999999999984 44 478899999999999998874       58999999998875 33 48899999999999


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      +|.+...  ..+..+++|+.|++++|++...
T Consensus       115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~  143 (199)
T d2omxa2         115 NNQITDI--DPLKNLTNLNRLELSSNTISDI  143 (199)
T ss_dssp             SSCCCCC--GGGTTCTTCSEEECCSSCCCCC
T ss_pred             ccccccc--cccchhhhhHHhhhhhhhhccc
Confidence            9998743  3578899999999999998764

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.89  E-value=1.6e-09  Score=91.83  Aligned_cols=99  Identities=28%  Similarity=0.401  Sum_probs=85.8

Q ss_pred             CCCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceecc
Q 040294            1 YLAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSL   73 (360)
Q Consensus         1 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l   73 (360)
                      .+++|+.|++++|+|++ +| .+.++++|+.|++++|.+..+       .++.++++.|.++.  +..+..+++|+.+++
T Consensus        88 ~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l  163 (210)
T d1h6ta2          88 NLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSL  163 (210)
T ss_dssp             TCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEEC
T ss_pred             cCccccccccccccccc-cc-cccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccc
Confidence            36889999999999985 55 589999999999999987764       58999999999975  446788999999999


Q ss_pred             cccccccCCCccccCCCCCCeEeCcCCccCcc
Q 040294           74 GHNRLQGSIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        74 ~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ++|++++ +++ ++++++|+.|+|++|+++.+
T Consensus       164 ~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~~l  193 (210)
T d1h6ta2         164 EDNQISD-IVP-LAGLTKLQNLYLSKNHISDL  193 (210)
T ss_dssp             CSSCCCC-CGG-GTTCTTCCEEECCSSCCCBC
T ss_pred             ccccccc-ccc-ccCCCCCCEEECCCCCCCCC
Confidence            9999995 443 89999999999999999864

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=1.6e-09  Score=93.54  Aligned_cols=37  Identities=19%  Similarity=0.268  Sum_probs=28.2

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeecccccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNEL   39 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l   39 (360)
                      ++++.|+|++|+|+...+..|.++++|++|++++|.+
T Consensus        29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~   65 (242)
T d1xwdc1          29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV   65 (242)
T ss_dssp             SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTT
T ss_pred             CCCCEEECcCCcCCccChhHhhccchhhhhhhccccc
Confidence            3678888888888755555688888888888888754

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.83  E-value=8.1e-11  Score=99.31  Aligned_cols=94  Identities=23%  Similarity=0.229  Sum_probs=78.3

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCC-ccccCCCccceecc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIP-TTIQGLKSLQFLSL   73 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p-~~~~~l~~L~~L~l   73 (360)
                      +++|+.|+|++|+|+ .+|..+..+.+|+.|++++|.++.+       .|+.|++++|+++.... ..+..+++|+.|+|
T Consensus        69 l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L  147 (198)
T d1m9la_          69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLL  147 (198)
T ss_dssp             HTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCHHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEE
T ss_pred             CccccChhhcccccc-cccccccccccccccccccccccccccccccccccccccccchhccccccccccCCCccceeec
Confidence            578999999999998 5776666778899999999999875       59999999999985422 46889999999999


Q ss_pred             cccccccCCCcc----------ccCCCCCCeEe
Q 040294           74 GHNRLQGSIPNS----------FDDLVSLESLD   96 (360)
Q Consensus        74 ~~N~l~g~~p~~----------~~~l~~L~~l~   96 (360)
                      ++|++....+..          +..+++|+.||
T Consensus       148 ~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         148 AGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             CSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             CCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            999998554432          56788999887

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.70  E-value=2.6e-08  Score=89.79  Aligned_cols=95  Identities=26%  Similarity=0.409  Sum_probs=78.9

Q ss_pred             CCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-----ccCeEEcCCCcccccCCccccCCCccceecccccc
Q 040294            3 AALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNR   77 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-----~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   77 (360)
                      .+|+.|||++|.|+ .+|+.   .++|++|+|++|+|+.+     +|+.|++++|+++. ++. +  .+.|++|++++|.
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~~~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L~~n~  109 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKA-LSD-L--PPLLEYLGVSNNQ  109 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CCS-C--CTTCCEEECCSSC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccchhhhhhhhhhhcccch-hhh-h--ccccccccccccc
Confidence            36899999999998 57864   46799999999999976     69999999999873 342 1  2469999999999


Q ss_pred             cccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           78 LQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        78 l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      ++ .+|. ++.+++|+.|++++|.++...+
T Consensus       110 l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~  137 (353)
T d1jl5a_         110 LE-KLPE-LQNSSFLKIIDVDNNSLKKLPD  137 (353)
T ss_dssp             CS-SCCC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred             cc-cccc-hhhhccceeecccccccccccc
Confidence            98 6775 6889999999999999987654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.68  E-value=1.7e-08  Score=86.31  Aligned_cols=100  Identities=24%  Similarity=0.384  Sum_probs=84.3

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-------ccCeEEcCCCcccccCCccccCCCccceeccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-------VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLG   74 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-------~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~   74 (360)
                      +++|+.+++++|...+..  .+...+.+..+.++.+.+...       .|+.|++++|.++..  ..++++++|+.|+|+
T Consensus       106 l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls  181 (227)
T d1h6ua2         106 LQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKAD  181 (227)
T ss_dssp             CTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECC
T ss_pred             cccccccccccccccccc--hhccccchhhhhchhhhhchhhhhccccccccccccccccccc--hhhcccccceecccC
Confidence            678999999999987543  366788899999999888653       589999999998754  348899999999999


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      +|++++ +|. |..+++|++|+|++|+++++.|
T Consensus       182 ~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i~~  212 (227)
T d1h6ua2         182 DNKISD-ISP-LASLPNLIEVHLKNNQISDVSP  212 (227)
T ss_dssp             SSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGG
T ss_pred             CCccCC-Chh-hcCCCCCCEEECcCCcCCCCcc
Confidence            999985 543 8999999999999999998655

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.49  E-value=6e-07  Score=80.57  Aligned_cols=73  Identities=27%  Similarity=0.396  Sum_probs=62.0

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccccccCCc-----ccCeEEcCCCcccccCCccccCCCccceeccccc
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL-----VLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHN   76 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-----~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N   76 (360)
                      +++|+.|+|++|+|+ .+|..+   .+|+.|++++|+++.+     .|++|++++|.+. .+|. ++.+++|+.|++++|
T Consensus        57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l~~lp~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~  130 (353)
T d1jl5a_          57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNN  130 (353)
T ss_dssp             CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSS
T ss_pred             CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchhhhhccccccccccccccc-cccc-hhhhccceeeccccc
Confidence            367999999999999 788764   4788889999988875     4899999999998 4564 688999999999999


Q ss_pred             cccc
Q 040294           77 RLQG   80 (360)
Q Consensus        77 ~l~g   80 (360)
                      .++.
T Consensus       131 ~~~~  134 (353)
T d1jl5a_         131 SLKK  134 (353)
T ss_dssp             CCSC
T ss_pred             cccc
Confidence            9874

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.48  E-value=7.5e-08  Score=82.66  Aligned_cols=99  Identities=22%  Similarity=0.309  Sum_probs=82.6

Q ss_pred             cEeeCCCCcccccCCccccCCcccCeeeccccccCCc---------ccCeEEcCCCcccccCC-ccccCCCccceeccc-
Q 040294            6 FQLDLRGNKLSGSIPTCFSNLTALRNLHLDSNELRHL---------VLTRTDFSRNNLLGDIP-TTIQGLKSLQFLSLG-   74 (360)
Q Consensus         6 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---------~L~~l~l~~N~l~~~~p-~~~~~l~~L~~L~l~-   74 (360)
                      +.++.+++.++ .+|+.+.  +++++|+|++|.++.+         +|+.|++++|.+...+| ..|.++++++++.+. 
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            57888888898 7887764  5799999999998754         58999999999987654 468899999999875 


Q ss_pred             ccccccCCCccccCCCCCCeEeCcCCccCcccc
Q 040294           75 HNRLQGSIPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        75 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      .|.+....|..|.++++|+.|++++|.+....+
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~  120 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD  120 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCC
T ss_pred             cccccccccccccccccccccccchhhhccccc
Confidence            578887778889999999999999999976544

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.29  E-value=1.2e-07  Score=76.60  Aligned_cols=77  Identities=27%  Similarity=0.318  Sum_probs=49.9

Q ss_pred             cCCccccCCcccCeeeccccccCCcccCeEEcCCCcccccCCccccCCCccceecccccccccCCCccccCCCCCCeEeC
Q 040294           18 SIPTCFSNLTALRNLHLDSNELRHLVLTRTDFSRNNLLGDIPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDL   97 (360)
Q Consensus        18 ~~p~~~~~l~~L~~L~l~~N~l~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l   97 (360)
                      .++..+..+++|+.|+|++|+|+.+.             .++..+..+++|+.|+|++|.++..-+..+....+|+.|+|
T Consensus        56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~-------------~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L  122 (162)
T d1koha1          56 TLRIIEENIPELLSLNLSNNRLYRLD-------------DMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL  122 (162)
T ss_dssp             HHHHHHHHCTTCCCCCCCSSCCCCCS-------------GGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCC
T ss_pred             hhHHHHHhCCCCCEeeCCCccccCCc-------------hhHHHHhhCCcccccccccCccccchhhhhhhccccceeec
Confidence            34444456888888888888876541             22344567777888888888877332223334456777888


Q ss_pred             cCCccCcccc
Q 040294           98 SNNNLSEIIP  107 (360)
Q Consensus        98 s~N~l~~~~p  107 (360)
                      ++|+++....
T Consensus       123 ~~Npl~~~~~  132 (162)
T d1koha1         123 DGNSLSDTFR  132 (162)
T ss_dssp             TTSTTSSSSS
T ss_pred             CCCCcCcCcc
Confidence            8887776544

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.24  E-value=1e-07  Score=77.04  Aligned_cols=51  Identities=24%  Similarity=0.272  Sum_probs=40.8

Q ss_pred             cCCccccCCCccceecccccccccC--CCccccCCCCCCeEeCcCCccCcccc
Q 040294           57 DIPTTIQGLKSLQFLSLGHNRLQGS--IPNSFDDLVSLESLDLSNNNLSEIIP  107 (360)
Q Consensus        57 ~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~l~ls~N~l~~~~p  107 (360)
                      .++..+..+++|++|+|++|+|+..  ++..+..+++|+.|||++|.++...+
T Consensus        56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~  108 (162)
T d1koha1          56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE  108 (162)
T ss_dssp             HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGG
T ss_pred             hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchh
Confidence            3444456789999999999999853  34557889999999999999997644

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.24  E-value=4.6e-08  Score=91.21  Aligned_cols=103  Identities=24%  Similarity=0.303  Sum_probs=80.2

Q ss_pred             CCCcEeeCCCCccccc-CCccccCCcccCeeeccccccCC-------------cccCeEEcCCCccccc----CCcccc-
Q 040294            3 AALFQLDLRGNKLSGS-IPTCFSNLTALRNLHLDSNELRH-------------LVLTRTDFSRNNLLGD----IPTTIQ-   63 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~-------------~~L~~l~l~~N~l~~~----~p~~~~-   63 (360)
                      .+|+.|||++|+++.. +..-+..+++|+.|+|++|.++.             -.|+.|+|++|+|+..    +...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            4689999999999863 23446778999999999998873             1599999999998521    222232 


Q ss_pred             CCCccceecccccccccC----CCccccCCCCCCeEeCcCCccCcc
Q 040294           64 GLKSLQFLSLGHNRLQGS----IPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        64 ~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ...+|+.|+|++|+++..    ++..+..+++|++|+|++|.++..
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~  127 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA  127 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhh
Confidence            235799999999999743    466788999999999999998754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.24  E-value=4.1e-06  Score=72.24  Aligned_cols=138  Identities=15%  Similarity=0.135  Sum_probs=87.9

Q ss_pred             HHHHHhCCCCCCCeeccCCCccEEEEEccCCcEEEehh-----------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEE
Q 040294          194 ELLRATNGFSANNLIGRGSFGSVYKARLQDGMEFAIKS-----------FDVECEVMKSIH-HRNLVKIISSCSNEDFRA  261 (360)
Q Consensus       194 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vavK~-----------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~  261 (360)
                      ++.+....|+..+..+-++.+.||+.... ++.+.+|.           +..|...++.+. +--+.+++.++..++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            33344445544333222334579987654 45556652           467888776654 333567788888888999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------
Q 040294          262 LVLEYMTNGSLEKVLYSSNCILDILQRLNIMINVTSALEYLHFGF-----------------------------------  306 (360)
Q Consensus       262 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~-----------------------------------  306 (360)
                      +||++++|.++.+......      ....++.++++.++.||...                                   
T Consensus        87 lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            9999999988865432211      12224455555555555210                                   


Q ss_pred             ---------------------CCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          307 ---------------------STPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       307 ---------------------~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                                           ...++|+|+.|.||++++++.+-|.||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 11278999999999999877777999988765

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.18  E-value=7.2e-07  Score=78.65  Aligned_cols=109  Identities=25%  Similarity=0.296  Sum_probs=71.4

Q ss_pred             CCCCcEeeCCCCcccccCCccccCCcccCeeeccc-cccCC----------cccCeEEcCCC-c----------------
Q 040294            2 LAALFQLDLRGNKLSGSIPTCFSNLTALRNLHLDS-NELRH----------LVLTRTDFSRN-N----------------   53 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~~----------~~L~~l~l~~N-~----------------   53 (360)
                      +++|+.|+|+++.++...+..++.+++|+.|++++ +.++.          -.|+.|+++++ +                
T Consensus        70 c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~  149 (284)
T d2astb2          70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET  149 (284)
T ss_dssp             BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred             CCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence            56777777777777766666677777777777776 34432          03555555542 1                


Q ss_pred             ------------ccc-cCCccccCCCccceeccccc-ccccCCCccccCCCCCCeEeCcC-CccCcccchhh
Q 040294           54 ------------LLG-DIPTTIQGLKSLQFLSLGHN-RLQGSIPNSFDDLVSLESLDLSN-NNLSEIIPLSL  110 (360)
Q Consensus        54 ------------l~~-~~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~l~ls~-N~l~~~~p~~l  110 (360)
                                  ++. .+..-+..+++|+.|+|++| .+++.....+.++++|++|+|++ +.++......+
T Consensus       150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L  221 (284)
T d2astb2         150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL  221 (284)
T ss_dssp             CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGG
T ss_pred             cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHH
Confidence                        111 11112346789999999886 57777778899999999999999 56765443333

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.06  E-value=3.3e-06  Score=72.49  Aligned_cols=65  Identities=12%  Similarity=0.124  Sum_probs=47.6

Q ss_pred             eccCCC-ccEEEEEccCCcEEEeh--------hhHHHHHHhhcCCC--CCeeEEEEEecCCCeEEEEEEccCCCCH
Q 040294          208 IGRGSF-GSVYKARLQDGMEFAIK--------SFDVECEVMKSIHH--RNLVKIISSCSNEDFRALVLEYMTNGSL  272 (360)
Q Consensus       208 iG~G~~-g~Vy~~~~~~~~~vavK--------~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L  272 (360)
                      +..|.. +.||+....++..+.+|        .+..|+..++.+..  -.+.+++.++.+++..++||||++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344443 57899888777778877        35678887776543  3356778888888889999999988654

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.97  E-value=3.3e-07  Score=85.15  Aligned_cols=104  Identities=25%  Similarity=0.246  Sum_probs=68.0

Q ss_pred             CCCCcEeeCCCCcccccCCccc-----cCCcccCeeeccccccCCc-------------ccCeEEcCCCccccc----CC
Q 040294            2 LAALFQLDLRGNKLSGSIPTCF-----SNLTALRNLHLDSNELRHL-------------VLTRTDFSRNNLLGD----IP   59 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~~p~~~-----~~l~~L~~L~l~~N~l~~~-------------~L~~l~l~~N~l~~~----~p   59 (360)
                      ++.+..+++++|.++..-...+     ...+.|+.+++++|.++..             .|+.|+|++|+++..    ++
T Consensus       282 ~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~  361 (460)
T d1z7xw1         282 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC  361 (460)
T ss_dssp             CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhh
Confidence            3567788888888763211111     2345678888888877541             478888888887542    33


Q ss_pred             cccc-CCCccceeccccccccc----CCCccccCCCCCCeEeCcCCccCcc
Q 040294           60 TTIQ-GLKSLQFLSLGHNRLQG----SIPNSFDDLVSLESLDLSNNNLSEI  105 (360)
Q Consensus        60 ~~~~-~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~l~ls~N~l~~~  105 (360)
                      ..+. ....|+.|+|++|.|+.    .++..+..+++|++|||++|+|+..
T Consensus       362 ~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~  412 (460)
T d1z7xw1         362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  412 (460)
T ss_dssp             HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             hhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence            3343 35668888888888863    2445566678888888888888754

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.92  E-value=1.2e-06  Score=79.23  Aligned_cols=102  Identities=20%  Similarity=0.271  Sum_probs=58.3

Q ss_pred             CCCcEeeCCCCccccc----CCccccCCcccCeeeccccccCC----------c----ccCeEEcCCCccccc----CCc
Q 040294            3 AALFQLDLRGNKLSGS----IPTCFSNLTALRNLHLDSNELRH----------L----VLTRTDFSRNNLLGD----IPT   60 (360)
Q Consensus         3 ~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~----------~----~L~~l~l~~N~l~~~----~p~   60 (360)
                      +.|+.+++++|+++-.    +...+..++.|+.|+|++|.++.          +    .|+.|++++|.++..    +..
T Consensus       158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~  237 (344)
T d2ca6a1         158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  237 (344)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence            4566777777766521    22234456667777777776542          0    366677777766432    334


Q ss_pred             cccCCCccceecccccccccCCC----ccccC--CCCCCeEeCcCCccCc
Q 040294           61 TIQGLKSLQFLSLGHNRLQGSIP----NSFDD--LVSLESLDLSNNNLSE  104 (360)
Q Consensus        61 ~~~~l~~L~~L~l~~N~l~g~~p----~~~~~--l~~L~~l~ls~N~l~~  104 (360)
                      .+..+++|++|+|++|.+++.-.    ..+..  ...|++||+++|+++.
T Consensus       238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~  287 (344)
T d2ca6a1         238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL  287 (344)
T ss_dssp             HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence            45566777777777777653211    11222  2457777777776654

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.90  E-value=1.1e-06  Score=79.31  Aligned_cols=103  Identities=22%  Similarity=0.276  Sum_probs=68.5

Q ss_pred             CCCCcEeeCCCCccccc----CCccccCCcccCeeeccccccCC----------------------cccCeEEcCCCccc
Q 040294            2 LAALFQLDLRGNKLSGS----IPTCFSNLTALRNLHLDSNELRH----------------------LVLTRTDFSRNNLL   55 (360)
Q Consensus         2 l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~----------------------~~L~~l~l~~N~l~   55 (360)
                      .++|+.|+|++|.++..    +...+..+++|+.|++++|.+..                      ..|+.+++++|+++
T Consensus        92 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~  171 (344)
T d2ca6a1          92 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE  171 (344)
T ss_dssp             CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred             CCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccc
Confidence            35688888888887653    22334566778888888886532                      13667777777765


Q ss_pred             c----cCCccccCCCccceecccccccccC-----CCccccCCCCCCeEeCcCCccCc
Q 040294           56 G----DIPTTIQGLKSLQFLSLGHNRLQGS-----IPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        56 ~----~~p~~~~~l~~L~~L~l~~N~l~g~-----~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      .    .+...+..++.|++|+|++|+++..     +...+..+++|+.|+|++|+++.
T Consensus       172 ~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~  229 (344)
T d2ca6a1         172 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH  229 (344)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHH
T ss_pred             ccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccc
Confidence            2    1223345677888888888887631     33456777888888888888754

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.47  E-value=1.8e-05  Score=63.61  Aligned_cols=100  Identities=12%  Similarity=0.110  Sum_probs=57.1

Q ss_pred             CCCCcEeeCCCC-ccccc----CCccccCCcccCeeeccccccCCc-------------ccCeEEcCCCccccc----CC
Q 040294            2 LAALFQLDLRGN-KLSGS----IPTCFSNLTALRNLHLDSNELRHL-------------VLTRTDFSRNNLLGD----IP   59 (360)
Q Consensus         2 l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~-------------~L~~l~l~~N~l~~~----~p   59 (360)
                      .++|+.|+|+++ .++..    +-..+...+.|+.|+|++|.+..-             .|+.|+|++|.++..    +-
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~   93 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL   93 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence            367889999874 45421    222456677788888888877531             366666666666532    11


Q ss_pred             ccccCCCccceecccccccccC-------CCccccCCCCCCeEeCcCCc
Q 040294           60 TTIQGLKSLQFLSLGHNRLQGS-------IPNSFDDLVSLESLDLSNNN  101 (360)
Q Consensus        60 ~~~~~l~~L~~L~l~~N~l~g~-------~p~~~~~l~~L~~l~ls~N~  101 (360)
                      ..+...++|++|+|++|.+...       +-..+..-++|+.|+++.+.
T Consensus        94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            2344455666666666654311       22233344566666665553

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.36  E-value=4e-05  Score=67.03  Aligned_cols=56  Identities=27%  Similarity=0.281  Sum_probs=24.4

Q ss_pred             cCeEEcCCCccccc-CCccccCCCccceecccccccccCCCccccCCCCCCeEeCcC
Q 040294           44 LTRTDFSRNNLLGD-IPTTIQGLKSLQFLSLGHNRLQGSIPNSFDDLVSLESLDLSN   99 (360)
Q Consensus        44 L~~l~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~ls~   99 (360)
                      |++||++++.++.. ++.-+..+++|++|+|+++.+++..+..+..+++|++|+|++
T Consensus        48 L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~  104 (284)
T d2astb2          48 VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG  104 (284)
T ss_dssp             CCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred             CCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence            44444444444322 122234444444444444444444444444444444444444

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.33  E-value=0.00021  Score=65.30  Aligned_cols=64  Identities=17%  Similarity=0.229  Sum_probs=42.6

Q ss_pred             CeeccCCCccEEEEEccC-CcEEEehh------------------hHHHHHHhhcCC---CCCeeEEEEEecCCCeEEEE
Q 040294          206 NLIGRGSFGSVYKARLQD-GMEFAIKS------------------FDVECEVMKSIH---HRNLVKIISSCSNEDFRALV  263 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~-~~~vavK~------------------~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv  263 (360)
                      +.||.|....||+....+ ++.+.||.                  ...|.+.++.+.   ...+.+++.+..+  ..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--MAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--TTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC--CCEEE
Confidence            468999999999998654 56777761                  234777776542   2456677766544  45789


Q ss_pred             EEccCCCC
Q 040294          264 LEYMTNGS  271 (360)
Q Consensus       264 ~e~~~~g~  271 (360)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99998743

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.55  E-value=0.00031  Score=55.84  Aligned_cols=101  Identities=14%  Similarity=0.139  Sum_probs=67.2

Q ss_pred             CCCCcEeeCCC-Cccccc----CCccccCCcccCeeeccccccCCc-------------ccCeEEcCCCccccc----CC
Q 040294            2 LAALFQLDLRG-NKLSGS----IPTCFSNLTALRNLHLDSNELRHL-------------VLTRTDFSRNNLLGD----IP   59 (360)
Q Consensus         2 l~~L~~L~L~~-N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~-------------~L~~l~l~~N~l~~~----~p   59 (360)
                      .++|+.|+|++ |.++..    +-..+...++|+.|++++|.++.-             .++.+++++|.+...    +-
T Consensus        16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~   95 (166)
T d1io0a_          16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV   95 (166)
T ss_dssp             CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred             CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence            46789999987 556522    222355778899999999987641             578888888887542    22


Q ss_pred             ccccCCCcccee--ccccccccc----CCCccccCCCCCCeEeCcCCcc
Q 040294           60 TTIQGLKSLQFL--SLGHNRLQG----SIPNSFDDLVSLESLDLSNNNL  102 (360)
Q Consensus        60 ~~~~~l~~L~~L--~l~~N~l~g----~~p~~~~~l~~L~~l~ls~N~l  102 (360)
                      ..+...++|+.+  +++.|.+..    .+-..+...++|+.|+++.|+.
T Consensus        96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            345667777764  445667642    2344566778888888877654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.43  E-value=0.00065  Score=54.09  Aligned_cols=81  Identities=15%  Similarity=0.163  Sum_probs=58.2

Q ss_pred             cCCcccCeeecccc-ccCC-------------cccCeEEcCCCccccc----CCccccCCCccceecccccccccC----
Q 040294           24 SNLTALRNLHLDSN-ELRH-------------LVLTRTDFSRNNLLGD----IPTTIQGLKSLQFLSLGHNRLQGS----   81 (360)
Q Consensus        24 ~~l~~L~~L~l~~N-~l~~-------------~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~----   81 (360)
                      .+.++|+.|+|+++ .++.             -.|+.|+|++|.+...    +-..+...+.|+.|+|++|.++..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45688999999874 4643             1588999999988632    222345678899999999998732    


Q ss_pred             CCccccCCCCCCeEeCcCCccCc
Q 040294           82 IPNSFDDLVSLESLDLSNNNLSE  104 (360)
Q Consensus        82 ~p~~~~~l~~L~~l~ls~N~l~~  104 (360)
                      +=..+...++|++|+|++|.+..
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~  114 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSV  114 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCC
T ss_pred             HHHHHHhCCcCCEEECCCCcCCC
Confidence            12346667889999999987654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.74  E-value=0.0089  Score=54.00  Aligned_cols=63  Identities=16%  Similarity=0.201  Sum_probs=41.1

Q ss_pred             CeeccCCCccEEEEEccCC--------cEEEehh---------hHHHHHHhhcCC-CCCeeEEEEEecCCCeEEEEEEcc
Q 040294          206 NLIGRGSFGSVYKARLQDG--------MEFAIKS---------FDVECEVMKSIH-HRNLVKIISSCSNEDFRALVLEYM  267 (360)
Q Consensus       206 ~~iG~G~~g~Vy~~~~~~~--------~~vavK~---------~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~  267 (360)
                      +.|+-|-.-.+|+.+..++        ..|.++.         ..+|..+++.+. +.-..+++++|..    .+||||+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi  123 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  123 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence            4577777778999876432        3454432         346877777665 3334578888764    6899999


Q ss_pred             CCCCH
Q 040294          268 TNGSL  272 (360)
Q Consensus       268 ~~g~L  272 (360)
                      +|..+
T Consensus       124 ~g~~l  128 (395)
T d1nw1a_         124 PSRPL  128 (395)
T ss_dssp             CEEEC
T ss_pred             ccccC
Confidence            87543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.23  E-value=0.023  Score=49.73  Aligned_cols=57  Identities=14%  Similarity=0.180  Sum_probs=36.6

Q ss_pred             ccEEEEEccCCcEEEehh----------hHHHHHHhhcCCCCCe--eEEE-----EEecCCCeEEEEEEccCCC
Q 040294          214 GSVYKARLQDGMEFAIKS----------FDVECEVMKSIHHRNL--VKII-----SSCSNEDFRALVLEYMTNG  270 (360)
Q Consensus       214 g~Vy~~~~~~~~~vavK~----------~~~E~~~l~~l~hpni--v~l~-----~~~~~~~~~~lv~e~~~~g  270 (360)
                      -.||+.+..+|+.|++|.          +..|.+.+..+....+  +...     ..+..++..+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            369999999999999983          4567777765542222  1111     1123455678899999873

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.98  E-value=0.048  Score=47.10  Aligned_cols=33  Identities=30%  Similarity=0.369  Sum_probs=28.7

Q ss_pred             CCCCeEEccCCCCceeecCCCcEEEeecccccc
Q 040294          306 FSTPIIHCDLKPHNVLLDDNIVAHLSDFGIAKL  338 (360)
Q Consensus       306 ~~~~iiHrdlk~~NiLl~~~~~~ki~DFGla~~  338 (360)
                      ...++||+|+.+.||+++++...-|.||+.+..
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCcchhhhhcccccceeEeccccccc
Confidence            356899999999999999888778999998753

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=92.17  E-value=0.02  Score=44.69  Aligned_cols=82  Identities=15%  Similarity=0.205  Sum_probs=53.6

Q ss_pred             ccCCcccCeeeccc-cccCC-------------cccCeEEcCCCcccccCC----ccccCCCccceecccccccccC---
Q 040294           23 FSNLTALRNLHLDS-NELRH-------------LVLTRTDFSRNNLLGDIP----TTIQGLKSLQFLSLGHNRLQGS---   81 (360)
Q Consensus        23 ~~~l~~L~~L~l~~-N~l~~-------------~~L~~l~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~g~---   81 (360)
                      ..+.++|+.|+|++ |.++.             ..|+.|++++|.++..--    ..+...++++.+++++|.+...   
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~   92 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL   92 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence            35678899999987 45643             147888888888764322    2345567888888888887622   


Q ss_pred             -CCccccCCCCCCeEeC--cCCccCc
Q 040294           82 -IPNSFDDLVSLESLDL--SNNNLSE  104 (360)
Q Consensus        82 -~p~~~~~l~~L~~l~l--s~N~l~~  104 (360)
                       +-..+...++|+.++|  ++|++..
T Consensus        93 ~l~~~l~~~~~L~~l~L~l~~n~i~~  118 (166)
T d1io0a_          93 ALVEALQSNTSLIELRIDNQSQPLGN  118 (166)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHHHHHhCccccEEeeccCCCcCcH
Confidence             2245666778876555  4566643